Citrus Sinensis ID: 016037

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390------
Protein Sequence
MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPLLSR
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEcccccEEEEEEEcccccEEEEEEccHHHHHHHHHHHHHHHHHHHHHHccccEEEcccEEEcccccEEEEEEEccccHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccEEEEcccccccccccccccccccccccccHHHcccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccHHHHHHHHHHHHccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccEEEcccccccccccccEEcccccccccccccccccccccccccccccccccEEEccccccEEEccccccccHHHHHHHHHHHHHHHHHHHHHcHHHccccccccccccccccccccccccccccccccHHHEEEEEEEEEEccEEEEEEEEccccEEEEEEEEEHHHHHHcccHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEccccEcEccccccHHHccHHHHccccEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHccccccccccccHHHHHHHHHHcccccccHHHHHc
Coil and Loop (DISEMBL)
mvssqlsslngdcagkpflnqlllprgppdalssdyvefdfsdvfgpapvqasieVGGEISyanelvydqpavihsrshslvgpssyvsqslklSKLTLHEAEdslglvegineetqegpnnlSVVDAalgkptghidnlpsenqcvgledfEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSErniltkvdhpfIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLhangimhrdlkpenilldadghvmltdfglakqfdentrsnsmcgtleymspeivlgkghdkaaDWWSVGILLFEMltgqppftggnrQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPLLSR
Flexible Loop (DISEMBL)
mvssqlsslngdcAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGafakvyqvrrigtseiyamkvmRKDKIMEKNHAEYMKSerniltkvdhpfIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSllkgvnsllsisvpllsr
Low Complexity Region (SEG)
MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRqkiqqkiikdkikLPAFLSSEAHSLLKGVNSLLSISVPLLSR
Disordered region (IsUnstruct)
****************PFLNQLLLPR****ALSSDYVEFDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHSR****************************************************L****GHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSIS******
Disordered Region (DISOPRED)
*********************************SDYVEFDFSDVFGPAP***************ELVYDQ**V*****************************************************************************DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPL***
Disordered Region (DISEMBL)
*********NGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHS***************LKLSKLTLHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPLLSR
Disordered Region (DISPRO)
*************AGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGIN********************************CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSI*******
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPLLSR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	396	2.2.26 [Sep-21-2011]
Q39030	471	Serine/threonine-protein	yes	no	0.931	0.783	0.695	1e-150
P42818	465	Serine/threonine-protein	no	no	0.919	0.782	0.671	1e-136
P28178	479	Protein kinase 2 OS=Dicty	yes	no	0.603	0.498	0.531	1e-74
P54644	444	RAC family serine/threoni	no	no	0.608	0.542	0.506	2e-70
Q6TJY3	527	Ribosomal protein S6 kina	yes	no	0.585	0.440	0.527	6e-70
P23443	525	Ribosomal protein S6 kina	yes	no	0.585	0.441	0.527	6e-70
P67999	525	Ribosomal protein S6 kina	yes	no	0.585	0.441	0.527	6e-70
P67998	525	Ribosomal protein S6 kina	yes	no	0.585	0.441	0.527	6e-70
Q8BSK8	525	Ribosomal protein S6 kina	yes	no	0.585	0.441	0.527	7e-70
Q9UBS0	482	Ribosomal protein S6 kina	no	no	0.654	0.537	0.479	3e-69

>sp|Q39030|KPK2_ARATH Serine/threonine-protein kinase AtPK2/AtPK19 OS=Arabidopsis thaliana GN=ATPK2 PE=1 SV=2

 Score =  531 bits (1369), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 267/384 (69%), Positives = 306/384 (79%), Gaps = 15/384 (3%)

Query: 1   MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEI 60
           MVSSQ S  N +  GKPF   L L   PP ++  D +E  FSDVFGP P   S E     
Sbjct: 1   MVSSQCSVANKNQTGKPFQKHLSLSISPPKSVLGDNLELQFSDVFGPMPEANSEE----- 55

Query: 61  SYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGP 120
             A ++ YD+PAV++SRSHSLVGPS  VS SLK++KLTL E EDS+ LVE +  E+ +  
Sbjct: 56  --ACDVAYDEPAVVYSRSHSLVGPSLVVSHSLKMNKLTLRETEDSVDLVECVEGESIKEN 113

Query: 121 NNLSVVDAALGKPTGHIDNLPSE-NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYA 179
           +  S      G      +  P E +  VG+EDFEVLKVVGQGAF KVYQVR+  TSEIYA
Sbjct: 114 DEFS------GNDDTDSEKSPEEVSGVVGIEDFEVLKVVGQGAFGKVYQVRKKDTSEIYA 167

Query: 180 MKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFF 239
           MKVMRKDKI+EKNHAEYMK+ER+ILTK+DHPFIVQL+YSFQTKYRLYLVLDF+NGGHLFF
Sbjct: 168 MKVMRKDKIVEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFF 227

Query: 240 QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ 299
           QLY QGLFREDLAR+YTAEIVSAVSHLH  GIMHRDLKPENIL+D DGHVMLTDFGLAK+
Sbjct: 228 QLYHQGLFREDLARVYTAEIVSAVSHLHEKGIMHRDLKPENILMDVDGHVMLTDFGLAKE 287

Query: 300 FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ 359
           F+ENTRSNSMCGT EYM+PEIV GKGHDKAADWWSVGILL+EMLTG+PPF  G++ KIQQ
Sbjct: 288 FEENTRSNSMCGTTEYMAPEIVRGKGHDKAADWWSVGILLYEMLTGKPPFL-GSKGKIQQ 346

Query: 360 KIIKDKIKLPAFLSSEAHSLLKGV 383
           KI+KDKIKLP FLS+EAH+LLKG+
Sbjct: 347 KIVKDKIKLPQFLSNEAHALLKGL 370

Downstream effector of TOR signaling pathway. May be involved in adaptation of plant to cold or high-salt conditions.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P42818|KPK1_ARATH Serine/threonine-protein kinase AtPK1/AtPK6 OS=Arabidopsis thaliana GN=ATPK1 PE=1 SV=1

 Score =  486 bits (1250), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 257/383 (67%), Positives = 301/383 (78%), Gaps = 19/383 (4%)

Query: 1   MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEI 60
           MVSSQ    N          Q  L   P +++  D VE +FSDVFGP P +A        
Sbjct: 1   MVSSQRPVPN------KIQKQQYLSISPSNSVLKDDVELEFSDVFGPLPEEA-------- 46

Query: 61  SYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGP 120
              N++ YD+PAV++SRSHSLVGP S  S SLKL+KLTL E EDS+ LVE +  E+ +  
Sbjct: 47  ---NDIAYDEPAVVYSRSHSLVGPCSLDSHSLKLTKLTLLETEDSIDLVECLEGESLKEN 103

Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           ++ S  D +  +     D L   +  VG++DFEV+KVVG+GAF KVYQVR+  TSEIYAM
Sbjct: 104 DDFSGNDDSDNEKALEGD-LVKVSGVVGIDDFEVMKVVGKGAFGKVYQVRKKETSEIYAM 162

Query: 181 KVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQ 240
           KVMRKD IMEKNHAEYMK+ER+ILTK+DHPFIVQL+YSFQTKYRLYLVLDF+NGGHLFFQ
Sbjct: 163 KVMRKDHIMEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFFQ 222

Query: 241 LYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
           LY QGLFREDLAR+YTAEIVSAVSHLH  GIMHRDLKPENIL+D DGHVMLTDFGLAK+F
Sbjct: 223 LYHQGLFREDLARVYTAEIVSAVSHLHEKGIMHRDLKPENILMDTDGHVMLTDFGLAKEF 282

Query: 301 DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQK 360
           +ENTRSNSMCGT EYM+PEIV GKGHDKAADWWSVGILL+EMLTG+PPF  G++ KIQQK
Sbjct: 283 EENTRSNSMCGTTEYMAPEIVRGKGHDKAADWWSVGILLYEMLTGKPPFL-GSKGKIQQK 341

Query: 361 IIKDKIKLPAFLSSEAHSLLKGV 383
           I+KDKIKLP FLS+EAH++LKG+
Sbjct: 342 IVKDKIKLPQFLSNEAHAILKGL 364

Downstream effector of TOR signaling pathway involved in osmotic stress response. Could be involved in the control of plant growth and development. Phosphorylates the ribosomal proteins P14, P16 and S6.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P28178|PK2_DICDI Protein kinase 2 OS=Dictyostelium discoideum GN=pkgB PE=1 SV=2

 Score =  280 bits (717), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 127/239 (53%), Positives = 174/239 (72%)

Query: 145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
           Q    +DFE+L V+G+G+F KV QV++ G  +I+AMKV+RKD I+ +    + KSE+ IL
Sbjct: 146 QSATKDDFELLNVIGKGSFGKVMQVKKKGEDKIFAMKVLRKDAIIARKQVNHTKSEKTIL 205

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
             + HPFIV L Y+FQTK +LY+VLDFVNGG LFF L R+G F E   +IY AEIVSA+ 
Sbjct: 206 QCISHPFIVNLHYAFQTKDKLYMVLDFVNGGELFFHLKREGRFSEPRVKIYAAEIVSALD 265

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGK 324
           HLH   I++RDLKPENILLD++GH+ +TDFGL+K+ +    + + CGT EY++PE++ G 
Sbjct: 266 HLHKQDIVYRDLKPENILLDSEGHICITDFGLSKKIETTDGTFTFCGTPEYLAPEVLNGH 325

Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV 383
           GH  A DWWS+G LL+EMLTG PPF   N   + QKI+  ++K+P ++S EA SLL+G+
Sbjct: 326 GHGCAVDWWSLGTLLYEMLTGLPPFYSQNVSTMYQKILNGELKIPTYISPEAKSLLEGL 384

Required for morphogenesis during multicellular development. Phosphorylates talB, gefN, gefS, PI4P 5-kinase and gacQ.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P54644|KRAC_DICDI RAC family serine/threonine-protein kinase homolog OS=Dictyostelium discoideum GN=pkbA PE=1 SV=1

 Score =  266 bits (680), Expect = 2e-70,   Method: Compositional matrix adjust.
 Identities = 123/243 (50%), Positives = 174/243 (71%), Gaps = 2/243 (0%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P +++ VG+ DFE+L +VG+G+F KV QVR+  T E+YAMKV+ K  I+E N  E+  SE
Sbjct: 109 PKKSEKVGVADFELLNLVGKGSFGKVIQVRKKDTGEVYAMKVLSKKHIVEHNEVEHTLSE 168

Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           RNIL K++HPF+V L YSFQT+ +LY +LD+VNGG LF+ L +   F ED  R Y AEIV
Sbjct: 169 RNILQKINHPFLVNLNYSFQTEDKLYFILDYVNGGELFYHLQKDKKFTEDRVRYYGAEIV 228

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ--FDENTRSNSMCGTLEYMSP 318
            A+ HLH +G+++RDLKPEN+LL  +GH+ +TDFGL K+       ++ + CGT EY++P
Sbjct: 229 LALEHLHLSGVIYRDLKPENLLLTNEGHICMTDFGLCKEGLLTPTDKTGTFCGTPEYLAP 288

Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHS 378
           E++ G G+ K  DWWS G LL+EMLTG PPF   + Q++ +KI+ +K+  P F+S +A S
Sbjct: 289 EVLQGNGYGKQVDWWSFGSLLYEMLTGLPPFYNQDVQEMYRKIMMEKLSFPHFISPDARS 348

Query: 379 LLK 381
           LL+
Sbjct: 349 LLE 351

Predominantly involved during the aggregation to control cell polarity and chemotaxis. Phosphorylates talB, gefN, gefS, PI4P 5-kinase and gacQ.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6TJY3|KS6B1_BOVIN Ribosomal protein S6 kinase beta-1 OS=Bos taurus GN=RPS6KB1 PE=2 SV=1

 Score =  265 bits (676), Expect = 6e-70,   Method: Compositional matrix adjust.
 Identities = 125/237 (52%), Positives = 175/237 (73%), Gaps = 5/237 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILT 205
           E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  I+       + K+ERNIL 
Sbjct: 89  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 148

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+F ED A  Y AEI  A+ H
Sbjct: 149 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 208

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           LH  GI++RDLKPENI+L+  GHV LTDFGL K+   + T +++ CGT+EYM+PEI++  
Sbjct: 209 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 268

Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
           GH++A DWWS+G L+++MLTG PPFTG NR+K   KI+K K+ LP +L+ EA  LLK
Sbjct: 269 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK 325

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial RMP leading to dissociation of a RMP:PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P23443|KS6B1_HUMAN Ribosomal protein S6 kinase beta-1 OS=Homo sapiens GN=RPS6KB1 PE=1 SV=2

 Score =  265 bits (676), Expect = 6e-70,   Method: Compositional matrix adjust.
 Identities = 125/237 (52%), Positives = 175/237 (73%), Gaps = 5/237 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILT 205
           E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  I+       + K+ERNIL 
Sbjct: 89  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 148

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+F ED A  Y AEI  A+ H
Sbjct: 149 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 208

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           LH  GI++RDLKPENI+L+  GHV LTDFGL K+   + T +++ CGT+EYM+PEI++  
Sbjct: 209 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 268

Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
           GH++A DWWS+G L+++MLTG PPFTG NR+K   KI+K K+ LP +L+ EA  LLK
Sbjct: 269 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK 325

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial URI1 leading to dissociation of a URI1-PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P67999|KS6B1_RAT Ribosomal protein S6 kinase beta-1 OS=Rattus norvegicus GN=Rps6kb1 PE=1 SV=1

 Score =  265 bits (676), Expect = 6e-70,   Method: Compositional matrix adjust.
 Identities = 125/237 (52%), Positives = 175/237 (73%), Gaps = 5/237 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILT 205
           E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  I+       + K+ERNIL 
Sbjct: 89  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 148

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+F ED A  Y AEI  A+ H
Sbjct: 149 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 208

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           LH  GI++RDLKPENI+L+  GHV LTDFGL K+   + T +++ CGT+EYM+PEI++  
Sbjct: 209 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 268

Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
           GH++A DWWS+G L+++MLTG PPFTG NR+K   KI+K K+ LP +L+ EA  LLK
Sbjct: 269 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK 325

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial RMP leading to dissociation of a RMP:PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P67998|KS6B1_RABIT Ribosomal protein S6 kinase beta-1 OS=Oryctolagus cuniculus GN=RPS6KB1 PE=2 SV=1

 Score =  265 bits (676), Expect = 6e-70,   Method: Compositional matrix adjust.
 Identities = 125/237 (52%), Positives = 175/237 (73%), Gaps = 5/237 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILT 205
           E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  I+       + K+ERNIL 
Sbjct: 89  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 148

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+F ED A  Y AEI  A+ H
Sbjct: 149 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 208

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           LH  GI++RDLKPENI+L+  GHV LTDFGL K+   + T +++ CGT+EYM+PEI++  
Sbjct: 209 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 268

Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
           GH++A DWWS+G L+++MLTG PPFTG NR+K   KI+K K+ LP +L+ EA  LLK
Sbjct: 269 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK 325

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial RMP leading to dissociation of a RMP:PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Oryctolagus cuniculus (taxid: 9986)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8BSK8|KS6B1_MOUSE Ribosomal protein S6 kinase beta-1 OS=Mus musculus GN=Rps6kb1 PE=1 SV=2

 Score =  264 bits (675), Expect = 7e-70,   Method: Compositional matrix adjust.
 Identities = 125/237 (52%), Positives = 175/237 (73%), Gaps = 5/237 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILT 205
           E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  I+       + K+ERNIL 
Sbjct: 89  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 148

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+F ED A  Y AEI  A+ H
Sbjct: 149 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 208

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           LH  GI++RDLKPENI+L+  GHV LTDFGL K+   + T +++ CGT+EYM+PEI++  
Sbjct: 209 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 268

Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
           GH++A DWWS+G L+++MLTG PPFTG NR+K   KI+K K+ LP +L+ EA  LLK
Sbjct: 269 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK 325

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial RMP leading to dissociation of a RMP:PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9UBS0|KS6B2_HUMAN Ribosomal protein S6 kinase beta-2 OS=Homo sapiens GN=RPS6KB2 PE=1 SV=2

 Score =  262 bits (670), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 130/271 (47%), Positives = 187/271 (69%), Gaps = 12/271 (4%)

Query: 123 LSVVDAALGKPTGHIDNLPSENQCV-------GLEDFEVLKVVGQGAFAKVYQVRRI-GT 174
           L+ + AA  +P GH + +      V       G   FE+L+V+G+G + KV+QVR++ GT
Sbjct: 31  LAELRAAGLEPVGHYEEVELTETSVNVGPERIGPHCFELLRVLGKGGYGKVFQVRKVQGT 90

Query: 175 S--EIYAMKVMRKDKIMEK-NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF 231
           +  +IYAMKV+RK KI+       + ++ERNIL  V HPFIV+L Y+FQT  +LYL+L+ 
Sbjct: 91  NLGKIYAMKVLRKAKIVRNAKDTAHTRAERNILESVKHPFIVELAYAFQTGGKLYLILEC 150

Query: 232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVML 291
           ++GG LF  L R+G+F ED A  Y AEI  A+ HLH+ GI++RDLKPENI+L + GH+ L
Sbjct: 151 LSGGELFTHLEREGIFLEDTACFYLAEITLALGHLHSQGIIYRDLKPENIMLSSQGHIKL 210

Query: 292 TDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFT 350
           TDFGL K+   E   +++ CGT+EYM+PEI++  GH++A DWWS+G L+++MLTG PPFT
Sbjct: 211 TDFGLCKESIHEGAVTHTFCGTIEYMAPEILVRSGHNRAVDWWSLGALMYDMLTGSPPFT 270

Query: 351 GGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
             NR+K   KII+ K+ LP +L+ +A  L+K
Sbjct: 271 AENRKKTMDKIIRGKLALPPYLTPDARDLVK 301

Phosphorylates specifically ribosomal protein S6.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	396
356532147	479	PREDICTED: serine/threonine-protein kina	0.952	0.787	0.741	1e-162
255575604	481	ribosomal protein S6 kinase, putative [R	0.941	0.775	0.737	1e-161
225439717	489	PREDICTED: serine/threonine-protein kina	0.967	0.783	0.733	1e-159
115452853	480	Os03g0334000 [Oryza sativa Japonica Grou	0.941	0.777	0.704	1e-156
224139384	475	predicted protein [Populus trichocarpa]	0.944	0.787	0.716	1e-156
363806700	479	uncharacterized protein LOC100805922 [Gl	0.952	0.787	0.720	1e-155
356551817	472	PREDICTED: serine/threonine-protein kina	0.936	0.786	0.694	1e-155
297735529	446	unnamed protein product [Vitis vinifera]	0.876	0.778	0.723	1e-154
326524133	481	predicted protein [Hordeum vulgare subsp	0.944	0.777	0.691	1e-154
224087877	475	predicted protein [Populus trichocarpa]	0.944	0.787	0.706	1e-153

>gi|356532147|ref|XP_003534635.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Glycine max]

 Score =  576 bits (1484), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 287/387 (74%), Positives = 323/387 (83%), Gaps = 10/387 (2%)

Query: 1   MVSSQLSSLNGDCAG-KPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQAS---IEV 56
           MVSSQ S L    AG KP   QLL P   PD ++++++E DFSDVFGP  V  +      
Sbjct: 1   MVSSQFSGLT--MAGYKPAQTQLLFPANLPDTVNTEHIELDFSDVFGPVTVDLNNIDSTT 58

Query: 57  GGEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEET 116
           G  +   NELVYD P VI++RSHSLVGPS+ VSQSLKL KLT+HE EDSL LV+ +N ET
Sbjct: 59  GEPLEEVNELVYDDPPVIYTRSHSLVGPSTCVSQSLKLGKLTIHETEDSLELVDHVNGET 118

Query: 117 QEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE 176
            +   + S VD +L    G++  +    Q V +EDFE+LKVVGQGAFAKVYQVR+ GTSE
Sbjct: 119 IKDIKDSSFVDKSLKDEDGNLKKI----QRVSIEDFEILKVVGQGAFAKVYQVRKKGTSE 174

Query: 177 IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGH 236
           IYAMKVMRKDKIMEKNHAEYMK+ER+I TK++HPF+VQLRYSFQTKYRLYLVLDFVNGGH
Sbjct: 175 IYAMKVMRKDKIMEKNHAEYMKAERDIWTKIEHPFVVQLRYSFQTKYRLYLVLDFVNGGH 234

Query: 237 LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGL 296
           LFFQLY QGLFREDLARIYTAEIV AVSHLH+NGIMHRDLKPENILLDADGHVMLTDFGL
Sbjct: 235 LFFQLYHQGLFREDLARIYTAEIVCAVSHLHSNGIMHRDLKPENILLDADGHVMLTDFGL 294

Query: 297 AKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQK 356
           AKQF+E+TRSNSMCGTLEYM+PEI+LGKGHDKAADWWSVGILLFEMLTG+PPF GGNR K
Sbjct: 295 AKQFEESTRSNSMCGTLEYMAPEIILGKGHDKAADWWSVGILLFEMLTGKPPFCGGNRDK 354

Query: 357 IQQKIIKDKIKLPAFLSSEAHSLLKGV 383
           IQQKI+KDKIKLPAFLSSEAHSLLKG+
Sbjct: 355 IQQKIVKDKIKLPAFLSSEAHSLLKGL 381

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255575604|ref|XP_002528702.1| ribosomal protein S6 kinase, putative [Ricinus communis] gi|223531874|gb|EEF33691.1| ribosomal protein S6 kinase, putative [Ricinus communis]

 Score =  573 bits (1477), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 289/392 (73%), Positives = 326/392 (83%), Gaps = 19/392 (4%)

Query: 1   MVSSQLSSLNGDCAGKPFLNQLLLPRGPP--DALSSDYVEFDFSDVFGPAPVQASIEVG- 57
           MVSSQ S L+     KPF +QLL    PP  DAL SD VE DF+DVFGP PVQ S EV  
Sbjct: 1   MVSSQFSELSKAHMCKPFRSQLLFTENPPPPDALVSD-VELDFADVFGPLPVQTSTEVNS 59

Query: 58  GEISY------ANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEG 111
           G+++         EL+YD P VIH+RSHSLVGPSS+VS SLKL+KLTLHE EDS+ L+E 
Sbjct: 60  GDLANPLSGADVTELIYDDPVVIHNRSHSLVGPSSFVSHSLKLNKLTLHETEDSMELLE- 118

Query: 112 INEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRR 171
           ++E + +  N+    D   G      D L  E + VG+EDFEVLKVVGQGAF KVYQV++
Sbjct: 119 LDESSLDDDNSEKATDDVSG------DAL--EVRSVGIEDFEVLKVVGQGAFGKVYQVKK 170

Query: 172 IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF 231
            GTSEIYAMKVMRKDKI+EKNH EYMK+ER+ILTKVDHPFIVQL+YSFQTKYRLYL+LDF
Sbjct: 171 KGTSEIYAMKVMRKDKIVEKNHVEYMKAERDILTKVDHPFIVQLKYSFQTKYRLYLILDF 230

Query: 232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVML 291
           +NGGHLFFQLY QGLFREDLARIY AEIVSAV HLHANGIMHRDLKPENILLDADGHVML
Sbjct: 231 INGGHLFFQLYHQGLFREDLARIYAAEIVSAVCHLHANGIMHRDLKPENILLDADGHVML 290

Query: 292 TDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           TDFGLAKQFDENTRSNSMCGT+EYM+PEIVLG+GHDKAADWWSVG+LL+EMLTG+PPF G
Sbjct: 291 TDFGLAKQFDENTRSNSMCGTVEYMAPEIVLGRGHDKAADWWSVGVLLYEMLTGKPPFIG 350

Query: 352 GNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV 383
           GNR+KIQQKI+KDK+KLPAFLSSEAHSLLKG+
Sbjct: 351 GNREKIQQKIVKDKMKLPAFLSSEAHSLLKGL 382

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225439717|ref|XP_002273012.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Vitis vinifera]

 Score =  568 bits (1464), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 286/390 (73%), Positives = 316/390 (81%), Gaps = 7/390 (1%)

Query: 1   MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEV---- 56
           MV S +  L      KP  NQLL P  P D +  D+VE DF+DVFGP PVQ   E+    
Sbjct: 1   MVFSDVPGLTKTRMCKPIQNQLLFPMNPTDIVPLDHVELDFADVFGPLPVQTPSEMNPGD 60

Query: 57  -GGEISYA--NELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGIN 113
            G  +S A  N+L+Y  P VI+SRSHSLVGPS+ +SQSLKLSKL LHE EDS  LVE ++
Sbjct: 61  SGDSVSAADTNDLIYGDPVVIYSRSHSLVGPSTCLSQSLKLSKLALHEIEDSEELVECLH 120

Query: 114 EETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIG 173
           EE  +     S  D    K    ID+  +  + VGLEDFEV+K+VGQGAF KV+QVR+  
Sbjct: 121 EEAVKELQRTSSSDDISEKSFEDIDSDSTTVETVGLEDFEVMKLVGQGAFGKVFQVRKRN 180

Query: 174 TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVN 233
           TSEIYAMKVMRKDKIMEK+HAEYMK+ER+ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVN
Sbjct: 181 TSEIYAMKVMRKDKIMEKDHAEYMKAERDILTKVDHPFIVQLRYSFQTKYRLYLVLDFVN 240

Query: 234 GGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTD 293
           GGHLFFQLY  GLFREDLARIY AEIVSAVSHLHANGIMHRDLKPENILLDADGH MLTD
Sbjct: 241 GGHLFFQLYNHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLDADGHAMLTD 300

Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           FGLAK+FDENTRSNSMCGT+EYMSPEI LGKGHDKAADWWSVGILLFEMLTG+PPF GGN
Sbjct: 301 FGLAKEFDENTRSNSMCGTVEYMSPEIFLGKGHDKAADWWSVGILLFEMLTGKPPFIGGN 360

Query: 354 RQKIQQKIIKDKIKLPAFLSSEAHSLLKGV 383
           RQKIQQKIIKDKIKLPAFLSS+AHS+LKG+
Sbjct: 361 RQKIQQKIIKDKIKLPAFLSSDAHSVLKGL 390

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|115452853|ref|NP_001050027.1| Os03g0334000 [Oryza sativa Japonica Group] gi|108707998|gb|ABF95793.1| Serine/threonine-protein kinase AtPK19, putative, expressed [Oryza sativa Japonica Group] gi|113548498|dbj|BAF11941.1| Os03g0334000 [Oryza sativa Japonica Group] gi|125586157|gb|EAZ26821.1| hypothetical protein OsJ_10738 [Oryza sativa Japonica Group] gi|215704239|dbj|BAG93079.1| unnamed protein product [Oryza sativa Japonica Group] gi|215769106|dbj|BAH01335.1| unnamed protein product [Oryza sativa Japonica Group]

 Score =  558 bits (1437), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 276/392 (70%), Positives = 322/392 (82%), Gaps = 19/392 (4%)

Query: 1   MVSSQLSSLNGDCAGKP--FLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVG- 57
           MVSS++SS+    A  P  F  ++LLP GPPD + S+ VEFDFSDVFGP  VQ   ++  
Sbjct: 1   MVSSEISSVTTTHAQGPKLFRGKILLPMGPPDVVPSENVEFDFSDVFGPTAVQTPTDLSI 60

Query: 58  ------GEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEG 111
                   ++ ++E +Y+ P VI  RSHSLVGPSS VSQSL LSKLTLHE++ +L L+E 
Sbjct: 61  LTPDSPAPLTESSEGIYNDPLVIVKRSHSLVGPSSLVSQSLPLSKLTLHESDSALDLLEC 120

Query: 112 INEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRR 171
             E+     N  ++ D  L       D+  +EN  VGL+DFEVLK+VGQGAF KV+QVR+
Sbjct: 121 TKEKKS---NQEALSDEEL-------DDTKNENGVVGLDDFEVLKLVGQGAFGKVFQVRK 170

Query: 172 IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF 231
            GTSEIYAMKVMRKDKI+EKNHAEYMK+ER+ILTKVDHPF+VQLRYSFQTKYRLYLVLDF
Sbjct: 171 KGTSEIYAMKVMRKDKILEKNHAEYMKAERDILTKVDHPFVVQLRYSFQTKYRLYLVLDF 230

Query: 232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVML 291
           +NGGHLFFQLY+QGLFRE+LARIYTAEIVSAV+HLHANGIMHRDLKPENILLDADGH ML
Sbjct: 231 INGGHLFFQLYQQGLFREELARIYTAEIVSAVAHLHANGIMHRDLKPENILLDADGHAML 290

Query: 292 TDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           TDFGLAK+FDENTRSNSMCGT+EYM+PEIV G+GHDKAADWWSVGILLFEMLTG+PPF G
Sbjct: 291 TDFGLAKEFDENTRSNSMCGTVEYMAPEIVQGRGHDKAADWWSVGILLFEMLTGKPPFVG 350

Query: 352 GNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV 383
           GNR K+QQKI+K+KIKLPA+LSSE HSLLKG+
Sbjct: 351 GNRDKVQQKIVKEKIKLPAYLSSEVHSLLKGL 382

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139384|ref|XP_002323086.1| predicted protein [Populus trichocarpa] gi|222867716|gb|EEF04847.1| predicted protein [Populus trichocarpa]

 Score =  556 bits (1434), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 276/385 (71%), Positives = 311/385 (80%), Gaps = 11/385 (2%)

Query: 1   MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEI 60
           MVSSQL  L          N+LL P  P D + SD+VE DF+DVFGP P    +  G  +
Sbjct: 1   MVSSQLPGLTK--------NRLLFPVNPSDTVVSDHVELDFTDVFGPLP-SIDVNCGDPL 51

Query: 61  SYAN--ELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQE 118
           S  +  EL+YD P V+H+RSHSLVGPSSYVSQSLKLSKL L E EDSL LVE + +ET +
Sbjct: 52  SVGDGSELIYDDPVVVHNRSHSLVGPSSYVSQSLKLSKLNLQETEDSLELVECVLDETIK 111

Query: 119 GPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIY 178
                 + D A+ K    +    S+ Q VG+EDFEVLKVVGQGAF KVYQVR+ GT EIY
Sbjct: 112 ELEESFIDDDAVEKDMEDVSGDTSKVQTVGIEDFEVLKVVGQGAFGKVYQVRKKGTPEIY 171

Query: 179 AMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF 238
           AMKVMRKD+I+EKNH EYM+ ER+ILTK+DHPFIVQL+YSFQTKYRLYLVLDF+NGGHLF
Sbjct: 172 AMKVMRKDRIVEKNHVEYMRGERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLF 231

Query: 239 FQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK 298
           FQLY  GLFREDLA IY AEI SAVSHLHANGIMHRDLKPENILLD+DGH MLTDFGLAK
Sbjct: 232 FQLYNHGLFREDLACIYAAEIASAVSHLHANGIMHRDLKPENILLDSDGHAMLTDFGLAK 291

Query: 299 QFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ 358
           +FDENTRSNSMCGT+EYM+PEIV GKGHDKAADWWSVGILL+EMLTG+PPF GGNR KIQ
Sbjct: 292 EFDENTRSNSMCGTVEYMAPEIVQGKGHDKAADWWSVGILLYEMLTGKPPFIGGNRNKIQ 351

Query: 359 QKIIKDKIKLPAFLSSEAHSLLKGV 383
           QKI+KDKIKLP+FLSSEAHSLLKG+
Sbjct: 352 QKIVKDKIKLPSFLSSEAHSLLKGL 376

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|363806700|ref|NP_001242011.1| uncharacterized protein LOC100805922 [Glycine max] gi|255636025|gb|ACU18357.1| unknown [Glycine max]

 Score =  555 bits (1430), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 279/387 (72%), Positives = 316/387 (81%), Gaps = 10/387 (2%)

Query: 1   MVSSQLSSLNGDCAG-KPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQAS---IEV 56
           MVSSQ S+     AG KP   QLL P    D ++++++E DFSDVFGP  +  +      
Sbjct: 1   MVSSQFSAFT--LAGYKPSQTQLLFPAKLVDTVNTEHIELDFSDVFGPVTLDLNNIDSTT 58

Query: 57  GGEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEET 116
              +   NELVYD P VI++RSHSLVGPS+ VSQSLK  KLT+HE EDSL LVE +N E 
Sbjct: 59  SEPMEEVNELVYDDPPVIYTRSHSLVGPSTCVSQSLKFGKLTIHETEDSLELVEHVNGEA 118

Query: 117 QEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE 176
            +     S V+ +L    G++  +      V ++DFE+LKVVGQGAFAKVYQVR+ GTSE
Sbjct: 119 IKDIKESSFVEESLKDEDGNLMKI----HRVSIDDFEILKVVGQGAFAKVYQVRKKGTSE 174

Query: 177 IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGH 236
           IYAMKVMRKDKIMEKNHAEYMK+ER+I TK++HPF VQLRYSFQTKYRLYLVLDFVNGGH
Sbjct: 175 IYAMKVMRKDKIMEKNHAEYMKAERDIWTKIEHPFGVQLRYSFQTKYRLYLVLDFVNGGH 234

Query: 237 LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGL 296
           LFFQLY QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGL
Sbjct: 235 LFFQLYHQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGL 294

Query: 297 AKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQK 356
           AKQF+E+TRSNSMCGTLEYM+PEI+LGKGHDKAADWWSVG+LLFEMLTG+PPF GGN  K
Sbjct: 295 AKQFEESTRSNSMCGTLEYMAPEIILGKGHDKAADWWSVGVLLFEMLTGKPPFCGGNCDK 354

Query: 357 IQQKIIKDKIKLPAFLSSEAHSLLKGV 383
           IQQKI+KDKIKLPAFLSSEAHSLLKG+
Sbjct: 355 IQQKIVKDKIKLPAFLSSEAHSLLKGL 381

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356551817|ref|XP_003544270.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Glycine max]

 Score =  553 bits (1424), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 273/393 (69%), Positives = 319/393 (81%), Gaps = 22/393 (5%)

Query: 1   MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDAL-SSDYVEFDFSDVFGPAPVQAS--IEVG 57
           MVS+Q S LN + + KPFLNQLLLP GPPD L SS+ V+F+FSDVFGP+PV+AS  I V 
Sbjct: 1   MVSAQFSILNENGSQKPFLNQLLLPNGPPDRLPSSNCVDFEFSDVFGPSPVEASNSISVS 60

Query: 58  GE-------ISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVE 110
            E          ++E +Y  P  IH RS SL+ P++ + QSL+LSKLT HE +D+L LVE
Sbjct: 61  SEKHGNSVATRGSSENIYKDPDCIHIRSQSLLAPTTCIGQSLQLSKLTFHETDDALDLVE 120

Query: 111 GINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVR 170
            +  ET E     SV +  L             NQ +G++DFEVLKVVGQGAF KVYQVR
Sbjct: 121 EVFIETHEELKEYSVNNYCLN------------NQTIGVQDFEVLKVVGQGAFGKVYQVR 168

Query: 171 RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD 230
           R GTSEIYAMKVMRKDKIM++NHAEY+KSER+ILTK+D+PF+V++RY+FQTKYRLYLVLD
Sbjct: 169 RTGTSEIYAMKVMRKDKIMQRNHAEYVKSERDILTKLDNPFVVRIRYAFQTKYRLYLVLD 228

Query: 231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM 290
           FVNGGHLFF LY QGLFREDLAR Y AEI+ AVS+LHAN IMHRDLKPENILLDADGH +
Sbjct: 229 FVNGGHLFFHLYHQGLFREDLARFYAAEIICAVSYLHANDIMHRDLKPENILLDADGHAV 288

Query: 291 LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFT 350
           LTDFGLAK+F+EN RSNSMCGT+EYM+PEIV+GKGHDKAADWWSVGILL+EMLTG+PPF+
Sbjct: 289 LTDFGLAKKFNENERSNSMCGTVEYMAPEIVMGKGHDKAADWWSVGILLYEMLTGKPPFS 348

Query: 351 GGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV 383
           GGNR KIQQKIIKDKIKLPAFLS+EAHSLLKG+
Sbjct: 349 GGNRHKIQQKIIKDKIKLPAFLSNEAHSLLKGL 381

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297735529|emb|CBI18023.3| unnamed protein product [Vitis vinifera]

 Score =  552 bits (1422), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 277/383 (72%), Positives = 302/383 (78%), Gaps = 36/383 (9%)

Query: 1   MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEI 60
           MV S +  L      KP  NQLL P  P D +  D+VE DF+DVFGP PVQ   +     
Sbjct: 1   MVFSDVPGLTKTRMCKPIQNQLLFPMNPTDIVPLDHVELDFADVFGPLPVQTPTDT---- 56

Query: 61  SYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGP 120
              N+L+Y  P VI+SRSHSLVGPS+ +SQSLKLSKL LHE EDS  LVE ++EE     
Sbjct: 57  ---NDLIYGDPVVIYSRSHSLVGPSTCLSQSLKLSKLALHEIEDSEELVECLHEEA---- 109

Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
                                     VGLEDFEV+K+VGQGAF KV+QVR+  TSEIYAM
Sbjct: 110 -------------------------TVGLEDFEVMKLVGQGAFGKVFQVRKRNTSEIYAM 144

Query: 181 KVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQ 240
           KVMRKDKIMEK+HAEYMK+ER+ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQ
Sbjct: 145 KVMRKDKIMEKDHAEYMKAERDILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQ 204

Query: 241 LYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
           LY  GLFREDLARIY AEIVSAVSHLHANGIMHRDLKPENILLDADGH MLTDFGLAK+F
Sbjct: 205 LYNHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLDADGHAMLTDFGLAKEF 264

Query: 301 DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQK 360
           DENTRSNSMCGT+EYMSPEI LGKGHDKAADWWSVGILLFEMLTG+PPF GGNRQKIQQK
Sbjct: 265 DENTRSNSMCGTVEYMSPEIFLGKGHDKAADWWSVGILLFEMLTGKPPFIGGNRQKIQQK 324

Query: 361 IIKDKIKLPAFLSSEAHSLLKGV 383
           IIKDKIKLPAFLSS+AHS+LKG+
Sbjct: 325 IIKDKIKLPAFLSSDAHSVLKGL 347

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|326524133|dbj|BAJ97077.1| predicted protein [Hordeum vulgare subsp. vulgare]

 Score =  551 bits (1419), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 271/392 (69%), Positives = 316/392 (80%), Gaps = 18/392 (4%)

Query: 1   MVSSQLSSLNGDCAGKP--FLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVG- 57
           MVSS++ S+      +P  F   +LLP+GPPD +  + VEFDF+DVFG   V    EV  
Sbjct: 1   MVSSEMPSVTTAHTQRPKLFTGMILLPKGPPDVVLPENVEFDFNDVFGATAVHTPTEVSI 60

Query: 58  ------GEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEG 111
                   ++ +NE VY+ P VI  RSHSLVGP+S VSQSL LSKLTLHE+E SL L+E 
Sbjct: 61  LTPGSPAPLAESNEEVYNDPVVITKRSHSLVGPTSLVSQSLPLSKLTLHESESSLDLLEC 120

Query: 112 INEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRR 171
           +++E +     L+            ++N   EN+ VGL+DFE+LK+VGQGAF KVYQVRR
Sbjct: 121 LSKEKKSEQGGLN---------DEELNNTTKENEAVGLDDFELLKLVGQGAFGKVYQVRR 171

Query: 172 IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF 231
             TSEIYAMKVMRKDKI+EKNHAEYMK+ER+ILTKVDHPF+VQLRYSFQTKYRLYLVLDF
Sbjct: 172 KCTSEIYAMKVMRKDKILEKNHAEYMKAERDILTKVDHPFVVQLRYSFQTKYRLYLVLDF 231

Query: 232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVML 291
           VNGGHLFFQLY+QGLFRE+LAR+YTAEIVSAV+HLHANGIMHRDLKPENILLDA GH ML
Sbjct: 232 VNGGHLFFQLYQQGLFREELARLYTAEIVSAVAHLHANGIMHRDLKPENILLDAHGHAML 291

Query: 292 TDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           TDFGLAK+FDENTRSNSMCGT+EYM+PEIV G+GHDKAADWWSVGILLFEMLTG+PPF G
Sbjct: 292 TDFGLAKEFDENTRSNSMCGTVEYMAPEIVQGRGHDKAADWWSVGILLFEMLTGKPPFFG 351

Query: 352 GNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV 383
           GNR KIQQKI+K+K+KLP +LSSE HSLLKG+
Sbjct: 352 GNRDKIQQKIVKEKMKLPTYLSSEVHSLLKGL 383

Source: Hordeum vulgare subsp. vulgare

Species: Hordeum vulgare

Genus: Hordeum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224087877|ref|XP_002308257.1| predicted protein [Populus trichocarpa] gi|222854233|gb|EEE91780.1| predicted protein [Populus trichocarpa]

 Score =  549 bits (1414), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 272/385 (70%), Positives = 310/385 (80%), Gaps = 11/385 (2%)

Query: 1   MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEI 60
           MVSSQL             N+LL P    D   SD+VE DF+DVFGP P    +  G  +
Sbjct: 1   MVSSQLPGSTK--------NRLLFPVNSLDTEVSDHVELDFTDVFGPLP-SIDVNCGDPL 51

Query: 61  SYAN--ELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQE 118
           S  +  EL+YD P VIH+RSHSLVGPSSYVSQSLKLSKL L+E EDS+ LV+ + +ET +
Sbjct: 52  SVGDGSELIYDNPVVIHNRSHSLVGPSSYVSQSLKLSKLNLNETEDSMELVKCVLDETIK 111

Query: 119 GPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIY 178
                S+ D A+ K    +     E Q VG+EDFEVLKVVGQGAF KVYQVR+ GT EIY
Sbjct: 112 ELEECSIDDDAIEKDVEGVSGDTLEVQTVGIEDFEVLKVVGQGAFGKVYQVRKKGTPEIY 171

Query: 179 AMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF 238
           AMKVMRKD+I+EKNH +YM+ ER+ILTK+ HPFIVQL+YSFQTKYRLYLVLDF+NGGHLF
Sbjct: 172 AMKVMRKDRIVEKNHVDYMRGERDILTKIAHPFIVQLKYSFQTKYRLYLVLDFINGGHLF 231

Query: 239 FQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK 298
           FQLY  GLFREDLARIY AEIVSAV HLHANGIMHRDLKPENILLD+DGHVMLTDFGLAK
Sbjct: 232 FQLYNHGLFREDLARIYAAEIVSAVCHLHANGIMHRDLKPENILLDSDGHVMLTDFGLAK 291

Query: 299 QFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ 358
           QFDENTRSNSMCGT+EYM+PEIV G+GHDKAADWWSVGILL+EMLTG+PPF GGNR KIQ
Sbjct: 292 QFDENTRSNSMCGTVEYMAPEIVQGRGHDKAADWWSVGILLYEMLTGKPPFVGGNRDKIQ 351

Query: 359 QKIIKDKIKLPAFLSSEAHSLLKGV 383
           QKI+KDKIKLP+FL+SEAH+LLKG+
Sbjct: 352 QKIVKDKIKLPSFLTSEAHTLLKGL 376

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	396
TAIR|locus:2077843	471	S6K2 "serine/threonine protein	0.931	0.783	0.666	3.6e-128
TAIR|locus:2077873	465	PK1 "protein-serine kinase 1"	0.883	0.752	0.661	2.8e-121
DICTYBASE|DDB_G0290157	479	pkgB "SGK family protein kinas	0.611	0.505	0.514	5.2e-65
DICTYBASE|DDB_G0268620	444	pkbA "AKT/PKB protein kinase P	0.608	0.542	0.489	3e-62
ZFIN|ZDB-GENE-040426-2038	502	rps6kb1b "ribosomal protein S6	0.616	0.486	0.489	3.8e-62
UNIPROTKB|E2R7K9	482	RPS6KB2 "Uncharacterized prote	0.686	0.564	0.452	1e-61
WB|WBGene00012929	550	rsks-1 [Caenorhabditis elegans	0.601	0.432	0.506	1e-61
UNIPROTKB|Q9NAH6	550	rsks-1 "Protein RSKS-1" [Caeno	0.601	0.432	0.506	1e-61
UNIPROTKB|Q9UBS0	482	RPS6KB2 "Ribosomal protein S6	0.714	0.587	0.451	1.3e-61
UNIPROTKB|F1P4J0	502	RPS6KB1 "Uncharacterized prote	0.585	0.462	0.506	1.6e-61

TAIR|locus:2077843 S6K2 "serine/threonine protein kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1258 (447.9 bits), Expect = 3.6e-128, P = 3.6e-128
 Identities = 256/384 (66%), Positives = 294/384 (76%)

Query:     1 MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEI 60
             MVSSQ S  N +  GKPF   L L   PP ++  D +E  FSDVFGP P   S E     
Sbjct:     1 MVSSQCSVANKNQTGKPFQKHLSLSISPPKSVLGDNLELQFSDVFGPMPEANSEE----- 55

Query:    61 SYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGP 120
               A ++ YD+PAV++SRSHSLVGPS  VS SLK++KLTL E EDS+ LVE +  E+ +  
Sbjct:    56 --ACDVAYDEPAVVYSRSHSLVGPSLVVSHSLKMNKLTLRETEDSVDLVECVEGESIKEN 113

Query:   121 NNLSVVDAALGKPTGHIDNLPSE-NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYA 179
             +  S      G      +  P E +  VG+EDFEVLKVVGQGAF KVYQVR+  TSEIYA
Sbjct:   114 DEFS------GNDDTDSEKSPEEVSGVVGIEDFEVLKVVGQGAFGKVYQVRKKDTSEIYA 167

Query:   180 MKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFF 239
             MKVMRKDKI+EKNHAEYMK+ER+ILTK+DHPFIVQL+YSFQTKYRLYLVLDF+NGGHLFF
Sbjct:   168 MKVMRKDKIVEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFF 227

Query:   240 QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ 299
             QLY QGLFREDLAR+YTAEIVSAVSHLH  GIMHRDLKPENIL+D DGHVMLTDFGLAK+
Sbjct:   228 QLYHQGLFREDLARVYTAEIVSAVSHLHEKGIMHRDLKPENILMDVDGHVMLTDFGLAKE 287

Query:   300 FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXX 359
             F+ENTRSNSMCGT EYM+PEIV GKGHDKAADWWSVGILL+EMLTG+PPF G ++     
Sbjct:   288 FEENTRSNSMCGTTEYMAPEIVRGKGHDKAADWWSVGILLYEMLTGKPPFLG-SKGKIQQ 346

Query:   360 XXXXXXXXLPAFLSSEAHSLLKGV 383
                     LP FLS+EAH+LLKG+
Sbjct:   347 KIVKDKIKLPQFLSNEAHALLKGL 370

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0045727 "positive regulation of translation" evidence=RCA;TAS

GO:0009409 "response to cold" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0009408 "response to heat" evidence=IEP

TAIR|locus:2077873 PK1 "protein-serine kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1193 (425.0 bits), Expect = 2.8e-121, P = 2.8e-121
 Identities = 240/363 (66%), Positives = 283/363 (77%)

Query:    21 QLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHSRSHS 80
             Q  L   P +++  D VE +FSDVFGP P +A           N++ YD+PAV++SRSHS
Sbjct:    15 QQYLSISPSNSVLKDDVELEFSDVFGPLPEEA-----------NDIAYDEPAVVYSRSHS 63

Query:    81 LVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNL 140
             LVGP S  S SLKL+KLTL E EDS+ LVE +  E+ +  ++ S  D +  +     D L
Sbjct:    64 LVGPCSLDSHSLKLTKLTLLETEDSIDLVECLEGESLKENDDFSGNDDSDNEKALEGD-L 122

Query:   141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
                +  VG++DFEV+KVVG+GAF KVYQVR+  TSEIYAMKVMRKD IMEKNHAEYMK+E
Sbjct:   123 VKVSGVVGIDDFEVMKVVGKGAFGKVYQVRKKETSEIYAMKVMRKDHIMEKNHAEYMKAE 182

Query:   201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
             R+ILTK+DHPFIVQL+YSFQTKYRLYLVLDF+NGGHLFFQLY QGLFREDLAR+YTAEIV
Sbjct:   183 RDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHQGLFREDLARVYTAEIV 242

Query:   261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
             SAVSHLH  GIMHRDLKPENIL+D DGHVMLTDFGLAK+F+ENTRSNSMCGT EYM+PEI
Sbjct:   243 SAVSHLHEKGIMHRDLKPENILMDTDGHVMLTDFGLAKEFEENTRSNSMCGTTEYMAPEI 302

Query:   321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
             V GKGHDKAADWWSVGILL+EMLTG+PPF G ++             LP FLS+EAH++L
Sbjct:   303 VRGKGHDKAADWWSVGILLYEMLTGKPPFLG-SKGKIQQKIVKDKIKLPQFLSNEAHAIL 361

Query:   381 KGV 383
             KG+
Sbjct:   362 KGL 364

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005737 "cytoplasm" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=IMP;IDA

GO:0045727 "positive regulation of translation" evidence=RCA;TAS

GO:0009409 "response to cold" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

DICTYBASE|DDB_G0290157 pkgB "SGK family protein kinase PkgB" [Dictyostelium discoideum (taxid:44689)]

 Score = 662 (238.1 bits), Expect = 5.2e-65, P = 5.2e-65
 Identities = 125/243 (51%), Positives = 169/243 (69%)

Query:   142 SEN-QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
             S+N Q    +DFE+L V+G+G+F KV QV++ G  +I+AMKV+RKD I+ +    + KSE
Sbjct:   142 SKNKQSATKDDFELLNVIGKGSFGKVMQVKKKGEDKIFAMKVLRKDAIIARKQVNHTKSE 201

Query:   201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
             + IL  + HPFIV L Y+FQTK +LY+VLDFVNGG LFF L R+G F E   +IY AEIV
Sbjct:   202 KTILQCISHPFIVNLHYAFQTKDKLYMVLDFVNGGELFFHLKREGRFSEPRVKIYAAEIV 261

Query:   261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
             SA+ HLH   I++RDLKPENILLD++GH+ +TDFGL+K+ +    + + CGT EY++PE+
Sbjct:   262 SALDHLHKQDIVYRDLKPENILLDSEGHICITDFGLSKKIETTDGTFTFCGTPEYLAPEV 321

Query:   321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
             + G GH  A DWWS+G LL+EMLTG PPF   N              +P ++S EA SLL
Sbjct:   322 LNGHGHGCAVDWWSLGTLLYEMLTGLPPFYSQNVSTMYQKILNGELKIPTYISPEAKSLL 381

Query:   381 KGV 383
             +G+
Sbjct:   382 EGL 384

GO:0006468 "protein phosphorylation" evidence=IEA;IGI;IDA

GO:0043327 "chemotaxis to cAMP" evidence=IGI

GO:0031288 "sorocarp morphogenesis" evidence=IMP

GO:0005886 "plasma membrane" evidence=IEA;IDA

GO:0004691 "cAMP-dependent protein kinase activity" evidence=IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0006935 "chemotaxis" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0044351 "macropinocytosis" evidence=RCA

DICTYBASE|DDB_G0268620 pkbA "AKT/PKB protein kinase PkbA" [Dictyostelium discoideum (taxid:44689)]

 Score = 636 (228.9 bits), Expect = 3.0e-62, P = 3.0e-62
 Identities = 119/243 (48%), Positives = 164/243 (67%)

Query:   141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
             P +++ VG+ DFE+L +VG+G+F KV QVR+  T E+YAMKV+ K  I+E N  E+  SE
Sbjct:   109 PKKSEKVGVADFELLNLVGKGSFGKVIQVRKKDTGEVYAMKVLSKKHIVEHNEVEHTLSE 168

Query:   201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
             RNIL K++HPF+V L YSFQT+ +LY +LD+VNGG LF+ L +   F ED  R Y AEIV
Sbjct:   169 RNILQKINHPFLVNLNYSFQTEDKLYFILDYVNGGELFYHLQKDKKFTEDRVRYYGAEIV 228

Query:   261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ--FDENTRSNSMCGTLEYMSP 318
              A+ HLH +G+++RDLKPEN+LL  +GH+ +TDFGL K+       ++ + CGT EY++P
Sbjct:   229 LALEHLHLSGVIYRDLKPENLLLTNEGHICMTDFGLCKEGLLTPTDKTGTFCGTPEYLAP 288

Query:   319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHS 378
             E++ G G+ K  DWWS G LL+EMLTG PPF   +               P F+S +A S
Sbjct:   289 EVLQGNGYGKQVDWWSFGSLLYEMLTGLPPFYNQDVQEMYRKIMMEKLSFPHFISPDARS 348

Query:   379 LLK 381
             LL+
Sbjct:   349 LLE 351

GO:0043327 "chemotaxis to cAMP" evidence=IGI;IMP

GO:0030010 "establishment of cell polarity" evidence=IGI

GO:0006468 "protein phosphorylation" evidence=IEA;IGI;IDA

GO:0000281 "cytokinesis after mitosis" evidence=IGI

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0005938 "cell cortex" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0045859 "regulation of protein kinase activity" evidence=TAS

GO:0031154 "culmination involved in sorocarp development" evidence=TAS

GO:0031036 "myosin II filament assembly" evidence=TAS

GO:0019887 "protein kinase regulator activity" evidence=TAS

GO:0007163 "establishment or maintenance of cell polarity" evidence=TAS

GO:0006935 "chemotaxis" evidence=IEA;TAS

GO:0048015 "phosphatidylinositol-mediated signaling" evidence=TAS

GO:0004691 "cAMP-dependent protein kinase activity" evidence=IDA

GO:0005524 "ATP binding" evidence=IEA;IC

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0044351 "macropinocytosis" evidence=RCA

ZFIN|ZDB-GENE-040426-2038 rps6kb1b "ribosomal protein S6 kinase b, polypeptide 1b" [Danio rerio (taxid:7955)]

 Score = 635 (228.6 bits), Expect = 3.8e-62, P = 3.8e-62
 Identities = 122/249 (48%), Positives = 172/249 (69%)

Query:   138 DNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEK-NH 193
             DN+    + +  E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  I+     
Sbjct:    51 DNVNQGTENIRPECFELLRVLGKGGYGKVFQVRKVSGAATGKIFAMKVLKKAMIVRNAKD 110

Query:   194 AEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
               + K+ERNIL +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+F ED A 
Sbjct:   111 TAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTAC 170

Query:   254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGT 312
              Y AEI  A+ HLH  GI++RDLKPENI+L+  GHV LTDFGL K+   + T +++ CGT
Sbjct:   171 FYLAEISMALGHLHQKGIIYRDLKPENIMLNNQGHVKLTDFGLCKESIHDGTVTHTFCGT 230

Query:   313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFL 372
             +EYM+PEI++  GH++A DWWS+G L+++MLTG PPFTG NR             LP +L
Sbjct:   231 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYL 290

Query:   373 SSEAHSLLK 381
             + EA  LLK
Sbjct:   291 TQEARDLLK 299

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0005840 "ribosome" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

UNIPROTKB|E2R7K9 RPS6KB2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 631 (227.2 bits), Expect = 1.0e-61, P = 1.0e-61
 Identities = 130/287 (45%), Positives = 189/287 (65%)

Query:   110 EGINEETQEGPNN---LSVVDAALGKPTGHIDNLP----SEN---QCVGLEDFEVLKVVG 159
             EG   E +  P++   L+   AA  +P GH + +     S N   + +G   FE+L+V+G
Sbjct:    13 EGSEGEPEFSPSDVCPLAESRAAGPEPVGHCEEVELTETSVNLGPERIGPHCFELLRVLG 72

Query:   160 QGAFAKVYQVRRI-GTS--EIYAMKVMRKDKIMEK-NHAEYMKSERNILTKVDHPFIVQL 215
             +G + KV+QVR++ GT+  +IYAMKV+RK KI+       + ++ERNIL  V HPFIV+L
Sbjct:    73 KGGYGKVFQVRKVQGTNLGKIYAMKVLRKAKIVRNAKDTAHTRAERNILESVKHPFIVEL 132

Query:   216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
              Y+FQT  +LYL+L+ ++GG LF  L R+G+F ED A  Y AEI  A+ HLH+ GI++RD
Sbjct:   133 AYAFQTGGKLYLILECLSGGELFTHLEREGIFLEDTACFYLAEITLALGHLHSQGIIYRD 192

Query:   276 LKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWS 334
             LKPENI+L++ GH+ LTDFGL K+   E   +++ CGT+EYM+PEI++  GH++A DWWS
Sbjct:   193 LKPENIMLNSQGHIKLTDFGLCKESIHEGAVTHTFCGTIEYMAPEILVRSGHNRAVDWWS 252

Query:   335 VGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
             +G L+++MLTG PPFT  NR             LP +L+ +A  L+K
Sbjct:   253 LGALMYDMLTGSPPFTAENRKKTMDKIIKGKLTLPPYLTPDARDLVK 299

GO:0045948 "positive regulation of translational initiation" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

WB|WBGene00012929 rsks-1 [Caenorhabditis elegans (taxid:6239)]

 Score = 631 (227.2 bits), Expect = 1.0e-61, P = 1.0e-61
 Identities = 123/243 (50%), Positives = 172/243 (70%)

Query:   144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE---IYAMKVMRKDKIME-KNHAEYMKS 199
             N  VG EDF++LKV+G+G + KV+QVR+   S+   I+AMKV++K  I+  +    + K+
Sbjct:    75 NVRVGPEDFQLLKVLGKGGYGKVFQVRKTTGSDNGQIFAMKVLQKATIVRNQKDTAHTKA 134

Query:   200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
             ERNIL  V  PFI  L Y+FQT  +LYL+L++++GG LF  L R+G+F E++A+ Y +EI
Sbjct:   135 ERNILEAVKSPFICDLLYAFQTGGKLYLILEYLSGGELFMHLEREGMFMENVAKFYLSEI 194

Query:   260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSP 318
             V ++ HLH  GI++RDLKPENILLDA GHV LTDFGL K+  + + ++++ CGT+EYM+P
Sbjct:   195 VVSLEHLHQQGIIYRDLKPENILLDAYGHVKLTDFGLCKEEIEGDQKTHTFCGTIEYMAP 254

Query:   319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHS 378
             EI++  GH KA DWWS+G L+F+MLTG PPFT  NR             LPA+LS+EA  
Sbjct:   255 EILMRCGHGKAVDWWSLGALMFDMLTGGPPFTAENRRKTIDKILKGRLTLPAYLSNEARD 314

Query:   379 LLK 381
             L+K
Sbjct:   315 LIK 317

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0002119 "nematode larval development" evidence=IGI;IMP

GO:0040007 "growth" evidence=IMP

GO:0008340 "determination of adult lifespan" evidence=IGI;IMP

GO:0000003 "reproduction" evidence=IMP

GO:0009408 "response to heat" evidence=IMP

GO:0006412 "translation" evidence=IMP

UNIPROTKB|Q9NAH6 rsks-1 "Protein RSKS-1" [Caenorhabditis elegans (taxid:6239)]

 Score = 631 (227.2 bits), Expect = 1.0e-61, P = 1.0e-61
 Identities = 123/243 (50%), Positives = 172/243 (70%)

Query:   144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE---IYAMKVMRKDKIME-KNHAEYMKS 199
             N  VG EDF++LKV+G+G + KV+QVR+   S+   I+AMKV++K  I+  +    + K+
Sbjct:    75 NVRVGPEDFQLLKVLGKGGYGKVFQVRKTTGSDNGQIFAMKVLQKATIVRNQKDTAHTKA 134

Query:   200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
             ERNIL  V  PFI  L Y+FQT  +LYL+L++++GG LF  L R+G+F E++A+ Y +EI
Sbjct:   135 ERNILEAVKSPFICDLLYAFQTGGKLYLILEYLSGGELFMHLEREGMFMENVAKFYLSEI 194

Query:   260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSP 318
             V ++ HLH  GI++RDLKPENILLDA GHV LTDFGL K+  + + ++++ CGT+EYM+P
Sbjct:   195 VVSLEHLHQQGIIYRDLKPENILLDAYGHVKLTDFGLCKEEIEGDQKTHTFCGTIEYMAP 254

Query:   319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHS 378
             EI++  GH KA DWWS+G L+F+MLTG PPFT  NR             LPA+LS+EA  
Sbjct:   255 EILMRCGHGKAVDWWSLGALMFDMLTGGPPFTAENRRKTIDKILKGRLTLPAYLSNEARD 314

Query:   379 LLK 381
             L+K
Sbjct:   315 LIK 317

GO:2000786 "positive regulation of autophagic vacuole assembly" evidence=IMP

UNIPROTKB|Q9UBS0 RPS6KB2 "Ribosomal protein S6 kinase beta-2" [Homo sapiens (taxid:9606)]

 Score = 630 (226.8 bits), Expect = 1.3e-61, P = 1.3e-61
 Identities = 134/297 (45%), Positives = 191/297 (64%)

Query:    97 LTLHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLP----SEN---QCVGL 149
             L L   E S G  EG  E +      L+ + AA  +P GH + +     S N   + +G 
Sbjct:     7 LDLETEEGSEG--EGEPELSPADACPLAELRAAGLEPVGHYEEVELTETSVNVGPERIGP 64

Query:   150 EDFEVLKVVGQGAFAKVYQVRRI-GTS--EIYAMKVMRKDKIMEK-NHAEYMKSERNILT 205
               FE+L+V+G+G + KV+QVR++ GT+  +IYAMKV+RK KI+       + ++ERNIL 
Sbjct:    65 HCFELLRVLGKGGYGKVFQVRKVQGTNLGKIYAMKVLRKAKIVRNAKDTAHTRAERNILE 124

Query:   206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
              V HPFIV+L Y+FQT  +LYL+L+ ++GG LF  L R+G+F ED A  Y AEI  A+ H
Sbjct:   125 SVKHPFIVELAYAFQTGGKLYLILECLSGGELFTHLEREGIFLEDTACFYLAEITLALGH 184

Query:   266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
             LH+ GI++RDLKPENI+L + GH+ LTDFGL K+   E   +++ CGT+EYM+PEI++  
Sbjct:   185 LHSQGIIYRDLKPENIMLSSQGHIKLTDFGLCKESIHEGAVTHTFCGTIEYMAPEILVRS 244

Query:   325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
             GH++A DWWS+G L+++MLTG PPFT  NR             LP +L+ +A  L+K
Sbjct:   245 GHNRAVDWWSLGALMYDMLTGSPPFTAENRKKTMDKIIRGKLALPPYLTPDARDLVK 301

GO:0004711 "ribosomal protein S6 kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0042277 "peptide binding" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0045948 "positive regulation of translational initiation" evidence=IMP

GO:0004672 "protein kinase activity" evidence=TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=TAS

GO:0006412 "translation" evidence=TAS

GO:0007165 "signal transduction" evidence=TAS

GO:0005654 "nucleoplasm" evidence=TAS

GO:0007173 "epidermal growth factor receptor signaling pathway" evidence=TAS

GO:0008543 "fibroblast growth factor receptor signaling pathway" evidence=TAS

GO:0048011 "neurotrophin TRK receptor signaling pathway" evidence=TAS

GO:0048015 "phosphatidylinositol-mediated signaling" evidence=TAS

UNIPROTKB|F1P4J0 RPS6KB1 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 629 (226.5 bits), Expect = 1.6e-61, P = 1.6e-61
 Identities = 120/237 (50%), Positives = 167/237 (70%)

Query:   150 EDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILT 205
             E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  I+       + K+ERNIL 
Sbjct:    66 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 125

Query:   206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+F ED A  Y AEI  A+ H
Sbjct:   126 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 185

Query:   266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
             LH  GI++RDLKPENI+L+  GHV LTDFGL K+   + T +++ CGT+EYM+PEI++  
Sbjct:   186 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 245

Query:   325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
             GH++A DWWS+G L+++MLTG PPFTG NR             LP +L+ EA  LLK
Sbjct:   246 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK 302

GO:0004435 "phosphatidylinositol phospholipase C activity" evidence=IEA

GO:0006629 "lipid metabolic process" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=IEA

GO:0005739 "mitochondrion" evidence=IEA

GO:0007281 "germ cell development" evidence=IEA

GO:0031929 "TOR signaling cascade" evidence=IEA

GO:0043066 "negative regulation of apoptotic process" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0045931 "positive regulation of mitotic cell cycle" evidence=IEA

GO:0045948 "positive regulation of translational initiation" evidence=IEA

GO:0071363 "cellular response to growth factor stimulus" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q39030	KPK2_ARATH	2, ., 7, ., 1, 1, ., 1	0.6953	0.9318	0.7834	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	396
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-132
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-107
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-104
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-96
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-89
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-89
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-89
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-85
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-84
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-83
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	8e-83
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-82
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-82
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	9e-82
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-81
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-80
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-80
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-79
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-78
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-76
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-74
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-73
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	6e-73
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	9e-73
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-72
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-72
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-71
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-71
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-70
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-69
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-68
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-68
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	6e-68
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-67
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-67
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-65
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-65
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-65
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-64
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-64
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-62
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-62
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-62
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-62
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	7e-62
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-61
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-61
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-60
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-60
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-60
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	8e-60
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-59
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-59
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-57
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-57
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-56
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-56
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-56
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-55
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-55
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-52
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-51
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-51
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	7e-51
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-50
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-49
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-49
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-49
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-49
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-48
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-48
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-48
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	8e-48
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-45
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-45
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-45
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-43
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-42
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-41
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-41
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	9e-41
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-40
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-40
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-40
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-40
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-40
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	9e-40
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-38
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	8e-38
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-37
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-37
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-37
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-37
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-37
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-37
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-36
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-36
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-36
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-35
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-35
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-34
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-34
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-34
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-33
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	9e-33
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-32
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-32
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-32
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-32
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-32
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-32
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-31
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-31
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-31
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-31
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	7e-31
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	7e-31
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-31
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-30
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-30
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	8e-30
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	9e-30
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-29
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-29
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-29
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-29
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-28
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-28
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-28
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-28
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-28
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	9e-28
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-27
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-27
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-27
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-27
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-27
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-27
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-27
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	8e-27
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	9e-27
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	9e-27
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-26
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-26
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-26
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-26
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-25
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-25
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-25
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-25
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-25
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-25
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-24
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-24
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-24
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-24
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-24
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-24
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	9e-24
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-23
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-23
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-23
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-23
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-23
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-23
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-23
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-23
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-23
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-22
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-22
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-22
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-22
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-22
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	7e-22
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-21
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-21
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-21
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-21
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-21
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-21
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-20
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-20
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-20
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-20
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-20
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-20
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-20
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-20
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-20
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-19
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-19
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-19
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-19
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-19
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	9e-19
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-18
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-18
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-18
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-18
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-18
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-17
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-17
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-17
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-17
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-17
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	9e-17
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-16
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-16
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-16
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-16
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-16
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-15
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-15
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-15
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-15
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-15
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-15
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-15
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	8e-15
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-14
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-14
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-14
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-14
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-14
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-14
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-13
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-13
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-13
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-13
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-13
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-13
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-13
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-12
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-12
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-12
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-12
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-12
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-12
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-12
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-12
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	9e-12
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-11
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-11
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-11
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	7e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	9e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-09
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	8e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	8e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-08
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-08
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	9e-08
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-07
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-07
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-07
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-07
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-07
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	9e-07
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-06
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-06
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	3e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-06
PRK09188	365	PRK09188, PRK09188, serine/threonine protein kinas	6e-06
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	9e-06
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-05
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	2e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	4e-05
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	5e-05
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-05
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	1e-04
COG4248	637	COG4248, COG4248, Uncharacterized protein with pro	3e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	6e-04
TIGR01982	437	TIGR01982, UbiB, 2-polyprenylphenol 6-hydroxylase	7e-04
COG0661	517	COG0661, AarF, Predicted unusual protein kinase [G	0.001
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.001
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	0.002
PRK01723	239	PRK01723, PRK01723, 3-deoxy-D-manno-octulosonic-ac	0.003

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  379 bits (977), Expect = e-132
 Identities = 125/226 (55%), Positives = 178/226 (78%), Gaps = 1/226 (0%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+F KV  VR+  T ++YAMKV++K KI+++   E+  +ERNIL++++HPFIV+L Y
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           +FQT+ +LYLVL++  GG LF  L ++G F E+ AR Y AEIV A+ +LH+ GI++RDLK
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 278 PENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
           PENILLDADGH+ LTDFGLAK+   E +R+N+ CGT EY++PE++LGKG+ KA DWWS+G
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLG 180

Query: 337 ILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG 382
           +LL+EMLTG+PPF   +R++I +KI+KD ++ P FLS EA  L+ G
Sbjct: 181 VLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISG 226

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  317 bits (815), Expect = e-107
 Identities = 106/233 (45%), Positives = 162/233 (69%), Gaps = 2/233 (0%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE +K +G G+F +V  VR  G+ + YA+K++ K KI++    E++ +E+ IL  + H
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF+V L  SFQ    LYLV+++V GG LF  L + G F E +AR Y A++V A+ +LH+ 
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKA 329
            I++RDLKPEN+LLD+DG++ +TDFG AK+    T   ++CGT EY++PEI+L KG+ KA
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY--TLCGTPEYLAPEIILSKGYGKA 178

Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG 382
            DWW++GIL++EML G PPF   N  +I +KI++ K++ P+F S +A  L++ 
Sbjct: 179 VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRN 231

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  308 bits (791), Expect = e-104
 Identities = 109/235 (46%), Positives = 156/235 (66%), Gaps = 6/235 (2%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+L+ +G+G+F KVY  R   T ++ A+KV++K KI  K   E +  E  IL K+ HP 
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+L   F+ + +LYLV+++  GG LF  L ++G   ED AR Y  +I+SA+ +LH+ GI
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAAD 331
           +HRDLKPENILLD DGHV L DFGLA+Q D   +  +  GT EYM+PE++LGKG+ KA D
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVD 178

Query: 332 WWSVGILLFEMLTGQPPFTG-GNRQKIQQKIIKDKIKLPAF---LSSEAHSLLKG 382
            WS+G++L+E+LTG+PPF G     ++ +KI K K   P     +S EA  L++ 
Sbjct: 179 IWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRK 233

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  290 bits (745), Expect = 2e-96
 Identities = 127/233 (54%), Positives = 172/233 (73%), Gaps = 7/233 (3%)

Query: 155 LKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIM--EKNHAEYMKSERNILTKVDH 209
           LKV+G+G + KV+QVR++    T +I+AMKV++K  I+  +K+ A + K+ERNIL  V H
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTA-HTKAERNILEAVKH 59

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PFIV L Y+FQT  +LYL+L++++GG LF  L R+G+F ED A  Y +EI  A+ HLH  
Sbjct: 60  PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           GI++RDLKPENILLDA GHV LTDFGL K+   E T +++ CGT+EYM+PEI++  GH K
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGK 179

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
           A DWWS+G L+++MLTG PPFT  NR+K   KI+K K+ LP +L+ EA  LLK
Sbjct: 180 AVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLK 232

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  272 bits (697), Expect = 2e-89
 Identities = 118/231 (51%), Positives = 170/231 (73%), Gaps = 5/231 (2%)

Query: 155 LKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           LKV+GQG+F KV+ VR+I      ++YAMKV++K  +  ++     K ER+IL +V+HPF
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVR-TKMERDILAEVNHPF 59

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+L Y+FQT+ +LYL+LDF+ GG LF +L ++ +F E+  + Y AE+  A+ HLH+ GI
Sbjct: 60  IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           ++RDLKPENILLD +GH+ LTDFGL+K+  D   ++ S CGT+EYM+PE+V  +GH ++A
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSA 179

Query: 331 DWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
           DWWS G+L+FEMLTG  PF G +R++    I+K K+ +P FLS EA SLL+
Sbjct: 180 DWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 230

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  270 bits (692), Expect = 3e-89
 Identities = 102/236 (43%), Positives = 156/236 (66%), Gaps = 11/236 (4%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           + +GA+ +V+  ++  T +IYA+KV++K  ++ KN  + + +ER+IL++   P++V+L Y
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           SFQ K  LYLV++++ GG L   L   G   ED+ARIY AEIV A+ +LH+NGI+HRDLK
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120

Query: 278 PENILLDADGHVMLTDFGLAK---------QFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           P+NIL+D++GH+ LTDFGL+K           D+      + GT +Y++PE++LG+GH K
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSK 180

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAF--LSSEAHSLLKG 382
             DWWS+G +L+E L G PPF G   ++I Q I+  KI+ P    +S EA  L+  
Sbjct: 181 TVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISK 236

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  270 bits (692), Expect = 5e-89
 Identities = 121/243 (49%), Positives = 172/243 (70%), Gaps = 13/243 (5%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEKNH-AEYMKSERNILTK 206
           +FE+L+V+G GA+ KV+ VR++G     ++YAMKV++K  I++K   AE+ ++ER +L  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 207 VDH-PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           V   PF+V L Y+FQT  +L+L+LD+VNGG LF  LY++  F E   R+Y AEIV A+ H
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLG 323
           LH  GI++RD+K ENILLD++GHV+LTDFGL+K+F  +E  R+ S CGT+EYM+PE++ G
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRG 180

Query: 324 K--GHDKAADWWSVGILLFEMLTGQPPFT---GGNRQK-IQQKIIKDKIKLPAFLSSEAH 377
              GHDKA DWWS+G+L FE+LTG  PFT     N Q  I ++I+K K   P  +S+EA 
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEAR 240

Query: 378 SLL 380
             +
Sbjct: 241 DFI 243

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  263 bits (673), Expect = 2e-85
 Identities = 107/265 (40%), Positives = 160/265 (60%), Gaps = 34/265 (12%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFEV+KV+G+GAF +V+ VR   T ++YAMKV+RK  ++++N   ++++ER+IL   D 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P+IV+L YSFQ +  LYLV++++ GG L   L R+ +F E+ AR Y AE+V A+  +H  
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-------------------------- 303
           G +HRD+KP+NIL+DADGH+ L DFGL K+ ++                           
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180

Query: 304 ----TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ 359
                R+NS  GT +Y++PE++ G  +    DWWS+G++L+EML G PPF     Q+   
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240

Query: 360 KIIKDKIKL--PAF--LSSEAHSLL 380
           KII  K  L  P    +S EA  L+
Sbjct: 241 KIINWKESLRFPPDPPVSPEAIDLI 265

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  256 bits (657), Expect = 3e-84
 Identities = 93/239 (38%), Positives = 142/239 (59%), Gaps = 3/239 (1%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+L+ +G G+F  VY+ +  GT +I A+K+++K     K        E  IL ++ HP 
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTAR-REIRILRRLSHPN 59

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+L  +F+ K  LYLV+++  GG LF  L R G   ED A+    +I+  + +LH+NGI
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-NSMCGTLEYMSPEIVL-GKGHDKA 329
           +HRDLKPENILLD +G V + DFGLAK+  +++ S  +  GT  YM+PE++L G G+   
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179

Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLS 388
            D WS+G++L+E+LTG+PPF+G N     Q I +       F   +  S  +    L+ 
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIK 238

Length = 260

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  254 bits (651), Expect = 4e-83
 Identities = 94/228 (41%), Positives = 149/228 (65%), Gaps = 4/228 (1%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F +V  V+    +  +A+K ++K  I+E    E++ SE+ IL + +HPFIV+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           +F+ K  +Y+++++  GG L+  L  +GLF E  AR Y A +V A  +LH  GI++RDLK
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 278 PENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGI 337
           PEN+LLD++G+V L DFG AK+     ++ + CGT EY++PEI+L KG+D + D+WS+GI
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGI 180

Query: 338 LLFEMLTGQPPFTGGNR--QKIQQKIIK--DKIKLPAFLSSEAHSLLK 381
           LL+E+LTG+PPF   +    +I   I+K   K++ P ++   A  L+K
Sbjct: 181 LLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIK 228

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  254 bits (650), Expect = 8e-83
 Identities = 96/262 (36%), Positives = 153/262 (58%), Gaps = 25/262 (9%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD- 208
           +DF+  K++G+G+F+ V   +   T++ YA+K++ K +++++   +Y+K E+ +LT+++ 
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I++L Y+FQ +  LY VL++   G L   + + G   E   R Y AEI+ A+ +LH+
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---------------------TRSN 307
            GI+HRDLKPENILLD D H+ +TDFG AK  D N                      R  
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180

Query: 308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK 367
           S  GT EY+SPE++  K   K++D W++G ++++MLTG+PPF G N     QKI+K +  
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS 240

Query: 368 LPAFLSSEAHSLLKGVNSLLSI 389
            P     +A  L   +  LL +
Sbjct: 241 FPPNFPPDAKDL---IEKLLVL 259

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  252 bits (645), Expect = 2e-82
 Identities = 99/240 (41%), Positives = 151/240 (62%), Gaps = 6/240 (2%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           FE+L+V+G+GAF KV  V++  T +++AMK M K K +EK     + +ER IL +++HPF
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           +V L YSFQ +  +YLV+D + GG L + L ++  F E+  + +  EIV A+ +LH+ GI
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAAD 331
           +HRD+KP+NILLD  GHV +TDF +A +   +T + S  GT  YM+PE++  +G+  A D
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVD 181

Query: 332 WWSVGILLFEMLTGQPPFTG---GNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLS 388
           WWS+G+  +E L G+ P+ G     R +I+ K     +  PA  S+EA      +N LL 
Sbjct: 182 WWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDA---INKLLE 238

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  253 bits (648), Expect = 5e-82
 Identities = 105/230 (45%), Positives = 156/230 (67%), Gaps = 2/230 (0%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQ 214
           KV+G+G+F KV   +     + YA+KV++K  I++K   +++ +ERN+L K V HPF+V 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L YSFQT  +LY VLD+VNGG LFF L R+  F E  AR Y AEI SA+ +LH+  I++R
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           DLKPENILLD+ GHV+LTDFGL K+  + +  +++ CGT EY++PE++  + +D+  DWW
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWW 180

Query: 334 SVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV 383
            +G +L+EML G PPF   +  ++   I+   ++L   +S  A  LL+G+
Sbjct: 181 CLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGL 230

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  253 bits (647), Expect = 9e-82
 Identities = 120/243 (49%), Positives = 175/243 (72%), Gaps = 12/243 (4%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEKNH-AEYMKSERNILTK 206
           +FE+LKV+G GA+ KV+ VR++    T ++YAMKV++K  +++K    E+ ++ERN+L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 207 V-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           V   PF+V L Y+FQT+ +L+L+LD+V+GG +F  LY++  F ED  R Y+ EI+ A+ H
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLG 323
           LH  GI++RD+K ENILLD++GHV+LTDFGL+K+F  +E  R+ S CGT+EYM+PEI+ G
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG 180

Query: 324 K-GHDKAADWWSVGILLFEMLTGQPPFT-GGNRQ---KIQQKIIKDKIKLPAFLSSEAHS 378
           K GH KA DWWS+GIL+FE+LTG  PFT  G R    ++ ++I+K     P+F+  EA  
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD 240

Query: 379 LLK 381
           LL 
Sbjct: 241 LLH 243

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  251 bits (641), Expect = 4e-81
 Identities = 106/227 (46%), Positives = 158/227 (69%), Gaps = 1/227 (0%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+F KV QVR+  T  IYA+K +RK  I+ ++   +  +ER +L +V+ PFIV L++
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           SFQ+  +LYLVL F+NGG LF  L R+G F    AR YTAE++ A+ +LH   +++RDLK
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120

Query: 278 PENILLDADGHVMLTDFGLAK-QFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
           PENILLD  GH+ L DFGL K    ++ ++N+ CGT EY++PE++LG G+ KA DWW++G
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLG 180

Query: 337 ILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV 383
           +LL+EMLTG PPF   N  ++ +KI+++ ++ P     +A  LL G+
Sbjct: 181 VLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGL 227

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  248 bits (636), Expect = 3e-80
 Identities = 105/265 (39%), Positives = 157/265 (59%), Gaps = 34/265 (12%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
            F+ +K++G+G   +V+ VR  GT +++A+KV+ K +++++N  + + +E+ IL  +DHP
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHA 268
           F+  L  SFQT+  L LV+D+  GG LF  L RQ      E++AR Y AE++ A+ +LH 
Sbjct: 62  FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL 121

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-------------------------- 302
            GI++RDLKPENILL   GH+ML+DF L+KQ D                           
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181

Query: 303 ----NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ 358
               + RSNS  GT EY++PE++ G GH  A DWW++GILL+EML G  PF G NR +  
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETF 241

Query: 359 QKIIKDKIKLP--AFLSSEAHSLLK 381
             I+K ++  P    +SS A  L++
Sbjct: 242 SNILKKEVTFPGSPPVSSSARDLIR 266

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  246 bits (630), Expect = 9e-80
 Identities = 97/232 (41%), Positives = 150/232 (64%), Gaps = 2/232 (0%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D E +K VG G F +V+ VR   +   YA+KVM   +++     +++ +E+ +L +V H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PFI++L ++   +  LY+++++V GG LF  L   G F       Y +EIV A+ +LH+ 
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKA 329
            I++RDLKPENILLD +GH+ LTDFG AK+  +  R+ ++CGT EY++PE++  KGH+KA
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD--RTWTLCGTPEYLAPEVIQSKGHNKA 178

Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
            DWW++GIL++EML G PPF   N   I +KI+  K++ P  L   A  L+K
Sbjct: 179 VDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIK 230

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  245 bits (627), Expect = 7e-79
 Identities = 100/229 (43%), Positives = 153/229 (66%), Gaps = 2/229 (0%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQ 214
           KV+G+G+F KV      GT E+YA+KV++KD I++ +  E   +E+ +L     HPF+ Q
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   FQTK RL+ V+++VNGG L F + R G F E  AR Y AEIV  +  LH  GI++R
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           DLK +N+LLD++GH+ + DFG+ K+       +++ CGT +Y++PEI+  + +  A DWW
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWW 180

Query: 334 SVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG 382
           ++G+LL+EML GQ PF G +  ++ Q I++D+++ P +LS EA S+LK 
Sbjct: 181 ALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKS 229

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  245 bits (627), Expect = 1e-78
 Identities = 101/235 (42%), Positives = 157/235 (66%), Gaps = 2/235 (0%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L DFE+ + +G G+F +V   +  GT E YA+K ++K +I++    +++  E++IL ++ 
Sbjct: 17  LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HPFIV +  SFQ + R+Y +L+FV GG LF  L + G F  D+A+ Y AE+V A  +LH+
Sbjct: 77  HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS 136

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             I++RDLKPEN+LLD  GHV +TDFG AK+  +  R+ ++CGT EY++PE++  KGH K
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD--RTFTLCGTPEYLAPEVIQSKGHGK 194

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV 383
           A DWW++G+LL+E + G PPF      +I +KI+  ++K P +    A  L+KG+
Sbjct: 195 AVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGL 249

Length = 329

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  236 bits (604), Expect = 8e-76
 Identities = 113/244 (46%), Positives = 174/244 (71%), Gaps = 13/244 (5%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEK-NHAEYMKSERNILTK 206
           +FE+LKV+G GA+ KV+ VR++    + ++YAMKV++K  I++K    E+ ++ER +L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 207 VDH-PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           +   PF+V L Y+FQT  +L+L+LD++NGG LF  L ++  F+E   +IY+ EIV A+ H
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLG 323
           LH  GI++RD+K ENILLD++GHV+LTDFGL+K+F  DE  R+ S CGT+EYM+P+IV G
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180

Query: 324 --KGHDKAADWWSVGILLFEMLTGQPPFT----GGNRQKIQQKIIKDKIKLPAFLSSEAH 377
              GHDKA DWWS+G+L++E+LTG  PFT      ++ +I ++I+K +   P  +S+ A 
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 240

Query: 378 SLLK 381
            +++
Sbjct: 241 DIIQ 244

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  233 bits (596), Expect = 4e-74
 Identities = 109/232 (46%), Positives = 154/232 (66%), Gaps = 6/232 (2%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIVQ 214
           +G+G F +VYQVR+  T  IYAMKV+ K +I+ K    +   ERNIL +    + PFIV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L++SFQT   LYLV D+++GG LF+ L ++G F ED A+ Y AE+V A+ HLH   I++R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAK-QFDENTRSNSMCGTLEYMSPEIVLG-KGHDKAADW 332
           DLKPENILLDA GH+ L DFGL+K    +N  +N+ CGT EY++PE++L  KG+ K  D+
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDF 180

Query: 333 WSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP-AFLSSEAHSLLKGV 383
           WS+G+L+FEM  G  PF   + Q++ + I   K++ P   LS E    +KG+
Sbjct: 181 WSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGL 232

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  232 bits (592), Expect = 1e-73
 Identities = 100/230 (43%), Positives = 154/230 (66%), Gaps = 3/230 (1%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           K++G+G F KV  VR   T + YAMK+++K+ I+ K+   +  +E  +L    HPF+  L
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +YSFQT  RL  V+++ NGG LFF L R+ +F ED AR Y AEIVSA+ +LH+  +++RD
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120

Query: 276 LKPENILLDADGHVMLTDFGLAKQ--FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           LK EN++LD DGH+ +TDFGL K+   D  T   + CGT EY++PE++    + +A DWW
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGISDGATMK-TFCGTPEYLAPEVLEDNDYGRAVDWW 179

Query: 334 SVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV 383
            +G++++EM+ G+ PF   + +K+ + I+ ++I+ P  LS EA SLL G+
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGL 229

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  228 bits (583), Expect = 6e-73
 Identities = 82/244 (33%), Positives = 143/244 (58%), Gaps = 10/244 (4%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
            +E++K +G+G+F KVY VRR    ++Y +K +    + EK   + +  E  IL K++HP
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN-EVKILKKLNHP 59

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHL 266
            I++   SF+ K +L +V+++ +GG L  ++ +Q      F E+    +  ++  A+ +L
Sbjct: 60  NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-NSMCGTLEYMSPEIVLGKG 325
           H+  I+HRD+KP+NI L ++G V L DFG++K          ++ GT  Y+SPE+   K 
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP 179

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-LPAFLSSEAHSLLKGVN 384
           ++  +D WS+G +L+E+ T + PF G N  ++  KI+K +   +P+  SSE  +L   V+
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNL---VS 236

Query: 385 SLLS 388
           SLL 
Sbjct: 237 SLLQ 240

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  231 bits (590), Expect = 9e-73
 Identities = 100/275 (36%), Positives = 160/275 (58%), Gaps = 43/275 (15%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE +KV+G+GAF +V  V++  T  IYAMK +RK +++EK    ++++ER+IL + D+
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++V+L YSFQ +  LYL+++++ GG +   L ++  F E+  R Y AE + A+  +H  
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN---------------------- 307
           G +HRD+KP+N+LLDA GH+ L+DFGL     ++ R+                       
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180

Query: 308 -----------------SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFT 350
                            S  GT +Y++PE+ L  G++K  DWWS+G++++EML G PPF 
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240

Query: 351 GGNRQKIQQKII--KDKIKLP--AFLSSEAHSLLK 381
             N Q+  +KII  K+ ++ P    LS EA  L+K
Sbjct: 241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIK 275

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  229 bits (585), Expect = 1e-72
 Identities = 104/230 (45%), Positives = 153/230 (66%), Gaps = 2/230 (0%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQ 214
           KV+G+G+F KV   +R      YA+KV++K  I++K    ++ +ERN+L K + HPF+V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L YSFQT  +LY VLD+VNGG LFF L R+  F E  AR Y AE+ SA+ +LH+  I++R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           DLKPENILLD+ GHV+LTDFGL K+  +    +++ CGT EY++PE++  + +D+  DWW
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWW 180

Query: 334 SVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV 383
            +G +L+EML G PPF   +  ++   I+   ++LP   +  A  LL G+
Sbjct: 181 CLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGL 230

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  228 bits (583), Expect = 2e-72
 Identities = 96/229 (41%), Positives = 146/229 (63%), Gaps = 2/229 (0%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT-KVDHPFIVQ 214
           KV+G+G+F KV      GT E+YA+KV++KD I++ +  +   +E+ IL     HPF+  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   FQTK RL+ V+++VNGG L FQ+ R   F E  +R Y AE+  A+  LH +G+++R
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           DLK +NILLDA+GH  L DFG+ K+       + + CGT +Y++PEI+    +  + DWW
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWW 180

Query: 334 SVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG 382
           ++G+L++EM+ GQPPF   N   + + I+ D +  P +LS EA S+LK 
Sbjct: 181 ALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKA 229

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  226 bits (577), Expect = 2e-71
 Identities = 99/235 (42%), Positives = 151/235 (64%), Gaps = 4/235 (1%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DF  L V+G+G+F KV    R GT E+YA+K+++KD I++ +  E    E+ +L     P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60

Query: 211 -FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
            F+ QL   FQT  RLY V+++VNGG L + + + G F+E  A  Y AEI   +  LH+ 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQ--FDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           GI++RDLK +N++LDA+GH+ + DFG+ K+  F   T + + CGT +Y++PEI+  + + 
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT-TRTFCGTPDYIAPEIIAYQPYG 179

Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG 382
           K+ DWW+ G+LL+EML GQPPF G +  ++ Q I++  +  P  LS EA S+ KG
Sbjct: 180 KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG 234

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  225 bits (574), Expect = 6e-71
 Identities = 104/230 (45%), Positives = 157/230 (68%), Gaps = 2/230 (0%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQ 214
           KV+G+G+F KV   R     + YA+KV++K  I++K   +++ SERN+L K V HPF+V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L +SFQT  +LY VLD++NGG LF+ L R+  F E  AR Y AEI SA+ +LH+  I++R
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           DLKPENILLD+ GH++LTDFGL K+  + N  +++ CGT EY++PE++  + +D+  DWW
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWW 180

Query: 334 SVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV 383
            +G +L+EML G PPF   N  ++   I+   ++L   +++ A  LL+G+
Sbjct: 181 CLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGL 230

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  225 bits (576), Expect = 1e-70
 Identities = 106/277 (38%), Positives = 157/277 (56%), Gaps = 48/277 (17%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  +K +G GAF +V  VR++ T+ +YAMK +RK  ++ +N A ++K+ER+IL + D+ +
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           +V+L YSFQ K  LY V+D++ GG +   L R G+F EDLAR Y AE+  A+  +H  G 
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQF-----------DENTRSNSM----------- 309
           +HRD+KP+NIL+D DGH+ LTDFGL   F            ++ R +SM           
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 310 ----------------------CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQP 347
                                  GT  Y++PE++L  G+ +  DWWSVG++L+EML GQP
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242

Query: 348 PFTGGNRQKIQQKII--KDKIKLP--AFLSSEAHSLL 380
           PF      + Q K+I  +  + +P  A LS EA  L+
Sbjct: 243 PFLADTPAETQLKVINWETTLHIPSQAKLSREASDLI 279

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  221 bits (564), Expect = 3e-69
 Identities = 95/240 (39%), Positives = 140/240 (58%), Gaps = 10/240 (4%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DF++L  VGQG + +V+  ++  T EI A+K M+K  + + N   ++ +ER+ILT     
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
           ++V+L Y+FQ    LYL +++V GG     L   G+  ED AR Y AE+  AV  LH  G
Sbjct: 62  WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121

Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
            +HRDLKPEN L+DA GH+ LTDFGL+K     T +NS+ G+ +YM+PE++ GKG+D   
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGI--VTYANSVVGSPDYMAPEVLRGKGYDFTV 179

Query: 331 DWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK--------DKIKLPAFLSSEAHSLLKG 382
           D+WS+G +L+E L G PPF+G    +  + +                  LS EA  L+  
Sbjct: 180 DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITK 239

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  219 bits (559), Expect = 1e-68
 Identities = 97/230 (42%), Positives = 153/230 (66%), Gaps = 3/230 (1%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           K++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L    HPF+  L
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +LH+  +++RD
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120

Query: 276 LKPENILLDADGHVMLTDFGLAKQ--FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           +K EN++LD DGH+ +TDFGL K+   D  T   + CGT EY++PE++    + +A DWW
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGISDGATM-KTFCGTPEYLAPEVLEDNDYGRAVDWW 179

Query: 334 SVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV 383
            +G++++EM+ G+ PF   + +++ + I+ ++I+ P  LS EA SLL G+
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 229

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  218 bits (557), Expect = 3e-68
 Identities = 99/229 (43%), Positives = 154/229 (67%), Gaps = 1/229 (0%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           K++G+G F KV  VR   + + YAMK+++K+ I+ K+   +  +E  +L    HPF+  L
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +YSFQTK RL  V+++VNGG LFF L R+ +F ED  R Y AEIVSA+ +LH+  I++RD
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120

Query: 276 LKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWS 334
           LK EN++LD DGH+ +TDFGL K+   +     + CGT EY++PE++    + +A DWW 
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 180

Query: 335 VGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV 383
           +G++++EM+ G+ PF   + +K+ + I+ + IK P  LS++A SLL G+
Sbjct: 181 LGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGL 229

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  217 bits (554), Expect = 6e-68
 Identities = 92/230 (40%), Positives = 146/230 (63%), Gaps = 2/230 (0%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT-KVDHPFIVQ 214
           KV+G+G+F KV      GT+E +A+K ++KD ++E +  E    ER +L    +HPF+  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L  +FQTK  L+ V++++NGG L F +   G F E  AR Y AEI+  +  LH  GI++R
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAK-QFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           DLK +N+LLD DGH+ + DFG+ K   +   ++++ CGT +Y++PEI+ G+ ++++ DWW
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWW 180

Query: 334 SVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV 383
           S G+LL+EML GQ PF G +  ++   I+ D+   P ++S EA   L  +
Sbjct: 181 SFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKL 230

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  214 bits (546), Expect = 1e-67
 Identities = 97/238 (40%), Positives = 144/238 (60%), Gaps = 11/238 (4%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL-TKVDHPFIV 213
           LK + +GAF  VY  ++  T + +A+KV++K  ++ KN    +K+ER I+  + + P++ 
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
           +L YSFQ+K  LYLV++++NGG     +   G   ED A+ Y AE+V  V  LH  GI+H
Sbjct: 61  KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120

Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           RD+KPEN+L+D  GH+ LTDFGL++   EN +     GT +Y++PE +LG G DK +DWW
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLENKK---FVGTPDYLAPETILGVGDDKMSDWW 177

Query: 334 SVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLKGVNSLL 387
           S+G ++FE L G PPF       +   I+  +I  P     F S EA  L   +N LL
Sbjct: 178 SLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDL---INRLL 232

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  214 bits (547), Expect = 7e-67
 Identities = 104/228 (45%), Positives = 151/228 (66%), Gaps = 2/228 (0%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQ 214
           KV+G+G+F KV   +R    + YA+KV++K  ++ +   +++ +ERN+L K V HPF+V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L YSFQT  +LY VLDFVNGG LFF L R+  F E  AR Y AEI SA+ +LH+  I++R
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           DLKPENILLD+ GHV+LTDFGL K+   ++  + + CGT EY++PE++  + +D   DWW
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWW 180

Query: 334 SVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
            +G +L+EML G PPF   +  ++   I+   + L    S  A S+L+
Sbjct: 181 CLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILE 228

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  211 bits (540), Expect = 1e-65
 Identities = 85/236 (36%), Positives = 142/236 (60%), Gaps = 9/236 (3%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL---TKVD 208
           F  L V+G+G F KV       T E+YA+K ++K  I+ ++  E +  E+ I        
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HPF+V L   FQT+  +  V+++  GG L   ++   +F E  A  Y A +V  + +LH 
Sbjct: 61  HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHE 119

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQ---FDENTRSNSMCGTLEYMSPEIVLGKG 325
           N I++RDLK +N+LLD +G V + DFGL K+   F +  R+++ CGT E+++PE++    
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETS 177

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
           + +A DWW +G+L++EML G+ PF G + +++   I+ D+++ P FLS EA S+++
Sbjct: 178 YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMR 233

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  210 bits (536), Expect = 3e-65
 Identities = 97/230 (42%), Positives = 152/230 (66%), Gaps = 2/230 (0%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           K++G+G F KV  V+   T   YAMK+++K+ I+ K+   +  +E  +L    HPF+  L
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHR 274
           +YSFQT  RL  V+++ NGG LFF L R+ +F ED AR Y AEIVSA+ +LH+   +++R
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           DLK EN++LD DGH+ +TDFGL K+   +     + CGT EY++PE++    + +A DWW
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 180

Query: 334 SVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV 383
            +G++++EM+ G+ PF   + +K+ + I+ ++I+ P  LS EA SLL G+
Sbjct: 181 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGL 230

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  207 bits (530), Expect = 5e-65
 Identities = 82/238 (34%), Positives = 133/238 (55%), Gaps = 9/238 (3%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++   +++G+G+F  VY      T E+ A+K +      E+      + E  IL+ + HP
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALER-EIRILSSLQHP 59

Query: 211 FIVQLRYSFQTKYR--LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            IV+   S + + +  L + L++V+GG L   L + G   E + R YT +I+  +++LH+
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKG 325
           NGI+HRD+K  NIL+D+DG V L DFG AK+  +      + S+ GT  +M+PE++ G+ 
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKIIKDKIK--LPAFLSSEAHSLL 380
           + +AAD WS+G  + EM TG+PP++  GN      KI        +P  LS EA   L
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  208 bits (532), Expect = 1e-64
 Identities = 98/241 (40%), Positives = 159/241 (65%), Gaps = 17/241 (7%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL-TKVDHPFIVQ 214
           +V+G+G++AKV  V    T  IYAMKV++K+ + +    +++++E+++  T  +HPF+V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   FQT+ RL+ V++FV+GG L F + RQ    E+ AR Y+AEI  A++ LH  GI++R
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAKQFDENTR----SNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLK +N+LLDA+GH+ LTD+G+ K   E  R    +++ CGT  Y++PEI+ G+ +  + 
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177

Query: 331 DWWSVGILLFEMLTGQPPF--TGGNRQKIQ-------QKIIKDKIKLPAFLSSEAHSLLK 381
           DWW++G+L+FEM+ G+ PF   G +    Q       Q I++ +I++P  LS +A S+LK
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237

Query: 382 G 382
           G
Sbjct: 238 G 238

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  207 bits (529), Expect = 3e-64
 Identities = 93/229 (40%), Positives = 144/229 (62%), Gaps = 2/229 (0%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQ 214
           +V+G+G+F KV   R   +  +YA+KV++KD I++ +  E   +E+ IL+   +HPF+ Q
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   FQT  RL+ V++FVNGG L F + +   F E  AR Y AEI SA+  LH  GI++R
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           DLK +N+LLD +GH  L DFG+ K+       +++ CGT +Y++PEI+    +  + DWW
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWW 180

Query: 334 SVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG 382
           ++G+LL+EML G  PF   N   + + I+ D++  P +LS +A  +LK 
Sbjct: 181 AMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKA 229

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  204 bits (519), Expect = 1e-62
 Identities = 96/235 (40%), Positives = 151/235 (64%), Gaps = 2/235 (0%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DF  L V+G+G+F KV    R GT E+YA+K+++KD +++ +  E    E+ +L   D P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 211 -FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
            F+ QL   FQT  RLY V+++VNGG L + + + G F+E  A  Y AEI   +  LH  
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           GI++RDLK +N++LD++GH+ + DFG+ K+   +   + + CGT +Y++PEI+  + + K
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGK 180

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV 383
           + DWW+ G+LL+EML GQPPF G +  ++ Q I++  +  P  LS EA S+ KG+
Sbjct: 181 SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGL 235

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  205 bits (522), Expect = 2e-62
 Identities = 105/281 (37%), Positives = 152/281 (54%), Gaps = 52/281 (18%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  +K +G GAF +V   R++ T  +YAMK +RK  ++ +N   ++K+ER+IL + D+ +
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           +V+L YSFQ K  LY V+D++ GG +   L R G+F EDLAR Y AE+  AV  +H  G 
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQF----------------------------DEN 303
           +HRD+KP+NIL+D DGH+ LTDFGL   F                              N
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 304 TR--------------------SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEML 343
            R                    ++S+ GT  Y++PE++L  G+ +  DWWSVG++L+EML
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 344 TGQPPFTGGNRQKIQQKIIKDK----IKLPAFLSSEAHSLL 380
            GQPPF      + Q K+I  +    I   A LS EA  L+
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLI 283

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  201 bits (514), Expect = 2e-62
 Identities = 79/231 (34%), Positives = 134/231 (58%), Gaps = 6/231 (2%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G F +V   +   T ++YA K + K ++ ++   +   +E+ IL KV   FIV L Y
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +F+TK  L LV+  +NGG L + +Y  G   F E  A  Y A+I+  + HLH   I++RD
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120

Query: 276 LKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSV 335
           LKPEN+LLD  G+V ++D GLA +     +     GT  YM+PE++ G+ +D + DW+++
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFAL 180

Query: 336 GILLFEMLTGQPPF----TGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG 382
           G  L+EM+ G+ PF        +++++++ ++  ++ P   S EA  L + 
Sbjct: 181 GCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEA 231

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  203 bits (517), Expect = 2e-62
 Identities = 93/235 (39%), Positives = 151/235 (64%), Gaps = 2/235 (0%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DF  L V+G+G+F KV    R GT E+YA+K+++KD +++ +  E    E+ +L     P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 211 -FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
            F+ QL   FQT  RLY V+++VNGG L +Q+ + G F+E  A  Y AEI   +  LH+ 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           GI++RDLK +N++LD++GH+ + DFG+ K+   +   + + CGT +Y++PEI+  + + K
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGK 180

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV 383
           + DWW+ G+LL+EML GQ PF G +  ++ Q I++  +  P  +S EA ++ KG+
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL 235

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  201 bits (514), Expect = 7e-62
 Identities = 99/250 (39%), Positives = 148/250 (59%), Gaps = 17/250 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DF+V  +VG+G F +V  VR   T +IYAMKVM+K  ++ +    + + ER+IL+  + 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA 268
           P+I QL+Y+FQ K  LYLV+++  GG L   L R +  F ED+A+ Y AE+V A+  +H 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM--CGTLEYMSPEIVL---- 322
            G +HRD+KPEN+L+D  GH+ L DFG A +   N   NS    GT +Y++PE++     
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNG 180

Query: 323 -GKG-HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII--KDKIKLPAFL--SSEA 376
            GKG +    DWWS+G++ +EM+ G+ PF  G   K    I+  +  +K P     SS+ 
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240

Query: 377 ----HSLLKG 382
                SLL G
Sbjct: 241 LDLIQSLLCG 250

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  202 bits (516), Expect = 1e-61
 Identities = 102/284 (35%), Positives = 154/284 (54%), Gaps = 52/284 (18%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF  +KV+G+GAF +V  V++  T +IYAMK + K ++ +K+   ++K+ER++L + D 
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++V L YSFQ    LYL+++F+ GG L   L +   F ED+ R Y AE V A+  +H  
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLA----KQFDEN---------------------- 303
           G +HRD+KP+NIL+D  GH+ L+DFGL+    KQ D                        
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180

Query: 304 ------TRSN----------------SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFE 341
                 T S+                S  GT +Y++PEI L +G+ +  DWWS+G ++FE
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240

Query: 342 MLTGQPPFTGGNRQKIQQKII--KDKIKLP--AFLSSEAHSLLK 381
            L G PPF   N  +  +KII  ++ +  P    LS EA  L++
Sbjct: 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIR 284

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  200 bits (509), Expect = 5e-61
 Identities = 101/242 (41%), Positives = 144/242 (59%), Gaps = 3/242 (1%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVR-RIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           P     +  EDF  ++ +G G+F +V     +       A+K   K KI+++   +++ S
Sbjct: 21  PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS 80

Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           ER IL  ++HPF V L  SF+ +  LYLVL+FV GG  F  L R   F  D+   Y A+I
Sbjct: 81  ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
           V    +L +  I++RDLKPEN+LLD DG + +TDFG AK  D  TR+ ++CGT EY++PE
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD--TRTYTLCGTPEYIAPE 198

Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSL 379
           I+L  GH KAADWW++GI ++E+L G PPF       I QKI++  I  P FL +    L
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHL 258

Query: 380 LK 381
           +K
Sbjct: 259 MK 260

Length = 340

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  195 bits (499), Expect = 2e-60
 Identities = 85/238 (35%), Positives = 129/238 (54%), Gaps = 13/238 (5%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM--RKDKIMEKNHAEYMKSERNILTKVD 208
            FE+L+ +G+G F +VY+ R   T +  A+KV+     +  EK   E       IL K  
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEI-----QILKKCK 55

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           HP IV+   S+  K  L++V++F +GG L    +   Q L    +A +   E++  + +L
Sbjct: 56  HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYV-CKELLKGLEYL 114

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           H+NGI+HRD+K  NILL +DG V L DFGL+ Q  +    N+M GT  +M+PE++ GK +
Sbjct: 115 HSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPY 174

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLK 381
           D  AD WS+GI   E+  G+PP++     K   KI  +    ++ P   S E    LK
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLK 232

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  197 bits (502), Expect = 2e-60
 Identities = 96/253 (37%), Positives = 153/253 (60%), Gaps = 19/253 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDFE +K++  GA+  VY VR   T + +AMK + K  ++ +N  + +  ER+ILT  ++
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF+V +  SF+TK  L +V+++V GG     L   G    D+AR+Y AE V A+ +LH  
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAK-------------QFDENTRS---NSMCGTL 313
           GI+HRDLKP+N+L+ + GH+ LTDFGL+K               +++TR      +CGT 
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180

Query: 314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA--- 370
           EY++PE++L +G+ K  DWW++GI+L+E L G  PF G   +++  ++I D I+ P    
Sbjct: 181 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE 240

Query: 371 FLSSEAHSLLKGV 383
            L ++A  L+  +
Sbjct: 241 ALPADAQDLISRL 253

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  198 bits (505), Expect = 6e-60
 Identities = 92/246 (37%), Positives = 148/246 (60%), Gaps = 11/246 (4%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  EDF+V+KV+G+GAF +V  VR   + ++YAMK++ K ++++++ + +   ER+I+  
Sbjct: 40  MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH 99

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
            +  +IVQL Y+FQ    LY+V++++ GG L   L       E  AR YTAE+V A+  +
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDL-VNLMSNYDIPEKWARFYTAEVVLALDAI 158

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGK 324
           H+ G +HRD+KP+N+LLD  GH+ L DFG   + D N   R ++  GT +Y+SPE++  +
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQ 218

Query: 325 GHD----KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII--KDKIKLP--AFLSSEA 376
           G D    +  DWWSVG+ L+EML G  PF   +      KI+  K+ +  P    +S +A
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA 278

Query: 377 HSLLKG 382
             L+  
Sbjct: 279 KDLICA 284

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  198 bits (504), Expect = 8e-60
 Identities = 105/281 (37%), Positives = 154/281 (54%), Gaps = 52/281 (18%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  +K +G GAF +V    ++ T  +YAMK +RK  ++ +N   ++K+ER+IL + D+ +
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           +V+L YSFQ K  LY V+D++ GG +   L R  +F E LAR Y AE+  A+  +H  G 
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQF--DENTR----------------------SN 307
           +HRD+KP+NIL+D DGH+ LTDFGL   F    N++                      SN
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 308 SMCG----TLE--------------------YMSPEIVLGKGHDKAADWWSVGILLFEML 343
             CG    TLE                    Y++PE++L KG+ +  DWWSVG++LFEML
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 344 TGQPPFTGGNRQKIQQKII--KDKIKLPA--FLSSEAHSLL 380
            GQPPF      + Q K+I  ++ + +P    LS EA  L+
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLI 283

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  195 bits (498), Expect = 1e-59
 Identities = 90/229 (39%), Positives = 148/229 (64%), Gaps = 6/229 (2%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQ 214
           K++G+G+F KV+     GT++ +A+K ++KD ++  +  E    E+ +L+   +HPF+  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR--IYTAEIVSAVSHLHANGIM 272
           L  +FQTK  L+ V++++NGG L F +  Q   + DL R   Y AEI+  +  LH+ GI+
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHI--QSCHKFDLPRATFYAAEIICGLQFLHSKGIV 118

Query: 273 HRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAAD 331
           +RDLK +NILLD DGH+ + DFG+ K+    + ++ + CGT +Y++PEI+LG+ ++ + D
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVD 178

Query: 332 WWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLL 380
           WWS G+LL+EML GQ PF G + +++ Q I  D    P +L+ EA  +L
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDIL 227

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  195 bits (496), Expect = 3e-59
 Identities = 94/236 (39%), Positives = 154/236 (65%), Gaps = 9/236 (3%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQ 214
           +V+G+G++AKV  VR     +IYAMKV++K+ + +    +++++E+++  +   +PF+V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   FQT  RL+LV+++VNGG L F + RQ    E+ AR Y AEI  A++ LH  GI++R
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           DLK +N+LLDADGH+ LTD+G+ K+       +++ CGT  Y++PEI+ G+ +  + DWW
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWW 180

Query: 334 SVGILLFEMLTGQPPF-------TGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG 382
           ++G+L+FEM+ G+ PF              + Q I++  I++P FLS +A  +LKG
Sbjct: 181 ALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKG 236

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  190 bits (484), Expect = 2e-57
 Identities = 94/237 (39%), Positives = 159/237 (67%), Gaps = 11/237 (4%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQ 214
           +V+G+G++AKV  VR   T  IYAMKV++K+ + +    +++++E+++  +  +HPF+V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   FQT+ RL+ V+++VNGG L F + RQ    E+ AR Y+AEI  A+++LH  GI++R
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           DLK +N+LLD++GH+ LTD+G+ K+       +++ CGT  Y++PEI+ G+ +  + DWW
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWW 180

Query: 334 SVGILLFEMLTGQPPF--TGGNRQKIQ-------QKIIKDKIKLPAFLSSEAHSLLK 381
           ++G+L+FEM+ G+ PF   G +    Q       Q I++ +I++P  LS +A S+LK
Sbjct: 181 ALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  185 bits (472), Expect = 5e-57
 Identities = 75/189 (39%), Positives = 114/189 (60%), Gaps = 6/189 (3%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G F  VY  R   T +  A+K+++K+        E +  E  IL K++HP IV+L  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSL--LEELLREIEILKKLNHPNIVKLYG 58

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
            F+ +  LYLV+++  GG L   L    G   ED       +I+  + +LH+NGI+HRDL
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118

Query: 277 KPENILLDAD-GHVMLTDFGLAKQFDENTR-SNSMCGTLEYMSPEIVLGKGH-DKAADWW 333
           KPENILLD+D G V L DFGL+K    +     ++ GT  YM+PE++LGKG+  + +D W
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIW 178

Query: 334 SVGILLFEM 342
           S+G++L+E+
Sbjct: 179 SLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  186 bits (475), Expect = 4e-56
 Identities = 95/245 (38%), Positives = 147/245 (60%), Gaps = 13/245 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE+LKV+G+GAF +V  V+   T ++YAMK++ K +++++      + ER++L   D 
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA 268
            +I  L Y+FQ +  LYLV+D+  GG L   L + +    ED+AR Y AE+V A+  +H 
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFG--LAKQFDENTRSNSMCGTLEYMSPEIVL---- 322
            G +HRD+KP+N+LLD +GH+ L DFG  L    D   +SN   GT +Y+SPEI+     
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180

Query: 323 GKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII--KDKIKLPAF---LSSEA 376
           GKG      DWWS+G+ ++EML G+ PF   +  +   KI+  K+  + P     +S EA
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA 240

Query: 377 HSLLK 381
             L++
Sbjct: 241 KDLIR 245

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  187 bits (477), Expect = 5e-56
 Identities = 93/258 (36%), Positives = 151/258 (58%), Gaps = 38/258 (14%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE LKV+G+GAF +V  V++  T  IYAMK++RK  ++EK    ++++ER+IL + D 
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
            ++V++ YSFQ K  LYL+++F+ GG +   L ++    E+  + Y AE V A+  +H  
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGL--------------------------------- 296
           G +HRD+KP+N+LLDA GHV L+DFGL                                 
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180

Query: 297 -AKQFDENTR--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
            A+ + +N R  + S  GT +Y++PE+ +  G++K  DWWS+G++++EML G PPF    
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240

Query: 354 RQKIQQKII--KDKIKLP 369
            Q+  +K++  K+ +  P
Sbjct: 241 PQETYRKVMNWKETLVFP 258

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  185 bits (472), Expect = 7e-56
 Identities = 88/229 (38%), Positives = 143/229 (62%), Gaps = 4/229 (1%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQ 214
           KV+G+G+F KV      G  E +A+K ++KD ++  +  E    E+ +L    ++PF+  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L  +FQTK  L+ V++F+NGG L F +  +G F    A  Y AEIV  +  LH+ GI++R
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAKQ--FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADW 332
           DLK +N++LD DGH+ + DFG+ K+  F +N R+++ CGT +Y++PEI+ G  +  + DW
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RASTFCGTPDYIAPEILQGLKYTFSVDW 179

Query: 333 WSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
           WS G+LL+EML GQ PF G +  ++ + I  D    P +++ E+  +L+
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILE 228

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  186 bits (474), Expect = 1e-55
 Identities = 92/258 (35%), Positives = 150/258 (58%), Gaps = 38/258 (14%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDFE LKV+G+GAF +V  V++  T  +YAMK++RK  ++EK    ++++ER+IL + D 
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
            ++V++ YSFQ K  LYL+++F+ GG +   L ++    E+  + Y AE V A+  +H  
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGL--------------------------------- 296
           G +HRD+KP+N+LLD+ GHV L+DFGL                                 
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180

Query: 297 -AKQFDENTR--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
            A+ +  N R  + S  GT +Y++PE+ +  G++K  DWWS+G++++EML G PPF    
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240

Query: 354 RQKIQQKII--KDKIKLP 369
            Q+  +K++  K+ +  P
Sbjct: 241 PQETYKKVMNWKETLIFP 258

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  182 bits (464), Expect = 6e-55
 Identities = 86/239 (35%), Positives = 137/239 (57%), Gaps = 8/239 (3%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK-SERNILTKVDHP 210
           F   +V+G+G F +V   +   T ++YA K + K +I +K   E M  +E+ IL KV+  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGEAMALNEKQILEKVNSR 60

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHA 268
           F+V L Y+++TK  L LVL  +NGG L F +Y      F E+ A  Y AEI   +  LH 
Sbjct: 61  FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR 120

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             I++RDLKPENILLD  GH+ ++D GLA +  E        GT+ YM+PE+V  + +  
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTF 180

Query: 329 AADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV 383
           + DWW +G L++EM+ G+ PF        R+++++++ +D+ +     S  A S+ + +
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQL 239

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  176 bits (448), Expect = 1e-52
 Identities = 96/245 (39%), Positives = 144/245 (58%), Gaps = 13/245 (5%)

Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIV 213
           ++G+G F +VY  R+  T ++YAMK + K +I  K       +ER +L+ V   D PFIV
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
            + Y+F T  +L  +LD +NGG L + L + G+F E   R Y AEI+  + H+H   +++
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120

Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG--HDKAAD 331
           RDLKP NILLD  GHV ++D GLA  F +  + ++  GT  YM+PE VL KG  +D +AD
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPE-VLQKGVAYDSSAD 178

Query: 332 WWSVGILLFEMLTGQPPFTG---GNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLS 388
           W+S+G +LF++L G  PF      ++ +I +  +   ++LP   S E  SLL+G   LL 
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG---LLQ 235

Query: 389 ISVPL 393
             V  
Sbjct: 236 RDVNR 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  176 bits (448), Expect = 1e-51
 Identities = 92/241 (38%), Positives = 149/241 (61%), Gaps = 11/241 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED+EV+KV+G+GAF +V  VR   T ++YAMK++ K ++++++ + +   ER+I+   + 
Sbjct: 43  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++VQL Y+FQ    LY+V++++ GG L   L       E  AR YTAE+V A+  +H+ 
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 161

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHD 327
           G +HRD+KP+N+LLD  GH+ L DFG   + ++    R ++  GT +Y+SPE++  +G D
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 221

Query: 328 ----KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII--KDKIKLP--AFLSSEAHSL 379
               +  DWWSVG+ L+EML G  PF   +      KI+  K+ +  P    +S EA +L
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 281

Query: 380 L 380
           +
Sbjct: 282 I 282

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  173 bits (439), Expect = 2e-51
 Identities = 85/236 (36%), Positives = 136/236 (57%), Gaps = 6/236 (2%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F   +V+G+G F +V   +   T ++YA K + K +I ++       +E+ IL KV+  F
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHAN 269
           +V L Y+++TK  L LVL  +NGG L F +Y  G   F E+ A  Y AEI+  +  LH  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKA 329
             ++RDLKPENILLD  GH+ ++D GLA +  E        GT+ YM+PE++  + +  +
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLS 181

Query: 330 ADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
            D+W +G L++EM+ GQ PF G      R+++ +++++ +    A  S EA S+ K
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK 237

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  174 bits (442), Expect = 7e-51
 Identities = 88/237 (37%), Positives = 145/237 (61%), Gaps = 9/237 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED++V+KV+G+GAF +V  VR   + ++YAMK++ K ++++++ + +   ER+I+   + 
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++VQL  +FQ    LY+V++++ GG L   L       E  A+ YTAE+V A+  +H+ 
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKFYTAEVVLALDAIHSM 161

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHD 327
           G++HRD+KP+N+LLD  GH+ L DFG   + DE    R ++  GT +Y+SPE++  +G D
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGD 221

Query: 328 ----KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII--KDKIKLPAFLSSEAHS 378
               +  DWWSVG+ LFEML G  PF   +      KI+  K+ +  P  +    H+
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHA 278

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  170 bits (432), Expect = 2e-50
 Identities = 89/234 (38%), Positives = 140/234 (59%), Gaps = 8/234 (3%)

Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIV 213
           ++G+G F +VY  R+  T ++YAMK + K +I  K       +ER +L+ V   D PFIV
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
            + Y+F T  +L  +LD +NGG L + L + G+F E   R Y  EI+  + H+H   +++
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120

Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL-GKGHDKAADW 332
           RDLKP NILLD  GHV ++D GLA  F +  + ++  GT  YM+PE++  G  +D +ADW
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGTAYDSSADW 179

Query: 333 WSVGILLFEMLTGQPPF---TGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV 383
           +S+G +LF++L G  PF      ++ +I +  +   ++LP   S E  SLL+G+
Sbjct: 180 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGL 233

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  167 bits (426), Expect = 1e-49
 Identities = 75/226 (33%), Positives = 126/226 (55%), Gaps = 3/226 (1%)

Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLR 216
           ++G+GAF  VY+   + T +  A+K +  +KI E+     M  E ++L  + HP IV+  
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIM-QEIDLLKNLKHPNIVKYI 65

Query: 217 YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
            S +T   LY++L++   G L   + + G F E L  +Y  +++  +++LH  G++HRD+
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDI 125

Query: 277 KPENILLDADGHVMLTDFGLAKQFDENTR-SNSMCGTLEYMSPEIVLGKGHDKAADWWSV 335
           K  NIL   DG V L DFG+A + ++ ++   S+ GT  +M+PE++   G   A+D WS+
Sbjct: 126 KAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSL 185

Query: 336 GILLFEMLTGQPPFTGGNRQKIQQKIIKDK-IKLPAFLSSEAHSLL 380
           G  + E+LTG PP+   N      +I++D    LP  +S E    L
Sbjct: 186 GCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFL 231

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  167 bits (426), Expect = 1e-49
 Identities = 85/245 (34%), Positives = 137/245 (55%), Gaps = 16/245 (6%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           D+EVL+ +G+G+F  V +VRR    +I   K +    + EK   + + SE NIL ++ HP
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-QQLVSEVNILRELKHP 59

Query: 211 FIVQL--RYSFQTKYRLYLVLDFVNGGHL--FFQLYRQ--GLFREDLA-RIYTAEIVSAV 263
            IV+   R   ++   LY+V+++  GG L    Q  ++      E+   RI T +++ A+
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT-QLLLAL 118

Query: 264 SHLH-----ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSMCGTLEYMS 317
              H      N ++HRDLKP NI LDA+ +V L DFGLAK    ++  + +  GT  YMS
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178

Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEA 376
           PE +    +D+ +D WS+G L++E+    PPFT  N+ ++  KI + K  ++P   SSE 
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSEL 238

Query: 377 HSLLK 381
           + ++K
Sbjct: 239 NEVIK 243

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  169 bits (430), Expect = 2e-49
 Identities = 92/246 (37%), Positives = 148/246 (60%), Gaps = 15/246 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE++KV+G+GAF +V  V+   T  IYAMK++ K +++++      + ERN+L   D 
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA 268
            +I  L Y+FQ +  LYLV+D+  GG L   L + +    ED+AR Y AE+V A+  +H 
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFG--LAKQFDENTRSNSMCGTLEYMSPEIV----- 321
              +HRD+KP+N+LLD +GH+ L DFG  L    D   +S+   GT +Y+SPEI+     
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 322 -LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII--KDKIKLPAFL---SSE 375
            +GK +    DWWS+G+ ++EML G+ PF   +  +   KI+  +++ + P+ +   S E
Sbjct: 181 GMGK-YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239

Query: 376 AHSLLK 381
           A  L++
Sbjct: 240 AKDLIQ 245

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  166 bits (422), Expect = 7e-49
 Identities = 84/218 (38%), Positives = 128/218 (58%), Gaps = 7/218 (3%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F   +V+G+G F +V   +   T ++YA K + K +I ++       +E+ IL KV+  F
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHAN 269
           +V L Y+++TK  L LVL  +NGG L F +Y  G   F E  A  Y AEI   +  LH  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKA 329
            I++RDLKPENILLD  GH+ ++D GLA    E        GT+ YM+PE+V  + +  +
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 181

Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK 367
            DWW++G LL+EM+ GQ PF     Q+ ++KI +++++
Sbjct: 182 PDWWALGCLLYEMIAGQSPF-----QQRKKKIKREEVE 214

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  169 bits (427), Expect = 1e-48
 Identities = 88/234 (37%), Positives = 133/234 (56%), Gaps = 18/234 (7%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
            + +L+ +G+G+F +VY  R     ++ A+KV+ K    +    E    E  IL  ++HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 211 -FIVQLRYSFQTKYRLYLVLDFVNGG---HLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             IV+L   FQ +  LYLV+++V+GG    L  ++ R+G   E  A    A+I+SA+ +L
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 267 HANGIMHRDLKPENILLDADGH-VMLTDFGLAKQFDE-------NTRSNSMCGTLEYMSP 318
           H+ GI+HRD+KPENILLD DG  V L DFGLAK   +           ++  GT  YM+P
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 319 EIVLGKGH---DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP 369
           E++LG        ++D WS+GI L+E+LTG PPF G        + +K  ++LP
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231

Length = 384

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  167 bits (424), Expect = 1e-48
 Identities = 89/231 (38%), Positives = 142/231 (61%), Gaps = 10/231 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDFE+LKV+G+GAF +V  V+     +++AMK++ K +++++      + ER++L   D+
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA 268
            +I  L Y+FQ +  LYLV+D+  GG L   L + +    ED+AR Y AE+V A+  +H 
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFG--LAKQFDENTRSNSMCGTLEYMSPEIVL---- 322
              +HRD+KP+NIL+D +GH+ L DFG  L    D   +S+   GT +Y+SPEI+     
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 323 GKG-HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII--KDKIKLPA 370
           GKG +    DWWS+G+ ++EML G+ PF   +  +   KI+  K++ + PA
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPA 231

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  164 bits (416), Expect = 5e-48
 Identities = 83/235 (35%), Positives = 139/235 (59%), Gaps = 9/235 (3%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G F +V   +   T ++YA K + K ++ ++   E    E+ IL KV   FIV L Y
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLY----RQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
           +FQTK  L LV+  +NGG L + +Y        F E  A  YTA+I+S + HLH   I++
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 274 RDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDKAADW 332
           RDLKPEN+LLD DG+V ++D GLA +  D  +++    GT  +M+PE++ G+ +D + D+
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDY 180

Query: 333 WSVGILLFEMLTGQPPF-TGGNR---QKIQQKIIKDKIKLPAFLSSEAHSLLKGV 383
           +++G+ L+EM+  + PF   G +   ++++Q+I+ D +  P   S  + S  + +
Sbjct: 181 FALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL 235

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  164 bits (415), Expect = 8e-48
 Identities = 83/236 (35%), Positives = 133/236 (56%), Gaps = 6/236 (2%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F   +V+G+G F +V   +   T ++YA K + K +I ++       +E+ IL KV+  F
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHAN 269
           +V L Y+++TK  L LVL  +NGG L F +Y  G   F E  A  Y AE+   +  L   
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKA 329
            I++RDLKPENILLD  GH+ ++D GLA Q  E        GT+ YM+PE++  + +  +
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS 181

Query: 330 ADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
            DWW +G L++EM+ GQ PF        R+++ +++ +D+ +     S +A S+ +
Sbjct: 182 PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR 237

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score =  158 bits (400), Expect = 1e-45
 Identities = 73/217 (33%), Positives = 131/217 (60%), Gaps = 6/217 (2%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G F +V  V+   T ++YA K + K ++ +K+  +    E+ IL KV+ PFIV L Y
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLHANGIMHRD 275
           +F++K  L LV+  +NGG L + +Y  G    ++ R+  Y+A+I   + HLH+  I++RD
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120

Query: 276 LKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSV 335
           +KPEN+LLD  G+  L+D GLA +  +        GT  YM+PEI+  + +    DW+++
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAM 180

Query: 336 GILLFEMLTGQPPFTGG----NRQKIQQKIIKDKIKL 368
           G  ++EM+ G+ PF        +++++++ ++D++K 
Sbjct: 181 GCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF 217

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  157 bits (399), Expect = 1e-45
 Identities = 69/197 (35%), Positives = 116/197 (58%), Gaps = 3/197 (1%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMR--KDKIMEKNHAEYMKSERNILTKVDHPFIV 213
           +++G G+F  VY+   +   + +A+K +    D    +   + ++ E  +L+K+ HP IV
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
           Q   + + +  LY+ L+ V GG L   L + G F E + R+YT +I+  + +LH    +H
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVH 125

Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG-HDKAADW 332
           RD+K  NIL+D +G V L DFG+AKQ  E + + S  G+  +M+PE++  +G +  AAD 
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI 185

Query: 333 WSVGILLFEMLTGQPPF 349
           WS+G  + EM TG+PP+
Sbjct: 186 WSLGCTVLEMATGKPPW 202

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  156 bits (397), Expect = 3e-45
 Identities = 73/204 (35%), Positives = 118/204 (57%), Gaps = 8/204 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
            D E +KV+GQG+   VY+VR   T +IYA+K +  D   ++   + +  E   L   + 
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVD--GDEEFRKQLLRELKTLRSCES 58

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED-LARIYTAEIVSAVSHLHA 268
           P++V+   +F  +  + +VL++++GG L   L + G   E  LA I   +I+  + +LH 
Sbjct: 59  PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYI-ARQILKGLDYLHT 117

Query: 269 N-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR--SNSMCGTLEYMSPEIVLGKG 325
              I+HRD+KP N+L+++ G V + DFG++K   ENT    N+  GT+ YMSPE + G+ 
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVL-ENTLDQCNTFVGTVTYMSPERIQGES 176

Query: 326 HDKAADWWSVGILLFEMLTGQPPF 349
           +  AAD WS+G+ L E   G+ PF
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPF 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  152 bits (386), Expect = 1e-43
 Identities = 71/206 (34%), Positives = 118/206 (57%), Gaps = 11/206 (5%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
              +G G F KVY    + T E+ A+K +R      K   E +  E  +L  + HP +V+
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKE-IADEMKVLELLKHPNLVK 63

Query: 215 LRYSFQT-KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
             Y  +  + ++Y+ +++ +GG L   L    +  E + R+YT +++  +++LH++GI+H
Sbjct: 64  Y-YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122

Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRS-----NSMCGTLEYMSPEIVLG---KG 325
           RD+KP NI LD +G + L DFG A +   NT +      S+ GT  YM+PE++ G   KG
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           H +AAD WS+G ++ EM TG+ P++ 
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRPWSE 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  147 bits (374), Expect = 5e-42
 Identities = 72/241 (29%), Positives = 127/241 (52%), Gaps = 8/241 (3%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DF+VLK +G+G++  VY+V+R+  ++ YA+K +    + +K   + +   R IL  V+HP
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIR-ILASVNHP 59

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVSHL 266
            I+  + +F    +L +V+++   G L   + ++     L  E        +++  +  L
Sbjct: 60  NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           H   I+HRDLK  NILL A+  V + D G++K   +   + +  GT  YM+PE+  G+ +
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVL-KKNMAKTQIGTPHYMAPEVWKGRPY 178

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSL 386
              +D WS+G LL+EM T  PPF   + Q ++ K+ +   K P      +  L   + S+
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG--KYPPIPPIYSQDLQNFIRSM 236

Query: 387 L 387
           L
Sbjct: 237 L 237

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  146 bits (370), Expect = 2e-41
 Identities = 62/203 (30%), Positives = 116/203 (57%), Gaps = 9/203 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F++L+ +G+G++  VY+     T ++ A+KV+  +        + +  E +IL + D 
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-----EDLQEIIKEISILKQCDS 57

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           P+IV+   S+     L++V+++   G +    ++  + L  E++A I   + +  + +LH
Sbjct: 58  PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAI-LYQTLKGLEYLH 116

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGH 326
           +N  +HRD+K  NILL+ +G   L DFG++ Q  D   + N++ GT  +M+PE++   G+
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176

Query: 327 DKAADWWSVGILLFEMLTGQPPF 349
           +  AD WS+GI   EM  G+PP+
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPY 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  144 bits (366), Expect = 8e-41
 Identities = 79/234 (33%), Positives = 123/234 (52%), Gaps = 8/234 (3%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME--KNHAEYMKSERNILTKVDHPFIV 213
           K++GQGAF +VY    + T    A+K +  D      K     ++ E  +L  + H  IV
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
           Q     +    L + ++++ GG +  QL   G   E + R YT +I+  V +LH+N I+H
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127

Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFD----ENTRSNSMCGTLEYMSPEIVLGKGHDKA 329
           RD+K  NIL D+ G+V L DFG +K+        T   S+ GT  +MSPE++ G+G+ + 
Sbjct: 128 RDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRK 187

Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI--KLPAFLSSEAHSLLK 381
           AD WSVG  + EMLT +PP+          KI       +LP+ +S +A + L+
Sbjct: 188 ADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLR 241

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  145 bits (368), Expect = 9e-41
 Identities = 65/201 (32%), Positives = 113/201 (56%), Gaps = 8/201 (3%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           ++ L+ +G+GA  +VY+     T +  A+K MR    + K + E + +E  I+    HP 
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHPN 76

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF--REDLARIYTAEIVSAVSHLHAN 269
           IV    S+     L++V+++++GG L   + +  +      +A +   E++  + +LH+ 
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV-CREVLQGLEYLHSQ 135

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDK 328
            ++HRD+K +NILL  DG V L DFG A Q   E ++ NS+ GT  +M+PE++  K +  
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGP 195

Query: 329 AADWWSVGILLFEMLTGQPPF 349
             D WS+GI+  EM  G+PP+
Sbjct: 196 KVDIWSLGIMCIEMAEGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  144 bits (364), Expect = 1e-40
 Identities = 74/235 (31%), Positives = 131/235 (55%), Gaps = 5/235 (2%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DFE+L  +G+G+F  V++V R     +YAMK +   K+  +   E +   R +L K+D  
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEAR-VLAKLDSS 59

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGG--HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           +I++   SF  K +L +V+++   G  H   ++ R     ED    +  +I+  ++HLH+
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNSMCGTLEYMSPEIVLGKGHD 327
             I+HRD+K  N+ LDA  +V + D G+AK   +NT  +N++ GT  Y+SPE+   K ++
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYN 179

Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-LPAFLSSEAHSLLK 381
           + +D W++G++L+E  TG+ PF   N+  +  KII+     +    S +   L+ 
Sbjct: 180 EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLID 234

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score =  150 bits (381), Expect = 3e-40
 Identities = 63/150 (42%), Positives = 103/150 (68%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F ++K + +GAF KVY  R+   S++YA+KV++K  ++ KN    +++ER+ L    
Sbjct: 3   IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            PFIV L YS Q+   +YLV++++ GG +   L+  G F E++A  Y +E+  A+ +LH 
Sbjct: 63  SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR 122

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAK 298
           +GI+HRDLKP+N+L+  +GH+ LTDFGL+K
Sbjct: 123 HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  143 bits (364), Expect = 3e-40
 Identities = 70/221 (31%), Positives = 121/221 (54%), Gaps = 14/221 (6%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN-HAEYMKSERNILTKVDHP 210
           +E +  +G+G + +VY+ R   T E+ A+K +R +   EK         E  +L K+ HP
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHP 58

Query: 211 FIVQLRYSFQTKYR--LYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHL 266
            IV+L+    +K +  +Y+V ++++  H    L      +   ++I  Y  +++  + +L
Sbjct: 59  NIVRLKEIVTSKGKGSIYMVFEYMD--HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL 116

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTR--SNSMCGTLEYMSPEIVLG 323
           H+NGI+HRD+K  NIL++ DG + L DFGLA+ +   N+   +N +  TL Y  PE++LG
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLG 175

Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK 363
              +    D WSVG +L E+  G+P F G    +  +KI +
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFE 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  143 bits (364), Expect = 4e-40
 Identities = 78/223 (34%), Positives = 125/223 (56%), Gaps = 21/223 (9%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E L+ +G+G +  VY+ R   T EI A+K +R D   E   +  ++ E ++L ++ HP 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-EISLLKELKHPN 59

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY-----RQGLFREDLARIYTAEIVSAVSHL 266
           IV+L     T+ +LYLV ++ +       L      R G    +L +    +++  +++ 
Sbjct: 60  IVKLLDVIHTERKLYLVFEYCD-----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLG 323
           H++ I+HRDLKP+NIL++ DG + L DFGLA+ F    R+     +  TL Y +PEI+LG
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPEILLG 172

Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK 363
            K +  A D WSVG +  EM+TG+P F G    +I Q  KI +
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGKPLFPG--DSEIDQLFKIFQ 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  143 bits (362), Expect = 5e-40
 Identities = 66/224 (29%), Positives = 120/224 (53%), Gaps = 12/224 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM----RKDKIMEKNHAEYMKSERNILT 205
           E F +L+ +G+G+F +VY+     T+++ A+KV+     +D+I      E ++ E   L+
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI------EDIQQEIQFLS 54

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           +   P+I +   SF    +L++++++  GG     L + G   E        E++  + +
Sbjct: 55  QCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPGKLDETYIAFILREVLLGLEY 113

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNSMCGTLEYMSPEIVLGK 324
           LH  G +HRD+K  NILL  +G V L DFG++ Q     ++ N+  GT  +M+PE++   
Sbjct: 114 LHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQS 173

Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKL 368
           G+D+ AD WS+GI   E+  G+PP +  +  ++   I K+    
Sbjct: 174 GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPS 217

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  142 bits (361), Expect = 9e-40
 Identities = 72/212 (33%), Positives = 113/212 (53%), Gaps = 14/212 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI--LTKV 207
             +EVL VVG+GA+  V + R   T EI A+K   K K  E +      + R +  L ++
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIK---KFKESEDDEDVKKTALREVKVLRQL 57

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL---YRQGLFREDLARIYTAEIVSAVS 264
            H  IV L+ +F+ K RLYLV ++V       +L      GL   D  R Y  +++ A++
Sbjct: 58  RHENIVNLKEAFRRKGRLYLVFEYV--ERTLLELLEASPGGL-PPDAVRSYIWQLLQAIA 114

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN--SMCGTLEYMSPEIVL 322
           + H++ I+HRD+KPENIL+   G + L DFG A+       S       T  Y +PE+++
Sbjct: 115 YCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLV 174

Query: 323 GKG-HDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G   + K  D W++G ++ E+L G+P F G +
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  137 bits (347), Expect = 6e-38
 Identities = 65/219 (29%), Positives = 123/219 (56%), Gaps = 8/219 (3%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-- 209
           ++ L+++G+GA+  VY+ + + T  + A+K++  D     +    ++ E  +L+++    
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQ 60

Query: 210 -PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            P I +   S+    RL++++++  GG +   L + G   E    +   E++ A+ ++H 
Sbjct: 61  PPNITKYYGSYLKGPRLWIIMEYAEGGSVR-TLMKAGPIAEKYISVIIREVLVALKYIHK 119

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS-MCGTLEYMSPEIVL-GKGH 326
            G++HRD+K  NIL+   G+V L DFG+A   ++N+   S   GT  +M+PE++  GK +
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK 365
           D  AD WS+GI ++EM TG PP++  +  +    I K K
Sbjct: 180 DTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK 218

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  137 bits (348), Expect = 8e-38
 Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 14/211 (6%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
            +++L  +G+GA   V++ +   T E  A+K +   ++      + ++ E   L    HP
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHP 59

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY-----RQGLFREDLARIYTAEIVSAVSH 265
           ++V+L   F       LV++++        L       +    E   + Y   ++  V++
Sbjct: 60  YVVKLLDVFPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSYMRMLLKGVAY 114

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS--NSMCGTLEYMSPEIVLG 323
           +HANGIMHRDLKP N+L+ ADG + + DFGLA+ F E      +    T  Y +PE++ G
Sbjct: 115 MHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174

Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
               D   D W+VG +  E+L G P F G N
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGEN 205

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  136 bits (344), Expect = 1e-37
 Identities = 75/233 (32%), Positives = 128/233 (54%), Gaps = 5/233 (2%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +  ++V+G+GAF +    RR     +   K +   ++ EK   + + +E  IL+ + HP 
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL-NEIVILSLLQHPN 60

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHAN 269
           I+     F     L + +++ NGG L+ ++ RQ   LF E++   Y  +IVSAVS++H  
Sbjct: 61  IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           GI+HRD+K  NI L   G + L DFG++K    E + + ++ GT  YMSPE+  G  ++ 
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNF 180

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII-KDKIKLPAFLSSEAHSLL 380
            +D W++G +L+E+LT +  F   N   +  KI+  +   + +  SSE  SL+
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLV 233

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  136 bits (343), Expect = 1e-37
 Identities = 81/235 (34%), Positives = 128/235 (54%), Gaps = 8/235 (3%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E++K +G+G+F K+Y  +    SE   +K +   K M     E  K E  +L K+ HP 
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK-MPVKEKEASKKEVILLAKMKHPN 60

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHAN 269
           IV    SFQ   RL++V+++ +GG L  ++ RQ   LF ED    +  +I   + H+H  
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120

Query: 270 GIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMC-GTLEYMSPEIVLGKGHD 327
            I+HRD+K +NI L  +G V  L DFG+A+Q +++      C GT  Y+SPEI   + ++
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYN 180

Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK--LPAFLSSEAHSLL 380
              D WS+G +L+E+ T + PF G N  ++  KI +       P F S +  SL+
Sbjct: 181 NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNF-SRDLRSLI 234

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  136 bits (343), Expect = 2e-37
 Identities = 73/215 (33%), Positives = 118/215 (54%), Gaps = 4/215 (1%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +  +K +G+G+F K   V+     + Y +K +   K+  K   E  K E  +L+ + HP 
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRK-EVAVLSNMKHPN 60

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHAN 269
           IVQ + SF+    LY+V+D+  GG L+ ++  Q   LF ED    +  +I  A+ H+H  
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMC-GTLEYMSPEIVLGKGHDK 328
            I+HRD+K +NI L  DG + L DFG+A+  +        C GT  Y+SPEI   + ++ 
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNN 180

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK 363
            +D W++G +L+EM T +  F  GN + +  KII+
Sbjct: 181 KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  136 bits (343), Expect = 2e-37
 Identities = 81/227 (35%), Positives = 121/227 (53%), Gaps = 18/227 (7%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIY-AMK-------VMRKDKIMEKNHAEYMKSERNI 203
           + VL+ +G GAF  VY+VR+    +   A+K          KDK         + SE  I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 204 LTK-VDHPFIVQLRYSFQTKYRLYLVLDFVNG---GHLFFQLY-RQGLFREDLARIYT-- 256
           + + + HP IV+   +F    RLY+V+D + G   G  F  L  ++  F E+  RI+   
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEE--RIWNIF 119

Query: 257 AEIVSAVSHLHANG-IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY 315
            ++V A+ +LH    I+HRDL P NI+L  D  V +TDFGLAKQ    ++  S+ GT+ Y
Sbjct: 120 VQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILY 179

Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII 362
             PEIV  + + + AD W+ G +L++M T QPPF   N   +  KI+
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV 226

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  135 bits (342), Expect = 3e-37
 Identities = 78/235 (33%), Positives = 126/235 (53%), Gaps = 8/235 (3%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L +F++ K +G+G F+ VY+   +    + A+K ++  ++M+    +    E ++L ++D
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG---HLFFQLYRQG-LFREDLARIYTAEIVSAVS 264
           HP +++   SF     L +VL+  + G    +     +Q  L  E     Y  ++ SA+ 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSMCGTLEYMSPEIVLG 323
           H+H+  IMHRD+KP N+ + A G V L D GL + F   T  ++S+ GT  YMSPE +  
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180

Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGG--NRQKIQQKIIK-DKIKLPAFLSSE 375
            G++  +D WS+G LL+EM   Q PF G   N   + +KI K D   LPA   SE
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSE 235

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  135 bits (341), Expect = 6e-37
 Identities = 78/267 (29%), Positives = 125/267 (46%), Gaps = 41/267 (15%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNILTKV 207
           ++ L  +G+G +  VY+ R   T EI A+K     KI  +  +E +      E  +L ++
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIK-----KIKLRFESEGIPKTALREIKLLKEL 55

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           +HP I++L   F+ K  LYLV +F++         RQ    E L + Y  +++  ++  H
Sbjct: 56  NHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-NSMCGTLEYMSPEIVLG-KG 325
           ++GI+HRDLKPEN+L++ +G + L DFGLA+ F    R       T  Y +PE++LG KG
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGN---------------RQKIQQKIIK----DKI 366
           +    D WSVG +  E+L+ +P F G +                 ++  K        K 
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235

Query: 367 KLPAF-----------LSSEAHSLLKG 382
             P              S +A  LL  
Sbjct: 236 SFPKKAGMPLPKLFPNASPQALDLLSQ 262

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  133 bits (337), Expect = 1e-36
 Identities = 68/206 (33%), Positives = 113/206 (54%), Gaps = 10/206 (4%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
            ED+E+++ +G G +  VY+ R I T E+ A+KV+   K+   +  E ++ E ++L +  
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECR 58

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           HP IV    S+  + +L++V+++  GG L   +Q+ R  L    +A +   E +  +++L
Sbjct: 59  HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYV-CRETLKGLAYL 117

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNSMCGTLEYMSPEIV---L 322
           H  G +HRD+K  NILL  DG V L DFG++ Q      +  S  GT  +M+PE+     
Sbjct: 118 HETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVER 177

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPP 348
             G+D   D W++GI   E+   QPP
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  132 bits (334), Expect = 2e-36
 Identities = 77/235 (32%), Positives = 127/235 (54%), Gaps = 6/235 (2%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
            + VL+VVG+G+F +   V+ + + + YAMK +R  K    +  E  + E  +L K+ HP
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHP 58

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLF--FQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            IV  + SF+    LY+V+++ +GG L    +L R  LF ED    +  ++   V H+H 
Sbjct: 59  NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHD 327
             ++HRD+K +NI L  +G V L DFG A+        + +  GT  Y+ PEI     ++
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYN 178

Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-LPAFLSSEAHSLLK 381
             +D WS+G +L+E+ T + PF   + + +  K+ +   K LP+  S E  SL+K
Sbjct: 179 NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIK 233

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  132 bits (335), Expect = 3e-36
 Identities = 60/203 (29%), Positives = 107/203 (52%), Gaps = 7/203 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D E L  +G G    V +V    T +I A+K +R +             E +IL K + 
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILR--ELDILHKCNS 58

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           P+IV    +F     + + +++++GG L    +  +  +    L +I  A ++  +++LH
Sbjct: 59  PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA-VLKGLTYLH 117

Query: 268 AN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
               I+HRD+KP NIL+++ G + L DFG++ Q   N+ + +  GT  YM+PE + G  +
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKTFVGTSSYMAPERIQGNDY 176

Query: 327 DKAADWWSVGILLFEMLTGQPPF 349
              +D WS+G+ L E+ TG+ P+
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPY 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  130 bits (329), Expect = 2e-35
 Identities = 65/209 (31%), Positives = 111/209 (53%), Gaps = 11/209 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D+E+++V+G GA A VY    +  +E  A+K +  +K  + +  E  K E   +++ +H
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK-CQTSVDELRK-EVQAMSQCNH 58

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGG---HLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P +V+   SF     L+LV+ +++GG    +    Y +G   E +      E++  + +L
Sbjct: 59  PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-----RSNSMCGTLEYMSPEIV 321
           H+NG +HRD+K  NILL  DG V + DFG++    +          +  GT  +M+PE++
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 322 -LGKGHDKAADWWSVGILLFEMLTGQPPF 349
               G+D  AD WS GI   E+ TG  P+
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPY 207

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  129 bits (326), Expect = 8e-35
 Identities = 71/217 (32%), Positives = 115/217 (52%), Gaps = 21/217 (9%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-D 208
             FE+++V+G+G + KVY+ R   T ++ A+K+M   +  E    E +K E NIL K  +
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE----EEIKEEYNILRKYSN 61

Query: 209 HPFIVQLRYSFQTK------YRLYLVLDFVNGG---HLFFQLYRQG-LFREDLARIYTAE 258
           HP I     +F  K       +L+LV++   GG    L   L ++G   +E+       E
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMS 317
            +  +++LH N ++HRD+K +NILL  +  V L DFG++ Q D    R N+  GT  +M+
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMA 181

Query: 318 PEIVLGK-----GHDKAADWWSVGILLFEMLTGQPPF 349
           PE++         +D  +D WS+GI   E+  G+PP 
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL 218

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  128 bits (324), Expect = 1e-34
 Identities = 67/215 (31%), Positives = 124/215 (57%), Gaps = 14/215 (6%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMK-------VMRKDKIMEKNHAEYMKSERNILTKVD 208
           +++G+G + +VY    + T E+ A+K       +  +    +K+  + ++SE   L  +D
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IVQ      T+  L + L++V GG +   L   G F E L R +T +++  +++LH+
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE---NTRSNSMCGTLEYMSPEIV--LG 323
            GI+HRDLK +N+L+DADG   ++DFG++K+ D+   N ++ SM G++ +M+PE++    
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186

Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ 358
           +G+    D WS+G ++ EM  G+ P+   + + I 
Sbjct: 187 QGYSAKVDIWSLGCVVLEMFAGRRPW--SDEEAIA 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  127 bits (322), Expect = 4e-34
 Identities = 70/213 (32%), Positives = 109/213 (51%), Gaps = 21/213 (9%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM-RKDKIMEKNHAEYMK-SERNILTKV-D 208
           ++V+K +G G F  VY  R   T E+ A+K M +K    E    E M   E   L K+ +
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE----ECMNLREVKSLRKLNE 56

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ---GLFREDLARIYTAEIVSAVSH 265
           HP IV+L+  F+    LY V +++ G    +QL +      F E + R    +I+  ++H
Sbjct: 57  HPNIVKLKEVFRENDELYFVFEYMEGN--LYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN----SMCGTLEYMSPEIV 321
           +H +G  HRDLKPEN+L+     V + DFGLA++     RS         T  Y +PEI+
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLARE----IRSRPPYTDYVSTRWYRAPEIL 170

Query: 322 LGKG-HDKAADWWSVGILLFEMLTGQPPFTGGN 353
           L    +    D W++G ++ E+ T +P F G +
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS 203

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  126 bits (318), Expect = 6e-34
 Identities = 65/217 (29%), Positives = 120/217 (55%), Gaps = 4/217 (1%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E ++VVG+GAF  V+  RR    ++  +K +  ++ M K+     ++E  +L  + HP 
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQ-MTKDERLAAQNECQVLKLLSHPN 60

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           I++   +F     L +V+++  GG L  + Q     L  ED    +  +I+ A+ H+H  
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120

Query: 270 GIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
            I+HRDLK +NILLD    V+ + DFG++K     +++ ++ GT  Y+SPE+  GK +++
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQ 180

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK 365
            +D W++G +L+E+ + +  F   N   +  KI+   
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT 217

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  125 bits (316), Expect = 1e-33
 Identities = 59/203 (29%), Positives = 115/203 (56%), Gaps = 9/203 (4%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVM---RKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           + +G GAF+  YQ R + T  + A+K +   R     ++   E ++ E  ++ +++HP I
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
           +++  +        L ++++ GG +   L + G F+E +   YT +++  +S+LH N I+
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQII 125

Query: 273 HRDLKPENILLDADGH-VMLTDFGLAKQFDEN-TRSN----SMCGTLEYMSPEIVLGKGH 326
           HRD+K  N+L+D+ G  + + DFG A +     T +      + GT+ +M+PE++ G+ +
Sbjct: 126 HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQY 185

Query: 327 DKAADWWSVGILLFEMLTGQPPF 349
            ++ D WSVG ++ EM T +PP+
Sbjct: 186 GRSCDVWSVGCVIIEMATAKPPW 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  124 bits (313), Expect = 9e-33
 Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 34/219 (15%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI--LTKVDH 209
           +E  K +G+G +A VY+ R   T  I A+K ++  +  E        + R I  L ++ H
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--------------- 254
           P I+ L   F  K  + LV +F+                 DL ++               
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFMET---------------DLEKVIKDKSIVLTPADIKS 106

Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTL 313
           Y    +  + +LH+N I+HRDLKP N+L+ +DG + L DFGLA+ F   N +      T 
Sbjct: 107 YMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTR 166

Query: 314 EYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
            Y +PE++ G + +    D WSVG +  E+L   P   G
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG 205

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  123 bits (312), Expect = 1e-32
 Identities = 67/230 (29%), Positives = 108/230 (46%), Gaps = 15/230 (6%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-----LTK 206
           +E L  +G+GA+  VY+ R + T    A+K +R   +        + + R I     L  
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR---VPLSEEGIPLSTLREIALLKQLES 57

Query: 207 VDHPFIVQLRYSFQTKYR-----LYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIV 260
            +HP IV+L              L LV + V+     +     +     +  +    +++
Sbjct: 58  FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLL 117

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
             V  LH++ I+HRDLKP+NIL+ +DG V + DFGLA+ +       S+  TL Y +PE+
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEV 177

Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA 370
           +L   +    D WSVG +  E+   +P F  G  +  Q   I D I LP+
Sbjct: 178 LLQSSYATPVDMWSVGCIFAELFRRRPLF-RGTSEADQLDKIFDVIGLPS 226

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  123 bits (310), Expect = 1e-32
 Identities = 87/245 (35%), Positives = 131/245 (53%), Gaps = 18/245 (7%)

Query: 150 EDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           E+F E++  +G GAF KVY+ +   T  + A KV+  D   E+   +YM  E +IL   D
Sbjct: 4   EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVI--DTKSEEELEDYM-VEIDILASCD 60

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL---FFQLYRQGLFREDLARIYTAEIVSAVSH 265
           HP IV+L  +F  +  L+++++F  GG +     +L R     E   R+   + + A+++
Sbjct: 61  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNY 118

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGL-AKQFDENTRSNSMCGTLEYMSPEIVL-- 322
           LH N I+HRDLK  NIL   DG + L DFG+ AK      R +S  GT  +M+PE+V+  
Sbjct: 119 LHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 178

Query: 323 ---GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLPAFLSSEA 376
               + +D  AD WS+GI L EM   +PP    N  ++  KI K +   +  P+  SSE 
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEF 238

Query: 377 HSLLK 381
              LK
Sbjct: 239 KDFLK 243

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  122 bits (307), Expect = 5e-32
 Identities = 73/202 (36%), Positives = 107/202 (52%), Gaps = 3/202 (1%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           FEVL VVG+GA+  V + R   T EI A+K   KD    +   E    E  +L  +    
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQEN 61

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+L+ +F+ + +LYLV ++V    L            +  R Y  +++ A+   H N I
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDI 121

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN--SMCGTLEYMSPEIVLGKGHDKA 329
           +HRD+KPEN+L+  +  + L DFG A+   E + +N      T  Y SPE++LG  + KA
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181

Query: 330 ADWWSVGILLFEMLTGQPPFTG 351
            D WSVG +L E+  GQP F G
Sbjct: 182 VDMWSVGCILGELSDGQPLFPG 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  121 bits (306), Expect = 5e-32
 Identities = 73/242 (30%), Positives = 126/242 (52%), Gaps = 20/242 (8%)

Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA------EYMKSERNILTKVDHP 210
           ++G G+F  VY      + E+ A+K +    +   +        + +  E  +L ++ H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IVQ   S      L + L++V GG +   L   G F E L R +  +I+  +++LH  G
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126

Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN-------SMCGTLEYMSPEIVLG 323
           I+HRD+K  NIL+D  G + ++DFG++K+ + N+ S        S+ G++ +M+PE+V  
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ 186

Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ----KIQQKIIKDKIKLPAFLSSEAHSL 379
             + + AD WS+G L+ EMLTG+ PF    +     KI +    +   +P+ +SSEA   
Sbjct: 187 TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPE---IPSNISSEAIDF 243

Query: 380 LK 381
           L+
Sbjct: 244 LE 245

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  122 bits (307), Expect = 5e-32
 Identities = 66/203 (32%), Positives = 116/203 (57%), Gaps = 4/203 (1%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++HP 
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 60

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
           IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H++ 
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120

Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KGHDK 328
           ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG K +  
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 180

Query: 329 AADWWSVGILLFEMLTGQPPFTG 351
           A D WS+G +  EM+T +  F G
Sbjct: 181 AVDIWSLGCIFAEMVTRRALFPG 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  121 bits (304), Expect = 6e-32
 Identities = 72/223 (32%), Positives = 124/223 (55%), Gaps = 13/223 (5%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L +F++ K +G+G F++VY+   +   +  A+K ++  ++M+    +    E ++L +++
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL-----FFQLYRQGLFREDLARIYTAEIVSAV 263
           HP +++   SF     L +VL+  + G L     +F+  ++ L  E     Y  ++ SAV
Sbjct: 61  HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKR-LIPERTVWKYFVQLCSAV 119

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVL 322
            H+H+  +MHRD+KP N+ + A G V L D GL + F  + T ++S+ GT  YMSPE + 
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNR------QKIQQ 359
             G++  +D WS+G LL+EM   Q PF G         QKI+Q
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ 222

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  120 bits (302), Expect = 1e-31
 Identities = 81/239 (33%), Positives = 122/239 (51%), Gaps = 12/239 (5%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNILTKVDHPFIV 213
           K++GQGAF +VY      T    A+K ++ D    +   E   ++ E  +L  + H  IV
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 214 QLRYSF---QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
           Q  Y       +  L + ++ + GG +  QL   G   E++ R YT +I+  VS+LH+N 
Sbjct: 68  QY-YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM 126

Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFD----ENTRSNSMCGTLEYMSPEIVLGKGH 326
           I+HRD+K  NIL D+ G+V L DFG +K+        T   S+ GT  +MSPE++ G+G+
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY 186

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI--KLPAFLSSEAHSLLKGV 383
            + AD WSVG  + EMLT +PP+          KI        LP  +S      LK +
Sbjct: 187 GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRI 245

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  120 bits (301), Expect = 2e-31
 Identities = 71/209 (33%), Positives = 117/209 (55%), Gaps = 8/209 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNILTKV 207
            ++ + K++G+GAF +VY      T    A+K +  D   ++   E   ++ E  +L  +
Sbjct: 2   VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61

Query: 208 DHPFIVQLRYSFQ--TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
            H  IVQ     +   + +L + ++++ GG +  QL   G   E++ R YT +I+  VS+
Sbjct: 62  RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD----ENTRSNSMCGTLEYMSPEIV 321
           LH+N I+HRD+K  NIL D+ G+V L DFG +K+        T   S+ GT  +MSPE++
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181

Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFT 350
            G+G+ + AD WSV   + EMLT +PP+ 
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPPWA 210

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  120 bits (301), Expect = 3e-31
 Identities = 83/244 (34%), Positives = 132/244 (54%), Gaps = 17/244 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E +E++  +G GAF KVY+ +   T  + A KV+  +   E+   +YM  E  IL   +H
Sbjct: 12  EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYM-VEIEILATCNH 68

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGH---LFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P+IV+L  +F    +L+++++F  GG    +  +L R GL  E   ++   +++ A+ +L
Sbjct: 69  PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDR-GL-TEPQIQVICRQMLEALQYL 126

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGL-AKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
           H+  I+HRDLK  N+LL  DG + L DFG+ AK      R +S  GT  +M+PE+V+ + 
Sbjct: 127 HSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186

Query: 326 -----HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLPAFLSSEAH 377
                +D  AD WS+GI L EM   +PP    N  ++  KI K +   +  P+  S E  
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR 246

Query: 378 SLLK 381
             LK
Sbjct: 247 DFLK 250

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  119 bits (300), Expect = 5e-31
 Identities = 77/244 (31%), Positives = 128/244 (52%), Gaps = 17/244 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + +E++  +G GAF KVY+ +   T    A K++   +I  +   E    E +IL++  H
Sbjct: 5   DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSECKH 61

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL---FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P IV L  ++  + +L+++++F +GG L     +L R     E   R    +++ A++ L
Sbjct: 62  PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG--LTEPQIRYVCRQMLEALNFL 119

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGL-AKQFDENTRSNSMCGTLEYMSPEIVL--- 322
           H++ ++HRDLK  NILL  DG V L DFG+ AK      + ++  GT  +M+PE+V    
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179

Query: 323 --GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAH 377
                +D  AD WS+GI L E+   +PP    N  ++  KI+K     +  P+  SS  +
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239

Query: 378 SLLK 381
             LK
Sbjct: 240 DFLK 243

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score =  118 bits (298), Expect = 7e-31
 Identities = 77/253 (30%), Positives = 128/253 (50%), Gaps = 34/253 (13%)

Query: 149 LEDFEV---LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDK--IMEKNHAEYMKSERNI 203
           L++ E+   LK++  G F KV  ++   T +++  K+++      +E    + MK     
Sbjct: 13  LKNCEIVKKLKLI-DGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMK----- 66

Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
               D+P  ++L YS  T     L++D++  G LF  L ++G   E   +    ++V A+
Sbjct: 67  ----DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEAL 122

Query: 264 SHLHANGIMHRDLKPENILLD-ADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + LH + I+H D+K EN+L D A   + L D+GL K     T S    GTL+Y SPE + 
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI--IGTPS-CYDGTLDYFSPEKIK 179

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKI--------QQKIIKDKIKLPAFLSS 374
           G  +D + DWW+VG+L +E+LTG+ PF     +++        QQK    K+     +S 
Sbjct: 180 GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK----KLPFIKNVSK 235

Query: 375 EAHSLLKGVNSLL 387
            A+     V S+L
Sbjct: 236 NANDF---VQSML 245

Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  118 bits (297), Expect = 7e-31
 Identities = 71/202 (35%), Positives = 113/202 (55%), Gaps = 8/202 (3%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNILTKVDHPFIV 213
           K++GQGAF +VY    + T    A K ++ D    +   E   ++ E  +L  + H  IV
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 214 QLRYSFQTKYR--LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           Q     + +    L + ++++ GG +  QL   G   E + R YT +I+  +S+LH+N I
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQFD----ENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +HRD+K  NIL D+ G+V L DFG +K+        T   S+ GT  +MSPE++ G+G+ 
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYG 187

Query: 328 KAADWWSVGILLFEMLTGQPPF 349
           + AD WS+G  + EMLT +PP+
Sbjct: 188 RKADVWSLGCTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  118 bits (297), Expect = 8e-31
 Identities = 67/209 (32%), Positives = 114/209 (54%), Gaps = 7/209 (3%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L +F + K +G+G F++VY+   +      A+K ++   +M+         E ++L +++
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL-----FFQLYRQGLFREDLARIYTAEIVSAV 263
           HP +++   SF     L +VL+  + G L      F+  ++ L  E     Y  ++ SA+
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR-LIPEKTVWKYFVQLCSAL 119

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVL 322
            H+H+  +MHRD+KP N+ + A G V L D GL + F  + T ++S+ GT  YMSPE + 
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTG 351
             G++  +D WS+G LL+EM   Q PF G
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYG 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  118 bits (297), Expect = 1e-30
 Identities = 69/213 (32%), Positives = 114/213 (53%), Gaps = 19/213 (8%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           FE+++VVG G + +VY+ R + T ++ A+KVM     + ++  E +K E N+L K  H  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHR 73

Query: 212 IVQLRY-SFQTKY------RLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            +   Y +F  K       +L+LV++F   G +    +  +    +ED       EI+  
Sbjct: 74  NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSMCGTLEYMSPEIV 321
           ++HLHA+ ++HRD+K +N+LL  +  V L DFG++ Q D    R N+  GT  +M+PE++
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 193

Query: 322 L-----GKGHDKAADWWSVGILLFEMLTGQPPF 349
                    +D  +D WS+GI   EM  G PP 
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  117 bits (296), Expect = 2e-30
 Identities = 66/208 (31%), Positives = 116/208 (55%), Gaps = 14/208 (6%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNILTKV 207
           ++ ++ +G+G +  VY+ R   T EI A+K     KI  +   E + S    E ++L ++
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALK-----KIRLETEDEGVPSTAIREISLLKEL 55

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGG--HLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           +HP IV+L     ++ +LYLV +F++             GL    L + Y  +++  +++
Sbjct: 56  NHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDP-PLIKSYLYQLLQGIAY 114

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG- 323
            H++ ++HRDLKP+N+L+D +G + L DFGLA+ F    R+ +    TL Y +PEI+LG 
Sbjct: 115 CHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGS 174

Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           + +    D WS+G +  EM+  +P F G
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVNRRPLFPG 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  116 bits (291), Expect = 8e-30
 Identities = 69/217 (31%), Positives = 123/217 (56%), Gaps = 8/217 (3%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F+ L+ +G+G +A VY+ R   T EI A+K +  D   E+        E +++ ++ H  
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDA--EEGTPSTAIREISLMKELKHEN 59

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHAN 269
           IV+L     T+ +L LV ++++     +   +  +G    +  + +T +++  ++  H N
Sbjct: 60  IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFD--ENTRSNSMCGTLEYMSPEIVLG-KGH 326
            ++HRDLKP+N+L++  G + L DFGLA+ F    NT SN +  TL Y +P+++LG + +
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTY 178

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK 363
             + D WSVG ++ EM+TG+P F G N +    KI +
Sbjct: 179 STSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFR 215

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  115 bits (289), Expect = 9e-30
 Identities = 65/209 (31%), Positives = 112/209 (53%), Gaps = 11/209 (5%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMR---KDKIMEKNHAEYMKSERNILTKVDHPFI 212
           +V+G+GA+  VY        ++ A+K +     + +  +   E ++ E ++L  + H  I
Sbjct: 6   EVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
           VQ   +      + + ++FV GG +   L R G   E +   YT +I+  V++LH N ++
Sbjct: 65  VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVV 124

Query: 273 HRDLKPENILLDADGHVMLTDFGLAKQFD----ENTRSN---SMCGTLEYMSPEIVLGKG 325
           HRD+K  N++L  +G + L DFG A++        T SN   SM GT  +M+PE++   G
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG 184

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNR 354
           + + +D WS+G  +FEM TG+PP    +R
Sbjct: 185 YGRKSDIWSIGCTVFEMATGKPPLASMDR 213

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  115 bits (289), Expect = 1e-29
 Identities = 72/237 (30%), Positives = 122/237 (51%), Gaps = 12/237 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
              +    +G+G+   V       T    A+K M    + ++   E + +E  I+    H
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM---DLRKQQRRELLFNEVVIMRDYQH 75

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV++  S+     L++V++F+ GG L   +    +  E +A +  A ++ A+S LHA 
Sbjct: 76  PNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLA-VLKALSFLHAQ 134

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSMCGTLEYMSPEIVLGKGHDK 328
           G++HRD+K ++ILL +DG V L+DFG   Q  +   R  S+ GT  +M+PE++    +  
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGT 194

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQ-QKIIKD----KIKLPAFLSSEAHSLL 380
             D WS+GI++ EM+ G+PP+   N   +Q  K I+D    K+K    +S    S L
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPYF--NEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFL 249

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  113 bits (285), Expect = 5e-29
 Identities = 62/200 (31%), Positives = 110/200 (55%), Gaps = 4/200 (2%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  L+ +G+G+F +VY+     T E+ A+K++  D    ++  E ++ E  +L++ D P+
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           I +   S+    +L+++++++ GG     L + G   E        EI+  + +LH+   
Sbjct: 64  ITRYYGSYLKGTKLWIIMEYLGGGSAL-DLLKPGPLEETYIATILREILKGLDYLHSERK 122

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           +HRD+K  N+LL   G V L DFG+A Q  D   + N+  GT  +M+PE++    +D  A
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182

Query: 331 DWWSVGILLFEMLTGQPPFT 350
           D WS+GI   E+  G+PP +
Sbjct: 183 DIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  113 bits (286), Expect = 6e-29
 Identities = 75/234 (32%), Positives = 117/234 (50%), Gaps = 27/234 (11%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT 205
           C  ++++E L  + +G +  VY+ R   T EI A+K ++ +K  E      ++ E NIL 
Sbjct: 1   CRSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILL 59

Query: 206 KVDHPFIVQLRY----SFQTKYRLYLVLDFV---------NGGHLFFQLYRQGLFREDLA 252
           K+ HP IV ++     S   K  +Y+V+++V              F Q   + L  + L 
Sbjct: 60  KLQHPNIVTVKEVVVGSNLDK--IYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLL- 116

Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-NSMCG 311
                   S V+HLH N I+HRDLK  N+LL+  G + + DFGLA+++    +    +  
Sbjct: 117 --------SGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV 168

Query: 312 TLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD 364
           TL Y +PE++LG      A D WSVG +  E+LT +P F G +      KI K 
Sbjct: 169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKL 222

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  113 bits (285), Expect = 6e-29
 Identities = 66/197 (33%), Positives = 108/197 (54%), Gaps = 5/197 (2%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   VY    + T +  A+K M   +  +K   E + +E  ++ +  HP IV    
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKHPNIVNYLD 83

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRDIK 142

Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            +NILL  DG V LTDFG   Q   E ++ ++M GT  +M+PE+V  K +    D WS+G
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 202

Query: 337 ILLFEMLTGQPPFTGGN 353
           I+  EM+ G+PP+   N
Sbjct: 203 IMAIEMVEGEPPYLNEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  113 bits (284), Expect = 1e-28
 Identities = 75/207 (36%), Positives = 112/207 (54%), Gaps = 9/207 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM--RKDKIMEKNHAEYMKSERNILTKV 207
           E +E L +VG+G++  V + +   T +I A+K     +D  M K  A  M+ E  +L ++
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIA--MR-EIRMLKQL 57

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHL-FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
            H  +V L   F+ K RLYLV +FV+   L   + Y  GL  E   R Y  +I+  +   
Sbjct: 58  RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGL-DESRVRKYLFQILRGIEFC 116

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-NSMCGTLEYMSPEIVLGK- 324
           H++ I+HRD+KPENIL+   G V L DFG A+              T  Y +PE+++G  
Sbjct: 117 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT 176

Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTG 351
            + +A D W+VG L+ EMLTG+P F G
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPG 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  112 bits (281), Expect = 1e-28
 Identities = 62/200 (31%), Positives = 111/200 (55%), Gaps = 4/200 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L+ +G+G+F +V++     T ++ A+K++  D    ++  E ++ E  +L++ D 
Sbjct: 4   ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 61

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++ +   S+    +L+++++++ GG     L R G F E        EI+  + +LH+ 
Sbjct: 62  PYVTKYYGSYLKGTKLWIIMEYLGGGSAL-DLLRAGPFDEFQIATMLKEILKGLDYLHSE 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             +HRD+K  N+LL   G V L DFG+A Q  D   + N+  GT  +M+PE++    +D 
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 180

Query: 329 AADWWSVGILLFEMLTGQPP 348
            AD WS+GI   E+  G+PP
Sbjct: 181 KADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  110 bits (278), Expect = 4e-28
 Identities = 66/229 (28%), Positives = 116/229 (50%), Gaps = 14/229 (6%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKV---MRKDKIMEKNHAEYMKSERNILTKVD 208
            E+ K +G+GAF +VY+    G  E    KV     K+   E+   E+++ E +I+ K+ 
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLE-EASIMKKLS 59

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           HP IV+L         LY+V +++ GG L  F + + + L  +DL +    +I   + +L
Sbjct: 60  HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQ-MALQIAKGMEYL 118

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE---YMSPEIVLG 323
            +   +HRDL   N L+  +  V ++DFGL++   E+       G      +M+PE +  
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKD 178

Query: 324 KGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQKIIKDKIKLPA 370
                 +D WS G+LL+E+ T G+ P+ G  N + ++   ++D  +LP 
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEL--LEDGYRLPR 225

Length = 258

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  110 bits (276), Expect = 6e-28
 Identities = 66/213 (30%), Positives = 110/213 (51%), Gaps = 19/213 (8%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           FE++++VG G + +VY+ R + T ++ A+KVM     +  +  E +K E N+L K  H  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63

Query: 212 IVQLRYSFQTKY-------RLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            +   Y    K        +L+LV++F   G +    +  +    +E+       EI+  
Sbjct: 64  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSMCGTLEYMSPEIV 321
           +SHLH + ++HRD+K +N+LL  +  V L DFG++ Q D    R N+  GT  +M+PE++
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183

Query: 322 L-----GKGHDKAADWWSVGILLFEMLTGQPPF 349
                    +D  +D WS+GI   EM  G PP 
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  111 bits (278), Expect = 7e-28
 Identities = 65/197 (32%), Positives = 108/197 (54%), Gaps = 5/197 (2%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   VY    I T +  A+K M    + ++   E + +E  ++ +  +P IV    
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 83

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALDFLHSNQVIHRDIK 142

Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            +NILL  DG V LTDFG   Q   E ++ ++M GT  +M+PE+V  K +    D WS+G
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 202

Query: 337 ILLFEMLTGQPPFTGGN 353
           I+  EM+ G+PP+   N
Sbjct: 203 IMAIEMVEGEPPYLNEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  110 bits (275), Expect = 9e-28
 Identities = 64/203 (31%), Positives = 106/203 (52%), Gaps = 7/203 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDFE+++ +G G +  VY+ R + T E+ A+KV+   K+        ++ E  ++    H
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDCKH 65

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
             IV    S+  + +L++ ++F  GG L    +  G   E      + E +  + +LH+ 
Sbjct: 66  SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK 125

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNSMCGTLEYMSPEIVLGK---G 325
           G MHRD+K  NILL  +GHV L DFG++ Q      +  S  GT  +M+PE+   +   G
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGG 185

Query: 326 HDKAADWWSVGILLFEMLTGQPP 348
           +++  D W+VGI   E+   QPP
Sbjct: 186 YNQLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  109 bits (275), Expect = 1e-27
 Identities = 64/245 (26%), Positives = 121/245 (49%), Gaps = 23/245 (9%)

Query: 156 KVVGQGAFAKVYQ---VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           K +G+GAF +VY+     + G +   A+K +++D   E+   +++K E  ++ K+ HP +
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA-SEEERKDFLK-EARVMKKLGHPNV 58

Query: 213 VQLR-YSFQTKYRLYLVLDFVNGGHL----------FFQLYRQGLFREDLARIYTAEIVS 261
           V+L       +  LYLVL+++ GG L          F    +  L  +DL      +I  
Sbjct: 59  VRLLGVCT-EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF-AIQIAK 116

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT---LEYMSP 318
            + +L +   +HRDL   N L+  D  V ++DFGL++   ++       G    + +M+P
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176

Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA 376
           E +        +D WS G+LL+E+ T G  P+ G + +++ + + K  ++  P +   E 
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDEL 236

Query: 377 HSLLK 381
           + L+ 
Sbjct: 237 YELML 241

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  109 bits (273), Expect = 2e-27
 Identities = 65/200 (32%), Positives = 113/200 (56%), Gaps = 7/200 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D +  +++G G    VY+   + T  I A+KV+  D  +E    + + SE  IL K D 
Sbjct: 1   QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ--KQIMSELEILYKCDS 58

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P+I+    +F  + R+ +  +F++GG L   +YR+ +    L RI  A +V  +++L + 
Sbjct: 59  PYIIGFYGAFFVENRISICTEFMDGGSL--DVYRK-IPEHVLGRIAVA-VVKGLTYLWSL 114

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKA 329
            I+HRD+KP N+L++  G V L DFG++ Q   N+ + +  GT  YM+PE + G+ +   
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-VNSIAKTYVGTNAYMAPERISGEQYGIH 173

Query: 330 ADWWSVGILLFEMLTGQPPF 349
           +D WS+GI   E+  G+ P+
Sbjct: 174 SDVWSLGISFMELALGRFPY 193

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score =  108 bits (270), Expect = 2e-27
 Identities = 69/229 (30%), Positives = 105/229 (45%), Gaps = 30/229 (13%)

Query: 161 GAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ 220
           G   KV  V    T + + +K +RK        +EY +    I+     P +V L     
Sbjct: 4   GVIDKVLLVMDTRTQQTFILKGLRKS-------SEYSRERLTIIPHC-VPNMVCLHKYIV 55

Query: 221 TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN 280
           ++  ++LVL    GG L+  + +     E+  + + AE+V A+  LH  GI+ RDL P N
Sbjct: 56  SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115

Query: 281 ILLDADGHVMLTDFG----LAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
           ILLD  GH+ LT F     +    D     N  C      +PE+       +A DWWS+G
Sbjct: 116 ILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYC------APEVGGISEETEACDWWSLG 169

Query: 337 ILLFEMLTG----QPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
            +LFE+LTG    +   +G N            + +P ++S EA SLL+
Sbjct: 170 AILFELLTGKTLVECHPSGINTHT--------TLNIPEWVSEEARSLLQ 210

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  112 bits (281), Expect = 3e-27
 Identities = 73/216 (33%), Positives = 121/216 (56%), Gaps = 20/216 (9%)

Query: 190 EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL--- 246
           ++  A Y +SE + L   DH  IV+    F++  +L L++++ +GG L  Q+ +Q L   
Sbjct: 105 DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI-KQRLKEH 163

Query: 247 --FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT 304
             F+E    +   +IV A+  +H+  +MHRDLK  NI L   G + L DFG +KQ+ ++ 
Sbjct: 164 LPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223

Query: 305 R---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKI 361
               ++S CGT  Y++PE+   K + K AD WS+G++L+E+LT   PF G ++++I Q++
Sbjct: 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV 283

Query: 362 IKDKIK-LPAFLSSEAHSLLKGVNSLLSISVPLLSR 396
           +  K    P  +SS   +LL           PLLS+
Sbjct: 284 LYGKYDPFPCPVSSGMKALLD----------PLLSK 309

Length = 478

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  109 bits (273), Expect = 3e-27
 Identities = 63/197 (31%), Positives = 108/197 (54%), Gaps = 5/197 (2%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   VY    + T +  A++ M    + ++   E + +E  ++ +  +P IV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 84

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRDIK 143

Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            +NILL  DG V LTDFG   Q   E ++ ++M GT  +M+PE+V  K +    D WS+G
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203

Query: 337 ILLFEMLTGQPPFTGGN 353
           I+  EM+ G+PP+   N
Sbjct: 204 IMAIEMIEGEPPYLNEN 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  109 bits (272), Expect = 3e-27
 Identities = 59/202 (29%), Positives = 111/202 (54%), Gaps = 4/202 (1%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L+ +G+G+F +V++     T ++ A+K++  ++   ++  E ++ E  +L++ D 
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDS 61

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++ +   S+    +L+++++++ GG     L   G   E        EI+  + +LH+ 
Sbjct: 62  PYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSE 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             +HRD+K  N+LL   G V L DFG+A Q  D   + N+  GT  +M+PE++    +D 
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180

Query: 329 AADWWSVGILLFEMLTGQPPFT 350
            AD WS+GI   E+  G+PP +
Sbjct: 181 KADIWSLGITAIELAKGEPPHS 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score =  111 bits (280), Expect = 5e-27
 Identities = 86/257 (33%), Positives = 133/257 (51%), Gaps = 36/257 (14%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME--KNHAEYMKSERNILTKVDHPFIV 213
           +V+G GA   V   +R+   E +A+KV+  + + E  KN A+   +E   L   D   IV
Sbjct: 38  RVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQ---AEVCCLLNCDFFSIV 94

Query: 214 QLRYSFQTK--------YRLYLVLDFVNGGHLFFQLYRQGL---------FREDLARIYT 256
           +    F  K          + LVLD+ N G L     RQ +         FRE  A +  
Sbjct: 95  KCHEDFAKKDPRNPENVLMIALVLDYANAGDL-----RQEIKSRAKTNRTFREHEAGLLF 149

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN----SMCGT 312
            +++ AV H+H+  ++HRD+K  NILL ++G V L DFG +K +   T S+    + CGT
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY-AATVSDDVGRTFCGT 208

Query: 313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-LPAF 371
             Y++PEI   K + K AD +S+G+LL+E+LT + PF G N +++  K +  +   LP  
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPS 268

Query: 372 LSSEAHSLLKGVNSLLS 388
           +S E   +   V +LLS
Sbjct: 269 ISPEMQEI---VTALLS 282

Length = 496

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  107 bits (269), Expect = 8e-27
 Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 11/206 (5%)

Query: 155 LKVVGQGAFAKVYQ----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
            K +G+GAF +VY+     +  G     A+K +++D   E+   E+++ E  I+ K+DHP
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA-SEQQIEEFLR-EARIMRKLDHP 61

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            IV+L      +  L +V++++ GG L  + +  R           +  +I   + +L +
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY--MSPEIVLGKGH 326
              +HRDL   N L+  +  V ++DFGL++   ++       G L    M+PE +     
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKF 181

Query: 327 DKAADWWSVGILLFEMLT-GQPPFTG 351
              +D WS G+LL+E+ T G+ P+ G
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEPYPG 207

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  107 bits (270), Expect = 9e-27
 Identities = 66/223 (29%), Positives = 113/223 (50%), Gaps = 16/223 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + +E L+ +G+G + KVY+ R   T ++ A+K  R +   E      ++ E ++L  +  
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSE 59

Query: 210 -PFIVQLRYSFQT-----KYRLYLVLDFVNGG-HLFFQLYRQGLFR---EDLARIYTAEI 259
             +IV+L           K  LYLV ++++     F     +G  R       + +  ++
Sbjct: 60  SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSM-CGTLEYMS 317
           +  V+H H +G+MHRDLKP+N+L+D    ++ + D GL + F    +S +    TL Y +
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRA 179

Query: 318 PEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ 359
           PE++LG  H     D WSVG +  EM   QP F G +  ++QQ
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS--ELQQ 220

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  107 bits (270), Expect = 9e-27
 Identities = 73/223 (32%), Positives = 112/223 (50%), Gaps = 12/223 (5%)

Query: 139 NLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK 198
            +  +     L D E L  +G G   +VY++R   T  + A+K MR+    E+N    M 
Sbjct: 4   TIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMD 63

Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYT 256
            +  +L   D P+IV+    F T   +++ ++ +       +L +  QG   ED+    T
Sbjct: 64  LDV-VLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMT 120

Query: 257 AEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLE 314
             IV A+ +L    G++HRD+KP NILLDA G+V L DFG++ +  D   ++ S  G   
Sbjct: 121 VAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-AGCAA 179

Query: 315 YMSPE-IVLGKGHDK---AADWWSVGILLFEMLTGQPPFTGGN 353
           YM+PE I     + K    AD WS+GI L E+ TGQ P+    
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK 222

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  107 bits (268), Expect = 2e-26
 Identities = 65/197 (32%), Positives = 109/197 (55%), Gaps = 5/197 (2%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   V+    + T +  A+K +   K  +K   E + +E  ++ ++ +P IV    
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK---ELIINEILVMKELKNPNIVNFLD 83

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           SF     L++V++++ GG L   +    +    +A +   E + A+  LHAN ++HRD+K
Sbjct: 84  SFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV-CRECLQALEFLHANQVIHRDIK 142

Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            +N+LL  DG V LTDFG   Q   E ++ ++M GT  +M+PE+V  K +    D WS+G
Sbjct: 143 SDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 202

Query: 337 ILLFEMLTGQPPFTGGN 353
           I+  EM+ G+PP+   N
Sbjct: 203 IMAIEMVEGEPPYLNEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  107 bits (269), Expect = 2e-26
 Identities = 67/235 (28%), Positives = 112/235 (47%), Gaps = 36/235 (15%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK----SER 201
           C  L D+E+L  +G+G F +VY+ R+I T  + A+K     KI+  N  +        E 
Sbjct: 4   CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREI 58

Query: 202 NILTKVDHPFIVQL-----RYSFQTKYRL---YLVLDFVN---GGHLFFQLYRQGLFRED 250
            IL K+ HP +V L         ++K +    Y+V  +++    G L     +     E 
Sbjct: 59  KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTES 115

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------- 303
             + Y  +++  +++LH N I+HRD+K  NIL+D  G + + DFGLA+ +D         
Sbjct: 116 QIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175

Query: 304 -----TRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGG 352
                 +  ++  T  Y  PE++LG + +  A D W +G +  EM T +P   G 
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  107 bits (270), Expect = 3e-26
 Identities = 75/220 (34%), Positives = 116/220 (52%), Gaps = 27/220 (12%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
           L + E +  +G GA   VY+V    T  +YA+KV+        NH + ++     E  IL
Sbjct: 73  LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYG------NHEDTVRRQICREIEIL 126

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
             V+HP +V+    F     + ++L+F++GG L         F  D+AR    +I+S ++
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIA 182

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFG----LAKQFDENTRSNSMCGTLEYMSPEI 320
           +LH   I+HRD+KP N+L+++  +V + DFG    LA+  D     NS  GT+ YMSPE 
Sbjct: 183 YLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP---CNSSVGTIAYMSPER 239

Query: 321 V---LGKG-HDK-AADWWSVGILLFEMLTGQPPFTGGNRQ 355
           +   L  G +D  A D WS+G+ + E   G+ PF  G RQ
Sbjct: 240 INTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG-RQ 278

Length = 353

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  105 bits (264), Expect = 4e-26
 Identities = 59/204 (28%), Positives = 109/204 (53%), Gaps = 12/204 (5%)

Query: 155 LKVVGQGAFAKVYQ---VRRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
            K +G+GAF +VY+     + G  ++  A+K +++D   E+   E+++ E  I+ K+DHP
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLR-EARIMRKLDHP 61

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            +V+L      +  LY+V++++ GG L  + +  R  L   DL   +  +I   + +L +
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLS-FALQIARGMEYLES 120

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGKGH 326
              +HRDL   N L+  +  V ++DFGL++    D+  R       + +M+PE +     
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF 180

Query: 327 DKAADWWSVGILLFEMLT-GQPPF 349
              +D WS G+LL+E+ T G+ P+
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQPY 204

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  105 bits (263), Expect = 1e-25
 Identities = 70/237 (29%), Positives = 111/237 (46%), Gaps = 28/237 (11%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK----SER 201
           C  +  +E L  +GQG F +V++ R   T +I A+K     K++ +N  E        E 
Sbjct: 8   CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALK-----KVLMENEKEGFPITALREI 62

Query: 202 NILTKVDHPFIVQL------RYSFQTKYR--LYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
            IL  + H  +V L      + +   +Y+   YLV +F    H    L      +  L+ 
Sbjct: 63  KILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE--HDLAGLLSNKNVKFTLSE 120

Query: 254 IYTA--EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD--ENTRSNSM 309
           I      +++ + ++H N I+HRD+K  NIL+  DG + L DFGLA+ F   +N++ N  
Sbjct: 121 IKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180

Query: 310 CG---TLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII 362
                TL Y  PE++LG + +    D W  G ++ EM T  P   G   Q  Q  +I
Sbjct: 181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH-QLTLI 236

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  105 bits (264), Expect = 2e-25
 Identities = 71/218 (32%), Positives = 115/218 (52%), Gaps = 23/218 (10%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME--KNHAEYMKSERNI--L 204
           L  +E+L+ +G+GA+  V++     T E+ A+K     KI +  +N  +  ++ R I  L
Sbjct: 6   LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALK-----KIFDAFRNATDAQRTFREIMFL 60

Query: 205 TKV-DHPFIVQLR--YSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIV 260
            ++ DHP IV+L      +    +YLV +++    H    + R  +  +   R    +++
Sbjct: 61  QELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLH---AVIRANILEDVHKRYIMYQLL 117

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM------CGTLE 314
            A+ ++H+  ++HRDLKP NILL++D  V L DFGLA+   E   +           T  
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177

Query: 315 YMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           Y +PEI+LG   + K  D WSVG +L EML G+P F G
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG 215

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  103 bits (257), Expect = 2e-25
 Identities = 69/234 (29%), Positives = 124/234 (52%), Gaps = 10/234 (4%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVM--RKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           ++VVG+G++ +V  VR     + Y +K +  R     E+  AE    E  +L+++ HP I
Sbjct: 5   VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAE---QEAQLLSQLKHPNI 61

Query: 213 VQLRYSFQTK-YRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHAN 269
           V  R S++ +   LY+V+ F  GG L+ +L  Q   L  E+    +  +I  A+ +LH  
Sbjct: 62  VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDK 328
            I+HRDLK +N+ L     + + D G+A+  + +   ++++ GT  YMSPE+   K ++ 
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNY 181

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAHSLLK 381
            +D W++G  ++EM T +  F   +   +  +II+ K+  +P   S E   L+ 
Sbjct: 182 KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIA 235

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  103 bits (259), Expect = 3e-25
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 23/214 (10%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK--DKIMEKNHAEYMKSERNILTKV-D 208
           +++L  +G+G F++V + +   T + YA+K M+K    + + N+      E   L ++  
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL----REIQALRRLSP 56

Query: 209 HPFIVQLR---YSFQTKYRLYLVLDFVNGGHLFFQLY-----RQGLFREDLARIYTAEIV 260
           HP I++L    +  +T  RL LV + ++       LY     R+    E   + Y  +++
Sbjct: 57  HPNILRLIEVLFDRKTG-RLALVFELMDM-----NLYELIKGRKRPLPEKRVKSYMYQLL 110

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
            ++ H+H NGI HRD+KPENIL+  D  + L DFG  +             T  Y +PE 
Sbjct: 111 KSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTRWYRAPEC 169

Query: 321 VLGKG-HDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +L  G +    D W+VG + FE+L+  P F G N
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  103 bits (258), Expect = 4e-25
 Identities = 68/210 (32%), Positives = 112/210 (53%), Gaps = 15/210 (7%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNILTK 206
           D+  ++ +G+G +  VY+ R   T +I AMK     KI  ++  E + S    E ++L +
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMK-----KIRLESEEEGVPSTAIREISLLKE 55

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVN---GGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
           + HP IV L+     + RLYL+ +F++     +L   L +      +L + Y  +I+  +
Sbjct: 56  LQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLD-SLPKGQYMDAELVKSYLYQILQGI 114

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVL 322
              H+  ++HRDLKP+N+L+D  G + L DFGLA+ F    R  +    TL Y +PE++L
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLL 174

Query: 323 GKG-HDKAADWWSVGILLFEMLTGQPPFTG 351
           G   +    D WS+G +  EM T +P F G
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKKPLFHG 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  103 bits (258), Expect = 6e-25
 Identities = 66/214 (30%), Positives = 110/214 (51%), Gaps = 13/214 (6%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-- 203
           C  + +FE L  +G+G +  VY+ R   + EI A+K +R D   E++    + S R I  
Sbjct: 3   CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN--ERDGIP-ISSLREITL 59

Query: 204 LTKVDHPFIVQLRYSFQTKY--RLYLVLDFVNG--GHLFFQLYRQGLFREDLARIYTAEI 259
           L  + HP IV+L+     K+   ++LV+++       L   +     F E   +    ++
Sbjct: 60  LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQL 117

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMC-GTLEYMSP 318
           +  + +LH N I+HRDLK  N+LL   G + + DFGLA+ +    +  +    TL Y +P
Sbjct: 118 LRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAP 177

Query: 319 EIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           E++LG   +  A D W+VG +L E+L  +P   G
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG 211

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  101 bits (253), Expect = 1e-24
 Identities = 60/203 (29%), Positives = 106/203 (52%), Gaps = 7/203 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
            D+E+++ VG G +  VY+ R + T E+ A+K++   K+   +    ++ E  ++ +  H
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVKECKH 65

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
             IV    S+ ++ +L++ +++  GG L    +  G   E        E +  +++LH+ 
Sbjct: 66  CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNSMCGTLEYMSPEIVL---GKG 325
           G MHRD+K  NILL  +G V L DFG+A +      +  S  GT  +M+PE+       G
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGG 185

Query: 326 HDKAADWWSVGILLFEMLTGQPP 348
           +++  D W+VGI   E+   QPP
Sbjct: 186 YNQLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  101 bits (253), Expect = 2e-24
 Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 8/207 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMR--KDKIMEKNHAEYMKSERNILTKV 207
           ED E +  +G G    V +V+ I T  + A KV+       + K     +  E  I+ + 
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQ----ILRELQIMHEC 60

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
             P+IV    +F  +  + + ++F++ G L     + G    ++       +V  +++L+
Sbjct: 61  RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY 120

Query: 268 -ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
             + IMHRD+KP NIL+++ G + L DFG++ +   N+ +++  GT  YMSPE + G  +
Sbjct: 121 NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL-INSIADTFVGTSTYMSPERIQGGKY 179

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGN 353
              +D WS+GI + E+  G+ PF   N
Sbjct: 180 TVKSDVWSLGISIIELALGKFPFAFSN 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  101 bits (253), Expect = 2e-24
 Identities = 56/193 (29%), Positives = 109/193 (56%), Gaps = 5/193 (2%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V   R   +    A+K+M    + ++   E + +E  I+    H  +V++  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L+++++F+ GG L   + +  L  E +A +  + ++ A+ +LH+ G++HRD+K
Sbjct: 86  SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCES-VLQALCYLHSQGVIHRDIK 144

Query: 278 PENILLDADGHVMLTDFGLAKQFDENT-RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            ++ILL  DG V L+DFG   Q  ++  +  S+ GT  +M+PE++    +    D WS+G
Sbjct: 145 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLG 204

Query: 337 ILLFEMLTGQPPF 349
           I++ EM+ G+PP+
Sbjct: 205 IMVIEMVDGEPPY 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  101 bits (254), Expect = 2e-24
 Identities = 75/251 (29%), Positives = 127/251 (50%), Gaps = 33/251 (13%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ F+++  +G+G + +VY+ R   T E+ A+K +R D   E      ++ E  IL +++
Sbjct: 6   VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLN 64

Query: 209 HPFIVQLR---------YSF-QTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYT 256
           H  IV L+           F + K   YLV ++++  H    L   GL  F ED  + + 
Sbjct: 65  HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD--HDLMGLLESGLVHFSEDHIKSFM 122

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR---SNSMCGTL 313
            +++  +++ H    +HRD+K  NILL+  G + L DFGLA+ ++       +N +  TL
Sbjct: 123 KQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TL 181

Query: 314 EYMSPEIVLGKG-HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK--------- 363
            Y  PE++LG+  +  A D WS G +L E+ T +P F   N++  Q ++I          
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ-ANQELAQLELISRLCGSPCPA 240

Query: 364 ---DKIKLPAF 371
              D IKLP F
Sbjct: 241 VWPDVIKLPYF 251

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score =  104 bits (262), Expect = 3e-24
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 17/220 (7%)

Query: 174 TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-YRLYLVLDFV 232
           T    A+K++R D   E++     + E  +  ++ HP IV L  S +     L+ V ++V
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61

Query: 233 NGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG---H 288
            G  L   L   G L   +  R+   +++ A++  H  GI+HRDLKP+NI++   G   H
Sbjct: 62  PGRTLREVLAADGALPAGETGRLML-QVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120

Query: 289 VMLTDFGL------AKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLF 340
             + DFG+       +  D    TR+  + GT  Y +PE + G+     +D ++ G++  
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180

Query: 341 EMLTGQPPFTGGNRQKI-QQKIIKDKIKLPAFLSSEAHSL 379
           E LTGQ    G +  +I  Q++    + LP ++    H L
Sbjct: 181 ECLTGQRVVQGASVAEILYQQLSPVDVSLPPWI--AGHPL 218

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  100 bits (250), Expect = 4e-24
 Identities = 74/263 (28%), Positives = 128/263 (48%), Gaps = 28/263 (10%)

Query: 138 DNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYM 197
           D+ P  +     + +E+++ +G+G + KV++V         A+K++  D I + +  E +
Sbjct: 11  DSFPDPS-----DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL--DPIHDID--EEI 61

Query: 198 KSERNILTKV-DHPFIVQL-----RYSFQTKYRLYLVLDFVNGGHLF----FQLYRQGLF 247
           ++E NIL  + DHP +V+      +   +   +L+LVL+  NGG +       L R    
Sbjct: 62  EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM 121

Query: 248 REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRS 306
            E +      E +  + HLH N  +HRD+K  NILL  +G V L DFG++ Q      R 
Sbjct: 122 EEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181

Query: 307 NSMCGTLEYMSPEIV-----LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKI 361
           N+  GT  +M+PE++     L   +D   D WS+GI   E+  G PP    +  +   KI
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI 241

Query: 362 IKD---KIKLPAFLSSEAHSLLK 381
            ++    +  P   S+E +  ++
Sbjct: 242 PRNPPPTLHQPELWSNEFNDFIR 264

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 99.7 bits (248), Expect = 9e-24
 Identities = 70/228 (30%), Positives = 121/228 (53%), Gaps = 10/228 (4%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V       + ++ A+K M    + ++   E + +E  I+    H  +V++  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   +    +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLKALSVLHAQGVIHRDIK 143

Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            ++ILL  DG V L+DFG   Q   E  R  S+ GT  +M+PE++    +    D WS+G
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLG 203

Query: 337 ILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSS--EAHSLLKG 382
           I++ EM+ G+PP+      K   K+I+D   LP  L +  +    LKG
Sbjct: 204 IMVIEMVDGEPPYFNEPPLK-AMKMIRD--NLPPKLKNLHKVSPSLKG 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 99.5 bits (248), Expect = 1e-23
 Identities = 65/208 (31%), Positives = 120/208 (57%), Gaps = 7/208 (3%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ +E ++ +G+G +  VY+ R   T+E  A+K +R ++  E   +  ++ E ++L ++ 
Sbjct: 1   MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQ 59

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED--LARIYTAEIVSAVSHL 266
           H  IV+L+    ++ RLYLV ++++   L   +     F ++  L + Y  +I+  +++ 
Sbjct: 60  HGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118

Query: 267 HANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLGK 324
           H++ ++HRDLKP+N+L+D   + + L DFGLA+ F    R+ +    TL Y +PEI+LG 
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGS 178

Query: 325 GH-DKAADWWSVGILLFEMLTGQPPFTG 351
            H     D WSVG +  EM+  +P F G
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVNQKPLFPG 206

Length = 294

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 74/281 (26%), Positives = 122/281 (43%), Gaps = 53/281 (18%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK---DKIMEKNHAEYMKSERNILTKVD 208
           ++ L  VG GA+ +V       T    A+K + +     I    HA+    E  +L  +D
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAI----HAKRTYRELRLLKHMD 72

Query: 209 HPFIVQL---------RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           H  ++ L            FQ    +YLV   +  G     + +     +D  +    +I
Sbjct: 73  HENVIGLLDVFTPASSLEDFQD---VYLVTHLM--GADLNNIVKCQKLSDDHIQFLVYQI 127

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYM 316
           +  + ++H+ GI+HRDLKP NI ++ D  + + DFGLA+  D+      M G   T  Y 
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 182

Query: 317 SPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNR-------------------QK 356
           +PEI+L   H ++  D WSVG ++ E+LTG+  F G +                    QK
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242

Query: 357 IQQKIIKDKIK-LPAFLSSEAHSLLKGVNSLLSISVPLLSR 396
           I  +  ++ I+ LP     +   +  G N L    + LL +
Sbjct: 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLA---IDLLEK 280

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 99.5 bits (249), Expect = 2e-23
 Identities = 60/230 (26%), Positives = 100/230 (43%), Gaps = 52/230 (22%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK---DKIMEKNHAEYMKSERNILTKVD 208
           +E+LK +G GA+  V       T    A+K +     D I     A+ +  E  +L  + 
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLI----DAKRILREIKLLRHLR 57

Query: 209 HPFIVQL--------RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI------ 254
           H  I+ L           F     +Y+V +               L   DL ++      
Sbjct: 58  HENIIGLLDILRPPSPEDFND---VYIVTE---------------LMETDLHKVIKSPQP 99

Query: 255 --------YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS 306
                   +  +I+  + +LH+  ++HRDLKP NIL++++  + + DFGLA+  D +   
Sbjct: 100 LTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159

Query: 307 NS-MCG---TLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +     T  Y +PE++L    + KA D WSVG +  E+LT +P F G
Sbjct: 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPG 209

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 98.5 bits (245), Expect = 2e-23
 Identities = 74/219 (33%), Positives = 115/219 (52%), Gaps = 26/219 (11%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-D 208
           + +E+++ +G+G + KVY+V       + A+K++  D I + +  E +++E NIL  + +
Sbjct: 22  DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL--DPISDVD--EEIEAEYNILQSLPN 77

Query: 209 HPFIVQLRYSF--QTKY---RLYLVLDFVNGG---HLFFQLYRQGLFREDLARI----YT 256
           HP +V+    F    K    +L+LVL+  NGG    L   L   G  R D A I    Y 
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ-RLDEAMISYILYG 136

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEY 315
           A +   + HLH N I+HRD+K  NILL  +G V L DFG++ Q      R N+  GT  +
Sbjct: 137 ALL--GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFW 194

Query: 316 MSPEIVLGK-----GHDKAADWWSVGILLFEMLTGQPPF 349
           M+PE++  +      +D   D WS+GI   E+  G PP 
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 97.6 bits (243), Expect = 3e-23
 Identities = 72/237 (30%), Positives = 117/237 (49%), Gaps = 17/237 (7%)

Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL--TKVDHPFIVQ 214
           V+G+G +  VY  R + T    A+K     +I E++          I   + + H  IVQ
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIK-----EIPERDSRYVQPLHEEIALHSYLKHRNIVQ 69

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSHLHANGI 271
              S        + ++ V GG L   L  +       E     YT +I+  + +LH N I
Sbjct: 70  YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129

Query: 272 MHRDLKPENILLDA-DGHVMLTDFGLAKQFDE-NTRSNSMCGTLEYMSPEIVLG--KGHD 327
           +HRD+K +N+L++   G V ++DFG +K+    N  + +  GTL+YM+PE++    +G+ 
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYG 189

Query: 328 KAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKI--IKDKIKLPAFLSSEAHSLLK 381
             AD WS+G  + EM TG+PPF   G  Q    K+   K   ++P  LS+EA + + 
Sbjct: 190 APADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFIL 246

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 98.2 bits (244), Expect = 3e-23
 Identities = 61/212 (28%), Positives = 116/212 (54%), Gaps = 5/212 (2%)

Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
           ++K  + ++   E + +E  I+    H  +V +  S+     L++V++F+ GG L   + 
Sbjct: 52  VKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT 111

Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD- 301
              +  E +A +  + ++ A+S+LH  G++HRD+K ++ILL +DG + L+DFG   Q   
Sbjct: 112 HTRMNEEQIATVCLS-VLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 170

Query: 302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ-QK 360
           E  +  S+ GT  +M+PE++    +    D WS+GI++ EM+ G+PP+   N   +Q  +
Sbjct: 171 EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYF--NEPPLQAMR 228

Query: 361 IIKDKIKLPAFLSSEAHSLLKGVNSLLSISVP 392
            I+D +      S +  S+L+G   L+ +  P
Sbjct: 229 RIRDNLPPRVKDSHKVSSVLRGFLDLMLVREP 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 97.9 bits (244), Expect = 3e-23
 Identities = 59/219 (26%), Positives = 113/219 (51%), Gaps = 12/219 (5%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNILTKV 207
           +E L+ +G+G +  V++ +   T EI A+K +R D     +  E + S    E  +L ++
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD-----DDDEGVPSSALREICLLKEL 56

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            H  IV+L     +  +L LV ++ +     +     G    ++ + +  +++  ++  H
Sbjct: 57  KHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R  S    TL Y  P+++ G K 
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 176

Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK 363
           +  + D WS G +  E+   G+P F G +     ++I +
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 97.9 bits (244), Expect = 4e-23
 Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 21/212 (9%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS---ERNILTK 206
           E    L  +G+GA   V + R   T  I+A+K      I    + +  K    E  I   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKT-----ITTDPNPDLQKQILRELEINKS 55

Query: 207 VDHPFIVQLRYSFQTKY--RLYLVLDFVNGGHLFFQLYRQGLFREDLARI------YTAE 258
              P+IV+   +F  +    + + +++  GG L   +Y++   ++   RI        AE
Sbjct: 56  CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLD-SIYKK--VKKRGGRIGEKVLGKIAE 112

Query: 259 -IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMS 317
            ++  +S+LH+  I+HRD+KP NILL   G V L DFG++ +   N+ + +  GT  YM+
Sbjct: 113 SVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL-VNSLAGTFTGTSFYMA 171

Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           PE + GK +   +D WS+G+ L E+   + PF
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 97.7 bits (244), Expect = 6e-23
 Identities = 66/229 (28%), Positives = 113/229 (49%), Gaps = 41/229 (17%)

Query: 152 FEVLKVVGQGAFAKVYQVRRI--GTSEIYAMKVMRKDKIMEKNHAEY----MKSERNI-- 203
           +E+   +G+G + +VY+ +R      + YA+K  + DK       +Y      + R I  
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDK------EQYTGISQSACREIAL 55

Query: 204 LTKVDHPFIVQLRYSFQTKY--RLYLVLDFVNGGHLFFQL---YRQGLFREDLARIYTA- 257
           L ++ H  +V L   F       +YL+ D+    H  +Q+   +RQ         I  + 
Sbjct: 56  LRELKHENVVSLVEVFLEHADKSVYLLFDYAE--HDLWQIIKFHRQ----AKRVSIPPSM 109

Query: 258 ------EIVSAVSHLHANGIMHRDLKPENILLDADGH----VMLTDFGLAKQFDENTRS- 306
                 +I++ V +LH+N ++HRDLKP NIL+  +G     V + D GLA+ F+   +  
Sbjct: 110 VKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169

Query: 307 ---NSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTG 351
              + +  T+ Y +PE++LG  H  KA D W++G +  E+LT +P F G
Sbjct: 170 ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG 218

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 95.9 bits (238), Expect = 2e-22
 Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 6/206 (2%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           LE +  L  +G+G +A V++ R   T  + A+K +R +   E+        E ++L  + 
Sbjct: 4   LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLK 61

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV L     T+  L LV ++++     +      L      +I+  +++  +S+ H 
Sbjct: 62  HANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGL--AKQFDENTRSNSMCGTLEYMSPEIVLGKG- 325
             I+HRDLKP+N+L++  G + L DFGL  AK     T SN +  TL Y  P+++LG   
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTE 180

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +    D W VG +L+EM TG+P F G
Sbjct: 181 YSTPIDMWGVGCILYEMATGRPMFPG 206

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 95.9 bits (238), Expect = 2e-22
 Identities = 70/242 (28%), Positives = 123/242 (50%), Gaps = 16/242 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK-SERNILTKVD 208
           + +E L+ +G+G++A VY+ +     ++ A+KV+R   + E+    +    E ++L  + 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIR---LQEEEGTPFTAIREASLLKGLK 61

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV L     TK  L LV ++V+     +     G    +  +++  +++  +S++H 
Sbjct: 62  HANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGL--AKQFDENTRSNSMCGTLEYMSPEIVLGKG- 325
             I+HRDLKP+N+L+   G + L DFGL  AK    +T SN +  TL Y  P+++LG   
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGSTE 180

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAHSLLKGVN 384
           +    D W VG +  EM+ G   F G        K I+D++ ++   L +       GV+
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFPG-------MKDIQDQLERIFLVLGTPNEDTWPGVH 233

Query: 385 SL 386
           SL
Sbjct: 234 SL 235

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 95.6 bits (238), Expect = 4e-22
 Identities = 65/208 (31%), Positives = 108/208 (51%), Gaps = 20/208 (9%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE L  +G G    V +V    +  I A K++         H E   + RN       
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLI---------HLEIKPAIRNQIIRELK 51

Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED-LARIYTAEIVS 261
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E+ L +I  A ++ 
Sbjct: 52  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA-VLR 110

Query: 262 AVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
            +++L     IMHRD+KP NIL+++ G + L DFG++ Q   ++ +NS  GT  YMSPE 
Sbjct: 111 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPER 169

Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPP 348
           + G  +   +D WS+G+ L EM  G+ P
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 95.3 bits (237), Expect = 4e-22
 Identities = 58/202 (28%), Positives = 103/202 (50%), Gaps = 8/202 (3%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  L+ +G G+F  VY  R + T+E+ A+K M           + +  E   L ++ HP 
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHL-FFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            ++ +  +  ++  +LV+++  G      +++++ L   ++A I     +  +++LH++ 
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAI-CHGALQGLAYLHSHE 135

Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG--KGH-D 327
            +HRD+K  NILL   G V L DFG A        +NS  GT  +M+PE++L   +G  D
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASLVSP---ANSFVGTPYWMAPEVILAMDEGQYD 192

Query: 328 KAADWWSVGILLFEMLTGQPPF 349
              D WS+GI   E+   +PP 
Sbjct: 193 GKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 94.4 bits (235), Expect = 6e-22
 Identities = 69/226 (30%), Positives = 112/226 (49%), Gaps = 21/226 (9%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK----SERNIL 204
           LE ++ L  +G+G++A VY+ R   T ++ A+K +R        H E        E ++L
Sbjct: 4   LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRL------EHEEGAPFTAIREASLL 57

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ---GLFREDLARIYTAEIVS 261
             + H  IV L     TK  L LV +++       + Y     G       R++  +++ 
Sbjct: 58  KDLKHANIVTLHDIIHTKKTLTLVFEYL---DTDLKQYMDDCGGGLSMHNVRLFLFQLLR 114

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGL--AKQFDENTRSNSMCGTLEYMSPE 319
            +++ H   ++HRDLKP+N+L+   G + L DFGL  AK     T SN +  TL Y  P+
Sbjct: 115 GLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPD 173

Query: 320 IVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ-QKIIK 363
           ++LG   +  + D W VG + +EM TG+P F G    + Q  KI +
Sbjct: 174 VLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFR 219

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 93.8 bits (233), Expect = 7e-22
 Identities = 63/232 (27%), Positives = 120/232 (51%), Gaps = 9/232 (3%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS--ERNILTKVDHPFIVQL 215
           +G+G+F  VY V+         +KV+++  + E N  E +++  E  +L+K+DHP IV+ 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67

Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQL--YRQG--LFREDLARIYTAEIVSAVSHLHANGI 271
             SF  +    ++ ++  G  L  +L   +       E+    +  +++  V ++H   I
Sbjct: 68  HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNSMCGTLEYMSPEIVLGKGHDKAA 330
           +HRDLK +NI L  +  + + DFG+++    +   + +  GT  YMSPE +  +G+D  +
Sbjct: 128 LHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKS 186

Query: 331 DWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK-DKIKLPAFLSSEAHSLLK 381
           D WS+G +L+EM      F G N   +  +I++     LP   S + +S+++
Sbjct: 187 DIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 93.6 bits (232), Expect = 2e-21
 Identities = 59/206 (28%), Positives = 106/206 (51%), Gaps = 8/206 (3%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  L+ +G G+F  VY  R + T+E+ A+K M           + +  E   L ++ HP 
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 212 IVQLRYSFQTKYRLYLVLDFVNG-GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            ++ +  +  ++  +LV+++  G      +++++ L   ++A I T   +  +++LH++ 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI-THGALQGLAYLHSHN 145

Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG---HD 327
           ++HRD+K  NILL   G V L DFG A      + +NS  GT  +M+PE++L      +D
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIA---SPANSFVGTPYWMAPEVILAMDEGQYD 202

Query: 328 KAADWWSVGILLFEMLTGQPPFTGGN 353
              D WS+GI   E+   +PP    N
Sbjct: 203 GKVDVWSLGITCIELAERKPPLFNMN 228

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 93.1 bits (232), Expect = 3e-21
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 20/215 (9%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS---ERNILTK 206
             ++ L  +G+GA+  V       T    A+K     KI    H  + +    E  IL +
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK-----KISPFEHQTFCQRTLREIKILRR 59

Query: 207 VDHPFIVQLR-----YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
             H  I+ +       SF++   +Y+V + +    L+  +  Q L   D  + +  +I+ 
Sbjct: 60  FKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHL-SNDHIQYFLYQILR 117

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+ +  + + DFGLA+  D              T  Y +
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177

Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ KA D WSVG +L EML+ +P F G
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 93.9 bits (233), Expect = 4e-21
 Identities = 65/211 (30%), Positives = 113/211 (53%), Gaps = 26/211 (12%)

Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLR 216
           ++G G+F  VY+   I TSE  A+K + +D        +Y   E  I+  ++H  I+ L+
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVAIKKVLQD-------PQYKNRELLIMKNLNHINIIFLK 125

Query: 217 -YSFQTKYR-------LYLVLDFV-NGGHLFFQLYRQG-----LFREDLARIYTAEIVSA 262
            Y +   ++       L +V++F+    H + + Y +      LF   L ++Y+ ++  A
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF---LVKLYSYQLCRA 182

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           ++++H+  I HRDLKP+N+L+D + H + L DFG AK      RS S   +  Y +PE++
Sbjct: 183 LAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELM 242

Query: 322 LGK-GHDKAADWWSVGILLFEMLTGQPPFTG 351
           LG   +    D WS+G ++ EM+ G P F+G
Sbjct: 243 LGATNYTTHIDLWSLGCIIAEMILGYPIFSG 273

Length = 440

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 92.8 bits (230), Expect = 5e-21
 Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 18/218 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V++V    +  I A K++         H E   + RN       
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLI---------HLEIKPAIRNQIIRELQ 55

Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  
Sbjct: 56  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 115

Query: 263 VSHL-HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +++L   + IMHRD+KP NIL+++ G + L DFG++ Q  + + +NS  GT  YMSPE +
Sbjct: 116 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERL 174

Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ 359
            G  +   +D WS+G+ L EM  G+ P    + ++++ 
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL 212

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 91.6 bits (227), Expect = 6e-21
 Identities = 73/233 (31%), Positives = 111/233 (47%), Gaps = 21/233 (9%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-----LTK 206
           +E +  +G GA+  VY+ R   +    A+K +R   +        + + R +     L  
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR---VQTNEDGLPLSTVREVALLKRLEA 58

Query: 207 VDHPFIVQL-------RYSFQTKYRLYLVLDFVNGGHLFF--QLYRQGLFREDLARIYTA 257
            DHP IV+L       R   +TK  + LV + V+     +  ++   GL  E + +    
Sbjct: 59  FDHPNIVRLMDVCATSRTDRETK--VTLVFEHVDQDLRTYLDKVPPPGLPAETI-KDLMR 115

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMS 317
           + +  +  LHAN I+HRDLKPENIL+ + G V L DFGLA+ +        +  TL Y +
Sbjct: 116 QFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRA 175

Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA 370
           PE++L   +    D WSVG +  EM   +P F  GN +  Q   I D I LP 
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC-GNSEADQLGKIFDLIGLPP 227

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 91.7 bits (227), Expect = 8e-21
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  L+ +G G+F  VY  R +  SE+ A+K M           + +  E   L K+ HP 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 212 IVQLRYSFQTKYRLYLVLDFVNG-GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            +Q R  +  ++  +LV+++  G      +++++ L   ++A + T   +  +++LH++ 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV-THGALQGLAYLHSHN 135

Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG---HD 327
           ++HRD+K  NILL   G V L DFG A        +N   GT  +M+PE++L      +D
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMDEGQYD 192

Query: 328 KAADWWSVGILLFEMLTGQPPFTGGN 353
              D WS+GI   E+   +PP    N
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMN 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 90.6 bits (225), Expect = 1e-20
 Identities = 66/239 (27%), Positives = 127/239 (53%), Gaps = 27/239 (11%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNI-LTK 206
           +D EV++ +G+GA+  V ++R + T  I A+K +R       N  E   +  + +I +  
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIR----ATVNSQEQKRLLMDLDISMRS 56

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGG--HLFFQLYRQGLF-REDLARIYTAEIVSAV 263
           VD P+ V    +   +  +++ ++ ++      + ++Y +GL   ED+       IV A+
Sbjct: 57  VDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKAL 116

Query: 264 SHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE-----YMS 317
            +LH+   ++HRD+KP N+L++ +G V L DFG++         +S+  T++     YM+
Sbjct: 117 EYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL-----VDSVAKTIDAGCKPYMA 171

Query: 318 PEIVLG----KGHDKAADWWSVGILLFEMLTGQPPFT--GGNRQKIQQKIIKDKIKLPA 370
           PE +      KG+D  +D WS+GI + E+ TG+ P+       Q+++Q + +   +LPA
Sbjct: 172 PERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPA 230

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 19/212 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNILT 205
           E +E L  +G+G++  V++ R   T +I A+K     K +E      +K     E  +L 
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIK-----KFVESEDDPVIKKIALREIRMLK 55

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVS 264
           ++ HP +V L   F+ K +L+LV ++ +   L   +   +G+  E L +    + + AV+
Sbjct: 56  QLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGV-PEHLIKKIIWQTLQAVN 114

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAK----QFDENTRSNSMCGTLEYMSPEI 320
             H +  +HRD+KPENIL+   G + L DFG A+      D+ T       T  Y +PE+
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT---DYVATRWYRAPEL 171

Query: 321 VLGK-GHDKAADWWSVGILLFEMLTGQPPFTG 351
           ++G   +    D W++G +  E+LTGQP + G
Sbjct: 172 LVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 55/225 (24%), Positives = 100/225 (44%), Gaps = 21/225 (9%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM----EKNHAEYMKSERNILTKV 207
           ++ ++ +G GA+  V       + +  A+K     KI         A+    E  IL   
Sbjct: 7   YKPIENIGSGAYGVVCSAIDTRSGKKVAIK-----KIPHAFDVPTLAKRTLRELKILRHF 61

Query: 208 DHPFIVQLRYSFQTKYRL----YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
            H  I+ +R   +         Y+V+D +    L   ++      E+  R +  +++  +
Sbjct: 62  KHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGL 120

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-----CGTLEYMSP 318
            ++H+  ++HRDLKP N+L++ D  + + DFG+A+    +   +         T  Y +P
Sbjct: 121 KYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180

Query: 319 EIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII 362
           E++L    +  A D WSVG +  EML  +  F G N    Q K+I
Sbjct: 181 ELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QLKLI 224

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 89.5 bits (222), Expect = 3e-20
 Identities = 70/247 (28%), Positives = 124/247 (50%), Gaps = 19/247 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++ EVL  +G+G +  VY+V    T    AMK +R +  ++++    +  E +IL K   
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVS 58

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFR----EDLARIYTAEIVSAVSH 265
           P+IV    +F  +  +Y+ +++++ G L  +LY  G+      ED+ R  T  +V  +  
Sbjct: 59  PYIVDFYGAFFIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLRRITYAVVKGLKF 117

Query: 266 L-HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGK 324
           L   + I+HRD+KP N+L++ +G V L DFG++      + + +  G   YM+PE +   
Sbjct: 118 LKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL-VASLAKTNIGCQSYMAPERIKSG 176

Query: 325 GHDKA------ADWWSVGILLFEMLTGQ---PPFTGGNRQKIQQKIIK-DKIKLPAFLSS 374
           G ++       +D WS+G+ + EM  G+   PP T  N       I+  D   LP+  S 
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD 236

Query: 375 EAHSLLK 381
           +A   + 
Sbjct: 237 DAQDFVA 243

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 90.1 bits (223), Expect = 3e-20
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 6/206 (2%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           LE +  L  +G+G +A VY+ R   T  + A+K +R +   E+        E ++L  + 
Sbjct: 5   LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLK 62

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV L     T+  L LV ++++     +             +++  +++  +++ H 
Sbjct: 63  HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR 122

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGL--AKQFDENTRSNSMCGTLEYMSPEIVLGK-G 325
             ++HRDLKP+N+L++  G + L DFGL  AK     T SN +  TL Y  P+I+LG   
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTD 181

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +    D W VG + +EM TG+P F G
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGRPLFPG 207

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 89.7 bits (222), Expect = 4e-20
 Identities = 61/206 (29%), Positives = 105/206 (50%), Gaps = 6/206 (2%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E +  L+ +G+G +A V++ R   T  + A+K +R +   E+        E ++L  + 
Sbjct: 5   METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLK 62

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV L     T   L LV ++++     +      +      +I+  +I+  +++ H 
Sbjct: 63  HANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR 122

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGL--AKQFDENTRSNSMCGTLEYMSPEIVLGKG- 325
             ++HRDLKP+N+L++  G + L DFGL  AK     T SN +  TL Y  P+++LG   
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSE 181

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +    D W VG + FEM +G+P F G
Sbjct: 182 YSTQIDMWGVGCIFFEMASGRPLFPG 207

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 89.8 bits (223), Expect = 4e-20
 Identities = 72/278 (25%), Positives = 126/278 (45%), Gaps = 58/278 (20%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSE-----------IYAMKVMRKDKIMEKNHAEYMKSE 200
           +E++K +GQGA+  V   R   TSE           +++ K++ K  + E     + +  
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61

Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY-RQGLFREDLARI----- 254
           +NI    D                    +D V  G+ F +LY  + L   DL +I     
Sbjct: 62  KNITCLYD--------------------MDIVFPGN-FNELYLYEELMEADLHQIIRSGQ 100

Query: 255 ---------YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR 305
                    +  +I+  + ++H+  ++HRDLKP N+L++AD  + + DFGLA+ F EN  
Sbjct: 101 PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPG 160

Query: 306 SNS-----MCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ 359
            N+        T  Y +PEI+L  + + KA D WSVG +L E+L  +P F G +      
Sbjct: 161 ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLN 220

Query: 360 KIIK-----DKIKLPAFLSSEAHSLLKGVNSLLSISVP 392
           +I++     D+  L    S +A + ++ + ++      
Sbjct: 221 QILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFE 258

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 90.0 bits (223), Expect = 5e-20
 Identities = 81/275 (29%), Positives = 131/275 (47%), Gaps = 54/275 (19%)

Query: 150 EDFEVLKVVGQGAFAKV-YQV-RRIGT------------SEIYAMKVMRKDKIMEKNHAE 195
           + +  LK VG GA+  V   + RR G             SE++A +  R+ ++++     
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK----- 69

Query: 196 YMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIY 255
           +MK E N++  +D   +     S    +  YLV+ F+  G    +L +     ED  +  
Sbjct: 70  HMKHE-NVIGLLD---VFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFL 123

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---T 312
             +++  + ++HA GI+HRDLKP N+ ++ D  + + DFGLA+Q D     + M G   T
Sbjct: 124 VYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD-----SEMTGYVVT 178

Query: 313 LEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNR----------------- 354
             Y +PE++L   H  +  D WSVG ++ EMLTG+P F G +                  
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238

Query: 355 --QKIQQKIIKDKIK-LPAFLSSEAHSLLKGVNSL 386
             QK+Q +  K+ +K LP F   +  SLL   N L
Sbjct: 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPL 273

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 91.7 bits (227), Expect = 6e-20
 Identities = 73/274 (26%), Positives = 139/274 (50%), Gaps = 35/274 (12%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L ++EV+K +G G F +V+ V+   T E +  K +    + E+  ++ +  E N++ ++ 
Sbjct: 12  LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQ-LVIEVNVMRELK 70

Query: 209 HPFIVQL--RYSFQTKYRLYLVLDFVNGGHL---FFQLYRQ-GLFREDLARIYTAEIVSA 262
           H  IV+   R+  +   +LY++++F + G L     + Y+  G   E      T +++ A
Sbjct: 71  HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130

Query: 263 VSHLH-----ANG--IMHRDLKPENILL---------------DADGHVM--LTDFGLAK 298
           +++ H      NG  ++HRDLKP+NI L               + +G  +  + DFGL+K
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190

Query: 299 QFDENTRSNSMCGTLEYMSPEIVL--GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQK 356
                + ++S  GT  Y SPE++L   K +D  +D W++G +++E+ +G+ PF   N   
Sbjct: 191 NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS 250

Query: 357 IQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSIS 390
                +K    LP    S+  ++L  + +LL++S
Sbjct: 251 QLISELKRGPDLPIKGKSKELNIL--IKNLLNLS 282

Length = 1021

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 88.5 bits (219), Expect = 9e-20
 Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 8/201 (3%)

Query: 155 LKVVGQGAFAKVYQ-VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIV 213
           L+ +G+G++A VY+ + RI   ++ A+KV+      E+        E ++L  + H  IV
Sbjct: 10  LEKLGEGSYATVYKGISRI-NGQLVALKVISMKT--EEGVPFTAIREASLLKGLKHANIV 66

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
            L     TK  L  V ++++     + +   G       R++  +++  ++++H   I+H
Sbjct: 67  LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126

Query: 274 RDLKPENILLDADGHVMLTDFGLA--KQFDENTRSNSMCGTLEYMSPEIVLGK-GHDKAA 330
           RDLKP+N+L+   G + L DFGLA  K     T S+ +  TL Y  P+++LG   +  A 
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSAL 185

Query: 331 DWWSVGILLFEMLTGQPPFTG 351
           D W  G +  EML GQP F G
Sbjct: 186 DIWGAGCIFIEMLQGQPAFPG 206

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 87.8 bits (218), Expect = 1e-19
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 18/208 (8%)

Query: 152 FEVLKVV---GQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
              LK +   G+G F KV   R       T E  A+K +      E+ H    + E  IL
Sbjct: 3   KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS--GEEQHRSDFEREIEIL 60

Query: 205 TKVDHPFIVQLRYSFQTKYR--LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIV 260
             +DH  IV+ +   +      L L+++++  G L  + Q +R  +  + L   ++++I 
Sbjct: 61  RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLL-FSSQIC 119

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNSMCGT-LEYM 316
             + +L +   +HRDL   NIL++++  V ++DFGLAK   +  +         + + + 
Sbjct: 120 KGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY 179

Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLT 344
           +PE +       A+D WS G+ L+E+ T
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 88.5 bits (219), Expect = 2e-19
 Identities = 63/221 (28%), Positives = 108/221 (48%), Gaps = 10/221 (4%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  +L  V+
Sbjct: 20  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKCVN 78

Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+    L  E ++ +   +++  
Sbjct: 79  HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLY-QMLCG 135

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    N        T  Y +PE++L
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL 195

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK 363
           G G+ +  D WSVG ++ E++ G   F G +      K+I+
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIE 236

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 87.0 bits (215), Expect = 3e-19
 Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 8/208 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L  +G G+F  VY      T+E+ A+K M           + +  E   L ++ H
Sbjct: 21  EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH 80

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNG-GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           P  ++ +  +  ++  +LV+++  G      +++++ L   ++A I T   +  +++LH+
Sbjct: 81  PNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI-THGALQGLAYLHS 139

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG--- 325
           + ++HRD+K  NILL   G V L DFG A +   ++ +NS  GT  +M+PE++L      
Sbjct: 140 HNMIHRDIKAGNILLTEPGQVKLADFGSASK---SSPANSFVGTPYWMAPEVILAMDEGQ 196

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +D   D WS+GI   E+   +PP    N
Sbjct: 197 YDGKVDVWSLGITCIELAERKPPLFNMN 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 63/242 (26%), Positives = 99/242 (40%), Gaps = 62/242 (25%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS-------------ERN 202
             +G+G + KV +     T +I A+K ++  +I   N     +              E  
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEI--SNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           I+ ++ H  I+ L   +     + LV+D +                 DL ++   +I   
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMDIMAS---------------DLKKVVDRKIRLT 117

Query: 263 VSH--------------LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-------- 300
            S               LH    MHRDL P NI +++ G   + DFGLA+++        
Sbjct: 118 ESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177

Query: 301 ---DENTRSN----SMCGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              DE  +      S   TL Y +PE+++G  K H  A D WSVG +  E+LTG+P F G
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHF-AVDMWSVGCIFAELLTGKPLFPG 236

Query: 352 GN 353
            N
Sbjct: 237 EN 238

Length = 335

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 87.2 bits (216), Expect = 4e-19
 Identities = 52/193 (26%), Positives = 94/193 (48%), Gaps = 11/193 (5%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           + V+K +  G+  +V+   + G  +   +K+ +K   +          E  +L  V+HP 
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTL---------IEAMLLQNVNHPS 118

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           +++++ +  +     +VL   +     +   R      D A I   +I+  + +LHA  I
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRI 178

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN-SMCGTLEYMSPEIVLGKGHDKAA 330
           +HRD+K ENI ++    V + D G A QF     +   + GT+E  +PE++    ++  A
Sbjct: 179 IHRDVKTENIFINDVDQVCIGDLG-AAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKA 237

Query: 331 DWWSVGILLFEML 343
           D WS GI+LFEML
Sbjct: 238 DIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 85.7 bits (212), Expect = 4e-19
 Identities = 58/200 (29%), Positives = 105/200 (52%), Gaps = 11/200 (5%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
           +K +G G F  V+  +     ++ A+K + +  + E++  E    E  ++ K+ HP +VQ
Sbjct: 9   MKELGSGQFGVVHLGKWRAQIKV-AIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQ 63

Query: 215 LRYSFQTKYR-LYLVLDFV-NGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
           L Y   T+ + LY+V +F+ NG  L +   RQG   +D+      ++   + +L  N  +
Sbjct: 64  L-YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122

Query: 273 HRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           HRDL   N L+ + G V ++DFG+ +    DE T S+     +++  PE+     +   +
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182

Query: 331 DWWSVGILLFEMLT-GQPPF 349
           D WS G+L++E+ T G+ PF
Sbjct: 183 DVWSFGVLMWEVFTEGKMPF 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 86.3 bits (213), Expect = 9e-19
 Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 18/207 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V +V+   +  I A K++         H E   + RN       
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLI---------HLEIKPAIRNQIIRELQ 55

Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L       E++    +  ++  
Sbjct: 56  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG 115

Query: 263 VSHL-HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +++L   + IMHRD+KP NIL+++ G + L DFG++ Q  + + +NS  GT  YMSPE +
Sbjct: 116 LAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERL 174

Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPP 348
            G  +   +D WS+G+ L E+  G+ P
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 85.1 bits (210), Expect = 1e-18
 Identities = 63/235 (26%), Positives = 115/235 (48%), Gaps = 20/235 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-----L 204
           + +E +  +G+GA+ KV++ R +     +    +++ ++        + + R +     L
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFV--ALKRVRVQTGEEGMPLSTIREVAVLRHL 58

Query: 205 TKVDHPFIVQL-------RYSFQTKYRLYLVLDFVNGGHLFF--QLYRQGLFREDLARIY 255
              +HP +V+L       R   +TK  L LV + V+     +  ++   G+  E +  + 
Sbjct: 59  ETFEHPNVVRLFDVCTVSRTDRETK--LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM- 115

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY 315
             +++  +  LH++ ++HRDLKP+NIL+ + G + L DFGLA+ +       S+  TL Y
Sbjct: 116 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 175

Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA 370
            +PE++L   +    D WSVG +  EM   +P F  G+    Q   I D I LP 
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR-GSSDVDQLGKILDVIGLPG 229

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 67/223 (30%), Positives = 112/223 (50%), Gaps = 16/223 (7%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V       T +  A+K + +       HA+    E  ++  V+
Sbjct: 15  LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNV-THAKRAYRELVLMKLVN 73

Query: 209 HPFIVQLRYSF--QTKYR----LYLVLDFVNGGHLFFQLYRQGLFREDLAR-IYTAEIVS 261
           H  I+ L   F  Q        +YLV++ ++      Q+ +  L  E ++  +Y  +++ 
Sbjct: 74  HKNIIGLLNVFTPQKSLEEFQDVYLVMELMD--ANLCQVIQMDLDHERMSYLLY--QMLC 129

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
            + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 189

Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KII 362
           LG G+ +  D WSVG ++ EM+ G   F G +   I Q  KII
Sbjct: 190 LGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH--IDQWNKII 230

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 83.6 bits (207), Expect = 2e-18
 Identities = 61/224 (27%), Positives = 109/224 (48%), Gaps = 13/224 (5%)

Query: 156 KVVGQGAFAKVYQ---VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           K +G G+F  V +       G     A+K ++ DK +     +++K E  I+  +DH  +
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDK-LSDIMDDFLK-EAAIMHSLDHENL 58

Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLHANG 270
           ++L Y     + L +V +    G L  +L +  L    ++ +  Y  +I + + +L +  
Sbjct: 59  IRL-YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117

Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSPEIVLGKGH 326
            +HRDL   NILL +D  V + DFGL +   +N     M   L+    + +PE +  +  
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177

Query: 327 DKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKLP 369
             A+D W  G+ L+EM T G+ P+ G +  +I +KI K+  +L 
Sbjct: 178 SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE 221

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 85.1 bits (210), Expect = 2e-18
 Identities = 60/221 (27%), Positives = 110/221 (49%), Gaps = 10/221 (4%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81

Query: 209 HPFIVQL------RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L      + S +    +Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLY-QMLCG 138

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK 363
           G G+ +  D WSVG ++ EM+ G   F G +      K+I+
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 84.0 bits (207), Expect = 5e-18
 Identities = 61/221 (27%), Positives = 109/221 (49%), Gaps = 10/221 (4%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 74

Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 75  HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLY-QMLCG 131

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK 363
           G G+ +  D WSVG ++ EM+  +  F G +      K+I+
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 84.8 bits (210), Expect = 1e-17
 Identities = 60/253 (23%), Positives = 121/253 (47%), Gaps = 37/253 (14%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI-MEKNHAEYMKSERNILTKV 207
           ++ +++++++G+G   +VY       S   A+K +R+D          +++ E  I   +
Sbjct: 1   MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLR-EAKIAADL 59

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNG---GHLFFQLYRQGLFREDLA---------RIY 255
            HP IV +         +Y  + ++ G     L   ++++    ++LA          I+
Sbjct: 60  IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK----------------- 298
             +I + + ++H+ G++HRDLKP+NILL   G V++ D+G A                  
Sbjct: 120 H-KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178

Query: 299 --QFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQK 356
              +   T    + GT +YM+PE +LG    ++ D +++G++L++MLT   P+    R+K
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY---RRKK 235

Query: 357 IQQKIIKDKIKLP 369
            ++   +D I  P
Sbjct: 236 GRKISYRDVILSP 248

Length = 932

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 81.0 bits (200), Expect = 2e-17
 Identities = 59/202 (29%), Positives = 106/202 (52%), Gaps = 11/202 (5%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
           LK +G G F  V+  +  G  ++ A+K++R+  + E +  E    E  ++ K+ HP +VQ
Sbjct: 9   LKELGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDDFIE----EAKVMMKLSHPNLVQ 63

Query: 215 LRYSFQTKYR-LYLVLDF-VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
           L Y   TK R +++V ++  NG  L +   R+G    +      +++  A+ +L +NG +
Sbjct: 64  L-YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI 122

Query: 273 HRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           HRDL   N L+  D  V ++DFGLA+    D+ T S      +++  PE+         +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKS 182

Query: 331 DWWSVGILLFEMLT-GQPPFTG 351
           D WS G+L++E+ + G+ P+  
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYER 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 82.6 bits (204), Expect = 2e-17
 Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 24/166 (14%)

Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-------DL 251
            E +IL  + H  I+ L ++++ K  + +V+            Y+  LF          L
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVM----------PKYKCDLFTYVDRSGPLPL 184

Query: 252 ARIYTAE--IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM 309
            +  T +  ++ A+++LH  GI+HRD+K ENI LD   + +L DFG A + D +  +   
Sbjct: 185 EQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT-PQ 243

Query: 310 C----GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           C    GTLE  SPE++    +    D WS G++LFEM        G
Sbjct: 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289

Length = 392

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 51/187 (27%), Positives = 93/187 (49%), Gaps = 28/187 (14%)

Query: 200 ERNILTKVDHPFIVQL-------------RYSFQTKYR-LYLVLDFVNGGHLFFQLYRQG 245
           E  I+ ++DH  IV++                  T+   +Y+V +++        +  QG
Sbjct: 52  EIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQG 109

Query: 246 LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENT 304
              E+ AR++  +++  + ++H+  ++HRDLKP N+ ++ +  V+ + DFGLA+  D + 
Sbjct: 110 PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY 169

Query: 305 RSNSMCGTLE-------YMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQK 356
              S  G L        Y SP ++L   +  KA D W+ G +  EMLTG+P F G +  +
Sbjct: 170 ---SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226

Query: 357 IQQKIIK 363
             Q I++
Sbjct: 227 QMQLILE 233

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 80.7 bits (199), Expect = 7e-17
 Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 19/207 (9%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
           LK VG GA+  V       T E  A+K + +     +  A+    E  +L  + H  ++ 
Sbjct: 20  LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKHMQHENVIG 78

Query: 215 LR------YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           L        S       YLV+ ++       Q        ED  +    +++  + ++H+
Sbjct: 79  LLDVFTSAVSGDEFQDFYLVMPYM---QTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHS 135

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPEIVLGKG 325
            GI+HRDLKP N+ ++ D  + + DFGLA+  D       M G   T  Y +PE++L   
Sbjct: 136 AGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILNWM 190

Query: 326 H-DKAADWWSVGILLFEMLTGQPPFTG 351
           H ++  D WSVG ++ EMLTG+  F G
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGKTLFKG 217

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 79.6 bits (196), Expect = 8e-17
 Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 15/201 (7%)

Query: 155 LKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++V+G+G F KV    Y     GT E+ A+K ++++    + +    K E NIL  + H 
Sbjct: 9   IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHE 66

Query: 211 FIVQLR--YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            IV+ +   S Q    L L++++V  G L   L +  L    L  ++  +I   +++LH+
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL-LFAQQICEGMAYLHS 125

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-----TRSNSMCGTLEYMSPEIVLG 323
              +HRDL   N+LLD D  V + DFGLAK   E       R +       Y + E +  
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLKE 184

Query: 324 KGHDKAADWWSVGILLFEMLT 344
                A+D WS G+ L+E+LT
Sbjct: 185 NKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 79.0 bits (195), Expect = 9e-17
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 10/217 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E+F + + +G G F +V++        + A+K+++ D        ++ K E   L ++ H
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSD--DLLKQQDFQK-EVQALKRLRH 61

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR---QGLFREDLARIYTAEIVSAVSHL 266
             ++ L         +Y++ + +  G L   L     Q L    L  +   ++   +++L
Sbjct: 62  KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDM-ACQVAEGMAYL 120

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT-LEYMSPEIVLGKG 325
                +HRDL   NIL+  D    + DFGLA+   E+   +S      ++ +PE      
Sbjct: 121 EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGT 180

Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKI 361
               +D WS GILL+EM T GQ P+ G N  ++  +I
Sbjct: 181 FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 81.3 bits (200), Expect = 1e-16
 Identities = 63/243 (25%), Positives = 111/243 (45%), Gaps = 35/243 (14%)

Query: 149 LEDFEVLKVVGQGAFAKVY-----------QVRRIGTSEIYAMKVMRKDKIMEK------ 191
           L  F V+  +  GAF K++           + RR   S        + ++++ K      
Sbjct: 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNST--NQGKPKCERLIAKRVKAGS 204

Query: 192 NHAEYMKSERNILTKVDHPFIVQ----LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF 247
             A  +++E   L +++H  I++    LR    T Y +    DF     L+  +Y +   
Sbjct: 205 RAAIQLENEILALGRLNHENILKIEEILRSEANT-YMITQKYDF----DLYSFMYDEAFD 259

Query: 248 RED-----LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE 302
            +D       R    +++ AV ++H   ++HRD+K ENI L+ DG ++L DFG A  F++
Sbjct: 260 WKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK 319

Query: 303 N--TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQK 360
                     GT+   SPEI+ G G+ +  D WS G++L +ML+      G    K  ++
Sbjct: 320 EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379

Query: 361 IIK 363
           ++K
Sbjct: 380 LLK 382

Length = 501

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 72/274 (26%), Positives = 117/274 (42%), Gaps = 60/274 (21%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMR--------KDKIMEKNHAEYMKSER 201
           ED + L  +G+GAF  V ++    +  I A+K +R        K  +M+      M+S  
Sbjct: 4   EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMD--LDVVMRSS- 60

Query: 202 NILTKVDHPFIVQ-----------------LRYSFQTKYRL-YLVLDFVNGGHLFFQLYR 243
                 D P+IV+                 +  S    Y+  Y VL              
Sbjct: 61  ------DCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVL-------------- 100

Query: 244 QGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDE 302
           + +  E++        V A+++L     I+HRD+KP NILLD +G++ L DFG++ Q  +
Sbjct: 101 KSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160

Query: 303 NTRSNSMCGTLEYMSPEIVL---GKGHDKAADWWSVGILLFEMLTGQPPFTGGNR--QKI 357
           +       G   YM+PE +      G+D  +D WS+GI L+E+ TG+ P+   N    ++
Sbjct: 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220

Query: 358 QQKIIKDKIKLPAFLSSEAH---SLLKGVNSLLS 388
            Q +  D   L    S E     S +  +N  L 
Sbjct: 221 TQVVKGDPPILSN--SEEREFSPSFVNFINLCLI 252

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 79.5 bits (196), Expect = 1e-16
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 15/205 (7%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNILTKVDHP 210
           L+ VG GAF  V   R   T +  A+K     KIM+       A+    E  +L  + H 
Sbjct: 15  LQPVGMGAFGLVCSARDQLTGQNVAIK-----KIMKPFSTPVLAKRTYRELKLLKHLRHE 69

Query: 211 FIVQLRYSFQTKYR-LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
            I+ L   F +    +Y V + +  G    +L       +   + +  +I+  + ++H+ 
Sbjct: 70  NIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG-KGHDK 328
           G++HRDLKP NIL++ +  + + DFGLA+  D   +      T  Y +PEI+L  + +D 
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARIQD--PQMTGYVSTRYYRAPEIMLTWQKYDV 185

Query: 329 AADWWSVGILLFEMLTGQPPFTGGN 353
             D WS G +  EML G+P F G +
Sbjct: 186 EVDIWSAGCIFAEMLEGKPLFPGKD 210

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 78.4 bits (193), Expect = 2e-16
 Identities = 55/219 (25%), Positives = 110/219 (50%), Gaps = 11/219 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D   LK +G G F  V   +  G  ++ A+K++++  + E    E    E  ++ K+ H
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMKLSH 58

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
             +VQL      +  +Y+V ++++ G L   L R+   R   +++     ++   +++L 
Sbjct: 59  EKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQLLEMCKDVCEGMAYLE 117

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGKG 325
           +   +HRDL   N L+D  G V ++DFGL++    DE T S      + +  PE++L   
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177

Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK 363
               +D W+ G+L++E+ + G+ P+   N  +  +K+ +
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ 216

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 51/160 (31%), Positives = 78/160 (48%), Gaps = 23/160 (14%)

Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF--REDLARIYT 256
           +E +IL  ++HP I+QL+ +F       L+L            Y+  L+        I  
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLIL----------PRYKTDLYCYLAAKRNIAI 181

Query: 257 AEIVS-------AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM 309
            +I++       A+ +LH N I+HRD+K ENI ++  G V L DFG A  F  +  +N  
Sbjct: 182 CDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKY 240

Query: 310 ---CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQ 346
               GT+   +PE++    +  A D WS GI+LFEM T  
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 78.6 bits (193), Expect = 3e-16
 Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 32/216 (14%)

Query: 158 VGQGAFAKVYQVRRI-GTSEI-YAMKVMRKDKIMEKNHAEYMKSERNI--LTKVDHPFIV 213
           VG+G +  VY+ +R  G  E  YA+K +    I        M + R I  L ++ HP ++
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-------MSACREIALLRELKHPNVI 61

Query: 214 QLRYSF--QTKYRLYLVLDFVNGG--HLFFQLYRQG-------LFREDLARIYTAEIVSA 262
            L+  F   +  +++L+ D+      H+  + +R              + +    +I+  
Sbjct: 62  ALQKVFLSHSDRKVWLLFDYAEHDLWHII-KFHRASKANKKPMQLPRSMVKSLLYQILDG 120

Query: 263 VSHLHANGIMHRDLKPENILLDAD----GHVMLTDFGLAKQFDENTRS----NSMCGTLE 314
           + +LHAN ++HRDLKP NIL+  +    G V + D G A+ F+   +     + +  T  
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 315 YMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPF 349
           Y +PE++LG  H  KA D W++G +  E+LT +P F
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 77.1 bits (190), Expect = 5e-16
 Identities = 60/216 (27%), Positives = 110/216 (50%), Gaps = 17/216 (7%)

Query: 153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           ++L+ +G G F +V++     T+ + A+K ++   +  K   +++  E  I+ K+ HP +
Sbjct: 9   QLLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTMDPK---DFLA-EAQIMKKLRHPKL 63

Query: 213 VQLRYSFQTKYR-LYLVLDFVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSHLHA 268
           +QL Y+  T    +Y+V + +  G L   L       L    L  +  A++ S +++L A
Sbjct: 64  IQL-YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM-AAQVASGMAYLEA 121

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT---LEYMSPEIVLGKG 325
              +HRDL   N+L+  +    + DFGLA+   E+    +  G    +++ +PE  L   
Sbjct: 122 QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YEAREGAKFPIKWTAPEAALYNR 180

Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
               +D WS GILL E++T G+ P+ G  N + +QQ
Sbjct: 181 FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ 216

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 76.6 bits (188), Expect = 7e-16
 Identities = 58/222 (26%), Positives = 116/222 (52%), Gaps = 21/222 (9%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  +++K +G G F +V+     G +++ A+K ++   +  ++  E    E  I+ K+ H
Sbjct: 6   ESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSPESFLE----EAQIMKKLRH 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-------DLARIYTAEIVSA 262
             +VQL Y+  ++  +Y+V ++++ G L   L + G  R        D+A    A++ + 
Sbjct: 61  DKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMA----AQVAAG 114

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEI 320
           ++++     +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE 
Sbjct: 115 MAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174

Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKI 361
            L       +D WS GILL E++T G+ P+ G N +++ +++
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 55/210 (26%), Positives = 104/210 (49%), Gaps = 12/210 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQ---VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           ED  + + +G+G F  VYQ   +         A+K  +          E    E  I+ +
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSV--REKFLQEAYIMRQ 63

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVS 264
            DHP IV+L     T+  +++V++    G L  + Q+ +  L    L  +Y+ ++ +A++
Sbjct: 64  FDHPHIVKL-IGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLI-LYSYQLSTALA 121

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMSPEIVL 322
           +L +   +HRD+   N+L+ +   V L DFGL++  ++ +   +  G L  ++M+PE + 
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181

Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +    A+D W  G+ ++E+L  G  PF G
Sbjct: 182 FRRFTSASDVWMFGVCMWEILMLGVKPFQG 211

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 63/227 (27%), Positives = 108/227 (47%), Gaps = 24/227 (10%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            E +KV+G GAF  VY+   I   E      A+KV+R++    K + E +  E  ++  V
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILD-EAYVMASV 66

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI-------YTAEIV 260
           DHP +V+L        ++ L+   +  G L   +      R     I       +  +I 
Sbjct: 67  DHPHVVRL-LGICLSSQVQLITQLMPLGCLLDYV------RNHKDNIGSQYLLNWCVQIA 119

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMS 317
             +S+L    ++HRDL   N+L+    HV +TDFGLAK  D + +     G    +++M+
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMA 179

Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK 363
            E +L + +   +D WS G+ ++E++T G  P+ G    +I   + K
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK 226

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 59/216 (27%), Positives = 105/216 (48%), Gaps = 32/216 (14%)

Query: 158 VGQGAFAKVYQVRRIGTSEI--YAMKVMRKDKIMEKNHAEYMKSERNI--LTKVDHPFIV 213
           VG+G +  VY+ +R    +   YA+K +    I        M + R I  L ++ HP ++
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-------MSACREIALLRELKHPNVI 61

Query: 214 QLRYSF--QTKYRLYLVLDFVNGG--HLFFQLYRQGLFRED-------LARIYTAEIVSA 262
            L+  F      +++L+ D+      H+  + +R     +        + +    +I+  
Sbjct: 62  SLQKVFLSHADRKVWLLFDYAEHDLWHII-KFHRASKANKKPVQLPRGMVKSLLYQILDG 120

Query: 263 VSHLHANGIMHRDLKPENILLDAD----GHVMLTDFGLAKQFDENTRS----NSMCGTLE 314
           + +LHAN ++HRDLKP NIL+  +    G V + D G A+ F+   +     + +  T  
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 315 YMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPF 349
           Y +PE++LG  H  KA D W++G +  E+LT +P F
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 75.1 bits (185), Expect = 2e-15
 Identities = 51/209 (24%), Positives = 98/209 (46%), Gaps = 17/209 (8%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGT--SEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
           +  ++ ++   +G+G F  V      G    +  A+K ++ D       A+   +E +++
Sbjct: 3   INSKELKLGATIGKGEFGDVML----GDYRGQKVAVKCLKDDS----TAAQAFLAEASVM 54

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY---RQGLFREDLARIYTAEIVS 261
           T + HP +VQL         LY+V +++  G L   L    R  +        +  ++  
Sbjct: 55  TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQ-LGFALDVCE 113

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
            + +L     +HRDL   N+L+  D    ++DFGLAK+  +   S  +   +++ +PE +
Sbjct: 114 GMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL--PVKWTAPEAL 171

Query: 322 LGKGHDKAADWWSVGILLFEMLT-GQPPF 349
             K     +D WS GILL+E+ + G+ P+
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 75.1 bits (184), Expect = 3e-15
 Identities = 61/229 (26%), Positives = 110/229 (48%), Gaps = 12/229 (5%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 14  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 67

Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 68  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127

Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 334 SVGILLFEMLT-GQPPFTGG-NRQKIQQKIIKDKIKLPAFLSSEAHSLL 380
           S GILL E+ T G+ P+ G  NR+ + Q     ++  P       H L+
Sbjct: 188 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM 236

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 74.6 bits (183), Expect = 3e-15
 Identities = 54/213 (25%), Positives = 112/213 (52%), Gaps = 9/213 (4%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +++G+G F +V++      + + A+K  ++D  + +       SE  IL + DHP IV+L
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPV-AVKTCKED--LPQELKIKFLSEARILKQYDHPNIVKL 57

Query: 216 RYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
                 +  +Y+V++ V GG    F +  +  L  + L + +  +  + +++L +   +H
Sbjct: 58  IGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVK-FALDAAAGMAYLESKNCIH 116

Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  + ++DFG+++Q D+   S+S      +++ +PE +    +   +D
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176

Query: 332 WWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK 363
            WS GILL+E  + G  P+ G   Q+ ++++ K
Sbjct: 177 VWSYGILLWETFSLGVCPYPGMTNQQAREQVEK 209

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 75.5 bits (185), Expect = 4e-15
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 12/211 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V         +  A+K + +       HA     E  +L  + H
Sbjct: 15  ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHMKH 73

Query: 210 PFIVQL------RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L        S +    +YLV + + G  L   +  Q L  ++  +    +++  +
Sbjct: 74  ENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKL-SDEHVQFLIYQLLRGL 131

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+ GI+HRDLKP N+ ++ D  + + DFGLA+Q D+         T  Y +PEI+L 
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM--TGYVATRWYRAPEIMLN 189

Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+L G+  F G +
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGKALFPGND 220

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 73.9 bits (181), Expect = 7e-15
 Identities = 54/205 (26%), Positives = 105/205 (51%), Gaps = 13/205 (6%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +++ ++L+ +G+G F  V      G     A+K ++ D       A+   +E +++T++ 
Sbjct: 5   MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-----AQAFLAEASVMTQLR 57

Query: 209 HPFIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSH 265
           H  +VQL     + K  LY+V +++  G L   L  +G  +   D    ++ ++  A+ +
Sbjct: 58  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
           L AN  +HRDL   N+L+  D    ++DFGL K+      +  +   +++ +PE +  K 
Sbjct: 118 LEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALREKK 175

Query: 326 HDKAADWWSVGILLFEMLT-GQPPF 349
               +D WS GILL+E+ + G+ P+
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 74.7 bits (183), Expect = 8e-15
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 12/221 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 17  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 75

Query: 210 PFIVQL------RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L        S +    +YLV   + G  L   +  Q L  +D  +    +I+  +
Sbjct: 76  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKL-TDDHVQFLIYQILRGL 133

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 134 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 191

Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK 363
             H ++  D WSVG ++ E+LTG+  F G +     + I++
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 232

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 72.6 bits (178), Expect = 2e-14
 Identities = 63/230 (27%), Positives = 108/230 (46%), Gaps = 28/230 (12%)

Query: 156 KVVGQGAFAKVYQ-----VRRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
             +G GAF +VY+     +   G+  I  A+K +RK    ++   E++K E ++++  +H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLK-EAHLMSNFNH 58

Query: 210 PFIV-QLRYSFQTKYRLYLVLDFVNGGHLFFQL--------YRQGLFREDLARIYTAEIV 260
           P IV  L      +   Y++++ + GG L   L            L  ++L  I   ++ 
Sbjct: 59  PNIVKLLGVCLLNE-PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDI-CLDVA 116

Query: 261 SAVSHLHANGIMHRDLKPENILL-----DADGHVMLTDFGLAKQF---DENTRSNSMCGT 312
               +L     +HRDL   N L+     DAD  V + DFGLA+     D   +       
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176

Query: 313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKI 361
           + +M+PE +L       +D WS G+L++E+LT GQ P+   N Q++ Q +
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 72.1 bits (177), Expect = 2e-14
 Identities = 55/211 (26%), Positives = 110/211 (52%), Gaps = 12/211 (5%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G F  VY+    G +E+ A+K  R     +    ++++    IL + DHP IV+L  
Sbjct: 3   IGKGNFGDVYKGVLKGNTEV-AVKTCRSTLPPD-LKRKFLQEAE-ILKQYDHPNIVKLIG 59

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRD 275
               K  +Y+V++ V GG L   L ++   L  + L ++ + +  + + +L +   +HRD
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQM-SLDAAAGMEYLESKNCIHRD 118

Query: 276 LKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT----LEYMSPEIVLGKGHDKAAD 331
           L   N L+  +  + ++DFG++++ +    + S  G     +++ +PE +    +   +D
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVS-DGLKQIPIKWTAPEALNYGRYTSESD 177

Query: 332 WWSVGILLFEMLT-GQPPFTGGNRQKIQQKI 361
            WS GILL+E  + G  P+ G + Q+ +++I
Sbjct: 178 VWSYGILLWETFSLGDTPYPGMSNQQTRERI 208

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 50/197 (25%), Positives = 102/197 (51%), Gaps = 13/197 (6%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +++G+G F  V Q    G  +  A+K ++ D       A+    E  ++TK+ H  +V+L
Sbjct: 12  EIIGEGEFGAVLQGEYTG--QKVAVKNIKCDVT-----AQAFLEETAVMTKLHHKNLVRL 64

Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLHANGIMH 273
                    LY+V++ ++ G+L   L  +G     + ++  ++ ++   + +L +  ++H
Sbjct: 65  -LGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVH 123

Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           RDL   NIL+  DG   ++DFGLA+       ++ +   +++ +PE +  K     +D W
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL--PVKWTAPEALKHKKFSSKSDVW 181

Query: 334 SVGILLFEMLT-GQPPF 349
           S G+LL+E+ + G+ P+
Sbjct: 182 SYGVLLWEVFSYGRAPY 198

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 32/220 (14%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +F+ +KV+G GAF  VY+   I   E      A+K +R +    K + E +  E  ++  
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEIL-DEAYVMAS 65

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF----REDLARI-------Y 255
           VD+P + +L           L +   +   L  QL   G      RE    I       +
Sbjct: 66  VDNPHVCRL-----------LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 114

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---T 312
             +I   +++L    ++HRDL   N+L+    HV +TDFGLAK    + +     G    
Sbjct: 115 CVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174

Query: 313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           +++M+ E +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 63/224 (28%), Positives = 110/224 (49%), Gaps = 37/224 (16%)

Query: 152 FEV------LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME--KNHAEYMKSERNI 203
           FEV      +K +G+GA+  V   +   T+E  A+K     KI     N  +  ++ R I
Sbjct: 1   FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIK-----KIANAFDNRIDAKRTLREI 55

Query: 204 --LTKVDHPFIVQL--------RYSFQTKYRLYLVLDFVNGGHLFFQLYR--QGLFREDL 251
             L  +DH  ++ +        R +F   Y +Y ++D         Q+ R  Q L  +D 
Sbjct: 56  KLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTL-SDDH 109

Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG 311
            + +  +++  + ++H+  ++HRDLKP N+LL+A+  + + DFGLA+    + + + M  
Sbjct: 110 CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTE 167

Query: 312 ---TLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              T  Y +PE++L    +  A D WSVG +  E+L  +P F G
Sbjct: 168 YVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG 211

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 36/103 (34%), Positives = 62/103 (60%), Gaps = 3/103 (2%)

Query: 250 DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK--QFDENTRSN 307
           D  +++  +I+  + +LH+ GI+HRD+KP N+L++++  + + DFGLA+  + DE+    
Sbjct: 103 DHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT 162

Query: 308 SMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPF 349
               T  Y +PEI++G  H   A D WSVG +  E+L  +  F
Sbjct: 163 QEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF 205

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 71.6 bits (176), Expect = 3e-14
 Identities = 63/220 (28%), Positives = 114/220 (51%), Gaps = 19/220 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++ + +G G F +V+     GT+++ A+K + K   M      +++ E  I+ K+ H
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTKV-AVKTL-KPGTMSP--EAFLQ-EAQIMKKLRH 60

Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVS 264
             +VQL Y+  ++   +Y+V ++++ G L     + G    L    L  +  A+I   ++
Sbjct: 61  DKLVQL-YAVCSEEEPIYIVTEYMSKGSLL-DFLKSGEGKKLRLPQLVDM-AAQIAEGMA 117

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPE-IV 321
           +L +   +HRDL   NIL+  +    + DFGLA+    DE T        +++ +PE   
Sbjct: 118 YLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAAN 177

Query: 322 LGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
            G+   K +D WS GILL E++T G+ P+ G  NR+ ++Q
Sbjct: 178 YGRFTIK-SDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ 216

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 72.5 bits (178), Expect = 4e-14
 Identities = 65/239 (27%), Positives = 113/239 (47%), Gaps = 34/239 (14%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +++ +V+G+G++  V       T E  A+K +  D     + A  +  E  +L  + HP 
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPD 60

Query: 212 IVQLRY-----SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFR-----EDLAR----IYTA 257
           IV++++     S +    +Y+V          F+L    L +     +DL       +  
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVV----------FELMESDLHQVIKANDDLTPEHHQFFLY 110

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS----NSMCGTL 313
           +++ A+ ++H   + HRDLKP+NIL +AD  + + DFGLA+    +T +         T 
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 314 EYMSPEIV---LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP 369
            Y +PE+      K +  A D WS+G +  E+LTG+P F G N    Q  +I D +  P
Sbjct: 171 WYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLITDLLGTP 227

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 71.4 bits (175), Expect = 5e-14
 Identities = 61/237 (25%), Positives = 118/237 (49%), Gaps = 21/237 (8%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVY--QVRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERN 202
           CV +E+     V+G G F +V   +++  G  EI+ A+K + K    EK   +++ SE +
Sbjct: 5   CVKIEE-----VIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFL-SEAS 57

Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIV 260
           I+ + DHP I+ L         + ++ +F+  G L  F +    G F           I 
Sbjct: 58  IMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIA 116

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL------E 314
           + + +L     +HRDL   NIL++++    ++DFGL++  +++T   +   +L       
Sbjct: 117 AGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR 176

Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKLPA 370
           + +PE +  +    A+D WS GI+++E+++ G+ P+   + Q +   I +D  +LP 
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-YRLPP 232

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 28/59 (47%), Positives = 39/59 (66%)

Query: 311 GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP 369
           GT +Y++PE++LGK H  A DWW++G+ LFE LTG PPF     Q++ Q I+   I  P
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 56/240 (23%), Positives = 107/240 (44%), Gaps = 22/240 (9%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY---AMKVMRKDKIMEKNHAEYMKSERNIL 204
           E   +++ +GQG+F  VY+   + +   E     A+K + ++  M +        E +++
Sbjct: 6   EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN--EASVM 63

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ--------GLFREDLARIY- 255
            + +   +V+L     T     +V++ +  G L   L  +        GL    L +   
Sbjct: 64  KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123

Query: 256 -TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTL 313
             AEI   +++L A   +HRDL   N ++  D  V + DFG+ +  ++ +       G L
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL 183

Query: 314 --EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQKIIKDKIKLP 369
              +M+PE +        +D WS G++L+EM T  + P+ G  N + ++  I    + LP
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLP 243

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 64/235 (27%), Positives = 116/235 (49%), Gaps = 22/235 (9%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+++ A+K ++   +M     E    E  I+ K+ H  +V L Y
Sbjct: 14  LGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPL-Y 67

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-------DLARIYTAEIVSAVSHLHANG 270
           +  ++  +Y+V +F+  G L     ++G  +        D+A    A+I   ++++    
Sbjct: 68  AVVSEEPIYIVTEFMGKGSLL-DFLKEGDGKYLKLPQLVDMA----AQIADGMAYIERMN 122

Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDK 328
            +HRDL+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L      
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 329 AADWWSVGILLFEMLT-GQPPFTGG-NRQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
            +D WS GILL E++T G+ P+ G  NR+ ++Q     ++  P       H L+K
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMK 237

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 69.6 bits (170), Expect = 1e-13
 Identities = 50/196 (25%), Positives = 98/196 (50%), Gaps = 9/196 (4%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F  V+    +   ++ A+K +R+  + E    E    E  ++ K+ HP +VQL  
Sbjct: 12  IGSGQFGLVWLGYWLEKRKV-AIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYG 66

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L   L  Q G F ++       ++   +++L ++ ++HRDL
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126

Query: 277 KPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWS 334
              N L+  +  V ++DFG+ +    D+ T S      +++ SPE+     +   +D WS
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186

Query: 335 VGILLFEMLT-GQPPF 349
            G+L++E+ + G+ P+
Sbjct: 187 FGVLMWEVFSEGKTPY 202

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 54/215 (25%), Positives = 109/215 (50%), Gaps = 15/215 (6%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +  +   E++K E  ++ ++ HP +VQL  
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLK-EAAVMKEIKHPNLVQLLG 69

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDL---ARIYTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L   L      R+++     +Y A +I SA+ +L     +H
Sbjct: 70  VCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKNFIH 127

Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT---LEYMSPEIVLGKGHDKAA 330
           RDL   N L+  +  V + DFGL++    +T + +  G    +++ +PE +        +
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKS 186

Query: 331 DWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD 364
           D W+ G+LL+E+ T G  P+ G +  ++ + + K 
Sbjct: 187 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG 221

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 47/213 (22%), Positives = 98/213 (46%), Gaps = 13/213 (6%)

Query: 158 VGQGAFAKVYQ--VRRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
           +G G F  V +         E+  A+K ++++  +     E+++ E +++ ++DHP IV+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH-IAAGKKEFLR-EASVMAQLDHPCIVR 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L    + +  L LV++    G L   L ++        +    ++   +++L +   +HR
Sbjct: 61  LIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119

Query: 275 DLKPENILLDADGHVMLTDFGLAK--QFDENTRSNSMCGT--LEYMSPE-IVLGKGHDKA 329
           DL   N+LL       ++DFG+++      +    +  G   L++ +PE I  GK     
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK-FSSK 178

Query: 330 ADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKI 361
           +D WS G+ L+E  + G  P+      ++   +
Sbjct: 179 SDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML 211

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 68.7 bits (168), Expect = 3e-13
 Identities = 54/207 (26%), Positives = 105/207 (50%), Gaps = 11/207 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  +++K +G G F +V+     G +++ A+K + K   M     E   +E N++ ++ H
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTKV-AIKSL-KQGSMS---PEAFLAEANLMKQLQH 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
           P +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++ + 
Sbjct: 61  PRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAK--QFDENTRSNSMCGTLEYMSPEIVLGKG 325
               +HRDL+  NIL+       + DFGLA+  + +E T        +++ +PE +    
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 179

Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTG 351
               +D WS GILL E++T G+ P+ G
Sbjct: 180 FTIKSDVWSFGILLTEIVTYGRIPYPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 54/233 (23%), Positives = 115/233 (49%), Gaps = 14/233 (6%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G F +V+  R    +   A+K  R + +     A++++  R IL +  HP IV+L  
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEAR-ILKQYSHPNIVRLIG 60

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRD 275
               K  +Y+V++ V GG     L  +G  L  ++L ++      + + +L +   +HRD
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQM-VENAAAGMEYLESKHCIHRD 119

Query: 276 LKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL-----EYMSPEIVLGKGHDKAA 330
           L   N L+     + ++DFG++++ ++   +++  G +     ++ +PE +    +   +
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYAST--GGMKQIPVKWTAPEALNYGRYSSES 177

Query: 331 DWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLK 381
           D WS GILL+E  + G  P+   + Q+ ++ I +  ++  P       + L++
Sbjct: 178 DVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLME 230

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 68.7 bits (168), Expect = 6e-13
 Identities = 69/244 (28%), Positives = 117/244 (47%), Gaps = 24/244 (9%)

Query: 156 KVVGQGAFAKVYQVRRIGTS-EIYAMKVMRKDKIMEKNHA-----EYMKSERNILTKV-D 208
           K +G GAF KV +    G S     MKV  K   M K  A     E + SE  I++ + +
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVK---MLKPTAHSSEREALMSELKIMSHLGN 97

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSH 265
           H  IV L  +      + ++ ++   G L   L R+    L  EDL   ++ ++   ++ 
Sbjct: 98  HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS-FSYQVAKGMAF 156

Query: 266 LHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQF--DEN--TRSNSMCGTLEYMSPEI 320
           L +   +HRDL   N+LL   G ++ + DFGLA+    D N   + N+    +++M+PE 
Sbjct: 157 LASKNCIHRDLAARNVLL-THGKIVKICDFGLARDIMNDSNYVVKGNARL-PVKWMAPES 214

Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKL--PAFLSSEAH 377
           +    +   +D WS GILL+E+ + G  P+ G        K+IK+  ++  P    +E +
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIY 274

Query: 378 SLLK 381
            ++K
Sbjct: 275 DIMK 278

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 67.7 bits (165), Expect = 7e-13
 Identities = 55/203 (27%), Positives = 104/203 (51%), Gaps = 17/203 (8%)

Query: 158 VGQGAFAKVYQ-VRRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +G G F  V + V ++   +I  A+KV++ +   EK+  + M  E  I+ ++D+P+IV++
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRM 60

Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS----HLHANGI 271
               + +  L LV++  +GG L   L  +   ++++      E++  VS    +L     
Sbjct: 61  IGVCEAE-ALMLVMEMASGGPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGKNF 116

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LEYMSPEIVLGKGHD 327
           +HRDL   N+LL    +  ++DFGL+K    D++       G   L++ +PE +  +   
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 328 KAADWWSVGILLFEMLT-GQPPF 349
             +D WS GI ++E  + GQ P+
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 67.6 bits (165), Expect = 8e-13
 Identities = 60/250 (24%), Positives = 124/250 (49%), Gaps = 23/250 (9%)

Query: 152 FEVLKVVGQGAFAKVYQVR---RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           F + +++G+G F  V + +     G+ +  A+K+++ D     +  E+++ E   + + D
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLR-EAACMKEFD 59

Query: 209 HPFIVQL---RYSFQTKYRL---YLVLDFVNGG--HLFFQLYRQG-----LFREDLARIY 255
           HP +++L       + K RL    ++L F+  G  H F  + R G     L  + L R +
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR-F 118

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--- 312
             +I S + +L +   +HRDL   N +L+ +  V + DFGL+K+          C +   
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP 178

Query: 313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK-DKIKLPA 370
           +++++ E +    +   +D W+ G+ ++E++T GQ P+ G    +I   +IK +++K P 
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238

Query: 371 FLSSEAHSLL 380
               + + L+
Sbjct: 239 DCLEDVYELM 248

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 67.8 bits (165), Expect = 1e-12
 Identities = 56/211 (26%), Positives = 103/211 (48%), Gaps = 14/211 (6%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-----KNHAEYMKSERNILT 205
           + + +KV+G GAF  VY  + I   E   +K+    KI+      K + E+M  E  I+ 
Sbjct: 8   ELKRVKVLGSGAFGTVY--KGIWVPEGETVKIPVAIKILNETTGPKANVEFM-DEALIMA 64

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVS 264
            +DHP +V+L         + LV   +  G L   ++  +      L   +  +I   + 
Sbjct: 65  SMDHPHLVRL-LGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMM 123

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPEIV 321
           +L    ++HRDL   N+L+ +  HV +TDFGLA+  + + +  +  G    +++M+ E +
Sbjct: 124 YLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183

Query: 322 LGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
             +     +D WS G+ ++E++T G  P+ G
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 64/257 (24%), Positives = 120/257 (46%), Gaps = 35/257 (13%)

Query: 155 LKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +G+G F  V    Y   +  T E+ A+K ++        H    + E  IL  + H 
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHD 65

Query: 211 FIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSH 265
            IV+ +   YS   +  L LV++++  G L  + Q +R+ L    L  +Y ++I   + +
Sbjct: 66  NIVKYKGVCYS-AGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLL-LYASQICKGMEY 123

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSPEIV 321
           L +   +HRDL   NIL++++  V + DFGL K   ++     +    E    + +PE +
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183

Query: 322 LGKGHDKAADWWSVGILLFEMLT-----GQPP-----FTGGNRQKIQ-----QKIIKDKI 366
                  A+D WS G++L+E+ T       PP       G ++Q         +++K+  
Sbjct: 184 TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG 243

Query: 367 KLPAFLS--SEAHSLLK 381
           +LPA     +E ++++K
Sbjct: 244 RLPAPPGCPAEIYAIMK 260

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 32/216 (14%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           +KV+G GAF  VY+   I   E      A+KV+R++   + N  + +  E  ++  V  P
Sbjct: 12  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSP 69

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF----REDLARI-------YTAEI 259
           ++ +L           L +   +   L  QL   G      RE+  RI       +  +I
Sbjct: 70  YVCRL-----------LGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI 118

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYM 316
              +S+L    ++HRDL   N+L+ +  HV +TDFGLA+  D +       G    +++M
Sbjct: 119 AKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM 178

Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           + E +L +     +D WS G+ ++E++T G  P+ G
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 54/207 (26%), Positives = 105/207 (50%), Gaps = 11/207 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++ K +G G F +V+       +++ A+K M+   +      E   +E N++  + H
Sbjct: 6   ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
             +V+L ++  TK  +Y++ +F+  G L   L      ++ L ++  ++A+I   ++ + 
Sbjct: 61  DKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKG 325
               +HRDL+  NIL+ A     + DFGLA+  ++N  T        +++ +PE +    
Sbjct: 120 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 179

Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTG 351
               +D WS GILL E++T G+ P+ G
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPG 206

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 58/234 (24%), Positives = 111/234 (47%), Gaps = 45/234 (19%)

Query: 156 KVVGQGAFAKVYQVR------RIGTSEIYAMKVMRKDKIMEKNHAEYMK--SERNILTKV 207
           K +G+G F KV +        R G + + A+K+++++     + +E     SE N+L +V
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTV-AVKMLKENA----SSSELRDLLSEFNLLKQV 60

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQ---------------GLFRED 250
           +HP +++L  +      L L++++   G L  F +  R+                L   D
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 251 LARIYTAEIVS-------AVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDE 302
              +   +++S        + +L    ++HRDL   N+L+ A+G  M ++DFGL++   E
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV-AEGRKMKISDFGLSRDVYE 179

Query: 303 N----TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                 RS      +++M+ E +    +   +D WS G+LL+E++T G  P+ G
Sbjct: 180 EDSYVKRSKGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 29/206 (14%)

Query: 158 VGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIV 213
           +G+G F KV    Y      T E  A+K ++ +     NH   +K E  IL  + H  IV
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIV 69

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR-----------IYTAEIVSA 262
                   KY+     D  NG  L  +    G  +E L R            Y  +I   
Sbjct: 70  --------KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKG 121

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGTLEYMSP 318
           + +L +   +HRDL   N+L++++  V + DFGL K  + +    T  + +   + + +P
Sbjct: 122 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP 181

Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E ++      A+D WS G+ L+E+LT
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 54/237 (22%), Positives = 98/237 (41%), Gaps = 28/237 (11%)

Query: 147 VGLEDFEVLKVVGQGAFAKVY-----QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           V  +   + + +G+GAF KV+      +      E+ A+K + K+        ++ + E 
Sbjct: 2   VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFER-EA 59

Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG---------------L 246
            +LT   H  IV+            +V +++  G L   L   G               L
Sbjct: 60  ELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119

Query: 247 FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF---DEN 303
               L +I   +I S + +L +   +HRDL   N L+  D  V + DFG+++     D  
Sbjct: 120 TLSQLLQI-AVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY 178

Query: 304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT--GQPPFTGGNRQKIQ 358
                    + +M PE ++ +     +D WS G++L+E+ T   QP +   N + I+
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 59/231 (25%), Positives = 107/231 (46%), Gaps = 25/231 (10%)

Query: 150 EDFEVLKVVGQGAFAKVYQV----RRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNIL 204
           +   +L+ +G GAF +VY+     R     E+  A+K + +    E++ ++++  E  I+
Sbjct: 6   DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLM-EALIM 63

Query: 205 TKVDHPFIVQL-RYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFR------EDLARIY 255
           +K +H  IV+L   SF+   R +++L+ + GG L  F +  R    R      +DL    
Sbjct: 64  SKFNHQNIVRLIGVSFERLPR-FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC- 121

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGH---VMLTDFGLAKQF---DENTRSNSM 309
             ++     +L  N  +HRD+   N LL   G      + DFG+A+         +    
Sbjct: 122 ARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRA 181

Query: 310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQ 359
              +++M PE  L        D WS G+LL+E+ + G  P+ G   Q++ +
Sbjct: 182 MLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME 232

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 65.3 bits (159), Expect = 5e-12
 Identities = 60/232 (25%), Positives = 117/232 (50%), Gaps = 28/232 (12%)

Query: 156 KVVGQGAFAKVY--QVRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           KV+G G F +V   +++  G  EI  A+K + K    EK   +++ SE +I+ + DHP I
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTL-KAGYTEKQRRDFL-SEASIMGQFDHPNI 67

Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------SAVSH 265
           + L         + +V +++  G L          R+   +    ++V       S + +
Sbjct: 68  IHLEGVVTKSKPVMIVTEYMENGSL------DAFLRKHDGQFTVIQLVGMLRGIASGMKY 121

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEYMSPE 319
           L   G +HRDL   NIL++++    ++DFGL++  +++      TR   +   + + +PE
Sbjct: 122 LSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTAPE 179

Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKLPA 370
            +  +    A+D WS GI+++E+++ G+ P+   + Q +  K I++  +LPA
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV-IKAIEEGYRLPA 230

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 65.1 bits (159), Expect = 6e-12
 Identities = 58/235 (24%), Positives = 117/235 (49%), Gaps = 20/235 (8%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQ--VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
            V +E     KV+G G F +V +  ++  G  EI       K    +K   +++ +E +I
Sbjct: 5   YVTIE-----KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-TEASI 58

Query: 204 LTKVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIV 260
           + + DHP I++L     TK R + ++ +++  G L  F +          L  +    I 
Sbjct: 59  MGQFDHPNIIRL-EGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRG-IA 116

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS--NSMCG--TLEYM 316
           S + +L     +HRDL   NIL++++    ++DFGL++   E++ +   +  G   + + 
Sbjct: 117 SGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSR-RLEDSEATYTTKGGKIPIRWT 175

Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKLPA 370
           +PE +  +    A+D WS GI+++E+++ G+ P+   + Q + +  ++D  +LP 
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKA-VEDGYRLPP 229

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 66.1 bits (161), Expect = 9e-12
 Identities = 30/88 (34%), Positives = 54/88 (61%), Gaps = 5/88 (5%)

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN----SMCGTL 313
           +++SA+ ++H  GI+HRD+K EN+L++    + L DFG A  F   + S      + GT+
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFG-AACFARGSWSTPFHYGIAGTV 326

Query: 314 EYMSPEIVLGKGHDKAADWWSVGILLFE 341
           +  +PE++ G  +  + D WS G+++FE
Sbjct: 327 DTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 51/208 (24%), Positives = 107/208 (51%), Gaps = 12/208 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  +++K +G G F +V+      ++++ A+K ++   +  +   E    E N++  + H
Sbjct: 6   ESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTMSVQAFLE----EANLMKTLQH 60

Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHL 266
             +V+L Y+  TK   +Y++ +++  G L   L      +  L ++  ++A+I   ++++
Sbjct: 61  DKLVRL-YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGK 324
                +HRDL+  N+L+       + DFGLA+  ++N  T        +++ +PE +   
Sbjct: 120 ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 179

Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTG 351
                +D WS GILL+E++T G+ P+ G
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKIPYPG 207

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 59/240 (24%), Positives = 114/240 (47%), Gaps = 26/240 (10%)

Query: 158 VGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIV 213
           +G G F  V    Y++++  + +  A+K+++ D        E ++ E N++ ++D+P+IV
Sbjct: 3   LGSGNFGTVKKGMYKMKK--SEKTVAVKILKNDNNDPALKDELLR-EANVMQQLDNPYIV 59

Query: 214 QLRYSFQTKYRLYLVLDFVNGG--HLFFQLYRQGLFREDLARIYTAEIVSAVS----HLH 267
           ++    + +    LV++    G  + F Q  +       +      E+V  VS    +L 
Sbjct: 60  RMIGICEAE-SWMLVMELAELGPLNKFLQKNKH------VTEKNITELVHQVSMGMKYLE 112

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LEYMSPEIVLG 323
               +HRDL   N+LL    +  ++DFGL+K    DEN       G   +++ +PE +  
Sbjct: 113 ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172

Query: 324 KGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK-DKIKLPAFLSSEAHSLLK 381
                 +D WS G+L++E  + GQ P+ G    ++ Q I   ++++ P     E + L+K
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMK 232

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 61/249 (24%), Positives = 112/249 (44%), Gaps = 32/249 (12%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIY-----AMKVMRKDKIMEKNHAEYMKSERNI 203
           L     L+ +G+GAF KVY+    G +E       A+K + K+    K   E+ + E  +
Sbjct: 4   LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTL-KENAEPKVQQEF-RQEAEL 61

Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-----------------L 246
           ++ + HP IV L      +    ++ +++  G L   L R                   L
Sbjct: 62  MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121

Query: 247 FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--- 303
              D   I   +I + + +L ++  +HRDL   N L+     V ++DFGL++        
Sbjct: 122 DCSDFLHI-AIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY 180

Query: 304 -TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKI 361
             +S S+   + +M PE +L       +D WS G++L+E+ + G  P+ G + Q++ + +
Sbjct: 181 RVQSKSLL-PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE-M 238

Query: 362 IKDKIKLPA 370
           I+ +  LP 
Sbjct: 239 IRSRQLLPC 247

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 59/234 (25%), Positives = 115/234 (49%), Gaps = 32/234 (13%)

Query: 156 KVVGQGAFAKVYQ--VRRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           KV+G G F +V++  ++  G  E+  A+K + K    EK   +++ SE +I+ +  H  I
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTL-KPGYTEKQRQDFL-SEASIMGQFSHHNI 68

Query: 213 VQLRYSFQTKYR-LYLVLDFVNGGHL----------FFQLYRQGLFREDLARIYTAEIVS 261
           ++L     TK++   ++ +++  G L          F      G+ R          I +
Sbjct: 69  IRLE-GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRG---------IAA 118

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNSMCGT-LEYMS 317
            + +L     +HRDL   NIL++++    ++DFGL++      E T + S     + + +
Sbjct: 119 GMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA 178

Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKLPA 370
           PE +  +    A+D WS GI+++E+++ G+ P+   +  ++  K I D  +LPA
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV-MKAINDGFRLPA 231

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 63.4 bits (154), Expect = 7e-11
 Identities = 65/251 (25%), Positives = 104/251 (41%), Gaps = 61/251 (24%)

Query: 135 GHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMR------KD-- 186
           GH   +  E+  V  + F++L ++G+G F KV +       E  A+K++R      +D  
Sbjct: 114 GHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAK 173

Query: 187 ---KIMEK-------NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGH 236
              + MEK       +    MK +R    +  H  IV  +Y                G  
Sbjct: 174 IEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY----------------GPC 217

Query: 237 LFFQLYRQGLFREDLARIYTAEIV----SAVSHLHAN-GIMHRDLKPENILLDADG---- 287
           L   + + G F       + A+I+     A+ + H    +MH DLKPENIL++       
Sbjct: 218 LLDWIMKHGPFSHR----HLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVD 273

Query: 288 ------------HVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSV 335
                        V + D G     DE     ++  T  Y SPE+VLG G   + D WS+
Sbjct: 274 PVTNRALPPDPCRVRICDLGGC--CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSM 331

Query: 336 GILLFEMLTGQ 346
           G +++E+ TG+
Sbjct: 332 GCIIYELYTGK 342

Length = 467

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 62.3 bits (151), Expect = 7e-11
 Identities = 56/252 (22%), Positives = 118/252 (46%), Gaps = 23/252 (9%)

Query: 151 DFEVLKVVGQGAFAKVYQ--VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV- 207
           D +   V+G+G F +V +  +++ G     A+K M K+   + +H ++   E  +L K+ 
Sbjct: 8   DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDF-AGELEVLCKLG 65

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI------------- 254
            HP I+ L  + + +  LYL +++   G+L   L +  +   D A               
Sbjct: 66  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125

Query: 255 ---YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG 311
              + A++   + +L     +HRDL   NIL+  +    + DFGL++  +   +      
Sbjct: 126 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 185

Query: 312 TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLP 369
            + +M+ E +    +   +D WS G+LL+E+++ G  P+ G    ++ +K+ +  +++ P
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 245

Query: 370 AFLSSEAHSLLK 381
                E + L++
Sbjct: 246 LNCDDEVYDLMR 257

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 38/115 (33%), Positives = 62/115 (53%), Gaps = 5/115 (4%)

Query: 241 LYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
           L++  L  EDL   Y+ ++   +  L +   +HRDL   NILL  +  V + DFGLA+  
Sbjct: 166 LWKSPLTMEDLI-CYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 224

Query: 301 DEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            ++    R  S    L++M+PE +  K +   +D WS G+LL+E+ + G  P+ G
Sbjct: 225 YKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 279

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 58/255 (22%), Positives = 120/255 (47%), Gaps = 27/255 (10%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ED +   V+G+G F +V +  +++ G     A+K M K+   E +H ++   E  +L K+
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIK-MLKEFASENDHRDF-AGELEVLCKL 59

Query: 208 -DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI------------ 254
             HP I+ L  + + +  LY+ +++   G+L   L +  +   D A              
Sbjct: 60  GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119

Query: 255 ----YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMC 310
               + +++ + + +L     +HRDL   N+L+  +    + DFGL++   E        
Sbjct: 120 QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTM 177

Query: 311 GTL--EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KI 366
           G L   +M+ E +    +   +D WS G+LL+E+++ G  P+ G    ++ +K+ +  ++
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRM 237

Query: 367 KLPAFLSSEAHSLLK 381
           + P     E + L++
Sbjct: 238 EKPRNCDDEVYELMR 252

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 59/256 (23%), Positives = 129/256 (50%), Gaps = 33/256 (12%)

Query: 156 KVVGQGAFAKVYQVRRIGTSE-------IYAMKVMRKDKIMEKNHAEYMKSERNILTKV- 207
           K +G+G F +V     +G  +         A+K M KD   EK+ ++ + SE  ++  + 
Sbjct: 21  KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVK-MLKDDATEKDLSD-LVSEMEMMKMIG 78

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQ-GL-FREDLARI--------- 254
            H  I+ L  +      LY+++++ + G+L  + +  R  G+ +  D+AR+         
Sbjct: 79  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138

Query: 255 ---YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
               T ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ +
Sbjct: 139 LVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198

Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD--K 365
               +++M+PE +  + +   +D WS G+L++E+ T G  P+ G   +++  K++K+  +
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FKLLKEGHR 257

Query: 366 IKLPAFLSSEAHSLLK 381
           +  PA  ++E + +++
Sbjct: 258 MDKPANCTNELYMMMR 273

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 38/116 (32%), Positives = 63/116 (54%), Gaps = 5/116 (4%)

Query: 240 QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ 299
           +LY++ L  EDL   Y+ ++   +  L +   +HRDL   NILL  +  V + DFGLA+ 
Sbjct: 164 ELYKEPLTLEDLIS-YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARD 222

Query: 300 FDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
             ++    R       L++M+PE +  K +   +D WS G+LL+E+ + G  P+ G
Sbjct: 223 IYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 59/232 (25%), Positives = 104/232 (44%), Gaps = 34/232 (14%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEI-YAMKV---MRKDKIMEKNHAEYMKSERNIL 204
            +   + K +G+GAF +V +   +G         V   M KD   EK+ ++ + SE  ++
Sbjct: 11  RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLV-SEMEMM 69

Query: 205 TKV-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FF-------QLYRQGLFREDLARI 254
             +  H  I+ L      +  LY+V+++   G+L  F        +       R     +
Sbjct: 70  KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129

Query: 255 YTAEIVS-------AVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDEN--- 303
              ++VS        +  L +   +HRDL   N+L+  + HVM + DFGLA+        
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV-TEDHVMKIADFGLARDIHHIDYY 188

Query: 304 -TRSNSMCGTL--EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
              +N   G L  ++M+PE +  + +   +D WS G+LL+E+ T G  P+ G
Sbjct: 189 RKTTN---GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 50/224 (22%), Positives = 104/224 (46%), Gaps = 33/224 (14%)

Query: 150 EDFEVLKVVGQGAFAKVYQ-----VRRIGTSEIYAMKVMRKDKIMEKNHA-----EYMKS 199
           +   +  ++ +G F +++       +     E++   V        K+HA       +  
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV--------KDHASEIQVTLLLQ 57

Query: 200 ERNILTKVDHPFIVQ-LRYSFQTKYRLYLVLDFVNGGHL--FFQLYR-------QGLFRE 249
           E  +L  + H  I+  L    +     +++  ++N G+L  F Q  R       Q L  +
Sbjct: 58  ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117

Query: 250 DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRS 306
            L  +   +I   +S+LH  G++H+D+   N ++D +  V +TD  L++     D +   
Sbjct: 118 QLVHMAI-QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176

Query: 307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
           ++    +++M+ E ++ K +  A+D WS G+LL+E++T GQ P+
Sbjct: 177 DNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY 220

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 41/149 (27%), Positives = 76/149 (51%), Gaps = 13/149 (8%)

Query: 241 LYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
           LY++ L  EDL   Y+ ++   +  L +   +HRDL   NILL  +  V + DFGLA+  
Sbjct: 171 LYKKVLTLEDLI-CYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 229

Query: 301 DEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQK 356
            ++    R       L++M+PE +  + +   +D WS G+LL+E+ + G  P+ G    K
Sbjct: 230 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG---VK 286

Query: 357 IQQKIIK-----DKIKLPAFLSSEAHSLL 380
           I ++  +      +++ P + + E +  +
Sbjct: 287 IDEEFCRRLKEGTRMRAPDYTTPEMYQTM 315

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 53/224 (23%), Positives = 104/224 (46%), Gaps = 30/224 (13%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKV------MRKDKIMEKNHAEYMKSERNILTKV-D 208
           K +G+G F +V     IG  +    +V      M K    EK+ ++ + SE  ++  +  
Sbjct: 24  KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIGK 82

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR---------------QGLFREDL 251
           H  I+ L  +      LY+++++ + G+L  + +  R               + L  +DL
Sbjct: 83  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142

Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
                 ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ +
Sbjct: 143 VSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201

Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+LL+E+ T G  P+ G
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 60.3 bits (146), Expect = 3e-10
 Identities = 62/240 (25%), Positives = 105/240 (43%), Gaps = 35/240 (14%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK------NHAEYMKSERNI--LTKV 207
             +G G F KV         E +    M K +++ K         E +   + +    ++
Sbjct: 1   DEIGNGWFGKVLL------GEAHRG--MSKARVVVKELRASATPDEQLLFLQEVQPYREL 52

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFRED-----LARIYTAEIVS 261
           +HP ++Q            LVL+F   G L   L   +G+  +      L R+   E+ S
Sbjct: 53  NHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM-ACEVAS 111

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA-KQFDENTRSNSMCGT--LEYMSP 318
            +  LH    +H DL   N  L AD  V + D+GLA +Q+ E+      C    L +++P
Sbjct: 112 GLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAP 171

Query: 319 EIVLGKGHD-------KAADWWSVGILLFEMLT--GQPPFTGGNRQKIQQKIIKDKIKLP 369
           E+V  +G D       K ++ WS+G+ ++E+ T   QP     + Q ++Q + +  IKLP
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP 231

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 52/241 (21%), Positives = 117/241 (48%), Gaps = 30/241 (12%)

Query: 155 LKVVGQGAFAKVYQ----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +G+ AF K+Y+    +  +  +++ A+K ++   I         + E +++ ++ HP
Sbjct: 10  MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD--INNPQQWGEFQQEASLMAELHHP 67

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQ------------GLFREDLAR---I 254
            IV L      +  + ++ +++N G L  F + R             G  +  L     +
Sbjct: 68  NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 255 YTA-EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSM 309
           + A +I + + +L ++  +H+DL   NIL+    HV ++D GL+++         +  S+
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKL 368
              + +M PE ++       +D WS G++L+E+ + G  P+ G + Q++ + + K ++ L
Sbjct: 188 L-PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL-L 245

Query: 369 P 369
           P
Sbjct: 246 P 246

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 58.5 bits (141), Expect = 9e-10
 Identities = 59/246 (23%), Positives = 118/246 (47%), Gaps = 23/246 (9%)

Query: 157 VVGQGAFAKVYQ--VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIV 213
           V+G+G F +V +  +++ G     A+K   K+   + +H ++   E  +L K+  HP I+
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIK-RMKEYASKDDHRDF-AGELEVLCKLGHHPNII 59

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED--LARIY-TAEIVSAVSHLH--- 267
            L  + + +  LYL +++   G+L   L +  +   D   A    TA  +S+   LH   
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 268 --ANGI--------MHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMS 317
             A G+        +HRDL   NIL+  +    + DFGL++  +   +       + +M+
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA 179

Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSE 375
            E +    +   +D WS G+LL+E+++ G  P+ G    ++ +K+ +  +++ P     E
Sbjct: 180 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDE 239

Query: 376 AHSLLK 381
            + L++
Sbjct: 240 VYDLMR 245

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 28/223 (12%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKV------MRKDKIMEKN------HAEYMK---SE 200
           K +G+G F +V     IG  +    K       M KD   +K+        E MK     
Sbjct: 18  KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77

Query: 201 RNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFF---QLYRQGLFREDLA 252
           +NI+  +     D P  V + Y+ +   R YL      G    F   +L  + L  +DL 
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137

Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNSM 309
                ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ + 
Sbjct: 138 SC-AYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
              +++M+PE +  + +   +D WS G+LL+E+ T G  P+ G
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 52/233 (22%), Positives = 107/233 (45%), Gaps = 19/233 (8%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSE-----IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +  +G+G F +V+  +  G  E     +  +K ++K K  ++N     + E ++  K+ H
Sbjct: 10  ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSH 67

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAV---- 263
             +V+L    +     Y++L++ + G L  F +  +    +     + T + V+      
Sbjct: 68  KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127

Query: 264 ---SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSP 318
               HL     +HRDL   N L+ +   V ++   L+K     E  +  +    L +++P
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187

Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKLPA 370
           E V        +D WS G+L++E+ T G+ PF G + +++  ++   K++LP 
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 55/226 (24%), Positives = 108/226 (47%), Gaps = 34/226 (15%)

Query: 156 KVVGQGAFAKVYQVRRIGTSE-------IYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           K +G+G F +V +    G  +         A+K M KD   +K+ A+ + SE  ++  + 
Sbjct: 18  KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVK-MLKDNATDKDLADLI-SEMELMKLIG 75

Query: 209 -HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR----------------QGLFRE 249
            H  I+ L      +  LY+++++   G+L  F +  R                Q  F++
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 250 DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRS 306
            ++  Y  ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++
Sbjct: 136 LVSCAY--QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193

Query: 307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           ++    +++M+PE +  + +   +D WS GIL++E+ T G  P+ G
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 63/256 (24%), Positives = 117/256 (45%), Gaps = 35/256 (13%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKD---KIMEKNHAEYMKSERNILTKVDHPFI 212
           K +G+G F  V + +     +   +KV  K     I  ++  E   SE   + + DHP +
Sbjct: 5   KTLGEGEFGSVMEGQL--NQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62

Query: 213 VQL-RYSFQTKYRL-----YLVLDFVNGG--HLFFQLYRQG-----LFREDLARIYTAEI 259
           ++L     QT          ++L F+  G  H F    R G     L  + L + +  +I
Sbjct: 63  MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK-FMTDI 121

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-----FDENTRSNSMCGTLE 314
            S + +L +   +HRDL   N +L+ + +V + DFGL+K+     +    R   M   ++
Sbjct: 122 ASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PVK 179

Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK-DKIKLPAFL 372
           +++ E +  + +   +D WS G+ ++E+ T GQ P+ G    +I   + + +++K P   
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPP-- 237

Query: 373 SSEAHSLLKGVNSLLS 388
                  L G+ SL+S
Sbjct: 238 -----DCLDGLYSLMS 248

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 59/247 (23%), Positives = 109/247 (44%), Gaps = 25/247 (10%)

Query: 156 KVVGQGAFAKVYQVR---RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           K++G+G F  V + +     G+    A+K M+ D        E++ SE   +   DHP +
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFL-SEAACMKDFDHPNV 63

Query: 213 VQL-RYSFQTKYRLYL-----VLDFVNGG--HLFFQLYRQGLFREDLAR----IYTAEIV 260
           ++L    F+      +     +L F+  G  H F    R G   E L       +  +I 
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-----FDENTRSNSMCGTLEY 315
             + +L     +HRDL   N +L  D  V + DFGL+K+     +    R   M   +++
Sbjct: 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKW 181

Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK-DKIKLPAFLS 373
           ++ E +  + +   +D W+ G+ ++E+ T GQ P+ G    +I   +   +++K P    
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCL 241

Query: 374 SEAHSLL 380
            E + L+
Sbjct: 242 DELYDLM 248

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 42/186 (22%), Positives = 85/186 (45%), Gaps = 20/186 (10%)

Query: 182 VMRKDKIMEKNHAEY--MKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGH--- 236
            ++K  +   +  +   ++ E     ++ HP I+    SF     LY+V   +  G    
Sbjct: 29  AVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88

Query: 237 LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGL 296
           L    + +G   E        ++++A+ ++H+ G +HR +K  +ILL  DG V+L+    
Sbjct: 89  LLKTHFPEG-LPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRY 147

Query: 297 AKQFDEN----------TRSNSMCGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLT 344
           +    ++           +S+     L ++SPE++    +G+++ +D +SVGI   E+  
Sbjct: 148 SVSMIKHGKRQRVVHDFPKSSVK--NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELAN 205

Query: 345 GQPPFT 350
           G  PF 
Sbjct: 206 GHVPFK 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 56.1 bits (135), Expect = 6e-09
 Identities = 50/212 (23%), Positives = 92/212 (43%), Gaps = 24/212 (11%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV------- 207
           LK++G G F  V+  + I   E  ++K+    K ++       +S R    ++       
Sbjct: 12  LKLLGSGVFGTVH--KGIWIPEGDSIKIPVAIKTIQD------RSGRQTFQEITDHMLAM 63

Query: 208 ---DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL-YRQGLFREDLARIYTAEIVSAV 263
              DH +IV+L         L LV      G L   +   +          +  +I   +
Sbjct: 64  GSLDHAYIVRL-LGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGM 122

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEI 320
            +L  + ++HR+L   NILL +D  V + DFG+A      D+    +     +++M+ E 
Sbjct: 123 YYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182

Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           +L   +   +D WS G+ ++EM++ G  P+ G
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 56.4 bits (136), Expect = 6e-09
 Identities = 53/232 (22%), Positives = 104/232 (44%), Gaps = 33/232 (14%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGT-----SEIYAMKVMRKDKIMEKNHAEYMKSERNILT 205
           + E ++ +GQGAF +V+Q R  G        + A+K M K++      A++ + E  ++ 
Sbjct: 6   NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQR-EAALMA 63

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYT-------- 256
           + DHP IV+L         + L+ +++  G L  F  +R    +  L+   +        
Sbjct: 64  EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123

Query: 257 -------------AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--- 300
                         ++ + +++L     +HRDL   N L+  +  V + DFGL++     
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 183

Query: 301 DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           D    S +    + +M PE +    +   +D W+ G++L+E+ + G  P+ G
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 56.4 bits (136), Expect = 8e-09
 Identities = 42/141 (29%), Positives = 76/141 (53%), Gaps = 11/141 (7%)

Query: 249 EDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQF--DEN-- 303
           +DL R +++++   +  L +   +HRD+   N+LL  DG V  + DFGLA+    D N  
Sbjct: 212 DDLLR-FSSQVAQGMDFLASKNCIHRDVAARNVLL-TDGRVAKICDFGLARDIMNDSNYV 269

Query: 304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKII 362
            + N+    +++M+PE +    +   +D WS GILL+E+ + G+ P+ G        K++
Sbjct: 270 VKGNARL-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV 328

Query: 363 KDKIKL--PAFLSSEAHSLLK 381
           K   ++  P F   E +S++K
Sbjct: 329 KRGYQMSRPDFAPPEIYSIMK 349

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 56.4 bits (136), Expect = 8e-09
 Identities = 42/141 (29%), Positives = 70/141 (49%), Gaps = 11/141 (7%)

Query: 249 EDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS 308
           EDL   ++ ++   +S L +   +HRDL   NILL       + DFGLA+  D    SN 
Sbjct: 214 EDLLS-FSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLAR--DIRNDSNY 270

Query: 309 MCG-----TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKII 362
           +        +++M+PE +    +   +D WS GILL+E+ + G  P+ G        K+I
Sbjct: 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI 330

Query: 363 KDKIKL--PAFLSSEAHSLLK 381
           K+  ++  P    SE + ++K
Sbjct: 331 KEGYRMLSPECAPSEMYDIMK 351

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 59/249 (23%), Positives = 113/249 (45%), Gaps = 30/249 (12%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGT-----SEIYAMKVMRKDKIMEKNHAEYMKSER 201
           + L     ++ +G+  F KVY+    GT     ++  A+K + KDK  E    E  K E 
Sbjct: 2   INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKA-EGPLREEFKHEA 59

Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG--HLFF---------------QLYRQ 244
            + +++ HP IV L      +  L ++  + +    H F                +  + 
Sbjct: 60  MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119

Query: 245 GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT 304
            L   D   I T +I + +  L ++ ++H+DL   N+L+    +V ++D GL ++     
Sbjct: 120 TLEPADFVHIVT-QIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAAD 178

Query: 305 RSNSMCGTL---EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQK 360
               M  +L    +MSPE ++       +D WS G++L+E+ + G  P+ G + Q + + 
Sbjct: 179 YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE- 237

Query: 361 IIKDKIKLP 369
           +I+++  LP
Sbjct: 238 MIRNRQVLP 246

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 58/236 (24%), Positives = 101/236 (42%), Gaps = 32/236 (13%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD------HPF 211
           +G G F KV        SEIY    + +  + E       K +   L + D      HP 
Sbjct: 3   IGNGWFGKVL------LSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPN 56

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED-----LARIYTAEIVSAVSHL 266
           I+Q            LV ++   G L   L ++   R +     L R+   EI + V+H+
Sbjct: 57  ILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM-ACEIAAGVTHM 115

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLA-KQFDEN--TRSNSMCGTLEYMSPEIVLG 323
           H +  +H DL   N  L +D  V + D+G+   ++ E+     +  C  L +++PE+V G
Sbjct: 116 HKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELV-G 174

Query: 324 KGHD--------KAADWWSVGILLFEML--TGQPPFTGGNRQKIQQKIIKDKIKLP 369
           + H         K ++ W++G+ L+E+     QP     +R+ +   I   ++KL 
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLF 230

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 22/213 (10%)

Query: 166 VYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL 225
           VY  R   T  +  +++   +   E+ H + +++E  +     HP I+     F T   L
Sbjct: 16  VYLARHTPTGTLVTVRITDLENCTEE-HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74

Query: 226 YLVLDFVNGG---HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL 282
           +++  F+  G    L    + +G+  E L        +  +++LH NG +HR++K  +IL
Sbjct: 75  WVISPFMAYGSANSLLKTYFPEGM-SEALIGNILFGALRGLNYLHQNGYIHRNIKASHIL 133

Query: 283 LDADGHVMLTD----FGLAKQ-------FDENTRSNSMCGTLEYMSPEIVLGK--GHDKA 329
           +  DG V L+     + L +        +D    S S+   L ++SPE++     G++  
Sbjct: 134 ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSV---LPWLSPELLRQDLYGYNVK 190

Query: 330 ADWWSVGILLFEMLTGQPPFTGGNR-QKIQQKI 361
           +D +SVGI   E+ TG+ PF    R Q + QK+
Sbjct: 191 SDIYSVGITACELATGRVPFQDMLRTQMLLQKL 223

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 57/258 (22%), Positives = 110/258 (42%), Gaps = 29/258 (11%)

Query: 151 DFEVLKVVGQGAFAKV-----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT 205
           D  + + +G+GAF KV     Y +       + A+K ++   +  +      + E  +LT
Sbjct: 6   DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD---FQREAELLT 62

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLY------------RQGLFREDL 251
            + H  IV+          L +V +++  G L  F + +            RQ      L
Sbjct: 63  NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122

Query: 252 ARIY--TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRS 306
           +++    ++I S + +L +   +HRDL   N L+ A+  V + DFG+++     D     
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 182

Query: 307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT--GQPPFTGGNRQKIQQKIIKD 364
                 + +M PE ++ +     +D WS G++L+E+ T   QP F   N + I+      
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 242

Query: 365 KIKLPAFLSSEAHSLLKG 382
            ++ P     E + ++ G
Sbjct: 243 VLERPRVCPKEVYDIMLG 260

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 53.5 bits (128), Expect = 9e-08
 Identities = 35/112 (31%), Positives = 58/112 (51%), Gaps = 5/112 (4%)

Query: 244 QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN 303
           +GL   DL   +T ++   +  L +   +HRDL   N+LL     V + DFGLA+    +
Sbjct: 232 EGLTTLDLLS-FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290

Query: 304 TRSNSMCGT---LEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           +   S   T   +++M+PE +    +   +D WS GILL+E+ + G  P+ G
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 44/169 (26%), Positives = 77/169 (45%), Gaps = 18/169 (10%)

Query: 196 YMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGH---LFFQLYRQGLFREDLA 252
           +++ E ++    +HP IV  R +F     L++V  F+  G    L    +  G+    +A
Sbjct: 45  FLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIA 104

Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM--- 309
            I    ++ A+ ++H  G +HR +K  +IL+  DG V L+  GL            +   
Sbjct: 105 YILQG-VLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVV 161

Query: 310 -------CGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPF 349
                     L ++SPE++    +G+D  +D +SVGI   E+  G  PF
Sbjct: 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 25/64 (39%), Positives = 37/64 (57%), Gaps = 2/64 (3%)

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE--Y 315
           ++++ +  LH  GI+HRD+KPEN+L+  DG V + DFG A         N + G L+  Y
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRY 376

Query: 316 MSPE 319
             PE
Sbjct: 377 SPPE 380

Length = 507

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 52/248 (20%), Positives = 108/248 (43%), Gaps = 24/248 (9%)

Query: 158 VGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +G+GAF KV+  +   +   +   +  ++  K   ++  +  + E  +LT + H  IV+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 216 RYSFQTKYR-LYLVLDFVNGG-------------HLFFQLYRQGLFREDLARIY--TAEI 259
            Y   T+ R L +V +++  G              +          +  L ++    ++I
Sbjct: 73  -YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYM 316
            S + +L +   +HRDL   N L+     V + DFG+++     D           + +M
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM 191

Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLT--GQPPFTGGNRQKIQQKIIKDKIKLPAFLSS 374
            PE +L +     +D WS G++L+E+ T   QP +   N + I+      +++ P     
Sbjct: 192 PPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTCPP 251

Query: 375 EAHSLLKG 382
           E +++++G
Sbjct: 252 EVYAIMQG 259

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 29/105 (27%), Positives = 54/105 (51%), Gaps = 4/105 (3%)

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT---RSNSMCGTL 313
            EI   +++L+AN  +HRDL   N ++  D  V + DFG+ +   E     +       +
Sbjct: 126 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKI 357
            +MSPE +        +D WS G++L+E+ T  + P+ G + +++
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV 230

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 56/253 (22%), Positives = 108/253 (42%), Gaps = 36/253 (14%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---------EKNHAEYMKSERNILTKVD 208
           +G+GAF KV+       +E Y +    +DKI+           N  +    E  +LT + 
Sbjct: 13  LGEGAFGKVF------LAECYNL-CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG--------------LFREDLARI 254
           H  IV+          L +V +++  G L   L   G              L +  +  I
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCG 311
              +I + + +L +   +HRDL   N L+  +  V + DFG+++     D          
Sbjct: 126 -AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184

Query: 312 TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKI-KLP 369
            + +M PE ++ +     +D WS+G++L+E+ T G+ P+   +  ++ + I + ++ + P
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRP 244

Query: 370 AFLSSEAHSLLKG 382
                E + L+ G
Sbjct: 245 RTCPKEVYDLMLG 257

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 50.7 bits (121), Expect = 4e-07
 Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 12/124 (9%)

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNSMCGTLE 314
           EI   + HLH N  +H DL   N LL AD  V + D+GL+    + D     + +   L 
Sbjct: 108 EIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR 167

Query: 315 YMSPEIV-------LGKGHDKAADWWSVGILLFEM--LTGQPPFTGGNRQKIQQKIIKDK 365
           +++PE+V       L     K ++ WS+G+ ++E+  L  QP     + Q +   + + +
Sbjct: 168 WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ 227

Query: 366 IKLP 369
           +KLP
Sbjct: 228 LKLP 231

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 4/99 (4%)

Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT-- 312
           ++ ++ + +  L +   +HRDL   N+L+     V + DFGLA+    ++   S   T  
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303

Query: 313 -LEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            L++M+PE +    +   +D WS GILL+E+ T G  P+
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 49.6 bits (118), Expect = 9e-07
 Identities = 36/166 (21%), Positives = 71/166 (42%), Gaps = 28/166 (16%)

Query: 156 KVVGQGAFAKVYQVRRIG---------------TSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           K++G G F  VY+ +                   +E   M+ +  + I + +     K+ 
Sbjct: 18  KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNI 77

Query: 201 RNILTKVDHPFIVQL----RYSFQTKYRLYLVLD--FVNGGHLFFQLYRQGLFREDLARI 254
            NI    DH  I +      +     Y  +++L+    N   +F    R     + L + 
Sbjct: 78  HNI----DHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIF---KRIKCKNKKLIKN 130

Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
              ++++ + ++H +GI H D+KPENI++D +    + D+G+A  F
Sbjct: 131 IMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHF 176

Length = 294

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 48/218 (22%), Positives = 99/218 (45%), Gaps = 35/218 (16%)

Query: 158 VGQGAFAKVYQVRRIGTSE--------------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           +G+G F +V+     G +E              + A+K++R D + +    +++K E  I
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLK-EIKI 70

Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF-------------RED 250
           ++++ +P I++L     +   L ++ +++  G L   L ++ +                +
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSN 307
           L  +   +I S + +L +   +HRDL   N L+     + + DFG+++     D      
Sbjct: 131 LLYM-AVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189

Query: 308 SMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLT 344
                + +M+ E I+LGK    A+D W+ G+ L+EM T
Sbjct: 190 RAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 27/84 (32%), Positives = 44/84 (52%), Gaps = 6/84 (7%)

Query: 272 MHRDLKPENILLDADGHVMLTDFGLA-----KQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           +HRDL   N +LD    V + DFGLA     K++            +++M+ E +  +  
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179

Query: 327 DKAADWWSVGILLFEMLT-GQPPF 349
              +D WS G+LL+E++T G PP+
Sbjct: 180 TTKSDVWSFGVLLWELMTRGAPPY 203

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 47.3 bits (113), Expect = 3e-06
 Identities = 38/155 (24%), Positives = 60/155 (38%), Gaps = 27/155 (17%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIY---AMKVMRKDKIMEKNHAEYMKSERNILTK----- 206
           + ++ QGA A +Y    +G   +      K  R  ++ EK   E  + E  IL K     
Sbjct: 1   MDLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAG 60

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA---EIVSAV 263
           V  P +    Y         +V++++ G           L ++ L         E+   V
Sbjct: 61  VPVPIV----YDVDP-DNGLIVMEYIEGE----------LLKDALEEARPDLLREVGRLV 105

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK 298
             LH  GI+H DL   NI+L     +   DFGL +
Sbjct: 106 GKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE 139

Length = 204

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 47.6 bits (113), Expect = 4e-06
 Identities = 40/177 (22%), Positives = 84/177 (47%), Gaps = 7/177 (3%)

Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYT 256
           +E   L + DH  IV+L         + +V ++++ G L  F + +   L    L  +  
Sbjct: 55  AEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLP 114

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG--TLE 314
             + S + +L   G +H+ L    +L+++D    ++ F   ++        +M G   + 
Sbjct: 115 G-LASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL 173

Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKLPA 370
           + +PE +       A+D WS GI+++E+++ G+ P+   + Q +  K ++D  +LPA
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV-IKAVEDGFRLPA 229

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|236400 PRK09188, PRK09188, serine/threonine protein kinase; Provisional

 Score = 47.5 bits (113), Expect = 6e-06
 Identities = 28/80 (35%), Positives = 34/80 (42%), Gaps = 8/80 (10%)

Query: 227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDL-KPENILLDA 285
           LV  +  G  L   L R      D A   +A    A+  LH  GI H DL KP+N L+  
Sbjct: 95  LVRGWTEGVPL--HLARP---HGDPAWFRSAH--RALRDLHRAGITHNDLAKPQNWLMGP 147

Query: 286 DGHVMLTDFGLAKQFDENTR 305
           DG   + DF LA  F     
Sbjct: 148 DGEAAVIDFQLASVFRRRGA 167

Length = 365

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 45.5 bits (108), Expect = 9e-06
 Identities = 27/77 (35%), Positives = 43/77 (55%), Gaps = 8/77 (10%)

Query: 273 HRDLKPENILLDADGHVMLTDFG-LAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAAD 331
           HR  K  NILL  DG + L   G +A +  E +R +       +M+PE++ G+ + + AD
Sbjct: 34  HRQAKSGNILLTWDGLLKL--DGSVAFKTPEQSRPDPY-----FMAPEVIQGQSYTEKAD 86

Query: 332 WWSVGILLFEMLTGQPP 348
            +S+GI L+E L  + P
Sbjct: 87  IYSLGITLYEALDYELP 103

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 27/106 (25%), Positives = 55/106 (51%), Gaps = 4/106 (3%)

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT---RSNSMCGT 312
            AEI   +++L+A   +HRDL   N ++  D  V + DFG+ +   E     +       
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKI 357
           + +M+PE +       ++D WS G++L+E+ +  + P+ G + +++
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 230

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.9 bits (104), Expect = 2e-05
 Identities = 31/145 (21%), Positives = 61/145 (42%), Gaps = 13/145 (8%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH--PFI 212
           +K++  G   +VY +      E Y +K+               + E  IL  +      +
Sbjct: 3   IKLLKGGLTNRVYLLG--TKDEDYVLKINPSR-----EKGADREREVAILQLLARKGLPV 55

Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
            ++  S ++    YL+++++ G  L          +ED+A    AE+++ +  L    + 
Sbjct: 56  PKVLASGESDGWSYLLMEWIEGETLDE---VSEEEKEDIAEQL-AELLAKLHQLPLLVLC 111

Query: 273 HRDLKPENILLDADGHVMLTDFGLA 297
           H DL P NIL+D    + + D+  A
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYA 136

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 44/195 (22%), Positives = 84/195 (43%), Gaps = 24/195 (12%)

Query: 171 RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD 230
           R G   + A+K++R D    KN       E  IL+++  P I++L      +  L ++ +
Sbjct: 42  RKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITE 99

Query: 231 FVNGGHLF-FQLYRQGLFRED------------LARIYTA------EIVSAVSHLHANGI 271
           ++  G L  F        +E+             A  Y++      +I S + +L +   
Sbjct: 100 YMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           +HRDL   N L+  +  + + DFG+++     D           + +M+ E +L      
Sbjct: 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTT 219

Query: 329 AADWWSVGILLFEML 343
           A+D W+ G+ L+E+L
Sbjct: 220 ASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 46.0 bits (110), Expect = 2e-05
 Identities = 37/157 (23%), Positives = 64/157 (40%), Gaps = 30/157 (19%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKV---MRKDKIMEKNHAEYMKSERNILTK-----VDH 209
           +G+GA A + +   +G   +   +V    R  ++ E+   E  ++E  +L++     V  
Sbjct: 341 IGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPT 400

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH---- 265
           P I    Y         +V++++ G             ++ L      E+V  V      
Sbjct: 401 PVI----YDV-DPEEKTIVMEYIGGK----------DLKDVLE--GNPELVRKVGEIVAK 443

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE 302
           LH  GI+H DL   N ++  D  + L DFGL K  D 
Sbjct: 444 LHKAGIVHGDLTTSNFIVR-DDRLYLIDFGLGKYSDL 479

Length = 535

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 45.2 bits (107), Expect = 4e-05
 Identities = 17/41 (41%), Positives = 26/41 (63%), Gaps = 1/41 (2%)

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLD-ADGHVMLTDFGLA 297
           +I+ A+  LH+ GI+HRD+KP+NI+     G   + D G A
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 43.7 bits (104), Expect = 5e-05
 Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 22/154 (14%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAM---KVMRKDKIMEKNHAEYMKSERNIL------- 204
           +K++ +GA A++Y    +G   +      K  R  ++ E+   E  + E  I+       
Sbjct: 1   MKLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAG 60

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
             V   + V             +V++++ G  L   +   G+   +L+R    EI   V 
Sbjct: 61  VNVPAVYFVDP-------ENFIIVMEYIEGEPLKDLINSNGMEELELSR----EIGRLVG 109

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAK 298
            LH+ GI+H DL   N++L + G + L DFGLA+
Sbjct: 110 KLHSAGIIHGDLTTSNMIL-SGGKIYLIDFGLAE 142

Length = 211

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 44.5 bits (105), Expect = 5e-05
 Identities = 46/183 (25%), Positives = 86/183 (46%), Gaps = 22/183 (12%)

Query: 179 AMKVMRKDKIMEKN-HAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL 237
           A+K++R+D    KN   +++K E  I++++  P I++L     T   L ++ +++  G L
Sbjct: 50  AVKMLREDA--NKNARNDFLK-EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106

Query: 238 FFQLYRQGLFREDLA------------RIYTAEIVSAVSHLHANGIMHRDLKPENILLDA 285
             Q   +   +E                    +I S + +L +   +HRDL   N L+  
Sbjct: 107 N-QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGK 165

Query: 286 DGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFE 341
           +  + + DFG+++     D           + +MS E I+LGK    A+D W+ G+ L+E
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWE 224

Query: 342 MLT 344
           +LT
Sbjct: 225 ILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 42.6 bits (101), Expect = 1e-04
 Identities = 37/154 (24%), Positives = 68/154 (44%), Gaps = 21/154 (13%)

Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKV---MRKDKIMEKNHAEYMKSERNILTK-----VD 208
           ++ +GA A +Y    +G   +   +V    R  ++ E+   E  ++E  +L++     V+
Sbjct: 1   LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVN 60

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            P +    Y         +V++++ G     +  +  +   +   +   EI   V  LH 
Sbjct: 61  TPVV----YDV-DPDNKTIVMEYIEG-----KPLKDVIEEGNDELLR--EIGRLVGKLHK 108

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE 302
            GI+H DL   NI++  D  + L DFGL K  DE
Sbjct: 109 AGIVHGDLTTSNIIVRDDK-LYLIDFGLGKYSDE 141

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|226699 COG4248, COG4248, Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 25/105 (23%), Positives = 45/105 (42%), Gaps = 7/105 (6%)

Query: 254 IYTA-EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT 312
           +  A  + SA + LH +G +  D+   + L+  D  V+L D    +     T      G 
Sbjct: 120 LRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTLHLCPVGV 179

Query: 313 LEYMSPE-----IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            E+  PE       +G       D + + +L+F +L  G+ P++G
Sbjct: 180 SEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224

Length = 637

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 41.0 bits (96), Expect = 6e-04
 Identities = 53/235 (22%), Positives = 106/235 (45%), Gaps = 33/235 (14%)

Query: 158 VGQGAFAKVYQ-VRR--IGTSEIYAMKVMRKDKIMEKNHAEYMKS---ERNILTKVDHPF 211
           +GQG F K+++ +RR      E++  +V+ K  +++K+H  Y +S     ++++++ H  
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLK--VLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANG 270
           +V             +V ++V  G L   L +         ++  A ++  A+  L   G
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG 120

Query: 271 IMHRDLKPENILLDADGH--------VMLTDFG-----LAKQFDENTRSNSMCGTLEYMS 317
           + H ++  +N+LL  +          + L+D G     L K+         +   + ++ 
Sbjct: 121 LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI--------LLERIPWVP 172

Query: 318 PEIVLGKGH-DKAADWWSVGILLFEMLTG-QPPFTGGNRQKIQQKIIKDKIKLPA 370
           PE +    +   AAD WS G  L+E+ +G   P +  + QK  Q   +D+ +LPA
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPA 226

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|233667 TIGR01982, UbiB, 2-polyprenylphenol 6-hydroxylase

 Score = 41.1 bits (97), Expect = 7e-04
 Identities = 16/56 (28%), Positives = 26/56 (46%)

Query: 250 DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR 305
           D   +      S ++ +  +G  H DL P NI +  DG ++  DFG+  +  E  R
Sbjct: 257 DRKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSEEDR 312

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol -> 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species [Biosynthesis of cofactors, prosthetic groups, and carriers, Menaquinone and ubiquinone]. Length = 437

>gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only]

 Score = 40.8 bits (96), Expect = 0.001
 Identities = 15/37 (40%), Positives = 22/37 (59%)

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR 305
           +G  H D  P NIL+ +DG ++L DFG+  + D   R
Sbjct: 284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPKFR 320

Length = 517

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 40/150 (26%), Positives = 74/150 (49%), Gaps = 14/150 (9%)

Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
           + K+ HP IV+L    +++   YL+ +++ G +L   L  + L  E   +I    I  A+
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL--RNLSWERRRKIAIG-IAKAL 793

Query: 264 SHLHAN---GIMHRDLKPENILLDA--DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
             LH      ++  +L PE I++D   + H+ L+  GL     +   S++      Y++P
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSA------YVAP 847

Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPP 348
           E    K   + +D +  G++L E+LTG+ P
Sbjct: 848 ETRETKDITEKSDIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 39.3 bits (92), Expect = 0.002
 Identities = 44/181 (24%), Positives = 81/181 (44%), Gaps = 18/181 (9%)

Query: 179 AMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF 238
           A+KV+R D     N  E    E  IL+++  P I +L         L ++++++  G L 
Sbjct: 50  AVKVLRPDAS--DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107

Query: 239 FQLYRQGLFREDLAR----------IYTA-EIVSAVSHLHANGIMHRDLKPENILLDADG 287
             L +       LA           +Y A +I S + +L +   +HRDL   N L+  + 
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNY 167

Query: 288 HVMLTDFGLAKQFDEN----TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEML 343
            + + DFG+++    +     +  +    + +M+ E VL       +D W+ G+ L+E+L
Sbjct: 168 TIKIADFGMSRNLYSSDYYRVQGRAPL-PIRWMAWESVLLGKFTTKSDVWAFGVTLWEIL 226

Query: 344 T 344
           T
Sbjct: 227 T 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|234975 PRK01723, PRK01723, 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

 Score = 38.7 bits (91), Expect = 0.003
 Identities = 15/29 (51%), Positives = 16/29 (55%)

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDF 294
            H  G+ H DL   NILLD DG   L DF
Sbjct: 158 FHDAGVYHADLNAHNILLDPDGKFWLIDF 186

Length = 239

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	396
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.92
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.88
PRK10345	210	hypothetical protein; Provisional	99.85
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.85
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.84
smart00090	237	RIO RIO-like kinase.	99.84
PRK14879	211	serine/threonine protein kinase; Provisional	99.83
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.77
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.76
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.73
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.71
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.69
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.61
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.59
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.59
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.51
KOG1243	690	consensus Protein kinase [General function predict	99.49
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.48
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.46
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.35
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.32
KOG3087	229	consensus Serine/threonine protein kinase [General	99.27
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.24
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.19
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.07
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.06
COG4248	637	Uncharacterized protein with protein kinase and he	98.95
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.92
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.87
PRK09902	216	hypothetical protein; Provisional	98.76
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.72
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.68
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.63
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.63
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.48
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.48
PF01636	239	APH: Phosphotransferase enzyme family This family	98.46
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.4
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.28
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.27
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.25
PLN02876	822	acyl-CoA dehydrogenase	98.13
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.11
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.11
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.08
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.03
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.96
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.93
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.79
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.62
PRK10593	297	hypothetical protein; Provisional	97.56
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.54
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.52
PRK05231	319	homoserine kinase; Provisional	97.5
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.5
KOG2270	520	consensus Serine/threonine protein kinase involved	97.48
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.35
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.12
PLN02236	344	choline kinase	96.99
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.97
PLN02756	418	S-methyl-5-thioribose kinase	96.89
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.85
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.69
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.51
PRK12396	409	5-methylribose kinase; Reviewed	96.16
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.11
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.09
PTZ00384	383	choline kinase; Provisional	96.08
KOG1093	725	consensus Predicted protein kinase (contains TBC a	95.98
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.83
PRK11768	325	serine/threonine protein kinase; Provisional	95.79
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.68
COG2334	331	Putative homoserine kinase type II (protein kinase	95.43
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.16
PRK06148	1013	hypothetical protein; Provisional	95.15
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.89
PTZ00296	442	choline kinase; Provisional	94.86

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=8e-62  Score=455.51  Aligned_cols=247  Identities=57%  Similarity=0.950  Sum_probs=235.3

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~  225 (396)
                      ....++|+++++||+|+||+||+++.+.|++.||||++++..+......+...+|.++|..++||+||.++..|++..++
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            35678999999999999999999999999999999999999988888889999999999999999999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccccc-CCCC
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENT  304 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~-~~~~  304 (396)
                      |+|+||+.||.|+.+|.+++.++|+.++.|+++|+.||.|||++|||||||||+|||+|.+|+++|+|||+++.. ....
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999964 4456


Q ss_pred             CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHHHHh
Q 016037          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAHSLLKGV  383 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~-~~p~~~s~~~~~li~~~  383 (396)
                      .+.++|||+.|||||++.+..|+.++||||||+++|||++|.+||.+.+..+++++|.+++. ..|..+|.++++||+++
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~L  260 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKL  260 (357)
T ss_pred             ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHH
Confidence            67788999999999999999999999999999999999999999999999999999999994 55556999999999999


Q ss_pred             hccCCCCCC
Q 016037          384 NSLLSISVP  392 (396)
Q Consensus       384 l~~~p~~RP  392 (396)
                      |+.+|.+|-
T Consensus       261 L~rdp~~RL  269 (357)
T KOG0598|consen  261 LKRDPRQRL  269 (357)
T ss_pred             hccCHHHhc
Confidence            999999994

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-58  Score=416.16  Aligned_cols=243  Identities=44%  Similarity=0.795  Sum_probs=235.3

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      ..+++|+.++.||.|+||+|.+++.+.+|..||+|++.+..+..-...+...+|.++|+.+.||+++++++.|.+...+|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            56789999999999999999999999999999999999988888888888999999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCc
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS  306 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~  306 (396)
                      +||||++||.|+.++++.+++++.+++.|++||+.||+|||+++|++|||||+|||+|.+|++||+|||+|++....  +
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T  198 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--T  198 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--E
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999987544  6


Q ss_pred             cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhcc
Q 016037          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSL  386 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~  386 (396)
                      .+.||||.|+|||+++.+.|..++|||||||++|||+.|.+||.+.++..++++|..+++.+|..+|+++++||+.+|+.
T Consensus       199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~v  278 (355)
T KOG0616|consen  199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQV  278 (355)
T ss_pred             EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHhh
Confidence            78999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCC
Q 016037          387 LSISV  391 (396)
Q Consensus       387 ~p~~R  391 (396)
                      |-.+|
T Consensus       279 D~t~R  283 (355)
T KOG0616|consen  279 DLTKR  283 (355)
T ss_pred             hhHhh
Confidence            98888

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.3e-57  Score=444.17  Aligned_cols=247  Identities=32%  Similarity=0.575  Sum_probs=239.3

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      .+|+..+.||+|+|+.+|++++..+|+.||+|++.+..+......+.+.+|+++.+.|+|||||+++++|++..++|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            57999999999999999999999999999999999988888888899999999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC-CCCccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNS  308 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~-~~~~~~  308 (396)
                      |+|..++|..++++++.++|.+++.++.||+.||.|||+++|||||||..|+|++++.++||+|||+|..+.. ..+..+
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~T  177 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKT  177 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccce
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999874 477889


Q ss_pred             cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCC
Q 016037          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLS  388 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p  388 (396)
                      .||||.|.|||++...+++..+||||+||+||.|++|++||...+..+.+.+|..+...+|..+|.++++||.+||+.||
T Consensus       178 lCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P  257 (592)
T KOG0575|consen  178 LCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNP  257 (592)
T ss_pred             ecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCC
Q 016037          389 ISVPLLSR  396 (396)
Q Consensus       389 ~~RPs~s~  396 (396)
                      .+|||+++
T Consensus       258 ~~Rpsl~~  265 (592)
T KOG0575|consen  258 SERPSLDE  265 (592)
T ss_pred             ccCCCHHH
Confidence            99999863

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-55  Score=439.04  Aligned_cols=253  Identities=38%  Similarity=0.734  Sum_probs=238.7

Q ss_pred             CCCCccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEE
Q 016037          141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSF  219 (396)
Q Consensus       141 ~~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~  219 (396)
                      |.....++.++|.++++||+|+||+|+++..+++++.||||+++++.+..++..+..+.|.+++.... ||+++.|+.+|
T Consensus       359 ~~~~~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f  438 (694)
T KOG0694|consen  359 PPRRGPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF  438 (694)
T ss_pred             CCCCCcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc
Confidence            33335678899999999999999999999999999999999999999999999999999999999875 99999999999


Q ss_pred             EecCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          220 QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       220 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                      +++.++|.||||+.||+ ..++.+.+.|++..++.|+++++.||.|||++||||||||.+|||+|.+|++||+|||+++.
T Consensus       439 QT~~~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  439 QTKEHLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             ccCCeEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccc
Confidence            99999999999999999 44555668899999999999999999999999999999999999999999999999999998


Q ss_pred             cC-CCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHH
Q 016037          300 FD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHS  378 (396)
Q Consensus       300 ~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~  378 (396)
                      .- ....++++||||.|||||++.+..|+.++|||||||+||||+.|+.||.+.+.+++...|..+++.+|.++|.++.+
T Consensus       518 ~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~  597 (694)
T KOG0694|consen  518 GMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIA  597 (694)
T ss_pred             cCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHH
Confidence            54 66678999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCCCCCCC
Q 016037          379 LLKGVNSLLSISVPLL  394 (396)
Q Consensus       379 li~~~l~~~p~~RPs~  394 (396)
                      +|+++|+.+|.+|--.
T Consensus       598 il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  598 IMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHHhccCcccccCC
Confidence            9999999999999654

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-55  Score=426.31  Aligned_cols=251  Identities=38%  Similarity=0.633  Sum_probs=238.3

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCe
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYR  224 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~  224 (396)
                      .-...||.+.+.||+|+|++|++|+.+.+++.||||++.+.-+..+...+++..|...|.+| .||+|++||..|+++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            34567999999999999999999999999999999999998888888899999999999999 89999999999999999


Q ss_pred             EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      +|+|+||+++|+|..++.+.+.|.+..++.|++||+.||+|||++|||||||||+|||++.+|++||+|||.|+.+....
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999874321


Q ss_pred             ------------C--ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc
Q 016037          305 ------------R--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA  370 (396)
Q Consensus       305 ------------~--~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~  370 (396)
                                  .  ..+++||..|.+||+|.....+..+|+|+|||+||+|+.|++||.+.+.-.++++|..-.+.||+
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~  308 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE  308 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC
Confidence                        1  25689999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCHHHHHHHHHhhccCCCCCCCCCC
Q 016037          371 FLSSEAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       371 ~~s~~~~~li~~~l~~~p~~RPs~s~  396 (396)
                      ++++.+++||+.+|-.||.+|++..|
T Consensus       309 ~fp~~a~dLv~KLLv~dp~~Rlt~~q  334 (604)
T KOG0592|consen  309 GFPEDARDLIKKLLVRDPSDRLTSQQ  334 (604)
T ss_pred             CCCHHHHHHHHHHHccCccccccHHH
Confidence            99999999999999999999998753

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.2e-56  Score=419.12  Aligned_cols=249  Identities=33%  Similarity=0.554  Sum_probs=226.7

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccch----hhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~  223 (396)
                      ..+.|.+.+.||+|+||.|-+|..+.||+.||||++.+.....    .......++|+++|++|+|||||+++++|+...
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4466888999999999999999999999999999998865544    223445679999999999999999999999999


Q ss_pred             eEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC---CcEEEEeccccccc
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD---GHVMLTDFGLAKQF  300 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~---~~ikL~Dfgla~~~  300 (396)
                      ..||||||++||+|++.+..++.+.++..+.+++||+.|+.|||++||+||||||+|||++.+   -.+||+|||+|+..
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence            999999999999999999999999999999999999999999999999999999999999877   57999999999999


Q ss_pred             CCCCCccccccCCCccchhhhcCCCC---CchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCC----ccC
Q 016037          301 DENTRSNSMCGTLEYMSPEIVLGKGH---DKAADWWSVGILLFEMLTGQPPFTGGNRQK-IQQKIIKDKIKLP----AFL  372 (396)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~~~~---~~~~DvwSlGvil~elltg~~Pf~~~~~~~-i~~~i~~~~~~~p----~~~  372 (396)
                      .+.....+.||||.|.|||++.++++   ..++|||||||+||-+++|.+||.+..-+. +.+.|.++++.+-    ..+
T Consensus       330 g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~I  409 (475)
T KOG0615|consen  330 GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRI  409 (475)
T ss_pred             ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhh
Confidence            88888999999999999999987653   458899999999999999999999876555 8999999988764    368


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCC
Q 016037          373 SSEAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       373 s~~~~~li~~~l~~~p~~RPs~s~  396 (396)
                      |+++.+||++||..||+.|||.++
T Consensus       410 seea~dlI~~mL~VdP~~R~s~~e  433 (475)
T KOG0615|consen  410 SEEALDLINWMLVVDPENRPSADE  433 (475)
T ss_pred             hHHHHHHHHHhhEeCcccCcCHHH
Confidence            999999999999999999999763

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.9e-55  Score=424.74  Aligned_cols=247  Identities=43%  Similarity=0.784  Sum_probs=230.2

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~  225 (396)
                      .++.++|+++++||+|+||.||+|+.+.||+.||||++++..+...+..+.++.|.++|...++|+||+||+.|++..++
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            46789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC---
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE---  302 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~---  302 (396)
                      ||||||++||++..+|.+.+.++++.++.|+++++.|++-||..|+|||||||+|+|||..||+||+||||+.-+..   
T Consensus       217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~  296 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR  296 (550)
T ss_pred             EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999863311   


Q ss_pred             ---------------------CC------------------------CccccccCCCccchhhhcCCCCCchhhHHHHHH
Q 016037          303 ---------------------NT------------------------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGI  337 (396)
Q Consensus       303 ---------------------~~------------------------~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGv  337 (396)
                                           ..                        ...+.+|||.|||||++.+.+|+..+|||||||
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~  376 (550)
T KOG0605|consen  297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC  376 (550)
T ss_pred             hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence                                 00                        013467999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCc--cCCHHHHHHHHHhhccCCCCCCC
Q 016037          338 LLFEMLTGQPPFTGGNRQKIQQKIIKDK--IKLPA--FLSSEAHSLLKGVNSLLSISVPL  393 (396)
Q Consensus       338 il~elltg~~Pf~~~~~~~i~~~i~~~~--~~~p~--~~s~~~~~li~~~l~~~p~~RPs  393 (396)
                      |||||+.|.+||.+.++++...+|...+  +++|.  .+|.++++||..||. ||.+|--
T Consensus       377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence            9999999999999999999999999986  66775  689999999999999 9998853

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-54  Score=410.37  Aligned_cols=245  Identities=34%  Similarity=0.584  Sum_probs=228.0

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|.+.+.||+|+||+||+|+++.++..||||.+.+..+ .....+.+..|+.+|+.++|||||.++++++.++.+|+|
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            4689999999999999999999999999999999988765 456677788999999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC------CcEEEEecccccccCC
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD------GHVMLTDFGLAKQFDE  302 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~------~~ikL~Dfgla~~~~~  302 (396)
                      ||||+||+|..++++++.++|+.++.++.|++.||++||+++||||||||+|||++..      -.+||+|||+|+.+.+
T Consensus        88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~  167 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP  167 (429)
T ss_pred             EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence            9999999999999999999999999999999999999999999999999999999875      4689999999999998


Q ss_pred             CCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCccCCHHHHHH
Q 016037          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI---KLPAFLSSEAHSL  379 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~---~~p~~~s~~~~~l  379 (396)
                      .....+.||++.|||||+++...|+.|+|+||+|+++|+|++|+.||...+..++...+.++.-   .+|..+++...+|
T Consensus       168 ~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~L  247 (429)
T KOG0595|consen  168 GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLREL  247 (429)
T ss_pred             hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhh
Confidence            8888999999999999999999999999999999999999999999999999999999988743   4556788888899


Q ss_pred             HHHhhccCCCCCCCC
Q 016037          380 LKGVNSLLSISVPLL  394 (396)
Q Consensus       380 i~~~l~~~p~~RPs~  394 (396)
                      +-..|+.++.+|-+.
T Consensus       248 l~~ll~~~~~~~~~~  262 (429)
T KOG0595|consen  248 LISLLQRNPKDRISF  262 (429)
T ss_pred             hhHHHhcCccccCch
Confidence            999999998888654

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-54  Score=405.99  Aligned_cols=248  Identities=29%  Similarity=0.476  Sum_probs=229.1

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC-e
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-R  224 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~-~  224 (396)
                      .+...+++.++.||+|..|+||+++++.|++.+|+|++...  .+....+.+.+|+++++..+||+||.+|+.|.... .
T Consensus        75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~  152 (364)
T KOG0581|consen   75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE  152 (364)
T ss_pred             ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence            46677899999999999999999999999999999999443  24556677889999999999999999999999998 4


Q ss_pred             EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      ++|+||||++|+|...+...+.++|.....++.++++||.|||. ++||||||||+|||++..|.+||||||.++.+...
T Consensus       153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            99999999999999999998999999999999999999999996 89999999999999999999999999999988666


Q ss_pred             CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhC-CCCCCcc-CCHHH
Q 016037          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG-----NRQKIQQKIIKD-KIKLPAF-LSSEA  376 (396)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~-----~~~~i~~~i~~~-~~~~p~~-~s~~~  376 (396)
                       ...+++||..|||||.+.+..|+.++||||||++++|+++|+.||...     +..+++..|+.+ -+.+|.. +|+++
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef  311 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEF  311 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence             567899999999999999999999999999999999999999999874     788899999986 5678886 99999


Q ss_pred             HHHHHHhhccCCCCCCCCCC
Q 016037          377 HSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       377 ~~li~~~l~~~p~~RPs~s~  396 (396)
                      ++||..||++||.+||++.|
T Consensus       312 ~~FV~~CL~Kdp~~R~s~~q  331 (364)
T KOG0581|consen  312 RSFVSCCLRKDPSERPSAKQ  331 (364)
T ss_pred             HHHHHHHhcCCcccCCCHHH
Confidence            99999999999999999754

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-55  Score=396.07  Aligned_cols=246  Identities=32%  Similarity=0.519  Sum_probs=223.9

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeE-EEEecCe-E
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY-SFQTKYR-L  225 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~-~~~~~~~-~  225 (396)
                      .+.+|+++++||+|+||+||++....+|..+|.|.+.-+. .+....+.+..|+.+|++|+|||||++++ .|.+... +
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl   95 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL   95 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence            4568999999999999999999999999999999998554 45566777888999999999999999998 6665555 9


Q ss_pred             EEEEEecCCCcHHHHHH----HhcCCCHHHHHHHHHHHHHHHHHHHH--CC--ceeccCCCCCEEEcCCCcEEEEecccc
Q 016037          226 YLVLDFVNGGHLFFQLY----RQGLFREDLARIYTAEIVSAVSHLHA--NG--IMHRDLKPENILLDADGHVMLTDFGLA  297 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~~LH~--~~--iiHrDlkp~NILl~~~~~ikL~Dfgla  297 (396)
                      +||||+|++|+|...++    .++.++|..+|.++.|+|.||.++|+  .+  |+||||||.||+++.+|.+||+|||++
T Consensus        96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~  175 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG  175 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence            99999999999987664    34679999999999999999999999  45  999999999999999999999999999


Q ss_pred             cccCCCC-CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CC-ccCCH
Q 016037          298 KQFDENT-RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-LP-AFLSS  374 (396)
Q Consensus       298 ~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~-~p-~~~s~  374 (396)
                      +.+.... ...+.+|||.||+||.+.+..|+.++||||+||++|||+.-+.||.+.+..++.++|.++..+ +| ..+|.
T Consensus       176 r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~  255 (375)
T KOG0591|consen  176 RFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYST  255 (375)
T ss_pred             hHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhh
Confidence            9886543 457889999999999999999999999999999999999999999999999999999999765 78 68999


Q ss_pred             HHHHHHHHhhccCCCCCCCC
Q 016037          375 EAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       375 ~~~~li~~~l~~~p~~RPs~  394 (396)
                      ++.+||..|+..||..||+.
T Consensus       256 ~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  256 DLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HHHHHHHHHccCCcccCCCc
Confidence            99999999999999999973

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-51  Score=402.75  Aligned_cols=249  Identities=37%  Similarity=0.652  Sum_probs=231.6

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccch--hhHHHHHHHHHHHHHhCC-CCCeeeeeEEEEecC
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME--KNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKY  223 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~  223 (396)
                      ...+.|.+.+.||+|+||+|+.|.+..+++.||+|++.+.....  ....+.+.+|+.+++.++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            44578999999999999999999999999999999887653221  134556778999999999 999999999999999


Q ss_pred             eEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC-CcEEEEeccccccc-C
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQF-D  301 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~-~~ikL~Dfgla~~~-~  301 (396)
                      .+|+||||+.||+|++++.+.+++.|..++.+++|++.|++|+|++||+||||||+|||++.+ +++||+|||++... .
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG  173 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence            999999999999999999999999999999999999999999999999999999999999999 99999999999988 4


Q ss_pred             CCCCccccccCCCccchhhhcCCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccC-CHHHHH
Q 016037          302 ENTRSNSMCGTLEYMSPEIVLGKG-HD-KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFL-SSEAHS  378 (396)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~-~~-~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~-s~~~~~  378 (396)
                      ........|||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.+.+...+..+|.++.+.+|..+ |++++.
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~~  253 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEARS  253 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHHHH
Confidence            667788999999999999999977 85 889999999999999999999999999999999999999999999 999999


Q ss_pred             HHHHhhccCCCCCCCCC
Q 016037          379 LLKGVNSLLSISVPLLS  395 (396)
Q Consensus       379 li~~~l~~~p~~RPs~s  395 (396)
                      ||+.||..+|.+|+++.
T Consensus       254 Li~~mL~~~P~~R~t~~  270 (370)
T KOG0583|consen  254 LIEKMLVPDPSTRITLL  270 (370)
T ss_pred             HHHHHcCCCcccCCCHH
Confidence            99999999999999864

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-51  Score=381.15  Aligned_cols=326  Identities=34%  Similarity=0.596  Sum_probs=268.8

Q ss_pred             ccccCCCeEEEeCCccCCCCCCcccccccccccchhhhhhccCCccCCcccccCCC---CCCcc----ccc-ccCCCCCC
Q 016037           65 ELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGP---NNLSV----VDA-ALGKPTGH  136 (396)
Q Consensus        65 ~~~~~~~~~~~~r~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~----~~~-~~~~~~~~  136 (396)
                      -+-.||++.||++||.+| +..|.........++....++++.-.. .......+.   ++...    .+. ...++...
T Consensus       159 yrcinckl~vhkkch~~v-~~~cg~~~~~~~~~p~~p~~~s~~~~~-~~s~~t~~~~~i~~~~~he~~~~~~~~~~~a~~  236 (593)
T KOG0695|consen  159 YRCINCKLLVHKKCHGLV-PLTCGKHMDSVMPSPEPPVDDSNEDAD-LPSEETDGIAYISSSRKHESIKDDSEDLKPAID  236 (593)
T ss_pred             ceeecceeehhhhhcccc-cchhhhhccCCCCCCCCCCCCccccCC-CCchhcCcccccCccccchhhhcCccchhhhhh
Confidence            345689999999999999 555555544444444444444432110 001110100   00000    000 00122222


Q ss_pred             CCCCCCCCccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeee
Q 016037          137 IDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQL  215 (396)
Q Consensus       137 ~~~~~~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l  215 (396)
                      ..+.....+.+++++|.++++||+|+|++|.+++.+.|.+.||||+++++-..+++.+++.+.|..+..+- +||++|-|
T Consensus       237 ~m~g~~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvgl  316 (593)
T KOG0695|consen  237 GMDGIKISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGL  316 (593)
T ss_pred             hccccccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEeh
Confidence            22233356778899999999999999999999999999999999999999888888999999999988875 79999999


Q ss_pred             eEEEEecCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecc
Q 016037          216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFG  295 (396)
Q Consensus       216 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfg  295 (396)
                      ..+|+++.++++|.||++||+|..++++++.++|+.++.|..+|+.||.|||++|||+||||.+|+|++.+|++||+|+|
T Consensus       317 hscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdyg  396 (593)
T KOG0695|consen  317 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYG  396 (593)
T ss_pred             hhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccc-CCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCC
Q 016037          296 LAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG--------GNRQKIQQKIIKDKI  366 (396)
Q Consensus       296 la~~~-~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~--------~~~~~i~~~i~~~~~  366 (396)
                      +++.- .+...++++||||.|.|||++.+..|...+|||+||++|+||+.|+.||.-        .+.+.+++.|....+
T Consensus       397 mcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi  476 (593)
T KOG0695|consen  397 MCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI  476 (593)
T ss_pred             hhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc
Confidence            99874 566778899999999999999999999999999999999999999999962        356778899999999


Q ss_pred             CCCccCCHHHHHHHHHhhccCCCCCC
Q 016037          367 KLPAFLSSEAHSLLKGVNSLLSISVP  392 (396)
Q Consensus       367 ~~p~~~s~~~~~li~~~l~~~p~~RP  392 (396)
                      .+|+.+|-.+..++|+.|++||.+|-
T Consensus       477 riprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  477 RIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             cccceeehhhHHHHHHhhcCCcHHhc
Confidence            99999999999999999999999984

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1e-50  Score=395.65  Aligned_cols=249  Identities=26%  Similarity=0.452  Sum_probs=222.6

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC-
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-  223 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~-  223 (396)
                      +.+...++.+...||+|+||+||+|.|.++.. ||+|++......... .+.+.+|+.+|.+++|||||++++++.+.. 
T Consensus        36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~-vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~  113 (362)
T KOG0192|consen   36 EEIDPDELPIEEVLGSGSFGTVYKGKWRGTDV-VAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPG  113 (362)
T ss_pred             eecChHHhhhhhhcccCCceeEEEEEeCCcee-EEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            34556677777889999999999999966543 999999887655544 778999999999999999999999998887 


Q ss_pred             eEEEEEEecCCCcHHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCCEEEcCCC-cEEEEecccccc
Q 016037          224 RLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANG-IMHRDLKPENILLDADG-HVMLTDFGLAKQ  299 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~-iiHrDlkp~NILl~~~~-~ikL~Dfgla~~  299 (396)
                      .++||||||++|+|..++..  ++.++...+..++.||++||+|||+++ ||||||||+|||++.++ ++||+|||+++.
T Consensus       114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE  193 (362)
T ss_pred             ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence            79999999999999999988  688999999999999999999999999 99999999999999998 999999999988


Q ss_pred             cCCC-CCccccccCCCccchhhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCH
Q 016037          300 FDEN-TRSNSMCGTLEYMSPEIVL--GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPAFLSS  374 (396)
Q Consensus       300 ~~~~-~~~~~~~gt~~y~APE~l~--~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--~~~~p~~~s~  374 (396)
                      .... .......||+.|||||++.  ...|+.|+||||||++||||+||+.||.+.....+...+..+  ++.+|..+++
T Consensus       194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~  273 (362)
T KOG0192|consen  194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPP  273 (362)
T ss_pred             eccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence            7654 3444478999999999999  568999999999999999999999999999887777777643  7788889999


Q ss_pred             HHHHHHHHhhccCCCCCCCCC
Q 016037          375 EAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       375 ~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .+..||+.||+.||..||+++
T Consensus       274 ~l~~l~~~CW~~dp~~RP~f~  294 (362)
T KOG0192|consen  274 HLSSLMERCWLVDPSRRPSFL  294 (362)
T ss_pred             HHHHHHHHhCCCCCCcCCCHH
Confidence            999999999999999999975

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-52  Score=384.30  Aligned_cols=248  Identities=42%  Similarity=0.772  Sum_probs=237.6

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCe
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~  224 (396)
                      ..+..++|..+++||+|.||+|.+++-+.+++.||||+++++.+..++....-..|-++|+..+||++..|..+|+..++
T Consensus       163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr  242 (516)
T KOG0690|consen  163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR  242 (516)
T ss_pred             ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence            34677899999999999999999999999999999999999988888888878889999999999999999999999999


Q ss_pred             EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccc-cCCC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDEN  303 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~-~~~~  303 (396)
                      +|+||||..||.|+.++.+.+.++|+..+.|..+|+.||.|||+++||+||||.+|+|+|.+|++||+|||+++. +...
T Consensus       243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g  322 (516)
T KOG0690|consen  243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG  322 (516)
T ss_pred             EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999986 4556


Q ss_pred             CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHh
Q 016037          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV  383 (396)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~  383 (396)
                      ....++||||.|+|||++....|+.++|||.+||+||||+||+.||...+-+.++..|.-+.+.||..+|++++.|+.++
T Consensus       323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGL  402 (516)
T KOG0690|consen  323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGL  402 (516)
T ss_pred             ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHHH
Confidence            67789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCC
Q 016037          384 NSLLSISVP  392 (396)
Q Consensus       384 l~~~p~~RP  392 (396)
                      |.+||.+|-
T Consensus       403 L~kdP~kRL  411 (516)
T KOG0690|consen  403 LKKDPKKRL  411 (516)
T ss_pred             hhcChHhhc
Confidence            999999984

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.8e-51  Score=384.63  Aligned_cols=249  Identities=40%  Similarity=0.685  Sum_probs=230.8

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCe
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~  224 (396)
                      ..+++++|++++.||.|.-|+||+++.++++..+|||++.+..+...+...+.+.|..||+.++||+++.||..|++...
T Consensus        72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~  151 (459)
T KOG0610|consen   72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY  151 (459)
T ss_pred             CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence            45778899999999999999999999999999999999999998888899999999999999999999999999999999


Q ss_pred             EEEEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC-
Q 016037          225 LYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-  301 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~-  301 (396)
                      .|++||||+||+|...++++  +.+++..++.|+++++.||+|||..|||+|||||+||||.++|+|+|+||.++.... 
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            99999999999998888766  579999999999999999999999999999999999999999999999999874320 


Q ss_pred             -----------------------------------C---------------------CCCccccccCCCccchhhhcCCC
Q 016037          302 -----------------------------------E---------------------NTRSNSMCGTLEYMSPEIVLGKG  325 (396)
Q Consensus       302 -----------------------------------~---------------------~~~~~~~~gt~~y~APE~l~~~~  325 (396)
                                                         .                     ..++.+++||-.|.|||++.|.+
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence                                               0                     01245678999999999999999


Q ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHHHhhccCCCCCCC
Q 016037          326 HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA--FLSSEAHSLLKGVNSLLSISVPL  393 (396)
Q Consensus       326 ~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~--~~s~~~~~li~~~l~~~p~~RPs  393 (396)
                      ++.++|||+|||+||||+.|..||.|.+..+.+.+|+...+.||.  .+|..+++||+++|.+||++|--
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg  381 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLG  381 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhc
Confidence            999999999999999999999999999999999999999888885  68999999999999999999964

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8e-51  Score=397.20  Aligned_cols=249  Identities=23%  Similarity=0.401  Sum_probs=222.7

Q ss_pred             CCCccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe
Q 016037          142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (396)
Q Consensus       142 ~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~  221 (396)
                      ...+.+....+++++.||+|.||+||+|.|+++. .||+|.++...+..    +.+.+|+++|++|+|+|||++++++..
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~-~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~  272 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGST-KVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTK  272 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCC-cccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEec
Confidence            3445566677888999999999999999997764 49999998765432    335689999999999999999999999


Q ss_pred             cCeEEEEEEecCCCcHHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          222 KYRLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                      +..+|||||||+.|+|.++|+.  ...+.......++.|||+||+||+++++|||||..+||||+++..+||+|||+|+.
T Consensus       273 ~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~  352 (468)
T KOG0197|consen  273 QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARL  352 (468)
T ss_pred             CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccc
Confidence            8899999999999999999987  56788889999999999999999999999999999999999999999999999996


Q ss_pred             cCCCCCc--cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHH
Q 016037          300 FDENTRS--NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSE  375 (396)
Q Consensus       300 ~~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~  375 (396)
                      ..+....  ....-+..|.|||.+....++.|+|||||||+||||+| |+.||.+.+..++.+.+.++ +++-|..++.+
T Consensus       353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~  432 (468)
T KOG0197|consen  353 IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDE  432 (468)
T ss_pred             cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHH
Confidence            6544332  22334679999999999999999999999999999999 99999999999999999988 89999999999


Q ss_pred             HHHHHHHhhccCCCCCCCCC
Q 016037          376 AHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       376 ~~~li~~~l~~~p~~RPs~s  395 (396)
                      +.++|+.||..+|++|||+.
T Consensus       433 vY~lM~~CW~~~P~~RPtF~  452 (468)
T KOG0197|consen  433 VYELMKSCWHEDPEDRPTFE  452 (468)
T ss_pred             HHHHHHHHhhCCcccCCCHH
Confidence            99999999999999999974

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6.4e-51  Score=397.00  Aligned_cols=242  Identities=36%  Similarity=0.594  Sum_probs=227.9

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|-+.+.||+|+||.||+|+.+.+.+.||+|.+.+.... +...+.+.+|+++++.++||||+.++++|++..++|+|+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~-~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN-EKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc-hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            5788889999999999999999999999999999876543 345667899999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC-ccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNS  308 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~-~~~  308 (396)
                      ||+.| +|+.++...+.++|+.++.++.|++.||.|||+++|+|||+||+|||++..|++|+||||+|+....++. ..+
T Consensus        81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts  159 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS  159 (808)
T ss_pred             hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence            99988 9999999999999999999999999999999999999999999999999999999999999998765543 456


Q ss_pred             cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCC
Q 016037          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLS  388 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p  388 (396)
                      ..|||.|||||++.+..|+..+|+|||||++|||++|++||...+..++.+.|.++....|...|.++.+|++++|++||
T Consensus       160 ikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP  239 (808)
T KOG0597|consen  160 IKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKDP  239 (808)
T ss_pred             ccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcCh
Confidence            78999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCC
Q 016037          389 ISVPL  393 (396)
Q Consensus       389 ~~RPs  393 (396)
                      .+|-+
T Consensus       240 ~~Rlt  244 (808)
T KOG0597|consen  240 AQRLT  244 (808)
T ss_pred             hhccc
Confidence            99976

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-50  Score=398.94  Aligned_cols=247  Identities=32%  Similarity=0.532  Sum_probs=233.5

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .+-|++.+.||.|+.|.|-+|++..||+.+|||++.+...........+.+|+-+|+.+.|||++++|+.|++..++|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            35699999999999999999999999999999999886444445556688999999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccc
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~  308 (396)
                      .||++||.|++++.+++++++..+..++.||+.|+.|+|..+|+||||||+|+|++.+++|||+|||+|..-.++.-..+
T Consensus        91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeT  170 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLET  170 (786)
T ss_pred             EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999998777777889


Q ss_pred             cccCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccC
Q 016037          309 MCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLL  387 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~  387 (396)
                      .||+|.|.|||++.|..| +.++||||.|||||.|+||+.||.+.|...++.|+.++.+.+|..+|+++++||.+||+.|
T Consensus       171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VD  250 (786)
T KOG0588|consen  171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVD  250 (786)
T ss_pred             cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccC
Confidence            999999999999999888 4899999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCC
Q 016037          388 SISVPLLS  395 (396)
Q Consensus       388 p~~RPs~s  395 (396)
                      |..|-++.
T Consensus       251 p~~RiT~~  258 (786)
T KOG0588|consen  251 PSTRITTE  258 (786)
T ss_pred             ccccccHH
Confidence            99998753

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.5e-49  Score=384.98  Aligned_cols=245  Identities=41%  Similarity=0.778  Sum_probs=228.1

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      ...++|++.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++..+..+|
T Consensus        15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   94 (329)
T PTZ00263         15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY   94 (329)
T ss_pred             CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence            45678999999999999999999999999999999998765444455667889999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCc
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS  306 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~  306 (396)
                      +||||+.+|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  .
T Consensus        95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~  172 (329)
T PTZ00263         95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--T  172 (329)
T ss_pred             EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--c
Confidence            99999999999999999889999999999999999999999999999999999999999999999999999876443  3


Q ss_pred             cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhcc
Q 016037          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSL  386 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~  386 (396)
                      ...+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+...++..+++.+|..++..+++||++||+.
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~  252 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQT  252 (329)
T ss_pred             ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHhhc
Confidence            34679999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 016037          387 LSISVPL  393 (396)
Q Consensus       387 ~p~~RPs  393 (396)
                      ||.+||+
T Consensus       253 dP~~R~~  259 (329)
T PTZ00263        253 DHTKRLG  259 (329)
T ss_pred             CHHHcCC
Confidence            9999997

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-49  Score=376.42  Aligned_cols=242  Identities=40%  Similarity=0.725  Sum_probs=224.4

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++...........+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36999999999999999999999999999999998655444445666888999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCcccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM  309 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~  309 (396)
                      ||+++|+|.+++...+.+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~~  158 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWTL  158 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--cccc
Confidence            99999999999998889999999999999999999999999999999999999999999999999999876433  3346


Q ss_pred             ccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCC
Q 016037          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSI  389 (396)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~  389 (396)
                      +||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...+.+.+...++.+|..++..+++||++||+.||.
T Consensus       159 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~  238 (291)
T cd05612         159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRT  238 (291)
T ss_pred             cCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCHH
Confidence            79999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCC
Q 016037          390 SVPL  393 (396)
Q Consensus       390 ~RPs  393 (396)
                      +||+
T Consensus       239 ~R~~  242 (291)
T cd05612         239 RRLG  242 (291)
T ss_pred             HccC
Confidence            9996

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-49  Score=379.29  Aligned_cols=251  Identities=29%  Similarity=0.519  Sum_probs=218.5

Q ss_pred             CccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccch-----------hhHHHHHHHHHHHHHhCCCCCe
Q 016037          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-----------KNHAEYMKSERNILTKVDHPFI  212 (396)
Q Consensus       144 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~-----------~~~~~~~~~E~~~L~~l~HpnI  212 (396)
                      .....+++|++++.||+|.||+|-+|++..+++.||||++.+.....           ....+..++|+.+|+++.||||
T Consensus        91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV  170 (576)
T KOG0585|consen   91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV  170 (576)
T ss_pred             ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence            34466789999999999999999999999999999999997744322           1234678899999999999999


Q ss_pred             eeeeEEEEe--cCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEE
Q 016037          213 VQLRYSFQT--KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM  290 (396)
Q Consensus       213 v~l~~~~~~--~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ik  290 (396)
                      |+|+.+..+  ...+|||+|||..|.+.+.--...-+.+++++.|+.+++.||+|||.+|||||||||.|+|++.+|++|
T Consensus       171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK  250 (576)
T KOG0585|consen  171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK  250 (576)
T ss_pred             eEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence            999999865  468999999999998754333322389999999999999999999999999999999999999999999


Q ss_pred             EEecccccccCCC------CCccccccCCCccchhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 016037          291 LTDFGLAKQFDEN------TRSNSMCGTLEYMSPEIVLGKG----HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQK  360 (396)
Q Consensus       291 L~Dfgla~~~~~~------~~~~~~~gt~~y~APE~l~~~~----~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~  360 (396)
                      |+|||.+..+...      ......+|||.|||||.+.+..    .+.+.||||+||+||.|+.|+.||.+....+++.+
T Consensus       251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K  330 (576)
T KOG0585|consen  251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK  330 (576)
T ss_pred             eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence            9999999876222      2234578999999999997732    35789999999999999999999999999999999


Q ss_pred             HHhCCCCCCcc--CCHHHHHHHHHhhccCCCCCCCC
Q 016037          361 IIKDKIKLPAF--LSSEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       361 i~~~~~~~p~~--~s~~~~~li~~~l~~~p~~RPs~  394 (396)
                      |.++.+.+|..  +.+++++||++||++||++|.++
T Consensus       331 Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l  366 (576)
T KOG0585|consen  331 IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITL  366 (576)
T ss_pred             HhcCcccCCCcccccHHHHHHHHHHhhcChhheeeh
Confidence            99999999965  89999999999999999999876

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-50  Score=355.93  Aligned_cols=250  Identities=33%  Similarity=0.613  Sum_probs=236.7

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCe
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~  224 (396)
                      ..+..++|++.+.||+|.||.||+|+.+.++-.||+|++.+..+........+.+|+.+...|+||||+++|++|-+...
T Consensus        17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r   96 (281)
T KOG0580|consen   17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR   96 (281)
T ss_pred             cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence            34667899999999999999999999999999999999999887777777889999999999999999999999999999


Q ss_pred             EEEEEEecCCCcHHHHHH--HhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          225 LYLVLDFVNGGHLFFQLY--RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      .|+++||...|+++..|.  ....+.+..++.|+.|++.||.|+|.+++|||||||+|+|++..|.+||+|||.+..-. 
T Consensus        97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen   97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            999999999999999998  66789999999999999999999999999999999999999999999999999997655 


Q ss_pred             CCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHH
Q 016037          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG  382 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~  382 (396)
                      ..+..+.|||..|.+||...+..++..+|+|++|++.||++.|.+||...+..+.+++|.+-++.+|..+|.++++||.+
T Consensus       176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~  255 (281)
T KOG0580|consen  176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISR  255 (281)
T ss_pred             CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHH
Confidence            55667899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCC
Q 016037          383 VNSLLSISVPLLS  395 (396)
Q Consensus       383 ~l~~~p~~RPs~s  395 (396)
                      ||.++|.+|..+.
T Consensus       256 ll~~~p~~r~~l~  268 (281)
T KOG0580|consen  256 LLVKNPIERLALT  268 (281)
T ss_pred             HhccCccccccHH
Confidence            9999999998764

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-49  Score=375.83  Aligned_cols=243  Identities=33%  Similarity=0.530  Sum_probs=212.9

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC--eEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY--RLYL  227 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~--~~~l  227 (396)
                      .+|...+.||+|+||.||++.+..+|+..|||.+.....   ...+.+.+|+.+|.+++|||||++++......  .++|
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            468889999999999999999999999999999877531   12667889999999999999999999854444  6999


Q ss_pred             EEEecCCCcHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC-CCcEEEEecccccccCC---
Q 016037          228 VLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHVMLTDFGLAKQFDE---  302 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~-~~~ikL~Dfgla~~~~~---  302 (396)
                      .|||+++|+|.+++.+.+ .++|..++.|++||++||+|||++|||||||||+|||++. ++.+||+|||+++....   
T Consensus        94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            999999999999999887 7999999999999999999999999999999999999999 79999999999988763   


Q ss_pred             -CCCccccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCccCCHHHH
Q 016037          303 -NTRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKIIKDK--IKLPAFLSSEAH  377 (396)
Q Consensus       303 -~~~~~~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~-~~~~~i~~~i~~~~--~~~p~~~s~~~~  377 (396)
                       ........||+.|||||++... ....++|||||||++.||+||+.||.. .......-++....  +.+|..+|.+++
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~  253 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAK  253 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHH
Confidence             2234567899999999999953 334599999999999999999999998 55555555555443  678999999999


Q ss_pred             HHHHHhhccCCCCCCCCC
Q 016037          378 SLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       378 ~li~~~l~~~p~~RPs~s  395 (396)
                      +||..|+..+|..|||++
T Consensus       254 ~Fl~~C~~~~p~~Rpta~  271 (313)
T KOG0198|consen  254 DFLRKCFKRDPEKRPTAE  271 (313)
T ss_pred             HHHHHHhhcCcccCcCHH
Confidence            999999999999999975

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.9e-50  Score=364.34  Aligned_cols=246  Identities=27%  Similarity=0.417  Sum_probs=213.9

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      +.|+.+.++|+|+||.||+|+++.||+.||||++.... .++...+-..+|+++|++|+|+|+|.|+.+|..+..+++|+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            46889999999999999999999999999999997654 23444555678999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC-CCCCccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNS  308 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~-~~~~~~~  308 (396)
                      |||+..-|.++-.....++...++.|++|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.+. .+.....
T Consensus        81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD  160 (396)
T KOG0593|consen   81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD  160 (396)
T ss_pred             eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence            999997776666666789999999999999999999999999999999999999999999999999999987 5555667


Q ss_pred             cccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------CCCC
Q 016037          309 MCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-------------------KIKL  368 (396)
Q Consensus       309 ~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~-------------------~~~~  368 (396)
                      ++.|.+|+|||.+.+ ..|+..+||||+||++.||++|++.|.+.+.-+....|.+.                   .+.+
T Consensus       161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l  240 (396)
T KOG0593|consen  161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL  240 (396)
T ss_pred             hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence            789999999999988 78999999999999999999999999998766555555421                   0122


Q ss_pred             C------------ccCCHHHHHHHHHhhccCCCCCCCCCC
Q 016037          369 P------------AFLSSEAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       369 p------------~~~s~~~~~li~~~l~~~p~~RPs~s~  396 (396)
                      |            +.++.-+-+|++.||..||.+|++-+|
T Consensus       241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~q  280 (396)
T KOG0593|consen  241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQ  280 (396)
T ss_pred             CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHH
Confidence            2            246788999999999999999998553

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1e-48  Score=379.64  Aligned_cols=238  Identities=41%  Similarity=0.747  Sum_probs=219.1

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCCC
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg  235 (396)
                      +.||+|+||.||+|+++.+|+.||+|++++...........+.+|+.+++.++||||+++++++.....+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999998765444455566778999999999999999999999999999999999999


Q ss_pred             cHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC-CCCCccccccCCC
Q 016037          236 HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLE  314 (396)
Q Consensus       236 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~-~~~~~~~~~gt~~  314 (396)
                      +|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ........+||+.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~  160 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE  160 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence            999999988999999999999999999999999999999999999999999999999999997642 2233455689999


Q ss_pred             ccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCCCC
Q 016037          315 YMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPL  393 (396)
Q Consensus       315 y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs  393 (396)
                      |||||++.+..++.++|||||||++|||++|+.||.+.+...+...+..+...+|..++.++.+||++||+.||.+||+
T Consensus       161 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~  239 (323)
T cd05571         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG  239 (323)
T ss_pred             ccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence            9999999999999999999999999999999999999999999999998999999999999999999999999999994

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.6e-48  Score=377.44  Aligned_cols=246  Identities=40%  Similarity=0.686  Sum_probs=225.8

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCCC-cEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTS-EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~  223 (396)
                      ..+..++|++.+.||+|+||.||+|.++.++ ..||+|++.+.........+.+.+|+.+++.++||||+++++++.+..
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            4466789999999999999999999987665 689999998765444555667888999999999999999999999999


Q ss_pred             eEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      .+|+||||+.+|+|..++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||+++.....
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999999876432


Q ss_pred             CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHh
Q 016037          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV  383 (396)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~  383 (396)
                        ....+||+.|||||++.+..++.++|||||||++|||++|..||.+.+...+.+++......+|..++.++++||++|
T Consensus       185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~  262 (340)
T PTZ00426        185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKL  262 (340)
T ss_pred             --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence              345689999999999999889999999999999999999999999999999999999998899999999999999999


Q ss_pred             hccCCCCCC
Q 016037          384 NSLLSISVP  392 (396)
Q Consensus       384 l~~~p~~RP  392 (396)
                      |+.+|.+|+
T Consensus       263 l~~dp~~R~  271 (340)
T PTZ00426        263 LSHDLTKRY  271 (340)
T ss_pred             cccCHHHcC
Confidence            999999996

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-47  Score=365.92  Aligned_cols=250  Identities=30%  Similarity=0.471  Sum_probs=221.7

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCe
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~  224 (396)
                      .....++|++..+||.|..++||+|+...+++.||||++..+.-  ....+.+++|+..|+.++||||++++.+|..+..
T Consensus        21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc--~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~   98 (516)
T KOG0582|consen   21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC--NNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE   98 (516)
T ss_pred             CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh--hhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence            34567899999999999999999999999999999999988763  3347889999999999999999999999999999


Q ss_pred             EEEEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      +|+||.||.+|++++++...  ..+.|..+..+++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+-.+.+
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            99999999999999998765  4589999999999999999999999999999999999999999999999998766533


Q ss_pred             CC-C---c-cccccCCCccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------
Q 016037          303 NT-R---S-NSMCGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP------  369 (396)
Q Consensus       303 ~~-~---~-~~~~gt~~y~APE~l~~--~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p------  369 (396)
                      .. +   . ..++||++|||||++..  .+|+.|+||||||++..||++|..||...-++++...-.++.++.+      
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~  258 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD  258 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence            22 1   1 56789999999999643  6799999999999999999999999999988887777777766532      


Q ss_pred             ----ccCCHHHHHHHHHhhccCCCCCCCCCC
Q 016037          370 ----AFLSSEAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       370 ----~~~s~~~~~li~~~l~~~p~~RPs~s~  396 (396)
                          ..++..++++|..||.+||.+|||+++
T Consensus       259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAsk  289 (516)
T KOG0582|consen  259 KDEDKKFSKSFREMIALCLVKDPSKRPTASK  289 (516)
T ss_pred             hHHhhhhcHHHHHHHHHHhhcCcccCCCHHH
Confidence                247889999999999999999999874

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-48  Score=372.57  Aligned_cols=237  Identities=45%  Similarity=0.813  Sum_probs=218.5

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCCCcH
Q 016037          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL  237 (396)
Q Consensus       158 IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L  237 (396)
                      ||+|+||.||+|++..+++.||+|++++...........+.+|+.++++++||||+++++++.....+|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            79999999999999999999999999876544455566678899999999999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC-CCCccccccCCCcc
Q 016037          238 FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNSMCGTLEYM  316 (396)
Q Consensus       238 ~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~-~~~~~~~~gt~~y~  316 (396)
                      ..++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.... .......+||+.|+
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~  160 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL  160 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence            99999888999999999999999999999999999999999999999999999999999986432 23344567999999


Q ss_pred             chhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCCCCC
Q 016037          317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       317 APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs~  394 (396)
                      |||++.+..++.++|||||||++|||++|+.||.+.+..++.+.+....+.+|..+++++++||++||+.+|.+||++
T Consensus       161 aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~  238 (312)
T cd05585         161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGY  238 (312)
T ss_pred             CHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCC
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999999975

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.6e-47  Score=364.45  Aligned_cols=244  Identities=33%  Similarity=0.591  Sum_probs=215.1

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      .|++.+.||+|+||+||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+++++++.+...+++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            38899999999999999999999999999999987654444444567789999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccc
Q 016037          231 FVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (396)
Q Consensus       231 ~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~  308 (396)
                      |+++|+|...+...  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG  160 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence            99999998777543  3689999999999999999999999999999999999999999999999999987655444456


Q ss_pred             cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCCCccCCHHHHHHHHHhh
Q 016037          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR----QKIQQKIIKDKIKLPAFLSSEAHSLLKGVN  384 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~----~~i~~~i~~~~~~~p~~~s~~~~~li~~~l  384 (396)
                      ..||..|||||++.+..++.++|||||||++|||++|+.||.+.+.    ..+...+......++..++.++.+||++||
T Consensus       161 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l  240 (285)
T cd05631         161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL  240 (285)
T ss_pred             CCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHh
Confidence            6799999999999999999999999999999999999999987653    334444445566778889999999999999


Q ss_pred             ccCCCCCCCC
Q 016037          385 SLLSISVPLL  394 (396)
Q Consensus       385 ~~~p~~RPs~  394 (396)
                      +.+|.+||+.
T Consensus       241 ~~~P~~R~~~  250 (285)
T cd05631         241 TKNPKERLGC  250 (285)
T ss_pred             hcCHHHhcCC
Confidence            9999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-49  Score=384.94  Aligned_cols=242  Identities=33%  Similarity=0.511  Sum_probs=223.0

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ..|....+||+|+.|.||.++...+++.||||.+....   +...+.+.+|+.+|+.++|+|||.+++.|..++.+|+||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~---Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM  349 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK---QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM  349 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc---CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence            46888899999999999999999999999999998765   344566889999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Cccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNS  308 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~~~  308 (396)
                      |||+||+|.+.+.. ..++|.++..++++++.||+|||.+||||||||.+|||++.+|.+||+|||++..+.... ...+
T Consensus       350 Eym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T  428 (550)
T KOG0578|consen  350 EYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST  428 (550)
T ss_pred             eecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence            99999998776655 458999999999999999999999999999999999999999999999999999886554 6678


Q ss_pred             cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCCccCCHHHHHHHHHhhc
Q 016037          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGVNS  385 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~---~~~~p~~~s~~~~~li~~~l~  385 (396)
                      .+|||+|||||++..+.|++++||||||++++||+-|++||...++-..+..|..+   ++..|..+|+++++|+.+||+
T Consensus       429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~  508 (550)
T KOG0578|consen  429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLV  508 (550)
T ss_pred             ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhh
Confidence            89999999999999999999999999999999999999999998888888888876   556788999999999999999


Q ss_pred             cCCCCCCCCC
Q 016037          386 LLSISVPLLS  395 (396)
Q Consensus       386 ~~p~~RPs~s  395 (396)
                      .|+.+|||+.
T Consensus       509 ~dv~~RasA~  518 (550)
T KOG0578|consen  509 VDVEQRASAK  518 (550)
T ss_pred             cchhcCCCHH
Confidence            9999999975

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2e-47  Score=370.49  Aligned_cols=244  Identities=38%  Similarity=0.730  Sum_probs=222.3

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCeEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      +|++++.||+|+||+||+|++..+++.||+|++++.........+....|..++..+ +|++|+++++++.....+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            589999999999999999999999999999999876544444455566788888777 5899999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC-CCCCccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNS  308 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~-~~~~~~~  308 (396)
                      ||+++|+|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~  160 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT  160 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence            999999999999888899999999999999999999999999999999999999999999999999997643 2233445


Q ss_pred             cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCC
Q 016037          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLS  388 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p  388 (396)
                      .+||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+...+.+.+......+|..++.++.+||++||+.+|
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p  240 (323)
T cd05616         161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP  240 (323)
T ss_pred             CCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccCH
Confidence            67999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCC
Q 016037          389 ISVPLL  394 (396)
Q Consensus       389 ~~RPs~  394 (396)
                      .+|++.
T Consensus       241 ~~R~~~  246 (323)
T cd05616         241 GKRLGC  246 (323)
T ss_pred             HhcCCC
Confidence            999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.7e-47  Score=369.71  Aligned_cols=244  Identities=40%  Similarity=0.743  Sum_probs=222.3

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCC-CeeeeeEEEEecCeEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP-FIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~Hp-nIv~l~~~~~~~~~~~lV~  229 (396)
                      +|++++.||+|+||.||+|.+..+++.||+|++++.........+.+..|+.+++.++|+ +|+++++++.....+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            589999999999999999999999999999999876544445566677899999999764 6888999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC-CCCCccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNS  308 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~-~~~~~~~  308 (396)
                      ||+++|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT  160 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence            999999999999888889999999999999999999999999999999999999999999999999987532 2233345


Q ss_pred             cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCC
Q 016037          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLS  388 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p  388 (396)
                      .+||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+..++.+.+......+|..++.++.+||++||+.+|
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P  240 (324)
T cd05587         161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHP  240 (324)
T ss_pred             ecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence            67999999999999998999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCC
Q 016037          389 ISVPLL  394 (396)
Q Consensus       389 ~~RPs~  394 (396)
                      .+|++.
T Consensus       241 ~~R~~~  246 (324)
T cd05587         241 AKRLGC  246 (324)
T ss_pred             HHcCCC
Confidence            999975

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.4e-47  Score=371.84  Aligned_cols=238  Identities=40%  Similarity=0.742  Sum_probs=217.9

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCCC
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg  235 (396)
                      +.||+|+||.||+++++.+|..||+|++++...........+.+|+.+++.++||||++++++|.....+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999999999999999998765444455566778999999999999999999999999999999999999


Q ss_pred             cHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC-CCCccccccCCC
Q 016037          236 HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNSMCGTLE  314 (396)
Q Consensus       236 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~-~~~~~~~~gt~~  314 (396)
                      +|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......+||+.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~  160 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE  160 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence            9999998888999999999999999999999999999999999999999999999999999876422 223345679999


Q ss_pred             ccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCCCC
Q 016037          315 YMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPL  393 (396)
Q Consensus       315 y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs  393 (396)
                      |+|||++.+..++.++|||||||++|||++|+.||.+.+.......+......+|..+++++++||++||+.+|.+||+
T Consensus       161 y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~  239 (323)
T cd05595         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG  239 (323)
T ss_pred             cCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCC
Confidence            9999999998999999999999999999999999999999999999998889999999999999999999999999984

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-49  Score=370.32  Aligned_cols=247  Identities=39%  Similarity=0.744  Sum_probs=235.2

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCe
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYR  224 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~  224 (396)
                      .+...+|..+.+||+|+||+|.++..+++.+.||||+++++.+.+.+..+.-..|.++|+.. +-|+++++..+|++-++
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            56778999999999999999999999999999999999999988888888888899999987 57899999999999999


Q ss_pred             EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccccc-CCC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DEN  303 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~-~~~  303 (396)
                      +|.||||+.||+|..++++-+.+.|..+..|+++|+-||-+||++|||+||||.+|||++.+|++||+|||+++.- -..
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~  504 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG  504 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCC
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999863 345


Q ss_pred             CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHh
Q 016037          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV  383 (396)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~  383 (396)
                      ..+.++||||.|+|||++....|+.++||||+||+||||+.|++||.+.+.+++++.|......+|..+|.++.++++++
T Consensus       505 ~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg~  584 (683)
T KOG0696|consen  505 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKGL  584 (683)
T ss_pred             cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHHH
Confidence            56788999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCC
Q 016037          384 NSLLSISVP  392 (396)
Q Consensus       384 l~~~p~~RP  392 (396)
                      |+++|.+|-
T Consensus       585 ltK~P~kRL  593 (683)
T KOG0696|consen  585 LTKHPGKRL  593 (683)
T ss_pred             hhcCCcccc
Confidence            999999984

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.7e-47  Score=372.11  Aligned_cols=238  Identities=42%  Similarity=0.747  Sum_probs=218.3

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCCC
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg  235 (396)
                      +.||+|+||.||+++++.+++.||+|++.+...........+.+|+++++.++||||+++++++.....+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999998765444555667788999999999999999999999999999999999999


Q ss_pred             cHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC-CCCccccccCCC
Q 016037          236 HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNSMCGTLE  314 (396)
Q Consensus       236 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~-~~~~~~~~gt~~  314 (396)
                      +|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......+||+.
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~  160 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE  160 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence            9999998888999999999999999999999999999999999999999999999999999976432 223345679999


Q ss_pred             ccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCCCC
Q 016037          315 YMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPL  393 (396)
Q Consensus       315 y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs  393 (396)
                      |+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+......+|..++.++.+||++||+.+|.+||+
T Consensus       161 y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~  239 (328)
T cd05593         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLG  239 (328)
T ss_pred             ccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCC
Confidence            9999999998999999999999999999999999999998888888888889999999999999999999999999984

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.7e-47  Score=375.58  Aligned_cols=244  Identities=38%  Similarity=0.722  Sum_probs=216.3

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++++.||+|+||+||+|+++.+++.||+|++++...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999998765555556677889999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-----
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-----  304 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-----  304 (396)
                      ||++||+|..++.+++.+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||+++.+....     
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~  160 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY  160 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence            999999999999988999999999999999999999999999999999999999999999999999997643211     


Q ss_pred             -------------------------------CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 016037          305 -------------------------------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN  353 (396)
Q Consensus       305 -------------------------------~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~  353 (396)
                                                     .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~  240 (363)
T cd05628         161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (363)
T ss_pred             ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence                                           0124589999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhC--CCCCCc--cCCHHHHHHHHHhhccCCCCC---CCC
Q 016037          354 RQKIQQKIIKD--KIKLPA--FLSSEAHSLLKGVNSLLSISV---PLL  394 (396)
Q Consensus       354 ~~~i~~~i~~~--~~~~p~--~~s~~~~~li~~~l~~~p~~R---Ps~  394 (396)
                      ..+...++...  .+.+|.  .+++++++||.+|+. +|.+|   |++
T Consensus       241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~  287 (363)
T cd05628         241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGV  287 (363)
T ss_pred             HHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCH
Confidence            88888888864  455664  479999999999875 55544   654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3e-47  Score=368.97  Aligned_cols=239  Identities=39%  Similarity=0.715  Sum_probs=218.1

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCeEEEEEEecCC
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (396)
                      +.||+|+||+||+|+++.+++.||+|++++.........+.+..|..+++.+ +||||+++++++.....+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999999876544445556667788888876 799999999999999999999999999


Q ss_pred             CcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC-CCCCccccccCC
Q 016037          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTL  313 (396)
Q Consensus       235 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~-~~~~~~~~~gt~  313 (396)
                      |+|..++.+.+.+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++... ........+||+
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP  160 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence            9999999888899999999999999999999999999999999999999999999999999987643 223345567999


Q ss_pred             CccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCCCC
Q 016037          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPL  393 (396)
Q Consensus       314 ~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs  393 (396)
                      .|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+....+.+|..++.++.+||++||+.||.+||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~  240 (320)
T cd05590         161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLG  240 (320)
T ss_pred             cccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCCC
Confidence            99999999998899999999999999999999999999999999999999999999999999999999999999999998


Q ss_pred             C
Q 016037          394 L  394 (396)
Q Consensus       394 ~  394 (396)
                      .
T Consensus       241 ~  241 (320)
T cd05590         241 S  241 (320)
T ss_pred             C
Confidence            6

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.6e-47  Score=368.09  Aligned_cols=242  Identities=35%  Similarity=0.666  Sum_probs=217.4

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHH---HhCCCCCeeeeeEEEEecCeEEEE
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL---TKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L---~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      |++++.||+|+||.||+|.+..+++.||+|++++.........+.+..|++++   +.++||||+++++++.....+|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            68899999999999999999999999999999876544444556677777665   456899999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC-CCCcc
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSN  307 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~-~~~~~  307 (396)
                      |||+++++|...+.. +.+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.... .....
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS  159 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence            999999999877754 5789999999999999999999999999999999999999999999999999875432 23345


Q ss_pred             ccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccC
Q 016037          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLL  387 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~  387 (396)
                      ..+|++.|||||.+.+..++.++|||||||++|||++|+.||.+.+..++...+......+|..++.++.+||++||+.+
T Consensus       160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~d  239 (324)
T cd05589         160 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRN  239 (324)
T ss_pred             ccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcC
Confidence            56899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 016037          388 SISVPLL  394 (396)
Q Consensus       388 p~~RPs~  394 (396)
                      |.+||+.
T Consensus       240 P~~R~~~  246 (324)
T cd05589         240 PERRLGS  246 (324)
T ss_pred             HhHcCCC
Confidence            9999964

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.5e-47  Score=367.17  Aligned_cols=239  Identities=38%  Similarity=0.751  Sum_probs=215.9

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHh-CCCCCeeeeeEEEEecCeEEEEEEecCC
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (396)
                      ++||+|+||+||+|++..+++.||+|++++.........+....|..++.. .+||||+++++++.....+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999999999999999987654444445555667777765 4899999999999999999999999999


Q ss_pred             CcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC-CCCccccccCC
Q 016037          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNSMCGTL  313 (396)
Q Consensus       235 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~-~~~~~~~~gt~  313 (396)
                      |+|..++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.... .......+||+
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~  160 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence            99999998888999999999999999999999999999999999999999999999999999986532 23345568999


Q ss_pred             CccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCCCC
Q 016037          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPL  393 (396)
Q Consensus       314 ~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs  393 (396)
                      .|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+......+|..++.++.+||++||+.+|.+||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~  240 (316)
T cd05592         161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLG  240 (316)
T ss_pred             cccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence            99999999998899999999999999999999999999999999999988888899999999999999999999999998


Q ss_pred             C
Q 016037          394 L  394 (396)
Q Consensus       394 ~  394 (396)
                      .
T Consensus       241 ~  241 (316)
T cd05592         241 V  241 (316)
T ss_pred             C
Confidence            6

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-49  Score=378.79  Aligned_cols=244  Identities=26%  Similarity=0.450  Sum_probs=225.5

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ..|..++.||+|+||.||+|.+..+++.||+|++..+.  .+...+.++.|+.+|.+++++||.++|++|..+..++++|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            35888899999999999999999999999999998865  3456778899999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Cccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNS  308 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~~~  308 (396)
                      |||.||++...++..+.+.|..+..++.+++.||.|||+++.+|||||+.|||+..+|.+||+|||.+..+.... +..+
T Consensus        91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t  170 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT  170 (467)
T ss_pred             HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence            999999999999988888999998999999999999999999999999999999999999999999998876543 3488


Q ss_pred             cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCccCCHHHHHHHHHhhccC
Q 016037          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-LPAFLSSEAHSLLKGVNSLL  387 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~-~p~~~s~~~~~li~~~l~~~  387 (396)
                      ++||+.|||||++.+..|+.|+||||||++.+||++|.+||....++.+...|-+..++ +-..+|+.+++||..||++|
T Consensus       171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~  250 (467)
T KOG0201|consen  171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKN  250 (467)
T ss_pred             ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhcC
Confidence            99999999999999999999999999999999999999999999999988888887554 44579999999999999999


Q ss_pred             CCCCCCCC
Q 016037          388 SISVPLLS  395 (396)
Q Consensus       388 p~~RPs~s  395 (396)
                      |+.|||++
T Consensus       251 P~~RpsA~  258 (467)
T KOG0201|consen  251 PEFRPSAK  258 (467)
T ss_pred             cccCcCHH
Confidence            99999975

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=7.1e-47  Score=366.35  Aligned_cols=238  Identities=40%  Similarity=0.747  Sum_probs=217.4

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCeEEEEEEecCC
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (396)
                      +.||+|+||+||+|+++.+++.||+|++++.........+.+..|..+++.+ +||||++++++|.....+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4699999999999999999999999999876554455556677788888866 799999999999999999999999999


Q ss_pred             CcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC-CCCCccccccCC
Q 016037          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTL  313 (396)
Q Consensus       235 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~-~~~~~~~~~gt~  313 (396)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........+||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP  160 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence            9999999888899999999999999999999999999999999999999999999999999997643 223344567999


Q ss_pred             CccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCCCC
Q 016037          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPL  393 (396)
Q Consensus       314 ~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs  393 (396)
                      .|+|||++.+..++.++|||||||++|||++|+.||.+.+.....+.+......+|..++.++.+||++||+.+|.+||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~  240 (321)
T cd05591         161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLG  240 (321)
T ss_pred             cccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCC
Confidence            99999999998999999999999999999999999999999999999999999999999999999999999999999994

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-48  Score=374.94  Aligned_cols=247  Identities=29%  Similarity=0.479  Sum_probs=215.5

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEEEecC-e
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKY-R  224 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~-~  224 (396)
                      +..++|.++++||.|.||.||+|+.+.+++.||||.+++.-.. .+..- -.+|+..|++++ ||||++|.+.+.+.. .
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~-nLREvksL~kln~hpniikL~Evi~d~~~~   84 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECM-NLREVKSLRKLNPHPNIIKLKEVIRDNDRI   84 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHH-HHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence            3457899999999999999999999999999999999875432 22222 256999999998 999999999998877 9


Q ss_pred             EEEEEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          225 LYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      +|+|||||+. .|+++++. ++.|++..++.|+.||+.||+|+|.+|+.|||+||||||+.....+||+|||+|+.+...
T Consensus        85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC
Confidence            9999999988 67777764 467999999999999999999999999999999999999998999999999999999888


Q ss_pred             CCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------------
Q 016037          304 TRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD------------------  364 (396)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~------------------  364 (396)
                      .....++-|.+|+|||++.. ..|+.+.|||++||+++|+++-++.|.|.++.+.+.+|..-                  
T Consensus       164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~  243 (538)
T KOG0661|consen  164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA  243 (538)
T ss_pred             CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence            87888899999999999865 56899999999999999999999999998887777776521                  


Q ss_pred             -CCCCC-----------ccCCHHHHHHHHHhhccCCCCCCCCCC
Q 016037          365 -KIKLP-----------AFLSSEAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       365 -~~~~p-----------~~~s~~~~~li~~~l~~~p~~RPs~s~  396 (396)
                       .+.+|           +.+++++.+||..||.+||.+||+++|
T Consensus       244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~  287 (538)
T KOG0661|consen  244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQ  287 (538)
T ss_pred             hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHH
Confidence             22233           247999999999999999999999864

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-47  Score=368.38  Aligned_cols=244  Identities=40%  Similarity=0.681  Sum_probs=219.5

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++++.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.....+|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999998765444455667788999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCcccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM  309 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~  309 (396)
                      ||+++|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  .....
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~  158 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSV  158 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCCc
Confidence            9999999999999888999999999999999999999999999999999999999999999999999987644  34456


Q ss_pred             ccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCc------cCCHHHHHHHH
Q 016037          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK--IKLPA------FLSSEAHSLLK  381 (396)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~--~~~p~------~~s~~~~~li~  381 (396)
                      +||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+....  +..|.      .++.++.+||+
T Consensus       159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~  238 (333)
T cd05600         159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLIT  238 (333)
T ss_pred             ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHH
Confidence            79999999999999999999999999999999999999999988888877776542  22232      46999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      +||+.+|.+||++.
T Consensus       239 ~~l~~~~~rr~s~~  252 (333)
T cd05600         239 KLINDPSRRFGSLE  252 (333)
T ss_pred             HHhhChhhhcCCHH
Confidence            99999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=9.6e-47  Score=374.13  Aligned_cols=245  Identities=41%  Similarity=0.728  Sum_probs=215.0

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      .|++++.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            68999999999999999999999999999999987665555667778999999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC------
Q 016037          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT------  304 (396)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~------  304 (396)
                      |+++|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.+....      
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~  161 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ  161 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence            99999999999988899999999999999999999999999999999999999999999999999976431100      


Q ss_pred             ------------------------------------------CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHH
Q 016037          305 ------------------------------------------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEM  342 (396)
Q Consensus       305 ------------------------------------------~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~el  342 (396)
                                                                .....+||+.|||||++.+..++.++|||||||++|||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el  241 (381)
T cd05626         162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM  241 (381)
T ss_pred             ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence                                                      11245799999999999998899999999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHHhC--CCCCCc--cCCHHHHHHHHHhhc--cCCCCCCCCC
Q 016037          343 LTGQPPFTGGNRQKIQQKIIKD--KIKLPA--FLSSEAHSLLKGVNS--LLSISVPLLS  395 (396)
Q Consensus       343 ltg~~Pf~~~~~~~i~~~i~~~--~~~~p~--~~s~~~~~li~~~l~--~~p~~RPs~s  395 (396)
                      ++|+.||...+..+...++...  .+.+|.  .+++++.+||++|+.  .++..||++.
T Consensus       242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~  300 (381)
T cd05626         242 LVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD  300 (381)
T ss_pred             HhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence            9999999998877777777643  445554  689999999999664  4555698864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-47  Score=372.02  Aligned_cols=243  Identities=41%  Similarity=0.768  Sum_probs=217.5

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+|+.++||||++++++|.++..+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47999999999999999999999999999999998765545556677888999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-----
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-----  304 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-----  304 (396)
                      ||+.+|+|..++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+....     
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY  160 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence            999999999999988899999999999999999999999999999999999999999999999999987643211     


Q ss_pred             ----------------------------------CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 016037          305 ----------------------------------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFT  350 (396)
Q Consensus       305 ----------------------------------~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~  350 (396)
                                                        .....+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~  240 (364)
T cd05599         161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC  240 (364)
T ss_pred             ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence                                              1123579999999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHHHhCC--CCCCc--cCCHHHHHHHHHhhccCCCCCCC
Q 016037          351 GGNRQKIQQKIIKDK--IKLPA--FLSSEAHSLLKGVNSLLSISVPL  393 (396)
Q Consensus       351 ~~~~~~i~~~i~~~~--~~~p~--~~s~~~~~li~~~l~~~p~~RPs  393 (396)
                      +.+..+...++...+  +.+|.  .+++++++||++||. +|.+|++
T Consensus       241 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~  286 (364)
T cd05599         241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLG  286 (364)
T ss_pred             CCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCC
Confidence            998888888887643  34444  579999999999997 9999997

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8.9e-47  Score=367.09  Aligned_cols=239  Identities=39%  Similarity=0.733  Sum_probs=214.3

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCeEEEEEEecCC
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (396)
                      +.||+|+||+||+|+++.+++.||+|++++.........+.+..|+.+++.+ +||||++++++|.....+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999999999999999999876555555667788899999988 799999999999999999999999999


Q ss_pred             CcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccccc-CCCCCccccccCC
Q 016037          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTL  313 (396)
Q Consensus       235 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~-~~~~~~~~~~gt~  313 (396)
                      |+|..++.+.+.+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.. .........+||+
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence            999999988889999999999999999999999999999999999999999999999999999753 2233445578999


Q ss_pred             CccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC---------CCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhh
Q 016037          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG---------GNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVN  384 (396)
Q Consensus       314 ~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~---------~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l  384 (396)
                      .|+|||++.+..++.++|||||||++|||++|+.||..         .....+.+.+....+.+|..++.++.+||++||
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L  240 (329)
T cd05588         161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFL  240 (329)
T ss_pred             cccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence            99999999999999999999999999999999999963         123446677777788999999999999999999


Q ss_pred             ccCCCCCCCC
Q 016037          385 SLLSISVPLL  394 (396)
Q Consensus       385 ~~~p~~RPs~  394 (396)
                      +.+|.+||+.
T Consensus       241 ~~dP~~R~~~  250 (329)
T cd05588         241 NKDPKERLGC  250 (329)
T ss_pred             ccCHHHcCCC
Confidence            9999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.2e-47  Score=368.58  Aligned_cols=238  Identities=41%  Similarity=0.746  Sum_probs=217.6

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCCC
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg  235 (396)
                      +.||+|+||+||++.+..+++.||+|++.+...........+..|+++++.++||||+++++++.....+|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999998765444455566778999999999999999999999999999999999999


Q ss_pred             cHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcEEEEecccccccC-CCCCccccccCC
Q 016037          236 HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTL  313 (396)
Q Consensus       236 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~-~~~~~~~~~gt~  313 (396)
                      +|..++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++... ........+||+
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP  160 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence            999999888899999999999999999999998 799999999999999999999999999997643 223334567999


Q ss_pred             CccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCCCC
Q 016037          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPL  393 (396)
Q Consensus       314 ~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs  393 (396)
                      .|||||++.+..++.++|||||||++|||++|+.||.+.+...+...+....+.+|..+++++.+||++||+.||.+|++
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~  240 (325)
T cd05594         161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLG  240 (325)
T ss_pred             ccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCC
Confidence            99999999998999999999999999999999999999999999999988899999999999999999999999999973

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.2e-46  Score=364.14  Aligned_cols=239  Identities=36%  Similarity=0.689  Sum_probs=215.3

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHh-CCCCCeeeeeEEEEecCeEEEEEEecCC
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (396)
                      +.||+|+||.||+|+++.+++.||+|++++.........+....|..++.. ++||||+++++++.+...+|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            469999999999999999999999999987543333444556667878775 4899999999999999999999999999


Q ss_pred             CcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC-CCCccccccCC
Q 016037          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNSMCGTL  313 (396)
Q Consensus       235 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~-~~~~~~~~gt~  313 (396)
                      |+|..++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... .......+||+
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence            99999998888899999999999999999999999999999999999999999999999999875322 22334567999


Q ss_pred             CccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCCCC
Q 016037          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPL  393 (396)
Q Consensus       314 ~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs  393 (396)
                      .|+|||++.+..++.++|||||||++|||++|+.||.+.+..++.+.+......+|..++.++++||++||+.||.+||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~  240 (316)
T cd05620         161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRLG  240 (316)
T ss_pred             CccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence            99999999999999999999999999999999999999999999999988888899999999999999999999999998


Q ss_pred             C
Q 016037          394 L  394 (396)
Q Consensus       394 ~  394 (396)
                      +
T Consensus       241 ~  241 (316)
T cd05620         241 V  241 (316)
T ss_pred             C
Confidence            6

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-47  Score=373.62  Aligned_cols=242  Identities=40%  Similarity=0.745  Sum_probs=214.8

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++++.||+|+||+||+|.++.+++.||||++.+.........+.+.+|+++++.++||||++++++|.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47999999999999999999999999999999998765545556677889999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-----
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-----  304 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-----  304 (396)
                      ||+++|+|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++++||+|||+++.+....     
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  160 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY  160 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            999999999999988899999999999999999999999999999999999999999999999999996432100     


Q ss_pred             -------------------------------------------CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHH
Q 016037          305 -------------------------------------------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFE  341 (396)
Q Consensus       305 -------------------------------------------~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~e  341 (396)
                                                                 .....+||+.|+|||++.+..++.++|||||||++||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (377)
T cd05629         161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE  240 (377)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence                                                       0013579999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHHhC--CCCCCc--cCCHHHHHHHHHhhccCCCCCC
Q 016037          342 MLTGQPPFTGGNRQKIQQKIIKD--KIKLPA--FLSSEAHSLLKGVNSLLSISVP  392 (396)
Q Consensus       342 lltg~~Pf~~~~~~~i~~~i~~~--~~~~p~--~~s~~~~~li~~~l~~~p~~RP  392 (396)
                      |++|+.||.+.+..+...++...  .+.+|.  .++.++++||++||+ +|.+|+
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~  294 (377)
T cd05629         241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRL  294 (377)
T ss_pred             hhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcC
Confidence            99999999998888888877753  455665  589999999999997 787765

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.6e-46  Score=362.94  Aligned_cols=244  Identities=39%  Similarity=0.745  Sum_probs=221.4

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEEEecCeEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      +|+..+.||+|+||+||+|+++.+++.||+|++.+.........+.+..|..+++.+. |++|+++++++.+...+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4788999999999999999999999999999998765444455566777888988886 578888999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-CCccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNS  308 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-~~~~~  308 (396)
                      ||+++|+|..++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~  160 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT  160 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence            99999999999988889999999999999999999999999999999999999999999999999999764322 23345


Q ss_pred             cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCC
Q 016037          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLS  388 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p  388 (396)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+.+.+......+|..++.++.+|+++||+.+|
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~p  240 (323)
T cd05615         161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHP  240 (323)
T ss_pred             ccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCH
Confidence            67999999999999988999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCC
Q 016037          389 ISVPLL  394 (396)
Q Consensus       389 ~~RPs~  394 (396)
                      .+|++.
T Consensus       241 ~~R~~~  246 (323)
T cd05615         241 SKRLGC  246 (323)
T ss_pred             hhCCCC
Confidence            999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=9.8e-47  Score=365.68  Aligned_cols=240  Identities=43%  Similarity=0.761  Sum_probs=214.8

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHH-HHHhCCCCCeeeeeEEEEecCeEEEEEEecCC
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN-ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~-~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (396)
                      +.||+|+||+||+|+++.+|+.||+|++.+...........+..|.. +++.++||||+++++.+.....+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999999999999999998754433333344444544 56789999999999999999999999999999


Q ss_pred             CcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC-CCCCccccccCC
Q 016037          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTL  313 (396)
Q Consensus       235 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~-~~~~~~~~~gt~  313 (396)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........+||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP  160 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence            9999999988899999999999999999999999999999999999999999999999999997643 233344567999


Q ss_pred             CccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCCCC
Q 016037          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPL  393 (396)
Q Consensus       314 ~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs  393 (396)
                      .|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+......++..++.++.+||++||+.+|.+||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~  240 (323)
T cd05575         161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLG  240 (323)
T ss_pred             hhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCC
Confidence            99999999999999999999999999999999999999999999999998888888999999999999999999999998


Q ss_pred             CC
Q 016037          394 LS  395 (396)
Q Consensus       394 ~s  395 (396)
                      ..
T Consensus       241 ~~  242 (323)
T cd05575         241 AK  242 (323)
T ss_pred             CC
Confidence            63

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-48  Score=368.30  Aligned_cols=248  Identities=39%  Similarity=0.660  Sum_probs=232.2

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCe
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~  224 (396)
                      +.+..+.|+.-++||+|+||.||-++-+.||+.||+|.+.+..+..+.......+|..+|.+++.++||.+-+.|++++.
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~  259 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA  259 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence            34566789999999999999999999999999999999988877766667778899999999999999999999999999


Q ss_pred             EEEEEEecCCCcHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      +|+|+..|+||+|..++.+.+  .|++..++.|+++|+.||++||..+||+|||||+|||+|++|+++|+|+|+|..+.+
T Consensus       260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999999999998877  799999999999999999999999999999999999999999999999999999988


Q ss_pred             CCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCCCCCccCCHHHHH
Q 016037          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKDKIKLPAFLSSEAHS  378 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~----~~~~i~~~i~~~~~~~p~~~s~~~~~  378 (396)
                      .......+||..|||||++++..|+...|||||||+||||+.|+.||...    ..+++.+.+..+...+|..+|+++++
T Consensus       340 g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaks  419 (591)
T KOG0986|consen  340 GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKS  419 (591)
T ss_pred             CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHH
Confidence            88877789999999999999999999999999999999999999999864    45678888888888999999999999


Q ss_pred             HHHHhhccCCCCCC
Q 016037          379 LLKGVNSLLSISVP  392 (396)
Q Consensus       379 li~~~l~~~p~~RP  392 (396)
                      |.+++|++||.+|-
T Consensus       420 lc~~LL~Kdp~~RL  433 (591)
T KOG0986|consen  420 LCEGLLTKDPEKRL  433 (591)
T ss_pred             HHHHHHccCHHHhc
Confidence            99999999999984

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.4e-48  Score=374.30  Aligned_cols=246  Identities=34%  Similarity=0.530  Sum_probs=230.6

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCe-EEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR-LYL  227 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~-~~l  227 (396)
                      .++|..++++|+|+||.++.++++..+..|++|.++.....+.... ....|+.+++++.|||||.+++.|..++. ++|
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~-~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I   81 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERR-SAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI   81 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhH-HHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence            4679999999999999999999999999999999998876665544 56779999999999999999999999888 999


Q ss_pred             EEEecCCCcHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-
Q 016037          228 VLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-  304 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-  304 (396)
                      ||+|++||++.+.+.+++  .++|+.+..|+.||+.|+.|||+++|+|||||+.|||++.++.|||+|||+|+...... 
T Consensus        82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~  161 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS  161 (426)
T ss_pred             EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence            999999999999887654  68999999999999999999999999999999999999999999999999999988776 


Q ss_pred             CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHh
Q 016037          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-IKLPAFLSSEAHSLLKGV  383 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~-~~~p~~~s~~~~~li~~~  383 (396)
                      ...+.+||+.||+||++.+..|+.|+|||||||++|||++-+.+|.+.+...+..+|.... .++|..+|.+++.||+.|
T Consensus       162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~  241 (426)
T KOG0589|consen  162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSM  241 (426)
T ss_pred             hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHH
Confidence            6788899999999999999999999999999999999999999999999999999999987 688999999999999999


Q ss_pred             hccCCCCCCCCC
Q 016037          384 NSLLSISVPLLS  395 (396)
Q Consensus       384 l~~~p~~RPs~s  395 (396)
                      |..+|..||+++
T Consensus       242 l~~~P~~RPsa~  253 (426)
T KOG0589|consen  242 LRKNPEHRPSAL  253 (426)
T ss_pred             hhcCCccCCCHH
Confidence            999999999975

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.8e-46  Score=363.17  Aligned_cols=239  Identities=42%  Similarity=0.769  Sum_probs=218.5

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCeEEEEEEecCC
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (396)
                      +.||+|+||+||+|+++.+++.||+|++++.........+.+..|+.+++.+ +||||+++++++.....+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999999876544455566677888999887 799999999999999999999999999


Q ss_pred             CcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC-CCCCccccccCC
Q 016037          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTL  313 (396)
Q Consensus       235 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~-~~~~~~~~~gt~  313 (396)
                      |+|..++.+.+.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++... ........+||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~  160 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP  160 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence            9999999888899999999999999999999999999999999999999999999999999997532 223344567999


Q ss_pred             CccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCCCC
Q 016037          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPL  393 (396)
Q Consensus       314 ~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs  393 (396)
                      .|+|||++.+..++.++|||||||++|+|++|+.||.+.+...+...+......+|..++.++.+||++||..+|.+||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s  240 (318)
T cd05570         161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLG  240 (318)
T ss_pred             cccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcCC
Confidence            99999999999999999999999999999999999999999999999998888999999999999999999999999999


Q ss_pred             C
Q 016037          394 L  394 (396)
Q Consensus       394 ~  394 (396)
                      +
T Consensus       241 ~  241 (318)
T cd05570         241 C  241 (318)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-47  Score=370.96  Aligned_cols=243  Identities=43%  Similarity=0.794  Sum_probs=220.7

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++.+.||+|+||+||+|++..+++.||+|++++...........+.+|+.+++.++||||+++++++.++..+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999999999999999998765545456677889999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-----
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-----  304 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-----  304 (396)
                      ||+++++|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......     
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY  160 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence            999999999999888899999999999999999999999999999999999999999999999999998765433     


Q ss_pred             -------------------------CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 016037          305 -------------------------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ  359 (396)
Q Consensus       305 -------------------------~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~  359 (396)
                                               ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~  240 (350)
T cd05573         161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN  240 (350)
T ss_pred             ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence                                     2344579999999999999999999999999999999999999999999888888


Q ss_pred             HHHh--CCCCCCc--cCCHHHHHHHHHhhccCCCCCCC
Q 016037          360 KIIK--DKIKLPA--FLSSEAHSLLKGVNSLLSISVPL  393 (396)
Q Consensus       360 ~i~~--~~~~~p~--~~s~~~~~li~~~l~~~p~~RPs  393 (396)
                      ++..  ..+.+|.  .+++++.+||+.||. +|.+||+
T Consensus       241 ~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~  277 (350)
T cd05573         241 KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLG  277 (350)
T ss_pred             HHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCC
Confidence            8887  4555554  459999999999998 9999998

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.7e-46  Score=363.53  Aligned_cols=239  Identities=43%  Similarity=0.745  Sum_probs=214.4

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHH-HHHHhCCCCCeeeeeEEEEecCeEEEEEEecCC
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER-NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~-~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (396)
                      +.||+|+||.||+|++..+++.||+|++.+...........+..|. .+++.++||||+++++++.+...+|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999999875543333344444454 467889999999999999999999999999999


Q ss_pred             CcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC-CCCCccccccCC
Q 016037          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTL  313 (396)
Q Consensus       235 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~-~~~~~~~~~gt~  313 (396)
                      ++|...+.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........+||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP  160 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence            9999988888889999999999999999999999999999999999999999999999999987642 233345567999


Q ss_pred             CccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCCCC
Q 016037          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPL  393 (396)
Q Consensus       314 ~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs  393 (396)
                      .|+|||++.+..++.++|||||||++|||++|+.||.+.+...+...+......+|...+.++.++|++||+.+|.+||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~  240 (321)
T cd05603         161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLG  240 (321)
T ss_pred             ccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCC
Confidence            99999999998899999999999999999999999999999999999998888999999999999999999999999997


Q ss_pred             C
Q 016037          394 L  394 (396)
Q Consensus       394 ~  394 (396)
                      .
T Consensus       241 ~  241 (321)
T cd05603         241 A  241 (321)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.4e-46  Score=361.06  Aligned_cols=240  Identities=37%  Similarity=0.701  Sum_probs=215.0

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHh-CCCCCeeeeeEEEEecCeEEEEEEecCC
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (396)
                      +.||+|+||+||+|++..+++.||+|++++.........+....|..+++. ++||||+++++++.+...+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            469999999999999999999999999987543333344555667777776 5999999999999999999999999999


Q ss_pred             CcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC-CCCccccccCC
Q 016037          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNSMCGTL  313 (396)
Q Consensus       235 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~-~~~~~~~~gt~  313 (396)
                      |+|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.... .......+||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence            99999998888899999999999999999999999999999999999999999999999999975422 22334567999


Q ss_pred             CccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCCCC
Q 016037          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPL  393 (396)
Q Consensus       314 ~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs  393 (396)
                      .|+|||++.+..++.++|||||||++|||++|+.||.+.+..++.+.+......+|..++.++++||.+||+.+|.+||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~  240 (316)
T cd05619         161 DYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLG  240 (316)
T ss_pred             cccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcCC
Confidence            99999999998999999999999999999999999999999998988888888889999999999999999999999998


Q ss_pred             CC
Q 016037          394 LS  395 (396)
Q Consensus       394 ~s  395 (396)
                      +.
T Consensus       241 ~~  242 (316)
T cd05619         241 VK  242 (316)
T ss_pred             Ch
Confidence            74

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.3e-46  Score=363.41  Aligned_cols=240  Identities=42%  Similarity=0.749  Sum_probs=213.7

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHH-HHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCC
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE-RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E-~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (396)
                      +.||+|+||+||+|+++.+++.||+|++.+...........+..| ..+++.++||||+++++++.....+|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            469999999999999999999999999987543333333333334 4457889999999999999999999999999999


Q ss_pred             CcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC-CCCCccccccCC
Q 016037          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTL  313 (396)
Q Consensus       235 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~-~~~~~~~~~gt~  313 (396)
                      |+|..++...+.+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........+||+
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  160 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP  160 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence            9999999888889999999999999999999999999999999999999999999999999997643 233345567999


Q ss_pred             CccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCCCC
Q 016037          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPL  393 (396)
Q Consensus       314 ~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs  393 (396)
                      .|||||++.+..++.++|||||||++|||++|+.||.+.+..+....+......++..++.++.+||+.||+.+|.+||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~  240 (325)
T cd05602         161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLG  240 (325)
T ss_pred             cccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCCC
Confidence            99999999999999999999999999999999999999999999999988888888899999999999999999999998


Q ss_pred             CC
Q 016037          394 LS  395 (396)
Q Consensus       394 ~s  395 (396)
                      ..
T Consensus       241 ~~  242 (325)
T cd05602         241 AK  242 (325)
T ss_pred             CC
Confidence            64

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-47  Score=361.43  Aligned_cols=244  Identities=30%  Similarity=0.564  Sum_probs=232.9

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      .+|++.+.||+|.||+|-+|+....|+.||||.|+++.+.++..+-.+++|+++|..|+||||+++|.+|+.++.+.|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            47999999999999999999999999999999999999998888889999999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCcccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM  309 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~  309 (396)
                      ||..+|.|++++.+++.++|..++.++.||+.|+.|+|.++++|||||.+|||+|.++++||+|||++..+.......++
T Consensus       133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTF  212 (668)
T KOG0611|consen  133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTF  212 (668)
T ss_pred             EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHHh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCC
Q 016037          310 CGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLS  388 (396)
Q Consensus       310 ~gt~~y~APE~l~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p  388 (396)
                      ||+|.|.+||++.|..| .+.+|-||||++||.|+.|..||.+.+-..+...|..+...-|. -+.++.-||.+||-.||
T Consensus       213 CGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-~PSdA~gLIRwmLmVNP  291 (668)
T KOG0611|consen  213 CGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-TPSDASGLIRWMLMVNP  291 (668)
T ss_pred             cCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-CCchHHHHHHHHHhcCc
Confidence            99999999999999888 58899999999999999999999999999999999998766553 46788999999999999


Q ss_pred             CCCCCC
Q 016037          389 ISVPLL  394 (396)
Q Consensus       389 ~~RPs~  394 (396)
                      ..|.++
T Consensus       292 ~RRATi  297 (668)
T KOG0611|consen  292 ERRATI  297 (668)
T ss_pred             ccchhH
Confidence            999875

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.5e-46  Score=371.12  Aligned_cols=242  Identities=43%  Similarity=0.753  Sum_probs=214.6

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      .|+++++||+|+||+||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||++++++|.+...+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            59999999999999999999999999999999987655455566778899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-------
Q 016037          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-------  303 (396)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-------  303 (396)
                      |+++|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++..+...       
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~  161 (382)
T cd05625          82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ  161 (382)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence            9999999999988888999999999999999999999999999999999999999999999999997533100       


Q ss_pred             -----------------------------------------CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHH
Q 016037          304 -----------------------------------------TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEM  342 (396)
Q Consensus       304 -----------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~el  342 (396)
                                                               ......+||+.|||||++.+..++.++|||||||+||||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el  241 (382)
T cd05625         162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  241 (382)
T ss_pred             cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence                                                     011235799999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHHhC--CCCCC--ccCCHHHHHHHHHhhccCCCCCCC
Q 016037          343 LTGQPPFTGGNRQKIQQKIIKD--KIKLP--AFLSSEAHSLLKGVNSLLSISVPL  393 (396)
Q Consensus       343 ltg~~Pf~~~~~~~i~~~i~~~--~~~~p--~~~s~~~~~li~~~l~~~p~~RPs  393 (396)
                      ++|+.||.+.+..+...++...  .+.+|  ..+++++.+||..|+ .+|.+|++
T Consensus       242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~  295 (382)
T cd05625         242 LVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLG  295 (382)
T ss_pred             HhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCC
Confidence            9999999998888777777753  34444  468999999999986 59999987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.3e-46  Score=363.23  Aligned_cols=238  Identities=52%  Similarity=0.905  Sum_probs=214.8

Q ss_pred             eEecccCceEEEEEEEc---CCCcEEEEEEeeccccch-hhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEe
Q 016037          156 KVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIME-KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~---~~~~~vAvK~i~~~~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (396)
                      +.||+|+||.||++++.   .+++.||+|++++..... ......+.+|+.+|+.++||||++++++|..+..+|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999999874   478899999998754322 23345567899999999999999999999999999999999


Q ss_pred             cCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC-CCCccccc
Q 016037          232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNSMC  310 (396)
Q Consensus       232 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~-~~~~~~~~  310 (396)
                      +.+++|..++.+.+.+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......+
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  161 (323)
T cd05584          82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC  161 (323)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccC
Confidence            99999999999888999999999999999999999999999999999999999999999999999975432 23344567


Q ss_pred             cCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCC
Q 016037          311 GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSIS  390 (396)
Q Consensus       311 gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~  390 (396)
                      ||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+......+|..++.++.+||+.||+.+|++
T Consensus       162 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  241 (323)
T cd05584         162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSS  241 (323)
T ss_pred             CCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCHhH
Confidence            99999999999998899999999999999999999999999999899999999999999999999999999999999999


Q ss_pred             CCC
Q 016037          391 VPL  393 (396)
Q Consensus       391 RPs  393 (396)
                      ||+
T Consensus       242 R~~  244 (323)
T cd05584         242 RLG  244 (323)
T ss_pred             cCC
Confidence            994

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-47  Score=367.62  Aligned_cols=245  Identities=31%  Similarity=0.491  Sum_probs=213.6

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec--CeEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--YRLY  226 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~--~~~~  226 (396)
                      .+.|+.+++||+|.||.||+|++..||+.||+|.++.+... ......+.+||.+|++|+||||++|.+...+.  ..+|
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            46799999999999999999999999999999999987643 34456678899999999999999999998876  7899


Q ss_pred             EEEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-
Q 016037          227 LVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-  304 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-  304 (396)
                      +|+|||+. +|.-++.. .-.|++.+++-|+.|++.||+|+|++||+|||||..|||||.+|.+||+|||||+.+.... 
T Consensus       195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~  273 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS  273 (560)
T ss_pred             EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence            99999998 44444443 3479999999999999999999999999999999999999999999999999999775443 


Q ss_pred             -CccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----------CCCCC---
Q 016037          305 -RSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD----------KIKLP---  369 (396)
Q Consensus       305 -~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~----------~~~~p---  369 (396)
                       ...+.+.|.+|+|||.+.| ..|+.++|+||.||||.||++|++.|.+.+..+.+.+|.+-          ...+|   
T Consensus       274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~  353 (560)
T KOG0600|consen  274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT  353 (560)
T ss_pred             cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence             3566788999999999988 56999999999999999999999999999988888888632          11233   


Q ss_pred             ----------------ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          370 ----------------AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       370 ----------------~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                      ..++..+.+|+..||..||.+|.|++
T Consensus       354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~  395 (560)
T KOG0600|consen  354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTAS  395 (560)
T ss_pred             ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHH
Confidence                            14789999999999999999999875

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.9e-46  Score=363.56  Aligned_cols=239  Identities=38%  Similarity=0.722  Sum_probs=213.3

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCeEEEEEEecCC
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (396)
                      +.||+|+||+||+|+++.+++.||+|++++.........+.+..|+.++.++ +||||+++++++.....+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999999999999999999876544455566678899888876 899999999999999999999999999


Q ss_pred             CcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC-CCCCccccccCC
Q 016037          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTL  313 (396)
Q Consensus       235 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~-~~~~~~~~~gt~  313 (396)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........+||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence            9999999888899999999999999999999999999999999999999999999999999997642 233345568999


Q ss_pred             CccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC---------CCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhh
Q 016037          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG---------GNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVN  384 (396)
Q Consensus       314 ~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~---------~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l  384 (396)
                      .|+|||++.+..++.++|||||||++|||++|+.||..         .....+.+.+......+|..++.++.+||++||
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L  240 (329)
T cd05618         161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFL  240 (329)
T ss_pred             cccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHh
Confidence            99999999999999999999999999999999999952         223456667777888999999999999999999


Q ss_pred             ccCCCCCCCC
Q 016037          385 SLLSISVPLL  394 (396)
Q Consensus       385 ~~~p~~RPs~  394 (396)
                      +.||.+||+.
T Consensus       241 ~~dP~~R~~~  250 (329)
T cd05618         241 NKDPKERLGC  250 (329)
T ss_pred             cCCHHHcCCC
Confidence            9999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.1e-46  Score=368.82  Aligned_cols=244  Identities=38%  Similarity=0.719  Sum_probs=218.0

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++++.||+|+||+||+|+++.+++.||+|++++...........+.+|+.++..++||||+++++.+.+...+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999998765555556677889999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-----
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-----  304 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-----  304 (396)
                      ||++||+|..++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||+++.+....     
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~  160 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY  160 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence            999999999999988899999999999999999999999999999999999999999999999999987543211     


Q ss_pred             -------------------------------CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 016037          305 -------------------------------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN  353 (396)
Q Consensus       305 -------------------------------~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~  353 (396)
                                                     .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~  240 (360)
T cd05627         161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (360)
T ss_pred             cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence                                           0124579999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhC--CCCCCc--cCCHHHHHHHHHhhccCCCCCCCC
Q 016037          354 RQKIQQKIIKD--KIKLPA--FLSSEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       354 ~~~i~~~i~~~--~~~~p~--~~s~~~~~li~~~l~~~p~~RPs~  394 (396)
                      ......++...  .+.+|.  .++.++++||.+|+. +|.+|++.
T Consensus       241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~  284 (360)
T cd05627         241 PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGS  284 (360)
T ss_pred             HHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCC
Confidence            88888888764  445554  379999999999874 99999863

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.4e-46  Score=363.24  Aligned_cols=240  Identities=43%  Similarity=0.719  Sum_probs=214.8

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHH-HHHhCCCCCeeeeeEEEEecCeEEEEEEecCC
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN-ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~-~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (396)
                      +.||+|+||+||+|+++.+|+.||+|++.+...........+..|.. +++.++||||+++++.+.....+|+||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999999999999998754433333344445554 57789999999999999999999999999999


Q ss_pred             CcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC-CCCCccccccCC
Q 016037          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTL  313 (396)
Q Consensus       235 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~-~~~~~~~~~gt~  313 (396)
                      |+|...+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........+||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP  160 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence            9999999888899999999999999999999999999999999999999999999999999997643 233345567999


Q ss_pred             CccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCCCC
Q 016037          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPL  393 (396)
Q Consensus       314 ~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs  393 (396)
                      .|||||++.+..++.++|||||||++|||++|+.||.+.+..++.+++......+++.++.++.++|+.||+.+|.+||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~  240 (325)
T cd05604         161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLG  240 (325)
T ss_pred             hhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcCC
Confidence            99999999999999999999999999999999999999999999999998888888899999999999999999999998


Q ss_pred             CC
Q 016037          394 LS  395 (396)
Q Consensus       394 ~s  395 (396)
                      ..
T Consensus       241 ~~  242 (325)
T cd05604         241 AK  242 (325)
T ss_pred             CC
Confidence            74

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.8e-46  Score=371.21  Aligned_cols=242  Identities=43%  Similarity=0.775  Sum_probs=213.3

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+|+.++||||+++++.|.++..+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            37999999999999999999999999999999998755444455667889999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC------
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------  303 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~------  303 (396)
                      ||+++|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++..+...      
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~  160 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence            99999999999998889999999999999999999999999999999999999999999999999998533100      


Q ss_pred             --------------------------------------CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhC
Q 016037          304 --------------------------------------TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTG  345 (396)
Q Consensus       304 --------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg  345 (396)
                                                            ......+||+.|||||++.+..++.++|||||||++|||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G  240 (376)
T cd05598         161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG  240 (376)
T ss_pred             ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence                                                  001235799999999999999999999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhC--CCCCC--ccCCHHHHHHHHHhhccCCCCCC
Q 016037          346 QPPFTGGNRQKIQQKIIKD--KIKLP--AFLSSEAHSLLKGVNSLLSISVP  392 (396)
Q Consensus       346 ~~Pf~~~~~~~i~~~i~~~--~~~~p--~~~s~~~~~li~~~l~~~p~~RP  392 (396)
                      +.||.+.+..+...++...  ...+|  ..++.++.+||..|+ .+|.+|+
T Consensus       241 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~  290 (376)
T cd05598         241 QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRL  290 (376)
T ss_pred             CCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcC
Confidence            9999998887777776654  23333  368999999999977 5999999

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6e-46  Score=360.99  Aligned_cols=239  Identities=39%  Similarity=0.739  Sum_probs=214.5

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCeEEEEEEecCC
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (396)
                      +.||+|+||+||+|.+..+++.||+|++++.........+.+..|+.++.++ +||||+++++++.....+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999999999999999999886655555667788899999888 699999999999999999999999999


Q ss_pred             CcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC-CCCCccccccCC
Q 016037          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTL  313 (396)
Q Consensus       235 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~-~~~~~~~~~gt~  313 (396)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........+||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP  160 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence            9999999888899999999999999999999999999999999999999999999999999997532 233345678999


Q ss_pred             CccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhcc
Q 016037          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG-------GNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSL  386 (396)
Q Consensus       314 ~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~-------~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~  386 (396)
                      .|+|||++.+..++.++|||||||++|||++|+.||..       .....+.+.+......+|..++..+.++|++||+.
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~  240 (327)
T cd05617         161 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNK  240 (327)
T ss_pred             ccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcc
Confidence            99999999999999999999999999999999999953       23345666777777889999999999999999999


Q ss_pred             CCCCCCCC
Q 016037          387 LSISVPLL  394 (396)
Q Consensus       387 ~p~~RPs~  394 (396)
                      ||.+||+.
T Consensus       241 dP~~R~~~  248 (327)
T cd05617         241 DPKERLGC  248 (327)
T ss_pred             CHHHcCCC
Confidence            99999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.5e-46  Score=363.53  Aligned_cols=239  Identities=48%  Similarity=0.853  Sum_probs=216.1

Q ss_pred             eEecccCceEEEEEEE---cCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEec
Q 016037          156 KVVGQGAFAKVYQVRR---IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFV  232 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~---~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~  232 (396)
                      +.||+|+||.||++++   ..+|+.||+|++.+..... ........|+.+|++++||||+++++++.....+|+||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            5799999999999886   3578999999998754322 23344677999999999999999999999999999999999


Q ss_pred             CCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-CCcccccc
Q 016037          233 NGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNSMCG  311 (396)
Q Consensus       233 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-~~~~~~~g  311 (396)
                      ++|+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ......+|
T Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  160 (318)
T cd05582          81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG  160 (318)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence            99999999988888999999999999999999999999999999999999999999999999999875443 33445689


Q ss_pred             CCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCC
Q 016037          312 TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISV  391 (396)
Q Consensus       312 t~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~R  391 (396)
                      |+.|+|||.+.+..++.++|||||||++|||++|+.||.+.+..+....+......+|..++.++.+||++||+.||.+|
T Consensus       161 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~R  240 (318)
T cd05582         161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPANR  240 (318)
T ss_pred             ChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhHc
Confidence            99999999999988999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCC
Q 016037          392 PLLS  395 (396)
Q Consensus       392 Ps~s  395 (396)
                      |+..
T Consensus       241 ~~a~  244 (318)
T cd05582         241 LGAG  244 (318)
T ss_pred             CCCC
Confidence            9953

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8e-46  Score=363.99  Aligned_cols=246  Identities=33%  Similarity=0.572  Sum_probs=229.0

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEEEecCeEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~l  227 (396)
                      ...|++.+.||+|.||.||+++.+.||+.+|+|++.+.........+.+.+|+.+|+++. |||||.+++.|++...+++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            357999999999999999999999999999999999877655556678899999999998 9999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC----CcEEEEecccccccCCC
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD----GHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~----~~ikL~Dfgla~~~~~~  303 (396)
                      |||++.||.|++.+... .++|..+..++.|++.++.|||+.||+||||||+|+|+...    +.+|++|||++......
T Consensus       114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~  192 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG  192 (382)
T ss_pred             EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence            99999999999999877 49999999999999999999999999999999999999644    47999999999998887


Q ss_pred             CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHH
Q 016037          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSL  379 (396)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~----~~s~~~~~l  379 (396)
                      ......|||+.|+|||++....|+..+||||+|+++|.|++|..||.+.+......+|..+++.++.    .+|..+++|
T Consensus       193 ~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~  272 (382)
T KOG0032|consen  193 ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDF  272 (382)
T ss_pred             ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHH
Confidence            7788899999999999999999999999999999999999999999999999999999999887763    589999999


Q ss_pred             HHHhhccCCCCCCCCC
Q 016037          380 LKGVNSLLSISVPLLS  395 (396)
Q Consensus       380 i~~~l~~~p~~RPs~s  395 (396)
                      |+.||..||.+|+++.
T Consensus       273 i~~ll~~dp~~R~ta~  288 (382)
T KOG0032|consen  273 IRKLLEFDPRKRLTAA  288 (382)
T ss_pred             HHHhcccCcccCCCHH
Confidence            9999999999999864

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=7.6e-46  Score=366.43  Aligned_cols=248  Identities=35%  Similarity=0.672  Sum_probs=218.1

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      ...++|++.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            45678999999999999999999999999999999998755444445566788999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC--
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--  304 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~--  304 (396)
                      +||||+++|+|..++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus       120 lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~  198 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV  198 (370)
T ss_pred             EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence            99999999999987765 468899999999999999999999999999999999999999999999999998764332  


Q ss_pred             CccccccCCCccchhhhcCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCc--cCCHHH
Q 016037          305 RSNSMCGTLEYMSPEIVLGK----GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPA--FLSSEA  376 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~----~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--~~~~p~--~~s~~~  376 (396)
                      .....+||+.|||||++.+.    .++.++|||||||++|||++|+.||.+.+......++...  .+.+|.  .+|.++
T Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  278 (370)
T cd05596         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA  278 (370)
T ss_pred             cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence            23456799999999998753    3789999999999999999999999999988888888765  355665  579999


Q ss_pred             HHHHHHhhccCCCC--CCCCC
Q 016037          377 HSLLKGVNSLLSIS--VPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~--RPs~s  395 (396)
                      ++||++||+.+|.+  ||++.
T Consensus       279 ~~li~~~L~~~p~r~~R~s~~  299 (370)
T cd05596         279 KDLICAFLTDREVRLGRNGVD  299 (370)
T ss_pred             HHHHHHHccChhhccCCCCHH
Confidence            99999999999987  88864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.9e-46  Score=336.00  Aligned_cols=245  Identities=27%  Similarity=0.437  Sum_probs=211.6

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      .+|..+++||+|.||.||+|++..||+.||||.++..+..+..... ..+|+++|+.++|+||+.|+++|...+.+.||+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~t-alREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRT-ALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHH-HHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            4688899999999999999999999999999999987654433333 567999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCc-c
Q 016037          230 DFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-N  307 (396)
Q Consensus       230 E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~-~  307 (396)
                      |||+. +|...++.. ..++...++.|+.++++|++|||++.|+||||||.|+|++.+|.+||+|||+|+.+...... .
T Consensus        81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~  159 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT  159 (318)
T ss_pred             Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence            99986 777777654 56899999999999999999999999999999999999999999999999999998755443 3


Q ss_pred             ccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC---------CCC------
Q 016037          308 SMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KI---------KLP------  369 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--~~---------~~p------  369 (396)
                      ..+.|.+|+|||.+.| +.|+..+||||.||++.||+.|.+-|.|.+.-+...+|.+.  .+         .+|      
T Consensus       160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~  239 (318)
T KOG0659|consen  160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ  239 (318)
T ss_pred             cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence            3478999999999988 56999999999999999999999999998877666666532  11         111      


Q ss_pred             -----------ccCCHHHHHHHHHhhccCCCCCCCCCC
Q 016037          370 -----------AFLSSEAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       370 -----------~~~s~~~~~li~~~l~~~p~~RPs~s~  396 (396)
                                 +..+.++-+|+.+|+++||.+|.+.+|
T Consensus       240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~q  277 (318)
T KOG0659|consen  240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQ  277 (318)
T ss_pred             cCCCCccccccccccHHHHHHHHhhhccCchhcccHHH
Confidence                       135788999999999999999999875

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.2e-45  Score=351.04  Aligned_cols=245  Identities=32%  Similarity=0.483  Sum_probs=208.2

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++.+.||+|+||+||+|+++.+++.||+|++...... ....+.+.+|+.+++.++||||+++++++.....+|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            3699999999999999999999999999999999765422 234456778999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC--Ccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--RSN  307 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~--~~~  307 (396)
                      ||++++.+..+......+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......  ...
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT  159 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence            999998776655555678999999999999999999999999999999999999999999999999998764332  223


Q ss_pred             ccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------------CCC
Q 016037          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-------------------IKL  368 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~-------------------~~~  368 (396)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+....                   ..+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07848         160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF  239 (287)
T ss_pred             ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence            4578999999999999889999999999999999999999999876544433332211                   111


Q ss_pred             C-------------ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          369 P-------------AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       369 p-------------~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      |             ..+|.++.+||++||++||.+|||++
T Consensus       240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~  279 (287)
T cd07848         240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTE  279 (287)
T ss_pred             CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHH
Confidence            1             23788999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-48  Score=343.56  Aligned_cols=246  Identities=31%  Similarity=0.536  Sum_probs=227.4

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .+.|++-++||+|.|+.|+++.+..||+.+|+|++....+... ..+.+.+|+++-+.|+||||++|.+.+.+....|||
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            3578899999999999999999999999999999987765544 556689999999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC---CcEEEEecccccccCCCCC
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD---GHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~---~~ikL~Dfgla~~~~~~~~  305 (396)
                      +|+|.|++|..-+-.+..++|..+-.+++||++||.|+|.+||||||+||+|+|+-..   .-+||+|||+|..+.....
T Consensus        89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~  168 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA  168 (355)
T ss_pred             EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence            9999999998888777888999999999999999999999999999999999999543   3599999999999987766


Q ss_pred             ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHH
Q 016037          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLK  381 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~----~~s~~~~~li~  381 (396)
                      -..++|||.|||||++....|+..+|||+-||+||-|+.|.+||.+.+...+++.|.++...+|.    .+++++++||+
T Consensus       169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lvr  248 (355)
T KOG0033|consen  169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIR  248 (355)
T ss_pred             cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHH
Confidence            77889999999999999999999999999999999999999999999999999999999888775    68999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      +||+.||.+|.|.+
T Consensus       249 rML~~dP~kRIta~  262 (355)
T KOG0033|consen  249 RMLTVNPKKRITAD  262 (355)
T ss_pred             HHhccChhhhccHH
Confidence            99999999999875

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-45  Score=360.03  Aligned_cols=248  Identities=24%  Similarity=0.395  Sum_probs=205.5

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEc-----CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSF  219 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~  219 (396)
                      .+..++|++.++||+|+||.||+|.+.     .+++.||+|+++...  .....+.+.+|+.+++.+ +||||+++++++
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (338)
T cd05102           3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGAC   80 (338)
T ss_pred             ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence            455678999999999999999999863     345689999987543  223345678899999999 899999999988


Q ss_pred             Eec-CeEEEEEEecCCCcHHHHHHHh------------------------------------------------------
Q 016037          220 QTK-YRLYLVLDFVNGGHLFFQLYRQ------------------------------------------------------  244 (396)
Q Consensus       220 ~~~-~~~~lV~E~~~gg~L~~~l~~~------------------------------------------------------  244 (396)
                      ... ..+|++|||+++|+|.+++...                                                      
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence            654 4689999999999999888653                                                      


Q ss_pred             --------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC---CccccccCC
Q 016037          245 --------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT---RSNSMCGTL  313 (396)
Q Consensus       245 --------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~---~~~~~~gt~  313 (396)
                              ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......   ......+++
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                    236677888899999999999999999999999999999999999999999998653321   122334668


Q ss_pred             CccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHhC-CCCCCccCCHHHHHHHHHhhccCCCC
Q 016037          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQK-IQQKIIKD-KIKLPAFLSSEAHSLLKGVNSLLSIS  390 (396)
Q Consensus       314 ~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~-i~~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p~~  390 (396)
                      .|||||++.+..++.++|||||||+||||++ |..||.+....+ +...+..+ ....|..+++++.+||..||+.+|.+
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  320 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKE  320 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence            8999999999889999999999999999997 999998865433 33434333 45667889999999999999999999


Q ss_pred             CCCCC
Q 016037          391 VPLLS  395 (396)
Q Consensus       391 RPs~s  395 (396)
                      |||+.
T Consensus       321 RPs~~  325 (338)
T cd05102         321 RPTFS  325 (338)
T ss_pred             CcCHH
Confidence            99975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.2e-45  Score=357.23  Aligned_cols=244  Identities=48%  Similarity=0.862  Sum_probs=213.3

Q ss_pred             CeEEEeEecccCceEEEEEEEc---CCCcEEEEEEeeccccch-hhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCeE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIME-KNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~---~~~~~vAvK~i~~~~~~~-~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~  225 (396)
                      +|++++.||+|+||.||++++.   .+++.||+|++.+..... ....+.+..|+.+++.+ +||||+++++++.....+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999998874   478999999998654322 23345677899999999 599999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC--
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--  303 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~--  303 (396)
                      |+||||+++|+|..++.+++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...  
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~  160 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK  160 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence            999999999999999988889999999999999999999999999999999999999999999999999999865332  


Q ss_pred             CCccccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCCCCCccCCHHHHH
Q 016037          304 TRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKDKIKLPAFLSSEAHS  378 (396)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~----~~~~i~~~i~~~~~~~p~~~s~~~~~  378 (396)
                      ......+||+.|||||++.+. .++.++|||||||++|||+||+.||...    ....+...+......+|..++..+++
T Consensus       161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (332)
T cd05614         161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD  240 (332)
T ss_pred             CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence            223456799999999999875 4789999999999999999999999642    34566667777788889999999999


Q ss_pred             HHHHhhccCCCCCCCC
Q 016037          379 LLKGVNSLLSISVPLL  394 (396)
Q Consensus       379 li~~~l~~~p~~RPs~  394 (396)
                      ||++||+.||.+||+.
T Consensus       241 li~~~l~~dp~~R~~~  256 (332)
T cd05614         241 LLHKLLRKDPKKRLGA  256 (332)
T ss_pred             HHHHHcCCCHHHcCCC
Confidence            9999999999999953

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-45  Score=349.33  Aligned_cols=243  Identities=34%  Similarity=0.591  Sum_probs=213.4

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      .|++.+.||+|+||+||++.+..+++.||+|++.............+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            48899999999999999999999999999999987554434444556789999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccc
Q 016037          231 FVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (396)
Q Consensus       231 ~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~  308 (396)
                      |+++|+|...+...  ..+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++...........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG  160 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence            99999998877654  4689999999999999999999999999999999999999999999999999987655444455


Q ss_pred             cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCccCCHHHHHHHHHhh
Q 016037          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQK----IQQKIIKDKIKLPAFLSSEAHSLLKGVN  384 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~----i~~~i~~~~~~~p~~~s~~~~~li~~~l  384 (396)
                      .+|++.|+|||++.+..++.++|||||||++|||++|+.||.+.+...    +...+......++..++..+++||..||
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05605         161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLL  240 (285)
T ss_pred             ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHc
Confidence            689999999999998889999999999999999999999999865433    3344444556677889999999999999


Q ss_pred             ccCCCCCCC
Q 016037          385 SLLSISVPL  393 (396)
Q Consensus       385 ~~~p~~RPs  393 (396)
                      +.||.+||+
T Consensus       241 ~~~P~~R~~  249 (285)
T cd05605         241 TKDPGFRLG  249 (285)
T ss_pred             cCCHHHhcC
Confidence            999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-46  Score=362.06  Aligned_cols=245  Identities=35%  Similarity=0.579  Sum_probs=228.3

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      +=|.+.+.||+|.|+.|-+|++.-||+.||||++.+..+..-.. ..+..|++.|+.++|||||+||.+..++..+|||+
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st-~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLST-GHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhh-hHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            34889999999999999999999999999999999987654433 44566999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE-cCCCcEEEEecccccccCCCCCcc
Q 016037          230 DFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL-DADGHVMLTDFGLAKQFDENTRSN  307 (396)
Q Consensus       230 E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl-~~~~~ikL~Dfgla~~~~~~~~~~  307 (396)
                      |+-++|+|++++.++ ..+.|+.++.|+.||+.|+.|+|...+|||||||+|+.+ ..-|-+||+|||++..+..+....
T Consensus        97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~  176 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLT  176 (864)
T ss_pred             EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhh
Confidence            999999999998765 579999999999999999999999999999999999866 456899999999999999999999


Q ss_pred             ccccCCCccchhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhcc
Q 016037          308 SMCGTLEYMSPEIVLGKGHD-KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSL  386 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~-~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~  386 (396)
                      +.||+..|-|||++.|-.|+ +++|||||||+||-|++|+.||...|..+-.-.|...+.+.|..+|.+.++||..||..
T Consensus       177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sMLvR  256 (864)
T KOG4717|consen  177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSMLVR  256 (864)
T ss_pred             cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHHHhc
Confidence            99999999999999998886 78999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCC
Q 016037          387 LSISVPLLS  395 (396)
Q Consensus       387 ~p~~RPs~s  395 (396)
                      ||.+|.|+.
T Consensus       257 dPkkRAslE  265 (864)
T KOG4717|consen  257 DPKKRASLE  265 (864)
T ss_pred             CchhhccHH
Confidence            999998864

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7.7e-46  Score=360.17  Aligned_cols=245  Identities=38%  Similarity=0.682  Sum_probs=217.4

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|.+.+.||+|+||+||+|+++.+++.||+|++++.........+.+.+|+.+++.++||||+++++++.....+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47999999999999999999999999999999998765545556677889999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC--c
Q 016037          230 DFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR--S  306 (396)
Q Consensus       230 E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~--~  306 (396)
                      ||+++|+|..++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++..+.....  .
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  160 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS  160 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence            999999999999876 7899999999999999999999999999999999999999999999999999987654332  2


Q ss_pred             cccccCCCccchhhhc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCC--ccCCHHH
Q 016037          307 NSMCGTLEYMSPEIVL------GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK--IKLP--AFLSSEA  376 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~------~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~--~~~p--~~~s~~~  376 (396)
                      ....||+.|+|||++.      +..++.++|||||||++|||++|+.||.+.+......++....  +.+|  ..++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (330)
T cd05601         161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF  240 (330)
T ss_pred             ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHH
Confidence            3357899999999986      4567899999999999999999999999988888888777542  3444  3689999


Q ss_pred             HHHHHHhhccCCCCCCCCC
Q 016037          377 HSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~RPs~s  395 (396)
                      .+||+.||+ +|.+||++.
T Consensus       241 ~~li~~ll~-~p~~R~t~~  258 (330)
T cd05601         241 LDLIQSLLC-GQKERLGYE  258 (330)
T ss_pred             HHHHHHHcc-ChhhCCCHH
Confidence            999999998 999999975

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.8e-45  Score=348.31  Aligned_cols=244  Identities=18%  Similarity=0.215  Sum_probs=213.0

Q ss_pred             cCCCeEEE--eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe----
Q 016037          148 GLEDFEVL--KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT----  221 (396)
Q Consensus       148 ~~~~~~~~--~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~----  221 (396)
                      ..++++..  ..||+|++|.||+|.+  +|+.||||+++..........+.+.+|+.+|++++||||+++++++.+    
T Consensus        16 ~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~   93 (283)
T PHA02988         16 ESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD   93 (283)
T ss_pred             CHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccC
Confidence            33444444  6799999999999998  678999999987654444456778899999999999999999999876    


Q ss_pred             cCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEeccccccc
Q 016037          222 KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~-~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~  300 (396)
                      ...+++||||+++|+|..++...+.+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++..
T Consensus        94 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~  173 (283)
T PHA02988         94 LPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKIL  173 (283)
T ss_pred             CCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence            457899999999999999999888899999999999999999999985 9999999999999999999999999999865


Q ss_pred             CCCCCccccccCCCccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHH
Q 016037          301 DENTRSNSMCGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPAFLSSEA  376 (396)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--~~~~p~~~s~~~  376 (396)
                      ...  .....|+..|+|||++.+  ..++.++|||||||++|||++|+.||.+.+..++...+...  ++.+|..++.++
T Consensus       174 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l  251 (283)
T PHA02988        174 SSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEI  251 (283)
T ss_pred             ccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHH
Confidence            432  234568899999999976  67899999999999999999999999998888888887654  566777899999


Q ss_pred             HHHHHHhhccCCCCCCCCC
Q 016037          377 HSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~RPs~s  395 (396)
                      ++||.+||+.||.+|||++
T Consensus       252 ~~li~~cl~~dp~~Rps~~  270 (283)
T PHA02988        252 KCIVEACTSHDSIKRPNIK  270 (283)
T ss_pred             HHHHHHHhcCCcccCcCHH
Confidence            9999999999999999975

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-47  Score=370.99  Aligned_cols=242  Identities=26%  Similarity=0.418  Sum_probs=221.5

Q ss_pred             CCccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       143 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      +.|.+.++.+.-+.-||.|+.|.||+|+..  ++.||||.++.-          -..+|+.|++|+||||+.+.++|...
T Consensus       117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqs  184 (904)
T KOG4721|consen  117 ELWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQS  184 (904)
T ss_pred             hhccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCC
Confidence            445566677777888999999999999994  577999987532          24578899999999999999999999


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      ..+|||||||..|-|...|+..+.+.......|..+|+.||.|||.+.|||||||.-||||+.+..|||+|||.++.+.+
T Consensus       185 PcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~  264 (904)
T KOG4721|consen  185 PCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD  264 (904)
T ss_pred             ceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999888


Q ss_pred             CCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHH
Q 016037          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPAFLSSEAHSLL  380 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--~~~~p~~~s~~~~~li  380 (396)
                      .....+++||..|||||++.+...+.|+|||||||+||||+||+.||.+-+...|+--+-.+  .++.|..++..++-||
T Consensus       265 ~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~  344 (904)
T KOG4721|consen  265 KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLL  344 (904)
T ss_pred             hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHH
Confidence            88888999999999999999999999999999999999999999999998888777777666  5577889999999999


Q ss_pred             HHhhccCCCCCCCCCC
Q 016037          381 KGVNSLLSISVPLLSR  396 (396)
Q Consensus       381 ~~~l~~~p~~RPs~s~  396 (396)
                      |+||+-.|..|||++|
T Consensus       345 Kqcw~sKpRNRPSFrq  360 (904)
T KOG4721|consen  345 KQCWNSKPRNRPSFRQ  360 (904)
T ss_pred             HHHHhcCCCCCccHHH
Confidence            9999999999999864

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.2e-45  Score=361.93  Aligned_cols=248  Identities=35%  Similarity=0.674  Sum_probs=214.9

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      ...++|++.+.||+|+||.||+++++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.++..+|
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34568999999999999999999999999999999998654444445566788999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC--
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--  304 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~--  304 (396)
                      +||||+++|+|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus       120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~  198 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV  198 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence            999999999999888654 68999999999999999999999999999999999999999999999999998764332  


Q ss_pred             CccccccCCCccchhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCc--cCCHHH
Q 016037          305 RSNSMCGTLEYMSPEIVLGKG----HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPA--FLSSEA  376 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~----~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--~~~~p~--~~s~~~  376 (396)
                      .....+||+.|||||++.+..    ++.++|||||||++|||++|+.||.+.+......++...  .+.+|.  .++..+
T Consensus       199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~  278 (370)
T cd05621         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHA  278 (370)
T ss_pred             ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHH
Confidence            234567999999999997643    788999999999999999999999999888888888764  355665  579999


Q ss_pred             HHHHHHhhccCCCC--CCCCC
Q 016037          377 HSLLKGVNSLLSIS--VPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~--RPs~s  395 (396)
                      ++||+.||+..+..  ||++.
T Consensus       279 ~~li~~~L~~~~~r~~R~~~~  299 (370)
T cd05621         279 KNLICAFLTDREVRLGRNGVE  299 (370)
T ss_pred             HHHHHHHccCchhccCCCCHH
Confidence            99999999854433  66653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.7e-44  Score=351.29  Aligned_cols=245  Identities=24%  Similarity=0.399  Sum_probs=212.2

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      ..++|++++.||+|+||.||++++..++..||+|++....  .....+.+.+|+++|++++||||+++++++.....+++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            3578999999999999999999999999999999997642  23345668889999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEecccccccCCCCCc
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS  306 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~-~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~  306 (396)
                      ||||+++++|.+++.....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...... ..
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~  159 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA  159 (331)
T ss_pred             EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-cc
Confidence            999999999999998888899999999999999999999986 6999999999999999999999999999876433 23


Q ss_pred             cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------------------------
Q 016037          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII------------------------  362 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~------------------------  362 (396)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++...+.                        
T Consensus       160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (331)
T cd06649         160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP  239 (331)
T ss_pred             ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccc
Confidence            45679999999999999899999999999999999999999998766554433221                        


Q ss_pred             ----------------------hC-CCCCC-ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          363 ----------------------KD-KIKLP-AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       363 ----------------------~~-~~~~p-~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                            .. ....+ ..++.++++||++||+.||++|||+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~  296 (331)
T cd06649         240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLK  296 (331)
T ss_pred             ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHH
Confidence                                  11 11122 24789999999999999999999974

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.5e-44  Score=368.66  Aligned_cols=243  Identities=30%  Similarity=0.479  Sum_probs=216.2

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCC-CcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGT-SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      ..|.+.+.||+|+||.||+|....+ ++.||+|.+....   ......+.+|+.+|+.++||||++++++|...+.+|||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv  143 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI  143 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence            3599999999999999999999887 7889999775432   33445678899999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          229 LDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      |||+++|+|..++..    ..++++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            999999999887753    3468999999999999999999999999999999999999999999999999998765432


Q ss_pred             ---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHH
Q 016037          305 ---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAHSLL  380 (396)
Q Consensus       305 ---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~-~~p~~~s~~~~~li  380 (396)
                         .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+..+.. .+|..++.++++||
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  303 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALL  303 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHH
Confidence               23456799999999999999999999999999999999999999999888888888877644 56788999999999


Q ss_pred             HHhhccCCCCCCCCC
Q 016037          381 KGVNSLLSISVPLLS  395 (396)
Q Consensus       381 ~~~l~~~p~~RPs~s  395 (396)
                      ..||+.+|.+||+..
T Consensus       304 ~~~L~~dP~~Rps~~  318 (478)
T PTZ00267        304 DPLLSKNPALRPTTQ  318 (478)
T ss_pred             HHHhccChhhCcCHH
Confidence            999999999999964

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=8e-45  Score=359.25  Aligned_cols=243  Identities=37%  Similarity=0.691  Sum_probs=212.6

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +..++|++.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.....+|
T Consensus        40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (371)
T cd05622          40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  119 (371)
T ss_pred             cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            45578999999999999999999999999999999997654444445566788999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC--
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--  304 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~--  304 (396)
                      +||||+++|+|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++......  
T Consensus       120 lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~  198 (371)
T cd05622         120 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  198 (371)
T ss_pred             EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence            99999999999888765 458999999999999999999999999999999999999999999999999998764332  


Q ss_pred             CccccccCCCccchhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCc--cCCHHH
Q 016037          305 RSNSMCGTLEYMSPEIVLGKG----HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPA--FLSSEA  376 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~----~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--~~~~p~--~~s~~~  376 (396)
                      .....+||+.|||||++.+..    ++.++|||||||++|||++|+.||.+.+......++...  .+.+|.  .++.++
T Consensus       199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  278 (371)
T cd05622         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA  278 (371)
T ss_pred             cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHH
Confidence            234567999999999997543    789999999999999999999999999988888888764  345554  689999


Q ss_pred             HHHHHHhhccCCCCC
Q 016037          377 HSLLKGVNSLLSISV  391 (396)
Q Consensus       377 ~~li~~~l~~~p~~R  391 (396)
                      ++||..||+ +|..|
T Consensus       279 ~~li~~~L~-~~~~r  292 (371)
T cd05622         279 KNLICAFLT-DREVR  292 (371)
T ss_pred             HHHHHHHcC-Chhhh
Confidence            999999998 55544

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.1e-44  Score=344.11  Aligned_cols=237  Identities=34%  Similarity=0.606  Sum_probs=207.2

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCCCcH
Q 016037          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL  237 (396)
Q Consensus       158 IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L  237 (396)
                      ||+|+||+||++.++.+++.||+|++.+.........+.+..|+++++.++||||+++.+++.....+|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999999999999999999876544444456677899999999999999999999999999999999999999


Q ss_pred             HHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC-ccccccC
Q 016037          238 FFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNSMCGT  312 (396)
Q Consensus       238 ~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~-~~~~~gt  312 (396)
                      ...+..    ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+..... .....||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~  160 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT  160 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence            877643    35689999999999999999999999999999999999999999999999999987644322 3345789


Q ss_pred             CCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCC
Q 016037          313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN----RQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLS  388 (396)
Q Consensus       313 ~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~----~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p  388 (396)
                      +.|+|||.+.+..++.++|||||||++|||++|+.||....    ...+...+......+|..++.++.+|+.+||+.+|
T Consensus       161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P  240 (280)
T cd05608         161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDP  240 (280)
T ss_pred             cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCH
Confidence            99999999999999999999999999999999999998653    23445555556667788899999999999999999


Q ss_pred             CCCCCC
Q 016037          389 ISVPLL  394 (396)
Q Consensus       389 ~~RPs~  394 (396)
                      .+||++
T Consensus       241 ~~R~~~  246 (280)
T cd05608         241 EKRLGF  246 (280)
T ss_pred             HHhcCC
Confidence            999965

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-45  Score=357.60  Aligned_cols=237  Identities=46%  Similarity=0.790  Sum_probs=209.6

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC---CCCCeeeeeEEEEecCeEEEEEEecCC
Q 016037          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (396)
Q Consensus       158 IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l---~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (396)
                      ||+|+||+||+|+++.+++.||+|++.+..............|..++..+   +||||+++++++.+...+|+||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999999999999999999765543333444455577777655   799999999999999999999999999


Q ss_pred             CcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC-CCCccccccCC
Q 016037          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNSMCGTL  313 (396)
Q Consensus       235 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~-~~~~~~~~gt~  313 (396)
                      |+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......+||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  160 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT  160 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence            99999998888999999999999999999999999999999999999999999999999999976432 23345568999


Q ss_pred             CccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-cCCHHHHHHHHHhhccCCCCC
Q 016037          314 EYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA-FLSSEAHSLLKGVNSLLSISV  391 (396)
Q Consensus       314 ~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~-~~s~~~~~li~~~l~~~p~~R  391 (396)
                      .|||||++.+. .++.++|||||||++|||++|+.||.+.+..++.+.+..+...+|. .++.++++||++||+.+|.+|
T Consensus       161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R  240 (330)
T cd05586         161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR  240 (330)
T ss_pred             cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHC
Confidence            99999999764 5899999999999999999999999999999999999888887775 589999999999999999999


Q ss_pred             CCC
Q 016037          392 PLL  394 (396)
Q Consensus       392 Ps~  394 (396)
                      |+.
T Consensus       241 ~~~  243 (330)
T cd05586         241 LGA  243 (330)
T ss_pred             CCC
Confidence            964

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.1e-44  Score=345.35  Aligned_cols=245  Identities=28%  Similarity=0.421  Sum_probs=206.5

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|++.++||.|+||.||+|+++.+++.||+|+++....  ......+.+|+.+++.++||||+++++++......|+|
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV   81 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence            5679999999999999999999999999999999975432  12234467899999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Cc
Q 016037          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RS  306 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~  306 (396)
                      |||+++ +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus        82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~  160 (288)
T cd07871          82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY  160 (288)
T ss_pred             EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence            999986 787777654 457899999999999999999999999999999999999999999999999997654322 23


Q ss_pred             cccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------------C
Q 016037          307 NSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-------------------I  366 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~-------------------~  366 (396)
                      ....|++.|+|||++.+ ..++.++|||||||++|||+||+.||.+.+..+....+....                   .
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd07871         161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY  240 (288)
T ss_pred             cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence            34578999999999875 568999999999999999999999999887666555543210                   0


Q ss_pred             CC-----------CccCCHHHHHHHHHhhccCCCCCCCCCC
Q 016037          367 KL-----------PAFLSSEAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       367 ~~-----------p~~~s~~~~~li~~~l~~~p~~RPs~s~  396 (396)
                      .+           ...++.++.+||++||++||.+|||+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~  281 (288)
T cd07871         241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEA  281 (288)
T ss_pred             ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHH
Confidence            11           1357889999999999999999999753

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.1e-44  Score=339.38  Aligned_cols=247  Identities=17%  Similarity=0.260  Sum_probs=213.9

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEc---CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~  223 (396)
                      +..++|++.+.||+|+||.||+|.++   ..+..||+|.++...  .....+.+.+|+.++++++||||+++++++....
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   79 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN   79 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence            34568999999999999999999875   456789999987653  2233456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      ..|+||||+++|+|..++... +.+++..++.++.|++.||+|||++|++||||||+|||++.++.+|++|||.+.....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            999999999999999888764 5789999999999999999999999999999999999999999999999998765432


Q ss_pred             CCC--ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHH
Q 016037          303 NTR--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHS  378 (396)
Q Consensus       303 ~~~--~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~  378 (396)
                      ...  .....++..|+|||.+.+..++.++|||||||++||+++ |+.||.+.+...+.+.+..+ ..+.|..++..+.+
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQ  239 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence            211  122345678999999999999999999999999999876 99999998888887877765 45677889999999


Q ss_pred             HHHHhhccCCCCCCCCC
Q 016037          379 LLKGVNSLLSISVPLLS  395 (396)
Q Consensus       379 li~~~l~~~p~~RPs~s  395 (396)
                      ++..||+.+|.+||++.
T Consensus       240 li~~c~~~~p~~RP~~~  256 (266)
T cd05064         240 LMLDCWQKERGERPRFS  256 (266)
T ss_pred             HHHHHcCCCchhCCCHH
Confidence            99999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.5e-44  Score=340.11  Aligned_cols=238  Identities=31%  Similarity=0.579  Sum_probs=204.7

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCCCcH
Q 016037          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL  237 (396)
Q Consensus       158 IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L  237 (396)
                      ||+|+||.||+++++.+|+.||+|.+................|+++++.++||||+++++++..+..+|+||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999999999999999999765443333344456699999999999999999999999999999999999999


Q ss_pred             HHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccccccCCCc
Q 016037          238 FFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY  315 (396)
Q Consensus       238 ~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~~gt~~y  315 (396)
                      ...+....  .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.............|+..|
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY  160 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence            88776543  5788888999999999999999999999999999999999999999999999877654444456789999


Q ss_pred             cchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCCC-ccCCHHHHHHHHHhhccCCCC
Q 016037          316 MSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN----RQKIQQKIIKDKIKLP-AFLSSEAHSLLKGVNSLLSIS  390 (396)
Q Consensus       316 ~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~----~~~i~~~i~~~~~~~p-~~~s~~~~~li~~~l~~~p~~  390 (396)
                      +|||++.+..++.++|||||||++|||++|+.||.+..    ...+...+....+.++ ..++.++++||+.||+.+|.+
T Consensus       161 ~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~  240 (277)
T cd05607         161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPED  240 (277)
T ss_pred             cCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhh
Confidence            99999998889999999999999999999999997643    3344455555554443 468999999999999999999


Q ss_pred             CCCCC
Q 016037          391 VPLLS  395 (396)
Q Consensus       391 RPs~s  395 (396)
                      ||++.
T Consensus       241 R~~~~  245 (277)
T cd05607         241 RLGSR  245 (277)
T ss_pred             CCCCc
Confidence            99973

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.9e-44  Score=341.02  Aligned_cols=242  Identities=43%  Similarity=0.806  Sum_probs=223.9

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++.+.||+|+||.||++.+..+++.+|+|++...........+.+.+|+++++.++||||+++++++..+..+|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36999999999999999999999999999999998765545555677889999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCcccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM  309 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~  309 (396)
                      ||+++++|..++...+.+++..+..++.|++.||.|||++|++|+||+|+|||++.++.+||+|||+++.....  ....
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~  158 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYTL  158 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCCC
Confidence            99999999999998899999999999999999999999999999999999999999999999999999876544  3455


Q ss_pred             ccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCC
Q 016037          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSI  389 (396)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~  389 (396)
                      +|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.....+++..+...+|..++..++++|++||+.+|.
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  238 (290)
T cd05580         159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLT  238 (290)
T ss_pred             CCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCCHH
Confidence            78999999999988888999999999999999999999999988888888888888999999999999999999999999


Q ss_pred             CCCC
Q 016037          390 SVPL  393 (396)
Q Consensus       390 ~RPs  393 (396)
                      +||+
T Consensus       239 ~R~~  242 (290)
T cd05580         239 KRLG  242 (290)
T ss_pred             HccC
Confidence            9983

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.8e-44  Score=346.29  Aligned_cols=244  Identities=26%  Similarity=0.421  Sum_probs=199.0

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|++.+.||+|+||+||+|+++.+++.||+|+++....  ........+|+.+++.++||||+++++++.+...+|+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            3689999999999999999999999999999999976432  12223456799999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-CCc
Q 016037          229 LDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRS  306 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-~~~  306 (396)
                      |||+.+ +|..++.. .+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..... ...
T Consensus        82 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  160 (303)
T cd07869          82 FEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY  160 (303)
T ss_pred             EECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence            999975 56565554 467899999999999999999999999999999999999999999999999999764322 223


Q ss_pred             cccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhC--C-----------------
Q 016037          307 NSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNR-QKIQQKIIKD--K-----------------  365 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~-~~i~~~i~~~--~-----------------  365 (396)
                      ...+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+. ......+...  .                 
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd07869         161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP  240 (303)
T ss_pred             CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence            44678999999999876 4588999999999999999999999987532 2222222110  0                 


Q ss_pred             --CC--CCc---------cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 --IK--LPA---------FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 --~~--~p~---------~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                        ..  .|.         .++.++++||+.||++||.+|||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~  283 (303)
T cd07869         241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQ  283 (303)
T ss_pred             ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHH
Confidence              00  010         2457899999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-44  Score=350.27  Aligned_cols=245  Identities=37%  Similarity=0.675  Sum_probs=210.7

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++++.||+|+||+||++++..+++.||+|++.+.........+.+.+|+.+++.++|+||++++++|.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999998755444455666888999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC--c
Q 016037          230 DFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR--S  306 (396)
Q Consensus       230 E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~--~  306 (396)
                      ||+++|+|..++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++..+.....  .
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS  160 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence            99999999999876 46789999999999999999999999999999999999999999999999999977644332  2


Q ss_pred             cccccCCCccchhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCc---cCCHHH
Q 016037          307 NSMCGTLEYMSPEIVLG-----KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPA---FLSSEA  376 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~-----~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--~~~~p~---~~s~~~  376 (396)
                      ...+||+.|||||++..     ..++.++|||||||++|||++|+.||.+.+..+...++...  .+.+|.   .++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  240 (331)
T cd05597         161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA  240 (331)
T ss_pred             cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence            33569999999999963     45788999999999999999999999998888887777654  344443   579999


Q ss_pred             HHHHHHhhccCCCC--CCCC
Q 016037          377 HSLLKGVNSLLSIS--VPLL  394 (396)
Q Consensus       377 ~~li~~~l~~~p~~--RPs~  394 (396)
                      ++||++||...+..  ||++
T Consensus       241 ~~li~~ll~~~~~r~~r~~~  260 (331)
T cd05597         241 KDLIRRLICSPETRLGRNGL  260 (331)
T ss_pred             HHHHHHHccCcccccCCCCH
Confidence            99999999753332  5554

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-46  Score=388.89  Aligned_cols=244  Identities=39%  Similarity=0.702  Sum_probs=224.5

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      ...+||.++++||+|+||.|.+++.+.|++.||||++.+..+........|..|.++|..-+.+-|+.|...|++..++|
T Consensus        72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY  151 (1317)
T KOG0612|consen   72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY  151 (1317)
T ss_pred             CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence            45679999999999999999999999999999999999977776777888999999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC--
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--  304 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~--  304 (396)
                      +|||||+||+|..++.+...++++++++|+++|+.||.-||+.|+|||||||+|||+|..||+||+|||.+-.++...  
T Consensus       152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V  231 (1317)
T KOG0612|consen  152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV  231 (1317)
T ss_pred             EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence            999999999999999999999999999999999999999999999999999999999999999999999998876433  


Q ss_pred             CccccccCCCccchhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCC--ccCCHH
Q 016037          305 RSNSMCGTLEYMSPEIVLG-----KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLP--AFLSSE  375 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~-----~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--~~~~p--~~~s~~  375 (396)
                      .+...+|||.|.+||+++.     +.|++.+||||+||++|||+.|..||+..+..+-+-+|..-  .+.||  ..+|.+
T Consensus       232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSee  311 (1317)
T KOG0612|consen  232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEE  311 (1317)
T ss_pred             EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHH
Confidence            3567899999999999953     45889999999999999999999999999999999999865  78899  579999


Q ss_pred             HHHHHHHhhccCCCCC
Q 016037          376 AHSLLKGVNSLLSISV  391 (396)
Q Consensus       376 ~~~li~~~l~~~p~~R  391 (396)
                      +++||.++++ +|..|
T Consensus       312 akdLI~~ll~-~~e~R  326 (1317)
T KOG0612|consen  312 AKDLIEALLC-DREVR  326 (1317)
T ss_pred             HHHHHHHHhc-Chhhh
Confidence            9999999885 34444

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.8e-44  Score=366.03  Aligned_cols=248  Identities=31%  Similarity=0.486  Sum_probs=217.8

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC---
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY---  223 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~---  223 (396)
                      ...++|.+.+.||+|+||+||+|++..+++.||||++...... ......+.+|+.++..++|+||++++..+....   
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            3446899999999999999999999999999999999876543 344556788999999999999999988775432   


Q ss_pred             -----eEEEEEEecCCCcHHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEec
Q 016037          224 -----RLYLVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDF  294 (396)
Q Consensus       224 -----~~~lV~E~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Df  294 (396)
                           .+++||||+++|+|.+++...    ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF  187 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF  187 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence                 378999999999999888643    46899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCC---CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCc
Q 016037          295 GLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPA  370 (396)
Q Consensus       295 gla~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~-~~p~  370 (396)
                      |+++.+...   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++..++..+.. .+|.
T Consensus       188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  267 (496)
T PTZ00283        188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPP  267 (496)
T ss_pred             ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence            999875432   223456899999999999999999999999999999999999999999998888888877644 5788


Q ss_pred             cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          371 FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       371 ~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .+++++.+||+.||+.+|.+||+++
T Consensus       268 ~~~~~l~~li~~~L~~dP~~RPs~~  292 (496)
T PTZ00283        268 SISPEMQEIVTALLSSDPKRRPSSS  292 (496)
T ss_pred             CCCHHHHHHHHHHcccChhhCcCHH
Confidence            9999999999999999999999974

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8.8e-44  Score=338.75  Aligned_cols=244  Identities=34%  Similarity=0.583  Sum_probs=213.1

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      .|+..+.||+|+||+||+|.+..+++.||+|++.............+.+|+++++.++|+||+++++.+..+...|++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            37888999999999999999999999999999987654444445567789999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccc
Q 016037          231 FVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (396)
Q Consensus       231 ~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~  308 (396)
                      |+.+++|...+...  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG  160 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence            99999998877654  3689999999999999999999999999999999999999999999999999977654443445


Q ss_pred             cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCccCCHHHHHHHHHhh
Q 016037          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKI----QQKIIKDKIKLPAFLSSEAHSLLKGVN  384 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i----~~~i~~~~~~~p~~~s~~~~~li~~~l  384 (396)
                      ..|+..|+|||.+.+..++.++|+||||+++|||++|..||.+......    ...+......++..++.++.+|+..||
T Consensus       161 ~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05632         161 RVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLL  240 (285)
T ss_pred             CCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHc
Confidence            6789999999999988899999999999999999999999988765433    333334455677789999999999999


Q ss_pred             ccCCCCCCCC
Q 016037          385 SLLSISVPLL  394 (396)
Q Consensus       385 ~~~p~~RPs~  394 (396)
                      +.+|.+||+.
T Consensus       241 ~~~P~~R~~~  250 (285)
T cd05632         241 TKDPKQRLGC  250 (285)
T ss_pred             cCCHhHcCCC
Confidence            9999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.6e-45  Score=338.96  Aligned_cols=248  Identities=31%  Similarity=0.462  Sum_probs=212.9

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe--cCe
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KYR  224 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~--~~~  224 (396)
                      -..++|+.+.+|++|.||.||+|+++.|++.||+|.++.+.-.....+.. .+|+.+|.+.+|||||.+..+...  -+.
T Consensus        73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPIts-LREIniLl~~~H~NIV~vkEVVvG~~~d~  151 (419)
T KOG0663|consen   73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITS-LREINILLKARHPNIVEVKEVVVGSNMDK  151 (419)
T ss_pred             ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchh-HHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence            44678999999999999999999999999999999998766333333443 569999999999999999887754  457


Q ss_pred             EEEEEEecCCCcHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      +|||||||+. +|...+..-+ +|....++-+..|+++|++|||.+.|+|||||++|+|++..|.+||+|||+|+.+...
T Consensus       152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            9999999998 6777776654 8999999999999999999999999999999999999999999999999999998765


Q ss_pred             C-CccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------
Q 016037          304 T-RSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-----------------  364 (396)
Q Consensus       304 ~-~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~-----------------  364 (396)
                      . .....+.|.+|+|||.+.+ ..|+.++||||+|||+.||+++++.|.|.+..+...+|.+.                 
T Consensus       231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~  310 (419)
T KOG0663|consen  231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA  310 (419)
T ss_pred             cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence            3 3456788999999999987 56999999999999999999999999999887777777532                 


Q ss_pred             --CCCCC------------cc-CCHHHHHHHHHhhccCCCCCCCCCC
Q 016037          365 --KIKLP------------AF-LSSEAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       365 --~~~~p------------~~-~s~~~~~li~~~l~~~p~~RPs~s~  396 (396)
                        .++++            .. +|....+|+..+|++||.+|-|+++
T Consensus       311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~  357 (419)
T KOG0663|consen  311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAED  357 (419)
T ss_pred             hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHH
Confidence              11121            12 6799999999999999999998764

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=7e-45  Score=371.47  Aligned_cols=251  Identities=22%  Similarity=0.376  Sum_probs=222.5

Q ss_pred             CccccCCCeEEEeEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEE
Q 016037          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYS  218 (396)
Q Consensus       144 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~  218 (396)
                      ...+...+.+..+.||+|+||+||+|+..+     ....||||.++...  +.+..+.|++|+.+|+.++|||||+|+|.
T Consensus       480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGV  557 (774)
T KOG1026|consen  480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGV  557 (774)
T ss_pred             eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence            344677889999999999999999998754     34679999998764  44467779999999999999999999999


Q ss_pred             EEecCeEEEEEEecCCCcHHHHHHHhc--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc
Q 016037          219 FQTKYRLYLVLDFVNGGHLFFQLYRQG--------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD  284 (396)
Q Consensus       219 ~~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~  284 (396)
                      |.+++.+|+|+|||..|+|.++|.-..              +++..+...+|.||+.||+||-++.+|||||..+|+||+
T Consensus       558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG  637 (774)
T ss_pred             EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec
Confidence            999999999999999999999996542              267788899999999999999999999999999999999


Q ss_pred             CCCcEEEEecccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 016037          285 ADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQK  360 (396)
Q Consensus       285 ~~~~ikL~Dfgla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~  360 (396)
                      ++..|||+|||+++.+-..+.   .....-..+||+||.|....|+.++|||||||+|||+++ |+.||.+.+.+++++.
T Consensus       638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~  717 (774)
T KOG1026|consen  638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC  717 (774)
T ss_pred             cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence            999999999999987643321   122334689999999999999999999999999999999 9999999999999999


Q ss_pred             HHhCC-CCCCccCCHHHHHHHHHhhccCCCCCCCCCC
Q 016037          361 IIKDK-IKLPAFLSSEAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       361 i~~~~-~~~p~~~s~~~~~li~~~l~~~p~~RPs~s~  396 (396)
                      |..++ +..|..++.++++||..||+.+|++|||+++
T Consensus       718 i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~e  754 (774)
T KOG1026|consen  718 IRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKE  754 (774)
T ss_pred             HHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHH
Confidence            99985 5778999999999999999999999999863

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4e-44  Score=348.32  Aligned_cols=243  Identities=25%  Similarity=0.382  Sum_probs=200.3

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec-----CeE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----YRL  225 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~-----~~~  225 (396)
                      +|++.+.||+|+||.||+|+++.++..||+|++..... .......+.+|+.+++.++||||+++++++...     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            58999999999999999999999999999999875322 222334577899999999999999999988543     358


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-  304 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-  304 (396)
                      |+||||+. ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            99999996 5888888888889999999999999999999999999999999999999999999999999998653221 


Q ss_pred             ---CccccccCCCccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------------
Q 016037          305 ---RSNSMCGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK----------------  363 (396)
Q Consensus       305 ---~~~~~~gt~~y~APE~l~~--~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~----------------  363 (396)
                         .....+||+.|+|||++.+  ..++.++|||||||++|||+||+.||.+.+.......+..                
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE  238 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence               1234579999999999876  6789999999999999999999999987664333222111                


Q ss_pred             ----------CCCCCC-----ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          364 ----------DKIKLP-----AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       364 ----------~~~~~p-----~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                .....+     +.+++++.+||++||+.+|.+|||++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~  285 (338)
T cd07859         239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAE  285 (338)
T ss_pred             hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHH
Confidence                      001111     24678899999999999999999975

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.1e-44  Score=349.51  Aligned_cols=241  Identities=37%  Similarity=0.677  Sum_probs=210.0

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++.++||+|+||+||+++++.+++.||+|++.+...........+.+|+.++..++|+||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999997654444455566788999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC--c
Q 016037          230 DFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR--S  306 (396)
Q Consensus       230 E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~--~  306 (396)
                      ||+.+|+|..++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....  .
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~  160 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  160 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence            99999999999977 46789999999999999999999999999999999999999999999999999976543222  2


Q ss_pred             cccccCCCccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCc---cCCHHH
Q 016037          307 NSMCGTLEYMSPEIVL-----GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK--IKLPA---FLSSEA  376 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~-----~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~--~~~p~---~~s~~~  376 (396)
                      ...+||+.|||||++.     ...++.++|||||||++|||++|+.||.+.+..+...++....  +.+|.   .++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~  240 (332)
T cd05623         161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA  240 (332)
T ss_pred             cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence            3457999999999986     3457899999999999999999999999999888888887653  44443   579999


Q ss_pred             HHHHHHhhccCCCC
Q 016037          377 HSLLKGVNSLLSIS  390 (396)
Q Consensus       377 ~~li~~~l~~~p~~  390 (396)
                      ++||+.||..++..
T Consensus       241 ~~li~~ll~~~~~r  254 (332)
T cd05623         241 KDLIRRLICSREHR  254 (332)
T ss_pred             HHHHHHHccChhhh
Confidence            99999999764443

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.5e-44  Score=350.16  Aligned_cols=240  Identities=37%  Similarity=0.681  Sum_probs=210.2

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++.+.||+|+||+||+++++.+++.||+|++.+...........+.+|+.++..++|+||+++++++.+....|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999998754444455566788999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC--c
Q 016037          230 DFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR--S  306 (396)
Q Consensus       230 E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~--~  306 (396)
                      ||+.||+|..++.+ ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  160 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS  160 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence            99999999999977 46789999999999999999999999999999999999999999999999999987644322  2


Q ss_pred             cccccCCCccchhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCc---cCCHHH
Q 016037          307 NSMCGTLEYMSPEIVLG-----KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPA---FLSSEA  376 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~-----~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--~~~~p~---~~s~~~  376 (396)
                      ...+||+.|||||++.+     ..++.++|||||||++|||++|+.||.+.+..+...++...  ++.+|.   .++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~  240 (331)
T cd05624         161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA  240 (331)
T ss_pred             ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence            34579999999999875     45788999999999999999999999998888888888764  345554   468999


Q ss_pred             HHHHHHhhccCCC
Q 016037          377 HSLLKGVNSLLSI  389 (396)
Q Consensus       377 ~~li~~~l~~~p~  389 (396)
                      ++||.+||...+.
T Consensus       241 ~~li~~ll~~~~~  253 (331)
T cd05624         241 KDLIQRLICSRER  253 (331)
T ss_pred             HHHHHHHccCchh
Confidence            9999999986543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=9.4e-44  Score=338.68  Aligned_cols=244  Identities=35%  Similarity=0.590  Sum_probs=210.4

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      .|++.+.||+|+||.||++.+..+++.||+|.+.+.........+.+..|+.+++.++|++|+++++.+.+...+|+|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            37888999999999999999999999999999987654444445556789999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccc
Q 016037          231 FVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (396)
Q Consensus       231 ~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~  308 (396)
                      |+++++|..++...  ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG  160 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence            99999998888654  3588999999999999999999999999999999999999999999999999987654444445


Q ss_pred             cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH-HhCCCCCCccCCHHHHHHHHHhh
Q 016037          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ---KIQQKI-IKDKIKLPAFLSSEAHSLLKGVN  384 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~---~i~~~i-~~~~~~~p~~~s~~~~~li~~~l  384 (396)
                      ..|+..|+|||++.+..++.++||||||+++|+|++|+.||......   .....+ ......++..++.++++||+.||
T Consensus       161 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05630         161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLL  240 (285)
T ss_pred             CCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHh
Confidence            67999999999999988999999999999999999999999875321   222222 22234567789999999999999


Q ss_pred             ccCCCCCCCC
Q 016037          385 SLLSISVPLL  394 (396)
Q Consensus       385 ~~~p~~RPs~  394 (396)
                      +.+|.+|||.
T Consensus       241 ~~~p~~R~s~  250 (285)
T cd05630         241 CKDPKERLGC  250 (285)
T ss_pred             hcCHHHccCC
Confidence            9999999983

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.9e-44  Score=339.62  Aligned_cols=247  Identities=22%  Similarity=0.375  Sum_probs=215.7

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCC-----cEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTS-----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~  221 (396)
                      +..++|++.+.||+|+||.||+|.+...+     ..||+|.++...  .......+.+|+.+++.++||||+++++++..
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   79 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK   79 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence            34568999999999999999999987665     679999987543  23345568889999999999999999999999


Q ss_pred             cCeEEEEEEecCCCcHHHHHHHh----------------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC
Q 016037          222 KYRLYLVLDFVNGGHLFFQLYRQ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA  285 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~  285 (396)
                      ....|++|||+++++|.+++...                ..+++..++.++.|++.||.|||++|++||||||+||+++.
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~  159 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE  159 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence            99999999999999999998765                45778888999999999999999999999999999999999


Q ss_pred             CCcEEEEecccccccCCCC---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 016037          286 DGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKI  361 (396)
Q Consensus       286 ~~~ikL~Dfgla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i  361 (396)
                      ++.++|+|||+++......   ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..++...+
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI  239 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999998653322   1233456789999999988889999999999999999998 99999998888888888


Q ss_pred             HhCC-CCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          362 IKDK-IKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       362 ~~~~-~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .... ...|..++.++.+|+++||+.+|.+||+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~  274 (283)
T cd05048         240 RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFK  274 (283)
T ss_pred             HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHH
Confidence            7664 456788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.3e-44  Score=356.36  Aligned_cols=250  Identities=24%  Similarity=0.369  Sum_probs=210.3

Q ss_pred             CccccCCCeEEEeEecccCceEEEEEEEcCCC-----cEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeE
Q 016037          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTS-----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRY  217 (396)
Q Consensus       144 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~  217 (396)
                      .+.+..++|++.+.||+|+||.||+|++..++     ..||+|+++....  ....+.+.+|+.+++.+ +|+||+++++
T Consensus        32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~  109 (374)
T cd05106          32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLG  109 (374)
T ss_pred             cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEee
Confidence            34566778999999999999999999975544     5799999976532  23456678899999999 8999999999


Q ss_pred             EEEecCeEEEEEEecCCCcHHHHHHHh-----------------------------------------------------
Q 016037          218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-----------------------------------------------------  244 (396)
Q Consensus       218 ~~~~~~~~~lV~E~~~gg~L~~~l~~~-----------------------------------------------------  244 (396)
                      ++.....+|+||||+++|+|.+++..+                                                     
T Consensus       110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (374)
T cd05106         110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS  189 (374)
T ss_pred             EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence            999999999999999999999888643                                                     


Q ss_pred             -----------------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC--
Q 016037          245 -----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR--  305 (396)
Q Consensus       245 -----------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~--  305 (396)
                                       ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.......  
T Consensus       190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence                             2367788899999999999999999999999999999999999999999999987643321  


Q ss_pred             -ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHH
Q 016037          306 -SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD--KIKLPAFLSSEAHSLLK  381 (396)
Q Consensus       306 -~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~--~~~~p~~~s~~~~~li~  381 (396)
                       .....++..|||||++.+..++.++|||||||++|||++ |+.||..........++...  ....|..++++++++|.
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  349 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMK  349 (374)
T ss_pred             eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHH
Confidence             112235568999999998889999999999999999997 99999886655444444444  44567788999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      .||+.+|.+|||+.
T Consensus       350 ~cl~~dp~~RPs~~  363 (374)
T cd05106         350 MCWNLEPTERPTFS  363 (374)
T ss_pred             HHcCCChhhCcCHH
Confidence            99999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-45  Score=357.17  Aligned_cols=250  Identities=26%  Similarity=0.370  Sum_probs=216.3

Q ss_pred             CCCCccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEE
Q 016037          141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (396)
Q Consensus       141 ~~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~  220 (396)
                      ..+.|.|..+++.+...||+|+||+||+|+|.++   ||||+++.+.... ++.+.|++|+.+|++-+|-||+=+.|++.
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~  458 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACM  458 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence            3467788889999999999999999999999775   9999998876554 48899999999999999999999999998


Q ss_pred             ecCeEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          221 TKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                      ..+. .||+.||+|.+|+.+++-. ..|.....+.|++||+.||.|||.++|||||||..|||+.++++|||+|||++..
T Consensus       459 ~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  459 NPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             CCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceee
Confidence            8776 9999999999999998744 5678888899999999999999999999999999999999999999999999864


Q ss_pred             c---CCCCCccccccCCCccchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----CC
Q 016037          300 F---DENTRSNSMCGTLEYMSPEIVLG---KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-----KL  368 (396)
Q Consensus       300 ~---~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~-----~~  368 (396)
                      -   ..........|...|||||++..   ..|+.++||||||+++|||+||..||...+.+.|+--+-++..     ..
T Consensus       538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~  617 (678)
T KOG0193|consen  538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKI  617 (678)
T ss_pred             eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhh
Confidence            2   22222344568899999999964   4689999999999999999999999998888887776666622     23


Q ss_pred             CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          369 PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       369 p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      -..++.++++|+..||++++++||.+.
T Consensus       618 ~s~~pk~mk~Ll~~C~~~~~~eRP~F~  644 (678)
T KOG0193|consen  618 RSNCPKAMKRLLSDCWKFDREERPLFP  644 (678)
T ss_pred             hccCHHHHHHHHHHHHhcCcccCccHH
Confidence            346788999999999999999999874

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.1e-44  Score=361.75  Aligned_cols=240  Identities=27%  Similarity=0.422  Sum_probs=200.4

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec-----
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----  222 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~-----  222 (396)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....       ....+|+.+|+.++||||++++++|...     
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            3467999999999999999999999999999999886532       1234699999999999999998877432     


Q ss_pred             ---CeEEEEEEecCCCcHHHHHH----HhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-cEEEEec
Q 016037          223 ---YRLYLVLDFVNGGHLFFQLY----RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HVMLTDF  294 (396)
Q Consensus       223 ---~~~~lV~E~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~-~ikL~Df  294 (396)
                         ..+++||||+++ +|..++.    ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus       137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence               247799999987 4544443    346789999999999999999999999999999999999998665 7999999


Q ss_pred             ccccccCCCCCccccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------
Q 016037          295 GLAKQFDENTRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---------  364 (396)
Q Consensus       295 gla~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~---------  364 (396)
                      |+++.+.........+||+.|||||++.+. .++.++|||||||+||||++|.+||.+.+..+...++.+.         
T Consensus       216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~  295 (440)
T PTZ00036        216 GSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL  295 (440)
T ss_pred             ccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            999987655555567889999999998764 6899999999999999999999999988766555554331         


Q ss_pred             --------CC------------CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 --------KI------------KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 --------~~------------~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                              .+            .+|...+.++.+||++||+++|.+|||+.
T Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~  346 (440)
T PTZ00036        296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPI  346 (440)
T ss_pred             HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHH
Confidence                    11            13456789999999999999999999874

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-43  Score=331.67  Aligned_cols=246  Identities=33%  Similarity=0.484  Sum_probs=216.8

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc--hhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM--EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.+......  .....+.+.+|+.++++++||||+++++++.....+|+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4699999999999999999999999999999998764322  22344568889999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCc-
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-  306 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~-  306 (396)
                      ++||+++++|.+.+...+.+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++........ 
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~  161 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG  161 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence            9999999999999988888999999999999999999999999999999999999999999999999999865432211 


Q ss_pred             ---cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHH
Q 016037          307 ---NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPAFLSSEAHSLLK  381 (396)
Q Consensus       307 ---~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--~~~~p~~~s~~~~~li~  381 (396)
                         ....|+..|+|||.+.+..++.++||||||+++|||++|+.||...+......++...  ...+|..++.++.+||+
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  241 (263)
T cd06625         162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLR  241 (263)
T ss_pred             ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHH
Confidence               3456788999999999988999999999999999999999999887766655555544  45678889999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      +||+.+|.+||++.
T Consensus       242 ~~l~~~p~~Rpt~~  255 (263)
T cd06625         242 RTFVENAKKRPSAE  255 (263)
T ss_pred             HHhhcCcccCCCHH
Confidence            99999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-45  Score=359.76  Aligned_cols=256  Identities=22%  Similarity=0.371  Sum_probs=225.9

Q ss_pred             CCCCCccccCCCeEEEeEecccCceEEEEEEEcCCCc---E-EEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeee
Q 016037          140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE---I-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL  215 (396)
Q Consensus       140 ~~~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~---~-vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l  215 (396)
                      .+...|.+.-++..+.++||+|+||+||+|+.+..+.   . ||+|..+............+.+|++++++++|||||++
T Consensus       147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~  226 (474)
T KOG0194|consen  147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF  226 (474)
T ss_pred             ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence            3445566777888888999999999999999876532   3 89999886554566777888899999999999999999


Q ss_pred             eEEEEecCeEEEEEEecCCCcHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEec
Q 016037          216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDF  294 (396)
Q Consensus       216 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Df  294 (396)
                      ||+...+..++||||+|+||+|.++|++.+ .++......++.+.+.||+|||++++|||||..+|+|++.++.+||+||
T Consensus       227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDF  306 (474)
T KOG0194|consen  227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDF  306 (474)
T ss_pred             EEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcc
Confidence            999999999999999999999999999887 4999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCcc-ccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC--CCCCCc
Q 016037          295 GLAKQFDENTRSN-SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD--KIKLPA  370 (396)
Q Consensus       295 gla~~~~~~~~~~-~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~--~~~~p~  370 (396)
                      |+++.-....... ...-+..|+|||.+....|+.++|||||||++||+++ |..||.+.+..++..+|..+  +.++|.
T Consensus       307 GLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~  386 (474)
T KOG0194|consen  307 GLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS  386 (474)
T ss_pred             ccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC
Confidence            9998654222222 2235689999999999999999999999999999999 89999999999999999654  567788


Q ss_pred             cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          371 FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       371 ~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ..+.++..++++||..+|.+||+++
T Consensus       387 ~~p~~~~~~~~~c~~~~p~~R~tm~  411 (474)
T KOG0194|consen  387 KTPKELAKVMKQCWKKDPEDRPTMS  411 (474)
T ss_pred             CCHHHHHHHHHHhccCChhhccCHH
Confidence            9999999999999999999999975

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.2e-43  Score=348.32  Aligned_cols=243  Identities=28%  Similarity=0.428  Sum_probs=204.1

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      ...++|+.+++||+|+||.||+|++..+++.||||++....  .....+.+.+|+.+++.++|+||+++++++.....+|
T Consensus        71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  148 (353)
T PLN00034         71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ  148 (353)
T ss_pred             CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence            45678999999999999999999999999999999986543  2334566789999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-C
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-R  305 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~  305 (396)
                      +||||+++++|..    .....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.... .
T Consensus       149 lv~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~  224 (353)
T PLN00034        149 VLLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP  224 (353)
T ss_pred             EEEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence            9999999998853    2345677888899999999999999999999999999999999999999999998765332 2


Q ss_pred             ccccccCCCccchhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHh-CCCCCCccCCHHH
Q 016037          306 SNSMCGTLEYMSPEIVLG-----KGHDKAADWWSVGILLFEMLTGQPPFTGGN---RQKIQQKIIK-DKIKLPAFLSSEA  376 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~-----~~~~~~~DvwSlGvil~elltg~~Pf~~~~---~~~i~~~i~~-~~~~~p~~~s~~~  376 (396)
                      .....||..|+|||.+..     ...+.++|||||||++|||++|+.||....   ...+...+.. .....+..++.++
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  304 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF  304 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHH
Confidence            345679999999998843     234568999999999999999999997533   2333333332 3455677899999


Q ss_pred             HHHHHHhhccCCCCCCCCC
Q 016037          377 HSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~RPs~s  395 (396)
                      ++||++||+.+|++||++.
T Consensus       305 ~~li~~~l~~~P~~Rpt~~  323 (353)
T PLN00034        305 RHFISCCLQREPAKRWSAM  323 (353)
T ss_pred             HHHHHHHccCChhhCcCHH
Confidence            9999999999999999975

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.1e-44  Score=339.27  Aligned_cols=244  Identities=25%  Similarity=0.394  Sum_probs=201.6

Q ss_pred             CCeEEEeEecccCceEEEEEEEcC-CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC---CCCCeeeeeEEEE-----
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIG-TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIVQLRYSFQ-----  220 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l---~HpnIv~l~~~~~-----  220 (396)
                      ++|++.+.||+|+||+||+|++.. +++.||+|+++....... ......+|+.+++.+   +||||+++++++.     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            369999999999999999999854 468899999876443222 222344566666655   7999999999885     


Q ss_pred             ecCeEEEEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccc
Q 016037          221 TKYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK  298 (396)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~  298 (396)
                      ....+++||||+.+ +|..++...  ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        80 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          80 RETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             CCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            34568999999975 787777653  458899999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CC----------
Q 016037          299 QFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-IK----------  367 (396)
Q Consensus       299 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~-~~----------  367 (396)
                      ............||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.+..+...++.... .+          
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (290)
T cd07862         159 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  238 (290)
T ss_pred             eccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence            7665545556679999999999998889999999999999999999999999988777776665421 00          


Q ss_pred             ----------------CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          368 ----------------LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       368 ----------------~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                      +.+.++..+++||.+||+.+|++|||+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~  282 (290)
T cd07862         239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY  282 (290)
T ss_pred             ccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHH
Confidence                            1135788899999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.6e-43  Score=344.87  Aligned_cols=245  Identities=26%  Similarity=0.438  Sum_probs=209.6

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      ..++|++.++||+|+||.||++.+..++..+|+|++....  .....+.+.+|+++++.++||||++++++|.....+|+
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            3478999999999999999999999999999999987643  23345567889999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEecccccccCCCCCc
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS  306 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~-~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~  306 (396)
                      ||||+.+++|.+++.+.+.+++..++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||++...... ..
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~  159 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA  159 (333)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-cc
Confidence            999999999999999888899999999999999999999985 7999999999999999999999999999765432 22


Q ss_pred             cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------------------------
Q 016037          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQK--------------------------  360 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~--------------------------  360 (396)
                      ....|+..|+|||.+.+..++.++|||||||++|||++|+.||...+...+...                          
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (333)
T cd06650         160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS  239 (333)
T ss_pred             ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhh
Confidence            345789999999999998899999999999999999999999986554333211                          


Q ss_pred             ------------------HHhC-CCCCCc-cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          361 ------------------IIKD-KIKLPA-FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       361 ------------------i~~~-~~~~p~-~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                        +... ...++. ..+.++++||.+||+.||.+|||+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~  294 (333)
T cd06650         240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLK  294 (333)
T ss_pred             hhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHH
Confidence                              1111 112222 3678999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.5e-43  Score=339.95  Aligned_cols=245  Identities=20%  Similarity=0.275  Sum_probs=205.2

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcC----------------CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCe
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIG----------------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI  212 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~----------------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnI  212 (396)
                      .++|++.++||+|+||.||+|.+..                ++..||+|+++...  .......+.+|+.++++++||||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence            4689999999999999999998643                34579999987643  23345567889999999999999


Q ss_pred             eeeeEEEEecCeEEEEEEecCCCcHHHHHHHhc-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 016037          213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-------------------LFREDLARIYTAEIVSAVSHLHANGIMH  273 (396)
Q Consensus       213 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-------------------~l~e~~~~~~~~qi~~aL~~LH~~~iiH  273 (396)
                      +++++++......++||||+.+|+|.+++....                   .+++..++.++.||+.||.|||++||+|
T Consensus        82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH  161 (304)
T cd05096          82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH  161 (304)
T ss_pred             eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            999999999999999999999999998886532                   3566778899999999999999999999


Q ss_pred             ccCCCCCEEEcCCCcEEEEecccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh--CCCC
Q 016037          274 RDLKPENILLDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT--GQPP  348 (396)
Q Consensus       274 rDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt--g~~P  348 (396)
                      |||||+|||++.++.+||+|||+++.......   .....++..|||||++.+..++.++||||||+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986543321   223456789999999988889999999999999999986  6789


Q ss_pred             CCCCCHHHHHHHHHhC--------CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          349 FTGGNRQKIQQKIIKD--------KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       349 f~~~~~~~i~~~i~~~--------~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      |.+.+..++...+...        ....|..++..+.+||.+||+.+|.+|||+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~  296 (304)
T cd05096         242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFS  296 (304)
T ss_pred             CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHH
Confidence            9887766655544321        2234567899999999999999999999975

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.7e-43  Score=332.23  Aligned_cols=245  Identities=22%  Similarity=0.353  Sum_probs=215.9

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +...+|.+.+.||+|+||.||+|.++.+++.||+|++..+.    .....+.+|+++++.++||||+++++++.....++
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (263)
T cd05052           3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   78 (263)
T ss_pred             CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence            45678999999999999999999999999999999987543    23445778999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          227 LVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      ++|||+++++|..++...  ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            999999999999988654  357888999999999999999999999999999999999999999999999998765432


Q ss_pred             Cc--cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHH
Q 016037          305 RS--NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLL  380 (396)
Q Consensus       305 ~~--~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li  380 (396)
                      ..  ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+... +...|..++.++.++|
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (263)
T cd05052         159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELM  238 (263)
T ss_pred             eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence            21  12234568999999998889999999999999999998 99999998888888877765 6677888999999999


Q ss_pred             HHhhccCCCCCCCCC
Q 016037          381 KGVNSLLSISVPLLS  395 (396)
Q Consensus       381 ~~~l~~~p~~RPs~s  395 (396)
                      ++||+.+|.+||++.
T Consensus       239 ~~cl~~~p~~Rp~~~  253 (263)
T cd05052         239 RACWQWNPSDRPSFA  253 (263)
T ss_pred             HHHccCCcccCCCHH
Confidence            999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=337.87  Aligned_cols=244  Identities=28%  Similarity=0.421  Sum_probs=207.6

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe-----cCe
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-----KYR  224 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~-----~~~  224 (396)
                      ..|..++.||+|+||.|+.+.++.+|+.||||.+... +......++..+|+++|+.++|+||+.+++.+..     -..
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            4566689999999999999999999999999998743 2344566778889999999999999999999865     357


Q ss_pred             EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC--
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE--  302 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~--  302 (396)
                      +|+|+|+|+ .+|...++.+..+++++++.+++|+++||.|+|+.+|+||||||.|+|++.+..+||+|||+|+....  
T Consensus       101 vYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  101 VYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF  179 (359)
T ss_pred             eEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence            899999994 47888888877799999999999999999999999999999999999999999999999999998864  


Q ss_pred             -CCCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------------------
Q 016037          303 -NTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII------------------  362 (396)
Q Consensus       303 -~~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~------------------  362 (396)
                       ......++.|.+|+|||++.. ..|+.+.||||.||+|.||++|++.|.|.+.-+.++.|.                  
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence             344566788999999999854 679999999999999999999999999975443333332                  


Q ss_pred             -----hCCCCCC--------ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          363 -----KDKIKLP--------AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       363 -----~~~~~~p--------~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                           +.-+..|        +..++.+.+|+.+||.+||.+|+|+.
T Consensus       260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~  305 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAE  305 (359)
T ss_pred             HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHH
Confidence                 1111111        36899999999999999999999964

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3e-43  Score=328.58  Aligned_cols=243  Identities=32%  Similarity=0.543  Sum_probs=215.6

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      +|++.+.||+|+||.||++.+..++..||+|.++....  ....+.+.+|+.+++.++|+||+++++.+..+..+|++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            58899999999999999999999999999999875432  2345567789999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Ccc
Q 016037          231 FVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSN  307 (396)
Q Consensus       231 ~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~~  307 (396)
                      |+++++|..++...  ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....... ...
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence            99999998887643  457899999999999999999999999999999999999999999999999998764322 233


Q ss_pred             ccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHHHHhhcc
Q 016037          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAHSLLKGVNSL  386 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~-~~p~~~s~~~~~li~~~l~~  386 (396)
                      ...|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.......+..+.. .+|..++.++++||++||+.
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  238 (255)
T cd08219         159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKR  238 (255)
T ss_pred             cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhC
Confidence            45688999999999988899999999999999999999999999888887777776643 56788999999999999999


Q ss_pred             CCCCCCCCC
Q 016037          387 LSISVPLLS  395 (396)
Q Consensus       387 ~p~~RPs~s  395 (396)
                      +|.+||++.
T Consensus       239 ~P~~Rp~~~  247 (255)
T cd08219         239 NPRSRPSAT  247 (255)
T ss_pred             CcccCCCHH
Confidence            999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-43  Score=351.94  Aligned_cols=239  Identities=26%  Similarity=0.324  Sum_probs=199.7

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +...+|++++.||+|+||.||+|++..+++.||+|....         ..+.+|+++|+.++||||++++++|......+
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~  159 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC  159 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence            455789999999999999999999999999999997542         23567999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC--C
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--T  304 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~--~  304 (396)
                      +|+|++. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  .
T Consensus       160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            9999996 578888888888999999999999999999999999999999999999999999999999999754322  2


Q ss_pred             CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHH---------------
Q 016037          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN-------RQKIQQKII---------------  362 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~-------~~~i~~~i~---------------  362 (396)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+       .......+.               
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            2345679999999999999899999999999999999999998876421       111111111               


Q ss_pred             -----------hCCCCCC---------ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          363 -----------KDKIKLP---------AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       363 -----------~~~~~~p---------~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                 ......|         ..++.++.+||.+||++||.+|||++
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~  371 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAE  371 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHH
Confidence                       1101111         13567899999999999999999975

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=9.4e-44  Score=352.11  Aligned_cols=248  Identities=23%  Similarity=0.349  Sum_probs=207.0

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEE-----cCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRR-----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSF  219 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~  219 (396)
                      .+..++|++.+.||+|+||+||+|.+     ..++..||+|+++....  ....+.+.+|+.+|+.+ +||||+++++++
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~  108 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGAC  108 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence            35567899999999999999999975     34567899999875432  23345678899999999 899999999999


Q ss_pred             EecCeEEEEEEecCCCcHHHHHHHhc------------------------------------------------------
Q 016037          220 QTKYRLYLVLDFVNGGHLFFQLYRQG------------------------------------------------------  245 (396)
Q Consensus       220 ~~~~~~~lV~E~~~gg~L~~~l~~~~------------------------------------------------------  245 (396)
                      ......|+||||+++|+|..++....                                                      
T Consensus       109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence            99999999999999999998886532                                                      


Q ss_pred             ---------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          246 ---------------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       246 ---------------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                                           .+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++......
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence                                 36777888999999999999999999999999999999999999999999998764332


Q ss_pred             C---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHHHhC-CCCCCccCCHHHHH
Q 016037          305 R---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQ-KIQQKIIKD-KIKLPAFLSSEAHS  378 (396)
Q Consensus       305 ~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~-~i~~~i~~~-~~~~p~~~s~~~~~  378 (396)
                      .   .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.... ...+.+..+ +...|...+.++++
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  348 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYD  348 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHH
Confidence            1   122335678999999999999999999999999999998 99999876544 334444433 34556778999999


Q ss_pred             HHHHhhccCCCCCCCCC
Q 016037          379 LLKGVNSLLSISVPLLS  395 (396)
Q Consensus       379 li~~~l~~~p~~RPs~s  395 (396)
                      ||..||+.+|.+|||++
T Consensus       349 li~~cl~~dP~~RPs~~  365 (375)
T cd05104         349 IMKSCWDADPLKRPTFK  365 (375)
T ss_pred             HHHHHccCChhHCcCHH
Confidence            99999999999999975

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.6e-43  Score=346.57  Aligned_cols=244  Identities=26%  Similarity=0.387  Sum_probs=201.5

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC----
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY----  223 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~----  223 (396)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++....    
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            35789999999999999999999999999999999976432 2334455678999999999999999999986543    


Q ss_pred             --eEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          224 --RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       224 --~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                        .+|+||||++++ |...+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        98 ~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~  174 (359)
T cd07876          98 FQDVYLVMELMDAN-LCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC  174 (359)
T ss_pred             cceeEEEEeCCCcC-HHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence              579999999875 444443  347888999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------------------
Q 016037          302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII-------------------  362 (396)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~-------------------  362 (396)
                      .........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.                   
T Consensus       175 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (359)
T cd07876         175 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR  254 (359)
T ss_pred             cCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence            5444455678999999999999999999999999999999999999998766433322221                   


Q ss_pred             ---hCCCCC--------------------CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          363 ---KDKIKL--------------------PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       363 ---~~~~~~--------------------p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                         ..+...                    ....+.++++||.+||+.||.+|||+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~  310 (359)
T cd07876         255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVD  310 (359)
T ss_pred             HHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHH
Confidence               111111                    112467899999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=6.7e-43  Score=325.60  Aligned_cols=244  Identities=31%  Similarity=0.524  Sum_probs=217.1

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      +|.+.+.||+|++|.||+|.++.+++.|++|.+...... ....+.+.+|+.+++.++||||+++++++......|+|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            588999999999999999999999999999998765433 3345567889999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC-cc
Q 016037          231 FVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SN  307 (396)
Q Consensus       231 ~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~-~~  307 (396)
                      |+++++|..++...  ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.+..... ..
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  159 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN  159 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence            99999999988764  5788999999999999999999999999999999999999999999999999987654322 23


Q ss_pred             ccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHHHHhhcc
Q 016037          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAHSLLKGVNSL  386 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~-~~p~~~s~~~~~li~~~l~~  386 (396)
                      ...|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+......++..+.. .++..++.++.++|.+||+.
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  239 (256)
T cd08529         160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTK  239 (256)
T ss_pred             ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccC
Confidence            45688999999999998899999999999999999999999998888887887777643 55668999999999999999


Q ss_pred             CCCCCCCCC
Q 016037          387 LSISVPLLS  395 (396)
Q Consensus       387 ~p~~RPs~s  395 (396)
                      +|++||++.
T Consensus       240 ~p~~Rp~~~  248 (256)
T cd08529         240 DYRQRPDTF  248 (256)
T ss_pred             CcccCcCHH
Confidence            999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.8e-43  Score=339.73  Aligned_cols=247  Identities=22%  Similarity=0.365  Sum_probs=210.1

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEE--EEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecC
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIY--AMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKY  223 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~v--AvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~  223 (396)
                      +..++|++.+.||+|+||.||+|.++.++..+  |+|.+...  ........+.+|+.++.++ +||||+++++++....
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~   81 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   81 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence            45678999999999999999999998877654  66665432  2334456678899999999 8999999999999999


Q ss_pred             eEEEEEEecCCCcHHHHHHHhc----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~  287 (396)
                      .+|+||||+++++|..++.+.+                .+++..++.++.|++.||+|||++|++||||||+|||++.++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  161 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence            9999999999999999887543                468889999999999999999999999999999999999999


Q ss_pred             cEEEEecccccccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-C
Q 016037          288 HVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-K  365 (396)
Q Consensus       288 ~ikL~Dfgla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~  365 (396)
                      .+||+|||++.............++..|+|||.+.+..++.++|||||||++|||+| |..||.+.+..+..+.+... .
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~  241 (303)
T cd05088         162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  241 (303)
T ss_pred             cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCc
Confidence            999999999864332222222334678999999988889999999999999999998 99999988888777777554 4


Q ss_pred             CCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 IKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 ~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ...|..+++++.+||.+||+.+|.+||++.
T Consensus       242 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~  271 (303)
T cd05088         242 LEKPLNCDDEVYDLMRQCWREKPYERPSFA  271 (303)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence            456677899999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.8e-44  Score=355.32  Aligned_cols=248  Identities=32%  Similarity=0.585  Sum_probs=234.8

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      ....|.+.+.||+|.|++|.+|++..++..||||++.+........ +.+.+|+++|+.++|||||+++.+...+..+|+
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~-~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKR-QKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHH-HHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            3467999999999999999999999999999999998877554443 448889999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCcc
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN  307 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~  307 (396)
                      ||||..+|.+++++.+++.+.+..++.++.|++.|++|||+++|+|||||.+|||++.+..+||+|||++..+.......
T Consensus       133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lq  212 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQ  212 (596)
T ss_pred             EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999888889


Q ss_pred             ccccCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhcc
Q 016037          308 SMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSL  386 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~  386 (396)
                      +.||++.|.|||++.+..| .+.+|+||+|++||-|++|..||.+.+..++......+++.+|..+|-+..+||+.+|-.
T Consensus       213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl  292 (596)
T KOG0586|consen  213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKFLVL  292 (596)
T ss_pred             ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHHhhcc
Confidence            9999999999999999877 589999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCC
Q 016037          387 LSISVPLLSR  396 (396)
Q Consensus       387 ~p~~RPs~s~  396 (396)
                      +|.+|++++|
T Consensus       293 ~Pskr~~~dq  302 (596)
T KOG0586|consen  293 NPSKRGPCDQ  302 (596)
T ss_pred             CccccCCHHH
Confidence            9999999864

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.8e-44  Score=338.05  Aligned_cols=236  Identities=32%  Similarity=0.508  Sum_probs=203.5

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC-----eE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----RL  225 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~-----~~  225 (396)
                      .|.-.+++|.|+||.||+|....+++.||||.+-.+.       ++-.+|+.+|+.++|||||+|..+|....     .+
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l   97 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL   97 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence            4888999999999999999999999999999986543       23456999999999999999998885432     45


Q ss_pred             EEEEEecCCCcHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC-CcEEEEeccccccc
Q 016037          226 YLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQF  300 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~-~~ikL~Dfgla~~~  300 (396)
                      .+|||||+. +|...++.    +..++.-.++.|.+||++||.|||+.||+||||||+|+|+|.+ |.+||||||.|+.+
T Consensus        98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen   98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            689999987 67776664    5678888899999999999999999999999999999999987 89999999999999


Q ss_pred             CCCCCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------------
Q 016037          301 DENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---------------  364 (396)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~---------------  364 (396)
                      ..+....++..|..|+|||.+.+ ..|+.+.||||.||+|.||+-|++.|.|.+..+....|.+-               
T Consensus       177 ~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~  256 (364)
T KOG0658|consen  177 VKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN  256 (364)
T ss_pred             ccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence            88888888999999999999988 56999999999999999999999999998765555555421               


Q ss_pred             --CCC------------CCccCCHHHHHHHHHhhccCCCCCCCC
Q 016037          365 --KIK------------LPAFLSSEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       365 --~~~------------~p~~~s~~~~~li~~~l~~~p~~RPs~  394 (396)
                        ...            +...+++++.+|++++|.++|.+|-+.
T Consensus       257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~  300 (364)
T KOG0658|consen  257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSA  300 (364)
T ss_pred             cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCH
Confidence              111            223578999999999999999999875

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.1e-43  Score=331.78  Aligned_cols=245  Identities=27%  Similarity=0.424  Sum_probs=209.6

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.++++++||||+++++++..+..+|+
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i   83 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI   83 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence            3468999999999999999999999999999999987543   2233457789999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Cc
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RS  306 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~  306 (396)
                      ||||+++++|.+++.+.+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....... ..
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06646          84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR  163 (267)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence            99999999999999888889999999999999999999999999999999999999999999999999998764332 23


Q ss_pred             cccccCCCccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-----CccCCHHHHH
Q 016037          307 NSMCGTLEYMSPEIVL---GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKL-----PAFLSSEAHS  378 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~---~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~-----p~~~s~~~~~  378 (396)
                      ....|+..|+|||.+.   ...++.++|||||||++|||++|+.||...+.......+....+..     +..++.++++
T Consensus       164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (267)
T cd06646         164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN  243 (267)
T ss_pred             CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHH
Confidence            4457889999999985   3447889999999999999999999997765544444443333322     2357899999


Q ss_pred             HHHHhhccCCCCCCCCC
Q 016037          379 LLKGVNSLLSISVPLLS  395 (396)
Q Consensus       379 li~~~l~~~p~~RPs~s  395 (396)
                      ||+.||+.+|++||+++
T Consensus       244 li~~~l~~~P~~Rp~~~  260 (267)
T cd06646         244 FVKISLTKNPKKRPTAE  260 (267)
T ss_pred             HHHHHhhCChhhCcCHH
Confidence            99999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=356.43  Aligned_cols=251  Identities=37%  Similarity=0.652  Sum_probs=240.2

Q ss_pred             CCccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       143 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      +...+.+.+++++..||-|+||.|-++..+.....+|+|++++..+.+....+.+..|.++|..++.|+||++|..|.+.
T Consensus       413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~  492 (732)
T KOG0614|consen  413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS  492 (732)
T ss_pred             hhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc
Confidence            34456778899999999999999999999887777999999998888888889999999999999999999999999999


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      ..+|+.||-|-||.+...+..++.|.+..++.|+..+++|++|||++|||+|||||+|.+++.+|-+||.|||+|+.+..
T Consensus       493 kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~  572 (732)
T KOG0614|consen  493 KYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS  572 (732)
T ss_pred             hhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHH
Q 016037          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPAFLSSEAHSLL  380 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--~~~~p~~~s~~~~~li  380 (396)
                      +.++.++||||.|.|||++.+++++.++|.||||+++|||++|.+||.+.+++..++.|.++  .+.+|..++..+.+||
T Consensus       573 g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li  652 (732)
T KOG0614|consen  573 GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLI  652 (732)
T ss_pred             CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHH
Confidence            99999999999999999999999999999999999999999999999999999999999997  7899999999999999


Q ss_pred             HHhhccCCCCCCC
Q 016037          381 KGVNSLLSISVPL  393 (396)
Q Consensus       381 ~~~l~~~p~~RPs  393 (396)
                      +.++.-+|.+|--
T Consensus       653 k~LCr~~P~ERLG  665 (732)
T KOG0614|consen  653 KKLCRDNPTERLG  665 (732)
T ss_pred             HHHHhcCcHhhhc
Confidence            9999999999854

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.6e-43  Score=339.42  Aligned_cols=246  Identities=23%  Similarity=0.378  Sum_probs=209.3

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcE----EEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEI----YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      +...+|++.+.||+|+||.||+|.+..+++.    ||+|+++...  .....+.+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~   81 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   81 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence            3456899999999999999999998776664    8999986532  233455678899999999999999999998764


Q ss_pred             CeEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                       ..++++||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence             578999999999999988764 468888899999999999999999999999999999999999999999999998765


Q ss_pred             CCCCc---cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHH
Q 016037          302 ENTRS---NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (396)
Q Consensus       302 ~~~~~---~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~  376 (396)
                      .....   ....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+....++.+.+... .++.|..++.++
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV  240 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence            43322   22334678999999999999999999999999999998 99999988777766555443 456677899999


Q ss_pred             HHHHHHhhccCCCCCCCCC
Q 016037          377 HSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~RPs~s  395 (396)
                      .++|..||..+|.+||++.
T Consensus       241 ~~li~~cl~~~p~~Rps~~  259 (316)
T cd05108         241 YMIMVKCWMIDADSRPKFR  259 (316)
T ss_pred             HHHHHHHccCChhhCcCHH
Confidence            9999999999999999975

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7.6e-43  Score=326.65  Aligned_cols=237  Identities=22%  Similarity=0.339  Sum_probs=206.4

Q ss_pred             EecccCceEEEEEEE--cCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCC
Q 016037          157 VVGQGAFAKVYQVRR--IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (396)
Q Consensus       157 ~IG~G~fG~Vy~~~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (396)
                      +||+|+||.||+|.+  ..++..+|+|+++.... .....+.+.+|+.+++.++||||+++++++. ....++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence            589999999999976  45678999999875432 3344566788999999999999999998875 4567999999999


Q ss_pred             CcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC----ccccc
Q 016037          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR----SNSMC  310 (396)
Q Consensus       235 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~----~~~~~  310 (396)
                      ++|..++...+.+++..+..++.|++.||.|||++|++||||||.||+++.++.+||+|||+++.......    .....
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05116          80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK  159 (257)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence            99999998888899999999999999999999999999999999999999999999999999987643322    12223


Q ss_pred             cCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHHhhccCC
Q 016037          311 GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGVNSLLS  388 (396)
Q Consensus       311 gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p  388 (396)
                      ++..|+|||.+.+..++.++|||||||++|||++ |+.||.+.+..++.+.+.++ ...+|..+++++++||.+||+.+|
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p  239 (257)
T cd05116         160 WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGV  239 (257)
T ss_pred             CCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCc
Confidence            4679999999988889999999999999999998 99999998888888888775 457788899999999999999999


Q ss_pred             CCCCCCC
Q 016037          389 ISVPLLS  395 (396)
Q Consensus       389 ~~RPs~s  395 (396)
                      ++||+++
T Consensus       240 ~~Rp~~~  246 (257)
T cd05116         240 DERPGFA  246 (257)
T ss_pred             hhCcCHH
Confidence            9999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=7.4e-43  Score=327.88  Aligned_cols=246  Identities=30%  Similarity=0.477  Sum_probs=211.1

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++.+.||+|+||.||+|+++.+++.||+|.+.............+.+|+.+++.++||||+++++++.....+++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57999999999999999999999999999999987654444555666788999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC
Q 016037          230 DFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       230 E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~  305 (396)
                      ||+++++|..++..    ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~  161 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence            99999999877753    34588999999999999999999999999999999999999999999999999987654322


Q ss_pred             -ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCC-CCCC-ccCCHHHHHHH
Q 016037          306 -SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN--RQKIQQKIIKDK-IKLP-AFLSSEAHSLL  380 (396)
Q Consensus       306 -~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~--~~~i~~~i~~~~-~~~p-~~~s~~~~~li  380 (396)
                       .....|++.|+|||.+.+..++.++|+||||+++|||++|+.||....  ...+.+.+.... .+.+ ..++..+++||
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  241 (267)
T cd08228         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELV  241 (267)
T ss_pred             HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHH
Confidence             234568899999999998889999999999999999999999997653  344555554432 2332 36788999999


Q ss_pred             HHhhccCCCCCCCCC
Q 016037          381 KGVNSLLSISVPLLS  395 (396)
Q Consensus       381 ~~~l~~~p~~RPs~s  395 (396)
                      ++||+.+|.+||++.
T Consensus       242 ~~cl~~~p~~Rp~~~  256 (267)
T cd08228         242 SMCIYPDPDQRPDIG  256 (267)
T ss_pred             HHHCCCCcccCcCHH
Confidence            999999999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1e-44  Score=327.00  Aligned_cols=247  Identities=28%  Similarity=0.489  Sum_probs=224.4

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeecccc-----chhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEec
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI-----MEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTK  222 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~-----~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~  222 (396)
                      ...|+--+.||+|..+.|-++..+.+|..+|+|++.....     ......+.-..|+.+|+++ .||+|+++.++|++.
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            3457777889999999999999999999999999965221     1223445566799999997 699999999999999


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      ..+++|+|.|+.|.|++++...-.++|...+.++.|+++|++|||.++|+||||||+|||++++.++||+|||+++.+..
T Consensus        96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~  175 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP  175 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCccccccCCCccchhhhcC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccC
Q 016037          303 NTRSNSMCGTLEYMSPEIVLG------KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFL  372 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~------~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~~~  372 (396)
                      +.+....||||.|+|||.+..      .+|+..+|+|++||+||.|+.|.+||+....+-+...|..+++.|-    ..+
T Consensus       176 GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadi  255 (411)
T KOG0599|consen  176 GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADI  255 (411)
T ss_pred             chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhc
Confidence            999999999999999999853      4688999999999999999999999999999999999999988774    368


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCC
Q 016037          373 SSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       373 s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      |.++++||.+||+.||++|-|..
T Consensus       256 s~~~KdLIsrlLqVdp~~Ritak  278 (411)
T KOG0599|consen  256 SATVKDLISRLLQVDPTKRITAK  278 (411)
T ss_pred             cccHHHHHHHHHeeCchhcccHH
Confidence            99999999999999999998753

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2e-42  Score=332.38  Aligned_cols=245  Identities=38%  Similarity=0.677  Sum_probs=216.9

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+...........+.+.+|+++++.++||||+++++.+..+..+|+||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36999999999999999999999999999999998765444455567788999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-----
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-----  304 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-----  304 (396)
                      ||++|++|..++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++......     
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY  160 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999986421100     


Q ss_pred             -----------CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc---
Q 016037          305 -----------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA---  370 (396)
Q Consensus       305 -----------~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~---  370 (396)
                                 ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||.+.+..++.+.+....+..|.   
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (305)
T cd05609         161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE  240 (305)
T ss_pred             ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccc
Confidence                       011245788999999998888999999999999999999999999998888888888877555443   


Q ss_pred             cCCHHHHHHHHHhhccCCCCCCCC
Q 016037          371 FLSSEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       371 ~~s~~~~~li~~~l~~~p~~RPs~  394 (396)
                      .++.++.+||++||+.+|.+||+.
T Consensus       241 ~~~~~~~~li~~~l~~~P~~R~~~  264 (305)
T cd05609         241 ALPADAQDLISRLLRQNPLERLGT  264 (305)
T ss_pred             cCCHHHHHHHHHHhccChhhccCc
Confidence            589999999999999999999984

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.8e-43  Score=329.97  Aligned_cols=243  Identities=36%  Similarity=0.581  Sum_probs=208.9

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEe
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (396)
                      |++.+.||+|+||+||++++..+++.||+|++......... .....+|+.+++.++||||+++++++......+++|||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence            78999999999999999999999999999999887543333 22335599999999999999999999999999999999


Q ss_pred             cCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccccc-CCCCCccccc
Q 016037          232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMC  310 (396)
Q Consensus       232 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~-~~~~~~~~~~  310 (396)
                      +.+++|..++...+.+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+... ..........
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  159 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV  159 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999998899999999999999999999999999999999999999999999999999999763 2334455677


Q ss_pred             cCCCccchhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCC----ccCCHHHHHHHHH
Q 016037          311 GTLEYMSPEIVL-GKGHDKAADWWSVGILLFEMLTGQPPFTGGN---RQKIQQKIIKDKIKLP----AFLSSEAHSLLKG  382 (396)
Q Consensus       311 gt~~y~APE~l~-~~~~~~~~DvwSlGvil~elltg~~Pf~~~~---~~~i~~~i~~~~~~~p----~~~s~~~~~li~~  382 (396)
                      ++..|+|||++. +..++.++||||||+++|+|++|..||...+   ......+........+    ...+.++.++|+.
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  239 (260)
T PF00069_consen  160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKK  239 (260)
T ss_dssp             SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHH
Confidence            899999999998 7889999999999999999999999999873   3333333333222111    1234899999999


Q ss_pred             hhccCCCCCCCCC
Q 016037          383 VNSLLSISVPLLS  395 (396)
Q Consensus       383 ~l~~~p~~RPs~s  395 (396)
                      ||+.+|.+||++.
T Consensus       240 ~l~~~p~~R~~~~  252 (260)
T PF00069_consen  240 MLSKDPEQRPSAE  252 (260)
T ss_dssp             HSSSSGGGSTTHH
T ss_pred             HccCChhHCcCHH
Confidence            9999999999974

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=7.9e-43  Score=332.35  Aligned_cols=246  Identities=20%  Similarity=0.346  Sum_probs=213.8

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEc-----CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~  221 (396)
                      +...+|.+.+.||+|+||+||++...     .++..+|+|.+....   ....+.+.+|+.++++++||||+++++++..
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVE   78 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            34568999999999999999999853     345679999887542   3345567889999999999999999999999


Q ss_pred             cCeEEEEEEecCCCcHHHHHHHhc-------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc
Q 016037          222 KYRLYLVLDFVNGGHLFFQLYRQG-------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~-------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~  288 (396)
                      ...+|++|||+++++|..++...+             .+++..++.++.|++.||+|||++|++||||||+|||++.++.
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL  158 (288)
T ss_pred             CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence            999999999999999999887554             3899999999999999999999999999999999999999999


Q ss_pred             EEEEecccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC
Q 016037          289 VMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD  364 (396)
Q Consensus       289 ikL~Dfgla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~  364 (396)
                      +||+|||+++.......   .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..++...+..+
T Consensus       159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~  238 (288)
T cd05093         159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG  238 (288)
T ss_pred             EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999986543221   223345778999999998889999999999999999999 99999998888888888877


Q ss_pred             C-CCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 K-IKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 ~-~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      . ...+..++.++.+|+.+||+.+|.+|||+.
T Consensus       239 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  270 (288)
T cd05093         239 RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIK  270 (288)
T ss_pred             CcCCCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence            5 456778999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3e-43  Score=329.17  Aligned_cols=244  Identities=39%  Similarity=0.680  Sum_probs=221.1

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      +|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|++++++++||||+++++++.....+|+|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            48999999999999999999999999999999987655454566778899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccccc
Q 016037          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMC  310 (396)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~~  310 (396)
                      |+.+++|..++.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.............
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~  160 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS  160 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccC
Confidence            99999999999887889999999999999999999999999999999999999999999999999998776554445567


Q ss_pred             cCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccC
Q 016037          311 GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN---RQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLL  387 (396)
Q Consensus       311 gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~---~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~  387 (396)
                      |+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+   ...+.+........+|..++.++.++|.+||+.+
T Consensus       161 ~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  240 (258)
T cd05578         161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERD  240 (258)
T ss_pred             CChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccCC
Confidence            8899999999998889999999999999999999999999877   4555555554667888899999999999999999


Q ss_pred             CCCCCCC
Q 016037          388 SISVPLL  394 (396)
Q Consensus       388 p~~RPs~  394 (396)
                      |.+||+.
T Consensus       241 p~~R~~~  247 (258)
T cd05578         241 PQKRLGD  247 (258)
T ss_pred             hhHcCCc
Confidence            9999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=8.5e-43  Score=329.90  Aligned_cols=247  Identities=20%  Similarity=0.291  Sum_probs=210.0

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~  221 (396)
                      +..++|++.+.||+|+||.||+|.+++     ++..||+|++.....  ......+.+|+.+++.++||||+++++++..
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~   80 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   80 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            455789999999999999999998753     356799999865331  2233457789999999999999999999999


Q ss_pred             cCeEEEEEEecCCCcHHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEE
Q 016037          222 KYRLYLVLDFVNGGHLFFQLYRQG----------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVML  291 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~----------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL  291 (396)
                      ....++||||+++++|..++....          .++...+..++.|++.||.|||+.|++||||||+||+++.++.++|
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999998886532          2466778889999999999999999999999999999999999999


Q ss_pred             EecccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-C
Q 016037          292 TDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDK-I  366 (396)
Q Consensus       292 ~Dfgla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~~-~  366 (396)
                      +|||+++.......   .....+++.|||||.+.+..++.++|||||||++|||++ |..||.+.+..+....+.... .
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~  240 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL  240 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            99999976533221   122345778999999998889999999999999999999 799999988888777776654 4


Q ss_pred             CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 ~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .++..++..+.+||.+||+.+|.+|||+.
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~  269 (277)
T cd05062         241 DKPDNCPDMLFELMRMCWQYNPKMRPSFL  269 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence            67788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=9e-43  Score=326.45  Aligned_cols=245  Identities=20%  Similarity=0.347  Sum_probs=211.9

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~  225 (396)
                      .+..++|+++++||+|+||.||+|.+. ++..||+|.+....    ...+.+.+|+.+++.++|+||+++++++......
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05072           2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI   76 (261)
T ss_pred             cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            356688999999999999999999975 45669999887543    2345678899999999999999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          226 YLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      |++|||+++++|..++...  ..+++..++.++.|++.||.|||+.+++||||||+||+++.++.++|+|||++......
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            9999999999999988653  46788888999999999999999999999999999999999999999999999876543


Q ss_pred             CC--ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHH
Q 016037          304 TR--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSL  379 (396)
Q Consensus       304 ~~--~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~l  379 (396)
                      ..  .....++..|+|||.+.+..++.++|||||||++|+|+| |..||.+.+.......+... ..+.+..++.++.+|
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDI  236 (261)
T ss_pred             ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            22  122345678999999988889999999999999999998 99999988887777777655 445556789999999


Q ss_pred             HHHhhccCCCCCCCCC
Q 016037          380 LKGVNSLLSISVPLLS  395 (396)
Q Consensus       380 i~~~l~~~p~~RPs~s  395 (396)
                      +++||+.+|++||+++
T Consensus       237 i~~~l~~~p~~Rp~~~  252 (261)
T cd05072         237 MKTCWKEKAEERPTFD  252 (261)
T ss_pred             HHHHccCCcccCcCHH
Confidence            9999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=6.9e-43  Score=326.55  Aligned_cols=243  Identities=22%  Similarity=0.379  Sum_probs=210.9

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      +.++|++.+.||+|+||.||++.++. +..+|+|.+......    .+.+.+|+.+++.++||||+++++++.....+++
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   76 (256)
T cd05114           2 NPSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI   76 (256)
T ss_pred             CHHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence            34679999999999999999998865 456999988754322    2346779999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCc
Q 016037          228 VLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS  306 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~  306 (396)
                      ||||+++|+|.+++... +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++........
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence            99999999999888653 56889999999999999999999999999999999999999999999999999865432221


Q ss_pred             --cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHH
Q 016037          307 --NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKG  382 (396)
Q Consensus       307 --~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~~  382 (396)
                        ....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+..+ .+..|...+.++.+|+.+
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS  236 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence              22235668999999998889999999999999999999 99999998888888888776 455677889999999999


Q ss_pred             hhccCCCCCCCCC
Q 016037          383 VNSLLSISVPLLS  395 (396)
Q Consensus       383 ~l~~~p~~RPs~s  395 (396)
                      ||+.+|.+|||+.
T Consensus       237 c~~~~p~~Rps~~  249 (256)
T cd05114         237 CWHEKPEGRPTFA  249 (256)
T ss_pred             HccCCcccCcCHH
Confidence            9999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.7e-43  Score=344.09  Aligned_cols=244  Identities=25%  Similarity=0.386  Sum_probs=202.8

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec-----
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----  222 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~-----  222 (396)
                      ..++|++.+.||+|+||.||++.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++...     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            35789999999999999999999999999999999876432 233445567899999999999999999988643     


Q ss_pred             -CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          223 -YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       223 -~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                       ..+|+||||++++ +...+.  ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        94 ~~~~~lv~e~~~~~-l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874          94 FQDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_pred             cceeEEEhhhhccc-HHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence             3579999999874 555554  347888899999999999999999999999999999999999999999999998766


Q ss_pred             CCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------
Q 016037          302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-----------------  364 (396)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~-----------------  364 (396)
                      .........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+...                 
T Consensus       171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (355)
T cd07874         171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  250 (355)
T ss_pred             CccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHH
Confidence            555555678999999999999999999999999999999999999999987654443332211                 


Q ss_pred             -----C-----CC---------------CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 -----K-----IK---------------LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 -----~-----~~---------------~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                           .     +.               .+...+.++++||.+||+.||.+|||+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~  306 (355)
T cd07874         251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD  306 (355)
T ss_pred             HHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHH
Confidence                 0     01               1122467889999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.7e-43  Score=347.18  Aligned_cols=243  Identities=23%  Similarity=0.321  Sum_probs=205.3

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC-----eE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----RL  225 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~-----~~  225 (396)
                      +|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++....     .+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            5788999999999999999999999999999986532 12233456778999999999999999999998776     89


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-  304 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-  304 (396)
                      |+||||+.+ +|...+...+.+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++...... 
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          80 YVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES  158 (372)
T ss_pred             EEEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence            999999975 777888777889999999999999999999999999999999999999999999999999998654322 


Q ss_pred             -CccccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------------------
Q 016037          305 -RSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK-------------------  363 (396)
Q Consensus       305 -~~~~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~-------------------  363 (396)
                       ......+|+.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+.......+..                   
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  238 (372)
T cd07853         159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA  238 (372)
T ss_pred             ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence             22344678999999999874 579999999999999999999999998876655554432                   


Q ss_pred             ----CC---------CCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          364 ----DK---------IKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       364 ----~~---------~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                          ..         ..+....+.++.+||.+||+.||.+|||++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~  283 (372)
T cd07853         239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAA  283 (372)
T ss_pred             HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHH
Confidence                11         122345688999999999999999999975

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.1e-42  Score=330.12  Aligned_cols=246  Identities=20%  Similarity=0.330  Sum_probs=211.4

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEc----CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRI----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~  223 (396)
                      ...+|++.+.||+|+||+||+|.+.    .++..+|+|.+....  .......+.+|+.+++.++||||+++++++..+.
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   80 (283)
T cd05090           3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ   80 (283)
T ss_pred             ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence            4568999999999999999999863    356789999987543  2334466788999999999999999999999999


Q ss_pred             eEEEEEEecCCCcHHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQG-----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD  286 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~-----------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~  286 (396)
                      ..|++|||+.+++|..++....                 .+++..+..++.|++.||.|||++|++||||||+|||++.+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence            9999999999999998885432                 36788888899999999999999999999999999999999


Q ss_pred             CcEEEEecccccccCCCC---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 016037          287 GHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKII  362 (396)
Q Consensus       287 ~~ikL~Dfgla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~  362 (396)
                      +.+||+|||+++......   ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+.+...+.+.+.
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~  240 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR  240 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            999999999998764322   1233456778999999988889999999999999999999 999999888777777776


Q ss_pred             hC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          363 KD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       363 ~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .. .+..+..++.+++++|.+||+.+|.+||++.
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~  274 (283)
T cd05090         241 KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFK  274 (283)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHH
Confidence            65 3466778999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.5e-43  Score=332.11  Aligned_cols=243  Identities=28%  Similarity=0.397  Sum_probs=200.3

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHh---CCCCCeeeeeEEEEe-----c
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---VDHPFIVQLRYSFQT-----K  222 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~---l~HpnIv~l~~~~~~-----~  222 (396)
                      +|++.+.||+|+||+||+|+++.+++.||+|.++....... ......+|+.+++.   ++||||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            48999999999999999999999999999999876432221 11223456666655   479999999998864     3


Q ss_pred             CeEEEEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccccc
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~  300 (396)
                      ..++++|||+.+ +|..++...  ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++..
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            468999999986 777777654  34899999999999999999999999999999999999999999999999999877


Q ss_pred             CCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------C---
Q 016037          301 DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-----------I---  366 (396)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~-----------~---  366 (396)
                      ..........||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+......++....           .   
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07863         159 SCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP  238 (288)
T ss_pred             cCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence            55444455678999999999998889999999999999999999999998877666555554310           0   


Q ss_pred             -------------CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 -------------KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 -------------~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                   .+.+.++.++++||.+||++||.+|||+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  280 (288)
T cd07863         239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAF  280 (288)
T ss_pred             ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHH
Confidence                         01135788899999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=8.4e-43  Score=335.62  Aligned_cols=244  Identities=27%  Similarity=0.425  Sum_probs=204.3

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|.+.+.||+|+||.||+|+++.+++.||+|+++....  ......+.+|+.+++.++||||+++++++..+...|+|
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence            4679999999999999999999999999999999976432  12233456799999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Cc
Q 016037          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RS  306 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~  306 (396)
                      |||+++ +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  161 (309)
T cd07872          83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY  161 (309)
T ss_pred             EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence            999986 676666554 457899999999999999999999999999999999999999999999999997654322 22


Q ss_pred             cccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------CC
Q 016037          307 NSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-------------------KI  366 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~-------------------~~  366 (396)
                      ....+|+.|+|||.+.+ ..++.++|||||||++|+|+||+.||.+.+..+....+...                   ..
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY  241 (309)
T ss_pred             ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence            34568899999999865 45899999999999999999999999987765555444321                   01


Q ss_pred             CCC-----------ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 KLP-----------AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 ~~p-----------~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .+|           ..++.++++||++||+.||.+|||+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~  281 (309)
T cd07872         242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAE  281 (309)
T ss_pred             hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHH
Confidence            111           25789999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.8e-42  Score=350.13  Aligned_cols=242  Identities=24%  Similarity=0.357  Sum_probs=196.8

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC------CCeeeeeEEEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH------PFIVQLRYSFQ  220 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~H------pnIv~l~~~~~  220 (396)
                      ...++|+++++||+|+||+||+|.+..+++.||||+++...    ...+....|+.+++.++|      .++++++++|.
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            34578999999999999999999999999999999997532    223334567777776654      56889998887


Q ss_pred             ec-CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCC-----------
Q 016037          221 TK-YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADG-----------  287 (396)
Q Consensus       221 ~~-~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDlkp~NILl~~~~-----------  287 (396)
                      .. .++|+|||++ |++|.+++.+.+.+++..++.++.||+.||.|||+ .|||||||||+|||++.++           
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence            64 5789999988 66788888888899999999999999999999998 5999999999999998765           


Q ss_pred             -----cEEEEecccccccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 016037          288 -----HVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII  362 (396)
Q Consensus       288 -----~ikL~Dfgla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~  362 (396)
                           .+||+|||.+....  ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.
T Consensus       281 ~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~  358 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME  358 (467)
T ss_pred             CCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence                 49999999886432  23345789999999999999999999999999999999999999999877655544443


Q ss_pred             hCCCCCCc------------------------------------------cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          363 KDKIKLPA------------------------------------------FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       363 ~~~~~~p~------------------------------------------~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +....+|.                                          ..+..+.+||.+||.+||.+|||+.
T Consensus       359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~  433 (467)
T PTZ00284        359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR  433 (467)
T ss_pred             HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence            32111111                                          1135678999999999999999975

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=7.8e-43  Score=343.82  Aligned_cols=243  Identities=26%  Similarity=0.401  Sum_probs=203.4

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec------
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------  222 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~------  222 (396)
                      .++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...      
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            5789999999999999999999999999999999976432 233345567899999999999999999887543      


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      ..+|+||||+++ .|...+.  ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  178 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  178 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence            367999999987 5555554  3478888999999999999999999999999999999999999999999999987655


Q ss_pred             CCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------------
Q 016037          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD------------------  364 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~------------------  364 (396)
                      ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...++...                  
T Consensus       179 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (364)
T cd07875         179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT  258 (364)
T ss_pred             CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHH
Confidence            54455668999999999999999999999999999999999999999988766655555431                  


Q ss_pred             ----CCCC--------------------CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 ----KIKL--------------------PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 ----~~~~--------------------p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                          +..+                    ....+.++++||.+||+.||.+|||+.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~  313 (364)
T cd07875         259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD  313 (364)
T ss_pred             HHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHH
Confidence                1100                    011356789999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.1e-42  Score=332.90  Aligned_cols=244  Identities=20%  Similarity=0.352  Sum_probs=208.9

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCc--EEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCeEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~  226 (396)
                      ++|++.+.||+|+||.||+|.++.++.  .+++|.++...  .....+.+.+|+.+++++ +||||+++++++.....+|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            579999999999999999999987765  46888776322  223345678899999999 7999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhc----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEE
Q 016037          227 LVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM  290 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ik  290 (396)
                      +++||+++++|.+++....                .+++..++.++.|++.||+|||++|++||||||+|||++.++.+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence            9999999999999886542                478889999999999999999999999999999999999999999


Q ss_pred             EEecccccccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCC
Q 016037          291 LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKL  368 (396)
Q Consensus       291 L~Dfgla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~  368 (396)
                      |+|||++..............+..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..++..++..+ ....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (297)
T cd05089         160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEK  239 (297)
T ss_pred             ECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence            999999865432222222233567999999998889999999999999999998 99999998888888887765 4566


Q ss_pred             CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          369 PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       369 p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      |..++.++.+||..||+.+|.+||++.
T Consensus       240 ~~~~~~~~~~li~~~l~~~p~~Rp~~~  266 (297)
T cd05089         240 PRNCDDEVYELMRQCWRDRPYERPPFA  266 (297)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence            778999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-42  Score=327.72  Aligned_cols=247  Identities=21%  Similarity=0.319  Sum_probs=213.5

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCC-----cEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTS-----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~  221 (396)
                      +..++|.+.+.||+|+||.||+|.++..+     ..||+|.+.....  ......+.+|+.+++.++||||+++++++..
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            55678999999999999999999987544     7899999865432  2233456789999999999999999999999


Q ss_pred             cCeEEEEEEecCCCcHHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEE
Q 016037          222 KYRLYLVLDFVNGGHLFFQLYRQG----------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVML  291 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~----------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL  291 (396)
                      ....|+||||+++|+|..++....          .+++..+..++.|++.||.|||+.+++||||||+|||++.++.+||
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence            999999999999999999886532          3567788889999999999999999999999999999999999999


Q ss_pred             EecccccccCCCC---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CC
Q 016037          292 TDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KI  366 (396)
Q Consensus       292 ~Dfgla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~  366 (396)
                      +|||+++......   ......++..|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..+..+.+... ..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~  240 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL  240 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence            9999998654332   1233456789999999988889999999999999999998 99999988888887777755 45


Q ss_pred             CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 ~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .+|..++.++.+||.+||+.+|.+|||+.
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~  269 (277)
T cd05032         241 DLPENCPDKLLELMRMCWQYNPKMRPTFL  269 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCCCHH
Confidence            77888999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.1e-42  Score=324.30  Aligned_cols=239  Identities=22%  Similarity=0.364  Sum_probs=206.0

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCCC
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg  235 (396)
                      +.||+|+||.||+|.++.+++.||+|.+....  ..+....+.+|+++++.++||||+++++++.....+|+||||+.++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            36999999999999999999999999886532  2344566788999999999999999999999999999999999999


Q ss_pred             cHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCcc---cccc
Q 016037          236 HLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN---SMCG  311 (396)
Q Consensus       236 ~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~---~~~g  311 (396)
                      +|..++...+ .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++..........   ...+
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence            9999887644 58999999999999999999999999999999999999999999999999997654322111   1122


Q ss_pred             CCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHHhhccCCC
Q 016037          312 TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGVNSLLSI  389 (396)
Q Consensus       312 t~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p~  389 (396)
                      +..|+|||.+.+..++.++||||||+++|||++ |..||...+.......+... ....|..++..+.+|+++||+.+|.
T Consensus       159 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  238 (252)
T cd05084         159 PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPG  238 (252)
T ss_pred             ceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChh
Confidence            456999999998889999999999999999998 99999887777766666554 5567788899999999999999999


Q ss_pred             CCCCCCC
Q 016037          390 SVPLLSR  396 (396)
Q Consensus       390 ~RPs~s~  396 (396)
                      +|||+++
T Consensus       239 ~Rps~~~  245 (252)
T cd05084         239 QRPSFST  245 (252)
T ss_pred             hCcCHHH
Confidence            9999753

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-42  Score=332.03  Aligned_cols=244  Identities=43%  Similarity=0.753  Sum_probs=217.9

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+.+.........+.+..|+.+++.++||||+++++.+......|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36999999999999999999999999999999998776555456677889999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC---
Q 016037          230 DFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT---  304 (396)
Q Consensus       230 E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~---  304 (396)
                      ||+.+++|..++.+.  ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.......   
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999999988754  568999999999999999999999999999999999999999999999999987543221   


Q ss_pred             ---------------------------CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 016037          305 ---------------------------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKI  357 (396)
Q Consensus       305 ---------------------------~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i  357 (396)
                                                 ......||..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence                                       11234688999999999998899999999999999999999999999888888


Q ss_pred             HHHHHhCCCCCCcc--CCHHHHHHHHHhhccCCCCCCC
Q 016037          358 QQKIIKDKIKLPAF--LSSEAHSLLKGVNSLLSISVPL  393 (396)
Q Consensus       358 ~~~i~~~~~~~p~~--~s~~~~~li~~~l~~~p~~RPs  393 (396)
                      ..++......++..  ++.++.+||++||..+|.+||+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s  278 (316)
T cd05574         241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLG  278 (316)
T ss_pred             HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCC
Confidence            88887776666654  7999999999999999999999

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4e-43  Score=329.83  Aligned_cols=241  Identities=31%  Similarity=0.504  Sum_probs=205.3

Q ss_pred             EEEeEecccCceEEEEEEEc----CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          153 EVLKVVGQGAFAKVYQVRRI----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       153 ~~~~~IG~G~fG~Vy~~~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      ++.+.||.|.||.||+|.+.    ..+..|+||+++...  .....+.+.+|++.+++++||||+++++++.....+++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS--SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS--SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc--ccccceeeeeccccccccccccccccccccccccccccc
Confidence            57789999999999999998    456789999995532  334467788899999999999999999999988889999


Q ss_pred             EEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC-
Q 016037          229 LDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-  305 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~-  305 (396)
                      +||+++|+|.+++...  ..+++.....++.||+.||.|||+++++|+||+++|||++.++.+||+|||++........ 
T Consensus        80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999886  7889999999999999999999999999999999999999999999999999987632211 


Q ss_pred             --ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHH
Q 016037          306 --SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLK  381 (396)
Q Consensus       306 --~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~  381 (396)
                        .....+...|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..++..++.++ +...|..++..+.++|.
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  239 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQ  239 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHH
Confidence              233446789999999988889999999999999999999 78999999999988888666 45677889999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      .||+.+|.+||+++
T Consensus       240 ~C~~~~p~~RPs~~  253 (259)
T PF07714_consen  240 QCWSHDPEKRPSFQ  253 (259)
T ss_dssp             HHT-SSGGGS--HH
T ss_pred             HHcCCChhhCcCHH
Confidence            99999999999974

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.7e-42  Score=325.35  Aligned_cols=245  Identities=30%  Similarity=0.488  Sum_probs=214.0

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccch------hhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCe
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME------KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~  224 (396)
                      +|.+.+.||+|+||.||+|.+..++..||+|.+.......      ....+.+.+|+.++++++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3677889999999999999999999999999987643221      2234667889999999999999999999999999


Q ss_pred             EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      .+++|||+++++|..++...+.+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||+++......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            99999999999999999888889999999999999999999999999999999999999999999999999998764221


Q ss_pred             -------CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHH
Q 016037          305 -------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (396)
Q Consensus       305 -------~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~  376 (396)
                             ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+......++... ...+|..++.++
T Consensus       161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06628         161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEA  240 (267)
T ss_pred             ccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHHH
Confidence                   112346889999999999888999999999999999999999999987665555555444 456778899999


Q ss_pred             HHHHHHhhccCCCCCCCCC
Q 016037          377 HSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~RPs~s  395 (396)
                      .++|++||+.+|.+||++.
T Consensus       241 ~~li~~~l~~~p~~Rp~~~  259 (267)
T cd06628         241 IDFLEKTFEIDHNKRPTAA  259 (267)
T ss_pred             HHHHHHHccCCchhCcCHH
Confidence            9999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-42  Score=323.27  Aligned_cols=243  Identities=29%  Similarity=0.467  Sum_probs=213.2

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|++....   ....+.+.+|+.++++++||||+++++++.....+|++|
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            57999999999999999999999999999999997653   224566888999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Ccc
Q 016037          230 DFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSN  307 (396)
Q Consensus       230 E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~~  307 (396)
                      ||+.+++|..++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++..+.... ...
T Consensus        80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  159 (262)
T cd06613          80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK  159 (262)
T ss_pred             eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence            999999999988776 789999999999999999999999999999999999999999999999999998765432 234


Q ss_pred             ccccCCCccchhhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----CCccCCHHHHHH
Q 016037          308 SMCGTLEYMSPEIVLGK---GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-----LPAFLSSEAHSL  379 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~---~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~-----~p~~~s~~~~~l  379 (396)
                      ...++..|+|||.+.+.   .++.++||||||+++|||++|+.||.+.+.......+....+.     .+..++.++.+|
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDF  239 (262)
T ss_pred             cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHH
Confidence            45788999999999776   7899999999999999999999999987766655555554222     234568899999


Q ss_pred             HHHhhccCCCCCCCCC
Q 016037          380 LKGVNSLLSISVPLLS  395 (396)
Q Consensus       380 i~~~l~~~p~~RPs~s  395 (396)
                      |++||+.+|.+||+++
T Consensus       240 i~~~l~~~p~~Rpt~~  255 (262)
T cd06613         240 IKKCLTKDPKKRPTAT  255 (262)
T ss_pred             HHHHcCCChhhCCCHH
Confidence            9999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=8e-43  Score=329.90  Aligned_cols=246  Identities=21%  Similarity=0.339  Sum_probs=213.4

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      ..++|.+.+.||+|+||.||+|.+..     +++.||+|+++...  .....+.+.+|+++|+.++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            34679999999999999999998754     46789999987643  223456788899999999999999999999999


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhc--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQG--------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~--------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~  288 (396)
                      ...|++|||+++++|..++...+              .+++..+..++.|++.|+.|||++|++||||||+||+++.++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence            99999999999999999987643              3778888999999999999999999999999999999999999


Q ss_pred             EEEEecccccccCCCC---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC
Q 016037          289 VMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD  364 (396)
Q Consensus       289 ikL~Dfgla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~  364 (396)
                      +||+|||+++......   ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+..+
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~  240 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG  240 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            9999999997653221   1233345788999999999999999999999999999999 99999998888888888877


Q ss_pred             CC-CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 KI-KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 ~~-~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .. ..+..++.++++||.+||+.+|.+||++.
T Consensus       241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~  272 (280)
T cd05049         241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIK  272 (280)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence            55 44668999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.7e-42  Score=319.79  Aligned_cols=244  Identities=27%  Similarity=0.479  Sum_probs=213.1

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe-cCeEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-KYRLYLVL  229 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~-~~~~~lV~  229 (396)
                      +|++.+.||+|++|.||++.++.+++.||+|.+...... ....+.+.+|+.++++++|+|++++++.+.. ...+|++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            489999999999999999999999999999999765432 2334557889999999999999999988864 44689999


Q ss_pred             EecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-CCc
Q 016037          230 DFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRS  306 (396)
Q Consensus       230 E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-~~~  306 (396)
                      ||+++++|...+...  ..+++..++.++.|++.|+.+||++|++||||||+||+++.++.++|+|||++...... ...
T Consensus        80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  159 (257)
T cd08223          80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA  159 (257)
T ss_pred             cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence            999999999888753  45899999999999999999999999999999999999999999999999999876432 223


Q ss_pred             cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHHHHhhc
Q 016037          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAHSLLKGVNS  385 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~-~~p~~~s~~~~~li~~~l~  385 (396)
                      ....|++.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+..+.+ .++..+++++.+||.+||+
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  239 (257)
T cd08223         160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLS  239 (257)
T ss_pred             ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhc
Confidence            445688999999999999899999999999999999999999998887777777776654 5667899999999999999


Q ss_pred             cCCCCCCCCC
Q 016037          386 LLSISVPLLS  395 (396)
Q Consensus       386 ~~p~~RPs~s  395 (396)
                      .+|.+||++.
T Consensus       240 ~~p~~Rp~~~  249 (257)
T cd08223         240 KRPEKRPSVK  249 (257)
T ss_pred             cCcccCCCHH
Confidence            9999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=6.9e-43  Score=328.33  Aligned_cols=244  Identities=28%  Similarity=0.462  Sum_probs=209.9

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|++.+.||+|+||.||+|.+..+++.||+|+++...   ......+.+|+.+++.++||||+++++++.....+|++
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv   84 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC   84 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence            457999999999999999999999999999999987653   22334567899999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Ccc
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSN  307 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~~  307 (396)
                      |||+++++|.+++...+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++....... ...
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06645          85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK  164 (267)
T ss_pred             EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence            9999999999999888899999999999999999999999999999999999999999999999999987654322 234


Q ss_pred             ccccCCCccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----ccCCHHHHHH
Q 016037          308 SMCGTLEYMSPEIVL---GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP-----AFLSSEAHSL  379 (396)
Q Consensus       308 ~~~gt~~y~APE~l~---~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p-----~~~s~~~~~l  379 (396)
                      ...|+..|+|||.+.   ...++.++|||||||++|+|++|..||...+.......+.......+     ..++..+.+|
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (267)
T cd06645         165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHF  244 (267)
T ss_pred             cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHH
Confidence            557899999999984   45588999999999999999999999987665554444444433222     2578899999


Q ss_pred             HHHhhccCCCCCCCCC
Q 016037          380 LKGVNSLLSISVPLLS  395 (396)
Q Consensus       380 i~~~l~~~p~~RPs~s  395 (396)
                      |++||+.+|++||+++
T Consensus       245 i~~~l~~~P~~R~~~~  260 (267)
T cd06645         245 VKMALTKNPKKRPTAE  260 (267)
T ss_pred             HHHHccCCchhCcCHH
Confidence            9999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.2e-42  Score=331.70  Aligned_cols=243  Identities=27%  Similarity=0.420  Sum_probs=208.6

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+....  .....+.+.+|+++++.++||||++++++|..+..+|++|
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence            36999999999999999999999999999999987542  2334556778999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~  308 (396)
                      ||+++++|..++.+.+.+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++...... ....
T Consensus        79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~  157 (308)
T cd06615          79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANS  157 (308)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-cccc
Confidence            999999999999888889999999999999999999998 59999999999999999999999999998765433 2345


Q ss_pred             cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------------------
Q 016037          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD------------------------  364 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~------------------------  364 (396)
                      .+|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+...                        
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (308)
T cd06615         158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM  237 (308)
T ss_pred             CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence            67899999999998888999999999999999999999999766544433322211                        


Q ss_pred             -------------CCCCCc-cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 -------------KIKLPA-FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 -------------~~~~p~-~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                   .+.+|. .++.++++||.+||+.+|++||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~  282 (308)
T cd06615         238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLK  282 (308)
T ss_pred             hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHH
Confidence                         112221 3688999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.1e-43  Score=349.97  Aligned_cols=205  Identities=33%  Similarity=0.520  Sum_probs=184.4

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-C-----CCeeeeeEEEEecCe
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-H-----PFIVQLRYSFQTKYR  224 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-H-----pnIv~l~~~~~~~~~  224 (396)
                      +|.+++.||+|+||.|.+|.+.+|++.||||++++..    ........|+.+|..|+ |     -|+|+++++|...++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            7999999999999999999999999999999998753    55566778999999997 4     399999999999999


Q ss_pred             EEEEEEecCCCcHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC--cEEEEeccccccc
Q 016037          225 LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG--HVMLTDFGLAKQF  300 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~--~ikL~Dfgla~~~  300 (396)
                      +|||+|.++. +|+++++.+.  .++...++.++.||+.||.+||+.||||+||||||||+.+-+  .|||+|||.++..
T Consensus       263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            9999999976 8999998764  588999999999999999999999999999999999997655  6999999999986


Q ss_pred             CCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 016037          301 DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII  362 (396)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~  362 (396)
                      ....  .+++.+..|+|||++.|..|+.+.||||||||++||++|.+.|.|.+..+.+..|.
T Consensus       342 ~q~v--ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~  401 (586)
T KOG0667|consen  342 SQRV--YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARII  401 (586)
T ss_pred             CCcc--eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHH
Confidence            5443  37788999999999999999999999999999999999999999988877666653

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=320.31  Aligned_cols=249  Identities=29%  Similarity=0.454  Sum_probs=213.6

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecC
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKY  223 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~  223 (396)
                      .....++.+.+..||.|+.|.||+++.+.+|...|||.+++..  ..+..+++...++++.+. ++|+||+.+++|....
T Consensus        87 ~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~  164 (391)
T KOG0983|consen   87 YQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT  164 (391)
T ss_pred             cccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence            3355678888999999999999999999999999999998865  345556667777776655 5899999999999999


Q ss_pred             eEEEEEEecCCCcHHHHH-HHhcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          224 RLYLVLDFVNGGHLFFQL-YRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l-~~~~~l~e~~~~~~~~qi~~aL~~LH~~-~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      .++|.||.|... +..++ .-+++++|..+-.+...+++||.||.++ ||||||+||.|||+|..|.+||||||++.++-
T Consensus       165 dV~IcMelMs~C-~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv  243 (391)
T KOG0983|consen  165 DVFICMELMSTC-AEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV  243 (391)
T ss_pred             hHHHHHHHHHHH-HHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceee
Confidence            999999998653 33333 3357899999999999999999999886 89999999999999999999999999999988


Q ss_pred             CCCCccccccCCCccchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCC-CC--ccCCH
Q 016037          302 ENTRSNSMCGTLEYMSPEIVLG---KGHDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQKIIKDKIK-LP--AFLSS  374 (396)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~---~~~~~~~DvwSlGvil~elltg~~Pf~~~~-~~~i~~~i~~~~~~-~p--~~~s~  374 (396)
                      ++.......|.+.|||||.+.-   ..|+..+||||||++++||+||+.||.+.+ .-++.-++.++.++ +|  .++|+
T Consensus       244 dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp  323 (391)
T KOG0983|consen  244 DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSP  323 (391)
T ss_pred             cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCH
Confidence            7777777789999999999953   468999999999999999999999999854 56788888887654 33  25899


Q ss_pred             HHHHHHHHhhccCCCCCCCCCC
Q 016037          375 EAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       375 ~~~~li~~~l~~~p~~RPs~s~  396 (396)
                      ++.+|++.||++|+.+||.+.+
T Consensus       324 ~F~~fv~~CL~kd~r~RP~Y~~  345 (391)
T KOG0983|consen  324 DFQSFVKDCLTKDHRKRPKYNK  345 (391)
T ss_pred             HHHHHHHHHhhcCcccCcchHH
Confidence            9999999999999999998753

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-42  Score=323.89  Aligned_cols=245  Identities=21%  Similarity=0.328  Sum_probs=212.9

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCC---CcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~  225 (396)
                      .++|++.+.||+|+||+||+|.++.+   ...||+|+++...  .......+.+|+.+++.++||||+++++++......
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            46799999999999999999998754   4579999987543  233445577899999999999999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          226 YLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      +++|||+++++|..++... +.+++..++.++.|++.||.|||+++|+||||||+|||++.++.++|+|||+++......
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            9999999999999988764 468999999999999999999999999999999999999999999999999998774211


Q ss_pred             C---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHH
Q 016037          305 R---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSL  379 (396)
Q Consensus       305 ~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~l  379 (396)
                      .   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......++...+... ....+..++..+.+|
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  240 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQL  240 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            1   122334678999999998889999999999999999998 99999988888888877765 456677899999999


Q ss_pred             HHHhhccCCCCCCCCC
Q 016037          380 LKGVNSLLSISVPLLS  395 (396)
Q Consensus       380 i~~~l~~~p~~RPs~s  395 (396)
                      +.+||+.+|.+||++.
T Consensus       241 i~~cl~~~p~~Rp~~~  256 (266)
T cd05033         241 MLDCWQKDRNERPTFS  256 (266)
T ss_pred             HHHHcCCCcccCcCHH
Confidence            9999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.3e-42  Score=326.05  Aligned_cols=246  Identities=21%  Similarity=0.354  Sum_probs=211.0

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      ..++|.+.+.||+|+||.||+|.+..     ++..||+|.+....  .......+..|+.+++.++|+||+++++++.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            34679999999999999999999987     77889999886543  222334577799999999999999999999999


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC---cEEEE
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQG-------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG---HVMLT  292 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~-------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~---~ikL~  292 (396)
                      ...++||||+++++|..++.+.+       .+++..+..++.||+.||.|||+++++||||||+||+++.++   .+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999999887654       478889999999999999999999999999999999998765   69999


Q ss_pred             ecccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCC
Q 016037          293 DFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIK  367 (396)
Q Consensus       293 Dfgla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~  367 (396)
                      |||+++.......   ......+..|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+... +..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~  241 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD  241 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            9999987632221   112233568999999998889999999999999999997 99999988877777766654 567


Q ss_pred             CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          368 LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       368 ~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .|..++.++.++|.+||+.+|.+|||+.
T Consensus       242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~  269 (277)
T cd05036         242 PPKGCPGPVYRIMTDCWQHTPEDRPNFA  269 (277)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHH
Confidence            7888999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.9e-42  Score=322.34  Aligned_cols=237  Identities=39%  Similarity=0.706  Sum_probs=215.7

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCCCcH
Q 016037          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL  237 (396)
Q Consensus       158 IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L  237 (396)
                      ||.|+||.||+|++..+++.+|+|++.+.........+.+.+|+.+++.++||||+++++.+.++..+|+++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            69999999999999999999999999876655555667788999999999999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccccccCCCccc
Q 016037          238 FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMS  317 (396)
Q Consensus       238 ~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~~gt~~y~A  317 (396)
                      .+++.+...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.............|+..|+|
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  160 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVA  160 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccC
Confidence            99998888899999999999999999999999999999999999999999999999999988765544455678999999


Q ss_pred             hhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHH--hCCCCCCccCCHHHHHHHHHhhccCCCCCCC
Q 016037          318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN--RQKIQQKII--KDKIKLPAFLSSEAHSLLKGVNSLLSISVPL  393 (396)
Q Consensus       318 PE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~--~~~i~~~i~--~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs  393 (396)
                      ||.+.+..++.++|+||||+++|+|++|..||...+  ..++.+++.  .....+|..++.++.++|++||+.+|.+||+
T Consensus       161 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~  240 (262)
T cd05572         161 PEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLG  240 (262)
T ss_pred             hhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcC
Confidence            999988889999999999999999999999998876  677777777  4577888888999999999999999999998


Q ss_pred             C
Q 016037          394 L  394 (396)
Q Consensus       394 ~  394 (396)
                      .
T Consensus       241 ~  241 (262)
T cd05572         241 N  241 (262)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.1e-42  Score=322.78  Aligned_cols=243  Identities=21%  Similarity=0.374  Sum_probs=209.9

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      ..++|++.+.||+|+||.||+|.+.+. ..+|+|.+......    .+.+.+|+.+++.++||||+++++++.....+|+
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~-~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   76 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI   76 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecCC-CcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence            346799999999999999999988653 45999998765432    2446789999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC-
Q 016037          228 VLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-  305 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~-  305 (396)
                      +|||+.+|+|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||+++....... 
T Consensus        77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence            99999999999988764 4689999999999999999999999999999999999999999999999999986543322 


Q ss_pred             -ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHH
Q 016037          306 -SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKG  382 (396)
Q Consensus       306 -~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~~  382 (396)
                       .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+...+...+..+ +...+...+..+++++..
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYS  236 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence             112335678999999998889999999999999999999 99999988888777777765 344567789999999999


Q ss_pred             hhccCCCCCCCCC
Q 016037          383 VNSLLSISVPLLS  395 (396)
Q Consensus       383 ~l~~~p~~RPs~s  395 (396)
                      ||+.+|.+||++.
T Consensus       237 cl~~~p~~Rp~~~  249 (256)
T cd05113         237 CWHEKAEERPTFQ  249 (256)
T ss_pred             HcCCCcccCCCHH
Confidence            9999999999975

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.4e-43  Score=328.11  Aligned_cols=245  Identities=28%  Similarity=0.461  Sum_probs=208.0

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC-eeeeeEEEEecC----
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF-IVQLRYSFQTKY----  223 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~Hpn-Iv~l~~~~~~~~----  223 (396)
                      ...|..+++||+|.||+||+|+.+.+|+.||+|+++.+... +-.-....+|+.+|+.++|+| |++|++++.+..    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            45688888999999999999999999999999999876532 122344578999999999999 999999998877    


Q ss_pred             --eEEEEEEecCCCcHHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccc
Q 016037          224 --RLYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA  297 (396)
Q Consensus       224 --~~~lV~E~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla  297 (396)
                        .+++|+||++. +|..++....    .++...++.++.||+.||+|||+++|+||||||+||||+++|.+||+|||+|
T Consensus        89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence              89999999987 7777776654    5777889999999999999999999999999999999999999999999999


Q ss_pred             cccCCC-CCccccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------
Q 016037          298 KQFDEN-TRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-----------  364 (396)
Q Consensus       298 ~~~~~~-~~~~~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~-----------  364 (396)
                      +.+.-. ......++|.+|+|||++.+. .|+..+||||+||+++||++++..|.+.+..+....|.+-           
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            977633 335667899999999999986 7999999999999999999999999998887777666421           


Q ss_pred             -------CCCCCc------------cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 -------KIKLPA------------FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 -------~~~~p~------------~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                             +..+|.            ..+.+..+++.+||+++|.+|.|+.
T Consensus       248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~  297 (323)
T KOG0594|consen  248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAK  297 (323)
T ss_pred             ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHH
Confidence                   111221            2235899999999999999999863

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-43  Score=369.02  Aligned_cols=247  Identities=22%  Similarity=0.380  Sum_probs=216.4

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCc-----EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSE-----IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~  221 (396)
                      +.....++.+.||+|+||.||.|......-     .||||.+++..  +......+.+|..+|++++|||||+++|.+.+
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            456788999999999999999999875433     38888887653  45666778889999999999999999999999


Q ss_pred             cCeEEEEEEecCCCcHHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEec
Q 016037          222 KYRLYLVLDFVNGGHLFFQLYRQ-------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDF  294 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Df  294 (396)
                      ....+|++|||+||+|..++++.       ..++......++.||++|+.||+++++|||||..+|+|++....+||+||
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence            99999999999999999999876       34778888999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCC--c-cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH-hCCCCCC
Q 016037          295 GLAKQFDENTR--S-NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKII-KDKIKLP  369 (396)
Q Consensus       295 gla~~~~~~~~--~-~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~-~~~~~~p  369 (396)
                      |+|+.+-....  . ....-...|||||.+....++.|+|||||||+|||++| |..||.+.+..++..... .+++..|
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P  926 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPP  926 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCC
Confidence            99995532221  1 11233579999999999999999999999999999999 999999999888888444 5599999


Q ss_pred             ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          370 AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       370 ~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .+++..+.++|.+||+.+|++||++.
T Consensus       927 ~~CP~~ly~lM~~CW~~~pe~RP~F~  952 (1025)
T KOG1095|consen  927 SYCPEKLYQLMLQCWKHDPEDRPSFR  952 (1025)
T ss_pred             CCCChHHHHHHHHHccCChhhCccHH
Confidence            99999999999999999999999964

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.8e-42  Score=325.78  Aligned_cols=246  Identities=24%  Similarity=0.383  Sum_probs=210.4

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCc----EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      +...+|++++.||+|+||+||+|.+..+++    .||+|+++...  .....+.+.+|+.+++.++||||+++++++...
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS   81 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence            345789999999999999999999887776    47999987543  233455678899999999999999999988754


Q ss_pred             CeEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                       ..++++||+++|+|.+++... +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++...
T Consensus        82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence             578999999999999988764 568999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCc---cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHH
Q 016037          302 ENTRS---NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (396)
Q Consensus       302 ~~~~~---~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~  376 (396)
                      .....   ....++..|+|||.+.+..++.++|||||||++|||++ |..||.......+...+... ..+.+..++.++
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDV  240 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHH
Confidence            33221   12234678999999998889999999999999999998 99999888777777766654 456677899999


Q ss_pred             HHHHHHhhccCCCCCCCCC
Q 016037          377 HSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~RPs~s  395 (396)
                      .++|.+||+.+|.+||++.
T Consensus       241 ~~li~~~l~~dp~~Rp~~~  259 (279)
T cd05109         241 YMIMVKCWMIDSECRPRFR  259 (279)
T ss_pred             HHHHHHHcCCChhhCcCHH
Confidence            9999999999999999974

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3e-42  Score=366.75  Aligned_cols=248  Identities=28%  Similarity=0.475  Sum_probs=208.7

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe--cCe
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KYR  224 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~--~~~  224 (396)
                      ...++|++++.||+|+||+||+|.+..++..+|+|++....... .....+..|+.+|++++||||++++++|..  ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            45578999999999999999999999999999999997654333 345567889999999999999999999854  457


Q ss_pred             EEEEEEecCCCcHHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC-------CceeccCCCCCEEEcC--------
Q 016037          225 LYLVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHAN-------GIMHRDLKPENILLDA--------  285 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~-------~iiHrDlkp~NILl~~--------  285 (396)
                      +||||||+++|+|..++...    +.+++..++.++.||+.||.|||+.       +||||||||+||||+.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            99999999999999888653    5799999999999999999999995       4999999999999964        


Q ss_pred             ---------CCcEEEEecccccccCCCCCccccccCCCccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 016037          286 ---------DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFTGGNR  354 (396)
Q Consensus       286 ---------~~~ikL~Dfgla~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~DvwSlGvil~elltg~~Pf~~~~~  354 (396)
                               .+.+||+|||++..+.........+||+.|+|||++.+  ..++.++|||||||+||||+||+.||...+.
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~  248 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN  248 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence                     23589999999987755544556679999999999864  4588999999999999999999999987654


Q ss_pred             HHHHHHHHhCCCCCC-ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          355 QKIQQKIIKDKIKLP-AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       355 ~~i~~~i~~~~~~~p-~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .............+| ...+.++.+||..||+.+|.+||++.
T Consensus       249 ~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~  290 (1021)
T PTZ00266        249 FSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSAL  290 (1021)
T ss_pred             HHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHH
Confidence            443333444434444 46899999999999999999999964

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.3e-42  Score=344.69  Aligned_cols=248  Identities=23%  Similarity=0.342  Sum_probs=207.1

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCC-----CcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGT-----SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSF  219 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~  219 (396)
                      .+..++|.+.++||+|+||.||+|.+...     +..||||+++...  .....+.+.+|+.+|+.++ ||||+++++++
T Consensus        33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            34567899999999999999999987543     3469999997543  2334456788999999996 99999999999


Q ss_pred             EecCeEEEEEEecCCCcHHHHHHHh-------------------------------------------------------
Q 016037          220 QTKYRLYLVLDFVNGGHLFFQLYRQ-------------------------------------------------------  244 (396)
Q Consensus       220 ~~~~~~~lV~E~~~gg~L~~~l~~~-------------------------------------------------------  244 (396)
                      .....+|+||||+++|+|.+++.++                                                       
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            9999999999999999999887653                                                       


Q ss_pred             -----------------------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE
Q 016037          245 -----------------------------------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL  283 (396)
Q Consensus       245 -----------------------------------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl  283 (396)
                                                               ..+++..+..++.||+.||.|||+.+++||||||+|||+
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill  270 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence                                                     136677788899999999999999999999999999999


Q ss_pred             cCCCcEEEEecccccccCCCC---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH-HH
Q 016037          284 DADGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQK-IQ  358 (396)
Q Consensus       284 ~~~~~ikL~Dfgla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~-i~  358 (396)
                      +.++.+||+|||+++......   ......++..|||||.+.+..++.++|||||||++|||++ |..||....... +.
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~  350 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY  350 (400)
T ss_pred             eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence            999999999999998654322   1233456788999999998889999999999999999997 999998765443 33


Q ss_pred             HHHHhC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          359 QKIIKD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       359 ~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ..+..+ ++..+..++.++.++|.+||+.+|.+||++.
T Consensus       351 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  388 (400)
T cd05105         351 NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFL  388 (400)
T ss_pred             HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHH
Confidence            444433 4566778999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=7.1e-42  Score=320.68  Aligned_cols=246  Identities=32%  Similarity=0.497  Sum_probs=213.2

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.++..........+.+.+|+.++++++|+||+++++++......+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57999999999999999999999999999999997655445555667889999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC
Q 016037          230 DFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       230 E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~  305 (396)
                      ||+++++|..++..    ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..+.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence            99999999988754    34588999999999999999999999999999999999999999999999999987644322


Q ss_pred             -ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhC-CCCCCc-cCCHHHHHHH
Q 016037          306 -SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN--RQKIQQKIIKD-KIKLPA-FLSSEAHSLL  380 (396)
Q Consensus       306 -~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~--~~~i~~~i~~~-~~~~p~-~~s~~~~~li  380 (396)
                       .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||....  ..+....+..+ ..++|. .++.++.++|
T Consensus       162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  241 (267)
T cd08224         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLV  241 (267)
T ss_pred             ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHH
Confidence             234568899999999998889999999999999999999999997643  33445555444 334554 7889999999


Q ss_pred             HHhhccCCCCCCCCC
Q 016037          381 KGVNSLLSISVPLLS  395 (396)
Q Consensus       381 ~~~l~~~p~~RPs~s  395 (396)
                      ++||+.+|++||++.
T Consensus       242 ~~cl~~~p~~Rp~~~  256 (267)
T cd08224         242 SRCINPDPEKRPDIS  256 (267)
T ss_pred             HHHcCCCcccCCCHH
Confidence            999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9.9e-43  Score=330.23  Aligned_cols=246  Identities=21%  Similarity=0.336  Sum_probs=212.4

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCC-----CcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGT-----SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      ...+|++.+.||+|+||+||+|.+..+     +..||+|+++...  .....+.+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            455788999999999999999998654     5789999997543  223446678899999999999999999999999


Q ss_pred             CeEEEEEEecCCCcHHHHHHHh----------------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD  286 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~  286 (396)
                      ...++++||+.+++|..++...                ..+++..+..++.|++.||.|||++|++||||||+||+++++
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            9999999999999999888532                347788888999999999999999999999999999999999


Q ss_pred             CcEEEEecccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 016037          287 GHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKII  362 (396)
Q Consensus       287 ~~ikL~Dfgla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~  362 (396)
                      +.+||+|||+++.......   .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..++...+.
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR  240 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999886543221   223345789999999988889999999999999999998 999999988888888887


Q ss_pred             hCC-CCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          363 KDK-IKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       363 ~~~-~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ... ..+|..++.++.+|+.+||+.+|.+||++.
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~  274 (283)
T cd05091         241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFK  274 (283)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHH
Confidence            764 456788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-42  Score=321.97  Aligned_cols=244  Identities=22%  Similarity=0.365  Sum_probs=211.2

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +..++|++.+.||+|+||.||+|.+.. ++.||+|.++....    ..+.+.+|+.++++++||||+++++++......|
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY   77 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence            455789999999999999999999855 46799999876542    2344678999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          227 LVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      ++|||+++++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++......
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            9999999999999887654  68999999999999999999999999999999999999999999999999998765332


Q ss_pred             Cc--cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHH
Q 016037          305 RS--NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLL  380 (396)
Q Consensus       305 ~~--~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li  380 (396)
                      ..  ....++..|+|||.+.+..++.++||||||+++|||+| |+.||.+.+...+...+... ....+..++..+.+++
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (261)
T cd05068         158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIM  237 (261)
T ss_pred             ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence            21  11122457999999998889999999999999999999 99999998888878777655 4456778999999999


Q ss_pred             HHhhccCCCCCCCCC
Q 016037          381 KGVNSLLSISVPLLS  395 (396)
Q Consensus       381 ~~~l~~~p~~RPs~s  395 (396)
                      .+||+.+|.+||+++
T Consensus       238 ~~~l~~~P~~Rp~~~  252 (261)
T cd05068         238 LDCWKEDPDDRPTFE  252 (261)
T ss_pred             HHHhhcCcccCCCHH
Confidence            999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-42  Score=320.77  Aligned_cols=238  Identities=26%  Similarity=0.448  Sum_probs=213.9

Q ss_pred             eEecccCceEEEEEEEcCC---CcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEec
Q 016037          156 KVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFV  232 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~  232 (396)
                      +.||+|+||.||+|.+...   +..||+|++.......  ..+.+.+|+++++.++|+||+++++++.....++++|||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            4699999999999999866   8899999998754322  4567888999999999999999999999999999999999


Q ss_pred             CCCcHHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          233 NGGHLFFQLYRQ---------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       233 ~gg~L~~~l~~~---------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      ++++|..++...         ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||.+......
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            999999999875         78999999999999999999999999999999999999999999999999999877543


Q ss_pred             C---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHH
Q 016037          304 T---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHS  378 (396)
Q Consensus       304 ~---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~  378 (396)
                      .   ......++..|+|||.+....++.++||||||+++|||++ |..||.+.+..++.+.+... ....|..++.++.+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYE  238 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHH
Confidence            2   2344567889999999988889999999999999999999 69999999888888888865 56778899999999


Q ss_pred             HHHHhhccCCCCCCCCC
Q 016037          379 LLKGVNSLLSISVPLLS  395 (396)
Q Consensus       379 li~~~l~~~p~~RPs~s  395 (396)
                      ++.+||+.+|.+|||+.
T Consensus       239 li~~~l~~~p~~Rps~~  255 (262)
T cd00192         239 LMLSCWQLDPEDRPTFS  255 (262)
T ss_pred             HHHHHccCCcccCcCHH
Confidence            99999999999999975

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=9.3e-42  Score=318.42  Aligned_cols=244  Identities=30%  Similarity=0.490  Sum_probs=216.7

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      +|++++.||.|+||.||.++...+++.+++|.+....... .....+.+|++++++++|+||+++++++.+...++++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            5899999999999999999999999999999987654333 344557789999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Ccc
Q 016037          231 FVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSN  307 (396)
Q Consensus       231 ~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~~  307 (396)
                      |+++++|..++.+.  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....... ...
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  159 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE  159 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence            99999999988765  468999999999999999999999999999999999999999999999999998764433 234


Q ss_pred             ccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHHHHhhcc
Q 016037          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAHSLLKGVNSL  386 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~-~~p~~~s~~~~~li~~~l~~  386 (396)
                      ...|++.|+|||.+.+..++.++||||||+++|||++|..||...+..+....+..... ..+..++.++.++|.+||..
T Consensus       160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  239 (256)
T cd08221         160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQ  239 (256)
T ss_pred             ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccc
Confidence            45689999999999988899999999999999999999999999888888877776644 34567899999999999999


Q ss_pred             CCCCCCCCC
Q 016037          387 LSISVPLLS  395 (396)
Q Consensus       387 ~p~~RPs~s  395 (396)
                      +|.+|||+.
T Consensus       240 ~p~~R~s~~  248 (256)
T cd08221         240 DPEKRPTAD  248 (256)
T ss_pred             CcccCCCHH
Confidence            999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-42  Score=323.12  Aligned_cols=242  Identities=21%  Similarity=0.389  Sum_probs=208.9

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      ..+|++.+.||+|+||.||+|.++. +..+|+|++......    .+.+.+|+.+++.++||||+++++++......|+|
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV   77 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence            4579999999999999999999864 567999998754322    23466799999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCc-
Q 016037          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-  306 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~-  306 (396)
                      |||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++...+.... 
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            9999999999988753 46889999999999999999999999999999999999999999999999999865432211 


Q ss_pred             -cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHHh
Q 016037          307 -NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGV  383 (396)
Q Consensus       307 -~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~~~  383 (396)
                       ....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+... .+..|..++.++.+++.+|
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  237 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSC  237 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHH
Confidence             11223457999999998889999999999999999999 89999988877777777665 5567778999999999999


Q ss_pred             hccCCCCCCCCC
Q 016037          384 NSLLSISVPLLS  395 (396)
Q Consensus       384 l~~~p~~RPs~s  395 (396)
                      |+.+|++|||+.
T Consensus       238 l~~~p~~Rpt~~  249 (256)
T cd05059         238 WHEKPEDRPAFK  249 (256)
T ss_pred             hcCChhhCcCHH
Confidence            999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-43  Score=359.32  Aligned_cols=244  Identities=28%  Similarity=0.401  Sum_probs=209.6

Q ss_pred             CccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeE-EEEe
Q 016037          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRY-SFQT  221 (396)
Q Consensus       144 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~-~~~~  221 (396)
                      .-.++..++++.+.|.+|||+.||+|.+...|..||+|++-..   ++...+.+.+|+++|++|. |+|||.+++ +...
T Consensus        31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~  107 (738)
T KOG1989|consen   31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN  107 (738)
T ss_pred             EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence            3446677899999999999999999999998899999998764   4677888999999999996 999999999 3321


Q ss_pred             ------cCeEEEEEEecCCCcHHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEcCCCcEEE
Q 016037          222 ------KYRLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLDADGHVML  291 (396)
Q Consensus       222 ------~~~~~lV~E~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~--iiHrDlkp~NILl~~~~~ikL  291 (396)
                            ...++|.||||.||.|.+++..  +..|+|.++..|+.|+|+|+.+||.++  |||||||-|||||+.+|++||
T Consensus       108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KL  187 (738)
T KOG1989|consen  108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKL  187 (738)
T ss_pred             ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEe
Confidence                  2468999999999999999863  456999999999999999999999996  999999999999999999999


Q ss_pred             EecccccccCCCCCc----------cccccCCCccchhhh---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 016037          292 TDFGLAKQFDENTRS----------NSMCGTLEYMSPEIV---LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ  358 (396)
Q Consensus       292 ~Dfgla~~~~~~~~~----------~~~~gt~~y~APE~l---~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~  358 (396)
                      ||||.|+..-.....          -...-|+.|+|||++   .+...+.|+|||+|||+||-||....||.+.-    .
T Consensus       188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg----~  263 (738)
T KOG1989|consen  188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG----K  263 (738)
T ss_pred             CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc----c
Confidence            999999754222111          112358999999998   46778999999999999999999999998753    2


Q ss_pred             HHHHhCCCCCCc--cCCHHHHHHHHHhhccCCCCCCCC
Q 016037          359 QKIIKDKIKLPA--FLSSEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       359 ~~i~~~~~~~p~--~~s~~~~~li~~~l~~~p~~RPs~  394 (396)
                      ..|+++++.||.  .+|..+++||+.||+.||.+||++
T Consensus       264 laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI  301 (738)
T KOG1989|consen  264 LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNI  301 (738)
T ss_pred             eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCH
Confidence            457778888885  799999999999999999999986

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.5e-42  Score=319.44  Aligned_cols=244  Identities=28%  Similarity=0.484  Sum_probs=217.1

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+...... ....+.+.+|+.+++.++||||+++++.+.....+++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            589999999999999999999999999999999865433 3345678889999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-cEEEEecccccccCCCCCcc
Q 016037          231 FVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HVMLTDFGLAKQFDENTRSN  307 (396)
Q Consensus       231 ~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~-~ikL~Dfgla~~~~~~~~~~  307 (396)
                      |+++++|.+++...  ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .+||+|||++..........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY  159 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence            99999999998764  3588999999999999999999999999999999999998654 57999999998876655555


Q ss_pred             ccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHHhhcc
Q 016037          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGVNSL  386 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~~~l~~  386 (396)
                      ...|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+.......+... ...++..++.+++++|.+||+.
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  239 (256)
T cd08220         160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNL  239 (256)
T ss_pred             ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccC
Confidence            567899999999999888899999999999999999999999988877777776665 4467788999999999999999


Q ss_pred             CCCCCCCCC
Q 016037          387 LSISVPLLS  395 (396)
Q Consensus       387 ~p~~RPs~s  395 (396)
                      +|.+|||+.
T Consensus       240 ~p~~Rpt~~  248 (256)
T cd08220         240 DPSKRPQLS  248 (256)
T ss_pred             ChhhCCCHH
Confidence            999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-42  Score=323.70  Aligned_cols=243  Identities=21%  Similarity=0.308  Sum_probs=208.0

Q ss_pred             eEEEeEecccCceEEEEEEEcCC---CcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCe----
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR----  224 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~----  224 (396)
                      |.+.+.||+|+||.||+|.+..+   +..||+|+++..... ....+.+.+|+.+++.++||||+++++.+.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            56789999999999999987653   478999998764432 3345567889999999999999999998865544    


Q ss_pred             --EEEEEEecCCCcHHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccc
Q 016037          225 --LYLVLDFVNGGHLFFQLYRQ------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGL  296 (396)
Q Consensus       225 --~~lV~E~~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgl  296 (396)
                        .++++||+++|+|..++...      ..+++..++.++.|++.||.|||+++++||||||+||++++++.+||+|||+
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence              79999999999998887543      3588899999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCcc
Q 016037          297 AKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAF  371 (396)
Q Consensus       297 a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~  371 (396)
                      ++.......   .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..++.+.+..+ ....|..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  239 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPED  239 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcC
Confidence            987643321   122335678999999988889999999999999999999 99999998888888877765 5567889


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCCC
Q 016037          372 LSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       372 ~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ++.++.++|.+||+.+|.+||+++
T Consensus       240 ~~~~~~~li~~~l~~~p~~Rp~~~  263 (273)
T cd05035         240 CLDELYDLMYSCWRADPKDRPTFT  263 (273)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHH
Confidence            999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.3e-42  Score=325.28  Aligned_cols=238  Identities=33%  Similarity=0.601  Sum_probs=208.1

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCCCcH
Q 016037          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL  237 (396)
Q Consensus       158 IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L  237 (396)
                      ||+|+||+||+|.+..+|+.||+|++...........+.+..|+.+++.++||||+++++++......|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999999999999999999765443344455567899999999999999999999999999999999999999


Q ss_pred             HHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccccccCCCc
Q 016037          238 FFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY  315 (396)
Q Consensus       238 ~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~~gt~~y  315 (396)
                      .+++.+..  .+++..++.++.|++.||.|||++|++||||+|+||+++.++.+||+|||++.............++..|
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY  160 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence            99887765  7899999999999999999999999999999999999999999999999999876544444455678899


Q ss_pred             cchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCC
Q 016037          316 MSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR----QKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISV  391 (396)
Q Consensus       316 ~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~----~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~R  391 (396)
                      +|||.+.+..++.++||||||+++|+|++|+.||...+.    ..+...+......+|..+++++.++|++||+.+|.+|
T Consensus       161 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  240 (277)
T cd05577         161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKR  240 (277)
T ss_pred             CCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHc
Confidence            999999888899999999999999999999999987543    4444444445667778899999999999999999999


Q ss_pred             CCCC
Q 016037          392 PLLS  395 (396)
Q Consensus       392 Ps~s  395 (396)
                      |+..
T Consensus       241 ~~~~  244 (277)
T cd05577         241 LGCR  244 (277)
T ss_pred             cCCC
Confidence            9653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-44  Score=350.06  Aligned_cols=240  Identities=26%  Similarity=0.381  Sum_probs=217.0

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      -|.-++.||.|+||.||-|++..+.+.||||.+.-..-...+..+.+..|+++|++++|||++.+.+||..+...|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            37888999999999999999999999999999987666666778889999999999999999999999999999999999


Q ss_pred             ecCCCcHHHHH-HHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCcccc
Q 016037          231 FVNGGHLFFQL-YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM  309 (396)
Q Consensus       231 ~~~gg~L~~~l-~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~  309 (396)
                      ||-|. -.+++ -.++++.+..+..++.+.+.||.|||+.+.||||||..|||+++.|.|||+|||.|....   ..+++
T Consensus       107 YClGS-AsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---PAnsF  182 (948)
T KOG0577|consen  107 YCLGS-ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA---PANSF  182 (948)
T ss_pred             HHhcc-HHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC---chhcc
Confidence            99774 44444 345789999999999999999999999999999999999999999999999999997654   34678


Q ss_pred             ccCCCccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCC-ccCCHHHHHHHHHhh
Q 016037          310 CGTLEYMSPEIVL---GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-IKLP-AFLSSEAHSLLKGVN  384 (396)
Q Consensus       310 ~gt~~y~APE~l~---~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~-~~~p-~~~s~~~~~li~~~l  384 (396)
                      +|||+|||||++.   .+.|+-++||||||++-.||.-.++|+.+.|.+....-|..+. ++++ ..+|..|++|+..||
T Consensus       183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CL  262 (948)
T KOG0577|consen  183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCL  262 (948)
T ss_pred             cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHH
Confidence            9999999999985   4679999999999999999999999999999999998898875 4555 469999999999999


Q ss_pred             ccCCCCCCCC
Q 016037          385 SLLSISVPLL  394 (396)
Q Consensus       385 ~~~p~~RPs~  394 (396)
                      ++-|++|||.
T Consensus       263 qKipqeRpts  272 (948)
T KOG0577|consen  263 QKIPQERPTS  272 (948)
T ss_pred             hhCcccCCcH
Confidence            9999999985

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.4e-42  Score=324.00  Aligned_cols=245  Identities=28%  Similarity=0.410  Sum_probs=206.9

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++...... ....+.+.+|+.++++++||||+++++++.....+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            4699999999999999999999999999999998754321 223345678999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Cccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNS  308 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~~~  308 (396)
                      ||++++.|...+.....+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ....
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence            999999888877777789999999999999999999999999999999999999999999999999998765443 2334


Q ss_pred             cccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------CCCC
Q 016037          309 MCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-------------------KIKL  368 (396)
Q Consensus       309 ~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~-------------------~~~~  368 (396)
                      ..++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+....+...                   ....
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07847         160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI  239 (286)
T ss_pred             cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence            567889999999876 45789999999999999999999999887655444433221                   0011


Q ss_pred             C------------ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          369 P------------AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       369 p------------~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      |            ..++..+.+||.+||+.+|.+||++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~  278 (286)
T cd07847         240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCE  278 (286)
T ss_pred             CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHH
Confidence            1            24688999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-42  Score=320.16  Aligned_cols=237  Identities=21%  Similarity=0.323  Sum_probs=205.7

Q ss_pred             eEecccCceEEEEEEEcCCC---cEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEec
Q 016037          156 KVVGQGAFAKVYQVRRIGTS---EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFV  232 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~  232 (396)
                      ++||+|+||.||+|.+..++   ..+|+|.+......  ...+.+.+|+++++.++||||+++++++. ...++++|||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence            46999999999999886655   78999999876533  34456788999999999999999999875 45689999999


Q ss_pred             CCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCc----cc
Q 016037          233 NGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS----NS  308 (396)
Q Consensus       233 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~----~~  308 (396)
                      ++++|.+++.+...+++..+..++.|++.||.|||.++++||||||+|||++.++.+||+|||+++........    ..
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence            99999999988888999999999999999999999999999999999999999999999999999876433321    11


Q ss_pred             cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHHhhcc
Q 016037          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGVNSL  386 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~~~l~~  386 (396)
                      ..++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..++...+... ....|..++..++++|.+||+.
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  237 (257)
T cd05060         158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKY  237 (257)
T ss_pred             ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcC
Confidence            123467999999998889999999999999999998 99999988887777777665 4567788999999999999999


Q ss_pred             CCCCCCCCC
Q 016037          387 LSISVPLLS  395 (396)
Q Consensus       387 ~p~~RPs~s  395 (396)
                      +|.+||++.
T Consensus       238 ~p~~Rp~~~  246 (257)
T cd05060         238 RPEDRPTFS  246 (257)
T ss_pred             ChhhCcCHH
Confidence            999999975

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5.1e-42  Score=327.19  Aligned_cols=247  Identities=20%  Similarity=0.291  Sum_probs=211.2

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCC----------------cEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTS----------------EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF  211 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~----------------~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~Hpn  211 (396)
                      ..++|++.+.||+|+||.||+|.+..++                ..||+|++.....  ....+.+.+|+++++.++|||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence            3468999999999999999999876644                5689999876532  244566788999999999999


Q ss_pred             eeeeeEEEEecCeEEEEEEecCCCcHHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 016037          212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-----------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN  280 (396)
Q Consensus       212 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~N  280 (396)
                      |+++++++......+++|||+++++|..++.+..           .+++..++.++.|++.||.|||++|++||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            9999999999999999999999999999987765           68999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecccccccCCCC---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHH
Q 016037          281 ILLDADGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT--GQPPFTGGNRQ  355 (396)
Q Consensus       281 ILl~~~~~ikL~Dfgla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt--g~~Pf~~~~~~  355 (396)
                      |+++.++.++|+|||+++......   ......+++.|||||.+.+..++.++|||||||++|||++  |..||...+..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            999999999999999998654332   1233456788999999988889999999999999999998  88899887777


Q ss_pred             HHHHHHHhC--------CCCCCccCCHHHHHHHHHhhccCCCCCCCCCC
Q 016037          356 KIQQKIIKD--------KIKLPAFLSSEAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       356 ~i~~~i~~~--------~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s~  396 (396)
                      .+...+...        ....|..++.++.+||.+||+.+|.+||++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~e  289 (296)
T cd05051         241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFRE  289 (296)
T ss_pred             HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHH
Confidence            766666532        12345677899999999999999999999753

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-42  Score=324.33  Aligned_cols=243  Identities=27%  Similarity=0.485  Sum_probs=214.8

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++.+.||.|+||.||+|.+..+++.||+|++....  .......+.+|+++++.++|+||+++++++.....+|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            36889999999999999999999999999999987653  2233455778999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-CCccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNS  308 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-~~~~~  308 (396)
                      ||+++++|..++... .+++..++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||+++..... .....
T Consensus        79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence            999999999888765 8899999999999999999999999999999999999999999999999999887544 23445


Q ss_pred             cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCcc-CCHHHHHHHHHhhcc
Q 016037          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-IKLPAF-LSSEAHSLLKGVNSL  386 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~-~~~p~~-~s~~~~~li~~~l~~  386 (396)
                      ..++..|+|||.+.+..++.++||||||+++|+|+||+.||...+.......+.... ..++.. ++.++.++|..||..
T Consensus       158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~  237 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNK  237 (274)
T ss_pred             ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhC
Confidence            678899999999998889999999999999999999999999887777766666653 344445 899999999999999


Q ss_pred             CCCCCCCCC
Q 016037          387 LSISVPLLS  395 (396)
Q Consensus       387 ~p~~RPs~s  395 (396)
                      +|++||+++
T Consensus       238 ~p~~Rpt~~  246 (274)
T cd06609         238 DPKERPSAK  246 (274)
T ss_pred             ChhhCcCHH
Confidence            999999964

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.2e-42  Score=327.55  Aligned_cols=249  Identities=21%  Similarity=0.375  Sum_probs=214.3

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCCC-----cEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEE
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTS-----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYS  218 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~  218 (396)
                      ..+..++|++.+.||+|+||.||++.+...+     ..+|+|.+.....  ......+.+|+.+++++ +|+||++++++
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   84 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGV   84 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            4466778999999999999999999987543     7899999876432  23345577899999999 89999999999


Q ss_pred             EEecCeEEEEEEecCCCcHHHHHHHh----------------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEE
Q 016037          219 FQTKYRLYLVLDFVNGGHLFFQLYRQ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL  282 (396)
Q Consensus       219 ~~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NIL  282 (396)
                      +.....++++|||+++|+|..++...                +.+++..++.++.|++.||.|||+.||+||||||+|||
T Consensus        85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil  164 (293)
T cd05053          85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL  164 (293)
T ss_pred             EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence            99999999999999999999988653                35788889999999999999999999999999999999


Q ss_pred             EcCCCcEEEEecccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 016037          283 LDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQ  358 (396)
Q Consensus       283 l~~~~~ikL~Dfgla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~  358 (396)
                      ++.++.+||+|||+++.......   .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..++.
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  244 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  244 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence            99999999999999987643321   122234578999999998889999999999999999998 99999998888888


Q ss_pred             HHHHhC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          359 QKIIKD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       359 ~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +.+... ....|...+.++.+|+.+||+.+|.+|||+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  282 (293)
T cd05053         245 KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFK  282 (293)
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHH
Confidence            777765 4567778999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.8e-42  Score=323.93  Aligned_cols=246  Identities=30%  Similarity=0.485  Sum_probs=211.3

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++.+.||+|+||.||+|++..+++.+|||.+.............+.+|+.+++.++||||+++++++.....++++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            57889999999999999999999999999999987655444555567788999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC
Q 016037          230 DFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       230 E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~  305 (396)
                      ||+++++|..++..    ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence            99999999888763    35689999999999999999999999999999999999999999999999999887643322


Q ss_pred             -ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCC-CCC-ccCCHHHHHHH
Q 016037          306 -SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR--QKIQQKIIKDKI-KLP-AFLSSEAHSLL  380 (396)
Q Consensus       306 -~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~--~~i~~~i~~~~~-~~p-~~~s~~~~~li  380 (396)
                       .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.+...  ....+.+..... +++ ..++.++++||
T Consensus       162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  241 (267)
T cd08229         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV  241 (267)
T ss_pred             ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHH
Confidence             2345788999999999988899999999999999999999999976543  344444443322 232 46889999999


Q ss_pred             HHhhccCCCCCCCCC
Q 016037          381 KGVNSLLSISVPLLS  395 (396)
Q Consensus       381 ~~~l~~~p~~RPs~s  395 (396)
                      .+||+.+|++||++.
T Consensus       242 ~~~l~~~p~~Rpt~~  256 (267)
T cd08229         242 NMCINPDPEKRPDIT  256 (267)
T ss_pred             HHhcCCCcccCCCHH
Confidence            999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.7e-42  Score=318.55  Aligned_cols=245  Identities=31%  Similarity=0.484  Sum_probs=214.8

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeecccc--chhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI--MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      +|+..+.||+|+||+||+|.+..+++.|++|.+.....  ..+...+.+.+|+.+++.++|+||+++++++.....+|++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            36777899999999999999998999999999876432  2234566788999999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccc
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~  308 (396)
                      +||+++++|..++.+.+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++...........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  160 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS  160 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence            99999999999998888899999999999999999999999999999999999999999999999999987655444455


Q ss_pred             cccCCCccchhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHHHHHhhc
Q 016037          309 MCGTLEYMSPEIVLGKG-HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK--DKIKLPAFLSSEAHSLLKGVNS  385 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~-~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~--~~~~~p~~~s~~~~~li~~~l~  385 (396)
                      ..|+..|+|||.+.... ++.++|+||||+++|+|++|+.||..........++..  ....+|..++.++.+||++||+
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  240 (258)
T cd06632         161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ  240 (258)
T ss_pred             cCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhh
Confidence            67899999999998776 89999999999999999999999987765555555544  2445677899999999999999


Q ss_pred             cCCCCCCCCC
Q 016037          386 LLSISVPLLS  395 (396)
Q Consensus       386 ~~p~~RPs~s  395 (396)
                      .+|.+||++.
T Consensus       241 ~~p~~Rp~~~  250 (258)
T cd06632         241 RDPSLRPTAA  250 (258)
T ss_pred             cCcccCcCHH
Confidence            9999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.9e-42  Score=321.90  Aligned_cols=243  Identities=24%  Similarity=0.372  Sum_probs=208.1

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +..++|++.++||+|+||.||+|.+..++ .||+|+++....    ..+.+.+|+++++.++||||+++++.+.. ...|
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (262)
T cd05071           3 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY   76 (262)
T ss_pred             CChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence            45578999999999999999999987664 599999876432    12456789999999999999999988754 5689


Q ss_pred             EEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          227 LVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      +||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||.++.+....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            999999999999988753  457889999999999999999999999999999999999999999999999998765433


Q ss_pred             Cc--cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHH
Q 016037          305 RS--NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLL  380 (396)
Q Consensus       305 ~~--~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li  380 (396)
                      ..  ....++..|+|||.+.+..++.++||||||+++|||+| |..||.+....++...+... ....+..++.++.+||
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  236 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM  236 (262)
T ss_pred             cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence            21  23346678999999988889999999999999999999 99999988877777777654 3455678999999999


Q ss_pred             HHhhccCCCCCCCCC
Q 016037          381 KGVNSLLSISVPLLS  395 (396)
Q Consensus       381 ~~~l~~~p~~RPs~s  395 (396)
                      .+||+.+|.+||++.
T Consensus       237 ~~~l~~~p~~Rp~~~  251 (262)
T cd05071         237 CQCWRKEPEERPTFE  251 (262)
T ss_pred             HHHccCCcccCCCHH
Confidence            999999999999974

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-44  Score=353.26  Aligned_cols=244  Identities=31%  Similarity=0.499  Sum_probs=218.4

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      +.|.++..||.|+||+||+|..+.++...|-|+|...   +.+.++.+.-|+.||..++||+||+|++.|-..+.+||+.
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili  108 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI  108 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence            3588899999999999999999999999999998654   3566677778999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC-CCCCcc
Q 016037          230 DFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSN  307 (396)
Q Consensus       230 E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~-~~~~~~  307 (396)
                      |||.||-....+.. ...+.++.+..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+.... ......
T Consensus       109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD  188 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD  188 (1187)
T ss_pred             eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence            99999988766644 5679999999999999999999999999999999999999999999999999875432 233457


Q ss_pred             ccccCCCccchhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---CCccCCHHHHHH
Q 016037          308 SMCGTLEYMSPEIVLG-----KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK---LPAFLSSEAHSL  379 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~-----~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~---~p~~~s~~~~~l  379 (396)
                      ++.|||+|||||+...     ..|+.++||||||++|.||..+.+|....+++.++-+|.+..++   -|..+|..+.+|
T Consensus       189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~Df  268 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDF  268 (1187)
T ss_pred             cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHH
Confidence            8899999999999854     57899999999999999999999999999999999999997553   477899999999


Q ss_pred             HHHhhccCCCCCCCCCC
Q 016037          380 LKGVNSLLSISVPLLSR  396 (396)
Q Consensus       380 i~~~l~~~p~~RPs~s~  396 (396)
                      ++.||.+||..||+.+|
T Consensus       269 Lk~cL~Knp~~Rp~aaq  285 (1187)
T KOG0579|consen  269 LKRCLVKNPRNRPPAAQ  285 (1187)
T ss_pred             HHHHHhcCCccCCCHHH
Confidence            99999999999998754

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6e-42  Score=324.90  Aligned_cols=241  Identities=32%  Similarity=0.489  Sum_probs=209.1

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEe
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (396)
                      |++.+.||+|+||.||+|.+..++..+++|.+....   ....+.+.+|+.+++.++||||+++++++..+...|+|+||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            678899999999999999999999999999986543   23455677899999999999999999999999999999999


Q ss_pred             cCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-CCcccc
Q 016037          232 VNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNSM  309 (396)
Q Consensus       232 ~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-~~~~~~  309 (396)
                      +++++|..++.+ ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++...... ......
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  163 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF  163 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence            999999887764 467899999999999999999999999999999999999999999999999999765332 223456


Q ss_pred             ccCCCccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---CCCCccCCHHHHHHHH
Q 016037          310 CGTLEYMSPEIVL-----GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLPAFLSSEAHSLLK  381 (396)
Q Consensus       310 ~gt~~y~APE~l~-----~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~---~~~p~~~s~~~~~li~  381 (396)
                      .++..|+|||.+.     +..++.++|||||||++|||++|+.||...+..+....+....   +..|..++.++++||+
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (282)
T cd06643         164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLK  243 (282)
T ss_pred             cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHH
Confidence            7899999999984     3457789999999999999999999999887777666665542   3456678999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      +||+.+|.+||++.
T Consensus       244 ~~l~~~p~~Rp~~~  257 (282)
T cd06643         244 KCLEKNVDARWTTT  257 (282)
T ss_pred             HHccCChhhCcCHH
Confidence            99999999999964

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.2e-42  Score=326.20  Aligned_cols=245  Identities=21%  Similarity=0.342  Sum_probs=211.5

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      ...+|.+.+.||+|+||.||+|.+..     ++..+++|.+....   ....+.+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            34679999999999999999998643     45568999886543   23345678899999999999999999999999


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhc----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD  286 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~  286 (396)
                      ...++||||+++++|.+++...+                .+++..++.++.||+.||+|||++|++||||||+|||++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence            99999999999999999987643                37888999999999999999999999999999999999999


Q ss_pred             CcEEEEecccccccCCCC---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 016037          287 GHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKII  362 (396)
Q Consensus       287 ~~ikL~Dfgla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~  362 (396)
                      +.++|+|||+++......   ......++..|+|||.+.+..++.++||||||+++|||+| |+.||...+..+..+.+.
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~  239 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT  239 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence            999999999997654322   1233456788999999999889999999999999999999 999999888888888777


Q ss_pred             hCCC-CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          363 KDKI-KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       363 ~~~~-~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .+.. ..+..++.++.+|+.+||+.+|.+||+++
T Consensus       240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~  273 (291)
T cd05094         240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIK  273 (291)
T ss_pred             CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHH
Confidence            7644 45677899999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=6.2e-42  Score=322.42  Aligned_cols=245  Identities=22%  Similarity=0.366  Sum_probs=211.2

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCc---EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSE---IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~  225 (396)
                      ..+|++.+.||+|+||.||+|.++.+++   .||+|++....  .....+.+..|+.+++.++||||+++++++..+..+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            4579999999999999999999987765   59999987542  234456688899999999999999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          226 YLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      ++||||+++++|..++... +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999999888754 568899999999999999999999999999999999999999999999999987654322


Q ss_pred             Cccc----c--ccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHH
Q 016037          305 RSNS----M--CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (396)
Q Consensus       305 ~~~~----~--~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~  376 (396)
                      ....    .  ..+..|+|||.+.+..++.++|||||||++|||++ |..||...+..++...+... ..+.+..++.++
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTAL  240 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHH
Confidence            2111    1  12457999999998889999999999999999997 99999998888888877654 456667889999


Q ss_pred             HHHHHHhhccCCCCCCCCC
Q 016037          377 HSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~RPs~s  395 (396)
                      .+++.+||+.+|.+||++.
T Consensus       241 ~~li~~~l~~~p~~Rp~~~  259 (269)
T cd05065         241 HQLMLDCWQKDRNARPKFG  259 (269)
T ss_pred             HHHHHHHcCCChhhCcCHH
Confidence            9999999999999999974

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.4e-41  Score=319.37  Aligned_cols=245  Identities=33%  Similarity=0.470  Sum_probs=210.3

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeecccc--chhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec--CeE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI--MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--YRL  225 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~--~~~  225 (396)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+.....  ......+.+.+|+.+++.++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            579999999999999999999999999999999864321  1233456788899999999999999999998763  568


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC--
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--  303 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~--  303 (396)
                      +++|||+++++|.+++.+...+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++.....  
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            899999999999999988788899999999999999999999999999999999999999999999999999865321  


Q ss_pred             --CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHH
Q 016037          304 --TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPAFLSSEAHSL  379 (396)
Q Consensus       304 --~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--~~~~p~~~s~~~~~l  379 (396)
                        .......|+..|+|||.+.+..++.++|||||||++|||++|+.||...+.......+...  ...+|..++..+.++
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (265)
T cd06652         162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDF  241 (265)
T ss_pred             cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHH
Confidence              1223456889999999998888999999999999999999999999887655555544433  345677889999999


Q ss_pred             HHHhhccCCCCCCCCC
Q 016037          380 LKGVNSLLSISVPLLS  395 (396)
Q Consensus       380 i~~~l~~~p~~RPs~s  395 (396)
                      |+.|+. +|.+||+.+
T Consensus       242 i~~~l~-~p~~Rp~~~  256 (265)
T cd06652         242 LKRIFV-EAKLRPSAD  256 (265)
T ss_pred             HHHHhc-ChhhCCCHH
Confidence            999994 999999964

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1e-41  Score=361.35  Aligned_cols=245  Identities=23%  Similarity=0.317  Sum_probs=205.2

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++.++||+|+||.||+|.+..+++.||+|+++..........+.+.+|+++++.++||||+++++++.+.+..|++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            68999999999999999999999999999999998654434445566888999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccc
Q 016037          230 DFVNGGHLFFQLYRQ-----------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK  298 (396)
Q Consensus       230 E~~~gg~L~~~l~~~-----------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~  298 (396)
                      ||++|++|..++...           ...+...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk  161 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI  161 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence            999999999888642           234455677889999999999999999999999999999999999999999998


Q ss_pred             ccCCC-------------------CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 016037          299 QFDEN-------------------TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ  359 (396)
Q Consensus       299 ~~~~~-------------------~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~  359 (396)
                      .....                   ......+||+.|||||.+.+..++.++|||||||++|||+||+.||...+...+..
T Consensus       162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~  241 (932)
T PRK13184        162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY  241 (932)
T ss_pred             ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh
Confidence            66211                   11123579999999999999999999999999999999999999998765444333


Q ss_pred             HHHhCC-CC--CCccCCHHHHHHHHHhhccCCCCCCCC
Q 016037          360 KIIKDK-IK--LPAFLSSEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       360 ~i~~~~-~~--~p~~~s~~~~~li~~~l~~~p~~RPs~  394 (396)
                      ...... ..  ....+++.+.+++.+||+.+|.+||+.
T Consensus       242 ~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss  279 (932)
T PRK13184        242 RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSS  279 (932)
T ss_pred             hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCH
Confidence            221111 11  124688999999999999999999863

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-43  Score=345.80  Aligned_cols=243  Identities=42%  Similarity=0.771  Sum_probs=217.3

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      ...-|..++.||-|+||+|.+++...|...||+|.+++......+.....+.|.+||..-+.+-||+||..|++++.+|+
T Consensus       627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF  706 (1034)
T KOG0608|consen  627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF  706 (1034)
T ss_pred             cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence            34569999999999999999999999999999999999887778888889999999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC------
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD------  301 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~------  301 (396)
                      ||+|++||++..+|.+.+.|.|+.+++|++++..|+++.|..|+|||||||+|||||.+|+|||+||||+.-+.      
T Consensus       707 VMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk  786 (1034)
T KOG0608|consen  707 VMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  786 (1034)
T ss_pred             EEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999997441      


Q ss_pred             ---CC----------------------------------CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh
Q 016037          302 ---EN----------------------------------TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT  344 (396)
Q Consensus       302 ---~~----------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt  344 (396)
                         ++                                  ....+.+||+.|+|||++...+|+..+||||.||+||||+.
T Consensus       787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~  866 (1034)
T KOG0608|consen  787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV  866 (1034)
T ss_pred             cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence               00                                  01234679999999999999999999999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHHhC--CCCCC--ccCCHHHHHHHHHhhccCCCCC
Q 016037          345 GQPPFTGGNRQKIQQKIIKD--KIKLP--AFLSSEAHSLLKGVNSLLSISV  391 (396)
Q Consensus       345 g~~Pf~~~~~~~i~~~i~~~--~~~~p--~~~s~~~~~li~~~l~~~p~~R  391 (396)
                      |+.||...+..+.+.++.+.  .+.+|  ..+|.++.+||.+++ +++++|
T Consensus       867 g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~R  916 (1034)
T KOG0608|consen  867 GQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSR  916 (1034)
T ss_pred             CCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhh
Confidence            99999999888888887765  34455  579999999997754 444444

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-41  Score=318.32  Aligned_cols=241  Identities=23%  Similarity=0.385  Sum_probs=213.4

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +..++|++.+.||.|+||.||+|...  |+.||+|.+.....    ..+.+.+|+.+++.++|+||+++++++......|
T Consensus         3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (256)
T cd05039           3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY   76 (256)
T ss_pred             cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence            45678999999999999999999874  67899999976532    4556788999999999999999999999899999


Q ss_pred             EEEEecCCCcHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          227 LVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      +||||+++++|.+++....  .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||.++......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            9999999999999987765  78999999999999999999999999999999999999999999999999998764332


Q ss_pred             CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHH
Q 016037          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKG  382 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~~  382 (396)
                      .  ...++..|+|||.+.+..++.++||||||+++|||++ |..||...+...+...+..+ +...|..+++++.+||.+
T Consensus       157 ~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  234 (256)
T cd05039         157 D--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKD  234 (256)
T ss_pred             c--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHH
Confidence            2  3345678999999988889999999999999999998 99999998888877777665 556778899999999999


Q ss_pred             hhccCCCCCCCCC
Q 016037          383 VNSLLSISVPLLS  395 (396)
Q Consensus       383 ~l~~~p~~RPs~s  395 (396)
                      ||+.+|++||+++
T Consensus       235 ~l~~~p~~Rp~~~  247 (256)
T cd05039         235 CWELDPAKRPTFK  247 (256)
T ss_pred             HhccChhhCcCHH
Confidence            9999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-41  Score=337.42  Aligned_cols=240  Identities=25%  Similarity=0.366  Sum_probs=199.5

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcC--CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCe
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIG--TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~  224 (396)
                      +...+|++++.||+|+||.||+|...+  +++.||+|.+....        ...+|+++|++++||||++++++|.....
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~  160 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKST  160 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence            344679999999999999999998653  56789999886532        24579999999999999999999999999


Q ss_pred             EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      +|++||++.+ +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus       161 ~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        161 VCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             EEEEehhcCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            9999999974 777888777889999999999999999999999999999999999999999999999999998765432


Q ss_pred             C---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhC--------------
Q 016037          305 R---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ---KIQQKIIKD--------------  364 (396)
Q Consensus       305 ~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~---~i~~~i~~~--------------  364 (396)
                      .   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....   ..+..+.+.              
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  319 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST  319 (392)
T ss_pred             ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence            2   23457999999999999999999999999999999999999999875321   111111110              


Q ss_pred             -------------C--CCCC-----ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 -------------K--IKLP-----AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 -------------~--~~~p-----~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                   +  ..+|     ..++.++++||++||..+|++|||+.
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~  370 (392)
T PHA03207        320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQ  370 (392)
T ss_pred             hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHH
Confidence                         0  1111     13577899999999999999999975

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1e-41  Score=319.96  Aligned_cols=244  Identities=28%  Similarity=0.433  Sum_probs=210.2

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeecccc---chhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI---MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      +|++.+.||+|+||+||+|.. .+++.+|+|.+.....   ........+.+|+.+++.++|+||+++++++.+...+|+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            478889999999999999987 4788899999875432   123344568889999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC-----
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-----  302 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~-----  302 (396)
                      ++||+++++|..++.+.+.+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.....     
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            999999999999998888899999999999999999999999999999999999999999999999999876521     


Q ss_pred             --CCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCCccCCHHHH
Q 016037          303 --NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAH  377 (396)
Q Consensus       303 --~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~---~~~~p~~~s~~~~  377 (396)
                        ........|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+...   ...++..++.++.
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAI  239 (265)
T ss_pred             cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHH
Confidence              11123456889999999999988999999999999999999999999876655544444433   2356778999999


Q ss_pred             HHHHHhhccCCCCCCCCC
Q 016037          378 SLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       378 ~li~~~l~~~p~~RPs~s  395 (396)
                      +||++||+.+|.+||++.
T Consensus       240 ~~i~~~l~~~p~~Rp~~~  257 (265)
T cd06631         240 DFVTSCLTRDQHERPSAL  257 (265)
T ss_pred             HHHHHHhcCCcccCCCHH
Confidence            999999999999999974

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=8.3e-42  Score=325.45  Aligned_cols=243  Identities=21%  Similarity=0.348  Sum_probs=208.6

Q ss_pred             CeEEEeEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~  225 (396)
                      +|++.+.||+|+||.||+|.+..     ....+|+|.+.....  ....+.+.+|+.+++.++||||+++++.+......
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            47889999999999999998754     235689998875432  23345678899999999999999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHh------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCE
Q 016037          226 YLVLDFVNGGHLFFQLYRQ------------------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENI  281 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~------------------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NI  281 (396)
                      |+++||+.+++|..++...                        ..+++..++.++.|++.||.|||+++++||||||+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni  158 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV  158 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence            9999999999999887642                        2467888899999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecccccccCCCC---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 016037          282 LLDADGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKI  357 (396)
Q Consensus       282 Ll~~~~~ikL~Dfgla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i  357 (396)
                      |+++++.+||+|||+++......   ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+....++
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~  238 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL  238 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            99999999999999998653322   1233346778999999998889999999999999999999 9999999888887


Q ss_pred             HHHHHhC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          358 QQKIIKD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       358 ~~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .+.+... +...|..++.++.+||..||+.+|.+||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~  277 (290)
T cd05045         239 FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFA  277 (290)
T ss_pred             HHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence            7776654 5566788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=6.7e-42  Score=324.64  Aligned_cols=246  Identities=21%  Similarity=0.339  Sum_probs=211.8

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEc-----CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~  221 (396)
                      +...+|.+.++||+|+||.||++...     .++..+|+|.+....   ....+.+.+|+++++.++|+||+++++++..
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTE   78 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence            34568999999999999999999753     356789999876543   3445668889999999999999999999999


Q ss_pred             cCeEEEEEEecCCCcHHHHHHHhc---------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC
Q 016037          222 KYRLYLVLDFVNGGHLFFQLYRQG---------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD  286 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~---------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~  286 (396)
                      ....+++|||+.+++|..++...+               .+++..++.++.|++.|+.|||++|++||||||+|||++++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~  158 (280)
T cd05092          79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG  158 (280)
T ss_pred             CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence            999999999999999999887653               47888899999999999999999999999999999999999


Q ss_pred             CcEEEEecccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 016037          287 GHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKII  362 (396)
Q Consensus       287 ~~ikL~Dfgla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~  362 (396)
                      +.+||+|||+++.......   .....+++.|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+.
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT  238 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence            9999999999976533221   223345678999999999889999999999999999998 999998888777777776


Q ss_pred             hC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          363 KD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       363 ~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .. ....|..+++.+.+||.+||+.+|.+||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~  272 (280)
T cd05092         239 QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIK  272 (280)
T ss_pred             cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence            65 4566788999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=9.3e-42  Score=323.68  Aligned_cols=246  Identities=20%  Similarity=0.327  Sum_probs=207.5

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcE----EEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEI----YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      +..++|++.+.||+|+||+||+|.+..+++.    +++|.+....  .......+..|+..++.++||||+++++++. .
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~   80 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G   80 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence            3457899999999999999999999887764    6667664321  2233455777888999999999999999875 4


Q ss_pred             CeEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      ...++++||+++|+|.+++... +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            5678999999999999998764 578999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHH
Q 016037          302 ENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (396)
Q Consensus       302 ~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~  376 (396)
                      ....   .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+.....+.+.+..+ .+..+..++.++
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV  240 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHH
Confidence            3322   223456778999999998889999999999999999998 99999988877776666655 445567789999


Q ss_pred             HHHHHHhhccCCCCCCCCC
Q 016037          377 HSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~RPs~s  395 (396)
                      .+++..||..+|.+|||+.
T Consensus       241 ~~li~~c~~~~p~~Rps~~  259 (279)
T cd05111         241 YMVMVKCWMIDENVRPTFK  259 (279)
T ss_pred             HHHHHHHcCCCcccCcCHH
Confidence            9999999999999999974

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8.6e-42  Score=328.30  Aligned_cols=247  Identities=21%  Similarity=0.366  Sum_probs=211.2

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCC-------CcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGT-------SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYS  218 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~  218 (396)
                      +..++|.+.+.||+|+||.||+|++.+.       ...+|+|.+....  .......+..|+.+++.+ +||||++++++
T Consensus        15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (307)
T cd05098          15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA   92 (307)
T ss_pred             eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            4457899999999999999999987543       3469999987643  223345577899999999 79999999999


Q ss_pred             EEecCeEEEEEEecCCCcHHHHHHHhc----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEE
Q 016037          219 FQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL  282 (396)
Q Consensus       219 ~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NIL  282 (396)
                      +......|+||||+.+|+|..++..+.                .++...+..++.|++.||+|||++|++||||||+||+
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  172 (307)
T cd05098          93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  172 (307)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence            999999999999999999999987642                4778888999999999999999999999999999999


Q ss_pred             EcCCCcEEEEecccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 016037          283 LDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQ  358 (396)
Q Consensus       283 l~~~~~ikL~Dfgla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~  358 (396)
                      ++.++.+||+|||+++.......   .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..++.
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~  252 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  252 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence            99999999999999976643221   122234578999999998889999999999999999998 99999988888888


Q ss_pred             HHHHhC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          359 QKIIKD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       359 ~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ..+... ....|..++.++.+||.+||..+|.+||++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  290 (307)
T cd05098         253 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK  290 (307)
T ss_pred             HHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHH
Confidence            777766 3577888999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.7e-42  Score=322.94  Aligned_cols=243  Identities=23%  Similarity=0.365  Sum_probs=213.5

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      ..+|++.++||.|+||.||+|.+.. +..+|+|++....   ......+.+|+.+++.++||||+++++++......++|
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence            3579999999999999999999988 8889999987654   22344577899999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC-
Q 016037          229 LDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-  305 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~-  305 (396)
                      |||+++++|.+++...  ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ 
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            9999999999998753  4678999999999999999999999999999999999999999999999999987643322 


Q ss_pred             ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHHh
Q 016037          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGV  383 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~~~  383 (396)
                      .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..++...+... +...|..++.++.++|.+|
T Consensus       161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  240 (261)
T cd05148         161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLEC  240 (261)
T ss_pred             ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHH
Confidence            223345678999999998889999999999999999999 89999988888777777765 5567788999999999999


Q ss_pred             hccCCCCCCCCC
Q 016037          384 NSLLSISVPLLS  395 (396)
Q Consensus       384 l~~~p~~RPs~s  395 (396)
                      |+.+|++|||+.
T Consensus       241 l~~~p~~Rpt~~  252 (261)
T cd05148         241 WAAEPEDRPSFK  252 (261)
T ss_pred             cCCCchhCcCHH
Confidence            999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=8e-42  Score=321.70  Aligned_cols=242  Identities=22%  Similarity=0.332  Sum_probs=205.0

Q ss_pred             EEEeEecccCceEEEEEEEcCCCc--EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec------Ce
Q 016037          153 EVLKVVGQGAFAKVYQVRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------YR  224 (396)
Q Consensus       153 ~~~~~IG~G~fG~Vy~~~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~------~~  224 (396)
                      .+.+.||+|+||.||+|.+..++.  .+|+|.++.... .....+.+..|+.+++.++||||+++++.+...      ..
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            467889999999999999987775  589998876432 334456678899999999999999999876432      35


Q ss_pred             EEEEEEecCCCcHHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccc
Q 016037          225 LYLVLDFVNGGHLFFQLYRQ------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK  298 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~  298 (396)
                      .+++|||+.+|+|..++...      ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence            78999999999998877422      347899999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCC
Q 016037          299 QFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLS  373 (396)
Q Consensus       299 ~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s  373 (396)
                      .......   .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..++...+..+ ....+..++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCL  240 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            7643321   122345778999999999899999999999999999999 89999988888887777765 446677899


Q ss_pred             HHHHHHHHHhhccCCCCCCCCC
Q 016037          374 SEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       374 ~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ..+.++|.+||+.+|.+|||+.
T Consensus       241 ~~~~~li~~~l~~~p~~Rps~~  262 (272)
T cd05075         241 DGLYSLMSSCWLLNPKDRPSFE  262 (272)
T ss_pred             HHHHHHHHHHcCCCcccCcCHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.9e-42  Score=336.68  Aligned_cols=248  Identities=23%  Similarity=0.383  Sum_probs=205.0

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSF  219 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~  219 (396)
                      .+..++|++.+.||+|+||.||+|++.+     +++.||+|+++...  .....+.+..|+.+++++ +|+||+++++++
T Consensus         3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~   80 (337)
T cd05054           3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGAC   80 (337)
T ss_pred             ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence            3455689999999999999999997654     35789999987543  223345567899999999 899999999987


Q ss_pred             Ee-cCeEEEEEEecCCCcHHHHHHHh------------------------------------------------------
Q 016037          220 QT-KYRLYLVLDFVNGGHLFFQLYRQ------------------------------------------------------  244 (396)
Q Consensus       220 ~~-~~~~~lV~E~~~gg~L~~~l~~~------------------------------------------------------  244 (396)
                      .. +..++++|||+++++|..++...                                                      
T Consensus        81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (337)
T cd05054          81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE  160 (337)
T ss_pred             ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence            64 46789999999999998887542                                                      


Q ss_pred             -------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC---CccccccCCC
Q 016037          245 -------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT---RSNSMCGTLE  314 (396)
Q Consensus       245 -------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~---~~~~~~gt~~  314 (396)
                             ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+....   ......++..
T Consensus       161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence                   257888899999999999999999999999999999999999999999999998764322   1233445678


Q ss_pred             ccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH-HhC-CCCCCccCCHHHHHHHHHhhccCCCCC
Q 016037          315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKI-IKD-KIKLPAFLSSEAHSLLKGVNSLLSISV  391 (396)
Q Consensus       315 y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i-~~~-~~~~p~~~s~~~~~li~~~l~~~p~~R  391 (396)
                      |||||.+.+..++.++|||||||++|||++ |+.||.+....+..... ... ....|...++++.+++.+||+.+|.+|
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R  320 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR  320 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhC
Confidence            999999999999999999999999999998 99999875544433333 332 445677889999999999999999999


Q ss_pred             CCCC
Q 016037          392 PLLS  395 (396)
Q Consensus       392 Ps~s  395 (396)
                      |++.
T Consensus       321 Ps~~  324 (337)
T cd05054         321 PTFS  324 (337)
T ss_pred             cCHH
Confidence            9975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-42  Score=325.30  Aligned_cols=243  Identities=30%  Similarity=0.486  Sum_probs=212.4

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++.+.||.|+||.||+|.+..++..+|+|++....   ....+.+..|+.++++++||||+++++.+..+..+|+||
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI   81 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence            56999999999999999999999999999999987542   334456778999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-CCcc
Q 016037          230 DFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSN  307 (396)
Q Consensus       230 E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-~~~~  307 (396)
                      ||+++++|..++... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...... ....
T Consensus        82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  161 (280)
T cd06611          82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD  161 (280)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence            999999999888764 57899999999999999999999999999999999999999999999999998765332 2234


Q ss_pred             ccccCCCccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---CCCCccCCHHHHHH
Q 016037          308 SMCGTLEYMSPEIVL-----GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLPAFLSSEAHSL  379 (396)
Q Consensus       308 ~~~gt~~y~APE~l~-----~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~---~~~p~~~s~~~~~l  379 (396)
                      ...|++.|+|||.+.     ...++.++||||||+++|||++|+.||.+.+......++....   +..|..++.++.+|
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (280)
T cd06611         162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDF  241 (280)
T ss_pred             eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHH
Confidence            456899999999985     3446789999999999999999999999888777777777653   23466899999999


Q ss_pred             HHHhhccCCCCCCCCC
Q 016037          380 LKGVNSLLSISVPLLS  395 (396)
Q Consensus       380 i~~~l~~~p~~RPs~s  395 (396)
                      |..||+.+|.+||++.
T Consensus       242 i~~~l~~~p~~Rps~~  257 (280)
T cd06611         242 LKSCLVKDPDDRPTAA  257 (280)
T ss_pred             HHHHhccChhhCcCHH
Confidence            9999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=6.9e-42  Score=318.80  Aligned_cols=241  Identities=27%  Similarity=0.448  Sum_probs=211.5

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++.+.||.|+||.||+|.+..++..+++|.+.....     .+.+.+|++++++++||||+++++++.....+|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            579999999999999999999999899999999875431     566888999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Ccc
Q 016037          230 DFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSN  307 (396)
Q Consensus       230 E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~~  307 (396)
                      ||+.+++|.+++.. ...+++..++.++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++....... ...
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN  157 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence            99999999998865 4578999999999999999999999999999999999999999999999999998765443 234


Q ss_pred             ccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCCccCCHHHHHHHHHhh
Q 016037          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGVN  384 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~---~~~~p~~~s~~~~~li~~~l  384 (396)
                      ...|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+...   .+..+..++.++.+||.+||
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  237 (256)
T cd06612         158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCL  237 (256)
T ss_pred             cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHH
Confidence            455889999999999989999999999999999999999999887655544443332   23445678899999999999


Q ss_pred             ccCCCCCCCCC
Q 016037          385 SLLSISVPLLS  395 (396)
Q Consensus       385 ~~~p~~RPs~s  395 (396)
                      +.+|.+|||++
T Consensus       238 ~~~P~~Rps~~  248 (256)
T cd06612         238 VKDPEERPSAI  248 (256)
T ss_pred             hcChhhCcCHH
Confidence            99999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=9.9e-42  Score=327.55  Aligned_cols=250  Identities=22%  Similarity=0.364  Sum_probs=210.6

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEc-----CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEE
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYS  218 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~  218 (396)
                      +.+..++|.+.+.||+|+||.||+|.+.     .++..+|+|+++...  .....+.+.+|+.+++++ +||||++++++
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  107 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGA  107 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence            3455678999999999999999999863     345679999987643  233456688899999999 79999999999


Q ss_pred             EEecCeEEEEEEecCCCcHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccc
Q 016037          219 FQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGL  296 (396)
Q Consensus       219 ~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgl  296 (396)
                      +.....+|++|||+.+|+|..++....  .+++..+..++.|++.||.|||+++++|+||||+|||++.++.++|+|||+
T Consensus       108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence            999999999999999999999887643  389999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC--CCCCCc
Q 016037          297 AKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD--KIKLPA  370 (396)
Q Consensus       297 a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~--~~~~p~  370 (396)
                      ++.......   .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+........+....  ....+.
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE  267 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCC
Confidence            986643321   122345778999999999889999999999999999998 99999887765555444443  334556


Q ss_pred             cCCHHHHHHHHHhhccCCCCCCCCCC
Q 016037          371 FLSSEAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       371 ~~s~~~~~li~~~l~~~p~~RPs~s~  396 (396)
                      ..+.++.+|+.+||+.+|++||++.+
T Consensus       268 ~~~~~~~~li~~cl~~~p~~Rpt~~e  293 (302)
T cd05055         268 HAPAEIYDIMKTCWDADPLKRPTFKQ  293 (302)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHH
Confidence            78999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.1e-41  Score=318.53  Aligned_cols=241  Identities=24%  Similarity=0.424  Sum_probs=208.6

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEE-EecCe
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSF-QTKYR  224 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~-~~~~~  224 (396)
                      .+...+|++.+.||+|+||.||++...  +..+|+|.++...     ..+.+.+|+.+++.++|+|++++++++ .....
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd05082           2 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   74 (256)
T ss_pred             CccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCc
Confidence            355678999999999999999999874  6679999986542     234577899999999999999999875 45567


Q ss_pred             EEEEEEecCCCcHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      .|++|||+++++|..++...+  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++....
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence            999999999999999887654  478899999999999999999999999999999999999999999999999986543


Q ss_pred             CCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHH
Q 016037          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLL  380 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li  380 (396)
                      ..  ....++..|+|||++.+..++.++|||||||++|||++ |+.||...+...+...+.++ ...++..++..+.++|
T Consensus       155 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  232 (256)
T cd05082         155 TQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVM  232 (256)
T ss_pred             cC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence            32  23345678999999998889999999999999999998 99999988888777777665 4566788999999999


Q ss_pred             HHhhccCCCCCCCCC
Q 016037          381 KGVNSLLSISVPLLS  395 (396)
Q Consensus       381 ~~~l~~~p~~RPs~s  395 (396)
                      .+||+.+|.+|||+.
T Consensus       233 ~~~l~~~p~~Rpt~~  247 (256)
T cd05082         233 KQCWHLDAATRPSFL  247 (256)
T ss_pred             HHHhcCChhhCcCHH
Confidence            999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.3e-41  Score=318.89  Aligned_cols=236  Identities=23%  Similarity=0.340  Sum_probs=202.6

Q ss_pred             EecccCceEEEEEEEc--CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCC
Q 016037          157 VVGQGAFAKVYQVRRI--GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (396)
Q Consensus       157 ~IG~G~fG~Vy~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (396)
                      .||+|+||.||+|.+.  .++..||+|++....  .....+.+.+|+.++++++||||++++++++. ...++||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence            3899999999999875  445679999987543  23445668889999999999999999998754 578999999999


Q ss_pred             CcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC----cccc
Q 016037          235 GHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR----SNSM  309 (396)
Q Consensus       235 g~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~----~~~~  309 (396)
                      ++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++........    ....
T Consensus        79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence            999988874 45789999999999999999999999999999999999999999999999999986543321    1112


Q ss_pred             ccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHHhhccC
Q 016037          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGVNSLL  387 (396)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~~~l~~~  387 (396)
                      .++..|+|||.+.+..++.++||||||+++|||++ |+.||.+.+...+...+.++ +..+|...++++.++|.+||..+
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~  238 (257)
T cd05115         159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYK  238 (257)
T ss_pred             CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence            23578999999988889999999999999999997 99999998888888777765 56778889999999999999999


Q ss_pred             CCCCCCCC
Q 016037          388 SISVPLLS  395 (396)
Q Consensus       388 p~~RPs~s  395 (396)
                      |.+||++.
T Consensus       239 ~~~Rp~~~  246 (257)
T cd05115         239 WEDRPNFA  246 (257)
T ss_pred             hhhCcCHH
Confidence            99999974

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.1e-41  Score=324.83  Aligned_cols=243  Identities=31%  Similarity=0.493  Sum_probs=209.7

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      +.|+++++||+|+||.||+|.+..++..+|+|++....   ....+.+.+|+.+++.++||||+++++++..+..+|+||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI   88 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence            56999999999999999999999999999999987542   344566778999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-CCcc
Q 016037          230 DFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSN  307 (396)
Q Consensus       230 E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-~~~~  307 (396)
                      ||+++++|..++.+ ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ....
T Consensus        89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  168 (292)
T cd06644          89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD  168 (292)
T ss_pred             ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence            99999999877654 456899999999999999999999999999999999999999999999999998764322 2234


Q ss_pred             ccccCCCccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---CCCCccCCHHHHHH
Q 016037          308 SMCGTLEYMSPEIVL-----GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLPAFLSSEAHSL  379 (396)
Q Consensus       308 ~~~gt~~y~APE~l~-----~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~---~~~p~~~s~~~~~l  379 (396)
                      ...+++.|+|||.+.     ...++.++|||||||++|||++|..||...+......++....   ...+..++.++.+|
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  248 (292)
T cd06644         169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDF  248 (292)
T ss_pred             eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHH
Confidence            456889999999985     3446889999999999999999999998877766666665442   23456789999999


Q ss_pred             HHHhhccCCCCCCCCC
Q 016037          380 LKGVNSLLSISVPLLS  395 (396)
Q Consensus       380 i~~~l~~~p~~RPs~s  395 (396)
                      |++||+.+|++||++.
T Consensus       249 i~~~l~~~p~~Rp~~~  264 (292)
T cd06644         249 LKTALDKHPETRPSAA  264 (292)
T ss_pred             HHHHhcCCcccCcCHH
Confidence            9999999999999864

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.3e-41  Score=323.90  Aligned_cols=248  Identities=19%  Similarity=0.287  Sum_probs=209.6

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~  220 (396)
                      .+..++|++.++||+|+||.||+|.++.     .+..||+|.+.....  ......+.+|+.+++.++||||+++++++.
T Consensus         2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            3566789999999999999999997653     355799998865432  222334677999999999999999999999


Q ss_pred             ecCeEEEEEEecCCCcHHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEE
Q 016037          221 TKYRLYLVLDFVNGGHLFFQLYRQG----------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM  290 (396)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~~----------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ik  290 (396)
                      .....|+||||+++|+|..++.+.+          ......+..++.|++.||.|||+++++||||||+||+++.++.++
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence            9999999999999999999987532          235567788999999999999999999999999999999999999


Q ss_pred             EEecccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-C
Q 016037          291 LTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-K  365 (396)
Q Consensus       291 L~Dfgla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~  365 (396)
                      |+|||+++.......   .....++..|+|||.+.+..++.++|||||||++|||++ |+.||.+.+..++...+... .
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  239 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY  239 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            999999986533221   122345678999999998889999999999999999999 89999998888888877765 4


Q ss_pred             CCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 IKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 ~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ..++..++.++++++.+||+.+|.+|||+.
T Consensus       240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  269 (288)
T cd05061         240 LDQPDNCPERVTDLMRMCWQFNPKMRPTFL  269 (288)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcCHH
Confidence            567778899999999999999999999974

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=7.4e-42  Score=331.92  Aligned_cols=241  Identities=21%  Similarity=0.322  Sum_probs=199.2

Q ss_pred             EEeEeccc--CceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEe
Q 016037          154 VLKVVGQG--AFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (396)
Q Consensus       154 ~~~~IG~G--~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (396)
                      ++++||+|  +|++||++.++.+|+.||+|++..... .....+.+++|+.+++.++||||++++++|..+...|+||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            46789999  789999999999999999999976543 234556788899999999999999999999999999999999


Q ss_pred             cCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-----
Q 016037          232 VNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-----  304 (396)
Q Consensus       232 ~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-----  304 (396)
                      +++|+|.+++...  ..+++..++.++.|++.||.|||++||+||||||+|||++.++.++++||+.+.......     
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence            9999999888653  458999999999999999999999999999999999999999999999998654332111     


Q ss_pred             ---CccccccCCCccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------------
Q 016037          305 ---RSNSMCGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK------------  367 (396)
Q Consensus       305 ---~~~~~~gt~~y~APE~l~~--~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~------------  367 (396)
                         ......++..|+|||++.+  ..++.++|||||||++|||++|+.||.................+            
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (327)
T cd08227         161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE  240 (327)
T ss_pred             cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence               1122356788999999976  45899999999999999999999999876554444333322111            


Q ss_pred             ----------------------------------CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          368 ----------------------------------LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       368 ----------------------------------~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                                        ....+++++.+||++||+.||.+|||++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~  302 (327)
T cd08227         241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSAS  302 (327)
T ss_pred             cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHH
Confidence                                              1123578999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.1e-41  Score=320.54  Aligned_cols=245  Identities=22%  Similarity=0.349  Sum_probs=210.5

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCC---cEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTS---EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~  225 (396)
                      ..+|++.+.||+|+||.||+|.++.++   ..+|+|.++...  .....+.+.+|+.+++.++||||+++++++......
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            467999999999999999999987554   379999987543  233456678899999999999999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          226 YLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      |+||||+++++|..++... +.+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999999999988765 467899999999999999999999999999999999999999999999999998764332


Q ss_pred             C----ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHH
Q 016037          305 R----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHS  378 (396)
Q Consensus       305 ~----~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~  378 (396)
                      .    .....++..|+|||.+.+..++.++|+||||+++||+++ |..||.+.+..+....+.+. +++.+..++.++.+
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQ  240 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHH
Confidence            1    112223568999999998889999999999999999887 99999988877777777665 44556678999999


Q ss_pred             HHHHhhccCCCCCCCCC
Q 016037          379 LLKGVNSLLSISVPLLS  395 (396)
Q Consensus       379 li~~~l~~~p~~RPs~s  395 (396)
                      ++.+||+.+|.+||++.
T Consensus       241 li~~~l~~~p~~Rp~~~  257 (267)
T cd05066         241 LMLDCWQKDRNERPKFE  257 (267)
T ss_pred             HHHHHcccCchhCCCHH
Confidence            99999999999999974

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1e-41  Score=319.35  Aligned_cols=243  Identities=22%  Similarity=0.365  Sum_probs=209.0

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +..++|+++++||+|+||.||+|..+ +++.||+|.+.....    ..+.+.+|+.+++.++|+||+++++++. ....|
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence            45678999999999999999999875 467799999876543    2345778999999999999999998874 45789


Q ss_pred             EEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          227 LVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      ++|||+.+++|.+++...  ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            999999999999888653  467888999999999999999999999999999999999999999999999998765322


Q ss_pred             C--ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHH
Q 016037          305 R--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLL  380 (396)
Q Consensus       305 ~--~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li  380 (396)
                      .  .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..++...+... +...+..++.++.++|
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELM  236 (260)
T ss_pred             cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            1  123345678999999998889999999999999999999 99999988887777777655 4566778899999999


Q ss_pred             HHhhccCCCCCCCCC
Q 016037          381 KGVNSLLSISVPLLS  395 (396)
Q Consensus       381 ~~~l~~~p~~RPs~s  395 (396)
                      ++||+.+|++||+++
T Consensus       237 ~~~l~~~p~~Rp~~~  251 (260)
T cd05067         237 RLCWKEKPEERPTFE  251 (260)
T ss_pred             HHHccCChhhCCCHH
Confidence            999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1e-41  Score=326.69  Aligned_cols=245  Identities=27%  Similarity=0.422  Sum_probs=204.6

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      ..++|++.+.||.|+||.||+|++..+++.||+|.++....  ......+.+|+.+++.++||||+++++++.....+|+
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l   81 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   81 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence            35689999999999999999999999999999999875432  1223345679999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-C
Q 016037          228 VLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-R  305 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~  305 (396)
                      ||||+.+ +|..++.. ...+++..++.++.|++.||.|||++|++|+||||+|||++.++.+||+|||++....... .
T Consensus        82 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (301)
T cd07873          82 VFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  160 (301)
T ss_pred             EEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence            9999985 77777765 3568899999999999999999999999999999999999999999999999997654322 2


Q ss_pred             ccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------C
Q 016037          306 SNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-------------------K  365 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~-------------------~  365 (396)
                      .....+++.|+|||.+.+ ..++.++|||||||++|||+||+.||.+.+..+....+...                   .
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (301)
T cd07873         161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS  240 (301)
T ss_pred             ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence            234467899999999876 45789999999999999999999999988766555443321                   1


Q ss_pred             CCCC-----------ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 IKLP-----------AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 ~~~p-----------~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ..+|           ..++.++++||.+||+.||.+|||++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~  281 (301)
T cd07873         241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAE  281 (301)
T ss_pred             cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHH
Confidence            1112           35788999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.4e-41  Score=327.95  Aligned_cols=247  Identities=20%  Similarity=0.355  Sum_probs=210.9

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcC-------CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIG-------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYS  218 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~  218 (396)
                      +..++|.+.+.||+|+||.||+|.+.+       ....+|+|+++...  .......+..|+.+++.+ +||||++++++
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGV   86 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence            445789999999999999999998643       34569999987543  223455577899999999 69999999999


Q ss_pred             EEecCeEEEEEEecCCCcHHHHHHHh----------------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEE
Q 016037          219 FQTKYRLYLVLDFVNGGHLFFQLYRQ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL  282 (396)
Q Consensus       219 ~~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NIL  282 (396)
                      +.....+|++|||+++|+|..++...                ..++...+..++.|++.||.|||++|++||||||+|||
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  166 (314)
T cd05099          87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL  166 (314)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence            99999999999999999999998764                24778888889999999999999999999999999999


Q ss_pred             EcCCCcEEEEecccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 016037          283 LDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQ  358 (396)
Q Consensus       283 l~~~~~ikL~Dfgla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~  358 (396)
                      ++.++.+||+|||+++.......   .....++..|||||.+.+..++.++||||||+++|||++ |..||.+.+..++.
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~  246 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF  246 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999987643221   122234568999999998889999999999999999999 99999998888888


Q ss_pred             HHHHhC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          359 QKIIKD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       359 ~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ..+... ...+|..++.++++||.+||+.+|.+|||+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~  284 (314)
T cd05099         247 KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFK  284 (314)
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHH
Confidence            887776 3567788999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.8e-41  Score=324.71  Aligned_cols=242  Identities=28%  Similarity=0.446  Sum_probs=209.3

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      .+|++.+.||+|+||.||+|.+..++..||+|.+.....   ...+.+.+|+.+++.++||||+++++.|......|+||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            579999999999999999999999999999999876542   23455778999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC-ccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNS  308 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~-~~~  308 (396)
                      ||+++++|..++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++........ ...
T Consensus        97 e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  175 (296)
T cd06654          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (296)
T ss_pred             cccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence            99999999988754 4678999999999999999999999999999999999999999999999999876543322 234


Q ss_pred             cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCCccCCHHHHHHHHHhhc
Q 016037          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGVNS  385 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~---~~~~p~~~s~~~~~li~~~l~  385 (396)
                      ..|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+...   ....|..++..+.+||.+||.
T Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  255 (296)
T cd06654         176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD  255 (296)
T ss_pred             ccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCc
Confidence            57889999999999888999999999999999999999999887664433333332   223466789999999999999


Q ss_pred             cCCCCCCCCC
Q 016037          386 LLSISVPLLS  395 (396)
Q Consensus       386 ~~p~~RPs~s  395 (396)
                      .+|.+||++.
T Consensus       256 ~~p~~Rpt~~  265 (296)
T cd06654         256 MDVEKRGSAK  265 (296)
T ss_pred             CCcccCcCHH
Confidence            9999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.1e-41  Score=316.11  Aligned_cols=244  Identities=30%  Similarity=0.528  Sum_probs=215.3

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      +|++.+.||+|+||.||++....+++.||+|.+....... ...+.+.+|+.++++++||||+++++++......|+|+|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            5899999999999999999999999999999987654332 234567889999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC-cc
Q 016037          231 FVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SN  307 (396)
Q Consensus       231 ~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~-~~  307 (396)
                      |+.+++|..++....  .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  159 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR  159 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence            999999998887543  578999999999999999999999999999999999999999999999999987644322 22


Q ss_pred             ccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHhhcc
Q 016037          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-IKLPAFLSSEAHSLLKGVNSL  386 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~-~~~p~~~s~~~~~li~~~l~~  386 (396)
                      ...|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+..++...+..+. ...|..++.++.++|++||+.
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  239 (256)
T cd08218         160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKR  239 (256)
T ss_pred             hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhC
Confidence            3457889999999998889999999999999999999999999888888777777664 456788999999999999999


Q ss_pred             CCCCCCCCC
Q 016037          387 LSISVPLLS  395 (396)
Q Consensus       387 ~p~~RPs~s  395 (396)
                      +|.+||++.
T Consensus       240 ~p~~Rp~~~  248 (256)
T cd08218         240 NPRDRPSVN  248 (256)
T ss_pred             ChhhCcCHH
Confidence            999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.6e-41  Score=321.81  Aligned_cols=239  Identities=27%  Similarity=0.433  Sum_probs=203.1

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++++.||+|+||.||+|++..+++.||+|++..+.  .....+.+.+|++++++++||||+++++++......++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            36889999999999999999999999999999987643  2334456788999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCcccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM  309 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~  309 (396)
                      ||+++++|..+    ..+++..+..++.|++.||.|||+.|++|+||||+|||++.++.++|+|||++...... .....
T Consensus        79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~  153 (279)
T cd06619          79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTY  153 (279)
T ss_pred             ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCC
Confidence            99999988543    35788889999999999999999999999999999999999999999999999876433 23446


Q ss_pred             ccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhC-CCCCC-ccCCHHHHHHH
Q 016037          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN-------RQKIQQKIIKD-KIKLP-AFLSSEAHSLL  380 (396)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~-------~~~i~~~i~~~-~~~~p-~~~s~~~~~li  380 (396)
                      +||..|+|||.+.+..++.++||||||+++|+|++|+.||....       .....+.+... ...++ ...++++.+||
T Consensus       154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  233 (279)
T cd06619         154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFI  233 (279)
T ss_pred             CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHH
Confidence            78999999999999889999999999999999999999997532       12333333332 22332 35889999999


Q ss_pred             HHhhccCCCCCCCCC
Q 016037          381 KGVNSLLSISVPLLS  395 (396)
Q Consensus       381 ~~~l~~~p~~RPs~s  395 (396)
                      .+||+.+|.+||++.
T Consensus       234 ~~~l~~~P~~Rp~~~  248 (279)
T cd06619         234 TQCMRKQPKERPAPE  248 (279)
T ss_pred             HHHhhCChhhCCCHH
Confidence            999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-41  Score=320.81  Aligned_cols=237  Identities=22%  Similarity=0.368  Sum_probs=202.5

Q ss_pred             EecccCceEEEEEEEcCCCcE--EEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCeEEEEEEecC
Q 016037          157 VVGQGAFAKVYQVRRIGTSEI--YAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVN  233 (396)
Q Consensus       157 ~IG~G~fG~Vy~~~~~~~~~~--vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~  233 (396)
                      .||+|+||.||+|.++.++..  +|+|.++...  .....+.+..|+.+++++ +||||+++++++.....+|++|||++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            589999999999999888764  5888776432  233445678899999999 89999999999999999999999999


Q ss_pred             CCcHHHHHHHhc----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccc
Q 016037          234 GGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA  297 (396)
Q Consensus       234 gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla  297 (396)
                      +|+|.+++....                .+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~  159 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS  159 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence            999999887643                3678889999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHH
Q 016037          298 KQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSE  375 (396)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~  375 (396)
                      ..............+..|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+..+.+... ....+..++.+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (270)
T cd05047         160 RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDE  239 (270)
T ss_pred             cccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCHH
Confidence            64332222222334567999999988889999999999999999997 99999988888877777665 45667788999


Q ss_pred             HHHHHHHhhccCCCCCCCCC
Q 016037          376 AHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       376 ~~~li~~~l~~~p~~RPs~s  395 (396)
                      +.+|+.+||..+|.+|||+.
T Consensus       240 ~~~li~~~l~~~p~~Rps~~  259 (270)
T cd05047         240 VYDLMRQCWREKPYERPSFA  259 (270)
T ss_pred             HHHHHHHHcccChhhCCCHH
Confidence            99999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-41  Score=317.18  Aligned_cols=244  Identities=23%  Similarity=0.358  Sum_probs=212.7

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +..++|.+.+.||+|+||.||+|.+.. +..+|+|.+.....    ..+.+.+|+.++++++|+||+++++++......+
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence            556789999999999999999999864 56799999876542    2345778999999999999999999999989999


Q ss_pred             EEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          227 LVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      ++|||+++++|.+++...  ..+++..+..++.|++.|+.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            999999999999988765  368899999999999999999999999999999999999999999999999998764322


Q ss_pred             C--ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHH
Q 016037          305 R--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLL  380 (396)
Q Consensus       305 ~--~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li  380 (396)
                      .  .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+.....+++... ....|...+.++.+++
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  237 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLM  237 (261)
T ss_pred             hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            1  112234578999999998889999999999999999999 99999988888888887765 4566778899999999


Q ss_pred             HHhhccCCCCCCCCC
Q 016037          381 KGVNSLLSISVPLLS  395 (396)
Q Consensus       381 ~~~l~~~p~~RPs~s  395 (396)
                      .+||+.+|++||++.
T Consensus       238 ~~~l~~~p~~Rp~~~  252 (261)
T cd05034         238 LQCWDKDPEERPTFE  252 (261)
T ss_pred             HHHcccCcccCCCHH
Confidence            999999999999974

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.8e-41  Score=321.48  Aligned_cols=243  Identities=29%  Similarity=0.450  Sum_probs=200.5

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      +|++.+.||+|++|.||+|.+..++..||+|+++..... ....+.+.+|+.+++.++||||+++++++..+..+|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            589999999999999999999999999999998764322 2233557789999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC-c
Q 016037          231 FVNGGHLFFQLYRQ---GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-S  306 (396)
Q Consensus       231 ~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~-~  306 (396)
                      |+.+ +|..++...   ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ .
T Consensus        80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (285)
T cd07861          80 FLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY  158 (285)
T ss_pred             cCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence            9984 777776542   5689999999999999999999999999999999999999999999999999976543222 2


Q ss_pred             cccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------------CC-
Q 016037          307 NSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD------------------KI-  366 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~------------------~~-  366 (396)
                      ....+++.|+|||.+.+. .++.++|||||||++|+|+||+.||.+.+.......+...                  +. 
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
T cd07861         159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT  238 (285)
T ss_pred             cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence            334678999999998764 4789999999999999999999999876543322222110                  00 


Q ss_pred             ----------CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 ----------KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 ----------~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                .....+++++.+||++||+.||.+|||+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~  277 (285)
T cd07861         239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAK  277 (285)
T ss_pred             ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHH
Confidence                      11235799999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.6e-41  Score=325.89  Aligned_cols=248  Identities=19%  Similarity=0.357  Sum_probs=212.5

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEc-------CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRI-------GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRY  217 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~  217 (396)
                      .+...+|.+.+.||+|+||.||+|++.       ..+..||+|.+....  .....+.+.+|+.+++.+ +||||+++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   88 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG   88 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence            456678999999999999999999753       234579999987542  233455678899999999 8999999999


Q ss_pred             EEEecCeEEEEEEecCCCcHHHHHHHhc----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCE
Q 016037          218 SFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENI  281 (396)
Q Consensus       218 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NI  281 (396)
                      ++......|++|||+.+|+|..++.+..                .++...+..++.||+.||.|||++|++||||||+||
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  168 (304)
T cd05101          89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV  168 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence            9999999999999999999999987642                356677888999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 016037          282 LLDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKI  357 (396)
Q Consensus       282 Ll~~~~~ikL~Dfgla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i  357 (396)
                      +++.++.+||+|||+++.......   .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..++
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  248 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  248 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            999999999999999987643221   223345678999999998889999999999999999998 8999999888888


Q ss_pred             HHHHHhC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          358 QQKIIKD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       358 ~~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ...+..+ ....|..++.++++||.+||..+|.+|||+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~  287 (304)
T cd05101         249 FKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFK  287 (304)
T ss_pred             HHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHH
Confidence            8888765 4456778999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.3e-41  Score=318.65  Aligned_cols=243  Identities=23%  Similarity=0.376  Sum_probs=208.8

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +..++|++.++||+|+||.||+|.+.. +..+|+|.+......    .+.+.+|+.++++++|+||+++++++. ....|
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~   76 (260)
T cd05070           3 IPRESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY   76 (260)
T ss_pred             CchHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence            455789999999999999999998764 556999998765432    234778999999999999999998875 45689


Q ss_pred             EEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          227 LVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      ++|||+++++|.+++...  ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            999999999999988753  357899999999999999999999999999999999999999999999999998764332


Q ss_pred             C--ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHH
Q 016037          305 R--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLL  380 (396)
Q Consensus       305 ~--~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li  380 (396)
                      .  .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..++...+... ..+.+...+..+.+|+
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELM  236 (260)
T ss_pred             cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence            2  122345668999999988889999999999999999999 99999988888877777665 5567788999999999


Q ss_pred             HHhhccCCCCCCCCC
Q 016037          381 KGVNSLLSISVPLLS  395 (396)
Q Consensus       381 ~~~l~~~p~~RPs~s  395 (396)
                      .+||+.+|.+|||+.
T Consensus       237 ~~~l~~~p~~Rpt~~  251 (260)
T cd05070         237 LQCWKKDPEERPTFE  251 (260)
T ss_pred             HHHcccCcccCcCHH
Confidence            999999999999974

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.3e-41  Score=316.97  Aligned_cols=244  Identities=27%  Similarity=0.455  Sum_probs=212.7

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++.+.||.|+||+||+|.+..++..+|+|++.......  ....+.+|+.+++.++|+||+++++.+......|++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            47999999999999999999999999999999987654322  5566889999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC-
Q 016037          230 DFVNGGHLFFQLYRQ---GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-  305 (396)
Q Consensus       230 E~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~-  305 (396)
                      |++++++|...+...   ..+++..++.++.|++.||.|||++|++||||+|+||++++++.++|+|||++........ 
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            999999999998764   4589999999999999999999999999999999999999999999999999987654322 


Q ss_pred             ----ccccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCC-----ccCCH
Q 016037          306 ----SNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLP-----AFLSS  374 (396)
Q Consensus       306 ----~~~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~-~~p-----~~~s~  374 (396)
                          .....|+..|+|||.+... .++.++|+||||+++|+|++|+.||...+..+...++..... .++     ..+++
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK  238 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence                2345688999999999876 789999999999999999999999998877776666665432 222     25789


Q ss_pred             HHHHHHHHhhccCCCCCCCCC
Q 016037          375 EAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       375 ~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ++.+||..||..+|.+||++.
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~  259 (267)
T cd06610         239 SFRKMISLCLQKDPSKRPTAE  259 (267)
T ss_pred             HHHHHHHHHcCCChhhCcCHH
Confidence            999999999999999999974

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.9e-42  Score=335.21  Aligned_cols=242  Identities=26%  Similarity=0.384  Sum_probs=200.7

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec------
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------  222 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~------  222 (396)
                      .++|.+++.||+|+||+||+|.+..+++.||+|++..... .....+.+.+|+.+|+.++||||++++++|...      
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            3679999999999999999999999999999999876432 223345567899999999999999999888543      


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      ..+|++++++ +++|..++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  170 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD  170 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence            4579999988 667766554 46789999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------------
Q 016037          303 NTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK----------------  365 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~----------------  365 (396)
                      .  ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....                
T Consensus       171 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07878         171 E--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHA  248 (343)
T ss_pred             C--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhH
Confidence            3  345578999999999977 568999999999999999999999998876555444443210                


Q ss_pred             -------CCCC--------ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 -------IKLP--------AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 -------~~~p--------~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                             ...|        ...++.+.+||++||+.||.+|||+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~  293 (343)
T cd07878         249 RKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISAS  293 (343)
T ss_pred             HHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHH
Confidence                   0011        24567889999999999999999975

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.5e-41  Score=323.15  Aligned_cols=246  Identities=22%  Similarity=0.375  Sum_probs=211.4

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      ..++|++.+.||+|+||.||+|.+.+     ++..||+|++....  .....+.+.+|+.+++.++||||+++++++..+
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            45689999999999999999999854     67889999987543  223345678899999999999999999999999


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhc----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQG----------------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN  280 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~----------------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~N  280 (396)
                      ..+|++|||+++|+|..++....                      .+++..++.++.|++.||.|||+++++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            99999999999999999887532                      36778889999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 016037          281 ILLDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQK  356 (396)
Q Consensus       281 ILl~~~~~ikL~Dfgla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~  356 (396)
                      |+++.++.++|+|||++........   .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999876532211   222334678999999998889999999999999999998 899999888888


Q ss_pred             HHHHHHhCCC-CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          357 IQQKIIKDKI-KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       357 i~~~i~~~~~-~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +...+..... ..|..++.++.+||.+||+.+|++|||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  280 (288)
T cd05050         241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFA  280 (288)
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHH
Confidence            8888776643 45778899999999999999999999975

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.7e-41  Score=315.51  Aligned_cols=244  Identities=32%  Similarity=0.549  Sum_probs=215.6

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe--cCeEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KYRLYLV  228 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~--~~~~~lV  228 (396)
                      +|++.+.||.|+||.||+|.+..++..+|+|++...... ....+.+..|+++++.++||||+++++++..  +..+|++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            588999999999999999999999999999998765433 3445667889999999999999999998754  4578999


Q ss_pred             EEecCCCcHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHH-----HCCceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          229 LDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLH-----ANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH-----~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                      |||+++++|..++..    ...+++..++.++.||+.||.|||     +.+++|+||+|+||+++.++.+||+|||++..
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            999999999988865    367899999999999999999999     88999999999999999999999999999987


Q ss_pred             cCCCCC-ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHH
Q 016037          300 FDENTR-SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAH  377 (396)
Q Consensus       300 ~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~-~~p~~~s~~~~  377 (396)
                      ...... .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+...+.+.+..... .+|..++.++.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (265)
T cd08217         160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELN  239 (265)
T ss_pred             ccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHH
Confidence            755443 3445789999999999988899999999999999999999999999888888888777654 56788999999


Q ss_pred             HHHHHhhccCCCCCCCCC
Q 016037          378 SLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       378 ~li~~~l~~~p~~RPs~s  395 (396)
                      +|+..||+.+|.+||++.
T Consensus       240 ~l~~~~l~~~p~~Rp~~~  257 (265)
T cd08217         240 EVIKSMLNVDPDKRPSTE  257 (265)
T ss_pred             HHHHHHccCCcccCCCHH
Confidence            999999999999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.5e-42  Score=335.54  Aligned_cols=239  Identities=24%  Similarity=0.357  Sum_probs=194.5

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      ....+|++++.||+|+||.||+|++..+++.||+|+.....         ...|+.+++.++||||+++++++......|
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  133 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITC  133 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence            34457999999999999999999999999999999865432         245899999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC
Q 016037          227 LVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~  305 (396)
                      +|||++.+ +|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       134 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  212 (357)
T PHA03209        134 MVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA  212 (357)
T ss_pred             EEEEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcc
Confidence            99999975 66666654 46789999999999999999999999999999999999999999999999999976544434


Q ss_pred             ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCH----------HHHHHHHHhCC---CCCC--
Q 016037          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPF-TGGNR----------QKIQQKIIKDK---IKLP--  369 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf-~~~~~----------~~i~~~i~~~~---~~~p--  369 (396)
                      .....||+.|+|||++.+..++.++|||||||++|||+++..++ .....          ..+...+....   ..+|  
T Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  292 (357)
T PHA03209        213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD  292 (357)
T ss_pred             cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence            44567999999999999989999999999999999999954444 33111          11111111100   0111  


Q ss_pred             ----------------------------ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          370 ----------------------------AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       370 ----------------------------~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                                  ..++.++.+||.+||+.||.+|||+.
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~  346 (357)
T PHA03209        293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAE  346 (357)
T ss_pred             CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHH
Confidence                                        13567888899999999999999974

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.7e-41  Score=317.74  Aligned_cols=245  Identities=32%  Similarity=0.481  Sum_probs=209.7

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeecccc--chhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe--cCeE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI--MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KYRL  225 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~--~~~~  225 (396)
                      .+|+..+.||+|+||.||+|.+..++..||+|++.....  ......+.+.+|+.+++.++||||+++++++..  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            368999999999999999999999999999999875432  123345668889999999999999999998865  3678


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-  304 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-  304 (396)
                      ++++||+++++|...+...+.+++...+.++.|++.||.|||+++++||||+|+||+++.++.+||+|||+++...... 
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence            9999999999999999888889999999999999999999999999999999999999999999999999997654321 


Q ss_pred             ---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHH
Q 016037          305 ---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPAFLSSEAHSL  379 (396)
Q Consensus       305 ---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--~~~~p~~~s~~~~~l  379 (396)
                         ......++..|+|||.+.+..++.++|||||||++|||++|+.||...+......++...  ...+|..+++.+++|
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (266)
T cd06651         162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF  241 (266)
T ss_pred             cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence               122345888999999999988999999999999999999999999887655544444432  456677899999999


Q ss_pred             HHHhhccCCCCCCCCC
Q 016037          380 LKGVNSLLSISVPLLS  395 (396)
Q Consensus       380 i~~~l~~~p~~RPs~s  395 (396)
                      | .||..+|.+||++.
T Consensus       242 i-~~~~~~p~~Rp~~~  256 (266)
T cd06651         242 L-GCIFVEARHRPSAE  256 (266)
T ss_pred             H-HHhcCChhhCcCHH
Confidence            9 68889999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.1e-41  Score=317.26  Aligned_cols=247  Identities=19%  Similarity=0.312  Sum_probs=210.6

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCc---EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSE---IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~  223 (396)
                      +..++|+..+.||+|+||.||+|.++.++.   .+|+|.+....  .....+.+..|+.+++.++||||+++++++....
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK   79 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence            345689999999999999999999876654   79999986543  2233456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      ..|+||||+++++|..++... +.+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            999999999999999888764 5789999999999999999999999999999999999999999999999999986643


Q ss_pred             CCCc----cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHH
Q 016037          303 NTRS----NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (396)
Q Consensus       303 ~~~~----~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~  376 (396)
                      ....    .....+..|+|||.+.+..++.++|||||||++|||++ |+.||...+..++...+... ..+.+..++.++
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  239 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAV  239 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHH
Confidence            2211    11223457999999998889999999999999999998 99999988877777777654 344556789999


Q ss_pred             HHHHHHhhccCCCCCCCCC
Q 016037          377 HSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~RPs~s  395 (396)
                      .+|+.+||+.+|.+||++.
T Consensus       240 ~~li~~c~~~~p~~Rp~~~  258 (268)
T cd05063         240 YQLMLQCWQQDRARRPRFV  258 (268)
T ss_pred             HHHHHHHcCCCcccCcCHH
Confidence            9999999999999999974

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.2e-41  Score=321.10  Aligned_cols=245  Identities=39%  Similarity=0.696  Sum_probs=223.1

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEEEecCeEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~lV  228 (396)
                      ++|.+.+.||+|+||.||+|.+..++..||+|++.+.........+.+.+|..++++++ ||||+++++++......+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47999999999999999999999999999999998765544555567888999999998 99999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC----
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT----  304 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~----  304 (396)
                      |||+.+++|..++.+.+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.+++++|+|||++.......    
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~  160 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES  160 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence            9999999999999988899999999999999999999999999999999999999999999999999998764322    


Q ss_pred             -----------------CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Q 016037          305 -----------------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK  367 (396)
Q Consensus       305 -----------------~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~  367 (396)
                                       ......|+..|+|||.+.+..++.++|+||||+++|++++|+.||...+.....+.+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  240 (280)
T cd05581         161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS  240 (280)
T ss_pred             CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCC
Confidence                             123345789999999998888999999999999999999999999998887888888888888


Q ss_pred             CCccCCHHHHHHHHHhhccCCCCCCCC
Q 016037          368 LPAFLSSEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       368 ~p~~~s~~~~~li~~~l~~~p~~RPs~  394 (396)
                      +|..+++.+.+||..||+.+|.+||++
T Consensus       241 ~~~~~~~~~~~li~~~l~~~p~~R~~~  267 (280)
T cd05581         241 FPPNFPPDAKDLIEKLLVLDPQDRLGV  267 (280)
T ss_pred             CCCccCHHHHHHHHHHhcCCHhhCCCc
Confidence            999999999999999999999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3e-41  Score=316.42  Aligned_cols=242  Identities=24%  Similarity=0.365  Sum_probs=206.7

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      ..++|++.+.||+|+||.||+|.+..++ .+|+|.+.....    ..+.+.+|+++++.++|||++++++++. ....|+
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   77 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI   77 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence            3467999999999999999999987664 589998876432    2345678999999999999999998875 456899


Q ss_pred             EEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC
Q 016037          228 VLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~  305 (396)
                      +|||+.+++|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||+++.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence            99999999999988764  3478888999999999999999999999999999999999999999999999987643322


Q ss_pred             --ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHH
Q 016037          306 --SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLK  381 (396)
Q Consensus       306 --~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~  381 (396)
                        .....++..|+|||.+.+..++.++||||||+++|||+| |+.||.+.+..+....+... ....+..++..+++|++
T Consensus       158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (260)
T cd05069         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMK  237 (260)
T ss_pred             cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHH
Confidence              122345678999999998889999999999999999999 99999998887777777665 45567789999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      +||..+|.+||++.
T Consensus       238 ~~l~~~p~~Rp~~~  251 (260)
T cd05069         238 LCWKKDPDERPTFE  251 (260)
T ss_pred             HHccCCcccCcCHH
Confidence            99999999999974

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.7e-41  Score=322.63  Aligned_cols=242  Identities=28%  Similarity=0.449  Sum_probs=211.6

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      .+|++.+.||.|+||.||+|.+..+++.||+|.+.....   ...+.+.+|+.+++.++||||+++++++.....+|+|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            569999999999999999999999999999999875432   23456788999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC-ccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNS  308 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~-~~~  308 (396)
                      ||+.+++|..++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++........ ...
T Consensus        96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~  174 (296)
T cd06655          96 EYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST  174 (296)
T ss_pred             EecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence            99999999887764 4689999999999999999999999999999999999999999999999999886643322 234


Q ss_pred             cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCCccCCHHHHHHHHHhhc
Q 016037          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGVNS  385 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~---~~~~p~~~s~~~~~li~~~l~  385 (396)
                      ..|+..|+|||.+.+..++.++|||||||++|+|++|+.||.+.+.......+...   .+..|..++..+.+||++||.
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  254 (296)
T cd06655         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLE  254 (296)
T ss_pred             cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhh
Confidence            56889999999999888999999999999999999999999988766555555443   234566789999999999999


Q ss_pred             cCCCCCCCCC
Q 016037          386 LLSISVPLLS  395 (396)
Q Consensus       386 ~~p~~RPs~s  395 (396)
                      .+|.+||++.
T Consensus       255 ~dp~~Rpt~~  264 (296)
T cd06655         255 MDVEKRGSAK  264 (296)
T ss_pred             cChhhCCCHH
Confidence            9999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.9e-42  Score=324.62  Aligned_cols=245  Identities=25%  Similarity=0.435  Sum_probs=211.0

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      ..++|++++.||+|+||+||++.+..++..||+|++....  .....+.+.+|+++++.++||||+++++++.....+|+
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            3467999999999999999999999999999999987543  23345668889999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCc
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS  306 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~  306 (396)
                      ||||+++++|..++.+.+.+++..++.++.+++.||.|||+ .+++||||+|+||+++.++.++|+|||++....... .
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-~  159 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-A  159 (284)
T ss_pred             EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-c
Confidence            99999999999988888889999999999999999999997 599999999999999999999999999987653322 2


Q ss_pred             cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHhC-CCCCCcc-CC
Q 016037          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ-----------KIQQKIIKD-KIKLPAF-LS  373 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~-----------~i~~~i~~~-~~~~p~~-~s  373 (396)
                      ...+|+..|+|||.+.+..++.++|||||||++|+|+||+.||...+..           +..+.+... ...++.. ++
T Consensus       160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd06620         160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP  239 (284)
T ss_pred             CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcC
Confidence            3457899999999998888999999999999999999999999865432           233344433 3344443 88


Q ss_pred             HHHHHHHHHhhccCCCCCCCCC
Q 016037          374 SEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       374 ~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .++.+||++||+.+|.+||++.
T Consensus       240 ~~~~~li~~~l~~dp~~Rpt~~  261 (284)
T cd06620         240 EDLRDFVDACLLKDPTERPTPQ  261 (284)
T ss_pred             HHHHHHHHHHhcCCcccCcCHH
Confidence            8999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.7e-41  Score=319.56  Aligned_cols=242  Identities=29%  Similarity=0.469  Sum_probs=204.7

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEec------
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTK------  222 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~------  222 (396)
                      +.|++.+.||+|+||.||+|.+..+++.||+|++....    .....+..|+.+++.+ +||||+++++++...      
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            46888999999999999999999999999999987543    2234467789999988 799999999998653      


Q ss_pred             CeEEEEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccccc
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~  300 (396)
                      ..+|++|||+.+++|..++...  ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++...
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            4689999999999999988763  46899999999999999999999999999999999999999999999999999876


Q ss_pred             CCC-CCccccccCCCccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCccC
Q 016037          301 DEN-TRSNSMCGTLEYMSPEIVL-----GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK--IKLPAFL  372 (396)
Q Consensus       301 ~~~-~~~~~~~gt~~y~APE~l~-----~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~--~~~p~~~  372 (396)
                      ... .......|+..|+|||++.     +..++.++|||||||++|||++|+.||...........+....  ...+..+
T Consensus       162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06637         162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW  241 (272)
T ss_pred             ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCc
Confidence            432 2334567899999999986     3457889999999999999999999998776665555554432  2233568


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCC
Q 016037          373 SSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       373 s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +.++.+||.+||+.+|.+|||+.
T Consensus       242 ~~~~~~li~~~l~~~p~~Rpt~~  264 (272)
T cd06637         242 SKKFQSFIESCLVKNHSQRPTTE  264 (272)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHH
Confidence            89999999999999999999964

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-41  Score=323.57  Aligned_cols=243  Identities=26%  Similarity=0.448  Sum_probs=207.1

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++++.||+|+||.||+|.+..++..||+|.++...  .......+.+|+.++++++||||+++++.+.....+|+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            36889999999999999999999999999999987542  2333456778999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC
Q 016037          230 DFVNGGHLFFQLYRQ---GLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       230 E~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~  305 (396)
                      ||+++++|..++...   ..+++..++.++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++..+... .
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~  157 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-L  157 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-c
Confidence            999999998887663   378999999999999999999997 59999999999999999999999999999776433 2


Q ss_pred             ccccccCCCccchhhhcCC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhC-CCCCCccCCHH
Q 016037          306 SNSMCGTLEYMSPEIVLGK------GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQK---IIKD-KIKLPAFLSSE  375 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~------~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~---i~~~-~~~~p~~~s~~  375 (396)
                      .....+++.|+|||.+.+.      .++.++|||||||++|+|++|+.||...+.......   +... ...+|..++.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd06622         158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD  237 (286)
T ss_pred             cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHH
Confidence            3345688899999998543      357899999999999999999999987655444333   3333 35677789999


Q ss_pred             HHHHHHHhhccCCCCCCCCC
Q 016037          376 AHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       376 ~~~li~~~l~~~p~~RPs~s  395 (396)
                      +.+||++||+.+|.+||++.
T Consensus       238 ~~~li~~~l~~~p~~Rp~~~  257 (286)
T cd06622         238 AQDFVAKCLNKIPNRRPTYA  257 (286)
T ss_pred             HHHHHHHHcccCcccCCCHH
Confidence            99999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.6e-41  Score=319.96  Aligned_cols=236  Identities=37%  Similarity=0.686  Sum_probs=198.0

Q ss_pred             EecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHH---HHhCCCCCeeeeeEEEEecCeEEEEEEecC
Q 016037          157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI---LTKVDHPFIVQLRYSFQTKYRLYLVLDFVN  233 (396)
Q Consensus       157 ~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~---L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  233 (396)
                      .||+|+||.||++.+..+++.+|+|.+.+.............+|..+   +...+||||+.+++++...+..|+||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            48999999999999999999999999977544333322333444443   344579999999999999999999999999


Q ss_pred             CCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccccccCC
Q 016037          234 GGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL  313 (396)
Q Consensus       234 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~~gt~  313 (396)
                      +++|..++..++.+++..+..++.|++.||.|||+++++||||||+|||++.++.++|+|||++....... .....|+.
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~  159 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH  159 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCCc
Confidence            99999999888899999999999999999999999999999999999999999999999999997654332 23457899


Q ss_pred             Cccchhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCC
Q 016037          314 EYMSPEIVL-GKGHDKAADWWSVGILLFEMLTGQPPFTGGN---RQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSI  389 (396)
Q Consensus       314 ~y~APE~l~-~~~~~~~~DvwSlGvil~elltg~~Pf~~~~---~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~  389 (396)
                      .|+|||.+. +..++.++|||||||++|+|++|..||....   ...+..........+|..++.+++++|++||..||.
T Consensus       160 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  239 (279)
T cd05633         160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVS  239 (279)
T ss_pred             CccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHH
Confidence            999999986 4568999999999999999999999997532   333333333445677888999999999999999999


Q ss_pred             CCCC
Q 016037          390 SVPL  393 (396)
Q Consensus       390 ~RPs  393 (396)
                      +||+
T Consensus       240 ~R~~  243 (279)
T cd05633         240 KRLG  243 (279)
T ss_pred             HhcC
Confidence            9995

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.8e-41  Score=318.44  Aligned_cols=245  Identities=26%  Similarity=0.484  Sum_probs=209.5

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeecccc---chhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI---MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      +|+..+.||+|+||.||+|.+..+++.||+|++.....   ......+.+..|+.+++.++|+||+++++++.+.+.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            47888999999999999999999999999999975432   122345678899999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-cEEEEecccccccCCCC--
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HVMLTDFGLAKQFDENT--  304 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~-~ikL~Dfgla~~~~~~~--  304 (396)
                      |+||+.+++|.+++.+.+.+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .+||+|||++.......  
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            999999999999998888999999999999999999999999999999999999998776 59999999997764321  


Q ss_pred             ---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHh--CCCCCCccCCHHH
Q 016037          305 ---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ---KIIK--DKIKLPAFLSSEA  376 (396)
Q Consensus       305 ---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~---~i~~--~~~~~p~~~s~~~  376 (396)
                         ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+......   .+..  ....+|..+++++
T Consensus       161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (268)
T cd06630         161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL  240 (268)
T ss_pred             CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHH
Confidence               1223468899999999988889999999999999999999999997654322222   2222  2345677899999


Q ss_pred             HHHHHHhhccCCCCCCCCC
Q 016037          377 HSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~RPs~s  395 (396)
                      .++|.+||+.+|.+||++.
T Consensus       241 ~~~i~~~l~~~p~~R~~~~  259 (268)
T cd06630         241 RDVTLRCLELQPEDRPPSR  259 (268)
T ss_pred             HHHHHHHcCCCcccCcCHH
Confidence            9999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-41  Score=317.61  Aligned_cols=246  Identities=25%  Similarity=0.396  Sum_probs=213.2

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCc----EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      +...+|++.+.||+|+||+||+|.++.+|+    .+|+|.+.....  ......+.+|+.+++.++||||+++++++.. 
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   80 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-   80 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence            345689999999999999999999887665    589998876542  3445567889999999999999999999887 


Q ss_pred             CeEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      ...+++|||+.+|+|.+++... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            7899999999999999988764 468999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCcc---ccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHH
Q 016037          302 ENTRSN---SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (396)
Q Consensus       302 ~~~~~~---~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~  376 (396)
                      ......   ...++..|+|||.+....++.++|+||||+++|||++ |+.||.+.+..++.+.+... ..+.|...+.++
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV  240 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence            332211   1223568999999988889999999999999999999 99999998888888888765 456777899999


Q ss_pred             HHHHHHhhccCCCCCCCCC
Q 016037          377 HSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~RPs~s  395 (396)
                      .+++.+||..+|.+||++.
T Consensus       241 ~~~~~~~l~~~p~~Rp~~~  259 (279)
T cd05057         241 YMVLVKCWMIDAESRPTFK  259 (279)
T ss_pred             HHHHHHHcCCChhhCCCHH
Confidence            9999999999999999874

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.5e-41  Score=319.14  Aligned_cols=243  Identities=26%  Similarity=0.429  Sum_probs=199.0

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHH-HHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN-ILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~-~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      ++|++.+.||+|+||.||+|+++.+|+.||+|+++..... ....+.+ .|+. .++.++||||+++++++......|++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~-~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLL-MDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-HHHHHHH-HHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            4799999999999999999999999999999999765322 2233333 3444 46778999999999999999999999


Q ss_pred             EEecCCCcHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          229 LDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~-~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      |||+++ +|..++..    +..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          79 MEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999975 66655543    34689999999999999999999997 9999999999999999999999999999876544


Q ss_pred             CCccccccCCCccchhhhcC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCC-ccCCHHH
Q 016037          304 TRSNSMCGTLEYMSPEIVLG----KGHDKAADWWSVGILLFEMLTGQPPFTGGN--RQKIQQKIIKDKIKLP-AFLSSEA  376 (396)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~----~~~~~~~DvwSlGvil~elltg~~Pf~~~~--~~~i~~~i~~~~~~~p-~~~s~~~  376 (396)
                      .......|+..|+|||.+.+    ..++.++|+|||||++|+|++|+.||....  ...+...+......+| ..+|.++
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  237 (283)
T cd06617         158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEF  237 (283)
T ss_pred             cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHH
Confidence            33344568899999999865    456889999999999999999999997532  2333333333344454 3589999


Q ss_pred             HHHHHHhhccCCCCCCCCC
Q 016037          377 HSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~RPs~s  395 (396)
                      .+||..||+.+|.+||++.
T Consensus       238 ~~li~~~l~~~p~~Rp~~~  256 (283)
T cd06617         238 QDFVNKCLKKNYKERPNYP  256 (283)
T ss_pred             HHHHHHHccCChhhCcCHH
Confidence            9999999999999999975

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=9.9e-42  Score=323.32  Aligned_cols=243  Identities=24%  Similarity=0.424  Sum_probs=199.6

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      +|++.+.||+|+||.||+|+++.+|+.||+|+++..... ......+.+|+.+++.++||||+++++++.+...+|+++|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            488999999999999999999999999999999764322 2223446679999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC-ccc
Q 016037          231 FVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNS  308 (396)
Q Consensus       231 ~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~-~~~  308 (396)
                      |+++ +|..++.. .+.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||+++....... ...
T Consensus        80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (284)
T cd07839          80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA  158 (284)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence            9986 66666654 56789999999999999999999999999999999999999999999999999986543322 233


Q ss_pred             cccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCC--------------------C
Q 016037          309 MCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPF-TGGNRQKIQQKIIKDK--------------------I  366 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf-~~~~~~~i~~~i~~~~--------------------~  366 (396)
                      ..++..|+|||.+.+. .++.++|||||||++|+|+||..|| .+.+..+..+.+.+..                    .
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07839         159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP  238 (284)
T ss_pred             CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence            4678999999998764 4789999999999999999988885 4444444444332210                    0


Q ss_pred             ---------CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 ---------KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 ---------~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                               ...+.+++++++||++||+.||.+|||+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~  276 (284)
T cd07839         239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAE  276 (284)
T ss_pred             CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHH
Confidence                     11135789999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.2e-41  Score=314.08  Aligned_cols=243  Identities=25%  Similarity=0.407  Sum_probs=212.9

Q ss_pred             eEEEeEecccCceEEEEEEEcCCC----cEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTS----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      |++.+.||+|+||.||++.+...+    ..||+|+++....  ....+.+..|+.+++.++|+||+++++++.+....|+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            356789999999999999998876    8999999976532  2255678889999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC
Q 016037          228 VLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~  305 (396)
                      +|||+++++|..++.....  +++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            9999999999998876554  89999999999999999999999999999999999999999999999999987654322


Q ss_pred             cc--ccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHH
Q 016037          306 SN--SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLK  381 (396)
Q Consensus       306 ~~--~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~  381 (396)
                      ..  ...++..|+|||.+.+..++.++||||||+++|+|++ |..||...+...+.+.+... ....+..++.++.+++.
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  238 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLML  238 (258)
T ss_pred             cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHH
Confidence            11  2336789999999988889999999999999999999 89999988888888888766 44667789999999999


Q ss_pred             HhhccCCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLSR  396 (396)
Q Consensus       382 ~~l~~~p~~RPs~s~  396 (396)
                      +||+.+|++|||+.+
T Consensus       239 ~~l~~~p~~Rpt~~~  253 (258)
T smart00219      239 QCWAEDPEDRPTFSE  253 (258)
T ss_pred             HHCcCChhhCcCHHH
Confidence            999999999999753

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=6e-41  Score=313.56  Aligned_cols=244  Identities=31%  Similarity=0.501  Sum_probs=216.5

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++.+.||+|++|.||+|.+..+++.|++|++......  ...+.+.+|+..+..++|+||+++++++.....+++||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence            3689999999999999999999999999999998775421  44566888999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCc-c
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-N  307 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~-~  307 (396)
                      ||+++++|..++.....+++..++.++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++......... .
T Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence            999999999999888889999999999999999999999 99999999999999999999999999999876544332 2


Q ss_pred             ccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhC-CCCCCcc-CCHHHHHHHHH
Q 016037          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG---NRQKIQQKIIKD-KIKLPAF-LSSEAHSLLKG  382 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~---~~~~i~~~i~~~-~~~~p~~-~s~~~~~li~~  382 (396)
                      ...++..|+|||.+.+..++.++|+||||+++|+|+||+.||...   ...+..+.+... ...++.. ++..+.++|+.
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  238 (264)
T cd06623         159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISA  238 (264)
T ss_pred             ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHH
Confidence            456889999999999988999999999999999999999999876   455556666554 3455666 89999999999


Q ss_pred             hhccCCCCCCCCC
Q 016037          383 VNSLLSISVPLLS  395 (396)
Q Consensus       383 ~l~~~p~~RPs~s  395 (396)
                      ||+.+|.+||++.
T Consensus       239 ~l~~~p~~R~~~~  251 (264)
T cd06623         239 CLQKDPKKRPSAA  251 (264)
T ss_pred             HccCChhhCCCHH
Confidence            9999999999974

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.8e-41  Score=319.67  Aligned_cols=242  Identities=26%  Similarity=0.463  Sum_probs=212.2

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      .|+.++.||.|+||.||+|.+..++..||+|++.....  ......+.+|+.+++.++||||+++++++.....+|+|||
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            57888999999999999999999999999999875432  2345668889999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Ccccc
Q 016037          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSM  309 (396)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~~~~  309 (396)
                      |+++++|.+++.. +.+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++....... .....
T Consensus        83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06640          83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccc
Confidence            9999999988764 578899999999999999999999999999999999999999999999999997764332 22344


Q ss_pred             ccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHHhhccCC
Q 016037          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGVNSLLS  388 (396)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p  388 (396)
                      .++..|+|||.+.+..++.++|+|||||++|||+||+.||...+.......+... ...++..++.++.+||+.||+.+|
T Consensus       162 ~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  241 (277)
T cd06640         162 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDP  241 (277)
T ss_pred             cCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccCc
Confidence            6788999999999888999999999999999999999999988777666665544 345566789999999999999999


Q ss_pred             CCCCCCC
Q 016037          389 ISVPLLS  395 (396)
Q Consensus       389 ~~RPs~s  395 (396)
                      ++||++.
T Consensus       242 ~~Rp~~~  248 (277)
T cd06640         242 SFRPTAK  248 (277)
T ss_pred             ccCcCHH
Confidence            9999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.8e-41  Score=327.92  Aligned_cols=249  Identities=20%  Similarity=0.354  Sum_probs=211.4

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCC-------CcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeee
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGT-------SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLR  216 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~  216 (396)
                      +.+...+|++.+.||+|+||.||+|++...       +..||+|.++...  .....+.+.+|+.+++++ +||||++++
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~   84 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLL   84 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence            345556899999999999999999987542       2368999887532  233456678899999999 899999999


Q ss_pred             EEEEecCeEEEEEEecCCCcHHHHHHHhc----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 016037          217 YSFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN  280 (396)
Q Consensus       217 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~N  280 (396)
                      +++.....+|+++||+++|+|..++.+..                .++...+..++.|++.||.|||++|++||||||+|
T Consensus        85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  164 (334)
T cd05100          85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN  164 (334)
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence            99999999999999999999999887542                35667788899999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 016037          281 ILLDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQK  356 (396)
Q Consensus       281 ILl~~~~~ikL~Dfgla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~  356 (396)
                      ||++.++.+||+|||+++.......   .....++..|||||++.+..++.++||||||+++|||++ |..||.+.+..+
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  244 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  244 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999987643321   122234567999999999999999999999999999999 999999988888


Q ss_pred             HHHHHHhC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          357 IQQKIIKD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       357 i~~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +...+... ....|..++.++.+||.+||+.+|.+||++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~  284 (334)
T cd05100         245 LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFK  284 (334)
T ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHH
Confidence            88887765 4567778999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.5e-41  Score=314.74  Aligned_cols=237  Identities=24%  Similarity=0.394  Sum_probs=206.1

Q ss_pred             eEecccCceEEEEEEEcC-CC--cEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEec
Q 016037          156 KVVGQGAFAKVYQVRRIG-TS--EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFV  232 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~-~~--~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~  232 (396)
                      ++||+|++|.||+|.+.. ++  ..||+|.+......  ...+.+.+|+.++++++||||+++++.+.. ..++++|||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            468999999999999865 33  36899999876543  556678889999999999999999999988 8999999999


Q ss_pred             CCCcHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC----c
Q 016037          233 NGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR----S  306 (396)
Q Consensus       233 ~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~----~  306 (396)
                      ++++|...+.+..  .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.+.....    .
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence            9999999987764  688999999999999999999999999999999999999999999999999987644221    1


Q ss_pred             cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHHHh
Q 016037          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD--KIKLPAFLSSEAHSLLKGV  383 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~--~~~~p~~~s~~~~~li~~~  383 (396)
                      ....++..|+|||.+.+..++.++|||||||++|||++ |+.||...+..++...+...  ....|..++.++.+++++|
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  237 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQC  237 (257)
T ss_pred             cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHH
Confidence            23456788999999998889999999999999999999 99999988888877777753  3455677899999999999


Q ss_pred             hccCCCCCCCCC
Q 016037          384 NSLLSISVPLLS  395 (396)
Q Consensus       384 l~~~p~~RPs~s  395 (396)
                      |+.+|.+|||+.
T Consensus       238 l~~~p~~Rps~~  249 (257)
T cd05040         238 WAHNPADRPTFA  249 (257)
T ss_pred             CCCCcccCCCHH
Confidence            999999999974

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-41  Score=320.09  Aligned_cols=245  Identities=31%  Similarity=0.481  Sum_probs=209.1

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++.... .....+.+.+|+++++.++|+||+++++++..+...|++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            369999999999999999999999999999999876432 2334566788999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC--Ccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--RSN  307 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~--~~~  307 (396)
                      ||++++.+.....+...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++.......  ...
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT  159 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence            999998777666666779999999999999999999999999999999999999999999999999998765443  234


Q ss_pred             ccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------------------
Q 016037          308 SMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---------------------  365 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~---------------------  365 (396)
                      ...++..|+|||++.+. .++.++||||||+++|+|++|+.||.+.+..+....+....                     
T Consensus       160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07833         160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA  239 (288)
T ss_pred             CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence            45688999999999887 88999999999999999999999998766544333332100                     


Q ss_pred             -----------CCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 -----------IKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 -----------~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                 ..++..++.++.+||++||+.+|++|||++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  280 (288)
T cd07833         240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCD  280 (288)
T ss_pred             cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHH
Confidence                       012344689999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3.2e-41  Score=315.04  Aligned_cols=237  Identities=43%  Similarity=0.767  Sum_probs=214.9

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCCCcH
Q 016037          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL  237 (396)
Q Consensus       158 IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L  237 (396)
                      ||.|+||.||++++..+++.+++|++...........+.+.+|+++++.++||||+++++.+..+...|+++||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999999999999999999876555556677788999999999999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC---------Cccc
Q 016037          238 FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT---------RSNS  308 (396)
Q Consensus       238 ~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~---------~~~~  308 (396)
                      ..++.+.+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......         ....
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  160 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR  160 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence            9999887889999999999999999999999999999999999999999999999999987653321         2234


Q ss_pred             cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccC--CHHHHHHHHHhhcc
Q 016037          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFL--SSEAHSLLKGVNSL  386 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~--s~~~~~li~~~l~~  386 (396)
                      ..++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+..+...+|..+  +.++.+||++||+.
T Consensus       161 ~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  240 (265)
T cd05579         161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVP  240 (265)
T ss_pred             cccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcC
Confidence            5678899999999888899999999999999999999999999998888888888777777766  99999999999999


Q ss_pred             CCCCCCCC
Q 016037          387 LSISVPLL  394 (396)
Q Consensus       387 ~p~~RPs~  394 (396)
                      +|.+||++
T Consensus       241 ~p~~Rpt~  248 (265)
T cd05579         241 DPEKRLGA  248 (265)
T ss_pred             CHhhcCCC
Confidence            99999997

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.5e-41  Score=337.19  Aligned_cols=249  Identities=22%  Similarity=0.336  Sum_probs=208.2

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEE
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYS  218 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~  218 (396)
                      +.+..++|.+.+.||+|+||.||+|++.+     +++.||+|+++....  ....+.+.+|+.+|.++. ||||++++++
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            45667789999999999999999999753     456899999976432  223345778999999997 9999999999


Q ss_pred             EEecCeEEEEEEecCCCcHHHHHHHhc-----------------------------------------------------
Q 016037          219 FQTKYRLYLVLDFVNGGHLFFQLYRQG-----------------------------------------------------  245 (396)
Q Consensus       219 ~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------------------------------------------------  245 (396)
                      +.....+++||||+.+|+|.+++.+.+                                                     
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            999999999999999999999886542                                                     


Q ss_pred             ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 016037          246 ---------------------------------------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN  280 (396)
Q Consensus       246 ---------------------------------------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~N  280 (396)
                                                                   .++...++.++.||+.||.|||+++++||||||+|
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N  269 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN  269 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence                                                         24556677889999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecccccccCCCC---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 016037          281 ILLDADGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQK  356 (396)
Q Consensus       281 ILl~~~~~ikL~Dfgla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~  356 (396)
                      ||++.++.+||+|||+++......   ......++..|||||.+.+..++.++||||||+++|||++ |..||......+
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            999999999999999998653221   1223457789999999998889999999999999999998 999998765444


Q ss_pred             HH-HHHHhC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          357 IQ-QKIIKD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       357 i~-~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .. ..+..+ ++..|..++.++.+||+.||..+|.+||+++
T Consensus       350 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~  390 (401)
T cd05107         350 QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFS  390 (401)
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHH
Confidence            43 333433 4567778999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=7.4e-41  Score=312.33  Aligned_cols=242  Identities=22%  Similarity=0.380  Sum_probs=209.8

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      ..+|++.+.||+|+||.||+|.+.. +..+|+|.+......    ...+.+|++++++++||||+++++++......|++
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence            4579999999999999999998864 667999998765432    23467799999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC--
Q 016037          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR--  305 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~--  305 (396)
                      |||+++++|.+++... +.+++..++.++.|++.|++|||+++++||||||+||+++.++.+||+|||++........  
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            9999999999888764 5688999999999999999999999999999999999999999999999999976543221  


Q ss_pred             ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHHh
Q 016037          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGV  383 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~~~  383 (396)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |..||...+...+.+.+..+ +...|...+.++.+|+++|
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  237 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHC  237 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence            122335678999999998889999999999999999998 99999988888888887765 4455677899999999999


Q ss_pred             hccCCCCCCCCC
Q 016037          384 NSLLSISVPLLS  395 (396)
Q Consensus       384 l~~~p~~RPs~s  395 (396)
                      |+.+|.+||++.
T Consensus       238 l~~~p~~Rp~~~  249 (256)
T cd05112         238 WKERPEDRPSFS  249 (256)
T ss_pred             cccChhhCCCHH
Confidence            999999999974

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-40  Score=312.22  Aligned_cols=245  Identities=32%  Similarity=0.466  Sum_probs=211.6

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccc--cchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec--CeE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDK--IMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--YRL  225 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~--~~~  225 (396)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+....  .........+.+|+.++++++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47999999999999999999999999999999885432  12234556788999999999999999999998764  568


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC--
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--  303 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~--  303 (396)
                      ++++||+++++|..++...+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.....  
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            999999999999999988888999999999999999999999999999999999999999999999999999875321  


Q ss_pred             --CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHH
Q 016037          304 --TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPAFLSSEAHSL  379 (396)
Q Consensus       304 --~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--~~~~p~~~s~~~~~l  379 (396)
                        .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.+........++...  +..+|..++.+++++
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  241 (264)
T cd06653         162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF  241 (264)
T ss_pred             cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHH
Confidence              1123456889999999999888999999999999999999999999887666655555543  456788999999999


Q ss_pred             HHHhhccCCCCCCCCC
Q 016037          380 LKGVNSLLSISVPLLS  395 (396)
Q Consensus       380 i~~~l~~~p~~RPs~s  395 (396)
                      |++||+ ++..||+..
T Consensus       242 i~~~l~-~~~~r~~~~  256 (264)
T cd06653         242 LKQIFV-EEKRRPTAE  256 (264)
T ss_pred             HHHHhc-CcccCccHH
Confidence            999999 579999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.5e-41  Score=319.15  Aligned_cols=244  Identities=28%  Similarity=0.470  Sum_probs=203.8

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEE-----e
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQ-----T  221 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~-----~  221 (396)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|++....    .....+.+|+.+++.+ +||||+++++++.     .
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            4578999999999999999999999999999999886532    1234467799999998 7999999999873     3


Q ss_pred             cCeEEEEEEecCCCcHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccc
Q 016037          222 KYRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA  297 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla  297 (396)
                      +..+|+||||+++++|..++..    ...+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|||++
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~  171 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS  171 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence            4678999999999999887642    356888999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCC-CccccccCCCccchhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCC
Q 016037          298 KQFDENT-RSNSMCGTLEYMSPEIVLG-----KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKL  368 (396)
Q Consensus       298 ~~~~~~~-~~~~~~gt~~y~APE~l~~-----~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~---~~~~  368 (396)
                      +...... ......|++.|+|||.+..     ..++.++|||||||++|||++|+.||...+......++...   ....
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  251 (286)
T cd06638         172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQ  251 (286)
T ss_pred             eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccC
Confidence            8764322 2334568999999999853     45788999999999999999999999887665544444333   2234


Q ss_pred             CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          369 PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       369 p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      |..++.++.+||.+||+.+|++|||+.
T Consensus       252 ~~~~~~~~~~li~~~l~~~p~~Rps~~  278 (286)
T cd06638         252 PELWSNEFNDFIRKCLTKDYEKRPTVS  278 (286)
T ss_pred             CCCcCHHHHHHHHHHccCCcccCCCHH
Confidence            556789999999999999999999974

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.2e-41  Score=318.96  Aligned_cols=243  Identities=27%  Similarity=0.439  Sum_probs=211.0

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++.+.||+|+||.||+|.++.+++.+|+|.+.....  ....+.+.+|+++++.++||||+++++.+.....+++++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            368888999999999999999999999999999877542  244556778999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCcc
Q 016037          230 DFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN  307 (396)
Q Consensus       230 E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~  307 (396)
                      ||+.+++|.+++... ..+++..++.++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.+......... 
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-  157 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-  157 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-
Confidence            999999999998876 788999999999999999999999 99999999999999999999999999998766433222 


Q ss_pred             ccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhC-CCCCCcc-CCHHHHHHH
Q 016037          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG-----NRQKIQQKIIKD-KIKLPAF-LSSEAHSLL  380 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~-----~~~~i~~~i~~~-~~~~p~~-~s~~~~~li  380 (396)
                      ...++..|+|||.+.+..++.++||||||+++|+|++|+.||...     ...+..+.+... ...++.. ++.++++||
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (265)
T cd06605         158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFV  237 (265)
T ss_pred             cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHH
Confidence            267889999999999989999999999999999999999999764     233444444443 4455555 899999999


Q ss_pred             HHhhccCCCCCCCCC
Q 016037          381 KGVNSLLSISVPLLS  395 (396)
Q Consensus       381 ~~~l~~~p~~RPs~s  395 (396)
                      ..||..+|.+||++.
T Consensus       238 ~~~l~~~p~~Rpt~~  252 (265)
T cd06605         238 NLCLIKDPRERPSYK  252 (265)
T ss_pred             HHHcCCCchhCcCHH
Confidence            999999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6e-41  Score=317.53  Aligned_cols=247  Identities=19%  Similarity=0.312  Sum_probs=211.3

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcC----CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe-
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIG----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-  221 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~-  221 (396)
                      +..++|.+.+.||+|+||.||+|.+..    ++..|++|.+....  .....+.+.+|+.+++.++||||+++++++.. 
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            455789999999999999999999976    35789999886432  34455667889999999999999999998765 


Q ss_pred             cCeEEEEEEecCCCcHHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEe
Q 016037          222 KYRLYLVLDFVNGGHLFFQLYRQ--------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTD  293 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~--------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~D  293 (396)
                      ....++++||+.+++|..++...        ..+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence            56789999999999999888654        4588999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCC
Q 016037          294 FGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKL  368 (396)
Q Consensus       294 fgla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~  368 (396)
                      ||+++.+.....   .....++..|+|||.+.+..++.++||||||+++||+++ |+.||...+..++...+..+ .+..
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  240 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ  240 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCC
Confidence            999986543221   122345678999999998889999999999999999999 99999988888877776665 4455


Q ss_pred             CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          369 PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       369 p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +..++.++.+++.+||..+|++|||+.
T Consensus       241 ~~~~~~~~~~li~~~l~~~p~~Rps~~  267 (280)
T cd05043         241 PINCPDELFAVMACCWALDPEERPSFS  267 (280)
T ss_pred             CCcCCHHHHHHHHHHcCCChhhCCCHH
Confidence            667899999999999999999999974

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.9e-41  Score=319.40  Aligned_cols=235  Identities=37%  Similarity=0.689  Sum_probs=200.7

Q ss_pred             EecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHH---HHHHhCCCCCeeeeeEEEEecCeEEEEEEecC
Q 016037          157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER---NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVN  233 (396)
Q Consensus       157 ~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~---~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  233 (396)
                      .||+|+||.||+|.+..+++.||+|++.+..............|.   .+++...||+|+++++++.....+|+||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999999999875433222222233333   44555689999999999999999999999999


Q ss_pred             CCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccccccCC
Q 016037          234 GGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL  313 (396)
Q Consensus       234 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~~gt~  313 (396)
                      |++|..++.+.+.+++..++.++.|++.||.|||+.+++||||||+||+++.++.+||+|||++..+... .....+|+.
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~  159 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTH  159 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcCcCCCc
Confidence            9999999988888999999999999999999999999999999999999999999999999999766433 233457999


Q ss_pred             CccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCC
Q 016037          314 EYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGG---NRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSI  389 (396)
Q Consensus       314 ~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~---~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~  389 (396)
                      .|+|||.+.+. .++.++||||+|+++|||++|+.||.+.   ....+...+......+|..+|.++.++|++||..+|.
T Consensus       160 ~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~  239 (278)
T cd05606         160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN  239 (278)
T ss_pred             CCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHH
Confidence            99999999754 6899999999999999999999999876   4455555555556778888999999999999999999


Q ss_pred             CCC
Q 016037          390 SVP  392 (396)
Q Consensus       390 ~RP  392 (396)
                      +||
T Consensus       240 ~R~  242 (278)
T cd05606         240 RRL  242 (278)
T ss_pred             hcc
Confidence            999

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-41  Score=313.21  Aligned_cols=236  Identities=39%  Similarity=0.720  Sum_probs=205.3

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHH-HHhCCCCCeeeeeEEEEecCeEEEEEEecCC
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~-L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (396)
                      +.||.|+||.||+|.+..+++.||+|++.+...........+..|..+ ....+|+||+++++++.....+|+|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            569999999999999999999999999976544333333334455544 4456899999999999999999999999999


Q ss_pred             CcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccccccCCC
Q 016037          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE  314 (396)
Q Consensus       235 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~~gt~~  314 (396)
                      ++|..++...+.+++..+..++.|++.||.|||+.+++||||+|+||+++.++.+||+|||+++....   .....|+..
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~  158 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTPD  158 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCcC
Confidence            99999998888899999999999999999999999999999999999999999999999999876433   234568899


Q ss_pred             ccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHhhccCCCC
Q 016037          315 YMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLKGVNSLLSIS  390 (396)
Q Consensus       315 y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~~~s~~~~~li~~~l~~~p~~  390 (396)
                      |+|||.+.+..++.++||||||+++|+|++|..||...+...+...+.......+    ..++.++.++|++||+.+|.+
T Consensus       159 y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~  238 (260)
T cd05611         159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAK  238 (260)
T ss_pred             ccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHH
Confidence            9999999888889999999999999999999999999888888887776654433    468999999999999999999


Q ss_pred             CCCC
Q 016037          391 VPLL  394 (396)
Q Consensus       391 RPs~  394 (396)
                      ||+.
T Consensus       239 R~~~  242 (260)
T cd05611         239 RLGA  242 (260)
T ss_pred             ccCC
Confidence            9976

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7.3e-41  Score=311.31  Aligned_cols=237  Identities=23%  Similarity=0.398  Sum_probs=203.8

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCCC
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg  235 (396)
                      ++||+|+||.||+|... ++..+|+|++....  .......+.+|+++++.++||||+++++++......++||||++++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   77 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG   77 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence            36899999999999864 57789999987543  2233445778999999999999999999999999999999999999


Q ss_pred             cHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCc--cccccC
Q 016037          236 HLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS--NSMCGT  312 (396)
Q Consensus       236 ~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~--~~~~gt  312 (396)
                      +|..++... ..+.+..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........  ....++
T Consensus        78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence            999888654 45788999999999999999999999999999999999999999999999999765433221  122345


Q ss_pred             CCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHHhhccCCCC
Q 016037          313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGVNSLLSIS  390 (396)
Q Consensus       313 ~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p~~  390 (396)
                      ..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.......+... +...+..++.++.+|+.+||+.+|++
T Consensus       158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  237 (250)
T cd05085         158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPEN  237 (250)
T ss_pred             ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCccc
Confidence            67999999998889999999999999999999 99999988877777777655 45677889999999999999999999


Q ss_pred             CCCCC
Q 016037          391 VPLLS  395 (396)
Q Consensus       391 RPs~s  395 (396)
                      ||++.
T Consensus       238 Rp~~~  242 (250)
T cd05085         238 RPKFS  242 (250)
T ss_pred             CCCHH
Confidence            99974

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-41  Score=322.25  Aligned_cols=245  Identities=19%  Similarity=0.297  Sum_probs=205.4

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCC--------------cEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeee
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTS--------------EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ  214 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~--------------~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~  214 (396)
                      ..+|++.++||+|+||.||+|++.+++              ..||+|.++...  .....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence            358999999999999999999876532              358999987643  2334556888999999999999999


Q ss_pred             eeEEEEecCeEEEEEEecCCCcHHHHHHHhc------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEE
Q 016037          215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL  282 (396)
Q Consensus       215 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NIL  282 (396)
                      +++++......++||||+.+++|..++....            .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            9999999999999999999999998886542            3577888889999999999999999999999999999


Q ss_pred             EcCCCcEEEEecccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHH
Q 016037          283 LDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT--GQPPFTGGNRQKI  357 (396)
Q Consensus       283 l~~~~~ikL~Dfgla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt--g~~Pf~~~~~~~i  357 (396)
                      ++.++.+||+|||++........   .....++..|+|||.+.+..++.++|||||||++|+|++  |..||...+..++
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            99999999999999976533221   122345678999999998889999999999999999998  7789988777766


Q ss_pred             HHHHHh-----C---CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          358 QQKIIK-----D---KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       358 ~~~i~~-----~---~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ...+..     .   ....+..+++.+.+||.+||+.+|.+|||++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~  287 (295)
T cd05097         242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFN  287 (295)
T ss_pred             HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence            655432     1   2334567899999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.8e-41  Score=315.62  Aligned_cols=245  Identities=29%  Similarity=0.483  Sum_probs=207.9

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc-------hhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-------EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~-------~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~  223 (396)
                      +|.+.+.||.|+||.||+|.+..+++.+|+|.++.....       .....+.+..|+.+++.++||||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            488899999999999999999999999999998643211       1123456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      .+++||||+++++|..++.+.+.+++..++.++.|++.||.|||+++++||||+|+||+++.++.++|+|||+++.....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999999765422


Q ss_pred             C---CccccccCCCccchhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCc----cC
Q 016037          304 T---RSNSMCGTLEYMSPEIVLGKG--HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPA----FL  372 (396)
Q Consensus       304 ~---~~~~~~gt~~y~APE~l~~~~--~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--~~~~p~----~~  372 (396)
                      .   ......|+..|+|||.+....  ++.++|+||||+++|+|++|..||...+......++...  ...++.    .+
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06629         162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL  241 (272)
T ss_pred             ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence            1   123456889999999987654  789999999999999999999999876655444444332  333443    46


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCC
Q 016037          373 SSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       373 s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +.++++||..||+.+|.+||++.
T Consensus       242 ~~~~~~li~~~l~~~p~~Rps~~  264 (272)
T cd06629         242 SPVALDFLNACFTINPDNRPTAR  264 (272)
T ss_pred             CHHHHHHHHHHhcCChhhCCCHH
Confidence            89999999999999999999964

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=5.1e-41  Score=321.13  Aligned_cols=245  Identities=21%  Similarity=0.328  Sum_probs=204.4

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcC----------------CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCe
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIG----------------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI  212 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~----------------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnI  212 (396)
                      .++|++.+.||+|+||.||++.+..                ++..+|+|+++...  .....+.+.+|+.+++.++|+||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence            3579999999999999999986543                34579999987543  23345667889999999999999


Q ss_pred             eeeeEEEEecCeEEEEEEecCCCcHHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCE
Q 016037          213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-----------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENI  281 (396)
Q Consensus       213 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NI  281 (396)
                      +++++++......|++|||+++++|..++....           .+++..++.++.|++.||.|||++|++||||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni  161 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC  161 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence            999999999999999999999999998887643           355678899999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHH
Q 016037          282 LLDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT--GQPPFTGGNRQK  356 (396)
Q Consensus       282 Ll~~~~~ikL~Dfgla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt--g~~Pf~~~~~~~  356 (396)
                      |++.++.++|+|||+++.+.....   .....++..|+|||...+..++.++|||||||++|||++  |..||...+..+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999986543221   122344678999999888889999999999999999998  889998877666


Q ss_pred             HHHHHHh--------CCCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          357 IQQKIIK--------DKIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       357 i~~~i~~--------~~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +......        ...+.|..++..+.+||.+||+.+|.+||+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~  288 (296)
T cd05095         242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQ  288 (296)
T ss_pred             HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence            5544321        12345567899999999999999999999975

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-42  Score=337.66  Aligned_cols=248  Identities=21%  Similarity=0.334  Sum_probs=222.6

Q ss_pred             CccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC
Q 016037          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (396)
Q Consensus       144 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~  223 (396)
                      .|.....++..-.+||-|.||.||.|.|++-...||||.++.+.    ...+.|..|+.+|+.++|||+|+|+++|..+.
T Consensus       261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep  336 (1157)
T KOG4278|consen  261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP  336 (1157)
T ss_pred             hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence            34455667888899999999999999999999999999998754    34566788999999999999999999999999


Q ss_pred             eEEEEEEecCCCcHHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      .+|||+|||..|.|.++|++...  ++.-....++.||..||+||..+++|||||..+|+|+.++..+|++|||+++.+.
T Consensus       337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt  416 (1157)
T KOG4278|consen  337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT  416 (1157)
T ss_pred             CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence            99999999999999999987643  5566677789999999999999999999999999999999999999999999876


Q ss_pred             CCCCc--cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHH
Q 016037          302 ENTRS--NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAH  377 (396)
Q Consensus       302 ~~~~~--~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~  377 (396)
                      ..+.+  ........|.|||-+....++.|+|||+|||+|||+.| |..||.+.+..+++..+.++ ++.-|.+|++.+.
T Consensus       417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVY  496 (1157)
T KOG4278|consen  417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVY  496 (1157)
T ss_pred             CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHH
Confidence            54432  12234678999999999999999999999999999999 99999999999999999887 8899999999999


Q ss_pred             HHHHHhhccCCCCCCCCC
Q 016037          378 SLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       378 ~li~~~l~~~p~~RPs~s  395 (396)
                      +||.+||+++|.+||++-
T Consensus       497 eLMraCW~WsPsDRPsFa  514 (1157)
T KOG4278|consen  497 ELMRACWNWSPSDRPSFA  514 (1157)
T ss_pred             HHHHHHhcCCcccCccHH
Confidence            999999999999999863

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-41  Score=315.84  Aligned_cols=243  Identities=30%  Similarity=0.498  Sum_probs=206.6

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecC----
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKY----  223 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~----  223 (396)
                      .++|++.+.||+|+||.||+|.++.+++.+++|++....    ...+.+.+|+.+++++ +|+||+++++++....    
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            368999999999999999999999999999999987653    2335678899999998 7999999999997644    


Q ss_pred             --eEEEEEEecCCCcHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccc
Q 016037          224 --RLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA  297 (396)
Q Consensus       224 --~~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla  297 (396)
                        .+|+||||+++++|.+++..    ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence              48999999999999888765    357899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCC-CccccccCCCccchhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---CCC
Q 016037          298 KQFDENT-RSNSMCGTLEYMSPEIVLG-----KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKL  368 (396)
Q Consensus       298 ~~~~~~~-~~~~~~gt~~y~APE~l~~-----~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~---~~~  368 (396)
                      ....... ......|+..|+|||.+..     ..++.++||||||++||+|++|+.||...+.......+....   +..
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  240 (275)
T cd06608         161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS  240 (275)
T ss_pred             eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCc
Confidence            7654322 2344568899999999854     346788999999999999999999998776666666665542   223


Q ss_pred             CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          369 PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       369 p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +..++.++++||++||+.||++|||+.
T Consensus       241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~  267 (275)
T cd06608         241 PENWSKKFNDFISECLIKNYEQRPFME  267 (275)
T ss_pred             hhhcCHHHHHHHHHHhhcChhhCcCHH
Confidence            345889999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-44  Score=329.22  Aligned_cols=239  Identities=25%  Similarity=0.408  Sum_probs=215.1

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      -|.++.+||+|+||.||++.++.+|..+|||.+..+.     ..+.+..|+.++++++.|++|++|+.|.....+|||||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            3888999999999999999999999999999987643     45557789999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHH-HhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Cccc
Q 016037          231 FVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNS  308 (396)
Q Consensus       231 ~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~~~  308 (396)
                      ||..|+..+.++ ++++++|+.+..+++..++||+|||...-||||||..|||++.+|+.||+|||.|..+.+.. ..++
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT  188 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT  188 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence            999999998885 56789999999999999999999999999999999999999999999999999998775443 3567


Q ss_pred             cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCCccCCHHHHHHHHHhhc
Q 016037          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGVNS  385 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~---~~~~p~~~s~~~~~li~~~l~  385 (396)
                      ..|||.|||||++..-+|+.++||||||++..||.-|++||.+..++..+--|-.+   .+.-|..+|.++.+||++||-
T Consensus       189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLi  268 (502)
T KOG0574|consen  189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLI  268 (502)
T ss_pred             cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhc
Confidence            78999999999999999999999999999999999999999998887765555444   334567899999999999999


Q ss_pred             cCCCCCCCC
Q 016037          386 LLSISVPLL  394 (396)
Q Consensus       386 ~~p~~RPs~  394 (396)
                      ++|++|-++
T Consensus       269 K~PE~R~TA  277 (502)
T KOG0574|consen  269 KKPEERKTA  277 (502)
T ss_pred             CCHHHHHHH
Confidence            999999764

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=9.9e-41  Score=312.38  Aligned_cols=244  Identities=31%  Similarity=0.527  Sum_probs=211.1

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      +|.+.+.||+|+||.||+|.+..+++.||+|+++..... ....+.+.+|+.+++.++|+||+++++.+.....+++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            488999999999999999999999999999999876533 3466778899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCc----
Q 016037          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS----  306 (396)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~----  306 (396)
                      |+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.........    
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~  159 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE  159 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence            9999999999988878899999999999999999999999999999999999999999999999999876543321    


Q ss_pred             -cccccCCCccchhhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhC-CCCCCccC--CHHHHH
Q 016037          307 -NSMCGTLEYMSPEIVLGKG---HDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQKIIKD-KIKLPAFL--SSEAHS  378 (396)
Q Consensus       307 -~~~~gt~~y~APE~l~~~~---~~~~~DvwSlGvil~elltg~~Pf~~~~-~~~i~~~i~~~-~~~~p~~~--s~~~~~  378 (396)
                       ....++..|+|||.+.+..   ++.++||||||+++|+|++|+.||...+ .......+... ...+|...  +..+.+
T Consensus       160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (264)
T cd06626         160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD  239 (264)
T ss_pred             ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence             1346789999999998766   8899999999999999999999997653 33333333332 44566544  999999


Q ss_pred             HHHHhhccCCCCCCCCC
Q 016037          379 LLKGVNSLLSISVPLLS  395 (396)
Q Consensus       379 li~~~l~~~p~~RPs~s  395 (396)
                      ||+.||+.+|.+||++.
T Consensus       240 li~~~l~~~p~~R~~~~  256 (264)
T cd06626         240 FLDRCLESDPKKRPTAS  256 (264)
T ss_pred             HHHHHccCCcccCCCHH
Confidence            99999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.2e-41  Score=319.89  Aligned_cols=245  Identities=31%  Similarity=0.430  Sum_probs=206.6

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++....... ...+.+.+|+++++.++||||+++++++..+...|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            46999999999999999999999999999999987644322 34455778999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC-ccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNS  308 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~-~~~  308 (396)
                      ||++++.|..+......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ ...
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD  159 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence            9999999888777767789999999999999999999999999999999999999999999999999987643322 233


Q ss_pred             cccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------------C--
Q 016037          309 MCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-------------------I--  366 (396)
Q Consensus       309 ~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~-------------------~--  366 (396)
                      ..++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+..+....+....                   .  
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07846         160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL  239 (286)
T ss_pred             ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence            567899999999875 447889999999999999999999998766544433333210                   0  


Q ss_pred             ----------CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 ----------KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 ----------~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                ..++.++..+.+||.+||+.+|.+||++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~  278 (286)
T cd07846         240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSS  278 (286)
T ss_pred             ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHH
Confidence                      01236789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.6e-41  Score=317.94  Aligned_cols=241  Identities=25%  Similarity=0.351  Sum_probs=197.4

Q ss_pred             eEEEeEecccCceEEEEEEE----cCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec--CeE
Q 016037          152 FEVLKVVGQGAFAKVYQVRR----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--YRL  225 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~----~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~--~~~  225 (396)
                      |++++.||+|+||+||++.+    ..++..||+|+++...  .......+.+|+++|+.++||||+++++++...  ..+
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            48999999999999988653    3567889999987643  223445677899999999999999999987653  468


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~  305 (396)
                      |++|||+++++|..++... .+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.......
T Consensus        84 ~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  162 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE  162 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence            9999999999999888664 589999999999999999999999999999999999999999999999999987643322


Q ss_pred             ----ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------------HHHHHHHHh-CC
Q 016037          306 ----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR---------------QKIQQKIIK-DK  365 (396)
Q Consensus       306 ----~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~---------------~~i~~~i~~-~~  365 (396)
                          .....++..|+|||.+.+..++.++||||||+++|||+||..||.....               ....+.+.. ..
T Consensus       163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (283)
T cd05080         163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR  242 (283)
T ss_pred             hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC
Confidence                1223456789999999888899999999999999999999999865321               111111111 13


Q ss_pred             CCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 IKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 ~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .+.|..++.++.+|+++||+.+|.+|||++
T Consensus       243 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~  272 (283)
T cd05080         243 LPCPKNCPQEVYILMKNCWETEAKFRPTFR  272 (283)
T ss_pred             CCCCCCCCHHHHHHHHHHhccChhhCCCHH
Confidence            345677899999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=8.9e-41  Score=314.70  Aligned_cols=245  Identities=22%  Similarity=0.377  Sum_probs=209.0

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCC---CcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCe
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~  224 (396)
                      ..++|.+.++||+|+||.||+|.+...   ...||+|......  .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~   80 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP   80 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence            446799999999999999999998654   4568999886543  13445667889999999999999999998875 45


Q ss_pred             EEEEEEecCCCcHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      .|+||||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            789999999999999987643 5899999999999999999999999999999999999999999999999999876433


Q ss_pred             CC--ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHH
Q 016037          304 TR--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSL  379 (396)
Q Consensus       304 ~~--~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~l  379 (396)
                      ..  .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+....+..+ .+..|..++.++.++
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  240 (270)
T cd05056         161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL  240 (270)
T ss_pred             cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence            21  112234568999999988889999999999999999996 99999988877777777665 567788999999999


Q ss_pred             HHHhhccCCCCCCCCC
Q 016037          380 LKGVNSLLSISVPLLS  395 (396)
Q Consensus       380 i~~~l~~~p~~RPs~s  395 (396)
                      |++|++.+|.+|||+.
T Consensus       241 i~~~l~~~P~~Rpt~~  256 (270)
T cd05056         241 MTKCWAYDPSKRPRFT  256 (270)
T ss_pred             HHHHcCCChhhCcCHH
Confidence            9999999999999974

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.7e-40  Score=316.42  Aligned_cols=243  Identities=28%  Similarity=0.454  Sum_probs=205.6

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEec-----
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTK-----  222 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~-----  222 (396)
                      .++|.+.+.||+|+||.||+|..+.+++.+|+|++....    .....+.+|+.+++++ +|||++++++++...     
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~   96 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG   96 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence            468999999999999999999999999999999986542    2234567789999988 899999999998653     


Q ss_pred             CeEEEEEEecCCCcHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccc
Q 016037          223 YRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK  298 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~  298 (396)
                      ..+|+||||+++++|.+++..    ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus        97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~  176 (291)
T cd06639          97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA  176 (291)
T ss_pred             CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence            368999999999999887753    4578999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCC-CccccccCCCccchhhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCC
Q 016037          299 QFDENT-RSNSMCGTLEYMSPEIVLGK-----GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLP  369 (396)
Q Consensus       299 ~~~~~~-~~~~~~gt~~y~APE~l~~~-----~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~---~~~~p  369 (396)
                      ...... ......|+..|+|||.+...     .++.++|||||||++|||++|+.||...+.......+...   .+..+
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  256 (291)
T cd06639         177 QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHP  256 (291)
T ss_pred             hcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcc
Confidence            764332 23345688999999998643     3688999999999999999999999987766655555544   22335


Q ss_pred             ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          370 AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       370 ~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ..++.++.+||.+||+.+|++||++.
T Consensus       257 ~~~~~~l~~li~~~l~~~p~~Rps~~  282 (291)
T cd06639         257 EKWCRSFNHFISQCLIKDFEARPSVT  282 (291)
T ss_pred             cccCHHHHHHHHHHhhcChhhCcCHH
Confidence            56888999999999999999999974

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-42  Score=339.96  Aligned_cols=247  Identities=22%  Similarity=0.377  Sum_probs=215.9

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCC----CcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGT----SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~----~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~  221 (396)
                      .+..+...+.+.||.|.||.||+|.+..-    .--||||..+.+..  .+..+.+..|..+|++++||||++|+|.+.+
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e  462 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE  462 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence            34555666678899999999999987432    34588998887653  3446778889999999999999999999977


Q ss_pred             cCeEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccccc
Q 016037          222 KYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~  300 (396)
                      . ..|||||+++-|.|..+++.+ ..++......|+.||+.||+|||+.++|||||..+|||+.....+||+|||+++.+
T Consensus       463 ~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~  541 (974)
T KOG4257|consen  463 Q-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYL  541 (974)
T ss_pred             c-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhc
Confidence            5 689999999999999999865 56888888999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCccc--cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHH
Q 016037          301 DENTRSNS--MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (396)
Q Consensus       301 ~~~~~~~~--~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~  376 (396)
                      .+......  ..-+..|||||.+.-..++.++|||.|||+|||++. |..||.+-...+++..|.++ +++.|+.+++.+
T Consensus       542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~L  621 (974)
T KOG4257|consen  542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPAL  621 (974)
T ss_pred             cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHH
Confidence            76654322  233578999999999999999999999999999999 99999998877777777776 899999999999


Q ss_pred             HHHHHHhhccCCCCCCCCC
Q 016037          377 HSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~RPs~s  395 (396)
                      ..|+.+||.++|.+||.+.
T Consensus       622 YslmskcWayeP~kRPrft  640 (974)
T KOG4257|consen  622 YSLMSKCWAYEPSKRPRFT  640 (974)
T ss_pred             HHHHHHHhccCcccCCcHH
Confidence            9999999999999999875

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-40  Score=310.37  Aligned_cols=237  Identities=24%  Similarity=0.382  Sum_probs=205.5

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCCC
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg  235 (396)
                      ++||+|+||.||+|.+.. ++.||+|.+......  ...+.+.+|++++++++|+||+++++++......|+||||+.++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            469999999999999987 899999998765432  34456788999999999999999999999999999999999999


Q ss_pred             cHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCc---ccccc
Q 016037          236 HLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCG  311 (396)
Q Consensus       236 ~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~---~~~~g  311 (396)
                      +|..++... ..+++..+..++.+++.||.|||+++++||||||+||+++.++.+||+|||+++........   ....+
T Consensus        78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            999988653 56788899999999999999999999999999999999999999999999999865422211   12234


Q ss_pred             CCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHHhhccCCC
Q 016037          312 TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGVNSLLSI  389 (396)
Q Consensus       312 t~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p~  389 (396)
                      +..|+|||.+.+..++.++||||||+++|||+| |..||...+.......+... .+..|..++.++.+||.+||+.+|.
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  237 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPE  237 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChh
Confidence            567999999988889999999999999999999 89999988877777776654 4566778999999999999999999


Q ss_pred             CCCCCC
Q 016037          390 SVPLLS  395 (396)
Q Consensus       390 ~RPs~s  395 (396)
                      +||++.
T Consensus       238 ~Rp~~~  243 (251)
T cd05041         238 NRPSFS  243 (251)
T ss_pred             hCcCHH
Confidence            999975

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.6e-40  Score=311.41  Aligned_cols=243  Identities=22%  Similarity=0.358  Sum_probs=207.9

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +..++|++.++||+|+||.||+|.+.. +..+|+|.+....    ...+.+.+|+.+++.++|+||+++++++.. ...|
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecC-CccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence            456789999999999999999998754 4569999887542    234567789999999999999999999887 7789


Q ss_pred             EEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          227 LVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      ++|||+++++|.+++...  ..++...++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++..+....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999999988763  356778888899999999999999999999999999999999999999999998764322


Q ss_pred             C--ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHH
Q 016037          305 R--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLL  380 (396)
Q Consensus       305 ~--~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li  380 (396)
                      .  .....++..|+|||.+....++.++|+|||||++|+|+| |..||.+.+...+...+... ....+...+.++.+++
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  236 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIM  236 (260)
T ss_pred             cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHH
Confidence            2  122345678999999998889999999999999999999 99999988887777777665 4455678999999999


Q ss_pred             HHhhccCCCCCCCCC
Q 016037          381 KGVNSLLSISVPLLS  395 (396)
Q Consensus       381 ~~~l~~~p~~RPs~s  395 (396)
                      .+||+.+|.+||++.
T Consensus       237 ~~~l~~~p~~Rp~~~  251 (260)
T cd05073         237 MRCWKNRPEERPTFE  251 (260)
T ss_pred             HHHcccCcccCcCHH
Confidence            999999999999964

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=9.9e-41  Score=319.72  Aligned_cols=242  Identities=29%  Similarity=0.445  Sum_probs=208.9

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+.....   ...+.+.+|+.+++.++||||+++++++......|+||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence            679999999999999999999999999999999876432   23455778999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC-ccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNS  308 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~-~~~  308 (396)
                      ||+++++|..++.+ ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++........ ...
T Consensus        96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  174 (297)
T cd06656          96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  174 (297)
T ss_pred             cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence            99999999888754 5678899999999999999999999999999999999999999999999999977643322 234


Q ss_pred             cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCCccCCHHHHHHHHHhhc
Q 016037          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGVNS  385 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~---~~~~p~~~s~~~~~li~~~l~  385 (396)
                      ..+++.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+.......+...   ....|..++..+++||.+||.
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  254 (297)
T cd06656         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLE  254 (297)
T ss_pred             ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHcc
Confidence            56889999999999988999999999999999999999999876654433333322   223456789999999999999


Q ss_pred             cCCCCCCCCC
Q 016037          386 LLSISVPLLS  395 (396)
Q Consensus       386 ~~p~~RPs~s  395 (396)
                      .+|.+||++.
T Consensus       255 ~~p~~Rps~~  264 (297)
T cd06656         255 MDVDRRGSAK  264 (297)
T ss_pred             CChhhCcCHH
Confidence            9999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-40  Score=309.05  Aligned_cols=237  Identities=52%  Similarity=0.933  Sum_probs=217.9

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCCCcH
Q 016037          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL  237 (396)
Q Consensus       158 IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L  237 (396)
                      ||+|+||.||++.+..+++.+|+|++++...........+..|+.++++++||||+++++.+..+...|++|||+.+++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            69999999999999999999999999887655555667788999999999999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-CCccccccCCCcc
Q 016037          238 FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNSMCGTLEYM  316 (396)
Q Consensus       238 ~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-~~~~~~~gt~~y~  316 (396)
                      .+++.....+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++...... .......++..|+
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  160 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL  160 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence            999988888999999999999999999999999999999999999999999999999999876543 2334556889999


Q ss_pred             chhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCCCCC
Q 016037          317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       317 APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs~  394 (396)
                      |||.+.+...+.++|+||||+++|+|++|+.||...+.....+.+....+.+|..++.++.++|++||+.+|++||+.
T Consensus       161 ~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~  238 (250)
T cd05123         161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGS  238 (250)
T ss_pred             ChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCc
Confidence            999999888899999999999999999999999988888888888888899999999999999999999999999997

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=9.5e-41  Score=315.13  Aligned_cols=245  Identities=21%  Similarity=0.377  Sum_probs=211.7

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~  223 (396)
                      .++|++++.||+|+||+||+|+++.     +...+++|.+....  .....+.+.+|++++++++|+||+++++++....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            4689999999999999999999764     34679999886533  2334566888999999999999999999999989


Q ss_pred             eEEEEEEecCCCcHHHHHHHhc---------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEec
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQG---------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDF  294 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Df  294 (396)
                      ..|+||||+++|+|..++....         .+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+||
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999999998766         6899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCC--CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCC--CCC
Q 016037          295 GLAKQFDENT--RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKI--KLP  369 (396)
Q Consensus       295 gla~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~~~--~~p  369 (396)
                      |++.......  ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.....+...+.....  ..+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  241 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP  241 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence            9987543221  2233456778999999988888999999999999999999 8999988877777777775544  446


Q ss_pred             ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          370 AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       370 ~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ..++..+.++|.+||+.+|.+||++.
T Consensus       242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~  267 (275)
T cd05046         242 EGCPSRLYKLMTRCWAVNPKDRPSFS  267 (275)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCCCHH
Confidence            67899999999999999999999975

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.8e-41  Score=320.82  Aligned_cols=242  Identities=27%  Similarity=0.461  Sum_probs=210.3

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      .|+..+.||+|+||.||+|.+..++..||+|.+.....  ....+.+.+|+.+++.++||||+++++++.....+|+|||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            46677889999999999999999999999999875432  2345678899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Ccccc
Q 016037          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSM  309 (396)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~~~~  309 (396)
                      |+++++|..++.. +.+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++..+.... .....
T Consensus        83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06642          83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcc
Confidence            9999999887754 578999999999999999999999999999999999999999999999999998765432 22334


Q ss_pred             ccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHHhhccCC
Q 016037          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGVNSLLS  388 (396)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p  388 (396)
                      .|+..|+|||.+.+..++.++|+||||+++|||++|+.||...+.......+... ...++..++.++.++|.+||+.+|
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  241 (277)
T cd06642         162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDP  241 (277)
T ss_pred             cCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCc
Confidence            6889999999999988999999999999999999999999887766666655544 334556789999999999999999


Q ss_pred             CCCCCCC
Q 016037          389 ISVPLLS  395 (396)
Q Consensus       389 ~~RPs~s  395 (396)
                      .+||++.
T Consensus       242 ~~Rp~~~  248 (277)
T cd06642         242 RFRPTAK  248 (277)
T ss_pred             ccCcCHH
Confidence            9999964

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-40  Score=337.53  Aligned_cols=237  Identities=20%  Similarity=0.292  Sum_probs=196.0

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      ...|.+.+.||+|+||.||+|.+..+++.||+|....         ....+|+++|++++|+||+++++++..+...++|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            3479999999999999999999999999999996432         1245799999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC--
Q 016037          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR--  305 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~--  305 (396)
                      ||++. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......  
T Consensus       239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            99996 5777776553 5689999999999999999999999999999999999999999999999999987643221  


Q ss_pred             -ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCC---CCCc---
Q 016037          306 -SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN--------RQKIQQKIIKDKI---KLPA---  370 (396)
Q Consensus       306 -~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~--------~~~i~~~i~~~~~---~~p~---  370 (396)
                       ....+||+.|||||++.+..++.++|||||||+||||++|..|+....        ...+.+.+.....   .+|.   
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~  397 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG  397 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence             234579999999999999999999999999999999999876654321        2333333332211   1111   


Q ss_pred             ----------------------------cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          371 ----------------------------FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       371 ----------------------------~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                                  .++.++.+||..||+.||.+|||+.
T Consensus       398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~  450 (461)
T PHA03211        398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAA  450 (461)
T ss_pred             hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHH
Confidence                                        2456899999999999999999964

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-42  Score=343.05  Aligned_cols=246  Identities=23%  Similarity=0.385  Sum_probs=220.2

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCC---CcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~  223 (396)
                      |..++.++.++||+|+||.|++|.|..-   -..||||+++.+....  ....|.+|+.+|.+|+|||+++||+...+ .
T Consensus       107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-q  183 (1039)
T KOG0199|consen  107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-Q  183 (1039)
T ss_pred             ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence            5556788899999999999999999753   3568999998876433  56778899999999999999999999987 6


Q ss_pred             eEEEEEEecCCCcHHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          224 RLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      ...+|+|++++|+|.+.|.+  +..|.......|+.||+.||.||.++++|||||..+|+|+-....|||+|||+.+.+.
T Consensus       184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence            78899999999999999976  4568888889999999999999999999999999999999999999999999999887


Q ss_pred             CCCCcccc----ccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHH
Q 016037          302 ENTRSNSM----CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSE  375 (396)
Q Consensus       302 ~~~~~~~~----~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~  375 (396)
                      .+...+.+    .....|+|||.+....++.++|||+|||+||||+| |+.||.+.+...|.++|.++ +++-|..+|++
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csed  343 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSED  343 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHH
Confidence            66554332    23568999999999999999999999999999999 99999999999999999865 78889999999


Q ss_pred             HHHHHHHhhccCCCCCCCCC
Q 016037          376 AHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       376 ~~~li~~~l~~~p~~RPs~s  395 (396)
                      ++++++.||..+|++||+++
T Consensus       344 IY~imk~cWah~paDRptFs  363 (1039)
T KOG0199|consen  344 IYQIMKNCWAHNPADRPTFS  363 (1039)
T ss_pred             HHHHHHHhccCCccccccHH
Confidence            99999999999999999975

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.1e-40  Score=306.51  Aligned_cols=244  Identities=33%  Similarity=0.512  Sum_probs=217.0

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec--CeEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--YRLYLV  228 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~--~~~~lV  228 (396)
                      +|.+.+.||+|++|.||+|.+..++..+++|++...... ....+.+.+|+.++++++||||+++++.+...  ..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            488899999999999999999999999999999775432 34567788999999999999999999999988  899999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC---
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR---  305 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~---  305 (396)
                      +||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........   
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999999988765543   


Q ss_pred             ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHh--CCCCCCccCCHHHHHHHHH
Q 016037          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQKIIK--DKIKLPAFLSSEAHSLLKG  382 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~-~~~i~~~i~~--~~~~~p~~~s~~~~~li~~  382 (396)
                      .....++..|+|||.+.+..++.++||||||+++|+|++|..||...+ .......+..  ....+|..++.++.+||.+
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~  239 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRK  239 (260)
T ss_pred             ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHH
Confidence            455678899999999998889999999999999999999999998765 4444444442  3456788899999999999


Q ss_pred             hhccCCCCCCCCC
Q 016037          383 VNSLLSISVPLLS  395 (396)
Q Consensus       383 ~l~~~p~~RPs~s  395 (396)
                      ||+.+|.+||++.
T Consensus       240 ~l~~~p~~Rp~~~  252 (260)
T cd06606         240 CLRRDPKKRPTAD  252 (260)
T ss_pred             hCcCChhhCCCHH
Confidence            9999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.2e-40  Score=326.91  Aligned_cols=243  Identities=27%  Similarity=0.418  Sum_probs=202.6

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec------
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------  222 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~------  222 (396)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.++++++||||++++++|...      
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4689999999999999999999999999999999865432 223345567799999999999999999988643      


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      ...|+||||+.+ +|...+...  +++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++....
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  170 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  170 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence            357999999976 676666544  88999999999999999999999999999999999999999999999999987755


Q ss_pred             CCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------------
Q 016037          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD------------------  364 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~------------------  364 (396)
                      ........++..|+|||.+.+..++.++|||||||++|+|++|+.||...+......++...                  
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (353)
T cd07850         171 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN  250 (353)
T ss_pred             CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence            54445567899999999999999999999999999999999999999887655444443321                  


Q ss_pred             ----CCC--------------C-------CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 ----KIK--------------L-------PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 ----~~~--------------~-------p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                          +..              +       +...+.++++||.+||+.||.+|||+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  306 (353)
T cd07850         251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD  306 (353)
T ss_pred             HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHH
Confidence                000              0       113466789999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.1e-40  Score=316.05  Aligned_cols=243  Identities=30%  Similarity=0.481  Sum_probs=203.2

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEe------
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQT------  221 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~------  221 (396)
                      .+.|++.+.||.|+||.||+|.+..+++.+|+|++....    .....+..|+.+++++ +|+||+++++++..      
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   90 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH   90 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence            467999999999999999999999999999999986542    2234567789999988 79999999999853      


Q ss_pred             cCeEEEEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          222 KYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                      ...+|++|||+.+|+|..++...  ..+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..
T Consensus        91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            46789999999999999888653  4578888999999999999999999999999999999999999999999999886


Q ss_pred             cCCC-CCccccccCCCccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CC-CCcc
Q 016037          300 FDEN-TRSNSMCGTLEYMSPEIVL-----GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-IK-LPAF  371 (396)
Q Consensus       300 ~~~~-~~~~~~~gt~~y~APE~l~-----~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~-~~-~p~~  371 (396)
                      .... .......|++.|+|||.+.     +..++.++|||||||++|||++|..||...........+.... .. .+..
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  250 (282)
T cd06636         171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKK  250 (282)
T ss_pred             hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccc
Confidence            5432 2234567899999999985     3467889999999999999999999998766554444443332 22 2346


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCCC
Q 016037          372 LSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       372 ~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ++.++.+||.+||+.+|.+||++.
T Consensus       251 ~~~~~~~li~~cl~~~p~~Rp~~~  274 (282)
T cd06636         251 WSKKFIDFIEGCLVKNYLSRPSTE  274 (282)
T ss_pred             cCHHHHHHHHHHhCCChhhCcCHH
Confidence            899999999999999999999964

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.8e-40  Score=319.14  Aligned_cols=242  Identities=25%  Similarity=0.369  Sum_probs=206.6

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      +.|++.+.||+|+||+||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++......|+|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            46999999999999999999999999999999987654444445566788999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHH-HhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccc
Q 016037          230 DFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (396)
Q Consensus       230 E~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~  308 (396)
                      ||+.+ ++...+. ....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......   ..
T Consensus        95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~  170 (307)
T cd06607          95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NS  170 (307)
T ss_pred             HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---CC
Confidence            99986 5555554 4567899999999999999999999999999999999999999999999999999765332   23


Q ss_pred             cccCCCccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCC-CccCCHHHHHHHHHh
Q 016037          309 MCGTLEYMSPEIVL---GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-IKL-PAFLSSEAHSLLKGV  383 (396)
Q Consensus       309 ~~gt~~y~APE~l~---~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~-~~~-p~~~s~~~~~li~~~  383 (396)
                      ..++..|+|||++.   ...++.++||||||+++|||+||+.||.+.+.......+.... ..+ +..++.++++||.+|
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  250 (307)
T cd06607         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSC  250 (307)
T ss_pred             ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHH
Confidence            46788999999884   3568899999999999999999999999887766665555442 333 345889999999999


Q ss_pred             hccCCCCCCCCC
Q 016037          384 NSLLSISVPLLS  395 (396)
Q Consensus       384 l~~~p~~RPs~s  395 (396)
                      |+.+|.+||++.
T Consensus       251 l~~~p~~Rp~~~  262 (307)
T cd06607         251 LQKIPQDRPSSE  262 (307)
T ss_pred             hcCChhhCcCHH
Confidence            999999999964

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-40  Score=305.80  Aligned_cols=244  Identities=30%  Similarity=0.531  Sum_probs=217.1

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      +|++.+.||+|++|.||++.+..+++.|++|.+...... ....+.+.+|++++++++|||++++++++.++..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            488999999999999999999999999999999876543 2445678899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC-cccc
Q 016037          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNSM  309 (396)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~-~~~~  309 (396)
                      |+++++|.+++...+.+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........ ....
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  159 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV  159 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence            999999999998888999999999999999999999999999999999999999999999999999987754433 2345


Q ss_pred             ccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hCCCCCCccCCHHHHHHHHHhhccCC
Q 016037          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII-KDKIKLPAFLSSEAHSLLKGVNSLLS  388 (396)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~-~~~~~~p~~~s~~~~~li~~~l~~~p  388 (396)
                      .++..|+|||.+.+..++.++||||||+++|+|++|+.||...+......++. .....+|..++.++.++|.+||+.+|
T Consensus       160 ~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  239 (254)
T cd06627         160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDP  239 (254)
T ss_pred             ccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCCh
Confidence            68899999999988888999999999999999999999998876655555554 34556788899999999999999999


Q ss_pred             CCCCCCC
Q 016037          389 ISVPLLS  395 (396)
Q Consensus       389 ~~RPs~s  395 (396)
                      ++||++.
T Consensus       240 ~~R~~~~  246 (254)
T cd06627         240 NLRPTAK  246 (254)
T ss_pred             hhCcCHH
Confidence            9999974

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.8e-40  Score=314.44  Aligned_cols=243  Identities=30%  Similarity=0.471  Sum_probs=206.2

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      +|++.+.||+|+||.||+|.+..+|..||+|++...... ....+.+.+|+.+++.++||||+++++++..+..+|+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            589999999999999999999999999999999765432 2334567889999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC--cc
Q 016037          231 FVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR--SN  307 (396)
Q Consensus       231 ~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~--~~  307 (396)
                      |+ +++|..++.. ...+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++........  ..
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS  158 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence            99 9999988865 35689999999999999999999999999999999999999999999999999987654331  33


Q ss_pred             ccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------CCC
Q 016037          308 SMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-------------------KIK  367 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~-------------------~~~  367 (396)
                      ...|+..|+|||.+.+. .++.++||||||+++|||++|++||.+.+.......+...                   ...
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07832         159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT  238 (286)
T ss_pred             cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence            45689999999998654 4689999999999999999999999877665555444331                   011


Q ss_pred             C-----------CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          368 L-----------PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       368 ~-----------p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +           ....+.++.+||++||+.+|.+||+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  277 (286)
T cd07832         239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAA  277 (286)
T ss_pred             CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHH
Confidence            1           124678999999999999999999975

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=7.9e-41  Score=327.11  Aligned_cols=248  Identities=23%  Similarity=0.391  Sum_probs=202.7

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEc-----CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSF  219 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~  219 (396)
                      .+..++|++.+.||+|+||+||+|.+.     .+++.||||+++...  .......+.+|+.+|..+ +||||+++++++
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (343)
T cd05103           3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC   80 (343)
T ss_pred             ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence            345578999999999999999999864     457889999997643  223345677899999999 689999999987


Q ss_pred             Ee-cCeEEEEEEecCCCcHHHHHHHhc-----------------------------------------------------
Q 016037          220 QT-KYRLYLVLDFVNGGHLFFQLYRQG-----------------------------------------------------  245 (396)
Q Consensus       220 ~~-~~~~~lV~E~~~gg~L~~~l~~~~-----------------------------------------------------  245 (396)
                      .. +..++++|||+++|+|.+++....                                                     
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (343)
T cd05103          81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD  160 (343)
T ss_pred             ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence            55 456899999999999998886431                                                     


Q ss_pred             --------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC---Cccc
Q 016037          246 --------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT---RSNS  308 (396)
Q Consensus       246 --------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~---~~~~  308 (396)
                                    .++...+..++.|++.||.|||++||+||||||+|||++.++++||+|||++.......   ....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                          35667778899999999999999999999999999999999999999999998653221   1222


Q ss_pred             cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHhC-CCCCCccCCHHHHHHHHHhhc
Q 016037          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQK-IQQKIIKD-KIKLPAFLSSEAHSLLKGVNS  385 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~-i~~~i~~~-~~~~p~~~s~~~~~li~~~l~  385 (396)
                      ..++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..... +...+..+ +...|..+++++.+++..||+
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~  320 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH  320 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence            345678999999998889999999999999999997 999998765433 33333333 456677889999999999999


Q ss_pred             cCCCCCCCCC
Q 016037          386 LLSISVPLLS  395 (396)
Q Consensus       386 ~~p~~RPs~s  395 (396)
                      .+|.+||++.
T Consensus       321 ~~p~~Rps~~  330 (343)
T cd05103         321 GEPSQRPTFS  330 (343)
T ss_pred             CChhhCcCHH
Confidence            9999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-42  Score=342.81  Aligned_cols=237  Identities=30%  Similarity=0.473  Sum_probs=207.2

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCCC
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg  235 (396)
                      -+||+|.||+||-|++..|...+|||-+....   ....+-+.+|+.+-+.|+|.|||+++|++.+.+.+-|.||-++||
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            35999999999999999999999999986432   233455788999999999999999999999999999999999999


Q ss_pred             cHHHHHHHh-cCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc-CCCcEEEEecccccccCC-CCCccccc
Q 016037          236 HLFFQLYRQ-GLF--REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD-ADGHVMLTDFGLAKQFDE-NTRSNSMC  310 (396)
Q Consensus       236 ~L~~~l~~~-~~l--~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~-~~~~ikL~Dfgla~~~~~-~~~~~~~~  310 (396)
                      +|..+++.. +++  +|..+..|..||++||.|||++.|||||||-+|+||+ ..|.+||+|||-++++.. +..+.++.
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT  737 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT  737 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence            999988766 666  7888999999999999999999999999999999996 578999999999998743 33467789


Q ss_pred             cCCCccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHH--HhCCCCCCccCCHHHHHHHHHhhc
Q 016037          311 GTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFTGG-NRQKIQQKI--IKDKIKLPAFLSSEAHSLLKGVNS  385 (396)
Q Consensus       311 gt~~y~APE~l~~--~~~~~~~DvwSlGvil~elltg~~Pf~~~-~~~~i~~~i--~~~~~~~p~~~s~~~~~li~~~l~  385 (396)
                      ||..|||||++..  .+|+.++|||||||++.||.||++||... +++..+-++  .+-.+++|..+|.++++||.+|..
T Consensus       738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFe  817 (1226)
T KOG4279|consen  738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFE  817 (1226)
T ss_pred             cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcC
Confidence            9999999999965  57999999999999999999999999874 333333332  345788999999999999999999


Q ss_pred             cCCCCCCCCC
Q 016037          386 LLSISVPLLS  395 (396)
Q Consensus       386 ~~p~~RPs~s  395 (396)
                      ++|.+|||++
T Consensus       818 pd~~~R~sA~  827 (1226)
T KOG4279|consen  818 PDPCDRPSAK  827 (1226)
T ss_pred             CCcccCccHH
Confidence            9999999975

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.4e-40  Score=319.37  Aligned_cols=246  Identities=22%  Similarity=0.376  Sum_probs=207.3

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCc----EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      +..++|+..+.||+|+||.||+|.+..+++    .+|+|.+.....  ......+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~   81 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP   81 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence            445789999999999999999999987776    468888765432  23334577899999999999999999988654


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                       ..++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus        82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence             4679999999999998887643 68899999999999999999999999999999999999999999999999998764


Q ss_pred             CCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHH
Q 016037          302 ENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (396)
Q Consensus       302 ~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~  376 (396)
                      ....   .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+.........+..+ .+..+..++.++
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDV  240 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence            3322   222345678999999998889999999999999999998 99999887766666655544 455667789999


Q ss_pred             HHHHHHhhccCCCCCCCCC
Q 016037          377 HSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~RPs~s  395 (396)
                      .++|..||..+|.+||++.
T Consensus       241 ~~li~~c~~~~p~~Rp~~~  259 (303)
T cd05110         241 YMVMVKCWMIDADSRPKFK  259 (303)
T ss_pred             HHHHHHHcCCChhhCcCHH
Confidence            9999999999999999975

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.8e-40  Score=313.91  Aligned_cols=240  Identities=27%  Similarity=0.409  Sum_probs=198.5

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEEEec--CeEEEE
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTK--YRLYLV  228 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~--~~~~lV  228 (396)
                      |++.+.||+|+||.||+|.+..+++.||+|++++... ...... ..+|+.+++++. |+||+++++++.+.  +.+++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~-~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQVN-NLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchhhh-HHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            6788999999999999999999999999999876432 122222 346888888885 99999999999887  899999


Q ss_pred             EEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCcc
Q 016037          229 LDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN  307 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~  307 (396)
                      |||+.+ ++...+.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++. +.+||+|||+++.........
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~  156 (282)
T cd07831          79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT  156 (282)
T ss_pred             EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence            999986 66666655 457899999999999999999999999999999999999999 999999999998775544444


Q ss_pred             ccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------------CCCC
Q 016037          308 SMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD------------------KIKL  368 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~------------------~~~~  368 (396)
                      ...++..|+|||.+.. ..++.++|||||||++|||++|..||.+.+..+....+...                  ...+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07831         157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF  236 (282)
T ss_pred             CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence            4568899999998754 55788999999999999999999999987766555444321                  1111


Q ss_pred             -----------CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          369 -----------PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       369 -----------p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                 ...++.++.+||++||+++|.+||++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~  274 (282)
T cd07831         237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAK  274 (282)
T ss_pred             cccccccHHHHcccccHHHHHHHHHHhccCcccccCHH
Confidence                       135789999999999999999999974

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.6e-40  Score=313.12  Aligned_cols=241  Identities=26%  Similarity=0.470  Sum_probs=211.2

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEe
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (396)
                      |++.+.||.|+||.||+|.+..+++.||+|++.....  ......+.+|+.+++.++||||+++++++..+..+|+||||
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            7788999999999999999999999999999865432  23445678899999999999999999999999999999999


Q ss_pred             cCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Cccccc
Q 016037          232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSMC  310 (396)
Q Consensus       232 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~~~~~  310 (396)
                      +++++|..++.. ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++..+.... ......
T Consensus        84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~  162 (277)
T cd06641          84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV  162 (277)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcccc
Confidence            999999887754 568899999999999999999999999999999999999999999999999987664332 223456


Q ss_pred             cCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHHhhccCCC
Q 016037          311 GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGVNSLLSI  389 (396)
Q Consensus       311 gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p~  389 (396)
                      ++..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+... ...++..++.++.++|..||+.+|.
T Consensus       163 ~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~  242 (277)
T cd06641         163 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPS  242 (277)
T ss_pred             CCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCChh
Confidence            888999999998888899999999999999999999999987777766666554 3456678899999999999999999


Q ss_pred             CCCCCC
Q 016037          390 SVPLLS  395 (396)
Q Consensus       390 ~RPs~s  395 (396)
                      +||++.
T Consensus       243 ~Rp~~~  248 (277)
T cd06641         243 FRPTAK  248 (277)
T ss_pred             hCcCHH
Confidence            999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.6e-40  Score=319.60  Aligned_cols=246  Identities=29%  Similarity=0.448  Sum_probs=204.5

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec--CeE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--YRL  225 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~--~~~  225 (396)
                      ..++|++.+.||+|+||.||+|.++.+|+.||+|+++...... .......+|+.++++++|+||+++++++...  ..+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence            4578999999999999999999999999999999987643222 1222345799999999999999999998754  568


Q ss_pred             EEEEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          226 YLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      |+||||+.+ +|..++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            999999976 67666654 4678999999999999999999999999999999999999999999999999998765432


Q ss_pred             C-ccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------------
Q 016037          305 R-SNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD------------------  364 (396)
Q Consensus       305 ~-~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~------------------  364 (396)
                      . .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+..+....+...                  
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07845         163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV  242 (309)
T ss_pred             CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence            2 223345788999999875 55789999999999999999999999998887777666542                  


Q ss_pred             -CCCCC-----------ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 -KIKLP-----------AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 -~~~~p-----------~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                       .+.++           ...++++.+||++||+.||++|||+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~  285 (309)
T cd07845         243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAE  285 (309)
T ss_pred             ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHH
Confidence             11111           13589999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.3e-40  Score=306.62  Aligned_cols=244  Identities=32%  Similarity=0.564  Sum_probs=217.8

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      +|++.+.||+|+||.||++.+..++..||+|++...... ......+.+|+++++.++|||++++.+.+......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            588999999999999999999999999999999765432 3445567889999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-C
Q 016037          231 FVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-R  305 (396)
Q Consensus       231 ~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~  305 (396)
                      |+++++|...+.+.    ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  159 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL  159 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence            99999999888764    678999999999999999999999999999999999999999999999999998765443 2


Q ss_pred             ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHhh
Q 016037          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-IKLPAFLSSEAHSLLKGVN  384 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~-~~~p~~~s~~~~~li~~~l  384 (396)
                      .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+...+...+.... ..+|..++.++.++|++||
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  239 (258)
T cd08215         160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLL  239 (258)
T ss_pred             ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence            344578899999999998889999999999999999999999999888887777777653 4567789999999999999


Q ss_pred             ccCCCCCCCCC
Q 016037          385 SLLSISVPLLS  395 (396)
Q Consensus       385 ~~~p~~RPs~s  395 (396)
                      +.+|++||++.
T Consensus       240 ~~~p~~Rp~~~  250 (258)
T cd08215         240 QKDPEERPSIA  250 (258)
T ss_pred             CCChhhCcCHH
Confidence            99999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.4e-40  Score=310.38  Aligned_cols=244  Identities=27%  Similarity=0.417  Sum_probs=203.2

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .+++.....||+|+||.||+|.+..++..||+|.+....   ....+.+.+|+.+++.++|+||+++++++..+...+++
T Consensus         7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            344555568999999999999999999999999887543   23455678899999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHh-cCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC-CCcEEEEecccccccCCCC
Q 016037          229 LDFVNGGHLFFQLYRQ-GLF--REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~l--~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~-~~~ikL~Dfgla~~~~~~~  304 (396)
                      +||+++++|..++... ..+  ++..+..++.|++.||.|||++||+||||||+||+++. ++.++|+|||++.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~  163 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN  163 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence            9999999999988764 455  78888889999999999999999999999999999976 6799999999997654322


Q ss_pred             -CccccccCCCccchhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH-HHHhCCCCCCccCCHHHHH
Q 016037          305 -RSNSMCGTLEYMSPEIVLGK--GHDKAADWWSVGILLFEMLTGQPPFTGGNRQK--IQQ-KIIKDKIKLPAFLSSEAHS  378 (396)
Q Consensus       305 -~~~~~~gt~~y~APE~l~~~--~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~--i~~-~i~~~~~~~p~~~s~~~~~  378 (396)
                       ......|++.|+|||.+.+.  .++.++||||||+++|+|++|+.||.......  ... ........+|..++.++++
T Consensus       164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (268)
T cd06624         164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKN  243 (268)
T ss_pred             CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHH
Confidence             23344688999999998664  37899999999999999999999997643222  111 1223345678889999999


Q ss_pred             HHHHhhccCCCCCCCCC
Q 016037          379 LLKGVNSLLSISVPLLS  395 (396)
Q Consensus       379 li~~~l~~~p~~RPs~s  395 (396)
                      |+++||+.+|.+||++.
T Consensus       244 li~~~l~~~p~~Rpt~~  260 (268)
T cd06624         244 FILRCFEPDPDKRASAH  260 (268)
T ss_pred             HHHHHcCCCchhCCCHH
Confidence            99999999999999964

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=8.2e-41  Score=314.31  Aligned_cols=239  Identities=24%  Similarity=0.400  Sum_probs=203.6

Q ss_pred             eEecccCceEEEEEEEcCCC------cEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          156 KVVGQGAFAKVYQVRRIGTS------EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      +.||+|+||.||+|.++...      ..+|+|.+....  .......+.+|+.+++.++||||+++++++......+++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            36899999999999987544      679999886542  1233455778999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-----cEEEEecccc
Q 016037          230 DFVNGGHLFFQLYRQ-------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-----HVMLTDFGLA  297 (396)
Q Consensus       230 E~~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~-----~ikL~Dfgla  297 (396)
                      ||+++++|..++...       ..+++..+..++.|++.||.|||+++++|+||||+||+++.++     .++|+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999988643       3367788889999999999999999999999999999999887     8999999999


Q ss_pred             cccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccC
Q 016037          298 KQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFL  372 (396)
Q Consensus       298 ~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~  372 (396)
                      +.......   .....++..|+|||.+.+..++.++|||||||++|||+| |+.||...+..+....+..+ .+..+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENC  238 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccc
Confidence            76543221   123345688999999999889999999999999999998 99999988877777776654 56777889


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCC
Q 016037          373 SSEAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       373 s~~~~~li~~~l~~~p~~RPs~s~  396 (396)
                      +.++.+||.+||+.+|.+||++++
T Consensus       239 ~~~~~~li~~~l~~~p~~Rp~~~~  262 (269)
T cd05044         239 PDKIYQLMTNCWAQDPSERPTFDR  262 (269)
T ss_pred             hHHHHHHHHHHcCCCcccCCCHHH
Confidence            999999999999999999999753

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.4e-40  Score=308.14  Aligned_cols=243  Identities=30%  Similarity=0.523  Sum_probs=216.0

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      +|++.++||+|+||.||++.++.+++.+|+|.+....... .....+.+|+.+++.++|+||+++++++......|+|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            5889999999999999999999999999999998755433 334556779999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCc
Q 016037          231 FVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS  306 (396)
Q Consensus       231 ~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~  306 (396)
                      |+++++|..++.+    ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++...... ..
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~  158 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MA  158 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Cc
Confidence            9999999988866    356889999999999999999999999999999999999999999999999999876544 33


Q ss_pred             cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHHHHhhc
Q 016037          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAHSLLKGVNS  385 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~-~~p~~~s~~~~~li~~~l~  385 (396)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..++...+..... .++..++.+++++|++||+
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  238 (256)
T cd08530         159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQ  238 (256)
T ss_pred             ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcC
Confidence            345688999999999998899999999999999999999999999888887777776643 5667899999999999999


Q ss_pred             cCCCCCCCCC
Q 016037          386 LLSISVPLLS  395 (396)
Q Consensus       386 ~~p~~RPs~s  395 (396)
                      .+|.+||++.
T Consensus       239 ~~p~~Rp~~~  248 (256)
T cd08530         239 VKPKLRPNCD  248 (256)
T ss_pred             CCcccCCCHH
Confidence            9999999964

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.7e-41  Score=315.64  Aligned_cols=233  Identities=21%  Similarity=0.322  Sum_probs=195.7

Q ss_pred             eEecccCceEEEEEEEcCCCcE-------EEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEI-------YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~-------vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      +.||+|+||.||+|.+..++..       +|+|.+....   ....+.+.+|+.+++.++||||+++++++..+...++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            3699999999999998765443       8888875432   33445677899999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc--------EEEEecccccc
Q 016037          229 LDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH--------VMLTDFGLAKQ  299 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~--------ikL~Dfgla~~  299 (396)
                      |||+++|+|..++..++ .+++..+..++.||+.||+|||++||+||||||+||+++.++.        ++++|||++..
T Consensus        78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            99999999999987654 5889999999999999999999999999999999999988765        69999999876


Q ss_pred             cCCCCCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhCCCCCCccCCHHHH
Q 016037          300 FDENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTG-QPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAH  377 (396)
Q Consensus       300 ~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg-~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~  377 (396)
                      ....   ....++..|+|||.+.+ ..++.++||||||+++|||++| ..||...+.... ..+...+..+|...+.++.
T Consensus       158 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  233 (258)
T cd05078         158 VLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDRHQLPAPKWTELA  233 (258)
T ss_pred             cCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHccccCCCCCcHHHH
Confidence            5332   33567889999999986 4578999999999999999998 566666555443 3344556778888899999


Q ss_pred             HHHHHhhccCCCCCCCCC
Q 016037          378 SLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       378 ~li~~~l~~~p~~RPs~s  395 (396)
                      +||++||+.+|++|||++
T Consensus       234 ~li~~~l~~~p~~Rps~~  251 (258)
T cd05078         234 NLINQCMDYEPDFRPSFR  251 (258)
T ss_pred             HHHHHHhccChhhCCCHH
Confidence            999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.8e-40  Score=309.80  Aligned_cols=239  Identities=23%  Similarity=0.406  Sum_probs=205.9

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +..++|++.+.||+|+||.||++..  +++.||+|.++...     ..+.+.+|+.+++.++||||+++++++... ..+
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   74 (254)
T cd05083           3 LNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLY   74 (254)
T ss_pred             ccHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcE
Confidence            3457899999999999999999875  67789999986532     234577899999999999999999998765 479


Q ss_pred             EEEEecCCCcHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          227 LVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      ++|||+.+++|..++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... 
T Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-  153 (254)
T cd05083          75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-  153 (254)
T ss_pred             EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence            9999999999999887653  4788889999999999999999999999999999999999999999999999764332 


Q ss_pred             CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHH
Q 016037          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKG  382 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~~  382 (396)
                       ......+..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+.++ ++..+..++.++.+|+.+
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  232 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTS  232 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHH
Confidence             122334578999999988889999999999999999998 99999998888877777665 445567889999999999


Q ss_pred             hhccCCCCCCCCC
Q 016037          383 VNSLLSISVPLLS  395 (396)
Q Consensus       383 ~l~~~p~~RPs~s  395 (396)
                      ||+.+|.+||++.
T Consensus       233 ~l~~~p~~Rp~~~  245 (254)
T cd05083         233 CWETEPKKRPSFH  245 (254)
T ss_pred             HcCCChhhCcCHH
Confidence            9999999999974

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.6e-40  Score=316.89  Aligned_cols=245  Identities=31%  Similarity=0.490  Sum_probs=205.9

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec--CeEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--YRLY  226 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~--~~~~  226 (396)
                      .++|++.+.||+|+||.||+|.++.+++.+|+|.++..... ......+.+|+.++++++||||+++++++...  ..+|
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence            35799999999999999999999999999999999765432 22233456799999999999999999998877  8999


Q ss_pred             EEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-C
Q 016037          227 LVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-T  304 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-~  304 (396)
                      +||||+.+ +|...+... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++...... .
T Consensus        83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK  161 (293)
T ss_pred             EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence            99999985 787777654 45899999999999999999999999999999999999999999999999999876544 2


Q ss_pred             CccccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------
Q 016037          305 RSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-------------------  364 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~-------------------  364 (396)
                      ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||...+......++...                   
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
T cd07843         162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK  241 (293)
T ss_pred             ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence            23345678899999998764 4689999999999999999999999988776666554321                   


Q ss_pred             ------------CCCCCcc-CCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 ------------KIKLPAF-LSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 ------------~~~~p~~-~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                  .-.++.. ++..+.+||++||+.+|++|||+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~  285 (293)
T cd07843         242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAE  285 (293)
T ss_pred             ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHH
Confidence                        0123333 689999999999999999999974

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.9e-40  Score=316.93  Aligned_cols=244  Identities=27%  Similarity=0.395  Sum_probs=205.5

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc--hhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM--EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      +|++.+.||+|+||.||+|.+..+++.||+|.++.....  .......+..|+.+++.++|+||+++++++.+...+|+|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            488899999999999999999999999999999875533  122344567799999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Cc
Q 016037          229 LDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RS  306 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~  306 (396)
                      |||+ +++|..++.... .+++..++.++.||++||.|||++|++|+||+|+||+++.++.++|+|||+++...... ..
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence            9999 889999888766 79999999999999999999999999999999999999999999999999998765432 22


Q ss_pred             cccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------------------
Q 016037          307 NSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK--------------------  365 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~--------------------  365 (396)
                      ....+++.|+|||.+.+ ..++.++|||||||++|||++|..||.+.+..+...++....                    
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T cd07841         160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF  239 (298)
T ss_pred             cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence            33456788999999865 457899999999999999999988888776655555553210                    


Q ss_pred             ---CC-----CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 ---IK-----LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 ---~~-----~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                         ..     +...++.++.+||.+||+++|.+|||+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~  277 (298)
T cd07841         240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITAR  277 (298)
T ss_pred             cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHH
Confidence               00     1134578999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-41  Score=327.83  Aligned_cols=248  Identities=24%  Similarity=0.312  Sum_probs=201.5

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC-
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-  223 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~-  223 (396)
                      ....+++|.-.+.||+|+||.||+|....+ ..||||++.......   ...+.+|+.+|.+++|||+|+|+|+|.+.+ 
T Consensus        70 l~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~  145 (361)
T KOG1187|consen   70 LRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGE  145 (361)
T ss_pred             HHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCc
Confidence            334567899999999999999999999665 789999877654321   333899999999999999999999999988 


Q ss_pred             eEEEEEEecCCCcHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCCEEEcCCCcEEEEeccccc
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHAN---GIMHRDLKPENILLDADGHVMLTDFGLAK  298 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~---~iiHrDlkp~NILl~~~~~ikL~Dfgla~  298 (396)
                      +.+||+|||++|+|.+++....  .+++.....|+.++++||+|||+.   .|||||||+.|||+|++.++||+|||+|+
T Consensus       146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~  225 (361)
T KOG1187|consen  146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAK  225 (361)
T ss_pred             eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcc
Confidence            5999999999999999998765  889999999999999999999996   39999999999999999999999999997


Q ss_pred             ccCC-CCCcccc-ccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---H----HHHHHHHHhCC----
Q 016037          299 QFDE-NTRSNSM-CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN---R----QKIQQKIIKDK----  365 (396)
Q Consensus       299 ~~~~-~~~~~~~-~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~---~----~~i~~~i~~~~----  365 (396)
                      .... ....... .||..|+|||.+.....+.++||||||++|+||+||+.+.....   .    +.....+.+.+    
T Consensus       226 ~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~ei  305 (361)
T KOG1187|consen  226 LGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREI  305 (361)
T ss_pred             cCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhe
Confidence            6654 3333333 89999999999998889999999999999999999998887532   1    11111222211    


Q ss_pred             --CCCC-ccCC--H---HHHHHHHHhhccCCCCCCCCCC
Q 016037          366 --IKLP-AFLS--S---EAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       366 --~~~p-~~~s--~---~~~~li~~~l~~~p~~RPs~s~  396 (396)
                        ..+. ....  .   .+..+-..|++.+|.+||++++
T Consensus       306 iD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~  344 (361)
T KOG1187|consen  306 VDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQ  344 (361)
T ss_pred             eCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHH
Confidence              1222 2223  2   3567778999999999999864

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.7e-40  Score=308.22  Aligned_cols=244  Identities=32%  Similarity=0.559  Sum_probs=211.8

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      +|.+.+.||+|+||.||+|.++.++..+|+|.+....... ...+.+.+|+.+++.++|+||+++++.+.....+|+|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            5889999999999999999999999999999987654322 334567789999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc-EEEEecccccccCCCCC-c
Q 016037          231 FVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH-VMLTDFGLAKQFDENTR-S  306 (396)
Q Consensus       231 ~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~-ikL~Dfgla~~~~~~~~-~  306 (396)
                      |+++++|..++.+..  .+++..+..++.|++.||.|||+++++|+||||+||+++.++. +||+|||.+........ .
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence            999999999887643  4789999999999999999999999999999999999998864 69999999987654332 2


Q ss_pred             cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHHHHhhc
Q 016037          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAHSLLKGVNS  385 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~-~~p~~~s~~~~~li~~~l~  385 (396)
                      ....|++.|+|||.+.+..++.++|+||||+++|||++|+.||...+..+....+..... .++..++.++.++|.+||+
T Consensus       160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  239 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFK  239 (257)
T ss_pred             cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhc
Confidence            234588999999999888899999999999999999999999998877776666665533 4566789999999999999


Q ss_pred             cCCCCCCCCC
Q 016037          386 LLSISVPLLS  395 (396)
Q Consensus       386 ~~p~~RPs~s  395 (396)
                      .+|.+|||+.
T Consensus       240 ~~p~~Rpt~~  249 (257)
T cd08225         240 VSPRDRPSIT  249 (257)
T ss_pred             cChhhCcCHH
Confidence            9999999964

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2e-40  Score=319.91  Aligned_cols=235  Identities=26%  Similarity=0.442  Sum_probs=184.5

Q ss_pred             EeEecccCceEEEEEEEc--CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe--cCeEEEEEE
Q 016037          155 LKVVGQGAFAKVYQVRRI--GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KYRLYLVLD  230 (396)
Q Consensus       155 ~~~IG~G~fG~Vy~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~--~~~~~lV~E  230 (396)
                      .++||+|+||+||+|+++  .+++.||+|.+.....     .....+|+.+|+.++||||+++++++..  ...+|++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            357999999999999976  4678899999875432     2235679999999999999999999854  467899999


Q ss_pred             ecCCCcHHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE----cCCCcEEEEecccc
Q 016037          231 FVNGGHLFFQLYRQ---------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL----DADGHVMLTDFGLA  297 (396)
Q Consensus       231 ~~~gg~L~~~l~~~---------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl----~~~~~ikL~Dfgla  297 (396)
                      |+.+ +|..++...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||++
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            9876 676666432         258899999999999999999999999999999999999    45678999999999


Q ss_pred             cccCCCC----CccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHh
Q 016037          298 KQFDENT----RSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ---------KIQQKIIK  363 (396)
Q Consensus       298 ~~~~~~~----~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~---------~i~~~i~~  363 (396)
                      +.+....    ......||+.|||||++.+ ..++.++|||||||++|||++|+.||...+..         .....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  239 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence            8764322    2345678999999999977 45899999999999999999999999754321         11111111


Q ss_pred             C----------------------------CCC----------CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          364 D----------------------------KIK----------LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       364 ~----------------------------~~~----------~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .                            ...          .....+.++.+||++||+.||.+|||+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~  309 (317)
T cd07868         240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE  309 (317)
T ss_pred             hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHH
Confidence            0                            000          0012356789999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.5e-40  Score=309.96  Aligned_cols=237  Identities=22%  Similarity=0.293  Sum_probs=192.3

Q ss_pred             eEecccCceEEEEEEEcC--CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecC
Q 016037          156 KVVGQGAFAKVYQVRRIG--TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVN  233 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  233 (396)
                      +.||+|+||.||+|.+..  ++..+|+|.++....  ......+.+|+.+++.++||||+++++++.+...+++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            368999999999998753  456799998876542  2233457789999999999999999999999999999999999


Q ss_pred             CCcHHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC---C
Q 016037          234 GGHLFFQLYRQG-----LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT---R  305 (396)
Q Consensus       234 gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~---~  305 (396)
                      +|+|.+++....     ..++..+..++.|++.||.|||+++++||||||+||+++.++++||+|||+++......   .
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999998886532     34566778899999999999999999999999999999999999999999997543221   1


Q ss_pred             ccccccCCCccchhhhcCC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCC-----Ccc
Q 016037          306 SNSMCGTLEYMSPEIVLGK-------GHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKL-----PAF  371 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~-------~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~-----p~~  371 (396)
                      .....|+..|+|||++.+.       .++.++||||||+++|||++ |+.||...+..+........ ...+     ...
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP  238 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence            2334678899999998642       35789999999999999997 99999887766655444332 2222     235


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCCC
Q 016037          372 LSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       372 ~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .+..+.++|+.|+ .+|.+|||+.
T Consensus       239 ~~~~~~~l~~~c~-~~P~~Rpt~~  261 (269)
T cd05087         239 LSDRWYEVMQFCW-LQPEQRPSAE  261 (269)
T ss_pred             CChHHHHHHHHHh-cCcccCCCHH
Confidence            7889999999999 6899999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.4e-40  Score=308.91  Aligned_cols=238  Identities=21%  Similarity=0.325  Sum_probs=197.0

Q ss_pred             eEecccCceEEEEEEEcC---CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEE-ecCeEEEEEEe
Q 016037          156 KVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ-TKYRLYLVLDF  231 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~-~~~~~~lV~E~  231 (396)
                      +.||+|+||.||+|.+..   .+..+|+|.+....  .....+.+.+|+.+++.++||||+++++.+. .....+++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            468999999999998754   34579999875422  2334556778999999999999999999765 45568999999


Q ss_pred             cCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-----C
Q 016037          232 VNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-----R  305 (396)
Q Consensus       232 ~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-----~  305 (396)
                      +.+|+|..++.+. ....+..+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||+++......     .
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence            9999999988764 345677778889999999999999999999999999999999999999999997653321     1


Q ss_pred             ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHHh
Q 016037          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGV  383 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~~~  383 (396)
                      .....++..|+|||.+.+..++.++|||||||++|||++ |.+||...+..++...+... ....+..++..+.+++.+|
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  238 (262)
T cd05058         159 HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSC  238 (262)
T ss_pred             cccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHH
Confidence            123345778999999988889999999999999999999 67788887777777776665 3455677899999999999


Q ss_pred             hccCCCCCCCCC
Q 016037          384 NSLLSISVPLLS  395 (396)
Q Consensus       384 l~~~p~~RPs~s  395 (396)
                      |..+|++||++.
T Consensus       239 l~~~p~~Rp~~~  250 (262)
T cd05058         239 WHPKPEMRPTFS  250 (262)
T ss_pred             cCCChhhCCCHH
Confidence            999999999975

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.9e-40  Score=311.37  Aligned_cols=243  Identities=22%  Similarity=0.354  Sum_probs=198.6

Q ss_pred             CCeEEEeEecccCceEEEEEEE----cCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe--cC
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRR----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KY  223 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~----~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~--~~  223 (396)
                      .+|++++.||+|+||.||+|..    ..+++.||+|.+....   ....+.+.+|+++++.++||||+++++++..  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            5799999999999999999984    4578899999987543   3445667889999999999999999987743  35


Q ss_pred             eEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      .+++||||+++++|..++.+. ..+++..++.++.|++.||.|||++|++||||||+||+++.++++||+|||+++....
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            689999999999999988764 4689999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCc----cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHH
Q 016037          303 NTRS----NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ----------------KIQQKII  362 (396)
Q Consensus       303 ~~~~----~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~----------------~i~~~i~  362 (396)
                      ....    ....++..|+|||.+.+..++.++||||||+++|||++|..++......                .+...+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence            3221    1122345699999999888999999999999999999988776543211                1111111


Q ss_pred             hC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          363 KD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       363 ~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .. .+..+..++.++.+||.+||+.+|.+|||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~  274 (284)
T cd05081         241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFS  274 (284)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence            11 3345567899999999999999999999974

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.9e-40  Score=313.18  Aligned_cols=244  Identities=26%  Similarity=0.381  Sum_probs=196.1

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|++.+.||+|+||.||+|.+..++..||+|++.....  ......+.+|+.+++.++|+||+++++++..+...|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence            3679999999999999999999999999999999876432  12223456799999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Cc
Q 016037          229 LDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RS  306 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~  306 (396)
                      |||+.+ ++...+.. ...+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++...... ..
T Consensus        82 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  160 (291)
T cd07870          82 FEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY  160 (291)
T ss_pred             EecccC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence            999975 55555543 4567888899999999999999999999999999999999999999999999997643222 23


Q ss_pred             cccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhC-C------------------
Q 016037          307 NSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNR-QKIQQKIIKD-K------------------  365 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~-~~i~~~i~~~-~------------------  365 (396)
                      ....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+. .+...++... .                  
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP  240 (291)
T ss_pred             CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence            34567899999999876 4578999999999999999999999986543 2222222110 0                  


Q ss_pred             ----CCCCc---------cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 ----IKLPA---------FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 ----~~~p~---------~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                          ...+.         ..+.++.+||++||..||.+|||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~  283 (291)
T cd07870         241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQ  283 (291)
T ss_pred             hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHH
Confidence                00000         1257899999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-40  Score=312.48  Aligned_cols=242  Identities=26%  Similarity=0.476  Sum_probs=207.0

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC---CCCeeeeeEEEEecCeEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD---HPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~---HpnIv~l~~~~~~~~~~~l  227 (396)
                      .|++.+.||+|+||.||+|.+..+++.||+|+++...  .....+.+.+|+.+++.++   |||++++++++..+...|+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            4788899999999999999999999999999987643  2334456778999999986   9999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC-c
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-S  306 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~-~  306 (396)
                      +|||+++++|..++.. +.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence            9999999999888765 5789999999999999999999999999999999999999999999999999987654332 3


Q ss_pred             cccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCc-cCCHHHHHHHHHh
Q 016037          307 NSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-IKLPA-FLSSEAHSLLKGV  383 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~-~~~p~-~~s~~~~~li~~~  383 (396)
                      ....|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+.......+.... ..++. .++.++.++|..|
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAAC  238 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHH
Confidence            44568999999999875 457899999999999999999999998877666555444432 23333 3789999999999


Q ss_pred             hccCCCCCCCCC
Q 016037          384 NSLLSISVPLLS  395 (396)
Q Consensus       384 l~~~p~~RPs~s  395 (396)
                      |+.+|.+||+..
T Consensus       239 l~~~p~~R~~~~  250 (277)
T cd06917         239 LDEEPKERLSAE  250 (277)
T ss_pred             cCCCcccCcCHH
Confidence            999999999863

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=9.3e-40  Score=302.06  Aligned_cols=242  Identities=35%  Similarity=0.524  Sum_probs=211.4

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      +|.+.+.||+|++|.||++.+..+++.+++|++.....   ...+.+.+|+.++++++|+||+++++++......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            58899999999999999999999999999999976542   345667889999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCcccc
Q 016037          231 FVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM  309 (396)
Q Consensus       231 ~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~  309 (396)
                      |+++++|.+++... ..+++..++.++.|++.||.+||.+|++||||+|+||+++.++.++|+|||.+............
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  157 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM  157 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccce
Confidence            99999999888776 67899999999999999999999999999999999999999999999999999877654434556


Q ss_pred             ccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCc--cCCHHHHHHHHHhhcc
Q 016037          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-KIKLPA--FLSSEAHSLLKGVNSL  386 (396)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~-~~~~p~--~~s~~~~~li~~~l~~  386 (396)
                      .++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+... ...++.  .++.++.++|++||+.
T Consensus       158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  237 (253)
T cd05122         158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQK  237 (253)
T ss_pred             ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccC
Confidence            7889999999999888999999999999999999999999887555444444432 333333  3489999999999999


Q ss_pred             CCCCCCCCC
Q 016037          387 LSISVPLLS  395 (396)
Q Consensus       387 ~p~~RPs~s  395 (396)
                      +|++|||+.
T Consensus       238 ~p~~R~t~~  246 (253)
T cd05122         238 NPEKRPTAE  246 (253)
T ss_pred             ChhhCCCHH
Confidence            999999974

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=6.3e-40  Score=312.31  Aligned_cols=244  Identities=45%  Similarity=0.839  Sum_probs=209.3

Q ss_pred             CeEEEeEecccCceEEEEEEEc---CCCcEEEEEEeeccccch-hhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCeE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIME-KNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~---~~~~~vAvK~i~~~~~~~-~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~  225 (396)
                      +|++.+.||.|+||.||+|.+.   .+|+.||+|+++...... ....+.+.+|+++++.+ +|+||++++++++....+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4889999999999999999885   478999999997643222 23345677899999999 599999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-  304 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-  304 (396)
                      |+||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+|||++.++++||+|||++....... 
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  160 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV  160 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence            9999999999999999888889999999999999999999999999999999999999999999999999998764432 


Q ss_pred             -CccccccCCCccchhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCCCCCccCCHHHH
Q 016037          305 -RSNSMCGTLEYMSPEIVLGK--GHDKAADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKDKIKLPAFLSSEAH  377 (396)
Q Consensus       305 -~~~~~~gt~~y~APE~l~~~--~~~~~~DvwSlGvil~elltg~~Pf~~~----~~~~i~~~i~~~~~~~p~~~s~~~~  377 (396)
                       ......|+..|+|||.+.+.  .++.++||||||+++|+|++|+.||...    ....+...+......+|..++..+.
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (290)
T cd05613         161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK  240 (290)
T ss_pred             cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHH
Confidence             22345689999999998753  4678999999999999999999999743    3345555555566677888999999


Q ss_pred             HHHHHhhccCCCCCCCC
Q 016037          378 SLLKGVNSLLSISVPLL  394 (396)
Q Consensus       378 ~li~~~l~~~p~~RPs~  394 (396)
                      +|+++||+.+|.+||+.
T Consensus       241 ~ll~~~l~~~p~~R~~~  257 (290)
T cd05613         241 DIIQRLLMKDPKKRLGC  257 (290)
T ss_pred             HHHHHHhcCCHHHhcCC
Confidence            99999999999999853

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=9.8e-41  Score=319.11  Aligned_cols=241  Identities=25%  Similarity=0.419  Sum_probs=207.4

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      .|.....||+|+||.||++.+..++..||+|.+....   ....+.+.+|+.+++.++||||+++++.+......|+|||
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e   99 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME   99 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence            4555677999999999999999999999999986533   2345567889999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Ccccc
Q 016037          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSM  309 (396)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~~~~  309 (396)
                      |+++++|..++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++....... .....
T Consensus       100 ~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~  178 (292)
T cd06658         100 FLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL  178 (292)
T ss_pred             CCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCcee
Confidence            9999999887754 568999999999999999999999999999999999999999999999999987653322 22345


Q ss_pred             ccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCCccCCHHHHHHHHHhhcc
Q 016037          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGVNSL  386 (396)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~---~~~~p~~~s~~~~~li~~~l~~  386 (396)
                      .|+..|+|||.+.+..++.++||||||+++|||++|+.||.+.+.......+...   .+.....++..+.+||..||..
T Consensus       179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  258 (292)
T cd06658         179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVR  258 (292)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccC
Confidence            6899999999998888999999999999999999999999988776666665543   2222346799999999999999


Q ss_pred             CCCCCCCCC
Q 016037          387 LSISVPLLS  395 (396)
Q Consensus       387 ~p~~RPs~s  395 (396)
                      +|.+|||+.
T Consensus       259 ~P~~Rpt~~  267 (292)
T cd06658         259 EPSQRATAQ  267 (292)
T ss_pred             ChhHCcCHH
Confidence            999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7.1e-40  Score=311.85  Aligned_cols=241  Identities=27%  Similarity=0.427  Sum_probs=209.1

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      .|...+.||+|++|.||++.+..+++.+++|++....   ....+.+.+|+.+++.++||||+++++++......|+++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            4556679999999999999999999999999886432   2334557789999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Ccccc
Q 016037          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSM  309 (396)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~~~~  309 (396)
                      |+.+++|.+++.. +.+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++....... .....
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~  175 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL  175 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence            9999999988877 678999999999999999999999999999999999999999999999999887654322 22345


Q ss_pred             ccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---CCccCCHHHHHHHHHhhcc
Q 016037          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK---LPAFLSSEAHSLLKGVNSL  386 (396)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~---~p~~~s~~~~~li~~~l~~  386 (396)
                      .|+..|+|||.+.+..++.++||||||+++|||++|+.||...+......++......   .+..++..+.+||.+||+.
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  255 (285)
T cd06648         176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVR  255 (285)
T ss_pred             cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHccc
Confidence            6899999999998888999999999999999999999999988877777777665322   2334889999999999999


Q ss_pred             CCCCCCCCC
Q 016037          387 LSISVPLLS  395 (396)
Q Consensus       387 ~p~~RPs~s  395 (396)
                      +|.+||++.
T Consensus       256 ~p~~Rpt~~  264 (285)
T cd06648         256 DPAQRATAA  264 (285)
T ss_pred             ChhhCcCHH
Confidence            999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.1e-40  Score=313.69  Aligned_cols=244  Identities=22%  Similarity=0.343  Sum_probs=201.1

Q ss_pred             CCeEEEeEecccCceEEEEEEE----cCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec--C
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRR----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--Y  223 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~----~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~--~  223 (396)
                      ..|++++.||+|+||.||++.+    ..++..||+|.++...  .....+.+.+|+.+++.++||||+++++++...  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            3578999999999999999985    4568889999987543  234456688999999999999999999998775  5


Q ss_pred             eEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      ..++||||++|++|..++.+. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.+..
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            789999999999999988665 3578999999999999999999999999999999999999999999999999987643


Q ss_pred             CCC----ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------------HHHHHHHHHh
Q 016037          303 NTR----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN---------------RQKIQQKIIK  363 (396)
Q Consensus       303 ~~~----~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~---------------~~~i~~~i~~  363 (396)
                      ...    .....++..|+|||.+.+..++.++||||||+++|||+|++.|+....               .......+..
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            321    223456778999999988889999999999999999999877653311               1111122222


Q ss_pred             -CCCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          364 -DKIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       364 -~~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                       ...+.+..++.++.+||.+||+.+|.+||++.
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~  274 (284)
T cd05079         242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQ  274 (284)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCCcccCcCHH
Confidence             23455678999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.7e-40  Score=318.20  Aligned_cols=240  Identities=25%  Similarity=0.433  Sum_probs=206.6

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEe
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (396)
                      |+....||+|+||.||+|.+..+++.||+|++.....   ...+.+.+|+.+++.++||||+++++++..+...|+++||
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~   99 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF   99 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence            4455679999999999999999999999999865432   2345577899999999999999999999999999999999


Q ss_pred             cCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Cccccc
Q 016037          232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSMC  310 (396)
Q Consensus       232 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~~~~~  310 (396)
                      +++++|..++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++..+.... .....+
T Consensus       100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~  178 (297)
T cd06659         100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV  178 (297)
T ss_pred             CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccccee
Confidence            999999876644 568999999999999999999999999999999999999999999999999997654332 234467


Q ss_pred             cCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---CCCCccCCHHHHHHHHHhhccC
Q 016037          311 GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLPAFLSSEAHSLLKGVNSLL  387 (396)
Q Consensus       311 gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~---~~~p~~~s~~~~~li~~~l~~~  387 (396)
                      |+..|+|||.+.+..++.++|||||||++|||++|+.||...+.......+....   ...+..++.++.++|++||+.+
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~  258 (297)
T cd06659         179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTRE  258 (297)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCC
Confidence            8999999999998889999999999999999999999999877666666555432   2334568899999999999999


Q ss_pred             CCCCCCCC
Q 016037          388 SISVPLLS  395 (396)
Q Consensus       388 p~~RPs~s  395 (396)
                      |.+||++.
T Consensus       259 P~~Rps~~  266 (297)
T cd06659         259 PQERATAQ  266 (297)
T ss_pred             cccCcCHH
Confidence            99999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=5.9e-40  Score=308.96  Aligned_cols=237  Identities=22%  Similarity=0.330  Sum_probs=191.4

Q ss_pred             eEecccCceEEEEEEEcC--CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecC
Q 016037          156 KVVGQGAFAKVYQVRRIG--TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVN  233 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  233 (396)
                      +.||+|+||+||+|....  ....+|+|.+....  .......+.+|+.+++.++||||+++++.+.....+|+||||++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence            369999999999997543  34568888776433  23334557789999999999999999999999999999999999


Q ss_pred             CCcHHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC---C
Q 016037          234 GGHLFFQLYRQG-----LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT---R  305 (396)
Q Consensus       234 gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~---~  305 (396)
                      +|+|..++....     ...+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......   .
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999999887643     24567788899999999999999999999999999999999999999999987543221   1


Q ss_pred             ccccccCCCccchhhhcC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCC-----CCcc
Q 016037          306 SNSMCGTLEYMSPEIVLG-------KGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIK-----LPAF  371 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~-------~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~-----~p~~  371 (396)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |..||......+....+... ..+     ++..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK  238 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence            223345678999999743       356789999999999999999 88999887766655555443 322     3346


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCCC
Q 016037          372 LSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       372 ~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ++..+.+++..|+ .+|.+|||++
T Consensus       239 ~~~~~~~~~~~~~-~dp~~Rpt~~  261 (269)
T cd05042         239 YSDRWYEVMQFCW-LDPETRPTAE  261 (269)
T ss_pred             CCHHHHHHHHHHh-cCcccccCHH
Confidence            8999999999998 5999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.1e-40  Score=309.74  Aligned_cols=233  Identities=20%  Similarity=0.276  Sum_probs=192.2

Q ss_pred             eEecccCceEEEEEEEcCC------------CcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC
Q 016037          156 KVVGQGAFAKVYQVRRIGT------------SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~------------~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~  223 (396)
                      +.||+|+||.||+|.+..+            ...+++|++....   ......+.+|+.+++.++||||+++++++....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            3689999999999986432            2358888876532   334456778899999999999999999999999


Q ss_pred             eEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc-------EEEEecc
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH-------VMLTDFG  295 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~-------ikL~Dfg  295 (396)
                      ..+++|||+++|+|..++.++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.       ++++|||
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999998888654 56899999999999999999999999999999999999987664       8999999


Q ss_pred             cccccCCCCCccccccCCCccchhhhc-CCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhCCCCCCccCC
Q 016037          296 LAKQFDENTRSNSMCGTLEYMSPEIVL-GKGHDKAADWWSVGILLFEML-TGQPPFTGGNRQKIQQKIIKDKIKLPAFLS  373 (396)
Q Consensus       296 la~~~~~~~~~~~~~gt~~y~APE~l~-~~~~~~~~DvwSlGvil~ell-tg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s  373 (396)
                      ++......   ....++..|+|||.+. +..++.++|||||||++|||+ +|..||......+.. .+...........+
T Consensus       158 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~  233 (262)
T cd05077         158 IPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVTPSC  233 (262)
T ss_pred             CCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCCCCh
Confidence            98765322   2345788999999987 466899999999999999998 599999876655443 33444444445567


Q ss_pred             HHHHHHHHHhhccCCCCCCCCC
Q 016037          374 SEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       374 ~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .++++||++||+.+|.+||++.
T Consensus       234 ~~~~~li~~cl~~dp~~Rp~~~  255 (262)
T cd05077         234 KELADLMTHCMNYDPNQRPFFR  255 (262)
T ss_pred             HHHHHHHHHHcCCChhhCcCHH
Confidence            8999999999999999999974

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5e-40  Score=309.23  Aligned_cols=245  Identities=32%  Similarity=0.511  Sum_probs=209.8

Q ss_pred             CeEEEeEecccCceEEEEEEEcC-CCcEEEEEEeecccc-------chhhHHHHHHHHHHHHHh-CCCCCeeeeeEEEEe
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIG-TSEIYAMKVMRKDKI-------MEKNHAEYMKSERNILTK-VDHPFIVQLRYSFQT  221 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~-~~~~vAvK~i~~~~~-------~~~~~~~~~~~E~~~L~~-l~HpnIv~l~~~~~~  221 (396)
                      +|++.+.||+|+||.||+|.+.. +++.+|+|.+.....       ........+..|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999988 788999999864321       122334556678888865 799999999999999


Q ss_pred             cCeEEEEEEecCCCcHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcEEEEeccc
Q 016037          222 KYRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVMLTDFGL  296 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDlkp~NILl~~~~~ikL~Dfgl  296 (396)
                      ....+++|||+++++|.+++..    ...+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999877642    3568999999999999999999996 6899999999999999999999999999


Q ss_pred             ccccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCc-cCCH
Q 016037          297 AKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-LPA-FLSS  374 (396)
Q Consensus       297 a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~-~p~-~~s~  374 (396)
                      +.............|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+...... .+. .++.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (269)
T cd08528         161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSE  240 (269)
T ss_pred             eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCH
Confidence            98765554445567899999999999888999999999999999999999999988888777777766433 233 6889


Q ss_pred             HHHHHHHHhhccCCCCCCCCC
Q 016037          375 EAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       375 ~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ++.+||.+||+.||.+||++.
T Consensus       241 ~l~~li~~cl~~~p~~Rp~~~  261 (269)
T cd08528         241 DVTDVITSCLTPDAEARPDII  261 (269)
T ss_pred             HHHHHHHHHCCCCCccCCCHH
Confidence            999999999999999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=9e-40  Score=315.93  Aligned_cols=241  Identities=26%  Similarity=0.390  Sum_probs=207.4

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      .|+..+.||+|+||.||+|.+..++..+|+|++.............+..|+++++.++|||++++++++......|+|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            48889999999999999999999999999999976544444555668889999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHH-HhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCcccc
Q 016037          231 FVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM  309 (396)
Q Consensus       231 ~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~  309 (396)
                      |+.| ++.+.+. ....+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....   ....
T Consensus       106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~~~  181 (317)
T cd06635         106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANSF  181 (317)
T ss_pred             CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---cccc
Confidence            9986 5655554 456789999999999999999999999999999999999999999999999999875432   2345


Q ss_pred             ccCCCccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CC-CccCCHHHHHHHHHhh
Q 016037          310 CGTLEYMSPEIVL---GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KL-PAFLSSEAHSLLKGVN  384 (396)
Q Consensus       310 ~gt~~y~APE~l~---~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~-~~-p~~~s~~~~~li~~~l  384 (396)
                      .|+..|+|||.+.   +..++.++|||||||++|||++|+.||...+.......+..... .. +..++..+++||.+||
T Consensus       182 ~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  261 (317)
T cd06635         182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCL  261 (317)
T ss_pred             cCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHc
Confidence            6889999999984   45688999999999999999999999998877776666666533 22 3468899999999999


Q ss_pred             ccCCCCCCCCC
Q 016037          385 SLLSISVPLLS  395 (396)
Q Consensus       385 ~~~p~~RPs~s  395 (396)
                      +.+|.+||++.
T Consensus       262 ~~~p~~Rpt~~  272 (317)
T cd06635         262 QKIPQDRPTSE  272 (317)
T ss_pred             cCCcccCcCHH
Confidence            99999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-42  Score=311.52  Aligned_cols=239  Identities=30%  Similarity=0.495  Sum_probs=209.5

Q ss_pred             CCCeEEE-eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHH-HHhCCCCCeeeeeEEEEe----c
Q 016037          149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-LTKVDHPFIVQLRYSFQT----K  222 (396)
Q Consensus       149 ~~~~~~~-~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~-L~~l~HpnIv~l~~~~~~----~  222 (396)
                      .++|.+- .+||-|-.|+|..+.++.||+.+|+|++....        ..++|+++ +..-.|||||.++++|++    .
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~--------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r  131 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP--------KARREVELHWMASGHPHIVSIIDVYENSYQGR  131 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH--------HHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence            3566664 56999999999999999999999999986432        24556665 344579999999998854    4


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC---CcEEEEecccc
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD---GHVMLTDFGLA  297 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~---~~ikL~Dfgla  297 (396)
                      ..+.+|||.|+||.|+..+..++.  |+|..+..++.||+.|+.|||+.+|.||||||+|+|....   ..+||+|||+|
T Consensus       132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA  211 (400)
T KOG0604|consen  132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA  211 (400)
T ss_pred             eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence            578999999999999999988876  9999999999999999999999999999999999999754   47999999999


Q ss_pred             cccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCCCc---
Q 016037          298 KQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN----RQKIQQKIIKDKIKLPA---  370 (396)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~----~~~i~~~i~~~~~~~p~---  370 (396)
                      +.-.......+.|.||+|.|||++....|+..+|+||+||+||-|++|.+||....    ...+..+|..+.+.||.   
T Consensus       212 K~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEW  291 (400)
T KOG0604|consen  212 KETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEW  291 (400)
T ss_pred             cccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhH
Confidence            98877777888999999999999999999999999999999999999999998743    45678899999888884   


Q ss_pred             -cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          371 -FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       371 -~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                       .+|++++++|+.+|..+|.+|-++.
T Consensus       292 s~VSe~aKdlIR~LLkt~PteRlTI~  317 (400)
T KOG0604|consen  292 SCVSEAAKDLIRKLLKTEPTERLTIE  317 (400)
T ss_pred             hHHHHHHHHHHHHHhcCCchhheeHH
Confidence             5899999999999999999998764

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.2e-39  Score=310.93  Aligned_cols=244  Identities=28%  Similarity=0.430  Sum_probs=200.8

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++.+.||+|++|.||+|.++.+++.||+|.+...... ....+.+.+|+++++.++||||+++++++.....+|+||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            5799999999999999999999999999999998764322 233455778999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC-CCcEEEEecccccccCCCCC-
Q 016037          230 DFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHVMLTDFGLAKQFDENTR-  305 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~-~~~ikL~Dfgla~~~~~~~~-  305 (396)
                      ||+++ +|..++.....  +++..++.++.||+.||.|||++|++||||+|+||+++. ++.+||+|||++........ 
T Consensus        81 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~  159 (294)
T PLN00009         81 EYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT  159 (294)
T ss_pred             ecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence            99975 67666655433  578888899999999999999999999999999999985 45799999999976543222 


Q ss_pred             ccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------------
Q 016037          306 SNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-------------------  365 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~-------------------  365 (396)
                      .....+++.|+|||.+.+ ..++.++||||||+++|+|+||+.||...+..+...++....                   
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (294)
T PLN00009        160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS  239 (294)
T ss_pred             cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence            233467889999999876 457899999999999999999999998876655555443210                   


Q ss_pred             --CC--------CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 --IK--------LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 --~~--------~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                        ..        ....++.++.++|.+||+.+|.+||++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~  279 (294)
T PLN00009        240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITAR  279 (294)
T ss_pred             hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHH
Confidence              00        1235789999999999999999999864

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=5.2e-40  Score=309.53  Aligned_cols=243  Identities=22%  Similarity=0.345  Sum_probs=204.1

Q ss_pred             eEEEeEecccCceEEEEEEEc---CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC-----
Q 016037          152 FEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----  223 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~-----  223 (396)
                      |++.+.||+|+||.||+|.+.   ++++.||||++..+... ....+.+.+|+++++.++||||+++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            567889999999999999865   35788999999765432 334566788999999999999999999886532     


Q ss_pred             -eEEEEEEecCCCcHHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccc
Q 016037          224 -RLYLVLDFVNGGHLFFQLYRQ------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGL  296 (396)
Q Consensus       224 -~~~lV~E~~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgl  296 (396)
                       ..+++++|+.+|+|..++...      ..++...++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence             247899999999998776432      2478888999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCcc
Q 016037          297 AKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAF  371 (396)
Q Consensus       297 a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~  371 (396)
                      ++.......   .....+++.|++||.+.+..++.++|||||||++|||++ |+.||.+.+..++...+... ....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  239 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPD  239 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCC
Confidence            987643221   223345678999999998889999999999999999999 99999988888877777665 4556678


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCCC
Q 016037          372 LSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       372 ~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .+..+.+++.+||+.+|.+|||++
T Consensus       240 ~~~~~~~l~~~~l~~~p~~Rps~~  263 (273)
T cd05074         240 CLEDVYELMCQCWSPEPKCRPSFQ  263 (273)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHH
Confidence            899999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=303.01  Aligned_cols=249  Identities=24%  Similarity=0.358  Sum_probs=207.0

Q ss_pred             CccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec-
Q 016037          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-  222 (396)
Q Consensus       144 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~-  222 (396)
                      ...++.++|++.+.||+|||+.||++....+++.||+|++.-..   .+..+...+|++..++++|||+++++++...+ 
T Consensus        15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~   91 (302)
T KOG2345|consen   15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREE   91 (302)
T ss_pred             cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence            44577889999999999999999999999999999999997654   45566778899999999999999998876433 


Q ss_pred             ----CeEEEEEEecCCCcHHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEcCCCcEEEE
Q 016037          223 ----YRLYLVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLDADGHVMLT  292 (396)
Q Consensus       223 ----~~~~lV~E~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~~--iiHrDlkp~NILl~~~~~ikL~  292 (396)
                          ...||++.|...|+|.+.+.+.    ..++|..+..|+.++++||++||+..  ++||||||.|||+++.+.++|+
T Consensus        92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~  171 (302)
T KOG2345|consen   92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM  171 (302)
T ss_pred             ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence                3589999999999998887543    47999999999999999999999998  9999999999999999999999


Q ss_pred             ecccccccCCCCC----------ccccccCCCccchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHH
Q 016037          293 DFGLAKQFDENTR----------SNSMCGTLEYMSPEIVLG---KGHDKAADWWSVGILLFEMLTGQPPFTGGN--RQKI  357 (396)
Q Consensus       293 Dfgla~~~~~~~~----------~~~~~gt~~y~APE~l~~---~~~~~~~DvwSlGvil~elltg~~Pf~~~~--~~~i  357 (396)
                      |||.++...-...          ......|..|+|||.+.-   ...+.++|||||||+||+|+.|..||...-  -..+
T Consensus       172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl  251 (302)
T KOG2345|consen  172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL  251 (302)
T ss_pred             eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence            9999986532111          112346899999999854   456799999999999999999999996411  1112


Q ss_pred             HHHHHhCCCCCCc--cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          358 QQKIIKDKIKLPA--FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       358 ~~~i~~~~~~~p~--~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .-.+....+.+|.  .+|+.+.+||++||+.||.+||+..
T Consensus       252 aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~  291 (302)
T KOG2345|consen  252 ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIP  291 (302)
T ss_pred             EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHH
Confidence            2233445666764  5999999999999999999999864

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1e-39  Score=307.95  Aligned_cols=232  Identities=28%  Similarity=0.508  Sum_probs=196.4

Q ss_pred             CCeEEEeEe--cccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCeEE
Q 016037          150 EDFEVLKVV--GQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       150 ~~~~~~~~I--G~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~  226 (396)
                      ++|++.+.+  |.|+||.||++..+.++..+|+|++.......        .|+.....+ +||||++++++|.....+|
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            456666665  99999999999999999999999987643211        122222222 7999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-cEEEEecccccccCCCCC
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~-~ikL~Dfgla~~~~~~~~  305 (396)
                      +||||+++++|..++..++.+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++......  
T Consensus        86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--  163 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--  163 (267)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence            9999999999999998888999999999999999999999999999999999999999998 9999999999766432  


Q ss_pred             ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhCCCCCCccCCHHHHHHH
Q 016037          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQK-----IQQKIIKDKIKLPAFLSSEAHSLL  380 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~-----i~~~i~~~~~~~p~~~s~~~~~li  380 (396)
                       ....|+..|+|||++.+..++.++||||||+++|||++|+.||.......     ..... ......+..+++.+++||
T Consensus       164 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li  241 (267)
T PHA03390        164 -SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNANDFV  241 (267)
T ss_pred             -ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHHHHH
Confidence             23468899999999998889999999999999999999999998654332     22222 344566778999999999


Q ss_pred             HHhhccCCCCCCC
Q 016037          381 KGVNSLLSISVPL  393 (396)
Q Consensus       381 ~~~l~~~p~~RPs  393 (396)
                      .+||+.+|.+||+
T Consensus       242 ~~~l~~~p~~R~~  254 (267)
T PHA03390        242 QSMLKYNINYRLT  254 (267)
T ss_pred             HHHhccChhhCCc
Confidence            9999999999996

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.2e-41  Score=334.02  Aligned_cols=240  Identities=22%  Similarity=0.361  Sum_probs=210.9

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc-hhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCe--EEEE
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR--LYLV  228 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~--~~lV  228 (396)
                      .+...+||+|+|-+||+|.+..+|..||--.++...+. .....+++..|+.+|+.|+||||+++|++|.+...  +.+|
T Consensus        42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence            34456799999999999999999999987666554332 34557889999999999999999999999987665  8899


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCCEEEcCC-CcEEEEecccccccCCCCC
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--GIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~--~iiHrDlkp~NILl~~~-~~ikL~Dfgla~~~~~~~~  305 (396)
                      +|.+..|+|+.|+++.+.++...++.|++||++||.|||++  .|||||||.+||||+.+ |.|||+|+|+|........
T Consensus       122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a  201 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA  201 (632)
T ss_pred             eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence            99999999999999999999999999999999999999999  69999999999999754 8999999999998765544


Q ss_pred             ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCccCCHHHHHHHHH
Q 016037          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKIIKDKIK--LPAFLSSEAHSLLKG  382 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~-~~~~~i~~~i~~~~~~--~p~~~s~~~~~li~~  382 (396)
                      .. .+|||.|||||++. ..|+..+||||||++|+||+|+..||.. .+..+|++++..+..+  |-.-=.+++++||.+
T Consensus       202 ks-vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIek  279 (632)
T KOG0584|consen  202 KS-VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEK  279 (632)
T ss_pred             ce-eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHH
Confidence            43 78999999999988 6799999999999999999999999986 5789999999988442  333447899999999


Q ss_pred             hhccCCCCCCCC
Q 016037          383 VNSLLSISVPLL  394 (396)
Q Consensus       383 ~l~~~p~~RPs~  394 (396)
                      ||.. ..+|||+
T Consensus       280 Cl~~-~~~R~sa  290 (632)
T KOG0584|consen  280 CLAT-KSERLSA  290 (632)
T ss_pred             HhcC-chhccCH
Confidence            9999 9999985

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5e-40  Score=311.31  Aligned_cols=232  Identities=22%  Similarity=0.300  Sum_probs=192.0

Q ss_pred             EecccCceEEEEEEEcCC------------------------CcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCe
Q 016037          157 VVGQGAFAKVYQVRRIGT------------------------SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI  212 (396)
Q Consensus       157 ~IG~G~fG~Vy~~~~~~~------------------------~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnI  212 (396)
                      .||+|+||.||+|.+..+                        ...||+|++....   ......+.+|+.+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence            599999999999986432                        2458888886532   2334557778999999999999


Q ss_pred             eeeeEEEEecCeEEEEEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC----
Q 016037          213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG----  287 (396)
Q Consensus       213 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~----  287 (396)
                      +++++++......|+||||+++|+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++..+    
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999888865 46789999999999999999999999999999999999997654    


Q ss_pred             ---cEEEEecccccccCCCCCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHH
Q 016037          288 ---HVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEML-TGQPPFTGGNRQKIQQKII  362 (396)
Q Consensus       288 ---~ikL~Dfgla~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~ell-tg~~Pf~~~~~~~i~~~i~  362 (396)
                         .+|++|||++......   ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.+....+... ..
T Consensus       159 ~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~  234 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FY  234 (274)
T ss_pred             ccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HH
Confidence               4899999988654222   22357788999999875 56899999999999999995 6999998876655433 33


Q ss_pred             hCCCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          363 KDKIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       363 ~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .....+|...+.++.+||++||+.+|.+|||+.
T Consensus       235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~  267 (274)
T cd05076         235 EKKHRLPEPSCKELATLISQCLTYEPTQRPSFR  267 (274)
T ss_pred             HhccCCCCCCChHHHHHHHHHcccChhhCcCHH
Confidence            445566677788999999999999999999974

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1e-39  Score=309.30  Aligned_cols=242  Identities=29%  Similarity=0.467  Sum_probs=202.9

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      +|++.++||.|++|.||+|++..+|+.||+|+++....  ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            58999999999999999999999999999999976532  2223446679999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC-c
Q 016037          231 FVNGGHLFFQLYRQ---GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-S  306 (396)
Q Consensus       231 ~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~-~  306 (396)
                      |+++ +|..++...   ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........ .
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  157 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF  157 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence            9986 677776554   3589999999999999999999999999999999999999999999999999976543322 2


Q ss_pred             cccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------------CC
Q 016037          307 NSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK------------------IK  367 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~------------------~~  367 (396)
                      ....++..|++||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+...++....                  ..
T Consensus       158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT  237 (284)
T ss_pred             ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence            33467889999999866 457899999999999999999999999887666555543210                  01


Q ss_pred             -----------CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          368 -----------LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       368 -----------~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                 +.+.++.+++++|.+||+.+|.+||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~  276 (284)
T cd07836         238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAH  276 (284)
T ss_pred             ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHH
Confidence                       1134688999999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-40  Score=311.41  Aligned_cols=244  Identities=26%  Similarity=0.418  Sum_probs=198.7

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|++.+.||+|++|.||+|.++.+++.||+|.+......  .....+.+|+.+++.++||||+++++++.+....|+|
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV   81 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence            46899999999999999999999999999999998764321  1223356799999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC-c
Q 016037          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-S  306 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~-~  306 (396)
                      |||+.+ +|..++.+. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++....... .
T Consensus        82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  160 (291)
T cd07844          82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY  160 (291)
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence            999986 788877654 4688999999999999999999999999999999999999999999999999876432211 2


Q ss_pred             cccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhC--------------------
Q 016037          307 NSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQKIIKD--------------------  364 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~-~~~i~~~i~~~--------------------  364 (396)
                      ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+ ..+....+.+.                    
T Consensus       161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07844         161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP  240 (291)
T ss_pred             cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence            23356889999999875 458899999999999999999999997655 33332222210                    


Q ss_pred             -CCC---------CCccCC--HHHHHHHHHhhccCCCCCCCCC
Q 016037          365 -KIK---------LPAFLS--SEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 -~~~---------~p~~~s--~~~~~li~~~l~~~p~~RPs~s  395 (396)
                       ...         ....++  .++.++|.+||+.+|.+|||++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~  283 (291)
T cd07844         241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAA  283 (291)
T ss_pred             ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHH
Confidence             000         001344  8899999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=364.60  Aligned_cols=243  Identities=31%  Similarity=0.511  Sum_probs=214.3

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      +|.....||.|.||.||.|.+..||+..|||-++-.... ........+|..+|..++|||+|++|++-.+...++|.||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            456667899999999999999999999999998765433 4445667889999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-----C
Q 016037          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-----R  305 (396)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-----~  305 (396)
                      ||++|+|.+.+...+...|-..+.|..|++.|+.|||+.|||||||||+||+++.+|.+|++|||.|..+..+.     .
T Consensus      1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred             HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence            99999999999998888888999999999999999999999999999999999999999999999999886553     2


Q ss_pred             ccccccCCCccchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhC-CCCCCccCCHHHHHHH
Q 016037          306 SNSMCGTLEYMSPEIVLG---KGHDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQKIIKD-KIKLPAFLSSEAHSLL  380 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~---~~~~~~~DvwSlGvil~elltg~~Pf~~~~-~~~i~~~i~~~-~~~~p~~~s~~~~~li  380 (396)
                      .....||+.|||||++.+   ++...++|||||||++.||+||+.||...+ .-.|+.++.-+ ++.+|..+|++.++||
T Consensus      1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred             HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHH
Confidence            346789999999999976   457789999999999999999999999754 33444444444 7889999999999999


Q ss_pred             HHhhccCCCCCCCC
Q 016037          381 KGVNSLLSISVPLL  394 (396)
Q Consensus       381 ~~~l~~~p~~RPs~  394 (396)
                      ..||.-||.+|=++
T Consensus      1475 e~Cl~~dP~~Rw~~ 1488 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTA 1488 (1509)
T ss_pred             HHHHhcCchhhhHH
Confidence            99999999999544

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.5e-39  Score=308.06  Aligned_cols=243  Identities=26%  Similarity=0.390  Sum_probs=203.2

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe--cCeEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KYRLYL  227 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~--~~~~~l  227 (396)
                      ++|+..+.||.|++|.||+|.+..+++.+|+|.+.....  ......+.+|+++++.++||||++++++|..  ...+|+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            469999999999999999999999999999999876432  2345667889999999999999999998865  347899


Q ss_pred             EEEecCCCcHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          228 VLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      ||||+++++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999999877643    345889999999999999999999999999999999999999999999999998765433


Q ss_pred             CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhC-CCCCC------cc
Q 016037          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG-----NRQKIQQKIIKD-KIKLP------AF  371 (396)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~-----~~~~i~~~i~~~-~~~~p------~~  371 (396)
                      .. ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...     ...+....+... ...++      ..
T Consensus       159 ~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd06621         159 LA-GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK  237 (287)
T ss_pred             cc-ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCc
Confidence            22 2456788999999999988999999999999999999999999865     233444444432 22222      13


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCCC
Q 016037          372 LSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       372 ~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +++++.+||.+||..+|.+|||+.
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rpt~~  261 (287)
T cd06621         238 WSEEFKDFIKQCLEKDPTRRPTPW  261 (287)
T ss_pred             hHHHHHHHHHHHcCCCcccCCCHH
Confidence            567899999999999999999974

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.1e-40  Score=311.58  Aligned_cols=243  Identities=28%  Similarity=0.452  Sum_probs=201.5

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      +|++++.||.|++|.||+|.+..++..||+|.++..... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            489999999999999999999999999999998764322 2233457789999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC-cc
Q 016037          231 FVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SN  307 (396)
Q Consensus       231 ~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~-~~  307 (396)
                      |+. ++|..++..  ...+++..++.++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++........ ..
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  158 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  158 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence            996 478777754  35688999999999999999999999999999999999999999999999999976643322 23


Q ss_pred             ccccCCCccchhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-C-----------------C--
Q 016037          308 SMCGTLEYMSPEIVLGKG-HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-K-----------------I--  366 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~~-~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~-~-----------------~--  366 (396)
                      ...++..|+|||.+.+.. ++.++||||||+++|||+||+.||.+.+......++... .                 .  
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07860         159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF  238 (284)
T ss_pred             cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence            345788999999887644 688999999999999999999999887654433333221 0                 0  


Q ss_pred             ---------CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 ---------KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 ---------~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                               .+...++.+++++|.+||+.||.+||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~  276 (284)
T cd07860         239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAK  276 (284)
T ss_pred             ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHH
Confidence                     11235788999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.4e-40  Score=314.73  Aligned_cols=245  Identities=24%  Similarity=0.395  Sum_probs=199.3

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEEEecCeEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~l  227 (396)
                      .++|...+.||+|+||.||++.+..+++.||+|.+......  .....+.+|+.++.++. |+||+++++++..+...++
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~   80 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI   80 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence            35677888999999999999999999999999998765422  33455778999999985 9999999999999999999


Q ss_pred             EEEecCCC--cHHHHHH--HhcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          228 VLDFVNGG--HLFFQLY--RQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       228 V~E~~~gg--~L~~~l~--~~~~l~e~~~~~~~~qi~~aL~~LH~~-~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      +|||+...  ++...+.  ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus        81 ~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          81 CMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             EEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            99998753  2222222  236789999999999999999999985 999999999999999999999999999987654


Q ss_pred             CCCccccccCCCccchhhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhC-CCCCC----ccCC
Q 016037          303 NTRSNSMCGTLEYMSPEIVLGK---GHDKAADWWSVGILLFEMLTGQPPFTGGNR-QKIQQKIIKD-KIKLP----AFLS  373 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~---~~~~~~DvwSlGvil~elltg~~Pf~~~~~-~~i~~~i~~~-~~~~p----~~~s  373 (396)
                      ........|+..|+|||.+.+.   .++.++|||||||++|||++|+.||...+. .+....+... ...++    ..++
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd06616         161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFS  240 (288)
T ss_pred             CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccC
Confidence            4444455789999999999776   689999999999999999999999986542 1222222222 22222    2478


Q ss_pred             HHHHHHHHHhhccCCCCCCCCC
Q 016037          374 SEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       374 ~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .++.+||++||+.+|.+|||+.
T Consensus       241 ~~l~~li~~~l~~~p~~Rpt~~  262 (288)
T cd06616         241 PSFVNFINLCLIKDESKRPKYK  262 (288)
T ss_pred             HHHHHHHHHHccCChhhCcCHH
Confidence            9999999999999999999964

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.2e-39  Score=310.00  Aligned_cols=245  Identities=47%  Similarity=0.841  Sum_probs=210.5

Q ss_pred             CeEEEeEecccCceEEEEEEEc---CCCcEEEEEEeeccccch-hhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCeE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIME-KNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~---~~~~~vAvK~i~~~~~~~-~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~  225 (396)
                      +|++.+.||+|+||.||++.+.   .+++.||+|++++..... ....+.+.+|+.++..+ +||||+++++++.....+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4889999999999999999864   467889999998644322 23445677899999999 599999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-  304 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-  304 (396)
                      |+||||+.+++|..++.....+++..++.++.|++.||.|||+.+++||||+|.||+++.++.++|+|||+++.+.... 
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE  160 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence            9999999999999999888889999999999999999999999999999999999999999999999999998764332 


Q ss_pred             -CccccccCCCccchhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCCCCCccCCHHHH
Q 016037          305 -RSNSMCGTLEYMSPEIVLGKG--HDKAADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKDKIKLPAFLSSEAH  377 (396)
Q Consensus       305 -~~~~~~gt~~y~APE~l~~~~--~~~~~DvwSlGvil~elltg~~Pf~~~----~~~~i~~~i~~~~~~~p~~~s~~~~  377 (396)
                       ......|+..|+|||.+.+..  .+.++||||||+++|||++|..||...    ...++.+.+.......|..++.+++
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  240 (288)
T cd05583         161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEAR  240 (288)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHH
Confidence             223456899999999987654  788999999999999999999999643    2345556666667788888999999


Q ss_pred             HHHHHhhccCCCCCCCCC
Q 016037          378 SLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       378 ~li~~~l~~~p~~RPs~s  395 (396)
                      ++|.+||+.+|++|||+.
T Consensus       241 ~li~~~l~~~p~~R~t~~  258 (288)
T cd05583         241 DFIQKLLEKDPKKRLGAN  258 (288)
T ss_pred             HHHHHHhcCCHhhccCcc
Confidence            999999999999999853

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5e-40  Score=306.75  Aligned_cols=231  Identities=20%  Similarity=0.270  Sum_probs=193.5

Q ss_pred             eEecccCceEEEEEEEcCCC----------cEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE
Q 016037          156 KVVGQGAFAKVYQVRRIGTS----------EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~----------~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~  225 (396)
                      +.||+|+||.||+|.+..++          ..+++|++.....    ....+.+|+.+++.++||||+++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            46999999999999998877          3578887665431    14567789999999999999999999988 778


Q ss_pred             EEEEEecCCCcHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-------cEEEEecccc
Q 016037          226 YLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-------HVMLTDFGLA  297 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~-------~ikL~Dfgla  297 (396)
                      ++||||+++|+|..++.... .+++..+..++.||+.||.|||++|++||||||+|||++.++       .+||+|||++
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999999998766 789999999999999999999999999999999999999888       8999999999


Q ss_pred             cccCCCCCccccccCCCccchhhhcCC--CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCCccCCH
Q 016037          298 KQFDENTRSNSMCGTLEYMSPEIVLGK--GHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKLPAFLSS  374 (396)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~  374 (396)
                      .....   .....++..|+|||.+.+.  .++.++||||||+++|||++ |..||...+......... .....|.....
T Consensus       156 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~  231 (259)
T cd05037         156 ITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMPDCA  231 (259)
T ss_pred             ccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCCCch
Confidence            87543   2334567889999999876  78999999999999999999 688898776444444333 22233434458


Q ss_pred             HHHHHHHHhhccCCCCCCCCC
Q 016037          375 EAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       375 ~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ++.+||++||+.+|.+||++.
T Consensus       232 ~~~~li~~~l~~~p~~Rpt~~  252 (259)
T cd05037         232 ELANLINQCWTYDPTKRPSFR  252 (259)
T ss_pred             HHHHHHHHHhccChhhCCCHH
Confidence            999999999999999999974

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=329.10  Aligned_cols=239  Identities=31%  Similarity=0.520  Sum_probs=217.2

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCC
Q 016037          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (396)
Q Consensus       155 ~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (396)
                      .++||.|.||+||-|.++++|+.||||+|.+.++..+. ...+++|+.+|+++.||+||.+-.-|++.+.+++|||.+.|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence            37899999999999999999999999999987765444 46789999999999999999999999999999999999999


Q ss_pred             CcHHHHHH-HhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC---CcEEEEecccccccCCCCCccccc
Q 016037          235 GHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD---GHVMLTDFGLAKQFDENTRSNSMC  310 (396)
Q Consensus       235 g~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~---~~ikL~Dfgla~~~~~~~~~~~~~  310 (396)
                      ..|.-.|. +.+.+++...+.++.||+.||.|||-+||+|.||||+|||+...   -.+||||||+|+.+.+.....+.+
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVV  727 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVV  727 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhc
Confidence            87766664 55889999999999999999999999999999999999999654   379999999999999998889999


Q ss_pred             cCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHHHhhcc
Q 016037          311 GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLKGVNSL  386 (396)
Q Consensus       311 gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~----~~s~~~~~li~~~l~~  386 (396)
                      |||.|+|||++++++|...-||||.||++|--++|..||..  .++|-..|.+..+.+|+    .+|.++.+||..+|+.
T Consensus       728 GTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqV  805 (888)
T KOG4236|consen  728 GTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQV  805 (888)
T ss_pred             CCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHH
Confidence            99999999999999999999999999999999999999965  45777888888888875    6999999999999999


Q ss_pred             CCCCCCCCCC
Q 016037          387 LSISVPLLSR  396 (396)
Q Consensus       387 ~p~~RPs~s~  396 (396)
                      ...+|=|.+|
T Consensus       806 km~kRysvdk  815 (888)
T KOG4236|consen  806 KMRKRYSVDK  815 (888)
T ss_pred             HHHHhcchHh
Confidence            9999877653

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.2e-39  Score=310.64  Aligned_cols=244  Identities=27%  Similarity=0.425  Sum_probs=199.8

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEEEecCe----
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYR----  224 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~----  224 (396)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++.... .......+.+|+.+++.+. ||||+++++++.....    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            369999999999999999999999999999999876432 1223345677999999995 6999999999987665    


Q ss_pred             -EEEEEEecCCCcHHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC-CCcEEEEecccc
Q 016037          225 -LYLVLDFVNGGHLFFQLYRQ-----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHVMLTDFGLA  297 (396)
Q Consensus       225 -~~lV~E~~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~-~~~ikL~Dfgla  297 (396)
                       .|+||||+++ +|..++...     ..+++..++.++.||+.||.|||++|++||||||+||+++. ++.+||+|||++
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence             8999999997 677766543     35799999999999999999999999999999999999998 889999999999


Q ss_pred             cccCCCC-CccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C-------
Q 016037          298 KQFDENT-RSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK--I-------  366 (396)
Q Consensus       298 ~~~~~~~-~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~--~-------  366 (396)
                      ..+.... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+......++....  .       
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T cd07837         159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG  238 (295)
T ss_pred             eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            8654322 2233457889999998865 457899999999999999999999999877665555443310  0       


Q ss_pred             --------CC-----------CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 --------KL-----------PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 --------~~-----------p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                              .+           .+.++.++.+||.+||+.+|.+||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~  286 (295)
T cd07837         239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAK  286 (295)
T ss_pred             hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHH
Confidence                    00           135789999999999999999999964

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.1e-39  Score=310.14  Aligned_cols=243  Identities=30%  Similarity=0.449  Sum_probs=211.5

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .+.|++.+.||.|+||.||+|.+..++..+++|++.....    ..+.+.+|+.+++.++|+||+++++++......|++
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   93 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV   93 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence            3568889999999999999999998899999999976532    345577899999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Cc
Q 016037          229 LDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RS  306 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~  306 (396)
                      +||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+++++|+|||++....... ..
T Consensus        94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  173 (286)
T cd06614          94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR  173 (286)
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhh
Confidence            99999999999998876 89999999999999999999999999999999999999999999999999987654322 22


Q ss_pred             cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-C--CCccCCHHHHHHHHHh
Q 016037          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-K--LPAFLSSEAHSLLKGV  383 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~-~--~p~~~s~~~~~li~~~  383 (396)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+..... .  .+..++.++.+||++|
T Consensus       174 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  253 (286)
T cd06614         174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKC  253 (286)
T ss_pred             ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHH
Confidence            344578899999999988899999999999999999999999998776665555554422 2  2334899999999999


Q ss_pred             hccCCCCCCCCC
Q 016037          384 NSLLSISVPLLS  395 (396)
Q Consensus       384 l~~~p~~RPs~s  395 (396)
                      |+.+|.+||++.
T Consensus       254 l~~~p~~Rpt~~  265 (286)
T cd06614         254 LVKDPEKRPSAE  265 (286)
T ss_pred             hccChhhCcCHH
Confidence            999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-41  Score=309.18  Aligned_cols=240  Identities=33%  Similarity=0.525  Sum_probs=210.5

Q ss_pred             eEEE-eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCeEEEEE
Q 016037          152 FEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       152 ~~~~-~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      |++. +.||+|+|+.|-.+....+|..||||++.+..   .....++.+|++++.+. .|+||++|+++|+++.++||||
T Consensus        79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf  155 (463)
T KOG0607|consen   79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF  155 (463)
T ss_pred             HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence            4443 56999999999999999999999999998753   45566788899999998 5999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc---EEEEecccccccCCCC--
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH---VMLTDFGLAKQFDENT--  304 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~---ikL~Dfgla~~~~~~~--  304 (396)
                      |.|.||.|...+.++..|+|..+..+..+|+.||.|||.+||.||||||+|||-...++   +|||||.+...+....  
T Consensus       156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~  235 (463)
T KOG0607|consen  156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC  235 (463)
T ss_pred             ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence            99999999999999999999999999999999999999999999999999999976664   8999999887653221  


Q ss_pred             ------CccccccCCCccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------C--------HHHHH
Q 016037          305 ------RSNSMCGTLEYMSPEIVL-----GKGHDKAADWWSVGILLFEMLTGQPPFTGG-------N--------RQKIQ  358 (396)
Q Consensus       305 ------~~~~~~gt~~y~APE~l~-----~~~~~~~~DvwSlGvil~elltg~~Pf~~~-------~--------~~~i~  358 (396)
                            ...+.+|+..|||||+..     ...|+.++|.|||||+||-|++|.+||.+.       +        ...++
T Consensus       236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF  315 (463)
T KOG0607|consen  236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF  315 (463)
T ss_pred             CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence                  124568999999999973     346899999999999999999999999863       1        25688


Q ss_pred             HHHHhCCCCCCc----cCCHHHHHHHHHhhccCCCCCCCC
Q 016037          359 QKIIKDKIKLPA----FLSSEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       359 ~~i~~~~~~~p~----~~s~~~~~li~~~l~~~p~~RPs~  394 (396)
                      ..|..+++.||.    .+|.++++||+.+|-.++.+|-+.
T Consensus       316 esIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa  355 (463)
T KOG0607|consen  316 ESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSA  355 (463)
T ss_pred             HHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhh
Confidence            889999999995    589999999999999999998664

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-41  Score=340.15  Aligned_cols=249  Identities=21%  Similarity=0.331  Sum_probs=222.6

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCC---cEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTS---EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      .+......+.++||.|.||+|++|+.+..|   ..||||.++..-  .+.....|..|+.||-+++||||++|-+.....
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks  702 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS  702 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence            366778999999999999999999998765   569999998653  345556688899999999999999999999999


Q ss_pred             CeEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      ..+.||+|||++|+|..+|+++ +.|..-++..+++.|+.||.||-+.|+|||||..+|||++.+-.||++|||+++.+.
T Consensus       703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence            9999999999999999999765 668888888899999999999999999999999999999999999999999999875


Q ss_pred             CCC-Cccc-cc--cCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHH
Q 016037          302 ENT-RSNS-MC--GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSE  375 (396)
Q Consensus       302 ~~~-~~~~-~~--gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~  375 (396)
                      +.. ...+ ..  -+.+|.|||.+....++.++||||+|++|||.++ |+.||.+.+.+++++.|.++ +++-|..++..
T Consensus       783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~a  862 (996)
T KOG0196|consen  783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAA  862 (996)
T ss_pred             cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHH
Confidence            443 2122 11  2579999999999999999999999999999999 99999999999999999988 88889999999


Q ss_pred             HHHHHHHhhccCCCCCCCCCC
Q 016037          376 AHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       376 ~~~li~~~l~~~p~~RPs~s~  396 (396)
                      +++||.+||++|=..||.+.|
T Consensus       863 L~qLMldCWqkdR~~RP~F~q  883 (996)
T KOG0196|consen  863 LYQLMLDCWQKDRNRRPKFAQ  883 (996)
T ss_pred             HHHHHHHHHHHHhhcCCCHHH
Confidence            999999999999999998754

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.8e-39  Score=343.13  Aligned_cols=150  Identities=42%  Similarity=0.765  Sum_probs=140.6

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|.++++||+|+||+||+|++..+++.||||+++............+..|+.+++.++||||+++++++.....+|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            46899999999999999999999999999999999876655556667788999999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccc
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK  298 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~  298 (396)
                      |||+.+++|..++...+.+.+..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999888889999999999999999999999999999999999999999999999999885

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-40  Score=309.97  Aligned_cols=242  Identities=28%  Similarity=0.452  Sum_probs=202.5

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEe
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (396)
                      |++.+.||.|++|.||+|.++.+|..||+|++...... ....+.+.+|+.+++.++||||+++++++.++...|++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            57789999999999999999999999999998765422 22334567799999999999999999999999999999999


Q ss_pred             cCCCcHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC-ccc
Q 016037          232 VNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNS  308 (396)
Q Consensus       232 ~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~-~~~  308 (396)
                      ++ ++|..++....  .+++..++.++.|++.||.|||+++++||||+|+||+++.++.++|+|||++........ ...
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  158 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH  158 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence            96 58888887665  689999999999999999999999999999999999999999999999999976543222 223


Q ss_pred             cccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------------------
Q 016037          309 MCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK----------------------  365 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~----------------------  365 (396)
                      ..++..|+|||++.+. .++.++||||||+++|+|++|+.||.+.+......++.+..                      
T Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd07835         159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP  238 (283)
T ss_pred             cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence            3568899999988664 57899999999999999999999998877655444443210                      


Q ss_pred             -C------CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 -I------KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 -~------~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                       .      .....++.++.++|.+||+.+|.+||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~  275 (283)
T cd07835         239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAK  275 (283)
T ss_pred             cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHH
Confidence             0      11246788999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.1e-39  Score=312.74  Aligned_cols=246  Identities=28%  Similarity=0.390  Sum_probs=198.1

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC----
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY----  223 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~----  223 (396)
                      ..++|++.++||+|+||.||+|.+..+++.||+|.+....... .......+|+.++++++||||+++++++....    
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            3467999999999999999999999999999999987543222 22233567999999999999999999886543    


Q ss_pred             ----eEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccc
Q 016037          224 ----RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK  298 (396)
Q Consensus       224 ----~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~  298 (396)
                          ..|+||||+.+ +|...+... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.
T Consensus        89 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  167 (310)
T cd07865          89 RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR  167 (310)
T ss_pred             CCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence                45999999976 666666544 368999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCC-----ccccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------
Q 016037          299 QFDENTR-----SNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-------  365 (396)
Q Consensus       299 ~~~~~~~-----~~~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~-------  365 (396)
                      .+.....     .....++..|+|||.+.+. .++.++||||||+++|||++|+.||.+.+.......+..-.       
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV  247 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            7643221     1234578899999998664 47889999999999999999999998877654443333210       


Q ss_pred             ------------CCCCc-------------cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 ------------IKLPA-------------FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 ------------~~~p~-------------~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                  ..+|.             ..+..+.+||.+||+.+|.+|||+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~  302 (310)
T cd07865         248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDAD  302 (310)
T ss_pred             cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHH
Confidence                        11111             2367788999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=8.7e-40  Score=312.60  Aligned_cols=243  Identities=28%  Similarity=0.449  Sum_probs=207.1

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|++.+.||+|+||.||++.+..++..||+|.+....   ....+.+.+|+.+++.++||||+++++++......|+|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            368999999999999999999999899999999986432   22345577899999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC-cc
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SN  307 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~-~~  307 (396)
                      +||+++++|..++.+ ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........ ..
T Consensus        95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~  173 (293)
T cd06647          95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  173 (293)
T ss_pred             EecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccc
Confidence            999999999888765 4578888999999999999999999999999999999999999999999999876543322 23


Q ss_pred             ccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-C--CCCCccCCHHHHHHHHHhh
Q 016037          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-K--IKLPAFLSSEAHSLLKGVN  384 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~-~--~~~p~~~s~~~~~li~~~l  384 (396)
                      ...|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+... .  +..+..++..+++||.+||
T Consensus       174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  253 (293)
T cd06647         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL  253 (293)
T ss_pred             cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHc
Confidence            456889999999998888999999999999999999999999876654433333322 2  2234567899999999999


Q ss_pred             ccCCCCCCCCC
Q 016037          385 SLLSISVPLLS  395 (396)
Q Consensus       385 ~~~p~~RPs~s  395 (396)
                      ..+|++||++.
T Consensus       254 ~~~p~~Rp~~~  264 (293)
T cd06647         254 EMDVEKRGSAK  264 (293)
T ss_pred             cCChhhCcCHH
Confidence            99999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.1e-40  Score=319.94  Aligned_cols=245  Identities=27%  Similarity=0.414  Sum_probs=200.3

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEEEecCeE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~  225 (396)
                      +....|+++++||+||.++||++...+.+. ||+|.+.... .+.....-+..|+.+|.+|+ |.+|++||++-..++.+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~i-yalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l  435 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQI-YALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL  435 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcc-hhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence            445679999999999999999999866554 6666554433 24456677889999999994 89999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          226 YLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      |+|||+-+. +|-..|.+... .+...++.|..||+.|+.++|..||||-||||.|+|+ -.|.+||+|||+|..+...+
T Consensus       436 YmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  436 YMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             EEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccc
Confidence            999998654 78777776654 4446788899999999999999999999999999999 78999999999999987665


Q ss_pred             C---ccccccCCCccchhhhcCCC-----------CCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhC--CCC
Q 016037          305 R---SNSMCGTLEYMSPEIVLGKG-----------HDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQKIIKD--KIK  367 (396)
Q Consensus       305 ~---~~~~~gt~~y~APE~l~~~~-----------~~~~~DvwSlGvil~elltg~~Pf~~~~-~~~i~~~i~~~--~~~  367 (396)
                      .   ..+.+||+.||+||.+....           .++++|||||||+||+|+.|+.||..-. ...-+..|...  +++
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ie  593 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIE  593 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccc
Confidence            4   46789999999999995432           3578999999999999999999997633 22223333332  567


Q ss_pred             CCccCCHH-HHHHHHHhhccCCCCCCCCC
Q 016037          368 LPAFLSSE-AHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       368 ~p~~~s~~-~~~li~~~l~~~p~~RPs~s  395 (396)
                      ||..-+.. +.++||.||..||.+||+..
T Consensus       594 fp~~~~~~~li~~mK~CL~rdPkkR~si~  622 (677)
T KOG0596|consen  594 FPDIPENDELIDVMKCCLARDPKKRWSIP  622 (677)
T ss_pred             ccCCCCchHHHHHHHHHHhcCcccCCCcH
Confidence            77655554 99999999999999999975

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.7e-39  Score=310.61  Aligned_cols=249  Identities=31%  Similarity=0.460  Sum_probs=202.4

Q ss_pred             CccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEec
Q 016037          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTK  222 (396)
Q Consensus       144 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~  222 (396)
                      .+.+..++|++.+.||+|+||.||+|.+..+++.||+|.++.....  .....+..|+.++.+. +||||+++++++.+.
T Consensus         9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~   86 (296)
T cd06618           9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITD   86 (296)
T ss_pred             eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence            3456678999999999999999999999999999999999764322  2233345566656555 599999999999999


Q ss_pred             CeEEEEEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcEEEEeccccccc
Q 016037          223 YRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~  300 (396)
                      ..+|++|||+.+ .+...+.. .+.+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.+||+|||++..+
T Consensus        87 ~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          87 SDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             CeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            999999999865 55555544 4678999999999999999999997 59999999999999999999999999999876


Q ss_pred             CCCCCccccccCCCccchhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCC-CCCC--ccC
Q 016037          301 DENTRSNSMCGTLEYMSPEIVLGKG----HDKAADWWSVGILLFEMLTGQPPFTGGNR-QKIQQKIIKDK-IKLP--AFL  372 (396)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~~~----~~~~~DvwSlGvil~elltg~~Pf~~~~~-~~i~~~i~~~~-~~~p--~~~  372 (396)
                      ..........++..|+|||.+.+..    ++.++||||||+++|+|++|+.||..... .+....+.... ..++  ..+
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (296)
T cd06618         166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGF  245 (296)
T ss_pred             cCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCC
Confidence            5444444456788999999997653    78899999999999999999999976432 33444444432 3333  347


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCC
Q 016037          373 SSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       373 s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +.++.+||++||+.+|.+||++.
T Consensus       246 ~~~l~~li~~~l~~~p~~Rp~~~  268 (296)
T cd06618         246 SPDFCSFVDLCLTKDHRKRPKYR  268 (296)
T ss_pred             CHHHHHHHHHHccCChhhCCCHH
Confidence            89999999999999999999974

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.8e-39  Score=309.32  Aligned_cols=247  Identities=18%  Similarity=0.228  Sum_probs=189.6

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCC---CcEEEEEEeeccccchhhH---H-----HHHHHHHHHHHhCCCCCeeee
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNH---A-----EYMKSERNILTKVDHPFIVQL  215 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~---~~~vAvK~i~~~~~~~~~~---~-----~~~~~E~~~L~~l~HpnIv~l  215 (396)
                      +..++|++.+.||+|+||+||+|.+..+   +..+|+|+...........   .     .....+...+..++|++|+++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            3446899999999999999999999887   6777888654322110000   0     011123344556789999999


Q ss_pred             eEEEEecC----eEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEE
Q 016037          216 RYSFQTKY----RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVML  291 (396)
Q Consensus       216 ~~~~~~~~----~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL  291 (396)
                      ++++....    ..++++|++.. ++...+......++..++.++.|++.||.|||+++++||||||+|||++.++.++|
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence            98775543    34778887754 55566665556788889999999999999999999999999999999999999999


Q ss_pred             EecccccccCCCC--------CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHH------
Q 016037          292 TDFGLAKQFDENT--------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN-RQK------  356 (396)
Q Consensus       292 ~Dfgla~~~~~~~--------~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~-~~~------  356 (396)
                      +|||+++.+....        ......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+ ...      
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~  247 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK  247 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence            9999998764221        1233469999999999999999999999999999999999999998763 222      


Q ss_pred             --HHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          357 --IQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       357 --i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                        ....+...+..+ ..++.++.++++.|++.+|++||++.
T Consensus       248 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~  287 (294)
T PHA02882        248 CDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYD  287 (294)
T ss_pred             HHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHH
Confidence              223333334333 45789999999999999999999975

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=312.90  Aligned_cols=244  Identities=26%  Similarity=0.435  Sum_probs=197.2

Q ss_pred             CeEEEeEecccCceEEEEEEEcC--CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec--CeEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIG--TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--YRLY  226 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~--~~~~  226 (396)
                      .|++.+.||+|+||.||+|.++.  +++.||+|.+...........+.+.+|+.+++.++||||+++++++...  ..+|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            48899999999999999999988  8999999999875433333445567899999999999999999999888  8899


Q ss_pred             EEEEecCCCcHHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC----CCcEEEEecccc
Q 016037          227 LVLDFVNGGHLFFQLYRQ-----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA----DGHVMLTDFGLA  297 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~----~~~ikL~Dfgla  297 (396)
                      +||||+++ ++...+...     ..+++..++.++.||+.||.|||+++++||||||+||+++.    ++.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999986 455544322     36889999999999999999999999999999999999999    899999999999


Q ss_pred             cccCCCCC----ccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHH-
Q 016037          298 KQFDENTR----SNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQK---------IQQKII-  362 (396)
Q Consensus       298 ~~~~~~~~----~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~---------i~~~i~-  362 (396)
                      +.......    ....+++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+...         ....+. 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            87643322    234567899999998876 457899999999999999999999998654321         001000 


Q ss_pred             -------------------------hCCCCCC-----------ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          363 -------------------------KDKIKLP-----------AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       363 -------------------------~~~~~~p-----------~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                               .....++           ...+.++.++|.+||+.+|++|||+.
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~  308 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAE  308 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHH
Confidence                                     0011111           15678899999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-39  Score=307.28  Aligned_cols=242  Identities=29%  Similarity=0.487  Sum_probs=203.2

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec--CeEEEEE
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--YRLYLVL  229 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~--~~~~lV~  229 (396)
                      |++.+.||.|+||.||+|.+..+++.+|+|++.... ........+.+|+.+++.++|||++++++++...  ...|+|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            678999999999999999999999999999998754 2233345577899999999999999999999888  8999999


Q ss_pred             EecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC--Cc
Q 016037          230 DFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--RS  306 (396)
Q Consensus       230 E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~--~~  306 (396)
                      ||+++ +|..++... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++.......  ..
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY  158 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence            99986 777777655 578999999999999999999999999999999999999999999999999998765443  12


Q ss_pred             cccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------------------
Q 016037          307 NSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-------------------  366 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~-------------------  366 (396)
                      ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.......+....-                   
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07840         159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL  238 (287)
T ss_pred             cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence            33456889999998765 4578999999999999999999999998776665555543100                   


Q ss_pred             ----C--------CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 ----K--------LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 ----~--------~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                          .        +...++.++.++|++||+.+|.+||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~  279 (287)
T cd07840         239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISAD  279 (287)
T ss_pred             cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHH
Confidence                0        0111388999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.5e-39  Score=313.49  Aligned_cols=234  Identities=26%  Similarity=0.449  Sum_probs=182.9

Q ss_pred             eEecccCceEEEEEEEcC--CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEE--ecCeEEEEEEe
Q 016037          156 KVVGQGAFAKVYQVRRIG--TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ--TKYRLYLVLDF  231 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~--~~~~~~lV~E~  231 (396)
                      .+||+|+||+||+|+++.  ++..||+|.+.....     ...+.+|+.+++.++||||+++++++.  ....+|+||||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            579999999999999764  568899999875432     223567999999999999999999885  35678999999


Q ss_pred             cCCCcHHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE----cCCCcEEEEeccccc
Q 016037          232 VNGGHLFFQLYRQ---------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL----DADGHVMLTDFGLAK  298 (396)
Q Consensus       232 ~~gg~L~~~l~~~---------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl----~~~~~ikL~Dfgla~  298 (396)
                      +.+ +|..++...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++++||+|||+++
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence            886 565655321         247889999999999999999999999999999999999    566799999999998


Q ss_pred             ccCCCC----CccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHh-
Q 016037          299 QFDENT----RSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ---------KIQQKIIK-  363 (396)
Q Consensus       299 ~~~~~~----~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~---------~i~~~i~~-  363 (396)
                      .+....    ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.....+         .....+.. 
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            764332    2234578999999999976 45799999999999999999999999754321         00000000 


Q ss_pred             ---------------------------CCC----------CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          364 ---------------------------DKI----------KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       364 ---------------------------~~~----------~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                                 ...          ......+..+.+||.+||+.||.+|||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~  309 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSE  309 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHH
Confidence                                       000          01113456788999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.4e-39  Score=307.83  Aligned_cols=244  Identities=24%  Similarity=0.363  Sum_probs=203.6

Q ss_pred             CCeEEEeEecccCceEEEEEEEcC----CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe--cC
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIG----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KY  223 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~--~~  223 (396)
                      .+|++.+.||+|+||.||+|.+..    ++..+|+|++......  ...+.+.+|+++++.++||||+++++++..  ..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            568889999999999999999753    4789999999865432  345678899999999999999999998877  56


Q ss_pred             eEEEEEEecCCCcHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      ..+++|||+++++|..++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            8999999999999999887654 588999999999999999999999999999999999999999999999999987653


Q ss_pred             CCC----ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHHHh
Q 016037          303 NTR----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ---------------KIQQKIIK  363 (396)
Q Consensus       303 ~~~----~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~---------------~i~~~i~~  363 (396)
                      ...    .....++..|+|||.+.+..++.++||||||+++|||+||+.||......               .+...+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE  241 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence            221    11223456799999998888999999999999999999999998764322               12222222


Q ss_pred             C-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          364 D-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       364 ~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      . +.+.+..++.++.+|+.+||+.+|.+||++.
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~  274 (284)
T cd05038         242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFA  274 (284)
T ss_pred             CCcCCCCccCCHHHHHHHHHHhccChhhCCCHH
Confidence            2 3455667889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.1e-40  Score=319.41  Aligned_cols=244  Identities=23%  Similarity=0.355  Sum_probs=202.2

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe----cCeE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT----KYRL  225 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~----~~~~  225 (396)
                      .+|++.+.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.+|+.++||||+++++++..    ...+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            579999999999999999999999999999999876432 22334556779999999999999999988753    4578


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~  305 (396)
                      |+||||+. ++|..++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            99999996 57888888778899999999999999999999999999999999999999999999999999977543221


Q ss_pred             -----ccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------------
Q 016037          306 -----SNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---------------  364 (396)
Q Consensus       306 -----~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~---------------  364 (396)
                           .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+.......+...               
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~  242 (334)
T cd07855         163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD  242 (334)
T ss_pred             CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence                 123478899999999866 45889999999999999999999999876544332222210               


Q ss_pred             -----------CCCC-----CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 -----------KIKL-----PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 -----------~~~~-----p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                 ....     .+.++.+++++|++||+.+|.+||+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~  289 (334)
T cd07855         243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVE  289 (334)
T ss_pred             hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHH
Confidence                       1111     135789999999999999999999974

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.9e-39  Score=310.39  Aligned_cols=240  Identities=25%  Similarity=0.371  Sum_probs=204.6

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEe
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (396)
                      |...++||+|+||+||+|.+..++..|++|++...........+.+.+|+.+++.++|||++++++++.+....|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            66778899999999999999999999999999765544445556678899999999999999999999999999999999


Q ss_pred             cCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccccc
Q 016037          232 VNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMC  310 (396)
Q Consensus       232 ~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~~  310 (396)
                      +.+ ++...+.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++....   ......
T Consensus       103 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~~~~~  178 (313)
T cd06633         103 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PANSFV  178 (313)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---CCCCcc
Confidence            975 55555544 4678999999999999999999999999999999999999999999999999986432   223457


Q ss_pred             cCCCccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CC-CccCCHHHHHHHHHhhc
Q 016037          311 GTLEYMSPEIVL---GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KL-PAFLSSEAHSLLKGVNS  385 (396)
Q Consensus       311 gt~~y~APE~l~---~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~-~~-p~~~s~~~~~li~~~l~  385 (396)
                      |+..|+|||.+.   ...++.++|||||||++|+|++|..||...+......++..... .. ...++..+++||.+||+
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  258 (313)
T cd06633         179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQ  258 (313)
T ss_pred             ccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHcc
Confidence            889999999984   35688899999999999999999999998876666666655433 22 24578899999999999


Q ss_pred             cCCCCCCCCC
Q 016037          386 LLSISVPLLS  395 (396)
Q Consensus       386 ~~p~~RPs~s  395 (396)
                      .+|.+||++.
T Consensus       259 ~~P~~Rp~~~  268 (313)
T cd06633         259 KIPQERPASA  268 (313)
T ss_pred             CChhhCcCHH
Confidence            9999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-39  Score=316.57  Aligned_cols=242  Identities=26%  Similarity=0.405  Sum_probs=196.9

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec-----Ce
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----YR  224 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~-----~~  224 (396)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++....  .......+.+|+.+++.++||||+++++++...     ..
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            57999999999999999999999999999999986432  223445567899999999999999999877543     35


Q ss_pred             EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      .|+++||+.+ +|...+ ....+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++......
T Consensus        83 ~~lv~e~~~~-~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          83 VYIVQELMET-DLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH  160 (336)
T ss_pred             EEEEehhccc-CHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence            8999999976 666655 44578999999999999999999999999999999999999999999999999998754322


Q ss_pred             C----ccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------------
Q 016037          305 R----SNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---------------  364 (396)
Q Consensus       305 ~----~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~---------------  364 (396)
                      .    .....||..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+...               
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL  240 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence            1    123568999999998755 56899999999999999999999999876543332222110               


Q ss_pred             -------------CCC---CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 -------------KIK---LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 -------------~~~---~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                   ...   +.+..+.++.+||.+||+.+|.+||++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~  287 (336)
T cd07849         241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVE  287 (336)
T ss_pred             hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHH
Confidence                         000   1134688999999999999999999964

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2e-39  Score=312.22  Aligned_cols=242  Identities=26%  Similarity=0.389  Sum_probs=205.2

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ..|...+.||+|+||.||+|+++.++..+|+|.+...........+.+.+|+.+++.++|+|++++++++......|+||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34778899999999999999999999999999987643333444556778999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHH-HhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccc
Q 016037          230 DFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (396)
Q Consensus       230 E~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~  308 (396)
                      ||+.+ ++...+. ....+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++......   ..
T Consensus        95 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---~~  170 (308)
T cd06634          95 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NX  170 (308)
T ss_pred             EccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---cc
Confidence            99975 6666554 4456899999999999999999999999999999999999999999999999998765432   34


Q ss_pred             cccCCCccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CC-CccCCHHHHHHHHHh
Q 016037          309 MCGTLEYMSPEIVL---GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KL-PAFLSSEAHSLLKGV  383 (396)
Q Consensus       309 ~~gt~~y~APE~l~---~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~-~~-p~~~s~~~~~li~~~  383 (396)
                      ..|+..|+|||.+.   ...++.++|||||||++|+|++|..||...+.......+..... .. +..++..+.+||++|
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  250 (308)
T cd06634         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  250 (308)
T ss_pred             ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHH
Confidence            56889999999985   34578899999999999999999999988776666665555433 22 347899999999999


Q ss_pred             hccCCCCCCCCC
Q 016037          384 NSLLSISVPLLS  395 (396)
Q Consensus       384 l~~~p~~RPs~s  395 (396)
                      |+.+|.+||++.
T Consensus       251 l~~~P~~Rp~~~  262 (308)
T cd06634         251 LQKIPQDRPTSE  262 (308)
T ss_pred             hhCCcccCCCHH
Confidence            999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-39  Score=305.77  Aligned_cols=242  Identities=28%  Similarity=0.419  Sum_probs=202.4

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC---CCCCeeeeeEEEEecCe----
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIVQLRYSFQTKYR----  224 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l---~HpnIv~l~~~~~~~~~----  224 (396)
                      |++.+.||+|+||.||+|.++.++..||+|+++..... ......+.+|+.+++++   +||||+++++++.....    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            67899999999999999999999999999999764432 22233455677776655   69999999999988776    


Q ss_pred             -EEEEEEecCCCcHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          225 -LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       225 -~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                       ++++|||+.+ +|..++....  .+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++....
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence             9999999986 6877776643  58999999999999999999999999999999999999999999999999998875


Q ss_pred             CCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-C----C---------
Q 016037          302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-I----K---------  367 (396)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~-~----~---------  367 (396)
                      .........++..|+|||.+.+..++.++|||||||++|||++|+.||.+.+..+...++...- .    .         
T Consensus       159 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07838         159 FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR  238 (287)
T ss_pred             CCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence            5544445568899999999999889999999999999999999999999888777666665420 0    0         


Q ss_pred             -------------CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          368 -------------LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       368 -------------~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                   ....++..+.+||.+||+.+|.+||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  279 (287)
T cd07838         239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAF  279 (287)
T ss_pred             hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHH
Confidence                         0124568899999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.8e-39  Score=316.57  Aligned_cols=244  Identities=23%  Similarity=0.369  Sum_probs=202.2

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec-----Ce
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----YR  224 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~-----~~  224 (396)
                      .+|++.+.||+|+||+||+|.+..+++.||||.+..... .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            479999999999999999999999999999999875432 222334566799999999999999999987654     35


Q ss_pred             EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-  303 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-  303 (396)
                      +|+++||+. ++|..++...+.+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|||+++..... 
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  162 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG  162 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence            899999997 578888888888999999999999999999999999999999999999999999999999999876443 


Q ss_pred             CCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------------
Q 016037          304 TRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD------------------  364 (396)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~------------------  364 (396)
                      .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+...                  
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07858         163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR  242 (337)
T ss_pred             ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence            22344568899999998865 46889999999999999999999999876544333322210                  


Q ss_pred             ----------CC---CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 ----------KI---KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 ----------~~---~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                ..   ...+.++.++.+||++||+.+|.+|||+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~  286 (337)
T cd07858         243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVE  286 (337)
T ss_pred             HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHH
Confidence                      00   11246889999999999999999999864

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.5e-39  Score=309.52  Aligned_cols=247  Identities=27%  Similarity=0.429  Sum_probs=201.9

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC---
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY---  223 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~---  223 (396)
                      ...++|++.+.||+|+||.||+|.++.+++.||+|+++.... .......+.+|+.+++.++||||+++++++.+..   
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            345789999999999999999999999999999999976432 1223345678999999999999999999887654   


Q ss_pred             -------eEEEEEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecc
Q 016037          224 -------RLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFG  295 (396)
Q Consensus       224 -------~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfg  295 (396)
                             .+|+|+||+++ ++...+.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg  161 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG  161 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence                   79999999987 55555554 3568999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCC--ccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C----
Q 016037          296 LAKQFDENTR--SNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK--I----  366 (396)
Q Consensus       296 la~~~~~~~~--~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~--~----  366 (396)
                      ++........  .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+....+....  .    
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (302)
T cd07864         162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV  241 (302)
T ss_pred             ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence            9987644331  122346788999998865 457899999999999999999999998877655554444320  0    


Q ss_pred             ------------------------CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 ------------------------KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 ------------------------~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                              .....++..+.+||..||+.+|.+||++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~  294 (302)
T cd07864         242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAE  294 (302)
T ss_pred             cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHH
Confidence                                    01124689999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.2e-39  Score=313.29  Aligned_cols=242  Identities=28%  Similarity=0.394  Sum_probs=202.2

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC-----
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----  223 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~-----  223 (396)
                      .++|++++.||+|+||.||+|.+..++..||+|++.... ......+.+.+|+.+++.++||||+++++++....     
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            457999999999999999999999999999999986543 22334456778999999999999999999987653     


Q ss_pred             -eEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          224 -RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       224 -~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                       .+++||||+ +++|..++. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS  170 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence             468999998 668876665 46789999999999999999999999999999999999999999999999999986543


Q ss_pred             CCCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------------
Q 016037          303 NTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK--------------  367 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~--------------  367 (396)
                      .  .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+......++.+....              
T Consensus       171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07880         171 E--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA  248 (343)
T ss_pred             C--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhH
Confidence            2  234567899999999876 45889999999999999999999999987765555544332111              


Q ss_pred             -----------------CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          368 -----------------LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       368 -----------------~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                       +...++.++.++|.+||+.+|.+|||..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~  293 (343)
T cd07880         249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAA  293 (343)
T ss_pred             HHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHH
Confidence                             1246788999999999999999999964

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.5e-39  Score=302.72  Aligned_cols=236  Identities=20%  Similarity=0.313  Sum_probs=190.6

Q ss_pred             EecccCceEEEEEEEcCCC--cEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCC
Q 016037          157 VVGQGAFAKVYQVRRIGTS--EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (396)
Q Consensus       157 ~IG~G~fG~Vy~~~~~~~~--~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (396)
                      .||+|+||+||+|.+...+  ..+++|.+....  .....+.+.+|+.+++.++||||+++++.+......|+||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            5999999999999764432  345666665432  223456678899999999999999999999999999999999999


Q ss_pred             CcHHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC---CCcc
Q 016037          235 GHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---TRSN  307 (396)
Q Consensus       235 g~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~---~~~~  307 (396)
                      |+|..++.+.    ....+..++.++.||+.||.|||+++++||||||+|||++.++.+||+|||++......   ....
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  159 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED  159 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence            9999988764    23566777889999999999999999999999999999999999999999998643211   1223


Q ss_pred             ccccCCCccchhhhcC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC------CCCCccCC
Q 016037          308 SMCGTLEYMSPEIVLG-------KGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDK------IKLPAFLS  373 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~-------~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~~------~~~p~~~s  373 (396)
                      ..+++..|+|||++..       ..++.++||||||+++|||++ |..||...+..+....+.++.      ..++..++
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd05086         160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYS  239 (268)
T ss_pred             CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCc
Confidence            4578899999999853       235789999999999999997 688998877776666655442      23445689


Q ss_pred             HHHHHHHHHhhccCCCCCCCCC
Q 016037          374 SEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       374 ~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ..+.+++..|| .+|.+||++.
T Consensus       240 ~~~~~l~~~c~-~~P~~Rp~~~  260 (268)
T cd05086         240 ERWYEVLQFCW-LSPEKRATAE  260 (268)
T ss_pred             HHHHHHHHHHh-hCcccCCCHH
Confidence            99999999999 6899999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-40  Score=329.01  Aligned_cols=237  Identities=32%  Similarity=0.515  Sum_probs=206.4

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHh-CCCCCeeeeeEEEEecCeEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~-l~HpnIv~l~~~~~~~~~~~  226 (396)
                      ..++|++...+|.|+|+.|-.+.+..++...++|++.+..       ....+|+.++.. -+||||+++.+.+.++.+.|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence            4568999999999999999999999999999999997652       113456655554 47999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE-cCCCcEEEEecccccccCCCCC
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL-DADGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl-~~~~~ikL~Dfgla~~~~~~~~  305 (396)
                      +|||.+.|+.+...+...+.+. ..+..|+++|+.|+.|||++|+|||||||+|||+ +..|+++|+|||.++.....  
T Consensus       393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            9999999999988887776666 7788899999999999999999999999999999 69999999999999887555  


Q ss_pred             ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCCccCCHHHHHHHHHhh
Q 016037          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ-KIQQKIIKDKIKLPAFLSSEAHSLLKGVN  384 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~-~i~~~i~~~~~~~p~~~s~~~~~li~~~l  384 (396)
                      ....|-|..|.|||++....|+.++||||||++||+|++|+.||.....+ ++...|...++.  ..+|.++++||.+||
T Consensus       470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl~~LL  547 (612)
T KOG0603|consen  470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLLQQLL  547 (612)
T ss_pred             hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHHHHhc
Confidence            34457789999999999999999999999999999999999999876555 566655554444  889999999999999


Q ss_pred             ccCCCCCCCCCC
Q 016037          385 SLLSISVPLLSR  396 (396)
Q Consensus       385 ~~~p~~RPs~s~  396 (396)
                      +.+|.+||++++
T Consensus       548 ~~dP~~Rl~~~~  559 (612)
T KOG0603|consen  548 QVDPALRLGADE  559 (612)
T ss_pred             cCChhhCcChhh
Confidence            999999999874

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-39  Score=315.27  Aligned_cols=243  Identities=26%  Similarity=0.353  Sum_probs=209.0

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC-----eE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----RL  225 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~-----~~  225 (396)
                      +|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++....     .+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            5889999999999999999999999999999987643 12344566788999999999999999999987765     78


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-  304 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-  304 (396)
                      |++|||+.+ +|...+.+...+++..++.++.|++.||.|||++|++||||||+|||++.++.++|+|||++....... 
T Consensus        80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            999999985 788888887889999999999999999999999999999999999999999999999999998765443 


Q ss_pred             ---CccccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------------
Q 016037          305 ---RSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-------------  367 (396)
Q Consensus       305 ---~~~~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~-------------  367 (396)
                         ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+....+....-.             
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK  238 (330)
T ss_pred             ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence               23445688999999999887 7899999999999999999999999988877666665542110             


Q ss_pred             ------------------CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          368 ------------------LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       368 ------------------~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                        +.+.++.++.+||.+||+.+|.+||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~  284 (330)
T cd07834         239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITAD  284 (330)
T ss_pred             hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHH
Confidence                              1234788999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.9e-39  Score=313.84  Aligned_cols=239  Identities=23%  Similarity=0.300  Sum_probs=194.6

Q ss_pred             eEeccc--CceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecC
Q 016037          156 KVVGQG--AFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVN  233 (396)
Q Consensus       156 ~~IG~G--~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  233 (396)
                      ..||+|  +||+||++.+..+|+.||+|++...... ....+.+.+|+.+++.++||||++++++|..+..+|+|+||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            356666  9999999999999999999998765433 3455778899999999999999999999999999999999999


Q ss_pred             CCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC------
Q 016037          234 GGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR------  305 (396)
Q Consensus       234 gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~------  305 (396)
                      +++|..++.+.  ..+++..++.++.|++.||+|||++|++||||||+|||++.++.++++||+.+........      
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY  162 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence            99999888764  3588999999999999999999999999999999999999999999999986543321111      


Q ss_pred             --ccccccCCCccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------------
Q 016037          306 --SNSMCGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI---------------  366 (396)
Q Consensus       306 --~~~~~gt~~y~APE~l~~--~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~---------------  366 (396)
                        .....++..|||||++.+  ..++.++|||||||++|||++|+.||.+.........+.....               
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (328)
T cd08226         163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR  242 (328)
T ss_pred             cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence              111234667999999976  3478999999999999999999999987665444333322111               


Q ss_pred             --------------------------------CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 --------------------------------KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 --------------------------------~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                                      ..+..++.++.+||++||+.||.+|||++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~  303 (328)
T cd08226         243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSAS  303 (328)
T ss_pred             hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHH
Confidence                                            11234678899999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.2e-39  Score=307.98  Aligned_cols=240  Identities=27%  Similarity=0.432  Sum_probs=205.6

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEe
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (396)
                      |....+||+|+||.||++..+.+++.||+|.+....   ......+.+|+.+++.++|+||+++++.+......|++|||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   98 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF   98 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence            333467999999999999999999999999885432   23445578899999999999999999999999999999999


Q ss_pred             cCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Cccccc
Q 016037          232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSMC  310 (396)
Q Consensus       232 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~~~~~  310 (396)
                      +++++|.+++. .+.+++..++.++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++....... ......
T Consensus        99 ~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~  177 (292)
T cd06657          99 LEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV  177 (292)
T ss_pred             CCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccc
Confidence            99999988664 4568999999999999999999999999999999999999999999999999987654322 233456


Q ss_pred             cCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCCccCCHHHHHHHHHhhccC
Q 016037          311 GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGVNSLL  387 (396)
Q Consensus       311 gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~---~~~~p~~~s~~~~~li~~~l~~~  387 (396)
                      |+..|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+....+...   .+.....++.++.++|.+||+.+
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  257 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD  257 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCC
Confidence            889999999998888899999999999999999999999987776666555443   22234568999999999999999


Q ss_pred             CCCCCCCC
Q 016037          388 SISVPLLS  395 (396)
Q Consensus       388 p~~RPs~s  395 (396)
                      |.+||++.
T Consensus       258 P~~R~~~~  265 (292)
T cd06657         258 PAQRATAA  265 (292)
T ss_pred             cccCcCHH
Confidence            99999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=317.77  Aligned_cols=247  Identities=21%  Similarity=0.301  Sum_probs=213.1

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +..+...+.++||+|.||+|.+|.-.+ +..||+|.++.+.  ..+....+.+|+++|.+|+||||+.|++.|..++.++
T Consensus       535 fPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic  611 (807)
T KOG1094|consen  535 FPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC  611 (807)
T ss_pred             cchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence            445678889999999999999999855 6889999998765  3455678999999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          227 LVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      +|+|||+.|+|.+++..+..  ........++.||+.||+||.+.++|||||.++|+|++.++++||+|||+++.+-...
T Consensus       612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence            99999999999999987733  2344455689999999999999999999999999999999999999999998653332


Q ss_pred             C---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHhC--------CCCCCcc
Q 016037          305 R---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT--GQPPFTGGNRQKIQQKIIKD--------KIKLPAF  371 (396)
Q Consensus       305 ~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt--g~~Pf~~~~~~~i~~~i~~~--------~~~~p~~  371 (396)
                      .   ....+-+.+|||+|.+....++.++|+|+||++|||+++  .+.||...+.+++..+...-        -+..|+-
T Consensus       692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~  771 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPA  771 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCc
Confidence            2   234456789999999999999999999999999999976  89999998888777766432        3356788


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCCCC
Q 016037          372 LSSEAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       372 ~s~~~~~li~~~l~~~p~~RPs~s~  396 (396)
                      ++.++.+||-.||..+-++|||+++
T Consensus       772 cp~~lyelml~Cw~~es~~RPsFe~  796 (807)
T KOG1094|consen  772 CPQGLYELMLRCWRRESEQRPSFEQ  796 (807)
T ss_pred             CcHHHHHHHHHHhchhhhcCCCHHH
Confidence            9999999999999999999999863

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.9e-39  Score=308.97  Aligned_cols=245  Identities=29%  Similarity=0.441  Sum_probs=198.5

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec------
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------  222 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~------  222 (396)
                      .++|++.++||+|+||.||+|.++.+++.+|+|++......+. ......+|+.+++.++||||+++++.+...      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            5789999999999999999999999999999999876442221 223456799999999999999999887543      


Q ss_pred             --CeEEEEEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          223 --YRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       223 --~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                        ..+|+||||+.+ ++...+.. ...+++..++.++.|+++||.|||++|++|+||||+||+++.++.++|+|||+++.
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  164 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP  164 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence              357999999987 45555543 45799999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCC------------ccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Q 016037          300 FDENTR------------SNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI  366 (396)
Q Consensus       300 ~~~~~~------------~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~  366 (396)
                      ......            .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.+.+.......+...--
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~  244 (311)
T cd07866         165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG  244 (311)
T ss_pred             ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            543221            122356888999998865 4578999999999999999999999998877666655543100


Q ss_pred             -----------------------CCC-------ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 -----------------------KLP-------AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 -----------------------~~p-------~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                             ..+       ..++.++.+||.+||+.+|.+|||+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~  303 (311)
T cd07866         245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTAS  303 (311)
T ss_pred             CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHH
Confidence                                   011       23457899999999999999999964

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-39  Score=304.68  Aligned_cols=242  Identities=30%  Similarity=0.482  Sum_probs=204.5

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEe
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (396)
                      |++.+.||.|++|.||+|.+..+++.+++|.+...... ......+.+|+.+++.++|+||+++++.+..+...++|+||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            56788999999999999999999999999998765432 23445677899999999999999999999999999999999


Q ss_pred             cCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Ccccc
Q 016037          232 VNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSM  309 (396)
Q Consensus       232 ~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~~~~  309 (396)
                      +++ ++...+.. ...+++..++.++.|++.||.|||+.+++|+||||+||+++.++.++|+|||.+....... .....
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY  158 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence            986 67666655 4688999999999999999999999999999999999999999999999999998775443 22334


Q ss_pred             ccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------------CC--
Q 016037          310 CGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-------------------IK--  367 (396)
Q Consensus       310 ~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~-------------------~~--  367 (396)
                      .++..|+|||.+.+. .++.++|+||||+++|+|+||+.||.+.+..+...++...-                   ..  
T Consensus       159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05118         159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP  238 (283)
T ss_pred             cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhc
Confidence            578899999999876 78999999999999999999999998877666555543210                   00  


Q ss_pred             ---------CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          368 ---------LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       368 ---------~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                               ....++.++.+||.+||+.+|.+||+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~  275 (283)
T cd05118         239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAE  275 (283)
T ss_pred             cccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHH
Confidence                     1124788999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-38  Score=312.06  Aligned_cols=242  Identities=26%  Similarity=0.353  Sum_probs=199.0

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec------
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------  222 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~------  222 (396)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.++++++||||+++++++...      
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            4689999999999999999999999999999999876432 223345577899999999999999999988543      


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      ...|++++++ +++|...+.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++....
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~  172 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  172 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence            3478888887 6688766654 4689999999999999999999999999999999999999999999999999976533


Q ss_pred             CCCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------------
Q 016037          303 NTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI---------------  366 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~---------------  366 (396)
                        ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.......+.....               
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (345)
T cd07877         173 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  250 (345)
T ss_pred             --cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhH
Confidence              2334568899999999876 5688999999999999999999999987765554444332110               


Q ss_pred             --------CC--------CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 --------KL--------PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 --------~~--------p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                              ..        ....+.++.+||++||+.+|.+||+.+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~  295 (345)
T cd07877         251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA  295 (345)
T ss_pred             HHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHH
Confidence                    11        113588999999999999999999864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-39  Score=330.82  Aligned_cols=247  Identities=25%  Similarity=0.353  Sum_probs=186.6

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCC-cEEEEEE--------------eeccccchhhHHHHHHHHHHHHHhCCCCCe
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTS-EIYAMKV--------------MRKDKIMEKNHAEYMKSERNILTKVDHPFI  212 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~-~~vAvK~--------------i~~~~~~~~~~~~~~~~E~~~L~~l~HpnI  212 (396)
                      ..++|+++++||+|+||+||+|..+... +.++.|.              +.+...........+.+|+.+|+.++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            3578999999999999999998875432 2222221              111111122344567889999999999999


Q ss_pred             eeeeEEEEecCeEEEEEEecCCCcHHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC
Q 016037          213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ-----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (396)
Q Consensus       213 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~  287 (396)
                      +++++++......|++++++.+ +|..++...     .......++.++.||+.||.|||++|||||||||+|||++.++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~  304 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG  304 (501)
T ss_pred             CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence            9999999999999999999965 565655432     2234566778999999999999999999999999999999999


Q ss_pred             cEEEEecccccccCCCC--CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC-CC--CHHHHHHHHH
Q 016037          288 HVMLTDFGLAKQFDENT--RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFT-GG--NRQKIQQKII  362 (396)
Q Consensus       288 ~ikL~Dfgla~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~-~~--~~~~i~~~i~  362 (396)
                      .+||+|||+++.+....  .....+||+.|+|||++.+..++.++|||||||+||||++|..++. +.  +......++.
T Consensus       305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~  384 (501)
T PHA03210        305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII  384 (501)
T ss_pred             CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence            99999999998775432  2334679999999999999999999999999999999999876443 22  2222222211


Q ss_pred             hC----CCCCC----------------------------ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          363 KD----KIKLP----------------------------AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       363 ~~----~~~~p----------------------------~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ..    ...+|                            ..++.++.++|.+||++||.+|||+.
T Consensus       385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~  449 (501)
T PHA03210        385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAA  449 (501)
T ss_pred             HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHH
Confidence            10    00011                            13567888999999999999999975

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=8.9e-39  Score=312.43  Aligned_cols=241  Identities=25%  Similarity=0.389  Sum_probs=197.6

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec-------
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-------  222 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~-------  222 (396)
                      .+|++.+.||.|+||.||+|.+..++..||+|.+.....   ...+.+.+|+.++++++||||+++++++...       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            579999999999999999999999999999999876542   3445677899999999999999998776543       


Q ss_pred             -------CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC-CCcEEEEec
Q 016037          223 -------YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHVMLTDF  294 (396)
Q Consensus       223 -------~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~-~~~ikL~Df  294 (396)
                             ..+|+||||+++ +|...+. .+.+++..++.++.||+.||.|||+.|++||||||+||+++. ++.+||+||
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df  159 (342)
T cd07854          82 VGSLTELNSVYIVQEYMET-DLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF  159 (342)
T ss_pred             cccccccceEEEEeecccc-cHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence                   358999999975 7776664 457899999999999999999999999999999999999974 557899999


Q ss_pred             ccccccCCCCC----ccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----
Q 016037          295 GLAKQFDENTR----SNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK----  365 (396)
Q Consensus       295 gla~~~~~~~~----~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~----  365 (396)
                      |+++.......    .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+....    
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07854         160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR  239 (342)
T ss_pred             ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99976543211    123357889999998754 568899999999999999999999998876655544443210    


Q ss_pred             ---------------------C-----CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 ---------------------I-----KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 ---------------------~-----~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                           .     .+...++.++.+||.+||+.+|.+|||++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  295 (342)
T cd07854         240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAE  295 (342)
T ss_pred             hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHH
Confidence                                 0     01235789999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-39  Score=302.79  Aligned_cols=241  Identities=31%  Similarity=0.489  Sum_probs=201.3

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEEEecCeEEEEEE
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      |.+.+.||+|+||+||+|.+..+++.||+|.+......  .......+|+..+++++ ||||+++++++..+...|+|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            67889999999999999999999999999998764321  11222346889999998 9999999999999999999999


Q ss_pred             ecCCCcHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccc
Q 016037          231 FVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (396)
Q Consensus       231 ~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~  308 (396)
                      |+ +|+|...+....  .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  157 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD  157 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCC
Confidence            99 778888887664  789999999999999999999999999999999999999999999999999987765444445


Q ss_pred             cccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------CCC-
Q 016037          309 MCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-------------------KIK-  367 (396)
Q Consensus       309 ~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~-------------------~~~-  367 (396)
                      ..++..|+|||.+.+ ..++.++|+||||+++|||++|+.||...+..+...++...                   ... 
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07830         158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF  237 (283)
T ss_pred             CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence            678899999998854 55789999999999999999999999887665555444321                   000 


Q ss_pred             ----------CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          368 ----------LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       368 ----------~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                +....+.++.+||..||+.+|.+||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~  275 (283)
T cd07830         238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTAS  275 (283)
T ss_pred             cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHH
Confidence                      0112368899999999999999999964

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=9.9e-39  Score=310.74  Aligned_cols=245  Identities=27%  Similarity=0.345  Sum_probs=202.3

Q ss_pred             CCeEE-EeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhh-----------HHHHHHHHHHHHHhCCCCCeeeeeE
Q 016037          150 EDFEV-LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN-----------HAEYMKSERNILTKVDHPFIVQLRY  217 (396)
Q Consensus       150 ~~~~~-~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~-----------~~~~~~~E~~~L~~l~HpnIv~l~~  217 (396)
                      ++|.. .+.||.|+||+||+|.++.+++.||+|+++........           ....+.+|+.+++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            45654 57799999999999999999999999998764322211           0123567999999999999999999


Q ss_pred             EEEecCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccc
Q 016037          218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA  297 (396)
Q Consensus       218 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla  297 (396)
                      ++..+...|++|||+.+ +|..++.....+++.....++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus        88 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         88 VYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             EEecCCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence            99999999999999974 88888888888999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCC---------------CCccccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 016037          298 KQFDEN---------------TRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKI  361 (396)
Q Consensus       298 ~~~~~~---------------~~~~~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i  361 (396)
                      ......               .......++..|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+....+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i  246 (335)
T PTZ00024        167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI  246 (335)
T ss_pred             eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            765411               112234568899999998764 4689999999999999999999999988776665555


Q ss_pred             HhCCC----------------------------CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          362 IKDKI----------------------------KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       362 ~~~~~----------------------------~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ....-                            ......+.++.+||+.||+.+|++|||+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~  308 (335)
T PTZ00024        247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK  308 (335)
T ss_pred             HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHH
Confidence            43110                            01124588999999999999999999974

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.9e-39  Score=312.55  Aligned_cols=242  Identities=26%  Similarity=0.382  Sum_probs=202.8

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCe----
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR----  224 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~----  224 (396)
                      .++|++.+.||+|+||.||+|++..++..||+|++..... .....+.+.+|+.++++++||||+++.+++.....    
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4679999999999999999999999999999999875432 23344556789999999999999999988866554    


Q ss_pred             --EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          225 --LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       225 --~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                        .|+|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD  170 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence              89999998 5588777765 5789999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------------
Q 016037          303 NTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI---------------  366 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~---------------  366 (396)
                      .  .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+.+.......+.....               
T Consensus       171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07851         171 E--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA  248 (343)
T ss_pred             c--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence            3  334567889999999865 4678999999999999999999999998776665555443211               


Q ss_pred             ----------------CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 ----------------KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 ----------------~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                      .....++.++.+||.+||+.+|.+|||+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~  293 (343)
T cd07851         249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAA  293 (343)
T ss_pred             HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHH
Confidence                            01124689999999999999999999974

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=9.7e-39  Score=298.96  Aligned_cols=244  Identities=25%  Similarity=0.431  Sum_probs=207.4

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc--hhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM--EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      +|.+.+.||+|+||.||++.+..++..+++|+++.....  .......+..|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            488999999999999999999888877888877653221  122233456789999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          229 LDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      +||+++++|...+..    ...+++..++.++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||+++......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~-~~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee-cCCEeecccCceeecCCCc
Confidence            999999999887753    35689999999999999999999999999999999999996 4679999999997764332


Q ss_pred             -CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHH
Q 016037          305 -RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKG  382 (396)
Q Consensus       305 -~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~~  382 (396)
                       ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+......++..+ ...++..++.++.++|.+
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQS  239 (260)
T ss_pred             ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHH
Confidence             233456889999999998888999999999999999999999999887777777776655 345677899999999999


Q ss_pred             hhccCCCCCCCCC
Q 016037          383 VNSLLSISVPLLS  395 (396)
Q Consensus       383 ~l~~~p~~RPs~s  395 (396)
                      ||+.+|++||++.
T Consensus       240 ~l~~~p~~Rp~~~  252 (260)
T cd08222         240 MLNKDPSLRPSAA  252 (260)
T ss_pred             HhcCChhhCcCHH
Confidence            9999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.7e-38  Score=307.59  Aligned_cols=243  Identities=28%  Similarity=0.371  Sum_probs=198.5

Q ss_pred             CeEEEeEecccCceEEEEEEEcCC--CcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEec----C
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGT--SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTK----Y  223 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~----~  223 (396)
                      +|++.+.||+|+||.||++++..+  +..||+|++.... ......+.+.+|+.+++++ +||||+++++.+...    .
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            488999999999999999999988  8999999987532 1223345567799999998 599999999875432    4


Q ss_pred             eEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      .+|+++||+. ++|...+.....+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.+...
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            5789999987 578888888888999999999999999999999999999999999999999999999999999876432


Q ss_pred             C-----CccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Q 016037          304 T-----RSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-------------  364 (396)
Q Consensus       304 ~-----~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~-------------  364 (396)
                      .     ......||..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+.......+...             
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG  238 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence            2     1234578999999998865 56899999999999999999999999876654444332221             


Q ss_pred             ---------------CCCC---CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 ---------------KIKL---PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 ---------------~~~~---p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                     ...+   -+.++.++.+||.+||+.+|.+||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~  287 (332)
T cd07857         239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVE  287 (332)
T ss_pred             hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence                           0111   124688999999999999999999964

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4e-38  Score=306.20  Aligned_cols=243  Identities=26%  Similarity=0.371  Sum_probs=198.9

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe-cCeEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-KYRLY  226 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~-~~~~~  226 (396)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.+... .....+.+..|+.+++.++||||++++++|.. ....|
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            34679999999999999999999999999999999865432 22344557789999999999999999999876 56789


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCc
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS  306 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~  306 (396)
                      +++||+. ++|..++. ...+++..+..++.|++.||.|||++|++||||+|.||+++.++.+||+|||++......  .
T Consensus        87 lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--~  162 (328)
T cd07856          87 FVTELLG-TDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--M  162 (328)
T ss_pred             EEeehhc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC--c
Confidence            9999985 57766665 456788889999999999999999999999999999999999999999999999765332  2


Q ss_pred             cccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------------------
Q 016037          307 NSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK----------------------  363 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~----------------------  363 (396)
                      ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+.+                      
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (328)
T cd07856         163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV  242 (328)
T ss_pred             CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHH
Confidence            34567889999999866 5689999999999999999999999987664332221111                      


Q ss_pred             ----CCCCCC-----ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          364 ----DKIKLP-----AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       364 ----~~~~~p-----~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                          .....|     +.++.++.++|++||+.+|.+||++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~  283 (328)
T cd07856         243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAA  283 (328)
T ss_pred             hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHH
Confidence                001111     35789999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-38  Score=300.53  Aligned_cols=242  Identities=33%  Similarity=0.502  Sum_probs=204.4

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEe
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (396)
                      |++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+..|+.+++.++|+||+++++++.....+++|+||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            5678899999999999999999999999999987542 223345567799999999999999999999999999999999


Q ss_pred             cCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Ccccc
Q 016037          232 VNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSM  309 (396)
Q Consensus       232 ~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~~~~  309 (396)
                      +++ +|..++.+. ..+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||+++...... .....
T Consensus        80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (282)
T cd07829          80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE  158 (282)
T ss_pred             cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence            985 898888776 579999999999999999999999999999999999999999999999999998765433 22334


Q ss_pred             ccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------------CCCCC-
Q 016037          310 CGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD------------------KIKLP-  369 (396)
Q Consensus       310 ~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~------------------~~~~p-  369 (396)
                      .++..|+|||.+.+. .++.++||||||+++|||++|+.||.+.+......++...                  ...++ 
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd07829         159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK  238 (282)
T ss_pred             ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence            567889999999776 7899999999999999999999999987766655544321                  00111 


Q ss_pred             ----------ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          370 ----------AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       370 ----------~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                +.++.++.++|++||..+|.+||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~  274 (282)
T cd07829         239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAK  274 (282)
T ss_pred             cCccchHHhcccccHHHHHHHHHhhccCcccCCCHH
Confidence                      13578999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-38  Score=309.80  Aligned_cols=240  Identities=28%  Similarity=0.388  Sum_probs=197.7

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec------C
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------Y  223 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~------~  223 (396)
                      .+|.+.+.||+|+||.||+|++..+++.||+|++.+... .......+.+|+.+++.++||||+++++++...      .
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            579999999999999999999999999999999876432 222334567899999999999999999998654      3


Q ss_pred             eEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      .+|+|+||+.. +|....  ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.... 
T Consensus        94 ~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~-  169 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-  169 (342)
T ss_pred             eEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-
Confidence            56999999975 555443  34689999999999999999999999999999999999999999999999999976533 


Q ss_pred             CCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------------
Q 016037          304 TRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD------------------  364 (396)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~------------------  364 (396)
                       ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+.......+...                  
T Consensus       170 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (342)
T cd07879         170 -EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK  248 (342)
T ss_pred             -CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchH
Confidence             2234567899999999876 45889999999999999999999999987765554444321                  


Q ss_pred             -----CCCC--------CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 -----KIKL--------PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 -----~~~~--------p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                           ...+        .+..+.++.+||.+||+.+|.+||+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~  292 (342)
T cd07879         249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTAT  292 (342)
T ss_pred             HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHH
Confidence                 0001        124678899999999999999999864

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.7e-38  Score=305.89  Aligned_cols=238  Identities=22%  Similarity=0.320  Sum_probs=192.5

Q ss_pred             Eeccc--CceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCC
Q 016037          157 VVGQG--AFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (396)
Q Consensus       157 ~IG~G--~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (396)
                      +||+|  ++|.||.++...+++.||+|+++.... .....+.+..|+.+++.++||||++++++|......|++|||+++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhHhhcCCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            34444  556677777777999999999987532 334556788999999999999999999999999999999999999


Q ss_pred             CcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC-------
Q 016037          235 GHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-------  305 (396)
Q Consensus       235 g~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~-------  305 (396)
                      |+|..++...  ..+++..++.++.|++.||.|||+++|+||||||+||+++.++.+||+|||.+........       
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~  163 (314)
T cd08216          84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD  163 (314)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence            9999988764  4688999999999999999999999999999999999999999999999998875532211       


Q ss_pred             -ccccccCCCccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhC-----------------
Q 016037          306 -SNSMCGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ-QKIIKD-----------------  364 (396)
Q Consensus       306 -~~~~~gt~~y~APE~l~~--~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~-~~i~~~-----------------  364 (396)
                       .....++..|+|||++.+  ..++.++|||||||++|||++|+.||......... +++...                 
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
T cd08216         164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM  243 (314)
T ss_pred             ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence             233456788999999976  45889999999999999999999999876543322 222100                 


Q ss_pred             ----------------CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 ----------------KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 ----------------~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                      ....+..++.++.+||..||+.+|.+|||+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~  290 (314)
T cd08216         244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSAS  290 (314)
T ss_pred             CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHH
Confidence                            0111234567899999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.1e-38  Score=310.92  Aligned_cols=244  Identities=31%  Similarity=0.462  Sum_probs=199.1

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEec--CeE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTK--YRL  225 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~--~~~  225 (396)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|.+..... .......+.+|+.+++++ +||||+++++++...  ..+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4679999999999999999999999999999998865322 122334566799999999 999999999988653  468


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-  304 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-  304 (396)
                      |+||||+.+ +|..++... .+.+...+.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....... 
T Consensus        85 ~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          85 YLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE  162 (337)
T ss_pred             EEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence            999999985 887777665 78888889999999999999999999999999999999999999999999998764322 


Q ss_pred             -----CccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Q 016037          305 -----RSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-------------  365 (396)
Q Consensus       305 -----~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~-------------  365 (396)
                           ......|+..|+|||.+.+ ..++.++||||||+++|+|+||+.||.+........++....             
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07852         163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS  242 (337)
T ss_pred             cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence                 2233568899999998865 457899999999999999999999998765544433332210             


Q ss_pred             ---------------C---CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 ---------------I---KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 ---------------~---~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                     .   ...+.++.++.+||..||+.+|.+|||+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~  290 (337)
T cd07852         243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAE  290 (337)
T ss_pred             hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHH
Confidence                           0   11123789999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=299.21  Aligned_cols=246  Identities=24%  Similarity=0.359  Sum_probs=203.2

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHH-HhCCCCCeeeeeEEEEecCeE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL-TKVDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L-~~l~HpnIv~l~~~~~~~~~~  225 (396)
                      +..++.+-+..||.|+||+|++-.++.+|+..|||.|+....  .....++..|.+.. +.-+.||||++|+....++..
T Consensus        61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc  138 (361)
T KOG1006|consen   61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC  138 (361)
T ss_pred             cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce
Confidence            344567778889999999999999999999999999998764  23344456666654 455799999999999999999


Q ss_pred             EEEEEecCCCcHHHHH-----HHhcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          226 YLVLDFVNGGHLFFQL-----YRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l-----~~~~~l~e~~~~~~~~qi~~aL~~LH~~-~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                      ||.||+|+- +|..+.     .++..++|+.+-.+....+.||.||.+. .|||||+||+|||++..|.+||||||++..
T Consensus       139 WiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq  217 (361)
T KOG1006|consen  139 WICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ  217 (361)
T ss_pred             eeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHh
Confidence            999999976 332211     2456799999999999999999999876 899999999999999999999999999998


Q ss_pred             cCCCCCccccccCCCccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCC---CCc---
Q 016037          300 FDENTRSNSMCGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQKIIKDKIK---LPA---  370 (396)
Q Consensus       300 ~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~DvwSlGvil~elltg~~Pf~~~~-~~~i~~~i~~~~~~---~p~---  370 (396)
                      +.++-......|...|||||.+..  .+|+.++||||||++|||++||..||.+.+ ..+....+..+.++   .+.   
T Consensus       218 Lv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~  297 (361)
T KOG1006|consen  218 LVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECV  297 (361)
T ss_pred             HHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccc
Confidence            877766667789999999999954  569999999999999999999999998764 33333344445443   222   


Q ss_pred             cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          371 FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       371 ~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ..|..+..+|..||.+|-.+||+++
T Consensus       298 ~~s~~~~~fintCl~Kd~~~Rpky~  322 (361)
T KOG1006|consen  298 HYSFSMVRFINTCLIKDRSDRPKYD  322 (361)
T ss_pred             ccCHHHHHHHHHHhhcccccCcchh
Confidence            3899999999999999999999986

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.1e-38  Score=292.56  Aligned_cols=220  Identities=30%  Similarity=0.451  Sum_probs=189.0

Q ss_pred             cCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCCCcHHHH
Q 016037          161 GAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQ  240 (396)
Q Consensus       161 G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~  240 (396)
                      |.+|+||+++++.+++.||+|+++....        ...|...+....||||+++++++......|++|||+++|+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            8899999999999999999999976431        22345555566799999999999999999999999999999999


Q ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccccccCCCccchhh
Q 016037          241 LYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI  320 (396)
Q Consensus       241 l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~~gt~~y~APE~  320 (396)
                      +.+...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||.+......  .....++..|+|||.
T Consensus        76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~  153 (237)
T cd05576          76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEV  153 (237)
T ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcc
Confidence            988888999999999999999999999999999999999999999999999999988765433  233456788999999


Q ss_pred             hcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCCCCC
Q 016037          321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       321 l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs~  394 (396)
                      +.+..++.++||||+|+++|||++|+.||...... +.   ....+.+|..+++++++||++||+.||.+||+.
T Consensus       154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSG-IN---THTTLNIPEWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-cc---cccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence            98888999999999999999999999988643211 10   112456788899999999999999999999985

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-39  Score=321.06  Aligned_cols=241  Identities=35%  Similarity=0.481  Sum_probs=198.3

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC------
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY------  223 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~------  223 (396)
                      ..|..-+.||+|+||.||+|+++.+|+.||||.+++..  .....+..-+|+++|++++|+|||+++++-++..      
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~   90 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR   90 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence            45777788999999999999999999999999998765  3344566778999999999999999988776544      


Q ss_pred             eEEEEEEecCCCcHHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc--CCC--cEEEEeccc
Q 016037          224 RLYLVLDFVNGGHLFFQLYR---QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD--ADG--HVMLTDFGL  296 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~--~~~--~ikL~Dfgl  296 (396)
                      ...+|||||.||+|+..+.+   ...+++.....++.+++.||.|||++||+||||||.||++-  .+|  ..||+|||.
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            46899999999999998864   35799999999999999999999999999999999999883  334  379999999


Q ss_pred             ccccCCCCCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhC-------
Q 016037          297 AKQFDENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKD-------  364 (396)
Q Consensus       297 a~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~----~~~~i~~~i~~~-------  364 (396)
                      |+.++++....+.+||..|.+||.+.. +.|+..+|.|||||++|+++||..||...    +..++...+...       
T Consensus       171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i  250 (732)
T KOG4250|consen  171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI  250 (732)
T ss_pred             cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence            999999988899999999999999984 78999999999999999999999999642    122233333211       


Q ss_pred             --------------CCCCCccCCH----HHHHHHHHhhccCCCCCC
Q 016037          365 --------------KIKLPAFLSS----EAHSLLKGVNSLLSISVP  392 (396)
Q Consensus       365 --------------~~~~p~~~s~----~~~~li~~~l~~~p~~RP  392 (396)
                                    .+++|..+++    .+..++..+|+.+|.+|=
T Consensus       251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                          2234445555    355667788888887763

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.8e-39  Score=337.48  Aligned_cols=243  Identities=30%  Similarity=0.460  Sum_probs=201.6

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec-----
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----  222 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~-----  222 (396)
                      -..+|+.+..||+||||.||+++++-+|+.||||+|....  .......+.+|+.+|++|+|||||++|..|.+.     
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            3568999999999999999999999999999999998765  445566688999999999999999996444210     


Q ss_pred             --------------------------------------------------------------------------------
Q 016037          223 --------------------------------------------------------------------------------  222 (396)
Q Consensus       223 --------------------------------------------------------------------------------  222 (396)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------------CeEEEEEEecCCCcHHHHHHHhcCC-CHHHHHHHHHHHHHHHHHHH
Q 016037          223 ----------------------------------YRLYLVLDFVNGGHLFFQLYRQGLF-REDLARIYTAEIVSAVSHLH  267 (396)
Q Consensus       223 ----------------------------------~~~~lV~E~~~gg~L~~~l~~~~~l-~e~~~~~~~~qi~~aL~~LH  267 (396)
                                                        ..+||-||||+..++.+++.++... ..+..|.+++||++||.|+|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence                                              1258999999998777777665554 46788999999999999999


Q ss_pred             HCCceeccCCCCCEEEcCCCcEEEEecccccccC-------------------CCCCccccccCCCccchhhhcCC---C
Q 016037          268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-------------------ENTRSNSMCGTLEYMSPEIVLGK---G  325 (396)
Q Consensus       268 ~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~-------------------~~~~~~~~~gt~~y~APE~l~~~---~  325 (396)
                      ++|||||||||.||+++.++.|||+|||+|+...                   ......+.+||..|+|||++.+.   .
T Consensus       715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~  794 (1351)
T KOG1035|consen  715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK  794 (1351)
T ss_pred             hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence            9999999999999999999999999999998721                   01134567899999999999764   4


Q ss_pred             CCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          326 HDKAADWWSVGILLFEMLTGQPPFT-GGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       326 ~~~~~DvwSlGvil~elltg~~Pf~-~~~~~~i~~~i~~~~~~~p~----~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      |+.|+||||||++++||+.   ||. ..+...+..++.++.+++|.    .--+.-..+|.+||+.||.+|||+.
T Consensus       795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~  866 (1351)
T KOG1035|consen  795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTAT  866 (1351)
T ss_pred             ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHH
Confidence            9999999999999999986   564 34566777778877777663    2345678899999999999999974

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=324.54  Aligned_cols=251  Identities=24%  Similarity=0.402  Sum_probs=215.5

Q ss_pred             CccccCCCeEEEeEecccCceEEEEEEEcC-------CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeee
Q 016037          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIG-------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQL  215 (396)
Q Consensus       144 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l  215 (396)
                      .+.+..++..+.+.||+|.||.|++|..++       ....||||.++.....  ...+.+..|+++|+.+ .|+||+.+
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~l  367 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNL  367 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhh
Confidence            455666677788899999999999997542       1456999998766532  5567788999999998 69999999


Q ss_pred             eEEEEecCeEEEEEEecCCCcHHHHHHHhc----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 016037          216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPE  279 (396)
Q Consensus       216 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~  279 (396)
                      ++++...+.+++|+||+..|+|..+++.++                .+.......++.||+.|++||++.++|||||..+
T Consensus       368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR  447 (609)
T KOG0200|consen  368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR  447 (609)
T ss_pred             eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence            999999999999999999999999998776                3778888999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEEecccccccCCCCCcc--ccc--cCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC-
Q 016037          280 NILLDADGHVMLTDFGLAKQFDENTRSN--SMC--GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGN-  353 (396)
Q Consensus       280 NILl~~~~~ikL~Dfgla~~~~~~~~~~--~~~--gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~-  353 (396)
                      |||++.+..+||+|||+|+.........  ...  -...|||||.+....|+.++||||||++||||+| |..||.+.. 
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~  527 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP  527 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence            9999999999999999999654433221  111  2456999999999999999999999999999999 999999855 


Q ss_pred             HHHHHHHHHhC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCCC
Q 016037          354 RQKIQQKIIKD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       354 ~~~i~~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s~  396 (396)
                      ..++.+.+..+ ++..|..++.++.++|+.||+.+|.+||++++
T Consensus       528 ~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~  571 (609)
T KOG0200|consen  528 TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSE  571 (609)
T ss_pred             HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHH
Confidence            66777777776 77999999999999999999999999999763

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=316.49  Aligned_cols=242  Identities=30%  Similarity=0.508  Sum_probs=214.9

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEe-----cC
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQT-----KY  223 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~-----~~  223 (396)
                      +-|++..+||.|.+|+||+++.+.+++.+|+|+.....    +..+.+..|.++|+.+ +|||++..|++|-.     ++
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            56999999999999999999999999999999987654    3345567789999987 69999999999843     56


Q ss_pred             eEEEEEEecCCCcHHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          224 RLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      .+|||||||.||+.-++++.  ...+.|.++..++.+++.|+.+||.+.+||||||-.|||++.++.+||+|||.+..++
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld  174 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  174 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence            89999999999999888764  4678899999999999999999999999999999999999999999999999998876


Q ss_pred             CC-CCccccccCCCccchhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCCccC
Q 016037          302 EN-TRSNSMCGTLEYMSPEIVLG-----KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFL  372 (396)
Q Consensus       302 ~~-~~~~~~~gt~~y~APE~l~~-----~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~---~~~~p~~~  372 (396)
                      .. .+.++.+|||.|||||++..     ..|+..+|+||||++..||.-|.+|+.+..++..+-+|-.+   ++.-|..+
T Consensus       175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kW  254 (953)
T KOG0587|consen  175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKW  254 (953)
T ss_pred             cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhH
Confidence            54 34577889999999999954     35678899999999999999999999999999999888887   33457789


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCC
Q 016037          373 SSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       373 s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +.++.+||..||.+|..+||+..
T Consensus       255 s~~FndFIs~cL~Kd~e~RP~~~  277 (953)
T KOG0587|consen  255 SKKFNDFISTCLVKDYEQRPSTE  277 (953)
T ss_pred             HHHHHHHHHHHHhhccccCcchh
Confidence            99999999999999999999875

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-38  Score=268.93  Aligned_cols=243  Identities=27%  Similarity=0.465  Sum_probs=207.9

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      +|..+++||+|.||+||+|+...+++.||+|.++.+...+.- -....+|+-+|+.++|.|||++++....+..+-+|+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegv-pssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGV-PSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCC-cHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            567788999999999999999999999999999987644333 3445679999999999999999999999999999999


Q ss_pred             ecCCCcHHHHH-HHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC-ccc
Q 016037          231 FVNGGHLFFQL-YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNS  308 (396)
Q Consensus       231 ~~~gg~L~~~l-~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~-~~~  308 (396)
                      ||.. +|..+. .-++.+..+.++.++.|+++||.++|++++.||||||+|.||+.+|++||+|||+++.+.-..+ .+.
T Consensus        82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysa  160 (292)
T KOG0662|consen   82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA  160 (292)
T ss_pred             HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec
Confidence            9987 454444 4567889999999999999999999999999999999999999999999999999998865543 345


Q ss_pred             cccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC--CC---------C--------
Q 016037          309 MCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD--KI---------K--------  367 (396)
Q Consensus       309 ~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~--~~---------~--------  367 (396)
                      .+.|.+|++|.++.+ +-|+...|+||-||++.|+.. |++.|.+.+.++..++|...  .+         .        
T Consensus       161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp  240 (292)
T KOG0662|consen  161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP  240 (292)
T ss_pred             eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence            577999999999988 458999999999999999998 99999999998888888632  11         1        


Q ss_pred             -CC---------ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          368 -LP---------AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       368 -~p---------~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                       +|         +.++..-++|+..+|.++|.+|.++.
T Consensus       241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisae  278 (292)
T KOG0662|consen  241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAE  278 (292)
T ss_pred             CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHH
Confidence             11         23566789999999999999998753

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-37  Score=292.92  Aligned_cols=253  Identities=26%  Similarity=0.369  Sum_probs=202.5

Q ss_pred             CCCCCCCCCCCCccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHh--CCCC
Q 016037          133 PTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK--VDHP  210 (396)
Q Consensus       133 ~~~~~~~~~~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~--l~Hp  210 (396)
                      .+|+...+|--.++....+..+.+.||+|.||+||+|+|.+  +.||||++....      .+...+|.++.+.  |+|+
T Consensus       194 tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wrG--e~VAVKiF~srd------E~SWfrEtEIYqTvmLRHE  265 (513)
T KOG2052|consen  194 TSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWRG--EDVAVKIFSSRD------ERSWFRETEIYQTVMLRHE  265 (513)
T ss_pred             cCCCCCCchhHhHHhhhheeEEEEEecCccccceeeccccC--CceEEEEecccc------hhhhhhHHHHHHHHHhccc
Confidence            34445566777777778899999999999999999999954  669999996532      2234557777765  6999


Q ss_pred             CeeeeeEEEEec----CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCC
Q 016037          211 FIVQLRYSFQTK----YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--------GIMHRDLKP  278 (396)
Q Consensus       211 nIv~l~~~~~~~----~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~--------~iiHrDlkp  278 (396)
                      ||+.+++.-...    ..+|||++|.+.|+|+++|.+ ..++.+....++..++.||+|||..        .|.|||||+
T Consensus       266 NILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKS  344 (513)
T KOG2052|consen  266 NILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKS  344 (513)
T ss_pred             hhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccc
Confidence            999998776443    378999999999999999998 5667777778899999999999974        499999999


Q ss_pred             CCEEEcCCCcEEEEecccccccCCCC-----CccccccCCCccchhhhcCCC----C--CchhhHHHHHHHHHHHHhC--
Q 016037          279 ENILLDADGHVMLTDFGLAKQFDENT-----RSNSMCGTLEYMSPEIVLGKG----H--DKAADWWSVGILLFEMLTG--  345 (396)
Q Consensus       279 ~NILl~~~~~ikL~Dfgla~~~~~~~-----~~~~~~gt~~y~APE~l~~~~----~--~~~~DvwSlGvil~elltg--  345 (396)
                      +|||+..+|.+.|+|+|+|-...+..     ..+..+||.+|||||++...-    +  -..+||||||+++||++.+  
T Consensus       345 KNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~  424 (513)
T KOG2052|consen  345 KNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCE  424 (513)
T ss_pred             ccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhh
Confidence            99999999999999999998876543     246789999999999996532    2  2469999999999999874  


Q ss_pred             --------CCCCCC-----CCHHHHHHHHHhC--CCCCCccCCH-----HHHHHHHHhhccCCCCCCCC
Q 016037          346 --------QPPFTG-----GNRQKIQQKIIKD--KIKLPAFLSS-----EAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       346 --------~~Pf~~-----~~~~~i~~~i~~~--~~~~p~~~s~-----~~~~li~~~l~~~p~~RPs~  394 (396)
                              ++||.+     .+.+++.+.+.-+  ++.+|..++.     .+.+||+.||..||..|-++
T Consensus       425 ~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA  493 (513)
T KOG2052|consen  425 SGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA  493 (513)
T ss_pred             cCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence                    578875     4556665555444  6677766543     57888999999999998653

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=4.3e-36  Score=275.34  Aligned_cols=232  Identities=46%  Similarity=0.738  Sum_probs=205.6

Q ss_pred             CceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCCCcHHHHH
Q 016037          162 AFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL  241 (396)
Q Consensus       162 ~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l  241 (396)
                      +||.||+|.+..+++.+|+|++........  .+.+.+|++.+++++|+||+++++++......++++||+.+++|..++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            589999999999999999999976543221  567888999999999999999999999999999999999999999998


Q ss_pred             HHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccccccCCCccchhhh
Q 016037          242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV  321 (396)
Q Consensus       242 ~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~~gt~~y~APE~l  321 (396)
                      .....++...++.++.+++.++.|||+.+++|+||+|.||+++.++.++|+|||.+.............++..|++||.+
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~  158 (244)
T smart00220       79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence            87776899999999999999999999999999999999999999999999999999887665455566788999999999


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcc---CCHHHHHHHHHhhccCCCCCCCCC
Q 016037          322 LGKGHDKAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKIIKDKIKLPAF---LSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       322 ~~~~~~~~~DvwSlGvil~elltg~~Pf~~-~~~~~i~~~i~~~~~~~p~~---~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .+..++.++||||||+++|+|++|..||.. .+...+.+.+..........   ++.++.+++.+||..+|.+||++.
T Consensus       159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~  236 (244)
T smart00220      159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAE  236 (244)
T ss_pred             ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHH
Confidence            988899999999999999999999999988 66666666666665544433   899999999999999999999874

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-38  Score=282.15  Aligned_cols=308  Identities=21%  Similarity=0.293  Sum_probs=263.7

Q ss_pred             cCCCCCCcccccccccccchhhhhhccC-CccCCcccccCCCCCCcccc-cccCCCCCCCCCCCCCCccccCCCeEEEeE
Q 016037           80 SLVGPSSYVSQSLKLSKLTLHEAEDSLG-LVEGINEETQEGPNNLSVVD-AALGKPTGHIDNLPSENQCVGLEDFEVLKV  157 (396)
Q Consensus        80 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (396)
                      -|+..++.+..+|+.+.++++++.+.+. .+..+.+..++.++.+++.+ .|.+..++..+...+...++..++..++.+
T Consensus       118 dli~~ga~v~icnk~g~tpldkakp~l~~~l~e~aek~gq~~nripfkdt~wkgtktr~rdatlsr~~gid~~~lnl~tk  197 (448)
T KOG0195|consen  118 DLISCGAAVNICNKKGMTPLDKAKPMLKNTLLEIAEKHGQSPNRIPFKDTTWKGTKTRTRDATLSRYTGIDVSSLNLITK  197 (448)
T ss_pred             HHHhccceeeecccCCCCchhhhchHHHHHHHHHHHHhCCCCCcccccccccccccccccccccccccCcchhhhhhhhh
Confidence            4677899999999999999999999887 67777888899999888887 567888888899999999999999999999


Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCCCcH
Q 016037          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL  237 (396)
Q Consensus       158 IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L  237 (396)
                      |.+...|+.|+|+|++++  ++.|++...... ....+.+.+|.-.|+.+.||||+++++.|....++.++..||+-|+|
T Consensus       198 l~e~hsgelwrgrwqgnd--ivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl  274 (448)
T KOG0195|consen  198 LAESHSGELWRGRWQGND--IVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL  274 (448)
T ss_pred             hccCCCcccccccccCcc--hhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence            999999999999998876  566766554332 23345578899999999999999999999999999999999999999


Q ss_pred             HHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHHC-Cceec-cCCCCCEEEcCCCcEEEE--ecccccccCCCCCcccccc
Q 016037          238 FFQLYRQGL--FREDLARIYTAEIVSAVSHLHAN-GIMHR-DLKPENILLDADGHVMLT--DFGLAKQFDENTRSNSMCG  311 (396)
Q Consensus       238 ~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~-~iiHr-Dlkp~NILl~~~~~ikL~--Dfgla~~~~~~~~~~~~~g  311 (396)
                      +..++.+..  +...++..++.+|++|++|||+. .++-| .|.+..+++|++.+.+|.  |-.++  +.+..+.    -
T Consensus       275 ynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs--fqe~gr~----y  348 (448)
T KOG0195|consen  275 YNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS--FQEVGRA----Y  348 (448)
T ss_pred             HHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee--eeccccc----c
Confidence            999988765  45567788999999999999998 45555 899999999999887765  54333  2233222    3


Q ss_pred             CCCccchhhhcCCCCC---chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHHHhhcc
Q 016037          312 TLEYMSPEIVLGKGHD---KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPAFLSSEAHSLLKGVNSL  386 (396)
Q Consensus       312 t~~y~APE~l~~~~~~---~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--~~~~p~~~s~~~~~li~~~l~~  386 (396)
                      .|.||+||.++.+.-+   .++|+|||++++|||.|.+.||.+..++++..+|..+  +..+|+++|..+..||+-|++.
T Consensus       349 ~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icmne  428 (448)
T KOG0195|consen  349 SPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNE  428 (448)
T ss_pred             CcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcC
Confidence            5899999999876544   6899999999999999999999999999999999876  7789999999999999999999


Q ss_pred             CCCCCCCCCC
Q 016037          387 LSISVPLLSR  396 (396)
Q Consensus       387 ~p~~RPs~s~  396 (396)
                      ||.+||.++.
T Consensus       429 dpgkrpkfdm  438 (448)
T KOG0195|consen  429 DPGKRPKFDM  438 (448)
T ss_pred             CCCcCCCcce
Confidence            9999999863

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=295.24  Aligned_cols=243  Identities=30%  Similarity=0.501  Sum_probs=202.8

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhH----HHHHHHHHHHHHhCCCCCeeeeeEEEE-ecCe
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNH----AEYMKSERNILTKVDHPFIVQLRYSFQ-TKYR  224 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~----~~~~~~E~~~L~~l~HpnIv~l~~~~~-~~~~  224 (396)
                      ++|-++..||+|+|++||+|.+....+.||+|+-..+..+.++.    .+..-+|.++-+.|+||.||++|++|. +...
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            56888899999999999999999999999999876655544332    334557999999999999999999995 4567


Q ss_pred             EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCCEEEcC---CCcEEEEecccccc
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--GIMHRDLKPENILLDA---DGHVMLTDFGLAKQ  299 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~--~iiHrDlkp~NILl~~---~~~ikL~Dfgla~~  299 (396)
                      +|-|+|||+|.+|..+|+.++.++|..++.++.||+.||.||.+.  .|||-||||.|||+-.   -|.+||+|||+++.
T Consensus       543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI  622 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI  622 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence            899999999999999999999999999999999999999999987  6999999999999944   35799999999998


Q ss_pred             cCCCCC--------ccccccCCCccchhhhcC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHH--HHhC
Q 016037          300 FDENTR--------SNSMCGTLEYMSPEIVLG----KGHDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQK--IIKD  364 (396)
Q Consensus       300 ~~~~~~--------~~~~~gt~~y~APE~l~~----~~~~~~~DvwSlGvil~elltg~~Pf~~~~-~~~i~~~--i~~~  364 (396)
                      ++....        ++...||.+|++||.+.-    ...+.++||||.||++|.++.|+.||.... .++|.+.  |.+.
T Consensus       623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA  702 (775)
T KOG1151|consen  623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA  702 (775)
T ss_pred             ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc
Confidence            864322        355779999999999843    346889999999999999999999997643 2333322  2222


Q ss_pred             -CCCCC--ccCCHHHHHHHHHhhccCCCCCC
Q 016037          365 -KIKLP--AFLSSEAHSLLKGVNSLLSISVP  392 (396)
Q Consensus       365 -~~~~p--~~~s~~~~~li~~~l~~~p~~RP  392 (396)
                       +..||  +.+|+++++||+.||.+-.++|-
T Consensus       703 tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~  733 (775)
T KOG1151|consen  703 TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRI  733 (775)
T ss_pred             eeccCCCCCccCHHHHHHHHHHHHhhhhhhh
Confidence             45566  57999999999999999888774

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=290.52  Aligned_cols=242  Identities=26%  Similarity=0.424  Sum_probs=200.8

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC--C----CeeeeeEEEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH--P----FIVQLRYSFQ  220 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~H--p----nIv~l~~~~~  220 (396)
                      +-.++|++++.+|+|.||+|-++.+..++..||+|+++.-    ....+...-|+++|.++.+  |    -+|++.++|.
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd  161 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD  161 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence            3457899999999999999999999999999999999753    3556667789999999842  2    4888999999


Q ss_pred             ecCeEEEEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC-------------
Q 016037          221 TKYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-------------  285 (396)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~-------------  285 (396)
                      -.++.|||+|.+. -++++++..+  .+++.++++.+++|++++++|||+.+++|-||||+|||+..             
T Consensus       162 yrghiCivfellG-~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  162 YRGHICIVFELLG-LSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             ccCceEEEEeccC-hhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence            9999999999984 4788999876  46899999999999999999999999999999999999842             


Q ss_pred             -------CCcEEEEecccccccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--
Q 016037          286 -------DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQK--  356 (396)
Q Consensus       286 -------~~~ikL~Dfgla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~--  356 (396)
                             +..|+|+|||.|+...+..  +..+.|..|+|||++.+.+++..+||||+||||+|++||...|...+.-+  
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL  318 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL  318 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence                   2369999999998754433  56778999999999999999999999999999999999999998765333  


Q ss_pred             -HHHHHHhC------------------CCCCCc-------------------------cCCHHHHHHHHHhhccCCCCCC
Q 016037          357 -IQQKIIKD------------------KIKLPA-------------------------FLSSEAHSLLKGVNSLLSISVP  392 (396)
Q Consensus       357 -i~~~i~~~------------------~~~~p~-------------------------~~s~~~~~li~~~l~~~p~~RP  392 (396)
                       +++.|...                  ++..|.                         ....++.+||+.||.+||.+|+
T Consensus       319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri  398 (415)
T KOG0671|consen  319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI  398 (415)
T ss_pred             HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence             45554431                  111010                         1234688999999999999999


Q ss_pred             CCC
Q 016037          393 LLS  395 (396)
Q Consensus       393 s~s  395 (396)
                      |+.
T Consensus       399 Tl~  401 (415)
T KOG0671|consen  399 TLR  401 (415)
T ss_pred             cHH
Confidence            975

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-37  Score=308.61  Aligned_cols=242  Identities=24%  Similarity=0.339  Sum_probs=213.0

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCc----EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      ..+..++||.|+||+||+|.|.-.|+    +||+|++....  .......+.+|+-.|.+++|||+++|++++.... +.
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence            45667899999999999999976665    57888876544  3344566888999999999999999999998765 88


Q ss_pred             EEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC
Q 016037          227 LVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~  305 (396)
                      ||++||++|.|.++++.+ ..+-.+....|..||++||.|||.++++||||..+|||+..-.++|++|||+++.......
T Consensus       774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999999999765 5677778888999999999999999999999999999999999999999999998765444


Q ss_pred             ccc---cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHH
Q 016037          306 SNS---MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLL  380 (396)
Q Consensus       306 ~~~---~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li  380 (396)
                      ...   ..-.+.|||-|.+....|+.++|||||||++||++| |..||.+....+|-..+.++ ++.-|+.++.++.-+|
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m  933 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM  933 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence            322   223678999999999999999999999999999999 99999999999999988886 8889999999999999


Q ss_pred             HHhhccCCCCCCCCC
Q 016037          381 KGVNSLLSISVPLLS  395 (396)
Q Consensus       381 ~~~l~~~p~~RPs~s  395 (396)
                      .+||-.|+..||.++
T Consensus       934 vkCwmid~~~rp~fk  948 (1177)
T KOG1025|consen  934 VKCWMIDADSRPTFK  948 (1177)
T ss_pred             HHHhccCcccCccHH
Confidence            999999999999875

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=8e-37  Score=280.29  Aligned_cols=246  Identities=28%  Similarity=0.474  Sum_probs=194.5

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCC----cEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe-cC
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTS----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-KY  223 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~-~~  223 (396)
                      ...|+.++.||+|.||.||+|..+++.    +.||+|.++.+...... ....-+|+.+++.++|||++.|..+|.+ +.
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGi-S~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGI-SMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCc-CHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            457999999999999999999765543    36899999765422222 2334569999999999999999999876 88


Q ss_pred             eEEEEEEecCCCcHHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC----CcEEEEec
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQ-----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD----GHVMLTDF  294 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~----~~ikL~Df  294 (396)
                      .+++++||.+. +|.+.++.+     ..++..+++.++.||+.|+.|||++=|+||||||.|||+..+    |.+||+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            99999999988 566666432     468899999999999999999999999999999999999888    89999999


Q ss_pred             ccccccCCCC----CccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHH
Q 016037          295 GLAKQFDENT----RSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ---------KIQQK  360 (396)
Q Consensus       295 gla~~~~~~~----~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~---------~i~~~  360 (396)
                      |+++.+...-    .....+.|.+|+|||.+.| ..|+.+.|||+.||++.||+|-++.|.+....         ....+
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            9999886542    2345678999999999988 56899999999999999999999988764210         11111


Q ss_pred             HHh--CC---------CCCCc--------------------------cCCHHHHHHHHHhhccCCCCCCCCCC
Q 016037          361 IIK--DK---------IKLPA--------------------------FLSSEAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       361 i~~--~~---------~~~p~--------------------------~~s~~~~~li~~~l~~~p~~RPs~s~  396 (396)
                      |.+  +.         .++|.                          .-++.+.+|+..||++||.+|.+.+|
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~q  333 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQ  333 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHH
Confidence            110  00         01111                          13556999999999999999998754

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=263.73  Aligned_cols=220  Identities=26%  Similarity=0.472  Sum_probs=184.2

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHh-CCCCCeeeeeEEEEecCeE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~-l~HpnIv~l~~~~~~~~~~  225 (396)
                      +..++..-+..||+|+||.|-+.++..+|...|+|.++..-.  .+..+++..|+++... ..+|++|.+|+.+.....+
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            444567777889999999999999999999999999986542  3344556678887665 4799999999999999999


Q ss_pred             EEEEEecCCCcHH----HHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEeccccccc
Q 016037          226 YLVLDFVNGGHLF----FQLYRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       226 ~lV~E~~~gg~L~----~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~-~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~  300 (396)
                      ||.||.|+. +|.    ..+.+.+.++|..+-.++..++.||.|||++ .+||||+||.|||++.+|++|+||||++..+
T Consensus       121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL  199 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence            999999976 443    2334567899999999999999999999998 8999999999999999999999999999988


Q ss_pred             CCCCCccccccCCCccchhhhcC----CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhC-CCCCC
Q 016037          301 DENTRSNSMCGTLEYMSPEIVLG----KGHDKAADWWSVGILLFEMLTGQPPFTGG-NRQKIQQKIIKD-KIKLP  369 (396)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~DvwSlGvil~elltg~~Pf~~~-~~~~i~~~i~~~-~~~~p  369 (396)
                      .++.......|...|||||.+..    ..|+.++||||||+++.||++++.||..+ ++-+....++.. .+.+|
T Consensus       200 ~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp  274 (282)
T KOG0984|consen  200 VDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLP  274 (282)
T ss_pred             hhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCc
Confidence            77766666778899999999843    47999999999999999999999999874 455666666654 33444

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=9.1e-36  Score=328.17  Aligned_cols=231  Identities=19%  Similarity=0.265  Sum_probs=184.1

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      .|...+.||+|+||.||+|+++.++..||+|.+.....       ....|+.++++++|||||++++++.+....|+|||
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence            46667889999999999999999999999999865321       11346788999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCcc
Q 016037          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH---ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN  307 (396)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH---~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~  307 (396)
                      |+++|+|.+++..   +++..+..++.|++.||+|||   +.+|+||||||+||+++.++..++. ||.......   ..
T Consensus       764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~~  836 (968)
T PLN00113        764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---DT  836 (968)
T ss_pred             CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---CC
Confidence            9999999998853   788889999999999999999   6699999999999999999888776 665543321   12


Q ss_pred             ccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHH---------hCC----CCCC
Q 016037          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN-----RQKIQQKII---------KDK----IKLP  369 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~-----~~~i~~~i~---------~~~----~~~p  369 (396)
                      ...||+.|||||++.+..++.++|||||||++|||+||+.||....     ..+......         ...    ...+
T Consensus       837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  916 (968)
T PLN00113        837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN  916 (968)
T ss_pred             CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence            3368899999999999999999999999999999999999985421     111111110         000    1111


Q ss_pred             ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          370 AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       370 ~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .....++.+++.+||+.+|.+||++.
T Consensus       917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~  942 (968)
T PLN00113        917 QNEIVEVMNLALHCTATDPTARPCAN  942 (968)
T ss_pred             HHHHHHHHHHHHhhCcCCchhCcCHH
Confidence            22234678899999999999999975

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-35  Score=281.83  Aligned_cols=239  Identities=23%  Similarity=0.387  Sum_probs=197.9

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHh--CCCCCeeeeeEEEEecC-
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK--VDHPFIVQLRYSFQTKY-  223 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~--l~HpnIv~l~~~~~~~~-  223 (396)
                      .......++.+||+|.||.||+|...  ++.||||++..      ...+.+++|.++.+.  ++|+||+++++.-..+. 
T Consensus       207 ~~l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~  278 (534)
T KOG3653|consen  207 LELDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA  278 (534)
T ss_pred             ccCCchhhHHHhhcCccceeehhhcc--CceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence            44667888999999999999999984  48899999864      445667889888875  58999999998876655 


Q ss_pred             ---eEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCCEEEcCCCcEEE
Q 016037          224 ---RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN---------GIMHRDLKPENILLDADGHVML  291 (396)
Q Consensus       224 ---~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~---------~iiHrDlkp~NILl~~~~~ikL  291 (396)
                         .++||+||.+.|+|.++|..+ .+++.....++.-|++||+|||+.         .|+|||||++||||..|+++.|
T Consensus       279 ~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI  357 (534)
T KOG3653|consen  279 DRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI  357 (534)
T ss_pred             cccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence               899999999999999999875 568888899999999999999974         5999999999999999999999


Q ss_pred             EecccccccCCC---CCccccccCCCccchhhhcCCCC-C-----chhhHHHHHHHHHHHHhCCC------------CCC
Q 016037          292 TDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGH-D-----KAADWWSVGILLFEMLTGQP------------PFT  350 (396)
Q Consensus       292 ~Dfgla~~~~~~---~~~~~~~gt~~y~APE~l~~~~~-~-----~~~DvwSlGvil~elltg~~------------Pf~  350 (396)
                      +|||+|..+...   ......+||.+|||||++.+... .     .+.||||+|.+||||+++..            ||.
T Consensus       358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe  437 (534)
T KOG3653|consen  358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE  437 (534)
T ss_pred             eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence            999999988643   23455889999999999976422 1     46999999999999998644            333


Q ss_pred             -----CCCHHHHHHHHHhC--CCCCCccC-----CHHHHHHHHHhhccCCCCCCCC
Q 016037          351 -----GGNRQKIQQKIIKD--KIKLPAFL-----SSEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       351 -----~~~~~~i~~~i~~~--~~~~p~~~-----s~~~~~li~~~l~~~p~~RPs~  394 (396)
                           ..+.++++..++..  |+.+|..+     -.-+++.|..||+.|++.|-|+
T Consensus       438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA  493 (534)
T KOG3653|consen  438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTA  493 (534)
T ss_pred             HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhh
Confidence                 24567777777654  67788644     3468999999999999999875

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.4e-34  Score=299.45  Aligned_cols=242  Identities=18%  Similarity=0.277  Sum_probs=169.5

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCC----CcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEE---
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGT----SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYS---  218 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~----~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~---  218 (396)
                      ....++|++.++||+|+||.||+|++..+    +..||+|.+......     +....|  .++...+.++..+...   
T Consensus       128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~  200 (566)
T PLN03225        128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLE  200 (566)
T ss_pred             CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhc
Confidence            34568999999999999999999999998    899999987643211     111111  1111122222222111   


Q ss_pred             ---EEecCeEEEEEEecCCCcHHHHHHHhcC--------------------CCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 016037          219 ---FQTKYRLYLVLDFVNGGHLFFQLYRQGL--------------------FREDLARIYTAEIVSAVSHLHANGIMHRD  275 (396)
Q Consensus       219 ---~~~~~~~~lV~E~~~gg~L~~~l~~~~~--------------------l~e~~~~~~~~qi~~aL~~LH~~~iiHrD  275 (396)
                         ......+++|+||+.+++|.+++.....                    ..+..++.++.||+.||.|||+++|+|||
T Consensus       201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD  280 (566)
T PLN03225        201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD  280 (566)
T ss_pred             ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence               2456689999999999999888865431                    12344667899999999999999999999


Q ss_pred             CCCCCEEEcC-CCcEEEEecccccccCCC--CCccccccCCCccchhhhcCC----------------------CCCchh
Q 016037          276 LKPENILLDA-DGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGK----------------------GHDKAA  330 (396)
Q Consensus       276 lkp~NILl~~-~~~ikL~Dfgla~~~~~~--~~~~~~~gt~~y~APE~l~~~----------------------~~~~~~  330 (396)
                      |||+|||++. ++.+||+|||+++.+...  ......++|+.|||||.+...                      .++.++
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            9999999986 579999999999865432  223556889999999976432                      234567


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------------------CCccCCHHHHHHHHHhhccCCC
Q 016037          331 DWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK---------------------LPAFLSSEAHSLLKGVNSLLSI  389 (396)
Q Consensus       331 DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~---------------------~p~~~s~~~~~li~~~l~~~p~  389 (396)
                      |||||||+||||+++..++... .......+......                     +.........+||++||++||.
T Consensus       361 DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            9999999999999987765432 22222222211111                     1111233456899999999999


Q ss_pred             CCCCCC
Q 016037          390 SVPLLS  395 (396)
Q Consensus       390 ~RPs~s  395 (396)
                      +|||+.
T Consensus       440 kR~ta~  445 (566)
T PLN03225        440 QRISAK  445 (566)
T ss_pred             cCCCHH
Confidence            999975

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.9e-37  Score=273.23  Aligned_cols=248  Identities=29%  Similarity=0.407  Sum_probs=200.2

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec----
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK----  222 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~----  222 (396)
                      ...+.|+.+.+||+|.||+||+|+.+.+|+.||+|++--+.-.+..... ..+|+++|..|+|+|++.++..|...    
T Consensus        14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpit-alreikiL~~lkHenv~nliEic~tk~Tp~   92 (376)
T KOG0669|consen   14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPIT-ALREIKILQLLKHENVVNLIEICRTKATPT   92 (376)
T ss_pred             ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHH-HHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence            3445688889999999999999999999999999876543322222233 45699999999999999998777432    


Q ss_pred             ----CeEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccc
Q 016037          223 ----YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA  297 (396)
Q Consensus       223 ----~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla  297 (396)
                          ..+|+|+.+|+. +|.-++... -.++...+..++.++..||.|+|+..|+|||+|++|+||+.+|.+||+|||++
T Consensus        93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence                358999999987 565566544 57899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCC-----CccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCC---
Q 016037          298 KQFDENT-----RSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK--DKI---  366 (396)
Q Consensus       298 ~~~~~~~-----~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~--~~~---  366 (396)
                      +.+....     +....+.|.+|++||.+.| +.|+++.|||+-||+|.||+||.+-+.+.+..+....|..  +.+   
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            8774332     2234567999999999987 6799999999999999999999999999877766665542  110   


Q ss_pred             -----------------CCCc-------------cCCHHHHHHHHHhhccCCCCCCCCCC
Q 016037          367 -----------------KLPA-------------FLSSEAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       367 -----------------~~p~-------------~~s~~~~~li~~~l~~~p~~RPs~s~  396 (396)
                                       ++|.             .-..++.+||..||..||.+|+..++
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~  311 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQ  311 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHh
Confidence                             0111             12448899999999999999998764

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=301.01  Aligned_cols=244  Identities=27%  Similarity=0.444  Sum_probs=220.9

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|+++.++|.|.||.||+++++.+++..|+|+++.+.   .+...-++.|+-+++..+||||+.+++.+.....+||+
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic   90 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC   90 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence            368999999999999999999999999999999998764   34455577899999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-CCcc
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSN  307 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-~~~~  307 (396)
                      ||||.||+|.+.-+-.++++|.++....++.+.||+|||++|-+|||||-.|||+++.|.+|++|||.+..+... .+..
T Consensus        91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk  170 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK  170 (829)
T ss_pred             EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence            999999999998888899999999999999999999999999999999999999999999999999998776533 3456


Q ss_pred             ccccCCCccchhhh---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----ccCCHHHHHH
Q 016037          308 SMCGTLEYMSPEIV---LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP-----AFLSSEAHSL  379 (396)
Q Consensus       308 ~~~gt~~y~APE~l---~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p-----~~~s~~~~~l  379 (396)
                      ++.||++|||||+.   ....|...+|||++|++..|+.--++|-.+..++.....+.+..+.-|     ..+++.+++|
T Consensus       171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~f  250 (829)
T KOG0576|consen  171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNF  250 (829)
T ss_pred             cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHH
Confidence            78999999999997   456799999999999999999999999999999888888887655444     4799999999


Q ss_pred             HHHhhccCCCCCCCCC
Q 016037          380 LKGVNSLLSISVPLLS  395 (396)
Q Consensus       380 i~~~l~~~p~~RPs~s  395 (396)
                      +|.+|+++|.+||+..
T Consensus       251 vK~altknpKkRptae  266 (829)
T KOG0576|consen  251 VKGALTKNPKKRPTAE  266 (829)
T ss_pred             HHHHhcCCCccCCChh
Confidence            9999999999999975

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=6e-36  Score=289.88  Aligned_cols=241  Identities=29%  Similarity=0.408  Sum_probs=205.2

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC------CCeeeeeEEEEecC
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH------PFIVQLRYSFQTKY  223 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~H------pnIv~l~~~~~~~~  223 (396)
                      ++|.+....|+|-|++|..|.+...|..||||+|+.+..+.+.    -..|+.+|++|+.      -++++|+..|....
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~Kt----Gl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKT----GLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhh----hhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            5799999999999999999999999999999999987654433    4569999999953      48999999999999


Q ss_pred             eEEEEEEecCCCcHHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-cEEEEecccccc
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HVMLTDFGLAKQ  299 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~-~ikL~Dfgla~~  299 (396)
                      ++|||+|-+.. .|.+.|++.+   .+....++.|++|++.||..|..+||+|.||||.|||+++.. .+||||||.|..
T Consensus       508 HLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~  586 (752)
T KOG0670|consen  508 HLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASF  586 (752)
T ss_pred             eeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccc
Confidence            99999998865 6888887765   477888999999999999999999999999999999998765 679999999998


Q ss_pred             cCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc--------
Q 016037          300 FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAF--------  371 (396)
Q Consensus       300 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~--------  371 (396)
                      ..++..+. +..+.+|.|||++.|..|+...|+||.||+||||+||++.|.|.+..+++.....-+-+||..        
T Consensus       587 ~~eneitP-YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~  665 (752)
T KOG0670|consen  587 ASENEITP-YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFK  665 (752)
T ss_pred             cccccccH-HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchh
Confidence            87665543 455789999999999999999999999999999999999999988777766655433333310        


Q ss_pred             ---------------------------------------------C-------CHHHHHHHHHhhccCCCCCCCCCC
Q 016037          372 ---------------------------------------------L-------SSEAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       372 ---------------------------------------------~-------s~~~~~li~~~l~~~p~~RPs~s~  396 (396)
                                                                   +       =.++++|+..||..||++|-+.+|
T Consensus       666 dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq  742 (752)
T KOG0670|consen  666 DQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ  742 (752)
T ss_pred             hhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence                                                         1       136889999999999999988754

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=277.51  Aligned_cols=240  Identities=23%  Similarity=0.357  Sum_probs=193.1

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-----C---CCeeeeeEEEEe
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-----H---PFIVQLRYSFQT  221 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-----H---pnIv~l~~~~~~  221 (396)
                      ++|-+.++||+|.|++||+|++..+.+.||+|+.+..    +...+....||++|++++     |   .+||+|++.|..
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh  153 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH  153 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence            7899999999999999999999999999999999864    466777888999999883     3   379999999964


Q ss_pred             ----cCeEEEEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEc----------
Q 016037          222 ----KYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLD----------  284 (396)
Q Consensus       222 ----~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~-~iiHrDlkp~NILl~----------  284 (396)
                          +.++|+|+|++.. .|..++...  +.++...++.|++||+.||.|||+. ||||.||||+|||+.          
T Consensus       154 sGpNG~HVCMVfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~  232 (590)
T KOG1290|consen  154 SGPNGQHVCMVFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDA  232 (590)
T ss_pred             cCCCCcEEEEEehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhh
Confidence                5699999999955 566666543  5799999999999999999999986 999999999999993          


Q ss_pred             --------------------------------------------------------------------------------
Q 016037          285 --------------------------------------------------------------------------------  284 (396)
Q Consensus       285 --------------------------------------------------------------------------------  284 (396)
                                                                                                      
T Consensus       233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~  312 (590)
T KOG1290|consen  233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN  312 (590)
T ss_pred             hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence                                                                                            


Q ss_pred             ------------------------CC----------------------------------------------------Cc
Q 016037          285 ------------------------AD----------------------------------------------------GH  288 (396)
Q Consensus       285 ------------------------~~----------------------------------------------------~~  288 (396)
                                              ..                                                    -+
T Consensus       313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~  392 (590)
T KOG1290|consen  313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR  392 (590)
T ss_pred             ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence                                    00                                                    03


Q ss_pred             EEEEecccccccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHH--
Q 016037          289 VMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG-------NRQKIQQ--  359 (396)
Q Consensus       289 ikL~Dfgla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~-------~~~~i~~--  359 (396)
                      |||+|||-|++....-  .....|..|+|||++.+..|+..+||||++|++|||+||...|.-.       +.+.+..  
T Consensus       393 vKIaDlGNACW~~khF--T~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~  470 (590)
T KOG1290|consen  393 VKIADLGNACWVHKHF--TEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIM  470 (590)
T ss_pred             EEEeeccchhhhhhhh--chhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHH
Confidence            6788888887754332  2335689999999999999999999999999999999999999631       2222211  


Q ss_pred             ---------------------------------------HHHhCCCCCCccCCHHHHHHHHHhhccCCCCCCCCCC
Q 016037          360 ---------------------------------------KIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       360 ---------------------------------------~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s~  396 (396)
                                                             +++.++..++..-..++.+||.-||+++|++|||+.+
T Consensus       471 ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~  546 (590)
T KOG1290|consen  471 ELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQ  546 (590)
T ss_pred             HHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHH
Confidence                                                   1122223344445678999999999999999999754

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.4e-33  Score=283.45  Aligned_cols=251  Identities=20%  Similarity=0.219  Sum_probs=182.0

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEc----------------CCCcEEEEEEeeccccchhh-----------HHHHHH
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRI----------------GTSEIYAMKVMRKDKIMEKN-----------HAEYMK  198 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~----------------~~~~~vAvK~i~~~~~~~~~-----------~~~~~~  198 (396)
                      .+..++|++.++||+|+||.||+|.+.                ..++.||||.+.........           ..+...
T Consensus       141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~  220 (507)
T PLN03224        141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM  220 (507)
T ss_pred             CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence            356789999999999999999999753                23467999998654311100           112233


Q ss_pred             HHHHHHHhCCCCCe-----eeeeEEEEe--------cCeEEEEEEecCCCcHHHHHHHhc--------------------
Q 016037          199 SERNILTKVDHPFI-----VQLRYSFQT--------KYRLYLVLDFVNGGHLFFQLYRQG--------------------  245 (396)
Q Consensus       199 ~E~~~L~~l~HpnI-----v~l~~~~~~--------~~~~~lV~E~~~gg~L~~~l~~~~--------------------  245 (396)
                      .|+.++.+++|.++     ++++++|..        +...|+|+||+++++|.+++....                    
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            46777777766554     566666642        456899999999999988876421                    


Q ss_pred             ----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccc--cccCCCccchh
Q 016037          246 ----LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS--MCGTLEYMSPE  319 (396)
Q Consensus       246 ----~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~--~~gt~~y~APE  319 (396)
                          .+.+..++.++.|++.+|.|||+++|+||||||+|||++.++.+||+|||+++..........  ..+|+.|+|||
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence                234567788999999999999999999999999999999999999999999976543322222  33478999999


Q ss_pred             hhcCCC--------------------C--CchhhHHHHHHHHHHHHhCCC-CCCCCCHH-----------HHHHHHHhCC
Q 016037          320 IVLGKG--------------------H--DKAADWWSVGILLFEMLTGQP-PFTGGNRQ-----------KIQQKIIKDK  365 (396)
Q Consensus       320 ~l~~~~--------------------~--~~~~DvwSlGvil~elltg~~-Pf~~~~~~-----------~i~~~i~~~~  365 (396)
                      .+....                    |  ..+.||||+||++|+|++|.. ||.+....           .....+....
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~  460 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK  460 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence            985432                    1  134799999999999999886 77642211           1111222233


Q ss_pred             CCC--CccCCHHHHHHHHHhhccCC---CCCCCCCC
Q 016037          366 IKL--PAFLSSEAHSLLKGVNSLLS---ISVPLLSR  396 (396)
Q Consensus       366 ~~~--p~~~s~~~~~li~~~l~~~p---~~RPs~s~  396 (396)
                      ..+  ....++..++|+.+||..+|   .+|+|+++
T Consensus       461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~e  496 (507)
T PLN03224        461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQ  496 (507)
T ss_pred             CCcccccccChHHHHHHHHHhccCCCCcccCCCHHH
Confidence            333  35689999999999999876   68998753

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-35  Score=297.06  Aligned_cols=233  Identities=27%  Similarity=0.405  Sum_probs=188.8

Q ss_pred             eEEEeEecccCceE-EEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCeEEEEE
Q 016037          152 FEVLKVVGQGAFAK-VYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       152 ~~~~~~IG~G~fG~-Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      |.--+.+|.|+.|+ ||+|..  .|+.||||.+-.      ......++|++.|+.. +|||||++|+.-.+...+||..
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence            33346689999987 799999  667899998754      3455678999999988 5999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCH----HHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC---CC--cEEEEeccccccc
Q 016037          230 DFVNGGHLFFQLYRQGLFRE----DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DG--HVMLTDFGLAKQF  300 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e----~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~---~~--~ikL~Dfgla~~~  300 (396)
                      |.|.. +|.+++...+.-.+    -..+....|++.||++||+.+||||||||+||||+.   ++  +++|+|||+++.+
T Consensus       583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            99987 78888876411111    234667899999999999999999999999999976   34  7899999999998


Q ss_pred             CCCC----CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCC---ccC
Q 016037          301 DENT----RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKLP---AFL  372 (396)
Q Consensus       301 ~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~~~~~p---~~~  372 (396)
                      ....    +.....||-+|+|||++.....+.++|||||||++|+.++ |.+||.+.  -+-..+|..+...+-   +..
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~--~~R~~NIl~~~~~L~~L~~~~  739 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS--LERQANILTGNYTLVHLEPLP  739 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch--HHhhhhhhcCccceeeeccCc
Confidence            6443    2455679999999999999888889999999999999999 69999653  344556666654432   222


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCC
Q 016037          373 SSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       373 s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ..++.+||.+|++++|+.|||++
T Consensus       740 d~eA~dLI~~ml~~dP~~RPsa~  762 (903)
T KOG1027|consen  740 DCEAKDLISRMLNPDPQLRPSAT  762 (903)
T ss_pred             hHHHHHHHHHhcCCCcccCCCHH
Confidence            23899999999999999999975

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=2e-34  Score=254.72  Aligned_cols=239  Identities=25%  Similarity=0.414  Sum_probs=198.0

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEEEec--Ce
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTK--YR  224 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~--~~  224 (396)
                      ..++|++++++|+|.|++||.|....+.+.++||++++-      ..+.+++|+.+|+.|. ||||++|++...++  ..
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            457899999999999999999999999999999998753      3455889999999997 99999999998654  46


Q ss_pred             EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-cEEEEecccccccCCC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HVMLTDFGLAKQFDEN  303 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~-~ikL~Dfgla~~~~~~  303 (396)
                      ..+|+||+++.+...+.   ..++.-.++.++.|++.||.|+|+.||+|||+||.|++|+... .++|+|||+|......
T Consensus       110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            78999999987654332   4577888999999999999999999999999999999998765 6999999999988777


Q ss_pred             CCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHH-------------HHHHHHhCCCCC
Q 016037          304 TRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGG-NRQK-------------IQQKIIKDKIKL  368 (396)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~-~~~~-------------i~~~i~~~~~~~  368 (396)
                      ...+-.+.+..|--||.+-. ..|+..-|+|||||++..|+..+.||..+ +..+             +...+.+-.+.+
T Consensus       187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L  266 (338)
T KOG0668|consen  187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL  266 (338)
T ss_pred             ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence            77777778889999999855 67899999999999999999999998653 2222             222222223333


Q ss_pred             Cc------------------------cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          369 PA------------------------FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       369 p~------------------------~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ++                        ..++++.+|+..+|-+|.++||++.
T Consensus       267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTak  317 (338)
T KOG0668|consen  267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAK  317 (338)
T ss_pred             ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchH
Confidence            32                        2468999999999999999999975

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=9e-34  Score=266.95  Aligned_cols=246  Identities=18%  Similarity=0.287  Sum_probs=207.4

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCC-----cEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEE-ec
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTS-----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ-TK  222 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~-~~  222 (396)
                      ..++++...+-+|.||.||.|.|...+     +.|-+|.++..  .++.+...+..|.-++..+.|||+.++.+... +.
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~  360 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY  360 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence            356788888999999999999887543     23455555433  24456677788999999999999999988774 45


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEec
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQG--------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDF  294 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~--------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Df  294 (396)
                      ...++++.++..|.|..++...+        .++..+...++.|++.|++|||+.|+||.||..+|++|++.-++||+|=
T Consensus       361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs  440 (563)
T KOG1024|consen  361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS  440 (563)
T ss_pred             CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence            57789999999999999987332        3555667778999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCC
Q 016037          295 GLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLP  369 (396)
Q Consensus       295 gla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p  369 (396)
                      .+++.+-..+.   ....-.+..||+||.+.+..|+.++|+||||++||||+| |+.||..-++.++...+.++ ++.-|
T Consensus       441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP  520 (563)
T KOG1024|consen  441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQP  520 (563)
T ss_pred             hhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCC
Confidence            99987643321   122234679999999999999999999999999999999 99999999999999999887 78889


Q ss_pred             ccCCHHHHHHHHHhhccCCCCCCCCCC
Q 016037          370 AFLSSEAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       370 ~~~s~~~~~li~~~l~~~p~~RPs~s~  396 (396)
                      .+++.++..+|.-||..+|++||+++|
T Consensus       521 ~NCPDeLf~vMacCWallpeeRPsf~Q  547 (563)
T KOG1024|consen  521 FNCPDELFTVMACCWALLPEERPSFSQ  547 (563)
T ss_pred             CCCcHHHHHHHHHHHhcCcccCCCHHH
Confidence            999999999999999999999999875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=282.59  Aligned_cols=203  Identities=29%  Similarity=0.504  Sum_probs=182.2

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHH-----HHHHHHHHHhCC---CCCeeeeeEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY-----MKSERNILTKVD---HPFIVQLRYSF  219 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~-----~~~E~~~L~~l~---HpnIv~l~~~~  219 (396)
                      ...+|..++.+|.|+||+|++|.++.+...|+||.|.++++..+...+.     +-.|+++|..++   |+||++++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            3467999999999999999999999999999999999977654443332     446999999997   99999999999


Q ss_pred             EecCeEEEEEEecC-CCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccc
Q 016037          220 QTKYRLYLVLDFVN-GGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK  298 (396)
Q Consensus       220 ~~~~~~~lV~E~~~-gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~  298 (396)
                      ++.+.+||+||-.. |-+|++++..+..+.|..+..++.|++.|+++||++||||||||-+|+.++.+|-+||+|||.+.
T Consensus       639 Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa  718 (772)
T KOG1152|consen  639 EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAA  718 (772)
T ss_pred             ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchh
Confidence            99999999999765 55999999999999999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCccccccCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q 016037          299 QFDENTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTG  351 (396)
Q Consensus       299 ~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~~DvwSlGvil~elltg~~Pf~~  351 (396)
                      ....+ .-..++||..|.|||++.|..| ...-|||+||++||.++..+.||.+
T Consensus       719 ~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  719 YTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            76443 3456899999999999999887 5678999999999999999999975

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=5.8e-32  Score=245.99  Aligned_cols=214  Identities=42%  Similarity=0.682  Sum_probs=187.4

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEe
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (396)
                      |.+.+.||.|++|.||+|....+++.+|+|.+......  ...+.+.+|+..++.++|+|++++++++......++++|+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            56788999999999999999998999999999875432  2456788899999999999999999999999999999999


Q ss_pred             cCCCcHHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC--Cccc
Q 016037          232 VNGGHLFFQLYRQGL-FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--RSNS  308 (396)
Q Consensus       232 ~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~--~~~~  308 (396)
                      +.+++|..++..... +++..++.++.+++.++.+||+++++|+||+|.||+++.++.++|+|||.+.......  ....
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence            999999999887766 8999999999999999999999999999999999999999999999999998875543  3345


Q ss_pred             cccCCCccchhhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CC-HHHHHHHHHhCCCC
Q 016037          309 MCGTLEYMSPEIV-LGKGHDKAADWWSVGILLFEMLTGQPPFTG-GN-RQKIQQKIIKDKIK  367 (396)
Q Consensus       309 ~~gt~~y~APE~l-~~~~~~~~~DvwSlGvil~elltg~~Pf~~-~~-~~~i~~~i~~~~~~  367 (396)
                      ..++..|++||.+ ....++.++|||+||+++|+|++|+.||.+ .+ ...+.+.+..+...
T Consensus       159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  220 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPL  220 (225)
T ss_pred             eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcc
Confidence            6788899999998 666778899999999999999999999988 44 44677777776543

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=262.16  Aligned_cols=242  Identities=24%  Similarity=0.389  Sum_probs=194.4

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC-----eE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----RL  225 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~-----~~  225 (396)
                      +.+-.+.||.|+||.||.+.+..+|+.||+|.+..- ...-...+.+.+|+++|..++|.|++..++..+...     .+
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            445567899999999999999999999999988542 122234456778999999999999999988775542     46


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~  305 (396)
                      |+++|.|.. +|...+-....++.+.++.+++||++||.|||+.||.||||||.|+|++.+-.+||||||+++..+....
T Consensus       133 YV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  133 YVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence            888898865 6666666677899999999999999999999999999999999999999999999999999997654433


Q ss_pred             --ccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------------------
Q 016037          306 --SNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII--------------------  362 (396)
Q Consensus       306 --~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~--------------------  362 (396)
                        ....+.|-+|+|||++.| ..|+.++||||.||++.||+.++..|...++-+..+.|.                    
T Consensus       212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~  291 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN  291 (449)
T ss_pred             hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence              344567899999999988 568999999999999999999999998876554444432                    


Q ss_pred             ---hCCCCCCc-----------cCCHHHHHHHHHhhccCCCCCCCC
Q 016037          363 ---KDKIKLPA-----------FLSSEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       363 ---~~~~~~p~-----------~~s~~~~~li~~~l~~~p~~RPs~  394 (396)
                         +...+-|.           .-..+...++..|+.++|.+|.+.
T Consensus       292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~  337 (449)
T KOG0664|consen  292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISV  337 (449)
T ss_pred             HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccH
Confidence               11111121           123467888889999999999764

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-33  Score=258.33  Aligned_cols=244  Identities=27%  Similarity=0.412  Sum_probs=200.1

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec----
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK----  222 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~----  222 (396)
                      ....+|.-++.+|.|.- .|..+-+.-+++.||+|.+... .....+.++..+|..++..++|+||++++.+|...    
T Consensus        14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~   91 (369)
T KOG0665|consen   14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE   91 (369)
T ss_pred             eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence            34567888999999988 7888889899999999998776 34456677788999999999999999999999543    


Q ss_pred             --CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccccc
Q 016037          223 --YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       223 --~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~  300 (396)
                        ...|+|||+|.. +|...+.  -.+....+..++.|++.|+.|||+.||+||||||+||++..+..+||.|||+|+..
T Consensus        92 ~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   92 EFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             HHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence              367999999987 5655555  23566778889999999999999999999999999999999999999999999887


Q ss_pred             CCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------------------
Q 016037          301 DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII------------------  362 (396)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~------------------  362 (396)
                      +..-.....+.|..|+|||++.+..|...+||||+||++.||++|...|.|.+.-+...++.                  
T Consensus       169 ~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~  248 (369)
T KOG0665|consen  169 DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV  248 (369)
T ss_pred             CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence            66656677889999999999999889999999999999999999999999864322222221                  


Q ss_pred             ----hCC-----CC----CCc-----------cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          363 ----KDK-----IK----LPA-----------FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       363 ----~~~-----~~----~p~-----------~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                          ..+     +.    +|.           .-+..+++|+..||-.||++|-|.+
T Consensus       249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~  305 (369)
T KOG0665|consen  249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVD  305 (369)
T ss_pred             HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHH
Confidence                110     11    111           1244689999999999999998853

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=6.3e-31  Score=234.74  Aligned_cols=205  Identities=37%  Similarity=0.618  Sum_probs=182.7

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCCCcH
Q 016037          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL  237 (396)
Q Consensus       158 IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L  237 (396)
                      ||.|++|.||++....+++.+++|++.......  ..+.+.+|++.++.++|++|+++++++......++++||+.+++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            689999999999998889999999998754321  346688899999999999999999999999999999999999999


Q ss_pred             HHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC-CCcEEEEecccccccCCCC-CccccccCCC
Q 016037          238 FFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHVMLTDFGLAKQFDENT-RSNSMCGTLE  314 (396)
Q Consensus       238 ~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~-~~~ikL~Dfgla~~~~~~~-~~~~~~gt~~  314 (396)
                      ..++... ..++...++.++.+++.++.+||+.|++|+||+|.||+++. +++++|+|||.+....... ......+...
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (215)
T cd00180          79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA  158 (215)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence            9988765 57889999999999999999999999999999999999999 8999999999998765432 1233557889


Q ss_pred             ccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCCCC
Q 016037          315 YMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPL  393 (396)
Q Consensus       315 y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs  393 (396)
                      |++||.+... .++.+.|+|+||+++|+|                               ..+.+++..|++.+|.+||+
T Consensus       159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R~~  207 (215)
T cd00180         159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKRPS  207 (215)
T ss_pred             ccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccCcC
Confidence            9999999887 788999999999999999                               89999999999999999998


Q ss_pred             CC
Q 016037          394 LS  395 (396)
Q Consensus       394 ~s  395 (396)
                      +.
T Consensus       208 ~~  209 (215)
T cd00180         208 AK  209 (215)
T ss_pred             HH
Confidence            64

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-29  Score=228.23  Aligned_cols=235  Identities=23%  Similarity=0.313  Sum_probs=183.7

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeE-EEEecCeEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRY-SFQTKYRLYL  227 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~-~~~~~~~~~l  227 (396)
                      +.|.+.+.||+|.||++.+++++++...+++|.+.+...    ..+.+.+|...--.| .|.||+.-|+ .|++.+.+++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF   99 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF   99 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence            569999999999999999999999999999999977543    334466666554444 5899998775 4678888999


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC--CCcEEEEecccccccCCCCC
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA--DGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~--~~~ikL~Dfgla~~~~~~~~  305 (396)
                      ++||++.|+|..-+.. ..+-|...+.++.|++.|+.|||++++||||||.+||||-.  ..++||||||+++..+....
T Consensus       100 ~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~  178 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK  178 (378)
T ss_pred             eeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence            9999999999765554 45678888899999999999999999999999999999943  34899999999976543322


Q ss_pred             ccccccCCCccchhhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhC-CCCCCc---cC
Q 016037          306 SNSMCGTLEYMSPEIVLGK-----GHDKAADWWSVGILLFEMLTGQPPFTGGN----RQKIQQKIIKD-KIKLPA---FL  372 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~-----~~~~~~DvwSlGvil~elltg~~Pf~~~~----~~~i~~~i~~~-~~~~p~---~~  372 (396)
                        ..--+..|.+||.....     ...+..|+|.||+++|.++||+.||....    .-.-..+-.+. ...+|.   .+
T Consensus       179 --~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~f  256 (378)
T KOG1345|consen  179 --YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPF  256 (378)
T ss_pred             --hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhccc
Confidence              22235679999987532     23678999999999999999999997532    11122222222 334553   58


Q ss_pred             CHHHHHHHHHhhccCCCCC
Q 016037          373 SSEAHSLLKGVNSLLSISV  391 (396)
Q Consensus       373 s~~~~~li~~~l~~~p~~R  391 (396)
                      |+.+..+.+.-|+.++.+|
T Consensus       257 s~~a~r~Fkk~lt~~~~dr  275 (378)
T KOG1345|consen  257 SEKALRLFKKSLTPRFKDR  275 (378)
T ss_pred             CHHHHHHHHHhcCCccccc
Confidence            9999999999999999988

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.5e-30  Score=256.56  Aligned_cols=226  Identities=45%  Similarity=0.761  Sum_probs=203.4

Q ss_pred             EecccCceEEEEEEE---cCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEEEecCeEEEEEEec
Q 016037          157 VVGQGAFAKVYQVRR---IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLDFV  232 (396)
Q Consensus       157 ~IG~G~fG~Vy~~~~---~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~lV~E~~  232 (396)
                      .+|.|+||.|++++.   ...|..||+|+.++......... .-..|..++...+ ||+++++...|+.+..+++++++.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            379999999998653   34577899999988665544444 4556889999887 999999999999999999999999


Q ss_pred             CCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccccccC
Q 016037          233 NGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT  312 (396)
Q Consensus       233 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~~gt  312 (396)
                      .||.|+..+.+...+.+...+.+..+++.+++++|+.+++|||+|++||+++.+|++++.|||+++..-+.+..   |||
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt  156 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGT  156 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999987554443   999


Q ss_pred             CCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCCC
Q 016037          313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVP  392 (396)
Q Consensus       313 ~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~RP  392 (396)
                      ..|||||++.  .+..++|+||||++++||+||..||..    ++...|.+.++.+|+.++.++++++..++..+|..|-
T Consensus       157 ~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrL  230 (612)
T KOG0603|consen  157 YEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRL  230 (612)
T ss_pred             hhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHh
Confidence            9999999998  688999999999999999999999988    7888899999999999999999999999999998874

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=2.4e-26  Score=217.06  Aligned_cols=240  Identities=39%  Similarity=0.596  Sum_probs=203.3

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCC-CeeeeeEEEEecCeEEEEEE
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP-FIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~Hp-nIv~l~~~~~~~~~~~lV~E  230 (396)
                      |.+.+.||.|+||.||++.+.   ..+++|.+.............+.+|+.+++.+.|+ +|+++++.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            788899999999999999997   67899999876544433567788899999999988 79999999988888899999


Q ss_pred             ecCCCcHHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-cEEEEecccccccCCCC--
Q 016037          231 FVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HVMLTDFGLAKQFDENT--  304 (396)
Q Consensus       231 ~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~-~ikL~Dfgla~~~~~~~--  304 (396)
                      ++.++++...+....   .+.+.....++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.++......  
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999999996666654   789999999999999999999999999999999999999998 79999999998664433  


Q ss_pred             -----CccccccCCCccchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCC-CCcc
Q 016037          305 -----RSNSMCGTLEYMSPEIVLG---KGHDKAADWWSVGILLFEMLTGQPPFTGGN----RQKIQQKIIKDKIK-LPAF  371 (396)
Q Consensus       305 -----~~~~~~gt~~y~APE~l~~---~~~~~~~DvwSlGvil~elltg~~Pf~~~~----~~~i~~~i~~~~~~-~p~~  371 (396)
                           .....+||..|+|||.+.+   ..++...|+|++|++++++++|..||....    .......+...... +...
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP  238 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence                 3466789999999999987   578899999999999999999999988776    35666666655433 2222


Q ss_pred             CC--------HHHHHHHHHhhccCCCCCCCC
Q 016037          372 LS--------SEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       372 ~s--------~~~~~li~~~l~~~p~~RPs~  394 (396)
                      ..        ..+.+++..++..+|..|.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~  269 (384)
T COG0515         239 LSPSNPELISKAASDLLKKLLAKDPKNRLSS  269 (384)
T ss_pred             cCccccchhhHHHHHHHHHHHhcCchhcCCH
Confidence            22        579999999999999999864

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.7e-27  Score=212.29  Aligned_cols=243  Identities=23%  Similarity=0.311  Sum_probs=203.9

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC-CCeeeeeEEEEecCe
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-PFIVQLRYSFQTKYR  224 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~H-pnIv~l~~~~~~~~~  224 (396)
                      .+..+.|+++++||.|+||.+|+|....+|+.||||+-....-     --.+..|.++.+.|++ ..|..++.++.++..
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y   85 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDY   85 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence            4566789999999999999999999999999999998765321     1225668899999975 688888888889999


Q ss_pred             EEEEEEecCCCcHHHHHH-HhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC---cEEEEeccccccc
Q 016037          225 LYLVLDFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG---HVMLTDFGLAKQF  300 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~---~ikL~Dfgla~~~  300 (396)
                      -.+||+.+.. +|.++.. ..+.++...+..++-||+.-++|+|.+++|||||||+|+|+.-+.   .+.|+|||+|+.+
T Consensus        86 nvlVMdLLGP-sLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   86 NVLVMDLLGP-SLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ceeeeeccCc-cHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence            9999999854 7766664 446789999999999999999999999999999999999997554   5789999999987


Q ss_pred             CCCC--------CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCC
Q 016037          301 DENT--------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN---RQKIQQKIIKDKIKLP  369 (396)
Q Consensus       301 ~~~~--------~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~---~~~i~~~i~~~~~~~p  369 (396)
                      .+..        ......||.+|.+-....+...+...|+-|+|.+|.+...|..||.+..   ..+-+++|...+...|
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~  244 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP  244 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence            5432        2345679999999998888889999999999999999999999999864   4455666777777666


Q ss_pred             -----ccCCHHHHHHHHHhhccCCCCCCCC
Q 016037          370 -----AFLSSEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       370 -----~~~s~~~~~li~~~l~~~p~~RPs~  394 (396)
                           .+++.|+.-.|..|=..-..+-|.+
T Consensus       245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             HHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence                 4789999999999999888888764

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=7.4e-29  Score=267.69  Aligned_cols=188  Identities=15%  Similarity=0.132  Sum_probs=137.3

Q ss_pred             hCCC-CCeeeeeEEE-------EecCeEEEEEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 016037          206 KVDH-PFIVQLRYSF-------QTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDL  276 (396)
Q Consensus       206 ~l~H-pnIv~l~~~~-------~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDl  276 (396)
                      .++| .||+.++++|       .....++.++||+ +++|..++.. ...+++..++.++.||+.||.|||++||+||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl  106 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV  106 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            3444 4666677766       2234677888987 4589998865 356899999999999999999999999999999


Q ss_pred             CCCCEEEcCCC-------------------cEEEEecccccccCCCC-----------------CccccccCCCccchhh
Q 016037          277 KPENILLDADG-------------------HVMLTDFGLAKQFDENT-----------------RSNSMCGTLEYMSPEI  320 (396)
Q Consensus       277 kp~NILl~~~~-------------------~ikL~Dfgla~~~~~~~-----------------~~~~~~gt~~y~APE~  320 (396)
                      ||+||||+..|                   .+|++|||+++......                 .....+||+.|||||+
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            99999996544                   45566666665321100                 0112468899999999


Q ss_pred             hcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCccCCHHHHHHHHHhhccCCCCCCCCCC
Q 016037          321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-LPAFLSSEAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       321 l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~-~p~~~s~~~~~li~~~l~~~p~~RPs~s~  396 (396)
                      +.+..|+.++|||||||+||||++|..|+....  .....+....++ .+..-..+...++.+||+++|.+||++.+
T Consensus       187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~e  261 (793)
T PLN00181        187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSE  261 (793)
T ss_pred             hccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHH
Confidence            999999999999999999999999999876422  222222222111 11123556789999999999999999753

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=8.6e-27  Score=226.22  Aligned_cols=241  Identities=27%  Similarity=0.394  Sum_probs=192.7

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCC-cEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC----CCeeeeeEEE-EecCe
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTS-EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH----PFIVQLRYSF-QTKYR  224 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~H----pnIv~l~~~~-~~~~~  224 (396)
                      +|++.++||+|+||.||.|.+..++ +.+|+|+........  . ..+..|+.++..+..    +++..+++.+ .....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--P-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--C-ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            7999999999999999999998775 679999877643211  1 146778888888863    6899999988 57778


Q ss_pred             EEEEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC-----CcEEEEecccc
Q 016037          225 LYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-----GHVMLTDFGLA  297 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~-----~~ikL~Dfgla  297 (396)
                      .|+||+.+ |.+|.++....  +.++...+..++.|++.+|++||+.|++||||||+|+++...     ..+.|.|||++
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            89999988 55888777544  579999999999999999999999999999999999999866     35999999999


Q ss_pred             cccC---CCC---C-----ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--
Q 016037          298 KQFD---ENT---R-----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--  364 (396)
Q Consensus       298 ~~~~---~~~---~-----~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--  364 (396)
                      +.+.   ...   .     ...+.||..|+++.+..+...+.+.|+|||++++.|++.|..||.+.+......++.+.  
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            9322   111   1     22355999999999999999999999999999999999999999876533223333322  


Q ss_pred             --CCC-CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 --KIK-LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 --~~~-~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                        ... +....+.++..+...+-+.+..++|.+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~  288 (322)
T KOG1164|consen  255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYE  288 (322)
T ss_pred             hhccccccCCChHHHHHHHHHhhccCCcCCCCHH
Confidence              222 3345678999999999999999999763

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=1.2e-27  Score=211.02  Aligned_cols=149  Identities=21%  Similarity=0.215  Sum_probs=122.5

Q ss_pred             CcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccccccCC
Q 016037          235 GHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL  313 (396)
Q Consensus       235 g~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~~gt~  313 (396)
                      |+|.+++.. .+.+++..++.++.|++.||.|||+++      ||+|||++.++.+|+  ||+++......    ..||+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence            678888876 456999999999999999999999998      999999999999999  99998754322    26899


Q ss_pred             CccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCC-------CCccCCH--HHHHHHHHh
Q 016037          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR-QKIQQKIIKDKIK-------LPAFLSS--EAHSLLKGV  383 (396)
Q Consensus       314 ~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~-~~i~~~i~~~~~~-------~p~~~s~--~~~~li~~~  383 (396)
                      .|||||++.+..++.++|||||||++|||+||+.||..... ......+......       .+..++.  ++++||+.|
T Consensus        69 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~c  148 (176)
T smart00750       69 YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVC  148 (176)
T ss_pred             cccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHH
Confidence            99999999999999999999999999999999999976543 2333333332221       1223444  799999999


Q ss_pred             hccCCCCCCCCC
Q 016037          384 NSLLSISVPLLS  395 (396)
Q Consensus       384 l~~~p~~RPs~s  395 (396)
                      |+.+|.+||++.
T Consensus       149 l~~~p~~Rp~~~  160 (176)
T smart00750      149 ASRLPQRREAAN  160 (176)
T ss_pred             HhcccccccCHH
Confidence            999999999974

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=2.1e-28  Score=233.27  Aligned_cols=194  Identities=27%  Similarity=0.520  Sum_probs=165.5

Q ss_pred             CCeEEEeEecccCceEEEEEEEcC---CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCeE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~  225 (396)
                      +.|..+++||.|+|++||++.+..   .++.||+|.+....     .-.++.+|+++|..+ .+.||+++.+++...+..
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v  110 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV  110 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence            569999999999999999999887   78999999987653     344588999999998 589999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC-CcEEEEecccccccCCC-
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDEN-  303 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~-~~ikL~Dfgla~~~~~~-  303 (396)
                      .+|+||++.....++...   ++...++.|++.++.||.++|.+|||||||||.|+|.+.. ++-.|+|||+|...+.. 
T Consensus       111 ~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~  187 (418)
T KOG1167|consen  111 AIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ  187 (418)
T ss_pred             EEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence            999999999877666543   5678899999999999999999999999999999999854 67899999999722100 


Q ss_pred             --------------------------------------------CCccccccCCCccchhhhcC-CCCCchhhHHHHHHH
Q 016037          304 --------------------------------------------TRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGIL  338 (396)
Q Consensus       304 --------------------------------------------~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvi  338 (396)
                                                                  .......||++|+|||++.. ...++++||||.|++
T Consensus       188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI  267 (418)
T KOG1167|consen  188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI  267 (418)
T ss_pred             hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence                                                        00112459999999999976 557899999999999


Q ss_pred             HHHHHhCCCCCCC
Q 016037          339 LFEMLTGQPPFTG  351 (396)
Q Consensus       339 l~elltg~~Pf~~  351 (396)
                      ++.+++++.||..
T Consensus       268 ~Lslls~~~PFf~  280 (418)
T KOG1167|consen  268 LLSLLSRRYPFFK  280 (418)
T ss_pred             eehhhcccccccc
Confidence            9999999999964

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1e-26  Score=227.14  Aligned_cols=168  Identities=20%  Similarity=0.186  Sum_probs=132.0

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcC-CCcEEEEEEeecccc--chhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIG-TSEIYAMKVMRKDKI--MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      ..-.++|.+.+.||+|+||+||+|+++. +++.+|||++.....  ......+.+.+|+++|++++|+||++.+..+   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            3455789999999999999999999876 678889998753311  1233456789999999999999998533222   


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCCEEEcCCCcEEEEecccccccC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDL-KPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDl-kp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      +..|+||||++|++|.. ..   ...   ...++.|++.+|.|||++||+|||| ||+|||++.++++||+|||+|+.+.
T Consensus        91 ~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~  163 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR  163 (365)
T ss_pred             CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence            46799999999999862 21   111   1457889999999999999999999 9999999999999999999999764


Q ss_pred             CCCC---------ccccccCCCccchhhhcC
Q 016037          302 ENTR---------SNSMCGTLEYMSPEIVLG  323 (396)
Q Consensus       302 ~~~~---------~~~~~gt~~y~APE~l~~  323 (396)
                      ....         ....++++.|+|||.+..
T Consensus       164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             cCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            4321         134567888999999854

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=4.3e-26  Score=211.54  Aligned_cols=240  Identities=23%  Similarity=0.348  Sum_probs=201.3

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEEEecCeEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~lV  228 (396)
                      -+|++.++||+|+||+++.|...-+++.||||.-....     ..-.+..|.+..+.|. .++|...|.+.+++-+-.||
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            47999999999999999999999999999999754332     2334677888888885 69999999999999999999


Q ss_pred             EEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-----cEEEEecccccccCC
Q 016037          229 LDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-----HVMLTDFGLAKQFDE  302 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~-----~ikL~Dfgla~~~~~  302 (396)
                      +|++.. +|.++..- .+.|+...+..+|.||+.-++|+|++.+|+|||||+|+||...+     .|.++|||+|+.+.+
T Consensus       103 idLLGP-SLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  103 IDLLGP-SLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             hhhhCc-CHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            999854 77777754 46799999999999999999999999999999999999997544     589999999998755


Q ss_pred             CCC--------ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCC--
Q 016037          303 NTR--------SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN---RQKIQQKIIKDKIKLP--  369 (396)
Q Consensus       303 ~~~--------~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~---~~~i~~~i~~~~~~~p--  369 (396)
                      ...        ..+..||.+||+-....+++.+...|+-|||-++.+.+.|..||.+..   ..+-+++|-..+-..|  
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~  261 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE  261 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH
Confidence            432        245679999999999999999999999999999999999999999864   4455566655444333  


Q ss_pred             ---ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          370 ---AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       370 ---~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                         .+++.++...|...=..+..+-|.++
T Consensus       262 ~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd  290 (449)
T KOG1165|consen  262 VLCEGFPEEFATYLRYVRRLDFFETPDYD  290 (449)
T ss_pred             HHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence               47899999999888888888887653

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.92  E-value=2.5e-25  Score=231.78  Aligned_cols=202  Identities=39%  Similarity=0.716  Sum_probs=168.6

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      .+|..++.|..|+||.||.++++.+.+.+|+| +++.++.-       +   ++|.....|++|                
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lil-------R---nilt~a~npfvv----------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLIL-------R---NILTFAGNPFVV----------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccchhh-------h---ccccccCCccee----------------
Confidence            58999999999999999999999999999994 44433211       1   134444555554                


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-----
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-----  304 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-----  304 (396)
                           |+-...++.-+.++.++        +.+++|||+.||+|||+||+|.+|+.-|++|++|||+.+......     
T Consensus       136 -----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~  202 (1205)
T KOG0606|consen  136 -----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK  202 (1205)
T ss_pred             -----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence                 44445566666777655        678999999999999999999999999999999999998653211     


Q ss_pred             -----------CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc---
Q 016037          305 -----------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA---  370 (396)
Q Consensus       305 -----------~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~---  370 (396)
                                 .....|||+.|+|||++..++|...+|||++|+++||.+-|+.||.+.+.++++...+.+.+..|.   
T Consensus       203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~de  282 (1205)
T KOG0606|consen  203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDE  282 (1205)
T ss_pred             hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCc
Confidence                       123458999999999999999999999999999999999999999999999999999999988885   


Q ss_pred             cCCHHHHHHHHHhhccCCCCC
Q 016037          371 FLSSEAHSLLKGVNSLLSISV  391 (396)
Q Consensus       371 ~~s~~~~~li~~~l~~~p~~R  391 (396)
                      -+.++++++|.++|..+|..|
T Consensus       283 a~p~Ea~dli~~LL~qnp~~R  303 (1205)
T KOG0606|consen  283 ALPPEAQDLIEQLLRQNPLCR  303 (1205)
T ss_pred             CCCHHHHHHHHHHHHhChHhh
Confidence            488999999999999999987

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.91  E-value=3.9e-24  Score=201.09  Aligned_cols=233  Identities=24%  Similarity=0.350  Sum_probs=154.6

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC-----------CCeeeeeE--
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-----------PFIVQLRY--  217 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~H-----------pnIv~l~~--  217 (396)
                      .+...+.||.|+++.||.+.+..|++.+|+|++...........+.+++|.-....+.+           ..++++--  
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            46778899999999999999999999999999987665556667777777655544332           22333211  


Q ss_pred             ------EEEecC--------eEEEEEEecCCCcHHHHHH---HhcCCC---HHHH-HHHHHHHHHHHHHHHHCCceeccC
Q 016037          218 ------SFQTKY--------RLYLVLDFVNGGHLFFQLY---RQGLFR---EDLA-RIYTAEIVSAVSHLHANGIMHRDL  276 (396)
Q Consensus       218 ------~~~~~~--------~~~lV~E~~~gg~L~~~l~---~~~~l~---e~~~-~~~~~qi~~aL~~LH~~~iiHrDl  276 (396)
                            ++....        +.+++|+-+.+ +|...+.   ......   ...+ ..+..|+++.+++||+.|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                  111111        34677887754 6655542   222221   1222 335589999999999999999999


Q ss_pred             CCCCEEEcCCCcEEEEecccccccCCCCCccccccCCCccchhhhcCC--------CCCchhhHHHHHHHHHHHHhCCCC
Q 016037          277 KPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGK--------GHDKAADWWSVGILLFEMLTGQPP  348 (396)
Q Consensus       277 kp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~~gt~~y~APE~l~~~--------~~~~~~DvwSlGvil~elltg~~P  348 (396)
                      +|+|++++.+|.++|+||+...........  ...+..|.+||.....        .++.+.|.|+||+++|.|+||..|
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP  249 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP  249 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence            999999999999999999988765443322  3455789999987432        468899999999999999999999


Q ss_pred             CCCCCHHHHHH-HHHhCCCCCCccCCHHHHHHHHHhhccCCCCC
Q 016037          349 FTGGNRQKIQQ-KIIKDKIKLPAFLSSEAHSLLKGVNSLLSISV  391 (396)
Q Consensus       349 f~~~~~~~i~~-~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~R  391 (396)
                      |.......... ...    ... .+++.++.||.+||+.+|.+|
T Consensus       250 f~~~~~~~~~~~~f~----~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  250 FGLSSPEADPEWDFS----RCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             TCCCGGGSTSGGGGT----TSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCccccccccch----hcC-CcCHHHHHHHHHHccCCcccC
Confidence            98654332221 111    222 789999999999999999988

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=3.3e-24  Score=195.98  Aligned_cols=174  Identities=15%  Similarity=0.167  Sum_probs=135.9

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHH------HHHHHHHHHhCCCCCeeeeeEEEEe
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY------MKSERNILTKVDHPFIVQLRYSFQT  221 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~------~~~E~~~L~~l~HpnIv~l~~~~~~  221 (396)
                      -.++|++++.||.|+||.||++..  ++..+|+|+++......+...+.      +.+|++.+.++.|++|..+..++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            357899999999999999999766  35579999998655434333333      6789999999999999999888654


Q ss_pred             c--------CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEe
Q 016037          222 K--------YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTD  293 (396)
Q Consensus       222 ~--------~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~D  293 (396)
                      .        ...+|+|||++|.+|.+..    .+++.    ...+++.++..+|+.|++|||+||.||+++.+| ++|+|
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD  177 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID  177 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence            3        3579999999999987653    22332    456999999999999999999999999999999 99999


Q ss_pred             cccccccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHH
Q 016037          294 FGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEML  343 (396)
Q Consensus       294 fgla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ell  343 (396)
                      ||..+...+.....           .......|+.++|+|+||+++..+.
T Consensus       178 fg~~~~~~e~~a~d-----------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        178 LSGKRCTAQRKAKD-----------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCCcccccchhhHH-----------HHHHHhHhcccccccceeEeehHHH
Confidence            99887653222111           1344556778999999999987653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=5e-24  Score=191.29  Aligned_cols=143  Identities=20%  Similarity=0.261  Sum_probs=112.5

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhh-----------------------HHHHHHHHHHHHHhCCCCC
Q 016037          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN-----------------------HAEYMKSERNILTKVDHPF  211 (396)
Q Consensus       155 ~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~-----------------------~~~~~~~E~~~L~~l~Hpn  211 (396)
                      ...||+|+||.||+|.+. +|+.||+|+++........                       .......|++++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            357999999999999997 8999999999875321111                       0123356999999998777


Q ss_pred             eeeeeEEEEecCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCCEEEcCCCcEE
Q 016037          212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL-HANGIMHRDLKPENILLDADGHVM  290 (396)
Q Consensus       212 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~L-H~~~iiHrDlkp~NILl~~~~~ik  290 (396)
                      +....... .. ..+|||||++|+++.......+.+++..+..++.|++.+|.+| |+.||+||||||+|||++ ++.++
T Consensus        81 v~~p~~~~-~~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          81 IPCPEPIL-LK-SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCCcEEE-ec-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            64332222 22 2389999999987765555567889999999999999999999 799999999999999998 58899


Q ss_pred             EEecccccccC
Q 016037          291 LTDFGLAKQFD  301 (396)
Q Consensus       291 L~Dfgla~~~~  301 (396)
                      |+|||+|....
T Consensus       158 LiDFG~a~~~~  168 (190)
T cd05147         158 IIDVSQSVEHD  168 (190)
T ss_pred             EEEccccccCC
Confidence            99999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=2.6e-25  Score=230.41  Aligned_cols=242  Identities=25%  Similarity=0.374  Sum_probs=191.5

Q ss_pred             EEEeEecccCceEEEEEEEcCCCcEEEEEEeec---cccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK---DKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       153 ~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~---~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ...+.+|.|++|.|+.+......+.++.|..+.   ...........+..|.-+-..+.|||++.....+.+....+-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            456789999999888888777666666666542   11122222232666777778889999988777766666556669


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-----C
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-----T  304 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-----~  304 (396)
                      |||++ +|+..+...+.+....+.-++.|++.|+.|||+.||.|||+|++|+++..+|.+||+|||.+..+...     .
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~  479 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH  479 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence            99999 99999988888888889999999999999999999999999999999999999999999999876432     2


Q ss_pred             CccccccCCCccchhhhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhCCC-------CCCccCCH
Q 016037          305 RSNSMCGTLEYMSPEIVLGKGHDK-AADWWSVGILLFEMLTGQPPFTGGNRQKIQ--QKIIKDKI-------KLPAFLSS  374 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~-~~DvwSlGvil~elltg~~Pf~~~~~~~i~--~~i~~~~~-------~~p~~~s~  374 (396)
                      .....+|+..|+|||++.+..|++ ..||||.|+++..|.+|+.||.-....+..  ........       .+-..++.
T Consensus       480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~  559 (601)
T KOG0590|consen  480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPR  559 (601)
T ss_pred             hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchh
Confidence            346678999999999999999975 699999999999999999999875443322  11111111       22346899


Q ss_pred             HHHHHHHHhhccCCCCCCCCC
Q 016037          375 EAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       375 ~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +.+.+|-.||+.+|.+|-++.
T Consensus       560 ~~~~~~~~~l~~~P~~R~ti~  580 (601)
T KOG0590|consen  560 ETRIIIYRMLQLDPTKRITIE  580 (601)
T ss_pred             hHHHHHHHHccCChhheecHH
Confidence            999999999999999998864

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=4.2e-23  Score=185.30  Aligned_cols=144  Identities=21%  Similarity=0.247  Sum_probs=114.6

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeeccccch-----------------------hhHHHHHHHHHHHHHhCCCCC
Q 016037          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-----------------------KNHAEYMKSERNILTKVDHPF  211 (396)
Q Consensus       155 ~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~-----------------------~~~~~~~~~E~~~L~~l~Hpn  211 (396)
                      .+.||+|+||.||+|.+. +|+.||||+++......                       .......+.|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999987 89999999998753110                       011234567999999999998


Q ss_pred             eeeeeEEEEecCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcEE
Q 016037          212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVM  290 (396)
Q Consensus       212 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDlkp~NILl~~~~~ik  290 (396)
                      +.....+...  ..|+||||++|+++.........+++.....++.|++.++.+||+ +||+||||||+|||++ ++.++
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~  157 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY  157 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence            7544333322  248999999998654443445677888889999999999999999 9999999999999998 89999


Q ss_pred             EEecccccccCC
Q 016037          291 LTDFGLAKQFDE  302 (396)
Q Consensus       291 L~Dfgla~~~~~  302 (396)
                      |+|||+++....
T Consensus       158 liDFG~a~~~~~  169 (190)
T cd05145         158 IIDVSQAVELDH  169 (190)
T ss_pred             EEEcccceecCC
Confidence            999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=1.7e-22  Score=181.35  Aligned_cols=189  Identities=18%  Similarity=0.191  Sum_probs=142.9

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhh-HHHHHHHHHHHHHhCC-CCCeeeeeEEEEecCeEEEEE
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN-HAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~-~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      +.+...|++|+||+|+.+..  .+..++.+.+......... ....+.+|+++|++|. |++|++++++    ...|++|
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            34567899999999997666  5666777766554432221 2235788999999995 5789998875    3469999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCCEEEcCCCcEEEEecccccccCCCCCc--
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDL-KPENILLDADGHVMLTDFGLAKQFDENTRS--  306 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDl-kp~NILl~~~~~ikL~Dfgla~~~~~~~~~--  306 (396)
                      ||+.|.+|...+..      . ...++.|++.+|.++|++||+|||| ||+|||++.++.++|+|||++.........  
T Consensus        78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r  150 (218)
T PRK12274         78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR  150 (218)
T ss_pred             eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence            99999988643321      1 1346789999999999999999999 799999999999999999999865543310  


Q ss_pred             ------------cccccCCCccchhhhcCC-CCC-chhhHHHHHHHHHHHHhCCCCCCCCC
Q 016037          307 ------------NSMCGTLEYMSPEIVLGK-GHD-KAADWWSVGILLFEMLTGQPPFTGGN  353 (396)
Q Consensus       307 ------------~~~~gt~~y~APE~l~~~-~~~-~~~DvwSlGvil~elltg~~Pf~~~~  353 (396)
                                  .-...++.|++|+...-. ..+ ...+|++.|+-+|.++|+..++.+.+
T Consensus       151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence                        111257888888865432 233 67899999999999999999987754

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2.7e-22  Score=190.26  Aligned_cols=248  Identities=26%  Similarity=0.378  Sum_probs=177.0

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCc-----------------------------------EEEEEEeeccccc-
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE-----------------------------------IYAMKVMRKDKIM-  189 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~-----------------------------------~vAvK~i~~~~~~-  189 (396)
                      .+..++|++...||+|....||.++....|.                                   +.|||.+-.-... 
T Consensus       153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s  232 (598)
T KOG4158|consen  153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS  232 (598)
T ss_pred             ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence            4667899999999999999999988765321                                   2466665432221 


Q ss_pred             -hhhHHHHHHHHH------HHH--------Hh--------CCCCCeeeeeEEEEec------------------------
Q 016037          190 -EKNHAEYMKSER------NIL--------TK--------VDHPFIVQLRYSFQTK------------------------  222 (396)
Q Consensus       190 -~~~~~~~~~~E~------~~L--------~~--------l~HpnIv~l~~~~~~~------------------------  222 (396)
                       +....+.+.+|.      .++        +.        -+|||||++...|.+.                        
T Consensus       233 ~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~  312 (598)
T KOG4158|consen  233 GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGA  312 (598)
T ss_pred             chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccccc
Confidence             112223333332      111        11        2599999998877432                        


Q ss_pred             ---CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc--CCC--cEEEEecc
Q 016037          223 ---YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD--ADG--HVMLTDFG  295 (396)
Q Consensus       223 ---~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~--~~~--~ikL~Dfg  295 (396)
                         ..+|+||..+.. +|..++-.+ ..+....+.++.|+++|+.|||.+||.|||+|++|||+.  +|+  .+.|+|||
T Consensus       313 g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFG  390 (598)
T KOG4158|consen  313 GEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFG  390 (598)
T ss_pred             CCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccc
Confidence               357999988876 677776554 346667778899999999999999999999999999984  343  57899999


Q ss_pred             cccccCC-------CCCccccccCCCccchhhhcCCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-
Q 016037          296 LAKQFDE-------NTRSNSMCGTLEYMSPEIVLGKG------HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKI-  361 (396)
Q Consensus       296 la~~~~~-------~~~~~~~~gt~~y~APE~l~~~~------~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i-  361 (396)
                      ++-.-+.       ....-...|...-||||+.....      .-.++|.|+.|.+.||+++...||.+.-.+.+-..- 
T Consensus       391 CcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y  470 (598)
T KOG4158|consen  391 CCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY  470 (598)
T ss_pred             eeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh
Confidence            8732111       11122345777889999986421      126899999999999999999999984433322222 


Q ss_pred             -HhCCCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          362 -IKDKIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       362 -~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                       ...-+.+|..+++.+++|+-.+|+.||.+|||..
T Consensus       471 qe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  471 QESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             hhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence             2235678899999999999999999999999863

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=1.1e-20  Score=171.66  Aligned_cols=135  Identities=19%  Similarity=0.181  Sum_probs=106.8

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-----CCCCeeeeeEEEEecC---eEE
Q 016037          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-----DHPFIVQLRYSFQTKY---RLY  226 (396)
Q Consensus       155 ~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-----~HpnIv~l~~~~~~~~---~~~  226 (396)
                      .+.||+|+||.||.  +..++.. +||++.....   ...+.+.+|+.+++.+     +||||+++++++++..   .++
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            46899999999995  7666665 6998876432   2345678999999999     6799999999998874   434


Q ss_pred             -EEEEe--cCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHH-HHHHHCCceeccCCCCCEEEcCC----CcEEEEeccccc
Q 016037          227 -LVLDF--VNGGHLFFQLYRQGLFREDLARIYTAEIVSAV-SHLHANGIMHRDLKPENILLDAD----GHVMLTDFGLAK  298 (396)
Q Consensus       227 -lV~E~--~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL-~~LH~~~iiHrDlkp~NILl~~~----~~ikL~Dfgla~  298 (396)
                       +|+||  +.+++|.+++.+. .+.+.  ..++.|++.++ +|||+++|+||||||+|||++..    ++++|+||+.+.
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~  157 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES  157 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence             78999  5579999999764 46666  35577888777 99999999999999999999743    379999955443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=5e-21  Score=203.11  Aligned_cols=222  Identities=22%  Similarity=0.355  Sum_probs=175.3

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC---CCCeeeeeEEEEec
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD---HPFIVQLRYSFQTK  222 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~---HpnIv~l~~~~~~~  222 (396)
                      .++...|.|.+.||+|+||+||+|.... |+.||+|+-+....++-....      +++.+|+   -+.|..+..++.-.
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~------q~~~RLk~~~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICL------QVMERLKPQMLPSIMHISSAHVFQ  766 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehH------HHHHhhchhhhcchHHHHHHHccC
Confidence            3556789999999999999999999977 999999998887655432222      2233333   23455555555666


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC-------CCcEEEEecc
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-------DGHVMLTDFG  295 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~-------~~~ikL~Dfg  295 (396)
                      +.-+||+||.+.|+|.+++...+.+++..+..++.||+..+++||..+|||+||||+|+||..       ..-++|+|||
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG  846 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG  846 (974)
T ss_pred             CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence            777899999999999999998899999999999999999999999999999999999999953       2359999999


Q ss_pred             ccccc---CCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----CCC
Q 016037          296 LAKQF---DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-----KIK  367 (396)
Q Consensus       296 la~~~---~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~-----~~~  367 (396)
                      .+..+   .+..+-...++|-.+-.+|+..|+.|+.++|-|+|+.+++.|+.|+.-=           ..++     ...
T Consensus       847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------~~~g~~~~~~~~  915 (974)
T KOG1166|consen  847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------VKNGSSWMVKTN  915 (974)
T ss_pred             cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------hcCCcceecccc
Confidence            98654   3444556677888999999999999999999999999999999987521           2222     223


Q ss_pred             CCccCCHH-HHHHHHHhhc
Q 016037          368 LPAFLSSE-AHSLLKGVNS  385 (396)
Q Consensus       368 ~p~~~s~~-~~~li~~~l~  385 (396)
                      +++.+-.+ +.+|+..+|+
T Consensus       916 ~~Ry~~~~~W~~~F~~lLN  934 (974)
T KOG1166|consen  916 FPRYWKRDMWNKFFDLLLN  934 (974)
T ss_pred             chhhhhHHHHHHHHHHHhC
Confidence            55555554 5677788887

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.84  E-value=6.7e-22  Score=206.64  Aligned_cols=230  Identities=21%  Similarity=0.286  Sum_probs=175.8

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccc--cchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDK--IMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      ++...+.||.+.|=+|.+|++.+ |. |+||++-+..  +.-....+++. |++ .+.++|||++++.-.-.....-|||
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~-~ik-~~l~~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLE-EIK-FALMKAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHH-HHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence            68888999999999999999854 44 8899886643  22233334333 444 6677999999998777777778889


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccccc--CCCCC-
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTR-  305 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~--~~~~~-  305 (396)
                      -+|... +|++.+..+..+.+-+.+.++.|++.||.-+|..||+|+|||.+||||+.=+.+.|+||..-+-.  .+... 
T Consensus       100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence            888876 78888888888888888889999999999999999999999999999999999999999866532  11111 


Q ss_pred             --c---cccccCCCccchhhhcCCC-----------CCchhhHHHHHHHHHHHHh-CCCCCCCC-----------CHHHH
Q 016037          306 --S---NSMCGTLEYMSPEIVLGKG-----------HDKAADWWSVGILLFEMLT-GQPPFTGG-----------NRQKI  357 (396)
Q Consensus       306 --~---~~~~gt~~y~APE~l~~~~-----------~~~~~DvwSlGvil~ellt-g~~Pf~~~-----------~~~~i  357 (396)
                        .   .+...-..|.|||.+-...           .+++-||||+||+++||++ |++||.-.           +.+..
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~  258 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL  258 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence              0   0111235799999984421           4578999999999999999 89999631           22222


Q ss_pred             HHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          358 QQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       358 ~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .++|.          +..+++||..|++.||++|-|+.
T Consensus       259 Le~Ie----------d~~~Rnlil~Mi~rdPs~RlSAe  286 (1431)
T KOG1240|consen  259 LEKIE----------DVSLRNLILSMIQRDPSKRLSAE  286 (1431)
T ss_pred             HHhCc----------CccHHHHHHHHHccCchhccCHH
Confidence            22222          34799999999999999998753

>smart00090 RIO RIO-like kinase

Probab=99.84  E-value=1.8e-20  Score=173.89  Aligned_cols=146  Identities=22%  Similarity=0.237  Sum_probs=115.3

Q ss_pred             CeEEEeEecccCceEEEEEE-EcCCCcEEEEEEeeccccch---------------------hhHHHHHHHHHHHHHhCC
Q 016037          151 DFEVLKVVGQGAFAKVYQVR-RIGTSEIYAMKVMRKDKIME---------------------KNHAEYMKSERNILTKVD  208 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~-~~~~~~~vAvK~i~~~~~~~---------------------~~~~~~~~~E~~~L~~l~  208 (396)
                      .|++.+.||+|+||.||+|. +..+|+.||+|+++......                     ......+..|+.+++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47888999999999999999 67789999999998643110                     011234678999999997


Q ss_pred             CCC--eeeeeEEEEecCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCCEEEcC
Q 016037          209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG-IMHRDLKPENILLDA  285 (396)
Q Consensus       209 Hpn--Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~-iiHrDlkp~NILl~~  285 (396)
                      +.+  +.+++..    ...++||||++|++|.........+....+..++.|++.++.+||+.| ++||||||+||+++ 
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-  183 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-  183 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence            533  3444432    235899999999888665544555666677889999999999999999 99999999999998 


Q ss_pred             CCcEEEEecccccccC
Q 016037          286 DGHVMLTDFGLAKQFD  301 (396)
Q Consensus       286 ~~~ikL~Dfgla~~~~  301 (396)
                      ++.++|+|||.+....
T Consensus       184 ~~~i~LiDFg~a~~~~  199 (237)
T smart00090      184 DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CCCEEEEEChhhhccC
Confidence            8899999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=1.4e-19  Score=164.52  Aligned_cols=137  Identities=25%  Similarity=0.356  Sum_probs=113.5

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccc-----hhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      +.||+|++|.||+|.+  +|..+++|+.......     .......+.+|+.++..+.|++|.....++......+++||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999998  5667999986543221     11223457789999999999988776667767778899999


Q ss_pred             ecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                      |++|++|.+.+.....    ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus        80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999888765432    6777899999999999999999999999999998 88999999999875

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=5e-19  Score=159.47  Aligned_cols=134  Identities=23%  Similarity=0.254  Sum_probs=106.9

Q ss_pred             EecccCceEEEEEEEcCCCcEEEEEEeeccccc-----hhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEe
Q 016037          157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (396)
Q Consensus       157 ~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (396)
                      .||+|+||.||+|.+  ++..+++|+.......     .....+.+.+|+++++.+.|+++.....++......++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            389999999999996  4567899986543211     122345677899999999988755444455566677999999


Q ss_pred             cCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccccc
Q 016037          232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       232 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~  300 (396)
                      ++|++|...+.....       .++.+++.+|.+||+.|++|+|++|+||+++ ++.++++|||++...
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999999887654321       6788999999999999999999999999998 899999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.79  E-value=3.3e-19  Score=177.89  Aligned_cols=193  Identities=22%  Similarity=0.310  Sum_probs=155.1

Q ss_pred             HHhCCCCCeeeeeEEEEecCeEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCc-eeccCCCCCE
Q 016037          204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGI-MHRDLKPENI  281 (396)
Q Consensus       204 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~i-iHrDlkp~NI  281 (396)
                      |+.+.|.|+.++++.+..+...++|.+||..|+|.+.+... -.+.......++++|+.||.|||.-.| .|+.+++.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            46789999999999999999999999999999999999873 345566667788999999999999866 9999999999


Q ss_pred             EEcCCCcEEEEecccccccCCC---CCccccccCCCccchhhhcCCC-------CCchhhHHHHHHHHHHHHhCCCCCCC
Q 016037          282 LLDADGHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKG-------HDKAADWWSVGILLFEMLTGQPPFTG  351 (396)
Q Consensus       282 Ll~~~~~ikL~Dfgla~~~~~~---~~~~~~~gt~~y~APE~l~~~~-------~~~~~DvwSlGvil~elltg~~Pf~~  351 (396)
                      +++....+||+|||+.......   .......-...|.|||.+.+..       -+.++||||||++++|+++.+.||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            9999999999999998776421   1111122345799999997631       35779999999999999999999987


Q ss_pred             C----CHHHHHHHHHh-CCC-CCCc-----cCCHHHHHHHHHhhccCCCCCCCCCC
Q 016037          352 G----NRQKIQQKIIK-DKI-KLPA-----FLSSEAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       352 ~----~~~~i~~~i~~-~~~-~~p~-----~~s~~~~~li~~~l~~~p~~RPs~s~  396 (396)
                      .    +.+++...+.+ +.. ..|.     ...+++..++++||..+|.+||++.+
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~  216 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQ  216 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHH
Confidence            3    34567777776 322 2221     34557999999999999999999753

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=5.8e-19  Score=159.34  Aligned_cols=140  Identities=19%  Similarity=0.192  Sum_probs=108.6

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchh-------------------hHHHHHHHHHHHHHhCCCCC-
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK-------------------NHAEYMKSERNILTKVDHPF-  211 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~-------------------~~~~~~~~E~~~L~~l~Hpn-  211 (396)
                      |.+.+.||+|+||.||++.+. +|+.||||+++.+.....                   ........|..++..+.|++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            777889999999999999885 789999999875431100                   01123567888999988774 


Q ss_pred             -eeeeeEEEEecCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEE
Q 016037          212 -IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM  290 (396)
Q Consensus       212 -Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ik  290 (396)
                       ++..++    ....++||||++|++|......      .....++.+++.++.++|+.|++||||||+||+++.++.++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence             444443    2345899999999988654321      33556888999999999999999999999999999999999


Q ss_pred             EEecccccccCC
Q 016037          291 LTDFGLAKQFDE  302 (396)
Q Consensus       291 L~Dfgla~~~~~  302 (396)
                      |+|||++.....
T Consensus       166 liDfg~~~~~~~  177 (198)
T cd05144         166 IIDWPQMVSTDH  177 (198)
T ss_pred             EEECCccccCCC
Confidence            999999976544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=1.5e-18  Score=179.74  Aligned_cols=139  Identities=22%  Similarity=0.261  Sum_probs=111.8

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccc-----cchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDK-----IMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~-----~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~  225 (396)
                      .|...+.||+|+||+||+|.+...+  +++|+.....     .......+.+.+|+++++.++|++++..+.++......
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            3466789999999999999986654  3444322211     11122345678899999999999998877777777778


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccccc
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~  300 (396)
                      ++||||++|++|.+++.        ....++.+++.+|.+||+.|++||||||+|||+ .++.++|+|||+++..
T Consensus       412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            99999999999988775        245688999999999999999999999999999 6889999999999764

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.77  E-value=2.1e-19  Score=176.61  Aligned_cols=163  Identities=29%  Similarity=0.387  Sum_probs=130.8

Q ss_pred             eEEEEEEecCCCcHHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccccc
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQGL---FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~  300 (396)
                      .+||.|++|.-.+|.+++.+...   .+......++.|++.|++|   ++.+|||+||.||++..+..+||.|||+....
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            58999999999999999976543   4556677899999999999   99999999999999999999999999999876


Q ss_pred             CCCC-------CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCC--CCc
Q 016037          301 DENT-------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIK--LPA  370 (396)
Q Consensus       301 ~~~~-------~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~~~~--~p~  370 (396)
                      ....       ......||..||+||.+.+..|+.++||||||++|+||++ =...|.   .......+..+.++  +-.
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r~g~ip~~~~~  483 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDIRDGIIPPEFLQ  483 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhhcCCCChHHhh
Confidence            5544       3456789999999999999999999999999999999998 333332   23333444444333  111


Q ss_pred             cCCHHHHHHHHHhhccCCCCCCC
Q 016037          371 FLSSEAHSLLKGVNSLLSISVPL  393 (396)
Q Consensus       371 ~~s~~~~~li~~~l~~~p~~RPs  393 (396)
                      . -++-..|+.+|+.+.|.+||+
T Consensus       484 d-~p~e~~ll~~lls~~p~~RP~  505 (516)
T KOG1033|consen  484 D-YPEEYTLLQQLLSPSPEERPS  505 (516)
T ss_pred             c-CcHHHHHHHHhcCCCcccCch
Confidence            2 234568999999999999995

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.76  E-value=2.8e-18  Score=152.92  Aligned_cols=140  Identities=25%  Similarity=0.297  Sum_probs=100.5

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHH---------------------HHHHHHHHHhCCCCC--
Q 016037          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY---------------------MKSERNILTKVDHPF--  211 (396)
Q Consensus       155 ~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~---------------------~~~E~~~L~~l~Hpn--  211 (396)
                      .+.||+|+||+||+|.+. +++.||||+++............                     ...|...+..+.+.+  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999986 78899999988643221111111                     135666666664432  


Q ss_pred             eeeeeEEEEecCeEEEEEEecCCCcHHH-HHHHhcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcE
Q 016037          212 IVQLRYSFQTKYRLYLVLDFVNGGHLFF-QLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHV  289 (396)
Q Consensus       212 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~-~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDlkp~NILl~~~~~i  289 (396)
                      +.+.+++    ...+++|||++++.+.. .+... ... ..++.++.+++.++.++|. .||+||||||+||+++ ++.+
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~  153 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV  153 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence            4444433    24589999999954321 11111 111 5677889999999999999 9999999999999999 9999


Q ss_pred             EEEecccccccCC
Q 016037          290 MLTDFGLAKQFDE  302 (396)
Q Consensus       290 kL~Dfgla~~~~~  302 (396)
                      +|+|||.+.....
T Consensus       154 ~liDfg~a~~~~~  166 (187)
T cd05119         154 YIIDVPQAVEIDH  166 (187)
T ss_pred             EEEECcccccccC
Confidence            9999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.73  E-value=1e-18  Score=182.87  Aligned_cols=250  Identities=33%  Similarity=0.481  Sum_probs=212.3

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCe
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~  224 (396)
                      .....+.+.+.+-+.+|+++.++.+.-..+|...+.|+............+....+..++-...+|.++.-...+.....
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP  878 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP  878 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence            45678899999999999999999999888888788887766544444444445555555555667888877767777888


Q ss_pred             EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC--
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE--  302 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~--  302 (396)
                      .+|+++|..+++|...++.-+..+++.++.+...+..+++|||+..++|||++|.|+|+..+++.+++|||.......  
T Consensus       879 ~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             cchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccccc
Confidence            999999999999999999988889999999999999999999999999999999999999999999999984432210  


Q ss_pred             ------------------------------CCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 016037          303 ------------------------------NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG  352 (396)
Q Consensus       303 ------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~  352 (396)
                                                    ........||+.|.+||.+.+......+|||++|++++|.++|..||...
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence                                          01134457899999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHHhCCCCCCc---cCCHHHHHHHHHhhccCCCCCCCC
Q 016037          353 NRQKIQQKIIKDKIKLPA---FLSSEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       353 ~~~~i~~~i~~~~~~~p~---~~s~~~~~li~~~l~~~p~~RPs~  394 (396)
                      ..+++++.|.+..++.|.   ..+.++++++..++..++.+|-.+
T Consensus      1039 tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred             chhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCc
Confidence            999999999999887764   689999999999999999998543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=2.4e-19  Score=186.11  Aligned_cols=245  Identities=27%  Similarity=0.410  Sum_probs=197.1

Q ss_pred             CCeEEEeEecccCceEEEEEEEcC-CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEEEecCeEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIG-TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~l  227 (396)
                      ..|.+.+.||+|+|+.|-...... +...+|+|.+.... ......+....|..+-+.+. |.|++.+++........++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            458888889999999998877744 34556777665543 23344555667888888887 9999999999999999999


Q ss_pred             EEEecCCCcHHHHH-HHhc-CCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCCEEEcCCC-cEEEEecccccccCC-
Q 016037          228 VLDFVNGGHLFFQL-YRQG-LFREDLARIYTAEIVSAVSHLH-ANGIMHRDLKPENILLDADG-HVMLTDFGLAKQFDE-  302 (396)
Q Consensus       228 V~E~~~gg~L~~~l-~~~~-~l~e~~~~~~~~qi~~aL~~LH-~~~iiHrDlkp~NILl~~~~-~ikL~Dfgla~~~~~-  302 (396)
                      +++|..|++++..+ .... ..+...+..++.|+..++.|+| ..++.|||+||+|.+++..+ .+++.|||+|..+.. 
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK  178 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence            99999999998888 5444 5677778889999999999999 99999999999999999999 999999999998765 


Q ss_pred             CC---Ccccccc-CCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhC--C--CCCCccC
Q 016037          303 NT---RSNSMCG-TLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ-QKIIKD--K--IKLPAFL  372 (396)
Q Consensus       303 ~~---~~~~~~g-t~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~-~~i~~~--~--~~~p~~~  372 (396)
                      ..   .....+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+......... ......  .  ......+
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSI  258 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccC
Confidence            22   2345678 9999999999885 4468899999999999999999999875433211 111111  2  3344679


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCC
Q 016037          373 SSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       373 s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +....+++..++..+|..|.+.+
T Consensus       259 ~~~~~~~l~k~l~~~~~~r~s~~  281 (601)
T KOG0590|consen  259 SDQAHDLLHKILKENPSNRLSIE  281 (601)
T ss_pred             ChhhhhcccccccCCchhccccc
Confidence            99999999999999999998875

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=2.6e-16  Score=146.30  Aligned_cols=137  Identities=20%  Similarity=0.294  Sum_probs=103.4

Q ss_pred             eEec-ccCceEEEEEEEcCCCcEEEEEEeeccccc----------hhhHHHHHHHHHHHHHhCCCCCe--eeeeEEEEec
Q 016037          156 KVVG-QGAFAKVYQVRRIGTSEIYAMKVMRKDKIM----------EKNHAEYMKSERNILTKVDHPFI--VQLRYSFQTK  222 (396)
Q Consensus       156 ~~IG-~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~----------~~~~~~~~~~E~~~L~~l~HpnI--v~l~~~~~~~  222 (396)
                      ..|| .|+.|+||.+...  +..+++|.+......          .......+.+|+.++..++|++|  +..++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            3476 7888888888773  667999988653321          11233557889999999998875  5566654332


Q ss_pred             -C---eEEEEEEecCC-CcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccc
Q 016037          223 -Y---RLYLVLDFVNG-GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA  297 (396)
Q Consensus       223 -~---~~~lV~E~~~g-g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla  297 (396)
                       .   ..++|||+++| .+|..++.. ..+++..    +.+++.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~  189 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG  189 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence             2   23599999997 588777654 4555543    568999999999999999999999999999999999999988


Q ss_pred             cc
Q 016037          298 KQ  299 (396)
Q Consensus       298 ~~  299 (396)
                      ..
T Consensus       190 ~~  191 (239)
T PRK01723        190 EL  191 (239)
T ss_pred             cc
Confidence            65

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.69  E-value=1.8e-16  Score=134.60  Aligned_cols=132  Identities=21%  Similarity=0.274  Sum_probs=110.9

Q ss_pred             EEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC--CCeeeeeEEEEecCeEEEEEEe
Q 016037          154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH--PFIVQLRYSFQTKYRLYLVLDF  231 (396)
Q Consensus       154 ~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~H--pnIv~l~~~~~~~~~~~lV~E~  231 (396)
                      +++.||+|.++.||++...+  ..+++|.+.....     ...+..|..+++.++|  .++++++.++...+..+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            45789999999999999855  6699999866432     3457789999999976  5899998888888889999999


Q ss_pred             cCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN---GIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       232 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~---~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                      +.|+.+..+       +......++.+++.++.+||..   +++|+|++|+||++++.+.++++|||.++.
T Consensus        75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            999877533       4455667789999999999985   799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.61  E-value=1e-15  Score=156.34  Aligned_cols=147  Identities=18%  Similarity=0.348  Sum_probs=98.3

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccch-------------------------------hhHHHHH
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-------------------------------KNHAEYM  197 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~-------------------------------~~~~~~~  197 (396)
                      ..+|+. +.||.|++|.||+|+.+.+|+.||||+.+++....                               .+..+.+
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345776 78999999999999999889999999998642100                               0122233


Q ss_pred             HHHHHHH------HhC----CCCCeeeeeEEEE-ecCeEEEEEEecCCCcHHHH--HHHhc----CCCHHHHHHHHHHHH
Q 016037          198 KSERNIL------TKV----DHPFIVQLRYSFQ-TKYRLYLVLDFVNGGHLFFQ--LYRQG----LFREDLARIYTAEIV  260 (396)
Q Consensus       198 ~~E~~~L------~~l----~HpnIv~l~~~~~-~~~~~~lV~E~~~gg~L~~~--l~~~~----~l~e~~~~~~~~qi~  260 (396)
                      .+|+++.      .++    .+...+.+-..+. -....+|||||+.|+.+.+.  +...+    .+.+..+..++.|+ 
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-  276 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-  276 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence            3344333      332    2332232222222 23456799999999998764  33333    23344444455554 


Q ss_pred             HHHHHHHHCCceeccCCCCCEEEcCCC----cEEEEecccccccCCC
Q 016037          261 SAVSHLHANGIMHRDLKPENILLDADG----HVMLTDFGLAKQFDEN  303 (396)
Q Consensus       261 ~aL~~LH~~~iiHrDlkp~NILl~~~~----~ikL~Dfgla~~~~~~  303 (396)
                            ...|++|+|+||.||+++.+|    +++++|||++..++..
T Consensus       277 ------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        277 ------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             ------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence                  458999999999999999988    9999999999887544

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.59  E-value=2.1e-14  Score=144.67  Aligned_cols=144  Identities=19%  Similarity=0.312  Sum_probs=97.1

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccch-------------------------------hhHHH------HHH
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-------------------------------KNHAE------YMK  198 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~-------------------------------~~~~~------~~~  198 (396)
                      +.||.|++|.||+|+.+ +|+.||||+.++.....                               ++...      .+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999985 68899999987642100                               00001      123


Q ss_pred             HHHHHHHhC----C-CCCeeeeeEEEEecCeEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHH-HHHHHHHCCc
Q 016037          199 SERNILTKV----D-HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVS-AVSHLHANGI  271 (396)
Q Consensus       199 ~E~~~L~~l----~-HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~-aL~~LH~~~i  271 (396)
                      +|...+.++    + ++++.--.-++......+|||||++|++|.+..... ....   ...++.+++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence            355444444    2 344322112222234568999999999987765432 1121   2334555555 4678899999


Q ss_pred             eeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          272 MHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       272 iHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      +|+|+||.||+++.+++++|+|||++..+...
T Consensus       279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~  310 (437)
T TIGR01982       279 FHADLHPGNIFVLKDGKIIALDFGIVGRLSEE  310 (437)
T ss_pred             eeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence            99999999999999999999999999887543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.59  E-value=1.9e-15  Score=151.39  Aligned_cols=242  Identities=22%  Similarity=0.226  Sum_probs=187.3

Q ss_pred             cCCCeEEEeEecc--cCceEEEEEEE--cCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEec
Q 016037          148 GLEDFEVLKVVGQ--GAFAKVYQVRR--IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTK  222 (396)
Q Consensus       148 ~~~~~~~~~~IG~--G~fG~Vy~~~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~  222 (396)
                      ....|.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+.... .......-.+|....+++ .|++.++.+..|...
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s-~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~  190 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS-PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS  190 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCC-CccccccccchhhcccccCccccccccCcccccC
Confidence            3445777888999  99999999988  88899999998543221 111222234466666666 499999999999999


Q ss_pred             CeEEEEEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHH----HHHHHHHCCceeccCCCCCEEEcCC-CcEEEEeccc
Q 016037          223 YRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVS----AVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGL  296 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~----aL~~LH~~~iiHrDlkp~NILl~~~-~~ikL~Dfgl  296 (396)
                      +.+|+-+|++.. +|..+... ...+++..++....+...    ||.++|+.+++|-|+||+||++..+ ..++++|||+
T Consensus       191 ~~lfiqtE~~~~-sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  191 GILFIQTELCGE-SLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             Ccceeeeccccc-hhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence            999999999974 55555544 455899999999999999    9999999999999999999999999 8899999999


Q ss_pred             ccccCCCCCc------cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCC
Q 016037          297 AKQFDENTRS------NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG---NRQKIQQKIIKDKIK  367 (396)
Q Consensus       297 a~~~~~~~~~------~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~---~~~~i~~~i~~~~~~  367 (396)
                      ...+.+....      ....|...|++||.+.+. ++.+.|+|+||.++.+..++..++...   .+.++.+....  .+
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip--~e  346 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP--LE  346 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc--hh
Confidence            9988665432      222577899999988765 889999999999999999988777654   33333322211  12


Q ss_pred             CCccCCHHHHHHHHHhhccCCCCCCCC
Q 016037          368 LPAFLSSEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       368 ~p~~~s~~~~~li~~~l~~~p~~RPs~  394 (396)
                      +-.+.+.++...+.+|++.++-.|++.
T Consensus       347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~  373 (524)
T KOG0601|consen  347 FCEGGSSSLRSVTSQMLDEDPRLRLTA  373 (524)
T ss_pred             hhcCcchhhhhHHHHhcCcchhhhhHH
Confidence            234577888889999999999998874

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.51  E-value=7.4e-15  Score=147.13  Aligned_cols=243  Identities=23%  Similarity=0.246  Sum_probs=186.6

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEc-CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecC
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRI-GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKY  223 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~  223 (396)
                      .....+|-.+..||.|.|+.|+.+... .++..|++|.+.+........+.. ..|+.+...+ .|.+++.++..|..-.
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~s-l~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFS-LGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcc-hhhhhHhhHhhcccccCCCCCCccccc
Confidence            345678999999999999999998766 678899999887765443333333 3466666665 5999999999998888


Q ss_pred             eEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC-CcEEEEecccccccCC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDE  302 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~-~~ikL~Dfgla~~~~~  302 (396)
                      +.|+-.|||+++++.....-...+.++..+.+..|++.++.++|+..++|+|+||.||++..+ +..++.|||++..+.-
T Consensus       340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~  419 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF  419 (524)
T ss_pred             cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence            889999999999887666555667888889999999999999999999999999999999876 7889999999975321


Q ss_pred             CCCccccccCCCcc--chhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Q 016037          303 NTRSNSMCGTLEYM--SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLL  380 (396)
Q Consensus       303 ~~~~~~~~gt~~y~--APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li  380 (396)
                      .  .......-+++  +++......+..+.|++|||..+.+..+|...-...   .....|..+.....+..+.++..+.
T Consensus       420 ~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~---~~~~~i~~~~~p~~~~~~~~~q~~~  494 (524)
T KOG0601|consen  420 S--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG---VQSLTIRSGDTPNLPGLKLQLQVLL  494 (524)
T ss_pred             e--cccccccccccccchhhccccccccccccccccccccccccCcccCccc---ccceeeecccccCCCchHHhhhhhh
Confidence            1  11122233444  444445566789999999999999999987643322   1233444565666666669999999


Q ss_pred             HHhhccCCCCCCCC
Q 016037          381 KGVNSLLSISVPLL  394 (396)
Q Consensus       381 ~~~l~~~p~~RPs~  394 (396)
                      +.++..++..||+.
T Consensus       495 kv~~~~~~~~~~l~  508 (524)
T KOG0601|consen  495 KVMINPDRKRRPSA  508 (524)
T ss_pred             hhhcCCccccchhh
Confidence            99999999999875

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.49  E-value=6.9e-13  Score=134.45  Aligned_cols=168  Identities=20%  Similarity=0.258  Sum_probs=128.8

Q ss_pred             EEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCCCcHHHHHHHhcCC
Q 016037          168 QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF  247 (396)
Q Consensus       168 ~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l  247 (396)
                      .|..+.++.+|.|.+.+...-   ...+...+-++.|+.++||||++++..+++.+.+|||+|-+..  |..++.+.+  
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~l~--  102 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKELG--  102 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHHhH--
Confidence            466777888899888876542   4455567778889999999999999999999999999999864  455565554  


Q ss_pred             CHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC-ccccccCCCccchhhhcCCC
Q 016037          248 REDLARIYTAEIVSAVSHLH-ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNSMCGTLEYMSPEIVLGKG  325 (396)
Q Consensus       248 ~e~~~~~~~~qi~~aL~~LH-~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~-~~~~~gt~~y~APE~l~~~~  325 (396)
                       ......-+.||+.||.||| .++++|++|.-..|+|+..|+.||++|.++........ .....---.|..|+.+....
T Consensus       103 -~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  103 -KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             -HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc
Confidence             4455556889999999997 56899999999999999999999999999876543332 11111112355666554332


Q ss_pred             CCchhhHHHHHHHHHHHHhC
Q 016037          326 HDKAADWWSVGILLFEMLTG  345 (396)
Q Consensus       326 ~~~~~DvwSlGvil~elltg  345 (396)
                        -..|.|.|||++||++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              347999999999999999

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.48  E-value=1.6e-13  Score=119.93  Aligned_cols=128  Identities=23%  Similarity=0.287  Sum_probs=95.2

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCee-eeeEEEEecCeEEEEEEecC
Q 016037          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIV-QLRYSFQTKYRLYLVLDFVN  233 (396)
Q Consensus       155 ~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv-~l~~~~~~~~~~~lV~E~~~  233 (396)
                      ++.|+.|.++.||+++..  +..|++|+......    .......|..+++.+.+.+++ +++....  ...++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence            467899999999999874  67799999765431    112346788888888655544 4444432  23479999999


Q ss_pred             CCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCc-----eeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          234 GGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI-----MHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       234 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~i-----iHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                      |.++...        ......++.+++.+|..||+.++     +|+|++|.||+++ ++.++++|||.+..
T Consensus        75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            9877532        11123456799999999999985     9999999999998 77899999998854

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.46  E-value=1.1e-12  Score=117.52  Aligned_cols=142  Identities=15%  Similarity=0.192  Sum_probs=102.1

Q ss_pred             eEecccCceEEEEEEEcC------CCcEEEEEEeeccccc-------------------hhhHHHH----HHHHHHHHHh
Q 016037          156 KVVGQGAFAKVYQVRRIG------TSEIYAMKVMRKDKIM-------------------EKNHAEY----MKSERNILTK  206 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~------~~~~vAvK~i~~~~~~-------------------~~~~~~~----~~~E~~~L~~  206 (396)
                      ..||.|--+.||.|....      .+..+|||+.+.....                   ..+..+.    .++|.+.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998653      3578999999752210                   0111222    3479999998


Q ss_pred             CCC--CCeeeeeEEEEecCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCCEEE
Q 016037          207 VDH--PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL-HANGIMHRDLKPENILL  283 (396)
Q Consensus       207 l~H--pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~L-H~~~iiHrDlkp~NILl  283 (396)
                      +..  -++.+.+++    ..-+|||||+.++.+.....+...+++.....+..+++.+|..| |..|+||+||++.|||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~  158 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW  158 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            853  355555554    34589999998764432222333455556667789999999998 89999999999999999


Q ss_pred             cCCCcEEEEecccccccCC
Q 016037          284 DADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       284 ~~~~~ikL~Dfgla~~~~~  302 (396)
                      + ++.+.|+|||.+....+
T Consensus       159 ~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         159 H-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             E-CCcEEEEECCCceeCCC
Confidence            6 57899999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.35  E-value=9.8e-12  Score=108.48  Aligned_cols=134  Identities=27%  Similarity=0.315  Sum_probs=100.0

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEe-----eccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVM-----RKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i-----~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      ..+++|+-+.++.+.|.+  ..+.+|.=     +...++.+-..++..+|++++.++.--.|..-+-++.+.....|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~g--~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLG--LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeeccC--cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            357899999999998844  33555532     22444455556777889999998865555444445566677789999


Q ss_pred             ecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                      |++|..|.+.+...   .    ..++..+-..+.-||..||+|+||.+.||++..++ +.++|||++..
T Consensus        80 ~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999888888765   2    33555666667789999999999999999996555 99999999964

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.32  E-value=1.9e-12  Score=121.14  Aligned_cols=192  Identities=17%  Similarity=0.203  Sum_probs=138.1

Q ss_pred             HHHHHhCCCCCeeeeeEEEEe-----cCeEEEEEEecCCCcHHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC--
Q 016037          201 RNILTKVDHPFIVQLRYSFQT-----KYRLYLVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHAN--  269 (396)
Q Consensus       201 ~~~L~~l~HpnIv~l~~~~~~-----~~~~~lV~E~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~--  269 (396)
                      .+-|-++.|.|||+...+|.+     ..+..+++|||..|++..+|++.    ..+.....++|+.||+.||.|||+.  
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            344666789999999888854     45688999999999999988654    4577778888999999999999998  


Q ss_pred             CceeccCCCCCEEEcCCCcEEEEecccccccC--CC---CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh
Q 016037          270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFD--EN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT  344 (396)
Q Consensus       270 ~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~--~~---~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt  344 (396)
                      .|+|+++..+-|++..+|-+|++--.-.....  ..   .....-.+-++|.|||.=.....+.++|||+||++.+||..
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            69999999999999999989887322111100  00   01112235688999997766667788999999999999999


Q ss_pred             CCCCCCC-CCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          345 GQPPFTG-GNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       345 g~~Pf~~-~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ++.--.. .+.......|.+--+-+-.+   --+.+|..|++..|..||++.
T Consensus       278 lEiq~tnseS~~~~ee~ia~~i~~len~---lqr~~i~kcl~~eP~~rp~ar  326 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVEENIANVIIGLENG---LQRGSITKCLEGEPNGRPDAR  326 (458)
T ss_pred             heeccCCCcceeehhhhhhhheeeccCc---cccCcCcccccCCCCCCcchh
Confidence            8876433 23233333333322222222   235678999999999999863

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.27  E-value=5.6e-11  Score=103.47  Aligned_cols=144  Identities=28%  Similarity=0.333  Sum_probs=105.5

Q ss_pred             EEeEecccCceEEEEEEEcCCCcEEEEE-----EeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          154 VLKVVGQGAFAKVYQVRRIGTSEIYAMK-----VMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       154 ~~~~IG~G~fG~Vy~~~~~~~~~~vAvK-----~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .+..|-+|+-+.|+++.+.  |+.+.||     ..+...+..+-...+.++|+++|.++.--.|.--.-+|.+...-+|+
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            5677889999999999994  4555555     33445555555677788999999988644444333345565666899


Q ss_pred             EEecCC-CcHHHHHHHh-cCCCHHH-HHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC---cEEEEecccccc
Q 016037          229 LDFVNG-GHLFFQLYRQ-GLFREDL-ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG---HVMLTDFGLAKQ  299 (396)
Q Consensus       229 ~E~~~g-g~L~~~l~~~-~~l~e~~-~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~---~ikL~Dfgla~~  299 (396)
                      |||++| .++.+++... ..-.++. ...++..|-..+.-||.++|||+||..+||++..++   .+.++|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999988 3566666543 2222333 367888999999999999999999999999998776   358999999854

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.24  E-value=4.3e-11  Score=108.91  Aligned_cols=140  Identities=17%  Similarity=0.244  Sum_probs=100.6

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCC--CeeeeeEEEEec---CeEEEEEE
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP--FIVQLRYSFQTK---YRLYLVLD  230 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~Hp--nIv~l~~~~~~~---~~~~lV~E  230 (396)
                      +.|+.|.++.||++...+ |+.+++|+.......  .....+..|..+++.+.+.  .+.+++.+....   +..++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            578999999999998744 578999998664321  1234567899999998753  456666666553   36789999


Q ss_pred             ecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 016037          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA------------------------------------------  268 (396)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~------------------------------------------  268 (396)
                      |++|.++...+.. ..+++.....++.+++.+|..||+                                          
T Consensus        81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9999877554321 334555555556666666666653                                          


Q ss_pred             --------------CCceeccCCCCCEEEcC--CCcEEEEecccccc
Q 016037          269 --------------NGIMHRDLKPENILLDA--DGHVMLTDFGLAKQ  299 (396)
Q Consensus       269 --------------~~iiHrDlkp~NILl~~--~~~ikL~Dfgla~~  299 (396)
                                    ..++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          24699999999999998  66789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.19  E-value=5e-10  Score=110.86  Aligned_cols=205  Identities=19%  Similarity=0.271  Sum_probs=149.8

Q ss_pred             CceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe----cCeEEEEEEecCCC-c
Q 016037          162 AFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT----KYRLYLVLDFVNGG-H  236 (396)
Q Consensus       162 ~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~gg-~  236 (396)
                      --.+.|++....+|..|++|++.-++......   .-.-.++++++.|+|+|++.+.|..    ...+++|++|.++. +
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk---~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNK---DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCccc---chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence            34678999999999999999995443322221   2234678999999999999988863    45789999998864 5


Q ss_pred             HHHHHHH---------------hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          237 LFFQLYR---------------QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       237 L~~~l~~---------------~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      |.++-..               ....+|..+|.|+.|+..||.++|+.|+..+-|.+.+||++.+.+++|.-.|+...+.
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            6544321               2346789999999999999999999999999999999999999899999888776654


Q ss_pred             CCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Q 016037          302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK  381 (396)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~  381 (396)
                      ....             |-+.   --.+-|.=.||.+++.|.||..--..   ....+.....+  +-..+|.+++++|.
T Consensus       445 ~d~~-------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~---~d~~~~s~~~~--I~~~yS~D~rn~v~  503 (655)
T KOG3741|consen  445 EDPT-------------EPLE---SQQQNDLRDLGLLLLALATGTENSNR---TDSTQSSHLTR--ITTTYSTDLRNVVE  503 (655)
T ss_pred             CCCC-------------cchh---HHhhhhHHHHHHHHHHHhhccccccc---ccchHHHHHHH--hhhhhhHHHHHHHH
Confidence            4331             1111   12457999999999999998643211   11122222221  22468889999999


Q ss_pred             HhhccCCCC
Q 016037          382 GVNSLLSIS  390 (396)
Q Consensus       382 ~~l~~~p~~  390 (396)
                      .+.+.++.+
T Consensus       504 yl~s~~~~~  512 (655)
T KOG3741|consen  504 YLESLNFRE  512 (655)
T ss_pred             HHHhcCccc
Confidence            888888774

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.07  E-value=4.7e-09  Score=99.03  Aligned_cols=133  Identities=16%  Similarity=0.085  Sum_probs=92.2

Q ss_pred             EEEEEEEcCCCcEEEEEEeeccccchh--------hHHHHHHHHHHHHHhCCCCC--eeeeeEEEEe-----cCeEEEEE
Q 016037          165 KVYQVRRIGTSEIYAMKVMRKDKIMEK--------NHAEYMKSERNILTKVDHPF--IVQLRYSFQT-----KYRLYLVL  229 (396)
Q Consensus       165 ~Vy~~~~~~~~~~vAvK~i~~~~~~~~--------~~~~~~~~E~~~L~~l~Hpn--Iv~l~~~~~~-----~~~~~lV~  229 (396)
                      .|.++.+  .|+.|.||..........        .......+|...+.+|..-+  +++.+++++.     ...-+|||
T Consensus        37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            3556555  456788887644321100        11113667888887774322  2233344433     23578999


Q ss_pred             EecCCC-cHHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC-------CCcEEEEecccccc
Q 016037          230 DFVNGG-HLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-------DGHVMLTDFGLAKQ  299 (396)
Q Consensus       230 E~~~gg-~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~-------~~~ikL~Dfgla~~  299 (396)
                      |++++. +|.+++..  .....+.....++.+++..+.-||..||+|+|+++.|||++.       ++.+.|+||+.+..
T Consensus       115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            999986 78777653  344566777889999999999999999999999999999975       46899999998853

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.06  E-value=2.4e-09  Score=95.54  Aligned_cols=129  Identities=26%  Similarity=0.317  Sum_probs=81.8

Q ss_pred             EEEEEEEcCCCcEEEEEEeeccc-----------------------cchhhHHHHHHHHHHHHHhCCCC--CeeeeeEEE
Q 016037          165 KVYQVRRIGTSEIYAMKVMRKDK-----------------------IMEKNHAEYMKSERNILTKVDHP--FIVQLRYSF  219 (396)
Q Consensus       165 ~Vy~~~~~~~~~~vAvK~i~~~~-----------------------~~~~~~~~~~~~E~~~L~~l~Hp--nIv~l~~~~  219 (396)
                      .||.|.. ..|..+|+|+.+...                       ..........++|.+.|.++..-  ++.+.+++-
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4888887 456789999987521                       11122345577899999999766  455555442


Q ss_pred             EecCeEEEEEEecC--CCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHH-HHHCCceeccCCCCCEEEcCCCcEEEEeccc
Q 016037          220 QTKYRLYLVLDFVN--GGHLFFQLYRQGLFREDLARIYTAEIVSAVSH-LHANGIMHRDLKPENILLDADGHVMLTDFGL  296 (396)
Q Consensus       220 ~~~~~~~lV~E~~~--gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~-LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgl  296 (396)
                          .-+|||||++  |..+.. +.... +.......++.+++..+.. +|..||+|+||.+.|||++++ .+.|+|||.
T Consensus        80 ----~~~ivME~I~~~G~~~~~-l~~~~-~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPR-LKDVD-LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGC-HHHCG-GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred             ----CCEEEEEecCCCccchhh-HHhcc-ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence                2369999999  655533 32221 1133445567777775555 579999999999999999776 999999999


Q ss_pred             ccccC
Q 016037          297 AKQFD  301 (396)
Q Consensus       297 a~~~~  301 (396)
                      +....
T Consensus       153 av~~~  157 (188)
T PF01163_consen  153 AVDSS  157 (188)
T ss_dssp             EEETT
T ss_pred             ceecC
Confidence            86653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.95  E-value=1.8e-08  Score=97.87  Aligned_cols=231  Identities=19%  Similarity=0.302  Sum_probs=149.7

Q ss_pred             EEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEE--------EecCe
Q 016037          154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSF--------QTKYR  224 (396)
Q Consensus       154 ~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~--------~~~~~  224 (396)
                      ..+.||+|+-+.+|-.-...+   .+-|++.+.....+.      ..+..|.+. .||-+-. .-.|        ..+..
T Consensus        15 ~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~a------qk~a~la~~p~~p~~~~-rvaWPqa~L~G~~~~~~   84 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQA------QKVAELAATPDAPLLNY-RVAWPQATLHGGRRGKV   84 (637)
T ss_pred             CCccccCCccceeeecchhhc---hhheeecCCCchHHH------HHHHHhccCCCCcchhh-hhcccHHHhhCCCccce
Confidence            346799999999996433222   345777654321111      122233333 5664332 1111        12223


Q ss_pred             EEEEEEecCCCcHHHHHH----Hh---cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccc
Q 016037          225 LYLVLDFVNGGHLFFQLY----RQ---GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA  297 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~----~~---~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla  297 (396)
                      .-+.|..+.|..-...+.    ++   ..+.++.+...+..++.+.+.||..|.+-+|++++|+|+++++.+.|.|-..-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence            667788877753322221    11   23567788888999999999999999999999999999999999999974432


Q ss_pred             cccCCCCCccccccCCCccchhhhc-----CCCCCchhhHHHHHHHHHHHHhC-CCCCCCCC-----HHHHHHHHHhC--
Q 016037          298 KQFDENTRSNSMCGTLEYMSPEIVL-----GKGHDKAADWWSVGILLFEMLTG-QPPFTGGN-----RQKIQQKIIKD--  364 (396)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~~DvwSlGvil~elltg-~~Pf~~~~-----~~~i~~~i~~~--  364 (396)
                      ..-.........+|...|.+||.-.     +.+-+...|-|.||+++++++.| ++||.+.-     ..-....|..+  
T Consensus       165 qi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f  244 (637)
T COG4248         165 QINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF  244 (637)
T ss_pred             eeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence            2223333445567899999999765     23346779999999999999995 99998721     11111133222  


Q ss_pred             ---------CCCCCc-----cCCHHHHHHHHHhhcc--CCCCCCCC
Q 016037          365 ---------KIKLPA-----FLSSEAHSLLKGVNSL--LSISVPLL  394 (396)
Q Consensus       365 ---------~~~~p~-----~~s~~~~~li~~~l~~--~p~~RPs~  394 (396)
                               ..+-|.     -++++++.|..+|++-  ++.-|||.
T Consensus       245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a  290 (637)
T COG4248         245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTA  290 (637)
T ss_pred             eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCH
Confidence                     222222     3788999999999986  46789985

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.92  E-value=4.7e-10  Score=114.55  Aligned_cols=137  Identities=22%  Similarity=0.386  Sum_probs=106.0

Q ss_pred             HHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEecccccccCCCCC----------ccccccCCCccchhhhcCCC
Q 016037          257 AEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR----------SNSMCGTLEYMSPEIVLGKG  325 (396)
Q Consensus       257 ~qi~~aL~~LH~~-~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~----------~~~~~gt~~y~APE~l~~~~  325 (396)
                      .+++.|+.|+|.. ++||++|.|++|.++..+.+||+.|+.+........          .....-...|.|||.+.+..
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            3555899999987 899999999999999999999999998865543211          01112356899999999988


Q ss_pred             CCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHh-----CCCCCCccCCHHHHHHHHHhhccCCCCCCCC
Q 016037          326 HDKAADWWSVGILLFEML-TGQPPFTGGNRQKIQQKIIK-----DKIKLPAFLSSEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       326 ~~~~~DvwSlGvil~ell-tg~~Pf~~~~~~~i~~~i~~-----~~~~~p~~~s~~~~~li~~~l~~~p~~RPs~  394 (396)
                      .+.++|+||||+++|.+. .|+.-+...+-.. ......     ........+++++++=|+.++..+..-||++
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~  259 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-SYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL  259 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcc-hhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcch
Confidence            899999999999999999 4776666543222 222222     1345567899999999999999999999965

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.87  E-value=4.4e-08  Score=89.01  Aligned_cols=106  Identities=25%  Similarity=0.308  Sum_probs=81.7

Q ss_pred             HHHHHHHHHHHhCCCC--CeeeeeEEEEec----CeEEEEEEecCCC-cHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH
Q 016037          195 EYMKSERNILTKVDHP--FIVQLRYSFQTK----YRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH  267 (396)
Q Consensus       195 ~~~~~E~~~L~~l~Hp--nIv~l~~~~~~~----~~~~lV~E~~~gg-~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH  267 (396)
                      ....+|...+..|..-  .+.+.+++.+..    ...++|+|++++. +|.+++......+......++.+++..+.-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            3466677777666422  233444444442    2458999999985 78888877555677778889999999999999


Q ss_pred             HCCceeccCCCCCEEEcCCC---cEEEEeccccccc
Q 016037          268 ANGIMHRDLKPENILLDADG---HVMLTDFGLAKQF  300 (396)
Q Consensus       268 ~~~iiHrDlkp~NILl~~~~---~ikL~Dfgla~~~  300 (396)
                      ..||+|+|+++.|||++.++   .+.|+||+.++..
T Consensus       136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999999999999999887   8999999988653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.76  E-value=1.4e-07  Score=85.12  Aligned_cols=141  Identities=12%  Similarity=0.180  Sum_probs=99.3

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeecccc--ch-hhHHHHHHHHHHHHHhCCCC--CeeeeeEEEEe----cCeEEEE
Q 016037          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI--ME-KNHAEYMKSERNILTKVDHP--FIVQLRYSFQT----KYRLYLV  228 (396)
Q Consensus       158 IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~--~~-~~~~~~~~~E~~~L~~l~Hp--nIv~l~~~~~~----~~~~~lV  228 (396)
                      -|+||-+-|+.....+.  .+-+|.-.....  .. ......+.+|...|..|..-  .+.+...+-..    ...-+||
T Consensus        26 ~~rgG~SgV~r~~~~g~--~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERNGK--KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeCCc--EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence            46788888888776443  577787642110  01 23445678899888887432  24444422212    2346899


Q ss_pred             EEecCCC-cHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc--EEEEeccccccc
Q 016037          229 LDFVNGG-HLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH--VMLTDFGLAKQF  300 (396)
Q Consensus       229 ~E~~~gg-~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~--ikL~Dfgla~~~  300 (396)
                      +|-++|- +|.+++...  ...++.....+..+++.++.-||..|+.|+|+.+.||+++.+|.  ++++||.-++..
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~  180 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR  180 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence            9988754 777776553  34577777889999999999999999999999999999987777  999999977653

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.72  E-value=1.5e-07  Score=87.09  Aligned_cols=140  Identities=19%  Similarity=0.211  Sum_probs=98.4

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc-----------------h--hhHHHHHHHHHHHHHhCCCC--
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----------------E--KNHAEYMKSERNILTKVDHP--  210 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~-----------------~--~~~~~~~~~E~~~L~~l~Hp--  210 (396)
                      ..+...||-|--+.||.|.+. .|..+|||.=+.....                 +  .-.....++|..+|.+|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            345678999999999999996 5778999975532110                 0  11223456788899988544  


Q ss_pred             CeeeeeEEEEecCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEE
Q 016037          211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM  290 (396)
Q Consensus       211 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ik  290 (396)
                      .+.+-+++    +.-.+|||+++|-.|...-     +.......++..|+.-+.-+-..|+||+|+.+=||+++++|.+.
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~  242 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV  242 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence            44444332    3457999999997664321     12334444556666666666689999999999999999999999


Q ss_pred             EEecccccccC
Q 016037          291 LTDFGLAKQFD  301 (396)
Q Consensus       291 L~Dfgla~~~~  301 (396)
                      ++||-.+....
T Consensus       243 vIDwPQ~v~~~  253 (304)
T COG0478         243 VIDWPQAVPIS  253 (304)
T ss_pred             EEeCcccccCC
Confidence            99998775543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.68  E-value=8.9e-08  Score=97.79  Aligned_cols=143  Identities=21%  Similarity=0.311  Sum_probs=91.6

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccc-------------------------------hhhHHHHHH------
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-------------------------------EKNHAEYMK------  198 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~-------------------------------~~~~~~~~~------  198 (396)
                      ..|+.++-|.||+|+.+. |+.||||+.+++-..                               -++..+.+.      
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            569999999999999966 899999999863210                               011122222      


Q ss_pred             HHHHHHHhC-----CCCCeeeeeEEEEecCeEEEEEEecCCCcHHHHH--HHhcCCCHHHHHHHHHHHHHH-HHHHHHCC
Q 016037          199 SERNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL--YRQGLFREDLARIYTAEIVSA-VSHLHANG  270 (396)
Q Consensus       199 ~E~~~L~~l-----~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l--~~~~~l~e~~~~~~~~qi~~a-L~~LH~~~  270 (396)
                      +|...+.++     +.+++.--.-+++-...-.|+|||++|..+.+..  .. ..++.+.+   +..++.+ +..+=..|
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~i---a~~~~~~f~~q~~~dg  285 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKEL---AELLVRAFLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHH---HHHHHHHHHHHHHhcC
Confidence            343334333     2343322222333345568999999998887664  33 33332222   2222211 22233489


Q ss_pred             ceeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       271 iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      ++|.|.+|.||+++.+|++.+.|||+...+++.
T Consensus       286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            999999999999999999999999999887654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.63  E-value=9.6e-07  Score=80.10  Aligned_cols=141  Identities=18%  Similarity=0.244  Sum_probs=89.9

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHH------HHHHHHHHHhCC---CCCeeeeeE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY------MKSERNILTKVD---HPFIVQLRY  217 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~------~~~E~~~L~~l~---HpnIv~l~~  217 (396)
                      +-.++|+..+++-......|.+..-  +|..+.+|..+......+.....      ..+++..+..+.   --.+..++.
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl  105 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL  105 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence            3456899999998888777777666  55779999987643221111111      122333233322   122222222


Q ss_pred             E-----EEecCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEE
Q 016037          218 S-----FQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLT  292 (396)
Q Consensus       218 ~-----~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~  292 (396)
                      +     +.-....+++|||++|..|.+...    +.+    .++..+..++.-||..|+.|+|.+|.|++++.++ ++++
T Consensus       106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iI  176 (229)
T PF06176_consen  106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRII  176 (229)
T ss_pred             eeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEE
Confidence            2     222345678999999987754321    222    2445677789999999999999999999997544 9999


Q ss_pred             eccccc
Q 016037          293 DFGLAK  298 (396)
Q Consensus       293 Dfgla~  298 (396)
                      ||+..+
T Consensus       177 D~~~k~  182 (229)
T PF06176_consen  177 DTQGKR  182 (229)
T ss_pred             ECcccc
Confidence            998664

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.63  E-value=4.9e-09  Score=106.22  Aligned_cols=186  Identities=20%  Similarity=0.265  Sum_probs=139.8

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC-eeeeeEEEEecCeEEEEEE
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF-IVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~Hpn-Iv~l~~~~~~~~~~~lV~E  230 (396)
                      +...+.+++|+++++++.+...+...+ .+++...        ....-++++|.+++||| .+..++.++.+...++.++
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~  314 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR  314 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence            555567889999999998887776655 6665432        22445889999999999 7777788888889999999


Q ss_pred             ecCCC--cHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccc
Q 016037          231 FVNGG--HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (396)
Q Consensus       231 ~~~gg--~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~  308 (396)
                      ++.++  .........-.+.+-........-++++++||+.--+|||    ||+. .++..+..||+....+.......+
T Consensus       315 i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~-s~~~~~~~~~~v~~~L~~~~~~~t  389 (829)
T KOG0576|consen  315 ICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG-SEEEVKLLDFAVPPQLTRTMKPRT  389 (829)
T ss_pred             hhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc-cccccccccccCCcccCccccccc
Confidence            99987  1111000001112222333455667889999998888998    7777 458899999999988877666778


Q ss_pred             cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 016037          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG  351 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~  351 (396)
                      ..+|+.|+|||+.....+....|.|++|.--.+|.-|-+|-..
T Consensus       390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence            8899999999999999999999999999877777777777644

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.48  E-value=2.2e-06  Score=78.99  Aligned_cols=134  Identities=15%  Similarity=0.127  Sum_probs=82.4

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC--eeeeeEEEEecCeEEEEEEecC
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVN  233 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~  233 (396)
                      ..||+|..+.||+.    .+..+++|......     ....+.+|.++++.+..-+  +.+.+.+........+|||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            57899999999973    24457888876532     1233577999988875433  3556677777777889999999


Q ss_pred             CCc-HH--------------HHHHH-----h----cCCCH-HHHHHHHH----------HHHH-HHHHHHHC----Ccee
Q 016037          234 GGH-LF--------------FQLYR-----Q----GLFRE-DLARIYTA----------EIVS-AVSHLHAN----GIMH  273 (396)
Q Consensus       234 gg~-L~--------------~~l~~-----~----~~l~e-~~~~~~~~----------qi~~-aL~~LH~~----~iiH  273 (396)
                      |.. +.              ..+.+     +    ..... .....+..          .+.. ...+|...    .++|
T Consensus        78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            963 11              11110     0    00010 00001100          1111 12233322    4789


Q ss_pred             ccCCCCCEEEcCCCcEEEEecccccc
Q 016037          274 RDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       274 rDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                      +|+.|.||++++++ +.++||+.+..
T Consensus       158 gD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       158 GDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             cCCCCCcEEEcCCC-cEEEechhcCc
Confidence            99999999999888 99999998864

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.48  E-value=2.4e-06  Score=78.47  Aligned_cols=140  Identities=22%  Similarity=0.250  Sum_probs=93.9

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhh---------------------HHHHHHHHHHHHHhCCCC--Ce
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN---------------------HAEYMKSERNILTKVDHP--FI  212 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~---------------------~~~~~~~E~~~L~~l~Hp--nI  212 (396)
                      ..|+.|--+.||+|.. +++..+|+|+++.....-+.                     ...+...|..-|+++...  .+
T Consensus        54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            4678888899999887 56788999999764322111                     122344566667666322  22


Q ss_pred             eeeeEEEEecCeEEEEEEecCCCcHHH-HHHHhcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcEE
Q 016037          213 VQLRYSFQTKYRLYLVLDFVNGGHLFF-QLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVM  290 (396)
Q Consensus       213 v~l~~~~~~~~~~~lV~E~~~gg~L~~-~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDlkp~NILl~~~~~ik  290 (396)
                      .+-+.+.    +-.|||||+.....-- .|.. -.+....+..+..++++.+.-|-. .++||+||..=|||+. ++.+.
T Consensus       133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~  206 (268)
T COG1718         133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY  206 (268)
T ss_pred             CCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence            3333333    3369999997652110 1111 122333577778888888888877 8999999999999997 99999


Q ss_pred             EEecccccccCC
Q 016037          291 LTDFGLAKQFDE  302 (396)
Q Consensus       291 L~Dfgla~~~~~  302 (396)
                      ++|||-|....+
T Consensus       207 iID~~QaV~~~h  218 (268)
T COG1718         207 IIDVSQAVTIDH  218 (268)
T ss_pred             EEECccccccCC
Confidence            999999976553

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.46  E-value=2.6e-06  Score=77.70  Aligned_cols=138  Identities=25%  Similarity=0.339  Sum_probs=81.1

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCC--CeeeeeEEE---EecCeEEEEE
Q 016037          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP--FIVQLRYSF---QTKYRLYLVL  229 (396)
Q Consensus       155 ~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~Hp--nIv~l~~~~---~~~~~~~lV~  229 (396)
                      ++.|+.|..+.||++...+ + .+++|+....     .....+..|..+++.+...  -+.+++...   ......+++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~-~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-G-RYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-S-EEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC-c-EEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            5789999999999999866 4 7999997653     3344566788888777432  244555533   2334579999


Q ss_pred             EecCCCcHHH----------------HHH---Hh----cCCCHHH------HHHH---------------HHHHHH-HHH
Q 016037          230 DFVNGGHLFF----------------QLY---RQ----GLFREDL------ARIY---------------TAEIVS-AVS  264 (396)
Q Consensus       230 E~~~gg~L~~----------------~l~---~~----~~l~e~~------~~~~---------------~~qi~~-aL~  264 (396)
                      ++++|..+..                .+.   ..    ..+....      ....               ...+.. .+.
T Consensus        75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (239)
T PF01636_consen   75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ  154 (239)
T ss_dssp             EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred             EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence            9999987766                111   11    0001000      0000               111222 333


Q ss_pred             HHHH-------CCceeccCCCCCEEEc-CCCcEEEEecccccc
Q 016037          265 HLHA-------NGIMHRDLKPENILLD-ADGHVMLTDFGLAKQ  299 (396)
Q Consensus       265 ~LH~-------~~iiHrDlkp~NILl~-~~~~ikL~Dfgla~~  299 (396)
                      .++.       ..++|+|+.|.|||++ .++.+.|+||+.+..
T Consensus       155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            3332       3599999999999999 667778999998754

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.40  E-value=1.8e-06  Score=88.09  Aligned_cols=142  Identities=20%  Similarity=0.321  Sum_probs=88.8

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccc----------------------------hhhHHHHHHHHHHH----
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM----------------------------EKNHAEYMKSERNI----  203 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~----------------------------~~~~~~~~~~E~~~----  203 (396)
                      +.||..+.|.||+|+.+. |+.||||+-++.--.                            -++..+.+..|++.    
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            569999999999999977 999999998753200                            01111222222222    


Q ss_pred             ------HHhCCCCC------eeeeeEEEEecCeEEEEEEecCCCcHH--HHHHHhcCCCHHHHHHHHHHHHHHH-HHHHH
Q 016037          204 ------LTKVDHPF------IVQLRYSFQTKYRLYLVLDFVNGGHLF--FQLYRQGLFREDLARIYTAEIVSAV-SHLHA  268 (396)
Q Consensus       204 ------L~~l~Hpn------Iv~l~~~~~~~~~~~lV~E~~~gg~L~--~~l~~~~~l~e~~~~~~~~qi~~aL-~~LH~  268 (396)
                            .+.+.|-+      |.++|..+  ...-.|+||||+|..+.  +.+.+.+.-+.+.+.    .+.++. .-|=.
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~----~l~~~~~~qIf~  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILN----KLVEAYLEQIFK  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHH----HHHHHHHHHHHh
Confidence                  23334544      44444333  33568999999998654  344444443332222    222221 11234


Q ss_pred             CCceeccCCCCCEEEcC----CCcEEEEecccccccCCCC
Q 016037          269 NGIMHRDLKPENILLDA----DGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       269 ~~iiHrDlkp~NILl~~----~~~ikL~Dfgla~~~~~~~  304 (396)
                      .|++|.|-+|.||+++.    ++.+.+-|||+...+.+..
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~~  359 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHKT  359 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHHH
Confidence            68999999999999984    5689999999998776543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.28  E-value=9.6e-06  Score=75.31  Aligned_cols=135  Identities=17%  Similarity=0.070  Sum_probs=81.4

Q ss_pred             EecccCc-eEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEEEecCeEEEEEEecCC
Q 016037          157 VVGQGAF-AKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLDFVNG  234 (396)
Q Consensus       157 ~IG~G~f-G~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (396)
                      .|..|.+ ..||++...  +..+.+|+.....      ...+.+|+.+++.+. +--+.+++++....+..++|||+++|
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   76 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG   76 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence            3555555 788988653  3568888865432      223566888888773 33355677777666678999999999


Q ss_pred             CcHHHHHH-------------------Hhc----CCCHH---HHHHHHH-------------------HHHHHHHHHHH-
Q 016037          235 GHLFFQLY-------------------RQG----LFRED---LARIYTA-------------------EIVSAVSHLHA-  268 (396)
Q Consensus       235 g~L~~~l~-------------------~~~----~l~e~---~~~~~~~-------------------qi~~aL~~LH~-  268 (396)
                      .++.....                   ...    .+...   .......                   .+...+..|-. 
T Consensus        77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  156 (244)
T cd05150          77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT  156 (244)
T ss_pred             ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence            87653310                   000    01100   0000000                   01111222211 


Q ss_pred             ------CCceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          269 ------NGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       269 ------~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                            ..++|+|+.|.|||++.++.+.|+||+.+..
T Consensus       157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence                  2489999999999999887788999998854

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.27  E-value=5.3e-06  Score=72.35  Aligned_cols=130  Identities=22%  Similarity=0.278  Sum_probs=92.7

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeee-eeEEEEecCeEEEEEE
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ-LRYSFQTKYRLYLVLD  230 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~-l~~~~~~~~~~~lV~E  230 (396)
                      ....+.||+|.+|.||+|.|.+  ..+|+|+-+.+.     ....++.|+++|..+.--++-+ +|.+-..    ++.||
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~~--~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me   92 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWRG--GEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRME   92 (201)
T ss_pred             hhhhhhhhcccccEEEEeeccC--ceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhh
Confidence            4556789999999999999954  468999876543     4556888999999998766554 4443322    45699


Q ss_pred             ecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC-CCCEEEcCCCcEEEEecccccc
Q 016037          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK-PENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlk-p~NILl~~~~~ikL~Dfgla~~  299 (396)
                      |+.|-.|.......   .    +.-...+++..--|-..||-|..|. |..+++-.++.+.|+||..|+.
T Consensus        93 ~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          93 YIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            99998775543321   1    2234456666556778899999885 5555555777999999999974

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.25  E-value=1.1e-05  Score=87.38  Aligned_cols=229  Identities=17%  Similarity=0.151  Sum_probs=159.0

Q ss_pred             ecccCceEEEEEEEcCCC----cEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC----eEEEEE
Q 016037          158 VGQGAFAKVYQVRRIGTS----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY----RLYLVL  229 (396)
Q Consensus       158 IG~G~fG~Vy~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~----~~~lV~  229 (396)
                      +..-.+|+++...|...-    +++-++.-.-.....+..+.....|...+.+..|+|++.++.+-.+..    ...+..
T Consensus       186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~  265 (1351)
T KOG1035|consen  186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQ  265 (1351)
T ss_pred             eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHH
Confidence            666677888877764321    111111111111123344555666888889999999999987764432    234556


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC---CEEEcCCCcEEEE--ecccccccCCCC
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPE---NILLDADGHVMLT--DFGLAKQFDENT  304 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~---NILl~~~~~ikL~--Dfgla~~~~~~~  304 (396)
                      +++..-++...+..-+..+....+.+..++.+||.|+|+....|.-+...   +--++.++.+.++  ||+..+......
T Consensus       266 ~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~  345 (1351)
T KOG1035|consen  266 EICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE  345 (1351)
T ss_pred             hhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCcc
Confidence            78888899999999999999999999999999999999997666655544   4455666777777  999998887777


Q ss_pred             CccccccCCCccchhhhcCCCCCch--hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHH
Q 016037          305 RSNSMCGTLEYMSPEIVLGKGHDKA--ADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG  382 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~--~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~  382 (396)
                      ......-+..|.++|......++.+  .|+|++|..+..+..|..+-...   .....+      ++.....+...++..
T Consensus       346 ~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~---~~~~~~------l~~~~~~~~~d~~~~  416 (1351)
T KOG1035|consen  346 KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKS---AVPVSL------LDVLSTSELLDALPK  416 (1351)
T ss_pred             cchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccc---cchhhh------hccccchhhhhhhhh
Confidence            6666667788999999887766554  79999999999998876553221   111111      111222267778888


Q ss_pred             hhccCCCCCCCCC
Q 016037          383 VNSLLSISVPLLS  395 (396)
Q Consensus       383 ~l~~~p~~RPs~s  395 (396)
                      |+.-+.++|++..
T Consensus       417 ~~~~~~~~Rl~~~  429 (1351)
T KOG1035|consen  417 CLDEDSEERLSAL  429 (1351)
T ss_pred             hcchhhhhccchh
Confidence            8888888888764

>PLN02876 acyl-CoA dehydrogenase

Probab=98.13  E-value=3.5e-05  Score=84.10  Aligned_cols=144  Identities=13%  Similarity=0.278  Sum_probs=89.7

Q ss_pred             EeEecccCceEEEEEEEcCCC--cEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCe--eeeeEEEEec---CeEE
Q 016037          155 LKVVGQGAFAKVYQVRRIGTS--EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFI--VQLRYSFQTK---YRLY  226 (396)
Q Consensus       155 ~~~IG~G~fG~Vy~~~~~~~~--~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnI--v~l~~~~~~~---~~~~  226 (396)
                      ++.|+.|.++.+|+..+...+  ..+++|+.......  .....+.+|.++|+.+. |.++  .+++.++.+.   +..|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence            567899999999998875433  35777775443211  12235778999999985 6654  6677776553   4678


Q ss_pred             EEEEecCCCcHHH--------------------HH---HHhc----------C---CCHHHHHHHHHH------------
Q 016037          227 LVLDFVNGGHLFF--------------------QL---YRQG----------L---FREDLARIYTAE------------  258 (396)
Q Consensus       227 lV~E~~~gg~L~~--------------------~l---~~~~----------~---l~e~~~~~~~~q------------  258 (396)
                      +||||++|..+.+                    .+   +.-.          .   .....+..|..+            
T Consensus       121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~  200 (822)
T PLN02876        121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR  200 (822)
T ss_pred             EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence            9999999864211                    11   1100          0   001122222111            


Q ss_pred             ---HHHHHHHHHH-----------CCceeccCCCCCEEEcCC-Cc-EEEEeccccccc
Q 016037          259 ---IVSAVSHLHA-----------NGIMHRDLKPENILLDAD-GH-VMLTDFGLAKQF  300 (396)
Q Consensus       259 ---i~~aL~~LH~-----------~~iiHrDlkp~NILl~~~-~~-ikL~Dfgla~~~  300 (396)
                         +...+.+|..           ..+||+|+++.|||++.+ +. +-|.||+++..-
T Consensus       201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence               2234566643           249999999999999853 34 579999998754

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.11  E-value=5.4e-05  Score=67.96  Aligned_cols=128  Identities=25%  Similarity=0.333  Sum_probs=90.5

Q ss_pred             CCeEEEeEecccCc-eEEEEEEEcCCCcEEEEEEeeccccchh------------------hHHHHHHHHHHHHHhCC--
Q 016037          150 EDFEVLKVVGQGAF-AKVYQVRRIGTSEIYAMKVMRKDKIMEK------------------NHAEYMKSERNILTKVD--  208 (396)
Q Consensus       150 ~~~~~~~~IG~G~f-G~Vy~~~~~~~~~~vAvK~i~~~~~~~~------------------~~~~~~~~E~~~L~~l~--  208 (396)
                      .+++.++.||.|.- |.||+++-  .|+.||+|+++.-.....                  ....-+..|.+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            68999999999999 99999988  566899999433111000                  22334667887777664  


Q ss_pred             -CCCe--eeeeEEEEec------------------CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH
Q 016037          209 -HPFI--VQLRYSFQTK------------------YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH  267 (396)
Q Consensus       209 -HpnI--v~l~~~~~~~------------------~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH  267 (396)
                       +.++  |+.+++..-.                  ...-||-||++...         .+...    -+.+|.+-+..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHHH
Confidence             4556  8888887211                  12467888877653         12222    3557778888899


Q ss_pred             HCCceeccCCCCCEEEcCCCcEEEEecccc
Q 016037          268 ANGIMHRDLKPENILLDADGHVMLTDFGLA  297 (396)
Q Consensus       268 ~~~iiHrDlkp~NILl~~~~~ikL~Dfgla  297 (396)
                      ..||+-+|+++.|..=     -||+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~~-----G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYRG-----GKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCccccccC-----CEEEecccC
Confidence            9999999999999862     489999865

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.11  E-value=8.5e-05  Score=66.95  Aligned_cols=134  Identities=23%  Similarity=0.277  Sum_probs=91.7

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccc-------------hhhHHHHHHHHHHHHHhCC------CCCeeeee
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-------------EKNHAEYMKSERNILTKVD------HPFIVQLR  216 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~-------------~~~~~~~~~~E~~~L~~l~------HpnIv~l~  216 (396)
                      ..||+|+.-.||.  +..+ ....||+++.....             .....+...+|+.....+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~--HP~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQ--HPDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEE--CCCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            5699999999994  4333 33788998876500             0112233455665555544      78999999


Q ss_pred             EEEEecCeEEEEEEecCCC------cHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC---
Q 016037          217 YSFQTKYRLYLVLDFVNGG------HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG---  287 (396)
Q Consensus       217 ~~~~~~~~~~lV~E~~~gg------~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~---  287 (396)
                      |..++...+-+|+|.+...      +|.+++.+ +.+++ .   +...+-+-..||-..+|+.+|++|.||++....   
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~  158 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE  158 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence            9999999999999986532      67777744 44555 2   233344456788899999999999999996443   


Q ss_pred             -cEEEEe-cccc
Q 016037          288 -HVMLTD-FGLA  297 (396)
Q Consensus       288 -~ikL~D-fgla  297 (396)
                       .+.|+| ||-.
T Consensus       159 ~~lvlIDG~G~~  170 (199)
T PF10707_consen  159 FRLVLIDGLGEK  170 (199)
T ss_pred             eEEEEEeCCCCc
Confidence             578887 4533

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.08  E-value=4.9e-07  Score=99.42  Aligned_cols=241  Identities=13%  Similarity=0.048  Sum_probs=155.8

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcE-EEEEEeecccc--chhhHHHHHHHHHHHHHhCCCCCeeeeeEEEE--ecC
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEI-YAMKVMRKDKI--MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ--TKY  223 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~-vAvK~i~~~~~--~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~--~~~  223 (396)
                      ..++++.--+|-|   .-+++.|.+.... +.+|+.+....  ..+-..+....|++.++...|+++...+.-..  +..
T Consensus      1228 ~e~~EV~l~i~~~---~~~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ 1304 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNH---FHFRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSEST 1304 (2724)
T ss_pred             hhhhheeeecccc---eeeccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCCh
Confidence            3445554444443   4445555443322 35565543221  11122344455666777788999887655442  234


Q ss_pred             eEEEEEEecCCCcHHHHHHHhc----CCCHHHHHHHHHHH-HHHHHHHHHC-C----ceeccCCCCCEEEcCCCcEEEEe
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEI-VSAVSHLHAN-G----IMHRDLKPENILLDADGHVMLTD  293 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi-~~aL~~LH~~-~----iiHrDlkp~NILl~~~~~ikL~D  293 (396)
                      ..|+.++|+.+|.++..+.+..    ...+..+. ...++ +.+..-+|+. +    .+|++||+-|.+|..+..+|+++
T Consensus      1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~-~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk 1383 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVH-LRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGK 1383 (2724)
T ss_pred             HHHHHHHHHHHhHHHHHHHhccccCCcchhchHH-HHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccc
Confidence            5689999999999999886642    22222222 23333 5566666665 2    68999999999999999999999


Q ss_pred             cccccc-cCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCcc
Q 016037          294 FGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-KIKLPAF  371 (396)
Q Consensus       294 fgla~~-~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~-~~~~p~~  371 (396)
                      +|+.+. -..........+++.|+++++...-.++.++|+|..|+.+|+...|..+|.......+...+.+. ...++..
T Consensus      1384 ~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l 1463 (2724)
T KOG1826|consen 1384 GGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKL 1463 (2724)
T ss_pred             cccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCccccccccccccc
Confidence            999983 23333345667889999999998888998999999999999999999888653333333333332 2345555


Q ss_pred             CCHHHHHHHHHhhccCCCCCCC
Q 016037          372 LSSEAHSLLKGVNSLLSISVPL  393 (396)
Q Consensus       372 ~s~~~~~li~~~l~~~p~~RPs  393 (396)
                      .|.++......+|...-..||.
T Consensus      1464 ~pgdaNve~~~~Ll~K~~~rp~ 1485 (2724)
T KOG1826|consen 1464 KPGDANVEALHRLLWKYMERPG 1485 (2724)
T ss_pred             CCCcccHHHHHHHHHHhhhcch
Confidence            5666666666666666666664

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.03  E-value=2e-05  Score=70.52  Aligned_cols=99  Identities=17%  Similarity=0.177  Sum_probs=77.4

Q ss_pred             HHHHHHHHhCCC-CCeeeeeEEEEecCeEEEEEEecCCCcHHH---HHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---C
Q 016037          198 KSERNILTKVDH-PFIVQLRYSFQTKYRLYLVLDFVNGGHLFF---QLYRQGLFREDLARIYTAEIVSAVSHLHAN---G  270 (396)
Q Consensus       198 ~~E~~~L~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~---~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~---~  270 (396)
                      ..|.-+|+.+++ +++++++|+|-.    ++++||...+++..   .+.+-...++..+..++.++++.+.+|+..   .
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            357888888876 699999999833    67889998775531   111222357888889999999999999984   4


Q ss_pred             ceeccCCCCCEEEcCCCcEEEEeccccccc
Q 016037          271 IMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       271 iiHrDlkp~NILl~~~~~ikL~Dfgla~~~  300 (396)
                      +.-.|++++|+-++++|++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            555699999999999999999999887544

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.96  E-value=6.6e-05  Score=69.43  Aligned_cols=30  Identities=30%  Similarity=0.438  Sum_probs=25.7

Q ss_pred             CceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          270 GIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       270 ~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                      +++|+|+.+.||+++.++...|+||+.+..
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            489999999999998766567999998754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.93  E-value=0.00013  Score=67.16  Aligned_cols=75  Identities=19%  Similarity=0.183  Sum_probs=47.5

Q ss_pred             EeEecccCceEEEEEEEcC-CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC-eeeeeEEEEecCeEEEEEEec
Q 016037          155 LKVVGQGAFAKVYQVRRIG-TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF-IVQLRYSFQTKYRLYLVLDFV  232 (396)
Q Consensus       155 ~~~IG~G~fG~Vy~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~Hpn-Iv~l~~~~~~~~~~~lV~E~~  232 (396)
                      ++.|..|-...+|++.... .+..|++|+......    ..-...+|..+++.+...+ .+++++.+. .   .++|||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEee
Confidence            4668888899999987643 356788997754321    1111346888888875333 344444332 2   3799999


Q ss_pred             CCCcH
Q 016037          233 NGGHL  237 (396)
Q Consensus       233 ~gg~L  237 (396)
                      +|.++
T Consensus        75 ~G~~l   79 (235)
T cd05157          75 PGRTL   79 (235)
T ss_pred             CCCcC
Confidence            98765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.79  E-value=0.00072  Score=67.37  Aligned_cols=79  Identities=11%  Similarity=0.083  Sum_probs=52.9

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeeccccc--h--hhHHHHHHHHHHHHHhCC---CCCeeeeeEEEEecCeEEE
Q 016037          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM--E--KNHAEYMKSERNILTKVD---HPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       155 ~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~--~--~~~~~~~~~E~~~L~~l~---HpnIv~l~~~~~~~~~~~l  227 (396)
                      .+.||.|.+..||++.....++.+.||.-......  +  .-..++...|...|+.+.   ..++++++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            46799999999999998654467999985422110  0  123455667888887763   2356666655  3355789


Q ss_pred             EEEecCCC
Q 016037          228 VLDFVNGG  235 (396)
Q Consensus       228 V~E~~~gg  235 (396)
                      ||||+++.
T Consensus       109 VME~L~~~  116 (401)
T PRK09550        109 VMEDLSDH  116 (401)
T ss_pred             EEecCCCc
Confidence            99999874

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.62  E-value=0.0002  Score=67.08  Aligned_cols=133  Identities=13%  Similarity=0.174  Sum_probs=74.8

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCe-eeeeEEEEecCeEEEEEEecCCCc
Q 016037          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI-VQLRYSFQTKYRLYLVLDFVNGGH  236 (396)
Q Consensus       158 IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~gg~  236 (396)
                      +..|-.+.+|+...  ++..+++|+......  .... ...+|..+++.+..-++ .+++....    -++||||++|..
T Consensus         4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~--~~~~-~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~   74 (256)
T TIGR02721         4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCK--ALGV-DRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV   74 (256)
T ss_pred             CCCcCcCCeEEEEe--CCccEEEeeCCcccc--cccC-cHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence            45677788898763  456788887544321  1001 13568888888754333 33333332    268999999865


Q ss_pred             HHH----------HH-------HHhc----CCCH-HHHHHHHHHH---------HHHHHHHHHC--------CceeccCC
Q 016037          237 LFF----------QL-------YRQG----LFRE-DLARIYTAEI---------VSAVSHLHAN--------GIMHRDLK  277 (396)
Q Consensus       237 L~~----------~l-------~~~~----~l~e-~~~~~~~~qi---------~~aL~~LH~~--------~iiHrDlk  277 (396)
                      +..          .+       +...    ++.. ..+..+..++         ...+..+-..        .++|+|+.
T Consensus        75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~  154 (256)
T TIGR02721        75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH  154 (256)
T ss_pred             cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence            421          11       1111    1111 1111221111         1112222221        48999999


Q ss_pred             CCCEEEcCCCcEEEEeccccccc
Q 016037          278 PENILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       278 p~NILl~~~~~ikL~Dfgla~~~  300 (396)
                      |.||++++++ ++|+||..+..-
T Consensus       155 ~~Nil~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       155 AYNLVVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             cCcEEEeCCC-CEEEeccccCcC
Confidence            9999998877 789999988653

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK10593 hypothetical protein; Provisional

Probab=97.56  E-value=0.0013  Score=63.17  Aligned_cols=79  Identities=9%  Similarity=0.041  Sum_probs=54.2

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC---CCeeeeeEEEEe---cCeE
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH---PFIVQLRYSFQT---KYRL  225 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~H---pnIv~l~~~~~~---~~~~  225 (396)
                      ..-.+.||.|..+.||.....+ + .+.+|..+..     .....+..|...|+.+..   -.+.++++.+..   .+..
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~   88 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQ-G-NPMPLMARSF-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD   88 (297)
T ss_pred             hheeeecCCccceeEEEEEcCC-C-CEEEEEeccc-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence            4445779999999999876533 3 3677774321     112457789888888743   356777776643   3668


Q ss_pred             EEEEEecCCCcH
Q 016037          226 YLVLDFVNGGHL  237 (396)
Q Consensus       226 ~lV~E~~~gg~L  237 (396)
                      +||||+++|+++
T Consensus        89 ~LVmE~i~G~~~  100 (297)
T PRK10593         89 VLLLERLRGVSV  100 (297)
T ss_pred             EEEEeccCCEec
Confidence            999999998754

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.54  E-value=0.00052  Score=65.83  Aligned_cols=75  Identities=13%  Similarity=0.138  Sum_probs=46.9

Q ss_pred             EeEecccCceEEEEEEEcC------CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCe-eeeeEEEEecCeEEE
Q 016037          155 LKVVGQGAFAKVYQVRRIG------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI-VQLRYSFQTKYRLYL  227 (396)
Q Consensus       155 ~~~IG~G~fG~Vy~~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnI-v~l~~~~~~~~~~~l  227 (396)
                      ++.|..|-...+|++....      +++.|++|+......    ......+|..+++.+...++ .++++++. +   .+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~   74 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFP-N---GR   74 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cc
Confidence            3556677778888887643      257799999765321    11234567777777743333 34555543 2   36


Q ss_pred             EEEecCCCcH
Q 016037          228 VLDFVNGGHL  237 (396)
Q Consensus       228 V~E~~~gg~L  237 (396)
                      |+||++|..+
T Consensus        75 v~e~i~G~~l   84 (302)
T cd05156          75 IEEFIPSRTL   84 (302)
T ss_pred             hhheeCCCcC
Confidence            8999988765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.52  E-value=0.0014  Score=62.51  Aligned_cols=140  Identities=20%  Similarity=0.200  Sum_probs=82.7

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC--eeeeeE------EEEecC
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF--IVQLRY------SFQTKY  223 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~Hpn--Iv~l~~------~~~~~~  223 (396)
                      ..-++.|..|....+|+....  +..+++|+....      ....+..|+.+++.+.+-+  +.+++.      .....+
T Consensus        16 ~~~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~   87 (296)
T cd05153          16 LLSFEGISAGIENTNYFVTTD--SGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG   87 (296)
T ss_pred             hhheecccCccccceEEEEeC--CCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence            334667888888899988653  335899987641      1233556777777664322  334332      123345


Q ss_pred             eEEEEEEecCCCcHHH----H---H-------HHh-cCCC--------HHHHH------------HHHHHHHHHHHHHHH
Q 016037          224 RLYLVLDFVNGGHLFF----Q---L-------YRQ-GLFR--------EDLAR------------IYTAEIVSAVSHLHA  268 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~----~---l-------~~~-~~l~--------e~~~~------------~~~~qi~~aL~~LH~  268 (396)
                      ..+++++|++|..+..    .   +       +.. ..+.        .....            .....+..++.++..
T Consensus        88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  167 (296)
T cd05153          88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA  167 (296)
T ss_pred             ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence            6789999999876411    0   1       100 0000        00000            011122334455543


Q ss_pred             -------CCceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          269 -------NGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       269 -------~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                             .+++|+|+.|.||+++.++.+.|+||+.+..
T Consensus       168 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         168 FDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             hhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence                   3799999999999999887789999998854

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.50  E-value=0.0034  Score=60.61  Aligned_cols=30  Identities=33%  Similarity=0.552  Sum_probs=26.3

Q ss_pred             CceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          270 GIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       270 ~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                      ++||+|+++.||+++.+...-|+||+.+..
T Consensus       188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        188 GVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             ccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            799999999999998666568999998864

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.50  E-value=0.0024  Score=61.46  Aligned_cols=142  Identities=21%  Similarity=0.206  Sum_probs=80.4

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC--eeeeeEE------EEec
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF--IVQLRYS------FQTK  222 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~Hpn--Iv~l~~~------~~~~  222 (396)
                      ....++.++.|....+|++.. .+| .+++|+.....  .   .+.+..|..++..|...+  +.+++..      ....
T Consensus        23 ~~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~   95 (307)
T TIGR00938        23 ELLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA   95 (307)
T ss_pred             CceeccccCCccccceEEEEe-CCC-cEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence            344567788888889998765 333 58889875422  1   122344556665553211  2333221      1224


Q ss_pred             CeEEEEEEecCCCcHH-----------HHH---HHh-cCCC-------HHHHH----------------HHHHHHHHHHH
Q 016037          223 YRLYLVLDFVNGGHLF-----------FQL---YRQ-GLFR-------EDLAR----------------IYTAEIVSAVS  264 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~-----------~~l---~~~-~~l~-------e~~~~----------------~~~~qi~~aL~  264 (396)
                      +..+++++|++|..+.           ..+   +.. ..++       ....+                .....+...++
T Consensus        96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~  175 (307)
T TIGR00938        96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD  175 (307)
T ss_pred             CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence            5678999999985431           111   110 0000       00000                00112233455


Q ss_pred             HHHH-------CCceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          265 HLHA-------NGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       265 ~LH~-------~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                      ++..       .+++|+|+++.||+++.++...|+||+.+..
T Consensus       176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       176 YLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             HHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            5543       4899999999999999888778999998853

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.48  E-value=0.0011  Score=64.55  Aligned_cols=145  Identities=18%  Similarity=0.264  Sum_probs=97.1

Q ss_pred             EEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc-----------------------hhhHHHHHHHHHHHHHhCCCC
Q 016037          154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----------------------EKNHAEYMKSERNILTKVDHP  210 (396)
Q Consensus       154 ~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~-----------------------~~~~~~~~~~E~~~L~~l~Hp  210 (396)
                      +-..|.-|--+.||-|.. .+|..+|||+++..-+.                       .+-..-+...|.+-|++++..
T Consensus       148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            446677888899999776 55777999998752211                       111223345677777777544


Q ss_pred             CeeeeeEEEEecCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCCEEEcCCCcE
Q 016037          211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL-HANGIMHRDLKPENILLDADGHV  289 (396)
Q Consensus       211 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~L-H~~~iiHrDlkp~NILl~~~~~i  289 (396)
                      .|.--- -..- ..-.|||+|+.....-.-..+.-.++...++.+-.|++.-|.-| |.+++||.||.-=|+|+ .+|.+
T Consensus       227 GIP~Pe-PIlL-k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~l  303 (520)
T KOG2270|consen  227 GIPCPE-PILL-KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKL  303 (520)
T ss_pred             CCCCCC-ceee-ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEE
Confidence            432110 0001 12368999997544333233445677777888888888777766 55699999999999999 88999


Q ss_pred             EEEecccccccCC
Q 016037          290 MLTDFGLAKQFDE  302 (396)
Q Consensus       290 kL~Dfgla~~~~~  302 (396)
                      .++|.+-+...++
T Consensus       304 yiIDVSQSVE~DH  316 (520)
T KOG2270|consen  304 YIIDVSQSVEHDH  316 (520)
T ss_pred             EEEEccccccCCC
Confidence            9999998876543

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.35  E-value=0.0002  Score=68.35  Aligned_cols=138  Identities=17%  Similarity=0.206  Sum_probs=93.1

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc-----------------hhhHHH--HHHHHHHHHHhCC-CCC
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----------------EKNHAE--YMKSERNILTKVD-HPF  211 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~-----------------~~~~~~--~~~~E~~~L~~l~-Hpn  211 (396)
                      +.+.+.||-|--+.||.+.+ ..|+..++|.=+.....                 ..-++.  ...+|...|+.|. |-+
T Consensus        94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            56778899999999999988 44677888865432211                 011111  2346888888874 433


Q ss_pred             -eeeeeEEEEecCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEE
Q 016037          212 -IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM  290 (396)
Q Consensus       212 -Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ik  290 (396)
                       +.+.+++    ..-++|||++.|-.|...-+-      ..+..+...+..-+.-|..+|+||+|.+-=||++++++.++
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~  242 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV  242 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence             3333333    355899999998766432211      11233444555566678889999999999999999999999


Q ss_pred             EEeccccccc
Q 016037          291 LTDFGLAKQF  300 (396)
Q Consensus       291 L~Dfgla~~~  300 (396)
                      ++||--....
T Consensus       243 vIDFPQmvS~  252 (465)
T KOG2268|consen  243 VIDFPQMVST  252 (465)
T ss_pred             EeechHhhcc
Confidence            9999866443

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.12  E-value=0.0043  Score=60.78  Aligned_cols=78  Identities=15%  Similarity=0.144  Sum_probs=48.3

Q ss_pred             EecccCceEEEEEEEcCCCcEEEEEEeeccccc---h-hhHHHHHHHHHHHHHhCC--CCCeeeeeEEEEecCeEEEEEE
Q 016037          157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---E-KNHAEYMKSERNILTKVD--HPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       157 ~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~---~-~~~~~~~~~E~~~L~~l~--HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      .||.|....||++.....++.++||.-......   + .-..++...|...|+...  -|..++-+.+| ++....+|||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-D~e~~~~vME   80 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-DTEMAVTVME   80 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-ccccceehHh
Confidence            589999999999998654467999976532110   0 123344556777777653  35434433333 3345568999


Q ss_pred             ecCCC
Q 016037          231 FVNGG  235 (396)
Q Consensus       231 ~~~gg  235 (396)
                      +++..
T Consensus        81 dL~~~   85 (370)
T TIGR01767        81 DLSHH   85 (370)
T ss_pred             hCccc
Confidence            98653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02236 choline kinase

Probab=96.99  E-value=0.0053  Score=60.23  Aligned_cols=140  Identities=16%  Similarity=0.182  Sum_probs=81.1

Q ss_pred             CeEEEeEecccCceEEEEEEEcC----CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCee-eeeEEEEecCeE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIG----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIV-QLRYSFQTKYRL  225 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv-~l~~~~~~~~~~  225 (396)
                      .+.+ +.|..|-...+|++.+..    +++.|.+|+.....   ....+ ..+|..+++.+..-++. ++++.+..+   
T Consensus        38 ~~~i-~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g---  109 (344)
T PLN02236         38 ALQV-IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG---  109 (344)
T ss_pred             cEEE-EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc---
Confidence            3444 456668889999987643    24678999876542   12222 25688888877543333 455655432   


Q ss_pred             EEEEEecCCCcHHHH----------H-------HHhc------CCCHHHHHHHHHHH-----------------HHHHHH
Q 016037          226 YLVLDFVNGGHLFFQ----------L-------YRQG------LFREDLARIYTAEI-----------------VSAVSH  265 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~----------l-------~~~~------~l~e~~~~~~~~qi-----------------~~aL~~  265 (396)
                       .|++|+++.++...          +       +...      ....+.+..+..++                 ...+..
T Consensus       110 -~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~  188 (344)
T PLN02236        110 -RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINL  188 (344)
T ss_pred             -eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHH
Confidence             58999987665311          1       1100      01112222232111                 111222


Q ss_pred             HH----H----CCceeccCCCCCEEEcC-CCcEEEEecccccc
Q 016037          266 LH----A----NGIMHRDLKPENILLDA-DGHVMLTDFGLAKQ  299 (396)
Q Consensus       266 LH----~----~~iiHrDlkp~NILl~~-~~~ikL~Dfgla~~  299 (396)
                      |.    .    ..++|+|+++.|||+++ ++.+.|+||..+..
T Consensus       189 L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        189 LEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            22    1    25899999999999986 46899999998864

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.97  E-value=0.0096  Score=57.48  Aligned_cols=150  Identities=15%  Similarity=0.179  Sum_probs=86.0

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC--CCeeeeeEEEEecC--eEEE
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH--PFIVQLRYSFQTKY--RLYL  227 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~H--pnIv~l~~~~~~~~--~~~l  227 (396)
                      ..+++.+..|-.-.+|.....  ++.+++. . +............++|..+++.+.-  --+...++++.++.  ..|.
T Consensus        27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~-P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~  102 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-K-PPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY  102 (321)
T ss_pred             CceeeeccCCcccceEEEecC--CceEEEe-c-CCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence            445555544544455655543  6678877 2 2122223345556778888887743  12333456665554  6799


Q ss_pred             EEEecCCCcH---------H-HHHH--------Hh--------------cCCCHHHHHHHHH--------------HHHH
Q 016037          228 VLDFVNGGHL---------F-FQLY--------RQ--------------GLFREDLARIYTA--------------EIVS  261 (396)
Q Consensus       228 V~E~~~gg~L---------~-~~l~--------~~--------------~~l~e~~~~~~~~--------------qi~~  261 (396)
                      ||+|++|..+         . .+..        .-              +......+..+..              .+..
T Consensus       103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~  182 (321)
T COG3173         103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR  182 (321)
T ss_pred             EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence            9999998322         1 1111        00              0001111111111              2223


Q ss_pred             HHHHHHHC--------CceeccCCCCCEEEcCCCcEEEEecccccccCCCCC
Q 016037          262 AVSHLHAN--------GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       262 aL~~LH~~--------~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~  305 (396)
                      ...||+.+        .++|+|+++.|+++++++-+-+.||+++...+....
T Consensus       183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~~D  234 (321)
T COG3173         183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPLED  234 (321)
T ss_pred             HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcHHH
Confidence            35566654        489999999999999999999999999987654433

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.89  E-value=0.012  Score=58.67  Aligned_cols=78  Identities=15%  Similarity=0.081  Sum_probs=50.0

Q ss_pred             EEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc-hh---hHHHHHHHHHHHHHhCC---CCCeeeeeEEEEecCeEE
Q 016037          154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-EK---NHAEYMKSERNILTKVD---HPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       154 ~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~-~~---~~~~~~~~E~~~L~~l~---HpnIv~l~~~~~~~~~~~  226 (396)
                      ..+.||.|....||++...  +..++||.-...... ..   ....+...|...|+.+.   ...+.+++.++.  ...+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            3677999999999998873  345888876532210 00   12333445666666553   246777777766  3457


Q ss_pred             EEEEecCCC
Q 016037          227 LVLDFVNGG  235 (396)
Q Consensus       227 lV~E~~~gg  235 (396)
                      ++||+++++
T Consensus       112 lvME~L~~~  120 (418)
T PLN02756        112 IGMRYLEPP  120 (418)
T ss_pred             EEEeecCCc
Confidence            889999873

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.85  E-value=0.012  Score=55.92  Aligned_cols=31  Identities=39%  Similarity=0.516  Sum_probs=26.0

Q ss_pred             CceeccCCCCCEEEcCCCc-EEEEeccccccc
Q 016037          270 GIMHRDLKPENILLDADGH-VMLTDFGLAKQF  300 (396)
Q Consensus       270 ~iiHrDlkp~NILl~~~~~-ikL~Dfgla~~~  300 (396)
                      .++|+|+++.|||++.++. .-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999987565 569999988653

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.69  E-value=0.0092  Score=58.19  Aligned_cols=141  Identities=14%  Similarity=0.176  Sum_probs=79.5

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCC---CcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCe-eeeeEEEEecCeE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI-VQLRYSFQTKYRL  225 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnI-v~l~~~~~~~~~~  225 (396)
                      +++++.. |..|=...+|++...+.   +..|.+|+......   .... ..+|..+++.+..-++ .++++++.. +  
T Consensus        15 ~~i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~Id-R~~E~~il~~l~~~gl~P~~l~~~~~-G--   86 (330)
T PLN02421         15 SDFSVER-ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVID-RERELQAIKYLSAAGFGAKLLGVFGN-G--   86 (330)
T ss_pred             CceEEEE-eCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEec-hHHHHHHHHHHHhcCCCCceeEEeCC-c--
Confidence            3455544 54578888998875442   33788998765321   1122 2568888888754444 345555532 2  


Q ss_pred             EEEEEecCCCcHHH----------HH-------HHhc-C----C-CHHHHHHHHHHH----------------------H
Q 016037          226 YLVLDFVNGGHLFF----------QL-------YRQG-L----F-REDLARIYTAEI----------------------V  260 (396)
Q Consensus       226 ~lV~E~~~gg~L~~----------~l-------~~~~-~----l-~e~~~~~~~~qi----------------------~  260 (396)
                       +|.+|++|..+..          .+       +... +    . ....+..|..++                      .
T Consensus        87 -~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~  165 (330)
T PLN02421         87 -MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELR  165 (330)
T ss_pred             -EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHH
Confidence             5899998765411          11       1111 0    1 112222222221                      1


Q ss_pred             HHHHHHH----HCC----ceeccCCCCCEEEcC-CCcEEEEecccccc
Q 016037          261 SAVSHLH----ANG----IMHRDLKPENILLDA-DGHVMLTDFGLAKQ  299 (396)
Q Consensus       261 ~aL~~LH----~~~----iiHrDlkp~NILl~~-~~~ikL~Dfgla~~  299 (396)
                      .-+..+.    ..+    ++|.|+.+.|||+++ ++.++++||..|..
T Consensus       166 ~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        166 DEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            1122221    112    799999999999975 57899999998864

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.51  E-value=0.1  Score=49.94  Aligned_cols=30  Identities=33%  Similarity=0.532  Sum_probs=26.0

Q ss_pred             CCceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       269 ~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                      .+++|+|+++.||+++. +.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            47899999999999987 6789999997753

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.16  E-value=0.031  Score=55.58  Aligned_cols=78  Identities=15%  Similarity=0.190  Sum_probs=49.8

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeeccccch---hhHHHHHHHHHHHHHhCC--CCC-eeeeeEEEEecCeEEEE
Q 016037          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME---KNHAEYMKSERNILTKVD--HPF-IVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       155 ~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~E~~~L~~l~--Hpn-Iv~l~~~~~~~~~~~lV  228 (396)
                      .+.||.|.-..||++.+...++.++||.-...-...   .-..++...|...|+...  -|. +.++| +| ++....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy-~~-D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVY-LF-DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEE-EE-CcHHhhHH
Confidence            677999999999999985434568888764321111   123455666788887663  354 44454 33 33455788


Q ss_pred             EEecCC
Q 016037          229 LDFVNG  234 (396)
Q Consensus       229 ~E~~~g  234 (396)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999864

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.11  E-value=0.13  Score=49.08  Aligned_cols=76  Identities=16%  Similarity=0.234  Sum_probs=46.2

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC---CCCeeeeeEEEEecCeEEEE
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD---HPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~---HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .+-.+.|+-|....+|+..  .++..+-+|+-...      ....+..|..-|+.|.   --.+.+.+.+......-||+
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl   90 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL   90 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence            4556779999999999877  56778999986522      2234666777777763   34577788888777777999


Q ss_pred             EEecCCC
Q 016037          229 LDFVNGG  235 (396)
Q Consensus       229 ~E~~~gg  235 (396)
                      |||++.+
T Consensus        91 le~l~~~   97 (288)
T PF03881_consen   91 LEFLEMG   97 (288)
T ss_dssp             EE-----
T ss_pred             EEeecCC
Confidence            9999877

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.09  E-value=0.14  Score=49.38  Aligned_cols=30  Identities=20%  Similarity=0.237  Sum_probs=27.8

Q ss_pred             CceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          270 GIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       270 ~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                      +++|+|+.+.|||++.++.+.++||..++.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            799999999999999999999999998854

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PTZ00384 choline kinase; Provisional

Probab=96.08  E-value=0.043  Score=54.64  Aligned_cols=79  Identities=16%  Similarity=0.209  Sum_probs=46.4

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCC-cE-----EEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC-eeeeeEEEEec
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTS-EI-----YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF-IVQLRYSFQTK  222 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~-~~-----vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~Hpn-Iv~l~~~~~~~  222 (396)
                      +++.+ +.|..|-...+|++...... ..     |.+++....   .....+ -.+|..+++.+...+ -.++++.|.. 
T Consensus        51 ~~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~---~~l~Id-R~~E~~i~~~Ls~~glgP~l~~~f~~-  124 (383)
T PTZ00384         51 EFIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY---NSLVID-NDLQYNIAKLLGDNNFGPKIIGRFGD-  124 (383)
T ss_pred             ccEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC---CceEec-cHHHHHHHHHHHhCCCCCeEEEecCC-
Confidence            34444 45666889999999764432 22     333332111   111122 256888888886544 4455666643 


Q ss_pred             CeEEEEEEecCCCcH
Q 016037          223 YRLYLVLDFVNGGHL  237 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L  237 (396)
                         +++.||++|..|
T Consensus       125 ---g~l~efIeGr~l  136 (383)
T PTZ00384        125 ---FTIQEWVEGNTM  136 (383)
T ss_pred             ---EEEEEEeccccC
Confidence               599999998765

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=95.98  E-value=0.029  Score=56.98  Aligned_cols=145  Identities=20%  Similarity=0.229  Sum_probs=90.4

Q ss_pred             HHHHHHHHHhCCCCCeeeeeEEEEec-CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 016037          197 MKSERNILTKVDHPFIVQLRYSFQTK-YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD  275 (396)
Q Consensus       197 ~~~E~~~L~~l~HpnIv~l~~~~~~~-~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrD  275 (396)
                      +.--.++++.+.|+|...++++-... .+..+|||++.. +|.+.+..+. +...       ++.           .|| 
T Consensus        29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~-l~~~-------s~~-----------~~~-   87 (725)
T KOG1093|consen   29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGN-LKDE-------SLL-----------AHG-   87 (725)
T ss_pred             HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcc-cchh-------hhc-----------ccc-
Confidence            34456789999999999988776443 357889999865 7777776653 2111       111           232 


Q ss_pred             CCCCCEEEcCCCcEEEEecccccccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 016037          276 LKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ  355 (396)
Q Consensus       276 lkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~  355 (396)
                      +-+.||       ++.+| -++.    ..  ....|                +|+|||++|.++.|+.-|...+......
T Consensus        88 ~~~~~~-------~~~td-~~~t----~~--~~~~~----------------pKsdVwsl~~i~~el~L~~~l~~~~~~s  137 (725)
T KOG1093|consen   88 VLHLNI-------IYITD-HFLT----KY--PSPIG----------------PKSDVWSLGFIILELYLGISLEAELTES  137 (725)
T ss_pred             cceehh-------hhccc-cccc----cC--CCCCC----------------cchhhhhHHHHHHHHHHhhHHHHHHHHH
Confidence            111222       33334 1111    00  11111                4899999999999999999888776555


Q ss_pred             HHHHHHHhCCCCCC-------------ccCCHHHHHHHHHhhccCCCCCCC
Q 016037          356 KIQQKIIKDKIKLP-------------AFLSSEAHSLLKGVNSLLSISVPL  393 (396)
Q Consensus       356 ~i~~~i~~~~~~~p-------------~~~s~~~~~li~~~l~~~p~~RPs  393 (396)
                      +....+.+-. ..+             -.+..-+..+.+.|+...|..||.
T Consensus       138 ~~l~~i~k~~-~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l  187 (725)
T KOG1093|consen  138 EYLEILLKYY-TDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPL  187 (725)
T ss_pred             HHHHHHHHhc-cCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccc
Confidence            5444444321 111             135667888899999999999984

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.83  E-value=0.065  Score=49.16  Aligned_cols=79  Identities=15%  Similarity=0.283  Sum_probs=53.3

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC---CCeeeeeEEEEecCeEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH---PFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~H---pnIv~l~~~~~~~~~~~l  227 (396)
                      +.+..+.+.-|.--..|...+  ....+-+|+=      .......+..|+.-|+.+.-   -.+.+++.+..+..+.|+
T Consensus        17 ~i~er~~v~gG~inea~~v~d--g~~~~FvK~n------~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~syl   88 (286)
T COG3001          17 EIKEREEVSGGDINEAWRLRD--GTDPFFVKCN------QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYL   88 (286)
T ss_pred             hhhcccccCCccccceeEeec--CCcceEEEec------chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEE
Confidence            344445565665566666555  2344777763      33455667788877776643   457777888888999999


Q ss_pred             EEEecCCCcH
Q 016037          228 VLDFVNGGHL  237 (396)
Q Consensus       228 V~E~~~gg~L  237 (396)
                      ||||++.+.+
T Consensus        89 Vle~L~~~~~   98 (286)
T COG3001          89 VLEYLPTGPL   98 (286)
T ss_pred             EEeeccCCCC
Confidence            9999997654

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.79  E-value=0.25  Score=47.99  Aligned_cols=28  Identities=32%  Similarity=0.376  Sum_probs=24.2

Q ss_pred             CceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          270 GIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       270 ~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                      ++||+|+.+.|||++ + .+.|+||+.+..
T Consensus       197 ~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        197 LRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             cceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            689999999999995 4 578999998864

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.68  E-value=0.024  Score=51.30  Aligned_cols=30  Identities=47%  Similarity=0.705  Sum_probs=21.7

Q ss_pred             CceeccCCCCCEEE-cCCCcEEEEecccccc
Q 016037          270 GIMHRDLKPENILL-DADGHVMLTDFGLAKQ  299 (396)
Q Consensus       270 ~iiHrDlkp~NILl-~~~~~ikL~Dfgla~~  299 (396)
                      -+.|.|+.+.|||+ +.++.++|+||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            48999999999999 8899999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.43  E-value=0.33  Score=47.34  Aligned_cols=135  Identities=24%  Similarity=0.304  Sum_probs=77.0

Q ss_pred             EecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC---CCCCeee---eeE----EEEecCeEE
Q 016037          157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIVQ---LRY----SFQTKYRLY  226 (396)
Q Consensus       157 ~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l---~HpnIv~---l~~----~~~~~~~~~  226 (396)
                      .|.. .-..+|+......+  +++|+.+.. . .   ...+..|...|..|   ..+-.++   +-|    ....+.+.+
T Consensus        33 ~l~s-~eN~~f~~~~~~g~--~iLki~~~~-~-~---~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a  104 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGR--YILKIYRPG-W-T---RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPA  104 (331)
T ss_pred             cccc-ccCceEEEEecCCC--eEEEEecCC-C-C---HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeE
Confidence            3444 55678887774433  599998775 1 1   22344566666655   2232222   111    112224778


Q ss_pred             EEEEecCCCcHHH-----HHHH----------h-cCC-----------CHH----HH---------HHHHHHHHHHHHHH
Q 016037          227 LVLDFVNGGHLFF-----QLYR----------Q-GLF-----------RED----LA---------RIYTAEIVSAVSHL  266 (396)
Q Consensus       227 lV~E~~~gg~L~~-----~l~~----------~-~~l-----------~e~----~~---------~~~~~qi~~aL~~L  266 (396)
                      -+.+|++|..+..     ++..          . ..+           .++    ..         .....++...+..+
T Consensus       105 ~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~  184 (331)
T COG2334         105 ALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRL  184 (331)
T ss_pred             EEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence            8999999986651     1100          0 001           111    00         01233445555555


Q ss_pred             HHC--------C--ceeccCCCCCEEEcCCCc-EEEEecccccc
Q 016037          267 HAN--------G--IMHRDLKPENILLDADGH-VMLTDFGLAKQ  299 (396)
Q Consensus       267 H~~--------~--iiHrDlkp~NILl~~~~~-ikL~Dfgla~~  299 (396)
                      .+.        +  +||+|+.|.||+++.+.. +.++||+-+..
T Consensus       185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         185 LARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             HhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            543        3  999999999999998885 88999998853

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.16  E-value=0.15  Score=49.95  Aligned_cols=73  Identities=26%  Similarity=0.351  Sum_probs=52.0

Q ss_pred             ecCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          221 TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~-~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                      +....|++|++-. +.+. .+   ..-...++..++.+.+..+.-+..+ .+=|||+.-.||||+ +|.|-|+||-+++.
T Consensus       297 e~~y~yl~~kdhg-t~is-~i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         297 ETLYLYLHFKDHG-TPIS-II---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             CceEEEEEEecCC-ceee-ee---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence            3345667777643 3332 11   1224456667777877777666665 789999999999998 99999999999984

>PRK06148 hypothetical protein; Provisional

Probab=95.15  E-value=0.64  Score=52.24  Aligned_cols=31  Identities=42%  Similarity=0.634  Sum_probs=26.3

Q ss_pred             CCceeccCCCCCEEEcCCC--cEE-EEecccccc
Q 016037          269 NGIMHRDLKPENILLDADG--HVM-LTDFGLAKQ  299 (396)
Q Consensus       269 ~~iiHrDlkp~NILl~~~~--~ik-L~Dfgla~~  299 (396)
                      .++||+|+++.|||++.++  ++. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            3799999999999999875  555 999998854

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.89  E-value=0.13  Score=47.02  Aligned_cols=116  Identities=16%  Similarity=0.215  Sum_probs=72.3

Q ss_pred             cCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEecCCCcHHHH
Q 016037          161 GAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQ  240 (396)
Q Consensus       161 G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~  240 (396)
                      ++-++.-.+..+- |- ..+|.++.-..  .-....+..+.++++++.  .|++|..-  ....+-++.|.|-.-..   
T Consensus        73 ~gNsTl~~~kt~i-G~-L~lKKi~slp~--~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKI-GP-LFLKKIRSLPC--CINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---  141 (308)
T ss_pred             CCceEEEEecccc-ch-hhhhhccCCCc--ccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---
Confidence            3344444443332 33 45555544321  112334567788888876  78888743  45567799998854311   


Q ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCCEEEcCCCcEEEEecccc
Q 016037          241 LYRQGLFREDLARIYTAEIVSAVSHLHAN--GIMHRDLKPENILLDADGHVMLTDFGLA  297 (396)
Q Consensus       241 l~~~~~l~e~~~~~~~~qi~~aL~~LH~~--~iiHrDlkp~NILl~~~~~ikL~Dfgla  297 (396)
                               ...-.+.+. +.+|.-.|+.  +.+|+|..|+||+-|..|.+||.|=+..
T Consensus       142 ---------~~~N~i~ag-i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  142 ---------NFSNFITAG-IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             ---------chhHHHHHh-HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence                     111122222 4567788954  7999999999999999999999996643

The function of this family is unknown.

>PTZ00296 choline kinase; Provisional

Probab=94.86  E-value=0.35  Score=49.10  Aligned_cols=79  Identities=16%  Similarity=0.188  Sum_probs=48.9

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCC--------CcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCee-eeeEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGT--------SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIV-QLRYSFQ  220 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~--------~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv-~l~~~~~  220 (396)
                      +++ -++.|..|=.-.+|++.....        ++.|.+++.....   .... ....|..+++.+..-+|- ++++.+.
T Consensus       106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~  180 (442)
T PTZ00296        106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELY-NPISEFEVYKTMSKYRIAPQLLNTFS  180 (442)
T ss_pred             ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---ccee-CHHHHHHHHHHHHHCCCCCceEEEeC
Confidence            455 566787888889999876522        4678899876543   1111 234577777776544443 3455543


Q ss_pred             ecCeEEEEEEecCCCcH
Q 016037          221 TKYRLYLVLDFVNGGHL  237 (396)
Q Consensus       221 ~~~~~~lV~E~~~gg~L  237 (396)
                       +   +.|.||++|..|
T Consensus       181 -g---g~I~efi~g~~l  193 (442)
T PTZ00296        181 -G---GRIEEWLYGDPL  193 (442)
T ss_pred             -C---CEEEEeeCCccC
Confidence             2   467899998644

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	396
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-67
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		9e-67
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-64
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-64
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-64
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-63
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-61
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-59
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-54
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-54
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-54
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-54
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-54
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-54
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-54
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-52
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-52
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-52
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-52
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-52
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-51
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-51
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-51
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-51
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-51
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-51
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-51
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-51
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-51
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-51
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-51
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-50
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-50
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-50
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-50
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-50
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-50
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-50
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-50
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-50
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-50
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-50
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-50
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-50
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-50
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-50
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-50
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-50
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-50
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-50
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-50
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-50
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-50
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-50
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-50
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-50
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-50
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-50
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-50
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-50
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-50
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-50
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-50
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-50
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-50
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-50
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-50
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-50
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-50
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		6e-50
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		6e-50
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-50
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-50
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		8e-50
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		8e-50
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		8e-50
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		8e-50
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		9e-50
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-49
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-49
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-49
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-49
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-49
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-49
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-49
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-49
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-49
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-49
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-49
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-49
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-49
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-49
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-49
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-49
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-49
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-49
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-49
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-49
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-49
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-48
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-47
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-47
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-47
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-46
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-45
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-43
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-43
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-43
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-42
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-42
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-42
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-42
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-42
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-40
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-40
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-40
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-39
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-38
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-38
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-38
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-38
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		7e-38
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-38
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		9e-38
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-37
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-37
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-37
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-37
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-37
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-37
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-37
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-37
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-37
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-37
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-37
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-37
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-37
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-37
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-37
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-37
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-37
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-37
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-37
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-37
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-37
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-37
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-37
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-37
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-37
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-37
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-36
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-36
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-36
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-36
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-36
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-36
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-36
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-36
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-36
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-36
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-36
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-36
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-36
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-35
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-35
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-35
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-35
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-35
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-34
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-34
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-34
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-34
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-34
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-33
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-33
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-33
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-33
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-33
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-33
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-33
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-33
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-33
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-33
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-33
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-33
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-32
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-32
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-32
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-32
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-32
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-32
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-31
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-31
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-31
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-31
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-31
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-31
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-31
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-31
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-30
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-30
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		9e-30
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-29
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-29
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-29
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-29
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-29
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-29
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-29
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-29
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-29
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-29
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-29
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		8e-29
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		9e-29
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-28
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-28
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-28
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-28
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-28
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-28
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-28
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-28
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-28
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-28
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-28
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-27
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-27
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-27
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-27
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-27
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-27
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-27
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-27
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-27
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-27
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		8e-27
3soa_A	444	Full-Length Human Camkii Length = 444		8e-27
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		9e-27
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-26
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-26
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-26
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-26
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-26
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-26
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-26
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-26
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-26
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		7e-26
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-26
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		7e-26
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-26
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		8e-26
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		9e-26
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		9e-26
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		9e-26
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-25
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-25
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-25
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-25
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-25
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-25
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-25
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-25
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-25
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-25
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-25
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-25
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-25
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-25
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-25
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-25
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-25
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-25
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-25
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-25
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-25
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-25
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-25
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-25
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-25
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-25
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-25
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-25
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-25
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-25
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-25
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-25
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-25
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-25
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-25
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-25
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-25
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-25
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-25
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		7e-25
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		7e-25
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		7e-25
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-25
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		7e-25
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		7e-25
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-25
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-25
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-25
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-25
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		8e-25
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		9e-25
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-24
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-24
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-24
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-24
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-24
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-24
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-24
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-24
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-24
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-24
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-24
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-24
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-24
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-24
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-24
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-24
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-24
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-24
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-24
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-24
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-24
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-24
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-24
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-24
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-24
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-24
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-24
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-24
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-24
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-24
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-24
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-24
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-24
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-24
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-24
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-24
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-24
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-24
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-24
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-24
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-24
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-24
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-24
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-24
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-24
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-24
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-24
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-24
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-24
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-24
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-24
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-24
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-24
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-24
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-24
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-24
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-24
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-24
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-24
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-24
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-24
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-24
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-24
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-24
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-24
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-24
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-24
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-24
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-24
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		9e-24
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-23
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-23
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-23
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-23
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-23
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-23
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-23
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-23
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-23
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-22
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-22
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-22
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-22
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-22
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-22
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-22
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		8e-22
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-22
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		9e-22
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-21
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-21
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-21
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-21
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-21
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-21
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-21
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-21
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-21
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-21
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-21
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-21
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-20
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-20
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-20
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-20
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-20
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-20
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-20
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-20
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-20
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-20
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-20
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-20
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-20
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-20
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-20
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-20
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-20
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-20
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-20
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		7e-20
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-20
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		8e-20
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		9e-20
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-20
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-19
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-19
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-19
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-19
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-19
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-19
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-19
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-19
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-19
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-19
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-19
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-19
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-19
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-19
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-19
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-19
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-19
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-19
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-19
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-19
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-19
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-19
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-19
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-19
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-19
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-19
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		5e-19
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-19
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-19
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		7e-19
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		8e-19
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		9e-19
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		9e-19
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-18
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-18
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-18
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-18
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-18
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-18
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-18
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-18
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-18
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-18
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-18
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-18
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		7e-18
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-18
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		8e-18
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		9e-18
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-17
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-17
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-17
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-17
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-17
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-17
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-17
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-17
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-17
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-17
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-17
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-17
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-17
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-17
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-17
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-17
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-17
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-17
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-17
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-17
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-17
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-17
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-17
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-17
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-17
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-17
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-17
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		4e-17
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		5e-17
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		5e-17
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		5e-17
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		5e-17
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-17
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-17
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-17
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-17
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		5e-17
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-17
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		5e-17
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-17
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-17
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-17
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-17
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-17
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-17
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		8e-17
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-17
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		9e-17
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		9e-17
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		9e-17
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-16
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-16
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-16
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-16
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-16
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-16
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-16
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-16
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-16
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-16
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-16
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-16
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-16
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-16
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-16
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-16
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-16
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-16
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-16
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-16
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-16
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-16
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-16
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-16
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-16
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-16
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-16
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-16
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-16
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-16
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-16
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		9e-16
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		9e-16
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-15
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-15
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-15
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-15
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-15
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-15
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-15
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-15
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		2e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-15
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-15
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-15
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-15
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-15
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-15
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-15
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-15
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-15
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-15
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-15
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-15
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-15
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-15
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-15
4h58_A	275	Braf In Complex With Compound 3 Length = 275		7e-15
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-15
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		8e-15
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		8e-15
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-15
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		8e-15
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		8e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		9e-15
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		9e-15
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		9e-15
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		9e-15
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		9e-15
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-15
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-14
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-14
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-14
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-14
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-14
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-14
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-14
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-14
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-14
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-14
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-14
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-14
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-14
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-14
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-14
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-14
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-14
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-14
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-14
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-14
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-14
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-14
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-14
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-14
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-14
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-14
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-14
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-14
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-14
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-14
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-14
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-14
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-14
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-14
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-14
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-14
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-14
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-14
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-14
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-14
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-14
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-14
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-14
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-14
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-14
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-14
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-14
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-14
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-14
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		4e-14
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-14
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-14
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-14
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-14
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-14
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-14
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-14
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-14
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-14
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-14
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		7e-14
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-14
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-14
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		9e-14
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-13
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-13
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-13
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-13
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-13
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-13
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-13
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-13
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-13
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-13
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-13
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-13
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-13
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-13
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-13
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-13
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-13
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-13
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-13
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-13
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-13
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-13
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-13
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-13
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-13
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-13
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-13
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-13
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-13
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-13
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-13
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-13
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		8e-13
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-13
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		9e-13
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-13
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-12
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-12
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-12
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-12
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-12
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-12
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-12
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-12
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-12
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-12
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-12
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-12
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-12
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-12
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-12
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-12
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-12
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-12
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		4e-12
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		4e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-12
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-12
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-12
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		5e-12
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		5e-12
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		5e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-12
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		6e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		6e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-12
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		6e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-12
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		7e-12
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		7e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		7e-12
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		7e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-12
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		8e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		8e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		9e-12
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-11
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-11
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-11
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		1e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-11
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-11
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		3e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-11
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-11
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-11
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-11
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-11
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-11
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-11
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-11
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-11
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		5e-11
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		5e-11
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-11
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-11
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-11
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-11
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		7e-11
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-11
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		7e-11
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		8e-11
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		8e-11
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-11
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-11
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		8e-11
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		8e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		9e-11
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		9e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		9e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		9e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-10
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-10
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-10
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-10
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-10
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-10
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-10
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-10
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-10
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-10
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-10
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-10
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-10
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-10
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-10
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-10
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-10
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		6e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-10
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		9e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-09
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		1e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-09
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-09
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		1e-09
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-09
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-09
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-09
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-09
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-09
3gni_B	389	Structure Of Strad And Mo25 Length = 389		3e-09
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-09
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-09
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		6e-09
2cmw_A	310	Structure Of Human Casein Kinase 1 Gamma-1 In Compl		7e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		8e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		8e-09
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		9e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-08
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-08
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
2izr_A	330	Structure Of Casein Kinase Gamma 3 In Complex With		3e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-08

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  251 bits (641), Expect = 5e-67,   Method: Compositional matrix adjust.
 Identities = 120/237 (50%), Positives = 167/237 (70%), Gaps = 5/237 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILT 205
           E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  I+       + K+ERNIL 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+F ED A  Y AEI  A+ H
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           LH  GI++RDLKPENI+L+  GHV LTDFGL K+   + T +++ CGT+EYM+PEI++  
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 196
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
           GH++A DWWS+G L+++MLTG PPFTG NR             LP +L+ EA  LLK
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK 253

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  250 bits (639), Expect = 9e-67,   Method: Compositional matrix adjust.
 Identities = 120/237 (50%), Positives = 166/237 (70%), Gaps = 5/237 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILT 205
           E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  I+       + K+ERNIL 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+F ED A  Y AEI  A+ H
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           LH  GI++RDLKPENI+L+  GHV LTDFGL K+   + T ++  CGT+EYM+PEI++  
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRS 196
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
           GH++A DWWS+G L+++MLTG PPFTG NR             LP +L+ EA  LLK
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK 253

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  243 bits (620), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 117/234 (50%), Positives = 167/234 (71%), Gaps = 5/234 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTS---EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           FE+LKV+GQG+F KV+ V++I  S   ++YAMKV++K  +  ++     K ER+IL +V+
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVN 85
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HPFIV+L Y+FQT+ +LYL+LDF+ GG LF +L ++ +F E+  + Y AE+  A+ HLH+
Sbjct: 86  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 145
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHD 327
            GI++RDLKPENILLD +GH+ LTDFGL+K+  D   ++ S CGT+EYM+PE+V  +GH 
Sbjct: 146 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 205
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
           ++ADWWS G+L+FEMLTG  PF G +R             +P FLS EA SLL+
Sbjct: 206 QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 259

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  243 bits (620), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 117/234 (50%), Positives = 167/234 (71%), Gaps = 5/234 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTS---EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           FE+LKV+GQG+F KV+ V++I  S   ++YAMKV++K  +  ++     K ER+IL +V+
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVN 84
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HPFIV+L Y+FQT+ +LYL+LDF+ GG LF +L ++ +F E+  + Y AE+  A+ HLH+
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHD 327
            GI++RDLKPENILLD +GH+ LTDFGL+K+  D   ++ S CGT+EYM+PE+V  +GH 
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 204
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
           ++ADWWS G+L+FEMLTG  PF G +R             +P FLS EA SLL+
Sbjct: 205 QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 258

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  243 bits (620), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 117/234 (50%), Positives = 167/234 (71%), Gaps = 5/234 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTS---EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           FE+LKV+GQG+F KV+ V++I  S   ++YAMKV++K  +  ++     K ER+IL +V+
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVN 84
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HPFIV+L Y+FQT+ +LYL+LDF+ GG LF +L ++ +F E+  + Y AE+  A+ HLH+
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHD 327
            GI++RDLKPENILLD +GH+ LTDFGL+K+  D   ++ S CGT+EYM+PE+V  +GH 
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 204
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
           ++ADWWS G+L+FEMLTG  PF G +R             +P FLS EA SLL+
Sbjct: 205 QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 258

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  239 bits (611), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 114/236 (48%), Positives = 165/236 (69%), Gaps = 5/236 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           FE+LKV+GQG+F KV+ VR++    +  +YAMKV++K  +  ++     K ER+IL  V+
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVR-TKMERDILADVN 88
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HPF+V+L Y+FQT+ +LYL+LDF+ GG LF +L ++ +F E+  + Y AE+   + HLH+
Sbjct: 89  HPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHS 148
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHD 327
            GI++RDLKPENILLD +GH+ LTDFGL+K+  D   ++ S CGT+EYM+PE+V  +GH 
Sbjct: 149 LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHS 208
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGV 383
            +ADWWS G+L+FEMLTG  PF G +R             +P FLS+EA SLL+ +
Sbjct: 209 HSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLSTEAQSLLRAL 264

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  231 bits (589), Expect = 5e-61,   Method: Compositional matrix adjust.
 Identities = 113/221 (51%), Positives = 161/221 (72%), Gaps = 9/221 (4%)
Query: 139 NLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEK-NHA 194
           NL    + VG+E+FE+LKV+G GA+ KV+ VR+I    T ++YAMKV++K  I++K    
Sbjct: 43  NLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT 102
Query: 195 EYMKSERNILTKVDH-PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
           E+ ++ER +L  +   PF+V L Y+FQT+ +L+L+LD++NGG LF  L ++  F E   +
Sbjct: 103 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQ 162
Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCG 311
           IY  EIV A+ HLH  GI++RD+K ENILLD++GHV+LTDFGL+K+F  DE  R+   CG
Sbjct: 163 IYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 222
Query: 312 TLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFT 350
           T+EYM+P+IV G   GHDKA DWWS+G+L++E+LTG  PFT
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 263

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  224 bits (571), Expect = 6e-59,   Method: Compositional matrix adjust.
 Identities = 109/245 (44%), Positives = 157/245 (64%), Gaps = 2/245 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS N      DF  LKV+G+G+F KV   R       YA+KV++K  I++K   +++ SE
Sbjct: 29  PSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSE 88
Query: 201 RNILTK-VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           RN+L K V HPF+V L +SFQT  +LY VLD++NGG LF+ L R+  F E  AR Y AEI
Sbjct: 89  RNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI 148
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSP 318
            SA+ +LH+  I++RDLKPENILLD+ GH++LTDFGL K+  + N+ +++ CGT EY++P
Sbjct: 149 ASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAP 208
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHS 378
           E++  + +D+  DWW +G +L+EML G PPF   N              L   +++ A  
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARH 268
Query: 379 LLKGV 383
           LL+G+
Sbjct: 269 LLEGL 273

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  210 bits (534), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 97/238 (40%), Positives = 148/238 (62%), Gaps = 1/238 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 5   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 64
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 65  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 124
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKG 325
           H+  +++RD+K EN++LD DGH+ +TDFGL K+   +     + CGT EY++PE++    
Sbjct: 125 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 184
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGV 383
           + +A DWW +G++++EM+ G+ PF   +               P  LS EA SLL G+
Sbjct: 185 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 242

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  209 bits (533), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 97/238 (40%), Positives = 148/238 (62%), Gaps = 1/238 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKG 325
           H+  +++RD+K EN++LD DGH+ +TDFGL K+   +     + CGT EY++PE++    
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGV 383
           + +A DWW +G++++EM+ G+ PF   +               P  LS EA SLL G+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 239

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  209 bits (533), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 97/238 (40%), Positives = 148/238 (62%), Gaps = 1/238 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKG 325
           H+  +++RD+K EN++LD DGH+ +TDFGL K+   +     + CGT EY++PE++    
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGV 383
           + +A DWW +G++++EM+ G+ PF   +               P  LS EA SLL G+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 239

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  209 bits (531), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 97/238 (40%), Positives = 147/238 (61%), Gaps = 1/238 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKG 325
           H+  +++RD+K EN++LD DGH+ +TDFGL K+   +       CGT EY++PE++    
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGV 383
           + +A DWW +G++++EM+ G+ PF   +               P  LS EA SLL G+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 239

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  209 bits (531), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 97/238 (40%), Positives = 147/238 (61%), Gaps = 1/238 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKG 325
           H+  +++RD+K EN++LD DGH+ +TDFGL K+   +       CGT EY++PE++    
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGV 383
           + +A DWW +G++++EM+ G+ PF   +               P  LS EA SLL G+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 239

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  209 bits (531), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 97/238 (40%), Positives = 147/238 (61%), Gaps = 1/238 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKG 325
           H+  +++RD+K EN++LD DGH+ +TDFGL K+   +       CGT EY++PE++    
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGV 383
           + +A DWW +G++++EM+ G+ PF   +               P  LS EA SLL G+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 239

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  208 bits (530), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 97/238 (40%), Positives = 147/238 (61%), Gaps = 1/238 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 7   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 66
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 67  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 126
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKG 325
           H+  +++RD+K EN++LD DGH+ +TDFGL K+   +       CGT EY++PE++    
Sbjct: 127 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 186
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGV 383
           + +A DWW +G++++EM+ G+ PF   +               P  LS EA SLL G+
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 244

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  203 bits (517), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 97/239 (40%), Positives = 147/239 (61%), Gaps = 2/239 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + +FE LK++G+G F KV  V+   T   YAMK+++K+ I+ K+   +  +E  +L  
Sbjct: 148 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 207
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+YSFQT  RL  V+++ NGG LFF L R+ +F ED AR Y AEIVSA+ +L
Sbjct: 208 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 267
Query: 267 HA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           H+   +++RDLK EN++LD DGH+ +TDFGL K+   +     + CGT EY++PE++   
Sbjct: 268 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 327
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGV 383
            + +A DWW +G++++EM+ G+ PF   +               P  L  EA SLL G+
Sbjct: 328 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGL 386

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  203 bits (516), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 97/239 (40%), Positives = 147/239 (61%), Gaps = 2/239 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + +FE LK++G+G F KV  V+   T   YAMK+++K+ I+ K+   +  +E  +L  
Sbjct: 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+YSFQT  RL  V+++ NGG LFF L R+ +F ED AR Y AEIVSA+ +L
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 264
Query: 267 HA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           H+   +++RDLK EN++LD DGH+ +TDFGL K+   +     + CGT EY++PE++   
Sbjct: 265 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 324
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGV 383
            + +A DWW +G++++EM+ G+ PF   +               P  L  EA SLL G+
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGL 383

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  202 bits (515), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 97/239 (40%), Positives = 146/239 (61%), Gaps = 2/239 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + +FE LK++G+G F KV  V+   T   YAMK+++K+ I+ K+   +  +E  +L  
Sbjct: 7   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 66
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+YSFQT  RL  V+++ NGG LFF L R+ +F ED AR Y AEIVSA+ +L
Sbjct: 67  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 126
Query: 267 HA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           H+   +++RDLK EN++LD DGH+ +TDFGL K+   +       CGT EY++PE++   
Sbjct: 127 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN 186
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGV 383
            + +A DWW +G++++EM+ G+ PF   +               P  L  EA SLL G+
Sbjct: 187 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGL 245

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  202 bits (515), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 97/239 (40%), Positives = 146/239 (61%), Gaps = 2/239 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + +FE LK++G+G F KV  V+   T   YAMK+++K+ I+ K+   +  +E  +L  
Sbjct: 5   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 64
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+YSFQT  RL  V+++ NGG LFF L R+ +F ED AR Y AEIVSA+ +L
Sbjct: 65  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 124
Query: 267 HA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           H+   +++RDLK EN++LD DGH+ +TDFGL K+   +       CGT EY++PE++   
Sbjct: 125 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN 184
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGV 383
            + +A DWW +G++++EM+ G+ PF   +               P  L  EA SLL G+
Sbjct: 185 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGL 243

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  202 bits (515), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 97/239 (40%), Positives = 146/239 (61%), Gaps = 2/239 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + +FE LK++G+G F KV  V+   T   YAMK+++K+ I+ K+   +  +E  +L  
Sbjct: 6   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 65
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+YSFQT  RL  V+++ NGG LFF L R+ +F ED AR Y AEIVSA+ +L
Sbjct: 66  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 125
Query: 267 HA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           H+   +++RDLK EN++LD DGH+ +TDFGL K+   +       CGT EY++PE++   
Sbjct: 126 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN 185
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGV 383
            + +A DWW +G++++EM+ G+ PF   +               P  L  EA SLL G+
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGL 244

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  199 bits (506), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 95/243 (39%), Positives = 151/243 (62%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+ ++CGT EY++PEI
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWTLCGTPEYLAPEI 210
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 270
Query: 381 KGV 383
           + +
Sbjct: 271 RNL 273

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  199 bits (505), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 95/243 (39%), Positives = 151/243 (62%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 19  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 77
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 78  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 137
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+ ++CGT EY++PEI
Sbjct: 138 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWTLCGTPEYLAPEI 195
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 196 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 255
Query: 381 KGV 383
           + +
Sbjct: 256 RNL 258

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  198 bits (504), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 95/243 (39%), Positives = 150/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  198 bits (504), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 95/243 (39%), Positives = 150/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 210
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 270
Query: 381 KGV 383
           + +
Sbjct: 271 RNL 273

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  198 bits (503), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 95/243 (39%), Positives = 150/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  198 bits (503), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 95/243 (39%), Positives = 150/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  198 bits (503), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 95/243 (39%), Positives = 150/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  198 bits (503), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 95/243 (39%), Positives = 150/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 210
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 270
Query: 381 KGV 383
           + +
Sbjct: 271 RNL 273

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  198 bits (503), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 95/243 (39%), Positives = 150/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  198 bits (503), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 95/243 (39%), Positives = 150/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  197 bits (501), Expect = 8e-51,   Method: Compositional matrix adjust.
 Identities = 99/246 (40%), Positives = 149/246 (60%), Gaps = 3/246 (1%)
Query: 141 PSEN-QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           PS N   V L DF  L V+G+G+F KV    R GT E+YA+K+++KD +++ +  E    
Sbjct: 9   PSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMV 68
Query: 200 ERNILTKVDHP-FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           E+ +L  +D P F+ QL   FQT  RLY V+++VNGG L + + + G F+E  A  Y AE
Sbjct: 69  EKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAE 128
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMS 317
           I   +  LH  GI++RDLK +N++LD++GH+ + DFG+ K+   +   +   CGT +Y++
Sbjct: 129 ISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIA 188
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAH 377
           PEI+  + + K+ DWW+ G+LL+EML GQPPF G +               P  LS EA 
Sbjct: 189 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAV 248
Query: 378 SLLKGV 383
           S+ KG+
Sbjct: 249 SICKGL 254

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  197 bits (500), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 95/243 (39%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 210
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 270
Query: 381 KGV 383
           + +
Sbjct: 271 RNL 273

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  197 bits (500), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 95/243 (39%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   +AMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L YSF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  197 bits (500), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 95/243 (39%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   +AMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L YSF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  197 bits (500), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 95/243 (39%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   +AMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L YSF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  197 bits (500), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 95/243 (39%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 210
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 270
Query: 381 KGV 383
           + +
Sbjct: 271 RNL 273

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  197 bits (500), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 95/243 (39%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 210
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 270
Query: 381 KGV 383
           + +
Sbjct: 271 RNL 273

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  197 bits (500), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 94/243 (38%), Positives = 150/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+++D  G++ +TDFGLAK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  197 bits (500), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 95/243 (39%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   YAMK++ K K+++    E+  +E
Sbjct: 26  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 84
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 85  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIV 144
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 145 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 202
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 203 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 262
Query: 381 KGV 383
           + +
Sbjct: 263 RNL 265

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  197 bits (500), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 95/243 (39%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   YAMK++ K K+++    E+  +E
Sbjct: 26  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 84
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 85  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 144
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 145 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 202
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 203 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 262
Query: 381 KGV 383
           + +
Sbjct: 263 RNL 265

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  197 bits (500), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 95/243 (39%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   YAMK++ K K+++    E+  +E
Sbjct: 54  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 112
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 113 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 172
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 230
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 290
Query: 381 KGV 383
           + +
Sbjct: 291 RNL 293

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  196 bits (499), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 94/243 (38%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ + DFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  196 bits (499), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 94/243 (38%), Positives = 150/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+++D  G++ +TDFGLAK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  196 bits (497), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 93/243 (38%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+++D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  196 bits (497), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 94/243 (38%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  196 bits (497), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 94/243 (38%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 54  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 112
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 113 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 172
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 230
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 290
Query: 381 KGV 383
           + +
Sbjct: 291 RNL 293

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  196 bits (497), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 94/243 (38%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  196 bits (497), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 94/243 (38%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  196 bits (497), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 94/243 (38%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  196 bits (497), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 94/243 (38%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  196 bits (497), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 94/243 (38%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 34  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 210
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 270
Query: 381 KGV 383
           + +
Sbjct: 271 RNL 273

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  196 bits (497), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 94/243 (38%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  196 bits (497), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 86/205 (41%), Positives = 148/205 (72%), Gaps = 2/205 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +GL+DF++L+V+G+G++AKV  VR   T  IYAM+V++K+ + +    +++++E+++  +
Sbjct: 49  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 207 V-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             +HPF+V L   FQT+ RL+ V+++VNGG L F + RQ    E+ AR Y+AEI  A+++
Sbjct: 109 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           LH  GI++RDLK +N+LLD++GH+ LTD+G+ K+       +++ CGT  Y++PEI+ G+
Sbjct: 169 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 228
Query: 325 GHDKAADWWSVGILLFEMLTGQPPF 349
            +  + DWW++G+L+FEM+ G+ PF
Sbjct: 229 DYGFSVDWWALGVLMFEMMAGRSPF 253

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  195 bits (496), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 93/243 (38%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+++D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  195 bits (496), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 94/243 (38%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  195 bits (496), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 94/243 (38%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  195 bits (496), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 88/207 (42%), Positives = 137/207 (66%), Gaps = 3/207 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+NS  GT +Y+SPE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 211
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGN 353
            K++D W++G ++++++ G PPF  GN
Sbjct: 212 SKSSDLWALGCIIYQLVAGLPPFRAGN 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  195 bits (496), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 94/243 (38%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 28  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 86
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 87  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 146
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 147 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 204
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 205 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 264
Query: 381 KGV 383
           + +
Sbjct: 265 RNL 267

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  195 bits (496), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 94/243 (38%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  195 bits (496), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 88/207 (42%), Positives = 137/207 (66%), Gaps = 3/207 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+NS  GT +Y+SPE++  K  
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 212
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGN 353
            K++D W++G ++++++ G PPF  GN
Sbjct: 213 CKSSDLWALGCIIYQLVAGLPPFRAGN 239

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  195 bits (496), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 94/243 (38%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 20  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 78
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 79  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 138
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 139 LTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 196
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 197 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 256
Query: 381 KGV 383
           + +
Sbjct: 257 RNL 259

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  195 bits (496), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 93/243 (38%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+++D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  195 bits (496), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 87/205 (42%), Positives = 147/205 (71%), Gaps = 2/205 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +GL+DF++L+V+G+G++AKV  VR   T  IYAMKV++K+ + +    +++++E+++  +
Sbjct: 17  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 76
Query: 207 V-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             +HPF+V L   FQT+ RL+ V+++VNGG L F + RQ    E+ AR Y+AEI  A+++
Sbjct: 77  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 136
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           LH  GI++RDLK +N+LLD++GH+ LTD+G+ K+       ++  CGT  Y++PEI+ G+
Sbjct: 137 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 196
Query: 325 GHDKAADWWSVGILLFEMLTGQPPF 349
            +  + DWW++G+L+FEM+ G+ PF
Sbjct: 197 DYGFSVDWWALGVLMFEMMAGRSPF 221

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  195 bits (495), Expect = 4e-50,   Method: Compositional matrix adjust.
 Identities = 87/205 (42%), Positives = 147/205 (71%), Gaps = 2/205 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +GL+DF++L+V+G+G++AKV  VR   T  IYAMKV++K+ + +    +++++E+++  +
Sbjct: 2   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 61
Query: 207 V-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             +HPF+V L   FQT+ RL+ V+++VNGG L F + RQ    E+ AR Y+AEI  A+++
Sbjct: 62  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 121
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           LH  GI++RDLK +N+LLD++GH+ LTD+G+ K+       ++  CGT  Y++PEI+ G+
Sbjct: 122 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 181
Query: 325 GHDKAADWWSVGILLFEMLTGQPPF 349
            +  + DWW++G+L+FEM+ G+ PF
Sbjct: 182 DYGFSVDWWALGVLMFEMMAGRSPF 206

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  195 bits (495), Expect = 4e-50,   Method: Compositional matrix adjust.
 Identities = 93/243 (38%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V++++ GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ + DFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  195 bits (495), Expect = 4e-50,   Method: Compositional matrix adjust.
 Identities = 93/243 (38%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V++++ GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ + DFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  194 bits (494), Expect = 5e-50,   Method: Compositional matrix adjust.
 Identities = 91/235 (38%), Positives = 143/235 (60%), Gaps = 3/235 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 155 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 214
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
            K++D W++G ++++++ G PPF  GN               PA    +A  L++
Sbjct: 215 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKARDLVE 269

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  194 bits (494), Expect = 6e-50,   Method: Compositional matrix adjust.
 Identities = 94/243 (38%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 54  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 112
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 113 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 172
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+    T   ++CGT EY++PEI
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATW--TLCGTPEYLAPEI 230
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 290
Query: 381 KGV 383
           + +
Sbjct: 291 RNL 293

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  194 bits (494), Expect = 6e-50,   Method: Compositional matrix adjust.
 Identities = 88/207 (42%), Positives = 137/207 (66%), Gaps = 3/207 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+NS  GT +Y+SPE++  K  
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 208
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGN 353
            K++D W++G ++++++ G PPF  GN
Sbjct: 209 CKSSDLWALGCIIYQLVAGLPPFRAGN 235

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  194 bits (494), Expect = 6e-50,   Method: Compositional matrix adjust.
 Identities = 93/243 (38%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L+++M  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  194 bits (493), Expect = 6e-50,   Method: Compositional matrix adjust.
 Identities = 87/205 (42%), Positives = 147/205 (71%), Gaps = 2/205 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +GL+DF++L+V+G+G++AKV  VR   T  IYAMKV++K+ + +    +++++E+++  +
Sbjct: 6   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 207 V-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             +HPF+V L   FQT+ RL+ V+++VNGG L F + RQ    E+ AR Y+AEI  A+++
Sbjct: 66  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           LH  GI++RDLK +N+LLD++GH+ LTD+G+ K+       ++  CGT  Y++PEI+ G+
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 185
Query: 325 GHDKAADWWSVGILLFEMLTGQPPF 349
            +  + DWW++G+L+FEM+ G+ PF
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGRSPF 210

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  194 bits (493), Expect = 7e-50,   Method: Compositional matrix adjust.
 Identities = 93/243 (38%), Positives = 148/243 (60%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+++D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 210
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 270
Query: 381 KGV 383
           + +
Sbjct: 271 RNL 273

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  194 bits (493), Expect = 8e-50,   Method: Compositional matrix adjust.
 Identities = 92/243 (37%), Positives = 149/243 (61%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+++D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           ++ KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 IISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  194 bits (493), Expect = 8e-50,   Method: Compositional matrix adjust.
 Identities = 87/207 (42%), Positives = 137/207 (66%), Gaps = 3/207 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N+  GT +Y+SPE++  K  
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSA 209
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGN 353
            K++D W++G ++++++ G PPF  GN
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGN 236

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  194 bits (493), Expect = 8e-50,   Method: Compositional matrix adjust.
 Identities = 92/243 (37%), Positives = 148/243 (60%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+ +L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+++D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 210
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 270
Query: 381 KGV 383
           + +
Sbjct: 271 RNL 273

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  194 bits (493), Expect = 8e-50,   Method: Compositional matrix adjust.
 Identities = 92/243 (37%), Positives = 148/243 (60%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+ +L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+++D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 210
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 270
Query: 381 KGV 383
           + +
Sbjct: 271 RNL 273

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  194 bits (492), Expect = 8e-50,   Method: Compositional matrix adjust.
 Identities = 92/243 (37%), Positives = 148/243 (60%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+ +L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+++D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 210
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 270
Query: 381 KGV 383
           + +
Sbjct: 271 RNL 273

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  194 bits (492), Expect = 9e-50,   Method: Compositional matrix adjust.
 Identities = 87/207 (42%), Positives = 136/207 (65%), Gaps = 3/207 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGN 353
            K++D W++G ++++++ G PPF  GN
Sbjct: 212 XKSSDLWALGCIIYQLVAGLPPFRAGN 238

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  193 bits (491), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 87/207 (42%), Positives = 136/207 (65%), Gaps = 3/207 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGN 353
            K++D W++G ++++++ G PPF  GN
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRAGN 238

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  193 bits (491), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 87/207 (42%), Positives = 136/207 (65%), Gaps = 3/207 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGN 353
            K++D W++G ++++++ G PPF  GN
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGN 236

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  193 bits (491), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 87/207 (42%), Positives = 136/207 (65%), Gaps = 3/207 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGN 353
            K++D W++G ++++++ G PPF  GN
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRAGN 238

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  193 bits (491), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 93/243 (38%), Positives = 148/243 (60%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++P I
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPAI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  193 bits (491), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 87/207 (42%), Positives = 136/207 (65%), Gaps = 3/207 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 212
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGN 353
            K++D W++G ++++++ G PPF  GN
Sbjct: 213 CKSSDLWALGCIIYQLVAGLPPFRAGN 239

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  193 bits (491), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 87/207 (42%), Positives = 136/207 (65%), Gaps = 3/207 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGN 353
            K++D W++G ++++++ G PPF  GN
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRAGN 238

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  193 bits (490), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 87/207 (42%), Positives = 136/207 (65%), Gaps = 3/207 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGN 353
            K++D W++G ++++++ G PPF  GN
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGN 236

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  193 bits (490), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 96/237 (40%), Positives = 146/237 (61%), Gaps = 2/237 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +G+++FE ++V+G+G+F KV   R   T ++YA+KV++KD I++ +  E   +E+ IL+ 
Sbjct: 20  LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 207 V-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             +HPF+ QL   FQT  RL+ V++FVNGG L F + +   F E  AR Y AEI+SA+  
Sbjct: 80  ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMF 139
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNSMCGTLEYMSPEIVLGK 324
           LH  GI++RDLK +N+LLD +GH  L DFG+ K+   N   + + CGT +Y++PEI+   
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM 199
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
            +  A DWW++G+LL+EML G  PF   N               P +L  +A  +LK
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILK 256

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  193 bits (490), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 87/207 (42%), Positives = 136/207 (65%), Gaps = 3/207 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGN 353
            K++D W++G ++++++ G PPF  GN
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRAGN 238

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  193 bits (490), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 87/207 (42%), Positives = 136/207 (65%), Gaps = 3/207 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 130 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 189
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGN 353
            K++D W++G ++++++ G PPF  GN
Sbjct: 190 CKSSDLWALGCIIYQLVAGLPPFRAGN 216

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  193 bits (490), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 87/207 (42%), Positives = 136/207 (65%), Gaps = 3/207 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 128
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 129 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 188
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGN 353
            K++D W++G ++++++ G PPF  GN
Sbjct: 189 CKSSDLWALGCIIYQLVAGLPPFRAGN 215

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  193 bits (490), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 87/207 (42%), Positives = 136/207 (65%), Gaps = 3/207 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 127 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 186
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGN 353
            K++D W++G ++++++ G PPF  GN
Sbjct: 187 CKSSDLWALGCIIYQLVAGLPPFRAGN 213

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  193 bits (490), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 87/207 (42%), Positives = 136/207 (65%), Gaps = 3/207 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 187
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGN 353
            K++D W++G ++++++ G PPF  GN
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGN 214

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  192 bits (489), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 87/207 (42%), Positives = 136/207 (65%), Gaps = 3/207 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 134 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 193
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGN 353
            K++D W++G ++++++ G PPF  GN
Sbjct: 194 CKSSDLWALGCIIYQLVAGLPPFRAGN 220

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  192 bits (489), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 87/207 (42%), Positives = 136/207 (65%), Gaps = 3/207 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 208
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGN 353
            K++D W++G ++++++ G PPF  GN
Sbjct: 209 CKSSDLWALGCIIYQLVAGLPPFRAGN 235

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  192 bits (489), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 87/207 (42%), Positives = 135/207 (65%), Gaps = 3/207 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L + FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 157 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 216
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGN 353
            K++D W++G ++++++ G PPF  GN
Sbjct: 217 CKSSDLWALGCIIYQLVAGLPPFRAGN 243

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  192 bits (488), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 93/243 (38%), Positives = 148/243 (60%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT E ++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEALAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  192 bits (488), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 88/232 (37%), Positives = 142/232 (61%), Gaps = 2/232 (0%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+DF++L+ +G G+F +V+ +R       YAMKV++K+ ++     E+   ER +L+ V 
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HPFI+++  +FQ   ++++++D++ GG LF  L +   F   +A+ Y AE+  A+ +LH+
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             I++RDLKPENILLD +GH+ +TDFG AK   + T    +CGT +Y++PE+V  K ++K
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--XLCGTPDYIAPEVVSTKPYNK 182
Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           + DWWS GIL++EML G  PF   N               P F + +   LL
Sbjct: 183 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL 234

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  192 bits (487), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 86/207 (41%), Positives = 135/207 (65%), Gaps = 3/207 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+     R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGN 353
            K++D W++G ++++++ G PPF  GN
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGN 236

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  191 bits (486), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 93/243 (38%), Positives = 148/243 (60%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  + GT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLAGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  191 bits (485), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 93/243 (38%), Positives = 148/243 (60%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  + GT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLXGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGV 383
           + +
Sbjct: 270 RNL 272

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  190 bits (483), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 92/243 (37%), Positives = 146/243 (60%), Gaps = 3/243 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE ++ +G G+F +V  V+   T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + I   V+ PF+V+L +SF+    LY+VL++  GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ + DFG AK+     R+  +CGT EY++PEI
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEI 210
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 270
Query: 381 KGV 383
           + +
Sbjct: 271 RNL 273

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  185 bits (469), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 92/244 (37%), Positives = 150/244 (61%), Gaps = 6/244 (2%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS    + +EDFE+ K++G+G+F KV+      T++ +A+K ++KD ++  +  E    E
Sbjct: 9   PSLQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 68
Query: 201 RNILT-KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR--IYTA 257
           + +L+   +HPF+  +  +FQTK  L+ V++++NGG L + +  Q   + DL+R   Y A
Sbjct: 69  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAA 126
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYM 316
           EI+  +  LH+ GI++RDLK +NILLD DGH+ + DFG+ K+    + ++N  CGT +Y+
Sbjct: 127 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYI 186
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEA 376
           +PEI+LG+ ++ + DWWS G+LL+EML GQ PF G +               P +L  EA
Sbjct: 187 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA 246
Query: 377 HSLL 380
             LL
Sbjct: 247 KDLL 250

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  185 bits (469), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 90/237 (37%), Positives = 142/237 (59%), Gaps = 2/237 (0%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L DF  L V+G+G+F KV    R GT E+YA+K+++KD +++ +  E    E+ +L    
Sbjct: 19  LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 78
Query: 209 HP-FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            P F+ QL   FQT  RLY V+++VNGG L + + + G F+E  A  Y AEI   +  L 
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 138
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGH 326
           + GI++RDLK +N++LD++GH+ + DFG+ K+   +   +   CGT +Y++PEI+  + +
Sbjct: 139 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPY 198
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGV 383
            K+ DWW+ G+LL+EML GQ PF G +               P  +S EA ++ KG+
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL 255

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  185 bits (469), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 90/237 (37%), Positives = 142/237 (59%), Gaps = 2/237 (0%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT-KV 207
           L DF  L V+G+G+F KV    R GT E+YA+K+++KD +++ +  E    E+ +L    
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 399
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
             PF+ QL   FQT  RLY V+++VNGG L + + + G F+E  A  Y AEI   +  L 
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGH 326
           + GI++RDLK +N++LD++GH+ + DFG+ K+   +   +   CGT +Y++PEI+  + +
Sbjct: 460 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPY 519
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGV 383
            K+ DWW+ G+LL+EML GQ PF G +               P  +S EA ++ KG+
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL 576

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  181 bits (460), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 91/244 (37%), Positives = 149/244 (61%), Gaps = 6/244 (2%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS    + +EDF + K++G+G+F KV+      T++ +A+K ++KD ++  +  E    E
Sbjct: 8   PSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 67
Query: 201 RNILT-KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR--IYTA 257
           + +L+   +HPF+  +  +FQTK  L+ V++++NGG L + +  Q   + DL+R   Y A
Sbjct: 68  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAA 125
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYM 316
           EI+  +  LH+ GI++RDLK +NILLD DGH+ + DFG+ K+    + ++N  CGT +Y+
Sbjct: 126 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYI 185
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEA 376
           +PEI+LG+ ++ + DWWS G+LL+EML GQ PF G +               P +L  EA
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA 245
Query: 377 HSLL 380
             LL
Sbjct: 246 KDLL 249

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 90/247 (36%), Positives = 144/247 (58%), Gaps = 6/247 (2%)
Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
           EN+ V  + FE+L+ +G+G+F KV  V++  T ++YAMK M K K +E+N    +  E  
Sbjct: 8   ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQ 67
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           I+  ++HPF+V L YSFQ +  +++V+D + GG L + L +   F+E+  +++  E+V A
Sbjct: 68  IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA 127
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV- 321
           + +L    I+HRD+KP+NILLD  GHV +TDF +A      T+  +M GT  YM+PE+  
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFS 187
Query: 322 --LGKGHDKAADWWSVGILLFEMLTGQPPF---TGGNRXXXXXXXXXXXXXLPAFLSSEA 376
              G G+  A DWWS+G+  +E+L G+ P+   +  +               P+  S E 
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEM 247
Query: 377 HSLLKGV 383
            SLLK +
Sbjct: 248 VSLLKKL 254

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 84/206 (40%), Positives = 134/206 (65%), Gaps = 7/206 (3%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED+EV+KV+G+GAF +V  VR   T ++YAMK++ K ++++++ + +   ER+I+   + 
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++VQL Y+FQ    LY+V++++ GG L   L       E  AR YTAE+V A+  +H+ 
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 187
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHD 327
           G +HRD+KP+N+LLD  GH+ L DFG   + ++    R ++  GT +Y+SPE++  +G D
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247
Query: 328 ----KAADWWSVGILLFEMLTGQPPF 349
               +  DWWSVG+ L+EML G  PF
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 84/206 (40%), Positives = 134/206 (65%), Gaps = 7/206 (3%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED+EV+KV+G+GAF +V  VR   T ++YAMK++ K ++++++ + +   ER+I+   + 
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++VQL Y+FQ    LY+V++++ GG L   L       E  AR YTAE+V A+  +H+ 
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHD 327
           G +HRD+KP+N+LLD  GH+ L DFG   + ++    R ++  GT +Y+SPE++  +G D
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 252
Query: 328 ----KAADWWSVGILLFEMLTGQPPF 349
               +  DWWSVG+ L+EML G  PF
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 84/206 (40%), Positives = 134/206 (65%), Gaps = 7/206 (3%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED+EV+KV+G+GAF +V  VR   T ++YAMK++ K ++++++ + +   ER+I+   + 
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++VQL Y+FQ    LY+V++++ GG L   L       E  AR YTAE+V A+  +H+ 
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHD 327
           G +HRD+KP+N+LLD  GH+ L DFG   + ++    R ++  GT +Y+SPE++  +G D
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 252
Query: 328 ----KAADWWSVGILLFEMLTGQPPF 349
               +  DWWSVG+ L+EML G  PF
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 82/206 (39%), Positives = 133/206 (64%), Gaps = 7/206 (3%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED++V+KV+G+GAF +V  VR   + ++YAMK++ K ++++++ + +   ER+I+   + 
Sbjct: 75  EDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 134
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++VQL  +FQ    LY+V++++ GG L   L       E  A+ YTAE+V A+  +H+ 
Sbjct: 135 PWVVQLFCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKFYTAEVVLALDAIHSM 193
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHD 327
           G++HRD+KP+N+LLD  GH+ L DFG   + DE      ++  GT +Y+SPE++  +G D
Sbjct: 194 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGD 253
Query: 328 ----KAADWWSVGILLFEMLTGQPPF 349
               +  DWWSVG+ LFEML G  PF
Sbjct: 254 GYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 92/242 (38%), Positives = 140/242 (57%), Gaps = 8/242 (3%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV- 207
           + DF V +++G+G F +VY  R+  T ++YAMK + K +I  K       +ER +L+ V 
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 208 --DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             D PFIV + Y+F T  +L  +LD +NGG L + L + G+F E   R Y AEI+  + H
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL-GK 324
           +H   +++RDLKP NILLD  GHV ++D GLA  F +  + ++  GT  YM+PE++  G 
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGV 366
Query: 325 GHDKAADWWSVGILLFEMLTGQPPF---TGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
            +D +ADW+S+G +LF++L G  PF      ++             LP   S E  SLL+
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 426
Query: 382 GV 383
           G+
Sbjct: 427 GL 428

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 92/242 (38%), Positives = 140/242 (57%), Gaps = 8/242 (3%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV- 207
           + DF V +++G+G F +VY  R+  T ++YAMK + K +I  K       +ER +L+ V 
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 208 --DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             D PFIV + Y+F T  +L  +LD +NGG L + L + G+F E   R Y AEI+  + H
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL-GK 324
           +H   +++RDLKP NILLD  GHV ++D GLA  F +  + ++  GT  YM+PE++  G 
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGV 366
Query: 325 GHDKAADWWSVGILLFEMLTGQPPF---TGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
            +D +ADW+S+G +LF++L G  PF      ++             LP   S E  SLL+
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 426
Query: 382 GV 383
           G+
Sbjct: 427 GL 428

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 92/242 (38%), Positives = 140/242 (57%), Gaps = 8/242 (3%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV- 207
           + DF V +++G+G F +VY  R+  T ++YAMK + K +I  K       +ER +L+ V 
Sbjct: 187 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 246
Query: 208 --DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             D PFIV + Y+F T  +L  +LD +NGG L + L + G+F E   R Y AEI+  + H
Sbjct: 247 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 306
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL-GK 324
           +H   +++RDLKP NILLD  GHV ++D GLA  F +  + ++  GT  YM+PE++  G 
Sbjct: 307 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGV 365
Query: 325 GHDKAADWWSVGILLFEMLTGQPPF---TGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
            +D +ADW+S+G +LF++L G  PF      ++             LP   S E  SLL+
Sbjct: 366 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 425
Query: 382 GV 383
           G+
Sbjct: 426 GL 427

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 92/242 (38%), Positives = 140/242 (57%), Gaps = 8/242 (3%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV- 207
           + DF V +++G+G F +VY  R+  T ++YAMK + K +I  K       +ER +L+ V 
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 208 --DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             D PFIV + Y+F T  +L  +LD +NGG L + L + G+F E   R Y AEI+  + H
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL-GK 324
           +H   +++RDLKP NILLD  GHV ++D GLA  F +  + ++  GT  YM+PE++  G 
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGV 366
Query: 325 GHDKAADWWSVGILLFEMLTGQPPF---TGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
            +D +ADW+S+G +LF++L G  PF      ++             LP   S E  SLL+
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 426
Query: 382 GV 383
           G+
Sbjct: 427 GL 428

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 84/209 (40%), Positives = 129/209 (61%), Gaps = 10/209 (4%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDFE++KV+G+GAF +V  V+   T  IYAMK++ K +++++      + ER++L   D 
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA 268
            +I  L Y+FQ +  LYLV+D+  GG L   L + +    ED+AR Y  E+V A+  +H 
Sbjct: 134 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ 193
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFG--LAKQFDENTRSNSMCGTLEYMSPEIV----- 321
              +HRD+KP+N+LLD +GH+ L DFG  L    D   +S+   GT +Y+SPEI+     
Sbjct: 194 LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 253
Query: 322 -LGKGHDKAADWWSVGILLFEMLTGQPPF 349
            +GK +    DWWS+G+ ++EML G+ PF
Sbjct: 254 GMGK-YGPECDWWSLGVCMYEMLYGETPF 281

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 84/209 (40%), Positives = 129/209 (61%), Gaps = 10/209 (4%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDFE++KV+G+GAF +V  V+   T  IYAMK++ K +++++      + ER++L   D 
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA 268
            +I  L Y+FQ +  LYLV+D+  GG L   L + +    ED+AR Y  E+V A+  +H 
Sbjct: 150 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ 209
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFG--LAKQFDENTRSNSMCGTLEYMSPEIV----- 321
              +HRD+KP+N+LLD +GH+ L DFG  L    D   +S+   GT +Y+SPEI+     
Sbjct: 210 LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 269
Query: 322 -LGKGHDKAADWWSVGILLFEMLTGQPPF 349
            +GK +    DWWS+G+ ++EML G+ PF
Sbjct: 270 GMGK-YGPECDWWSLGVCMYEMLYGETPF 297

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  161 bits (407), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 82/208 (39%), Positives = 129/208 (62%), Gaps = 8/208 (3%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDFE+LKV+G+GAF +V  V+     +++AMK++ K +++++      + ER++L   D 
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA 268
            +I  L Y+FQ    LYLV+D+  GG L   L + +    E++AR Y AE+V A+  +H 
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVL---- 322
              +HRD+KP+NIL+D +GH+ L DFG   +   D   +S+   GT +Y+SPEI+     
Sbjct: 194 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 323 GKG-HDKAADWWSVGILLFEMLTGQPPF 349
           GKG +    DWWS+G+ ++EML G+ PF
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score =  160 bits (406), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 84/210 (40%), Positives = 126/210 (60%), Gaps = 10/210 (4%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE+LKV+G+GAF++V  V+   T ++YAMK+M K  ++++      + ER++L   D 
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHA 268
            +I QL ++FQ +  LYLV+++  GG L   L + G     ++AR Y AEIV A+  +H 
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR 180
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFG--LAKQFDENTRSNSMCGTLEYMSPEIVLG--- 323
            G +HRD+KP+NILLD  GH+ L DFG  L  + D   RS    GT +Y+SPEI+     
Sbjct: 181 LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGG 240
Query: 324 ----KGHDKAADWWSVGILLFEMLTGQPPF 349
                 +    DWW++G+  +EM  GQ PF
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFYGQTPF 270

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 76/241 (31%), Positives = 133/241 (55%), Gaps = 1/241 (0%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           + S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ 
Sbjct: 3   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL 122
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
            +A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ PE
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPE 181
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSL 379
           ++ G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  L
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 241
Query: 380 L 380
           +
Sbjct: 242 I 242

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 77/242 (31%), Positives = 133/242 (54%), Gaps = 1/242 (0%)
Query: 139 NLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK 198
           N  S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++
Sbjct: 23  NEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 82
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
            E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E
Sbjct: 83  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 142
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           + +A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ P
Sbjct: 143 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPP 201
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHS 378
           E++ G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 261
Query: 379 LL 380
           L+
Sbjct: 262 LI 263

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  155 bits (391), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 77/242 (31%), Positives = 133/242 (54%), Gaps = 1/242 (0%)
Query: 139 NLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK 198
           N  S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++
Sbjct: 23  NEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 82
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
            E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E
Sbjct: 83  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 142
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           + +A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     ++R + +CGTL+Y+ P
Sbjct: 143 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRDDLCGTLDYLPP 201
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHS 378
           E++ G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 261
Query: 379 LL 380
           L+
Sbjct: 262 LI 263

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  155 bits (391), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 77/242 (31%), Positives = 133/242 (54%), Gaps = 1/242 (0%)
Query: 139 NLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK 198
           N  S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++
Sbjct: 14  NEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 73
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
            E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E
Sbjct: 74  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 133
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           + +A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ P
Sbjct: 134 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPP 192
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHS 378
           E++ G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 252
Query: 379 LL 380
           L+
Sbjct: 253 LI 254

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 76/239 (31%), Positives = 133/239 (55%), Gaps = 1/239 (0%)
Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E 
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     ++R +++CGTL+Y+ PE++
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRDTLCGTLDYLPPEMI 179
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
            G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  L+
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 238

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  154 bits (389), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 76/241 (31%), Positives = 133/241 (55%), Gaps = 1/241 (0%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           + S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ 
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
            +A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ PE
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPE 179
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSL 379
           ++ G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  L
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 239
Query: 380 L 380
           +
Sbjct: 240 I 240

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  154 bits (389), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 76/241 (31%), Positives = 133/241 (55%), Gaps = 1/241 (0%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           + S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ 
Sbjct: 3   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 122
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
            +A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ PE
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPE 181
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSL 379
           ++ G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  L
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 241
Query: 380 L 380
           +
Sbjct: 242 I 242

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 76/241 (31%), Positives = 133/241 (55%), Gaps = 1/241 (0%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           + S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ 
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
            +A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ PE
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPE 179
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSL 379
           ++ G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  L
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 239
Query: 380 L 380
           +
Sbjct: 240 I 240

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 78/246 (31%), Positives = 134/246 (54%), Gaps = 4/246 (1%)
Query: 135 GHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA 194
           GH +   S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +    
Sbjct: 1   GHXE---SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE 57
Query: 195 EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI 254
             ++ E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     
Sbjct: 58  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 117
Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE 314
           Y  E+ +A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+
Sbjct: 118 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLD 176
Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSS 374
           Y+ PE + G+ HD+  D WS+G+L +E L G+PPF                   P F++ 
Sbjct: 177 YLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 236
Query: 375 EAHSLL 380
            A  L+
Sbjct: 237 GARDLI 242

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 129/233 (55%), Gaps = 1/233 (0%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ PE++ G+ HD
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHD 184
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +  D WS+G+L +E L G+PPF                   P F++  A  L+
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 237

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 76/239 (31%), Positives = 132/239 (55%), Gaps = 1/239 (0%)
Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E 
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     + R++ +CGTL+Y+ PE++
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-LCGTLDYLPPEMI 179
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
            G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  L+
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 238

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 76/239 (31%), Positives = 132/239 (55%), Gaps = 1/239 (0%)
Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E 
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 124
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     + R++ +CGTL+Y+ PE++
Sbjct: 125 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-LCGTLDYLPPEMI 183
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
            G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  L+
Sbjct: 184 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 242

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 129/233 (55%), Gaps = 1/233 (0%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 129
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ PE++ G+ HD
Sbjct: 130 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHD 188
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +  D WS+G+L +E L G+PPF                   P F++  A  L+
Sbjct: 189 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 241

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 129/233 (55%), Gaps = 1/233 (0%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ PE++ G+ HD
Sbjct: 126 SKKVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRAALCGTLDYLPPEMIEGRMHD 184
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +  D WS+G+L +E L G+PPF                   P F++  A  L+
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGARDLI 237

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 128/233 (54%), Gaps = 1/233 (0%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     ++R   +CGTL+Y+ PE++ G+ HD
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTELCGTLDYLPPEMIEGRMHD 184
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +  D WS+G+L +E L G+PPF                   P F++  A  L+
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 237

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 129/233 (55%), Gaps = 1/233 (0%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     ++R + +CGTL+Y+ PE++ G+ HD
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRDDLCGTLDYLPPEMIEGRMHD 187
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +  D WS+G+L +E L G+PPF                   P F++  A  L+
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 240

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 76/239 (31%), Positives = 131/239 (54%), Gaps = 1/239 (0%)
Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E 
Sbjct: 2   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 61
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +
Sbjct: 62  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 121
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     ++R   +CGTL+Y+ PE++
Sbjct: 122 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRXXLCGTLDYLPPEMI 180
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
            G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  L+
Sbjct: 181 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 239

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 129/233 (55%), Gaps = 1/233 (0%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 124
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ PE++ G+ HD
Sbjct: 125 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHD 183
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +  D WS+G+L +E L G+PPF                   P F++  A  L+
Sbjct: 184 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 236

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 129/233 (55%), Gaps = 1/233 (0%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     + R++ +CGTL+Y+ PE++ G+ HD
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-LCGTLDYLPPEMIEGRMHD 184
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +  D WS+G+L +E L G+PPF                   P F++  A  L+
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 237

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 129/233 (55%), Gaps = 1/233 (0%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ PE++ G+ HD
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRAALCGTLDYLPPEMIEGRMHD 187
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +  D WS+G+L +E L G+PPF                   P F++  A  L+
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 240

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 76/241 (31%), Positives = 132/241 (54%), Gaps = 1/241 (0%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           + S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ 
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
            +A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     ++R   +CGTL+Y+ PE
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRXXLCGTLDYLPPE 179
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSL 379
           ++ G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  L
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 239
Query: 380 L 380
           +
Sbjct: 240 I 240

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 129/233 (55%), Gaps = 1/233 (0%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     + R++ +CGTL+Y+ PE++ G+ HD
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-LCGTLDYLPPEMIEGRMHD 184
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +  D WS+G+L +E L G+PPF                   P F++  A  L+
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 237

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 75/239 (31%), Positives = 132/239 (55%), Gaps = 1/239 (0%)
Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E 
Sbjct: 2   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 61
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +
Sbjct: 62  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 121
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           A+S+ H+  ++HRD+KPEN+LL + G + + +FG +     ++R  ++CGTL+Y+ PE++
Sbjct: 122 ALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVH-APSSRRTTLCGTLDYLPPEMI 180
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
            G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  L+
Sbjct: 181 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 239

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 75/241 (31%), Positives = 133/241 (55%), Gaps = 1/241 (0%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           + S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ 
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
            +A+S+ H+  ++HRD+KPEN+LL + G + + +FG +     ++R  ++CGTL+Y+ PE
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVH-APSSRRTTLCGTLDYLPPE 179
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSL 379
           ++ G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  L
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 239
Query: 380 L 380
           +
Sbjct: 240 I 240

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 129/233 (55%), Gaps = 1/233 (0%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ PE++ G+ HD
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRAALCGTLDYLPPEMIEGRMHD 184
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +  D WS+G+L +E L G+PPF                   P F++  A  L+
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 237

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 128/233 (54%), Gaps = 1/233 (0%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     ++R   +CGTL+Y+ PE++ G+ HD
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTXLCGTLDYLPPEMIEGRMHD 184
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +  D WS+G+L +E L G+PPF                   P F++  A  L+
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 237

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 73/232 (31%), Positives = 125/232 (53%), Gaps = 1/232 (0%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++DF++++ +G+G F  VY  R      I A+KV+ K ++ ++     ++ E  I + + 
Sbjct: 13  IDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I+++   F  + R+YL+L+F   G L+ +L + G F E  +  +  E+  A+ + H 
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             ++HRD+KPEN+L+   G + + DFG +     + R   MCGTL+Y+ PE++ GK HD+
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVH-APSLRRRXMCGTLDYLPPEMIEGKTHDE 191
Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
             D W  G+L +E L G PPF   +               P FLS  +  L+
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLI 243

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 74/232 (31%), Positives = 130/232 (56%), Gaps = 1/232 (0%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           LEDF++ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + + 
Sbjct: 11  LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H+
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             ++HRD+KPEN+LL ++G + + DFG +     ++R +++CGTL+Y+ PE++ G+ HD+
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSVH-APSSRRDTLCGTLDYLPPEMIEGRMHDE 189
Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
             D WS+G+L +E L G PPF                   P F++  A  L+
Sbjct: 190 KVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLI 241

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 128/233 (54%), Gaps = 1/233 (0%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     ++R   +CGTL+Y+ PE++ G+ HD
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRXXLCGTLDYLPPEMIEGRMHD 184
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +  D WS+G+L +E L G+PPF                   P F++  A  L+
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 237

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 128/233 (54%), Gaps = 1/233 (0%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R      I A+KV+ K ++ +      ++ E  I + +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 122
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ PE++ G+ HD
Sbjct: 123 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHD 181
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +  D WS+G+L +E L G+PPF                   P F++  A  L+
Sbjct: 182 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 234

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 74/232 (31%), Positives = 129/232 (55%), Gaps = 1/232 (0%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           LEDF++ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + + 
Sbjct: 11  LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H+
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             ++HRD+KPEN+LL ++G + + DFG +     ++R  ++CGTL+Y+ PE++ G+ HD+
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHDE 189
Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
             D WS+G+L +E L G PPF                   P F++  A  L+
Sbjct: 190 KVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLI 241

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 80/232 (34%), Positives = 135/232 (58%), Gaps = 2/232 (0%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T +  A+K++ K ++   +  +  +  R I+  ++HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVR-IMKVLNHP 73
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYLV+++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-KA 329
           I+HRDLK EN+LLDAD ++ + DFG + +F    + ++ CG+  Y +PE+  GK +D   
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
            D WS+G++L+ +++G  PF G N              +P ++S++  +LLK
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 245

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 80/232 (34%), Positives = 135/232 (58%), Gaps = 2/232 (0%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T +  A+K++ K ++   +  +  +  R I+  ++HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVR-IMKVLNHP 73
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYLV+++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-KA 329
           I+HRDLK EN+LLDAD ++ + DFG + +F    + ++ CG+  Y +PE+  GK +D   
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
            D WS+G++L+ +++G  PF G N              +P ++S++  +LLK
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 245

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 80/232 (34%), Positives = 135/232 (58%), Gaps = 2/232 (0%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T +  A+K++ K ++   +  +  +  R I+  ++HP
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVR-IMKVLNHP 66
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYLV+++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKF 126
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-KA 329
           I+HRDLK EN+LLDAD ++ + DFG + +F    + ++ CG+  Y +PE+  GK +D   
Sbjct: 127 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 186
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
            D WS+G++L+ +++G  PF G N              +P ++S++  +LLK
Sbjct: 187 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 238

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 84/209 (40%), Positives = 120/209 (57%), Gaps = 2/209 (0%)
Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
           E Q V    F   +V+G+G F +V   +   T ++YA K + K +I ++       +E+ 
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIV 260
           IL KV+  F+V L Y+++TK  L LVL  +NGG L F +Y  G   F E  A  Y AEI 
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC 296
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
             +  LH   I++RDLKPENILLD  GH+ ++D GLA    E        GT+ YM+PE+
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           V  + +  + DWW++G LL+EM+ GQ PF
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 80/232 (34%), Positives = 134/232 (57%), Gaps = 2/232 (0%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T +  A+K++ K ++   +  +  +  R I+  ++HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVR-IMKVLNHP 73
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYLV+++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-KA 329
           I+HRDLK EN+LLDAD ++ + DFG + +F    + ++ CG   Y +PE+  GK +D   
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
            D WS+G++L+ +++G  PF G N              +P ++S++  +LLK
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 245

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 84/209 (40%), Positives = 120/209 (57%), Gaps = 2/209 (0%)
Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
           E Q V    F   +V+G+G F +V   +   T ++YA K + K +I ++       +E+ 
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIV 260
           IL KV+  F+V L Y+++TK  L LVL  +NGG L F +Y  G   F E  A  Y AEI 
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC 296
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
             +  LH   I++RDLKPENILLD  GH+ ++D GLA    E        GT+ YM+PE+
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           V  + +  + DWW++G LL+EM+ GQ PF
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 79/232 (34%), Positives = 135/232 (58%), Gaps = 2/232 (0%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T +  A++++ K ++   +  +  +  R I+  ++HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVR-IMKVLNHP 73
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYLV+++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-KA 329
           I+HRDLK EN+LLDAD ++ + DFG + +F    + ++ CG+  Y +PE+  GK +D   
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
            D WS+G++L+ +++G  PF G N              +P ++S++  +LLK
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 245

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 73/232 (31%), Positives = 124/232 (53%), Gaps = 1/232 (0%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++DF++ + +G+G F  VY  R      I A+KV+ K ++ ++     ++ E  I + + 
Sbjct: 14  IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 73
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I+++   F  + R+YL+L+F   G L+ +L + G F E  +  +  E+  A+ + H 
Sbjct: 74  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 133
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             ++HRD+KPEN+L+   G + + DFG +     + R   MCGTL+Y+ PE++ GK HD+
Sbjct: 134 RKVIHRDIKPENLLMGYKGELKIADFGWSVH-APSLRRRXMCGTLDYLPPEMIEGKTHDE 192
Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
             D W  G+L +E L G PPF   +               P FLS  +  L+
Sbjct: 193 KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLI 244

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 75/241 (31%), Positives = 131/241 (54%), Gaps = 1/241 (0%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           + S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ 
Sbjct: 3   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL 122
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
            +A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     ++R   + GTL+Y+ PE
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRXXLXGTLDYLPPE 181
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSL 379
           ++ G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  L
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 241
Query: 380 L 380
           +
Sbjct: 242 I 242

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 79/232 (34%), Positives = 134/232 (57%), Gaps = 2/232 (0%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T    A+K++ K ++   +  +  +  R I+  ++HP
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVR-IMKILNHP 71
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYL++++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 131
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-KA 329
           I+HRDLK EN+LLDAD ++ + DFG + +F    + ++ CG+  Y +PE+  GK +D   
Sbjct: 132 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPE 191
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
            D WS+G++L+ +++G  PF G N              +P ++S++  +LLK
Sbjct: 192 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 243

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 79/232 (34%), Positives = 134/232 (57%), Gaps = 2/232 (0%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T +  A++++ K ++   +  +  +  R I+  ++HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVR-IMKVLNHP 73
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYLV+++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-KA 329
           I+HRDLK EN+LLDAD ++ + DFG + +F    + +  CG+  Y +PE+  GK +D   
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPE 193
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
            D WS+G++L+ +++G  PF G N              +P ++S++  +LLK
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 245

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 128/233 (54%), Gaps = 1/233 (0%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     ++R  ++ GTL+Y+ PE++ G+ HD
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSCH-APSSRRTTLSGTLDYLPPEMIEGRMHD 185
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +  D WS+G+L +E L G+PPF                   P F++  A  L+
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 238

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  149 bits (375), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 79/232 (34%), Positives = 133/232 (57%), Gaps = 2/232 (0%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T    A+K++ K ++   +  +  +  R I+  ++HP
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVR-IMKILNHP 74
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYL++++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-KA 329
           I+HRDLK EN+LLDAD ++ + DFG + +F    + ++ CG   Y +PE+  GK +D   
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPE 194
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
            D WS+G++L+ +++G  PF G N              +P ++S++  +LLK
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 246

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 74/201 (36%), Positives = 128/201 (63%), Gaps = 7/201 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  ++V+G GAF++V+ V++  T +++A+K ++K      +  E   +E  +L K+ H  
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHEN 67
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV L   +++    YLV+  V+GG LF ++  +G++ E  A +   +++SAV +LH NGI
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 272 MHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           +HRDLKPEN+L    + +  +M+TDFGL+K  ++N   ++ CGT  Y++PE++  K + K
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTACGTPGYVAPEVLAQKPYSK 186
Query: 329 AADWWSVGILLFEMLTGQPPF 349
           A D WS+G++ + +L G PPF
Sbjct: 187 AVDCWSIGVITYILLCGYPPF 207

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 80/232 (34%), Positives = 131/232 (56%), Gaps = 2/232 (0%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T +  A+K++ K ++   +  +  +  R I   ++HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVR-IXKVLNHP 73
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYLV ++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF 133
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-KA 329
           I+HRDLK EN+LLDAD ++ + DFG + +F    + ++ CG   Y +PE+  GK +D   
Sbjct: 134 IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
            D WS+G++L+ +++G  PF G N              +P + S++  +LLK
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXSTDCENLLK 245

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 80/212 (37%), Positives = 131/212 (61%), Gaps = 5/212 (2%)
Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
           E Q +G + F   +V+G+G F +V+  +   T ++YA K + K ++ ++   +    E+ 
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAE 258
           IL KV   FIV L Y+F+TK  L LV+  +NGG + + +Y        F+E  A  YTA+
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNSMCGTLEYMS 317
           IVS + HLH   I++RDLKPEN+LLD DG+V ++D GLA +     T++    GT  +M+
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           PE++LG+ +D + D++++G+ L+EM+  + PF
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 80/212 (37%), Positives = 131/212 (61%), Gaps = 5/212 (2%)
Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
           E Q +G + F   +V+G+G F +V+  +   T ++YA K + K ++ ++   +    E+ 
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAE 258
           IL KV   FIV L Y+F+TK  L LV+  +NGG + + +Y        F+E  A  YTA+
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNSMCGTLEYMS 317
           IVS + HLH   I++RDLKPEN+LLD DG+V ++D GLA +     T++    GT  +M+
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           PE++LG+ +D + D++++G+ L+EM+  + PF
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 80/212 (37%), Positives = 131/212 (61%), Gaps = 5/212 (2%)
Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
           E Q +G + F   +V+G+G F +V+  +   T ++YA K + K ++ ++   +    E+ 
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAE 258
           IL KV   FIV L Y+F+TK  L LV+  +NGG + + +Y        F+E  A  YTA+
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNSMCGTLEYMS 317
           IVS + HLH   I++RDLKPEN+LLD DG+V ++D GLA +     T++    GT  +M+
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           PE++LG+ +D + D++++G+ L+EM+  + PF
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 80/212 (37%), Positives = 131/212 (61%), Gaps = 5/212 (2%)
Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
           E Q +G + F   +V+G+G F +V+  +   T ++YA K + K ++ ++   +    E+ 
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAE 258
           IL KV   FIV L Y+F+TK  L LV+  +NGG + + +Y        F+E  A  YTA+
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNSMCGTLEYMS 317
           IVS + HLH   I++RDLKPEN+LLD DG+V ++D GLA +     T++    GT  +M+
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           PE++LG+ +D + D++++G+ L+EM+  + PF
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 78/217 (35%), Positives = 128/217 (58%), Gaps = 6/217 (2%)
Query: 141 PSENQCVGLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           P   Q   + D ++   V+G GAF++V       T ++ A+K + K+ +  K  +  M++
Sbjct: 8   PRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS--MEN 65
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  +L K+ HP IV L   +++   LYL++  V+GG LF ++  +G + E  A     ++
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQV 125
Query: 260 VSAVSHLHANGIMHRDLKPENIL---LDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYM 316
           + AV +LH  GI+HRDLKPEN+L   LD D  +M++DFGL+K  D  +  ++ CGT  Y+
Sbjct: 126 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 185
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +PE++  K + KA D WS+G++ + +L G PPF   N
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 222

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 78/217 (35%), Positives = 128/217 (58%), Gaps = 6/217 (2%)
Query: 141 PSENQCVGLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           P   Q   + D ++   V+G GAF++V       T ++ A+K + K+ +  K  +  M++
Sbjct: 8   PRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS--MEN 65
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  +L K+ HP IV L   +++   LYL++  V+GG LF ++  +G + E  A     ++
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQV 125
Query: 260 VSAVSHLHANGIMHRDLKPENIL---LDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYM 316
           + AV +LH  GI+HRDLKPEN+L   LD D  +M++DFGL+K  D  +  ++ CGT  Y+
Sbjct: 126 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 185
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +PE++  K + KA D WS+G++ + +L G PPF   N
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 222

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 78/217 (35%), Positives = 128/217 (58%), Gaps = 6/217 (2%)
Query: 141 PSENQCVGLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           P   Q   + D ++   V+G GAF++V       T ++ A+K + K+ +  K  +  M++
Sbjct: 8   PRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS--MEN 65
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  +L K+ HP IV L   +++   LYL++  V+GG LF ++  +G + E  A     ++
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQV 125
Query: 260 VSAVSHLHANGIMHRDLKPENIL---LDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYM 316
           + AV +LH  GI+HRDLKPEN+L   LD D  +M++DFGL+K  D  +  ++ CGT  Y+
Sbjct: 126 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 185
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +PE++  K + KA D WS+G++ + +L G PPF   N
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 222

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 78/217 (35%), Positives = 127/217 (58%), Gaps = 6/217 (2%)
Query: 141 PSENQCVGLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           P   Q   + D ++   V+G GAF++V       T ++ A+K + K  +  K  +  M++
Sbjct: 8   PRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS--MEN 65
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  +L K+ HP IV L   +++   LYL++  V+GG LF ++  +G + E  A     ++
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQV 125
Query: 260 VSAVSHLHANGIMHRDLKPENIL---LDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYM 316
           + AV +LH  GI+HRDLKPEN+L   LD D  +M++DFGL+K  D  +  ++ CGT  Y+
Sbjct: 126 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 185
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +PE++  K + KA D WS+G++ + +L G PPF   N
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 222

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 77/203 (37%), Positives = 122/203 (60%), Gaps = 12/203 (5%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK--DKIMEKNHAEYMKSERNILTKVDH 209
           FEV   +G+GA + VY+ ++ GT + YA+KV++K  DK       + +++E  +L ++ H
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-------KIVRTEIGVLLRLSH 107
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P I++L+  F+T   + LVL+ V GG LF ++  +G + E  A     +I+ AV++LH N
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 270 GIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPEN+L      D  + + DFGL+K  +      ++CGT  Y +PEI+ G  +
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY 227
Query: 327 DKAADWWSVGILLFEMLTGQPPF 349
               D WSVGI+ + +L G  PF
Sbjct: 228 GPEVDMWSVGIITYILLCGFEPF 250

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 77/231 (33%), Positives = 135/231 (58%), Gaps = 10/231 (4%)
Query: 131 GKPTGHIDNLP----SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKD 186
           G P  H+   P      +  +  + ++  +V+G+G+F +V   +   T +  A+KV+ K 
Sbjct: 27  GGPGDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 86
Query: 187 KIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL 246
           ++ +K   E +  E  +L ++DHP I++L   F+ K   YLV +   GG LF ++  +  
Sbjct: 87  QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR 146
Query: 247 FRE-DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDE 302
           F E D ARI   +++S ++++H N I+HRDLKPEN+LL++   D ++ + DFGL+  F+ 
Sbjct: 147 FSEVDAARI-IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 205
Query: 303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           + +     GT  Y++PE++ G  +D+  D WS G++L+ +L+G PPF G N
Sbjct: 206 SKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGAN 255

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 74/227 (32%), Positives = 128/227 (56%), Gaps = 2/227 (0%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ + K +G+G FAKV   R + T    A+K++ K ++   +  +  +  R I+  ++HP
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVR-IMKILNHP 74
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYLV+++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKY 134
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-KA 329
           I+HRDLK EN+LLD D ++ + DFG + +F    + ++ CG+  Y +PE+  GK +D   
Sbjct: 135 IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPE 194
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEA 376
            D WS+G++L+ +++G  PF G N              +P ++S++ 
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDC 241

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 77/231 (33%), Positives = 135/231 (58%), Gaps = 10/231 (4%)
Query: 131 GKPTGHIDNLP----SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKD 186
           G P  H+   P      +  +  + ++  +V+G+G+F +V   +   T +  A+KV+ K 
Sbjct: 26  GGPGDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 85
Query: 187 KIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL 246
           ++ +K   E +  E  +L ++DHP I++L   F+ K   YLV +   GG LF ++  +  
Sbjct: 86  QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR 145
Query: 247 FRE-DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDE 302
           F E D ARI   +++S ++++H N I+HRDLKPEN+LL++   D ++ + DFGL+  F+ 
Sbjct: 146 FSEVDAARI-IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 204
Query: 303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           + +     GT  Y++PE++ G  +D+  D WS G++L+ +L+G PPF G N
Sbjct: 205 SKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGAN 254

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 78/239 (32%), Positives = 133/239 (55%), Gaps = 4/239 (1%)
Query: 146 CVG--LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           C+G  +EDF+V  ++G+G+FA VY+   I T    A+K++ K  + +    + +++E  I
Sbjct: 5   CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSA 262
             ++ HP I++L   F+    +YLVL+  + G +   L  R   F E+ AR +  +I++ 
Sbjct: 65  HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITG 124
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIV 321
           + +LH++GI+HRDL   N+LL  + ++ + DFGLA Q    + +  ++CGT  Y+SPEI 
Sbjct: 125 MLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIA 184
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
               H   +D WS+G + + +L G+PPF                  +P+FLS EA  L+
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLI 243

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 125/202 (61%), Gaps = 6/202 (2%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +V+G+G+F +V   +   T +  A+KV+ K ++ +K   E +  E  +L ++DHP I++L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYTAEIVSAVSHLHANGIMHR 274
              F+ K   YLV +   GG LF ++  +  F E D ARI   +++S ++++H N I+HR
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-IRQVLSGITYMHKNKIVHR 150
Query: 275 DLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAAD 331
           DLKPEN+LL++   D ++ + DFGL+  F+ + +     GT  Y++PE++ G  +D+  D
Sbjct: 151 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCD 209
Query: 332 WWSVGILLFEMLTGQPPFTGGN 353
            WS G++L+ +L+G PPF G N
Sbjct: 210 VWSTGVILYILLSGCPPFNGAN 231

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 125/202 (61%), Gaps = 6/202 (2%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +V+G+G+F +V   +   T +  A+KV+ K ++ +K   E +  E  +L ++DHP I++L
Sbjct: 38  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 97
Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYTAEIVSAVSHLHANGIMHR 274
              F+ K   YLV +   GG LF ++  +  F E D ARI   +++S ++++H N I+HR
Sbjct: 98  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-IRQVLSGITYMHKNKIVHR 156
Query: 275 DLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAAD 331
           DLKPEN+LL++   D ++ + DFGL+  F+ + +     GT  Y++PE++ G  +D+  D
Sbjct: 157 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCD 215
Query: 332 WWSVGILLFEMLTGQPPFTGGN 353
            WS G++L+ +L+G PPF G N
Sbjct: 216 VWSTGVILYILLSGCPPFNGAN 237

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 123/202 (60%), Gaps = 6/202 (2%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +V+G+G+F +V   +   T +  A+KV+ K ++ +K   E +  E  +L ++DHP I +L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKL 91
Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYTAEIVSAVSHLHANGIMHR 274
              F+ K   YLV +   GG LF ++  +  F E D ARI   +++S +++ H N I+HR
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-IRQVLSGITYXHKNKIVHR 150
Query: 275 DLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAAD 331
           DLKPEN+LL++   D ++ + DFGL+  F+ + +     GT  Y++PE++ G  +D+  D
Sbjct: 151 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT-YDEKCD 209
Query: 332 WWSVGILLFEMLTGQPPFTGGN 353
            WS G++L+ +L+G PPF G N
Sbjct: 210 VWSTGVILYILLSGCPPFNGAN 231

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 72/205 (35%), Positives = 121/205 (59%), Gaps = 5/205 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           FE  + +G GAF++V       T +++A+K + K  +  K  +  +++E  +L K+ H  
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESS--IENEIAVLRKIKHEN 81
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV L   +++   LYLV+  V+GG LF ++  +G + E  A     +++ AV +LH  GI
Sbjct: 82  IVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGI 141
Query: 272 MHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           +HRDLKPEN+L    D +  +M++DFGL+K   +    ++ CGT  Y++PE++  K + K
Sbjct: 142 VHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYSK 201
Query: 329 AADWWSVGILLFEMLTGQPPFTGGN 353
           A D WS+G++ + +L G PPF   N
Sbjct: 202 AVDCWSIGVIAYILLCGYPPFYDEN 226

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 124/232 (53%), Gaps = 1/232 (0%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++DFE+ + +G+G F  VY  R   +  I A+KV+ K +I ++     ++ E  I   + 
Sbjct: 22  IDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLH 81
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I++L   F  + R+YL+L++   G L+ +L +   F E        E+  A+ + H 
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHG 141
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             ++HRD+KPEN+LL   G + + DFG +     + R  +MCGTL+Y+ PE++ G+ H++
Sbjct: 142 KKVIHRDIKPENLLLGLKGELKIADFGWSVH-APSLRRKTMCGTLDYLPPEMIEGRMHNE 200
Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
             D W +G+L +E+L G PPF   +               PA + + A  L+
Sbjct: 201 KVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLI 252

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 73/208 (35%), Positives = 127/208 (61%), Gaps = 7/208 (3%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E + ++ ++G+G+F +V + +   T + YA+KV+ K     K+ +  ++ E  +L K+DH
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDH 80
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYTAEIVSAVSHLHA 268
           P I++L    +     Y+V +   GG LF ++ ++  F E D ARI   ++ S ++++H 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-IKQVFSGITYMHK 139
Query: 269 NGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
           + I+HRDLKPENILL++   D  + + DFGL+  F +NT+     GT  Y++PE++ G  
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-T 198
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +D+  D WS G++L+ +L+G PPF G N
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKN 226

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  137 bits (346), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 73/208 (35%), Positives = 127/208 (61%), Gaps = 7/208 (3%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E + ++ ++G+G+F +V + +   T + YA+KV+ K     K+ +  ++ E  +L K+DH
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDH 80
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYTAEIVSAVSHLHA 268
           P I++L    +     Y+V +   GG LF ++ ++  F E D ARI   ++ S ++++H 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-IKQVFSGITYMHK 139
Query: 269 NGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
           + I+HRDLKPENILL++   D  + + DFGL+  F +NT+     GT  Y++PE++ G  
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-T 198
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +D+  D WS G++L+ +L+G PPF G N
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKN 226

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  137 bits (345), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 73/208 (35%), Positives = 127/208 (61%), Gaps = 7/208 (3%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E + ++ ++G+G+F +V + +   T + YA+KV+ K     K+ +  ++ E  +L K+DH
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDH 80
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYTAEIVSAVSHLHA 268
           P I++L    +     Y+V +   GG LF ++ ++  F E D ARI   ++ S ++++H 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-IKQVFSGITYMHK 139
Query: 269 NGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
           + I+HRDLKPENILL++   D  + + DFGL+  F +NT+     GT  Y++PE++ G  
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-T 198
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +D+  D WS G++L+ +L+G PPF G N
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKN 226

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 123/206 (59%), Gaps = 12/206 (5%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNILTKVDHP 210
           K +G GA  +V       T +  A+K++ K K       E + A  +++E  IL K++HP
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV +LH NG
Sbjct: 76  CIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 134
Query: 271 IMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG---K 324
           I+HRDLKPEN+LL   + D  + +TDFG +K   E +   ++CGT  Y++PE+++     
Sbjct: 135 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA 194
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFT 350
           G+++A D WS+G++LF  L+G PPF+
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFS 220

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 72/212 (33%), Positives = 127/212 (59%), Gaps = 12/212 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNIL 204
           +++ + K +G GA  +V       T +  A+K++ K K       E + A  +++E  IL
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            K++HP I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV 
Sbjct: 76  KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 134
Query: 265 HLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +LH NGI+HRDLKPEN+LL   + D  + +TDFG +K   E +   ++CGT  Y++PE++
Sbjct: 135 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 194
Query: 322 LG---KGHDKAADWWSVGILLFEMLTGQPPFT 350
           +     G+++A D WS+G++LF  L+G PPF+
Sbjct: 195 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 226

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 123/206 (59%), Gaps = 12/206 (5%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNILTKVDHP 210
           K +G GA  +V       T +  A+K++ K K       E + A  +++E  IL K++HP
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV +LH NG
Sbjct: 76  CIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 134
Query: 271 IMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG---K 324
           I+HRDLKPEN+LL   + D  + +TDFG +K   E +   ++CGT  Y++PE+++     
Sbjct: 135 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA 194
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFT 350
           G+++A D WS+G++LF  L+G PPF+
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFS 220

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 123/206 (59%), Gaps = 12/206 (5%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNILTKVDHP 210
           K +G GA  +V       T +  A+K++ K K       E + A  +++E  IL K++HP
Sbjct: 15  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 74
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV +LH NG
Sbjct: 75  CIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 133
Query: 271 IMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG---K 324
           I+HRDLKPEN+LL   + D  + +TDFG +K   E +   ++CGT  Y++PE+++     
Sbjct: 134 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA 193
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFT 350
           G+++A D WS+G++LF  L+G PPF+
Sbjct: 194 GYNRAVDCWSLGVILFICLSGYPPFS 219

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 123/206 (59%), Gaps = 12/206 (5%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNILTKVDHP 210
           K +G GA  +V       T +  A+K++ K K       E + A  +++E  IL K++HP
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV +LH NG
Sbjct: 76  CIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 134
Query: 271 IMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG---K 324
           I+HRDLKPEN+LL   + D  + +TDFG +K   E +   ++CGT  Y++PE+++     
Sbjct: 135 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA 194
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFT 350
           G+++A D WS+G++LF  L+G PPF+
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFS 220

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 74/228 (32%), Positives = 123/228 (53%), Gaps = 9/228 (3%)
Query: 131 GKPTGHID--NLPSENQCVGLEDFEVLK------VVGQGAFAKVYQVRRIGTSEIYAMKV 182
            KP+ H+D  + P +     L D   +K       +G+G FAK Y++  + T E++A KV
Sbjct: 15  AKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKV 74
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
           + K  +++ +  E M +E  I   +D+P +V     F+    +Y+VL+      L     
Sbjct: 75  VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHK 134
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD- 301
           R+    E  AR +  + +  V +LH N ++HRDLK  N+ L+ D  V + DFGLA + + 
Sbjct: 135 RRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF 194
Query: 302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           +  R  ++CGT  Y++PE++  KGH    D WS+G +L+ +L G+PPF
Sbjct: 195 DGERKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 74/228 (32%), Positives = 122/228 (53%), Gaps = 9/228 (3%)
Query: 131 GKPTGHID--NLPSENQCVGLEDFEVLK------VVGQGAFAKVYQVRRIGTSEIYAMKV 182
            KP+ H+D  + P +     L D   +K       +G+G FAK Y++  + T E++A KV
Sbjct: 15  AKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKV 74
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
           + K  +++ +  E M +E  I   +D+P +V     F+    +Y+VL+      L     
Sbjct: 75  VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHK 134
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD- 301
           R+    E  AR +  + +  V +LH N ++HRDLK  N+ L+ D  V + DFGLA + + 
Sbjct: 135 RRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF 194
Query: 302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           +  R   +CGT  Y++PE++  KGH    D WS+G +L+ +L G+PPF
Sbjct: 195 DGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 74/228 (32%), Positives = 122/228 (53%), Gaps = 9/228 (3%)
Query: 131 GKPTGHID--NLPSENQCVGLEDFEVLK------VVGQGAFAKVYQVRRIGTSEIYAMKV 182
            KP+ H+D  + P +     L D   +K       +G+G FAK Y++  + T E++A KV
Sbjct: 15  AKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKV 74
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
           + K  +++ +  E M +E  I   +D+P +V     F+    +Y+VL+      L     
Sbjct: 75  VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHK 134
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD- 301
           R+    E  AR +  + +  V +LH N ++HRDLK  N+ L+ D  V + DFGLA + + 
Sbjct: 135 RRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF 194
Query: 302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           +  R   +CGT  Y++PE++  KGH    D WS+G +L+ +L G+PPF
Sbjct: 195 DGERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 123/205 (60%), Gaps = 5/205 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ +K +G GA+ +V   R   T    A+K++RK  +   ++++ ++ E  +L  +DH
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE-EVAVLKLLDH 95
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P I++L   F+ K   YLV++   GG LF ++  +  F E  A +   +++S V++LH +
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 270 GIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
            I+HRDLKPEN+LL++   D  + + DFGL+  F+   +     GT  Y++PE VL K +
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPE-VLRKKY 214
Query: 327 DKAADWWSVGILLFEMLTGQPPFTG 351
           D+  D WS+G++LF +L G PPF G
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPFGG 239

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 123/206 (59%), Gaps = 12/206 (5%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNILTKVDHP 210
           K +G GA  +V       T +  A++++ K K       E + A  +++E  IL K++HP
Sbjct: 155 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 214
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV +LH NG
Sbjct: 215 CIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 273
Query: 271 IMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG---K 324
           I+HRDLKPEN+LL   + D  + +TDFG +K   E +   ++CGT  Y++PE+++     
Sbjct: 274 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA 333
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFT 350
           G+++A D WS+G++LF  L+G PPF+
Sbjct: 334 GYNRAVDCWSLGVILFICLSGYPPFS 359

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 123/206 (59%), Gaps = 12/206 (5%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNILTKVDHP 210
           K +G GA  +V       T +  A++++ K K       E + A  +++E  IL K++HP
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV +LH NG
Sbjct: 201 CIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 259
Query: 271 IMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG---K 324
           I+HRDLKPEN+LL   + D  + +TDFG +K   E +   ++CGT  Y++PE+++     
Sbjct: 260 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA 319
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFT 350
           G+++A D WS+G++LF  L+G PPF+
Sbjct: 320 GYNRAVDCWSLGVILFICLSGYPPFS 345

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 110/195 (56%), Gaps = 1/195 (0%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           + +G+G FAK Y++  + T E++A KV+ K  +++ +  E M +E  I   +D+P +V  
Sbjct: 32  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 91
Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
              F+    +Y+VL+      L     R+    E  AR +  + +  V +LH N ++HRD
Sbjct: 92  HGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRD 151
Query: 276 LKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWS 334
           LK  N+ L+ D  V + DFGLA + + +  R   +CGT  Y++PE++  KGH    D WS
Sbjct: 152 LKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWS 211
Query: 335 VGILLFEMLTGQPPF 349
           +G +L+ +L G+PPF
Sbjct: 212 LGCILYTLLVGKPPF 226

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 122/208 (58%), Gaps = 5/208 (2%)
Query: 148 GLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           GL D ++ +K +G GA+ +V   +   T    A+K+++K  +   +++  +  E  +L +
Sbjct: 18  GLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQ 77
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           +DHP I++L   F+ K   YLV++   GG LF ++  +  F E  A +   +++S  ++L
Sbjct: 78  LDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYL 137
Query: 267 HANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           H + I+HRDLKPEN+LL++   D  + + DFGL+  F+   +     GT  Y++PE VL 
Sbjct: 138 HKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPE-VLR 196
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           K +D+  D WS G++L+ +L G PPF G
Sbjct: 197 KKYDEKCDVWSCGVILYILLCGYPPFGG 224

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 122/208 (58%), Gaps = 5/208 (2%)
Query: 148 GLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           GL D ++ +K +G GA+ +V   +   T    A+K+++K  +   +++  +  E  +L +
Sbjct: 1   GLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQ 60
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           +DHP I++L   F+ K   YLV++   GG LF ++  +  F E  A +   +++S  ++L
Sbjct: 61  LDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYL 120
Query: 267 HANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           H + I+HRDLKPEN+LL++   D  + + DFGL+  F+   +     GT  Y++PE VL 
Sbjct: 121 HKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPE-VLR 179
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           K +D+  D WS G++L+ +L G PPF G
Sbjct: 180 KKYDEKCDVWSCGVILYILLCGYPPFGG 207

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 113/208 (54%), Gaps = 4/208 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E +  L+ +G+G+F K   V+       Y +K +   ++  K   E  + E  +L  + 
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREE-SRREVAVLANMK 81
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHL 266
           HP IVQ R SF+    LY+V+D+  GG LF ++  Q   LF+ED    +  +I  A+ H+
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMC-GTLEYMSPEIVLGKG 325
           H   I+HRD+K +NI L  DG V L DFG+A+  +        C GT  Y+SPEI   K 
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGN 353
           ++  +D W++G +L+E+ T +  F  G+
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGS 229

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  127 bits (320), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 117/204 (57%), Gaps = 5/204 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +++++ + +G+GAF+ V +  +I T + YA K++   K+  ++H + ++ E  I   + H
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDH-QKLEREARICRLLKH 62
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S   +   YLV D V GG LF  +  +  + E  A     +I+ +V+H H N
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN 122
Query: 270 GIMHRDLKPENILLDADGH---VMLTDFGLAKQFDENTRSN-SMCGTLEYMSPEIVLGKG 325
           GI+HRDLKPEN+LL +      V L DFGLA +   + ++     GT  Y+SPE++    
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 326 HDKAADWWSVGILLFEMLTGQPPF 349
           + K  D W+ G++L+ +L G PPF
Sbjct: 183 YGKPVDMWACGVILYILLVGYPPF 206

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 117/204 (57%), Gaps = 5/204 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +++++ + +G+GAF+ V +  +I T + YA K++   K+  ++H + ++ E  I   + H
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQK-LEREARICRLLKH 62
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S   +   YLV D V GG LF  +  +  + E  A     +I+ +V+H H N
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN 122
Query: 270 GIMHRDLKPENILLDADGH---VMLTDFGLAKQFDENTRSN-SMCGTLEYMSPEIVLGKG 325
           GI+HRDLKPEN+LL +      V L DFGLA +   + ++     GT  Y+SPE++    
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 326 HDKAADWWSVGILLFEMLTGQPPF 349
           + K  D W+ G++L+ +L G PPF
Sbjct: 183 YGKPVDMWACGVILYILLVGYPPF 206

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 76/226 (33%), Positives = 119/226 (52%), Gaps = 18/226 (7%)
Query: 140 LPSENQCVGL-EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM--------RKDKIME 190
           LP  +   G  E++E  +++G+G  + V +     T + YA+K++          +++ E
Sbjct: 6   LPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQE 65
Query: 191 KNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE 249
              A     E +IL KV  HP I+QL+ +++T    +LV D +  G LF  L  +    E
Sbjct: 66  LREATL--KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123
Query: 250 DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM 309
              R     ++  +  LH   I+HRDLKPENILLD D ++ LTDFG + Q D   +  S+
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSV 183
Query: 310 CGTLEYMSPEIVLGK------GHDKAADWWSVGILLFEMLTGQPPF 349
           CGT  Y++PEI+         G+ K  D WS G++++ +L G PPF
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 117/203 (57%), Gaps = 4/203 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++++V + +G+GAF+ V +     T   +A K++   K+  ++  + ++ E  I  K+ H
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQH 87
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S Q +   YLV D V GG LF  +  +  + E  A     +I+ ++++ H+N
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 270 GIMHRDLKPENILLDADGH---VMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HR+LKPEN+LL +      V L DFGLA + +++   +   GT  Y+SPE++    +
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 327 DKAADWWSVGILLFEMLTGQPPF 349
            K  D W+ G++L+ +L G PPF
Sbjct: 208 SKPVDIWACGVILYILLVGYPPF 230

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 117/203 (57%), Gaps = 4/203 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++++V + +G+GAF+ V +     T   +A K++   K+  ++  + ++ E  I  K+ H
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQH 64
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S Q +   YLV D V GG LF  +  +  + E  A     +I+ ++++ H+N
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 270 GIMHRDLKPENILLDADGH---VMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HR+LKPEN+LL +      V L DFGLA + +++   +   GT  Y+SPE++    +
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 327 DKAADWWSVGILLFEMLTGQPPF 349
            K  D W+ G++L+ +L G PPF
Sbjct: 185 SKPVDIWACGVILYILLVGYPPF 207

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 117/203 (57%), Gaps = 4/203 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++++V + +G+GAF+ V +     T   +A K++   K+  ++  + ++ E  I  K+ H
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQH 64
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S Q +   YLV D V GG LF  +  +  + E  A     +I+ ++++ H+N
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 270 GIMHRDLKPENILLDADGH---VMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HR+LKPEN+LL +      V L DFGLA + +++   +   GT  Y+SPE++    +
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 327 DKAADWWSVGILLFEMLTGQPPF 349
            K  D W+ G++L+ +L G PPF
Sbjct: 185 SKPVDIWACGVILYILLVGYPPF 207

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 117/203 (57%), Gaps = 4/203 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++++V + +G+GAF+ V +     T   +A K++   K+  ++  + ++ E  I  K+ H
Sbjct: 5   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQH 63
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S Q +   YLV D V GG LF  +  +  + E  A     +I+ ++++ H+N
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 123
Query: 270 GIMHRDLKPENILLDADGH---VMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HR+LKPEN+LL +      V L DFGLA + +++   +   GT  Y+SPE++    +
Sbjct: 124 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 183
Query: 327 DKAADWWSVGILLFEMLTGQPPF 349
            K  D W+ G++L+ +L G PPF
Sbjct: 184 SKPVDIWACGVILYILLVGYPPF 206

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 116/225 (51%), Gaps = 1/225 (0%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G FAK +++    T E++A K++ K  +++ +  E M  E +I   + H  +V    
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
            F+    +++VL+      L     R+    E  AR Y  +IV    +LH N ++HRDLK
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 148
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
             N+ L+ D  V + DFGLA + + +  R  ++CGT  Y++PE++  KGH    D WS+G
Sbjct: 149 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIG 208
Query: 337 ILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
            +++ +L G+PPF                  +P  ++  A SL++
Sbjct: 209 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 253

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 116/225 (51%), Gaps = 1/225 (0%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G FAK +++    T E++A K++ K  +++ +  E M  E +I   + H  +V    
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
            F+    +++VL+      L     R+    E  AR Y  +IV    +LH N ++HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
             N+ L+ D  V + DFGLA + + +  R  ++CGT  Y++PE++  KGH    D WS+G
Sbjct: 145 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIG 204
Query: 337 ILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
            +++ +L G+PPF                  +P  ++  A SL++
Sbjct: 205 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 249

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 116/225 (51%), Gaps = 1/225 (0%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G FAK +++    T E++A K++ K  +++ +  E M  E +I   + H  +V    
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
            F+    +++VL+      L     R+    E  AR Y  +IV    +LH N ++HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
             N+ L+ D  V + DFGLA + + +  R  ++CGT  Y++PE++  KGH    D WS+G
Sbjct: 145 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIG 204
Query: 337 ILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
            +++ +L G+PPF                  +P  ++  A SL++
Sbjct: 205 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 249

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 75/226 (33%), Positives = 118/226 (52%), Gaps = 18/226 (7%)
Query: 140 LPSENQCVGL-EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM--------RKDKIME 190
           LP  +   G  E++E  +++G+G  + V +     T + YA+K++          +++ E
Sbjct: 6   LPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQE 65
Query: 191 KNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE 249
              A     E +IL KV  HP I+QL+ +++T    +LV D +  G LF  L  +    E
Sbjct: 66  LREATL--KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123
Query: 250 DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM 309
              R     ++  +  LH   I+HRDLKPENILLD D ++ LTDFG + Q D   +   +
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV 183
Query: 310 CGTLEYMSPEIVLGK------GHDKAADWWSVGILLFEMLTGQPPF 349
           CGT  Y++PEI+         G+ K  D WS G++++ +L G PPF
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 119/204 (58%), Gaps = 11/204 (5%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQ 214
           K +G+G+F+   +     +++ +A+K++ K   ME N     + E   L   + HP IV+
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEAN----TQKEITALKLCEGHPNIVK 70
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   F  +   +LV++ +NGG LF ++ ++  F E  A     ++VSAVSH+H  G++HR
Sbjct: 71  LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR 130
Query: 275 DLKPENILLDADG---HVMLTDFGLAK-QFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPEN+L   +     + + DFG A+ +  +N    + C TL Y +PE++   G+D++ 
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESC 190
Query: 331 DWWSVGILLFEMLTGQPPFTGGNR 354
           D WS+G++L+ ML+GQ PF   +R
Sbjct: 191 DLWSLGVILYTMLSGQVPFQSHDR 214

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  124 bits (311), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 114/215 (53%), Gaps = 17/215 (7%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM--------RKDKIMEKNHAEYMKSER 201
           E++E  +++G+G  + V +     T + YA+K++          +++ E   A     E 
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATL--KEV 61
Query: 202 NILTKVD-HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           +IL KV  HP I+QL+ +++T    +LV D +  G LF  L  +    E   R     ++
Sbjct: 62  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 121
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
             +  LH   I+HRDLKPENILLD D ++ LTDFG + Q D   +   +CGT  Y++PEI
Sbjct: 122 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 181
Query: 321 VLGK------GHDKAADWWSVGILLFEMLTGQPPF 349
           +         G+ K  D WS G++++ +L G PPF
Sbjct: 182 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 77/221 (34%), Positives = 124/221 (56%), Gaps = 17/221 (7%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK-----------DKIMEKNHAE 195
           +G   F+V K+ G GA+ +V   +        A+KV++K           +K +EK H E
Sbjct: 34  IGESYFKVRKL-GSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92
Query: 196 YMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIY 255
            + +E ++L  +DHP I++L   F+ K   YLV +F  GG LF Q+  +  F E  A   
Sbjct: 93  -IYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI 151
Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADG---HVMLTDFGLAKQFDENTRSNSMCGT 312
             +I+S + +LH + I+HRD+KPENILL+      ++ + DFGL+  F ++ +     GT
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGT 211
Query: 313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
             Y++PE VL K +++  D WS G++++ +L G PPF G N
Sbjct: 212 AYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 115/225 (51%), Gaps = 1/225 (0%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G FAK +++    T E++A K++ K  +++ +  E M  E +I   + H  +V    
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
            F+    +++VL+      L     R+    E  AR Y  +IV    +LH N ++HRDLK
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
             N+ L+ D  V + DFGLA + + +  R   +CGT  Y++PE++  KGH    D WS+G
Sbjct: 169 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 228
Query: 337 ILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
            +++ +L G+PPF                  +P  ++  A SL++
Sbjct: 229 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 273

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 115/225 (51%), Gaps = 1/225 (0%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G FAK +++    T E++A K++ K  +++ +  E M  E +I   + H  +V    
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
            F+    +++VL+      L     R+    E  AR Y  +IV    +LH N ++HRDLK
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 166
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
             N+ L+ D  V + DFGLA + + +  R   +CGT  Y++PE++  KGH    D WS+G
Sbjct: 167 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 226
Query: 337 ILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
            +++ +L G+PPF                  +P  ++  A SL++
Sbjct: 227 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 271

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 115/225 (51%), Gaps = 1/225 (0%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G FAK +++    T E++A K++ K  +++ +  E M  E +I   + H  +V    
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
            F+    +++VL+      L     R+    E  AR Y  +IV    +LH N ++HRDLK
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
             N+ L+ D  V + DFGLA + + +  R   +CGT  Y++PE++  KGH    D WS+G
Sbjct: 143 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 202
Query: 337 ILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
            +++ +L G+PPF                  +P  ++  A SL++
Sbjct: 203 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 247

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 130/245 (53%), Gaps = 5/245 (2%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           +++++K +G+G+F KV       T +  A+K++ K  + + +    ++ E + L  + HP
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I++L    ++K  + +V+++  G  LF  + ++    E  AR +  +I+SAV + H + 
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 127
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-DKA 329
           I+HRDLKPEN+LLD   +V + DFGL+    +     + CG+  Y +PE++ GK +    
Sbjct: 128 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 187
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKG---VNSL 386
            D WS G++L+ ML  + PF   +              LP FLS  A  L+K    VN L
Sbjct: 188 VDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPL 247
Query: 387 LSISV 391
             IS+
Sbjct: 248 NRISI 252

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 130/245 (53%), Gaps = 5/245 (2%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           +++++K +G+G+F KV       T +  A+K++ K  + + +    ++ E + L  + HP
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I++L    ++K  + +V+++  G  LF  + ++    E  AR +  +I+SAV + H + 
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 123
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-DKA 329
           I+HRDLKPEN+LLD   +V + DFGL+    +     + CG+  Y +PE++ GK +    
Sbjct: 124 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 183
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKG---VNSL 386
            D WS G++L+ ML  + PF   +              LP FLS  A  L+K    VN L
Sbjct: 184 VDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPL 243
Query: 387 LSISV 391
             IS+
Sbjct: 244 NRISI 248

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 130/245 (53%), Gaps = 5/245 (2%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           +++++K +G+G+F KV       T +  A+K++ K  + + +    ++ E + L  + HP
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I++L    ++K  + +V+++  G  LF  + ++    E  AR +  +I+SAV + H + 
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 132
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-DKA 329
           I+HRDLKPEN+LLD   +V + DFGL+    +     + CG+  Y +PE++ GK +    
Sbjct: 133 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 192
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKG---VNSL 386
            D WS G++L+ ML  + PF   +              LP FLS  A  L+K    VN L
Sbjct: 193 VDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPL 252
Query: 387 LSISV 391
             IS+
Sbjct: 253 NRISI 257

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 77/223 (34%), Positives = 125/223 (56%), Gaps = 10/223 (4%)
Query: 139 NLPSEN---QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA- 194
           +L +EN   Q +  + +E+ + +G G FA V + R+ GT + YA K ++K ++       
Sbjct: 12  DLGTENLYFQSMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGV 71
Query: 195 --EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLA 252
             E ++ E NIL ++ HP I+ L   F+ K  + L+L+ V+GG LF  L  +    ED A
Sbjct: 72  SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA 131
Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENI-LLDA---DGHVMLTDFGLAKQFDENTRSNS 308
             +  +I+  V +LH+  I H DLKPENI LLD    +  + L DFG+A + +      +
Sbjct: 132 TQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 191
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           + GT E+++PEIV  +     AD WS+G++ + +L+G  PF G
Sbjct: 192 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 234

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 130/245 (53%), Gaps = 5/245 (2%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           +++++K +G+G+F KV       T +  A+K++ K  + + +    ++ E + L  + HP
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I++L    ++K  + +V+++  G  LF  + ++    E  AR +  +I+SAV + H + 
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 133
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-DKA 329
           I+HRDLKPEN+LLD   +V + DFGL+    +     + CG+  Y +PE++ GK +    
Sbjct: 134 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 193
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKG---VNSL 386
            D WS G++L+ ML  + PF   +              LP FLS  A  L+K    VN L
Sbjct: 194 VDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPL 253
Query: 387 LSISV 391
             IS+
Sbjct: 254 NRISI 258

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 73/210 (34%), Positives = 118/210 (56%), Gaps = 7/210 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVD 208
           +E+ + +G G FA V + R+ GT + YA K ++K ++         E ++ E NIL ++ 
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I+ L   F+ K  + L+L+ V+GG LF  L  +    ED A  +  +I+  V +LH+
Sbjct: 74  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 133
Query: 269 NGIMHRDLKPENI-LLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGK 324
             I H DLKPENI LLD    +  + L DFG+A + +      ++ GT E+++PEIV  +
Sbjct: 134 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 193
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNR 354
                AD WS+G++ + +L+G  PF G  +
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGETK 223

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 73/210 (34%), Positives = 118/210 (56%), Gaps = 7/210 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVD 208
           +E+ + +G G FA V + R+ GT + YA K ++K ++         E ++ E NIL ++ 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I+ L   F+ K  + L+L+ V+GG LF  L  +    ED A  +  +I+  V +LH+
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 269 NGIMHRDLKPENI-LLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGK 324
             I H DLKPENI LLD    +  + L DFG+A + +      ++ GT E+++PEIV  +
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 186
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNR 354
                AD WS+G++ + +L+G  PF G  +
Sbjct: 187 PLGLEADMWSIGVITYILLSGASPFLGETK 216

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  121 bits (303), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 71/205 (34%), Positives = 108/205 (52%), Gaps = 12/205 (5%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVM-----RKDKIMEKNHAEYMKSERNILTKV-DHP 210
           V+G+G  + V +     T   +A+K+M     R      +   E  + E +IL +V  HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I+ L  S+++   ++LV D +  G LF  L  +    E   R     ++ AVS LHAN 
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN 220
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGK------ 324
           I+HRDLKPENILLD +  + L+DFG +   +   +   +CGT  Y++PEI+         
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHP 280
Query: 325 GHDKAADWWSVGILLFEMLTGQPPF 349
           G+ K  D W+ G++LF +L G PPF
Sbjct: 281 GYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 115/201 (57%), Gaps = 7/201 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E++K +G G F     +R   ++E+ A+K + + + +++N    + + R++     HP 
Sbjct: 20  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSL----RHPN 75
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+ +    T   L +V+++ +GG LF ++   G F ED AR +  +++S VS+ HA  +
Sbjct: 76  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 135
Query: 272 MHRDLKPENILLDAD--GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-K 328
            HRDLK EN LLD      + + DFG +K    +++  S  GT  Y++PE++L K +D K
Sbjct: 136 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 195
Query: 329 AADWWSVGILLFEMLTGQPPF 349
            AD WS G+ L+ ML G  PF
Sbjct: 196 VADVWSCGVTLYVMLVGAYPF 216

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 111/202 (54%), Gaps = 5/202 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +++ + +G+GAF+ V +  ++   + YA K++   K+  ++H + ++ E  I   + HP 
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQK-LEREARICRLLKHPN 82
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+L  S   +   YL+ D V GG LF  +  +  + E  A     +I+ AV H H  G+
Sbjct: 83  IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 142
Query: 272 MHRDLKPENILLDAD---GHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +HRDLKPEN+LL +      V L DFGLA + + E        GT  Y+SPE++    + 
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYG 202
Query: 328 KAADWWSVGILLFEMLTGQPPF 349
           K  D W+ G++L+ +L G PPF
Sbjct: 203 KPVDLWACGVILYILLVGYPPF 224

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 114/204 (55%), Gaps = 5/204 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D+++ + +G+GAF+ V +  +   ++ YA K++   K+  ++H + ++ E  I   + H
Sbjct: 31  DDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQK-LEREARICRLLKH 89
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S   +   YLV D V GG LF  +  +  + E  A     +I+ +V+H+H +
Sbjct: 90  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQH 149
Query: 270 GIMHRDLKPENILLDAD---GHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKG 325
            I+HRDLKPEN+LL +      V L DFGLA +   E        GT  Y+SPE++    
Sbjct: 150 DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDP 209
Query: 326 HDKAADWWSVGILLFEMLTGQPPF 349
           + K  D W+ G++L+ +L G PPF
Sbjct: 210 YGKPVDIWACGVILYILLVGYPPF 233

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/209 (37%), Positives = 117/209 (55%), Gaps = 15/209 (7%)
Query: 150 EDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           EDF E++  +G GAF KVY+ +   TS + A KV+  D   E+   +YM  E +IL   D
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELEDYM-VEIDILASCD 92
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL---FFQLYRQGLFREDLARIYTAEIVSAVSH 265
           HP IV+L  +F  +  L+++++F  GG +     +L R     E   ++   + + A+++
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNY 150
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGL-AKQFDENTRSNSMCGTLEYMSPEIVL-- 322
           LH N I+HRDLK  NIL   DG + L DFG+ AK      R +S  GT  +M+PE+V+  
Sbjct: 151 LHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 210
Query: 323 ---GKGHDKAADWWSVGILLFEMLTGQPP 348
               + +D  AD WS+GI L EM   +PP
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/209 (37%), Positives = 117/209 (55%), Gaps = 15/209 (7%)
Query: 150 EDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           EDF E++  +G GAF KVY+ +   TS + A KV+  D   E+   +YM  E +IL   D
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELEDYM-VEIDILASCD 92
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL---FFQLYRQGLFREDLARIYTAEIVSAVSH 265
           HP IV+L  +F  +  L+++++F  GG +     +L R     E   ++   + + A+++
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNY 150
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGL-AKQFDENTRSNSMCGTLEYMSPEIVL-- 322
           LH N I+HRDLK  NIL   DG + L DFG+ AK      R +S  GT  +M+PE+V+  
Sbjct: 151 LHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCE 210
Query: 323 ---GKGHDKAADWWSVGILLFEMLTGQPP 348
               + +D  AD WS+GI L EM   +PP
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 113/201 (56%), Gaps = 7/201 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E++K +G G F     +R   ++E+ A+K + + + +  N    + + R++     HP 
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSL----RHPN 76
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+ +    T   L +V+++ +GG LF ++   G F ED AR +  +++S VS+ HA  +
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 272 MHRDLKPENILLDAD--GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-K 328
            HRDLK EN LLD      + + DFG +K    +++  S  GT  Y++PE++L K +D K
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196
Query: 329 AADWWSVGILLFEMLTGQPPF 349
            AD WS G+ L+ ML G  PF
Sbjct: 197 VADVWSCGVTLYVMLVGAYPF 217

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 119/210 (56%), Gaps = 10/210 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN--HAEYMKSERNILTKVDH 209
           +E+ +V+G+GAF+ V +     T + +A+K++   K         E +K E +I   + H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVSH 265
           P IV+L  ++ +   LY+V +F++G  L F++ ++     ++ E +A  Y  +I+ A+ +
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 266 LHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDEN-TRSNSMCGTLEYMSPEIV 321
            H N I+HRD+KPEN+LL   +    V L DFG+A Q  E+   +    GT  +M+PE+V
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
             + + K  D W  G++LF +L+G  PF G
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLPFYG 235

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 114/204 (55%), Gaps = 5/204 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +++++ + +G+GAF+ V +  ++ T   YA K++   K+  ++H + ++ E  I   + H
Sbjct: 4   DEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQK-LEREARICRLLKH 62
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
             IV+L  S   +   YLV D V GG LF  +  +  + E  A     +I+ AV H H  
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 122
Query: 270 GIMHRDLKPENILLDAD---GHVMLTDFGLAKQFDENTRSN-SMCGTLEYMSPEIVLGKG 325
           G++HRDLKPEN+LL +      V L DFGLA +   + ++     GT  Y+SPE++  + 
Sbjct: 123 GVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEA 182
Query: 326 HDKAADWWSVGILLFEMLTGQPPF 349
           + K  D W+ G++L+ +L G PPF
Sbjct: 183 YGKPVDIWACGVILYILLVGYPPF 206

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 114/201 (56%), Gaps = 7/201 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E++K +G G F     +R    +E+ A+K + + + +++N    + + R++     HP 
Sbjct: 21  YELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSL----RHPN 76
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+ +    T   L +V+++ +GG LF ++   G F ED AR +  +++S VS+ HA  +
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQV 136
Query: 272 MHRDLKPENILLDAD--GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-K 328
            HRDLK EN LLD      + + DFG +K    +++  S  GT  Y++PE++L K +D K
Sbjct: 137 AHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGK 196
Query: 329 AADWWSVGILLFEMLTGQPPF 349
            AD WS G+ L+ ML G  PF
Sbjct: 197 VADVWSCGVTLYVMLVGAYPF 217

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 110/206 (53%), Gaps = 11/206 (5%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +EV + +G G+++   +     T+  +A+K++ K K       E +      L    HP 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEIL------LRYGQHPN 77
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           I+ L+  +     +Y+V + + GG L  ++ RQ  F E  A      I   V +LHA G+
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 272 MHRDLKPENIL-LDADGH---VMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGH 326
           +HRDLKP NIL +D  G+   + + DFG AKQ   EN    + C T  +++PE++  +G+
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY 197
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGG 352
           D A D WS+G+LL+ MLTG  PF  G
Sbjct: 198 DAACDIWSLGVLLYTMLTGYTPFANG 223

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           + V + +G G++++  +     T+  YA+KV+ K K       E +      L    HP 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEIL------LRYGQHPN 82
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           I+ L+  +     +YLV + + GG L  ++ RQ  F E  A      I   V +LH+ G+
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGV 142
Query: 272 MHRDLKPENIL-LDADGH---VMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGH 326
           +HRDLKP NIL +D  G+   + + DFG AKQ   EN    + C T  +++PE++  +G+
Sbjct: 143 VHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGY 202
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGG 352
           D+  D WS+GILL+ ML G  PF  G
Sbjct: 203 DEGCDIWSLGILLYTMLAGYTPFANG 228

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 112/204 (54%), Gaps = 5/204 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E++++ + +G+GAF+ V +  ++   + YA  ++   K+  ++H + ++ E  I   + H
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK-LEREARICRLLKH 69
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S   +   YL+ D V GG LF  +  +  + E  A     +I+ AV H H  
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 270 GIMHRDLKPENILLDAD---GHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKG 325
           G++HR+LKPEN+LL +      V L DFGLA + + E        GT  Y+SPE++    
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189
Query: 326 HDKAADWWSVGILLFEMLTGQPPF 349
           + K  D W+ G++L+ +L G PPF
Sbjct: 190 YGKPVDLWACGVILYILLVGYPPF 213

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           + V + +G G++++  +     T+  YA+KV+ K K       E +      L    HP 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEIL------LRYGQHPN 82
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           I+ L+  +     +YLV + + GG L  ++ RQ  F E  A      I   V +LH+ G+
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGV 142
Query: 272 MHRDLKPENIL-LDADGH---VMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGH 326
           +HRDLKP NIL +D  G+   + + DFG AKQ   EN    + C T  +++PE++  +G+
Sbjct: 143 VHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGY 202
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGG 352
           D+  D WS+GILL+ ML G  PF  G
Sbjct: 203 DEGCDIWSLGILLYTMLAGYTPFANG 228

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 77/209 (36%), Positives = 116/209 (55%), Gaps = 15/209 (7%)
Query: 150 EDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           EDF E++  +G GAF KVY+ +   TS + A KV+  D   E+   +YM  E +IL   D
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELEDYM-VEIDILASCD 92
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL---FFQLYRQGLFREDLARIYTAEIVSAVSH 265
           HP IV+L  +F  +  L+++++F  GG +     +L R     E   ++   + + A+++
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNY 150
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGL-AKQFDENTRSNSMCGTLEYMSPEIVL-- 322
           LH N I+HRDLK  NIL   DG + L DFG+ AK      R +   GT  +M+PE+V+  
Sbjct: 151 LHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCE 210
Query: 323 ---GKGHDKAADWWSVGILLFEMLTGQPP 348
               + +D  AD WS+GI L EM   +PP
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 114/201 (56%), Gaps = 7/201 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E++K +G G F     +R   ++E+ A+K + + + +++N    + + R++     HP 
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSL----RHPN 76
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+ +    T   L +V+++ +GG LF ++   G F ED AR +  +++S VS+ HA  +
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 272 MHRDLKPENILLDAD--GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-K 328
            HRDLK EN LLD      + +  FG +K    +++  S  GT  Y++PE++L K +D K
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196
Query: 329 AADWWSVGILLFEMLTGQPPF 349
            AD WS G+ L+ ML G  PF
Sbjct: 197 VADVWSCGVTLYVMLVGAYPF 217

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 108/206 (52%), Gaps = 11/206 (5%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +EV + +G G+++   +     T+  +A+K++ K K       E +      L    HP 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEIL------LRYGQHPN 77
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           I+ L+  +     +Y+V +   GG L  ++ RQ  F E  A      I   V +LHA G+
Sbjct: 78  IITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 272 MHRDLKPENIL-LDADGH---VMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGH 326
           +HRDLKP NIL +D  G+   + + DFG AKQ   EN    + C T  +++PE++  +G+
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLERQGY 197
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGG 352
           D A D WS+G+LL+  LTG  PF  G
Sbjct: 198 DAACDIWSLGVLLYTXLTGYTPFANG 223

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 72/231 (31%), Positives = 119/231 (51%), Gaps = 6/231 (2%)
Query: 154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI--LTKVDHPF 211
           + + +G+G+F KV       T +  A+K + +   + K    +M+ ER I  L  + HP 
Sbjct: 13  IRETLGEGSFGKVKLATHYKTQQKVALKFISRQ--LLKKSDMHMRVEREISYLKLLRHPH 70
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           I++L     T   + +V+++  GG LF  +  +    ED  R +  +I+ A+ + H + I
Sbjct: 71  IIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKI 129
Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-DKAA 330
           +HRDLKPEN+LLD + +V + DFGL+    +     + CG+  Y +PE++ GK +     
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEV 189
Query: 331 DWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
           D WS GI+L+ ML G+ PF                  +P FLS  A SL++
Sbjct: 190 DVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIR 240

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 73/214 (34%), Positives = 120/214 (56%), Gaps = 8/214 (3%)
Query: 149 LEDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNIL 204
           +EDF ++ + +G G FA V + R   T   YA K ++K +          E ++ E +IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            +V HP I+ L   ++ +  + L+L+ V+GG LF  L ++    E+ A  +  +I+  V+
Sbjct: 70  RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 265 HLHANGIMHRDLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
           +LH   I H DLKPENI LLD +    H+ L DFGLA + ++     ++ GT E+++PEI
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR 354
           V  +     AD WS+G++ + +L+G  PF G  +
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 113/201 (56%), Gaps = 7/201 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E++K +G G F     +R   ++E+ A+K + + + +++N    + + R++     HP 
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLR----HPN 76
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+ +    T   L +V+++ +GG LF ++   G F ED AR +  +++S VS+ HA  +
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 272 MHRDLKPENILLDAD--GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-K 328
            HRDLK EN LLD      + +  FG +K    +++     GT  Y++PE++L K +D K
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGK 196
Query: 329 AADWWSVGILLFEMLTGQPPF 349
            AD WS G+ L+ ML G  PF
Sbjct: 197 VADVWSCGVTLYVMLVGAYPF 217

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 112/224 (50%), Gaps = 1/224 (0%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F KV       T    A+K++ + KI   +    +K E   L    HP I++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
              T    ++V+++V+GG LF  + + G   E  AR    +I+SAV + H + ++HRDLK
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK 138
Query: 278 PENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSVG 336
           PEN+LLDA  +  + DFGL+    +     + CG+  Y +PE++ G+ +     D WS G
Sbjct: 139 PENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCG 198
Query: 337 ILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           ++L+ +L G  PF   +              +P +L+    +LL
Sbjct: 199 VILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLL 242

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 111/224 (49%), Gaps = 1/224 (0%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F KV       T    A+K++ + KI   +    +K E   L    HP I++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
              T    ++V+++V+GG LF  + + G   E  AR    +I+SAV + H + ++HRDLK
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK 138
Query: 278 PENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSVG 336
           PEN+LLDA  +  + DFGL+    +       CG+  Y +PE++ G+ +     D WS G
Sbjct: 139 PENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCG 198
Query: 337 ILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           ++L+ +L G  PF   +              +P +L+    +LL
Sbjct: 199 VILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLL 242

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + ++    E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 115/215 (53%), Gaps = 20/215 (9%)
Query: 144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAE---YMKSE 200
           NQ   LE+      +G+G++ +V    + GT      ++ R  K + K   E     K E
Sbjct: 8   NQYYTLEN-----TIGRGSWGEVKIAVQKGT------RIRRAAKKIPKYFVEDVDRFKQE 56
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYTAEI 259
             I+  +DHP I++L  +F+    +YLV++   GG LF ++  + +FRE D ARI   ++
Sbjct: 57  IEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-MKDV 115
Query: 260 VSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYM 316
           +SAV++ H   + HRDLKPEN L      D  + L DFGLA +F       +  GT  Y+
Sbjct: 116 LSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYV 175
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           SP+++ G  +    D WS G++++ +L G PPF+ 
Sbjct: 176 SPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSA 209

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + ++    E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 115/215 (53%), Gaps = 20/215 (9%)
Query: 144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAE---YMKSE 200
           NQ   LE+      +G+G++ +V    + GT      ++ R  K + K   E     K E
Sbjct: 25  NQYYTLEN-----TIGRGSWGEVKIAVQKGT------RIRRAAKKIPKYFVEDVDRFKQE 73
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYTAEI 259
             I+  +DHP I++L  +F+    +YLV++   GG LF ++  + +FRE D ARI   ++
Sbjct: 74  IEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-MKDV 132
Query: 260 VSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYM 316
           +SAV++ H   + HRDLKPEN L      D  + L DFGLA +F       +  GT  Y+
Sbjct: 133 LSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYV 192
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           SP+++ G  +    D WS G++++ +L G PPF+ 
Sbjct: 193 SPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSA 226

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 118/209 (56%), Gaps = 7/209 (3%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-KNHAEYMKSERNILTKV 207
           L +F + K +G+G F++VY+   +      A+K ++   +M+ K  A+ +K E ++L ++
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQL 89
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY----RQGLFREDLARIYTAEIVSAV 263
           +HP +++   SF     L +VL+  + G L   +     ++ L  E     Y  ++ SA+
Sbjct: 90  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVL 322
            H+H+  +MHRD+KP N+ + A G V L D GL + F  + T ++S+ GT  YMSPE + 
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTG 351
             G++  +D WS+G LL+EM   Q PF G
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYG 238

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 108/197 (54%), Gaps = 5/197 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   VY    + T +  A++ M    + ++   E + +E  ++ +  +P IV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRDIK 143
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            +NILL  DG V LTDFG   Q   E ++ ++M GT  +M+PE+V  K +    D WS+G
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203
Query: 337 ILLFEMLTGQPPFTGGN 353
           I+  EM+ G+PP+   N
Sbjct: 204 IMAIEMIEGEPPYLNEN 220

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 112/201 (55%), Gaps = 7/201 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           ++ +K +G G F     +R   T E+ A+K + +   +++N    + + R++     HP 
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL----RHPN 77
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+ +    T   L +++++ +GG L+ ++   G F ED AR +  +++S VS+ H+  I
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQI 137
Query: 272 MHRDLKPENILLDAD--GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-K 328
            HRDLK EN LLD      + + DFG +K    +++  S  GT  Y++PE++L + +D K
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGK 197
Query: 329 AADWWSVGILLFEMLTGQPPF 349
            AD WS G+ L+ ML G  PF
Sbjct: 198 IADVWSCGVTLYVMLVGAYPF 218

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 112/226 (49%), Gaps = 1/226 (0%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLR 216
            +G G F KV   +   T    A+K++ + KI   +    ++ E   L    HP I++L 
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 217 YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
               T   +++V+++V+GG LF  + + G   E  +R    +I+S V + H + ++HRDL
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDL 142
Query: 277 KPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSV 335
           KPEN+LLDA  +  + DFGL+    +       CG+  Y +PE++ G+ +     D WS 
Sbjct: 143 KPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSS 202
Query: 336 GILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
           G++L+ +L G  PF   +               P +L+    SLLK
Sbjct: 203 GVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLK 248

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 107/197 (54%), Gaps = 5/197 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   VY    + T +  A++ M    + ++   E + +E  ++ +  +P IV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRDIK 143
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            +NILL  DG V LTDFG   Q   E ++ + M GT  +M+PE+V  K +    D WS+G
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203
Query: 337 ILLFEMLTGQPPFTGGN 353
           I+  EM+ G+PP+   N
Sbjct: 204 IMAIEMIEGEPPYLNEN 220

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 120/207 (57%), Gaps = 4/207 (1%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           G+E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L ++
Sbjct: 1   GMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           +HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-K 324
           H++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG K
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTG 351
            +  A D WS+G +  EM+T +  F G
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 107/197 (54%), Gaps = 5/197 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   VY    + T +  A++ M    + ++   E + +E  ++ +  +P IV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRDIK 143
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            +NILL  DG V LTDFG   Q   E ++ + M GT  +M+PE+V  K +    D WS+G
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203
Query: 337 ILLFEMLTGQPPFTGGN 353
           I+  EM+ G+PP+   N
Sbjct: 204 IMAIEMIEGEPPYLNEN 220

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 61
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPW 206

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINAMLN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 107/197 (54%), Gaps = 5/197 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   VY    + T +  A++ M    + ++   E + +E  ++ +  +P IV    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 85
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRDIK 144
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            +NILL  DG V LTDFG   Q   E ++ + M GT  +M+PE+V  K +    D WS+G
Sbjct: 145 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLG 204
Query: 337 ILLFEMLTGQPPFTGGN 353
           I+  EM+ G+PP+   N
Sbjct: 205 IMAIEMIEGEPPYLNEN 221

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 116/208 (55%), Gaps = 8/208 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ +++G G  ++V+  R +      A+KV+R D   + +     + E      ++HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 212 IVQLRYSFQTKYRL----YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           IV +  + + +       Y+V+++V+G  L   ++ +G      A    A+   A++  H
Sbjct: 74  IVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGTLEYMSPEIVLG 323
            NGI+HRD+KP NI++ A   V + DFG+A+   ++    T++ ++ GT +Y+SPE   G
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              D  +D +S+G +L+E+LTG+PPFTG
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 116/208 (55%), Gaps = 8/208 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ +++G G  ++V+  R +      A+KV+R D   + +     + E      ++HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 212 IVQLRYSFQTKYRL----YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           IV +  + + +       Y+V+++V+G  L   ++ +G      A    A+   A++  H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGTLEYMSPEIVLG 323
            NGI+HRD+KP NI++ A   V + DFG+A+   ++    T++ ++ GT +Y+SPE   G
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              D  +D +S+G +L+E+LTG+PPFTG
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 116/208 (55%), Gaps = 8/208 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ +++G G  ++V+  R +      A+KV+R D   + +     + E      ++HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 212 IVQLRYSFQTKYRL----YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           IV +  + + +       Y+V+++V+G  L   ++ +G      A    A+   A++  H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGTLEYMSPEIVLG 323
            NGI+HRD+KP NI++ A   V + DFG+A+   ++    T++ ++ GT +Y+SPE   G
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              D  +D +S+G +L+E+LTG+PPFTG
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 116/208 (55%), Gaps = 8/208 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ +++G G  ++V+  R +      A+KV+R D   + +     + E      ++HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 212 IVQLRYSFQTKYRL----YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           IV +  + + +       Y+V+++V+G  L   ++ +G      A    A+   A++  H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGTLEYMSPEIVLG 323
            NGI+HRD+KP NI++ A   V + DFG+A+   ++    T++ ++ GT +Y+SPE   G
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              D  +D +S+G +L+E+LTG+PPFTG
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 120/208 (57%), Gaps = 4/208 (1%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKE 62
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           ++HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++ 
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG- 323
            H++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG 
Sbjct: 123 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 182
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           K +  A D WS+G +  EM+T +  F G
Sbjct: 183 KYYSTAVDIWSLGCIFAEMVTRRALFPG 210

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 119/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  +S  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG K 
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 108/197 (54%), Gaps = 5/197 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   VY    + T +  A++ M    + ++   E + +E  ++ +  +P IV    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 85
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HR++K
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRNIK 144
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            +NILL  DG V LTDFG   Q   E ++ ++M GT  +M+PE+V  K +    D WS+G
Sbjct: 145 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 204
Query: 337 ILLFEMLTGQPPFTGGN 353
           I+  EM+ G+PP+   N
Sbjct: 205 IMAIEMIEGEPPYLNEN 221

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 115/208 (55%), Gaps = 8/208 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ +++G G  ++V+  R +      A+KV+R D   + +     + E      ++HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 212 IVQLRYSFQTKYRL----YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           IV +  + + +       Y+V+++V+G  L   ++ +G      A    A+   A++  H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGTLEYMSPEIVLG 323
            NGI+HRD+KP NIL+ A   V + DFG+A+   ++     ++ ++ GT +Y+SPE   G
Sbjct: 134 QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARG 193
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              D  +D +S+G +L+E+LTG+PPFTG
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 74/222 (33%), Positives = 122/222 (54%), Gaps = 10/222 (4%)
Query: 141 PSENQCVGLEDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EY 196
           P + Q V  EDF ++ + +G G FA V + R   T   YA K ++K +          E 
Sbjct: 4   PFKQQKV--EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 197 MKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYT 256
           ++ E +IL +V H  ++ L   ++ +  + L+L+ V+GG LF  L ++    E+ A  + 
Sbjct: 62  IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 257 AEIVSAVSHLHANGIMHRDLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGT 312
            +I+  V++LH   I H DLKPENI LLD +    H+ L DFGLA + ++     ++ GT
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR 354
            E+++PEIV  +     AD WS+G++ + +L+G  PF G  +
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKPEN+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 123 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 182
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPG 208

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 61
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKPEN+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 122 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPG 207

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKPEN+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 124 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPG 209

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 116/208 (55%), Gaps = 8/208 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ +++G G  ++V+  R +      A+KV+R D   + +     + E      ++HP 
Sbjct: 31  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 90
Query: 212 IVQLRYSFQTKYRL----YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           IV +  + + +       Y+V+++V+G  L   ++ +G      A    A+   A++  H
Sbjct: 91  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 150
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGTLEYMSPEIVLG 323
            NGI+HRD+KP NI++ A   V + DFG+A+   ++    T++ ++ GT +Y+SPE   G
Sbjct: 151 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 210
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              D  +D +S+G +L+E+LTG+PPFTG
Sbjct: 211 DSVDARSDVYSLGCVLYEVLTGEPPFTG 238

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 61
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKPEN+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 122 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPG 207

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 119/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 67
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG K 
Sbjct: 128 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 187
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRRALFPG 213

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 119/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 67
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG K 
Sbjct: 128 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKY 187
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRRALFPG 213

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 116/205 (56%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA  +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 119/214 (55%), Gaps = 8/214 (3%)
Query: 149 LEDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNIL 204
           +EDF ++ + +G G FA V + R   T   YA K ++K +          E ++ E +IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            +V H  ++ L   ++ +  + L+L+ V+GG LF  L ++    E+ A  +  +I+  V+
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 265 HLHANGIMHRDLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
           +LH   I H DLKPENI LLD +    H+ L DFGLA + ++     ++ GT E+++PEI
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR 354
           V  +     AD WS+G++ + +L+G  PF G  +
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 116/201 (57%), Gaps = 6/201 (2%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +++G G F +V++     T    A K+++   + +K   E +K+E +++ ++DH  ++QL
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHANLIQL 151
Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI-YTAEIVSAVSHLHANGIMHR 274
             +F++K  + LV+++V+GG LF ++  +     +L  I +  +I   + H+H   I+H 
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHL 211
Query: 275 DLKPENIL-LDADG-HVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADW 332
           DLKPENIL ++ D   + + DFGLA+++    +     GT E+++PE+V         D 
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDM 271
Query: 333 WSVGILLFEMLTGQPPFTGGN 353
           WSVG++ + +L+G  PF G N
Sbjct: 272 WSVGVIAYMLLSGLSPFLGDN 292

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 119/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 61
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG K 
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 181
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPG 207

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 119/214 (55%), Gaps = 8/214 (3%)
Query: 149 LEDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNIL 204
           +EDF ++ + +G G FA V + R   T   YA K ++K +          E ++ E +IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            +V H  ++ L   ++ +  + L+L+ V+GG LF  L ++    E+ A  +  +I+  V+
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 265 HLHANGIMHRDLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
           +LH   I H DLKPENI LLD +    H+ L DFGLA + ++     ++ GT E+++PEI
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR 354
           V  +     AD WS+G++ + +L+G  PF G  +
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPG 209

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 116/215 (53%), Gaps = 15/215 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED+EVL  +G G++ +  ++RR    +I   K +    + E    + + SE N+L ++ H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKH 64
Query: 210 PFIVQL--RYSFQTKYRLYLVLDFVNGGHLFFQLY-----RQGLFREDLARIYTAEIVSA 262
           P IV+   R   +T   LY+V+++  GG L   +      RQ L  E + R+ T ++  A
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT-QLTLA 123
Query: 263 VSHLH-----ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNSMCGTLEYM 316
           +   H      + ++HRDLKP N+ LD   +V L DFGLA+  + +T  + +  GT  YM
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           SPE +    +++ +D WS+G LL+E+    PPFT 
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 119/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG K 
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 119/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG K 
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPG 205

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 115/216 (53%), Gaps = 5/216 (2%)
Query: 135 GHIDNLPSENQCVGLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNH 193
            H+    +++  V  E+ F  L  +G+G+F +VY+     T E+ A+K++  D    ++ 
Sbjct: 3   AHLRGFANQHSRVDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKII--DLEEAEDE 60
Query: 194 AEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
            E ++ E  +L++ D P+I +   S+    +L+++++++ GG     L + G   E    
Sbjct: 61  IEDIQQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSAL-DLLKPGPLEETYIA 119
Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGT 312
               EI+  + +LH+   +HRD+K  N+LL   G V L DFG+A Q  D   + N   GT
Sbjct: 120 TILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGT 179
Query: 313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPP 348
             +M+PE++    +D  AD WS+GI   E+  G+PP
Sbjct: 180 PFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 215

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 114/208 (54%), Gaps = 10/208 (4%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDK-IMEKNHAEYMKS-ERNI--LT 205
           E ++++  +G G  + VY    +    I  +KV  K   I  +   E +K  ER +   +
Sbjct: 11  ERYKIVDKLGGGGMSTVY----LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSS 66
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           ++ H  IV +    +     YLV++++ G  L   +   G    D A  +T +I+  + H
Sbjct: 67  QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKH 126
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLG 323
            H   I+HRD+KP+NIL+D++  + + DFG+AK   E   T++N + GT++Y SPE   G
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           +  D+  D +S+GI+L+EML G+PPF G
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPFNG 214

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 116/215 (53%), Gaps = 15/215 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED+EVL  +G G++ +  ++RR    +I   K +    + E    + + SE N+L ++ H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKH 64
Query: 210 PFIVQL--RYSFQTKYRLYLVLDFVNGGHLFFQLY-----RQGLFREDLARIYTAEIVSA 262
           P IV+   R   +T   LY+V+++  GG L   +      RQ L  E + R+ T ++  A
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT-QLTLA 123
Query: 263 VSHLH-----ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNSMCGTLEYM 316
           +   H      + ++HRDLKP N+ LD   +V L DFGLA+  + +T  + +  GT  YM
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYM 183
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           SPE +    +++ +D WS+G LL+E+    PPFT 
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 110/214 (51%), Gaps = 19/214 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           FE++++VG G + +VY+ R + T ++ A+KVM     +  +  E +K E N+L K  H  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 81
Query: 212 IVQLRYSFQTKY-------RLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            +   Y    K        +L+LV++F   G +    +  +    +E+       EI+  
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSMCGTLEYMSPEIV 321
           +SHLH + ++HRD+K +N+LL  +  V L DFG++ Q D    R N+  GT  +M+PE++
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201
Query: 322 L-----GKGHDKAADWWSVGILLFEMLTGQPPFT 350
                    +D  +D WS+GI   EM  G PP  
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 119/214 (55%), Gaps = 8/214 (3%)
Query: 149 LEDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNIL 204
           +EDF ++ + +G G FA V + R   T   YA K ++K +          E ++ E +IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            +V H  ++ L   ++ +  + L+L+ V+GG LF  L ++    E+ A  +  +I+  V+
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 265 HLHANGIMHRDLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
           +LH   I H DLKPENI LLD +    H+ L DFGLA + ++     ++ GT E+++PEI
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR 354
           V  +     AD WS+G++ + +L+G  PF G  +
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 118/207 (57%), Gaps = 4/207 (1%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           +HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-K 324
           H++ ++HRDLKPEN+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K
Sbjct: 120 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTG 351
            +  A D WS+G +  EM+T +  F G
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 119/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG K 
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKY 180
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 119/214 (55%), Gaps = 8/214 (3%)
Query: 149 LEDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNIL 204
           +EDF ++ + +G G FA V + R   T   YA K ++K +          E ++ E +IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            +V H  ++ L   ++ +  + L+L+ V+GG LF  L ++    E+ A  +  +I+  V+
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 265 HLHANGIMHRDLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
           +LH   I H DLKPENI LLD +    H+ L DFGLA + ++     ++ GT E+++PEI
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR 354
           V  +     AD WS+G++ + +L+G  PF G  +
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 115/209 (55%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 64  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 116
Query: 216 RYSF----QTKYRLYL--VLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F    + K  +YL  VLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 117 RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 174
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 175 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 234
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 235 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 263

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 64
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 125 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 184
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 185 YSTAVDIWSLGCIFAEMVTRRALFPG 210

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 182
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPG 208

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/246 (33%), Positives = 128/246 (52%), Gaps = 29/246 (11%)
Query: 119 GPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIY 178
           G  +LS V   +  P G   + P E   V   D    KV+G G+F  VYQ +   + E+ 
Sbjct: 1   GAMSLSKVTTVVATP-GQGPDRPQE---VSYTD---TKVIGNGSFGVVYQAKLCDSGELV 53
Query: 179 AMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSF----QTKYRLYL--VLDFV 232
           A+K + +DK        +   E  I+ K+DH  IV+LRY F    + K  +YL  VLD+V
Sbjct: 54  AIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 106
Query: 233 NGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG 287
                 +++ R     ++ L     ++Y  ++  +++++H+ GI HRD+KP+N+LLD D 
Sbjct: 107 --PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT 164
Query: 288 HVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTG 345
            V+ L DFG AKQ      + S   +  Y +PE++ G   +  + D WS G +L E+L G
Sbjct: 165 AVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 224
Query: 346 QPPFTG 351
           QP F G
Sbjct: 225 QPIFPG 230

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 115/209 (55%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 112
Query: 216 RYSF----QTKYRLYL--VLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F    + K  +YL  VLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 171 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 230
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 259

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPG 209

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 115/209 (55%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 54  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 106
Query: 216 RYSF----QTKYRLYL--VLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F    + K  +YL  VLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 107 RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 164
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 165 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 224
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 225 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 253

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 118/205 (57%), Gaps = 4/205 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 60
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           P IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H+
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KGH 326
           + ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG K +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 327 DKAADWWSVGILLFEMLTGQPPFTG 351
             A D WS+G +  EM+T +  F G
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPG 205

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 115/209 (55%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 112
Query: 216 RYSF----QTKYRLYL--VLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F    + K  +YL  VLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 171 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 230
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 259

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPG 209

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 182
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPG 208

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 115/209 (55%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 62  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 114
Query: 216 RYSF----QTKYRLYL--VLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F    + K  +YL  VLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 115 RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 172
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 173 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 232
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 233 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 261

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 115/209 (55%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 105 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 157
Query: 216 RYSF----QTKYRLYL--VLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F    + K  +YL  VLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 158 RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 215
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 216 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 275
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 276 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 304

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 61
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPG 207

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 179
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPG 205

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 115/209 (55%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 90
Query: 216 RYSF----QTKYRLYL--VLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F    + K  +YL  VLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 149 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 208
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 209 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 237

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 61
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPG 207

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 115/209 (55%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 34  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 86
Query: 216 RYSF----QTKYRLYL--VLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F    + K  +YL  VLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 87  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 144
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 145 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 204
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 205 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 233

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 179
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPG 205

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 115/209 (55%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 45  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 97
Query: 216 RYSF----QTKYRLYL--VLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F    + K  +YL  VLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 98  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 155
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 156 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 215
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 216 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 244

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 115/209 (55%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 30  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 82
Query: 216 RYSF----QTKYRLYL--VLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F    + K  +YL  VLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 83  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 140
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 141 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 200
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 201 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 229

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 110/204 (53%), Gaps = 7/204 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT E+++PEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLFEMLTGQPPFTGGNR 354
           D WS+G++ + +L+G  PF G  +
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTK 222

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 115/209 (55%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 39  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 91
Query: 216 RYSF----QTKYRLYL--VLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F    + K  +YL  VLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 92  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 149
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 150 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 209
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 210 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 238

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 115/209 (55%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 78
Query: 216 RYSF----QTKYRLYL--VLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F    + K  +YL  VLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 225

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 110/204 (53%), Gaps = 7/204 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT E+++PEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLFEMLTGQPPFTGGNR 354
           D WS+G++ + +L+G  PF G  +
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTK 222

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 115/209 (55%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 90
Query: 216 RYSF----QTKYRLYL--VLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F    + K  +YL  VLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 149 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 208
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 209 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 237

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 110/204 (53%), Gaps = 7/204 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT E+++PEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLFEMLTGQPPFTGGNR 354
           D WS+G++ + +L+G  PF G  +
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTK 222

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 110/204 (53%), Gaps = 7/204 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 137
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT E+++PEIV  +     A
Sbjct: 138 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 197
Query: 331 DWWSVGILLFEMLTGQPPFTGGNR 354
           D WS+G++ + +L+G  PF G  +
Sbjct: 198 DMWSIGVITYILLSGASPFLGDTK 221

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 114/209 (54%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 27  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 79
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 80  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 137
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 138 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 197
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 198 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 226

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 114/209 (54%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 78
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 225

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV + V+     F            L + Y  +++  ++  H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG K 
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPG 205

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 110/200 (55%), Gaps = 4/200 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L+ +G+G+F +V++     T ++ A+K++  D    ++  E ++ E  +L++ D 
Sbjct: 23  ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 80
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
            ++ +   S+    +L+++++++ GG     L R G F E        EI+  + +LH+ 
Sbjct: 81  SYVTKYYGSYLKGSKLWIIMEYLGGGSAL-DLLRAGPFDEFQIATMLKEILKGLDYLHSE 139
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             +HRD+K  N+LL   G V L DFG+A Q  D   + N+  GT  +M+PE++    +D 
Sbjct: 140 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 199
Query: 329 AADWWSVGILLFEMLTGQPP 348
            AD WS+GI   E+  G+PP
Sbjct: 200 KADIWSLGITAIELAKGEPP 219

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPG 209

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 110/204 (53%), Gaps = 7/204 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 137
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT E+++PEIV  +     A
Sbjct: 138 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 197
Query: 331 DWWSVGILLFEMLTGQPPFTGGNR 354
           D WS+G++ + +L+G  PF G  +
Sbjct: 198 DMWSIGVITYILLSGASPFLGDTK 221

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 110/204 (53%), Gaps = 7/204 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT E+++PEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLFEMLTGQPPFTGGNR 354
           D WS+G++ + +L+G  PF G  +
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTK 222

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 110/204 (53%), Gaps = 7/204 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT E+++PEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLFEMLTGQPPFTGGNR 354
           D WS+G++ + +L+G  PF G  +
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTK 222

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 115/209 (55%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 78
Query: 216 RYSF----QTKYRLYL--VLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F    + K  +YL  VLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 225

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 110/204 (53%), Gaps = 7/204 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT E+++PEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLFEMLTGQPPFTGGNR 354
           D WS+G++ + +L+G  PF G  +
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTK 222

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 110/204 (53%), Gaps = 7/204 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT E+++PEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLFEMLTGQPPFTGGNR 354
           D WS+G++ + +L+G  PF G  +
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTK 222

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 110/204 (53%), Gaps = 7/204 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT E+++PEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLFEMLTGQPPFTGGNR 354
           D WS+G++ + +L+G  PF G  +
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTK 222

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 110/204 (53%), Gaps = 7/204 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT E+++PEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLFEMLTGQPPFTGGNR 354
           D WS+G++ + +L+G  PF G  +
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTK 222

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 182
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPG 208

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 115/210 (54%), Gaps = 10/210 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN--HAEYMKSERNILTKVDH 209
           +E+ +V+G+G F+ V +     T + +A+K++   K         E +K E +I   + H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVSH 265
           P IV+L  ++ +   LY+V +F++G  L F++ ++     ++ E +A  Y  +I+ A+ +
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 266 LHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDEN-TRSNSMCGTLEYMSPEIV 321
            H N I+HRD+KP  +LL   +    V L  FG+A Q  E+   +    GT  +M+PE+V
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 207
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
             + + K  D W  G++LF +L+G  PF G
Sbjct: 208 KREPYGKPVDVWGCGVILFILLSGCLPFYG 237

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 117/208 (56%), Gaps = 14/208 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E +E++  +G GAF KVY+ +   T  + A KV+      E+   +Y+  E  IL   DH
Sbjct: 11  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYI-VEIEILATCDH 67
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGG---HLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P+IV+L  ++    +L+++++F  GG    +  +L R GL  E   ++   +++ A++ L
Sbjct: 68  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR-GL-TEPQIQVVCRQMLEALNFL 125
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGL-AKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
           H+  I+HRDLK  N+L+  +G + L DFG+ AK      + +S  GT  +M+PE+V+ + 
Sbjct: 126 HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCET 185
Query: 326 -----HDKAADWWSVGILLFEMLTGQPP 348
                +D  AD WS+GI L EM   +PP
Sbjct: 186 MKDTPYDYKADIWSLGITLIEMAQIEPP 213

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 110/204 (53%), Gaps = 7/204 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT E+++PEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLFEMLTGQPPFTGGNR 354
           D WS+G++ + +L+G  PF G  +
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTK 222

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 115/203 (56%), Gaps = 9/203 (4%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F+VL+ +G+G++  VY+     T +I A+K +     +E +  E +K E +I+ + D 
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP----VESDLQEIIK-EISIMQQCDS 83
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           P +V+   S+     L++V+++   G +    +L  + L  +++A I  + +   + +LH
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL-KGLEYLH 142
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGH 326
               +HRD+K  NILL+ +GH  L DFG+A Q  D   + N + GT  +M+PE++   G+
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGY 202
Query: 327 DKAADWWSVGILLFEMLTGQPPF 349
           +  AD WS+GI   EM  G+PP+
Sbjct: 203 NCVADIWSLGITAIEMAEGKPPY 225

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 113/209 (54%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 78
Query: 216 RYSFQTK------YRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F +         L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 79  RYFFYSSGEKKDVVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 225

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 109/200 (54%), Gaps = 4/200 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L+ +G+G+F +V++     T ++ A+K++  D    ++  E ++ E  +L++ D 
Sbjct: 27  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 84
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++ +   S+    +L+++++++ GG     L   G   E        EI+  + +LH+ 
Sbjct: 85  PYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSE 143
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             +HRD+K  N+LL   G V L DFG+A Q  D   + N+  GT  +M+PE++    +D 
Sbjct: 144 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 203
Query: 329 AADWWSVGILLFEMLTGQPP 348
            AD WS+GI   E+  G+PP
Sbjct: 204 KADIWSLGITAIELARGEPP 223

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 115/210 (54%), Gaps = 10/210 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN--HAEYMKSERNILTKVDH 209
           +E+ +V+G+G F+ V +     T + +A+K++   K         E +K E +I   + H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVSH 265
           P IV+L  ++ +   LY+V +F++G  L F++ ++     ++ E +A  Y  +I+ A+ +
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 266 LHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDEN-TRSNSMCGTLEYMSPEIV 321
            H N I+HRD+KP  +LL   +    V L  FG+A Q  E+   +    GT  +M+PE+V
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
             + + K  D W  G++LF +L+G  PF G
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLPFYG 235

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 117/208 (56%), Gaps = 14/208 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E +E++  +G GAF KVY+ +   T  + A KV+      E+   +Y+  E  IL   DH
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYI-VEIEILATCDH 75
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGG---HLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P+IV+L  ++    +L+++++F  GG    +  +L R GL  E   ++   +++ A++ L
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR-GL-TEPQIQVVCRQMLEALNFL 133
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGL-AKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
           H+  I+HRDLK  N+L+  +G + L DFG+ AK      + +S  GT  +M+PE+V+ + 
Sbjct: 134 HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCET 193
Query: 326 -----HDKAADWWSVGILLFEMLTGQPP 348
                +D  AD WS+GI L EM   +PP
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPP 221

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 117/206 (56%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV + V+     F            L + Y  +++  ++  H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPG 209

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+  +R D   E   +  ++ E ++L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG K 
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+  +R D   E   +  ++ E ++L +++
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG K 
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPG 205

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 114/235 (48%), Gaps = 25/235 (10%)
Query: 135 GHIDNLPSENQCVGLEDFEVL--KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN 192
           G  D+LP +      ED   L  +++G+GA+AKV     +   + YA+K++ K     ++
Sbjct: 1   GSTDSLPGK-----FEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRS 55
Query: 193 HAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLA 252
                +    +     +  I++L   F+   R YLV + + GG +   + +Q  F E  A
Sbjct: 56  RV--FREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREA 113
Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH---VMLTDFGLAKQFDENTRSNSM 309
                ++ +A+  LH  GI HRDLKPENIL ++      V + DF L      N     +
Sbjct: 114 SRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPI 173
Query: 310 --------CGTLEYMSPEIV-----LGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
                   CG+ EYM+PE+V         +DK  D WS+G++L+ ML+G PPF G
Sbjct: 174 TTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVG 228

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 109/200 (54%), Gaps = 4/200 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L+ +G+G+F +V++     T ++ A+K++  D    ++  E ++ E  +L++ D 
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 64
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++ +   S+    +L+++++++ GG     L   G   E        EI+  + +LH+ 
Sbjct: 65  PYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSE 123
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             +HRD+K  N+LL   G V L DFG+A Q  D   + N+  GT  +M+PE++    +D 
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 183
Query: 329 AADWWSVGILLFEMLTGQPP 348
            AD WS+GI   E+  G+PP
Sbjct: 184 KADIWSLGITAIELARGEPP 203

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N M GTL Y++PE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N M GTL Y++PE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKMLN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N M GTL Y++PE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 183
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 108/200 (54%), Gaps = 4/200 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L+ +G+G+F +V++     T ++ A+K++  D    ++  E ++ E  +L++ D 
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 79
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++ +   S+    +L+++++++ GG     L   G   E        EI+  + +LH+ 
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSE 138
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             +HRD+K  N+LL   G V L DFG+A Q  D   + N   GT  +M+PE++    +D 
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDS 198
Query: 329 AADWWSVGILLFEMLTGQPP 348
            AD WS+GI   E+  G+PP
Sbjct: 199 KADIWSLGITAIELARGEPP 218

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N M GTL Y++PE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N M GTL Y++PE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 108/200 (54%), Gaps = 4/200 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L+ +G+G+F +V++     T ++ A+K++  D    ++  E ++ E  +L++ D 
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 64
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++ +   S+    +L+++++++ GG     L   G   E        EI+  + +LH+ 
Sbjct: 65  PYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSE 123
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             +HRD+K  N+LL   G V L DFG+A Q  D   + N   GT  +M+PE++    +D 
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDS 183
Query: 329 AADWWSVGILLFEMLTGQPP 348
            AD WS+GI   E+  G+PP
Sbjct: 184 KADIWSLGITAIELARGEPP 203

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 114/215 (53%), Gaps = 15/215 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED+EVL  +G G++ +  ++RR    +I   K +    + E    + + SE N+L ++ H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKH 64
Query: 210 PFIVQL--RYSFQTKYRLYLVLDFVNGGHLFFQLY-----RQGLFREDLARIYTAEIVSA 262
           P IV+   R   +T   LY+V+++  GG L   +      RQ L  E + R+ T ++  A
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT-QLTLA 123
Query: 263 VSHLH-----ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNSMCGTLEYM 316
           +   H      + ++HRDLKP N+ LD   +V L DFGLA+  + +   +    GT  YM
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYM 183
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           SPE +    +++ +D WS+G LL+E+    PPFT 
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 118/206 (57%), Gaps = 6/206 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E ++ L+ VG+G +  VY+ +      I A+K +R D   E   +  ++ E ++L ++ 
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELH 77
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV L     ++  L LV +F+           + GL ++   +IY  +++  V+H H
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGL-QDSQIKIYLYQLLRGVAHCH 136
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
            + I+HRDLKP+N+L+++DG + L DFGLA+ F    RS +    TL Y +P++++G K 
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKK 196
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  + D WS+G +  EM+TG+P F G
Sbjct: 197 YSTSVDIWSIGCIFAEMITGKPLFPG 222

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 118/206 (57%), Gaps = 6/206 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E ++ L+ VG+G +  VY+ +      I A+K +R D   E   +  ++ E ++L ++ 
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELH 77
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV L     ++  L LV +F+           + GL ++   +IY  +++  V+H H
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGL-QDSQIKIYLYQLLRGVAHCH 136
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
            + I+HRDLKP+N+L+++DG + L DFGLA+ F    RS +    TL Y +P++++G K 
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKK 196
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  + D WS+G +  EM+TG+P F G
Sbjct: 197 YSTSVDIWSIGCIFAEMITGKPLFPG 222

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 6/208 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ +++ + +G GAF  V++V    T   +A K +      +K   E ++ E   ++ + 
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLR 212
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLH 267
           HP +V L  +F+    + ++ +F++GG LF ++  +     ED A  Y  ++   + H+H
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 268 ANGIMHRDLKPENILLDA--DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
            N  +H DLKPENI+        + L DFGL    D         GT E+ +PE+  GK 
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 332
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGN 353
                D WSVG+L + +L+G  PF G N
Sbjct: 333 VGYYTDMWSVGVLSYILLSGLSPFGGEN 360

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 109/204 (53%), Gaps = 7/204 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT  +++PEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLFEMLTGQPPFTGGNR 354
           D WS+G++ + +L+G  PF G  +
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTK 222

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 113/209 (54%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + + K        +   E  I+ K+DH  IV+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGK-------AFKNRELQIMRKLDHCNIVRL 78
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPAT--VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 225

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 6/208 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ +++ + +G GAF  V++V    T   +A K +      +K   E ++ E   ++ + 
Sbjct: 50  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLR 106
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLH 267
           HP +V L  +F+    + ++ +F++GG LF ++  +     ED A  Y  ++   + H+H
Sbjct: 107 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 166
Query: 268 ANGIMHRDLKPENILLDAD--GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
            N  +H DLKPENI+        + L DFGL    D         GT E+ +PE+  GK 
Sbjct: 167 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 226
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGN 353
                D WSVG+L + +L+G  PF G N
Sbjct: 227 VGYYTDMWSVGVLSYILLSGLSPFGGEN 254

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 112/203 (55%), Gaps = 10/203 (4%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           + +G GAF  V+ V    +     +K + KD+   +   E +++E  +L  +DHP I+++
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI----VSAVSHLHANGI 271
              F+  + +Y+V++   GG L  ++       + L+  Y AE+    ++A+++ H+  +
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHV 145
Query: 272 MHRDLKPENILL-DADGH--VMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           +H+DLKPENIL  D   H  + + DFGLA+ F  +  S +  GT  YM+PE V  +    
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE-VFKRDVTF 204
Query: 329 AADWWSVGILLFEMLTGQPPFTG 351
             D WS G++++ +LTG  PFTG
Sbjct: 205 KCDIWSAGVVMYFLLTGCLPFTG 227

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 109/204 (53%), Gaps = 7/204 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+ + V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT E+++PEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLFEMLTGQPPFTGGNR 354
           D WS+G++ + +L+G  PF G  +
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTK 222

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 114/209 (54%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + + K        +   E  I+ K+DH  IV+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGK-------AFKNRELQIMRKLDHCNIVRL 78
Query: 216 RYSF----QTKYRLYL--VLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F    + K  +YL  VLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 225

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 113/209 (54%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + + K        +   E  I+ K+DH  IV+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGK-------AFKNRELQIMRKLDHCNIVRL 78
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 225

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 114/225 (50%), Gaps = 8/225 (3%)
Query: 131 GKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME 190
           GK TG++  +  +     + D E L  +G G   +V+++R   T  + A+K MR+    E
Sbjct: 7   GKQTGYL-TIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE 65
Query: 191 KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED 250
           +N    M  +  +L   D P+IVQ   +F T   +++ ++ +       +   QG   E 
Sbjct: 66  ENKRILMDLD-VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPER 124
Query: 251 LARIYTAEIVSAVSHL-HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM 309
           +    T  IV A+ +L   +G++HRD+KP NILLD  G + L DFG++ +  ++   +  
Sbjct: 125 ILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS 184
Query: 310 CGTLEYMSPEIV-----LGKGHDKAADWWSVGILLFEMLTGQPPF 349
            G   YM+PE +         +D  AD WS+GI L E+ TGQ P+
Sbjct: 185 AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY 229

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 110/213 (51%), Gaps = 22/213 (10%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNH--AEYMKSERNILTKVDHPFIVQ 214
           V+G+GA A+V     + TS+ YA+K++ K    +  H  +   +    +     H  +++
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEK----QPGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   F+ + R YLV + + GG +   ++++  F E  A +   ++ SA+  LH  GI HR
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHR 135
Query: 275 DLKPENILLDADGH---VMLTDFGLAKQFDENTRSNSM--------CGTLEYMSPEIVLG 323
           DLKPENIL +       V + DFGL      N   + +        CG+ EYM+PE+V  
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195
Query: 324 KG-----HDKAADWWSVGILLFEMLTGQPPFTG 351
                  +DK  D WS+G++L+ +L+G PPF G
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 110/203 (54%), Gaps = 6/203 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +++L+ +G GAF  V++     T  ++  K +     ++K     +K+E +I+ ++ HP 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---VKNEISIMNQLHHPK 109
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI-YTAEIVSAVSHLHANG 270
           ++ L  +F+ KY + L+L+F++GG LF ++  +     +   I Y  +    + H+H + 
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 271 IMHRDLKPENILLDAD--GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           I+H D+KPENI+ +      V + DFGLA + + +        T E+ +PEIV  +    
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGF 229
Query: 329 AADWWSVGILLFEMLTGQPPFTG 351
             D W++G+L + +L+G  PF G
Sbjct: 230 YTDMWAIGVLGYVLLSGLSPFAG 252

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 109/193 (56%), Gaps = 5/193 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V   R   +    A+K+M    + ++   E + +E  I+    H  +V++  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L+++++F+ GG L   + +  L  E +A +  A ++ A+++LHA G++HRD+K
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEA-VLQALAYLHAQGVIHRDIK 168
Query: 278 PENILLDADGHVMLTDFGLAKQFDENT-RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            ++ILL  DG V L+DFG   Q  ++  +   + GT  +M+PE++    +    D WS+G
Sbjct: 169 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLG 228
Query: 337 ILLFEMLTGQPPF 349
           I++ EM+ G+PP+
Sbjct: 229 IMVIEMVDGEPPY 241

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 112/210 (53%), Gaps = 13/210 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
           +E +E L +VG+G++  V + R   T  I A+K     K +E +  + +K     E  +L
Sbjct: 24  MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREIKLL 78
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAV 263
            ++ H  +V L    + K R YLV +FV+   L   +L+  GL  + + + Y  +I++ +
Sbjct: 79  KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQ-VVQKYLFQIINGI 137
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNSMCGTLEYMSPEIVL 322
              H++ I+HRD+KPENIL+   G V L DFG A+         +    T  Y +PE+++
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLV 197
Query: 323 GK-GHDKAADWWSVGILLFEMLTGQPPFTG 351
           G   + KA D W++G L+ EM  G+P F G
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGEPLFPG 227

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 109/213 (51%), Gaps = 22/213 (10%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNH--AEYMKSERNILTKVDHPFIVQ 214
           V+G+GA A+V     + TS+ YA+K++ K    +  H  +   +    +     H  +++
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEK----QPGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   F+ + R YLV + + GG +   ++++  F E  A +   ++ SA+  LH  GI HR
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHR 135
Query: 275 DLKPENILLDADGH---VMLTDFGLAKQFDENTRSNSM--------CGTLEYMSPEIVLG 323
           DLKPENIL +       V + DF L      N   + +        CG+ EYM+PE+V  
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195
Query: 324 KG-----HDKAADWWSVGILLFEMLTGQPPFTG 351
                  +DK  D WS+G++L+ +L+G PPF G
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 113/237 (47%), Gaps = 30/237 (12%)
Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----------- 190
           S   CV L  + +   +G+G++  V        +  YAMKV+ K K++            
Sbjct: 5   SSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPR 64
Query: 191 ------------KNHAEYMKSERNILTKVDHPFIVQLRYSFQ--TKYRLYLVLDFVNGGH 236
                       +   E +  E  IL K+DHP +V+L        +  LY+V + VN G 
Sbjct: 65  GTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP 124
Query: 237 LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGL 296
           +  ++       ED AR Y  +++  + +LH   I+HRD+KP N+L+  DGH+ + DFG+
Sbjct: 125 VM-EVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 297 AKQFD-ENTRSNSMCGTLEYMSPEIVLGKGH---DKAADWWSVGILLFEMLTGQPPF 349
           + +F   +   ++  GT  +M+PE +         KA D W++G+ L+  + GQ PF
Sbjct: 184 SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 106/193 (54%), Gaps = 5/193 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V       + ++ A+K M    + ++   E + +E  I+    H  +V++  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 215
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   +    +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 216 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 274
Query: 278 PENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            ++ILL  DG V L+DFG   Q   E  R   + GT  +M+PE++    +    D WS+G
Sbjct: 275 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 334
Query: 337 ILLFEMLTGQPPF 349
           I++ EM+ G+PP+
Sbjct: 335 IMVIEMVDGEPPY 347

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 106/193 (54%), Gaps = 5/193 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V       + ++ A+K M    + ++   E + +E  I+    H  +V++  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 93
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   +    +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 94  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 152
Query: 278 PENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            ++ILL  DG V L+DFG   Q   E  R   + GT  +M+PE++    +    D WS+G
Sbjct: 153 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 212
Query: 337 ILLFEMLTGQPPF 349
           I++ EM+ G+PP+
Sbjct: 213 IMVIEMVDGEPPY 225

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 106/193 (54%), Gaps = 5/193 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V       + ++ A+K M    + ++   E + +E  I+    H  +V++  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 95
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   +    +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 96  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 154
Query: 278 PENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            ++ILL  DG V L+DFG   Q   E  R   + GT  +M+PE++    +    D WS+G
Sbjct: 155 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 214
Query: 337 ILLFEMLTGQPPF 349
           I++ EM+ G+PP+
Sbjct: 215 IMVIEMVDGEPPY 227

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 106/193 (54%), Gaps = 5/193 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V       + ++ A+K M    + ++   E + +E  I+    H  +V++  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   +    +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 143
Query: 278 PENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            ++ILL  DG V L+DFG   Q   E  R   + GT  +M+PE++    +    D WS+G
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 203
Query: 337 ILLFEMLTGQPPF 349
           I++ EM+ G+PP+
Sbjct: 204 IMVIEMVDGEPPY 216

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 106/193 (54%), Gaps = 5/193 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V       + ++ A+K M    + ++   E + +E  I+    H  +V++  
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 138
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   +    +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 139 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 197
Query: 278 PENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            ++ILL  DG V L+DFG   Q   E  R   + GT  +M+PE++    +    D WS+G
Sbjct: 198 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 257
Query: 337 ILLFEMLTGQPPF 349
           I++ EM+ G+PP+
Sbjct: 258 IMVIEMVDGEPPY 270

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 106/193 (54%), Gaps = 5/193 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V       + ++ A+K M    + ++   E + +E  I+    H  +V++  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 88
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   +    +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 89  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 147
Query: 278 PENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            ++ILL  DG V L+DFG   Q   E  R   + GT  +M+PE++    +    D WS+G
Sbjct: 148 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 207
Query: 337 ILLFEMLTGQPPF 349
           I++ EM+ G+PP+
Sbjct: 208 IMVIEMVDGEPPY 220

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 108/208 (51%), Gaps = 16/208 (7%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA-EYMKSERNILTKVDHPFIVQ 214
           +++G G F KVY+   IG     A+K  R D   + +   E ++ E  +   + HP I+ 
Sbjct: 13  EIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI--- 271
           LR     +  L LV++F  GG L   L  + +   D+   +  +I   +++LH   I   
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRI-PPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 272 MHRDLKPENILL-------DADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           +HRDLK  NIL+       D    ++ +TDFGLA+++   T+  S  G   +M+PE++  
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM-SAAGAYAWMAPEVIRA 188
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTG 351
               K +D WS G+LL+E+LTG+ PF G
Sbjct: 189 SMFSKGSDVWSYGVLLWELLTGEVPFRG 216

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ + +G G F  V +     T E  A+K  R++ +  KN   +   E  I+ K++HP 
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWC-LEIQIMKKLNHPN 73
Query: 212 IVQLRYSFQTKYRL------YLVLDFVNGGHL---FFQLYRQGLFREDLARIYTAEIVSA 262
           +V  R       +L       L +++  GG L     Q       +E   R   ++I SA
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVML---TDFGLAKQFDENTRSNSMCGTLEYMSPE 319
           + +LH N I+HRDLKPENI+L      ++    D G AK+ D+        GTL+Y++PE
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           ++  K +    D+WS G L FE +TG  PF
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ + +G G F  V +     T E  A+K  R++ +  KN   +   E  I+ K++HP 
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWC-LEIQIMKKLNHPN 74
Query: 212 IVQLRYSFQTKYRL------YLVLDFVNGGHL---FFQLYRQGLFREDLARIYTAEIVSA 262
           +V  R       +L       L +++  GG L     Q       +E   R   ++I SA
Sbjct: 75  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 134
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVML---TDFGLAKQFDENTRSNSMCGTLEYMSPE 319
           + +LH N I+HRDLKPENI+L      ++    D G AK+ D+        GTL+Y++PE
Sbjct: 135 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 194
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           ++  K +    D+WS G L FE +TG  PF
Sbjct: 195 LLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 17/218 (7%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  +D+E+ +V+G GA A V         E  A+K +  +K  + +  E +K E   +++
Sbjct: 7   INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLK-EIQAMSQ 64
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL--------YRQGLFREDLARIYTAE 258
             HP IV    SF  K  L+LV+  ++GG +   +        ++ G+  E        E
Sbjct: 65  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 124
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK------QFDENTRSNSMCGT 312
           ++  + +LH NG +HRD+K  NILL  DG V + DFG++           N    +  GT
Sbjct: 125 VLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184
Query: 313 LEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPF 349
             +M+PE++   +G+D  AD WS GI   E+ TG  P+
Sbjct: 185 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 222

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 17/218 (7%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  +D+E+ +V+G GA A V         E  A+K +  +K  + +  E +K E   +++
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLK-EIQAMSQ 69
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL--------YRQGLFREDLARIYTAE 258
             HP IV    SF  K  L+LV+  ++GG +   +        ++ G+  E        E
Sbjct: 70  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK------QFDENTRSNSMCGT 312
           ++  + +LH NG +HRD+K  NILL  DG V + DFG++           N    +  GT
Sbjct: 130 VLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 313 LEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPF 349
             +M+PE++   +G+D  AD WS GI   E+ TG  P+
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 116/211 (54%), Gaps = 13/211 (6%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F+ L+ +G G +A VY+     T    A+K ++ D   E+        E +++ ++ H  
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHEN 64
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR------QGLFREDLARIYTAEIVSAVSH 265
           IV+L     T+ +L LV +F++     +   R      +GL   +L + +  +++  ++ 
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGL-ELNLVKYFQWQLLQGLAF 123
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLG 323
            H N I+HRDLKP+N+L++  G + L DFGLA+ F    NT S+ +  TL Y +P++++G
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVLMG 182
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
            + +  + D WS G +L EM+TG+P F G N
Sbjct: 183 SRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 121/233 (51%), Gaps = 39/233 (16%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DFE + V+GQGAF +V + R    S  YA+K +R      +     + SE  +L  ++H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQ 62
Query: 211 FIVQL------RYSF-------QTKYRLYLVLDFVNGGHLFFQLYRQGLF--REDLARIY 255
           ++V+       R +F       + K  L++ +++   G L+  ++ + L   R++  R++
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE------------- 302
             +I+ A+S++H+ GI+HRDLKP NI +D   +V + DFGLAK                 
Sbjct: 123 R-QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 303 --NTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGG 352
             +    S  GT  Y++ E++ G GH ++  D +S+GI+ FEM+    PF+ G
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 116/230 (50%), Gaps = 12/230 (5%)
Query: 134 TGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNH 193
           +G +   P ++     ED + L  +G+GA+  V ++    + +I A+K +R   + EK  
Sbjct: 6   SGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS-TVDEKEQ 64
Query: 194 AEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF-----R 248
            + +     ++   D P+IVQ   +   +   ++ ++ ++     F  Y   +       
Sbjct: 65  KQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPE 124
Query: 249 EDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN 307
           E L +I T   V A++HL  N  I+HRD+KP NILLD  G++ L DFG++ Q  ++    
Sbjct: 125 EILGKI-TLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT 183
Query: 308 SMCGTLEYMSPEIV----LGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
              G   YM+PE +      +G+D  +D WS+GI L+E+ TG+ P+   N
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 7/202 (3%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           K +G+G FA V Q     T + YA K ++K +  +   AE +     +      P ++ L
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 216 RYSFQTKYRLYLVLDFVNGGHLF---FQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
              ++    + L+L++  GG +F        + +   D+ R+   +I+  V +LH N I+
Sbjct: 95  HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL-IKQILEGVYYLHQNNIV 153
Query: 273 HRDLKPENILLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKA 329
           H DLKP+NILL +    G + + DFG++++         + GT EY++PEI+       A
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTA 213
Query: 330 ADWWSVGILLFEMLTGQPPFTG 351
            D W++GI+ + +LT   PF G
Sbjct: 214 TDMWNIGIIAYMLLTHTSPFVG 235

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 112/205 (54%), Gaps = 4/205 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E +  L+ +G+G +  VY+ +     E +A+K +R +K  E   +  ++ E +IL ++ 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIR-EISILKELK 58
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV+L     TK RL LV + ++          +G      A+ +  ++++ +++ H 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KGH 326
             ++HRDLKP+N+L++ +G + + DFGLA+ F    R  +    TL Y +P++++G K +
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKY 178
Query: 327 DKAADWWSVGILLFEMLTGQPPFTG 351
               D WSVG +  EM+ G P F G
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPG 203

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 112/205 (54%), Gaps = 4/205 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E +  L+ +G+G +  VY+ +     E +A+K +R +K  E   +  ++ E +IL ++ 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIR-EISILKELK 58
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV+L     TK RL LV + ++          +G      A+ +  ++++ +++ H 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KGH 326
             ++HRDLKP+N+L++ +G + + DFGLA+ F    R  +    TL Y +P++++G K +
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKY 178
Query: 327 DKAADWWSVGILLFEMLTGQPPFTG 351
               D WSVG +  EM+ G P F G
Sbjct: 179 STTIDIWSVGCIFAEMVNGAPLFPG 203

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 112/205 (54%), Gaps = 4/205 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E +  L+ +G+G +  VY+ +     E +A+K +R +K  E   +  ++ E +IL ++ 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIR-EISILKELK 58
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV+L     TK RL LV + ++          +G      A+ +  ++++ +++ H 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KGH 326
             ++HRDLKP+N+L++ +G + + DFGLA+ F    R  +    TL Y +P++++G K +
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 327 DKAADWWSVGILLFEMLTGQPPFTG 351
               D WSVG +  EM+ G P F G
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPG 203

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 115/211 (54%), Gaps = 17/211 (8%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 22  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 76
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 77  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 134
Query: 262 AVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    + C T  Y++P
Sbjct: 135 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 194
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           E++  + +DK+ D WS+G++++ +L G PPF
Sbjct: 195 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 225

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 115/211 (54%), Gaps = 17/211 (8%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 30  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 84
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 85  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 142
Query: 262 AVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    + C T  Y++P
Sbjct: 143 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 202
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           E++  + +DK+ D WS+G++++ +L G PPF
Sbjct: 203 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 233

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 111/200 (55%), Gaps = 10/200 (5%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLR 216
           V+G+G +  VY  R +      A+K + +    +  +++ +  E  +   + H  IVQ  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPE---RDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 217 YSFQTKYRLYLVLDFVNGGHLFFQLY-RQGLFREDLARI--YTAEIVSAVSHLHANGIMH 273
            SF     + + ++ V GG L   L  + G  +++   I  YT +I+  + +LH N I+H
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 145
Query: 274 RDLKPENILLDA-DGHVMLTDFGLAKQFDE-NTRSNSMCGTLEYMSPEIVLG--KGHDKA 329
           RD+K +N+L++   G + ++DFG +K+    N  + +  GTL+YM+PEI+    +G+ KA
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA 205
Query: 330 ADWWSVGILLFEMLTGQPPF 349
           AD WS+G  + EM TG+PPF
Sbjct: 206 ADIWSLGCTIIEMATGKPPF 225

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 115/211 (54%), Gaps = 17/211 (8%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 68
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 69  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 126
Query: 262 AVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    + C T  Y++P
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 186
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           E++  + +DK+ D WS+G++++ +L G PPF
Sbjct: 187 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 115/211 (54%), Gaps = 17/211 (8%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 21  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 75
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 76  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 133
Query: 262 AVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    + C T  Y++P
Sbjct: 134 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 193
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           E++  + +DK+ D WS+G++++ +L G PPF
Sbjct: 194 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 224

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 115/211 (54%), Gaps = 17/211 (8%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 66  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 120
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 121 --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 178
Query: 262 AVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    + C T  Y++P
Sbjct: 179 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 238
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           E++  + +DK+ D WS+G++++ +L G PPF
Sbjct: 239 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 269

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 113/247 (45%), Gaps = 51/247 (20%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN--HAEYMKSERNILTKVDHPFIVQL 215
           +GQG++  V       T  I A+K+M K+KI + N    E +K+E  ++ K+ HP I +L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQL---------------------------------- 241
              ++ +  + LV++  +GGHL  +L                                  
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 242 ---YRQGL---FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG--HVMLTD 293
              +R+ L    RE L      +I SA+ +LH  GI HRD+KPEN L   +    + L D
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVD 213
Query: 294 FGLAKQF-----DENTRSNSMCGTLEYMSPEIV--LGKGHDKAADWWSVGILLFEMLTGQ 346
           FGL+K+F      E     +  GT  +++PE++    + +    D WS G+LL  +L G 
Sbjct: 214 FGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
Query: 347 PPFTGGN 353
            PF G N
Sbjct: 274 VPFPGVN 280

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 115/211 (54%), Gaps = 17/211 (8%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 114
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 115 --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 262 AVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    + C T  Y++P
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           E++  + +DK+ D WS+G++++ +L G PPF
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 115/211 (54%), Gaps = 17/211 (8%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 15  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 69
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 70  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 127
Query: 262 AVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    + C T  Y++P
Sbjct: 128 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 187
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           E++  + +DK+ D WS+G++++ +L G PPF
Sbjct: 188 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 218

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 105/193 (54%), Gaps = 5/193 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V       T +  A+K M    + ++   E + +E  I+    H  +V +  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKM---DLRKQQRRELLFNEVVIMRDYHHDNVVDMYS 109
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   +    +  E +A +  + ++ A+S+LH  G++HRD+K
Sbjct: 110 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLS-VLRALSYLHNQGVIHRDIK 168
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            ++ILL +DG + L+DFG   Q   E  +   + GT  +M+PE++    +    D WS+G
Sbjct: 169 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLG 228
Query: 337 ILLFEMLTGQPPF 349
           I++ EM+ G+PP+
Sbjct: 229 IMVIEMIDGEPPY 241

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 115/211 (54%), Gaps = 17/211 (8%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 20  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 74
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 75  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 132
Query: 262 AVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    + C T  Y++P
Sbjct: 133 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 192
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           E++  + +DK+ D WS+G++++ +L G PPF
Sbjct: 193 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 223

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 115/211 (54%), Gaps = 17/211 (8%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 70
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 71  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 262 AVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    + C T  Y++P
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 188
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           E++  + +DK+ D WS+G++++ +L G PPF
Sbjct: 189 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 115/211 (54%), Gaps = 17/211 (8%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 70
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 71  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 262 AVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    + C T  Y++P
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 188
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           E++  + +DK+ D WS+G++++ +L G PPF
Sbjct: 189 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 111/200 (55%), Gaps = 10/200 (5%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLR 216
           V+G+G +  VY  R +      A+K + +    +  +++ +  E  +   + H  IVQ  
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPE---RDSRYSQPLHEEIALHKHLKHKNIVQYL 71
Query: 217 YSFQTKYRLYLVLDFVNGGHLFFQLY-RQGLFREDLARI--YTAEIVSAVSHLHANGIMH 273
            SF     + + ++ V GG L   L  + G  +++   I  YT +I+  + +LH N I+H
Sbjct: 72  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 131
Query: 274 RDLKPENILLDA-DGHVMLTDFGLAKQFDE-NTRSNSMCGTLEYMSPEIVLG--KGHDKA 329
           RD+K +N+L++   G + ++DFG +K+    N  + +  GTL+YM+PEI+    +G+ KA
Sbjct: 132 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA 191
Query: 330 ADWWSVGILLFEMLTGQPPF 349
           AD WS+G  + EM TG+PPF
Sbjct: 192 ADIWSLGCTIIEMATGKPPF 211

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 114/211 (54%), Gaps = 17/211 (8%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 68
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 69  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 126
Query: 262 AVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +      C T  Y++P
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAP 186
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           E++  + +DK+ D WS+G++++ +L G PPF
Sbjct: 187 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 120/233 (51%), Gaps = 39/233 (16%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DFE + V+GQGAF +V + R    S  YA+K +R      +     + SE  +L  ++H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQ 62
Query: 211 FIVQL------RYSF-------QTKYRLYLVLDFVNGGHLFFQLYRQGLF--REDLARIY 255
           ++V+       R +F       + K  L++ +++     L+  ++ + L   R++  R++
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE------------- 302
             +I+ A+S++H+ GI+HRDLKP NI +D   +V + DFGLAK                 
Sbjct: 123 R-QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 303 --NTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGG 352
             +    S  GT  Y++ E++ G GH ++  D +S+GI+ FEM+    PF+ G
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 5/206 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI--LTKVDH 209
           +E L  +G+G FA VY+ R   T++I A+K ++     E        + R I  L ++ H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P I+ L  +F  K  + LV DF+             +      + Y    +  + +LH +
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 131
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-NSMCGTLEYMSPEIVLG-KGHD 327
            I+HRDLKP N+LLD +G + L DFGLAK F    R+      T  Y +PE++ G + + 
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYG 191
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGN 353
              D W+VG +L E+L  + PF  G+
Sbjct: 192 VGVDMWAVGCILAELLL-RVPFLPGD 216

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 106/207 (51%), Gaps = 3/207 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ +E L+ +G+G +  V++ +   T EI A+K +R D   E   +  ++ E  +L ++ 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELK 59
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV+L     +  +L LV +F +     +     G    ++ + +  +++  +   H+
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KGH 326
             ++HRDLKP+N+L++ +G + L DFGLA+ F    R  S    TL Y  P+++ G K +
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGN 353
             + D WS G +  E+     P   GN
Sbjct: 180 STSIDMWSAGCIFAELANAARPLFPGN 206

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V++V    +  + A K++         H E   + RN       
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---------HLEIKPAIRNQIIRELQ 118
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  
Sbjct: 119 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 178
Query: 263 VSHLH-ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +++L   + IMHRD+KP NIL+++ G + L DFG++ Q   ++ +NS  GT  YMSPE +
Sbjct: 179 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERL 237
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPF 349
            G  +   +D WS+G+ L EM  G+ P 
Sbjct: 238 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 112/211 (53%), Gaps = 17/211 (8%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K ++      +    + ++ +      
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXLQDCPKARREVELHWRASQC----- 114
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V + ++GG LF ++  +G   F E  A      I  
Sbjct: 115 --PHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGE 172
Query: 262 AVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    + C T  Y++P
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           E++  + +DK+ D WS+G++ + +L G PPF
Sbjct: 233 EVLGPEKYDKSCDXWSLGVIXYILLCGYPPF 263

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 109/212 (51%), Gaps = 18/212 (8%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V++V    +  + A K++         H E   + RN       
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---------HLEIKPAIRNQIIRELQ 75
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  
Sbjct: 76  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 135
Query: 263 VSHLH-ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +++L   + IMHRD+KP NIL+++ G + L DFG++ Q  ++  +NS  GT  YMSPE +
Sbjct: 136 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERL 194
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
            G  +   +D WS+G+ L EM  G+ P   G+
Sbjct: 195 QGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGS 226

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 112/230 (48%), Gaps = 29/230 (12%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L  +E++K +G+GA+  V++     T E+ A+K +  D       A+    E  ILT++ 
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-DAFQNSTDAQRTFREIMILTELS 66
Query: 209 -HPFIVQLRYSFQ--TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
            H  IV L    +      +YLV D++        + R  +      +    +++  + +
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYMETD--LHAVIRANILEPVHKQYVVYQLIKVIKY 124
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--------------DENTRS----- 306
           LH+ G++HRD+KP NILL+A+ HV + DFGL++ F              +ENT +     
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 307 ---NSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGG 352
                   T  Y +PEI+LG   + K  D WS+G +L E+L G+P F G 
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  L+ +G G+F  VY  R +  SE+ A+K M           + +  E   L K+ HP 
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 212 IVQLRYSFQTKYRLYLVLDFVNG-GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            +Q R  +  ++  +LV+++  G      +++++ L   ++A + T   +  +++LH++ 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV-THGALQGLAYLHSHN 174
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG---HD 327
           ++HRD+K  NILL   G V L DFG A        +N   GT  +M+PE++L      +D
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMDEGQYD 231
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGN 353
              D WS+GI   E+   +PP    N
Sbjct: 232 GKVDVWSLGITCIELAERKPPLFNMN 257

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 13/210 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
           +E +E +  +G+G++  V++ R   T +I A+K     K +E      +K     E  +L
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRML 56
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAV 263
            ++ HP +V L   F+ K RL+LV ++ +   L     Y++G+  E L +  T + + AV
Sbjct: 57  KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGV-PEHLVKSITWQTLQAV 115
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVL 322
           +  H +  +HRD+KPENIL+     + L DFG A+     +   +    T  Y SPE+++
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLV 175
Query: 323 GKG-HDKAADWWSVGILLFEMLTGQPPFTG 351
           G   +    D W++G +  E+L+G P + G
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSGVPLWPG 205

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V++V    +  + A K++         H E   + RN       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---------HLEIKPAIRNQIIRELQ 56
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  
Sbjct: 57  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 116
Query: 263 VSHLH-ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +++L   + IMHRD+KP NIL+++ G + L DFG++ Q   ++ +NS  GT  YMSPE +
Sbjct: 117 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERL 175
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPF 349
            G  +   +D WS+G+ L EM  G+ P 
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V++V    +  + A K++         H E   + RN       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---------HLEIKPAIRNQIIRELQ 56
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  
Sbjct: 57  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 116
Query: 263 VSHLH-ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +++L   + IMHRD+KP NIL+++ G + L DFG++ Q   ++ +NS  GT  YMSPE +
Sbjct: 117 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERL 175
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPF 349
            G  +   +D WS+G+ L EM  G+ P 
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V++V    +  + A K++         H E   + RN       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---------HLEIKPAIRNQIIRELQ 56
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  
Sbjct: 57  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 116
Query: 263 VSHLH-ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +++L   + IMHRD+KP NIL+++ G + L DFG++ Q   ++ +NS  GT  YMSPE +
Sbjct: 117 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERL 175
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPF 349
            G  +   +D WS+G+ L EM  G+ P 
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  L+ +G G+F  VY  R +  SE+ A+K M           + +  E   L K+ HP 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 212 IVQLRYSFQTKYRLYLVLDFVNG-GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            +Q R  +  ++  +LV+++  G      +++++ L   ++A + T   +  +++LH++ 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV-THGALQGLAYLHSHN 135
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG---HD 327
           ++HRD+K  NILL   G V L DFG A        +N   GT  +M+PE++L      +D
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMDEGQYD 192
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGN 353
              D WS+GI   E+   +PP    N
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMN 218

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 7/208 (3%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS-----ERNIL 204
           + +  +  +G GAF  V+       ++   +K ++K+K++E    E  K      E  IL
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAV 263
           ++V+H  I+++   F+ +    LV++    G  LF  + R     E LA     ++VSAV
Sbjct: 84  SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            +L    I+HRD+K ENI++  D  + L DFG A   +      + CGT+EY +PE+++G
Sbjct: 144 GYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMG 203
Query: 324 KGHD-KAADWWSVGILLFEMLTGQPPFT 350
             +     + WS+G+ L+ ++  + PF 
Sbjct: 204 NPYRGPELEMWSLGVTLYTLVFEENPFC 231

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V++V    +  + A K++         H E   + RN       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---------HLEIKPAIRNQIIRELQ 83
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  
Sbjct: 84  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 143
Query: 263 VSHLH-ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +++L   + IMHRD+KP NIL+++ G + L DFG++ Q   ++ +NS  GT  YMSPE +
Sbjct: 144 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERL 202
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPF 349
            G  +   +D WS+G+ L EM  G+ P 
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V++V    +  + A K++         H E   + RN       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---------HLEIKPAIRNQIIRELQ 56
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  
Sbjct: 57  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 116
Query: 263 VSHLH-ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +++L   + IMHRD+KP NIL+++ G + L DFG++ Q   ++ +NS  GT  YMSPE +
Sbjct: 117 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERL 175
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPF 349
            G  +   +D WS+G+ L EM  G+ P 
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V++V    +  + A K++         H E   + RN       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---------HLEIKPAIRNQIIRELQ 56
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  
Sbjct: 57  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 116
Query: 263 VSHLH-ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +++L   + IMHRD+KP NIL+++ G + L DFG++ Q   ++ +NS  GT  YMSPE +
Sbjct: 117 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERL 175
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPF 349
            G  +   +D WS+G+ L EM  G+ P 
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 120/237 (50%), Gaps = 20/237 (8%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 19  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 67
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 68  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 127
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 128 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 187
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF
Sbjct: 188 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 109/208 (52%), Gaps = 4/208 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ +E L+ +G+G +  V++ +   T EI A+K +R D   E   +  ++ E  +L ++ 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELK 59
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV+L     +  +L LV +F +     +     G    ++ + +  +++  +   H+
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KGH 326
             ++HRDLKP+N+L++ +G + L +FGLA+ F    R  S    TL Y  P+++ G K +
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 327 DKAADWWSVGILLFEML-TGQPPFTGGN 353
             + D WS G +  E+   G+P F G +
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGND 207

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 120/237 (50%), Gaps = 20/237 (8%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 25  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 73
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 74  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 133
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 134 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 193
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF
Sbjct: 194 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 249

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 120/237 (50%), Gaps = 20/237 (8%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 19  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 67
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 68  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 127
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 128 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 187
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF
Sbjct: 188 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 120/237 (50%), Gaps = 20/237 (8%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 18  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 66
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 67  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 126
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 127 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 186
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF
Sbjct: 187 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 120/237 (50%), Gaps = 20/237 (8%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 19  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 67
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 68  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 127
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 128 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 187
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF
Sbjct: 188 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 120/237 (50%), Gaps = 20/237 (8%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 6   NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 54
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 55  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 114
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 115 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 174
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF
Sbjct: 175 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 120/237 (50%), Gaps = 20/237 (8%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 38  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 86
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 87  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 146
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 147 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 206
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF
Sbjct: 207 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 262

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 120/237 (50%), Gaps = 20/237 (8%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 33  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 81
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 82  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 141
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 142 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 201
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF
Sbjct: 202 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 120/237 (50%), Gaps = 20/237 (8%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 33  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 81
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 82  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 141
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 142 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 201
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF
Sbjct: 202 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 120/237 (50%), Gaps = 20/237 (8%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 18  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 66
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 67  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 126
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 127 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 186
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF
Sbjct: 187 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 120/237 (50%), Gaps = 20/237 (8%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 5   NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 53
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 54  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 113
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 114 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 173
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF
Sbjct: 174 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 229

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 120/237 (50%), Gaps = 20/237 (8%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 6   NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 54
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 55  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 114
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 115 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 174
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF
Sbjct: 175 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 120/237 (50%), Gaps = 20/237 (8%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 19  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 67
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 68  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 127
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 128 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 187
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF
Sbjct: 188 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 120/237 (50%), Gaps = 20/237 (8%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 18  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 66
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 67  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 126
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 127 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 186
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF
Sbjct: 187 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 120/237 (50%), Gaps = 20/237 (8%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 6   NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 54
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 55  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 114
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 115 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 174
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF
Sbjct: 175 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 120/237 (50%), Gaps = 20/237 (8%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 5   NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 53
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 54  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 113
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 114 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 173
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF
Sbjct: 174 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 229

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 120/237 (50%), Gaps = 20/237 (8%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 18  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 66
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 67  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 126
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 127 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 186
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF
Sbjct: 187 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 112/212 (52%), Gaps = 23/212 (10%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL- 215
           ++GQGA A V++ R   T +++A+KV      +     +    E  +L K++H  IV+L 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLF 73
Query: 216 --RYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHAN 269
                  T++++ L+++F   G L+  L       GL   +   I   ++V  ++HL  N
Sbjct: 74  AIEEETTTRHKV-LIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHLREN 131
Query: 270 GIMHRDLKPENIL--LDADGHVM--LTDFGLAKQFDENTRSNSMCGTLEYMSPEI----V 321
           GI+HR++KP NI+  +  DG  +  LTDFG A++ +++ +  S+ GT EY+ P++    V
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAV 191
Query: 322 LGKGHDK----AADWWSVGILLFEMLTGQPPF 349
           L K H K      D WS+G+  +   TG  PF
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 110/206 (53%), Gaps = 9/206 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+ +     LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 266 LHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE-IVLG 323
            H  G++HRD+K ENIL+D + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 188
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPF 349
           + H ++A  WS+GILL++M+ G  PF
Sbjct: 189 RYHGRSAAVWSLGILLYDMVCGDIPF 214

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 120/233 (51%), Gaps = 39/233 (16%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DFE + V+GQGAF +V + R    S  YA+K +R  +  EK     + SE  +L  ++H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EK--LSTILSEVXLLASLNHQ 62
Query: 211 FIVQL------RYSF-------QTKYRLYLVLDFVNGGHLFFQLYRQGLF--REDLARIY 255
           ++V+       R +F       + K  L++  ++     L+  ++ + L   R++  R++
Sbjct: 63  YVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE------------- 302
             +I+ A+S++H+ GI+HR+LKP NI +D   +V + DFGLAK                 
Sbjct: 123 R-QILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 303 --NTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGG 352
             +    S  GT  Y++ E++ G GH ++  D +S+GI+ FE +    PF+ G
Sbjct: 182 GSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY---PFSTG 231

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 18/207 (8%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V++V    +  + A K++         H E   + RN       
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---------HLEIKPAIRNQIIRELQ 59
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  
Sbjct: 60  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 119
Query: 263 VSHLH-ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +++L   + IMHRD+KP NIL+++ G + L DFG++ Q  +   +N   GT  YMSPE +
Sbjct: 120 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEM-ANEFVGTRSYMSPERL 178
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPP 348
            G  +   +D WS+G+ L EM  G+ P
Sbjct: 179 QGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 112/219 (51%), Gaps = 18/219 (8%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ F+V ++ GQG F  V   +   T    A+K + +D        + M+     L  + 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQD----LAVLH 77
Query: 209 HPFIVQLRYSFQT-----KYRLYL--VLDFV-NGGHLFFQLY--RQGLFREDLARIYTAE 258
           HP IVQL+  F T     +  +YL  V+++V +  H   + Y  RQ      L +++  +
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 259 IVSAVSHLH--ANGIMHRDLKPENILL-DADGHVMLTDFGLAKQFDENTRSNSMCGTLEY 315
           ++ ++  LH  +  + HRD+KP N+L+ +ADG + L DFG AK+   +  + +   +  Y
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYY 197
Query: 316 MSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
            +PE++ G  H   A D WSVG +  EM+ G+P F G N
Sbjct: 198 RAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 109/206 (52%), Gaps = 9/206 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 266 LHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE-IVLG 323
            H  G++HRD+K ENIL+D + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 189
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPF 349
           + H ++A  WS+GILL++M+ G  PF
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 109/206 (52%), Gaps = 9/206 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 266 LHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE-IVLG 323
            H  G++HRD+K ENIL+D + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 188
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPF 349
           + H ++A  WS+GILL++M+ G  PF
Sbjct: 189 RYHGRSAAVWSLGILLYDMVCGDIPF 214

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 109/206 (52%), Gaps = 9/206 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 266 LHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE-IVLG 323
            H  G++HRD+K ENIL+D + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 189
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPF 349
           + H ++A  WS+GILL++M+ G  PF
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 122/259 (47%), Gaps = 40/259 (15%)
Query: 109 VEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQ 168
           + G+     + PN +  V A+ GK TG    +   N C         KV+G G+F  V+Q
Sbjct: 10  LNGVKLNPLDDPNKVIKVLASDGK-TGEQREIAYTN-C---------KVIGNGSFGVVFQ 58
Query: 169 VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSF------QTK 222
            + + + E+   KV++  +        +   E  I+  V HP +V L+  F      + +
Sbjct: 59  AKLVESDEVAIKKVLQDKR--------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110
Query: 223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLA--------RIYTAEIVSAVSHLHANGIMHR 274
             L LVL++V        +YR       L         ++Y  +++ +++++H+ GI HR
Sbjct: 111 VFLNLVLEYVPE-----TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHR 165
Query: 275 DLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG-KGHDKAADW 332
           D+KP+N+LLD    V+ L DFG AK       + S   +  Y +PE++ G   +    D 
Sbjct: 166 DIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFGATNYTTNIDI 225
Query: 333 WSVGILLFEMLTGQPPFTG 351
           WS G ++ E++ GQP F G
Sbjct: 226 WSTGCVMAELMQGQPLFPG 244

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 109/206 (52%), Gaps = 9/206 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 33  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 92
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 93  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 152
Query: 266 LHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE-IVLG 323
            H  G++HRD+K ENIL+D + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 153 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 211
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPF 349
           + H ++A  WS+GILL++M+ G  PF
Sbjct: 212 RYHGRSAAVWSLGILLYDMVCGDIPF 237

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 109/206 (52%), Gaps = 9/206 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 266 LHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE-IVLG 323
            H  G++HRD+K ENIL+D + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 189
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPF 349
           + H ++A  WS+GILL++M+ G  PF
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 48/133 (36%), Positives = 80/133 (60%), Gaps = 6/133 (4%)
Query: 222 KYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPE 279
           K  L ++++ + GG LF ++  +G   F E  A     +I +A+  LH++ I HRD+KPE
Sbjct: 98  KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPE 157
Query: 280 NILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
           N+L    + D  + LTDFG AK+  +N      C T  Y++PE++  + +DK+ D WS+G
Sbjct: 158 NLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVLGPEKYDKSCDMWSLG 216
Query: 337 ILLFEMLTGQPPF 349
           ++++ +L G PPF
Sbjct: 217 VIMYILLCGFPPF 229

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 109/206 (52%), Gaps = 9/206 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 266 LHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE-IVLG 323
            H  G++HRD+K ENIL+D + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 184
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPF 349
           + H ++A  WS+GILL++M+ G  PF
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 48/133 (36%), Positives = 80/133 (60%), Gaps = 6/133 (4%)
Query: 222 KYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPE 279
           K  L ++++ + GG LF ++  +G   F E  A     +I +A+  LH++ I HRD+KPE
Sbjct: 79  KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPE 138
Query: 280 NILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
           N+L    + D  + LTDFG AK+  +N      C T  Y++PE++  + +DK+ D WS+G
Sbjct: 139 NLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVLGPEKYDKSCDMWSLG 197
Query: 337 ILLFEMLTGQPPF 349
           ++++ +L G PPF
Sbjct: 198 VIMYILLCGFPPF 210

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 111/212 (52%), Gaps = 23/212 (10%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL- 215
           ++GQGA A V++ R   T +++A+KV      +     +    E  +L K++H  IV+L 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLF 73
Query: 216 --RYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHAN 269
                  T++++ L+++F   G L+  L       GL   +   I   ++V  ++HL  N
Sbjct: 74  AIEEETTTRHKV-LIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHLREN 131
Query: 270 GIMHRDLKPENIL--LDADGHVM--LTDFGLAKQFDENTRSNSMCGTLEYMSPEI----V 321
           GI+HR++KP NI+  +  DG  +  LTDFG A++ +++ +   + GT EY+ P++    V
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYERAV 191
Query: 322 LGKGHDK----AADWWSVGILLFEMLTGQPPF 349
           L K H K      D WS+G+  +   TG  PF
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 109/206 (52%), Gaps = 9/206 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 266 LHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE-IVLG 323
            H  G++HRD+K ENIL+D + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 126 CHNXGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 184
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPF 349
           + H ++A  WS+GILL++M+ G  PF
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 109/206 (52%), Gaps = 9/206 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 266 LHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE-IVLG 323
            H  G++HRD+K ENIL+D + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 184
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPF 349
           + H ++A  WS+GILL++M+ G  PF
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 109/206 (52%), Gaps = 9/206 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 68
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 69  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 128
Query: 266 LHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE-IVLG 323
            H  G++HRD+K ENIL+D + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 129 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 187
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPF 349
           + H ++A  WS+GILL++M+ G  PF
Sbjct: 188 RYHGRSAAVWSLGILLYDMVCGDIPF 213

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 19/217 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-----LTK 206
           +E +  +G GA+  VY+ R   +    A+K +R            + + R +     L  
Sbjct: 11  YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 207 VDHPFIVQLRYSFQT-----KYRLYLVLDFVNGGHLFF--QLYRQGLFRE---DLARIYT 256
            +HP +V+L     T     + ++ LV + V+     +  +    GL  E   DL R   
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR--- 127
Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYM 316
            + +  +  LHAN I+HRDLKPENIL+ + G V L DFGLA+ +        +  TL Y 
Sbjct: 128 -QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYR 186
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +PE++L   +    D WSVG +  EM   +P F G +
Sbjct: 187 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 223

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+F +V+++    T    A+K +R    +E   AE + +   + +    P IV L  
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVR----LEVFRAEELMACAGLTS----PRIVPLYG 152
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           + +    + + ++ + GG L   +  QG   ED A  Y  + +  + +LH+  I+H D+K
Sbjct: 153 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 212
Query: 278 PENILLDADG-HVMLTDFGLAKQFDENTRSNSMC------GTLEYMSPEIVLGKGHDKAA 330
            +N+LL +DG H  L DFG A     +    S+       GT  +M+PE+VLG+  D   
Sbjct: 213 ADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKV 272
Query: 331 DWWSVGILLFEMLTGQPPFT 350
           D WS   ++  ML G  P+T
Sbjct: 273 DVWSSCCMMLHMLNGCHPWT 292

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 110/222 (49%), Gaps = 19/222 (8%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-- 203
           C   + +E +  +G+GA+ KV++ R +     +    +++ ++        + + R +  
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFV--ALKRVRVQTGEEGMPLSTIREVAV 64
Query: 204 ---LTKVDHPFIVQL-------RYSFQTKYRLYLVLDFVNGGHLFF--QLYRQGLFREDL 251
              L   +HP +V+L       R   +TK  L LV + V+     +  ++   G+  E +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETK--LTLVFEHVDQDLTTYLDKVPEPGVPTETI 122
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG 311
             +   +++  +  LH++ ++HRDLKP+NIL+ + G + L DFGLA+ +       S+  
Sbjct: 123 KDMM-FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 312 TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           TL Y +PE++L   +    D WSVG +  EM   +P F G +
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 223

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  +L  V+
Sbjct: 21  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKCVN 79
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+    L  E ++ +   +++  
Sbjct: 80  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYL-LYQMLCG 136
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    N        T  Y +PE++L
Sbjct: 137 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVIL 196
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ E++ G   F G +
Sbjct: 197 GMGYKENVDIWSVGCIMGELVKGSVIFQGTD 227

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 6/208 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E +  L  +G+G +A VY+ +   T  + A+K +R +   E+        E ++L  + 
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLK 58
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV L     T+  L LV ++++     +      +      +++  +++  +++ H 
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGL--AKQFDENTRSNSMCGTLEYMSPEIVLGK-G 325
             ++HRDLKP+N+L++  G + L DFGL  AK     T  N +  TL Y  P+I+LG   
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTD 177
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +    D W VG + +EM TG+P F G  
Sbjct: 178 YSTQIDMWGVGCIFYEMATGRPLFPGST 205

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 11/209 (5%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKV 207
           ++ +  ++G+G F  V+   R+      A+KV+ +++++     + +     E  +L KV
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 208 D----HPFIVQLRYSFQTKYRLYLVLDF-VNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
                HP +++L   F+T+    LVL+  +    LF  +  +G   E  +R +  ++V+A
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151
Query: 263 VSHLHANGIMHRDLKPENILLD-ADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE-I 320
           + H H+ G++HRD+K ENIL+D   G   L DFG      +   ++   GT  Y  PE I
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD-FDGTRVYSPPEWI 210
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPF 349
              + H   A  WS+GILL++M+ G  PF
Sbjct: 211 SRHQYHALPATVWSLGILLYDMVCGDIPF 239

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 110/222 (49%), Gaps = 19/222 (8%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-- 203
           C   + +E +  +G+GA+ KV++ R +     +    +++ ++        + + R +  
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFV--ALKRVRVQTGEEGMPLSTIREVAV 64
Query: 204 ---LTKVDHPFIVQL-------RYSFQTKYRLYLVLDFVNGGHLFF--QLYRQGLFREDL 251
              L   +HP +V+L       R   +TK  L LV + V+     +  ++   G+  E +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETK--LTLVFEHVDQDLTTYLDKVPEPGVPTETI 122
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG 311
             +   +++  +  LH++ ++HRDLKP+NIL+ + G + L DFGLA+ +       S+  
Sbjct: 123 KDM-MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 312 TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           TL Y +PE++L   +    D WSVG +  EM   +P F G +
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 223

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 110/222 (49%), Gaps = 19/222 (8%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-- 203
           C   + +E +  +G+GA+ KV++ R +     +    +++ ++        + + R +  
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFV--ALKRVRVQTGEEGMPLSTIREVAV 64
Query: 204 ---LTKVDHPFIVQL-------RYSFQTKYRLYLVLDFVNGGHLFF--QLYRQGLFREDL 251
              L   +HP +V+L       R   +TK  L LV + V+     +  ++   G+  E +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETK--LTLVFEHVDQDLTTYLDKVPEPGVPTETI 122
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG 311
             +   +++  +  LH++ ++HRDLKP+NIL+ + G + L DFGLA+ +       S+  
Sbjct: 123 KDM-MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 312 TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           TL Y +PE++L   +    D WSVG +  EM   +P F G +
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 223

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 105/206 (50%), Gaps = 9/206 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +EVLKV+G+G+F +V +       +  A+K++R +K   +  AE ++   + L K D   
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEH-LRKQDKDN 157
Query: 212 IVQLRYSFQT-KYRLYLVLDFVNGGHLFFQLYRQGLFRE---DLARIYTAEIVSAVSHLH 267
            + + +  +   +R ++ + F       ++L ++  F+     L R +   I+  +  LH
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 268 ANGIMHRDLKPENILLDADGH--VMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
            N I+H DLKPENILL   G   + + DFG      E+ R  +   +  Y +PE++LG  
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVILGAR 275
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +    D WS+G +L E+LTG P   G
Sbjct: 276 YGMPIDMWSLGCILAELLTGYPLLPG 301

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 106/206 (51%), Gaps = 9/206 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +EVLKV+G+G+F +V +       +  A+K++R +K   +  AE ++   + L K D   
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEH-LRKQDKDN 157
Query: 212 IVQLRYSFQT-KYRLYLVLDFVNGGHLFFQLYRQGLFRE---DLARIYTAEIVSAVSHLH 267
            + + +  +   +R ++ + F       ++L ++  F+     L R +   I+  +  LH
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 268 ANGIMHRDLKPENILLDADGH--VMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
            N I+H DLKPENILL   G   + + DFG +    E+ R  +   +  Y +PE++LG  
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEVILGAR 275
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +    D WS+G +L E+LTG P   G
Sbjct: 276 YGMPIDMWSLGCILAELLTGYPLLPG 301

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 16/214 (7%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-----LTK 206
           +E +  +G GA+  VY+ R   +    A+K +R   +        + + R +     L  
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR---VPNGEEGLPISTVREVALLRRLEA 62
Query: 207 VDHPFIVQLRYSFQT-----KYRLYLVLDFVNGGHLFF--QLYRQGLFREDLARIYTAEI 259
            +HP +V+L     T     + ++ LV + V+     +  +    GL  E +  +   + 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR-QF 121
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
           +  +  LHAN I+HRDLKPENIL+ + G V L DFGLA+ +      + +  TL Y +PE
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPE 181
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           ++L   +    D WSVG +  EM   +P F G +
Sbjct: 182 VLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 215

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 106/208 (50%), Gaps = 18/208 (8%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V +V+   +  I A K++         H E   + RN       
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLI---------HLEIKPAIRNQIIRELQ 66
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L       E++    +  ++  
Sbjct: 67  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG 126
Query: 263 VSHLH-ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +++L   + IMHRD+KP NIL+++ G + L DFG++ Q   ++ +NS  GT  YM+PE +
Sbjct: 127 LAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMAPERL 185
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPF 349
            G  +   +D WS+G+ L E+  G+ P 
Sbjct: 186 QGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +    +V  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLV-G 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG+++ EM+ G   F G +
Sbjct: 199 GMGYKENVDIWSVGVIMGEMIKGGVLFPGTD 229

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 10/209 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 119
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 176
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 236
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           G G+ +  D WSVG ++ EM+  +  F G
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHKILFPG 265

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +    +V  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLV-G 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG+++ EM+ G   F G +
Sbjct: 199 GMGYKENVDIWSVGVIMGEMIKGGVLFPGTD 229

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 27/228 (11%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK----SER 201
           C  +  +E L  +GQG F +V++ R   T +  A+K     K++ +N  E        E 
Sbjct: 14  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREI 68
Query: 202 NILTKVDHPFIVQLRYSFQTKYR--------LYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
            IL  + H  +V L    +TK          +YLV DF    H    L    L +  L+ 
Sbjct: 69  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--HDLAGLLSNVLVKFTLSE 126
Query: 254 IYTAE--IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD--ENTRSNSM 309
           I      +++ + ++H N I+HRD+K  N+L+  DG + L DFGLA+ F   +N++ N  
Sbjct: 127 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 310 CG---TLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                TL Y  PE++LG + +    D W  G ++ EM T  P   G  
Sbjct: 187 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 234

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 27/228 (11%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK----SER 201
           C  +  +E L  +GQG F +V++ R   T +  A+K     K++ +N  E        E 
Sbjct: 14  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREI 68
Query: 202 NILTKVDHPFIVQLRYSFQTKYR--------LYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
            IL  + H  +V L    +TK          +YLV DF    H    L    L +  L+ 
Sbjct: 69  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--HDLAGLLSNVLVKFTLSE 126
Query: 254 IYTAE--IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD--ENTRSNSM 309
           I      +++ + ++H N I+HRD+K  N+L+  DG + L DFGLA+ F   +N++ N  
Sbjct: 127 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 310 CG---TLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                TL Y  PE++LG + +    D W  G ++ EM T  P   G  
Sbjct: 187 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 234

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 99/200 (49%), Gaps = 15/200 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+F +V+++    T    A+K +R    +E   AE + +   + +    P IV L  
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVR----LEVFRAEELMACAGLTS----PRIVPLYG 133
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           + +    + + ++ + GG L   +  QG   ED A  Y  + +  + +LH+  I+H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 193
Query: 278 PENILLDADG-HVMLTDFGLAKQFDENTRSNSMC------GTLEYMSPEIVLGKGHDKAA 330
            +N+LL +DG H  L DFG A     +     +       GT  +M+PE+VLG+  D   
Sbjct: 194 ADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKV 253
Query: 331 DWWSVGILLFEMLTGQPPFT 350
           D WS   ++  ML G  P+T
Sbjct: 254 DVWSSCCMMLHMLNGCHPWT 273

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 82
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 139
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+ G   F G +
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+ G   F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 9/206 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +EVLKV+G+G F +V +       +  A+K++R +K   +  AE ++   + L K D   
Sbjct: 99  YEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEH-LRKQDKDN 157
Query: 212 IVQLRYSFQT-KYRLYLVLDFVNGGHLFFQLYRQGLFRE---DLARIYTAEIVSAVSHLH 267
            + + +  +   +R ++ + F       ++L ++  F+     L R +   I+  +  LH
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 268 ANGIMHRDLKPENILLDADGH--VMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
            N I+H DLKPENILL   G   + + DFG +    E+ R      +  Y +PE++LG  
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYXXIQSRFYRAPEVILGAR 275
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +    D WS+G +L E+LTG P   G
Sbjct: 276 YGMPIDMWSLGCILAELLTGYPLLPG 301

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 27/228 (11%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK----SER 201
           C  +  +E L  +GQG F +V++ R   T +  A+K     K++ +N  E        E 
Sbjct: 14  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREI 68
Query: 202 NILTKVDHPFIVQLRYSFQTKYR--------LYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
            IL  + H  +V L    +TK          +YLV DF    H    L    L +  L+ 
Sbjct: 69  KILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCE--HDLAGLLSNVLVKFTLSE 126
Query: 254 IYTAE--IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD--ENTRSNSM 309
           I      +++ + ++H N I+HRD+K  N+L+  DG + L DFGLA+ F   +N++ N  
Sbjct: 127 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 310 CG---TLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                TL Y  PE++LG + +    D W  G ++ EM T  P   G  
Sbjct: 187 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 234

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+ G   F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+ G   F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+ G   F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 16/214 (7%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-----LTK 206
           +E +  +G GA+  VY+ R   +    A+K +R   +        + + R +     L  
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR---VPNGEEGLPISTVREVALLRRLEA 62
Query: 207 VDHPFIVQLRYSFQT-----KYRLYLVLDFVNGGHLFF--QLYRQGLFREDLARIYTAEI 259
            +HP +V+L     T     + ++ LV + V+     +  +    GL  E +  +   + 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR-QF 121
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
           +  +  LHAN I+HRDLKPENIL+ + G V L DFGLA+ +        +  TL Y +PE
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPE 181
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           ++L   +    D WSVG +  EM   +P F G +
Sbjct: 182 VLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 215

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 10/209 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 119
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 176
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 236
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           G G+ +  D WSVG ++ EM+  +  F G
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHKILFPG 265

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+ G   F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 27/228 (11%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK----SER 201
           C  +  +E L  +GQG F +V++ R   T +  A+K     K++ +N  E        E 
Sbjct: 13  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREI 67
Query: 202 NILTKVDHPFIVQLRYSFQTKYR--------LYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
            IL  + H  +V L    +TK          +YLV DF    H    L    L +  L+ 
Sbjct: 68  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--HDLAGLLSNVLVKFTLSE 125
Query: 254 IYTAE--IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD--ENTRSNSM 309
           I      +++ + ++H N I+HRD+K  N+L+  DG + L DFGLA+ F   +N++ N  
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 310 CG---TLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                TL Y  PE++LG + +    D W  G ++ EM T  P   G  
Sbjct: 186 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 233

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  +L  V+
Sbjct: 23  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+    L  E ++ +   +++  
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    N        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+    D WSVG ++ E++ G   F G +
Sbjct: 199 GMGYAANVDIWSVGCIMGELVKGCVIFQGTD 229

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 82
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 139
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 200 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 230

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 25  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 83
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 84  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 140
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 141 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVIL 200
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+ G   F G +
Sbjct: 201 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 231

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 229

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 109/215 (50%), Gaps = 15/215 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ +E+  ++G+G+F +V +       E  A+K+++  K    N A+       ++ K D
Sbjct: 34  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF-LNQAQIEVRLLELMNKHD 92
Query: 209 HP---FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE---DLARIYTAEIVSA 262
                +IV L+  F  +  L LV + ++  +  + L R   FR    +L R +  ++ +A
Sbjct: 93  TEMKYYIVHLKRHFMFRNHLCLVFEMLS--YNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 150
Query: 263 VSHLHAN--GIMHRDLKPENILL--DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           +  L      I+H DLKPENILL       + + DFG + Q  +  R      +  Y SP
Sbjct: 151 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQXIQSRFYRSP 208
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           E++LG  +D A D WS+G +L EM TG+P F+G N
Sbjct: 209 EVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 243

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 22  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 80
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 81  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 137
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 138 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 197
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 198 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 228

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 229

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 82
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 139
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 200 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 230

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 74
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 131
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+ G   F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 75
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 76  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 132
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 133 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 192
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 193 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 223

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKXVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 229

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 16/214 (7%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-----LTK 206
           +E +  +G GA+  VY+ R   +    A+K +R   +        + + R +     L  
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR---VPNGEEGLPISTVREVALLRRLEA 62
Query: 207 VDHPFIVQLRYSFQT-----KYRLYLVLDFVNGGHLFF--QLYRQGLFREDLARIYTAEI 259
            +HP +V+L     T     + ++ LV + V+     +  +    GL  E +  +   + 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR-QF 121
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
           +  +  LHAN I+HRDLKPENIL+ + G V L DFGLA+ +        +  TL Y +PE
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPE 181
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           ++L   +    D WSVG +  EM   +P F G +
Sbjct: 182 VLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 215

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 75
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 76  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 132
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 133 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 192
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 193 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 223

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +    +V  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLV-G 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+ G   F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 109/215 (50%), Gaps = 15/215 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ +E+  ++G+G+F +V +       E  A+K+++  K    N A+       ++ K D
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF-LNQAQIEVRLLELMNKHD 111
Query: 209 HP---FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE---DLARIYTAEIVSA 262
                +IV L+  F  +  L LV + ++  +  + L R   FR    +L R +  ++ +A
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLS--YNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 263 VSHLHAN--GIMHRDLKPENILL--DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           +  L      I+H DLKPENILL       + + DFG + Q  +  R      +  Y SP
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQXIQSRFYRSP 227
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           E++LG  +D A D WS+G +L EM TG+P F+G N
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 111/216 (51%), Gaps = 9/216 (4%)
Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           ++N  V  +D E +  +G+GA+  V ++R + + +I A+K +R     ++     M  + 
Sbjct: 43  NQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI 102
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG--HLFFQLYRQG-LFREDLARIYTAE 258
           ++ T VD PF V    +   +  +++ ++ ++      + Q+  +G    ED+       
Sbjct: 103 SMRT-VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVS 161
Query: 259 IVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMS 317
           IV A+ HLH+   ++HRD+KP N+L++A G V + DFG++    ++       G   YM+
Sbjct: 162 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMA 221
Query: 318 PEIV----LGKGHDKAADWWSVGILLFEMLTGQPPF 349
           PE +      KG+   +D WS+GI + E+   + P+
Sbjct: 222 PERINPELNQKGYSVKSDIWSLGITMIELAILRFPY 257

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKXVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 229

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKXVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYL-LYQMLXG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 229

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 111/228 (48%), Gaps = 37/228 (16%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEI-------------YAMKVMRKDKIMEKNHAEYM 197
           DF++  ++G+GA+  V       T EI             +A++ +R+ KI++     + 
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK-----HF 66
Query: 198 KSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA 257
           K E NI+T     F +Q   SF+    +Y++ + +       ++    +  +D  + +  
Sbjct: 67  KHE-NIITI----FNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIY 119
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS--------- 308
           + + AV  LH + ++HRDLKP N+L++++  + + DFGLA+  DE+   NS         
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 309 --MCGTLEYMSPEIVLGKG-HDKAADWWSVGILLFEMLTGQPPFTGGN 353
                T  Y +PE++L    + +A D WS G +L E+   +P F G +
Sbjct: 180 TEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 111/228 (48%), Gaps = 37/228 (16%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEI-------------YAMKVMRKDKIMEKNHAEYM 197
           DF++  ++G+GA+  V       T EI             +A++ +R+ KI++     + 
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK-----HF 66
Query: 198 KSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA 257
           K E NI+T     F +Q   SF+    +Y++ + +       ++    +  +D  + +  
Sbjct: 67  KHE-NIITI----FNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIY 119
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS--------- 308
           + + AV  LH + ++HRDLKP N+L++++  + + DFGLA+  DE+   NS         
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 309 --MCGTLEYMSPEIVLGKG-HDKAADWWSVGILLFEMLTGQPPFTGGN 353
                T  Y +PE++L    + +A D WS G +L E+   +P F G +
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 109/211 (51%), Gaps = 9/211 (4%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V  +D E +  +G+GA+  V ++R + + +I A+K +R     ++     M  + ++ T 
Sbjct: 4   VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT- 62
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGG--HLFFQLYRQG-LFREDLARIYTAEIVSAV 263
           VD PF V    +   +  +++ ++ ++      + Q+  +G    ED+       IV A+
Sbjct: 63  VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 264 SHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV- 321
            HLH+   ++HRD+KP N+L++A G V + DFG++    ++   +   G   YM+PE + 
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERIN 182
Query: 322 ---LGKGHDKAADWWSVGILLFEMLTGQPPF 349
                KG+   +D WS+GI + E+   + P+
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIELAILRFPY 213

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 109/215 (50%), Gaps = 15/215 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ +E+  ++G+G+F +V +       E  A+K+++  K    N A+       ++ K D
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF-LNQAQIEVRLLELMNKHD 111
Query: 209 HP---FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE---DLARIYTAEIVSA 262
                +IV L+  F  +  L LV + ++  +  + L R   FR    +L R +  ++ +A
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLS--YNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 263 VSHLHAN--GIMHRDLKPENILL--DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           +  L      I+H DLKPENILL       + + DFG + Q  +  R      +  Y SP
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQ--RIYQXIQSRFYRSP 227
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           E++LG  +D A D WS+G +L EM TG+P F+G N
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 111/228 (48%), Gaps = 37/228 (16%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEI-------------YAMKVMRKDKIMEKNHAEYM 197
           DF++  ++G+GA+  V       T EI             +A++ +R+ KI++     + 
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK-----HF 66
Query: 198 KSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA 257
           K E NI+T     F +Q   SF+    +Y++ + +       ++    +  +D  + +  
Sbjct: 67  KHE-NIITI----FNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIY 119
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS--------- 308
           + + AV  LH + ++HRDLKP N+L++++  + + DFGLA+  DE+   NS         
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 309 --MCGTLEYMSPEIVLGKG-HDKAADWWSVGILLFEMLTGQPPFTGGN 353
                T  Y +PE++L    + +A D WS G +L E+   +P F G +
Sbjct: 180 TEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 74
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYL-LYQMLXG 131
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 28  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 86
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 87  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 143
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 144 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 203
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 204 GMGYKENVDLWSVGCIMGEMVCHKILFPGRD 234

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYL-LYQMLXG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 229

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 75
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 76  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 132
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 133 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 192
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 193 GMGYKENVDLWSVGCIMGEMVCHKILFPGRD 223

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 109/210 (51%), Gaps = 18/210 (8%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  ++ EV +VVG+GAF  V + +       +  K +   +I  ++  +    E   L++
Sbjct: 6   IDYKEIEVEEVVGRGAFGVVCKAK-------WRAKDVAIKQIESESERKAFIVELRQLSR 58
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ---GLFREDLARIYTAEIVSAV 263
           V+HP IV+L  +      + LV+++  GG L+  L+       +    A  +  +    V
Sbjct: 59  VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 116
Query: 264 SHLHA---NGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
           ++LH+     ++HRDLKP N+LL A G V+ + DFG A     +  +N   G+  +M+PE
Sbjct: 117 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE 174
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           +  G  + +  D +S GI+L+E++T + PF
Sbjct: 175 VFEGSNYSEKCDVFSWGIILWEVITRRKPF 204

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 121/234 (51%), Gaps = 16/234 (6%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMR- 184
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 13  TDVNTHRPREYWDYASHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 72
Query: 185 --KDKI-MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
             K+KI  E    E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 73  VKKNKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 124
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQF 300
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ +
Sbjct: 125 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 182
Query: 301 DENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                 N    +  +  PE+++  + +D + D WS+G +L  M+  + PF  G+
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 113/229 (49%), Gaps = 28/229 (12%)
Query: 142 SENQCVGLED--FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           S N+C+ ++   + +LK +G G  +KV+QV      +IYA+K +     +E+   + + S
Sbjct: 46  SANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN----LEEADNQTLDS 100
Query: 200 ERNILTKVD----HPFIVQLRYSFQ-TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI 254
            RN +  ++    H   +   Y ++ T   +Y+V++  N   L   L ++        + 
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWERKS 159
Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCG 311
           Y   ++ AV  +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   +S  G
Sbjct: 160 YWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVG 218
Query: 312 TLEYMSPEIVLGKGHDK-----------AADWWSVGILLFEMLTGQPPF 349
           T+ YM PE +      +            +D WS+G +L+ M  G+ PF
Sbjct: 219 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 113/229 (49%), Gaps = 28/229 (12%)
Query: 142 SENQCVGLED--FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           S N+C+ ++   + +LK +G G  +KV+QV      +IYA+K +     +E+   + + S
Sbjct: 46  SANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN----LEEADNQTLDS 100
Query: 200 ERNILTKVD----HPFIVQLRYSFQ-TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI 254
            RN +  ++    H   +   Y ++ T   +Y+V++  N   L   L ++        + 
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWERKS 159
Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCG 311
           Y   ++ AV  +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   +S  G
Sbjct: 160 YWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVG 218
Query: 312 TLEYMSPEIVLGKGHDK-----------AADWWSVGILLFEMLTGQPPF 349
           T+ YM PE +      +            +D WS+G +L+ M  G+ PF
Sbjct: 219 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 109/210 (51%), Gaps = 18/210 (8%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  ++ EV +VVG+GAF  V + +       +  K +   +I  ++  +    E   L++
Sbjct: 5   IDYKEIEVEEVVGRGAFGVVCKAK-------WRAKDVAIKQIESESERKAFIVELRQLSR 57
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ---GLFREDLARIYTAEIVSAV 263
           V+HP IV+L  +      + LV+++  GG L+  L+       +    A  +  +    V
Sbjct: 58  VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 264 SHLHA---NGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
           ++LH+     ++HRDLKP N+LL A G V+ + DFG A     +  +N   G+  +M+PE
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE 173
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           +  G  + +  D +S GI+L+E++T + PF
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPF 203

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 109/231 (47%), Gaps = 26/231 (11%)
Query: 140 LPSENQCVGLEDFEV------LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNH 193
           +P E + V  + F+V      L+ +G+GA+  V          +   +V  K KI    H
Sbjct: 27  VPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSS----AYDHVRKTRVAIK-KISPFEH 81
Query: 194 AEYMKS---ERNILTKVDHPFIVQLR-----YSFQTKYRLYLVLDFVNGGHLFFQLYRQG 245
             Y +    E  IL +  H  ++ +R      + +    +Y+V D +      ++L +  
Sbjct: 82  QTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETD--LYKLLKSQ 139
Query: 246 LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK----QFD 301
               D    +  +I+  + ++H+  ++HRDLKP N+L++    + + DFGLA+    + D
Sbjct: 140 QLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHD 199
Query: 302 ENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
                     T  Y +PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 200 HTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 250

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 199 GMGYKENVDLWSVGCIMGEMVCHKILFPGRD 229

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVCHKILFPGRD 229

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 104/236 (44%), Gaps = 56/236 (23%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMR-------KDKIMEKNHAEYMKSER 201
           L DFE ++ +G+G F  V++ +       YA+K +R       ++K+M +  A       
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKA------- 56
Query: 202 NILTKVDHPFIVQLRYSFQTKY----------RLYLVL-----------DFVNGGHLFFQ 240
             L K++HP IV+   ++  K           ++YL +           D++NG     +
Sbjct: 57  --LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE 114
Query: 241 LYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
             R       L      +I  AV  LH+ G+MHRDLKP NI    D  V + DFGL    
Sbjct: 115 RERSVCLHIFL------QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 168
Query: 301 DEN-------------TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEML 343
           D++              R     GT  YMSPE + G  +    D +S+G++LFE+L
Sbjct: 169 DQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +R+I   E   Y  + +R+ KI+ +   E +    
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 92  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 139
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           VG+G+F +V++++   T    A+K +R +         +   E      +  P IV L  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--------FRVEELVACAGLSSPRIVPLYG 133
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           + +    + + ++ + GG L   + + G   ED A  Y  + +  + +LH   I+H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 193
Query: 278 PENILLDADG-HVMLTDFGLAKQFDENTRSNSMC------GTLEYMSPEIVLGKGHDKAA 330
            +N+LL +DG    L DFG A     +    S+       GT  +M+PE+V+GK  D   
Sbjct: 194 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV 253
Query: 331 DWWSVGILLFEMLTGQPPFT 350
           D WS   ++  ML G  P+T
Sbjct: 254 DIWSSCCMMLHMLNGCHPWT 273

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           VG+G+F +V++++   T    A+K +R +         +   E      +  P IV L  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--------FRVEELVACAGLSSPRIVPLYG 117
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           + +    + + ++ + GG L   + + G   ED A  Y  + +  + +LH   I+H D+K
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177
Query: 278 PENILLDADG-HVMLTDFGLAKQFDENTRSNSMC------GTLEYMSPEIVLGKGHDKAA 330
            +N+LL +DG    L DFG A     +    S+       GT  +M+PE+V+GK  D   
Sbjct: 178 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV 237
Query: 331 DWWSVGILLFEMLTGQPPFT 350
           D WS   ++  ML G  P+T
Sbjct: 238 DIWSSCCMMLHMLNGCHPWT 257

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 112/227 (49%), Gaps = 28/227 (12%)
Query: 144 NQCVGLED--FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           N+C+ ++   + +LK +G G  +KV+QV      +IYA+K +     +E+   + + S R
Sbjct: 4   NECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN----LEEADNQTLDSYR 58
Query: 202 NILTKVD----HPFIVQLRYSFQ-TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYT 256
           N +  ++    H   +   Y ++ T   +Y+V++  N   L   L ++        + Y 
Sbjct: 59  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWERKSYW 117
Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTL 313
             ++ AV  +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   +S  GT+
Sbjct: 118 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 176
Query: 314 EYMSPEIVLGKGHDK-----------AADWWSVGILLFEMLTGQPPF 349
            YM PE +      +            +D WS+G +L+ M  G+ PF
Sbjct: 177 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 223

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 112/227 (49%), Gaps = 28/227 (12%)
Query: 144 NQCVGLED--FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           N+C+ ++   + +LK +G G  +KV+QV      +IYA+K +     +E+   + + S R
Sbjct: 1   NECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN----LEEADNQTLDSYR 55
Query: 202 NILTKVD----HPFIVQLRYSFQ-TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYT 256
           N +  ++    H   +   Y ++ T   +Y+V++  N   L   L ++        + Y 
Sbjct: 56  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWERKSYW 114
Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTL 313
             ++ AV  +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   +S  GT+
Sbjct: 115 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 173
Query: 314 EYMSPEIVLGKGHDK-----------AADWWSVGILLFEMLTGQPPF 349
            YM PE +      +            +D WS+G +L+ M  G+ PF
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 220

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 112/229 (48%), Gaps = 28/229 (12%)
Query: 142 SENQCVGLED--FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           S N+C+ ++   + +LK +G G  +KV+QV      +IYA+K +     +E+   + + S
Sbjct: 46  SANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN----LEEADNQTLDS 100
Query: 200 ERNILTKVD----HPFIVQLRYSFQ-TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI 254
            RN +  ++    H   +   Y ++ T   +Y+V++  N   L   L ++        + 
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWERKS 159
Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCG 311
           Y   ++ AV  +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   +S  G
Sbjct: 160 YWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVG 218
Query: 312 TLEYMSPEIVLGKGHDK-----------AADWWSVGILLFEMLTGQPPF 349
            + YM PE +      +            +D WS+G +L+ M  G+ PF
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 30  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 89
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 90  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 137
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 232

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 33  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 92
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 93  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 140
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 141 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 200
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 235

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 34  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 93
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 94  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 141
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 142 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 201
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 202 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 236

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 25  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 84
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 85  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 132
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 133 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 192
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 193 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 227

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 92  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 139
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 28  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 88  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 135
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 26  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 85
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 86  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 133
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 134 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 228

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 112/210 (53%), Gaps = 11/210 (5%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           D  + + +G G+F  V++    G+    A+K++ +     +   E+++ E  I+ ++ HP
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLR-EVAIMKRLRHP 94
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDL---ARIYTA-EIVSAVSHL 266
            IV    +      L +V ++++ G L+  L++ G  RE L    R+  A ++   +++L
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYL 153
Query: 267 HANG--IMHRDLKPENILLDADGHVMLTDFGLAK-QFDENTRSNSMCGTLEYMSPEIVLG 323
           H     I+HRDLK  N+L+D    V + DFGL++ +      S    GT E+M+PE++  
Sbjct: 154 HNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRD 213
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +  ++ +D +S G++L+E+ T Q P+   N
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLN 243

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 113/210 (53%), Gaps = 11/210 (5%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           D  + + +G G+F  V++    G+    A+K++ +     +   E+++ E  I+ ++ HP
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLR-EVAIMKRLRHP 94
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDL---ARIYTA-EIVSAVSHL 266
            IV    +      L +V ++++ G L+  L++ G  RE L    R+  A ++   +++L
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYL 153
Query: 267 HANG--IMHRDLKPENILLDADGHVMLTDFGLAK-QFDENTRSNSMCGTLEYMSPEIVLG 323
           H     I+HR+LK  N+L+D    V + DFGL++ +      S S  GT E+M+PE++  
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +  ++ +D +S G++L+E+ T Q P+   N
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLN 243

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 48  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 107
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 108 DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 155
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 250

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 92  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 139
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 199
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 33  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 92
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 93  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 140
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 141 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 200
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 235

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 26  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 85
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 86  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 133
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 134 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 228

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 36  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 95
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 96  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 143
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 144 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 203
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 204 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 238

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 28  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 88  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 135
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 92  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 139
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 28  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 88  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 135
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 28  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 88  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 135
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 92  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKCQHLSNDHICYFLYQILR 139
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+F +V++++   T    A+K +R +         +   E      +  P IV L  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--------FRVEELVACAGLSSPRIVPLYG 131
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           + +    + + ++ + GG L   + + G   ED A  Y  + +  + +LH   I+H D+K
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 191
Query: 278 PENILLDADG-HVMLTDFGLAKQFDENTRSNSMC------GTLEYMSPEIVLGKGHDKAA 330
            +N+LL +DG    L DFG A     +    S+       GT  +M+PE+V+GK  D   
Sbjct: 192 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV 251
Query: 331 DWWSVGILLFEMLTGQPPFT 350
           D WS   ++  ML G  P+T
Sbjct: 252 DIWSSCCMMLHMLNGCHPWT 271

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 112/232 (48%), Gaps = 19/232 (8%)
Query: 161 GAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ 220
           GA   + ++ R   SE++A +  R+ ++++     +M+ E N++  +D   +     +  
Sbjct: 50  GAKVAIKKLYRPFQSELFAKRAYRELRLLK-----HMRHE-NVIGLLD---VFTPDETLD 100
Query: 221 TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN 280
                YLV+ F+  G    +L +     ED  +    +++  + ++HA GI+HRDLKP N
Sbjct: 101 DFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGN 158
Query: 281 ILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILL 339
           + ++ D  + + DFGLA+Q D       +  T  Y +PE++L    + +  D WSVG ++
Sbjct: 159 LAVNEDCELKILDFGLARQADSEMXGXVV--TRWYRAPEVILNWMRYTQTVDIWSVGCIM 216
Query: 340 FEMLTGQPPFTGGNRXXXXXXXXXXXXXLPA-----FLSSEAHSLLKGVNSL 386
            EM+TG+  F G +               PA       S EA + +KG+  L
Sbjct: 217 AEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPEL 268

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 48  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 107
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +YLV   + G  L+  L  Q L  + +   +  +I+ 
Sbjct: 108 DIIRA---PTIEQMK-------DVYLVTHLM-GADLYKLLKTQHLSNDHIC-YFLYQILR 155
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 250

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 28  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 88  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 135
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 117/248 (47%), Gaps = 24/248 (9%)
Query: 111 GINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVR 170
           G  E   +GP ++SV  A            PS      ++ +  +  +G+G + +VY+  
Sbjct: 10  GTLEAQTQGPGSMSVSAA------------PS---ATSIDRYRRITKLGEGTYGEVYKAI 54
Query: 171 RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD 230
              T+E  A+K +R +   E      ++ E ++L ++ H  I++L+      +RL+L+ +
Sbjct: 55  DTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113
Query: 231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADG 287
           +     L   + +       + + +  ++++ V+  H+   +HRDLKP+N+LL   DA  
Sbjct: 114 YAEND-LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASE 172
Query: 288 HVMLT--DFGLAKQFDENTRS-NSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEML 343
             +L   DFGLA+ F    R       TL Y  PEI+LG  H   + D WS+  +  EML
Sbjct: 173 TPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232
Query: 344 TGQPPFTG 351
              P F G
Sbjct: 233 MKTPLFPG 240

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+     E +    
Sbjct: 30  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIN 89
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 90  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 137
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 232

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGIN 91
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 92  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 139
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/187 (32%), Positives = 99/187 (52%), Gaps = 9/187 (4%)
Query: 171 RIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRL 225
           R+  +   A+K + KD+I    E  +   +  E  +L KV   F  +++L   F+     
Sbjct: 72  RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 131
Query: 226 YLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
            L+L+       LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D
Sbjct: 132 VLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 191
Query: 285 AD-GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEM 342
            + G + L DFG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M
Sbjct: 192 LNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 250
Query: 343 LTGQPPF 349
           + G  PF
Sbjct: 251 VCGDIPF 257

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 108/230 (46%), Gaps = 39/230 (16%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F V++ +G G F +V   + I   + YA+KV+R  K     +    K E +IL K+ +  
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDD 92
Query: 212 IVQ---LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVS 264
           I     ++Y  +  Y  ++ L F   G   +++  +    G   ED+ ++Y  EI+ A++
Sbjct: 93  INNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDI-KLYCIEILKALN 151
Query: 265 HLHANGIMHRDLKPENILLD--------------ADGH-----------VMLTDFGLAKQ 299
           +L    + H DLKPENILLD               DG            + L DFG A  
Sbjct: 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA-T 210
Query: 300 FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           F  +    S+  T +Y +PE++L  G D ++D WS G +L E+ TG   F
Sbjct: 211 FKSDYHG-SIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 86
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-----DLARIYTAEIVSAVSHLHANGIM 272
            + TK +L +V  +  G  L+  L+      E     D+AR    +    + +LHA  I+
Sbjct: 87  GYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR----QTARGMDYLHAKSII 142
Query: 273 HRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN---SMCGTLEYMSPEIVLGKGHDK- 328
           HRDLK  NI L  D  V + DFGLA +    + S+    + G++ +M+PE++  +  +  
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 329 --AADWWSVGILLFEMLTGQPPFTGGN 353
              +D ++ GI+L+E++TGQ P++  N
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNIN 229

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+     E +    
Sbjct: 30  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIN 89
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 90  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 137
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 232

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 38/211 (18%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 70
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 71  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 262 AVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+                   
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE------------------- 169
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
               G+ +DK+ D WS+G++++ +L G PPF
Sbjct: 170 --TTGEKYDKSCDMWSLGVIMYILLCGYPPF 198

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 111/226 (49%), Gaps = 28/226 (12%)
Query: 145 QCVGLED--FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
           +C+ ++   + +LK +G G  +KV+QV      +IYA+K +     +E+   + + S RN
Sbjct: 1   ECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN----LEEADNQTLDSYRN 55
Query: 203 ILTKVD----HPFIVQLRYSFQ-TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA 257
            +  ++    H   +   Y ++ T   +Y+V++  N   L   L ++        + Y  
Sbjct: 56  EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWERKSYWK 114
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLE 314
            ++ AV  +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   +S  GT+ 
Sbjct: 115 NMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 173
Query: 315 YMSPEIVLGKGHDK-----------AADWWSVGILLFEMLTGQPPF 349
           YM PE +      +            +D WS+G +L+ M  G+ PF
Sbjct: 174 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 219

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 74
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-----DLARIYTAEIVSAVSHLHANGIM 272
            + TK +L +V  +  G  L+  L+      E     D+AR    +    + +LHA  I+
Sbjct: 75  GYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR----QTARGMDYLHAKSII 130
Query: 273 HRDLKPENILLDADGHVMLTDFGLA---KQFDENTRSNSMCGTLEYMSPEIVLGKGHDK- 328
           HRDLK  NI L  D  V + DFGLA    ++  + +   + G++ +M+PE++  +  +  
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 190
Query: 329 --AADWWSVGILLFEMLTGQPPFTGGN 353
              +D ++ GI+L+E++TGQ P++  N
Sbjct: 191 SFQSDVYAFGIVLYELMTGQLPYSNIN 217

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 112/231 (48%), Gaps = 26/231 (11%)
Query: 138 DNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYM 197
           +NL  ++  V    + +LK +G G  +KV+QV      +IYA+K +     +E+   + +
Sbjct: 16  ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN----LEEADNQTL 70
Query: 198 KSERNILTKVD----HPFIVQLRYSFQ-TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLA 252
            S RN +  ++    H   +   Y ++ T   +Y+V++  N   L   L ++        
Sbjct: 71  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWER 129
Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSM 309
           + Y   ++ AV  +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   +S 
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 188
Query: 310 CGTLEYMSPEIVLGKGHDK-----------AADWWSVGILLFEMLTGQPPF 349
            GT+ YM PE +      +            +D WS+G +L+ M  G+ PF
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 12/206 (5%)
Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
           L+ VG GA+  V         +  A+K + +       HA     E  +L  + H  ++ 
Sbjct: 33  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHLKHENVIG 91
Query: 215 L------RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           L        S +    +YLV   + G  L   +  Q L  E + +    +++  + ++H+
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKSQALSDEHV-QFLVYQLLRGLKYIHS 149
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-D 327
            GI+HRDLKP N+ ++ D  + + DFGLA+Q DE         T  Y +PEI+L   H +
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEM--TGYVATRWYRAPEIMLNWMHYN 207
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGN 353
           +  D WSVG ++ E+L G+  F G +
Sbjct: 208 QTVDIWSVGCIMAELLQGKALFPGSD 233

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 25/211 (11%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DF+ ++++G G F +V++ +     + Y +K +       K + E  + E   L K+DH 
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-------KYNNEKAEREVKALAKLDHV 64
Query: 211 FIVQL---------------RYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLA 252
            IV                 + S ++K + L++ ++F + G L  + +  R     + LA
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT 312
                +I   V ++H+  +++RDLKP NI L     V + DFGL      + +     GT
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGT 184
Query: 313 LEYMSPEIVLGKGHDKAADWWSVGILLFEML 343
           L YMSPE +  + + K  D +++G++L E+L
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 70
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 71  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 277 KPENILLDADGHVMLTDFGLAKQFDENTRSN---SMCGTLEYMSPEIVLGKGHDK----- 328
           K  NI L  D  V + DFGLA +    + S+    + G++ +M+PE++  +  DK     
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI--RMQDKNPYSF 188
Query: 329 AADWWSVGILLFEMLTGQPPFTGGN 353
            +D ++ GI+L+E++TGQ P++  N
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 12/206 (5%)
Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
           L+ VG GA+  V         +  A+K + +       HA     E  +L  + H  ++ 
Sbjct: 33  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHLKHENVIG 91
Query: 215 L------RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           L        S +    +YLV   + G  L   +  Q L  E + +    +++  + ++H+
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKCQALSDEHV-QFLVYQLLRGLKYIHS 149
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-D 327
            GI+HRDLKP N+ ++ D  + + DFGLA+Q DE         T  Y +PEI+L   H +
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEM--TGYVATRWYRAPEIMLNWMHYN 207
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGN 353
           +  D WSVG ++ E+L G+  F G +
Sbjct: 208 QTVDIWSVGCIMAELLQGKALFPGSD 233

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL-----T 64
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +   F  DLA +  Y  ++
Sbjct: 65  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMS 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G L  ++M+
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMA 180
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           PE +  +    A+D W  G+ ++E+L  G  PF G
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 75
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 76  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 135
Query: 277 KPENILLDADGHVMLTDFGLA---KQFDENTRSNSMCGTLEYMSPEIVLGKGHDK----- 328
           K  NI L  D  V + DFGLA    ++  + +   + G++ +M+PE++  +  DK     
Sbjct: 136 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI--RMQDKNPYSF 193
Query: 329 AADWWSVGILLFEMLTGQPPFTGGN 353
            +D ++ GI+L+E++TGQ P++  N
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 75
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 76  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 135
Query: 277 KPENILLDADGHVMLTDFGLA---KQFDENTRSNSMCGTLEYMSPEIVLGKGHDK----- 328
           K  NI L  D  V + DFGLA    ++  + +   + G++ +M+PE++  +  DK     
Sbjct: 136 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI--RMQDKNPYSF 193
Query: 329 AADWWSVGILLFEMLTGQPPFTGGN 353
            +D ++ GI+L+E++TGQ P++  N
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 90
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 91  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 150
Query: 277 KPENILLDADGHVMLTDFGLAKQFDENTRSN---SMCGTLEYMSPEIVLGKGHDK----- 328
           K  NI L  D  V + DFGLA +    + S+    + G++ +M+PE++  +  DK     
Sbjct: 151 KSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI--RMQDKNPYSF 208
Query: 329 AADWWSVGILLFEMLTGQPPFTGGN 353
            +D ++ GI+L+E++TGQ P++  N
Sbjct: 209 QSDVYAFGIVLYELMTGQLPYSNIN 233

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 98
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 99  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 158
Query: 277 KPENILLDADGHVMLTDFGLAKQFDENTRSN---SMCGTLEYMSPEIVLGKGHDK----- 328
           K  NI L  D  V + DFGLA +    + S+    + G++ +M+PE++  +  DK     
Sbjct: 159 KSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI--RMQDKNPYSF 216
Query: 329 AADWWSVGILLFEMLTGQPPFTGGN 353
            +D ++ GI+L+E++TGQ P++  N
Sbjct: 217 QSDVYAFGIVLYELMTGQLPYSNIN 241

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 70
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 71  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 277 KPENILLDADGHVMLTDFGLA---KQFDENTRSNSMCGTLEYMSPEIVLGKGHDK----- 328
           K  NI L  D  V + DFGLA    ++  + +   + G++ +M+PE++  +  DK     
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI--RMQDKNPYSF 188
Query: 329 AADWWSVGILLFEMLTGQPPFTGGN 353
            +D ++ GI+L+E++TGQ P++  N
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 72
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 73  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 132
Query: 277 KPENILLDADGHVMLTDFGLA---KQFDENTRSNSMCGTLEYMSPEIVLGKGHDK----- 328
           K  NI L  D  V + DFGLA    ++  + +   + G++ +M+PE++  +  DK     
Sbjct: 133 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI--RMQDKNPYSF 190
Query: 329 AADWWSVGILLFEMLTGQPPFTGGN 353
            +D ++ GI+L+E++TGQ P++  N
Sbjct: 191 QSDVYAFGIVLYELMTGQLPYSNIN 215

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-----T 69
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +  L   DLA +  Y  ++
Sbjct: 70  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 125
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMS 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G L  ++M+
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 185
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           PE +  +    A+D W  G+ ++E+L  G  PF G
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 220

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 12/206 (5%)
Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
           L+ VG GA+  V         +  A+K + +       HA     E  +L  + H  ++ 
Sbjct: 25  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHLKHENVIG 83
Query: 215 L------RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           L        S +    +YLV   + G  L   +  Q L  E + +    +++  + ++H+
Sbjct: 84  LLDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKCQALSDEHV-QFLVYQLLRGLKYIHS 141
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-D 327
            GI+HRDLKP N+ ++ D  + + DFGLA+Q DE         T  Y +PEI+L   H +
Sbjct: 142 AGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEM--TGYVATRWYRAPEIMLNWMHYN 199
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGN 353
           +  D WSVG ++ E+L G+  F G +
Sbjct: 200 QTVDIWSVGCIMAELLQGKALFPGSD 225

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 13  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-----T 67
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +  L   DLA +  Y  ++
Sbjct: 68  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 123
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMS 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G L  ++M+
Sbjct: 124 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 183
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           PE +  +    A+D W  G+ ++E+L  G  PF G
Sbjct: 184 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 218

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 38  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-----T 92
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +  L   DLA +  Y  ++
Sbjct: 93  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 148
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMS 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G L  ++M+
Sbjct: 149 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 208
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           PE +  +    A+D W  G+ ++E+L  G  PF G
Sbjct: 209 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 243

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 12  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-----T 66
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +  L   DLA +  Y  ++
Sbjct: 67  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 122
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMS 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G L  ++M+
Sbjct: 123 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 182
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           PE +  +    A+D W  G+ ++E+L  G  PF G
Sbjct: 183 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 217

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 86
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-----DLARIYTAEIVSAVSHLHANGIM 272
            + T  +L +V  +  G  L+  L+      E     D+AR    +    + +LHA  I+
Sbjct: 87  GYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR----QTARGMDYLHAKSII 142
Query: 273 HRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN---SMCGTLEYMSPEIVLGKGHDK- 328
           HRDLK  NI L  D  V + DFGLA +    + S+    + G++ +M+PE++  +  +  
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 329 --AADWWSVGILLFEMLTGQPPFTGGN 353
              +D ++ GI+L+E++TGQ P++  N
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNIN 229

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 108/207 (52%), Gaps = 25/207 (12%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMK-VMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
           +V+G+G F +  +V    T E+  MK ++R D   E+    ++K E  ++  ++HP +++
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLK-EVKVMRCLEHPNVLK 71
Query: 215 LRYSFQTKYRLYLVLDFVNGGHL---FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
                    RL  + +++ GG L      +  Q  + + ++  +  +I S +++LH+  I
Sbjct: 72  FIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVS--FAKDIASGMAYLHSMNI 129
Query: 272 MHRDLKPENILLDADGHVMLTDFGLAK-QFDENT--------------RSNSMCGTLEYM 316
           +HRDL   N L+  + +V++ DFGLA+   DE T              +  ++ G   +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEML 343
           +PE++ G+ +D+  D +S GI+L E++
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 98
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 99  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 158
Query: 277 KPENILLDADGHVMLTDFGLA---KQFDENTRSNSMCGTLEYMSPEIVLGKGHDK----- 328
           K  NI L  D  V + DFGLA    ++  + +   + G++ +M+PE++  +  DK     
Sbjct: 159 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI--RMQDKNPYSF 216
Query: 329 AADWWSVGILLFEMLTGQPPFTGGN 353
            +D ++ GI+L+E++TGQ P++  N
Sbjct: 217 QSDVYAFGIVLYELMTGQLPYSNIN 241

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 97
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 98  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 157
Query: 277 KPENILLDADGHVMLTDFGLA---KQFDENTRSNSMCGTLEYMSPEIVLGKGHDK----- 328
           K  NI L  D  V + DFGLA    ++  + +   + G++ +M+PE++  +  DK     
Sbjct: 158 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI--RMQDKNPYSF 215
Query: 329 AADWWSVGILLFEMLTGQPPFTGGN 353
            +D ++ GI+L+E++TGQ P++  N
Sbjct: 216 QSDVYAFGIVLYELMTGQLPYSNIN 240

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-----T 61
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +  L   DLA +  Y  ++
Sbjct: 62  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 117
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMS 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G L  ++M+
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           PE +  +    A+D W  G+ ++E+L  G  PF G
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-----T 64
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +  L   DLA +  Y  ++
Sbjct: 65  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMS 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G L  ++M+
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 180
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           PE +  +    A+D W  G+ ++E+L  G  PF G
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 107/215 (49%), Gaps = 22/215 (10%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL-----T 64
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +   F  DLA +  Y  ++
Sbjct: 65  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMS 317
            +A+++L +   +HRD+   N+L+ A   V L DFGL++  +++T   +  G L  ++M+
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 180
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           PE +  +    A+D W  G+ ++E+L  G  PF G
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL-----T 64
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +  L   DLA +  Y  ++
Sbjct: 65  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMS 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G L  ++M+
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 180
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           PE +  +    A+D W  G+ ++E+L  G  PF G
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 76
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCAKLTDDHVQFLIYQILRGL 134
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 192
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 107/215 (49%), Gaps = 22/215 (10%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL-----T 444
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +   F  DLA +  Y  ++
Sbjct: 445 MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 500
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMS 317
            +A+++L +   +HRD+   N+L+ A   V L DFGL++  +++T   +  G L  ++M+
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           PE +  +    A+D W  G+ ++E+L  G  PF G
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 105/216 (48%), Gaps = 11/216 (5%)
Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
           EN  V  +D E +  +G+GA+  V + R + + +I A+K +R    +     + +  + +
Sbjct: 27  ENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRA--TVNSQEQKRLLXDLD 84
Query: 203 ILTK-VDHPFIVQLRYSFQTKYRLYLVLDFVNGG--HLFFQLYRQG-LFREDLARIYTAE 258
           I  + VD PF V    +   +  +++  +  +      + Q+  +G    ED+       
Sbjct: 85  ISXRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVS 144
Query: 259 IVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMS 317
           IV A+ HLH+   ++HRD+KP N+L++A G V   DFG++    ++   +   G   Y +
Sbjct: 145 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXA 204
Query: 318 PEIV----LGKGHDKAADWWSVGILLFEMLTGQPPF 349
           PE +      KG+   +D WS+GI   E+   + P+
Sbjct: 205 PERINPELNQKGYSVKSDIWSLGITXIELAILRFPY 240

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL-----T 444
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +   F  DLA +  Y  ++
Sbjct: 445 MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 500
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMS 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G L  ++M+
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           PE +  +    A+D W  G+ ++E+L  G  PF G
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 99
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 157
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 158 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 215
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 216 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 246

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 100
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 158
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 159 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 216
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 247

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 100
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 158
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 159 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--XGXVATRWYRAPEIMLN 216
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 247

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 98/194 (50%), Gaps = 15/194 (7%)
Query: 161 GAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ 220
           G    + ++ R   SEI+A +  R+  +++     +M+ E N++  +D   +     S +
Sbjct: 67  GEKVAIKKLSRPFQSEIFAKRAYRELLLLK-----HMQHE-NVIGLLD---VFTPASSLR 117
Query: 221 TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN 280
             Y  YLV+ F+       Q      F E+  +    +++  + ++H+ G++HRDLKP N
Sbjct: 118 NFYDFYLVMPFMQTD---LQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGN 174
Query: 281 ILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILL 339
           + ++ D  + + DFGLA+  D          T  Y +PE++L   H ++  D WSVG ++
Sbjct: 175 LAVNEDCELKILDFGLARHAD--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIM 232
Query: 340 FEMLTGQPPFTGGN 353
            EMLTG+  F G +
Sbjct: 233 AEMLTGKTLFKGKD 246

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + K       HA+    E  +L  + H
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSK-PFQSIIHAKRTYRELRLLKHMKH 92
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 151 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 208
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 239

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 98/194 (50%), Gaps = 15/194 (7%)
Query: 161 GAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ 220
           G    + ++ R   SEI+A +  R+  +++     +M+ E N++  +D   +     S +
Sbjct: 49  GEKVAIKKLSRPFQSEIFAKRAYRELLLLK-----HMQHE-NVIGLLD---VFTPASSLR 99
Query: 221 TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN 280
             Y  YLV+ F+       Q      F E+  +    +++  + ++H+ G++HRDLKP N
Sbjct: 100 NFYDFYLVMPFMQTD---LQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGN 156
Query: 281 ILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILL 339
           + ++ D  + + DFGLA+  D          T  Y +PE++L   H ++  D WSVG ++
Sbjct: 157 LAVNEDCELKILDFGLARHAD--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIM 214
Query: 340 FEMLTGQPPFTGGN 353
            EMLTG+  F G +
Sbjct: 215 AEMLTGKTLFKGKD 228

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 76
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 192
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 155 LKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +G+G F KV    Y     GT E+ A+K ++ D      H    K E +IL  + H 
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHE 93
Query: 211 FIVQLRYSFQTK--YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            I++ +   +      L LV+++V  G L   L R  +    L  ++  +I   +++LHA
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLL-LFAQQICEGMAYLHA 152
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-----NTRSNSMCGTLEYMSPEIVLG 323
              +HRDL   N+LLD D  V + DFGLAK   E       R +       Y +PE +  
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWY-APECLKE 211
Query: 324 KGHDKAADWWSVGILLFEMLT 344
                A+D WS G+ L+E+LT
Sbjct: 212 YKFYYASDVWSFGVTLYELLT 232

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 76
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--AGFVATRWYRAPEIMLN 192
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 86
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 145 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 202
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 38/224 (16%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DF+ ++++G G F +V++ +     + Y ++ +       K + E  + E   L K+DH 
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRV-------KYNNEKAEREVKALAKLDHV 65
Query: 211 FIVQL----------------------------RYSFQTKYR-LYLVLDFVNGGHL--FF 239
            IV                              + S ++K + L++ ++F + G L  + 
Sbjct: 66  NIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI 125
Query: 240 QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ 299
           +  R     + LA     +I   V ++H+  ++HRDLKP NI L     V + DFGL   
Sbjct: 126 EKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 300 FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEML 343
              + +     GTL YMSPE +  + + K  D +++G++L E+L
Sbjct: 186 LKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 32  ERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 90
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 91  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 148
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 149 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 206
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 207 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 237

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--AGFVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 AMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--AGFVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 107/246 (43%), Gaps = 14/246 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V     + +    A+K + +       HA+    E  +L  + H
Sbjct: 51  ERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 109
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 110 ENVIGLLDVFTPATSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 167
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 168 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 225
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSE--AHSLL 380
             H +   D WSVG ++ E+LTG+  F G +               PA + S   +H   
Sbjct: 226 WMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEAR 285
Query: 381 KGVNSL 386
             +NSL
Sbjct: 286 NYINSL 291

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 108/224 (48%), Gaps = 13/224 (5%)
Query: 130 LGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM 189
           +G      D        + +++ ++L+ +G+G F  V      G     A+K ++ D   
Sbjct: 1   MGGSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT- 57
Query: 190 EKNHAEYMKSERNILTKVDHPFIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQG--L 246
               A+   +E +++T++ H  +VQL     + K  LY+V +++  G L   L  +G  +
Sbjct: 58  ----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV 113
Query: 247 FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS 306
              D    ++ ++  A+ +L  N  +HRDL   N+L+  D    ++DFGL K+      +
Sbjct: 114 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 173
Query: 307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
             +   +++ +PE +  K     +D WS GILL+E+ + G+ P+
Sbjct: 174 GKL--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 215

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 82
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 141 KYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 198
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 87/188 (46%), Gaps = 2/188 (1%)
Query: 166 VYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL 225
           VY+        I A+K+  +    +       + E     ++  P +V +    +   +L
Sbjct: 50  VYEAEDTVRERIVALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQL 109
Query: 226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA 285
           Y+    +NG  L   L RQG      A     +I SA+   HA G  HRD+KPENIL+ A
Sbjct: 110 YVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSA 169
Query: 286 DGHVMLTDFGLAK-QFDEN-TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEML 343
           D    L DFG+A    DE  T+  +  GTL Y +PE          AD +++  +L+E L
Sbjct: 170 DDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRADIYALTCVLYECL 229
Query: 344 TGQPPFTG 351
           TG PP+ G
Sbjct: 230 TGSPPYQG 237

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 86
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 145 KYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 202
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 155 LKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +G+G F KV    Y     GT E+ A+K ++ D      H    K E +IL  + H 
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--CGPQHRSGWKQEIDILRTLYHE 76
Query: 211 FIVQLRYSF--QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            I++ +     Q +  L LV+++V  G L   L R  +    L  ++  +I   +++LHA
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLL-LFAQQICEGMAYLHA 135
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-----NTRSNSMCGTLEYMSPEIVLG 323
              +HR+L   N+LLD D  V + DFGLAK   E       R +       Y +PE +  
Sbjct: 136 QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKE 194
Query: 324 KGHDKAADWWSVGILLFEMLT 344
                A+D WS G+ L+E+LT
Sbjct: 195 YKFYYASDVWSFGVTLYELLT 215

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 3/203 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS  +    + F+ L  +G G++ +V++VR      +YA+K         K+ A  +   
Sbjct: 48  PSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEV 107
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEI 259
            +      HP  V+L  +++    LYL  +   G  L       G    E     Y  + 
Sbjct: 108 GSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDT 166
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
           + A++HLH+ G++H D+KP NI L   G   L DFGL  +           G   YM+PE
Sbjct: 167 LLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE 226
Query: 320 IVLGKGHDKAADWWSVGILLFEM 342
           ++ G  +  AAD +S+G+ + E+
Sbjct: 227 LLQGS-YGTAADVFSLGLTILEV 248

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGXVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 70
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + T  +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 71  GYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 277 KPENILLDADGHVMLTDFGLA---KQFDENTRSNSMCGTLEYMSPEIVLGKGHDK----- 328
           K  NI L  D  V + DFGLA    ++  + +   + G++ +M+PE++  +  DK     
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI--RMQDKNPYSF 188
Query: 329 AADWWSVGILLFEMLTGQPPFTGGN 353
            +D ++ GI+L+E++TGQ P++  N
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 99
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 157
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 158 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 215
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 216 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 246

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 92
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 151 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 208
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 239

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 92
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 151 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 208
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 239

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 100
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 158
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 159 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 216
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 247

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 103
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 104 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 161
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 162 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 219
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 220 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 250

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 82
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 141 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 198
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 85
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 144 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 201
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 82
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 141 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 198
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 82
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 141 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 198
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 85
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 144 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 201
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 86
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 145 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 202
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 20  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 78
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 79  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 136
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 137 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 194
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 195 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 21  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 79
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 80  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 137
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 138 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 195
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 196 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 226

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 91
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 92  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 149
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 150 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 207
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 208 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 238

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 87
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 203
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 76
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 192
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 77
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 135
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 136 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 193
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 194 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 224

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 119/234 (50%), Gaps = 16/234 (6%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E  A+K+++ 
Sbjct: 13  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKP 72
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 73  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 124
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQF 300
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+L+D +   + L D+GLA+ +
Sbjct: 125 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFY 182
Query: 301 DENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                 N    +  +  PE+++  + +D + D WS+G +L  M+  + PF  G+
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 85
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 144 KYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 201
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 77
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 135
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 136 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 193
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 194 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 224

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGL +  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 91
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 92  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 149
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 150 KYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 207
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 208 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 238

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 110/231 (47%), Gaps = 26/231 (11%)
Query: 138 DNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYM 197
           +NL  ++  V    + +LK +G G  +KV+QV      +IYA+K +     +E+   + +
Sbjct: 16  ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN----LEEADNQTL 70
Query: 198 KSERNILTKVD----HPFIVQLRYSFQ-TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLA 252
            S RN +  ++    H   +   Y ++ T   +Y+V++  N   L   L ++        
Sbjct: 71  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWER 129
Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR---SNSM 309
           + Y   ++ AV  +H +GI+H DLKP N L+  DG + L DFG+A Q   +      +S 
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQ 188
Query: 310 CGTLEYMSPEIVLGKGHDK-----------AADWWSVGILLFEMLTGQPPF 349
            GT+ YM PE +      +            +D WS+G +L+ M  G+ PF
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 103
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 104 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 161
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 162 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--XGYVATRWYRAPEIMLN 219
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 220 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 250

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 86
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 145 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 202
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 106/216 (49%), Gaps = 13/216 (6%)
Query: 138 DNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYM 197
           D        + +++ ++L+ +G+G F  V      G     A+K ++ D       A+  
Sbjct: 181 DEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-----AQAF 233
Query: 198 KSERNILTKVDHPFIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARI 254
            +E +++T++ H  +VQL     + K  LY+V +++  G L   L  +G  +   D    
Sbjct: 234 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 293
Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE 314
           ++ ++  A+ +L  N  +HRDL   N+L+  D    ++DFGL K+      +  +   ++
Sbjct: 294 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVK 351
Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
           + +PE +  K     +D WS GILL+E+ + G+ P+
Sbjct: 352 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 387

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 108/207 (52%), Gaps = 20/207 (9%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  +KV+  D   E+  A   ++E  +L K  H  I+ L  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVV--DPTPEQFQA--FRNEVAVLRKTRHVNIL-LFM 98
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ----GLFRE-DLARIYTAEIVSAVSHLHANGIM 272
            + TK  L +V  +  G  L+  L+ Q     +F+  D+AR    +    + +LHA  I+
Sbjct: 99  GYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIAR----QTAQGMDYLHAKNII 154
Query: 273 HRDLKPENILLDADGHVMLTDFGLA---KQFDENTRSNSMCGTLEYMSPEIVLGKGHDK- 328
           HRD+K  NI L     V + DFGLA    ++  + +     G++ +M+PE++  + ++  
Sbjct: 155 HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPF 214
Query: 329 --AADWWSVGILLFEMLTGQPPFTGGN 353
              +D +S GI+L+E++TG+ P++  N
Sbjct: 215 SFQSDVYSYGIVLYELMTGELPYSHIN 241

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 105/207 (50%), Gaps = 13/207 (6%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           + +++ ++L+ +G+G F  V      G     A+K ++ D       A+   +E +++T+
Sbjct: 3   LNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-----AQAFLAEASVMTQ 55
Query: 207 VDHPFIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAV 263
           + H  +VQL     + K  LY+V +++  G L   L  +G  +   D    ++ ++  A+
Sbjct: 56  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            +L  N  +HRDL   N+L+  D    ++DFGL K+      +  +   +++ +PE +  
Sbjct: 116 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALRE 173
Query: 324 KGHDKAADWWSVGILLFEMLT-GQPPF 349
           K     +D WS GILL+E+ + G+ P+
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPY 200

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 155 LKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +G+G F KV    Y     GT E+ A+K ++ D      H    K E +IL  + H 
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--CGPQHRSGWKQEIDILRTLYHE 76
Query: 211 FIVQLRYSF--QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            I++ +     Q +  L LV+++V  G L   L R  +    L  ++  +I   +++LH+
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLL-LFAQQICEGMAYLHS 135
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-----NTRSNSMCGTLEYMSPEIVLG 323
              +HR+L   N+LLD D  V + DFGLAK   E       R +       Y +PE +  
Sbjct: 136 QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKE 194
Query: 324 KGHDKAADWWSVGILLFEMLT 344
                A+D WS G+ L+E+LT
Sbjct: 195 YKFYYASDVWSFGVTLYELLT 215

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  +G GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 27  ERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 85
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 144 KYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 201
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 104/227 (45%), Gaps = 28/227 (12%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK--------------DKIMEKNHA 194
           + D+ +++ + QG F K+    +   ++ YA+K   K              DKI  K+  
Sbjct: 30  INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 195 EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFV-NGGHLFFQLYRQGLFRE---- 249
           +  K+E  I+T + + + +           +Y++ +++ N   L F  Y   L +     
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 250 ---DLARIYTAEIVSAVSHLH-ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR 305
               + +     ++++ S++H    I HRD+KP NIL+D +G V L+DFG ++   +   
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 306 SNSMCGTLEYMSPEIVLGKGHDKAA--DWWSVGILLFEMLTGQPPFT 350
             S  GT E+M PE    +     A  D WS+GI L+ M     PF+
Sbjct: 208 KGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 111/210 (52%), Gaps = 10/210 (4%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQ---VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           +  ED  + +++G+G F +VY+       G     A+K  +KD  ++ N  ++M SE  I
Sbjct: 21  IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD-NKEKFM-SEAVI 78
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI-YTAEIVSA 262
           +  +DHP IV+L    + +   +++++    G L   L R     + L  + Y+ +I  A
Sbjct: 79  MKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 137
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCG-TLEYMSPEI 320
           +++L +   +HRD+   NIL+ +   V L DFGL++   DE+    S+    +++MSPE 
Sbjct: 138 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 197
Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
           +  +    A+D W   + ++E+L+ G+ PF
Sbjct: 198 INFRRFTTASDVWMFAVCMWEILSFGKQPF 227

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 104/207 (50%), Gaps = 13/207 (6%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           + +++ ++L+ +G+G F  V      G     A+K ++ D       A+   +E +++T+
Sbjct: 9   LNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-----AQAFLAEASVMTQ 61
Query: 207 VDHPFIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAV 263
           + H  +VQL     + K  LY+V +++  G L   L  +G  +   D    ++ ++  A+
Sbjct: 62  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 121
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            +L  N  +HRDL   N+L+  D    ++DFGL K+      +  +   +++ +PE +  
Sbjct: 122 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALRE 179
Query: 324 KGHDKAADWWSVGILLFEMLT-GQPPF 349
                 +D WS GILL+E+ + G+ P+
Sbjct: 180 AAFSTKSDVWSFGILLWEIYSFGRVPY 206

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + D+GLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 98/206 (47%), Gaps = 13/206 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMR---KDKIMEKNHAEYMKSERNILTK 206
           E + + + +G+G F  V++     + + Y  K ++    D+++       +K E +IL  
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-------VKKEISILNI 57
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEIVSAVSH 265
             H  I+ L  SF++   L ++ +F++G  +F ++        E     Y  ++  A+  
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117
Query: 266 LHANGIMHRDLKPENILLDA--DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           LH++ I H D++PENI+        + + +FG A+Q         +    EY +PE+   
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPF 349
                A D WS+G L++ +L+G  PF
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPF 203

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 111/210 (52%), Gaps = 10/210 (4%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQ---VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           +  ED  + +++G+G F +VY+       G     A+K  +KD  ++ N  ++M SE  I
Sbjct: 5   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD-NKEKFM-SEAVI 62
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI-YTAEIVSA 262
           +  +DHP IV+L    + +   +++++    G L   L R     + L  + Y+ +I  A
Sbjct: 63  MKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 121
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCG-TLEYMSPEI 320
           +++L +   +HRD+   NIL+ +   V L DFGL++   DE+    S+    +++MSPE 
Sbjct: 122 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 181
Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
           +  +    A+D W   + ++E+L+ G+ PF
Sbjct: 182 INFRRFTTASDVWMFAVCMWEILSFGKQPF 211

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 112/210 (53%), Gaps = 16/210 (7%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA----EYMKSERNILT 205
           +D+++++ +G+G +++V++   I  +E   +K+++  K  +        E ++   NI+T
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 96
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             D   IV+   S        LV + VN    F QLY Q L   D+ R Y  EI+ A+ +
Sbjct: 97  LAD---IVKDPVSRTPA----LVFEHVNNTD-FKQLY-QTLTDYDI-RFYMYEILKALDY 146
Query: 266 LHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG- 323
            H+ GIMHRD+KP N+++D +   + L D+GLA+ +      N    +  +  PE+++  
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           + +D + D WS+G +L  M+  + PF  G+
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 111/210 (52%), Gaps = 10/210 (4%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQ---VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           +  ED  + +++G+G F +VY+       G     A+K  +KD  ++ N  ++M SE  I
Sbjct: 9   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD-NKEKFM-SEAVI 66
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI-YTAEIVSA 262
           +  +DHP IV+L    + +   +++++    G L   L R     + L  + Y+ +I  A
Sbjct: 67  MKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 125
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCG-TLEYMSPEI 320
           +++L +   +HRD+   NIL+ +   V L DFGL++   DE+    S+    +++MSPE 
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 185
Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
           +  +    A+D W   + ++E+L+ G+ PF
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQPF 215

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 109/240 (45%), Gaps = 52/240 (21%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           K +G G+F  V +V  I + + +A+K + +D         Y   E +I+  +DH  I++L
Sbjct: 13  KTLGTGSFGIVCEVFDIESGKRFALKKVLQD-------PRYKNRELDIMKVLDHVNIIKL 65
Query: 216 RYSF---------------------------------------QTKYRLYLVLDFVNGG- 235
              F                                       Q KY L +++++V    
Sbjct: 66  VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY-LNVIMEYVPDTL 124
Query: 236 -HLFFQLYRQGL-FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHVMLT 292
             +     R G     +L  IY  ++  AV  +H+ GI HRD+KP+N+L+++ D  + L 
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLC 184
Query: 293 DFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG-HDKAADWWSVGILLFEMLTGQPPFTG 351
           DFG AK+   +  S +   +  Y +PE++LG   +  + D WS+G +  E++ G+P F+G
Sbjct: 185 DFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG 244

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 117/234 (50%), Gaps = 16/234 (6%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 13  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 72
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN     F+ 
Sbjct: 73  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD--FKQ 123
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQF 300
            RQ L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ +
Sbjct: 124 LRQTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 182
Query: 301 DENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                 N    +  +  PE+++  + +D + D WS+G +L  M+  + PF  G+
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 118/234 (50%), Gaps = 16/234 (6%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 13  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 72
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 73  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 124
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQF 300
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ +
Sbjct: 125 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 182
Query: 301 DENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                 N    +  +  PE+++  + +D + D WS+G +L  M+  + PF  G+
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 118/234 (50%), Gaps = 16/234 (6%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 13  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 72
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 73  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 124
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQF 300
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ +
Sbjct: 125 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 182
Query: 301 DENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                 N    +  +  PE+++  + +D + D WS+G +L  M+  + PF  G+
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 118/234 (50%), Gaps = 16/234 (6%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 13  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 72
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 73  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 124
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQF 300
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ +
Sbjct: 125 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 182
Query: 301 DENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                 N    +  +  PE+++  + +D + D WS+G +L  M+  + PF  G+
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 14/212 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 87
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVL 322
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+   DE T       T  Y +PEI+L
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT---GYVATRWYRAPEIML 202
Query: 323 GKGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
              H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 118/234 (50%), Gaps = 16/234 (6%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 18  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 77
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 78  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 129
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQF 300
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ +
Sbjct: 130 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 187
Query: 301 DENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                 N    +  +  PE+++  + +D + D WS+G +L  M+  + PF  G+
Sbjct: 188 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 241

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 118/234 (50%), Gaps = 16/234 (6%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 13  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 72
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 73  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 124
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQF 300
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ +
Sbjct: 125 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 182
Query: 301 DENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                 N    +  +  PE+++  + +D + D WS+G +L  M+  + PF  G+
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 118/234 (50%), Gaps = 16/234 (6%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 12  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 71
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 72  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 123
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQF 300
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ +
Sbjct: 124 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181
Query: 301 DENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                 N    +  +  PE+++  + +D + D WS+G +L  M+  + PF  G+
Sbjct: 182 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 118/234 (50%), Gaps = 16/234 (6%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 12  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 71
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 72  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 123
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQF 300
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ +
Sbjct: 124 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181
Query: 301 DENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                 N    +  +  PE+++  + +D + D WS+G +L  M+  + PF  G+
Sbjct: 182 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 118/234 (50%), Gaps = 16/234 (6%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 13  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 72
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 73  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 124
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQF 300
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ +
Sbjct: 125 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 182
Query: 301 DENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                 N    +  +  PE+++  + +D + D WS+G +L  M+  + PF  G+
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 118/234 (50%), Gaps = 16/234 (6%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 13  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 72
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 73  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 124
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQF 300
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ +
Sbjct: 125 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 182
Query: 301 DENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                 N    +  +  PE+++  + +D + D WS+G +L  M+  + PF  G+
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 118/234 (50%), Gaps = 16/234 (6%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 13  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 72
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 73  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 124
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQF 300
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ +
Sbjct: 125 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 182
Query: 301 DENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                 N    +  +  PE+++  + +D + D WS+G +L  M+  + PF  G+
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 14/212 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 87
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVL 322
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+   DE T       T  Y +PEI+L
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT---GYVATRWYRAPEIML 202
Query: 323 GKGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
              H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 118/234 (50%), Gaps = 16/234 (6%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 11  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 70
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 71  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 122
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQF 300
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ +
Sbjct: 123 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180
Query: 301 DENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                 N    +  +  PE+++  + +D + D WS+G +L  M+  + PF  G+
Sbjct: 181 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 14/212 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 87
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVL 322
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+   DE T       T  Y +PEI+L
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT---GYVATRWYRAPEIML 202
Query: 323 GKGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
              H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 109/214 (50%), Gaps = 21/214 (9%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  +++K +G G F +V+     G +++ A+K ++   +  ++  E    E  I+ K+ H
Sbjct: 9   ESLQLIKRLGNGQFGEVWMGTWNGNTKV-AIKTLKPGTMSPESFLE----EAQIMKKLKH 63
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-------DLARIYTAEIVSA 262
             +VQL Y+  ++  +Y+V +++N G L     + G  R        D+A    A++ + 
Sbjct: 64  DKLVQL-YAVVSEEPIYIVTEYMNKGSLL-DFLKDGEGRALKLPNLVDMA----AQVAAG 117
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEI 320
           ++++     +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE 
Sbjct: 118 MAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEA 177
Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGN 353
            L       +D WS GILL E++T G+ P+ G N
Sbjct: 178 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 211

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 26/217 (11%)
Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
           ++ +G+G F+ V  V  +     YA+K   +    E+   E  + E ++    +HP I++
Sbjct: 34  IQKLGEGGFSYVDLVEGLHDGHFYALK---RILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 215 L-RYSFQ---TKYRLYLVLDFVNGGHLFFQLYR---QGLF-REDLARIYTAEIVSAVSHL 266
           L  Y  +    K+  +L+L F   G L+ ++ R   +G F  ED        I   +  +
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQ---FDENTR--------SNSMCGTLEY 315
           HA G  HRDLKP NILL  +G  +L D G   Q     E +R        +   C T+ Y
Sbjct: 151 HAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC-TISY 209
Query: 316 MSPEIVLGKGH---DKAADWWSVGILLFEMLTGQPPF 349
            +PE+   + H   D+  D WS+G +L+ M+ G+ P+
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 100/199 (50%), Gaps = 11/199 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 23  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 76
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V +++N G L  F +       R       +A+I S ++++     +HRD
Sbjct: 77  AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 334 SVGILLFEMLT-GQPPFTG 351
           S GILL E+ T G+ P+ G
Sbjct: 197 SFGILLTELTTKGRVPYPG 215

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DF LA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 100/199 (50%), Gaps = 11/199 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 23  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 76
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V +++N G L  F +       R       +A+I S ++++     +HRD
Sbjct: 77  AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 334 SVGILLFEMLT-GQPPFTG 351
           S GILL E+ T G+ P+ G
Sbjct: 197 SFGILLTELTTKGRVPYPG 215

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 105/203 (51%), Gaps = 17/203 (8%)
Query: 158 VGQGAFAKVYQ-VRRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +G G F  V Q V R+   +I  A+KV+++    EK   E M  E  I+ ++D+P+IV+L
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS----HLHANGI 271
               Q +  L LV++   GG L   L  +   RE++     AE++  VS    +L     
Sbjct: 76  IGVCQAE-ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LEYMSPEIVLGKGHD 327
           +HRDL   N+LL    +  ++DFGL+K    D++  +    G   L++ +PE +  +   
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 328 KAADWWSVGILLFEMLT-GQPPF 349
             +D WS G+ ++E L+ GQ P+
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKPY 214

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + +  FGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 103/216 (47%), Gaps = 14/216 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +++E+++ +G GA+  V   RR  T +  A+K +     +  N    ++ E  IL    H
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKH 113
Query: 210 PFIVQLRYSFQTKY------RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             I+ ++   +          +Y+VLD +           Q L  E + R +  +++  +
Sbjct: 114 DNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHV-RYFLYQLLRGL 172
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS-----MCGTLEYMSP 318
            ++H+  ++HRDLKP N+L++ +  + + DFG+A+    +   +         T  Y +P
Sbjct: 173 KYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 232
Query: 319 EIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           E++L    + +A D WSVG +  EML  +  F G N
Sbjct: 233 ELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 268

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 105/207 (50%), Gaps = 11/207 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++ K +G G F +V+       +++ A+K M+   +      E   +E N++  + H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 242
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
             +V+L ++  TK  +Y++ +F+  G L   L      ++ L ++  ++A+I   ++ + 
Sbjct: 243 DKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKG 325
               +HRDL+  NIL+ A     + DFGLA+  ++N  T        +++ +PE +    
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 361
Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTG 351
               +D WS GILL E++T G+ P+ G
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPG 388

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 105/207 (50%), Gaps = 11/207 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++ K +G G F +V+       +++ A+K M+   +      E   +E N++  + H
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 69
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
             +V+L ++  TK  +Y++ +F+  G L   L      ++ L ++  ++A+I   ++ + 
Sbjct: 70  DKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 128
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKG 325
               +HRDL+  NIL+ A     + DFGLA+  ++N  T        +++ +PE +    
Sbjct: 129 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 188
Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTG 351
               +D WS GILL E++T G+ P+ G
Sbjct: 189 FTIKSDVWSFGILLMEIVTYGRIPYPG 215

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 114/240 (47%), Gaps = 17/240 (7%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY-MKSERNILTKVDHPFIVQL 215
           ++G+G++ KV +V    T    A+K+++K K+    + E  +K E  +L ++ H  ++QL
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 216 RYSF--QTKYRLYLVLDF-VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
                 + K ++Y+V+++ V G         +  F    A  Y  +++  + +LH+ GI+
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIV 131
Query: 273 HRDLKPENILLDADGHVMLTDFGLAKQF-----DENTRSNSMCGTLEYMSPEIVLGKGHD 327
           H+D+KP N+LL   G + ++  G+A+       D+  R++   G+  +  PEI    G D
Sbjct: 132 HKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSPAFQPPEIA--NGLD 187
Query: 328 K----AADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGV 383
                  D WS G+ L+ + TG  PF G N              +P         LLKG+
Sbjct: 188 TFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGM 247

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + D GLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + D GLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 17/203 (8%)
Query: 158 VGQGAFAKVYQ-VRRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +G G F  V Q V R+   +I  A+KV+++    EK   E M  E  I+ ++D+P+IV+L
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS----HLHANGI 271
               Q +  L LV++   GG L   L  +   RE++     AE++  VS    +L     
Sbjct: 402 IGVCQAE-ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LEYMSPEIVLGKGHD 327
           +HR+L   N+LL    +  ++DFGL+K    D++  +    G   L++ +PE +  +   
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 328 KAADWWSVGILLFEMLT-GQPPF 349
             +D WS G+ ++E L+ GQ P+
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPY 540

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 115/236 (48%), Gaps = 34/236 (14%)
Query: 139 NLPSENQCV-GLEDFEVLKVVGQGAFAKVYQVRRIGTSEI--YAMKVMRKDKIMEKNHAE 195
            L SE + V  L ++E  KV G+G +  VY+ +R    +   YA+K +    I       
Sbjct: 10  KLSSERERVEDLFEYEGCKV-GRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS------ 62
Query: 196 YMKSERNI--LTKVDHPFIVQLRYSF--QTKYRLYLVLDFVNGG--HLFFQLYRQGLFRE 249
            M + R I  L ++ HP ++ L+  F      +++L+ D+      H+  + +R     +
Sbjct: 63  -MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHII-KFHRASKANK 120
Query: 250 D-------LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD----GHVMLTDFGLAK 298
                   + +    +I+  + +LHAN ++HRDLKP NIL+  +    G V + D G A+
Sbjct: 121 KPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180
Query: 299 QFDENTRS----NSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPF 349
            F+   +     + +  T  Y +PE++LG  H  KA D W++G +  E+LT +P F
Sbjct: 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 102/216 (47%), Gaps = 14/216 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +++E+++ +G GA+  V   RR  T +  A+K +     +  N    ++ E  IL    H
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKH 112
Query: 210 PFIVQLRYSFQTKY------RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             I+ ++   +          +Y+VLD +           Q L  E + R +  +++  +
Sbjct: 113 DNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHV-RYFLYQLLRGL 171
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-----DENTRSNSMCGTLEYMSP 318
            ++H+  ++HRDLKP N+L++ +  + + DFG+A+       +          T  Y +P
Sbjct: 172 KYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 231
Query: 319 EIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           E++L    + +A D WSVG +  EML  +  F G N
Sbjct: 232 ELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 267

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + D GLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 108/221 (48%), Gaps = 12/221 (5%)
Query: 141 PSENQCVGLEDFEV--LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK---DKIMEKNHAE 195
           P++ Q   L++ E+  +KV+G GAF  VY+   +   E   + V  K   +    K + E
Sbjct: 27  PNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE 86
Query: 196 YMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARI 254
           +M  E  I+  +DHP +V+L         + LV   +  G L   ++  +      L   
Sbjct: 87  FM-DEALIMASMDHPHLVRL-LGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN 144
Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG--- 311
           +  +I   + +L    ++HRDL   N+L+ +  HV +TDFGLA+  + + +  +  G   
Sbjct: 145 WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 204
Query: 312 TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +++M+ E +  +     +D WS G+ ++E++T G  P+ G
Sbjct: 205 PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 245

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     IME   A   K+ + IL +    
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIMELREATSPKANKEILDEAYVM 105
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 106 ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 163
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 164 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 223
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 224 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 256

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 11/199 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V+++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 334 SVGILLFEMLT-GQPPFTG 351
           S GILL E+ T G+ P+ G
Sbjct: 200 SFGILLTELTTKGRVPYPG 218

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 11/199 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V+++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 334 SVGILLFEMLT-GQPPFTG 351
           S GILL E+ T G+ P+ G
Sbjct: 200 SFGILLTELTTKGRVPYPG 218

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 72/128 (56%), Gaps = 5/128 (3%)
Query: 227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD-A 285
           LV +++N    F QLY Q L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D  
Sbjct: 112 LVFEYINNTD-FKQLY-QILTDFDI-RFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQ 168
Query: 286 DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLT 344
              + L D+GLA+ +      N    +  +  PE+++  + +D + D WS+G +L  M+ 
Sbjct: 169 QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 228
Query: 345 GQPPFTGG 352
            + PF  G
Sbjct: 229 RREPFFHG 236

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 275 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 328
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 329 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 388
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 334 SVGILLFEMLT-GQPPFTG 351
           S GILL E+ T G+ P+ G
Sbjct: 449 SFGILLTELTTKGRVPYPG 467

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 11/199 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V+++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 334 SVGILLFEMLT-GQPPFTG 351
           S GILL E+ T G+ P+ G
Sbjct: 200 SFGILLTELTTKGRVPYPG 218

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKIRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 334 SVGILLFEMLT-GQPPFTG 351
           S GILL E+ T G+ P+ G
Sbjct: 200 SFGILLTELTTKGRVPYPG 218

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 72/128 (56%), Gaps = 5/128 (3%)
Query: 227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD-A 285
           LV +++N    F QLY Q L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D  
Sbjct: 117 LVFEYINNTD-FKQLY-QILTDFDI-RFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQ 173
Query: 286 DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLT 344
              + L D+GLA+ +      N    +  +  PE+++  + +D + D WS+G +L  M+ 
Sbjct: 174 QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 233
Query: 345 GQPPFTGG 352
            + PF  G
Sbjct: 234 RREPFFHG 241

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F  V+    +   ++ A+K +R+  + E++  E    E  ++ K+ HP +VQL  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYG 69
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L   L  Q GLF  +       ++   +++L    ++HRDL
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDL 129
Query: 277 KPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWS 334
              N L+  +  + ++DFG+ +    D+ T S      +++ SPE+     +   +D WS
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 335 VGILLFEMLT-GQPPF 349
            G+L++E+ + G+ P+
Sbjct: 190 FGVLMWEVFSEGKIPY 205

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 110/209 (52%), Gaps = 15/209 (7%)
Query: 153 EVLKVVGQGAFAKVYQ--VRRIGTSE-IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++ +V+G G F +V +  ++  G  E   A+K + K    E+   E++ SE +I+ + +H
Sbjct: 19  KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTL-KGGYTERQRREFL-SEASIMGQFEH 76
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           P I++L         + ++ +F+  G L  F +L   G F           I S + +L 
Sbjct: 77  PNIIRLEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRGIASGMRYLA 135
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGT--LEYMSPEIV 321
               +HRDL   NIL++++    ++DFGL++  +EN    T ++S+ G   + + +PE +
Sbjct: 136 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAI 195
Query: 322 LGKGHDKAADWWSVGILLFEMLT-GQPPF 349
             +    A+D WS GI+++E+++ G+ P+
Sbjct: 196 AFRKFTSASDAWSYGIVMWEVMSFGERPY 224

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 75
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L++  +  G L  + + ++  +  + L   +  +I   
Sbjct: 76  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 133
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 134 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 193
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 194 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 226

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 334 SVGILLFEMLT-GQPPFTG 351
           S GILL E+ T G+ P+ G
Sbjct: 200 SFGILLTELTTKGRVPYPG 218

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 72
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L++  +  G L  + + ++  +  + L   +  +I   
Sbjct: 73  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGXLLDYVREHKDNIGSQYLLN-WCVQIAKG 130
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 131 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 190
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 191 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 223

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 108/221 (48%), Gaps = 12/221 (5%)
Query: 141 PSENQCVGLEDFEV--LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK---DKIMEKNHAE 195
           P++ Q   L++ E+  +KV+G GAF  VY+   +   E   + V  K   +    K + E
Sbjct: 4   PNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE 63
Query: 196 YMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARI 254
           +M  E  I+  +DHP +V+L         + LV   +  G L   ++  +      L   
Sbjct: 64  FM-DEALIMASMDHPHLVRL-LGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN 121
Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG--- 311
           +  +I   + +L    ++HRDL   N+L+ +  HV +TDFGLA+  + + +  +  G   
Sbjct: 122 WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 181
Query: 312 TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +++M+ E +  +     +D WS G+ ++E++T G  P+ G
Sbjct: 182 PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 222

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F  V+    +   ++ A+K +R+  + E++  E    E  ++ K+ HP +VQL  
Sbjct: 13  IGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYG 67
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L   L  Q GLF  +       ++   +++L    ++HRDL
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 127
Query: 277 KPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWS 334
              N L+  +  + ++DFG+ +    D+ T S      +++ SPE+     +   +D WS
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 187
Query: 335 VGILLFEMLT-GQPPF 349
            G+L++E+ + G+ P+
Sbjct: 188 FGVLMWEVFSEGKIPY 203

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 19  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 72
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 73  AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 132
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 133 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 192
Query: 334 SVGILLFEMLT-GQPPFTG 351
           S GILL E+ T G+ P+ G
Sbjct: 193 SFGILLTELTTKGRVPYPG 211

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F  V+    +   ++ A+K +R+  + E++  E    E  ++ K+ HP +VQL  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYG 69
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L   L  Q GLF  +       ++   +++L    ++HRDL
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 129
Query: 277 KPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWS 334
              N L+  +  + ++DFG+ +    D+ T S      +++ SPE+     +   +D WS
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 335 VGILLFEMLT-GQPPF 349
            G+L++E+ + G+ P+
Sbjct: 190 FGVLMWEVFSEGKIPY 205

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 104/217 (47%), Gaps = 11/217 (5%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           +P +   +  ED  + + +G+G F +V+  R    + + A+K  R + +     A++++ 
Sbjct: 104 VPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQE 162
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAE 258
            R IL +  HP IV+L      K  +Y+V++ V GG     L  +G   R         +
Sbjct: 163 AR-ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGD 221
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL----- 313
             + + +L +   +HRDL   N L+     + ++DFG++++  +   + S  G L     
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAAS--GGLRQVPV 279
Query: 314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
           ++ +PE +    +   +D WS GILL+E  + G  P+
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L++  +  G L  + + ++  +  + L   +  +I   
Sbjct: 74  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 131
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 132 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 14/207 (6%)
Query: 155 LKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           +KV+G GAF  VY+   I   E      A+KV+R++   + N    +  E  ++  V  P
Sbjct: 22  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKE--ILDEAYVMAGVGSP 79
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY--RQGLFREDLARIYTAEIVSAVSHLHA 268
           ++ +L         + LV   +  G L   +   R  L  +DL   +  +I   +S+L  
Sbjct: 80  YVSRL-LGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLN-WCMQIAKGMSYLED 137
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGT--LEYMSPEIVLGKG 325
             ++HRDL   N+L+ +  HV +TDFGLA+  D + T  ++  G   +++M+ E +L + 
Sbjct: 138 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRR 197
Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTG 351
               +D WS G+ ++E++T G  P+ G
Sbjct: 198 FTHQSDVWSYGVTVWELMTFGAKPYDG 224

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 245
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 246 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 334 SVGILLFEMLT-GQPPFTG 351
           S GILL E+ T G+ P+ G
Sbjct: 366 SFGILLTELTTKGRVPYPG 384

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L++  +  G L  + + ++  +  + L   +  +I   
Sbjct: 75  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 132
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 133 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL------ 204
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL      
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 72
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L++  +  G L  + + ++  +  + L   +  +I   
Sbjct: 73  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 130
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 131 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 190
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 191 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 223

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 245
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 246 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 334 SVGILLFEMLT-GQPPFTG 351
           S GILL E+ T G+ P+ G
Sbjct: 366 SFGILLTELTTKGRVPYPG 384

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 15  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 68
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 69  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 128
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 129 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 188
Query: 334 SVGILLFEMLT-GQPPFTG 351
           S GILL E+ T G+ P+ G
Sbjct: 189 SFGILLTELTTKGRVPYPG 207

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L++  +  G L  + + ++  +  + L   +  +I   
Sbjct: 72  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 129
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F  V+    +   ++ A+K +R+  + E++  E    E  ++ K+ HP +VQL  
Sbjct: 18  IGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYG 72
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L   L  Q GLF  +       ++   +++L    ++HRDL
Sbjct: 73  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 132
Query: 277 KPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWS 334
              N L+  +  + ++DFG+ +    D+ T S      +++ SPE+     +   +D WS
Sbjct: 133 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 192
Query: 335 VGILLFEMLT-GQPPF 349
            G+L++E+ + G+ P+
Sbjct: 193 FGVLMWEVFSEGKIPY 208

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 104/206 (50%), Gaps = 13/206 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D   LK +G G F  V   +  G  ++ A+K++++  + E    E    E  ++  + H
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMNLSH 78
Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             +VQL Y   TK R ++++ +++  G L  + +  R     + L  +   ++  A+ +L
Sbjct: 79  EKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYL 136
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGK 324
            +   +HRDL   N L++  G V ++DFGL++    DE T S      + +  PE+++  
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYS 196
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPF 349
                +D W+ G+L++E+ + G+ P+
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMPY 222

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 334 SVGILLFEMLT-GQPPFTG 351
           S GILL E+ T G+ P+ G
Sbjct: 200 SFGILLTELTTKGRVPYPG 218

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 17  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 70
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 71  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 130
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 131 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 334 SVGILLFEMLT-GQPPFTG 351
           S GILL E+ T G+ P+ G
Sbjct: 191 SFGILLTELTTKGRVPYPG 209

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 104/217 (47%), Gaps = 11/217 (5%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           +P +   +  ED  + + +G+G F +V+  R    + + A+K  R + +     A++++ 
Sbjct: 104 VPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQE 162
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAE 258
            R IL +  HP IV+L      K  +Y+V++ V GG     L  +G   R         +
Sbjct: 163 AR-ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGD 221
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL----- 313
             + + +L +   +HRDL   N L+     + ++DFG++++  +   + S  G L     
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS--GGLRQVPV 279
Query: 314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
           ++ +PE +    +   +D WS GILL+E  + G  P+
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 27/222 (12%)
Query: 152 FEVLKVVGQGAFAKVYQV--RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +E++  +G+GAF KV +    + G   +    V   D+  E   +E    E    T  + 
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 210 PF-IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHL 266
            F  VQ+   F+    + +V + + G   +  +   G   FR D  R    +I  +V+ L
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134
Query: 267 HANGIMHRDLKPENILLDADGH-------------------VMLTDFGLAKQFDENTRSN 307
           H+N + H DLKPENIL     +                   + + DFG A   DE+   +
Sbjct: 135 HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HS 192
Query: 308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           ++  T  Y +PE++L  G  +  D WS+G +L E   G   F
Sbjct: 193 TLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 15/199 (7%)
Query: 157 VVGQGAFAKVYQ-VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-LTKVDHPFIVQ 214
           ++G G F KVY+ V R G       KV  K +  E +            L+   HP +V 
Sbjct: 46  LIGHGVFGKVYKGVLRDGA------KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVS 99
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV----SAVSHLHANG 270
           L      +  + L+  ++  G+L   LY   L    ++     EI       + +LH   
Sbjct: 100 LIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA 159
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           I+HRD+K  NILLD +    +TDFG++K   + D+      + GTL Y+ PE  +     
Sbjct: 160 IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLT 219
Query: 328 KAADWWSVGILLFEMLTGQ 346
           + +D +S G++LFE+L  +
Sbjct: 220 EKSDVYSFGVVLFEVLCAR 238

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 52/99 (52%), Gaps = 13/99 (13%)
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-------- 309
           +I  AV  LH+ G+MHRDLKP NI    D  V + DFGL    D++    ++        
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231
Query: 310 -----CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEML 343
                 GT  YMSPE + G  +    D +S+G++LFE+L
Sbjct: 232 THXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 334 SVGILLFEMLT-GQPPFTG 351
           S GILL E+ T G+ P+ G
Sbjct: 200 SFGILLTELTTKGRVPYPG 218

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 105/220 (47%), Gaps = 28/220 (12%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           CV +E     +V+G G F +V    ++  G  EI+      K    EK   +++ SE +I
Sbjct: 34  CVKIE-----QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFL-SEASI 87
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV--- 260
           + + DHP ++ L         + ++ +F+  G L          R++  +    ++V   
Sbjct: 88  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL------DSFLRQNDGQFTVIQLVGML 141
Query: 261 ----SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--- 313
               + + +L     +HRDL   NIL++++    ++DFGL++  +++T   +    L   
Sbjct: 142 RGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 201
Query: 314 ---EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
               + +PE +  +    A+D WS GI+++E+++ G+ P+
Sbjct: 202 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 241

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 151 DFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +  + KVVG G F +V   +++     EI       K    EK   +++  E +I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------S 261
           HP I++L         + +V +++  G L          R+  A+    ++V       S
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEY 315
            + +L   G +HRDL   NIL++++    ++DFGLA+  +++      TR   +   + +
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKI--PIRW 216
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            SPE +  +    A+D WS GI+L+E+++ G+ P+
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F  V+    +   ++ A+K +R+  + E++  E    E  ++ K+ HP +VQL  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYG 70
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L   L  Q GLF  +       ++   +++L    ++HRDL
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 130
Query: 277 KPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWS 334
              N L+  +  + ++DFG+ +    D+ T S      +++ SPE+     +   +D WS
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 335 VGILLFEMLT-GQPPF 349
            G+L++E+ + G+ P+
Sbjct: 191 FGVLMWEVFSEGKIPY 206

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 110/209 (52%), Gaps = 15/209 (7%)
Query: 153 EVLKVVGQGAFAKVYQ--VRRIGTSE-IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++ +V+G G F +V +  ++  G  E   A+K + K    E+   E++ SE +I+ + +H
Sbjct: 17  KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTL-KGGYTERQRREFL-SEASIMGQFEH 74
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           P I++L         + ++ +F+  G L  F +L   G F           I S + +L 
Sbjct: 75  PNIIRLEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRGIASGMRYLA 133
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGT--LEYMSPEIV 321
               +HRDL   NIL++++    ++DFGL++  +EN    T ++S+ G   + + +PE +
Sbjct: 134 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAI 193
Query: 322 LGKGHDKAADWWSVGILLFEMLT-GQPPF 349
             +    A+D WS GI+++E+++ G+ P+
Sbjct: 194 AFRKFTSASDAWSYGIVMWEVMSFGERPY 222

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 104/206 (50%), Gaps = 13/206 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D   LK +G G F  V   +  G  ++ A+K++++  + E    E    E  ++  + H
Sbjct: 9   KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMNLSH 63
Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             +VQL Y   TK R ++++ +++  G L  + +  R     + L  +   ++  A+ +L
Sbjct: 64  EKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYL 121
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGK 324
            +   +HRDL   N L++  G V ++DFGL++    DE T S      + +  PE+++  
Sbjct: 122 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYS 181
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPF 349
                +D W+ G+L++E+ + G+ P+
Sbjct: 182 KFSSKSDIWAFGVLMWEIYSLGKMPY 207

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 104/206 (50%), Gaps = 13/206 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D   LK +G G F  V   +  G  ++ A+K++++  + E    E    E  ++  + H
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMNLSH 78
Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             +VQL Y   TK R ++++ +++  G L  + +  R     + L  +   ++  A+ +L
Sbjct: 79  EKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYL 136
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGK 324
            +   +HRDL   N L++  G V ++DFGL++    DE T S      + +  PE+++  
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 196
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPF 349
                +D W+ G+L++E+ + G+ P+
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMPY 222

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 64/116 (55%), Gaps = 6/116 (5%)
Query: 244 QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDE 302
           QG   E+ AR++  +++  + ++H+  ++HRDLKP N+ ++ +  V+ + DFGLA+  D 
Sbjct: 114 QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173
Query: 303 NTRSNSMCG----TLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +            T  Y SP ++L    + KA D W+ G +  EMLTG+  F G +
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 245
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 246 AVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 334 SVGILLFEMLT-GQPPFTG 351
           S GILL E+ T G+ P+ G
Sbjct: 366 SFGILLTELTTKGRVPYPG 384

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 74  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 131
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 132 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 77
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 78  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 135
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 136 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 195
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 196 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 228

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 75  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 132
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 133 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 72  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGXLLDYVREHKDNIGSQYLLN-WCVQIAKG 129
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 75  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 132
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 133 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL------ 204
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL      
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 79  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 136
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 137 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 229

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 16/219 (7%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRR------IGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           +G +D  +L+ +G G+F  V   RR       G +   A+K ++ D + +    +    E
Sbjct: 15  IGEKDLRLLEKLGDGSFGVV---RRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 71
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEI 259
            N +  +DH  +++L Y       + +V +    G L  +L + QG F       Y  ++
Sbjct: 72  VNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 130
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG----TLEY 315
              + +L +   +HRDL   N+LL     V + DFGL +   +N     M         +
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 190
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGN 353
            +PE +  +    A+D W  G+ L+EM T GQ P+ G N
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L   NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 140 LAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 334 SVGILLFEMLT-GQPPFTG 351
           S GILL E+ T G+ P+ G
Sbjct: 200 SFGILLTELTTKGRVPYPG 218

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 72  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 129
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 109/206 (52%), Gaps = 13/206 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E+  +LK +G G F  V   +  G  ++ A+K++++  + E    +    E   + K+ H
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSMSEDEFFQ----EAQTMMKLSH 62
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           P +V+       +Y +Y+V ++++ G L  + + + +GL    L  +   ++   ++ L 
Sbjct: 63  PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM-CYDVCEGMAFLE 121
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT---LEYMSPEIVLGK 324
           ++  +HRDL   N L+D D  V ++DFG+ +   ++   +S+ GT   +++ +PE+    
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV-GTKFPVKWSAPEVFHYF 180
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPF 349
            +   +D W+ GIL++E+ + G+ P+
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMPY 206

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 151 DFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +  + KVVG G F +V   +++     EI       K    EK   +++  E +I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------S 261
           HP I++L         + +V +++  G L          R+  A+    ++V       S
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEY 315
            + +L   G +HRDL   NIL++++    ++DFGL++  +++      TR   +   + +
Sbjct: 159 GMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 216
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            SPE +  +    A+D WS GI+L+E+++ G+ P+
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 75  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 132
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 133 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 115/233 (49%), Gaps = 16/233 (6%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 8   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 67
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 68  KKKKIKREIKILQNLXGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 118
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFD 301
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ + 
Sbjct: 119 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 177
Query: 302 ENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                N    +  +  PE+++  + +D + D WS+G +   M+  + PF  G+
Sbjct: 178 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 230

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 115/233 (49%), Gaps = 16/233 (6%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 8   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 67
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 68  KKKKIKREIKILQNLXGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 118
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFD 301
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ + 
Sbjct: 119 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 177
Query: 302 ENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                N    +  +  PE+++  + +D + D WS+G +   M+  + PF  G+
Sbjct: 178 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 230

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 104/206 (50%), Gaps = 13/206 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D   LK +G G F  V   +  G  ++ A+K++++  + E    E    E  ++  + H
Sbjct: 15  KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMNLSH 69
Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             +VQL Y   TK R ++++ +++  G L  + +  R     + L  +   ++  A+ +L
Sbjct: 70  EKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYL 127
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGK 324
            +   +HRDL   N L++  G V ++DFGL++    DE T S      + +  PE+++  
Sbjct: 128 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 187
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPF 349
                +D W+ G+L++E+ + G+ P+
Sbjct: 188 KFSSKSDIWAFGVLMWEIYSLGKMPY 213

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 96
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 97  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 154
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 155 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 214
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 215 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 247

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 16/219 (7%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRR------IGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           +G +D  +L+ +G G+F     VRR       G +   A+K ++ D + +    +    E
Sbjct: 5   IGEKDLRLLEKLGDGSFG---VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEI 259
            N +  +DH  +++L Y       + +V +    G L  +L + QG F       Y  ++
Sbjct: 62  VNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG----TLEY 315
              + +L +   +HRDL   N+LL     V + DFGL +   +N     M         +
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 180
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGN 353
            +PE +  +    A+D W  G+ L+EM T GQ P+ G N
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 193 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGNM----SPEAFLQEAQVMKKLRHEKLVQL-Y 246
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 247 AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 306
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGL +  ++N  T        +++ +PE  L       +D W
Sbjct: 307 LRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 366
Query: 334 SVGILLFEMLT-GQPPFTG 351
           S GILL E+ T G+ P+ G
Sbjct: 367 SFGILLTELTTKGRVPYPG 385

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 97/196 (49%), Gaps = 9/196 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F  V+    +   ++ A+K +++  + E +  E    E  ++ K+ HP +VQL  
Sbjct: 35  IGSGQFGLVHLGYWLNKDKV-AIKTIKEGSMSEDDFIE----EAEVMMKLSHPKLVQLYG 89
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L   L  Q GLF  +       ++   +++L    ++HRDL
Sbjct: 90  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 149
Query: 277 KPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWS 334
              N L+  +  + ++DFG+ +    D+ T S      +++ SPE+     +   +D WS
Sbjct: 150 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 209
Query: 335 VGILLFEMLT-GQPPF 349
            G+L++E+ + G+ P+
Sbjct: 210 FGVLMWEVFSEGKIPY 225

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL------ 204
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL      
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 72  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 129
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 151 DFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +  + KVVG G F +V   +++     EI       K    EK   +++  E +I+ + D
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 92
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------S 261
           HP I++L         + +V +++  G L          R+  A+    ++V       S
Sbjct: 93  HPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIAS 146
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEY 315
            + +L   G +HRDL   NIL++++    ++DFGL++  +++      TR   +   + +
Sbjct: 147 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 204
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            SPE +  +    A+D WS GI+L+E+++ G+ P+
Sbjct: 205 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 239

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 115/233 (49%), Gaps = 16/233 (6%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 29  DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 88
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 89  KKKKIKREIKILQNLXGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 139
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFD 301
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ + 
Sbjct: 140 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 198
Query: 302 ENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                N    +  +  PE+++  + +D + D WS+G +   M+  + PF  G+
Sbjct: 199 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 251

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 115/233 (49%), Gaps = 16/233 (6%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 8   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 67
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 68  KKKKIKREIKILQNLXGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 118
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFD 301
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ + 
Sbjct: 119 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 177
Query: 302 ENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                N    +  +  PE+++  + +D + D WS+G +   M+  + PF  G+
Sbjct: 178 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 230

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 115/233 (49%), Gaps = 16/233 (6%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 9   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 68
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 69  KKKKIKREIKILQNLXGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 119
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFD 301
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ + 
Sbjct: 120 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 178
Query: 302 ENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                N    +  +  PE+++  + +D + D WS+G +   M+  + PF  G+
Sbjct: 179 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 231

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 68
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 69  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAEG 126
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 127 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 186
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 187 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 219

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 81
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 82  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 139
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 140 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 199
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 200 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 232

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 151 DFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +  + KVVG G F +V   +++     EI       K    EK   +++  E +I+ + D
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 75
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------S 261
           HP I++L         + +V +++  G L          R+  A+    ++V       S
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIAS 129
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEY 315
            + +L   G +HRDL   NIL++++    ++DFGL++  +++      TR   +   + +
Sbjct: 130 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 187
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            SPE +  +    A+D WS GI+L+E+++ G+ P+
Sbjct: 188 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 222

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 104/206 (50%), Gaps = 13/206 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D   LK +G G F  V   +  G  ++ A+K++++  + E    E    E  ++  + H
Sbjct: 8   KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMNLSH 62
Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             +VQL Y   TK R ++++ +++  G L  + +  R     + L  +   ++  A+ +L
Sbjct: 63  EKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYL 120
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGK 324
            +   +HRDL   N L++  G V ++DFGL++    DE T S      + +  PE+++  
Sbjct: 121 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 180
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPF 349
                +D W+ G+L++E+ + G+ P+
Sbjct: 181 KFSSKSDIWAFGVLMWEIYSLGKMPY 206

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 115/233 (49%), Gaps = 16/233 (6%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 8   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 67
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 68  KKKKIKREIKILQNLMGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 118
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFD 301
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ + 
Sbjct: 119 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 177
Query: 302 ENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                N    +  +  PE+++  + +D + D WS+G +   M+  + PF  G+
Sbjct: 178 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 230

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 16/219 (7%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRR------IGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           +G +D  +L+ +G G+F  V   RR       G +   A+K ++ D + +    +    E
Sbjct: 9   IGEKDLRLLEKLGDGSFGVV---RRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 65
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEI 259
            N +  +DH  +++L Y       + +V +    G L  +L + QG F       Y  ++
Sbjct: 66  VNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 124
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG----TLEY 315
              + +L +   +HRDL   N+LL     V + DFGL +   +N     M         +
Sbjct: 125 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGN 353
            +PE +  +    A+D W  G+ L+EM T GQ P+ G N
Sbjct: 185 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 223

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 104/206 (50%), Gaps = 13/206 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D   LK +G G F  V   +  G  ++ A+K++++  + E    E    E  ++  + H
Sbjct: 9   KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMNLSH 63
Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             +VQL Y   TK R ++++ +++  G L  + +  R     + L  +   ++  A+ +L
Sbjct: 64  EKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYL 121
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGK 324
            +   +HRDL   N L++  G V ++DFGL++    DE T S      + +  PE+++  
Sbjct: 122 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 181
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPF 349
                +D W+ G+L++E+ + G+ P+
Sbjct: 182 KFSSKSDIWAFGVLMWEIYSLGKMPY 207

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 110/249 (44%), Gaps = 38/249 (15%)
Query: 138 DNLPSENQCVGL-----------EDFEVLKVVGQGAFAKV-----YQVRRIGTSEIYAMK 181
           D LP +  C  L           +   + K +G+GAF +V     + + +  T    A+K
Sbjct: 4   DELPLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVK 63
Query: 182 VMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY--RLYLVLDFVNGGHL-- 237
           ++++     ++ A  + SE  IL  + H   V       TK    L ++++F   G+L  
Sbjct: 64  MLKEGATHSEHRA--LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 121
Query: 238 -----------FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD 286
                      +  LY+  L  E L   Y+ ++   +  L +   +HRDL   NILL   
Sbjct: 122 YLRSKRNEFVPYKDLYKDFLTLEHLI-CYSFQVAKGMEFLASRKXIHRDLAARNILLSEK 180
Query: 287 GHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEML 343
             V + DFGLA+   ++    R       L++M+PE +  + +   +D WS G+LL+E+ 
Sbjct: 181 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 240
Query: 344 T-GQPPFTG 351
           + G  P+ G
Sbjct: 241 SLGASPYPG 249

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 66  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 123
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 216

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 151 DFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +  + KVVG G F +V   +++     EI       K    EK   +++  E +I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------S 261
           HP I++L         + +V +++  G L          R+  A+    ++V       S
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEY 315
            + +L   G +HRDL   NIL++++    ++DFGL++  +++      TR   +   + +
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 216
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            SPE +  +    A+D WS GI+L+E+++ G+ P+
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 16/219 (7%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRR------IGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           +G +D  +L+ +G G+F  V   RR       G +   A+K ++ D + +    +    E
Sbjct: 15  IGEKDLRLLEKLGDGSFGVV---RRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 71
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEI 259
            N +  +DH  +++L Y       + +V +    G L  +L + QG F       Y  ++
Sbjct: 72  VNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 130
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG----TLEY 315
              + +L +   +HRDL   N+LL     V + DFGL +   +N     M         +
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGN 353
            +PE +  +    A+D W  G+ L+EM T GQ P+ G N
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 151 DFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +  + KVVG G F +V   +++     EI       K    EK   +++  E +I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------S 261
           HP I++L         + +V +++  G L          R+  A+    ++V       S
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEY 315
            + +L   G +HRDL   NIL++++    ++DFGL++  +++      TR   +   + +
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 216
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            SPE +  +    A+D WS GI+L+E+++ G+ P+
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 151 DFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +  + KVVG G F +V   +++     EI       K    EK   +++  E +I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------S 261
           HP I++L         + +V +++  G L          R+  A+    ++V       S
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEY 315
            + +L   G +HRDL   NIL++++    ++DFGL++  +++      TR   +   + +
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 216
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            SPE +  +    A+D WS GI+L+E+++ G+ P+
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 104/206 (50%), Gaps = 13/206 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D   LK +G G F  V   +  G  ++ A+K++++  + E    E    E  ++  + H
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMNLSH 58
Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             +VQL Y   TK R ++++ +++  G L  + +  R     + L  +   ++  A+ +L
Sbjct: 59  EKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYL 116
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGK 324
            +   +HRDL   N L++  G V ++DFGL++    DE T S      + +  PE+++  
Sbjct: 117 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPF 349
                +D W+ G+L++E+ + G+ P+
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPY 202

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 151 DFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +  + KVVG G F +V   +++     EI       K    EK   +++  E +I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------S 261
           HP I++L         + +V +++  G L          R+  A+    ++V       S
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEY 315
            + +L   G +HRDL   NIL++++    ++DFGL++  +++      TR   +   + +
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 216
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            SPE +  +    A+D WS GI+L+E+++ G+ P+
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 115/233 (49%), Gaps = 16/233 (6%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 10  DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 69
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 70  KKKKIKREIKILQNLCGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 120
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFD 301
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ + 
Sbjct: 121 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 179
Query: 302 ENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                N    +  +  PE+++  + +D + D WS+G +   M+  + PF  G+
Sbjct: 180 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 232

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 151 DFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +  + KVVG G F +V   +++     EI       K    EK   +++  E +I+ + D
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 102
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------S 261
           HP I++L         + +V +++  G L          R+  A+    ++V       S
Sbjct: 103 HPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIAS 156
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEY 315
            + +L   G +HRDL   NIL++++    ++DFGL++  +++      TR   +   + +
Sbjct: 157 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 214
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            SPE +  +    A+D WS GI+L+E+++ G+ P+
Sbjct: 215 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 249

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 115/233 (49%), Gaps = 16/233 (6%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 8   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 67
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 68  KKKKIKREIKILQNLCGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 118
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFD 301
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ + 
Sbjct: 119 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 177
Query: 302 ENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                N    +  +  PE+++  + +D + D WS+G +   M+  + PF  G+
Sbjct: 178 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 230

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 115/233 (49%), Gaps = 16/233 (6%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 8   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 67
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 68  KKKKIKREIKILQNLCGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 118
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFD 301
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ + 
Sbjct: 119 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 177
Query: 302 ENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                N    +  +  PE+++  + +D + D WS+G +   M+  + PF  G+
Sbjct: 178 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 230

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 16/219 (7%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRR------IGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           +G +D  +L+ +G G+F     VRR       G +   A+K ++ D + +    +    E
Sbjct: 5   IGEKDLRLLEKLGDGSFG---VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEI 259
            N +  +DH  +++L Y       + +V +    G L  +L + QG F       Y  ++
Sbjct: 62  VNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG----TLEY 315
              + +L +   +HRDL   N+LL     V + DFGL +   +N     M         +
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGN 353
            +PE +  +    A+D W  G+ L+EM T GQ P+ G N
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 103/215 (47%), Gaps = 25/215 (11%)
Query: 151 DFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +  + KVVG G F +V   +++     EI       K    EK   +++  E +I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------S 261
           HP I++L         + +V +++  G L          R+  A+    ++V       S
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEY 315
            + +L   G +HRDL   NIL++++    ++DFGL +  +++      TR   +   + +
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI--PIRW 216
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            SPE +  +    A+D WS GI+L+E+++ G+ P+
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 157 VVGQGAFAKVYQ-VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-LTKVDHPFIVQ 214
           ++G G F KVY+ V R G       KV  K +  E +            L+   HP +V 
Sbjct: 46  LIGHGVFGKVYKGVLRDGA------KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVS 99
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV----SAVSHLHANG 270
           L      +  + L+  ++  G+L   LY   L    ++     EI       + +LH   
Sbjct: 100 LIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA 159
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN---SMCGTLEYMSPEIVLGKGHD 327
           I+HRD+K  NILLD +    +TDFG++K+  E  +++    + GTL Y+ PE  +     
Sbjct: 160 IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLT 219
Query: 328 KAADWWSVGILLFEMLTGQ 346
           + +D +S G++LFE+L  +
Sbjct: 220 EKSDVYSFGVVLFEVLCAR 238

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 16/219 (7%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRR------IGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           +G +D  +L+ +G G+F  V   RR       G +   A+K ++ D + +    +    E
Sbjct: 9   IGEKDLRLLEKLGDGSFGVV---RRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 65
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEI 259
            N +  +DH  +++L Y       + +V +    G L  +L + QG F       Y  ++
Sbjct: 66  VNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 124
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG----TLEY 315
              + +L +   +HRDL   N+LL     V + DFGL +   +N     M         +
Sbjct: 125 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGN 353
            +PE +  +    A+D W  G+ L+EM T GQ P+ G N
Sbjct: 185 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 223

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 115/233 (49%), Gaps = 16/233 (6%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 9   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 68
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 69  KKKKIKREIKILQNLCGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 119
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFD 301
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ + 
Sbjct: 120 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 178
Query: 302 ENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                N    +  +  PE+++  + +D + D WS+G +   M+  + PF  G+
Sbjct: 179 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 231

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 16/219 (7%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRR------IGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           +G +D  +L+ +G G+F     VRR       G +   A+K ++ D + +    +    E
Sbjct: 5   IGEKDLRLLEKLGDGSFG---VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEI 259
            N +  +DH  +++L Y       + +V +    G L  +L + QG F       Y  ++
Sbjct: 62  VNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG----TLEY 315
              + +L +   +HRDL   N+LL     V + DFGL +   +N     M         +
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGN 353
            +PE +  +    A+D W  G+ L+EM T GQ P+ G N
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL------ 204
           +F+ +KV+  GAF  VY+   I   E    KV     I E   A   K+ + IL      
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L++  +  G L  + + ++  +  + L   +  +I   
Sbjct: 79  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 136
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 137 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 229

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L++  +  G L  + + ++  +  + L   +  +I   
Sbjct: 74  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 131
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFG AK      +     G    +++M+ E
Sbjct: 132 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L++  +  G L  + + ++  +  + L   +  +I   
Sbjct: 74  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 131
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFG AK      +     G    +++M+ E
Sbjct: 132 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 102/201 (50%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 74
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R++++ +   Y A +I SA+ +L     +H
Sbjct: 75  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 193 VWAFGVLLWEIATYGMSPYPG 213

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 110/249 (44%), Gaps = 38/249 (15%)
Query: 138 DNLPSENQCVGL-----------EDFEVLKVVGQGAFAKV-----YQVRRIGTSEIYAMK 181
           D LP +  C  L           +   + K +G+GAF +V     + + +  T    A+K
Sbjct: 4   DELPLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVK 63
Query: 182 VMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY--RLYLVLDFVNGGHL-- 237
           ++++     ++ A  + SE  IL  + H   V       TK    L ++++F   G+L  
Sbjct: 64  MLKEGATHSEHRA--LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 121
Query: 238 -----------FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD 286
                      +  LY+  L  E L   Y+ ++   +  L +   +HRDL   NILL   
Sbjct: 122 YLRSKRNEFVPYKDLYKDFLTLEHLI-XYSFQVAKGMEFLASRKXIHRDLAARNILLSEK 180
Query: 287 GHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEML 343
             V + DFGLA+   ++    R       L++M+PE +  + +   +D WS G+LL+E+ 
Sbjct: 181 NVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 240
Query: 344 T-GQPPFTG 351
           + G  P+ G
Sbjct: 241 SLGASPYPG 249

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 75
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L++  +  G L  + + ++  +  + L   +  +I   
Sbjct: 76  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 133
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFG AK      +     G    +++M+ E
Sbjct: 134 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 193
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 194 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 226

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 74
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++++F+  G+L    Y +   R++++ +   Y A +I SA+ +L     +H
Sbjct: 75  VCTREPPFYIIIEFMTYGNLL--DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 193 VWAFGVLLWEIATYGMSPYPG 213

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 16  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 69
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  + +V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 70  AVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 129
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 130 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 189
Query: 334 SVGILLFEMLT-GQPPFTG 351
           S GILL E+ T G+ P+ G
Sbjct: 190 SFGILLTELTTKGRVPYPG 208

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 10/200 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+F  VY+     T+   A   + +D+ + K+  +  K E   L  + HP IV+   
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCEL-QDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 218 SFQT----KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG--I 271
           S+++    K  + LV +    G L   L R  + +  + R +  +I+  +  LH     I
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 272 MHRDLKPENILLDA-DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           +HRDLK +NI +    G V + D GLA      + + ++ GT E+ +PE    K +D++ 
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXYEEK-YDESV 210
Query: 331 DWWSVGILLFEMLTGQPPFT 350
           D ++ G    E  T + P++
Sbjct: 211 DVYAFGXCXLEXATSEYPYS 230

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 76
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++++F+  G+L    Y +   R++++ +   Y A +I SA+ +L     +H
Sbjct: 77  VCTREPPFYIIIEFMTYGNLL--DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 195 VWAFGVLLWEIATYGMSPYPG 215

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 110/253 (43%), Gaps = 42/253 (16%)
Query: 138 DNLPSENQCVGL-----------EDFEVLKVVGQGAFAKV-----YQVRRIGTSEIYAMK 181
           D LP +  C  L           +  ++ K +G+GAF +V     + + +  T    A+K
Sbjct: 4   DELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK 63
Query: 182 VMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY--RLYLVLDFVNGGHLFF 239
           ++++     ++ A  + SE  IL  + H   V       TK    L ++++F   G+L  
Sbjct: 64  MLKEGATHSEHRA--LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 121
Query: 240 -----------------QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL 282
                             LY+  L  E L   Y+ ++   +  L +   +HRDL   NIL
Sbjct: 122 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLI-CYSFQVAKGMEFLASRKCIHRDLAARNIL 180
Query: 283 LDADGHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILL 339
           L     V + DFGLA+   ++    R       L++M+PE +  + +   +D WS G+LL
Sbjct: 181 LSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240
Query: 340 FEMLT-GQPPFTG 351
           +E+ + G  P+ G
Sbjct: 241 WEIFSLGASPYPG 253

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 76
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++++F+  G+L    Y +   R++++ +   Y A +I SA+ +L     +H
Sbjct: 77  VCTREPPFYIIIEFMTYGNLL--DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 195 VWAFGVLLWEIATYGMSPYPG 215

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 27/222 (12%)
Query: 152 FEVLKVVGQGAFAKVYQV--RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +E++  +G+GAF KV +    + G   +    V   D+  E   +E    E    T  + 
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 210 PF-IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHL 266
            F  VQ+   F+    + +V + + G   +  +   G   FR D  R    +I  +V+ L
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134
Query: 267 HANGIMHRDLKPENILLDADGH-------------------VMLTDFGLAKQFDENTRSN 307
           H+N + H DLKPENIL     +                   + + DFG A   DE+   +
Sbjct: 135 HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HS 192
Query: 308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           ++     Y +PE++L  G  +  D WS+G +L E   G   F
Sbjct: 193 TLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 30/223 (13%)
Query: 156 KVVGQGAFAKV-----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           K +G+GAF +V     + + +  T    A+K++++     ++ A  + SE  IL  + H 
Sbjct: 34  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHH 91
Query: 211 FIVQLRYSFQTKY--RLYLVLDFVNGGHLFF----------------QLYRQGLFREDLA 252
             V       TK    L ++++F   G+L                   LY+  L  E L 
Sbjct: 92  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLI 151
Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---TRSNSM 309
             Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    R    
Sbjct: 152 -CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
              L++M+PE +  + +   +D WS G+LL+E+ + G  P+ G
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 104/220 (47%), Gaps = 28/220 (12%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           CV +E     +V+G G F +V    ++  G  EI+      K    EK   +++ SE +I
Sbjct: 8   CVKIE-----QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFL-SEASI 61
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV--- 260
           + + DHP ++ L         + ++ +F+  G L          R++  +    ++V   
Sbjct: 62  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL------DSFLRQNDGQFTVIQLVGML 115
Query: 261 ----SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--- 313
               + + +L     +HR L   NIL++++    ++DFGL++  +++T   +    L   
Sbjct: 116 RGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 175
Query: 314 ---EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
               + +PE +  +    A+D WS GI+++E+++ G+ P+
Sbjct: 176 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 215

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 103/215 (47%), Gaps = 25/215 (11%)
Query: 151 DFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +  + KVVG G F +V   +++     EI       K    EK   +++  E +I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------S 261
           HP I++L         + +V + +  G L          R+  A+    ++V       S
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEY 315
            + +L   G +HRDL   NIL++++    ++DFGL++  +++      TR   +   + +
Sbjct: 159 GMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 216
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            SPE +  +    A+D WS GI+L+E+++ G+ P+
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 103/215 (47%), Gaps = 25/215 (11%)
Query: 151 DFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +  + KVVG G F +V   +++     EI       K    EK   +++  E +I+ + D
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 75
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------S 261
           HP I++L         + +V + +  G L          R+  A+    ++V       S
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRKHDAQFTVIQLVGMLRGIAS 129
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEY 315
            + +L   G +HRDL   NIL++++    ++DFGL++  +++      TR   +   + +
Sbjct: 130 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 187
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            SPE +  +    A+D WS GI+L+E+++ G+ P+
Sbjct: 188 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 222

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL------ 204
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL      
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 79  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 136
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFG AK      +     G    +++M+ E
Sbjct: 137 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 229

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 111/250 (44%), Gaps = 38/250 (15%)
Query: 138 DNLPSENQCVGL-----------EDFEVLKVVGQGAFAKV-----YQVRRIGTSEIYAMK 181
           D LP +  C  L           +  ++ K +G+GAF +V     + + +  T    A+K
Sbjct: 6   DELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVK 65
Query: 182 VMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY--RLYLVLDFVNGGHL-- 237
           ++++     ++ A  + SE  IL  + H   V       TK    L ++++F   G+L  
Sbjct: 66  MLKEGATHSEHRA--LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 123
Query: 238 --------FFQLYRQGLFREDLAR----IYTAEIVSAVSHLHANGIMHRDLKPENILLDA 285
                   F     + L+++ L       Y+ ++   +  L +   +HRDL   NILL  
Sbjct: 124 YLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSE 183
Query: 286 DGHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEM 342
              V + DFGLA+   ++    R       L++M+PE +  + +   +D WS G+LL+E+
Sbjct: 184 KNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
Query: 343 LT-GQPPFTG 351
            + G  P+ G
Sbjct: 244 FSLGASPYPG 253

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 74  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 131
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFG AK      +     G    +++M+ E
Sbjct: 132 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL------ 204
           +F+ +KV+  GAF  VY+   I   E    KV     I E   A   K+ + IL      
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 79  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 136
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 137 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 229

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 106/220 (48%), Gaps = 30/220 (13%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           C+ +E     KV+G G F +V   +++  G  EI       K    +K   +++ SE +I
Sbjct: 30  CIKIE-----KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFL-SEASI 83
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV--- 260
           + + DHP I+ L         + ++ +++  G L          R++  R    ++V   
Sbjct: 84  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFTVIQLVGML 137
Query: 261 ----SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMC 310
               S + +L     +HRDL   NIL++++    ++DFG+++  +++      TR   + 
Sbjct: 138 RGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI- 196
Query: 311 GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
             + + +PE +  +    A+D WS GI+++E+++ G+ P+
Sbjct: 197 -PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 235

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 102/201 (50%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 77
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++++F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 78  VCTREPPFYIIIEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 135
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 195
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 196 VWAFGVLLWEIATYGMSPYPG 216

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+  GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 72  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 129
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 107/222 (48%), Gaps = 22/222 (9%)
Query: 150 EDFEVLKVVGQGAFAKVYQVR---RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           + F + +++G+G F  V + +     G+    A+K+++ D I   +  E+++ E   + +
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR-EAACMKE 81
Query: 207 VDHPFIVQL---RYSFQTKYRL---YLVLDFVNGG--HLFFQLYRQG-----LFREDLAR 253
            DHP + +L       + K RL    ++L F+  G  H F    R G     L  + L R
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT- 312
            +  +I   + +L +   +HRDL   N +L  D  V + DFGL+++          C + 
Sbjct: 142 -FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK 200
Query: 313 --LEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
             +++++ E +    +   +D W+ G+ ++E++T GQ P+ G
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAG 242

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 110/253 (43%), Gaps = 42/253 (16%)
Query: 138 DNLPSENQCVGL-----------EDFEVLKVVGQGAFAKV-----YQVRRIGTSEIYAMK 181
           D LP +  C  L           +  ++ K +G+GAF +V     + + +  T    A+K
Sbjct: 41  DELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK 100
Query: 182 VMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY--RLYLVLDFVNGGHLFF 239
           ++++     ++ A  + SE  IL  + H   V       TK    L ++++F   G+L  
Sbjct: 101 MLKEGATHSEHRA--LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 158
Query: 240 -----------------QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL 282
                             LY+  L  E L   Y+ ++   +  L +   +HRDL   NIL
Sbjct: 159 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLI-CYSFQVAKGMEFLASRKCIHRDLAARNIL 217
Query: 283 LDADGHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILL 339
           L     V + DFGLA+   ++    R       L++M+PE +  + +   +D WS G+LL
Sbjct: 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 277
Query: 340 FEMLT-GQPPFTG 351
           +E+ + G  P+ G
Sbjct: 278 WEIFSLGASPYPG 290

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 103/215 (47%), Gaps = 25/215 (11%)
Query: 151 DFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +  + KVVG G F +V   +++     EI       K    EK   +++  E +I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------S 261
           HP I++L         + +V + +  G L          R+  A+    ++V       S
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEY 315
            + +L   G +HRDL   NIL++++    ++DFGL++  +++      TR   +   + +
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 216
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            SPE +  +    A+D WS GI+L+E+++ G+ P+
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 72  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 129
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFG AK      +     G    +++M+ E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 106/220 (48%), Gaps = 30/220 (13%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           C+ +E     KV+G G F +V   +++  G  EI       K    +K   +++ SE +I
Sbjct: 9   CIKIE-----KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFL-SEASI 62
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV--- 260
           + + DHP I+ L         + ++ +++  G L          R++  R    ++V   
Sbjct: 63  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFTVIQLVGML 116
Query: 261 ----SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMC 310
               S + +L     +HRDL   NIL++++    ++DFG+++  +++      TR   + 
Sbjct: 117 RGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI- 175
Query: 311 GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
             + + +PE +  +    A+D WS GI+++E+++ G+ P+
Sbjct: 176 -PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 214

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 106/220 (48%), Gaps = 30/220 (13%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           C+ +E     KV+G G F +V   +++  G  EI       K    +K   +++ SE +I
Sbjct: 15  CIKIE-----KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFL-SEASI 68
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV--- 260
           + + DHP I+ L         + ++ +++  G L          R++  R    ++V   
Sbjct: 69  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFTVIQLVGML 122
Query: 261 ----SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMC 310
               S + +L     +HRDL   NIL++++    ++DFG+++  +++      TR   + 
Sbjct: 123 RGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI- 181
Query: 311 GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
             + + +PE +  +    A+D WS GI+++E+++ G+ P+
Sbjct: 182 -PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 220

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 31/224 (13%)
Query: 156 KVVGQGAFAKV-----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           K +G+GAF +V     + + +  T    A+K++++     ++ A  + SE  IL  + H 
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHH 81
Query: 211 FIVQLRYSFQTKY--RLYLVLDFVNGGHLFF-----------------QLYRQGLFREDL 251
             V       TK    L ++++F   G+L                    LY+  L  E L
Sbjct: 82  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---TRSNS 308
              Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    R   
Sbjct: 142 I-CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               L++M+PE +  + +   +D WS G+LL+E+ + G  P+ G
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 110/253 (43%), Gaps = 42/253 (16%)
Query: 138 DNLPSENQCVGL-----------EDFEVLKVVGQGAFAKV-----YQVRRIGTSEIYAMK 181
           D LP +  C  L           +  ++ K +G+GAF +V     + + +  T    A+K
Sbjct: 4   DELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK 63
Query: 182 VMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY--RLYLVLDFVNGGHLFF 239
           ++++     ++ A  + SE  IL  + H   V       TK    L ++++F   G+L  
Sbjct: 64  MLKEGATHSEHRA--LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 121
Query: 240 -----------------QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL 282
                             LY+  L  E L   Y+ ++   +  L +   +HRDL   NIL
Sbjct: 122 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLI-CYSFQVAKGMEFLASRKCIHRDLAARNIL 180
Query: 283 LDADGHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILL 339
           L     V + DFGLA+   ++    R       L++M+PE +  + +   +D WS G+LL
Sbjct: 181 LSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240
Query: 340 FEMLT-GQPPFTG 351
           +E+ + G  P+ G
Sbjct: 241 WEIFSLGASPYPG 253

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 110/253 (43%), Gaps = 42/253 (16%)
Query: 138 DNLPSENQCVGL-----------EDFEVLKVVGQGAFAKV-----YQVRRIGTSEIYAMK 181
           D LP +  C  L           +  ++ K +G+GAF +V     + + +  T    A+K
Sbjct: 4   DELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK 63
Query: 182 VMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY--RLYLVLDFVNGGHLFF 239
           ++++     ++ A  + SE  IL  + H   V       TK    L ++++F   G+L  
Sbjct: 64  MLKEGATHSEHRA--LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 121
Query: 240 -----------------QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL 282
                             LY+  L  E L   Y+ ++   +  L +   +HRDL   NIL
Sbjct: 122 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLI-CYSFQVAKGMEFLASRKCIHRDLAARNIL 180
Query: 283 LDADGHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILL 339
           L     V + DFGLA+   ++    R       L++M+PE +  + +   +D WS G+LL
Sbjct: 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240
Query: 340 FEMLT-GQPPFTG 351
           +E+ + G  P+ G
Sbjct: 241 WEIFSLGASPYPG 253

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 107/216 (49%), Gaps = 31/216 (14%)
Query: 154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP--- 210
           +++ +G G F+ V+  + +  +   AMK++R DK+    + E  + E  +L +V+     
Sbjct: 23  LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNT 78
Query: 211 --------FIVQLRYSFQTK--YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
                    I++L   F  K    +++V+ F   G     L ++   R  +  IY  +I 
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR-GIPLIYVKQIS 137
Query: 261 S----AVSHLHAN-GIMHRDLKPENILLD-ADG-----HVMLTDFGLAKQFDENTRSNSM 309
                 + ++H   GI+H D+KPEN+L++  D       + + D G A  +DE+  +NS+
Sbjct: 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-TNSI 196
Query: 310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTG 345
             T EY SPE++LG      AD WS   L+FE++TG
Sbjct: 197 -QTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 107/216 (49%), Gaps = 31/216 (14%)
Query: 154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP--- 210
           +++ +G G F+ V+  + +  +   AMK++R DK+    + E  + E  +L +V+     
Sbjct: 23  LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNT 78
Query: 211 --------FIVQLRYSFQTK--YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
                    I++L   F  K    +++V+ F   G     L ++   R  +  IY  +I 
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR-GIPLIYVKQIS 137
Query: 261 S----AVSHLHAN-GIMHRDLKPENILLD-ADG-----HVMLTDFGLAKQFDENTRSNSM 309
                 + ++H   GI+H D+KPEN+L++  D       + + D G A  +DE+  +NS+
Sbjct: 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-TNSI 196
Query: 310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTG 345
             T EY SPE++LG      AD WS   L+FE++TG
Sbjct: 197 -QTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 110/253 (43%), Gaps = 42/253 (16%)
Query: 138 DNLPSENQCVGL-----------EDFEVLKVVGQGAFAKV-----YQVRRIGTSEIYAMK 181
           D LP +  C  L           +  ++ K +G+GAF +V     + + +  T    A+K
Sbjct: 6   DELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK 65
Query: 182 VMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY--RLYLVLDFVNGGHLFF 239
           ++++     ++ A  + SE  IL  + H   V       TK    L ++++F   G+L  
Sbjct: 66  MLKEGATHSEHRA--LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 123
Query: 240 -----------------QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL 282
                             LY+  L  E L   Y+ ++   +  L +   +HRDL   NIL
Sbjct: 124 YLRSKRNEFVPYKEAPEDLYKDFLTLEHLI-CYSFQVAKGMEFLASRKCIHRDLAARNIL 182
Query: 283 LDADGHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILL 339
           L     V + DFGLA+   ++    R       L++M+PE +  + +   +D WS G+LL
Sbjct: 183 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 242
Query: 340 FEMLT-GQPPFTG 351
           +E+ + G  P+ G
Sbjct: 243 WEIFSLGASPYPG 255

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 102/201 (50%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 81
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R++++ +   Y A +I SA+ +L     +H
Sbjct: 82  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 200 VWAFGVLLWEIATYGMSPYPG 220

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 44/226 (19%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIG--TSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           C G+ D E + V  +  F  V   R +   +      +V+R+ +++   H   +   R+I
Sbjct: 39  CAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR-IYTAEIVSA 262
               + P            ++LYLV +               L R DLA+ I+   IV +
Sbjct: 98  FVHFEEP----------AMHKLYLVTE---------------LMRTDLAQVIHDQRIVIS 132
Query: 263 VSH--------------LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS 308
             H              LH  G++HRDL P NILL  +  + + DF LA++   +     
Sbjct: 133 PQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH 192
Query: 309 MCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                 Y +PE+V+  KG  K  D WS G ++ EM   +  F G  
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 102/201 (50%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 76
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R++++ +   Y A +I SA+ +L     +H
Sbjct: 77  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 195 VWAFGVLLWEIATYGMSPYPG 215

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 44/226 (19%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIG--TSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           C G+ D E + V  +  F  V   R +   +      +V+R+ +++   H   +   R+I
Sbjct: 39  CAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR-IYTAEIVSA 262
               + P            ++LYLV +               L R DLA+ I+   IV +
Sbjct: 98  FVHFEEP----------AMHKLYLVTE---------------LMRTDLAQVIHDQRIVIS 132
Query: 263 VSH--------------LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS 308
             H              LH  G++HRDL P NILL  +  + + DF LA++   +     
Sbjct: 133 PQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH 192
Query: 309 MCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                 Y +PE+V+  KG  K  D WS G ++ EM   +  F G  
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 102/201 (50%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 81
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++++F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 82  VCTREPPFYIIIEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 200 VWAFGVLLWEIATYGMSPYPG 220

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 104/240 (43%), Gaps = 48/240 (20%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HP 210
             V +V+ +G FA VY+ + +G+   YA+K +  ++  EKN A  +  E   + K+  HP
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRA--IIQEVCFMKKLSGHP 86
Query: 211 FIVQL-------RYSFQTKYRLYLVLDFVNGGHL---FFQLYRQGLFREDLARIYTAEIV 260
            IVQ        +    T    +L+L  +  G L     ++  +G    D       +  
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 261 SAVSHLHANG--IMHRDLKPENILLDADGHVMLTDFGLAKQF-----------------D 301
            AV H+H     I+HRDLK EN+LL   G + L DFG A                    +
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 302 ENTRSNSMCGTLEYMSPEIV-------LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR 354
           E TR+     T  Y +PEI+       +G+      D W++G +L+ +   Q PF  G +
Sbjct: 207 EITRNT----TPMYRTPEIIDLYSNFPIGEKQ----DIWALGCILYLLCFRQHPFEDGAK 258

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 102/201 (50%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 76
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R++++ +   Y A +I SA+ +L     +H
Sbjct: 77  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 195 VWAFGVLLWEIATYGMSPYPG 215

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 105/208 (50%), Gaps = 13/208 (6%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           D  +   +G G + +VY+      S   A+K +++D +  +   E++K E  ++ ++ HP
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLK-EAAVMKEIKHP 276
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHL 266
            +VQL      +   Y++ +F+  G+L    Y +   R++++ +   Y A +I SA+ +L
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGK 324
                +HR+L   N L+  +  V + DFGL++    +T +        +++ +PE +   
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 394
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTG 351
                +D W+ G+LL+E+ T G  P+ G
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSPYPG 422

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++ K +G G F +V+       +++ A+K M+   +      E   +E N++  + H
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 236
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
             +V+L ++  TK  +Y++ +F+  G L   L      ++ L ++  ++A+I   ++ + 
Sbjct: 237 DKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 295
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNSMCGTLEYMSPEIVLGK 324
               +HRDL+  NIL+ A     + DFGLA+   +F            +++ +PE +   
Sbjct: 296 QRNYIHRDLRAANILVSASLVCKIADFGLARVGAKF-----------PIKWTAPEAINFG 344
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTG 351
                +D WS GILL E++T G+ P+ G
Sbjct: 345 SFTIKSDVWSFGILLMEIVTYGRIPYPG 372

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKV------MRKDKIMEKNHAEYMKSERNILTKV-D 208
           K +G+GAF +V     IG  +    +V      M K    EK+ ++ + SE  ++  +  
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIGK 92
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR---------------QGLFREDL 251
           H  I+ L  +      LY+++++ + G+L  + Q  R               + L  +DL
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
                 ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ +
Sbjct: 153 VSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTN 211
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+LL+E+ T G  P+ G
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 255

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKN------HAEYMK---SE 200
           K +G+GAF +V     +G  +      +     M KD   EK+        E MK     
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 201 RNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDL 251
           +NI+T +     D P  V + Y+ +   R YL      G    + + R    Q  F++ +
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
           +  Y  ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ +
Sbjct: 161 SCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKN------HAEYMK---SE 200
           K +G+GAF +V     +G  +      +     M KD   EK+        E MK     
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 201 RNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDL 251
           +NI+  +     D P  V + Y+ +   R YL      G    + + R    Q  F++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNSMC 310
           +  Y  ++   + +L +   +HRDL   N+L+  +  + + DFGLA+  +  +   N+  
Sbjct: 161 SCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTN 218
Query: 311 GTL--EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           G L  ++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 102/201 (50%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 74
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R++++ +   Y A +I SA+ +L     +H
Sbjct: 75  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 193 VWAFGVLLWEIATYGMSPYPG 213

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 31/224 (13%)
Query: 156 KVVGQGAFAKV-----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           K +G+GAF +V     + + +  T    A+K++++     ++ A  + SE  IL  + H 
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHH 81
Query: 211 FIVQLRYSFQTKY--RLYLVLDFVNGGHLFF-----------------QLYRQGLFREDL 251
             V       TK    L ++ +F   G+L                    LY+  L  E L
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---TRSNS 308
              Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    R   
Sbjct: 142 I-CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               L++M+PE +  + +   +D WS G+LL+E+ + G  P+ G
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 121/274 (44%), Gaps = 52/274 (18%)
Query: 109 VEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQ 168
           V G  +E Q+   + S       KPT  +    S+ Q    + +E+  ++G G++  V +
Sbjct: 20  VSGSQQEGQQRKQHHS------SKPTASMPRPHSDWQIP--DRYEIRHLIGTGSYGHVCE 71
Query: 169 VRRIGTSEIYAMK-VMR--KDKIMEKNHAEYMKSERNILTKVDHPFIVQ-----LRYSFQ 220
                   + A+K ++R  +D I      + +  E  IL +++H  +V+     +    +
Sbjct: 72  AYDKLEKRVVAIKKILRVFEDLI----DCKRILREIAILNRLNHDHVVKVLDIVIPKDVE 127
Query: 221 TKYRLYLVLDFVNGGHLFFQLYRQGLFREDL-ARIYTAEIVSAVSHLHANGIMHRDLKPE 279
               LY+VL+  +    F +L+R  ++  +L  +     ++  V ++H+ GI+HRDLKP 
Sbjct: 128 KFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPA 185
Query: 280 NILLDADGHVMLTDFGLAKQFDENTRSNSMCG---------------------------- 311
           N L++ D  V + DFGLA+  D     NS                               
Sbjct: 186 NCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVV 245
Query: 312 TLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLT 344
           T  Y +PE I+L + + +A D WS+G +  E+L 
Sbjct: 246 TRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 90/192 (46%), Gaps = 26/192 (13%)
Query: 161 GAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ 220
           GA   V Q++  G  +       R+ +I++  H++++   R +      P          
Sbjct: 36  GALVAVKQLQHSGPDQ--QRDFQREIQILKALHSDFIVKYRGVSYGPGRP---------- 83
Query: 221 TKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEIVSAVSHLHANGIMHRDL 276
               L LV++++  G L  F Q +R    R D +R+  Y+++I   + +L +   +HRDL
Sbjct: 84  ---ELRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSRRCVHRDL 137
Query: 277 KPENILLDADGHVMLTDFGLAKQF----DENTRSNSMCGTLEYMSPEIVLGKGHDKAADW 332
              NIL++++ HV + DFGLAK      D           + + +PE +      + +D 
Sbjct: 138 AARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDV 197
Query: 333 WSVGILLFEMLT 344
           WS G++L+E+ T
Sbjct: 198 WSFGVVLYELFT 209

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 103/222 (46%), Gaps = 27/222 (12%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  E  E+ +++G+G F +VY  R  G   I  + + R ++    +  +  K E     +
Sbjct: 30  IPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNE----DQLKAFKREVMAYRQ 85
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDL--ARIYTAEIVSAVS 264
             H  +V    +  +   L ++     G  L+  + R      D+   R    EIV  + 
Sbjct: 86  TRHENVVLFMGACMSPPHLAIITSLCKGRTLY-SVVRDAKIVLDVNKTRQIAQEIVKGMG 144
Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGL--------AKQFDENTRSNSMCGTLEYM 316
           +LHA GI+H+DLK +N+  D +G V++TDFGL        A + ++  R  +  G L ++
Sbjct: 145 YLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQN--GWLCHL 201
Query: 317 SPEIVLGKGHD---------KAADWWSVGILLFEMLTGQPPF 349
           +PEI+     D         K +D +++G + +E+   + PF
Sbjct: 202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 61/115 (53%), Gaps = 5/115 (4%)
Query: 241 LYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
            Y++ +  EDL   Y+ ++   +  L +   +HRDL   NILL  +  V + DFGLA+  
Sbjct: 191 FYKEPITMEDLIS-YSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDI 249
Query: 301 DEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +N    R       L++M+PE +  K +   +D WS G+LL+E+ + G  P+ G
Sbjct: 250 YKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPG 304

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 81
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 82  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 200 VWAFGVLLWEIATYGMSPYPG 220

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 155 LKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +G+G F KV    Y     GT E+ A+K +++    +       + E  IL  + H 
Sbjct: 14  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSG--WQREIEILRTLYHE 71
Query: 211 FIVQLRYSF--QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            IV+ +     Q +  + LV+++V  G L   L R  +    L  ++  +I   +++LHA
Sbjct: 72  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLL-LFAQQICEGMAYLHA 130
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-----NTRSNSMCGTLEYMSPEIVLG 323
              +HR L   N+LLD D  V + DFGLAK   E       R +       Y +PE +  
Sbjct: 131 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKE 189
Query: 324 KGHDKAADWWSVGILLFEMLT 344
                A+D WS G+ L+E+LT
Sbjct: 190 CKFYYASDVWSFGVTLYELLT 210

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 81
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 82  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 200 VWAFGVLLWEIATYGMSPYPG 220

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 155 LKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +G+G F KV    Y     GT E+ A+K +++    +       + E  IL  + H 
Sbjct: 13  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSG--WQREIEILRTLYHE 70
Query: 211 FIVQLRYSF--QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            IV+ +     Q +  + LV+++V  G L   L R  +    L  ++  +I   +++LHA
Sbjct: 71  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLL-LFAQQICEGMAYLHA 129
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-----NTRSNSMCGTLEYMSPEIVLG 323
              +HR L   N+LLD D  V + DFGLAK   E       R +       Y +PE +  
Sbjct: 130 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKE 188
Query: 324 KGHDKAADWWSVGILLFEMLT 344
                A+D WS G+ L+E+LT
Sbjct: 189 CKFYYASDVWSFGVTLYELLT 209

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKN------HAEYMK---SE 200
           K +G+GAF +V     +G  +      +     M KD   EK+        E MK     
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 201 RNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDL 251
           +NI+  +     D P  V + Y+ +   R YL      G    + + R    Q  F++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
           +  Y  ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ +
Sbjct: 161 SCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 77
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 78  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 135
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSD 195
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 196 VWAFGVLLWEIATYGMSPYPG 216

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 78
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 79  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 197 VWAFGVLLWEIATYGMSPYPG 217

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKN------HAEYMK---SE 200
           K +G+GAF +V     +G  +      +     M KD   EK+        E MK     
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 201 RNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDL 251
           +NI+  +     D P  V + Y+ +   R YL      G    + + R    Q  F++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
           +  Y  ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ +
Sbjct: 161 SCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 104/208 (50%), Gaps = 13/208 (6%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           D  +   +G G + +VY+      S   A+K +++D +  +   E++K E  ++ ++ HP
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLK-EAAVMKEIKHP 315
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHL 266
            +VQL      +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L
Sbjct: 316 NLVQLLGVCTREPPFYIITEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYL 373
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGK 324
                +HR+L   N L+  +  V + DFGL++    +T +        +++ +PE +   
Sbjct: 374 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 433
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTG 351
                +D W+ G+LL+E+ T G  P+ G
Sbjct: 434 KFSIKSDVWAFGVLLWEIATYGMSPYPG 461

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 97/201 (48%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY    +G  + Y++ V  K    +    E    E  ++ ++ HP +VQL  
Sbjct: 40  LGGGQYGEVY----VGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 95
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y+V +++  G+L    Y +   RE++  +   Y A +I SA+ +L     +H
Sbjct: 96  VCTLEPPFYIVTEYMPYGNLL--DYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIH 153
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 154 RDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSD 213
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 214 VWAFGVLLWEIATYGMSPYPG 234

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 81
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 82  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 200 VWAFGVLLWEIATYGMSPYPG 220

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 104/217 (47%), Gaps = 18/217 (8%)
Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           E  C+ +E     +V+G G F +V   +++  G  E+       K    EK   +++  E
Sbjct: 20  EASCITIE-----RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFL-GE 73
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL-FFQLYRQGLFREDLARIYTAEI 259
            +I+ + DHP I+ L         + +V +++  G L  F     G F           I
Sbjct: 74  ASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGI 133
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTL 313
            + + +L   G +HRDL   NIL++++    ++DFGL++  +++      TR   +   +
Sbjct: 134 SAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PI 191
Query: 314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            + +PE +  +    A+D WS GI+++E+++ G+ P+
Sbjct: 192 RWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPY 228

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 80
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 81  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 138
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 198
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 199 VWAFGVLLWEIATYGMSPYPG 219

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 78
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 79  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 197 VWAFGVLLWEIATYGMSPYPG 217

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 31/224 (13%)
Query: 156 KVVGQGAFAKV-----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           K +G+GAF +V     + + +  T    A+K++++     ++ A  + SE  IL  + H 
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHH 81
Query: 211 FIVQLRYSFQTKY--RLYLVLDFVNGGHLFF-----------------QLYRQGLFREDL 251
             V       TK    L ++ +F   G+L                    LY+  L  E L
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---TRSNS 308
              Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    R   
Sbjct: 142 I-CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               L++M+PE +  + +   +D WS G+LL+E+ + G  P+ G
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 89
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 90  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 147
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 148 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 207
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 208 VWAFGVLLWEIATYGMSPYPG 228

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 78
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 79  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 197 VWAFGVLLWEIATYGMSPYPG 217

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G F  VY+   +  + +   K+     I  +   +    E  ++ K  H  +V+L  
Sbjct: 39  MGEGGFGVVYK-GYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYR-------QGLFREDLARIYTAEIVSAVSHLHANG 270
                  L LV  ++  G L  +L             R  +A+       + ++ LH N 
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQ----GAANGINFLHENH 153
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
            +HRD+K  NILLD      ++DFGLA+   +F +    + + GT  YM+PE + G+   
Sbjct: 154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGEITP 213
Query: 328 KAADWWSVGILLFEMLTGQP 347
           K +D +S G++L E++TG P
Sbjct: 214 K-SDIYSFGVVLLEIITGLP 232

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 31/224 (13%)
Query: 156 KVVGQGAFAKV-----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           K +G+GAF +V     + + +  T    A+K++++     ++ A  + SE  IL  + H 
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHH 81
Query: 211 FIVQLRYSFQTKY--RLYLVLDFVNGGHLFF-----------------QLYRQGLFREDL 251
             V       TK    L ++ +F   G+L                    LY+  L  E L
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---TRSNS 308
              Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    R   
Sbjct: 142 I-CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               L++M+PE +  + +   +D WS G+LL+E+ + G  P+ G
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 15  LKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 71
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++F+  G L  + Q +++ +    L + YT++I   
Sbjct: 72  QHDNIVKYKGVCYS-AGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQ-YTSQICKG 129
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 76
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 77  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 195 VWAFGVLLWEIATYGMSPYPG 215

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 81/158 (51%), Gaps = 13/158 (8%)
Query: 197 MKSERNILTKVDHPFIVQLR-YSFQT-KYRLYLVLDFVNGGHL--FFQLYRQGLFREDLA 252
            + E  IL  +   FIV+ R  S+   +  L LV++++  G L  F Q +R    R D +
Sbjct: 59  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDAS 115
Query: 253 RI--YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF----DENTRS 306
           R+  Y+++I   + +L +   +HRDL   NIL++++ HV + DFGLAK      D     
Sbjct: 116 RLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 175
Query: 307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT 344
                 + + +PE +      + +D WS G++L+E+ T
Sbjct: 176 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 103/236 (43%), Gaps = 40/236 (16%)
Query: 150 EDFEVLKVVGQGAFAKVYQV--RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           E +E++  +G+G F +V Q    R G + + A+K++   K +EK + E  + E N+L K+
Sbjct: 33  ERYEIVSTLGEGTFGRVVQCVDHRRGGARV-ALKII---KNVEK-YKEAARLEINVLEKI 87
Query: 208 DHP------FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE---DLARIYTAE 258
           +          VQ+   F   Y  ++ + F   G   F   +   +        R    +
Sbjct: 88  NEKDPDNKNLCVQMFDWFD--YHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQ 145
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGH-------------------VMLTDFGLAKQ 299
           +  AV  LH N + H DLKPENIL     +                   V + DFG A  
Sbjct: 146 LCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSAT- 204
Query: 300 FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPF-TGGNR 354
           FD    S ++  T  Y +PE++L  G  +  D WS+G ++FE   G   F T  NR
Sbjct: 205 FDHEHHS-TIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNR 259

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 81/158 (51%), Gaps = 13/158 (8%)
Query: 197 MKSERNILTKVDHPFIVQLR-YSFQT-KYRLYLVLDFVNGGHL--FFQLYRQGLFREDLA 252
            + E  IL  +   FIV+ R  S+   +  L LV++++  G L  F Q +R    R D +
Sbjct: 58  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDAS 114
Query: 253 RI--YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF----DENTRS 306
           R+  Y+++I   + +L +   +HRDL   NIL++++ HV + DFGLAK      D     
Sbjct: 115 RLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 174
Query: 307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT 344
                 + + +PE +      + +D WS G++L+E+ T
Sbjct: 175 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 81/158 (51%), Gaps = 13/158 (8%)
Query: 197 MKSERNILTKVDHPFIVQLR-YSF-QTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLA 252
            + E  IL  +   FIV+ R  S+   +  L LV++++  G L  F Q +R    R D +
Sbjct: 71  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDAS 127
Query: 253 RI--YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF----DENTRS 306
           R+  Y+++I   + +L +   +HRDL   NIL++++ HV + DFGLAK      D     
Sbjct: 128 RLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 187
Query: 307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT 344
                 + + +PE +      + +D WS G++L+E+ T
Sbjct: 188 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKV------MRKDKIMEKNHAEYMKSERNILTKV-D 208
           K +G+GAF +V     IG  +    +V      M K    EK+ ++ + SE  ++  +  
Sbjct: 27  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIGK 85
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR---------------QGLFREDL 251
           H  I+ L  +      LY+++++ + G+L  + Q  R               + L  +DL
Sbjct: 86  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 145
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
                 ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ +
Sbjct: 146 VSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 204
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+LL+E+ T G  P+ G
Sbjct: 205 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 248

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKV------MRKDKIMEKNHAEYMKSERNILTKV-D 208
           K +G+GAF +V     IG  +    +V      M K    EK+ ++ + SE  ++  +  
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIGK 92
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR---------------QGLFREDL 251
           H  I+ L  +      LY+++++ + G+L  + Q  R               + L  +DL
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
                 ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ +
Sbjct: 153 VSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+LL+E+ T G  P+ G
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 255

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKV------MRKDKIMEKNHAEYMKSERNILTKV-D 208
           K +G+GAF +V     IG  +    +V      M K    EK+ ++ + SE  ++  +  
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIGK 133
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR---------------QGLFREDL 251
           H  I+ L  +      LY+++++ + G+L  + Q  R               + L  +DL
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
                 ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ +
Sbjct: 194 VSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+LL+E+ T G  P+ G
Sbjct: 253 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 107/208 (51%), Gaps = 12/208 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  +++K +G G F +V+      ++++ A+K ++   +  +   E    E N++  + H
Sbjct: 12  ESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTMSVQAFLE----EANLMKTLQH 66
Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHL 266
             +V+L Y+  TK   +Y++ +F+  G L   L      +  L ++  ++A+I   ++++
Sbjct: 67  DKLVRL-YAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 125
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGK 324
                +HRDL+  N+L+       + DFGLA+  ++N  T        +++ +PE +   
Sbjct: 126 ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 185
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTG 351
                ++ WS GILL+E++T G+ P+ G
Sbjct: 186 CFTIKSNVWSFGILLYEIVTYGKIPYPG 213

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 76
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 77  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 195 VWAFGVLLWEIATYGMSPYPG 215

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKV------MRKDKIMEKNHAEYMKSERNILTKV-D 208
           K +G+GAF +V     IG  +    +V      M K    EK+ ++ + SE  ++  +  
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIGK 92
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR---------------QGLFREDL 251
           H  I+ L  +      LY+++++ + G+L  + Q  R               + L  +DL
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
                 ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ +
Sbjct: 153 VSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+LL+E+ T G  P+ G
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 255

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 104/224 (46%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSE-------IYAMKVMRKDKIMEK-----NHAEYMK---SE 200
           K +G+GAF +V     +G  +         A+K+++ D   E      +  E MK     
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKH 100
Query: 201 RNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDL 251
           +NI+  +     D P  V + Y+ +   R YL      G    + + R    Q  F++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
           +  Y  ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ +
Sbjct: 161 SCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKV------MRKDKIMEKNHAEYMKSERNILTKV-D 208
           K +G+GAF +V     IG  +    +V      M K    EK+ ++ + SE  ++  +  
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIGK 77
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR---------------QGLFREDL 251
           H  I+ L  +      LY+++++ + G+L  + Q  R               + L  +DL
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
                 ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ +
Sbjct: 138 VSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+LL+E+ T G  P+ G
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKV------MRKDKIMEKNHAEYMKSERNILTKV-D 208
           K +G+GAF +V     IG  +    +V      M K    EK+ ++ + SE  ++  +  
Sbjct: 26  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIGK 84
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR---------------QGLFREDL 251
           H  I+ L  +      LY+++++ + G+L  + Q  R               + L  +DL
Sbjct: 85  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 144
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
                 ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ +
Sbjct: 145 VSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 203
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+LL+E+ T G  P+ G
Sbjct: 204 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 247

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKV------MRKDKIMEKNHAEYMKSERNILTKV-D 208
           K +G+GAF +V     IG  +    +V      M K    EK+ ++ + SE  ++  +  
Sbjct: 23  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIGK 81
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR---------------QGLFREDL 251
           H  I+ L  +      LY+++++ + G+L  + Q  R               + L  +DL
Sbjct: 82  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 141
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
                 ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ +
Sbjct: 142 VSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 200
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+LL+E+ T G  P+ G
Sbjct: 201 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 244

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 16/200 (8%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G F  VY+   +  + +   K+     I  +   +    E  ++ K  H  +V+L  
Sbjct: 39  MGEGGFGVVYK-GYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYR-------QGLFREDLARIYTAEIVSAVSHLHANG 270
                  L LV  ++  G L  +L             R  +A+       + ++ LH N 
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQ----GAANGINFLHENH 153
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
            +HRD+K  NILLD      ++DFGLA+   +F +      + GT  YM+PE + G+   
Sbjct: 154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGEITP 213
Query: 328 KAADWWSVGILLFEMLTGQP 347
           K +D +S G++L E++TG P
Sbjct: 214 K-SDIYSFGVVLLEIITGLP 232

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 71/138 (51%), Gaps = 20/138 (14%)
Query: 224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--------GIMHRD 275
           +LYL+ D+   G L+  L    L  + + ++  +  VS + HLH           I HRD
Sbjct: 109 QLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSS-VSGLCHLHTEIFSTQGKPAIAHRD 167
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDENTRS-----NSMCGTLEYMSPEIV---LGKGHD 327
           LK +NIL+  +G   + D GLA +F  +T       N+  GT  YM PE++   L + H 
Sbjct: 168 LKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHF 227
Query: 328 KA---ADWWSVGILLFEM 342
           ++   AD +S G++L+E+
Sbjct: 228 QSYIMADMYSFGLILWEV 245

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 116/246 (47%), Gaps = 25/246 (10%)
Query: 112 INEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVY--QV 169
           I+ ET E PN       A+ +    +D       C+ +E     +V+G G F +V   ++
Sbjct: 21  IDPETYEDPNR------AVHQFAKELDA-----SCIKIE-----RVIGAGEFGEVCSGRL 64
Query: 170 RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL 229
           +  G  ++       K    EK   +++  E +I+ + DHP +V L         + +V+
Sbjct: 65  KLPGKRDVAVAIKTLKVGYTEKQRRDFL-CEASIMGQFDHPNVVHLEGVVTRGKPVMIVI 123
Query: 230 DFVNGGHL-FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH 288
           +F+  G L  F     G F           I + + +L   G +HRDL   NIL++++  
Sbjct: 124 EFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLV 183
Query: 289 VMLTDFGLAKQFDENTRS--NSMCGTL--EYMSPEIVLGKGHDKAADWWSVGILLFEMLT 344
             ++DFGL++  +++  +   +  G +   + +PE +  +    A+D WS GI+++E+++
Sbjct: 184 CKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243
Query: 345 -GQPPF 349
            G+ P+
Sbjct: 244 YGERPY 249

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 104/207 (50%), Gaps = 10/207 (4%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  +++K +G G F +V+      ++++ A+K ++   +  +   E    E N++  + H
Sbjct: 13  ESIKLVKRLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTMSVQAFLE----EANLMKTLQH 67
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
             +V+L      +  +Y++ +++  G L   L      +  L ++  ++A+I   ++++ 
Sbjct: 68  DKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 127
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKG 325
               +HRDL+  N+L+       + DFGLA+  ++N  T        +++ +PE +    
Sbjct: 128 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGC 187
Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTG 351
               +D WS GILL+E++T G+ P+ G
Sbjct: 188 FTIKSDVWSFGILLYEIVTYGKIPYPG 214

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V  E  ++++ +G G F +V+     G +++ A+K +++  +      +   +E N++ +
Sbjct: 18  VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQ 72
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVS 264
           + H  +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++
Sbjct: 73  LQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 131
Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVL 322
            +     +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE + 
Sbjct: 132 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 191
Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                  +D WS GILL E++T G+ P+ G
Sbjct: 192 YGTFTIKSDVWSFGILLTEIVTHGRIPYPG 221

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKN------HAEYMK---SE 200
           K +G+GAF +V     +G  +      +     M KD   EK+        E MK     
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 201 RNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDL 251
           +NI+  +     D P  V + Y+ +   R YL      G    + + R    Q  F++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
           +  Y  ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ +
Sbjct: 161 SCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTN 218
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V  E  ++++ +G G F +V+     G +++ A+K +++  +      +   +E N++ +
Sbjct: 12  VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQ 66
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVS 264
           + H  +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++
Sbjct: 67  LQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 125
Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVL 322
            +     +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE + 
Sbjct: 126 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 185
Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                  +D WS GILL E++T G+ P+ G
Sbjct: 186 YGTFTIKSDVWSFGILLTEIVTHGRIPYPG 215

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V  E  ++++ +G G F +V+     G +++ A+K +++  +      +   +E N++ +
Sbjct: 19  VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQ 73
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVS 264
           + H  +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++
Sbjct: 74  LQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 132
Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVL 322
            +     +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE + 
Sbjct: 133 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 192
Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                  +D WS GILL E++T G+ P+ G
Sbjct: 193 YGTFTIKSDVWSFGILLTEIVTHGRIPYPG 222

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 16/200 (8%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G F  VY+   +  + +   K+     I  +   +    E  ++ K  H  +V+L  
Sbjct: 33  MGEGGFGVVYK-GYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 91
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYR-------QGLFREDLARIYTAEIVSAVSHLHANG 270
                  L LV  ++  G L  +L             R  +A+       + ++ LH N 
Sbjct: 92  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQ----GAANGINFLHENH 147
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
            +HRD+K  NILLD      ++DFGLA+   +F +      + GT  YM+PE + G+   
Sbjct: 148 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGEITP 207
Query: 328 KAADWWSVGILLFEMLTGQP 347
           K +D +S G++L E++TG P
Sbjct: 208 K-SDIYSFGVVLLEIITGLP 226

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V  E  ++++ +G G F +V+     G +++ A+K +++  +      +   +E N++ +
Sbjct: 16  VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQ 70
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVS 264
           + H  +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++
Sbjct: 71  LQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 129
Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVL 322
            +     +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE + 
Sbjct: 130 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 189
Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                  +D WS GILL E++T G+ P+ G
Sbjct: 190 YGTFTIKSDVWSFGILLTEIVTHGRIPYPG 219

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V  E  ++++ +G G F +V+     G +++ A+K +++  +      +   +E N++ +
Sbjct: 20  VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQ 74
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVS 264
           + H  +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++
Sbjct: 75  LQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 133
Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVL 322
            +     +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE + 
Sbjct: 134 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 193
Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                  +D WS GILL E++T G+ P+ G
Sbjct: 194 YGTFTIKSDVWSFGILLTEIVTHGRIPYPG 223

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V  E  ++++ +G G F +V+     G +++ A+K +++  +      +   +E N++ +
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQ 64
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVS 264
           + H  +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++
Sbjct: 65  LQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVL 322
            +     +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE + 
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 183
Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                  +D WS GILL E++T G+ P+ G
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 101/224 (45%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKN------HAEYMK---SE 200
           K +G+GAF +V     +G  +      +     M KD   EK+        E MK     
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 201 RNIL-----TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDL 251
           +NI+        D P  V + Y+ +   R YL      G    + + R    Q  F++ +
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
           +  Y  ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ +
Sbjct: 161 SCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 19  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 75
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 76  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 133
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 134 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 193
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 194 ESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V  E  ++++ +G G F +V+     G +++ A+K +++  +      +   +E N++ +
Sbjct: 11  VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQ 65
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVS 264
           + H  +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++
Sbjct: 66  LQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 124
Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVL 322
            +     +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE + 
Sbjct: 125 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 184
Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                  +D WS GILL E++T G+ P+ G
Sbjct: 185 YGTFTIKSDVWSFGILLTEIVTHGRIPYPG 214

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 29/209 (13%)
Query: 155 LKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +G+G F KV    Y      T E  A+K ++ +     NH   +K E  IL  + H 
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHE 83
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR-----------IYTAEI 259
            IV        KY+     D  NG  L  +    G  +E L +            Y  +I
Sbjct: 84  NIV--------KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----Y 315
              + +L +   +HRDL   N+L++++  V + DFGL K  + +    ++    +    +
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFW 195
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT 344
            +PE ++      A+D WS G+ L E+LT
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V  E  ++++ +G G F +V+     G +++ A+K +++  +      +   +E N++ +
Sbjct: 5   VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQ 59
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVS 264
           + H  +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++
Sbjct: 60  LQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 118
Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVL 322
            +     +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE + 
Sbjct: 119 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 178
Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                  +D WS GILL E++T G+ P+ G
Sbjct: 179 YGTFTIKSDVWSFGILLTEIVTHGRIPYPG 208

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 43  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 99
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 100 QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 157
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 158 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 217
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V  E  ++++ +G G F +V+     G +++ A+K +++  +      +   +E N++ +
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQ 64
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVS 264
           + H  +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++
Sbjct: 65  LQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVL 322
            +     +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE + 
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 183
Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                  +D WS GILL E++T G+ P+ G
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 17  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 73
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 74  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 131
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 132 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 191
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 192 ESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKN------HAEYMK---SE 200
           K +G+GAF +V     +G  +      +     M KD   EK+        E MK     
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 201 RNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDL 251
           +NI+  +     D P  V + Y+ +   R YL      G    + + R    Q  F++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
           +  Y  ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ +
Sbjct: 161 SCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V  E  ++++ +G G F +V+     G +++ A+K +++  +      +   +E N++ +
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQ 64
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVS 264
           + H  +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++
Sbjct: 65  LQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVL 322
            +     +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE + 
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                  +D WS GILL E++T G+ P+ G
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V  E  ++++ +G G F +V+     G +++ A+K +++  +      +   +E N++ +
Sbjct: 16  VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQ 70
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVS 264
           + H  +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++
Sbjct: 71  LQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 129
Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVL 322
            +     +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE + 
Sbjct: 130 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 189
Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                  +D WS GILL E++T G+ P+ G
Sbjct: 190 YGTFTIKSDVWSFGILLTEIVTHGRIPYPG 219

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V  E  ++++ +G G F +V+     G +++ A+K +++  +      +   +E N++ +
Sbjct: 15  VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQ 69
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVS 264
           + H  +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++
Sbjct: 70  LQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 128
Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVL 322
            +     +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE + 
Sbjct: 129 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 188
Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                  +D WS GILL E++T G+ P+ G
Sbjct: 189 YGTFTIKSDVWSFGILLTEIVTHGRIPYPG 218

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 106/236 (44%), Gaps = 37/236 (15%)
Query: 150 EDFEVLKVVGQGAFAKV-----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
           E+ E  KV+G GAF KV     Y + + G S   A+K++++    + +  E + SE  ++
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMM 102
Query: 205 TKV-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY-RQGLFREDLAR--------- 253
           T++  H  IV L  +      +YL+ ++   G L   L  ++  F ED            
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 254 -------------IYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
                         +  ++   +  L     +HRDL   N+L+     V + DFGLA+  
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 301 --DEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
             D N   R N+    +++M+PE +    +   +D WS GILL+E+ + G  P+ G
Sbjct: 223 MSDSNYVVRGNARL-PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 10  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 66
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 67  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 124
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 125 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 184
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 185 ESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 30  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 86
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 87  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 144
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 145 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 204
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 205 ESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 16  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 72
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 73  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 130
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 131 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 190
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 191 ESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 68
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 69  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 126
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 186
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 15  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 71
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 72  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 129
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 30  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 86
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 87  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 144
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 145 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 204
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 205 ESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 18  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 74
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 75  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 132
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 133 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 192
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 193 ESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 11  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 67
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 68  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 125
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 126 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 185
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 186 ESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 29/209 (13%)
Query: 155 LKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +G+G F KV    Y      T E  A+K ++ +     NH   +K E  IL  + H 
Sbjct: 14  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHE 71
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR-----------IYTAEI 259
            IV        KY+     D  NG  L  +    G  +E L +            Y  +I
Sbjct: 72  NIV--------KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 123
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----Y 315
              + +L +   +HRDL   N+L++++  V + DFGL K  + +    ++    +    +
Sbjct: 124 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFW 183
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT 344
            +PE ++      A+D WS G+ L E+LT
Sbjct: 184 YAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 68
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 69  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 126
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 186
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 105/234 (44%), Gaps = 51/234 (21%)
Query: 150 EDFEVLKVVGQGAFAKVY--------------QVRRIGTSEIYAMKVMRKDKIMEKNHAE 195
           +++ +  ++G+G++  VY              +V R+    I   +++R+  I+ +  ++
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 196 YMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF-REDLARI 254
           Y+    +++   D      L++       LY+VL+  +      +L++  +F  E+  + 
Sbjct: 86  YIIRLYDLIIPDD-----LLKFD-----ELYIVLEIADSD--LKKLFKTPIFLTEEHIKT 133
Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN------- 307
               ++   + +H +GI+HRDLKP N LL+ D  V + DFGLA+  +    +N       
Sbjct: 134 ILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193
Query: 308 ----------------SMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLT 344
                           S   T  Y +PE I+L + + K+ D WS G +  E+L 
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKN------HAEYMK---SE 200
           K +G+GAF +V     +G  +      +     M KD   EK+        E MK     
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 201 RNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDL 251
           +NI+  +     D P  V + Y+ +   R YL      G    + + R    Q  F++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
           +  Y  ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ +
Sbjct: 161 SCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 105/214 (49%), Gaps = 20/214 (9%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM-----RKDKIMEKNHAEYMKSERNILT 205
           + E  K +G+G F  V++ R +    + A+K +       +  M +   E+ + E  I++
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR-EVFIMS 78
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVS 264
            ++HP IV+L        R+  V++FV  G L+ +L  +    +  +      +I   + 
Sbjct: 79  NLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 265 HLHANG--IMHRDLKPENILL-----DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMS 317
           ++      I+HRDL+  NI L     +A     + DFGL++Q   +   + + G  ++M+
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV--SGLLGNFQWMA 194
Query: 318 PEIVLGK--GHDKAADWWSVGILLFEMLTGQPPF 349
           PE +  +   + + AD +S  ++L+ +LTG+ PF
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 111/243 (45%), Gaps = 28/243 (11%)
Query: 132 KPTGHIDNLPSENQ----------------CVGLEDFEVLKVVGQGAFAKVYQVRRIGTS 175
           KP  H  ++P+E                   V  ++F    ++G+G F KVY+ R +   
Sbjct: 4   KPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGR-LADG 62
Query: 176 EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG 235
            + A+K +++++   +      ++E  +++   H  +++LR    T     LV  ++  G
Sbjct: 63  TLVAVKRLKEERX--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 120
Query: 236 HLFFQLYRQGLFREDLARIYTAEIV----SAVSHLHAN---GIMHRDLKPENILLDADGH 288
            +   L  +   +  L       I       +++LH +    I+HRD+K  NILLD +  
Sbjct: 121 SVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 180
Query: 289 VMLTDFGLAKQFDENTR--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQ 346
            ++ DFGLAK  D        ++ GT+ +++PE +      +  D +  G++L E++TGQ
Sbjct: 181 AVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 240
Query: 347 PPF 349
             F
Sbjct: 241 RAF 243

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 101/224 (45%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKN------HAEYMK---SE 200
           K +G+G F +V     +G  +      +     M KD   EK+        E MK     
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 201 RNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDL 251
           +NI+  +     D P  V + Y+ +   R YL      G    + + R    Q  F++ +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
           +  Y  ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ +
Sbjct: 207 SCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 265 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 308

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 101/224 (45%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKN------HAEYMK---SE 200
           K +G+G F +V     +G  +      +     M KD   EK+        E MK     
Sbjct: 30  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 89
Query: 201 RNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDL 251
           +NI+  +     D P  V + Y+ +   R YL      G    + + R    Q  F++ +
Sbjct: 90  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
           +  Y  ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ +
Sbjct: 150 SCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 207
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 208 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 251

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 101/224 (45%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKN------HAEYMK---SE 200
           K +G+G F +V     +G  +      +     M KD   EK+        E MK     
Sbjct: 33  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 92
Query: 201 RNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDL 251
           +NI+  +     D P  V + Y+ +   R YL      G    + + R    Q  F++ +
Sbjct: 93  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
           +  Y  ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ +
Sbjct: 153 SCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 210
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 211 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 254

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 101/224 (45%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKN------HAEYMK---SE 200
           K +G+G F +V     +G  +      +     M KD   EK+        E MK     
Sbjct: 28  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 87
Query: 201 RNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDL 251
           +NI+  +     D P  V + Y+ +   R YL      G    + + R    Q  F++ +
Sbjct: 88  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
           +  Y  ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ +
Sbjct: 148 SCTY--QLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 205
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 206 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 249

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 32/217 (14%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM--RKDKIMEKNHAEY---MKSERNIL 204
            D  +L+ VG+G + +V+  R     E  A+K+   R +K   +    Y   M    NIL
Sbjct: 8   RDITLLECVGKGRYGEVW--RGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENIL 65
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
                 FI     S  +  +L+L+  +   G L+  L    L      RI  + I S ++
Sbjct: 66  G-----FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS-IASGLA 119
Query: 265 HLHAN--------GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-----SNSMCG 311
           HLH           I HRDLK +NIL+  +G   + D GLA    ++T      +N   G
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179
Query: 312 TLEYMSPEI------VLGKGHDKAADWWSVGILLFEM 342
           T  YM+PE+      V      K  D W+ G++L+E+
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V  E  ++++ +G G F +V+     G +++ A+K +++  +      +   +E N++ +
Sbjct: 6   VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQ 60
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVS 264
           + H  +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++
Sbjct: 61  LQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 119
Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVL 322
            +     +HR+L+  NIL+       + DFGLA+  ++N  T        +++ +PE + 
Sbjct: 120 FIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 179
Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                  +D WS GILL E++T G+ P+ G
Sbjct: 180 YGTFTIKSDVWSFGILLTEIVTHGRIPYPG 209

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 104/224 (46%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKV------MRKDKIMEKNHAEYMKSERNILTKV-D 208
           K +G+GAF +V     IG  +    +V      M K    EK+ ++ + SE  ++  +  
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIGK 92
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR---------------QGLFREDL 251
           H  I+ L  +      LY+++++ + G+L  + Q                  + L  +DL
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
                 ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ +
Sbjct: 153 VSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+LL+E+ T G  P+ G
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 255

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 15  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 71
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q + + +    L + YT++I   
Sbjct: 72  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQ-YTSQICKG 129
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 54/90 (60%), Gaps = 4/90 (4%)
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNSMCGTLEYMS 317
           + ++ LH N  +HRD+K  NILLD      ++DFGLA+   +F +    + + GT  Y +
Sbjct: 135 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXA 194
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQP 347
           PE + G+   K +D +S G++L E++TG P
Sbjct: 195 PEALRGEITPK-SDIYSFGVVLLEIITGLP 223

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 68
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 69  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 126
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAP 186
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 32/209 (15%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVM--RKDKIMEKNHAEY---MKSERNILTKVDHPFI 212
           +G+G F +V++ +  G  E  A+K+   R+++   +    Y   M    NIL      FI
Sbjct: 50  IGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEIYQTVMLRHENILG-----FI 102
Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--- 269
                   T  +L+LV D+   G LF  L R  +  E + ++  +   S ++HLH     
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVG 161
Query: 270 -----GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-----NSMCGTLEYMSPE 319
                 I HRDLK +NIL+  +G   + D GLA + D  T +     N   GT  YM+PE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 320 IV---LGKGH---DKAADWWSVGILLFEM 342
           ++   +   H    K AD +++G++ +E+
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 107/244 (43%), Gaps = 56/244 (22%)
Query: 150 EDFEVLKVVGQGAFAKVYQV--RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER---NIL 204
           E +E++  +G+G F KV +      G S++ A+K++R       N  +Y ++ R   N+L
Sbjct: 51  ERYEIVGNLGEGTFGKVVECLDHARGKSQV-ALKIIR-------NVGKYREAARLEINVL 102
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVN-GGHLF--FQLYRQGLF---REDLARIY--- 255
            K+            + K+   L+ D+ N  GH+   F+L  +  F   +E+  + Y   
Sbjct: 103 KKIKEK-------DKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLP 155
Query: 256 -----TAEIVSAVSHLHANGIMHRDLKPENILLD-------------------ADGHVML 291
                  ++  A+  LH N + H DLKPENIL                      +  + +
Sbjct: 156 HVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 215
Query: 292 TDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPF-T 350
            DFG A  FD    + ++  T  Y  PE++L  G  +  D WS+G +LFE   G   F T
Sbjct: 216 ADFGSA-TFDHEHHT-TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 273
Query: 351 GGNR 354
             NR
Sbjct: 274 HENR 277

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 32/209 (15%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVM--RKDKIMEKNHAEY---MKSERNILTKVDHPFI 212
           +G+G F +V++ +  G  E  A+K+   R+++   +    Y   M    NIL      FI
Sbjct: 37  IGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEIYQTVMLRHENIL-----GFI 89
Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--- 269
                   T  +L+LV D+   G LF  L R  +  E + ++      S ++HLH     
Sbjct: 90  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL-ALSTASGLAHLHMEIVG 148
Query: 270 -----GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-----NSMCGTLEYMSPE 319
                 I HRDLK +NIL+  +G   + D GLA + D  T +     N   GT  YM+PE
Sbjct: 149 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 208
Query: 320 IV---LGKGH---DKAADWWSVGILLFEM 342
           ++   +   H    K AD +++G++ +E+
Sbjct: 209 VLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 107/244 (43%), Gaps = 56/244 (22%)
Query: 150 EDFEVLKVVGQGAFAKVYQV--RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER---NIL 204
           E +E++  +G+G F KV +      G S++ A+K++R       N  +Y ++ R   N+L
Sbjct: 28  ERYEIVGNLGEGTFGKVVECLDHARGKSQV-ALKIIR-------NVGKYREAARLEINVL 79
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVN-GGHLF--FQLYRQGLF---REDLARIY--- 255
            K+            + K+   L+ D+ N  GH+   F+L  +  F   +E+  + Y   
Sbjct: 80  KKIKEK-------DKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLP 132
Query: 256 -----TAEIVSAVSHLHANGIMHRDLKPENILLD-------------------ADGHVML 291
                  ++  A+  LH N + H DLKPENIL                      +  + +
Sbjct: 133 HVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 192
Query: 292 TDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPF-T 350
            DFG A  FD    + ++  T  Y  PE++L  G  +  D WS+G +LFE   G   F T
Sbjct: 193 ADFGSA-TFDHEHHT-TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 250
Query: 351 GGNR 354
             NR
Sbjct: 251 HENR 254

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 28/211 (13%)
Query: 154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY---MKSERNILTKVDHP 210
           +L+ VG+G + +V++    G +    +   R +K   +    Y   M    NIL      
Sbjct: 41  LLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILG----- 95
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN- 269
           FI     S  +  +L+L+  +   G L+  L    L      RI  + I S ++HLH   
Sbjct: 96  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS-IASGLAHLHIEI 154
Query: 270 -------GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-----SNSMCGTLEYMS 317
                   I HRDLK +NIL+  +G   + D GLA    ++T      +N   GT  YM+
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 318 PEI------VLGKGHDKAADWWSVGILLFEM 342
           PE+      V      K  D W+ G++L+E+
Sbjct: 215 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 104/214 (48%), Gaps = 20/214 (9%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM-----RKDKIMEKNHAEYMKSERNILT 205
           + E  K +G+G F  V++ R +    + A+K +       +  M +   E+ + E  I++
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR-EVFIMS 78
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVS 264
            ++HP IV+L        R+  V++FV  G L+ +L  +    +  +      +I   + 
Sbjct: 79  NLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 265 HLHANG--IMHRDLKPENILL-----DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMS 317
           ++      I+HRDL+  NI L     +A     + DFG ++Q   +   + + G  ++M+
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSV--SGLLGNFQWMA 194
Query: 318 PEIVLGK--GHDKAADWWSVGILLFEMLTGQPPF 349
           PE +  +   + + AD +S  ++L+ +LTG+ PF
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 107/244 (43%), Gaps = 56/244 (22%)
Query: 150 EDFEVLKVVGQGAFAKVYQV--RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER---NIL 204
           E +E++  +G+G F KV +      G S++ A+K++R       N  +Y ++ R   N+L
Sbjct: 19  ERYEIVGNLGEGTFGKVVECLDHARGKSQV-ALKIIR-------NVGKYREAARLEINVL 70
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVN-GGHLF--FQLYRQGLF---REDLARIY--- 255
            K+            + K+   L+ D+ N  GH+   F+L  +  F   +E+  + Y   
Sbjct: 71  KKIKEK-------DKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLP 123
Query: 256 -----TAEIVSAVSHLHANGIMHRDLKPENILLD-------------------ADGHVML 291
                  ++  A+  LH N + H DLKPENIL                      +  + +
Sbjct: 124 HVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 292 TDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPF-T 350
            DFG A  FD    + ++  T  Y  PE++L  G  +  D WS+G +LFE   G   F T
Sbjct: 184 ADFGSA-TFDHEHHT-TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241
Query: 351 GGNR 354
             NR
Sbjct: 242 HENR 245

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 103/237 (43%), Gaps = 54/237 (22%)
Query: 150 EDFEVLKVVGQGAFAKVY--------------QVRRIGTSEIYAMKVMRKDKIMEKNHAE 195
           +++E+  ++G+G++  VY              +V R+    I   +++R+  I+ +  ++
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 196 YMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF-REDLARI 254
           Y+    +++   D      L++       LY+VL+  +      +L++  +F  E   + 
Sbjct: 88  YIIRLHDLIIPED-----LLKFD-----ELYIVLEIADSD--LKKLFKTPIFLTEQHVKT 135
Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----------- 303
               ++     +H +GI+HRDLKP N LL+ D  V + DFGLA+  + +           
Sbjct: 136 ILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEE 195
Query: 304 ---------------TRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLT 344
                           +  S   T  Y +PE I+L + +  + D WS G +  E+L 
Sbjct: 196 KEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLN 252

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 32/209 (15%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVM--RKDKIMEKNHAEY---MKSERNILTKVDHPFI 212
           +G+G F +V++ +  G  E  A+K+   R+++   +    Y   M    NIL      FI
Sbjct: 12  IGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEIYQTVMLRHENIL-----GFI 64
Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--- 269
                   T  +L+LV D+   G LF  L R  +  E + ++  +   S ++HLH     
Sbjct: 65  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVG 123
Query: 270 -----GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-----NSMCGTLEYMSPE 319
                 I HRDLK +NIL+  +G   + D GLA + D  T +     N   GT  YM+PE
Sbjct: 124 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 183
Query: 320 IV---LGKGH---DKAADWWSVGILLFEM 342
           ++   +   H    K AD +++G++ +E+
Sbjct: 184 VLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 32/209 (15%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVM--RKDKIMEKNHAEY---MKSERNILTKVDHPFI 212
           +G+G F +V++ +  G  E  A+K+   R+++   +    Y   M    NIL      FI
Sbjct: 14  IGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEIYQTVMLRHENIL-----GFI 66
Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--- 269
                   T  +L+LV D+   G LF  L R  +  E + ++  +   S ++HLH     
Sbjct: 67  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVG 125
Query: 270 -----GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-----NSMCGTLEYMSPE 319
                 I HRDLK +NIL+  +G   + D GLA + D  T +     N   GT  YM+PE
Sbjct: 126 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 185
Query: 320 IV---LGKGH---DKAADWWSVGILLFEM 342
           ++   +   H    K AD +++G++ +E+
Sbjct: 186 VLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 32/209 (15%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVM--RKDKIMEKNHAEY---MKSERNILTKVDHPFI 212
           +G+G F +V++ +  G  E  A+K+   R+++   +    Y   M    NIL      FI
Sbjct: 17  IGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEIYQTVMLRHENIL-----GFI 69
Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--- 269
                   T  +L+LV D+   G LF  L R  +  E + ++  +   S ++HLH     
Sbjct: 70  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVG 128
Query: 270 -----GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-----NSMCGTLEYMSPE 319
                 I HRDLK +NIL+  +G   + D GLA + D  T +     N   GT  YM+PE
Sbjct: 129 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 188
Query: 320 IV---LGKGH---DKAADWWSVGILLFEM 342
           ++   +   H    K AD +++G++ +E+
Sbjct: 189 VLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 13  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 69
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 70  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 127
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HR+L   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 128 MEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAP 187
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 188 ESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 32/209 (15%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVM--RKDKIMEKNHAEY---MKSERNILTKVDHPFI 212
           +G+G F +V++ +  G  E  A+K+   R+++   +    Y   M    NIL      FI
Sbjct: 11  IGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEIYQTVMLRHENIL-----GFI 63
Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--- 269
                   T  +L+LV D+   G LF  L R  +  E + ++  +   S ++HLH     
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVG 122
Query: 270 -----GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-----NSMCGTLEYMSPE 319
                 I HRDLK +NIL+  +G   + D GLA + D  T +     N   GT  YM+PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 320 IV---LGKGH---DKAADWWSVGILLFEM 342
           ++   +   H    K AD +++G++ +E+
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 104/214 (48%), Gaps = 20/214 (9%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM-----RKDKIMEKNHAEYMKSERNILT 205
           + E  K +G+G F  V++ R +    + A+K +       +  M +   E+ + E  I++
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR-EVFIMS 78
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVS 264
            ++HP IV+L        R+  V++FV  G L+ +L  +    +  +      +I   + 
Sbjct: 79  NLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 265 HLHANG--IMHRDLKPENILL-----DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMS 317
           ++      I+HRDL+  NI L     +A     + DF L++Q   +   + + G  ++M+
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSV--SGLLGNFQWMA 194
Query: 318 PEIVLGK--GHDKAADWWSVGILLFEMLTGQPPF 349
           PE +  +   + + AD +S  ++L+ +LTG+ PF
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 102/212 (48%), Gaps = 12/212 (5%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V  ++F    ++G+G F KVY+  R+    + A+K +++++   +      ++E  +++ 
Sbjct: 27  VASDNFXNKNILGRGGFGKVYK-GRLADGXLVAVKRLKEERT--QGGELQFQTEVEMISM 83
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV----SA 262
             H  +++LR    T     LV  ++  G +   L  +   +  L       I       
Sbjct: 84  AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARG 143
Query: 263 VSHLHAN---GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR--SNSMCGTLEYMS 317
           +++LH +    I+HRD+K  NILLD +   ++ DFGLAK  D        ++ G + +++
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIA 203
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           PE +      +  D +  G++L E++TGQ  F
Sbjct: 204 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 241 LYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
           LY+  L  E L   Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+  
Sbjct: 185 LYKDFLTLEHLI-CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243
Query: 301 DEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            ++    R       L++M+PE +  + +   +D WS G+LL+E+ + G  P+ G
Sbjct: 244 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 298

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 241 LYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
           LY+  L  E L   Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+  
Sbjct: 183 LYKDFLTLEHLI-CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 241
Query: 301 DEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            ++    R       L++M+PE +  + +   +D WS G+LL+E+ + G  P+ G
Sbjct: 242 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 296

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 32/213 (15%)
Query: 154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVM--RKDKIMEKNHAEY---MKSERNILTKVD 208
           +L+ VG+G + +V+  R     E  A+K+   R +K   +    Y   M    NIL    
Sbjct: 12  LLECVGKGRYGEVW--RGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILG--- 66
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
             FI     S  +  +L+L+  +   G L+  L    L      RI  + I S ++HLH 
Sbjct: 67  --FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS-IASGLAHLHI 123
Query: 269 N--------GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-----SNSMCGTLEY 315
                     I HRDLK +NIL+  +G   + D GLA    ++T      +N   GT  Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 316 MSPEI------VLGKGHDKAADWWSVGILLFEM 342
           M+PE+      V      K  D W+ G++L+E+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 241 LYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
           LY+  L  E L   Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+  
Sbjct: 192 LYKDFLTLEHLI-CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 250
Query: 301 DEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            ++    R       L++M+PE +  + +   +D WS G+LL+E+ + G  P+ G
Sbjct: 251 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 305

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 241 LYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
           LY+  L  E L   Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+  
Sbjct: 190 LYKDFLTLEHLI-CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 248
Query: 301 DEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            ++    R       L++M+PE +  + +   +D WS G+LL+E+ + G  P+ G
Sbjct: 249 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 303

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 108/205 (52%), Gaps = 15/205 (7%)
Query: 156 KVVGQGAFAKVY--QVRRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           K++G G   +V   ++R  G  ++  A+K + K    E+   +++ SE +I+ + DHP I
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFL-SEASIMGQFDHPNI 112
Query: 213 VQLRYSFQTKYRLYLVL-DFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           ++L     T+ RL +++ +++  G L  F + +        L  +    + + + +L   
Sbjct: 113 IRLE-GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRG-VGAGMRYLSDL 170
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAK--QFDENTRSNSMCGT--LEYMSPEIVLGKG 325
           G +HRDL   N+L+D++    ++DFGL++  + D +    +  G   + + +PE +  + 
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRT 230
Query: 326 HDKAADWWSVGILLFEMLT-GQPPF 349
              A+D WS G++++E+L  G+ P+
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERPY 255

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 151 DFEVLKVVGQGAFAKVYQVR--RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV- 207
           D +   V+G+G F +V + R  + G     A+K M K+   + +H ++   E  +L K+ 
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFA-GELEVLCKLG 83
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI------------- 254
            HP I+ L  + + +  LYL +++   G+L   L +  +   D A               
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 255 ---YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG 311
              + A++   + +L     +HRDL   NIL+  +    + DFGL++  +   +      
Sbjct: 144 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 203
Query: 312 TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            + +M+ E +    +   +D WS G+LL+E+++ G  P+ G
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 244

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 151 DFEVLKVVGQGAFAKVYQVR--RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV- 207
           D +   V+G+G F +V + R  + G     A+K M K+   + +H ++   E  +L K+ 
Sbjct: 16  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFA-GELEVLCKLG 73
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI------------- 254
            HP I+ L  + + +  LYL +++   G+L   L +  +   D A               
Sbjct: 74  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 133
Query: 255 ---YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG 311
              + A++   + +L     +HRDL   NIL+  +    + DFGL++  +   +      
Sbjct: 134 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 193
Query: 312 TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            + +M+ E +    +   +D WS G+LL+E+++ G  P+ G
Sbjct: 194 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 234

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           +E N++ ++D+P+IV++    + +  + LV++    G L   L +    ++        +
Sbjct: 61  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 119
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LE 314
           +   + +L  +  +HRDL   N+LL    +  ++DFGL+K    DEN       G   ++
Sbjct: 120 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVK 179
Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           + +PE +        +D WS G+L++E  + GQ P+ G
Sbjct: 180 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 217

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           +E N++ ++D+P+IV++    + +  + LV++    G L   L +    ++        +
Sbjct: 75  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 133
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LE 314
           +   + +L  +  +HRDL   N+LL    +  ++DFGL+K    DEN       G   ++
Sbjct: 134 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 193
Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           + +PE +        +D WS G+L++E  + GQ P+ G
Sbjct: 194 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 231

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           +E N++ ++D+P+IV++    + +  + LV++    G L   L +    ++        +
Sbjct: 419 AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 477
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LE 314
           +   + +L  +  +HRDL   N+LL    +  ++DFGL+K    DEN       G   ++
Sbjct: 478 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 537
Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           + +PE +        +D WS G+L++E  + GQ P+ G
Sbjct: 538 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 575

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           +E N++ ++D+P+IV++    + +  + LV++    G L   L +    ++        +
Sbjct: 420 AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 478
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LE 314
           +   + +L  +  +HRDL   N+LL    +  ++DFGL+K    DEN       G   ++
Sbjct: 479 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 538
Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           + +PE +        +D WS G+L++E  + GQ P+ G
Sbjct: 539 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 576

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 23/216 (10%)
Query: 152 FEVLKVVGQG--AFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +E+L V+G+G      V   R   T E   ++ +  +         +++ E ++    +H
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNH 85
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGH---LFFQLYRQGLFREDLARIYTAE-IVSAVSH 265
           P IV  R +F     L++V  F+  G    L    +  G+   +LA  Y  + ++ A+ +
Sbjct: 86  PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM--NELAIAYILQGVLKALDY 143
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----------CGTLEY 315
           +H  G +HR +K  +IL+  DG V L+  GL       +                  L +
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 316 MSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPF 349
           +SPE++    +G+D  +D +SVGI   E+  G  PF
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 23/216 (10%)
Query: 152 FEVLKVVGQG--AFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +E+L V+G+G      V   R   T E   ++ +  +         +++ E ++    +H
Sbjct: 11  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNH 69
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGH---LFFQLYRQGLFREDLARIYTAE-IVSAVSH 265
           P IV  R +F     L++V  F+  G    L    +  G+   +LA  Y  + ++ A+ +
Sbjct: 70  PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM--NELAIAYILQGVLKALDY 127
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----------CGTLEY 315
           +H  G +HR +K  +IL+  DG V L+  GL       +                  L +
Sbjct: 128 IHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 185
Query: 316 MSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPF 349
           +SPE++    +G+D  +D +SVGI   E+  G  PF
Sbjct: 186 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 221

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           +E N++ ++D+P+IV++    + +  + LV++    G L   L +    ++        +
Sbjct: 77  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 135
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LE 314
           +   + +L  +  +HRDL   N+LL    +  ++DFGL+K    DEN       G   ++
Sbjct: 136 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 195
Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           + +PE +        +D WS G+L++E  + GQ P+ G
Sbjct: 196 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 233

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           +E N++ ++D+P+IV++    + +  + LV++    G L   L +    ++        +
Sbjct: 77  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 135
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LE 314
           +   + +L  +  +HRDL   N+LL    +  ++DFGL+K    DEN       G   ++
Sbjct: 136 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 195
Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           + +PE +        +D WS G+L++E  + GQ P+ G
Sbjct: 196 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 233

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           +E N++ ++D+P+IV++    + +  + LV++    G L   L +    ++        +
Sbjct: 67  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 125
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LE 314
           +   + +L  +  +HRDL   N+LL    +  ++DFGL+K    DEN       G   ++
Sbjct: 126 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           + +PE +        +D WS G+L++E  + GQ P+ G
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 106/204 (51%), Gaps = 13/204 (6%)
Query: 156 KVVGQGAFAKVY--QVRRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           K++G G   +V   ++R  G  ++  A+K + K    E+   +++ SE +I+ + DHP I
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFL-SEASIMGQFDHPNI 112
Query: 213 VQLRYSFQTKYRLYLVL-DFVNGGHL-FFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
           ++L     T+ RL +++ +++  G L  F     G F           + + + +L   G
Sbjct: 113 IRLE-GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAK--QFDENTRSNSMCGT--LEYMSPEIVLGKGH 326
            +HRDL   N+L+D++    ++DFGL++  + D +    +  G   + + +PE +  +  
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF 231
Query: 327 DKAADWWSVGILLFEMLT-GQPPF 349
             A+D WS G++++E+L  G+ P+
Sbjct: 232 SSASDVWSFGVVMWEVLAYGERPY 255

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 80/158 (50%), Gaps = 6/158 (3%)
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YT 256
           +E N++ ++ H  +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    
Sbjct: 57  AEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115
Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD--ENTRSNSMCGTLE 314
           A+I   ++ +     +HRDL+  NIL+       + DFGLA+  +  E T        ++
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIK 175
Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           + +PE +        +D WS GILL E++T G+ P+ G
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           +E N++ ++D+P+IV++    + +  + LV++    G L   L +    ++        +
Sbjct: 61  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 119
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LE 314
           +   + +L  +  +HRDL   N+LL    +  ++DFGL+K    DEN       G   ++
Sbjct: 120 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 179
Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           + +PE +        +D WS G+L++E  + GQ P+ G
Sbjct: 180 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 217

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           +E N++ ++D+P+IV++    + +  + LV++    G L   L +    ++        +
Sbjct: 55  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 113
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LE 314
           +   + +L  +  +HRDL   N+LL    +  ++DFGL+K    DEN       G   ++
Sbjct: 114 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 173
Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           + +PE +        +D WS G+L++E  + GQ P+ G
Sbjct: 174 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 211

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           +E N++ ++D+P+IV++    + +  + LV++    G L   L +    ++        +
Sbjct: 57  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 115
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LE 314
           +   + +L  +  +HRDL   N+LL    +  ++DFGL+K    DEN       G   ++
Sbjct: 116 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175
Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           + +PE +        +D WS G+L++E  + GQ P+ G
Sbjct: 176 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 213

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 156 KVVGQGAFAKVYQ---VRRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           KV+G G F +VY+       G  E+  A+K + K    EK   +++  E  I+ +  H  
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFL-GEAGIMGQFSHHN 107
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHL-FFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
           I++L         + ++ +++  G L  F   + G F           I + + +L    
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG----TLEYMSPEIVLGKGH 326
            +HRDL   NIL++++    ++DFGL++  +++  +          + + +PE +  +  
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227
Query: 327 DKAADWWSVGILLFEMLT-GQPPF 349
             A+D WS GI+++E++T G+ P+
Sbjct: 228 TSASDVWSFGIVMWEVMTYGERPY 251

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/263 (24%), Positives = 117/263 (44%), Gaps = 24/263 (9%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKV-DHPF 211
           K +G GAF KV +    G  +  A+  +    +    HA   E + SE  I++ +  H  
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 103
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG---LFREDLARI-------YTAEIVS 261
           IV L  +      + ++ ++   G L   L R+    L +ED   +       +++++  
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 163
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQF--DEN--TRSNSMCGTLEYM 316
            ++ L +   +HRD+   N+LL  +GHV  + DFGLA+    D N   + N+    +++M
Sbjct: 164 GMAFLASKNCIHRDVAARNVLL-TNGHVAKIGDFGLARDIMNDSNYIVKGNARL-PVKWM 221
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG--GNRXXXXXXXXXXXXXLPAFLS 373
           +PE +    +   +D WS GILL+E+ + G  P+ G   N               PAF  
Sbjct: 222 APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAP 281
Query: 374 SEAHSLLKGVNSLLSISVPLLSR 396
              +S+++   +L     P   +
Sbjct: 282 KNIYSIMQACWALEPTHRPTFQQ 304

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 114/247 (46%), Gaps = 46/247 (18%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVR------RIGTSEIYAMKVMRKDKIMEKNH 193
            P +N  +G       K +G+G F KV +        R G + + A+K+++++     + 
Sbjct: 20  FPRKNLVLG-------KTLGEGEFGKVVKATAFHLKGRAGYTTV-AVKMLKENA--SPSE 69
Query: 194 AEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQ------- 244
              + SE N+L +V+HP +++L  +      L L++++   G L  F +  R+       
Sbjct: 70  LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 245 ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH 288
                            L   DL   +  +I   + +L    ++HRDL   NIL+     
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLIS-FAWQISQGMQYLAEMSLVHRDLAARNILVAEGRK 188
Query: 289 VMLTDFGLAKQ-FDENTRSNSMCGTL--EYMSPEIVLGKGHDKAADWWSVGILLFEMLT- 344
           + ++DFGL++  ++E++      G +  ++M+ E +    +   +D WS G+LL+E++T 
Sbjct: 189 MKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248
Query: 345 GQPPFTG 351
           G  P+ G
Sbjct: 249 GGNPYPG 255

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 114/247 (46%), Gaps = 46/247 (18%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVR------RIGTSEIYAMKVMRKDKIMEKNH 193
            P +N  +G       K +G+G F KV +        R G + + A+K+++++     + 
Sbjct: 20  FPRKNLVLG-------KTLGEGEFGKVVKATAFHLKGRAGYTTV-AVKMLKENA--SPSE 69
Query: 194 AEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQ------- 244
              + SE N+L +V+HP +++L  +      L L++++   G L  F +  R+       
Sbjct: 70  LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 245 ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH 288
                            L   DL   +  +I   + +L    ++HRDL   NIL+     
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLIS-FAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK 188
Query: 289 VMLTDFGLAKQ-FDENTRSNSMCGTL--EYMSPEIVLGKGHDKAADWWSVGILLFEMLT- 344
           + ++DFGL++  ++E++      G +  ++M+ E +    +   +D WS G+LL+E++T 
Sbjct: 189 MKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248
Query: 345 GQPPFTG 351
           G  P+ G
Sbjct: 249 GGNPYPG 255

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/263 (24%), Positives = 117/263 (44%), Gaps = 24/263 (9%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKV-DHPF 211
           K +G GAF KV +    G  +  A+  +    +    HA   E + SE  I++ +  H  
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG---LFREDLARI-------YTAEIVS 261
           IV L  +      + ++ ++   G L   L R+    L +ED   +       +++++  
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 171
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQF--DEN--TRSNSMCGTLEYM 316
            ++ L +   +HRD+   N+LL  +GHV  + DFGLA+    D N   + N+    +++M
Sbjct: 172 GMAFLASKNCIHRDVAARNVLL-TNGHVAKIGDFGLARDIMNDSNYIVKGNARL-PVKWM 229
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG--GNRXXXXXXXXXXXXXLPAFLS 373
           +PE +    +   +D WS GILL+E+ + G  P+ G   N               PAF  
Sbjct: 230 APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAP 289
Query: 374 SEAHSLLKGVNSLLSISVPLLSR 396
              +S+++   +L     P   +
Sbjct: 290 KNIYSIMQACWALEPTHRPTFQQ 312

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 58/107 (54%), Gaps = 13/107 (12%)
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGH-----VMLTDFGLAKQF-DENTRSN---- 307
           +++S + ++H+  +++RD+KPEN L+   G+     + + DFGLAK++ D  T+ +    
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYR 172
Query: 308 ---SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
              S+ GT  YMS    LGK   +  D  ++G +    L G  P+ G
Sbjct: 173 EHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG 219

>pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 59/107 (55%), Gaps = 13/107 (12%)
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADG----HVM-LTDFGLAKQF-DENTRSN---- 307
           +++S + ++H+  +++RD+KPEN L+   G    HV+ + DFGLAK++ D  T+ +    
Sbjct: 105 QLLSRMEYVHSKNLIYRDVKPENFLIGRQGNKKEHVIHIIDFGLAKEYIDPETKKHIPYR 164
Query: 308 ---SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
              S+ GT  YMS    LGK   +  D  ++G +    L G  P+ G
Sbjct: 165 EHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG 211

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 151 DFEVLKVVGQGAFAKVYQVR--RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV- 207
           D +   V+G+G F +V + R  + G     A+K M K+   + +H ++   E  +L K+ 
Sbjct: 23  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFA-GELEVLCKLG 80
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI------------- 254
            HP I+ L  + + +  LYL +++   G+L   L +  +   D A               
Sbjct: 81  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 140
Query: 255 ---YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG 311
              + A++   + +L     +HR+L   NIL+  +    + DFGL++  +   +      
Sbjct: 141 LLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 200
Query: 312 TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            + +M+ E +    +   +D WS G+LL+E+++ G  P+ G
Sbjct: 201 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 241

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 114/247 (46%), Gaps = 46/247 (18%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVR------RIGTSEIYAMKVMRKDKIMEKNH 193
            P +N  +G       K +G+G F KV +        R G + + A+K+++++     + 
Sbjct: 20  FPRKNLVLG-------KTLGEGEFGKVVKATAFHLKGRAGYTTV-AVKMLKENA--SPSE 69
Query: 194 AEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQ------- 244
              + SE N+L +V+HP +++L  +      L L++++   G L  F +  R+       
Sbjct: 70  LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 245 ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH 288
                            L   DL   +  +I   + +L    ++HRDL   NIL+     
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLIS-FAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK 188
Query: 289 VMLTDFGLAKQ-FDENTRSNSMCGTL--EYMSPEIVLGKGHDKAADWWSVGILLFEMLT- 344
           + ++DFGL++  ++E++      G +  ++M+ E +    +   +D WS G+LL+E++T 
Sbjct: 189 MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248
Query: 345 GQPPFTG 351
           G  P+ G
Sbjct: 249 GGNPYPG 255

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/233 (22%), Positives = 97/233 (41%), Gaps = 43/233 (18%)
Query: 152 FEVLKVVGQGAFAKVYQVR---RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           F++   +G+G F+ VY      ++G  E  A+K      ++  +H   + +E   LT   
Sbjct: 23  FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALK-----HLIPTSHPIRIAAELQCLTVAG 77
Query: 209 -HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
               ++ ++Y F+    + + + ++     F  +     F+E   R Y   +  A+  +H
Sbjct: 78  GQDNVMGVKYCFRKNDHVVIAMPYLEHES-FLDILNSLSFQE--VREYMLNLFKALKRIH 134
Query: 268 ANGIMHRDLKPENILLDAD-GHVMLTDFGLAK----------QFDENTRSNSMC------ 310
             GI+HRD+KP N L +       L DFGLA+          +F ++      C      
Sbjct: 135 QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCS 194
Query: 311 -------------GTLEYMSPEIVL-GKGHDKAADWWSVGILLFEMLTGQPPF 349
                        GT  + +PE++        A D WS G++   +L+G+ PF
Sbjct: 195 ICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 156 KVVGQGAFAKVYQ---VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           K++G+G F  V +    +  GTS   A+K M+ D   ++   E++ SE   +    HP +
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFL-SEAACMKDFSHPNV 98
Query: 213 VQL-----RYSFQTKYRLYLVLDFVNGG----HLFFQLYRQGLFREDLARI--YTAEIVS 261
           ++L       S Q   +  ++L F+  G    +L +     G     L  +  +  +I  
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSP 318
            + +L     +HRDL   N +L  D  V + DFGL+K+    D   +       +++++ 
Sbjct: 159 GMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           E +  + +   +D W+ G+ ++E+ T G  P+ G
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG 252

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 118/276 (42%), Gaps = 37/276 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKV-DHPF 211
           K +G GAF KV +    G  +  A+  +    +    HA   E + SE  I++ +  H  
Sbjct: 37  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 96
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----------------QGLFREDLARI- 254
           IV L  +      + ++ ++   G L   L R                +GL +ED   + 
Sbjct: 97  IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLE 156
Query: 255 ------YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQF--DEN-- 303
                 +++++   ++ L +   +HRD+   N+LL  +GHV  + DFGLA+    D N  
Sbjct: 157 LRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL-TNGHVAKIGDFGLARDIMNDSNYI 215
Query: 304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG--GNRXXXXXX 360
            + N+    +++M+PE +    +   +D WS GILL+E+ + G  P+ G   N       
Sbjct: 216 VKGNARL-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 274
Query: 361 XXXXXXXLPAFLSSEAHSLLKGVNSLLSISVPLLSR 396
                   PAF     +S+++   +L     P   +
Sbjct: 275 KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQ 310

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 77/156 (49%), Gaps = 12/156 (7%)
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRL-----YLVLDFVNGGHLFFQLYRQGLFREDLARIY 255
           R  L +V HP IVQ+    +   R      Y+V+++V G  L     ++    E +A  Y
Sbjct: 130 RQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA--Y 187
Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY 315
             EI+ A+S+LH+ G+++ DLKPENI+L  +  + L D G   + +       + GT  +
Sbjct: 188 LLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS---FGYLYGTPGF 243
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
            +PEIV   G   A D ++VG  L  +    P   G
Sbjct: 244 QAPEIVR-TGPTVATDIYTVGRTLAALTLDLPTRNG 278

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 15/210 (7%)
Query: 156 KVVGQGAFAKVYQ---VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           +V+G+G F  VY    +   G     A+K +  ++I +        +E  I+    HP +
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 213 VQLR-YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           + L     +++    +VL ++  G L  F +        +DL   +  ++   +  L + 
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG-FGLQVAKGMKFLASK 211
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLA-----KQFDENTRSNSMCGTLEYMSPEIVLGK 324
             +HRDL   N +LD    V + DFGLA     K+FD           +++M+ E +  +
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTGGN 353
                +D WS G+LL+E++T G PP+   N
Sbjct: 272 KFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301

>pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 57/107 (53%), Gaps = 13/107 (12%)
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGH-----VMLTDFGLAKQF-DENTRSN---- 307
           +++S + ++H+  +++RD+KPEN L+   G+     + + DF LAK++ D  T+ +    
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 172
Query: 308 ---SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
              S+ GT  YMS    LGK   +  D  ++G +    L G  P+ G
Sbjct: 173 EHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG 219

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNILTK 206
           +   LKV+G G F  V++   I   E  ++K+    K++E    +   + +      +  
Sbjct: 32  ELRKLKVLGSGVFGTVHKGVWIPEGE--SIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGS 89
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSH 265
           +DH  IV+L         L LV  ++  G L   + + +G     L   +  +I   + +
Sbjct: 90  LDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 148
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVL 322
           L  +G++HR+L   N+LL +   V + DFG+A      D+    +     +++M+ E + 
Sbjct: 149 LEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 208
Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
              +   +D WS G+ ++E++T G  P+ G
Sbjct: 209 FGKYTHQSDVWSYGVTVWELMTFGAEPYAG 238
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	396
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-147
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-146
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-146
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-145
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-144
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-141
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-141
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-139
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-139
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-138
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-137
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-135
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-135
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-135
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-134
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-133
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-131
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-130
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-130
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-128
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-127
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-127
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-109
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-108
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-95
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-86
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-85
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	9e-85
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-84
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-84
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-83
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-81
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-79
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	9e-78
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-77
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-76
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-76
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-75
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-75
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-75
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-75
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-74
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-74
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-74
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-74
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-74
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-73
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-73
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-73
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-73
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-73
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-73
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-73
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-73
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-72
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-72
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-72
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	9e-72
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-71
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-71
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-71
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-71
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-71
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-70
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-70
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-69
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-69
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-69
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-69
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-68
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-68
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-68
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-68
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-68
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-67
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-67
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-67
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-66
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-66
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-66
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-65
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-65
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-65
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-65
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-64
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	8e-64
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	9e-64
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-63
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-63
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-62
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-61
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-60
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-58
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-57
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-56
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-54
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-54
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-53
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-53
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-52
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-51
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-51
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-51
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-50
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-48
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-48
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-48
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-48
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	9e-48
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-47
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-46
3aln_A	327	Dual specificity mitogen-activated protein kinase;	8e-46
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-45
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-45
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-45
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-44
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-44
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-43
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-43
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-43
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-43
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-43
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-42
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-42
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-41
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-41
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-41
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-40
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-40
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	9e-40
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-40
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-39
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-39
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-39
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-39
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-39
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-39
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-39
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-39
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-39
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-38
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-38
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-36
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-35
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-35
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-34
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-34
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-34
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-34
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-34
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-33
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-33
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-31
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-31
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-31
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-30
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-30
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-29
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	9e-29
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	9e-29
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-28
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-27
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-26
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-26
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-26
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-25
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-25
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-25
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-24
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-23
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-23
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-23
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-23
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-23
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-23
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-23
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	5e-23
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-23
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	8e-23
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	9e-23
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-23
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-22
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-22
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-22
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	8e-22
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-21
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-21
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-21
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-21
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-21
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-21
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-21
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-21
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-21
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-21
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-21
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-21
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-21
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-20
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-20
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-20
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-20
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-20
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-20
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-20
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-20
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-20
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-20
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-20
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	8e-20
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-19
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-19
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-19
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-19
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-18
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-18
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-18
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-18
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-18
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-16
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-16
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-16
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-16
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-15
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-15
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-15
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-15
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-15
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-15
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-14
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-14
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-14
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-13
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-04
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-05

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  418 bits (1078), Expect = e-147
 Identities = 127/257 (49%), Positives = 181/257 (70%), Gaps = 8/257 (3%)

Query: 131 GKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDK 187
           G     ++  P +   +  E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  
Sbjct: 1   GSSETSVNRGPEK---IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAM 57

Query: 188 IMEK-NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL 246
           I+       + K+ERNIL +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+
Sbjct: 58  IVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGI 117

Query: 247 FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTR 305
           F ED A  Y AEI  A+ HLH  GI++RDLKPENI+L+  GHV LTDFGL K+   + T 
Sbjct: 118 FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV 177

Query: 306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK 365
           +++ CGT+EYM+PEI++  GH++A DWWS+G L+++MLTG PPFTG NR+K   KI+K K
Sbjct: 178 THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK 237

Query: 366 IKLPAFLSSEAHSLLKG 382
           + LP +L+ EA  LLK 
Sbjct: 238 LNLPPYLTQEARDLLKK 254

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  416 bits (1071), Expect = e-146
 Identities = 119/249 (47%), Positives = 177/249 (71%), Gaps = 5/249 (2%)

Query: 138 DNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHA 194
            ++   ++      FE+LKV+GQG+F KV+ V++I      ++YAMKV++K  +  ++  
Sbjct: 12  HHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV 71

Query: 195 EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI 254
              K ER+IL +V+HPFIV+L Y+FQT+ +LYL+LDF+ GG LF +L ++ +F E+  + 
Sbjct: 72  R-TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF 130

Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTL 313
           Y AE+  A+ HLH+ GI++RDLKPENILLD +GH+ LTDFGL+K+  D   ++ S CGT+
Sbjct: 131 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190

Query: 314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLS 373
           EYM+PE+V  +GH ++ADWWS G+L+FEMLTG  PF G +R++    I+K K+ +P FLS
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLS 250

Query: 374 SEAHSLLKG 382
            EA SLL+ 
Sbjct: 251 PEAQSLLRM 259

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  417 bits (1075), Expect = e-146
 Identities = 116/274 (42%), Positives = 175/274 (63%), Gaps = 4/274 (1%)

Query: 111 GINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVR 170
           GI++  +  P  ++   A    P+  I+  PS N      DF  LKV+G+G+F KV   R
Sbjct: 1   GISQPQE--PELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLAR 58

Query: 171 RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQLRYSFQTKYRLYLVL 229
                  YA+KV++K  I++K   +++ SERN+L K V HPF+V L +SFQT  +LY VL
Sbjct: 59  HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 118

Query: 230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
           D++NGG LF+ L R+  F E  AR Y AEI SA+ +LH+  I++RDLKPENILLD+ GH+
Sbjct: 119 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHI 178

Query: 290 MLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPP 348
           +LTDFGL K+  + N+ +++ CGT EY++PE++  + +D+  DWW +G +L+EML G PP
Sbjct: 179 VLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

Query: 349 FTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG 382
           F   N  ++   I+   ++L   +++ A  LL+G
Sbjct: 239 FYSRNTAEMYDNILNKPLQLKPNITNSARHLLEG 272

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  413 bits (1064), Expect = e-145
 Identities = 99/255 (38%), Positives = 155/255 (60%), Gaps = 3/255 (1%)

Query: 131 GKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME 190
           G  +      P + +    EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I++
Sbjct: 11  GAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK 70

Query: 191 KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED 250
           +N   Y+  ER++++++DHPF V+L ++FQ   +LY  L +   G L   + + G F E 
Sbjct: 71  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 130

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSN 307
             R YTAEIVSA+ +LH  GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N
Sbjct: 131 CTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 190

Query: 308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK 367
           S  GT +Y+SPE++  K   K++D W++G ++++++ G PPF  GN   I QKIIK +  
Sbjct: 191 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 250

Query: 368 LPAFLSSEAHSLLKG 382
            P     +A  L++ 
Sbjct: 251 FPEKFFPKARDLVEK 265

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  411 bits (1059), Expect = e-144
 Identities = 91/236 (38%), Positives = 151/236 (63%), Gaps = 2/236 (0%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
             L+DF++L+ +G G+F +V+ +R       YAMKV++K+ ++     E+   ER +L+ 
Sbjct: 3   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           V HPFI+++  +FQ   ++++++D++ GG LF  L +   F   +A+ Y AE+  A+ +L
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 122

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           H+  I++RDLKPENILLD +GH+ +TDFG AK   + T   ++CGT +Y++PE+V  K +
Sbjct: 123 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--YTLCGTPDYIAPEVVSTKPY 180

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG 382
           +K+ DWWS GIL++EML G  PF   N  K  +KI+  +++ P F + +   LL  
Sbjct: 181 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 236

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  404 bits (1041), Expect = e-141
 Identities = 99/237 (41%), Positives = 157/237 (66%), Gaps = 1/237 (0%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKG 325
           H+  +++RD+K EN++LD DGH+ +TDFGL K+   +     + CGT EY++PE++    
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG 382
           + +A DWW +G++++EM+ G+ PF   + +++ + I+ ++I+ P  LS EA SLL G
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  404 bits (1041), Expect = e-141
 Identities = 122/299 (40%), Positives = 182/299 (60%), Gaps = 13/299 (4%)

Query: 97  LTLHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLK 156
           +  H                               K      NL    + VG+E+FE+LK
Sbjct: 1   MAHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLK 60

Query: 157 VVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILTKVDH-PF 211
           V+G GA+ KV+ VR+I    T ++YAMKV++K  I++K    E+ ++ER +L  +   PF
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           +V L Y+FQT+ +L+L+LD++NGG LF  L ++  F E   +IY  EIV A+ HLH  GI
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI 180

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLG--KGHD 327
           ++RD+K ENILLD++GHV+LTDFGL+K+F  DE  R+   CGT+EYM+P+IV G   GHD
Sbjct: 181 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHD 240

Query: 328 KAADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKDKIKLPAFLSSEAHSLLKG 382
           KA DWWS+G+L++E+LTG  PFT      ++ +I ++I+K +   P  +S+ A  L++ 
Sbjct: 241 KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQR 299

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  401 bits (1032), Expect = e-139
 Identities = 92/246 (37%), Positives = 151/246 (61%), Gaps = 2/246 (0%)

Query: 139 NLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK 198
           +       + L DF  L V+G+G+F KV    R GT E+YA+K+++KD +++ +  E   
Sbjct: 9   DNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM 68

Query: 199 SERNILTKVD-HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA 257
            E+ +L      PF+ QL   FQT  RLY V+++VNGG L + + + G F+E  A  Y A
Sbjct: 69  VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA 128

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYM 316
           EI   +  L + GI++RDLK +N++LD++GH+ + DFG+ K+   +   + + CGT +Y+
Sbjct: 129 EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYI 188

Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEA 376
           +PEI+  + + K+ DWW+ G+LL+EML GQ PF G +  ++ Q I++  +  P  +S EA
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 248

Query: 377 HSLLKG 382
            ++ KG
Sbjct: 249 VAICKG 254

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  401 bits (1032), Expect = e-139
 Identities = 97/253 (38%), Positives = 154/253 (60%), Gaps = 2/253 (0%)

Query: 132 KPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK 191
                     + +  +G+++FE ++V+G+G+F KV   R   T ++YA+KV++KD I++ 
Sbjct: 5   SSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD 64

Query: 192 NHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED 250
           +  E   +E+ IL+   +HPF+ QL   FQT  RL+ V++FVNGG L F + +   F E 
Sbjct: 65  DDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA 124

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSM 309
            AR Y AEI+SA+  LH  GI++RDLK +N+LLD +GH  L DFG+ K+       + + 
Sbjct: 125 RARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF 184

Query: 310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP 369
           CGT +Y++PEI+    +  A DWW++G+LL+EML G  PF   N   + + I+ D++  P
Sbjct: 185 CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP 244

Query: 370 AFLSSEAHSLLKG 382
            +L  +A  +LK 
Sbjct: 245 TWLHEDATGILKS 257

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  397 bits (1021), Expect = e-138
 Identities = 98/272 (36%), Positives = 158/272 (58%), Gaps = 4/272 (1%)

Query: 113 NEETQEGPNNLSVVDAALGKPTGHIDNL--PSENQCVGLEDFEVLKVVGQGAFAKVYQVR 170
           N    +  +    V   L K                  L+ F+ +K +G G+F +V  V+
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61

Query: 171 RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD 230
              +   YAMK++ K K+++    E+  +E+ IL  V+ PF+V+L +SF+    LY+V++
Sbjct: 62  HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121

Query: 231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM 290
           +V GG +F  L R G F E  AR Y A+IV    +LH+  +++RDLKPEN+L+D  G++ 
Sbjct: 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

Query: 291 LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFT 350
           +TDFG AK+    T   ++CGT E ++PEI+L KG++KA DWW++G+L++EM  G PPF 
Sbjct: 182 VTDFGFAKRVKGRT--WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

Query: 351 GGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG 382
                +I +KI+  K++ P+  SS+   LL+ 
Sbjct: 240 ADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  397 bits (1022), Expect = e-137
 Identities = 91/247 (36%), Positives = 146/247 (59%), Gaps = 6/247 (2%)

Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
            EN+ V  + FE+L+ +G+G+F KV  V++  T ++YAMK M K K +E+N    +  E 
Sbjct: 7   DENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKEL 66

Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            I+  ++HPF+V L YSFQ +  +++V+D + GG L + L +   F+E+  +++  E+V 
Sbjct: 67  QIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM 126

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           A+ +L    I+HRD+KP+NILLD  GHV +TDF +A      T+  +M GT  YM+PE+ 
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMF 186

Query: 322 L---GKGHDKAADWWSVGILLFEMLTGQPPFTG---GNRQKIQQKIIKDKIKLPAFLSSE 375
               G G+  A DWWS+G+  +E+L G+ P+      + ++I        +  P+  S E
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQE 246

Query: 376 AHSLLKG 382
             SLLK 
Sbjct: 247 MVSLLKK 253

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  391 bits (1007), Expect = e-135
 Identities = 97/262 (37%), Positives = 169/262 (64%), Gaps = 11/262 (4%)

Query: 132 KPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK 191
           K   +       +  +GL+DF++L+V+G+G++AKV  VR   T  IYAM+V++K+ + + 
Sbjct: 34  KEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD 93

Query: 192 NHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED 250
              +++++E+++  +  +HPF+V L   FQT+ RL+ V+++VNGG L F + RQ    E+
Sbjct: 94  EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE 153

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSM 309
            AR Y+AEI  A+++LH  GI++RDLK +N+LLD++GH+ LTD+G+ K+       +++ 
Sbjct: 154 HARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF 213

Query: 310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFT---------GGNRQKIQQK 360
           CGT  Y++PEI+ G+ +  + DWW++G+L+FEM+ G+ PF                + Q 
Sbjct: 214 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273

Query: 361 IIKDKIKLPAFLSSEAHSLLKG 382
           I++ +I++P  LS +A S+LK 
Sbjct: 274 ILEKQIRIPRSLSVKAASVLKS 295

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  389 bits (1002), Expect = e-135
 Identities = 97/247 (39%), Positives = 166/247 (67%), Gaps = 11/247 (4%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +GL+DF++L+V+G+G++AKV  VR   T  IYAMKV++K+ + +    +++++E+++  +
Sbjct: 6   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65

Query: 207 V-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             +HPF+V L   FQT+ RL+ V+++VNGG L F + RQ    E+ AR Y+AEI  A+++
Sbjct: 66  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGK 324
           LH  GI++RDLK +N+LLD++GH+ LTD+G+ K+       +++ CGT  Y++PEI+ G+
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 185

Query: 325 GHDKAADWWSVGILLFEMLTGQPPFT---------GGNRQKIQQKIIKDKIKLPAFLSSE 375
            +  + DWW++G+L+FEM+ G+ PF                + Q I++ +I++P  LS +
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 245

Query: 376 AHSLLKG 382
           A S+LK 
Sbjct: 246 AASVLKS 252

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  392 bits (1009), Expect = e-135
 Identities = 103/275 (37%), Positives = 166/275 (60%), Gaps = 2/275 (0%)

Query: 110 EGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQV 169
           +G+ ++     +  S   +          +L      V + +FE LK++G+G F KV  V
Sbjct: 108 DGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILV 167

Query: 170 RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL 229
           +   T   YAMK+++K+ I+ K+   +  +E  +L    HPF+  L+YSFQT  RL  V+
Sbjct: 168 KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227

Query: 230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGH 288
           ++ NGG LFF L R+ +F ED AR Y AEIVSA+ +LH+   +++RDLK EN++LD DGH
Sbjct: 228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH 287

Query: 289 VMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQP 347
           + +TDFGL K+   +     + CGT EY++PE++    + +A DWW +G++++EM+ G+ 
Sbjct: 288 IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347

Query: 348 PFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG 382
           PF   + +K+ + I+ ++I+ P  L  EA SLL G
Sbjct: 348 PFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSG 382

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  394 bits (1014), Expect = e-134
 Identities = 100/323 (30%), Positives = 156/323 (48%), Gaps = 13/323 (4%)

Query: 70  QPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPNNLSVVDAA 129
           +    +  SH+       V + L  +     E      L + +   T E    LSV   A
Sbjct: 103 RNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHE---YLSVAPFA 159

Query: 130 LGKPTGHIDNL----PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
               + + +        E Q V    F   +V+G+G F +V   +   T ++YA K + K
Sbjct: 160 DYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEK 219

Query: 186 DKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG 245
            +I ++       +E+ IL KV+  F+V L Y+++TK  L LVL  +NGG L F +Y  G
Sbjct: 220 KRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG 279

Query: 246 --LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN 303
              F E  A  Y AEI   +  LH   I++RDLKPENILLD  GH+ ++D GLA    E 
Sbjct: 280 QAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339

Query: 304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ----KIQQ 359
                  GT+ YM+PE+V  + +  + DWW++G LL+EM+ GQ PF    ++    ++++
Sbjct: 340 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER 399

Query: 360 KIIKDKIKLPAFLSSEAHSLLKG 382
            + +   +     S +A SL   
Sbjct: 400 LVKEVPEEYSERFSPQARSLCSQ 422

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  395 bits (1016), Expect = e-133
 Identities = 103/346 (29%), Positives = 173/346 (50%), Gaps = 2/346 (0%)

Query: 39  FDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLT 98
           F   +      +   I      S  + +      +   +   + G    +SQ        
Sbjct: 230 FQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNV 289

Query: 99  LHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVV 158
               E S G  E   +  +      +         T    +       + L DF  L V+
Sbjct: 290 PVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVL 349

Query: 159 GQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRY 217
           G+G+F KV    R GT E+YA+K+++KD +++ +  E    E+ +L      PF+ QL  
Sbjct: 350 GKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 409

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
            FQT  RLY V+++VNGG L + + + G F+E  A  Y AEI   +  L + GI++RDLK
Sbjct: 410 CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLK 469

Query: 278 PENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            +N++LD++GH+ + DFG+ K+   +   + + CGT +Y++PEI+  + + K+ DWW+ G
Sbjct: 470 LDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFG 529

Query: 337 ILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG 382
           +LL+EML GQ PF G +  ++ Q I++  +  P  +S EA ++ KG
Sbjct: 530 VLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG 575

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  380 bits (979), Expect = e-131
 Identities = 90/251 (35%), Positives = 139/251 (55%), Gaps = 15/251 (5%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  +DFE+LKV+G+GAF++V  V+   T ++YAMK+M K  ++++      + ER++L  
Sbjct: 58  LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN 117

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSH 265
            D  +I QL ++FQ +  LYLV+++  GG L   L + G     ++AR Y AEIV A+  
Sbjct: 118 GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDS 177

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLG 323
           +H  G +HRD+KP+NILLD  GH+ L DFG   +   D   RS    GT +Y+SPEI+  
Sbjct: 178 VHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237

Query: 324 KG-------HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP-----AF 371
            G       +    DWW++G+  +EM  GQ PF   +  +   KI+  K  L        
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEG 297

Query: 372 LSSEAHSLLKG 382
           +  EA   ++ 
Sbjct: 298 VPEEARDFIQR 308

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  383 bits (986), Expect = e-130
 Identities = 83/251 (33%), Positives = 145/251 (57%), Gaps = 9/251 (3%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
             E Q +G + F   +V+G+G F +V+  +   T ++YA K + K ++ ++   +    E
Sbjct: 176 WLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE 235

Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY----RQGLFREDLARIYT 256
           + IL KV   FIV L Y+F+TK  L LV+  +NGG + + +Y        F+E  A  YT
Sbjct: 236 KKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEY 315
           A+IVS + HLH   I++RDLKPEN+LLD DG+V ++D GLA +     T++    GT  +
Sbjct: 296 AQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGF 355

Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN----RQKIQQKIIKDKIKLPAF 371
           M+PE++LG+ +D + D++++G+ L+EM+  + PF         ++++Q++++  +  P  
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK 415

Query: 372 LSSEAHSLLKG 382
            S  +    + 
Sbjct: 416 FSPASKDFCEA 426

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  376 bits (967), Expect = e-130
 Identities = 91/244 (37%), Positives = 151/244 (61%), Gaps = 2/244 (0%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS    + +EDF + K++G+G+F KV+      T++ +A+K ++KD ++  +  E    E
Sbjct: 8   PSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 67

Query: 201 RNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           + +L+   +HPF+  +  +FQTK  L+ V++++NGG L + +     F    A  Y AEI
Sbjct: 68  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 127

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSP 318
           +  +  LH+ GI++RDLK +NILLD DGH+ + DFG+ K+    + ++N+ CGT +Y++P
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAP 187

Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHS 378
           EI+LG+ ++ + DWWS G+LL+EML GQ PF G + +++   I  D    P +L  EA  
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 247

Query: 379 LLKG 382
           LL  
Sbjct: 248 LLVK 251

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  374 bits (961), Expect = e-128
 Identities = 90/246 (36%), Positives = 148/246 (60%), Gaps = 11/246 (4%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  ED+EV+KV+G+GAF +V  VR   T ++YAMK++ K ++++++ + +   ER+I+  
Sbjct: 66  MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 125

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
            + P++VQL Y+FQ    LY+V++++ GG L   +       E  AR YTAE+V A+  +
Sbjct: 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAI 184

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGK 324
           H+ G +HRD+KP+N+LLD  GH+ L DFG   + ++    R ++  GT +Y+SPE++  +
Sbjct: 185 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 244

Query: 325 G----HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEA 376
           G    + +  DWWSVG+ L+EML G  PF   +      KI+  K  L       +S EA
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 304

Query: 377 HSLLKG 382
            +L+  
Sbjct: 305 KNLICA 310

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  382 bits (982), Expect = e-127
 Identities = 100/320 (31%), Positives = 163/320 (50%), Gaps = 16/320 (5%)

Query: 75  HSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPT 134
           +     L     +   +++  +  L + +    L +      +E   NL          +
Sbjct: 112 YIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQ---PYIEEICQNLRGDVFQKFIES 168

Query: 135 GHIDNL-----PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM 189
                         N  + + DF V +++G+G F +VY  R+  T ++YAMK + K +I 
Sbjct: 169 DKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK 228

Query: 190 EKNHAEYMKSERNILTKV---DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL 246
            K       +ER +L+ V   D PFIV + Y+F T  +L  +LD +NGG L + L + G+
Sbjct: 229 MKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV 288

Query: 247 FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS 306
           F E   R Y AEI+  + H+H   +++RDLKP NILLD  GHV ++D GLA  F +  + 
Sbjct: 289 FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KP 347

Query: 307 NSMCGTLEYMSPEIVL-GKGHDKAADWWSVGILLFEMLTGQPPFTGGN---RQKIQQKII 362
           ++  GT  YM+PE++  G  +D +ADW+S+G +LF++L G  PF       + +I +  +
Sbjct: 348 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407

Query: 363 KDKIKLPAFLSSEAHSLLKG 382
              ++LP   S E  SLL+G
Sbjct: 408 TMAVELPDSFSPELRSLLEG 427

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  373 bits (959), Expect = e-127
 Identities = 85/249 (34%), Positives = 140/249 (56%), Gaps = 13/249 (5%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  EDFE+LKV+G+GAF +V  V+     +++AMK++ K +++++      + ER++L  
Sbjct: 71  LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN 130

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSH 265
            D  +I  L Y+FQ    LYLV+D+  GG L   L + +    E++AR Y AE+V A+  
Sbjct: 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDS 190

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLG 323
           +H    +HRD+KP+NIL+D +GH+ L DFG   +   D   +S+   GT +Y+SPEI+  
Sbjct: 191 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250

Query: 324 K-----GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP-----AFLS 373
                  +    DWWS+G+ ++EML G+ PF   +  +   KI+  K +         +S
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVS 310

Query: 374 SEAHSLLKG 382
             A  L++ 
Sbjct: 311 ENAKDLIRR 319

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  322 bits (827), Expect = e-109
 Identities = 75/234 (32%), Positives = 131/234 (55%), Gaps = 1/234 (0%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++DF++ + +G+G F  VY  R      I A+KV+ K ++ ++     ++ E  I + + 
Sbjct: 13  IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I+++   F  + R+YL+L+F   G L+ +L + G F E  +  +  E+  A+ + H 
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             ++HRD+KPEN+L+   G + + DFG +       R  +MCGTL+Y+ PE++ GK HD+
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR-RTMCGTLDYLPPEMIEGKTHDE 191

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG 382
             D W  G+L +E L G PPF   +  +  ++I+   +K P FLS  +  L+  
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISK 245

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  318 bits (818), Expect = e-108
 Identities = 78/240 (32%), Positives = 137/240 (57%), Gaps = 1/240 (0%)

Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E 
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60

Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     + R   +CGTL+Y+ PE++
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-TDLCGTLDYLPPEMI 179

Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
            G+ HD+  D WS+G+L +E L G+PPF     Q+  ++I + +   P F++  A  L+ 
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 239

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  285 bits (732), Expect = 7e-95
 Identities = 73/274 (26%), Positives = 116/274 (42%), Gaps = 9/274 (3%)

Query: 112 INEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRR 171
                Q  P  +S       +        PS  +    + F+ L  +G G++ +V++VR 
Sbjct: 20  FQSMHQLQPRRVSF-RGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRS 78

Query: 172 IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLD 230
                +YA+K         K+ A  +  E     KV  HP  V+L  +++    LYL  +
Sbjct: 79  KEDGRLYAVKRSMSPFRGPKDRARKLA-EVGSHEKVGQHPCCVRLEQAWEEGGILYLQTE 137

Query: 231 FVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
              G  L       G    E     Y  + + A++HLH+ G++H D+KP NI L   G  
Sbjct: 138 LC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRC 196

Query: 290 MLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQP-P 348
            L DFGL  +           G   YM+PE +L   +  AAD +S+G+ + E+      P
Sbjct: 197 KLGDFGLLVELGTAGAGEVQEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMELP 255

Query: 349 FTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG 382
             G   Q+++Q  +  +    A LSSE  S+L  
Sbjct: 256 HGGEGWQQLRQGYLPPEF--TAGLSSELRSVLVM 287

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  261 bits (670), Expect = 5e-86
 Identities = 77/235 (32%), Positives = 135/235 (57%), Gaps = 2/235 (0%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +EDF+V  ++G+G+FA VY+   I T    A+K++ K  + +    + +++E  I  ++ 
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL-YRQGLFREDLARIYTAEIVSAVSHLH 267
           HP I++L   F+    +YLVL+  + G +   L  R   F E+ AR +  +I++ + +LH
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGH 326
           ++GI+HRDL   N+LL  + ++ + DFGLA Q    + +  ++CGT  Y+SPEI     H
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH 189

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
              +D WS+G + + +L G+PPF     +    K++    ++P+FLS EA  L+ 
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIH 244

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  259 bits (664), Expect = 6e-85
 Identities = 69/234 (29%), Positives = 124/234 (52%), Gaps = 1/234 (0%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
              +   + +G+G FAK +++    T E++A K++ K  +++ +  E M  E +I   + 
Sbjct: 14  RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V     F+    +++VL+      L     R+    E  AR Y  +IV    +LH 
Sbjct: 74  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHD 327
           N ++HRDLK  N+ L+ D  V + DFGLA + + +  R   +CGT  Y++PE++  KGH 
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 193

Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
              D WS+G +++ +L G+PPF     ++   +I K++  +P  ++  A SL++
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 247

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  260 bits (667), Expect = 9e-85
 Identities = 69/234 (29%), Positives = 124/234 (52%), Gaps = 1/234 (0%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
              +   + +G+G FAK +++    T E++A K++ K  +++ +  E M  E +I   + 
Sbjct: 40  RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V     F+    +++VL+      L     R+    E  AR Y  +IV    +LH 
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHD 327
           N ++HRDLK  N+ L+ D  V + DFGLA + + +  R   +CGT  Y++PE++  KGH 
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 219

Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
              D WS+G +++ +L G+PPF     ++   +I K++  +P  ++  A SL++
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 273

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  260 bits (665), Expect = 2e-84
 Identities = 60/278 (21%), Positives = 112/278 (40%), Gaps = 48/278 (17%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK--------------DKIMEKNHA 194
           + D+ +++ + QG F K+    +   ++ YA+K   K              DKI  K+  
Sbjct: 30  INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87

Query: 195 EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG--------L 246
           +  K+E  I+T + + + +           +Y++ +++    +                 
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147

Query: 247 FREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR 305
               + +     ++++ S++H    I HRD+KP NIL+D +G V L+DFG ++   +   
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207

Query: 306 SNSMCGTLEYMSPEIVLGKG--HDKAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKII 362
                GT E+M PE    +   +    D WS+GI L+ M     PF+   +  ++   I 
Sbjct: 208 -KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266

Query: 363 KDKIKLPA-------------------FLSSEAHSLLK 381
              I+ P                    FLS+E    LK
Sbjct: 267 TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLK 304

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  259 bits (664), Expect = 4e-84
 Identities = 76/238 (31%), Positives = 124/238 (52%), Gaps = 5/238 (2%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E +  L+ +G+G+F K   V+       Y +K +   + M     E  + E  +L  + 
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR-MSSKEREESRREVAVLANMK 81

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHL 266
           HP IVQ R SF+    LY+V+D+  GG LF ++  Q   LF+ED    +  +I  A+ H+
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSMCGTLEYMSPEIVLGKG 325
           H   I+HRD+K +NI L  DG V L DFG+A+  +     + +  GT  Y+SPEI   K 
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-LPAFLSSEAHSLLKG 382
           ++  +D W++G +L+E+ T +  F  G+ + +  KII      +    S +  SL+  
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQ 259

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  254 bits (652), Expect = 5e-83
 Identities = 74/271 (27%), Positives = 127/271 (46%), Gaps = 37/271 (13%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
             DFE + V+GQGAF +V + R    S  YA+K +R  +         + SE  +L  ++
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLST----ILSEVMLLASLN 60

Query: 209 HPFIVQLRYSFQ-------------TKYRLYLVLDFVNGGHLFFQLYRQGLF-REDLARI 254
           H ++V+   ++               K  L++ +++   G L+  ++ + L  + D    
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-------- 306
              +I+ A+S++H+ GI+HRDLKP NI +D   +V + DFGLAK    +           
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180

Query: 307 -------NSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ 358
                   S  GT  Y++ E++ G GH ++  D +S+GI+ FEM+   P  TG  R  I 
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNIL 238

Query: 359 QKIIKDKIKLPAFLSSEAHSLLKG-VNSLLS 388
           +K+    I+ P         + K  +  L+ 
Sbjct: 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLID 269

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  252 bits (646), Expect = 6e-81
 Identities = 65/243 (26%), Positives = 111/243 (45%), Gaps = 23/243 (9%)

Query: 144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           +Q      + +  ++GQGA A V++ R   T +++A+KV      +     +    E  +
Sbjct: 3   SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEV 60

Query: 204 LTKVDHPFIVQLR--YSFQTKYRLYLVLDFVNGGHLFFQLYRQG---LFREDLARIYTAE 258
           L K++H  IV+L       T     L+++F   G L+  L          E    I   +
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 259 IVSAVSHLHANGIMHRDLKPENILL----DADGHVMLTDFGLAKQFDENTRSNSMCGTLE 314
           +V  ++HL  NGI+HR++KP NI+     D      LTDFG A++ +++ +  S+ GT E
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180

Query: 315 YMSPEIV--------LGKGHDKAADWWSVGILLFEMLTGQPPF----TGGNRQKIQQKII 362
           Y+ P++           K +    D WS+G+  +   TG  PF         +++  KII
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240

Query: 363 KDK 365
             K
Sbjct: 241 TGK 243

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  246 bits (631), Expect = 1e-79
 Identities = 66/256 (25%), Positives = 114/256 (44%), Gaps = 23/256 (8%)

Query: 144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           +Q      + +  ++GQGA A V++ R   T +++A+KV      +     +    E  +
Sbjct: 3   SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEV 60

Query: 204 LTKVDHPFIVQLR--YSFQTKYRLYLVLDFVNGGHLFFQLYRQG---LFREDLARIYTAE 258
           L K++H  IV+L       T     L+++F   G L+  L          E    I   +
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 259 IVSAVSHLHANGIMHRDLKPENILL----DADGHVMLTDFGLAKQFDENTRSNSMCGTLE 314
           +V  ++HL  NGI+HR++KP NI+     D      LTDFG A++ +++ +  S+ GT E
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180

Query: 315 YMSPEIV--------LGKGHDKAADWWSVGILLFEMLTGQPPF----TGGNRQKIQQKII 362
           Y+ P++           K +    D WS+G+  +   TG  PF         +++  KII
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240

Query: 363 KDKIKLPAFLSSEAHS 378
             K         +A +
Sbjct: 241 TGKPSGAISGVQKAEN 256

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  241 bits (618), Expect = 9e-78
 Identities = 74/242 (30%), Positives = 123/242 (50%), Gaps = 9/242 (3%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L +F + K +G+G F++VY+   +      A+K ++   +M+         E ++L +++
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVS 264
           HP +++   SF     L +VL+  + G L   +        L  E     Y  ++ SA+ 
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSMCGTLEYMSPEIVLG 323
           H+H+  +MHRD+KP N+ + A G V L D GL + F   T  ++S+ GT  YMSPE +  
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 210

Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTG--GNRQKIQQKIIKDKIK-LPA-FLSSEAHSL 379
            G++  +D WS+G LL+EM   Q PF G   N   + +KI +     LP+   S E   L
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL 270

Query: 380 LK 381
           + 
Sbjct: 271 VN 272

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  239 bits (613), Expect = 6e-77
 Identities = 70/264 (26%), Positives = 120/264 (45%), Gaps = 23/264 (8%)

Query: 138 DNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYM 197
           +NL  ++  V    + +LK +G G  +KV+QV      +IYA+K +  ++  +    +  
Sbjct: 16  ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSY 73

Query: 198 KSERNILTKVDHP--FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIY 255
           ++E   L K+      I++L     T   +Y+V++      L   L ++        + Y
Sbjct: 74  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSY 132

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGT 312
              ++ AV  +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   +S  GT
Sbjct: 133 WKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 191

Query: 313 LEYMSPEIVLGKG-----------HDKAADWWSVGILLFEMLTGQPPFTG--GNRQKIQQ 359
           + YM PE +                   +D WS+G +L+ M  G+ PF        K+  
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 251

Query: 360 KIIKD-KIKLPAFLSSEAHSLLKG 382
            I  + +I+ P     +   +LK 
Sbjct: 252 IIDPNHEIEFPDIPEKDLQDVLKC 275

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  237 bits (607), Expect = 1e-76
 Identities = 71/254 (27%), Positives = 130/254 (51%), Gaps = 17/254 (6%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
            ED+EVL  +G G++ +  ++RR    +I   K +     M +   + + SE N+L ++ 
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLRELK 63

Query: 209 HPFIVQLRYSFQTKY--RLYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSA 262
           HP IV+       +    LY+V+++  GG L   + +         E+       ++  A
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123

Query: 263 VSHLH-----ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSMCGTLEYM 316
           +   H      + ++HRDLKP N+ LD   +V L DFGLA+  + +T  + +  GT  YM
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSE 375
           SPE +    +++ +D WS+G LL+E+    PPFT  +++++  KI + K  ++P   S E
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 243

Query: 376 AHSLLKGVNSLLSI 389
            + +   +  +L++
Sbjct: 244 LNEI---ITRMLNL 254

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  237 bits (608), Expect = 2e-76
 Identities = 76/245 (31%), Positives = 135/245 (55%), Gaps = 11/245 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++++V + +G+GAF+ V +     T   +A K++   K+  ++  + ++ E  I  K+ H
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQH 64

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S Q +   YLV D V GG LF  +  +  + E  A     +I+ ++++ H+N
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124

Query: 270 GIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HR+LKPEN+LL        V L DFGLA + +++   +   GT  Y+SPE++    +
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLKG 382
            K  D W+ G++L+ +L G PPF   ++ ++  +I       P+     ++ EA SL   
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL--- 241

Query: 383 VNSLL 387
           ++S+L
Sbjct: 242 IDSML 246

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  237 bits (606), Expect = 1e-75
 Identities = 69/260 (26%), Positives = 117/260 (45%), Gaps = 23/260 (8%)

Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           +E   V    + +LK +G G  +KV+QV      +IYA+K +  ++  +    +  ++E 
Sbjct: 1   NECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEI 58

Query: 202 NILTKVDHP--FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
             L K+      I++L     T   +Y+V++      L   L ++        + Y   +
Sbjct: 59  AYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNM 117

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYM 316
           + AV  +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   +S  GT+ YM
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176

Query: 317 SPEIVLGKG-----------HDKAADWWSVGILLFEMLTGQPPFTG--GNRQKIQQKIIK 363
            PE +                   +D WS+G +L+ M  G+ PF        K+   I  
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 236

Query: 364 D-KIKLPAFLSSEAHSLLKG 382
           + +I+ P     +   +LK 
Sbjct: 237 NHEIEFPDIPEKDLQDVLKC 256

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  237 bits (607), Expect = 2e-75
 Identities = 76/245 (31%), Positives = 133/245 (54%), Gaps = 11/245 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++++V + +G+GAF+ V +     T   +A K++   K +     + ++ E  I  K+ H
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQH 87

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S Q +   YLV D V GG LF  +  +  + E  A     +I+ ++++ H+N
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147

Query: 270 GIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HR+LKPEN+LL        V L DFGLA + +++   +   GT  Y+SPE++    +
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLKG 382
            K  D W+ G++L+ +L G PPF   ++ ++  +I       P+     ++ EA SL   
Sbjct: 208 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL--- 264

Query: 383 VNSLL 387
           ++S+L
Sbjct: 265 IDSML 269

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  240 bits (614), Expect = 5e-75
 Identities = 76/239 (31%), Positives = 132/239 (55%), Gaps = 9/239 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E + ++ ++G+G+F +V + +   T + YA+KV+ K     K+    +  E  +L K+DH
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT-STILREVELLKKLDH 80

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P I++L    +     Y+V +   GG LF ++ ++  F E  A     ++ S ++++H +
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 270 GIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
            I+HRDLKPENILL   + D  + + DFGL+  F +NT+     GT  Y++PE VL   +
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VLRGTY 199

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLK 381
           D+  D WS G++L+ +L+G PPF G N   I +++   K          +S +A  L++
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  233 bits (597), Expect = 7e-75
 Identities = 75/239 (31%), Positives = 131/239 (54%), Gaps = 9/239 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E + ++ ++G+G+F +V + +   T + YA+KV+ K    +      +  E  +L K+DH
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDH 80

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P I++L    +     Y+V +   GG LF ++ ++  F E  A     ++ S ++++H +
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 270 GIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
            I+HRDLKPENILL   + D  + + DFGL+  F +NT+     GT  Y++PE VL   +
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VLRGTY 199

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLK 381
           D+  D WS G++L+ +L+G PPF G N   I +++   K          +S +A  L++
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  233 bits (596), Expect = 2e-74
 Identities = 76/223 (34%), Positives = 133/223 (59%), Gaps = 7/223 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + F  ++V+G GAF++V+ V++  T +++A+K ++K           +++E  +L K+ H
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD---SSLENEIAVLKKIKH 65

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
             IV L   +++    YLV+  V+GG LF ++  +G++ E  A +   +++SAV +LH N
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125

Query: 270 GIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPEN+L    + +  +M+TDFGL+K       S + CGT  Y++PE++  K +
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS-TACGTPGYVAPEVLAQKPY 184

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP 369
            KA D WS+G++ + +L G PPF      K+ +KI +   +  
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE 227

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  232 bits (594), Expect = 2e-74
 Identities = 59/260 (22%), Positives = 107/260 (41%), Gaps = 32/260 (12%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
             DF+ ++++G G F +V++ +     + Y +K ++ +        E  + E   L K+D
Sbjct: 10  GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD 62

Query: 209 HPFIVQLRYSFQ----------------TKYRLYLVLDFVNGGHLFFQL--YRQGLFRED 250
           H  IV     +                     L++ ++F + G L   +   R     + 
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMC 310
           LA     +I   V ++H+  +++RDLKP NI L     V + DFGL      + +     
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK 182

Query: 311 GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA 370
           GTL YMSPE +  + + K  D +++G++L E+L            K    +      +  
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF--ETSKFFTDLR--DGIISD 238

Query: 371 FLSSEAHSLLKGVNSLLSIS 390
               +  +LL+    LLS  
Sbjct: 239 IFDKKEKTLLQ---KLLSKK 255

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  238 bits (610), Expect = 2e-74
 Identities = 78/239 (32%), Positives = 134/239 (56%), Gaps = 8/239 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + ++  +V+G+G+F +V   +   T +  A+KV+ K ++ +K   E +  E  +L ++DH
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P I++L   F+ K   YLV +   GG LF ++  +  F E  A     +++S ++++H N
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145

Query: 270 GIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
            I+HRDLKPEN+LL     D ++ + DFGL+  F+ + +     GT  Y++PE VL   +
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE-VLHGTY 204

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLK 381
           D+  D WS G++L+ +L+G PPF G N   I +K+ K K          +S  A  L++
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR 263

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  230 bits (590), Expect = 6e-74
 Identities = 75/258 (29%), Positives = 127/258 (49%), Gaps = 22/258 (8%)

Query: 131 GKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME 190
           G   G I+           + + +   +G+G++ +V    + GT    A K + K  + +
Sbjct: 1   GSTKGDIN-----------QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED 49

Query: 191 KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED 250
               +  K E  I+  +DHP I++L  +F+    +YLV++   GG LF ++  + +FRE 
Sbjct: 50  V---DRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRES 106

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSN 307
            A     +++SAV++ H   + HRDLKPEN L      D  + L DFGLA +F       
Sbjct: 107 DAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR 166

Query: 308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK 367
           +  GT  Y+SP+ VL   +    D WS G++++ +L G PPF+     ++  KI +    
Sbjct: 167 TKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFT 225

Query: 368 LPA----FLSSEAHSLLK 381
            P      +S +A SL++
Sbjct: 226 FPEKDWLNVSPQAESLIR 243

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  230 bits (589), Expect = 9e-74
 Identities = 69/242 (28%), Positives = 121/242 (50%), Gaps = 13/242 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + F   + +G GAF  V+ V    +     +K + KD+       E +++E  +L  +DH
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDH 79

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLF----FQLYRQGLFREDLARIYTAEIVSAVSH 265
           P I+++   F+  + +Y+V++   GG L         R     E        ++++A+++
Sbjct: 80  PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139

Query: 266 LHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
            H+  ++H+DLKPENIL         + + DFGLA+ F  +  S +  GT  YM+PE V 
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE-VF 198

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKL---PAFLSSEAHSL 379
            +      D WS G++++ +LTG  PFTG + +++QQK    +         L+ +A  L
Sbjct: 199 KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDL 258

Query: 380 LK 381
           LK
Sbjct: 259 LK 260

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  233 bits (595), Expect = 1e-73
 Identities = 45/265 (16%), Positives = 97/265 (36%), Gaps = 27/265 (10%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAE 195
           P     +G +   V  ++G+GAFA+VY+  +         + + +KV +     E     
Sbjct: 56  PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF---Y 112

Query: 196 YMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF-----FQLYRQGLFRED 250
                   L        ++   +   +    LV +  + G L      ++   + +  + 
Sbjct: 113 IGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQG 172

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILL-----------DADGHVMLTDFGLA-- 297
           L   +   ++  +  +H   I+H D+KP+N +L           D    + L D G +  
Sbjct: 173 LVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232

Query: 298 -KQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQK 356
            K F + T   + C T  +   E++  K  +   D++ V   ++ ML G          +
Sbjct: 233 MKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292

Query: 357 IQQKIIKDKIKLPAFLSSEAHSLLK 381
            + + +  ++      +   H +L 
Sbjct: 293 CKPEGLFRRLPHLDMWNEFFHVMLN 317

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  230 bits (590), Expect = 2e-73
 Identities = 68/227 (29%), Positives = 118/227 (51%), Gaps = 7/227 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTK 206
           + +++ + +G G FA V + R   T   YA K ++K +          E ++ E +IL +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           V H  ++ L   ++ +  + L+L+ V+GG LF  L ++    E+ A  +  +I+  V++L
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 267 HANGIMHRDLKPENILL----DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           H   I H DLKPENI+L        H+ L DFGLA + ++     ++ GT E+++PEIV 
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP 369
            +     AD WS+G++ + +L+G  PF G  +Q+    I        
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD 238

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  236 bits (603), Expect = 2e-73
 Identities = 82/239 (34%), Positives = 134/239 (56%), Gaps = 9/239 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ +K +G GA+ +V   R   T    A+K++RK  +   ++   +  E  +L  +DH
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN-SKLLEEVAVLKLLDH 95

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P I++L   F+ K   YLV++   GG LF ++  +  F E  A +   +++S V++LH +
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155

Query: 270 GIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
            I+HRDLKPEN+LL   + D  + + DFGL+  F+   +     GT  Y++PE VL K +
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPE-VLRKKY 214

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLK 381
           D+  D WS+G++LF +L G PPF G   Q+I +K+ K K    +     +S  A  L+K
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIK 273

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  233 bits (595), Expect = 2e-73
 Identities = 75/306 (24%), Positives = 125/306 (40%), Gaps = 27/306 (8%)

Query: 100 HEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPS----ENQCVGLEDFEVL 155
           H    S GLV   +   +                    D+  S    E   V    + +L
Sbjct: 2   HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL 61

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP--FIV 213
           K +G G  +KV+QV      +IYA+K +  ++  +    +  ++E   L K+      I+
Sbjct: 62  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKII 119

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
           +L     T   +Y+V++      L   L ++        + Y   ++ AV  +H +GI+H
Sbjct: 120 RLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVH 178

Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG----- 325
            DLKP N L+  DG + L DFG+A Q   +T S   +S  G + YM PE +         
Sbjct: 179 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSREN 237

Query: 326 ------HDKAADWWSVGILLFEMLTGQPPFTG--GNRQKIQQKIIKD-KIKLPAFLSSEA 376
                     +D WS+G +L+ M  G+ PF        K+   I  + +I+ P     + 
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL 297

Query: 377 HSLLKG 382
             +LK 
Sbjct: 298 QDVLKC 303

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  234 bits (599), Expect = 3e-73
 Identities = 74/246 (30%), Positives = 130/246 (52%), Gaps = 12/246 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E++++ + +G+GAF+ V +  ++   + YA  ++   K+  ++H + ++ E  I   + H
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH-QKLEREARICRLLKH 69

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S   +   YL+ D V GG LF  +  +  + E  A     +I+ AV H H  
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129

Query: 270 GIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRS-NSMCGTLEYMSPEIVLGKG 325
           G++HR+LKPEN+LL        V L DFGLA + +   ++     GT  Y+SPE++    
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLK 381
           + K  D W+ G++L+ +L G PPF   ++ ++ Q+I       P+     ++ EA  L  
Sbjct: 190 YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL-- 247

Query: 382 GVNSLL 387
            +N +L
Sbjct: 248 -INKML 252

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  230 bits (589), Expect = 4e-73
 Identities = 71/249 (28%), Positives = 122/249 (48%), Gaps = 14/249 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTK 206
           + ++  + +G G FA V + R   T   YA K ++K +          E ++ E +IL +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           + HP ++ L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +L
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130

Query: 267 HANGIMHRDLKPENILL----DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           H+  I H DLKPENI+L         + + DFGLA + D      ++ GT E+++PEIV 
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHS 378
            +     AD WS+G++ + +L+G  PF G  +Q+    +     +         S+ A  
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD 250

Query: 379 LLKGVNSLL 387
               +  LL
Sbjct: 251 F---IRRLL 256

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  228 bits (585), Expect = 4e-73
 Identities = 73/227 (32%), Positives = 121/227 (53%), Gaps = 7/227 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTK 206
           + +E+ + +G G FA V + R+ GT + YA K ++K ++         E ++ E NIL +
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           + HP I+ L   F+ K  + L+L+ V+GG LF  L  +    ED A  +  +I+  V +L
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124

Query: 267 HANGIMHRDLKPENILL----DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           H+  I H DLKPENI+L      +  + L DFG+A + +      ++ GT E+++PEIV 
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN 184

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP 369
            +     AD WS+G++ + +L+G  PF G  +Q+    I        
Sbjct: 185 YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD 231

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  231 bits (591), Expect = 5e-73
 Identities = 70/227 (30%), Positives = 119/227 (52%), Gaps = 7/227 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTK 206
           + +++ + +G G FA V + R   T   YA K ++K +          E ++ E +IL +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           V HP I+ L   ++ +  + L+L+ V+GG LF  L ++    E+ A  +  +I+  V++L
Sbjct: 72  VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 267 HANGIMHRDLKPENILL----DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           H   I H DLKPENI+L        H+ L DFGLA + ++     ++ GT E+++PEIV 
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP 369
            +     AD WS+G++ + +L+G  PF G  +Q+    I        
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD 238

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  234 bits (598), Expect = 2e-72
 Identities = 83/269 (30%), Positives = 137/269 (50%), Gaps = 29/269 (10%)

Query: 130 LGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI- 188
           + K  G I            E +  ++ +G GA+ +V   +        A+KV++K +  
Sbjct: 27  VRKKEGKIG-----------ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFD 75

Query: 189 ---------MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFF 239
                      +   E + +E ++L  +DHP I++L   F+ K   YLV +F  GG LF 
Sbjct: 76  KGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFE 135

Query: 240 QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGL 296
           Q+  +  F E  A     +I+S + +LH + I+HRD+KPENILL   ++  ++ + DFGL
Sbjct: 136 QIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGL 195

Query: 297 AKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQK 356
           +  F ++ +     GT  Y++PE VL K +++  D WS G++++ +L G PPF G N Q 
Sbjct: 196 SSFFSKDYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD 254

Query: 357 IQQKIIKDKIKLPA----FLSSEAHSLLK 381
           I +K+ K K          +S EA  L+K
Sbjct: 255 IIKKVEKGKYYFDFNDWKNISDEAKELIK 283

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  226 bits (579), Expect = 4e-72
 Identities = 76/262 (29%), Positives = 124/262 (47%), Gaps = 18/262 (6%)

Query: 138 DNLPSENQCVGLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA-- 194
             LP  +   G  + +E  +++G+G  + V +     T + YA+K++        +    
Sbjct: 4   AALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEV 63

Query: 195 ----EYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE 249
               E    E +IL KV  HP I+QL+ +++T    +LV D +  G LF  L  +    E
Sbjct: 64  QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123

Query: 250 DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM 309
              R     ++  +  LH   I+HRDLKPENILLD D ++ LTDFG + Q D   +   +
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV 183

Query: 310 CGTLEYMSPEIVLG------KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK 363
           CGT  Y++PEI+         G+ K  D WS G++++ +L G PPF    +  + + I+ 
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243

Query: 364 DKIKLPA----FLSSEAHSLLK 381
              +  +      S     L+ 
Sbjct: 244 GNYQFGSPEWDDYSDTVKDLVS 265

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  227 bits (582), Expect = 7e-72
 Identities = 74/241 (30%), Positives = 130/241 (53%), Gaps = 12/241 (4%)

Query: 140 LPSENQCVGLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA--EY 196
           L   +  V  ED +E+ +V+G+G F+ V +     T + +A+K++   K         E 
Sbjct: 13  LDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED 72

Query: 197 MKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----LFREDLA 252
           +K E +I   + HP IV+L  ++ +   LY+V +F++G  L F++ ++     ++ E +A
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132

Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDEN-TRSNS 308
             Y  +I+ A+ + H N I+HRD+KP  +LL   +    V L  FG+A Q  E+   +  
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 192

Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKL 368
             GT  +M+PE+V  + + K  D W  G++LF +L+G  PF G   +++ + IIK K K+
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKM 251

Query: 369 P 369
            
Sbjct: 252 N 252

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  229 bits (587), Expect = 9e-72
 Identities = 79/248 (31%), Positives = 141/248 (56%), Gaps = 17/248 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNIL 204
           +++ + K +G GA  +V       T +  A++++ K K       E + A  +++E  IL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            K++HP I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV 
Sbjct: 195 KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253

Query: 265 HLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +LH NGI+HRDLKPEN+LL   + D  + +TDFG +K   E +   ++CGT  Y++PE++
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 313

Query: 322 LG---KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ-KIQQKIIKDKIKLP----AFLS 373
           +     G+++A D WS+G++LF  L+G PPF+    Q  ++ +I   K        A +S
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 373

Query: 374 SEAHSLLK 381
            +A  L+K
Sbjct: 374 EKALDLVK 381

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  226 bits (578), Expect = 1e-71
 Identities = 80/248 (32%), Positives = 141/248 (56%), Gaps = 17/248 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNIL 204
           +++ + K +G GA  +V       T +  A+K++ K K       E + A  +++E  IL
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            K++HP I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV 
Sbjct: 70  KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128

Query: 265 HLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +LH NGI+HRDLKPEN+LL   + D  + +TDFG +K   E +   ++CGT  Y++PE++
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188

Query: 322 LG---KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ-KIQQKIIKDKIKLP----AFLS 373
           +     G+++A D WS+G++LF  L+G PPF+    Q  ++ +I   K        A +S
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248

Query: 374 SEAHSLLK 381
            +A  L+K
Sbjct: 249 EKALDLVK 256

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  235 bits (600), Expect = 2e-71
 Identities = 68/253 (26%), Positives = 111/253 (43%), Gaps = 14/253 (5%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
                      +E+ + +G G F  V +     T E  A+K  R++   +  + E    E
Sbjct: 5   SPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK--NRERWCLE 62

Query: 201 RNILTKVDHPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLY---RQGLFREDL 251
             I+ K++HP +V  R       +L       L +++  GG L   L         +E  
Sbjct: 63  IQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP 122

Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH---VMLTDFGLAKQFDENTRSNS 308
            R   ++I SA+ +LH N I+HRDLKPENI+L          + D G AK+ D+      
Sbjct: 123 IRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE 182

Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKL 368
             GTL+Y++PE++  K +    D+WS G L FE +TG  PF    +       +++K   
Sbjct: 183 FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242

Query: 369 PAFLSSEAHSLLK 381
              +  +    +K
Sbjct: 243 HIVVYDDLTGAVK 255

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  225 bits (576), Expect = 5e-71
 Identities = 85/275 (30%), Positives = 141/275 (51%), Gaps = 14/275 (5%)

Query: 100 HEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDF-EVLKVV 158
           H +       E +  ++       +    A   P   ID    +     L DF EV   +
Sbjct: 6   HHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDA----LSDFFEVESEL 61

Query: 159 GQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYS 218
           G+GA + VY+ ++ GT + YA+KV++K    +      +++E  +L ++ HP I++L+  
Sbjct: 62  GRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI-----VRTEIGVLLRLSHPNIIKLKEI 116

Query: 219 FQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKP 278
           F+T   + LVL+ V GG LF ++  +G + E  A     +I+ AV++LH NGI+HRDLKP
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKP 176

Query: 279 ENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSV 335
           EN+L      D  + + DFGL+K  +      ++CGT  Y +PEI+ G  +    D WSV
Sbjct: 177 ENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSV 236

Query: 336 GILLFEMLTGQPPFTG-GNRQKIQQKIIKDKIKLP 369
           GI+ + +L G  PF      Q + ++I+  +    
Sbjct: 237 GIITYILLCGFEPFYDERGDQFMFRRILNCEYYFI 271

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  224 bits (573), Expect = 8e-71
 Identities = 82/242 (33%), Positives = 147/242 (60%), Gaps = 4/242 (1%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
             E   +G  ++ +LK +G+G FAKV   R I T    A+K++ K ++   +  + +  E
Sbjct: 8   ADEQPHIG--NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS-LQKLFRE 64

Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
             I+  ++HP IV+L    +T+  LYL++++ +GG +F  L   G  +E  AR    +IV
Sbjct: 65  VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV 124

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
           SAV + H   I+HRDLK EN+LLDAD ++ + DFG + +F    + ++ CG   Y +PE+
Sbjct: 125 SAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPEL 184

Query: 321 VLGKGHD-KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSL 379
             GK +D    D WS+G++L+ +++G  PF G N +++++++++ K ++P ++S++  +L
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENL 244

Query: 380 LK 381
           LK
Sbjct: 245 LK 246

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  224 bits (573), Expect = 8e-71
 Identities = 75/243 (30%), Positives = 130/243 (53%), Gaps = 22/243 (9%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQ 214
           K +G+G+F+   +     +++ +A+K++ K            + E   L   + HP IV+
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITALKLCEGHPNIVK 70

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   F  +   +LV++ +NGG LF ++ ++  F E  A     ++VSAVSH+H  G++HR
Sbjct: 71  LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR 130

Query: 275 DLKPENILL---DADGHVMLTDFGLAKQFDENTRS-NSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPEN+L    + +  + + DFG A+    + +   + C TL Y +PE++   G+D++ 
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESC 190

Query: 331 DWWSVGILLFEMLTGQPPFTGGNRQ-------KIQQKIIKDKIKLP----AFLSSEAHSL 379
           D WS+G++L+ ML+GQ PF   +R        +I +KI K            +S EA  L
Sbjct: 191 DLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDL 250

Query: 380 LKG 382
           ++G
Sbjct: 251 IQG 253

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  225 bits (575), Expect = 1e-70
 Identities = 79/286 (27%), Positives = 129/286 (45%), Gaps = 17/286 (5%)

Query: 113 NEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLED-FEVLKVVGQGAFAKVYQVRR 171
            E  +         +    +  G  D LP           ++   V+G+G  + V +   
Sbjct: 56  AEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVH 115

Query: 172 IGTSEIYAMKVMRKDKIMEKNHA-----EYMKSERNILTKV-DHPFIVQLRYSFQTKYRL 225
             T   +A+K+M                E  + E +IL +V  HP I+ L  S+++   +
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175

Query: 226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA 285
           +LV D +  G LF  L  +    E   R     ++ AVS LHAN I+HRDLKPENILLD 
Sbjct: 176 FLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD 235

Query: 286 DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG------KGHDKAADWWSVGILL 339
           +  + L+DFG +   +   +   +CGT  Y++PEI+         G+ K  D W+ G++L
Sbjct: 236 NMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

Query: 340 FEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLK 381
           F +L G PPF    +  + + I++ + +  +      SS    L+ 
Sbjct: 296 FTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLIS 341

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  224 bits (572), Expect = 6e-70
 Identities = 66/245 (26%), Positives = 125/245 (51%), Gaps = 13/245 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + +++L+ +G GAF  V++     T  ++  K +     ++K     +K+E +I+ ++ H
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHH 107

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHA 268
           P ++ L  +F+ KY + L+L+F++GG LF ++  +     E     Y  +    + H+H 
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167

Query: 269 NGIMHRDLKPENILL--DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           + I+H D+KPENI+        V + DFGLA + + +        T E+ +PEIV  +  
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV 227

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKL--PAF--LSSEAHSLLKG 382
               D W++G+L + +L+G  PF G +  +  Q + +   +    AF  +S EA      
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF--- 284

Query: 383 VNSLL 387
           + +LL
Sbjct: 285 IKNLL 289

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  222 bits (568), Expect = 2e-69
 Identities = 68/244 (27%), Positives = 126/244 (51%), Gaps = 13/244 (5%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
                +++G G F +V++     T    A K+++   + +K   E +K+E +++ ++DH 
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHA 146

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHAN 269
            ++QL  +F++K  + LV+++V+GG LF ++  +     E    ++  +I   + H+H  
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206

Query: 270 GIMHRDLKPENILL--DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
            I+H DLKPENIL        + + DFGLA+++    +     GT E+++PE+V      
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVS 266

Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKL--PAF--LSSEAHSLLKGV 383
              D WSVG++ + +L+G  PF G N  +    I+  +  L    F  +S EA      +
Sbjct: 267 FPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEF---I 323

Query: 384 NSLL 387
           + LL
Sbjct: 324 SKLL 327

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  218 bits (559), Expect = 2e-69
 Identities = 71/242 (29%), Positives = 121/242 (50%), Gaps = 1/242 (0%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
              +  V +  + +   +G G F KV       T    A+K++ + KI   +    +K E
Sbjct: 2   SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE 61

Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
              L    HP I++L     T    ++V+++V+GG LF  + + G   E  AR    +I+
Sbjct: 62  IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL 121

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
           SAV + H + ++HRDLKPEN+LLDA  +  + DFGL+    +     + CG+  Y +PE+
Sbjct: 122 SAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 181

Query: 321 VLGKGHD-KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSL 379
           + G+ +     D WS G++L+ +L G  PF   +   + +KI      +P +L+    +L
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATL 241

Query: 380 LK 381
           L 
Sbjct: 242 LM 243

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  219 bits (560), Expect = 6e-69
 Identities = 61/245 (24%), Positives = 110/245 (44%), Gaps = 14/245 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E + + + +G+G F  V++     + + Y  K ++     +      +K E +IL    H
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARH 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
             I+ L  SF++   L ++ +F++G  +F           E     Y  ++  A+  LH+
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 269 NGIMHRDLKPENILL--DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           + I H D++PENI+        + + +FG A+Q         +    EY +PE+      
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKL--PAF--LSSEAHSLLKG 382
             A D WS+G L++ +L+G  PF     Q+I + I+  +      AF  +S EA      
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF--- 237

Query: 383 VNSLL 387
           V+ LL
Sbjct: 238 VDRLL 242

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  219 bits (561), Expect = 8e-69
 Identities = 73/229 (31%), Positives = 115/229 (50%), Gaps = 16/229 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VD 208
           + +EV + +G G+++   +     T+  +A+K++ K K            E  IL +   
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRYGQ 74

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I+ L+  +     +Y+V + + GG L  ++ RQ  F E  A      I   V +LHA
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134

Query: 269 NGIMHRDLKPENILL----DADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLG 323
            G++HRDLKP NIL          + + DFG AKQ   EN    + C T  +++PE++  
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER 194

Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGG---NRQKIQQKIIKDKIKLP 369
           +G+D A D WS+G+LL+ MLTG  PF  G     ++I  +I   K  L 
Sbjct: 195 QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS 243

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  218 bits (558), Expect = 1e-68
 Identities = 62/259 (23%), Positives = 111/259 (42%), Gaps = 27/259 (10%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  + +  ++ +G+G F+ V  V  +     YA+K +      E+   E  + E ++   
Sbjct: 26  IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL---CHEQQDREEAQREADMHRL 82

Query: 207 VDHPFIVQLRYSF----QTKYRLYLVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAE 258
            +HP I++L          K+  +L+L F   G L+ ++ R         ED        
Sbjct: 83  FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142

Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM--------- 309
           I   +  +HA G  HRDLKP NILL  +G  +L D G   Q   +   +           
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 310 -CGTLEYMSPEIVLGKGH---DKAADWWSVGILLFEMLTGQPPFTGGNRQ-KIQQKIIKD 364
              T+ Y +PE+   + H   D+  D WS+G +L+ M+ G+ P+    ++       +++
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262

Query: 365 KIKLPAF--LSSEAHSLLK 381
           ++ +P     SS    LL 
Sbjct: 263 QLSIPQSPRHSSALWQLLN 281

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  218 bits (558), Expect = 2e-68
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 7/220 (3%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-PFIVQ 214
           K +G+G FA V Q     T + YA K ++K +  +   AE +  E  +L      P ++ 
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAE-ILHEIAVLELAKSCPRVIN 93

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLY--RQGLFREDLARIYTAEIVSAVSHLHANGIM 272
           L   ++    + L+L++  GG +F         +  E+       +I+  V +LH N I+
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIV 153

Query: 273 HRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKA 329
           H DLKP+NILL      G + + DFG++++         + GT EY++PEI+       A
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTA 213

Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP 369
            D W++GI+ + +LT   PF G + Q+    I +  +   
Sbjct: 214 TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS 253

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  218 bits (558), Expect = 2e-68
 Identities = 75/287 (26%), Positives = 121/287 (42%), Gaps = 55/287 (19%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNILTKV 207
           + + +   +GQG++  V       T  I A+K+M K+KI + N  +   +K+E  ++ K+
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF----------------------------- 238
            HP I +L   ++ +  + LV++  +GGHL                              
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145

Query: 239 -----------FQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL--DA 285
                      F+     + RE L      +I SA+ +LH  GI HRD+KPEN L   + 
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205

Query: 286 DGHVMLTDFGLAKQFD-----ENTRSNSMCGTLEYMSPEIVLGKGH--DKAADWWSVGIL 338
              + L DFGL+K+F      E     +  GT  +++PE++           D WS G+L
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265

Query: 339 LFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLK 381
           L  +L G  PF G N      +++  K+         LS  A  LL 
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLS 312

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  224 bits (572), Expect = 5e-68
 Identities = 65/239 (27%), Positives = 112/239 (46%), Gaps = 10/239 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + +++ + +G GAF  V++V    T   +A K +      +K   E ++ E   ++ + H
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLRH 213

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           P +V L  +F+    + ++ +F++GG LF           ED A  Y  ++   + H+H 
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273

Query: 269 NGIMHRDLKPENILL--DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           N  +H DLKPENI+        + L DFGL    D         GT E+ +PE+  GK  
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV 333

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKL--PAF--LSSEAHSLLK 381
               D WSVG+L + +L+G  PF G N  +  + +      +   AF  +S +    ++
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 392

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  216 bits (551), Expect = 6e-68
 Identities = 69/269 (25%), Positives = 111/269 (41%), Gaps = 36/269 (13%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L DFE ++ +G+G F  V++ +       YA+K +R     E    + +  E   L K++
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREK-VMREVKALAKLE 61

Query: 209 HPFIVQLRYSF------------QTKYRLYLVLDFVNGGHLFFQLYRQG---LFREDLAR 253
           HP IV+   ++              K  LY+ +      +L   +  +         +  
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--------- 304
               +I  AV  LH+ G+MHRDLKP NI    D  V + DFGL    D++          
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 305 ----RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQK 360
               R     GT  YMSPE + G  +    D +S+G++LFE+L   P  T   R +    
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTD 239

Query: 361 IIKDKI-KLPAFLSSEAHSLLKGVNSLLS 388
           +   K   L        + +++    +LS
Sbjct: 240 VRNLKFPPLFTQKYPCEYVMVQ---DMLS 265

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  215 bits (550), Expect = 3e-67
 Identities = 67/249 (26%), Positives = 122/249 (48%), Gaps = 15/249 (6%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
             E +      +  +  +G GAF  V+       ++   +K ++K+K++E    E  K  
Sbjct: 17  ACEGEYSQ--KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLG 74

Query: 201 R-----NILTKVDHPFIVQLRYSFQTKYRLYLVLDF-VNGGHLFFQLYRQGLFREDLARI 254
           +      IL++V+H  I+++   F+ +    LV++   +G  LF  + R     E LA  
Sbjct: 75  KVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY 134

Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE 314
              ++VSAV +L    I+HRD+K ENI++  D  + L DFG A   +      + CGT+E
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIE 194

Query: 315 YMSPEIVLGKGHD-KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLS 373
           Y +PE+++G  +     + WS+G+ L+ ++  + PF         ++ ++  I  P  +S
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPYLVS 248

Query: 374 SEAHSLLKG 382
            E  SL+ G
Sbjct: 249 KELMSLVSG 257

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  213 bits (544), Expect = 4e-67
 Identities = 72/240 (30%), Positives = 126/240 (52%), Gaps = 9/240 (3%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 326 HD-KAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKIIKDKIKLP--AFLSSEAHSLLK 381
              +  D WS GI+L  ML G+ P+    +  +      + K  L     + S   +LL 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  214 bits (547), Expect = 2e-66
 Identities = 42/276 (15%), Positives = 88/276 (31%), Gaps = 51/276 (18%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER--------- 201
                 V+GQ       +     T E + + V    +    N  + MK E          
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 202 ----------------NILTKVDHPFIVQLRYSFQTKYRLYLVL-------DFVNGGHLF 238
                           +++       ++++R   +  + L           +    G + 
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 239 FQLYRQGLFREDLARIY-TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA 297
                        AR+  T +++  ++ LH  G++H  L+P +I+LD  G V LT F   
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 298 KQFDENTRSNSMCGTLEYMSPEIVLGKG-----------HDKAADWWSVGILLFEMLTGQ 346
            +            +  +  PE+   +               + D W++G++++ +    
Sbjct: 254 VRDGARV---VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 347 PPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG 382
            P T        + I +    +P        +LL+G
Sbjct: 311 LPITKDAALGGSEWIFRSCKNIP----QPVRALLEG 342

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  213 bits (544), Expect = 2e-66
 Identities = 70/243 (28%), Positives = 127/243 (52%), Gaps = 4/243 (1%)

Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           +    + +G   + + + +G+G+F KV       T +  A+K + +  + + +    ++ 
Sbjct: 1   MAISKRHIG--PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER 58

Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E + L  + HP I++L     T   + +V+++  GG LF  +  +    ED  R +  +I
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQI 117

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
           + A+ + H + I+HRDLKPEN+LLD + +V + DFGL+    +     + CG+  Y +PE
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPE 177

Query: 320 IVLGKGHD-KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHS 378
           ++ GK +     D WS GI+L+ ML G+ PF       + +K+      +P FLS  A S
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQS 237

Query: 379 LLK 381
           L++
Sbjct: 238 LIR 240

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  213 bits (544), Expect = 5e-66
 Identities = 73/242 (30%), Positives = 125/242 (51%), Gaps = 13/242 (5%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
            + ++ +K +G G F     +R   T E+ A+K + +   ++    E ++ E      + 
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLR 74

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP IV+ +    T   L +++++ +GG L+ ++   G F ED AR +  +++S VS+ H+
Sbjct: 75  HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS 134

Query: 269 NGIMHRDLKPENILLDAD--GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
             I HRDLK EN LLD      + + DFG +K    +++  S  GT  Y++PE++L + +
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEY 194

Query: 327 D-KAADWWSVGILLFEMLTGQPPFTGGNR----QKIQQKIIKDKIKLP--AFLSSEAHSL 379
           D K AD WS G+ L+ ML G  PF         +K  Q+I+  K  +P    +S E   L
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHL 254

Query: 380 LK 381
           + 
Sbjct: 255 IS 256

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  210 bits (537), Expect = 1e-65
 Identities = 72/240 (30%), Positives = 126/240 (52%), Gaps = 9/240 (3%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + ++    E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 326 HD-KAADWWSVGILLFEMLTGQPPF-TGGNRQKIQQKIIKDKIKLP--AFLSSEAHSLLK 381
              +  D WS GI+L  ML G+ P+    +  +      + K  L     + S   +LL 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  209 bits (535), Expect = 3e-65
 Identities = 70/239 (29%), Positives = 116/239 (48%), Gaps = 30/239 (12%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQ 214
            V+G+GA A+V     + TS+ YA+K++ K     +     +  E  +L +   H  +++
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQCQGHRNVLE 75

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   F+ + R YLV + + GG +   ++++  F E  A +   ++ SA+  LH  GI HR
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHR 135

Query: 275 DLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSM--------CGTLEYMSPEIVLG 323
           DLKPENIL    +    V + DF L      N   + +        CG+ EYM+PE+V  
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195

Query: 324 -----KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ----------QKIIKDKIK 367
                  +DK  D WS+G++L+ +L+G PPF G                 Q ++ + I+
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQ 254

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  213 bits (545), Expect = 4e-65
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 1/242 (0%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
              +  V +  + +   +G G F KV   +   T    A+K++ + KI   +    ++ E
Sbjct: 7   QKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE 66

Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
              L    HP I++L     T   +++V+++V+GG LF  + + G   E  +R    +I+
Sbjct: 67  IQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL 126

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
           S V + H + ++HRDLKPEN+LLDA  +  + DFGL+    +     + CG+  Y +PE+
Sbjct: 127 SGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 186

Query: 321 VLGKGHD-KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSL 379
           + G+ +     D WS G++L+ +L G  PF   +   + +KI       P +L+    SL
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISL 246

Query: 380 LK 381
           LK
Sbjct: 247 LK 248

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  208 bits (531), Expect = 5e-65
 Identities = 70/271 (25%), Positives = 122/271 (45%), Gaps = 32/271 (11%)

Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           S   CV L  + +   +G+G++  V        +  YAMKV+ K K++ +         R
Sbjct: 5   SSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPR 64

Query: 202 N-----------------------ILTKVDHPFIVQLR--YSFQTKYRLYLVLDFVNGGH 236
                                   IL K+DHP +V+L        +  LY+V + VN G 
Sbjct: 65  GTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP 124

Query: 237 LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGL 296
           +  ++       ED AR Y  +++  + +LH   I+HRD+KP N+L+  DGH+ + DFG+
Sbjct: 125 VM-EVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGV 183

Query: 297 AKQF-DENTRSNSMCGTLEYMSPEIVLGKGHD---KAADWWSVGILLFEMLTGQPPFTGG 352
           + +F   +   ++  GT  +M+PE +         KA D W++G+ L+  + GQ PF   
Sbjct: 184 SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243

Query: 353 NRQKIQQKIIKDKIKLPAF--LSSEAHSLLK 381
               +  KI    ++ P    ++ +   L+ 
Sbjct: 244 RIMCLHSKIKSQALEFPDQPDIAEDLKDLIT 274

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  207 bits (530), Expect = 1e-64
 Identities = 62/240 (25%), Positives = 115/240 (47%), Gaps = 9/240 (3%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY-MKSERNILTKVDHP 210
           + +  ++G+G++ KV +V    T    A+K+++K K+    + E  +K E  +L ++ H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 211 FIVQLR--YSFQTKYRLYLVLDFVNGGHL-FFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            ++QL      + K ++Y+V+++   G         +  F    A  Y  +++  + +LH
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH 126

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM---CGTLEYMSPEIVLG- 323
           + GI+H+D+KP N+LL   G + ++  G+A+        ++     G+  +  PEI  G 
Sbjct: 127 SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGL 186

Query: 324 KGHD-KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG 382
                   D WS G+ L+ + TG  PF G N  K+ + I K    +P         LLKG
Sbjct: 187 DTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKG 246

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  206 bits (525), Expect = 8e-64
 Identities = 69/260 (26%), Positives = 121/260 (46%), Gaps = 15/260 (5%)

Query: 131 GKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME 190
                     P + +      ++V  ++G G F  VY   R+  +   A+K + KD+I +
Sbjct: 24  CNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 83

Query: 191 KNHAEYM---KSERNILTKVDH--PFIVQLRYSFQTKYRLYLVLDFVNG-GHLFFQLYRQ 244
                       E  +L KV      +++L   F+      L+L+       LF  +  +
Sbjct: 84  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 143

Query: 245 GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDEN 303
           G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L DFG      + 
Sbjct: 144 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 203

Query: 304 TRSNSMCGTLEYMSPEIVLGKGHD-KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII 362
             ++   GT  Y  PE +    +  ++A  WS+GILL++M+ G  PF         ++II
Sbjct: 204 VYTDF-DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEII 256

Query: 363 KDKIKLPAFLSSEAHSLLKG 382
           + ++     +SSE   L++ 
Sbjct: 257 RGQVFFRQRVSSECQHLIRW 276

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  205 bits (524), Expect = 9e-64
 Identities = 66/242 (27%), Positives = 120/242 (49%), Gaps = 17/242 (7%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYM---KSERNILTKV 207
           ++ +  ++G+G F  V+   R+      A+KV+ +++++  +          E  +L KV
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 208 D----HPFIVQLRYSFQTKYRLYLVLDF-VNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
                HP +++L   F+T+    LVL+  +    LF  +  +G   E  +R +  ++V+A
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151

Query: 263 VSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           + H H+ G++HRD+K ENIL+D   G   L DFG       +       GT  Y  PE +
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDFDGTRVYSPPEWI 210

Query: 322 LGKGHD-KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLL 380
               +    A  WS+GILL++M+ G  PF         Q+I++ ++  PA +S +  +L+
Sbjct: 211 SRHQYHALPATVWSLGILLYDMVCGDIPFER------DQEILEAELHFPAHVSPDCCALI 264

Query: 381 KG 382
           + 
Sbjct: 265 RR 266

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  206 bits (525), Expect = 1e-63
 Identities = 64/229 (27%), Positives = 118/229 (51%), Gaps = 21/229 (9%)

Query: 150 EDFEVLK-VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV- 207
           +D+++ K V+G G   KV +     T +  A+K++       +        E +   +  
Sbjct: 28  DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ--------EVDHHWQAS 79

Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV +   ++  +     L ++++ + GG LF ++  +G   F E  A     +I +
Sbjct: 80  GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139

Query: 262 AVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+  LH++ I HRD+KPEN+L    + D  + LTDFG AK+  +N    + C T  Y++P
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ-TPCYTPYYVAP 198

Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK 367
           E++  + +DK+ D WS+G++++ +L G PPF     Q I   + + +I+
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR-RIR 246

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  207 bits (529), Expect = 2e-63
 Identities = 68/248 (27%), Positives = 125/248 (50%), Gaps = 20/248 (8%)

Query: 131 GKPTGHIDNLPSENQCVGLEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM 189
             P  H+ +     +   ++D++V  +V+G G   KV Q+    T E +A+K+++     
Sbjct: 42  QFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA 101

Query: 190 EKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKY----RLYLVLDFVNGGHLFFQLYRQ 244
            +        E  +  +    P IV++   ++  Y     L +V++ ++GG LF ++  +
Sbjct: 102 RR--------EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR 153

Query: 245 G--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQ 299
           G   F E  A      I  A+ +LH+  I HRD+KPEN+L      +  + LTDFG AK+
Sbjct: 154 GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213

Query: 300 FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ 359
              +    + C T  Y++PE++  + +DK+ D WS+G++++ +L G PPF   +   I  
Sbjct: 214 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 273

Query: 360 KIIKDKIK 367
             +K +I+
Sbjct: 274 G-MKTRIR 280

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  200 bits (511), Expect = 4e-62
 Identities = 42/258 (16%), Positives = 95/258 (36%), Gaps = 31/258 (12%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
             +F  L+ +G G F  V++  +     IYA+K  +K      +    ++          
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG----HLFFQLYRQGLFREDLARIYTAEIVSAVS 264
           H  +V+   ++     + +  ++ NGG     +         F+E   +    ++   + 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 265 HLHANGIMHRDLKPENILLDADGHVM-------------------LTDFGLAKQFDENTR 305
           ++H+  ++H D+KP NI +                          + D G   +    + 
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---SS 186

Query: 306 SNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD 364
                G   +++ E++     H   AD +++ + +      +P    G+      +I + 
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQG 243

Query: 365 KI-KLPAFLSSEAHSLLK 381
           ++ ++P  LS E   LLK
Sbjct: 244 RLPRIPQVLSQEFTELLK 261

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  202 bits (514), Expect = 4e-61
 Identities = 45/271 (16%), Positives = 90/271 (33%), Gaps = 44/271 (16%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER---------- 201
                V+GQ       +     T E + + V    +    N  + MK E           
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 202 ---------------NILTKVDHPFIVQLRYSFQTKYRLYLVLDF----VNGGHLFFQLY 242
                          +++       ++++R   +  + L     +     N       L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 243 RQGLFREDL---ARIY-TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK 298
                 + L   AR+  T +++  ++ LH  G++H  L+P +I+LD  G V LT F    
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 299 QFDEN--TRSNSMCGTLEYMSPEIVLGKGHDK-----AADWWSVGILLFEMLTGQPPFTG 351
           +   +  +         E  +  ++    H       A D W++G+ ++ +     P T 
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319

Query: 352 GNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG 382
                  + I +    +P        +LL+G
Sbjct: 320 DAALGGSEWIFRSCKNIPQ----PVRALLEG 346

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  197 bits (503), Expect = 2e-60
 Identities = 59/243 (24%), Positives = 107/243 (44%), Gaps = 18/243 (7%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +        VG+G+F +V++++   T    A+K +R +    +        E      + 
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------ELVACAGLS 108

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            P IV L  + +    + + ++ + GG L   + + G   ED A  Y  + +  + +LH 
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT 168

Query: 269 NGIMHRDLKPENILLDADG-HVMLTDFGLAKQFDEN------TRSNSMCGTLEYMSPEIV 321
             I+H D+K +N+LL +DG    L DFG A     +         + + GT  +M+PE+V
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228

Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHS 378
           +GK  D   D WS   ++  ML G  P+T   R  +  KI  +     ++P   +     
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQ 288

Query: 379 LLK 381
            ++
Sbjct: 289 AIQ 291

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  194 bits (494), Expect = 1e-58
 Identities = 45/312 (14%), Positives = 97/312 (31%), Gaps = 40/312 (12%)

Query: 113 NEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRI 172
            E  +E    +  V A +             +Q  G    ++++ +  G  + V+ VR +
Sbjct: 27  EEALKEPAAMVEAVTATVWPQNAETTVDSLLSQ--GERKLKLVEPLRVGDRSVVFLVRDV 84

Query: 173 GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLR---------------- 216
              E +A+KV        ++  E +        ++      + R                
Sbjct: 85  ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQS 144

Query: 217 ----------YSFQTKYRLYLVLDFVNG------GHLFFQLYRQGLFREDLARIYTAEIV 260
                               L++   +         L F    +G        I TA+++
Sbjct: 145 QPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLI 204

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
              ++L + G++H    P+N+ +  DG +ML D     +    TR  +    + Y   E 
Sbjct: 205 RLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK--VGTRGPASSVPVTYAPREF 262

Query: 321 VLGKG--HDKAADWWSVGILLFEMLTGQPPFTGGN--RQKIQQKIIKDKIKLPAFLSSEA 376
           +         A + W +G+ ++ +     PF       +   ++         +      
Sbjct: 263 LNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSC 322

Query: 377 HSLLKGVNSLLS 388
             L   V +L+ 
Sbjct: 323 TPLPDFVKTLIG 334

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  188 bits (480), Expect = 2e-57
 Identities = 70/236 (29%), Positives = 121/236 (51%), Gaps = 13/236 (5%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
            V+G+G +  VY  R +      A+K + +       +++ +  E  +   + H  IVQ 
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQY 84

Query: 216 RYSFQTKYRLYLVLDFVNGG---HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
             SF     + + ++ V GG    L    +      E     YT +I+  + +LH N I+
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144

Query: 273 HRDLKPENILLDA-DGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLG--KGHDK 328
           HRD+K +N+L++   G + ++DFG +K+    N  + +  GTL+YM+PEI+    +G+ K
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGK 204

Query: 329 AADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKIIKDKI--KLPAFLSSEAHSLLK 381
           AAD WS+G  + EM TG+PPF   G  Q    K+   K+  ++P  +S+EA + + 
Sbjct: 205 AADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFIL 260

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  186 bits (475), Expect = 4e-56
 Identities = 67/267 (25%), Positives = 108/267 (40%), Gaps = 38/267 (14%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +G     V +V+ +G FA VY+ + +G+   YA+K +      E+     +  E   + K
Sbjct: 25  LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS---NEEEKNRAIIQEVCFMKK 81

Query: 207 V-DHPFIVQLRYSF-------QTKYRLYLVLDFVNGGHLFFQLYR---QGLFREDLARIY 255
           +  HP IVQ   +         T    +L+L  +  G L   L +   +G    D     
Sbjct: 82  LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI 141

Query: 256 TAEIVSAVSHLHANG--IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS----- 308
             +   AV H+H     I+HRDLK EN+LL   G + L DFG A         +      
Sbjct: 142 FYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRR 201

Query: 309 --------MCGTLEYMSPEIV---LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKI 357
                      T  Y +PEI+         +  D W++G +L+ +   Q PF  G     
Sbjct: 202 ALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA---- 257

Query: 358 QQKIIKDKIKLPAFL--SSEAHSLLKG 382
           + +I+  K  +P      +  HSL++ 
Sbjct: 258 KLRIVNGKYSIPPHDTQYTVFHSLIRA 284

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  184 bits (470), Expect = 2e-54
 Identities = 53/271 (19%), Positives = 106/271 (39%), Gaps = 30/271 (11%)

Query: 132 KPTGHIDNLPSENQC--VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM 189
            P+   D+   E     VG   F    V+G GA   +   R +  +   A+K +  +   
Sbjct: 4   SPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF- 61

Query: 190 EKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY--RQGL 246
                 +   E  +L + D HP +++   + + +   Y+ ++         +    +   
Sbjct: 62  -----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA--TLQEYVEQKDFA 114

Query: 247 FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH-----VMLTDFGLAKQFD 301
                      +  S ++HLH+  I+HRDLKP NIL+           M++DFGL K+  
Sbjct: 115 HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174

Query: 302 ENTRS----NSMCGTLEYMSPEIVLG---KGHDKAADWWSVGILLFEMLT-GQPPFTGGN 353
               S    + + GT  +++PE++     +      D +S G + + +++ G  PF    
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234

Query: 354 RQKIQQKIIK---DKIKLPAFLSSEAHSLLK 381
           +++    +     D +         A  L++
Sbjct: 235 QRQANILLGACSLDCLHPEKHEDVIARELIE 265

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  183 bits (467), Expect = 5e-54
 Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 52/286 (18%)

Query: 137 IDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY 196
           I N+P+  Q +        K++G G+   V   +        A+K M  D        + 
Sbjct: 3   IANIPNFEQSLK-NLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFC------DI 54

Query: 197 MKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIY 255
              E  +LT+ D HP +++   S  T   LY+ L+  N   L   +  + +  E+L    
Sbjct: 55  ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLN-LQDLVESKNVSDENLKLQK 113

Query: 256 TAE-------IVSAVSHLHANGIMHRDLKPENILLD-------------ADGHVMLTDFG 295
                     I S V+HLH+  I+HRDLKP+NIL+               +  ++++DFG
Sbjct: 114 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173

Query: 296 LAKQFDEN-----TRSNSMCGTLEYMSPEIVLG-------KGHDKAADWWSVGILLFEML 343
           L K+ D       T  N+  GT  + +PE++         +   ++ D +S+G + + +L
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233

Query: 344 T-GQPPFTGGNRQKIQQKIIKDKIKLPAF-------LSSEAHSLLK 381
           + G+ PF  G++   +  II+    L          L +EA  L+ 
Sbjct: 234 SKGKHPF--GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLIS 277

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  179 bits (455), Expect = 1e-53
 Identities = 65/266 (24%), Positives = 121/266 (45%), Gaps = 48/266 (18%)

Query: 136 HIDNLPSENQCVGLEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA 194
           H+ +     +   ++D++V  +V+G G   KV Q+    T E +A+K+++      +   
Sbjct: 3   HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--- 59

Query: 195 EYMKSERNILTKV-DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LF 247
                E  +  +    P IV++   ++  Y     L +V++ ++GG LF ++  +G   F
Sbjct: 60  -----EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 114

Query: 248 REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENT 304
            E  A      I  A+ +LH+  I HRD+KPEN+L      +  + LTDFG AK+     
Sbjct: 115 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE----- 169

Query: 305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR----QKIQQK 360
                             G+ +DK+ D WS+G++++ +L G PPF   +       ++ +
Sbjct: 170 ----------------TTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 213

Query: 361 IIKDKIKLPA----FLSSEAHSLLKG 382
           I   + + P      +S E   L++ 
Sbjct: 214 IRMGQYEFPNPEWSEVSEEVKMLIRN 239

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  178 bits (454), Expect = 2e-53
 Identities = 59/201 (29%), Positives = 110/201 (54%), Gaps = 4/201 (1%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L+ +G+G+F +V++     T ++ A+K++  ++  ++   E ++ E  +L++ D 
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDS 79

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++ +   S+    +L+++++++ GG     L   G   E        EI+  + +LH+ 
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSE 138

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             +HRD+K  N+LL   G V L DFG+A Q  D   + N+  GT  +M+PE++    +D 
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 198

Query: 329 AADWWSVGILLFEMLTGQPPF 349
            AD WS+GI   E+  G+PP 
Sbjct: 199 KADIWSLGITAIELARGEPPH 219

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  177 bits (450), Expect = 1e-52
 Identities = 68/312 (21%), Positives = 106/312 (33%), Gaps = 77/312 (24%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM-------------KVMRKDKIMEK-NHA 194
           L DFE ++ +G+G F  V++ +       YA+             KVMR+ K + K  H 
Sbjct: 5   LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64

Query: 195 EYMKS-----------------------------------------ERNILTKVDHPFIV 213
             ++                                          +   +        V
Sbjct: 65  GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF---REDLARIYTAEIVSAVSHLHANG 270
                   K  LY+ +      +L   + R+         +      +I  AV  LH+ G
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184

Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFD-------------ENTRSNSMCGTLEYMS 317
           +MHRDLKP NI    D  V + DFGL    D                      GT  YMS
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244

Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEA 376
           PE + G  +    D +S+G++LFE+L      T   R +I   +   K   L      + 
Sbjct: 245 PEQIHGNNYSHKVDIFSLGLILFELLY--SFSTQMERVRIITDVRNLKFPLLFTQKYPQE 302

Query: 377 HSLLKGVNSLLS 388
           H +++    +LS
Sbjct: 303 HMMVQ---DMLS 311

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  171 bits (435), Expect = 9e-51
 Identities = 57/236 (24%), Positives = 109/236 (46%), Gaps = 13/236 (5%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
             +G+G+F  VY+     T+   A   ++  K+  K+  +  K E  +L  + HP IV+ 
Sbjct: 32  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 216 RYSF----QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG- 270
             S+    + K  + LV + +  G L   L R  + +  + R +  +I+  +  LH    
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP 150

Query: 271 -IMHRDLKPENILLDA-DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
            I+HRDLK +NI +    G V + D GLA     +    ++ GT E+M+PE +  + +D+
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIGTPEFMAPE-MYEEKYDE 208

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK---LPAFLSSEAHSLLK 381
           + D ++ G+ + EM T + P++         + +   +K          E   +++
Sbjct: 209 SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 264

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  173 bits (440), Expect = 9e-51
 Identities = 63/250 (25%), Positives = 120/250 (48%), Gaps = 8/250 (3%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNILTK 206
            +DFE +  +G G    V++V    +  + A K++     +E   A    +  E  +L +
Sbjct: 32  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH----LEIKPAIRNQIIRELQVLHE 87

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
            + P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  +++L
Sbjct: 88  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 147

Query: 267 HANG-IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
                IMHRD+KP NIL+++ G + L DFG++ Q   ++ +NS  GT  YMSPE + G  
Sbjct: 148 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTH 206

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNS 385
           +   +D WS+G+ L EM  G+ P    + ++++           A       +  + +N 
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266

Query: 386 LLSISVPLLS 395
               S P ++
Sbjct: 267 FGMDSRPPMA 276

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  172 bits (437), Expect = 9e-51
 Identities = 60/236 (25%), Positives = 118/236 (50%), Gaps = 8/236 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
              +    +G+G+   V   R   +    A+K+M    + ++   E + +E  I+    H
Sbjct: 45  LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQH 101

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
             +V++  S+     L+++++F+ GG L   +  Q    E+        ++ A+++LHA 
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALT-DIVSQVRLNEEQIATVCEAVLQALAYLHAQ 160

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           G++HRD+K ++ILL  DG V L+DFG   Q   +  +  S+ GT  +M+PE++    +  
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYAT 220

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLK 381
             D WS+GI++ EM+ G+PP+   +  +  +++      K+K    +S      L+
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLE 276

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  170 bits (434), Expect = 2e-50
 Identities = 68/236 (28%), Positives = 120/236 (50%), Gaps = 8/236 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + +   + +GQGA   VY    + T +  A++ M    + ++   E + +E  ++ +  +
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKN 76

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV    S+     L++V++++ GG L   +  +    E        E + A+  LH+N
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALEFLHSN 135

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDK 328
            ++HRD+K +NILL  DG V LTDFG   Q   E ++ ++M GT  +M+PE+V  K +  
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLK 381
             D WS+GI+  EM+ G+PP+   N  +    I  +   +++ P  LS+     L 
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  166 bits (423), Expect = 1e-48
 Identities = 68/228 (29%), Positives = 114/228 (50%), Gaps = 14/228 (6%)

Query: 131 GKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME 190
           GK TG++  +  +     + D E L  +G G   +V+++R   T  + A+K MR      
Sbjct: 7   GKQTGYLT-IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR----RS 61

Query: 191 KNHAEY--MKSERNILTK-VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF 247
            N  E   +  + +++ K  D P+IVQ   +F T   +++ ++ +       +   QG  
Sbjct: 62  GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPI 121

Query: 248 REDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS 306
            E +    T  IV A+ +L   +G++HRD+KP NILLD  G + L DFG++ +  ++   
Sbjct: 122 PERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK 181

Query: 307 NSMCGTLEYMSPEIV-----LGKGHDKAADWWSVGILLFEMLTGQPPF 349
           +   G   YM+PE +         +D  AD WS+GI L E+ TGQ P+
Sbjct: 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY 229

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  166 bits (421), Expect = 4e-48
 Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 6/203 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + F  L+ +G G+F  VY  R +  SE+ A+K M           + +  E   L K+ H
Sbjct: 54  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P  +Q R  +  ++  +LV+++  G         +   +E      T   +  +++LH++
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG---KGH 326
            ++HRD+K  NILL   G V L DFG A        +NS  GT  +M+PE++L      +
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVILAMDEGQY 230

Query: 327 DKAADWWSVGILLFEMLTGQPPF 349
           D   D WS+GI   E+   +PP 
Sbjct: 231 DGKVDVWSLGITCIELAERKPPL 253

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  164 bits (418), Expect = 5e-48
 Identities = 68/237 (28%), Positives = 118/237 (49%), Gaps = 10/237 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F+VL+ +G+G++  VY+     T +I A+K +     +E +  E +K E +I+ + D 
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP----VESDLQEIIK-EISIMQQCDS 83

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           P +V+   S+     L++V+++   G +      R     ED         +  + +LH 
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHD 327
              +HRD+K  NILL+ +GH  L DFG+A Q  D   + N++ GT  +M+PE++   G++
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 203

Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLK 381
             AD WS+GI   EM  G+PP+   +  +    I  +     + P   S      +K
Sbjct: 204 CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVK 260

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  164 bits (417), Expect = 6e-48
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 17/215 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D+E+ +V+G GA A V         E  A+K +  +K       + +  E   +++  H
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAMSQCHH 72

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGG--------HLFFQLYRQGLFREDLARIYTAEIVS 261
           P IV    SF  K  L+LV+  ++GG         +    ++ G+  E        E++ 
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ------FDENTRSNSMCGTLEY 315
            + +LH NG +HRD+K  NILL  DG V + DFG++           N    +  GT  +
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192

Query: 316 MSPEIVL-GKGHDKAADWWSVGILLFEMLTGQPPF 349
           M+PE++   +G+D  AD WS GI   E+ TG  P+
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  163 bits (416), Expect = 9e-48
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 4/203 (1%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           + + ++VG+G    VY+        I A+K+M +    +      M+ E     ++  P 
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95

Query: 212 IVQLRYSF-QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
           +V + + F +   +LY+ +  +NG  L   L RQG      A     +I SA+   HA G
Sbjct: 96  VVPI-HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154

Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDK 328
             HRD+KPENIL+ AD    L DFG+A    +   T+  +  GTL YM+PE         
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATY 214

Query: 329 AADWWSVGILLFEMLTGQPPFTG 351
            AD +++  +L+E LTG PP+ G
Sbjct: 215 RADIYALTCVLYECLTGSPPYQG 237

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  162 bits (412), Expect = 3e-47
 Identities = 74/242 (30%), Positives = 122/242 (50%), Gaps = 13/242 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E +E++  +G GAF KVY+ +   T  + A KV+      E    E    E  IL   DH
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYIVEIEILATCDH 75

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           P+IV+L  ++    +L+++++F  GG +    L       E   ++   +++ A++ LH+
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVL----- 322
             I+HRDLK  N+L+  +G + L DFG++ +      + +S  GT  +M+PE+V+     
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 195

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSL 379
              +D  AD WS+GI L EM   +PP    N  ++  KI K     +  P+  S E    
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDF 255

Query: 380 LK 381
           LK
Sbjct: 256 LK 257

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  158 bits (403), Expect = 6e-46
 Identities = 61/202 (30%), Positives = 110/202 (54%), Gaps = 2/202 (0%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           ++++  +G G  + VY       +   A+K +      ++   +  + E +  +++ H  
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV +    +     YLV++++ G  L   +   G    D A  +T +I+  + H H   I
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKA 329
           +HRD+KP+NIL+D++  + + DFG+AK   E   T++N + GT++Y SPE   G+  D+ 
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192

Query: 330 ADWWSVGILLFEMLTGQPPFTG 351
            D +S+GI+L+EML G+PPF G
Sbjct: 193 TDIYSIGIVLYEMLVGEPPFNG 214

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  159 bits (404), Expect = 8e-46
 Identities = 63/229 (27%), Positives = 116/229 (50%), Gaps = 18/229 (7%)

Query: 134 TGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNH 193
           +G +   P ++     ED + L  +G+GA+  V ++    + +I A+K +R       + 
Sbjct: 6   SGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR----STVDE 61

Query: 194 AEY--MKSERNILTK-VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFF----QLYRQGL 246
            E   +  + +++ +  D P+IVQ   +   +   ++ ++ ++     F          +
Sbjct: 62  KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDV 121

Query: 247 FRED-LARIYTAEIVSAVSHLHANG-IMHRDLKPENILLDADGHVMLTDFGLAKQFDENT 304
             E+ L +I T   V A++HL  N  I+HRD+KP NILLD  G++ L DFG++ Q  ++ 
Sbjct: 122 IPEEILGKI-TLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI 180

Query: 305 RSNSMCGTLEYMSPEIV----LGKGHDKAADWWSVGILLFEMLTGQPPF 349
                 G   YM+PE +      +G+D  +D WS+GI L+E+ TG+ P+
Sbjct: 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY 229

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  160 bits (407), Expect = 1e-45
 Identities = 49/214 (22%), Positives = 88/214 (41%), Gaps = 15/214 (7%)

Query: 150 EDFEVLKVVGQGA--FAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
             +E+L V+G+G      V   R   T E   ++ +  +         +++ E ++    
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLF 83

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF--FQLYRQGLFREDLARIYTAEIVSAVSH 265
           +HP IV  R +F     L++V  F+  G        +      E         ++ A+ +
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMC-------GTLEYMS 317
           +H  G +HR +K  +IL+  DG V L+             R   +          L ++S
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203

Query: 318 PEIV--LGKGHDKAADWWSVGILLFEMLTGQPPF 349
           PE++    +G+D  +D +SVGI   E+  G  PF
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  158 bits (402), Expect = 2e-45
 Identities = 66/215 (30%), Positives = 110/215 (51%), Gaps = 19/215 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-D 208
             FE++++VG G + +VY+ R + T ++ A+KVM     +  +  E +K E N+L K   
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79

Query: 209 HPFIVQLRYSF------QTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIV 260
           H  I     +F          +L+LV++F   G +    +  +    +E+       EI+
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNSMCGTLEYMSPE 319
             +SHLH + ++HRD+K +N+LL  +  V L DFG++ Q D    R N+  GT  +M+PE
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 199

Query: 320 IVLGK-----GHDKAADWWSVGILLFEMLTGQPPF 349
           ++         +D  +D WS+GI   EM  G PP 
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  155 bits (395), Expect = 6e-45
 Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 17/215 (7%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNIL 204
           V  +D E +  +G+GA+  V ++R + + +I A+K +R       N  E   +  + +I 
Sbjct: 4   VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR----ATVNSQEQKRLLMDLDIS 59

Query: 205 TK-VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFF---QLYRQGLFRED-LARIYTAEI 259
            + VD PF V    +   +  +++ ++ ++     F    + +     ED L +I    I
Sbjct: 60  MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKI-AVSI 118

Query: 260 VSAVSHLHANG-IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           V A+ HLH+   ++HRD+KP N+L++A G V + DFG++    ++   +   G   YM+P
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAP 178

Query: 319 EIVLG----KGHDKAADWWSVGILLFEMLTGQPPF 349
           E +      KG+   +D WS+GI + E+   + P+
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPY 213

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  154 bits (391), Expect = 4e-44
 Identities = 63/208 (30%), Positives = 113/208 (54%), Gaps = 8/208 (3%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ +++G G  ++V+  R +      A+KV+R D   + +     + E      ++HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73

Query: 212 IVQL----RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           IV +              Y+V+++V+G  L   ++ +G      A    A+   A++  H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGTLEYMSPEIVLG 323
            NGI+HRD+KP NI++ A   V + DFG+A+   ++    T++ ++ GT +Y+SPE   G
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193

Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              D  +D +S+G +L+E+LTG+PPFTG
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  152 bits (387), Expect = 2e-43
 Identities = 64/226 (28%), Positives = 112/226 (49%), Gaps = 20/226 (8%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
            ++ EV +VVG+GAF  V + +        A+K +  +   +     ++  E   L++V+
Sbjct: 7   YKEIEVEEVVGRGAFGVVCKAKWRAK--DVAIKQIESESERK----AFIV-ELRQLSRVN 59

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSH 265
           HP IV+L Y       + LV+++  GG L+  L+       +    A  +  +    V++
Sbjct: 60  HPNIVKL-YGACLN-PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117

Query: 266 LHA---NGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           LH+     ++HRDLKP N+LL A G V+ + DFG A   D  T   +  G+  +M+PE+ 
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVF 175

Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTG--GNRQKIQQKIIKDK 365
            G  + +  D +S GI+L+E++T + PF    G   +I   +    
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT 221

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  153 bits (388), Expect = 2e-43
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 15/226 (6%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ER 201
              +E +E L +VG+G++  V + R   T  I A+K     K +E +  + +K     E 
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREI 75

Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            +L ++ H  +V L    + K R YLV +FV+   L             + + Y  +I++
Sbjct: 76  KLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIIN 135

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS-MCGTLEYMSPEI 320
            +   H++ I+HRD+KPENIL+   G V L DFG A+              T  Y +PE+
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPEL 195

Query: 321 VLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK 363
           ++G     KA D W++G L+ EM  G+P F G +   I Q   I+ 
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS--DIDQLYHIMM 239

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  159 bits (404), Expect = 2e-43
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 25/219 (11%)

Query: 152 FEVLKVVGQGAFAKVYQVR--RIGTSEIYAMKVMRKDKIMEKNHAEYMK---SERNILTK 206
           +EV   +  G    +Y      +    +  +K +          AE      +ER  L +
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPV-VLKGLVHS-----GDAEAQAMAMAERQFLAE 135

Query: 207 VDHPFIVQLRYSF------QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           V HP IVQ+ ++F            Y+V+++V G  L  +  +        A  Y  EI+
Sbjct: 136 VVHPSIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSL--KRSKGQKLPVAEAIAYLLEIL 192

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
            A+S+LH+ G+++ DLKPENI+L  +  + L D G   +         + GT  + +PEI
Sbjct: 193 PALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRI---NSFGYLYGTPGFQAPEI 248

Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ 359
           V   G   A D ++VG  L  +    P   G     + +
Sbjct: 249 VRT-GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE 286

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  152 bits (386), Expect = 3e-43
 Identities = 64/223 (28%), Positives = 108/223 (48%), Gaps = 15/223 (6%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
           +E +E +  +G+G++  V++ R   T +I A+K     K +E      +K     E  +L
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRML 56

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            ++ HP +V L   F+ K RL+LV ++ +   L      Q    E L +  T + + AV+
Sbjct: 57  KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVN 116

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS-MCGTLEYMSPEIVLG 323
             H +  +HRD+KPENIL+     + L DFG A+     +        T  Y SPE+++G
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVG 176

Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK 363
                   D W++G +  E+L+G P + G  +  + Q   I K
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSGVPLWPG--KSDVDQLYLIRK 217

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  151 bits (383), Expect = 5e-43
 Identities = 53/211 (25%), Positives = 107/211 (50%), Gaps = 13/211 (6%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGT--SEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
             D  + + +G G+F  V++            A+K++ +     +   E+++ E  I+ +
Sbjct: 36  WCDLNIKEKIGAGSFGTVHR----AEWHGSDVAVKILMEQDFHAERVNEFLR-EVAIMKR 90

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYT--AEIVSAV 263
           + HP IV    +      L +V ++++ G L+  L++ G   + D  R  +   ++   +
Sbjct: 91  LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150

Query: 264 SHLHANG--IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-NSMCGTLEYMSPEI 320
           ++LH     I+HR+LK  N+L+D    V + DFGL++       S  S  GT E+M+PE+
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV 210

Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           +  +  ++ +D +S G++L+E+ T Q P+  
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATLQQPWGN 241

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  150 bits (381), Expect = 1e-42
 Identities = 61/233 (26%), Positives = 101/233 (43%), Gaps = 19/233 (8%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-- 203
            +    +E +  +G GA+  VY+ R   +    A+K +R            + + R +  
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 204 ---LTKVDHPFIVQLR-----YSFQTKYRLYLVLDFVNGGH---LFFQLYRQGLFREDLA 252
              L   +HP +V+L           + ++ LV + V+       +           +  
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD--QDLRTYLDKAPPPGLPAETI 122

Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT 312
           +    + +  +  LHAN I+HRDLKPENIL+ + G V L DFGLA+ +        +  T
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVT 182

Query: 313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK 363
           L Y +PE++L   +    D WSVG +  EM   +P F G +  +  Q  KI  
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS--EADQLGKIFD 233

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  147 bits (373), Expect = 2e-41
 Identities = 63/227 (27%), Positives = 114/227 (50%), Gaps = 21/227 (9%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNILT 205
             F+ L+ +G G +A VY+     T    A+K ++    ++    E   S    E +++ 
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK----LDSE--EGTPSTAIREISLMK 58

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVN---GGHL--FFQLYRQGLFREDLARIYTAEIV 260
           ++ H  IV+L     T+ +L LV +F++     ++              +L + +  +++
Sbjct: 59  ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS-MCGTLEYMSPE 319
             ++  H N I+HRDLKP+N+L++  G + L DFGLA+ F     + S    TL Y +P+
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178

Query: 320 IVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK 363
           +++G + +  + D WS G +L EM+TG+P F G N    +Q   I  
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN--DEEQLKLIFD 223

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  145 bits (369), Expect = 4e-41
 Identities = 51/224 (22%), Positives = 102/224 (45%), Gaps = 18/224 (8%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYM----KSERNIL 204
             + E  K +G+G F  V++ R +    + A+K +       +          + E  I+
Sbjct: 18  DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEIVSAV 263
           + ++HP IV+L Y         +V++FV  G L+ +L  +    +  +      +I   +
Sbjct: 78  SNLNHPNIVKL-YGLMHN-PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135

Query: 264 SHLHANG--IMHRDLKPENILLDADG-----HVMLTDFGLAKQFDENTRSNSMCGTLEYM 316
            ++      I+HRDL+  NI L +          + DFGL++        + + G  ++M
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWM 193

Query: 317 SPEIVLGKG--HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ 358
           +PE +  +   + + AD +S  ++L+ +LTG+ PF   +  KI+
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  145 bits (367), Expect = 7e-41
 Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 12/209 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
               V + +G G+F  VY+ +  G     A+K++       +    + K+E  +L K  H
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAF-KNEVGVLRKTRH 79

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEIVSAVSHLHA 268
             I+     + T  +L +V  +  G  L+  L+     F          +    + +LHA
Sbjct: 80  VNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM---CGTLEYMSPEIVLGKG 325
             I+HRDLK  NI L  D  V + DFGLA +    + S+      G++ +M+PE++  + 
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198

Query: 326 H---DKAADWWSVGILLFEMLTGQPPFTG 351
                  +D ++ GI+L+E++TGQ P++ 
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSN 227

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  144 bits (366), Expect = 2e-40
 Identities = 62/226 (27%), Positives = 110/226 (48%), Gaps = 22/226 (9%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
           +E +  L  +G+G +A VY+ +   T  + A+K +R    +E  H E        E ++L
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR----LE--HEEGAPCTAIREVSLL 54

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVN---GGHLFFQLYRQGLFREDLARIYTAEIVS 261
             + H  IV L     T+  L LV ++++     +L        +      +++  +++ 
Sbjct: 55  KDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYL---DDCGNIINMHNVKLFLFQLLR 111

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS-MCGTLEYMSPEI 320
            +++ H   ++HRDLKP+N+L++  G + L DFGLA+     T++      TL Y  P+I
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDI 171

Query: 321 VLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK 363
           +LG   +    D W VG + +EM TG+P F G      +Q   I +
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST--VEEQLHFIFR 215

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  145 bits (367), Expect = 3e-40
 Identities = 65/226 (28%), Positives = 108/226 (47%), Gaps = 18/226 (7%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
            + +E L  +G+G FA VY+ R   T++I A+K ++          + +      E  +L
Sbjct: 9   AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLG--HRSEAKDGINRTALREIKLL 66

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNG---GHLFFQLYRQGLFREDLARIYTAEIVS 261
            ++ HP I+ L  +F  K  + LV DF+       +        +      + Y    + 
Sbjct: 67  QELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQ 123

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS-MCGTLEYMSPEI 320
            + +LH + I+HRDLKP N+LLD +G + L DFGLAK F    R+ +    T  Y +PE+
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 183

Query: 321 VLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK 363
           + G + +    D W+VG +L E+L   P   G     + Q  +I +
Sbjct: 184 LFGARMYGVGVDMWAVGCILAELLLRVPFLPG--DSDLDQLTRIFE 227

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  143 bits (363), Expect = 9e-40
 Identities = 59/247 (23%), Positives = 110/247 (44%), Gaps = 41/247 (16%)

Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRI-GTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
            +  C   + +E +  +G+GA+ KV++ R +       A+K +R            +++ 
Sbjct: 3   KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------------VQTG 50

Query: 201 ---------RNI-----LTKVDHPFIVQLR-----YSFQTKYRLYLVLDFVNGGH---LF 238
                    R +     L   +HP +V+L           + +L LV + V+       +
Sbjct: 51  EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD--QDLTTY 108

Query: 239 FQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK 298
                +     +  +    +++  +  LH++ ++HRDLKP+NIL+ + G + L DFGLA+
Sbjct: 109 LDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168

Query: 299 QFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ 358
            +       S+  TL Y +PE++L   +    D WSVG +  EM   +P F G +   + 
Sbjct: 169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DVD 226

Query: 359 Q--KIIK 363
           Q  KI+ 
Sbjct: 227 QLGKILD 233

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  143 bits (363), Expect = 9e-40
 Identities = 59/239 (24%), Positives = 116/239 (48%), Gaps = 23/239 (9%)

Query: 139 NLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK 198
           ++ +      ++ +  +  +G+G + +VY+     T+E  A+K +R +   E+   E + 
Sbjct: 23  SVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH--EE---EGVP 77

Query: 199 S----ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLAR 253
                E ++L ++ H  I++L+      +RL+L+ ++    + L   + +       + +
Sbjct: 78  GTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE--NDLKKYMDKNPDVSMRVIK 135

Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDA-----DGHVMLTDFGLAKQFDENTRSNS 308
            +  ++++ V+  H+   +HRDLKP+N+LL          + + DFGLA+ F    R  +
Sbjct: 136 SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT 195

Query: 309 M-CGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK 363
               TL Y  PEI+LG + +  + D WS+  +  EML   P F G    +I Q  KI +
Sbjct: 196 HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG--DSEIDQLFKIFE 252

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  144 bits (366), Expect = 2e-39
 Identities = 76/273 (27%), Positives = 126/273 (46%), Gaps = 36/273 (13%)

Query: 113 NEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLED----FEVLKVVGQGAFAKVYQ 168
           + +  + P+    +  +  K    +  + +             +   KV+G G+F  VYQ
Sbjct: 13  SCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQ 72

Query: 169 VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR---- 224
            +   + E+ A+K     K+       +   E  I+ K+DH  IV+LRY F +       
Sbjct: 73  AKLCDSGELVAIK-----KV--LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125

Query: 225 --LYLVLDFVNGGHLFFQLYR--------QGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
             L LVLD+V        +YR        +        ++Y  ++  +++++H+ GI HR
Sbjct: 126 VYLNLVLDYVPE-----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR 180

Query: 275 DLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG-KGHDKAADW 332
           D+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G   +  + D 
Sbjct: 181 DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDV 240

Query: 333 WSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK 363
           WS G +L E+L GQP F G     + Q  +IIK
Sbjct: 241 WSAGCVLAELLLGQPIFPG--DSGVDQLVEIIK 271

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  140 bits (355), Expect = 3e-39
 Identities = 40/230 (17%), Positives = 93/230 (40%), Gaps = 16/230 (6%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
            +    L  + +    ++++ R  G  +I  +KV++      +   ++ + E   L    
Sbjct: 9   FKQLNFLTKLNENHSGELWKGRWQGN-DI-VVKVLKVRDWSTRKSRDFNE-ECPRLRIFS 65

Query: 209 HPFIVQLR--YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYT--AEIVSAVS 264
           HP ++ +             L+  ++  G L+  L+    F  D ++      ++   ++
Sbjct: 66  HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125

Query: 265 HLHA--NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
            LH     I    L   ++++D D    ++   +   F    R         +++PE + 
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR----MYAPAWVAPEALQ 181

Query: 323 GKGHD---KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP 369
            K  D   ++AD WS  +LL+E++T + PF   +  +I  K+  + ++  
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT 231

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  141 bits (358), Expect = 3e-39
 Identities = 72/226 (31%), Positives = 120/226 (53%), Gaps = 22/226 (9%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
           +E ++ L+ VG+G +  VY+ +      I A+K +R D   E    E + S    E ++L
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA--ED---EGIPSTAIREISLL 73

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVN---GGHLFFQLYRQGLFREDLARIYTAEIVS 261
            ++ HP IV L     ++  L LV +F+       L      +   ++   +IY  +++ 
Sbjct: 74  KELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVL---DENKTGLQDSQIKIYLYQLLR 130

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS-MCGTLEYMSPEI 320
            V+H H + I+HRDLKP+N+L+++DG + L DFGLA+ F    RS +    TL Y +P++
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190

Query: 321 VLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK 363
           ++G K +  + D WS+G +  EM+TG+P F G       Q  KI  
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG--VTDDDQLPKIFS 234

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  141 bits (357), Expect = 4e-39
 Identities = 53/225 (23%), Positives = 100/225 (44%), Gaps = 21/225 (9%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
            E  E+ +++G+G F +VY  R  G     A++++  ++  E     + K E     +  
Sbjct: 32  FEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAF-KREVMAYRQTR 87

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEIVSAVSHLH 267
           H  +V    +  +   L ++     G  L+  +    +    +  R    EIV  + +LH
Sbjct: 88  HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNSM---CGTLEYMSPEIV 321
           A GI+H+DLK +N+  D +G V++TDFGL           R + +    G L +++PEI+
Sbjct: 148 AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206

Query: 322 ---------LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKI 357
                          K +D +++G + +E+   + PF     + I
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI 251

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  142 bits (360), Expect = 4e-39
 Identities = 66/241 (27%), Positives = 101/241 (41%), Gaps = 33/241 (13%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ER 201
           C  +  +E L  +GQG F +V++ R   T +  A+K +  +   EK   E        E 
Sbjct: 13  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN--EK---EGFPITALREI 67

Query: 202 NILTKVDHPFIVQLR--------YSFQTKYRLYLVLDFVN---GGHLFFQLYRQGLFRED 250
            IL  + H  +V L            + K  +YLV DF      G L         F   
Sbjct: 68  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL---SNVLVKFTLS 124

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMC 310
             +     +++ + ++H N I+HRD+K  N+L+  DG + L DFGLA+ F     S    
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184

Query: 311 G-----TLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KII 362
                 TL Y  PE++LG + +    D W  G ++ EM T  P   G    +  Q   I 
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG--NTEQHQLALIS 242

Query: 363 K 363
           +
Sbjct: 243 Q 243

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  140 bits (356), Expect = 4e-39
 Identities = 66/226 (29%), Positives = 119/226 (52%), Gaps = 22/226 (9%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
           +E +  L+ +G+G +  VY+ +     E +A+K +R +K  E    E + S    E +IL
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEK--ED---EGIPSTTIREISIL 54

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVN---GGHLFFQLYRQGLFREDLARIYTAEIVS 261
            ++ H  IV+L     TK RL LV + ++      L      +G      A+ +  ++++
Sbjct: 55  KELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLN 111

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS-MCGTLEYMSPEI 320
            +++ H   ++HRDLKP+N+L++ +G + + DFGLA+ F    R  +    TL Y +P++
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171

Query: 321 VLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK 363
           ++G K +    D WSVG +  EM+ G P F G +  +  Q  +I +
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--EADQLMRIFR 215

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  140 bits (355), Expect = 5e-39
 Identities = 61/226 (26%), Positives = 113/226 (50%), Gaps = 20/226 (8%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
           ++ +E L+ +G+G +  V++ +   T EI A+K +R D   +    E + S    E  +L
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DD---EGVPSSALREICLL 55

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNG--GHLFFQLYRQGLFREDLARIYTAEIVSA 262
            ++ H  IV+L     +  +L LV +F +      F      G    ++ + +  +++  
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKG 113

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS-MCGTLEYMSPEIV 321
           +   H+  ++HRDLKP+N+L++ +G + L +FGLA+ F    R  S    TL Y  P+++
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

Query: 322 LG-KGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQ--KIIK 363
            G K +  + D WS G +  E+   G+P F G +     Q  +I +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFR 217

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  139 bits (352), Expect = 7e-39
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 16/215 (7%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-KNHAEYMKSERNILTKV 207
             +  + +++G G F KVY+   IG     A+K  R D   +     E ++ E  +   +
Sbjct: 6   FAELTLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAML 63

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I+ LR     +  L LV++F  GG L   L  + +  + L      +I   +++LH
Sbjct: 64  KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW-AVQIARGMNYLH 122

Query: 268 ANG---IMHRDLKPENILLDADGH--------VMLTDFGLAKQFDENTRSNSMCGTLEYM 316
                 I+HRDLK  NIL+             + +TDFGLA+++   T+  S  G   +M
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM-SAAGAYAWM 181

Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           +PE++      K +D WS G+LL+E+LTG+ PF G
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  140 bits (354), Expect = 1e-38
 Identities = 50/238 (21%), Positives = 102/238 (42%), Gaps = 20/238 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
            D    +V+G+G F +  +V    T E+  MK + +     +        E  ++  ++H
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ---RTFLKEVKVMRCLEH 66

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE-IVSAVSHLHA 268
           P +++         RL  + +++ GG L   +           R+  A+ I S +++LH+
Sbjct: 67  PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT---------------RSNSMCGTL 313
             I+HRDL   N L+  + +V++ DFGLA+   +                 +  ++ G  
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQKIIKDKIKLPA 370
            +M+PE++ G+ +D+  D +S GI+L E++           R       ++  +    
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC 244

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  140 bits (356), Expect = 3e-38
 Identities = 68/230 (29%), Positives = 115/230 (50%), Gaps = 33/230 (14%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +   KV+G G+F  V+Q + + + E+ A+K + +DK        +   E  I+  V HP 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEV-AIKKVLQDK-------RFKNRELQIMRIVKHPN 93

Query: 212 IVQLRYSFQT------KYRLYLVLDFVNGGHLFFQLYR--------QGLFREDLARIYTA 257
           +V L+  F +      +  L LVL++V        +YR        +      L ++Y  
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVPE-----TVYRASRHYAKLKQTMPMLLIKLYMY 148

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYM 316
           +++ +++++H+ GI HRD+KP+N+LLD    V+ L DFG AK       + S   +  Y 
Sbjct: 149 QLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR 208

Query: 317 SPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK 363
           +PE++ G   +    D WS G ++ E++ GQP F G     I Q  +IIK
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG--ESGIDQLVEIIK 256

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  133 bits (337), Expect = 3e-36
 Identities = 50/226 (22%), Positives = 93/226 (41%), Gaps = 33/226 (14%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI--LTKV 207
              ++L+V  +G F  V++ + +   E  A+K      I      +  ++E  +  L  +
Sbjct: 24  MPLQLLEVKARGRFGCVWKAQLLN--EYVAVK------IFPIQDKQSWQNEYEVYSLPGM 75

Query: 208 DHPFIVQL----RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
            H  I+Q     +        L+L+  F   G L   L    +   +L  I    +   +
Sbjct: 76  KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAE-TMARGL 134

Query: 264 SHLHAN----------GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM---C 310
           ++LH +           I HRD+K +N+LL  +    + DFGLA +F+    +       
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV 194

Query: 311 GTLEYMSPE-----IVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           GT  YM+PE     I   +      D +++G++L+E+ +      G
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  131 bits (331), Expect = 3e-35
 Identities = 58/243 (23%), Positives = 98/243 (40%), Gaps = 34/243 (13%)

Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           LP   Q    +  +++K +G+G + +V+  +  G  E  A+KV                 
Sbjct: 27  LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRG--EKVAVKVFFTT------EEASWFR 78

Query: 200 ERNI--LTKVDHPFIVQL----RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
           E  I     + H  I+           +  +LYL+ D+   G L+  L    L  + + +
Sbjct: 79  ETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLK 138

Query: 254 IYTAEIVSAVSHLHA--------NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR 305
           +     VS + HLH           I HRDLK +NIL+  +G   + D GLA +F  +T 
Sbjct: 139 L-AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197

Query: 306 -----SNSMCGTLEYMSPEIVLGKGH------DKAADWWSVGILLFEMLTGQPPFTGGNR 354
                 N+  GT  YM PE++    +         AD +S G++L+E+            
Sbjct: 198 EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257

Query: 355 QKI 357
            ++
Sbjct: 258 YQL 260

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  130 bits (329), Expect = 3e-35
 Identities = 56/233 (24%), Positives = 92/233 (39%), Gaps = 34/233 (14%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI--LTKV 207
            D  +L+ VG+G + +V++    G  E  A+K+            +    E  +     +
Sbjct: 8   RDITLLECVGKGRYGEVWRGSWQG--ENVAVKIFSSR------DEKSWFRETELYNTVML 59

Query: 208 DHPFIVQL----RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
            H  I+        S  +  +L+L+  +   G L+  L    L      RI    I S +
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRI-VLSIASGL 118

Query: 264 SHLHA--------NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-----RSNSMC 310
           +HLH           I HRDLK +NIL+  +G   + D GLA    ++T      +N   
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178

Query: 311 GTLEYMSPEIVLGK------GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKI 357
           GT  YM+PE++            K  D W+ G++L+E+             K 
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  132 bits (333), Expect = 1e-34
 Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 31/219 (14%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---- 207
           +EVLKV+G+G+F +V +       +  A+K++R +K            E  IL  +    
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF----HRQAAEEIRILEHLRKQD 154

Query: 208 --DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFR---EDLARIYTAEIVSA 262
             +   ++ +  +F   +R ++ + F       ++L ++  F+     L R +   I+  
Sbjct: 155 KDNTMNVIHMLENFT--FRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212

Query: 263 VSHLHANGIMHRDLKPENILLDADGH--VMLTDFGLAKQFDEN------TRSNSMCGTLE 314
           +  LH N I+H DLKPENILL   G   + + DFG +    +       +R         
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-------- 264

Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           Y +PE++LG  +    D WS+G +L E+LTG P   G +
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  130 bits (329), Expect = 1e-34
 Identities = 63/237 (26%), Positives = 111/237 (46%), Gaps = 34/237 (14%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ F+V ++ GQG F  V   +   T    A+K + +D        + M+     L  + 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ----DLAVLH 77

Query: 209 HPFIVQLRYSFQTKYR-------LYLVLDFVNGGHLFFQLYR---------QGLFREDLA 252
           HP IVQL+  F T          L +V+++V        L+R                L 
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-----TLHRCCRNYYRRQVAP-PPILI 131

Query: 253 RIYTAEIVSAVSHLHAN--GIMHRDLKPENILLD-ADGHVMLTDFGLAKQFDENTRSNSM 309
           +++  +++ ++  LH     + HRD+KP N+L++ ADG + L DFG AK+   +  + + 
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY 191

Query: 310 CGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK 363
             +  Y +PE++ G + +  A D WSVG +  EM+ G+P F G       Q  +I++
Sbjct: 192 ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRG--DNSAGQLHEIVR 246

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  129 bits (325), Expect = 3e-34
 Identities = 58/243 (23%), Positives = 96/243 (39%), Gaps = 34/243 (13%)

Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           LP   Q        + + +G+G F +V++ +  G  E  A+K+                 
Sbjct: 32  LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRG--EEVAVKIFSSR------EERSWFR 83

Query: 200 ERNI--LTKVDHPFIVQL----RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
           E  I     + H  I+           T  +L+LV D+   G LF  L R  +  E + +
Sbjct: 84  EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK 143

Query: 254 IYTAEIVSAVSHLHAN--------GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR 305
           +      S ++HLH           I HRDLK +NIL+  +G   + D GLA + D  T 
Sbjct: 144 L-ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202

Query: 306 -----SNSMCGTLEYMSPEIVLGKG------HDKAADWWSVGILLFEMLTGQPPFTGGNR 354
                 N   GT  YM+PE++            K AD +++G++ +E+            
Sbjct: 203 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262

Query: 355 QKI 357
            ++
Sbjct: 263 YQL 265

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  129 bits (325), Expect = 5e-34
 Identities = 60/259 (23%), Positives = 109/259 (42%), Gaps = 54/259 (20%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + + + K +G G+F  V +V  I + + +A+K     K++      Y   E +I+  +DH
Sbjct: 7   KKYSLGKTLGTGSFGIVCEVFDIESGKRFALK-----KVL--QDPRYKNRELDIMKVLDH 59

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFR--------------------- 248
             I++L   F T              H        G+                       
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 249 --EDLARI------------------YTAEIVSAVSHLHANGIMHRDLKPENILLDADGH 288
             + L ++                  Y  ++  AV  +H+ GI HRD+KP+N+L+++  +
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179

Query: 289 VM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQ 346
            + L DFG AK+   +  S +   +  Y +PE++LG      + D WS+G +  E++ G+
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

Query: 347 PPFTGGNRQKIQQ--KIIK 363
           P F+G     I Q  +II+
Sbjct: 240 PLFSG--ETSIDQLVRIIQ 256

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  128 bits (324), Expect = 1e-33
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 27/227 (11%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRR--IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
              L ++E  KV G+G +  VY+ +R      + YA+K +    I      E       +
Sbjct: 18  VEDLFEYEGCKV-GRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIA-----L 71

Query: 204 LTKVDHPFIVQLR--YSFQTKYRLYLVLDFV--------NGGHLFFQLYRQGLFREDLAR 253
           L ++ HP ++ L+  +      +++L+ D+                   +       + +
Sbjct: 72  LRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131

Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDAD----GHVMLTDFGLAKQFDENTRSNSM 309
               +I+  + +LHAN ++HRDLKP NIL+  +    G V + D G A+ F+   +  + 
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191

Query: 310 CG----TLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTG 351
                 T  Y +PE++LG  H  KA D W++G +  E+LT +P F  
Sbjct: 192 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  125 bits (316), Expect = 3e-33
 Identities = 50/231 (21%), Positives = 100/231 (43%), Gaps = 45/231 (19%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGT--SEIYAMKVMRKDKIMEKNHAEYMKSERNI--L 204
           L++ ++L+++G+G +  VY+    G+      A+KV          + +   +E+NI  +
Sbjct: 12  LDNLKLLELIGRGRYGAVYK----GSLDERPVAVKVFSF------ANRQNFINEKNIYRV 61

Query: 205 TKVDHPFIVQL-----RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
             ++H  I +      R +   +    LV+++   G L   L           R+    +
Sbjct: 62  PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-AHSV 120

Query: 260 VSAVSHLHA---------NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR----- 305
              +++LH            I HRDL   N+L+  DG  +++DFGL+ +   N       
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180

Query: 306 ----SNSMCGTLEYMSPEIVLG-------KGHDKAADWWSVGILLFEMLTG 345
               + S  GT+ YM+PE++ G       +   K  D +++G++ +E+   
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  122 bits (308), Expect = 1e-31
 Identities = 56/223 (25%), Positives = 105/223 (47%), Gaps = 29/223 (13%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---- 207
           + +++ +G G F+ V+  + +  +   AMK++R DK+  +      + E  +L +V    
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA----EDEIKLLQRVNDAD 76

Query: 208 -------DHPFIVQLRYSFQTK--YRLYLVLDF-VNGGHLFFQL--YRQGLFREDLARIY 255
                      I++L   F  K    +++V+ F V G +L   +  Y          +  
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 136

Query: 256 TAEIVSAVSHLHAN-GIMHRDLKPENILLD------ADGHVMLTDFGLAKQFDENTRSNS 308
           + +++  + ++H   GI+H D+KPEN+L++          + + D G A  + +   +NS
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEHYTNS 195

Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           +  T EY SPE++LG      AD WS   L+FE++TG   F  
Sbjct: 196 IQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  119 bits (300), Expect = 2e-31
 Identities = 28/202 (13%), Positives = 62/202 (30%), Gaps = 28/202 (13%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           + +L   G     + +Q          A+  +    ++  +  +   S    L+++D P 
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           + ++     T+    +V +++ GG L  ++           R     + +A    H  G+
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQ-EVADTSPSPVGAIRA-MQSLAAAADAAHRAGV 150

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAAD 331
                 P  + +  DG V+L                        M          +   D
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA-------------------TMPDA-------NPQDD 184

Query: 332 WWSVGILLFEMLTGQPPFTGGN 353
              +G  L+ +L  + P     
Sbjct: 185 IRGIGASLYALLVNRWPLPEAG 206

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  120 bits (302), Expect = 4e-31
 Identities = 56/205 (27%), Positives = 106/205 (51%), Gaps = 14/205 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-D 208
           +D+++++ +G+G +++V++   I  +E   +K+++  K       + +K E  IL  +  
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRG 89

Query: 209 HPFIVQLRYSFQ--TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
            P I+ L    +        LV + VN    F QLY+     +   R Y  EI+ A+ + 
Sbjct: 90  GPNIITLADIVKDPVSRTPALVFEHVNNT-DFKQLYQT--LTDYDIRFYMYEILKALDYC 146

Query: 267 HANGIMHRDLKPENILLD-ADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG-K 324
           H+ GIMHRD+KP N+++D     + L D+GLA+ +      N    +  +  PE+++  +
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206

Query: 325 GHDKAADWWSVGILLFEMLTGQPPF 349
            +D + D WS+G +L  M+  + PF
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPF 231

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  120 bits (302), Expect = 1e-30
 Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 33/221 (14%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---- 207
           +E+  ++G+G+F +V +       E  A+K+++  K          + E  +L  +    
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF----LNQAQIEVRLLELMNKHD 111

Query: 208 --DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFR---EDLARIYTAEIVSA 262
                +IV L+  F   +R +L L F    +  + L R   FR    +L R +  ++ +A
Sbjct: 112 TEMKYYIVHLKRHFM--FRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169

Query: 263 VSHLHAN--GIMHRDLKPENILLDADGH--VMLTDFGLAKQFDEN------TRSNSMCGT 312
           +  L      I+H DLKPENILL       + + DFG + Q  +       +R       
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF------ 223

Query: 313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
             Y SPE++LG  +D A D WS+G +L EM TG+P F+G N
Sbjct: 224 --YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  120 bits (302), Expect = 2e-30
 Identities = 61/248 (24%), Positives = 111/248 (44%), Gaps = 24/248 (9%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNIL 204
           L+ ++ LK +G GA   V            A+K     K+      + HA+    E  ++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK-----KLSRPFQNQTHAKRAYRELVLM 115

Query: 205 TKVDHPFIVQLRYSFQTKYR------LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
             V+H  I+ L   F  +        +YLV++ +       Q+ +  L   +       +
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMEL-DHERMSYLLYQ 172

Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           ++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +P
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 232

Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP-----AFLS 373
           E++LG G+ +  D WSVG ++ EM+  +  F G +    Q   + +++  P       L 
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKKLQ 291

Query: 374 SEAHSLLK 381
               + ++
Sbjct: 292 PTVRNYVE 299

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  115 bits (291), Expect = 3e-29
 Identities = 61/249 (24%), Positives = 112/249 (44%), Gaps = 26/249 (10%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNIL 204
           L+ ++ LK +G GA   V            A+K     K+      + HA+    E  ++
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK-----KLSRPFQNQTHAKRAYRELVLM 78

Query: 205 TKVDHPFIVQLRYSFQTKYR------LYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTA 257
             V+H  I+ L   F  +        +Y+V++ ++       Q+ +  L   +       
Sbjct: 79  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLC---QVIQMEL-DHERMSYLLY 134

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMS 317
           +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194

Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP-----AFL 372
           PE++LG G+ +  D WSVG ++ EM+ G   F G +    Q   + +++  P       L
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMKKL 253

Query: 373 SSEAHSLLK 381
                + ++
Sbjct: 254 QPTVRTYVE 262

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  114 bits (287), Expect = 9e-29
 Identities = 50/239 (20%), Positives = 84/239 (35%), Gaps = 53/239 (22%)

Query: 152 FEVLKVVGQGAFAKVYQVR-RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV--- 207
           +E++  +G+G F KV +           A+K++R          E  + E N+L K+   
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKY----REAARLEINVLKKIKEK 76

Query: 208 ---DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF--FQLYRQGL-----------FREDL 251
              +    V +   F   +           GH+   F+L  +             +    
Sbjct: 77  DKENKFLCVLMSDWFN--FH----------GHMCIAFELLGKNTFEFLKENNFQPYPLPH 124

Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN---- 307
            R    ++  A+  LH N + H DLKPENIL        L +   + +      ++    
Sbjct: 125 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184

Query: 308 ---SMCGTLEYM----------SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
              S     E+            PE++L  G  +  D WS+G +LFE   G   F    
Sbjct: 185 DFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  114 bits (287), Expect = 9e-29
 Identities = 63/251 (25%), Positives = 94/251 (37%), Gaps = 73/251 (29%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---- 207
           F V++ +G G F +V   + I   + YA+KV+R  K          K E +IL K+    
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY----TRSAKIEADILKKIQNDD 92

Query: 208 -DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF--FQLYRQGL-----------FREDLAR 253
            ++  IV+    F   Y            H+   F+     L           F  +  +
Sbjct: 93  INNNNIVKYHGKFM--YY----------DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIK 140

Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLT--------------------- 292
           +Y  EI+ A+++L    + H DLKPENILLD                             
Sbjct: 141 LYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200

Query: 293 ----DFGLAKQFDEN------TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEM 342
               DFG A    +       TR         Y +PE++L  G D ++D WS G +L E+
Sbjct: 201 IKLIDFGCATFKSDYHGSIINTRQ--------YRAPEVILNLGWDVSSDMWSFGCVLAEL 252

Query: 343 LTGQPPFTGGN 353
            TG   F    
Sbjct: 253 YTGSLLFRTHE 263

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  112 bits (283), Expect = 2e-28
 Identities = 53/239 (22%), Positives = 88/239 (36%), Gaps = 53/239 (22%)

Query: 152 FEVLKVVGQGAFAKVYQVR-RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV--- 207
           +E++  +G+GAF KV +           A+K+++          E  +SE  +L  +   
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRY----CEAARSEIQVLEHLNTT 71

Query: 208 ---DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF--FQLYRQGL-----------FREDL 251
                   VQ+   F+  +           GH+   F+L                FR D 
Sbjct: 72  DPNSTFRCVQMLEWFE--HH----------GHICIVFELLGLSTYDFIKENGFLPFRLDH 119

Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN---- 307
            R    +I  +V+ LH+N + H DLKPENIL     +    +  + +        +    
Sbjct: 120 IRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179

Query: 308 ---SMCGTLEYMS----------PEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
              S     E+ S          PE++L  G  +  D WS+G +L E   G   F   +
Sbjct: 180 DFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  109 bits (275), Expect = 4e-27
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 29/229 (12%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNILT 205
           + +     VG GA+  V       + E  A+K     K+      +  A+    E  +L 
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK-----KLSRPFQSEIFAKRAYRELLLLK 78

Query: 206 KVDHPFIVQLRYSFQTKYR------LYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAE 258
            + H  ++ L   F            YLV+ F+        ++       E+  +    +
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQ---KIMGLKF-SEEKIQYLVYQ 134

Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEY 315
           ++  + ++H+ G++HRDLKP N+ ++ D  + + DFGLA+  D       M G   T  Y
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWY 189

Query: 316 MSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK 363
            +PE++L    +++  D WSVG ++ EMLTG+  F G +      +I+K
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 238

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  108 bits (271), Expect = 1e-26
 Identities = 59/238 (24%), Positives = 103/238 (43%), Gaps = 53/238 (22%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS---ERNILT 205
             DF++  ++G+GA+  V       T EI A+K     KI   +   +      E  IL 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK-----KIEPFDKPLFALRTLREIKILK 64

Query: 206 KVDHPFIVQLRYSFQTKYR-----LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
              H  I+ +    +         +Y++ +               L + DL R+ + +++
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQE---------------LMQTDLHRVISTQML 109

Query: 261 S-------------AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN 307
           S             AV  LH + ++HRDLKP N+L++++  + + DFGLA+  DE+   N
Sbjct: 110 SDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169

Query: 308 SMCGTLE-----------YMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           S     +           Y +PE++L    + +A D WS G +L E+   +P F G +
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  107 bits (269), Expect = 3e-26
 Identities = 60/230 (26%), Positives = 96/230 (41%), Gaps = 46/230 (20%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS---ERNILTK 206
             +  L  +G+GA+  V            A+K     KI    H  Y +    E  IL +
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-----KISPFEHQTYCQRTLREIKILLR 81

Query: 207 VDHPFIVQLRYSFQTKYR-----LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
             H  I+ +    +         +Y+V D               L   DL ++   + +S
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQD---------------LMETDLYKLLKTQHLS 126

Query: 262 -------------AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS 308
                         + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +     
Sbjct: 127 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186

Query: 309 M----CGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                  T  Y +PEI+L  KG+ K+ D WSVG +L EML+ +P F G +
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  106 bits (267), Expect = 6e-26
 Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 28/229 (12%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNILT 205
             +  L+ VG GA+  V       T    A+K     K+      +  A+    E  +L 
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK-----KLYRPFQSELFAKRAYRELRLLK 79

Query: 206 KVDHPFIVQLRYSFQTKYR------LYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAE 258
            + H  ++ L   F            YLV+ F+        +L +     ED  +    +
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLG---KLMKHEKLGEDRIQFLVYQ 136

Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEY 315
           ++  + ++HA GI+HRDLKP N+ ++ D  + + DFGLA+Q D     + M G   T  Y
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-----SEMTGYVVTRWY 191

Query: 316 MSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK 363
            +PE++L    + +  D WSVG ++ EM+TG+  F G +     ++I+K
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 240

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  104 bits (262), Expect = 3e-25
 Identities = 50/228 (21%), Positives = 84/228 (36%), Gaps = 35/228 (15%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS---------- 199
             + V + +  G++  V            A+K     ++          +          
Sbjct: 22  SPYTVQRFISSGSYGAVCAGVD-SEGIPVAIK-----RVFNTVSDGRTVNILSDSFLCKR 75

Query: 200 ---ERNILTKVDHPFIVQLRYSFQTKYR-----LYLVLDFVNGGHLFFQLYR-----QGL 246
              E  +L    HP I+ LR  F          LYLV + +        L +     + +
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-----TDLAQVIHDQRIV 130

Query: 247 FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS 306
                 + +   I+  +  LH  G++HRDL P NILL  +  + + DF LA++   +   
Sbjct: 131 ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190

Query: 307 NSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                   Y +PE+V+  KG  K  D WS G ++ EM   +  F G  
Sbjct: 191 THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  103 bits (259), Expect = 4e-25
 Identities = 55/228 (24%), Positives = 101/228 (44%), Gaps = 31/228 (13%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN--HAEYMKSERNILTK 206
              +  LK +G G    V+        +  A+K     KI+  +    ++   E  I+ +
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK-----KIVLTDPQSVKHALREIKIIRR 64

Query: 207 VDHPFIVQLR--------------YSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDL 251
           +DH  IV++                S      +Y+V +++         +  QG   E+ 
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLA---NVLEQGPLLEEH 121

Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHVMLTDFGLAKQFDENTRSNSM- 309
           AR++  +++  + ++H+  ++HRDLKP N+ ++  D  + + DFGLA+  D +       
Sbjct: 122 ARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181

Query: 310 ---CGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                T  Y SP ++L    + KA D W+ G +  EMLTG+  F G +
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  103 bits (258), Expect = 6e-25
 Identities = 54/222 (24%), Positives = 108/222 (48%), Gaps = 14/222 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQ---VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILT 205
            +F+ +KV+G GAF  VY+   +      +I  A+K + ++    K + E +  E  ++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DEAYVMA 72

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAV 263
            VD+P + +L         + L+   +  G L  + + ++  +  + L   +  +I   +
Sbjct: 73  SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKGM 130

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT---LEYMSPEI 320
           ++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E 
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190

Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKI 361
           +L + +   +D WS G+ ++E++T G  P+ G    +I   +
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  103 bits (258), Expect = 1e-24
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 26/216 (12%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNILTKV 207
           ++ L  VG GA+  V       T    A+K     K+        HA+    E  +L  +
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVK-----KLSRPFQSIIHAKRTYRELRLLKHM 85

Query: 208 DHPFIVQLRYSFQTKYR------LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            H  ++ L   F           +YLV   + G  L   +  Q L  +D  +    +I+ 
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKL-TDDHVQFLIYQILR 143

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSP 318
            + ++H+  I+HRDLKP N+ ++ D  + + DFGLA+   +      M G   T  Y +P
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAP 198

Query: 319 EIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           EI+L    +++  D WSVG ++ E+LTG+  F G +
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 98.1 bits (245), Expect = 1e-23
 Identities = 56/220 (25%), Positives = 109/220 (49%), Gaps = 15/220 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
           E  E+ + +G+G F  V+Q          +  A+K  +     +    +++  E   + +
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFL-QEALTMRQ 72

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVS 264
            DHP IV+L     T+  ++++++    G L  F Q+ +  L    L   Y  ++ +A++
Sbjct: 73  FDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL-YAYQLSTALA 130

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMSPE-IV 321
           +L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G L  ++M+PE I 
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 190

Query: 322 LGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
             +    A+D W  G+ ++E+L  G  PF G  N   I +
Sbjct: 191 FRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 229

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 54/222 (24%), Positives = 108/222 (48%), Gaps = 14/222 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQ---VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILT 205
            +F+ +KV+G GAF  VY+   +      +I  A+K + ++    K + E +  E  ++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DEAYVMA 72

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAV 263
            VD+P + +L         + L+   +  G L  + + ++  +  + L   +  +I   +
Sbjct: 73  SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKGM 130

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT---LEYMSPEI 320
           ++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E 
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190

Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKI 361
           +L + +   +D WS G+ ++E++T G  P+ G    +I   +
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  100 bits (251), Expect = 2e-23
 Identities = 56/220 (25%), Positives = 107/220 (48%), Gaps = 13/220 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E   +   +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSP----EAFLQEAQVMKKLRH 238

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR-QGLFREDLARIYTAEIVSAVSHL 266
             +VQL Y+  ++  +Y+V ++++ G L  F +    + L    L  +  A+I S ++++
Sbjct: 239 EKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM-AAQIASGMAYV 296

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY--MSPEIVLGK 324
                +HRDL+  NIL+  +    + DFGLA+  ++N  +            +PE  L  
Sbjct: 297 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 356

Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK 363
                +D WS GILL E+ T G+ P+ G   +++  ++ +
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 98.1 bits (245), Expect = 2e-23
 Identities = 56/231 (24%), Positives = 105/231 (45%), Gaps = 12/231 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQ---VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +D  +L+ +G G+F  V +       G +   A+K ++ D + +    +    E N +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVS 264
           +DH  +++L Y       + +V +    G L    + ++       L+R Y  ++   + 
Sbjct: 78  LDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR-YAVQVAEGMG 135

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAK--QFDENTRSNSMCGTLEY--MSPEI 320
           +L +   +HRDL   N+LL     V + DFGL +    +++         + +   +PE 
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195

Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKLPA 370
           +  +    A+D W  G+ L+EM T GQ P+ G N  +I  KI K+  +LP 
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 246

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 99.6 bits (248), Expect = 2e-23
 Identities = 54/271 (19%), Positives = 94/271 (34%), Gaps = 85/271 (31%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---- 207
           + V++ +G G F+ V+    I   +  AMKV++  +    ++ E    E  +L  V    
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSD 94

Query: 208 -DHP---FIVQLRYSFQTKYRLYLVLDFVNGGHL-------------FFQLYRQGLFRED 250
            + P    +VQL   F+        +  VNG H+             +            
Sbjct: 95  PNDPNREMVVQLLDDFK--------ISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLP 146

Query: 251 LARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDAD----------------------- 286
             +    +++  + +LH    I+H D+KPENILL  +                       
Sbjct: 147 CVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206

Query: 287 --------------------------GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
                                       V + D G A    ++   +    T +Y S E+
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ--TRQYRSLEV 264

Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           ++G G++  AD WS   + FE+ TG   F  
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGDYLFEP 295

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  101 bits (252), Expect = 3e-23
 Identities = 56/219 (25%), Positives = 110/219 (50%), Gaps = 13/219 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
           E  E+ + +G+G F  V+Q          +  A+K   K+   +    +++  E   + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFL-QEALTMRQ 447

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVS 264
            DHP IV+L     T+  ++++++    G L  F Q+ +  L    L   Y  ++ +A++
Sbjct: 448 FDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLIL-YAYQLSTALA 505

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMSPEIVL 322
           +L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G L  ++M+PE + 
Sbjct: 506 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 565

Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
            +    A+D W  G+ ++E+L  G  PF G  N   I +
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 604

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 97.3 bits (243), Expect = 3e-23
 Identities = 58/220 (26%), Positives = 108/220 (49%), Gaps = 15/220 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
           ED  + +++G+G F +VY+         +I  A+K  +KD     N  ++M  E  I+  
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMS-EAVIMKN 69

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVS 264
           +DHP IV+L      +   +++++    G L  + +  +  L    L   Y+ +I  A++
Sbjct: 70  LDHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVL-YSLQICKAMA 127

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMSPE-IV 321
           +L +   +HRD+   NIL+ +   V L DFGL++  ++     +    L  ++MSPE I 
Sbjct: 128 YLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN 187

Query: 322 LGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
             +    A+D W   + ++E+L+ G+ PF    N+  I  
Sbjct: 188 FRR-FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV 226

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 97.2 bits (243), Expect = 5e-23
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 30/210 (14%)

Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN--HAEYMKSERNILTKVDHPFIVQ 214
            +G+G F  VY+     T    A+K +     +       ++   E  ++ K  H  +V+
Sbjct: 38  KMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQF-DQEIKVMAKCQHENLVE 94

Query: 215 LR-YSFQTKYRLYLVLDFV-NG---GHLFFQLYRQGL-----FR--EDLARIYTAEIVSA 262
           L  +S        LV  ++ NG     L        L      +  +  A          
Sbjct: 95  LLGFSSDGDDLC-LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN--------G 145

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPE 319
           ++ LH N  +HRD+K  NILLD      ++DFGLA+  ++  +   ++ + GT  YM+PE
Sbjct: 146 INFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE 205

Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
            + G+   K +D +S G++L E++TG P  
Sbjct: 206 ALRGEITPK-SDIYSFGVVLLEIITGLPAV 234

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 99.2 bits (247), Expect = 8e-23
 Identities = 56/220 (25%), Positives = 107/220 (48%), Gaps = 13/220 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E   +   +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSP----EAFLQEAQVMKKLRH 321

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR-QGLFREDLARIYTAEIVSAVSHL 266
             +VQL Y+  ++  +Y+V ++++ G L  F +    + L    L  +  A+I S ++++
Sbjct: 322 EKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM-AAQIASGMAYV 379

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY--MSPEIVLGK 324
                +HRDL+  NIL+  +    + DFGLA+  ++N  +            +PE  L  
Sbjct: 380 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 439

Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK 363
                +D WS GILL E+ T G+ P+ G   +++  ++ +
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 97.1 bits (242), Expect = 8e-23
 Identities = 59/237 (24%), Positives = 103/237 (43%), Gaps = 26/237 (10%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-P 210
           F V K +G G F ++   + + T+E  A+K+        K+ A  +  E     ++    
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEP-----MKSRAPQLHLEYRFYKQLGSGD 65

Query: 211 FIVQLRYSFQTKYRLYLVLDFV--NGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            I Q+ Y         +VL+ +  +   LF    R   F      +   +++S + ++H+
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRT--FSLKTVLMIAIQLISRMEYVHS 123

Query: 269 NGIMHRDLKPENILLDADGH-----VMLTDFGLAKQF-DENTRS-------NSMCGTLEY 315
             +++RD+KPEN L+   G+     + + DF LAK++ D  T+         S+ GT  Y
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183

Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG---GNRQKIQQKIIKDKIKLP 369
           MS    LGK   +  D  ++G +    L G  P+ G      ++  QKI   K   P
Sbjct: 184 MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 98.7 bits (246), Expect = 9e-23
 Identities = 68/307 (22%), Positives = 130/307 (42%), Gaps = 27/307 (8%)

Query: 67  VYDQPAVIHSRSHSLVGPSSYVSQSLK---LSKLTLHEAEDSLGLVEGINEETQEGPNNL 123
           +  +  V H R ++      YVS   +   L++L  H +  + GL+             L
Sbjct: 145 LRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLI-----------TTL 193

Query: 124 SVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM 183
                   KPT +  +   +   +   D  +   +G G + +VY+      S   A+K +
Sbjct: 194 HYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL 253

Query: 184 RKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHLFFQL- 241
           ++D +      E    E  ++ ++ HP +VQL     T+    Y++ +F+  G+L   L 
Sbjct: 254 KEDTMEV----EEFLKEAAVMKEIKHPNLVQL-LGVCTREPPFYIITEFMTYGNLLDYLR 308

Query: 242 --YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ 299
              RQ +    L  +   +I SA+ +L     +HR+L   N L+  +  V + DFGL++ 
Sbjct: 309 ECNRQEVSAVVLLYM-ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL 367

Query: 300 FDENTRSNSMCGTLEY--MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQK 356
              +T +            +PE +        +D W+ G+LL+E+ T G  P+ G +  +
Sbjct: 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 427

Query: 357 IQQKIIK 363
           + + + K
Sbjct: 428 VYELLEK 434

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 97.7 bits (244), Expect = 9e-23
 Identities = 53/219 (24%), Positives = 105/219 (47%), Gaps = 14/219 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED  + + +G+G F +V+  R    + + A+K  R+        A++++ E  IL +  H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQ-EARILKQYSH 171

Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P IV+L     T+ + +Y+V++ V GG    F +     L  + L ++   +  + + +L
Sbjct: 172 PNIVRL-IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQM-VGDAAAGMEYL 229

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY----MSPEIVL 322
            +   +HRDL   N L+     + ++DFG++++  +     +  G  +      +PE + 
Sbjct: 230 ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV-YAASGGLRQVPVKWTAPEALN 288

Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
              +   +D WS GILL+E  + G  P+    N+Q  + 
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF 327

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 97.1 bits (242), Expect = 1e-22
 Identities = 69/251 (27%), Positives = 109/251 (43%), Gaps = 69/251 (27%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNIL 204
           L  +E++K +G+GA+  V++     T E+ A+K     KI +       A+    E  IL
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK-----KIFDAFQNSTDAQRTFREIMIL 62

Query: 205 TK-VDHPFIVQLR-----YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           T+   H  IV L       + +    +YLV D++                 DL  +  A 
Sbjct: 63  TELSGHENIVNLLNVLRADNDRD---VYLVFDYME---------------TDLHAVIRAN 104

Query: 259 IVS-------------AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR 305
           I+               + +LH+ G++HRD+KP NILL+A+ HV + DFGL++ F    R
Sbjct: 105 ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164

Query: 306 SNSMCGTLE----------------------YMSPEIVLG-KGHDKAADWWSVGILLFEM 342
             +                            Y +PEI+LG   + K  D WS+G +L E+
Sbjct: 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224

Query: 343 LTGQPPFTGGN 353
           L G+P F G +
Sbjct: 225 LCGKPIFPGSS 235

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 94.2 bits (235), Expect = 3e-22
 Identities = 47/217 (21%), Positives = 107/217 (49%), Gaps = 14/217 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
            +   ++ +G G F  V+    +   ++ A+K +R+   M +   ++++ E  ++ K+ H
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGA-MSE--EDFIE-EAEVMMKLSH 62

Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P +VQL Y    +   + LV +F+  G L  + +  R     E L  +   ++   +++L
Sbjct: 63  PKLVQL-YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM-CLDVCEGMAYL 120

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMSPEIVLGK 324
               ++HRDL   N L+  +  + ++DFG+ +   ++  ++S       ++ SPE+    
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 180

Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
            +   +D WS G+L++E+ + G+ P+    N + ++ 
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 217

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 97.2 bits (242), Expect = 3e-22
 Identities = 55/266 (20%), Positives = 103/266 (38%), Gaps = 60/266 (22%)

Query: 132 KPTGHIDNLPSENQCVGLEDFEV------LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
           +   H  + P+ +      D+++        ++G G++  V +        + A+K    
Sbjct: 29  QRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK---- 84

Query: 186 DKIME----KNHAEYMKSERNILTKVDHPFIVQLR-----YSFQTKYRLYLVLDFVNGGH 236
            KI+         + +  E  IL +++H  +V++         +    LY+VL+  +   
Sbjct: 85  -KILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-- 141

Query: 237 LFFQLYR-----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVML 291
                 +       L  E   +     ++  V ++H+ GI+HRDLKP N L++ D  V +
Sbjct: 142 ---DFKKLFRTPVYL-TELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKV 197

Query: 292 TDFGLAKQFDENTRSNSMCG----------------------------TLEYMSPEIVLG 323
            DFGLA+  D     NS                               T  Y +PE++L 
Sbjct: 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL 257

Query: 324 -KGHDKAADWWSVGILLFEMLTGQPP 348
            + + +A D WS+G +  E+L     
Sbjct: 258 QENYTEAIDVWSIGCIFAELLNMIKE 283

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 93.0 bits (232), Expect = 8e-22
 Identities = 51/217 (23%), Positives = 114/217 (52%), Gaps = 14/217 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E+  +LK +G G F  V   +  G  ++ A+K++++   M ++  E+ + E   + K+ H
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGS-MSED--EFFQ-EAQTMMKLSH 62

Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P +V+  Y   +K   +Y+V ++++ G L  + + + +GL    L  +   ++   ++ L
Sbjct: 63  PKLVKF-YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM-CYDVCEGMAFL 120

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMSPEIVLGK 324
            ++  +HRDL   N L+D D  V ++DFG+ +   ++   +S+      ++ +PE+    
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYF 180

Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
            +   +D W+ GIL++E+ + G+ P+    N + + +
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK 217

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 93.6 bits (233), Expect = 1e-21
 Identities = 47/239 (19%), Positives = 100/239 (41%), Gaps = 30/239 (12%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNILTKVDH 209
           ++V + +G+G+F  +++   +  ++  A+K        E   ++   ++ E      +  
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-------FEPRRSDAPQLRDEYRTYKLLAG 64

Query: 210 -PFIVQLRYSFQTKYRLYLVLDFV--NGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
              I  + Y  Q      LV+D +  +   L     R+  F      +   ++++ V  +
Sbjct: 65  CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSI 122

Query: 267 HANGIMHRDLKPENILLDADGH-----VMLTDFGLAKQF-DENTRS-------NSMCGTL 313
           H   +++RD+KP+N L+          + + DFG+ K + D  T+         ++ GT 
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182

Query: 314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG---GNRQKIQQKIIKDKIKLP 369
            YMS    LG+   +  D  ++G +    L G  P+ G      ++  ++I + K   P
Sbjct: 183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 95.2 bits (237), Expect = 1e-21
 Identities = 51/255 (20%), Positives = 98/255 (38%), Gaps = 67/255 (26%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM----EKNHAEYMKSERNIL 204
            +++ +  ++G+G++  VY      T +  A+K     K+     +    + +  E  IL
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK-----KVNRMFEDLIDCKRILREITIL 79

Query: 205 TKVDHPFIVQLR-----YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE- 258
            ++   +I++L              LY+VL+  +                DL +++    
Sbjct: 80  NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD---------------SDLKKLFKTPI 124

Query: 259 -------------IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR 305
                        ++   + +H +GI+HRDLKP N LL+ D  V + DFGLA+  +    
Sbjct: 125 FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184

Query: 306 SNSMCGTLE-----------------------YMSPEIVLG-KGHDKAADWWSVGILLFE 341
           +N +    E                       Y +PE++L  + + K+ D WS G +  E
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAE 244

Query: 342 MLTGQPPFTGGNRQK 356
           +L            +
Sbjct: 245 LLNMLQSHINDPTNR 259

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 92.7 bits (231), Expect = 1e-21
 Identities = 46/214 (21%), Positives = 100/214 (46%), Gaps = 11/214 (5%)

Query: 156 KVVGQGAFAKVYQ--VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIV 213
           K +G G F  V +   +     +  A+K+++ +   +    + + +E N++ ++D+P+IV
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE-ANDPALKDELLAEANVMQQLDNPYIV 81

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
           ++           LV++    G L  +    + +  +++      ++   + +L  +  +
Sbjct: 82  RM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE-LVHQVSMGMKYLEESNFV 139

Query: 273 HRDLKPENILLDADGHVMLTDFGLAK--QFDENTRSNSMCGTL--EYMSPEIVLGKGHDK 328
           HRDL   N+LL    +  ++DFGL+K  + DEN       G    ++ +PE +       
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 199

Query: 329 AADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKI 361
            +D WS G+L++E  + GQ P+ G    ++   +
Sbjct: 200 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 92.7 bits (231), Expect = 1e-21
 Identities = 50/217 (23%), Positives = 112/217 (51%), Gaps = 14/217 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D   LK +G G F  V   +  G  ++ A+K++++   M ++  E+++ E  ++  + H
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGS-MSED--EFIE-EAKVMMNLSH 78

Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             +VQL Y   TK R ++++ +++  G L  + +  R     + L  +   ++  A+ +L
Sbjct: 79  EKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYL 136

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMSPEIVLGK 324
            +   +HRDL   N L++  G V ++DFGL++   ++  ++S+       +  PE+++  
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 196

Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
                +D W+ G+L++E+ + G+ P+    N +  + 
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 233

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 14/217 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++ K +G G F +V+       +++ A+K M+   +  +       +E N++  + H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEA----FLAEANVMKTLQH 242

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY---RQGLFREDLARIYTAEIVSAVSHL 266
             +V+L ++  TK  +Y++ +F+  G L   L            L    +A+I   ++ +
Sbjct: 243 DKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF-SAQIAEGMAFI 300

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGK 324
                +HRDL+  NIL+ A     + DFGLA+  ++N  T        +++ +PE +   
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 360

Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
                +D WS GILL E++T G+ P+ G  N + I+ 
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA 397

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 92.8 bits (231), Expect = 2e-21
 Identities = 50/222 (22%), Positives = 100/222 (45%), Gaps = 14/222 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQ---VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILT 205
            +   LKV+G G F  V++   +    + +I   +KV+ +DK   ++           + 
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVT-DHMLAIG 70

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAV 263
            +DH  IV+L         L LV  ++  G L    + +R  L  + L   +  +I   +
Sbjct: 71  SLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLN-WGVQIAKGM 128

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT---LEYMSPEI 320
            +L  +G++HR+L   N+LL +   V + DFG+A     + +          +++M+ E 
Sbjct: 129 YYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188

Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKI 361
           +    +   +D WS G+ ++E++T G  P+ G    ++   +
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 92.0 bits (229), Expect = 3e-21
 Identities = 52/237 (21%), Positives = 100/237 (42%), Gaps = 28/237 (11%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNILTKVDH 209
           + + + +G G+F  +Y    I   E  A+K       +E    ++  +  E  I   +  
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-------LECVKTKHPQLHIESKIYKMMQG 63

Query: 210 -PFIVQLRYSFQTKYRLYLVLDFV--NGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
              I  +R+         +V++ +  +   LF    R+  F      +   +++S + ++
Sbjct: 64  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYI 121

Query: 267 HANGIMHRDLKPENILLDADGH---VMLTDFGLAKQF-DENTRS-------NSMCGTLEY 315
           H+   +HRD+KP+N L+        V + DFGLAK++ D  T          ++ GT  Y
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181

Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG---GNRQKIQQKIIKDKIKLP 369
            S    LG    +  D  S+G +L     G  P+ G     +++  ++I + K+  P
Sbjct: 182 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 92.8 bits (231), Expect = 3e-21
 Identities = 50/222 (22%), Positives = 105/222 (47%), Gaps = 15/222 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKV---MRKDKIMEKNHAEYMKSERNILTK 206
                 KV+G G F +VY+     +S    + V     K    EK   +++  E  I+ +
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG-EAGIMGQ 102

Query: 207 VDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAV 263
             H  I++L     +KY+ + ++ +++  G L  F +          L  +    I + +
Sbjct: 103 FSHHNIIRL-EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM-LRGIAAGM 160

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS--NSMCGTL--EYMSPE 319
            +L     +HRDL   NIL++++    ++DFGL++  +++  +   +  G +   + +PE
Sbjct: 161 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220

Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
            +  +    A+D WS GI+++E++T G+ P+    N + ++ 
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA 262

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 92.3 bits (230), Expect = 3e-21
 Identities = 60/209 (28%), Positives = 106/209 (50%), Gaps = 19/209 (9%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           +F+   ++G G F KVY+      +++ A+K    +    +   E+ ++E   L+   HP
Sbjct: 40  NFDHKFLIGHGVFGKVYKGVLRDGAKV-ALKRRTPES--SQGIEEF-ETEIETLSFCRHP 95

Query: 211 FIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDL---ARIYTAEIVSA--VS 264
            +V L  +  +    + L+  ++  G+L   LY   L    +    R+    I +A  + 
Sbjct: 96  HLVSLIGFCDERNEMI-LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC-IGAARGLH 153

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIV 321
           +LH   I+HRD+K  NILLD +    +TDFG++K+  E  +   S  + GTL Y+ PE  
Sbjct: 154 YLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYF 213

Query: 322 LGKGH--DKAADWWSVGILLFEMLTGQPP 348
           + KG   +K +D +S G++LFE+L  +  
Sbjct: 214 I-KGRLTEK-SDVYSFGVVLFEVLCARSA 240

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 91.6 bits (228), Expect = 4e-21
 Identities = 52/224 (23%), Positives = 101/224 (45%), Gaps = 17/224 (7%)

Query: 153 EVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
              +V+G+G F  VY   +      +I+ A+K +          ++++ +E  I+    H
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFL-TEGIIMKDFSH 85

Query: 210 PFIVQLR-YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P ++ L     +++    +VL ++  G L  F +        +DL      ++   + +L
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAKGMKYL 144

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--RSNSMCGTL---EYMSPE-I 320
            +   +HRDL   N +LD    V + DFGLA+   +      ++  G     ++M+ E +
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204

Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK 363
              K     +D WS G+LL+E++T G PP+   N   I   +++
Sbjct: 205 QTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 91.2 bits (227), Expect = 5e-21
 Identities = 49/238 (20%), Positives = 96/238 (40%), Gaps = 43/238 (18%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIY-------AMKVMRKDKIMEKNHAEYMKSERN 202
           ED    + +GQG F K+++  R    +          +KV+ K      N++E      +
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAAS 64

Query: 203 ILTKVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEI 259
           +++K+ H  +V   Y          LV +FV  G L  + +  +  +       +   ++
Sbjct: 65  MMSKLSHKHLVLN-YGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV-AKQL 122

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGH--------VMLTDFGLAKQFDENTRSNSMCG 311
            +A+  L  N ++H ++  +NILL  +          + L+D G++              
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-------- 174

Query: 312 TLEY-------MSPE-IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
             +        + PE I   K  + A D WS G  L+E+ + G  P +   +++K+Q 
Sbjct: 175 --DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 91.6 bits (228), Expect = 6e-21
 Identities = 52/222 (23%), Positives = 108/222 (48%), Gaps = 16/222 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
               + K++G G   +V    +R  G  ++  A+K ++     E+   +++  E +I+ +
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLS-EASIMGQ 106

Query: 207 VDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAV 263
            DHP I++L     T+ R   +V +++  G L  F + +        L  +    + + +
Sbjct: 107 FDHPNIIRL-EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM-LRGVGAGM 164

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK--QFDENTRSNSMCGTL--EYMSPE 319
            +L   G +HRDL   N+L+D++    ++DFGL++  + D +    +  G +   + +PE
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE 224

Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
            +  +    A+D WS G++++E+L  G+ P+    NR  I  
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS 266

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 90.7 bits (226), Expect = 7e-21
 Identities = 53/217 (24%), Positives = 105/217 (48%), Gaps = 14/217 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++++ +G G F +V+     G +++ A+K +++   M     +   +E N++ ++ H
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGS-MSP---DAFLAEANLMKQLQH 67

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFR-EDLARIYTAEIVSAVSHL 266
             +V+L Y+  T+  +Y++ +++  G L  F +           L  +  A+I   ++ +
Sbjct: 68  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM-AAQIAEGMAFI 125

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY--MSPEIVLGK 324
                +HRDL+  NIL+       + DFGLA+  ++N  +            +PE +   
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185

Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
                +D WS GILL E++T G+ P+ G  N + IQ 
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 222

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 91.7 bits (228), Expect = 1e-20
 Identities = 58/222 (26%), Positives = 112/222 (50%), Gaps = 16/222 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
            +  + KVVG G F +V    ++     EI  A+K ++     EK   +++  E +I+ +
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLG-EASIMGQ 102

Query: 207 VDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAV 263
            DHP I++L     TK + + +V +++  G L  F + +        L  +    I S +
Sbjct: 103 FDHPNIIRL-EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM-LRGIASGM 160

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS--NSMCGTL--EYMSPE 319
            +L   G +HRDL   NIL++++    ++DFGL +  +++  +   +  G +   + SPE
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE 220

Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
            +  +    A+D WS GI+L+E+++ G+ P+    N+  I+ 
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA 262

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 93.1 bits (231), Expect = 1e-20
 Identities = 54/214 (25%), Positives = 103/214 (48%), Gaps = 14/214 (6%)

Query: 156 KVVGQGAFAKVYQ-VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIV 213
             +G G F  V Q V R+   +I  A+KV+++    + +  E M+ E  I+ ++D+P+IV
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMR-EAQIMHQLDNPYIV 399

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           +L         L LV++   GG L  F    R+ +   ++A     ++   + +L     
Sbjct: 400 RL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE-LLHQVSMGMKYLEEKNF 457

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAK--QFDENTRSNSMCGTL--EYMSPEIVLGKGHD 327
           +HR+L   N+LL    +  ++DFGL+K    D++  +    G    ++ +PE +  +   
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517

Query: 328 KAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
             +D WS G+ ++E L+ GQ P+      + +  
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF 551

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 50/233 (21%), Positives = 100/233 (42%), Gaps = 44/233 (18%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
           + F + +++G+G F  V +  +++   S +  A+K+++ D I   +  E++  E   + +
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL-REAACMKE 81

Query: 207 VDHPFIVQL------RYSFQTKYRLYLVLDFVNGGHL--FFQLYR-----QGLFREDLAR 253
            DHP + +L        +        ++L F+  G L  F    R       L  + L R
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141

Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL 313
               +I   + +L +   +HRDL   N +L  D  V + DFGL+++              
Sbjct: 142 F-MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG---------- 190

Query: 314 EY-------------MSPE-IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           +Y             ++ E +     +   +D W+ G+ ++E++T GQ P+ G
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAG 242

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 36/217 (16%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIG----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILT 205
              + L+ +G+G F  V   R       T E+ A+K ++     E++  ++ + E  IL 
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER-EIEILK 97

Query: 206 KVDHPFIVQLR--YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVS 261
            + H  IV+ +       +  L L+++++  G L  + Q +++ +    L + YT++I  
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICK 156

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY------ 315
            + +L     +HRDL   NIL++ +  V + DFGL K   ++          EY      
Sbjct: 157 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK---------EYYKVKEP 207

Query: 316 -------MSPE-IVLGKGHDKAADWWSVGILLFEMLT 344
                   +PE +   K    A+D WS G++L+E+ T
Sbjct: 208 GESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFT 243

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 55/221 (24%), Positives = 106/221 (47%), Gaps = 15/221 (6%)

Query: 150 EDFEVLKVV-GQGAFAKVYQ-VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
           ++  +  +  G G F  V Q V R+   +I  A+KV+++    + +  E M+ E  I+ +
Sbjct: 9   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMR-EAQIMHQ 66

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVS 264
           +D+P+IV+L         L LV++   GG L  F    R+ +   ++A     ++   + 
Sbjct: 67  LDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE-LLHQVSMGMK 124

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAK--QFDENTRSNSMCGTL--EYMSPEI 320
           +L     +HRDL   N+LL    +  ++DFGL+K    D++  +    G    ++ +PE 
Sbjct: 125 YLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 184

Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
           +  +     +D WS G+ ++E L+ GQ P+      + +  
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF 225

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 55/242 (22%), Positives = 100/242 (41%), Gaps = 35/242 (14%)

Query: 150 EDFEVLKVVGQGAFAKVYQ----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT 205
              + +  +G+G F  V           T  + A+K ++     ++   ++ + E  IL 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ--RDFQR-EIQILK 79

Query: 206 KVDHPFIVQLR-YSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVS 261
            +   FIV+ R  S+    + L LV++++  G L  F Q +R  L    L   Y+++I  
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL-YSSQICK 138

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY------ 315
            + +L +   +HRDL   NIL++++ HV + DFGLAK    +           Y      
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD--------YYVVREPG 190

Query: 316 ------MSPE-IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIK 367
                  +PE +       + +D WS G++L+E+ T      +            +D   
Sbjct: 191 QSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA 249

Query: 368 LP 369
           L 
Sbjct: 250 LS 251

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 89.3 bits (222), Expect = 3e-20
 Identities = 52/217 (23%), Positives = 100/217 (46%), Gaps = 36/217 (16%)

Query: 150 EDFEVLKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT 205
              + L+ +G+G F  V    Y   +  T E+ A+K ++     E++  ++ + E  IL 
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER-EIEILK 66

Query: 206 KVDHPFIVQLR--YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVS 261
            + H  IV+ +       +  L L+++++  G L  + Q +++ +    L + YT++I  
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICK 125

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY------ 315
            + +L     +HRDL   NIL++ +  V + DFGL K   ++          E+      
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK---------EFFKVKEP 176

Query: 316 -------MSPE-IVLGKGHDKAADWWSVGILLFEMLT 344
                   +PE +   K    A+D WS G++L+E+ T
Sbjct: 177 GESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFT 212

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 90.2 bits (224), Expect = 3e-20
 Identities = 46/245 (18%), Positives = 88/245 (35%), Gaps = 33/245 (13%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTS--------EIYAMKVMRKD-------KIMEKNHAEY 196
           +++     +     +Y+     T         + +++K+  KD          ++     
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103

Query: 197 MKSERNILTKVDHPFIVQLRYS--FQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLA 252
             ++   L       I         Q KYR +LVL  + G  L     +  + +  E   
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYR-FLVLPSL-GRSLQSALDVSPKHVLSERSV 161

Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD--GHVMLTDFGLAKQF-DENT----- 304
                 ++ A+  LH N  +H ++  ENI +D +    V L  +G A ++          
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV 221

Query: 305 --RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII 362
               +   G LE++S ++  G G  + +D  S+G  + + L G  P+T            
Sbjct: 222 EGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIM-- 279

Query: 363 KDKIK 367
           K K K
Sbjct: 280 KQKQK 284

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 88.9 bits (221), Expect = 4e-20
 Identities = 51/217 (23%), Positives = 94/217 (43%), Gaps = 35/217 (16%)

Query: 150 EDFEVLKVVGQGAFAKVYQ----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT 205
              + ++ +G+G F KV           T E  A+K + K +    + A+  K E  IL 
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKK-EIEILR 78

Query: 206 KVDHPFIVQLR--YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVS 261
            + H  IV+ +   +      + L+++F+  G L  +    +  +  +   + Y  +I  
Sbjct: 79  NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK-YAVQICK 137

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY------ 315
            + +L +   +HRDL   N+L++++  V + DFGL K  + +          EY      
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK---------EYYTVKDD 188

Query: 316 -------MSPE-IVLGKGHDKAADWWSVGILLFEMLT 344
                   +PE ++  K    A+D WS G+ L E+LT
Sbjct: 189 RDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLT 224

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 88.5 bits (220), Expect = 4e-20
 Identities = 52/217 (23%), Positives = 100/217 (46%), Gaps = 12/217 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
            D  +   +G G + +VY+      S   A+K +++D  ME    E++  E  ++ ++ H
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVE--EFL-KEAAVMKEIKH 68

Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P +VQL     T+    Y++ +F+  G+L  + +   +      +      +I SA+ +L
Sbjct: 69  PNLVQL-LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMSPEIVLGK 324
                +HRDL   N L+  +  V + DFGL++    +T +         ++ +PE +   
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 187

Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
                +D W+ G+LL+E+ T G  P+ G    Q  + 
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 224

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 88.8 bits (221), Expect = 5e-20
 Identities = 61/215 (28%), Positives = 112/215 (52%), Gaps = 24/215 (11%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++F    ++G+G F KVY+ R    + + A+K + K++  +    ++ ++E  +++   H
Sbjct: 30  DNFSNKNILGRGGFGKVYKGRLADGTLV-AVKRL-KEERTQGGELQF-QTEVEMISMAVH 86

Query: 210 PFIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDL---ARIYTAEIVSA--V 263
             +++LR +      RL LV  ++  G +   L  +   +  L    R   A + SA  +
Sbjct: 87  RNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPESQPPLDWPKRQRIA-LGSARGL 144

Query: 264 SHLH--AN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-----TRSNSMCGTLEY 315
           ++LH   +  I+HRD+K  NILLD +   ++ DFGLAK  D       T    + GT+ +
Sbjct: 145 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA---VRGTIGH 201

Query: 316 MSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           ++PE +  GK  +K  D +  G++L E++TGQ  F
Sbjct: 202 IAPEYLSTGKSSEK-TDVFGYGVMLLELITGQRAF 235

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 90.1 bits (223), Expect = 8e-20
 Identities = 57/237 (24%), Positives = 103/237 (43%), Gaps = 28/237 (11%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNILTKV-D 208
           F + + +G G+F ++Y    I T+E  A+K       +E    ++  +  E  I   +  
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-------LENVKTKHPQLLYESKIYRILQG 61

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFV--NGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
              I  +R+         LV+D +  +   LF    R+         +   ++++ V  +
Sbjct: 62  GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFV 119

Query: 267 HANGIMHRDLKPENILLDADGH---VMLTDFGLAKQF-DENTRS-------NSMCGTLEY 315
           H+   +HRD+KP+N L+        V + DFGLAK++ D +T          ++ GT  Y
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179

Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG---GNRQKIQQKIIKDKIKLP 369
            S    LG    +  D  S+G +L   L G  P+ G   G +++  +KI + K+   
Sbjct: 180 ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 48/223 (21%), Positives = 99/223 (44%), Gaps = 25/223 (11%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
               + K++G+G F  V +  +++   + +  A+K M+ D   ++   E++ SE   +  
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFL-SEAACMKD 92

Query: 207 VDHPFIVQL-----RYSFQTKYRLYLVLDFVNGGHL--FFQLYR-----QGLFREDLARI 254
             HP +++L       S Q   +  ++L F+  G L  +    R     + +  + L + 
Sbjct: 93  FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152

Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--RSNSMCGT 312
              +I   + +L     +HRDL   N +L  D  V + DFGL+K+       R       
Sbjct: 153 -MVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGR-IAK 210

Query: 313 L--EYMSPE-IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           +  ++++ E +     +   +D W+ G+ ++E+ T G  P+ G
Sbjct: 211 MPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPG 252

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 34/222 (15%)

Query: 150 EDFEVLKVVGQGAFAKVYQ----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT 205
              + ++ +G+G F KV          GT E+ A+K ++ D    ++ + + + E +IL 
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQ-EIDILR 88

Query: 206 KVDHPFIVQLR--YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
            + H  I++ +          L LV+++V  G L   L R  +    L  ++  +I   +
Sbjct: 89  TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-LLFAQQICEGM 147

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY-------- 315
           ++LHA   +HRDL   N+LLD D  V + DFGLAK   E           EY        
Sbjct: 148 AYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH---------EYYRVREDGD 198

Query: 316 -----MSPE-IVLGKGHDKAADWWSVGILLFEMLT-GQPPFT 350
                 +PE +   K    A+D WS G+ L+E+LT      +
Sbjct: 199 SPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQS 239

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 52/224 (23%), Positives = 100/224 (44%), Gaps = 17/224 (7%)

Query: 153 EVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
              +V+G+G F  VY   +      +I+ A+K +          ++++ +E  I+    H
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFL-TEGIIMKDFSH 149

Query: 210 PFIVQLR-YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P ++ L     +++    +VL ++  G L  F +        +DL      ++   +  L
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAKGMKFL 208

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT-----LEYMSPE-I 320
            +   +HRDL   N +LD    V + DFGLA+   +    +    T     +++M+ E +
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268

Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK 363
              K     +D WS G+LL+E++T G PP+   N   I   +++
Sbjct: 269 QTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 85.4 bits (212), Expect = 6e-19
 Identities = 46/225 (20%), Positives = 90/225 (40%), Gaps = 20/225 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
                 +V+G+G F  VY         + I  A+K +       +    ++  E  ++  
Sbjct: 21  VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFL-REGLLMRG 78

Query: 207 VDHPFIVQLRY--SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
           ++HP ++ L        +   +++L ++  G L  F +  ++    +DL      ++   
Sbjct: 79  LNHPNVLAL-IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF-GLQVARG 136

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTL---EYMS 317
           + +L     +HRDL   N +LD    V + DFGLA+   +                ++ +
Sbjct: 137 MEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196

Query: 318 PE-IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
            E +   +     +D WS G+LL+E+LT G PP+           
Sbjct: 197 LESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF 240

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 44/254 (17%), Positives = 93/254 (36%), Gaps = 34/254 (13%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSE---IYAMKVMRKD--------KIMEKNHAEYMKSE 200
           + + K +G G F  +Y        E    + +KV  ++        K  ++   +    +
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98

Query: 201 RNILTKVDHPFIVQLRYS-----FQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLAR 253
                ++D+  I     S         YR ++V++ + G  L           F++    
Sbjct: 99  WIERKQLDYLGIPLFYGSGLTEFKGRSYR-FMVMERL-GIDLQKISGQNGT--FKKSTVL 154

Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDAD--GHVMLTDFGLAKQF-DENTR----- 305
                ++  + ++H N  +H D+K  N+LL       V L D+GL+ ++           
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214

Query: 306 --SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK 363
                  GT+E+ S +   G    + +D   +G  +   L G+ P+    +  +  +  K
Sbjct: 215 NPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK 274

Query: 364 -DKIK-LPAFLSSE 375
            + +  LP  +   
Sbjct: 275 TNLLDELPQSVLKW 288

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 47/258 (18%), Positives = 90/258 (34%), Gaps = 59/258 (22%)

Query: 152 FEVLKVVGQGAFAKVYQVRR-----IGTSEIYAMKVMRKD--------KIMEKNHAEYMK 198
           ++V   +GQG F  +Y         +G+     +KV   D        K  ++       
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96

Query: 199 SERNILTKVDHPFIVQLRYS-----FQTKYRLYLVLD---------FVNGGHLF-----F 239
            +     K+ +  + +   S         YR ++++D         +      F      
Sbjct: 97  QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYR-FMIMDRFGSDLQKIYEANAKRFSRKTVL 155

Query: 240 QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD--GHVMLTDFGLA 297
           QL  +              I+  + ++H +  +H D+K  N+LL+      V L D+GLA
Sbjct: 156 QLSLR--------------ILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201

Query: 298 KQF-DENTRS-------NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
            ++  E               GT+E+ S +   G    +  D   +G  + + LTG  P+
Sbjct: 202 YRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW 261

Query: 350 TGGNRQKIQQKIIKDKIK 367
               +     +    KI+
Sbjct: 262 EDNLKDPKYVR--DSKIR 277

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 83.8 bits (208), Expect = 2e-18
 Identities = 55/219 (25%), Positives = 108/219 (49%), Gaps = 22/219 (10%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++ ++L+ +G+G F  V      G     A+K ++ D   +        +E +++T++ H
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQA-----FLAEASVMTQLRH 73

Query: 210 PFIVQLRYS--FQTKYRLYLVLDFVNGGHLFFQL---YRQGLFREDLARIYTAEIVSAVS 264
             +VQL      + K  LY+V +++  G L   L    R  L  + L +  + ++  A+ 
Sbjct: 74  SNLVQL-LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-SLDVCEAME 131

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMSPEIVL 322
           +L  N  +HRDL   N+L+  D    ++DFGL K  + ++  ++  G L  ++ +PE + 
Sbjct: 132 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDT--GKLPVKWTAPEALR 187

Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
            K     +D WS GILL+E+ + G+ P+     +  + +
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 226

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 85.1 bits (211), Expect = 3e-18
 Identities = 54/217 (24%), Positives = 108/217 (49%), Gaps = 18/217 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++ ++L+ +G+G F  V      G     A+K ++ D       A+   +E +++T++ H
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKND-----ATAQAFLAEASVMTQLRH 245

Query: 210 PFIVQLRY--SFQTKYRLYLVLDFVNGGHLFFQL---YRQGLFREDLARIYTAEIVSAVS 264
             +VQL      + K  LY+V +++  G L   L    R  L  + L +  + ++  A+ 
Sbjct: 246 SNLVQL-LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-SLDVCEAME 303

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGK 324
           +L  N  +HRDL   N+L+  D    ++DFGL K  + ++  ++    +++ +PE +  K
Sbjct: 304 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVKWTAPEALREK 361

Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
                +D WS GILL+E+ + G+ P+     +  + +
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 398

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 83.1 bits (206), Expect = 5e-18
 Identities = 50/224 (22%), Positives = 101/224 (45%), Gaps = 27/224 (12%)

Query: 150 EDFEVLKVVGQGAFAKVYQ-----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
           E   + + +GQG+F  VY+     V +       A+K    +    +   E++ +E +++
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK-TVNEAASMRERIEFL-NEASVM 82

Query: 205 TKVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYT----- 256
            + +   +V+L     ++ +   ++++ +  G L  + +  R  +    +    +     
Sbjct: 83  KEFNCHHVVRL-LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141

Query: 257 ---AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCG 311
               EI   +++L+AN  +HRDL   N ++  D  V + DFG+ +   E    R     G
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK-G 200

Query: 312 TL--EYMSPE-IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            L   +MSPE +  G      +D WS G++L+E+ T  + P+ G
Sbjct: 201 LLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQG 243

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 54/234 (23%), Positives = 104/234 (44%), Gaps = 30/234 (12%)

Query: 150 EDFEVLKVVGQGAFAKVYQ-----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
           ++  +++ +G GAF +VY+     +    +    A+K +  +   E++  +++  E  I+
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFL-MEALII 87

Query: 205 TKVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYR------QGLFREDLARIY 255
           +K +H  IV+       +    +++++ + GG L  F +  R        L   DL  + 
Sbjct: 88  SKFNHQNIVRC-IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV- 145

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLD--ADGHVM-LTDFGLAKQFDEN--TRSNSMC 310
             +I     +L  N  +HRD+   N LL     G V  + DFG+A+        R     
Sbjct: 146 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC- 204

Query: 311 GTL--EYMSPE-IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
             L  ++M PE  + G       D WS G+LL+E+ + G  P+    N++ ++ 
Sbjct: 205 AMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 257

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 63/264 (23%), Positives = 110/264 (41%), Gaps = 46/264 (17%)

Query: 138 DNLPSENQCVGL-----------EDFEVLKVVGQGAFAKVYQ-----VRRIGTSEIYAMK 181
           D LP +  C  L           +  ++ K +G+GAF +V +     + +  T    A+K
Sbjct: 4   DELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK 63

Query: 182 VMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRY--SFQTKYRLYLVLDFVNGGHL- 237
            M K+      H   M SE  IL  +  H  +V L      +    L ++++F   G+L 
Sbjct: 64  -MLKEGATHSEHRALM-SELKILIHIGHHLNVVNL-LGACTKPGGPLMVIVEFCKFGNLS 120

Query: 238 ----------------FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENI 281
                              LY+  L  E L    + ++   +  L +   +HRDL   NI
Sbjct: 121 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY-SFQVAKGMEFLASRKCIHRDLAARNI 179

Query: 282 LLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTL--EYMSPEIVLGKGHDKAADWWSVGIL 338
           LL     V + DFGLA+  + +          L  ++M+PE +  + +   +D WS G+L
Sbjct: 180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 239

Query: 339 LFEMLT-GQPPFTG--GNRQKIQQ 359
           L+E+ + G  P+ G   + +  ++
Sbjct: 240 LWEIFSLGASPYPGVKIDEEFCRR 263

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 78.2 bits (193), Expect = 4e-16
 Identities = 56/234 (23%), Positives = 104/234 (44%), Gaps = 30/234 (12%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY---AMKVMRKDKIMEKNHAEYMKSERNIL 204
           ++  +++ +G GAF +VY+  V  +         A+K +  +   E++  +++  E  I+
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFL-MEALII 128

Query: 205 TKVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYR------QGLFREDLARIY 255
           +K +H  IV+       +    +++L+ + GG L  F +  R        L   DL  + 
Sbjct: 129 SKFNHQNIVRC-IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV- 186

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLD--ADGHVM-LTDFGLAKQFDEN--TRSNSMC 310
             +I     +L  N  +HRD+   N LL     G V  + DFG+A+        R     
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC- 245

Query: 311 GTL--EYMSPE-IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
             L  ++M PE  + G       D WS G+LL+E+ + G  P+    N++ ++ 
Sbjct: 246 AMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 298

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 77.7 bits (192), Expect = 4e-16
 Identities = 54/225 (24%), Positives = 100/225 (44%), Gaps = 28/225 (12%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            D +   V+G+G F +V +  +++ G     A+K   K+   + +H ++   E  +L K+
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIK-RMKEYASKDDHRDFA-GELEVLCKL 82

Query: 208 -DHPFIVQLR-YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYT------- 256
             HP I+ L        Y LYL +++   G+L  F +  R        A   +       
Sbjct: 83  GHHPNIINLLGACEHRGY-LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141

Query: 257 -------AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM 309
                  A++   + +L     +HRDL   NIL+  +    + DFGL++  +   +    
Sbjct: 142 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM- 200

Query: 310 CGTL--EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            G L   +M+ E +    +   +D WS G+LL+E+++ G  P+ G
Sbjct: 201 -GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 244

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 56/246 (22%), Positives = 103/246 (41%), Gaps = 40/246 (16%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIG-TSEIYAMKV---MRKDKIMEKNHAEYMKSERNILT 205
           ++  + K +G+G F KV +              V   M K+        + + SE N+L 
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL-SEFNVLK 81

Query: 206 KVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYR------------------- 243
           +V+HP +++L Y   ++   L L++++   G L  F +  R                   
Sbjct: 82  QVNHPHVIKL-YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140

Query: 244 ----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ 299
               + L   DL      +I   + +L    ++HRDL   NIL+     + ++DFGL++ 
Sbjct: 141 HPDERALTMGDLISF-AWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199

Query: 300 FDENT--RSNSMCGTL--EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GN 353
             E       S  G +  ++M+ E +    +   +D WS G+LL+E++T G  P+ G   
Sbjct: 200 VYEEDSYVKRS-QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258

Query: 354 RQKIQQ 359
            +    
Sbjct: 259 ERLFNL 264

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 53/229 (23%), Positives = 95/229 (41%), Gaps = 32/229 (13%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIYAMKV---MRKDKIMEKNHAEYMKSERNIL 204
            + +  K +G GAF KV +     +G  +   +KV   M K           M SE  I+
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKED-AVLKVAVKMLKSTAHADEKEALM-SELKIM 103

Query: 205 TKVD-HPFIVQLRYSFQTKYR-LYLVLDFVNGGHL---------------FFQLYRQGLF 247
           + +  H  IV L     T    + ++ ++   G L                F +      
Sbjct: 104 SHLGQHENIVNL-LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162

Query: 248 REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---- 303
             DL    ++++   ++ L +   +HRD+   N+LL       + DFGLA+    +    
Sbjct: 163 TRDLLHF-SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221

Query: 304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            + N+    +++M+PE +    +   +D WS GILL+E+ + G  P+ G
Sbjct: 222 VKGNARL-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 55/234 (23%), Positives = 108/234 (46%), Gaps = 38/234 (16%)

Query: 150 EDFEVLKVVGQGAFAKVYQ---VRRIGTSEIYAMKV---MRKDKIMEKNHAEYMKSERNI 203
           +   + K +G+GAF +V     V         A+ V   M KD   EK+ ++ + SE  +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEM 93

Query: 204 LTKV-DHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYR---------------Q 244
           +  +  H  I+ L     T+   LY+++++ + G+L  + +  R               +
Sbjct: 94  MKMIGKHKNIINL-LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152

Query: 245 GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN- 303
            +  +DL    T ++   + +L +   +HRDL   N+L+  +  + + DFGLA+  +   
Sbjct: 153 QMTFKDLVSC-TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211

Query: 304 ---TRSNSMCGTL--EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                +N     L  ++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 212 YYKKTTNGR---LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 73.8 bits (182), Expect = 6e-15
 Identities = 54/241 (22%), Positives = 103/241 (42%), Gaps = 38/241 (15%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTS-EIYAMKV---MRKDKIMEKNHAEYMKSERNILT 205
                ++ +G+  F KVY+    G +       V     KDK       E+   E  +  
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR-HEAMLRA 67

Query: 206 KVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL-----------------FFQLYRQGLF 247
           ++ HP +V L     TK + L ++  + + G L                   +  +  L 
Sbjct: 68  RLQHPNVVCL-LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126

Query: 248 REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---- 303
             D   +  A+I + + +L ++ ++H+DL   N+L+    +V ++D GL ++        
Sbjct: 127 PPDFVHL-VAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185

Query: 304 TRSNSMCGTL--EYMSPE-IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQ 358
              NS+   L   +M+PE I+ GK     +D WS G++L+E+ + G  P+ G  N+  ++
Sbjct: 186 LLGNSL---LPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 241

Query: 359 Q 359
            
Sbjct: 242 M 242

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 73.8 bits (182), Expect = 6e-15
 Identities = 55/230 (23%), Positives = 86/230 (37%), Gaps = 30/230 (13%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIG-TSEIYAMKV---MRKDKIMEKNHAEYMKSERNILT 205
                 K +G GAF KV +    G      AM V   M K           M SE  +L+
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SELKVLS 81

Query: 206 KV-DHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL----------FFQLYRQGLFREDLAR 253
            + +H  IV L     T      ++ ++   G L          F          ED   
Sbjct: 82  YLGNHMNIVNL-LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 254 IYT--------AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENT 304
                       ++   ++ L +   +HRDL   NILL       + DFGLA+   +++ 
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 305 RSNSMCGTL--EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                   L  ++M+PE +    +   +D WS GI L+E+ + G  P+ G
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 74.7 bits (184), Expect = 6e-15
 Identities = 54/234 (23%), Positives = 107/234 (45%), Gaps = 38/234 (16%)

Query: 150 EDFEVLKVVGQGAFAKVYQ---VRRIGTSEIYAMKV---MRKDKIMEKNHAEYMKSERNI 203
           +   + K +G+G F +V     V         A+ V   M KD   EK+ ++ + SE  +
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEM 139

Query: 204 LTKV-DHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYR---------------Q 244
           +  +  H  I+ L     T+   LY+++++ + G+L  + +  R               +
Sbjct: 140 MKMIGKHKNIINL-LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198

Query: 245 GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN- 303
            +  +DL    T ++   + +L +   +HRDL   N+L+  +  + + DFGLA+  +   
Sbjct: 199 QMTFKDLVSC-TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257

Query: 304 ---TRSNSMCGTL--EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                +N     L  ++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 258 YYKKTTNGR---LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 308

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 53/241 (21%), Positives = 98/241 (40%), Gaps = 52/241 (21%)

Query: 150 EDFEVLKVVGQGAFAKVYQ---VRRIGTSEIYAMKV---MRKDKIMEKNHAEYMKSERNI 203
           +   + K +G+GAF +V     +           KV   M K    EK+ ++ + SE  +
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEM 127

Query: 204 LTKV-DHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL-----------------FFQLYRQ 244
           +  +  H  I+ L     T+   LY+++++ + G+L                       +
Sbjct: 128 MKMIGKHKNIINL-LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186

Query: 245 GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT 304
            L  +DL      ++   + +L +   +HRDL   N+L+  D  + + DFGLA+      
Sbjct: 187 QLSSKDLVSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI- 244

Query: 305 RSNSMCGTLEY-------------MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFT 350
                    +Y             M+PE +  + +   +D WS G+LL+E+ T G  P+ 
Sbjct: 245 ---------DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295

Query: 351 G 351
           G
Sbjct: 296 G 296

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 52/239 (21%), Positives = 98/239 (41%), Gaps = 36/239 (15%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY---AMKVMRKDKIMEKNHAEYMKSERNIL 204
            D  +   +G+GAF KV+      +   +     A+K +++     +   ++   E  +L
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ--DFQ-REAELL 97

Query: 205 TKVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL----------------FFQLYRQGLF 247
           T + H  IV+  +   T+ R L +V +++  G L                   +    L 
Sbjct: 98  TMLQHQHIVRF-FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156

Query: 248 REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TR 305
              L  +  +++ + + +L     +HRDL   N L+     V + DFG+++        R
Sbjct: 157 LGQLLAV-ASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 215

Query: 306 SNSMCGTL--EYMSPE-IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
                  L   +M PE I+  K     +D WS G++L+E+ T G+ P+    N + I  
Sbjct: 216 VGG-RTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 71.2 bits (175), Expect = 7e-14
 Identities = 48/241 (19%), Positives = 98/241 (40%), Gaps = 47/241 (19%)

Query: 150 EDFEVLKVVGQGAFAKVYQ-----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
            + E ++ +G+GAF +V+Q     +       + A+K M K++      A++   E  ++
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQ-REAALM 104

Query: 205 TKVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL-------------------------F 238
            + D+P IV+L        + + L+ +++  G L                          
Sbjct: 105 AEFDNPNIVKL-LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163

Query: 239 FQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK 298
                  L   +   I   ++ + +++L     +HRDL   N L+  +  V + DFGL++
Sbjct: 164 SSPGPPPLSCAEQLCI-ARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 222

Query: 299 QFDEN----TRSNSMCGTL--EYMSPE-IVLGKGHDKAADWWSVGILLFEMLT-GQPPFT 350
                       N     +   +M PE I   + +   +D W+ G++L+E+ + G  P+ 
Sbjct: 223 NIYSADYYKADGNDA---IPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYY 278

Query: 351 G 351
           G
Sbjct: 279 G 279

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 57/239 (23%), Positives = 99/239 (41%), Gaps = 35/239 (14%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGT-SEIYAMKV---MRKDKIMEKNHAEYMKSERNILT 205
            D  + + +G+GAF KV+             M V     KD  +     ++ + E  +LT
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQR-EAELLT 72

Query: 206 KVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYR---------------QGLF 247
            + H  IV+  Y        L +V +++  G L  F + +                  L 
Sbjct: 73  NLQHEHIVKF-YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131

Query: 248 REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TR 305
              +  I  ++I S + +L +   +HRDL   N L+ A+  V + DFG+++        R
Sbjct: 132 LSQMLHI-ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 190

Query: 306 SNSMCGTL--EYMSPE-IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
                  L   +M PE I+  K     +D WS G++L+E+ T G+ P+    N + I+ 
Sbjct: 191 VGG-HTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 247

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 69.9 bits (170), Expect = 2e-13
 Identities = 42/258 (16%), Positives = 79/258 (30%), Gaps = 60/258 (23%)

Query: 144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN-----HAEYMK 198
           + C+  E  +  + +G+G F +V+Q     T    A+K++  +     N       E + 
Sbjct: 14  SHCLPTEKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEIL 71

Query: 199 SERNILTKV---------DHP--------FIVQLRY----------------------SF 219
            E  I  ++                      VQ  Y                       F
Sbjct: 72  PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDF 131

Query: 220 QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKP 278
               +L++VL+F  GG    Q  R  L     A+    ++ ++++   A+    HRDL  
Sbjct: 132 FKDDQLFIVLEFEFGGIDLEQ-MRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHW 190

Query: 279 ENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGIL 338
            N+LL       L      K     +                V    +  +       ++
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGL------------QVSIIDYTLSRLERDGIVV 238

Query: 339 LFEMLTGQPPFTGGNRQK 356
             ++   +  FTG    +
Sbjct: 239 FCDVSMDEDLFTGDGDYQ 256

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 63/237 (26%), Positives = 99/237 (41%), Gaps = 39/237 (16%)

Query: 150 EDFEVLKVVGQGAFAKVYQ-----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
           E+ E  KV+G GAF KV       + + G S   A+K M K+K         M SE  ++
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK-MLKEKADSSEREALM-SELKMM 102

Query: 205 TKV-DHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYR----------------- 243
           T++  H  IV L     T    +YL+ ++   G L  + +  R                 
Sbjct: 103 TQLGSHENIVNL-LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161

Query: 244 -----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK 298
                  L  EDL      ++   +  L     +HRDL   N+L+     V + DFGLA+
Sbjct: 162 EEEDLNVLTFEDLLCF-AYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220

Query: 299 Q-FDENTRSNSMCGTL--EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               ++         L  ++M+PE +    +   +D WS GILL+E+ + G  P+ G
Sbjct: 221 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 60.3 bits (146), Expect = 3e-10
 Identities = 36/117 (30%), Positives = 58/117 (49%), Gaps = 5/117 (4%)

Query: 239 FQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK 298
             LY+  L  E L   Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+
Sbjct: 183 EDLYKDFLTLEHLIC-YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

Query: 299 QF---DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                 +  R       L++M+PE +  + +   +D WS G+LL+E+ + G  P+ G
Sbjct: 242 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 298

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 31/168 (18%), Positives = 59/168 (35%), Gaps = 13/168 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQ-----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
           +  ++ K +G+GAF +V +     + +  T    A+K M K+      H   M  E  IL
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKEGATHSEHRALMS-ELKIL 79

Query: 205 TKVD-HPFIVQ-LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
             +  H  +V  L    +    L ++++F   G+L   L      + +    Y  +    
Sbjct: 80  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS----KRNEFVPYKTKGARF 135

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMC 310
                  G +  DLK     + +      + F   K   +     +  
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE 183

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 31/153 (20%), Positives = 58/153 (37%), Gaps = 23/153 (15%)

Query: 158 VGQGAFAKVYQVRRIGTSEIY---AMKVMRKDKIMEKNHAEYMKSERNILTK-----VDH 209
           +G+GA A + +   +    I      K  R +++ E         E   L       +  
Sbjct: 344 IGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPA 403

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P+I  +           +++ ++NG         + +  ++L   Y  +I   V  LH N
Sbjct: 404 PYIFDV-----DLDNKRIMMSYINGKLA------KDVIEDNLDIAY--KIGEIVGKLHKN 450

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDE 302
            ++H DL   N +   D  + + DFGL K  + 
Sbjct: 451 DVIHNDLTTSNFIF--DKDLYIIDFGLGKISNL 481

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.6 bits (107), Expect = 2e-05
 Identities = 41/289 (14%), Positives = 84/289 (29%), Gaps = 86/289 (29%)

Query: 122 NLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMK 181
              V D      T HI     ++  + L   EV  +       K      +         
Sbjct: 274 FKQVTDFLSAATTTHI---SLDHHSMTLTPDEVKSL-----LLKY-----LD-------- 312

Query: 182 VMRKDKI---MEKNH-------AEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF 231
             R   +   +   +       AE ++          H    +L    ++      VL+ 
Sbjct: 313 -CRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLN---VLEP 368

Query: 232 VNGGHLFFQLYRQGLFRED-------LARIYTA----EIVSAVSHLHANGIMHRDLKPE- 279
                +F +L    +F          L+ I+      +++  V+ LH   ++ +  K   
Sbjct: 369 AEYRKMFDRL---SVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKEST 425

Query: 280 ----NILLDADGHV---------MLTDFGLAKQFDENTRS-----NSMCGTLEYMSPEIV 321
               +I L+    +         ++  + + K FD +              + +      
Sbjct: 426 ISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH------ 479

Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA 370
               H K  +     + LF M+     F   + + ++QKI  D     A
Sbjct: 480 ----HLKNIEH-PERMTLFRMV-----FL--DFRFLEQKIRHDSTAWNA 516

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	396
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.75
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.41
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.29
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.16
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.1
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.82
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.63
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.62
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.48
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.4
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.31
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.19
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.08
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.07
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.76
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.66
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.56
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.47
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.32
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.32
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.3
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.25
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.23
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.03
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.85
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.8
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.8
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.91
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.67
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	85.36

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.7e-65  Score=487.51  Aligned_cols=250  Identities=39%  Similarity=0.689  Sum_probs=235.4

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      ...++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|++++|||||+++++|+++..+|
T Consensus        29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y  108 (311)
T 4aw0_A           29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY  108 (311)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            34578999999999999999999999999999999998876656666778999999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC---
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---  303 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~---  303 (396)
                      ||||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+...   
T Consensus       109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999987533   


Q ss_pred             CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHh
Q 016037          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV  383 (396)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~  383 (396)
                      ....+.|||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+..++.++|.+..+.+|..+|+++++||++|
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~l  268 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKL  268 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHH
T ss_pred             ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHH
Confidence            33567899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCCC
Q 016037          384 NSLLSISVPLLSR  396 (396)
Q Consensus       384 l~~~p~~RPs~s~  396 (396)
                      |++||.+|||+.|
T Consensus       269 L~~dp~~R~t~~e  281 (311)
T 4aw0_A          269 LVLDATKRLGCEE  281 (311)
T ss_dssp             SCSSGGGSTTSGG
T ss_pred             ccCCHhHCcChHH
Confidence            9999999999753

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=6.8e-63  Score=466.30  Aligned_cols=246  Identities=29%  Similarity=0.513  Sum_probs=212.2

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|++++|||||+++++|.++..+|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            46899999999999999999999999999999999887665555667789999999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccc
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~  308 (396)
                      |||+ +|+|.+++.+++.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.........+
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~  170 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT  170 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCC
Confidence            9999 679999999999999999999999999999999999999999999999999999999999999998776666677


Q ss_pred             cccCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccC
Q 016037          309 MCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLL  387 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~  387 (396)
                      .+||+.|||||++.+..| +.++|||||||++|||+||+.||.+.+..++.+++..+.+.+|..+|+++++||++||++|
T Consensus       171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d  250 (275)
T 3hyh_A          171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVN  250 (275)
T ss_dssp             ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSS
T ss_pred             eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCC
Confidence            899999999999998876 5899999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCC
Q 016037          388 SISVPLLS  395 (396)
Q Consensus       388 p~~RPs~s  395 (396)
                      |.+|||+.
T Consensus       251 P~~R~s~~  258 (275)
T 3hyh_A          251 PLNRISIH  258 (275)
T ss_dssp             GGGSCCHH
T ss_pred             hhHCcCHH
Confidence            99999864

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.4e-62  Score=474.75  Aligned_cols=247  Identities=31%  Similarity=0.528  Sum_probs=220.9

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++.+..... ...+.+.+|+++|++++|||||+++++|++...+||
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi  100 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYI  100 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            4579999999999999999999999999999999998766543 446678899999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-
Q 016037          228 VLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-  304 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-  304 (396)
                      |||||+||+|.+++..+  ..+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+.... 
T Consensus       101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred             EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence            99999999999999754  357999999999999999999999999999999999999999999999999999875432 


Q ss_pred             CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHHHHh
Q 016037          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAHSLLKGV  383 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~-~~p~~~s~~~~~li~~~  383 (396)
                      .....+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+..++..+|..+.+ +++..+|+++++||++|
T Consensus       181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~  260 (350)
T 4b9d_A          181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQL  260 (350)
T ss_dssp             HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHH
T ss_pred             cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHH
Confidence            23457899999999999999999999999999999999999999999999999999998865 57789999999999999


Q ss_pred             hccCCCCCCCCC
Q 016037          384 NSLLSISVPLLS  395 (396)
Q Consensus       384 l~~~p~~RPs~s  395 (396)
                      |+.||.+|||+.
T Consensus       261 L~~dP~~R~s~~  272 (350)
T 4b9d_A          261 FKRNPRDRPSVN  272 (350)
T ss_dssp             TCSSGGGSCCHH
T ss_pred             ccCChhHCcCHH
Confidence            999999999864

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.8e-62  Score=466.64  Aligned_cols=247  Identities=48%  Similarity=0.850  Sum_probs=221.3

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEc---CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~  223 (396)
                      +..++|++++.||+|+||+||+|++.   .+++.||||++++....... ...+.+|+++|++++|||||+++++|++..
T Consensus        21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   99 (304)
T 3ubd_A           21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEG   99 (304)
T ss_dssp             CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETT
T ss_pred             CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            34568999999999999999999984   46889999999876543322 234678999999999999999999999999


Q ss_pred             eEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC-
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-  302 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~-  302 (396)
                      .+|||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.... 
T Consensus       100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999987543 


Q ss_pred             CCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHH
Q 016037          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG  382 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~  382 (396)
                      .....+.+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+..++..+|.+..+.+|..+|+++++||++
T Consensus       180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  259 (304)
T 3ubd_A          180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRM  259 (304)
T ss_dssp             -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence            34456789999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCC
Q 016037          383 VNSLLSISVPLL  394 (396)
Q Consensus       383 ~l~~~p~~RPs~  394 (396)
                      ||+.||.+|||.
T Consensus       260 ~L~~dP~~R~ta  271 (304)
T 3ubd_A          260 LFKRNPANRLGA  271 (304)
T ss_dssp             HTCSSGGGSTTC
T ss_pred             HcccCHHHCCCC
Confidence            999999999985

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.3e-61  Score=467.91  Aligned_cols=242  Identities=26%  Similarity=0.410  Sum_probs=221.5

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      +.|+++++||+|+||+||+|+++.+|+.||||++......   ..+.+.+|+.+|++++|||||+++++|.++..+||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            5699999999999999999999999999999999765432   2345778999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-CCccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNS  308 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-~~~~~  308 (396)
                      |||+||+|.+++.+ +.+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.+... ....+
T Consensus       151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  229 (346)
T 4fih_A          151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  229 (346)
T ss_dssp             CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence            99999999988865 67999999999999999999999999999999999999999999999999999987543 44567


Q ss_pred             cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---CCCCccCCHHHHHHHHHhhc
Q 016037          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLPAFLSSEAHSLLKGVNS  385 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~---~~~p~~~s~~~~~li~~~l~  385 (396)
                      .+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..++...|..+.   +..+..+|+++++||++||+
T Consensus       230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~  309 (346)
T 4fih_A          230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV  309 (346)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSC
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcC
Confidence            899999999999999999999999999999999999999999999999999998863   34456899999999999999


Q ss_pred             cCCCCCCCCC
Q 016037          386 LLSISVPLLS  395 (396)
Q Consensus       386 ~~p~~RPs~s  395 (396)
                      .||.+|||+.
T Consensus       310 ~dP~~R~ta~  319 (346)
T 4fih_A          310 RDPAQRATAA  319 (346)
T ss_dssp             SSTTTSCCHH
T ss_pred             CChhHCcCHH
Confidence            9999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.4e-60  Score=462.12  Aligned_cols=240  Identities=25%  Similarity=0.341  Sum_probs=218.5

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      ..+.|++.++||+|+||+||+|+++.+|+.||||+++....        ..+|+.+|+.++|||||+++++|.++..+||
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i  127 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNI  127 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45679999999999999999999999999999999987543        2469999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-cEEEEecccccccCCCC--
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HVMLTDFGLAKQFDENT--  304 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~-~ikL~Dfgla~~~~~~~--  304 (396)
                      |||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+|||++.+| ++||+|||+|+.+....  
T Consensus       128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            999999999999999999999999999999999999999999999999999999999988 69999999999875432  


Q ss_pred             ----CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCccCCHHHH
Q 016037          305 ----RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI---KLPAFLSSEAH  377 (396)
Q Consensus       305 ----~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~---~~p~~~s~~~~  377 (396)
                          .....+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+..++..+|..+..   .+|+.+|++++
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~  287 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA  287 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred             cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHH
Confidence                22346899999999999999999999999999999999999999999888888889988765   46789999999


Q ss_pred             HHHHHhhccCCCCCCCCC
Q 016037          378 SLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       378 ~li~~~l~~~p~~RPs~s  395 (396)
                      +||++||++||.+|||+.
T Consensus       288 ~li~~~L~~dP~~R~sa~  305 (336)
T 4g3f_A          288 QAIQEGLRKEPVHRASAM  305 (336)
T ss_dssp             HHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHccCCHhHCcCHH
Confidence            999999999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.9e-60  Score=469.53  Aligned_cols=242  Identities=26%  Similarity=0.410  Sum_probs=221.8

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      +.|+++++||+|+||+||+|+++.+|+.||||++......   ..+.+.+|+.+|+.++|||||+++++|.+...+||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence            5799999999999999999999999999999999865432   2345788999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-CCccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNS  308 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-~~~~~  308 (396)
                      |||+||+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.+... ....+
T Consensus       228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  306 (423)
T 4fie_A          228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  306 (423)
T ss_dssp             ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred             eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence            99999999988764 67999999999999999999999999999999999999999999999999999987543 44567


Q ss_pred             cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---CCCCccCCHHHHHHHHHhhc
Q 016037          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLPAFLSSEAHSLLKGVNS  385 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~---~~~p~~~s~~~~~li~~~l~  385 (396)
                      .+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+++..|..+.   +..+..+|+++++||++||+
T Consensus       307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~  386 (423)
T 4fie_A          307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV  386 (423)
T ss_dssp             CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSC
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcC
Confidence            899999999999999999999999999999999999999999999999999998873   34556899999999999999


Q ss_pred             cCCCCCCCCC
Q 016037          386 LLSISVPLLS  395 (396)
Q Consensus       386 ~~p~~RPs~s  395 (396)
                      .||.+|||+.
T Consensus       387 ~dP~~R~ta~  396 (423)
T 4fie_A          387 RDPAQRATAA  396 (423)
T ss_dssp             SSTTTSCCHH
T ss_pred             CChhHCcCHH
Confidence            9999999864

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.3e-60  Score=451.49  Aligned_cols=247  Identities=20%  Similarity=0.340  Sum_probs=221.1

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~  220 (396)
                      .+..++|.+.++||+|+||+||+|++..     ++..||||+++...   ....+.+.+|+++|++++|||||++++++.
T Consensus         9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~   85 (299)
T 4asz_A            9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCV   85 (299)
T ss_dssp             BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            3566789999999999999999999863     57889999997643   345567889999999999999999999999


Q ss_pred             ecCeEEEEEEecCCCcHHHHHHHhc-------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC
Q 016037          221 TKYRLYLVLDFVNGGHLFFQLYRQG-------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (396)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~~-------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~  287 (396)
                      ++..+|||||||++|+|.+++.+.+             .+++..+..++.||+.||.|||+++||||||||+|||++.++
T Consensus        86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence            9999999999999999999997653             689999999999999999999999999999999999999999


Q ss_pred             cEEEEecccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 016037          288 HVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK  363 (396)
Q Consensus       288 ~ikL~Dfgla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~  363 (396)
                      ++||+|||+|+.......   ....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..++...+..
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  245 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  245 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999987654332   234569999999999999999999999999999999999 9999999999999999988


Q ss_pred             C-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          364 D-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       364 ~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      + ++++|..+|+++.+||..||+.||.+|||++
T Consensus       246 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~  278 (299)
T 4asz_A          246 GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIK  278 (299)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCCCccchHHHHHHHHHHcCCChhHCcCHH
Confidence            7 4678999999999999999999999999975

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=7e-59  Score=450.45  Aligned_cols=247  Identities=20%  Similarity=0.325  Sum_probs=216.0

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~  220 (396)
                      .+..++|.+.++||+|+||+||+|+++.     +++.||||+++...   ....+.+.+|+++|++++|||||+++++|.
T Consensus        37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~  113 (329)
T 4aoj_A           37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVCT  113 (329)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            3566789999999999999999999864     68899999997643   345567889999999999999999999999


Q ss_pred             ecCeEEEEEEecCCCcHHHHHHHh---------------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC
Q 016037          221 TKYRLYLVLDFVNGGHLFFQLYRQ---------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA  285 (396)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~---------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~  285 (396)
                      +...+|||||||++|+|.+++.+.               +++++..+..++.||+.||.|||+++||||||||+|||++.
T Consensus       114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence            999999999999999999998754               35899999999999999999999999999999999999999


Q ss_pred             CCcEEEEecccccccCCCC---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 016037          286 DGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKI  361 (396)
Q Consensus       286 ~~~ikL~Dfgla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i  361 (396)
                      ++++||+|||+|+......   .....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..++...+
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  273 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI  273 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999998764332   2345679999999999999999999999999999999999 99999999999999999


Q ss_pred             HhC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          362 IKD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       362 ~~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ..+ ++++|..+++++.+||..||+.||.+|||++
T Consensus       274 ~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~  308 (329)
T 4aoj_A          274 TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIK  308 (329)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHH
T ss_pred             HcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHH
Confidence            886 6788999999999999999999999999975

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.5e-59  Score=442.54  Aligned_cols=241  Identities=24%  Similarity=0.389  Sum_probs=212.9

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe----cCeEEE
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT----KYRLYL  227 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~----~~~~~l  227 (396)
                      |++.++||+|+||+||+|+++.+++.||+|++...... ....+.+.+|+++|++++|||||+++++|.+    +..+||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence            47888999999999999999999999999999876543 3445678899999999999999999999975    356899


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEcC-CCcEEEEecccccccCCCC
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLDA-DGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~--iiHrDlkp~NILl~~-~~~ikL~Dfgla~~~~~~~  304 (396)
                      |||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++|  ||||||||+|||++. +|++||+|||+|+... ..
T Consensus       107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~-~~  185 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-AS  185 (290)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC-TT
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC-CC
Confidence            9999999999999999999999999999999999999999998  999999999999974 7999999999998643 34


Q ss_pred             CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCC--CCCccCCHHHHHHHH
Q 016037          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG-NRQKIQQKIIKDKI--KLPAFLSSEAHSLLK  381 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~-~~~~i~~~i~~~~~--~~p~~~s~~~~~li~  381 (396)
                      ...+.+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+. +...+.+.+..+..  .++..+++++++||+
T Consensus       186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  264 (290)
T 3fpq_A          186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE  264 (290)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHH
T ss_pred             ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHH
Confidence            4567799999999999876 5999999999999999999999999875 45666666666533  356778999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      +||+.||.+|||+.
T Consensus       265 ~~L~~dP~~R~s~~  278 (290)
T 3fpq_A          265 GCIRQNKDERYSIK  278 (290)
T ss_dssp             HHSCSSGGGSCCHH
T ss_pred             HHccCChhHCcCHH
Confidence            99999999999864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.3e-59  Score=446.32  Aligned_cols=247  Identities=19%  Similarity=0.324  Sum_probs=220.2

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEc-----CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~  221 (396)
                      +...+++++++||+|+||+||+|++.     .+++.||||+++...  .....+.+.+|+.+|++++|||||++++++.+
T Consensus        23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~  100 (308)
T 4gt4_A           23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK  100 (308)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence            55678999999999999999999975     367889999997543  22334668899999999999999999999999


Q ss_pred             cCeEEEEEEecCCCcHHHHHHHh----------------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC
Q 016037          222 KYRLYLVLDFVNGGHLFFQLYRQ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA  285 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~  285 (396)
                      ...+|||||||++|+|.+++..+                ..+++..+..++.||+.||+|||+++||||||||+|||++.
T Consensus       101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD  180 (308)
T ss_dssp             SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence            99999999999999999999753                35889999999999999999999999999999999999999


Q ss_pred             CCcEEEEecccccccCCCC---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 016037          286 DGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKI  361 (396)
Q Consensus       286 ~~~ikL~Dfgla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i  361 (396)
                      ++++||+|||+|+......   .....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..++...+
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i  260 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI  260 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH
T ss_pred             CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            9999999999998764332   3455689999999999999999999999999999999999 99999999999999998


Q ss_pred             HhC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          362 IKD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       362 ~~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ..+ +++.|..++.++.+||..||+.||.+|||++
T Consensus       261 ~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~  295 (308)
T 4gt4_A          261 RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFK  295 (308)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHH
Confidence            876 5678999999999999999999999999975

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=8.6e-58  Score=437.99  Aligned_cols=247  Identities=23%  Similarity=0.322  Sum_probs=207.8

Q ss_pred             CccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC
Q 016037          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (396)
Q Consensus       144 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~  223 (396)
                      .|.+..++|++.++||+|+||+||+|++++   .||||+++.... .....+.+.+|+.+|++++|||||++++++. ++
T Consensus        30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~  104 (307)
T 3omv_A           30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KD  104 (307)
T ss_dssp             CCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             CcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CC
Confidence            456778899999999999999999998754   489999976443 3445677899999999999999999999875 45


Q ss_pred             eEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      .+|||||||+||+|.+++... +.+++..+..++.||+.||+|||+++||||||||+|||++.++++||+|||+|+....
T Consensus       105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            789999999999999999764 6799999999999999999999999999999999999999999999999999987643


Q ss_pred             C---CCccccccCCCccchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------CCCc
Q 016037          303 N---TRSNSMCGTLEYMSPEIVLG---KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI------KLPA  370 (396)
Q Consensus       303 ~---~~~~~~~gt~~y~APE~l~~---~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~------~~p~  370 (396)
                      .   ......+||+.|||||++.+   ..|+.++|||||||+||||+||+.||.+.+.......+.....      .++.
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~  264 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYK  264 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCT
T ss_pred             CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Confidence            2   23456789999999999964   3589999999999999999999999998765544444443322      3456


Q ss_pred             cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          371 FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       371 ~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .+++++.+||..||+.||.+|||++
T Consensus       265 ~~~~~l~~li~~cl~~dP~~RPs~~  289 (307)
T 3omv_A          265 NCPKAMKRLVADCVKKVKEERPLFP  289 (307)
T ss_dssp             TSCHHHHHHHHHHTCSSSTTSCCHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHH
Confidence            7999999999999999999999974

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.5e-56  Score=465.37  Aligned_cols=248  Identities=36%  Similarity=0.660  Sum_probs=223.8

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHH---HHHHHhCCCCCeeeeeEEEEec
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE---RNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E---~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      .+..++|+++++||+|+||+||+|+++.+|+.||||++.+..+..........+|   +.+++.++|||||+++++|++.
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~  264 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP  264 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence            4567899999999999999999999999999999999987655444433444444   5666778999999999999999


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      ..+|||||||+||+|+.++.+.+.+++..++.|++||+.||+|||++|||||||||+|||++.+|++||+|||+|+.+..
T Consensus       265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998754


Q ss_pred             CCCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCCccCCHHHHH
Q 016037          303 NTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGG---NRQKIQQKIIKDKIKLPAFLSSEAHS  378 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~---~~~~i~~~i~~~~~~~p~~~s~~~~~  378 (396)
                      . ...+.|||+.|||||++.+ ..|+.++|||||||+||||++|+.||.+.   +..++...+....+.+|..+|+++++
T Consensus       345 ~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~d  423 (689)
T 3v5w_A          345 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS  423 (689)
T ss_dssp             C-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             C-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHHH
Confidence            3 4567899999999999974 67999999999999999999999999763   45678888889999999999999999


Q ss_pred             HHHHhhccCCCCCCCC
Q 016037          379 LLKGVNSLLSISVPLL  394 (396)
Q Consensus       379 li~~~l~~~p~~RPs~  394 (396)
                      ||++||+.||.+|++.
T Consensus       424 LI~~lL~~dP~~Rl~~  439 (689)
T 3v5w_A          424 LLEGLLQRDVNRRLGC  439 (689)
T ss_dssp             HHHHHTCSCGGGCTTC
T ss_pred             HHHHHccCCHhHCCCC
Confidence            9999999999999984

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6.5e-57  Score=440.33  Aligned_cols=249  Identities=22%  Similarity=0.394  Sum_probs=216.8

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCCC-----cEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC-CCeeeeeEE
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTS-----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-PFIVQLRYS  218 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~H-pnIv~l~~~  218 (396)
                      |.+..++|++.++||+|+||+||+|.+.+++     +.||||++.....  ....+.+.+|+.+|++++| ||||+++++
T Consensus        59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            4567789999999999999999999987654     6799999976542  3345668899999999975 999999999


Q ss_pred             EEe-cCeEEEEEEecCCCcHHHHHHHh----------------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCE
Q 016037          219 FQT-KYRLYLVLDFVNGGHLFFQLYRQ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENI  281 (396)
Q Consensus       219 ~~~-~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NI  281 (396)
                      |.+ ...+|||||||++|+|.++++..                ..+++..+..++.||+.||+|||+++||||||||+||
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI  216 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI  216 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence            866 45789999999999999999763                3478999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecccccccCCCC---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH-HH
Q 016037          282 LLDADGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNR-QK  356 (396)
Q Consensus       282 Ll~~~~~ikL~Dfgla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~-~~  356 (396)
                      |++.++++||+|||+|+.+....   .....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+. +.
T Consensus       217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~  296 (353)
T 4ase_A          217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  296 (353)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999998764432   2345679999999999999999999999999999999998 9999998764 44


Q ss_pred             HHHHHHhC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          357 IQQKIIKD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       357 i~~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +...+..+ ++.+|..+++++.+||..||+.||.+|||++
T Consensus       297 ~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~  336 (353)
T 4ase_A          297 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS  336 (353)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHH
Confidence            55555554 6788999999999999999999999999975

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.5e-56  Score=438.91  Aligned_cols=244  Identities=24%  Similarity=0.339  Sum_probs=213.6

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe------cC
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT------KY  223 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~------~~  223 (396)
                      ++|++++.||+|+||+||+|+++.+|+.||||++++.... ....+.+.+|+++|+.++|||||++++++..      ..
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc-hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            5799999999999999999999999999999999765432 3345667889999999999999999998764      36


Q ss_pred             eEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      .+|||||||+ |+|..++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+...
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS  211 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred             EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence            8999999996 579999998899999999999999999999999999999999999999999999999999999876432


Q ss_pred             -----CCccccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---------
Q 016037          304 -----TRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKL---------  368 (396)
Q Consensus       304 -----~~~~~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~---------  368 (396)
                           ....+.+||+.|||||++.+. .|+.++||||+||++|||++|+.||.+.+..+..++|.......         
T Consensus       212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~  291 (398)
T 4b99_A          212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG  291 (398)
T ss_dssp             ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred             ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence                 234567999999999999875 56999999999999999999999999999988888886532211         


Q ss_pred             ----------------------CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          369 ----------------------PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       369 ----------------------p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                            .+.+|+++.+||++||++||.+|||+.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~  340 (398)
T 4b99_A          292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAA  340 (398)
T ss_dssp             --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHH
Confidence                                  124799999999999999999999964

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.9e-56  Score=426.78  Aligned_cols=241  Identities=28%  Similarity=0.420  Sum_probs=194.2

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC------
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY------  223 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~------  223 (396)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++...  .....+.+.+|+++|++++|||||+++++|.+..      
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~   82 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ   82 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence            57999999999999999999999999999999997654  3344567889999999999999999999997654      


Q ss_pred             ------eEEEEEEecCCCcHHHHHHHhcCC---CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEec
Q 016037          224 ------RLYLVLDFVNGGHLFFQLYRQGLF---REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDF  294 (396)
Q Consensus       224 ------~~~lV~E~~~gg~L~~~l~~~~~l---~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Df  294 (396)
                            .+|||||||+||+|.+++..++.+   .+..++.++.||+.||+|||++|||||||||+|||++.+|++||+||
T Consensus        83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF  162 (299)
T 4g31_A           83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF  162 (299)
T ss_dssp             ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence                  379999999999999999876554   45668889999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCC-------------ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHH
Q 016037          295 GLAKQFDENTR-------------SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQK  360 (396)
Q Consensus       295 gla~~~~~~~~-------------~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~-~~~i~~~  360 (396)
                      |+|+.+.....             ....+||+.|||||++.+..|+.++|||||||++|||++   ||.+.. .......
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~  239 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTD  239 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHH
Confidence            99988754321             234689999999999999999999999999999999996   886532 2233333


Q ss_pred             HHhCCCC-CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          361 IIKDKIK-LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       361 i~~~~~~-~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +....++ .+...++++.+||++||+.||.+|||+.
T Consensus       240 ~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~  275 (299)
T 4g31_A          240 VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAI  275 (299)
T ss_dssp             HHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHH
Confidence            4433221 2235678899999999999999999864

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1e-54  Score=450.69  Aligned_cols=244  Identities=26%  Similarity=0.487  Sum_probs=225.9

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++....   ....+.+.+|+++|+.++|||||+++++|.+...+|||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv  232 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  232 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            468999999999999999999999999999999997754   23346678899999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC--CcEEEEecccccccCCCCC
Q 016037          229 LDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD--GHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~--~~ikL~Dfgla~~~~~~~~  305 (396)
                      ||||+||+|++++.+ .+.+++..++.|+.||+.||.|||++||+||||||+|||++.+  +++||+|||+|+.+.....
T Consensus       233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~  312 (573)
T 3uto_A          233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  312 (573)
T ss_dssp             EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred             EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence            999999999998864 4689999999999999999999999999999999999999854  8999999999999877777


Q ss_pred             ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHH
Q 016037          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLK  381 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~~~s~~~~~li~  381 (396)
                      ....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+++.+|......++    ..+|+++++||+
T Consensus       313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~  392 (573)
T 3uto_A          313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR  392 (573)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHH
T ss_pred             eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence            7778999999999999999999999999999999999999999999999999999999877665    468999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      +||+.||.+|||+.
T Consensus       393 ~~L~~dp~~R~t~~  406 (573)
T 3uto_A          393 KLLLADPNTRMTIH  406 (573)
T ss_dssp             TTSCSSGGGSCCHH
T ss_pred             HHccCChhHCcCHH
Confidence            99999999999864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5.3e-53  Score=413.55  Aligned_cols=249  Identities=39%  Similarity=0.729  Sum_probs=225.4

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCe
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYR  224 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~  224 (396)
                      .+..++|++++.||+|+||+||+|+++.+++.||||++++.........+.+.+|+.+++.+ +||||++++++|.+...
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence            36678999999999999999999999999999999999887655556667788899999988 79999999999999999


Q ss_pred             EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC-CC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-EN  303 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~-~~  303 (396)
                      +|+||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++... ..
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998643 33


Q ss_pred             CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHh
Q 016037          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV  383 (396)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~  383 (396)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++.++|....+.+|..++.++.+||++|
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~l  258 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSF  258 (353)
T ss_dssp             -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred             ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            44566789999999999998889999999999999999999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCC
Q 016037          384 NSLLSISVPLL  394 (396)
Q Consensus       384 l~~~p~~RPs~  394 (396)
                      |+.||.+||+.
T Consensus       259 L~~dP~~R~~~  269 (353)
T 3txo_A          259 MTKNPTMRLGS  269 (353)
T ss_dssp             TCSSGGGSTTS
T ss_pred             hhhCHHHccCC
Confidence            99999999986

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1e-52  Score=408.97  Aligned_cols=246  Identities=40%  Similarity=0.759  Sum_probs=229.7

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +..++|++++.||+|+||+||+|+++.+|+.||+|++++.........+.+.+|+.+|+.++||||++++++|.+...+|
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            45678999999999999999999999999999999998765444555667888999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC-CCCC
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTR  305 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~-~~~~  305 (396)
                      +||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++... ....
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999998643 3344


Q ss_pred             ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhc
Q 016037          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNS  385 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~  385 (396)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+.+.+....+.+|..+++++++||++||+
T Consensus       162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~  241 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK  241 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred             ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence            56778999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCC
Q 016037          386 LLSISVP  392 (396)
Q Consensus       386 ~~p~~RP  392 (396)
                      .||.+||
T Consensus       242 ~dP~~R~  248 (337)
T 1o6l_A          242 KDPKQRL  248 (337)
T ss_dssp             SSTTTST
T ss_pred             cCHHHhc
Confidence            9999999

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6.3e-53  Score=413.91  Aligned_cols=238  Identities=24%  Similarity=0.391  Sum_probs=198.5

Q ss_pred             CCeEEEeEecccCceEEEEEEEc---CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCeE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~  225 (396)
                      ++|++.++||+|+||+||+|+++   .+++.||+|++.+..     ....+.+|+++|+.+ +||||++++++|.+..++
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            57999999999999999999875   467899999987643     223467899999988 699999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC-CcEEEEecccccccCCCC
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~-~~ikL~Dfgla~~~~~~~  304 (396)
                      |+||||++||+|.+++   +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +++||+|||+|+......
T Consensus        96 ~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~  172 (361)
T 4f9c_A           96 VIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK  172 (361)
T ss_dssp             EEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred             EEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence            9999999999999887   358999999999999999999999999999999999999877 899999999998654321


Q ss_pred             -----------------------------CccccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-C
Q 016037          305 -----------------------------RSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGG-N  353 (396)
Q Consensus       305 -----------------------------~~~~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~-~  353 (396)
                                                   .....+||+.|||||++.+. .|+.++||||+||++|||+||+.||... +
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~  252 (361)
T 4f9c_A          173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD  252 (361)
T ss_dssp             CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence                                         12346899999999999875 5899999999999999999999999654 3


Q ss_pred             HHHHHHHHHh--------------------------------------CCC----------------CCCccCCHHHHHH
Q 016037          354 RQKIQQKIIK--------------------------------------DKI----------------KLPAFLSSEAHSL  379 (396)
Q Consensus       354 ~~~i~~~i~~--------------------------------------~~~----------------~~p~~~s~~~~~l  379 (396)
                      ..+....|..                                      ...                .....+|+++.+|
T Consensus       253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL  332 (361)
T 4f9c_A          253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL  332 (361)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred             HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence            3333333321                                      000                1123589999999


Q ss_pred             HHHhhccCCCCCCCCC
Q 016037          380 LKGVNSLLSISVPLLS  395 (396)
Q Consensus       380 i~~~l~~~p~~RPs~s  395 (396)
                      |++||++||.+|||+.
T Consensus       333 l~~lL~~dP~~R~ta~  348 (361)
T 4f9c_A          333 LDKLLDLNPASRITAE  348 (361)
T ss_dssp             HHHHTCSCTTTSCCHH
T ss_pred             HHHHCcCChhHCcCHH
Confidence            9999999999999974

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.8e-52  Score=404.34  Aligned_cols=247  Identities=34%  Similarity=0.616  Sum_probs=231.4

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      ..++|++++.||+|+||.||+|++..+|+.||+|++.+.... ....+.+.+|+++|+.++||||+++++++.+...+|+
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   91 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL   91 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            457899999999999999999999999999999999876543 3445667889999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCcc
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN  307 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~  307 (396)
                      ||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.........
T Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  171 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD  171 (328)
T ss_dssp             EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGG
T ss_pred             EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999998877666667


Q ss_pred             ccccCCCccchhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhcc
Q 016037          308 SMCGTLEYMSPEIVLGKGHD-KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSL  386 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~-~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~  386 (396)
                      ..+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..++..++..+...+|..+|.++.+||++||+.
T Consensus       172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~  251 (328)
T 3fe3_A          172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVL  251 (328)
T ss_dssp             TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHCCS
T ss_pred             cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHCCC
Confidence            78999999999999988775 79999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCC
Q 016037          387 LSISVPLLS  395 (396)
Q Consensus       387 ~p~~RPs~s  395 (396)
                      ||.+|||+.
T Consensus       252 dP~~R~t~~  260 (328)
T 3fe3_A          252 NPIKRGTLE  260 (328)
T ss_dssp             STTTSCCHH
T ss_pred             ChhHCcCHH
Confidence            999999974

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.7e-53  Score=408.62  Aligned_cols=239  Identities=22%  Similarity=0.317  Sum_probs=193.7

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC----eE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY----RL  225 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~----~~  225 (396)
                      ++|.+.++||+|+||+||+|++  +|+.||||++....    ........|+..+.+++|||||++++++.+..    .+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            4689999999999999999998  57899999997543    22223345777778899999999999997654    68


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCCEEEcCCCcEEEEecccc
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--------GIMHRDLKPENILLDADGHVMLTDFGLA  297 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~--------~iiHrDlkp~NILl~~~~~ikL~Dfgla  297 (396)
                      |||||||++|+|.+++.+ ..+++..+..++.|++.||+|||++        +||||||||+|||++.++++||+|||+|
T Consensus        77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            999999999999999876 4688899999999999999999987        9999999999999999999999999999


Q ss_pred             cccCCCCC-----ccccccCCCccchhhhcCC------CCCchhhHHHHHHHHHHHHhCCCCCC----------C-----
Q 016037          298 KQFDENTR-----SNSMCGTLEYMSPEIVLGK------GHDKAADWWSVGILLFEMLTGQPPFT----------G-----  351 (396)
Q Consensus       298 ~~~~~~~~-----~~~~~gt~~y~APE~l~~~------~~~~~~DvwSlGvil~elltg~~Pf~----------~-----  351 (396)
                      +.......     ....+||+.|||||++.+.      .++.++|||||||+||||+||..||.          +     
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            87654332     2346899999999999764      35779999999999999999976553          2     


Q ss_pred             CCHHHHHHHHHhC--CCCCCcc-----CCHHHHHHHHHhhccCCCCCCCCC
Q 016037          352 GNRQKIQQKIIKD--KIKLPAF-----LSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       352 ~~~~~i~~~i~~~--~~~~p~~-----~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .....+...+...  ++.+|..     .+..+.+||.+||+.||.+|||++
T Consensus       236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  286 (303)
T 3hmm_A          236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL  286 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHH
T ss_pred             chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHH
Confidence            1334555555554  3455643     335789999999999999999974

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.4e-52  Score=413.63  Aligned_cols=249  Identities=39%  Similarity=0.744  Sum_probs=226.7

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCe
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYR  224 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~  224 (396)
                      .+..++|+++++||+|+||+||+|+++.+++.||+|++++.........+.+.+|+.+|+++ +||||++++++|.+...
T Consensus        48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~  127 (396)
T 4dc2_A           48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR  127 (396)
T ss_dssp             -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence            46678999999999999999999999999999999999987665566666788899999876 89999999999999999


Q ss_pred             EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccccc-CCC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DEN  303 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~-~~~  303 (396)
                      +|+||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.. ...
T Consensus       128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999863 344


Q ss_pred             CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC---------CCHHHHHHHHHhCCCCCCccCCH
Q 016037          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG---------GNRQKIQQKIIKDKIKLPAFLSS  374 (396)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~---------~~~~~i~~~i~~~~~~~p~~~s~  374 (396)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..         .....+.+.+....+.+|..+|.
T Consensus       208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~  287 (396)
T 4dc2_A          208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV  287 (396)
T ss_dssp             CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCCH
Confidence            556778999999999999999999999999999999999999999963         24566888899999999999999


Q ss_pred             HHHHHHHHhhccCCCCCCCC
Q 016037          375 EAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       375 ~~~~li~~~l~~~p~~RPs~  394 (396)
                      ++++||++||+.||.+||+.
T Consensus       288 ~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          288 KAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             HHHHHHHHHTCSCTTTSTTC
T ss_pred             HHHHHHHHHhcCCHhHcCCC
Confidence            99999999999999999985

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.6e-52  Score=406.43  Aligned_cols=250  Identities=36%  Similarity=0.682  Sum_probs=229.7

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCe
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYR  224 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~  224 (396)
                      .+..++|++.+.||+|+||+||+|+++.+++.||||++++.........+.+..|..+++.+ +||||++++++|.+...
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            45678999999999999999999999999999999999876544444556677899999876 99999999999999999


Q ss_pred             EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC-CC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-EN  303 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~-~~  303 (396)
                      +|+||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++... ..
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  172 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  172 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence            99999999999999999998999999999999999999999999999999999999999999999999999998653 23


Q ss_pred             CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHh
Q 016037          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV  383 (396)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~  383 (396)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++..++......+|..++.++++||++|
T Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~l  252 (345)
T 1xjd_A          173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL  252 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred             CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHHHH
Confidence            34567789999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCC
Q 016037          384 NSLLSISVPLLS  395 (396)
Q Consensus       384 l~~~p~~RPs~s  395 (396)
                      |+.||.+||++.
T Consensus       253 L~~dp~~R~~~~  264 (345)
T 1xjd_A          253 FVREPEKRLGVR  264 (345)
T ss_dssp             SCSSGGGSBTTB
T ss_pred             hcCCHhHcCCCh
Confidence            999999999974

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.7e-52  Score=409.71  Aligned_cols=251  Identities=42%  Similarity=0.745  Sum_probs=223.1

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHH-HHhCCCCCeeeeeEEEEecC
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-LTKVDHPFIVQLRYSFQTKY  223 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~-L~~l~HpnIv~l~~~~~~~~  223 (396)
                      .....++|++++.||+|+||+||+|+++.+++.||||++++.........+.+..|..+ ++.++||||++++++|.+..
T Consensus        33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~  112 (373)
T 2r5t_A           33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD  112 (373)
T ss_dssp             TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred             CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence            34667899999999999999999999999999999999988766555555666777776 56789999999999999999


Q ss_pred             eEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC-C
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-E  302 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~-~  302 (396)
                      .+|+||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++... .
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999998743 3


Q ss_pred             CCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHH
Q 016037          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG  382 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~  382 (396)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++.++|....+.+|..++.++++||++
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~  272 (373)
T 2r5t_A          193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEG  272 (373)
T ss_dssp             CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHHH
T ss_pred             CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Confidence            44556789999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCC
Q 016037          383 VNSLLSISVPLLS  395 (396)
Q Consensus       383 ~l~~~p~~RPs~s  395 (396)
                      ||+.||.+||+..
T Consensus       273 lL~~dp~~R~~~~  285 (373)
T 2r5t_A          273 LLQKDRTKRLGAK  285 (373)
T ss_dssp             HTCSSGGGSTTTT
T ss_pred             HcccCHHhCCCCC
Confidence            9999999999863

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.9e-52  Score=406.13  Aligned_cols=249  Identities=37%  Similarity=0.705  Sum_probs=229.9

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCe
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYR  224 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~  224 (396)
                      .+..++|++++.||+|+||+||+|+++.+++.||||++++.........+.+..|+.+|+.+ +||||++++++|++...
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            35678999999999999999999999999999999999886554455566788899999987 89999999999999999


Q ss_pred             EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC-CC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-EN  303 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~-~~  303 (396)
                      +|+||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++... ..
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence            99999999999999999988999999999999999999999999999999999999999999999999999998643 33


Q ss_pred             CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHh
Q 016037          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV  383 (396)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~  383 (396)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++.++|....+.+|..+|.++++||++|
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~l  255 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL  255 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred             cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence            44567789999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCC
Q 016037          384 NSLLSISVPLL  394 (396)
Q Consensus       384 l~~~p~~RPs~  394 (396)
                      |+.||.+||+.
T Consensus       256 L~~dP~~R~~~  266 (353)
T 2i0e_A          256 MTKHPGKRLGC  266 (353)
T ss_dssp             TCSCTTSCTTC
T ss_pred             hhcCHHHcCCC
Confidence            99999999975

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.6e-51  Score=401.66  Aligned_cols=248  Identities=39%  Similarity=0.742  Sum_probs=229.1

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCeE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~  225 (396)
                      +..++|++++.||+|+||+||+|+++.+++.||+|++++.........+.+.+|+.+++++ +||||++++++|.+...+
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   85 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   85 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence            4567899999999999999999999999999999999987766666777888999999987 899999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC-CCC
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENT  304 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~-~~~  304 (396)
                      |+||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++... ...
T Consensus        86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence            9999999999999999998999999999999999999999999999999999999999999999999999998643 334


Q ss_pred             CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC---------CCHHHHHHHHHhCCCCCCccCCHH
Q 016037          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG---------GNRQKIQQKIIKDKIKLPAFLSSE  375 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~---------~~~~~i~~~i~~~~~~~p~~~s~~  375 (396)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..         .+...+.+.+....+.+|..++.+
T Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~  245 (345)
T 3a8x_A          166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK  245 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCCHH
Confidence            45677899999999999999999999999999999999999999975         355678888889999999999999


Q ss_pred             HHHHHHHhhccCCCCCCCC
Q 016037          376 AHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       376 ~~~li~~~l~~~p~~RPs~  394 (396)
                      +++||++||+.||.+||+.
T Consensus       246 ~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          246 AASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             HHHHHHHHTCSSTTTSTTC
T ss_pred             HHHHHHHHhcCCHhHCCCC
Confidence            9999999999999999985

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1e-51  Score=398.75  Aligned_cols=245  Identities=37%  Similarity=0.711  Sum_probs=228.9

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +..++|++++.||+|+||+||+|+++.+|+.||+|++++.........+.+.+|+.+++.++||||+++++++.+...+|
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence            34678999999999999999999999999999999998765444455667888999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCc
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS  306 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~  306 (396)
                      +||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....  ..
T Consensus        83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--~~  160 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VT  160 (318)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--CB
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--cc
Confidence            9999999999999999989999999999999999999999999999999999999999999999999999987643  34


Q ss_pred             cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhcc
Q 016037          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSL  386 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~  386 (396)
                      ...+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+......++....+.+|..++.++++||++||+.
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~  240 (318)
T 1fot_A          161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITR  240 (318)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcc
Confidence            56789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 016037          387 LSISVPL  393 (396)
Q Consensus       387 ~p~~RPs  393 (396)
                      ||.+||+
T Consensus       241 dp~~R~~  247 (318)
T 1fot_A          241 DLSQRLG  247 (318)
T ss_dssp             CTTTCTT
T ss_pred             CHHHcCC
Confidence            9999993

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.3e-51  Score=400.28  Aligned_cols=245  Identities=38%  Similarity=0.725  Sum_probs=230.0

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      ...++|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+++|+.++||||+++++++.+...+|
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  117 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            44578999999999999999999999999999999998765544455677888999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCc
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS  306 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~  306 (396)
                      +||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....  .
T Consensus       118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~  195 (350)
T 1rdq_E          118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--T  195 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--B
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--c
Confidence            99999999999999999899999999999999999999999999999999999999999999999999999876543  3


Q ss_pred             cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhcc
Q 016037          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSL  386 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~  386 (396)
                      ...+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++..++..+.+.+|..++.++.+||++||+.
T Consensus       196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~  275 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQV  275 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCS
T ss_pred             ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhc
Confidence            56789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 016037          387 LSISVPL  393 (396)
Q Consensus       387 ~p~~RPs  393 (396)
                      ||.+||+
T Consensus       276 dp~~R~~  282 (350)
T 1rdq_E          276 DLTKRFG  282 (350)
T ss_dssp             CTTTCTT
T ss_pred             CHHhccC
Confidence            9999998

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.2e-51  Score=404.34  Aligned_cols=249  Identities=35%  Similarity=0.637  Sum_probs=230.4

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCe
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~  224 (396)
                      ..+..++|++++.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.+|+.++||||++++++|.+...
T Consensus        10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   89 (384)
T 4fr4_A           10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED   89 (384)
T ss_dssp             CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            44667899999999999999999999999999999999987665555566778899999999999999999999999999


Q ss_pred             EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      +|+||||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++......
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET  169 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence            99999999999999999998899999999999999999999999999999999999999999999999999999887776


Q ss_pred             CccccccCCCccchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhCCCCCCccCCHHHHH
Q 016037          305 RSNSMCGTLEYMSPEIVLG---KGHDKAADWWSVGILLFEMLTGQPPFTG---GNRQKIQQKIIKDKIKLPAFLSSEAHS  378 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~---~~~~~~~DvwSlGvil~elltg~~Pf~~---~~~~~i~~~i~~~~~~~p~~~s~~~~~  378 (396)
                      .....+||+.|+|||++.+   ..++.++|||||||++|||++|+.||..   ....++...+......+|..++.++.+
T Consensus       170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~  249 (384)
T 4fr4_A          170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVS  249 (384)
T ss_dssp             CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHH
Confidence            7778899999999999974   4589999999999999999999999974   456777788888889999999999999


Q ss_pred             HHHHhhccCCCCCCC
Q 016037          379 LLKGVNSLLSISVPL  393 (396)
Q Consensus       379 li~~~l~~~p~~RPs  393 (396)
                      ||++||+.||.+||+
T Consensus       250 li~~lL~~dP~~R~s  264 (384)
T 4fr4_A          250 LLKKLLEPNPDQRFS  264 (384)
T ss_dssp             HHHHHSCSSGGGSCC
T ss_pred             HHHHHhcCCHhHhcc
Confidence            999999999999998

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.7e-50  Score=396.91  Aligned_cols=247  Identities=29%  Similarity=0.465  Sum_probs=227.4

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchh---hHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK---NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~  225 (396)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++.+......   ...+.+.+|+.+|+.++||||++++++|.+...+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            3579999999999999999999999999999999987543221   1345688999999999999999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC----cEEEEecccccccC
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG----HVMLTDFGLAKQFD  301 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~----~ikL~Dfgla~~~~  301 (396)
                      |+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++    ++||+|||+++...
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~  170 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence            99999999999999998888999999999999999999999999999999999999998877    79999999999887


Q ss_pred             CCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHH
Q 016037          302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAH  377 (396)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~~~s~~~~  377 (396)
                      ........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+......++    ..+|.+++
T Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  250 (361)
T 2yab_A          171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAK  250 (361)
T ss_dssp             TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHH
T ss_pred             CCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHH
Confidence            66666778899999999999999999999999999999999999999999999999999999888776    46899999


Q ss_pred             HHHHHhhccCCCCCCCCC
Q 016037          378 SLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       378 ~li~~~l~~~p~~RPs~s  395 (396)
                      +||+.||+.||.+|||+.
T Consensus       251 ~li~~~L~~dP~~R~t~~  268 (361)
T 2yab_A          251 DFIRKLLVKETRKRLTIQ  268 (361)
T ss_dssp             HHHHHHSCSSTTTSCCHH
T ss_pred             HHHHHHCCCChhHCcCHH
Confidence            999999999999999964

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=7.2e-50  Score=386.73  Aligned_cols=249  Identities=51%  Similarity=0.887  Sum_probs=216.9

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEc---CCCcEEEEEEeeccccch-hhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIME-KNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~---~~~~~vAvK~i~~~~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      +..++|++.+.||+|+||.||+|++.   .+++.||+|++++..... ......+.+|+.+|+.++||||+++++++...
T Consensus        14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   93 (327)
T 3a62_A           14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG   93 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence            55678999999999999999999985   689999999998754322 23445577899999999999999999999999


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      ..+|+||||+++++|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++....
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  173 (327)
T 3a62_A           94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH  173 (327)
T ss_dssp             SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred             CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence            99999999999999999999989999999999999999999999999999999999999999999999999999986432


Q ss_pred             -CCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Q 016037          303 -NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK  381 (396)
Q Consensus       303 -~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~  381 (396)
                       .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+......++....+.+|..++.++++||+
T Consensus       174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  253 (327)
T 3a62_A          174 DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK  253 (327)
T ss_dssp             -----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred             CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence             2334567899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      +||+.||.+||+..
T Consensus       254 ~~L~~dp~~R~~~~  267 (327)
T 3a62_A          254 KLLKRNAASRLGAG  267 (327)
T ss_dssp             HHSCSCGGGSTTSS
T ss_pred             HHHhcCHhhccCCC
Confidence            99999999999653

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.2e-51  Score=399.51  Aligned_cols=247  Identities=28%  Similarity=0.483  Sum_probs=226.2

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            35789999999999999999999999999999999987544333444568899999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCcc
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN  307 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~  307 (396)
                      ||||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus        87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~  165 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK  165 (336)
T ss_dssp             EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTC
T ss_pred             EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccc
Confidence            99999 67899999888999999999999999999999999999999999999999999999999999999877766667


Q ss_pred             ccccCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhcc
Q 016037          308 SMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSL  386 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~  386 (396)
                      ..+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+...+.+++......+|..+|+++.+||++||+.
T Consensus       166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~  245 (336)
T 3h4j_B          166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVA  245 (336)
T ss_dssp             CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTTSCS
T ss_pred             cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHHcCC
Confidence            7899999999999998776 789999999999999999999999887777777777777888999999999999999999


Q ss_pred             CCCCCCCCC
Q 016037          387 LSISVPLLS  395 (396)
Q Consensus       387 ~p~~RPs~s  395 (396)
                      ||.+|||+.
T Consensus       246 dP~~Rpt~~  254 (336)
T 3h4j_B          246 DPMQRITIQ  254 (336)
T ss_dssp             SGGGSCCHH
T ss_pred             ChhHCcCHH
Confidence            999999974

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.8e-50  Score=422.84  Aligned_cols=249  Identities=37%  Similarity=0.705  Sum_probs=230.9

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCe
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYR  224 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~  224 (396)
                      .+..++|++++.||+|+||+||+|+++.+++.||||++++.........+.+..|..+|..+ +||+|++++++|++...
T Consensus       337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~  416 (674)
T 3pfq_A          337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR  416 (674)
T ss_dssp             ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred             cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence            45678999999999999999999999999999999999876555555566778899999987 79999999999999999


Q ss_pred             EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC-CC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-EN  303 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~-~~  303 (396)
                      +|+||||++||+|..++.+.+.+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+++... ..
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred             EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998643 34


Q ss_pred             CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHh
Q 016037          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV  383 (396)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~  383 (396)
                      ......+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..++.++|....+.+|..++.++++||++|
T Consensus       497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~l  576 (674)
T 3pfq_A          497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL  576 (674)
T ss_dssp             CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHHH
T ss_pred             cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHH
Confidence            45567899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCC
Q 016037          384 NSLLSISVPLL  394 (396)
Q Consensus       384 l~~~p~~RPs~  394 (396)
                      |+.||.+||+.
T Consensus       577 L~~dP~~R~~~  587 (674)
T 3pfq_A          577 MTKHPGKRLGC  587 (674)
T ss_dssp             SCSSSTTCTTC
T ss_pred             ccCCHHHCCCC
Confidence            99999999986

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.3e-50  Score=406.39  Aligned_cols=247  Identities=40%  Similarity=0.750  Sum_probs=218.4

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~  225 (396)
                      .+..++|++++.||+|+||.||+|+++.+++.||||++.+...........+.+|+.+++.++||||++++++|.....+
T Consensus       144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~  223 (446)
T 4ejn_A          144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL  223 (446)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred             CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence            45668899999999999999999999999999999999876544555566678899999999999999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcEEEEecccccccC-CC
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-EN  303 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~-~~  303 (396)
                      |+||||+++|+|..++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++++||+|||+++... ..
T Consensus       224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  303 (446)
T 4ejn_A          224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  303 (446)
T ss_dssp             EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred             EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence            9999999999999999999999999999999999999999998 999999999999999999999999999998643 33


Q ss_pred             CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHh
Q 016037          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGV  383 (396)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~  383 (396)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+...+....+.+|..+++++.+||++|
T Consensus       304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~  383 (446)
T 4ejn_A          304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGL  383 (446)
T ss_dssp             ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred             cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHH
Confidence            34566789999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCC
Q 016037          384 NSLLSISVP  392 (396)
Q Consensus       384 l~~~p~~RP  392 (396)
                      |+.||.+||
T Consensus       384 L~~dP~~R~  392 (446)
T 4ejn_A          384 LKKDPKQRL  392 (446)
T ss_dssp             TCSSTTTST
T ss_pred             cccCHHHhC
Confidence            999999999

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.1e-50  Score=408.48  Aligned_cols=250  Identities=28%  Similarity=0.488  Sum_probs=232.5

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~  225 (396)
                      .+..++|.+.+.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+...+
T Consensus        12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~   91 (476)
T 2y94_A           12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI   91 (476)
T ss_dssp             CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            35567899999999999999999999999999999999876544444566788999999999999999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~  305 (396)
                      |+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~  171 (476)
T 2y94_A           92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  171 (476)
T ss_dssp             EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence            99999999999999998888999999999999999999999999999999999999999999999999999998776666


Q ss_pred             ccccccCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhh
Q 016037          306 SNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVN  384 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l  384 (396)
                      ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+...+..++..+.+..|..+++++.+||++||
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L  251 (476)
T 2y94_A          172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHML  251 (476)
T ss_dssp             BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHHHT
T ss_pred             ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHHHc
Confidence            677899999999999998765 6899999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCC
Q 016037          385 SLLSISVPLLS  395 (396)
Q Consensus       385 ~~~p~~RPs~s  395 (396)
                      +.||.+|||+.
T Consensus       252 ~~dP~~Rpt~~  262 (476)
T 2y94_A          252 QVDPMKRATIK  262 (476)
T ss_dssp             CSSTTTSCCHH
T ss_pred             CCCchhCcCHH
Confidence            99999999964

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=9e-50  Score=391.77  Aligned_cols=246  Identities=30%  Similarity=0.525  Sum_probs=226.1

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++...... ....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            35799999999999999999999999999999999876543 34456688999999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC---cEEEEecccccccCCCCC
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG---HVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~---~ikL~Dfgla~~~~~~~~  305 (396)
                      |||+.+|+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++.......
T Consensus       107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~  186 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  186 (362)
T ss_dssp             ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence            99999999999998888999999999999999999999999999999999999998654   599999999988776665


Q ss_pred             ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHH
Q 016037          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLK  381 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~----~~s~~~~~li~  381 (396)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...+...+..+...+|.    .+++++++||.
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  266 (362)
T 2bdw_A          187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID  266 (362)
T ss_dssp             CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHH
T ss_pred             cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence            66778999999999999989999999999999999999999999999999999999998777663    68999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      .||+.||.+||++.
T Consensus       267 ~~L~~dP~~R~t~~  280 (362)
T 2bdw_A          267 SMLTVNPKKRITAD  280 (362)
T ss_dssp             HHSCSSGGGSCCHH
T ss_pred             HHcCCChhhCcCHH
Confidence            99999999999864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-50  Score=385.25  Aligned_cols=243  Identities=24%  Similarity=0.397  Sum_probs=223.8

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....    ...+.+.+|+.+++.++||||+++++++.+...+|+|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   79 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence            368999999999999999999999999999999987543    3345678899999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC--CCcEEEEecccccccCCCCC
Q 016037          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA--DGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~--~~~ikL~Dfgla~~~~~~~~  305 (396)
                      |||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++.+.....
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~  159 (321)
T 1tki_A           80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence            9999999999988765 47999999999999999999999999999999999999987  78999999999998876665


Q ss_pred             ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHH
Q 016037          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLK  381 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~----~~s~~~~~li~  381 (396)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+......++.    .+|.++.+||+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  239 (321)
T 1tki_A          160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD  239 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred             cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHH
Confidence            56678999999999999988999999999999999999999999999999999999999887774    78999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      +||+.||.+|||+.
T Consensus       240 ~~L~~dp~~Rpt~~  253 (321)
T 1tki_A          240 RLLVKERKSRMTAS  253 (321)
T ss_dssp             TTSCSSGGGSCCHH
T ss_pred             HHcCCChhHCcCHH
Confidence            99999999999964

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.4e-49  Score=379.41  Aligned_cols=243  Identities=28%  Similarity=0.446  Sum_probs=218.0

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++.....   ...+.+.+|+.+++.++||||++++++|.....+|+|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   95 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence            3679999999999999999999999999999999976542   2245578899999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Ccc
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSN  307 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~~  307 (396)
                      |||+++|+|.+++.+. .+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||++....... ...
T Consensus        96 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  174 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (297)
T ss_dssp             EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             EECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence            9999999999888764 68999999999999999999999999999999999999999999999999998765433 345


Q ss_pred             ccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCCccCCHHHHHHHHHhh
Q 016037          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGVN  384 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~---~~~~p~~~s~~~~~li~~~l  384 (396)
                      ..+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+...   .+..|..++..+.+||.+||
T Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  254 (297)
T 3fxz_A          175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL  254 (297)
T ss_dssp             CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHS
T ss_pred             CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHc
Confidence            568999999999999999999999999999999999999999998877776666554   34557889999999999999


Q ss_pred             ccCCCCCCCCC
Q 016037          385 SLLSISVPLLS  395 (396)
Q Consensus       385 ~~~p~~RPs~s  395 (396)
                      +.||.+|||++
T Consensus       255 ~~dp~~Rps~~  265 (297)
T 3fxz_A          255 EMDVEKRGSAK  265 (297)
T ss_dssp             CSSTTTSCCHH
T ss_pred             cCChhHCcCHH
Confidence            99999999964

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.3e-49  Score=407.41  Aligned_cols=249  Identities=32%  Similarity=0.591  Sum_probs=227.7

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~  225 (396)
                      .+..++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+|++++||||++++++|.+...+
T Consensus       181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL  260 (543)
T ss_dssp             CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence            35668899999999999999999999999999999999876654445566788899999999999999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          226 YLVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      |+||||++||+|..++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.+.
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999999998764    369999999999999999999999999999999999999999999999999998875


Q ss_pred             CCCC-ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCCCCCccCCHHH
Q 016037          302 ENTR-SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKDKIKLPAFLSSEA  376 (396)
Q Consensus       302 ~~~~-~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~----~~~~i~~~i~~~~~~~p~~~s~~~  376 (396)
                      .... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.    +..++.+.+......+|..+|.++
T Consensus       341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~  420 (543)
T 3c4z_A          341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS  420 (543)
T ss_dssp             TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHH
Confidence            5433 34568999999999999999999999999999999999999999875    467888899999999999999999


Q ss_pred             HHHHHHhhccCCCCCCCC
Q 016037          377 HSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       377 ~~li~~~l~~~p~~RPs~  394 (396)
                      ++||++||+.||.+||+.
T Consensus       421 ~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          421 KDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             HHHHHHHSCSSGGGSCCC
T ss_pred             HHHHHHhccCCHhHCCCC
Confidence            999999999999999986

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.7e-50  Score=401.81  Aligned_cols=248  Identities=36%  Similarity=0.679  Sum_probs=221.4

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +..++|+++++||+|+||+||+|+++.+++.||+|++++.........+.+.+|+.+++.++||||++++++|.+...+|
T Consensus        66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~  145 (410)
T 3v8s_A           66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  145 (410)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            45678999999999999999999999999999999998754433344455778999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC--
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--  304 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~--  304 (396)
                      +||||++||+|..++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++......  
T Consensus       146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~  224 (410)
T 3v8s_A          146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  224 (410)
T ss_dssp             EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred             EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence            99999999999998865 578999999999999999999999999999999999999999999999999998775443  


Q ss_pred             CccccccCCCccchhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCC--ccCCHHH
Q 016037          305 RSNSMCGTLEYMSPEIVLGKG----HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLP--AFLSSEA  376 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~----~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--~~~~p--~~~s~~~  376 (396)
                      .....+||+.|+|||++.+..    ++.++|||||||+||||++|+.||.+.+...+..+|...  .+.+|  ..+|.++
T Consensus       225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~  304 (410)
T 3v8s_A          225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA  304 (410)
T ss_dssp             ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHH
T ss_pred             cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHH
Confidence            245678999999999998765    789999999999999999999999999999999999865  35555  4799999


Q ss_pred             HHHHHHhhccCCCC--CCCCC
Q 016037          377 HSLLKGVNSLLSIS--VPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~--RPs~s  395 (396)
                      ++||++||+.+|.+  ||++.
T Consensus       305 ~~li~~lL~~~~~rlgR~~~~  325 (410)
T 3v8s_A          305 KNLICAFLTDREVRLGRNGVE  325 (410)
T ss_dssp             HHHHHHHSSCGGGCTTSSCHH
T ss_pred             HHHHHHHccChhhhCCCCCHH
Confidence            99999999988888  88853

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.1e-49  Score=398.10  Aligned_cols=246  Identities=29%  Similarity=0.519  Sum_probs=223.6

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|++.+.||+|+||+||+|.++.+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            36799999999999999999999999999999999876543 33456688999999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc---CCCcEEEEecccccccCCCC-
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD---ADGHVMLTDFGLAKQFDENT-  304 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~---~~~~ikL~Dfgla~~~~~~~-  304 (396)
                      |||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...... 
T Consensus        89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~  168 (444)
T 3soa_A           89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ  168 (444)
T ss_dssp             ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred             EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence            99999999999999999999999999999999999999999999999999999998   46789999999998775433 


Q ss_pred             CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHH
Q 016037          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLL  380 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~----~~s~~~~~li  380 (396)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+..+...+|.    .+++++++||
T Consensus       169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  248 (444)
T 3soa_A          169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI  248 (444)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHH
T ss_pred             eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHH
Confidence            235578999999999999989999999999999999999999999999999999999998777663    6899999999


Q ss_pred             HHhhccCCCCCCCCC
Q 016037          381 KGVNSLLSISVPLLS  395 (396)
Q Consensus       381 ~~~l~~~p~~RPs~s  395 (396)
                      +.||+.||.+|||+.
T Consensus       249 ~~~L~~dP~~Rpta~  263 (444)
T 3soa_A          249 NKMLTINPSKRITAA  263 (444)
T ss_dssp             HHHSCSSTTTSCCHH
T ss_pred             HHHcCCChhHCCCHH
Confidence            999999999999964

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.1e-49  Score=373.60  Aligned_cols=249  Identities=32%  Similarity=0.616  Sum_probs=226.7

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~  225 (396)
                      .+..++|++.+.||+|+||.||+|.+..++..||+|++...........+.+.+|+.+++.++||||+++++++.+....
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   84 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence            35678999999999999999999999999999999999876544444566788999999999999999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~  305 (396)
                      |+||||+++++|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-~  163 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-R  163 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-c
Confidence            999999999999999998899999999999999999999999999999999999999999999999999998665433 2


Q ss_pred             ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhc
Q 016037          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNS  385 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~  385 (396)
                      .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+......+|..++.++.+||+.||+
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  243 (279)
T 3fdn_A          164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK  243 (279)
T ss_dssp             ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHCC
T ss_pred             ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHhc
Confidence            34567999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCCCC
Q 016037          386 LLSISVPLLS  395 (396)
Q Consensus       386 ~~p~~RPs~s  395 (396)
                      .+|.+|||+.
T Consensus       244 ~~p~~Rps~~  253 (279)
T 3fdn_A          244 HNPSQRPMLR  253 (279)
T ss_dssp             SSGGGSCCHH
T ss_pred             cChhhCCCHH
Confidence            9999999974

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.4e-50  Score=403.37  Aligned_cols=249  Identities=34%  Similarity=0.636  Sum_probs=221.9

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +..++|+++++||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||++++++|.+...+|
T Consensus        71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  150 (437)
T 4aw2_A           71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY  150 (437)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence            45678999999999999999999999999999999998755444444455788999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC
Q 016037          227 LVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~  305 (396)
                      +||||++||+|..++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.......
T Consensus       151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~  230 (437)
T 4aw2_A          151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  230 (437)
T ss_dssp             EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence            99999999999999987 57899999999999999999999999999999999999999999999999999987654332


Q ss_pred             --ccccccCCCccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCc---cCC
Q 016037          306 --SNSMCGTLEYMSPEIVL-----GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPA---FLS  373 (396)
Q Consensus       306 --~~~~~gt~~y~APE~l~-----~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--~~~~p~---~~s  373 (396)
                        ....+||+.|||||++.     ...++.++|||||||+||||++|+.||.+.+..+...+|...  ++.+|.   .+|
T Consensus       231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s  310 (437)
T 4aw2_A          231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVS  310 (437)
T ss_dssp             EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSC
T ss_pred             cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCC
Confidence              34468999999999997     566899999999999999999999999999999999998754  466665   489


Q ss_pred             HHHHHHHHHhhccCCCC--CCCCC
Q 016037          374 SEAHSLLKGVNSLLSIS--VPLLS  395 (396)
Q Consensus       374 ~~~~~li~~~l~~~p~~--RPs~s  395 (396)
                      +++++||++||+.+|.+  ||++.
T Consensus       311 ~~~~dLi~~lL~~~~~r~~r~~~~  334 (437)
T 4aw2_A          311 ENAKDLIRRLICSREHRLGQNGIE  334 (437)
T ss_dssp             HHHHHHHHTTSSCGGGCTTTTTTH
T ss_pred             HHHHHHHHHHhcccccccCCCCHH
Confidence            99999999999888777  88763

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.1e-49  Score=381.26  Aligned_cols=246  Identities=28%  Similarity=0.450  Sum_probs=225.1

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchh---hHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK---NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++........   ...+.+.+|+.+|+.++||||+++++++.....+|
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            569999999999999999999999999999999987543221   13466888999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC----cEEEEecccccccCC
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG----HVMLTDFGLAKQFDE  302 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~----~ikL~Dfgla~~~~~  302 (396)
                      +||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++    ++||+|||+++....
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~  170 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  170 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence            9999999999999998888999999999999999999999999999999999999999888    899999999998766


Q ss_pred             CCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHH
Q 016037          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHS  378 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~~~s~~~~~  378 (396)
                      .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......++    ..++.++.+
T Consensus       171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (326)
T 2y0a_A          171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD  250 (326)
T ss_dssp             TSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             CCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHH
Confidence            5556677899999999999999999999999999999999999999999999999999888877766    468999999


Q ss_pred             HHHHhhccCCCCCCCCC
Q 016037          379 LLKGVNSLLSISVPLLS  395 (396)
Q Consensus       379 li~~~l~~~p~~RPs~s  395 (396)
                      ||+.||+.||.+|||+.
T Consensus       251 li~~~L~~dP~~Rpt~~  267 (326)
T 2y0a_A          251 FIRRLLVKDPKKRMTIQ  267 (326)
T ss_dssp             HHHHHSCSSGGGSCCHH
T ss_pred             HHHHHccCChhhCCCHH
Confidence            99999999999999964

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=397.22  Aligned_cols=245  Identities=36%  Similarity=0.647  Sum_probs=219.3

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +..++|++++.||+|+||+||+|+++.+++.||||++++.........+.+.+|+.++..++||||++++++|++...+|
T Consensus        58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  137 (412)
T 2vd5_A           58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY  137 (412)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            45678999999999999999999999999999999998755444444556788999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC
Q 016037          227 LVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~  305 (396)
                      +||||++||+|..++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.......
T Consensus       138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~  217 (412)
T 2vd5_A          138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT  217 (412)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence            9999999999999998764 799999999999999999999999999999999999999999999999999988754432


Q ss_pred             --ccccccCCCccchhhhc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCC---cc
Q 016037          306 --SNSMCGTLEYMSPEIVL-------GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLP---AF  371 (396)
Q Consensus       306 --~~~~~gt~~y~APE~l~-------~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--~~~~p---~~  371 (396)
                        ....+||+.|+|||++.       +..++.++|||||||++|||++|+.||.+.+..+++.+|...  .+.+|   ..
T Consensus       218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  297 (412)
T 2vd5_A          218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEG  297 (412)
T ss_dssp             EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----C
T ss_pred             cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccC
Confidence              34568999999999997       456899999999999999999999999999999999888763  34455   57


Q ss_pred             CCHHHHHHHHHhhccCCCCCC
Q 016037          372 LSSEAHSLLKGVNSLLSISVP  392 (396)
Q Consensus       372 ~s~~~~~li~~~l~~~p~~RP  392 (396)
                      +|+++++||++||+ +|.+|+
T Consensus       298 ~s~~~~dli~~lL~-~p~~Rl  317 (412)
T 2vd5_A          298 VPEEARDFIQRLLC-PPETRL  317 (412)
T ss_dssp             CCHHHHHHHHTTSS-CGGGCT
T ss_pred             CCHHHHHHHHHHcC-ChhhcC
Confidence            99999999999999 999985

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=9.7e-49  Score=372.97  Aligned_cols=247  Identities=26%  Similarity=0.439  Sum_probs=218.2

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +..++|++++.||+|+||.||+|++..+++.||+|++...........+.+.+|+.++++++||||+++++++.....+|
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   87 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY   87 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence            34578999999999999999999999999999999997765555666778899999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC--
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--  304 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~--  304 (396)
                      +||||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||+++......  
T Consensus        88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  167 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT  167 (294)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999998765432  


Q ss_pred             CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----CCccCCHHHHHH
Q 016037          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-----LPAFLSSEAHSL  379 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~-----~p~~~s~~~~~l  379 (396)
                      .....+||+.|+|||++.+..++.++||||||+++|+|+||+.||.+.+......+.......     ++..++..+.++
T Consensus       168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  247 (294)
T 4eqm_A          168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNV  247 (294)
T ss_dssp             -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHH
T ss_pred             ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHH
Confidence            234467999999999999999999999999999999999999999998887777776665432     346799999999


Q ss_pred             HHHhhccCCCCCCC
Q 016037          380 LKGVNSLLSISVPL  393 (396)
Q Consensus       380 i~~~l~~~p~~RPs  393 (396)
                      |.+||+.+|.+||+
T Consensus       248 i~~~l~~dp~~R~~  261 (294)
T 4eqm_A          248 ILRATEKDKANRYK  261 (294)
T ss_dssp             HHHHSCSSGGGSCS
T ss_pred             HHHHhcCCHhHccc
Confidence            99999999999995

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.9e-48  Score=369.87  Aligned_cols=249  Identities=28%  Similarity=0.509  Sum_probs=230.6

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+....|+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            34679999999999999999999999999999999987765556667778899999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-CCc
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRS  306 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-~~~  306 (396)
                      ||||+++++|.+++...+.+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++..... ...
T Consensus        93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  172 (294)
T 2rku_A           93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK  172 (294)
T ss_dssp             EEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcccc
Confidence            9999999999999988889999999999999999999999999999999999999999999999999999876532 334


Q ss_pred             cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhcc
Q 016037          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSL  386 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~  386 (396)
                      ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+......+|..++.++.+||++||+.
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  252 (294)
T 2rku_A          173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQT  252 (294)
T ss_dssp             CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHHccc
Confidence            55679999999999999889999999999999999999999999999989899999989999999999999999999999


Q ss_pred             CCCCCCCCCC
Q 016037          387 LSISVPLLSR  396 (396)
Q Consensus       387 ~p~~RPs~s~  396 (396)
                      +|.+|||+.+
T Consensus       253 ~p~~Rps~~~  262 (294)
T 2rku_A          253 DPTARPTINE  262 (294)
T ss_dssp             SGGGSCCGGG
T ss_pred             ChhhCcCHHH
Confidence            9999999864

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.6e-49  Score=407.45  Aligned_cols=248  Identities=35%  Similarity=0.596  Sum_probs=227.5

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +..++|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+++|+.++||||++++++|.+...+|
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            55678999999999999999999999999999999998765544455666788999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          227 LVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      +||||++||+|..++...+.  +++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++......
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence            99999999999999887544  9999999999999999999999999999999999999999999999999999887665


Q ss_pred             CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCCCCCccCCHHHHHHH
Q 016037          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKDKIKLPAFLSSEAHSLL  380 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~----~~~~i~~~i~~~~~~~p~~~s~~~~~li  380 (396)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.    ....+...+......+|..+|.++++||
T Consensus       341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dLI  420 (576)
T 2acx_A          341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLC  420 (576)
T ss_dssp             CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence            556679999999999999989999999999999999999999999875    4577888888888889999999999999


Q ss_pred             HHhhccCCCCCCCC
Q 016037          381 KGVNSLLSISVPLL  394 (396)
Q Consensus       381 ~~~l~~~p~~RPs~  394 (396)
                      ++||+.||.+||+.
T Consensus       421 ~~lL~~dP~~R~g~  434 (576)
T 2acx_A          421 SQLLCKDPAERLGC  434 (576)
T ss_dssp             HHHTCSSGGGSTTC
T ss_pred             HHhccCCHHHcCCC
Confidence            99999999999953

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.7e-48  Score=378.02  Aligned_cols=248  Identities=28%  Similarity=0.511  Sum_probs=230.7

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|.+.+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+...+|+|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            46799999999999999999999999999999999877655566677788999999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-CCcc
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSN  307 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-~~~~  307 (396)
                      |||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus       120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  199 (335)
T 2owb_A          120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK  199 (335)
T ss_dssp             ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccccc
Confidence            999999999999988889999999999999999999999999999999999999999999999999999876532 3345


Q ss_pred             ccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccC
Q 016037          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLL  387 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~  387 (396)
                      ..+||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+......+|..++.++.+||++||+.|
T Consensus       200 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  279 (335)
T 2owb_A          200 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD  279 (335)
T ss_dssp             CCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred             ccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHccCC
Confidence            56799999999999998899999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCC
Q 016037          388 SISVPLLSR  396 (396)
Q Consensus       388 p~~RPs~s~  396 (396)
                      |.+|||+.+
T Consensus       280 p~~Rps~~e  288 (335)
T 2owb_A          280 PTARPTINE  288 (335)
T ss_dssp             GGGSCCGGG
T ss_pred             hhHCcCHHH
Confidence            999999864

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.4e-48  Score=366.77  Aligned_cols=246  Identities=30%  Similarity=0.525  Sum_probs=226.2

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++...... ....+.+.+|+.++++++||||+++++++......|+|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            46899999999999999999999999999999999876543 34456688999999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc---EEEEecccccccCCCCC
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH---VMLTDFGLAKQFDENTR  305 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~---ikL~Dfgla~~~~~~~~  305 (396)
                      |||+++++|...+...+.+++..++.++.|++.||.|||++||+||||||+||+++.++.   +||+|||++........
T Consensus        84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  163 (284)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence            999999999999999899999999999999999999999999999999999999987665   99999999988776666


Q ss_pred             ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHH
Q 016037          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLK  381 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~~~s~~~~~li~  381 (396)
                      .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+......+|    ..+++++.+||+
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (284)
T 3kk8_A          164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID  243 (284)
T ss_dssp             CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHH
T ss_pred             ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHH
Confidence            6677899999999999999999999999999999999999999999999999999988876655    478999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      .||+.+|.+|||+.
T Consensus       244 ~~l~~dp~~Rps~~  257 (284)
T 3kk8_A          244 SMLTVNPKKRITAD  257 (284)
T ss_dssp             HHSCSSTTTSCCHH
T ss_pred             HHcccChhhCCCHH
Confidence            99999999999964

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=8.7e-49  Score=382.92  Aligned_cols=246  Identities=30%  Similarity=0.525  Sum_probs=216.6

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchh--hHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK--NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      .++|++.+.||+|+||+||+|.++.+++.||+|++........  ...+.+.+|+.+++.++||||+++++++.+...+|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            3579999999999999999999999999999999976432211  13456889999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc---EEEEecccccc
Q 016037          227 LVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH---VMLTDFGLAKQ  299 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~---ikL~Dfgla~~  299 (396)
                      +||||++|++|.+.+.+.    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++.
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            999999999998777544    25899999999999999999999999999999999999987654   99999999988


Q ss_pred             cCCCCC-ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCH
Q 016037          300 FDENTR-SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSS  374 (396)
Q Consensus       300 ~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~~~s~  374 (396)
                      ...... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+. ...+...+..+...++    ..++.
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~~s~  261 (351)
T 3c0i_A          183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSHISE  261 (351)
T ss_dssp             CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred             ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccccCCH
Confidence            765433 45568999999999999999999999999999999999999999874 5677788888877665    46899


Q ss_pred             HHHHHHHHhhccCCCCCCCCC
Q 016037          375 EAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       375 ~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ++++||++||+.||.+|||+.
T Consensus       262 ~~~~li~~~L~~dP~~R~s~~  282 (351)
T 3c0i_A          262 SAKDLVRRMLMLDPAERITVY  282 (351)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHHHHHCCCChhHCcCHH
Confidence            999999999999999999864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9.2e-49  Score=370.18  Aligned_cols=248  Identities=31%  Similarity=0.623  Sum_probs=228.7

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +..++|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+...+|
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY   90 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence            55678999999999999999999999999999999998755434444566889999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCc
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS  306 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~  306 (396)
                      +||||+++++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ..
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-~~  169 (284)
T 2vgo_A           91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-RR  169 (284)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-CB
T ss_pred             EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-cc
Confidence            99999999999999998889999999999999999999999999999999999999999999999999999766433 33


Q ss_pred             cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhcc
Q 016037          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSL  386 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~  386 (396)
                      ...+||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+......+|..++.++++||++||+.
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  249 (284)
T 2vgo_A          170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRY  249 (284)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHSCS
T ss_pred             ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHHHhhc
Confidence            45679999999999999989999999999999999999999999999999999999989999999999999999999999


Q ss_pred             CCCCCCCCC
Q 016037          387 LSISVPLLS  395 (396)
Q Consensus       387 ~p~~RPs~s  395 (396)
                      +|.+||+++
T Consensus       250 ~p~~Rps~~  258 (284)
T 2vgo_A          250 HPPQRLPLK  258 (284)
T ss_dssp             SGGGSCCHH
T ss_pred             CHhhCCCHH
Confidence            999999964

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=8.4e-49  Score=368.40  Aligned_cols=250  Identities=28%  Similarity=0.482  Sum_probs=220.5

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~  225 (396)
                      .+..++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++......
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (276)
T 2h6d_A            7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF   86 (276)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence            35567899999999999999999999999999999999875544444566788999999999999999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~  305 (396)
                      |+||||+++++|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  166 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  166 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred             EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence            99999999999999999888999999999999999999999999999999999999999999999999999988766555


Q ss_pred             ccccccCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhh
Q 016037          306 SNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVN  384 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l  384 (396)
                      .....||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||.+.+...+.+.+......+|..++.++.+||++||
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  246 (276)
T 2h6d_A          167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHML  246 (276)
T ss_dssp             ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred             eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHHHc
Confidence            556789999999999988765 6899999999999999999999999999999999999988999999999999999999


Q ss_pred             ccCCCCCCCCC
Q 016037          385 SLLSISVPLLS  395 (396)
Q Consensus       385 ~~~p~~RPs~s  395 (396)
                      +.||.+|||+.
T Consensus       247 ~~~p~~Rps~~  257 (276)
T 2h6d_A          247 QVDPLKRATIK  257 (276)
T ss_dssp             CSSGGGSCCHH
T ss_pred             cCChhhCCCHH
Confidence            99999999974

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=8e-49  Score=376.60  Aligned_cols=249  Identities=22%  Similarity=0.389  Sum_probs=212.1

Q ss_pred             CccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC
Q 016037          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (396)
Q Consensus       144 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~  223 (396)
                      ...+..++|++.+.||+|+||+||+|++  ++..||+|++..... .....+.+.+|+.++++++||||+++++++....
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP  107 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            3446678999999999999999999988  577899999987653 3344566888999999999999999999999999


Q ss_pred             eEEEEEEecCCCcHHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEcCCCcEEEEeccccc
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQGL---FREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLDADGHVMLTDFGLAK  298 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~~LH~~~--iiHrDlkp~NILl~~~~~ikL~Dfgla~  298 (396)
                      .+|+||||+++|+|.+++.+.+.   +++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+++
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR  187 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred             ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence            99999999999999999986543   899999999999999999999999  9999999999999999999999999998


Q ss_pred             ccCCCC-CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHH
Q 016037          299 QFDENT-RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK--DKIKLPAFLSSE  375 (396)
Q Consensus       299 ~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~--~~~~~p~~~s~~  375 (396)
                      ...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+..  ....+|..++++
T Consensus       188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (309)
T 3p86_A          188 LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ  267 (309)
T ss_dssp             --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHH
Confidence            654332 23456799999999999999999999999999999999999999999998888877754  366788999999


Q ss_pred             HHHHHHHhhccCCCCCCCCC
Q 016037          376 AHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       376 ~~~li~~~l~~~p~~RPs~s  395 (396)
                      +.+||++||+.+|.+|||+.
T Consensus       268 l~~li~~~l~~dP~~Rps~~  287 (309)
T 3p86_A          268 VAAIIEGCWTNEPWKRPSFA  287 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHccCChhhCcCHH
Confidence            99999999999999999974

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.5e-48  Score=365.66  Aligned_cols=243  Identities=29%  Similarity=0.496  Sum_probs=224.8

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|++.+.||+|+||.||+|.+..++..+|+|++.....   ...+.+.+|+.++++++||||+++++++......|+|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV   84 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence            3579999999999999999999999999999999976542   2245678899999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE---cCCCcEEEEecccccccCCCCC
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl---~~~~~ikL~Dfgla~~~~~~~~  305 (396)
                      |||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++........
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~  164 (277)
T 3f3z_A           85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM  164 (277)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence            9999999999999998999999999999999999999999999999999999999   7889999999999998776666


Q ss_pred             ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHH
Q 016037          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLK  381 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~----~~s~~~~~li~  381 (396)
                      .....||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+.+..++...+..+...+|.    .+++++.+||+
T Consensus       165 ~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (277)
T 3f3z_A          165 MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIR  243 (277)
T ss_dssp             BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHH
T ss_pred             hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHH
Confidence            6777899999999998765 899999999999999999999999999999999999999888885    68999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      +||+.+|.+|||+.
T Consensus       244 ~~l~~dp~~R~s~~  257 (277)
T 3f3z_A          244 RLLTKSPKQRITSL  257 (277)
T ss_dssp             HHTCSSTTTSCCHH
T ss_pred             HHccCChhhCcCHH
Confidence            99999999999864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5.7e-49  Score=377.11  Aligned_cols=247  Identities=26%  Similarity=0.419  Sum_probs=214.6

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC----
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY----  223 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~----  223 (396)
                      ..++|++.+.||+|+||.||+|++..+++.||+|+++..........+.+.+|+.++++++||||+++++++....    
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            3568999999999999999999999999999999998866555666777889999999999999999999987654    


Q ss_pred             eEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      ..|+||||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  169 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS  169 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence            35999999999999999998899999999999999999999999999999999999999999999999999999876443


Q ss_pred             C----CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHH
Q 016037          304 T----RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSE  375 (396)
Q Consensus       304 ~----~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~~~s~~  375 (396)
                      .    .....+||+.|+|||++.+..++.++||||||+++|||++|+.||.+.+.......+.......+    ..++.+
T Consensus       170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (311)
T 3ork_A          170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD  249 (311)
T ss_dssp             ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHH
T ss_pred             ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHH
Confidence            2    23345789999999999999999999999999999999999999999998888877777655443    459999


Q ss_pred             HHHHHHHhhccCCCCCCCC
Q 016037          376 AHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       376 ~~~li~~~l~~~p~~RPs~  394 (396)
                      +.+||.+||+.||.+||+.
T Consensus       250 l~~li~~~l~~dP~~R~~~  268 (311)
T 3ork_A          250 LDAVVLKALAKNPENRYQT  268 (311)
T ss_dssp             HHHHHHHHTCSSGGGSCSS
T ss_pred             HHHHHHHHHhcCHhhChhh
Confidence            9999999999999999985

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.8e-48  Score=383.55  Aligned_cols=248  Identities=20%  Similarity=0.371  Sum_probs=220.4

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcC-------CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIG-------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRY  217 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~  217 (396)
                      .+..++|++.+.||+|+||+||+|++..       ++..||+|+++...  .....+.+.+|+.+++.+ +||||+++++
T Consensus        77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            4556889999999999999999999853       45679999997653  334566788999999999 8999999999


Q ss_pred             EEEecCeEEEEEEecCCCcHHHHHHHhc----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCE
Q 016037          218 SFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENI  281 (396)
Q Consensus       218 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NI  281 (396)
                      ++.....+|+||||+++|+|.+++...+                .+++..++.++.||+.||.|||++||+||||||+||
T Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  234 (370)
T 2psq_A          155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  234 (370)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence            9999999999999999999999998754                478899999999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecccccccCCCC---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 016037          282 LLDADGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKI  357 (396)
Q Consensus       282 Ll~~~~~ikL~Dfgla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i  357 (396)
                      |++.++++||+|||+++......   ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~  314 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  314 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            99999999999999998765432   2334567889999999999999999999999999999999 9999999988888


Q ss_pred             HHHHHhC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          358 QQKIIKD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       358 ~~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ...+..+ +...|..++.++.+||++||+.+|.+||++.
T Consensus       315 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~  353 (370)
T 2psq_A          315 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFK  353 (370)
T ss_dssp             HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence            8888776 5678889999999999999999999999974

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.7e-48  Score=381.07  Aligned_cols=245  Identities=29%  Similarity=0.468  Sum_probs=206.2

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      ...++|++++.||+|+||+||+|+++.+++.||+|++......    .+.+.+|+.+++.++||||+++++++.+...+|
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   92 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLA   92 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence            3457899999999999999999999999999999999765422    244678999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc--EEEEecccccccCCCC
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH--VMLTDFGLAKQFDENT  304 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~--ikL~Dfgla~~~~~~~  304 (396)
                      +||||+++|+|..++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus        93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~  172 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  172 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence            99999999999999998899999999999999999999999999999999999999987765  9999999998655555


Q ss_pred             CccccccCCCccchhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCCCc--cCCHHHH
Q 016037          305 RSNSMCGTLEYMSPEIVLGKGHDKA-ADWWSVGILLFEMLTGQPPFTGGN----RQKIQQKIIKDKIKLPA--FLSSEAH  377 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~-~DvwSlGvil~elltg~~Pf~~~~----~~~i~~~i~~~~~~~p~--~~s~~~~  377 (396)
                      .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+    .....+.+......+|.  .+++++.
T Consensus       173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  252 (361)
T 3uc3_A          173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECC  252 (361)
T ss_dssp             --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHH
T ss_pred             CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHH
Confidence            5566789999999999988887655 899999999999999999998743    35666667777666665  6899999


Q ss_pred             HHHHHhhccCCCCCCCCC
Q 016037          378 SLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       378 ~li~~~l~~~p~~RPs~s  395 (396)
                      +||++||+.+|.+|||+.
T Consensus       253 ~li~~~L~~dP~~Rps~~  270 (361)
T 3uc3_A          253 HLISRIFVADPATRISIP  270 (361)
T ss_dssp             HHHHHHSCSCTTTSCCHH
T ss_pred             HHHHHHccCChhHCcCHH
Confidence            999999999999999964

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.6e-48  Score=367.85  Aligned_cols=245  Identities=23%  Similarity=0.429  Sum_probs=210.8

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++++.||+|+||+||+|+++.+++.||+|++..... .....+.+.+|+.++++++||||+++++++.+...+|+||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            579999999999999999999999999999999987553 3344566788999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-CCccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNS  308 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-~~~~~  308 (396)
                      ||++++.+..+....+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus        81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (292)
T 3o0g_A           81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCS
T ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccC
Confidence            99998655555555788999999999999999999999999999999999999999999999999999876533 33455


Q ss_pred             cccCCCccchhhhcCCC-CCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhC----------------------
Q 016037          309 MCGTLEYMSPEIVLGKG-HDKAADWWSVGILLFEMLTGQPP-FTGGNRQKIQQKIIKD----------------------  364 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~-~~~~~DvwSlGvil~elltg~~P-f~~~~~~~i~~~i~~~----------------------  364 (396)
                      .+||+.|+|||++.+.. ++.++|||||||++|||++|..| |.+.+..+....+...                      
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  240 (292)
T 3o0g_A          161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP  240 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred             CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccc
Confidence            67899999999998765 89999999999999999997777 5666666666666542                      


Q ss_pred             -------CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 -------KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 -------~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                             ...+.+.++.++++||++||+.||.+|||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  278 (292)
T 3o0g_A          241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE  278 (292)
T ss_dssp             CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             cccCCcchhhcccccChHHHHHHHHHhccChhhCCCHH
Confidence                   0112345899999999999999999999964

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.1e-48  Score=370.49  Aligned_cols=248  Identities=28%  Similarity=0.505  Sum_probs=213.7

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccch-----------------------hhHHHHHHHHHHH
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-----------------------KNHAEYMKSERNI  203 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~-----------------------~~~~~~~~~E~~~  203 (396)
                      +..++|++.+.||+|+||.||+|++..+++.||+|++.......                       ....+.+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            45678999999999999999999999999999999997654321                       1123567889999


Q ss_pred             HHhCCCCCeeeeeEEEEe--cCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCE
Q 016037          204 LTKVDHPFIVQLRYSFQT--KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENI  281 (396)
Q Consensus       204 L~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NI  281 (396)
                      |+.++||||+++++++..  ...+|+||||+++++|..++ ..+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL  168 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            999999999999999986  67899999999999987644 346799999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecccccccCCCC-CccccccCCCccchhhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 016037          282 LLDADGHVMLTDFGLAKQFDENT-RSNSMCGTLEYMSPEIVLGKG---HDKAADWWSVGILLFEMLTGQPPFTGGNRQKI  357 (396)
Q Consensus       282 Ll~~~~~ikL~Dfgla~~~~~~~-~~~~~~gt~~y~APE~l~~~~---~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i  357 (396)
                      |++.++++||+|||+++...... .....+||+.|+|||++.+..   ++.++|||||||++|+|++|+.||.+.+...+
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  248 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL  248 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence            99999999999999998775433 234568999999999998765   37889999999999999999999999998888


Q ss_pred             HHHHHhCCCCCC--ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          358 QQKIIKDKIKLP--AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       358 ~~~i~~~~~~~p--~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ...+......+|  ..+++++.+||++||+.||.+|||+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~  288 (298)
T 2zv2_A          249 HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVP  288 (298)
T ss_dssp             HHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred             HHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHH
Confidence            888888876665  47999999999999999999999964

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-48  Score=384.97  Aligned_cols=244  Identities=25%  Similarity=0.471  Sum_probs=221.0

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|++++.||+|+||.||+|.++.+++.||+|++....   ......+.+|+.+|+.++||||+++++++.+...+|+|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  126 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  126 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence            468999999999999999999999999999999997653   22344678899999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC--CCcEEEEecccccccCCCCC
Q 016037          229 LDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA--DGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~--~~~ikL~Dfgla~~~~~~~~  305 (396)
                      |||+.+|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++.......
T Consensus       127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence            99999999999887654 7899999999999999999999999999999999999974  47899999999998766555


Q ss_pred             ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHH
Q 016037          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLK  381 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~~~s~~~~~li~  381 (396)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+......++    ..++.++++||+
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  286 (387)
T 1kob_A          207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK  286 (387)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHH
T ss_pred             eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHH
Confidence            5567899999999999999999999999999999999999999999999898999988766554    468999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      +||+.||.+|||+.
T Consensus       287 ~~L~~dP~~Rpt~~  300 (387)
T 1kob_A          287 NLLQKEPRKRLTVH  300 (387)
T ss_dssp             TTSCSSGGGSCCHH
T ss_pred             HHcCCChhHCcCHH
Confidence            99999999999964

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=8.6e-48  Score=393.49  Aligned_cols=247  Identities=31%  Similarity=0.494  Sum_probs=222.4

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchh----------hHHHHHHHHHHHHHhCCCCCeeeeeE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK----------NHAEYMKSERNILTKVDHPFIVQLRY  217 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~----------~~~~~~~~E~~~L~~l~HpnIv~l~~  217 (396)
                      ..++|+++++||+|+||+||+|.++.+++.||+|++.+......          ...+.+.+|+.+|+.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            34689999999999999999999999999999999987543221          23466888999999999999999999


Q ss_pred             EEEecCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC---cEEEEec
Q 016037          218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG---HVMLTDF  294 (396)
Q Consensus       218 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~---~ikL~Df  294 (396)
                      ++.+...+|+||||+++|+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+||
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence            9999999999999999999999999999999999999999999999999999999999999999998876   6999999


Q ss_pred             ccccccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----c
Q 016037          295 GLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----A  370 (396)
Q Consensus       295 gla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~  370 (396)
                      |+++...........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..++...+..+.+.++    .
T Consensus       194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  272 (504)
T 3q5i_A          194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWK  272 (504)
T ss_dssp             TTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHT
T ss_pred             CCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccC
Confidence            99998876666677889999999999875 589999999999999999999999999999999999999988776    5


Q ss_pred             cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          371 FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       371 ~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .+|.++++||+.||+.||.+|||+.
T Consensus       273 ~~s~~~~~li~~~L~~dp~~R~t~~  297 (504)
T 3q5i_A          273 NISDEAKELIKLMLTYDYNKRCTAE  297 (504)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             CCCHHHHHHHHHHcCCChhHCCCHH
Confidence            7999999999999999999999964

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.5e-48  Score=373.27  Aligned_cols=247  Identities=28%  Similarity=0.458  Sum_probs=225.7

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchh---hHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK---NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~  225 (396)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++........   ...+.+.+|+.++++++||||+++++++.+...+
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            3579999999999999999999999999999999987543221   1356688899999999999999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC----cEEEEecccccccC
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG----HVMLTDFGLAKQFD  301 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~----~ikL~Dfgla~~~~  301 (396)
                      |+||||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++    ++||+|||+++...
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~  170 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence            99999999999999999888899999999999999999999999999999999999999888    89999999999877


Q ss_pred             CCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHH
Q 016037          302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAH  377 (396)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~~~s~~~~  377 (396)
                      .........||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+......++    ..++.++.
T Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  250 (321)
T 2a2a_A          171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAK  250 (321)
T ss_dssp             TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHH
T ss_pred             ccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHH
Confidence            66556667899999999999999999999999999999999999999999999999999988877666    46899999


Q ss_pred             HHHHHhhccCCCCCCCCC
Q 016037          378 SLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       378 ~li~~~l~~~p~~RPs~s  395 (396)
                      +||++||+.||.+|||+.
T Consensus       251 ~li~~~l~~dp~~Rps~~  268 (321)
T 2a2a_A          251 DFIRKLLVKETRKRLTIQ  268 (321)
T ss_dssp             HHHHTTSCSSTTTSCCHH
T ss_pred             HHHHHHcCCChhhCcCHH
Confidence            999999999999999964

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=8.4e-49  Score=386.63  Aligned_cols=252  Identities=22%  Similarity=0.370  Sum_probs=223.0

Q ss_pred             CCCccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe
Q 016037          142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (396)
Q Consensus       142 ~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~  221 (396)
                      ...+.+..++|++.+.||+|+||+||+|+++.+++.||||+++...  .....+.+.+|+++|++++||||+++++++..
T Consensus       106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  183 (377)
T 3cbl_A          106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ  183 (377)
T ss_dssp             CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec
Confidence            3455677789999999999999999999999999999999987542  23444567889999999999999999999999


Q ss_pred             cCeEEEEEEecCCCcHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccccc
Q 016037          222 KYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~  300 (396)
                      ...+|+||||+++|+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       184 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~  263 (377)
T 3cbl_A          184 KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREE  263 (377)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence            999999999999999999997654 6899999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCCc---cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHH
Q 016037          301 DENTRS---NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSE  375 (396)
Q Consensus       301 ~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~  375 (396)
                      ......   ....+++.|+|||++.+..++.++|||||||++|||+| |..||.+.+..++...+..+ +++.|..++.+
T Consensus       264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (377)
T 3cbl_A          264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDA  343 (377)
T ss_dssp             TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            433211   22235778999999998889999999999999999999 99999999988888877765 67788899999


Q ss_pred             HHHHHHHhhccCCCCCCCCC
Q 016037          376 AHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       376 ~~~li~~~l~~~p~~RPs~s  395 (396)
                      +.+||+.||+.+|.+|||+.
T Consensus       344 l~~li~~cl~~dP~~Rps~~  363 (377)
T 3cbl_A          344 VFRLMEQCWAYEPGQRPSFS  363 (377)
T ss_dssp             HHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHcCCCchhCcCHH
Confidence            99999999999999999964

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1e-48  Score=398.05  Aligned_cols=248  Identities=31%  Similarity=0.533  Sum_probs=227.5

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +..++|++.+.||+|+||.||+|+++.+++.||||++.+.........+.+.+|+.++++++||||+++++++.....+|
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            34468999999999999999999999999999999998765544455677889999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE---cCCCcEEEEecccccccCCC
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl---~~~~~ikL~Dfgla~~~~~~  303 (396)
                      +||||+.+|+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.+...
T Consensus       103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            999999999999999999999999999999999999999999999999999999999   56789999999999988766


Q ss_pred             CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHH
Q 016037          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSL  379 (396)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~~~s~~~~~l  379 (396)
                      ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..++..++..+...++    ..+|+++++|
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  261 (484)
T 3nyv_A          183 KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL  261 (484)
T ss_dssp             CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHH
T ss_pred             cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHH
Confidence            66667789999999999987 599999999999999999999999999999999999999876554    4689999999


Q ss_pred             HHHhhccCCCCCCCCC
Q 016037          380 LKGVNSLLSISVPLLS  395 (396)
Q Consensus       380 i~~~l~~~p~~RPs~s  395 (396)
                      |++||+.+|.+|||+.
T Consensus       262 i~~~L~~dp~~R~s~~  277 (484)
T 3nyv_A          262 IRKMLTYVPSMRISAR  277 (484)
T ss_dssp             HHHHTCSSGGGSCCHH
T ss_pred             HHHHCCCChhHCcCHH
Confidence            9999999999999964

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5e-48  Score=382.06  Aligned_cols=247  Identities=21%  Similarity=0.315  Sum_probs=211.2

Q ss_pred             cCCCeEEEeEeccc--CceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE
Q 016037          148 GLEDFEVLKVVGQG--AFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       148 ~~~~~~~~~~IG~G--~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~  225 (396)
                      ..++|+++++||+|  +||+||+|+++.+++.||||++..... .....+.+.+|+.+++.++||||++++++|.+...+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL  101 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence            45689999999999  999999999999999999999987653 345567788999999999999999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          226 YLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      |+||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+......
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~  181 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH  181 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred             EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence            9999999999999999876  77999999999999999999999999999999999999999999999999998654221


Q ss_pred             --------CCccccccCCCccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------
Q 016037          304 --------TRSNSMCGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-------  366 (396)
Q Consensus       304 --------~~~~~~~gt~~y~APE~l~~--~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~-------  366 (396)
                              ......+||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+.+.......+..+.+       
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (389)
T 3gni_B          182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS  261 (389)
T ss_dssp             TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred             cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence                    12234578999999999987  6789999999999999999999999988665554444333211       


Q ss_pred             ---------------------------------------CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 ---------------------------------------KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 ---------------------------------------~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                                             .++..+++++.+||++||+.||.+|||+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~  329 (389)
T 3gni_B          262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAS  329 (389)
T ss_dssp             --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred             ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHH
Confidence                                                   24567899999999999999999999964

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1e-48  Score=368.46  Aligned_cols=247  Identities=32%  Similarity=0.566  Sum_probs=198.5

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++......|+|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            46799999999999999999999999999999999865544444456788999999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-CCc
Q 016037          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRS  306 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-~~~  306 (396)
                      |||+++++|..++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ...
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  169 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH  169 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcc
Confidence            9999999999988865 67899999999999999999999999999999999999999999999999999876532 223


Q ss_pred             cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhcc
Q 016037          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSL  386 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~  386 (396)
                      ....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+......++......+|..++.++.+||++||+.
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  249 (278)
T 3cok_A          170 YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRR  249 (278)
T ss_dssp             ----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHHSCS
T ss_pred             eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHHccc
Confidence            45679999999999998889999999999999999999999999887777777777777788999999999999999999


Q ss_pred             CCCCCCCCC
Q 016037          387 LSISVPLLS  395 (396)
Q Consensus       387 ~p~~RPs~s  395 (396)
                      ||.+|||++
T Consensus       250 dp~~Rps~~  258 (278)
T 3cok_A          250 NPADRLSLS  258 (278)
T ss_dssp             SGGGSCCHH
T ss_pred             CHhhCCCHH
Confidence            999999964

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.6e-48  Score=375.51  Aligned_cols=248  Identities=20%  Similarity=0.318  Sum_probs=218.5

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCc---EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE---IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      .+..++|++.+.||+|+||+||+|++..+++   .||||+++...  .....+.+.+|+.+++.++||||+++++++...
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  122 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG  122 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            4566889999999999999999999986554   59999997643  234456688999999999999999999999999


Q ss_pred             CeEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      ..+|+||||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999999998755 679999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCC----ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHH
Q 016037          302 ENTR----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSE  375 (396)
Q Consensus       302 ~~~~----~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~  375 (396)
                      ....    .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+.+..++...+... ....|..++.+
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHA  282 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHH
Confidence            4321    223346778999999998889999999999999999999 99999999999988888876 66778899999


Q ss_pred             HHHHHHHhhccCCCCCCCCC
Q 016037          376 AHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       376 ~~~li~~~l~~~p~~RPs~s  395 (396)
                      +.+||..||+.+|.+|||++
T Consensus       283 l~~li~~~l~~dp~~Rps~~  302 (325)
T 3kul_A          283 LHQLMLDCWHKDRAQRPRFS  302 (325)
T ss_dssp             HHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHccCChhhCcCHH
Confidence            99999999999999999974

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=378.45  Aligned_cols=240  Identities=27%  Similarity=0.456  Sum_probs=212.9

Q ss_pred             EEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEec
Q 016037          153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFV  232 (396)
Q Consensus       153 ~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~  232 (396)
                      ...+.||+|+||.||+|.+..+|+.||+|+++....   ...+.+.+|+.+|++++||||+++++++.....+|+||||+
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~  168 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV  168 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            336789999999999999999999999999987542   34456889999999999999999999999999999999999


Q ss_pred             CCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE--cCCCcEEEEecccccccCCCCCcccc
Q 016037          233 NGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL--DADGHVMLTDFGLAKQFDENTRSNSM  309 (396)
Q Consensus       233 ~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl--~~~~~ikL~Dfgla~~~~~~~~~~~~  309 (396)
                      ++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+  +.++++||+|||+++...........
T Consensus       169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~  248 (373)
T 2x4f_A          169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN  248 (373)
T ss_dssp             TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCC
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccc
Confidence            999998888654 468999999999999999999999999999999999999  56789999999999988766666667


Q ss_pred             ccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHhhc
Q 016037          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLKGVNS  385 (396)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~~~s~~~~~li~~~l~  385 (396)
                      +||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+......++    ..+++++.+||++||+
T Consensus       249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~  328 (373)
T 2x4f_A          249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLI  328 (373)
T ss_dssp             CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSC
T ss_pred             cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcC
Confidence            899999999999998899999999999999999999999999999999999998876665    4689999999999999


Q ss_pred             cCCCCCCCCC
Q 016037          386 LLSISVPLLS  395 (396)
Q Consensus       386 ~~p~~RPs~s  395 (396)
                      .||.+|||+.
T Consensus       329 ~dp~~Rps~~  338 (373)
T 2x4f_A          329 KEKSWRISAS  338 (373)
T ss_dssp             SSGGGSCCHH
T ss_pred             CChhhCCCHH
Confidence            9999999864

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4.7e-48  Score=393.59  Aligned_cols=248  Identities=30%  Similarity=0.536  Sum_probs=221.7

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~  225 (396)
                      +...++|++++.||+|+||+||+|+++.+++.||+|++.+..... ...+.+.+|+.+|++++||||+++++++.....+
T Consensus        18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   96 (486)
T 3mwu_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (486)
T ss_dssp             CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence            344578999999999999999999999999999999997644322 2345678899999999999999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc---CCCcEEEEecccccccCC
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD---ADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~---~~~~ikL~Dfgla~~~~~  302 (396)
                      |+||||+.+|+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.+..
T Consensus        97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            99999999999999999889999999999999999999999999999999999999995   456899999999988776


Q ss_pred             CCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHH
Q 016037          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHS  378 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~~~s~~~~~  378 (396)
                      .......+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..++...+..+...++    ..+|+++++
T Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  255 (486)
T 3mwu_A          177 NTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD  255 (486)
T ss_dssp             C----CCTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHH
T ss_pred             CCccCCCcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHH
Confidence            6666677899999999999864 99999999999999999999999999999999999998876544    468999999


Q ss_pred             HHHHhhccCCCCCCCCC
Q 016037          379 LLKGVNSLLSISVPLLS  395 (396)
Q Consensus       379 li~~~l~~~p~~RPs~s  395 (396)
                      ||++||+.+|.+|||+.
T Consensus       256 li~~~L~~dp~~R~t~~  272 (486)
T 3mwu_A          256 LIRKMLTFHPSLRITAT  272 (486)
T ss_dssp             HHHHHTCSSTTTSCCHH
T ss_pred             HHHHHcCCChhhCcCHH
Confidence            99999999999999964

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.2e-48  Score=377.91  Aligned_cols=243  Identities=33%  Similarity=0.534  Sum_probs=201.1

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++....     ..+.+.+|+.+|++++||||+++++++.....+|+
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            3467999999999999999999999999999999997643     23457789999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC---CCcEEEEecccccccCCCC
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~---~~~ikL~Dfgla~~~~~~~  304 (396)
                      ||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++......
T Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  205 (349)
T 2w4o_A          126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV  205 (349)
T ss_dssp             EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence            9999999999999988888999999999999999999999999999999999999975   8899999999998876555


Q ss_pred             CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCC----ccCCHHHHHH
Q 016037          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ-KIQQKIIKDKIKLP----AFLSSEAHSL  379 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~-~i~~~i~~~~~~~p----~~~s~~~~~l  379 (396)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.. .+...+......++    ..++.++.+|
T Consensus       206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  285 (349)
T 2w4o_A          206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDL  285 (349)
T ss_dssp             -------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred             ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHH
Confidence            556678999999999999989999999999999999999999999876544 46777777655443    4689999999


Q ss_pred             HHHhhccCCCCCCCCC
Q 016037          380 LKGVNSLLSISVPLLS  395 (396)
Q Consensus       380 i~~~l~~~p~~RPs~s  395 (396)
                      |++||+.||.+|||+.
T Consensus       286 i~~~L~~dP~~Rpt~~  301 (349)
T 2w4o_A          286 VRKLIVLDPKKRLTTF  301 (349)
T ss_dssp             HHTTSCSSGGGSCCHH
T ss_pred             HHHHccCChhhCcCHH
Confidence            9999999999999964

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.1e-48  Score=375.91  Aligned_cols=245  Identities=29%  Similarity=0.445  Sum_probs=210.5

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|++++.||+|+||+||+|++..+++.||+|++.....  ....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   83 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            4789999999999999999999999999999999976542  22335578899999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC---CC
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---TR  305 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~---~~  305 (396)
                      |||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...   ..
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  163 (323)
T 3tki_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (323)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence            999999999999988888999999999999999999999999999999999999999999999999999866432   22


Q ss_pred             ccccccCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCC--CccCCHHHHHHHH
Q 016037          306 SNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQ-KIQQKIIKDKIKL--PAFLSSEAHSLLK  381 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~-~i~~~i~~~~~~~--p~~~s~~~~~li~  381 (396)
                      ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.. ............+  ...++.++.+||+
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (323)
T 3tki_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  243 (323)
T ss_dssp             BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHH
Confidence            345689999999999988765 78899999999999999999999876543 3333333333332  3579999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      +||+.||.+|||+.
T Consensus       244 ~~L~~dP~~R~t~~  257 (323)
T 3tki_A          244 KILVENPSARITIP  257 (323)
T ss_dssp             HHSCSSTTTSCCHH
T ss_pred             HHccCChhhCcCHH
Confidence            99999999999964

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8.9e-48  Score=392.43  Aligned_cols=245  Identities=32%  Similarity=0.524  Sum_probs=218.2

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|++++.||+|+||+||+|+++.++..||+|++.+...... ..+.+.+|+.+++.++||||++++++|.+...+|+|
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3579999999999999999999999999999999987543222 245578899999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC---CcEEEEecccccccCCCCC
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD---GHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~---~~ikL~Dfgla~~~~~~~~  305 (396)
                      |||+.+|+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++..   +.+||+|||+++.+.....
T Consensus       115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~  194 (494)
T 3lij_A          115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK  194 (494)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence            9999999999999998999999999999999999999999999999999999999764   4599999999998876666


Q ss_pred             ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHH
Q 016037          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLK  381 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~~~s~~~~~li~  381 (396)
                      ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..++..++..+...++    ..+|+++++||+
T Consensus       195 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  273 (494)
T 3lij_A          195 MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIK  273 (494)
T ss_dssp             BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHH
T ss_pred             ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHH
Confidence            677889999999999874 599999999999999999999999999999999999999877665    368999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      +||+.+|.+|||+.
T Consensus       274 ~~L~~dp~~R~s~~  287 (494)
T 3lij_A          274 QMLQFDSQRRISAQ  287 (494)
T ss_dssp             HHTCSSTTTSCCHH
T ss_pred             HHCCCChhhCccHH
Confidence            99999999999964

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.4e-47  Score=361.30  Aligned_cols=246  Identities=30%  Similarity=0.495  Sum_probs=219.1

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchh---hHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK---NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      ++|++.+.||+|+||.||+|++..+++.||+|++........   ...+.+.+|+.++++++||||+++++++......|
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            569999999999999999999999999999999987543221   13566888999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC----cEEEEecccccccCC
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG----HVMLTDFGLAKQFDE  302 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~----~ikL~Dfgla~~~~~  302 (396)
                      +||||+++++|.+++.....+++..++.++.||+.||.|||++|++||||||+||+++.++    .+||+|||++.....
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~  164 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA  164 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence            9999999999999999888999999999999999999999999999999999999998887    899999999988766


Q ss_pred             CCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHH
Q 016037          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHS  378 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~~~s~~~~~  378 (396)
                      ........||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+......++    ..++.++.+
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (283)
T 3bhy_A          165 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKD  244 (283)
T ss_dssp             -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHH
T ss_pred             CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHH
Confidence            5555667799999999999998999999999999999999999999999998888888888776665    468999999


Q ss_pred             HHHHhhccCCCCCCCCC
Q 016037          379 LLKGVNSLLSISVPLLS  395 (396)
Q Consensus       379 li~~~l~~~p~~RPs~s  395 (396)
                      ||++||+.+|.+|||+.
T Consensus       245 li~~~l~~dp~~Rps~~  261 (283)
T 3bhy_A          245 FIRRLLVKDPKRRMTIA  261 (283)
T ss_dssp             HHHTTSCSSGGGSCCHH
T ss_pred             HHHHHccCCHhHCcCHH
Confidence            99999999999999964

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.6e-48  Score=371.97  Aligned_cols=245  Identities=20%  Similarity=0.326  Sum_probs=211.4

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~  225 (396)
                      .+..++|++.+.||+|+||+||+|.+..+++.||+|++...   .....+.+.+|+.++++++||||+++++++.+....
T Consensus         6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   82 (310)
T 3s95_A            6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL   82 (310)
T ss_dssp             EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence            35568999999999999999999999999999999998653   345566788999999999999999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          226 YLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      ++||||+++|+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            999999999999999987 5679999999999999999999999999999999999999999999999999998764332


Q ss_pred             Cc---------------cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhC
Q 016037          305 RS---------------NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQK-----IQQKIIKD  364 (396)
Q Consensus       305 ~~---------------~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~-----i~~~i~~~  364 (396)
                      ..               ...+||+.|+|||++.+..++.++||||||+++|||++|..||.......     ....... 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~-  241 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD-  241 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH-
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc-
Confidence            21               25679999999999999999999999999999999999999997632111     1111111 


Q ss_pred             CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 ~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                       ..+|..+++++.+||..||+.||.+|||+.
T Consensus       242 -~~~~~~~~~~l~~li~~~l~~dP~~Rps~~  271 (310)
T 3s95_A          242 -RYCPPNCPPSFFPITVRCCDLDPEKRPSFV  271 (310)
T ss_dssp             -HTCCTTCCTTHHHHHHHHTCSSGGGSCCHH
T ss_pred             -ccCCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence             235778999999999999999999999964

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3e-48  Score=378.18  Aligned_cols=240  Identities=30%  Similarity=0.497  Sum_probs=214.5

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCeEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~l  227 (396)
                      .++|++.+.||+|+||+||+|+++.+++.||+|++.+....       ..+|+.++.++ +||||+++++++.+...+|+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l   93 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV   93 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence            46799999999999999999999999999999999765421       34577778776 79999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC----CcEEEEecccccccCCC
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD----GHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~----~~ikL~Dfgla~~~~~~  303 (396)
                      ||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+..+    +.+||+|||+++.....
T Consensus        94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A           94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence            99999999999999998999999999999999999999999999999999999998543    35999999999876543


Q ss_pred             -CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhCCCCCC----ccCCHH
Q 016037          304 -TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG---GNRQKIQQKIIKDKIKLP----AFLSSE  375 (396)
Q Consensus       304 -~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~---~~~~~i~~~i~~~~~~~p----~~~s~~  375 (396)
                       ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+   .+..++...+..+.+.++    ..+|.+
T Consensus       174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  253 (342)
T 2qr7_A          174 NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT  253 (342)
T ss_dssp             TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHH
T ss_pred             CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHH
Confidence             334567899999999999888899999999999999999999999986   467888999998887765    468999


Q ss_pred             HHHHHHHhhccCCCCCCCCC
Q 016037          376 AHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       376 ~~~li~~~l~~~p~~RPs~s  395 (396)
                      +++||++||+.||.+||++.
T Consensus       254 ~~~li~~~L~~dP~~R~t~~  273 (342)
T 2qr7_A          254 AKDLVSKMLHVDPHQRLTAA  273 (342)
T ss_dssp             HHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHHHHCCCChhHCcCHH
Confidence            99999999999999999864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.1e-47  Score=371.23  Aligned_cols=241  Identities=31%  Similarity=0.566  Sum_probs=196.6

Q ss_pred             CCeEEE---eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEEEecCeE
Q 016037          150 EDFEVL---KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       150 ~~~~~~---~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~  225 (396)
                      ++|++.   +.||+|+||.||+|.++.+++.||+|++.+..      .....+|+.+++.+. ||||+++++++.+....
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~   81 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHT   81 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence            457765   78999999999999999999999999997532      344678999999997 99999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC---cEEEEecccccccCC
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG---HVMLTDFGLAKQFDE  302 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~---~ikL~Dfgla~~~~~  302 (396)
                      |+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~  161 (325)
T 3kn6_A           82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP  161 (325)
T ss_dssp             EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred             EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence            99999999999999999999999999999999999999999999999999999999998766   899999999987643


Q ss_pred             C-CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHhCCCCCCc----
Q 016037          303 N-TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG-------NRQKIQQKIIKDKIKLPA----  370 (396)
Q Consensus       303 ~-~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~-------~~~~i~~~i~~~~~~~p~----  370 (396)
                      . ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.       ...++..++..+.+.++.    
T Consensus       162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (325)
T 3kn6_A          162 DNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK  241 (325)
T ss_dssp             ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHH
T ss_pred             CCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccccc
Confidence            3 2345667899999999999999999999999999999999999999864       346788888888777763    


Q ss_pred             cCCHHHHHHHHHhhccCCCCCCCCCC
Q 016037          371 FLSSEAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       371 ~~s~~~~~li~~~l~~~p~~RPs~s~  396 (396)
                      .+++++++||++||+.||.+|||+++
T Consensus       242 ~~s~~~~~li~~~L~~dP~~Rpt~~e  267 (325)
T 3kn6_A          242 NVSQEAKDLIQGLLTVDPNKRLKMSG  267 (325)
T ss_dssp             TSCHHHHHHHHHHHCCCTTTCCCTTT
T ss_pred             CCCHHHHHHHHHHCCCChhHCCCHHH
Confidence            68999999999999999999999874

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-47  Score=363.53  Aligned_cols=245  Identities=28%  Similarity=0.461  Sum_probs=212.2

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      ..++|.+.+.||+|+||.||+|.+..++..+|+|++.....  ....+.+.+|+++++.++||||+++++++.+...+|+
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   97 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI   97 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence            34679999999999999999999999999999999987542  2235668889999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE---cCCCcEEEEeccccccc
Q 016037          228 VLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQF  300 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl---~~~~~ikL~Dfgla~~~  300 (396)
                      ||||+++|+|.+.+...    ..+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||+++..
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A           98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999999888543    679999999999999999999999999999999999999   55678999999999887


Q ss_pred             CCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---ccCCHHHH
Q 016037          301 DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP---AFLSSEAH  377 (396)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p---~~~s~~~~  377 (396)
                      .........+||+.|+|||++. ..++.++||||||+++|||++|+.||.+.+..++...+......++   ..+++++.
T Consensus       178 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (285)
T 3is5_A          178 KSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAV  256 (285)
T ss_dssp             ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHH
T ss_pred             CCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHH
Confidence            6666666778999999999986 4689999999999999999999999999999998888887765544   34899999


Q ss_pred             HHHHHhhccCCCCCCCCC
Q 016037          378 SLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       378 ~li~~~l~~~p~~RPs~s  395 (396)
                      +||++||+.||.+|||+.
T Consensus       257 ~li~~~L~~dP~~Rps~~  274 (285)
T 3is5_A          257 DLLKQMLTKDPERRPSAA  274 (285)
T ss_dssp             HHHHHHTCSCTTTSCCHH
T ss_pred             HHHHHHccCChhhCcCHH
Confidence            999999999999999974

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-48  Score=373.60  Aligned_cols=248  Identities=20%  Similarity=0.348  Sum_probs=220.0

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~  220 (396)
                      .+..++|++.+.||+|+||.||+|++..     +++.||+|+++...  .....+.+.+|+.++++++||||+++++++.
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            3456789999999999999999999974     45889999998653  2345567889999999999999999999999


Q ss_pred             ecCeEEEEEEecCCCcHHHHHHHh------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 016037          221 TKYRLYLVLDFVNGGHLFFQLYRQ------------------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDL  276 (396)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~------------------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDl  276 (396)
                      ....+|+||||+++|+|.+++...                        ..+++..++.++.||+.||.|||++||+||||
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl  200 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL  200 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            999999999999999999999764                        56899999999999999999999999999999


Q ss_pred             CCCCEEEcCCCcEEEEecccccccCCCC---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 016037          277 KPENILLDADGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGG  352 (396)
Q Consensus       277 kp~NILl~~~~~ikL~Dfgla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~  352 (396)
                      ||+|||++.++.+||+|||+++......   ......||+.|+|||++.+..++.++||||||+++|||+| |..||.+.
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            9999999999999999999998764332   2334568899999999998889999999999999999999 99999999


Q ss_pred             CHHHHHHHHHhCC-CCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          353 NRQKIQQKIIKDK-IKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       353 ~~~~i~~~i~~~~-~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +..++...+..+. ..+|..++.++.+||+.||+.+|.+||+++
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  324 (343)
T 1luf_A          281 AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFC  324 (343)
T ss_dssp             CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             ChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHH
Confidence            9999888888774 467889999999999999999999999964

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.5e-48  Score=371.36  Aligned_cols=247  Identities=27%  Similarity=0.405  Sum_probs=212.5

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC--e
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY--R  224 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~--~  224 (396)
                      +..++|++.+.||+|+||+||+|++..+++.||||++......  ...+.+.+|+.++++++||||+++++++....  .
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   83 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH   83 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence            3456899999999999999999999999999999999765432  23455678999999999999999999998755  8


Q ss_pred             EEEEEEecCCCcHHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE----cCCCcEEEEecccc
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGL---FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL----DADGHVMLTDFGLA  297 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl----~~~~~ikL~Dfgla  297 (396)
                      +|+||||+++++|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            8999999999999999986543   8999999999999999999999999999999999999    78888999999999


Q ss_pred             cccCCCCCccccccCCCccchhhhc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCC
Q 016037          298 KQFDENTRSNSMCGTLEYMSPEIVL--------GKGHDKAADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKDK  365 (396)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~--------~~~~~~~~DvwSlGvil~elltg~~Pf~~~----~~~~i~~~i~~~~  365 (396)
                      +...........+||+.|+|||++.        +..++.++|||||||++|||++|+.||...    ...++..++..+.
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (319)
T 4euu_A          164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (319)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred             eecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence            9887766666778999999999986        577899999999999999999999999743    2345555565543


Q ss_pred             C-------------------------CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 I-------------------------KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 ~-------------------------~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +                         .++..++..+.+||+.||+.||.+|||++
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~  298 (319)
T 4euu_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD  298 (319)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHH
T ss_pred             CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHH
Confidence            2                         23345677899999999999999999975

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.5e-47  Score=359.06  Aligned_cols=246  Identities=21%  Similarity=0.366  Sum_probs=219.2

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCe
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~  224 (396)
                      +.+..++|++.+.||+|+||.||+|.+.. +..||+|++......    .+.+.+|+.++++++||||+++++++.+...
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   79 (269)
T 4hcu_A            5 WVIDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP   79 (269)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             EEeChhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence            44667899999999999999999999974 667999999875432    2457889999999999999999999999999


Q ss_pred             EEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      .|+||||+++++|.+++... +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence            99999999999999998654 56899999999999999999999999999999999999999999999999999876433


Q ss_pred             C--CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHH
Q 016037          304 T--RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSL  379 (396)
Q Consensus       304 ~--~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~l  379 (396)
                      .  ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..++...+... ....|..++.++.+|
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (269)
T 4hcu_A          160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQI  239 (269)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred             ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHH
Confidence            2  2334456788999999998889999999999999999999 99999999999998888877 566778899999999


Q ss_pred             HHHhhccCCCCCCCCC
Q 016037          380 LKGVNSLLSISVPLLS  395 (396)
Q Consensus       380 i~~~l~~~p~~RPs~s  395 (396)
                      |+.||+.+|.+|||+.
T Consensus       240 i~~~l~~~p~~Rps~~  255 (269)
T 4hcu_A          240 MNHCWRERPEDRPAFS  255 (269)
T ss_dssp             HHHHTCSSGGGSCCHH
T ss_pred             HHHHccCCcccCcCHH
Confidence            9999999999999974

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.8e-48  Score=378.94  Aligned_cols=247  Identities=20%  Similarity=0.303  Sum_probs=216.6

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEE-----cCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRR-----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~  221 (396)
                      +..++|++++.||+|+||+||+|++     ..+++.||||+++...  .......+.+|+.++++++||||+++++++..
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  145 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  145 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            5567899999999999999999995     4567889999997543  23344557789999999999999999999999


Q ss_pred             cCeEEEEEEecCCCcHHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC---cEEE
Q 016037          222 KYRLYLVLDFVNGGHLFFQLYRQG-------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG---HVML  291 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~-------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~---~ikL  291 (396)
                      ....|+||||+++|+|.+++...+       .+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence            999999999999999999998764       488999999999999999999999999999999999999655   5999


Q ss_pred             EecccccccCC---CCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CC
Q 016037          292 TDFGLAKQFDE---NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KI  366 (396)
Q Consensus       292 ~Dfgla~~~~~---~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~  366 (396)
                      +|||+++....   ........||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+..++...+..+ ..
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~  305 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM  305 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            99999986532   223345678999999999998899999999999999999998 99999999999998888876 46


Q ss_pred             CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 ~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ..|..++.++.+||++||+.+|.+|||+.
T Consensus       306 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~  334 (367)
T 3l9p_A          306 DPPKNCPGPVYRIMTQCWQHQPEDRPNFA  334 (367)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCccCCHHHHHHHHHHcCCCHhHCcCHH
Confidence            77889999999999999999999999974

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=8.2e-48  Score=370.44  Aligned_cols=244  Identities=27%  Similarity=0.434  Sum_probs=197.6

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|++++.||+|+||+||+|.++.+++.||+|+++...  .....+.+.+|+.+++.++||||+++++++..+..+|+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   81 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV   81 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence            467999999999999999999999999999999997654  222334567899999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          229 LDFVNGGHLFFQLYRQ------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      |||+++ +|..++...      ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           82 FEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI  160 (317)
T ss_dssp             EECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred             EEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence            999985 888888654      3589999999999999999999999999999999999999999999999999987653


Q ss_pred             C-CCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC------------
Q 016037          303 N-TRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KI------------  366 (396)
Q Consensus       303 ~-~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--~~------------  366 (396)
                      . ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+...  ..            
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (317)
T 2pmi_A          161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP  240 (317)
T ss_dssp             CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred             CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence            3 23345679999999999986 46899999999999999999999999998888777776541  00            


Q ss_pred             --------------------CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 --------------------KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 --------------------~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                          ..+..++.++.+||++||+.||.+|||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  289 (317)
T 2pmi_A          241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAK  289 (317)
T ss_dssp             TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHH
Confidence                                01235789999999999999999999964

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.7e-47  Score=364.51  Aligned_cols=246  Identities=28%  Similarity=0.409  Sum_probs=209.1

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|++++.||+|+||+||+|++..+++.||+|++..... .....+.+.+|+.++++++||||+++++++......++|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            3689999999999999999999999999999999876542 334456678899999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-CCcc
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSN  307 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-~~~~  307 (396)
                      |||+++++|..++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD  160 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence            999999999998888888999999999999999999999999999999999999999999999999999876533 2334


Q ss_pred             ccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------------CC
Q 016037          308 SMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-------------------IK  367 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~-------------------~~  367 (396)
                      ..+||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+....                   ..
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK  240 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence            5679999999999976 668999999999999999999999999988776666554320                   11


Q ss_pred             CC------------ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          368 LP------------AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       368 ~p------------~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +|            +.++.++.+||++||+.||.+|||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  280 (311)
T 4agu_A          241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCE  280 (311)
T ss_dssp             CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHH
T ss_pred             CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHH
Confidence            11            35899999999999999999999974

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4.3e-47  Score=370.75  Aligned_cols=242  Identities=26%  Similarity=0.386  Sum_probs=215.1

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      +.|++++.||+|+||+||+|++..+++.||||++...........+.+.+|+.++++++||||+++++++......|+||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45999999999999999999999999999999998765555566677889999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHH-HhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccc
Q 016037          230 DFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (396)
Q Consensus       230 E~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~  308 (396)
                      ||+.| +|.+.+. ....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....   ...
T Consensus       134 e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~~~  209 (348)
T 1u5q_A          134 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANS  209 (348)
T ss_dssp             ECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCC
T ss_pred             ecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---CCc
Confidence            99985 6666664 557899999999999999999999999999999999999999999999999999987643   245


Q ss_pred             cccCCCccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCccCCHHHHHHHHHh
Q 016037          309 MCGTLEYMSPEIVL---GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK--LPAFLSSEAHSLLKGV  383 (396)
Q Consensus       309 ~~gt~~y~APE~l~---~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~--~p~~~s~~~~~li~~~  383 (396)
                      .+||+.|+|||++.   +..++.++|||||||++|||++|+.||.+.+.......+......  .+..++.++.+||+.|
T Consensus       210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  289 (348)
T 1u5q_A          210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  289 (348)
T ss_dssp             CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHH
T ss_pred             ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence            67999999999985   467899999999999999999999999998888777777776432  3467999999999999


Q ss_pred             hccCCCCCCCCC
Q 016037          384 NSLLSISVPLLS  395 (396)
Q Consensus       384 l~~~p~~RPs~s  395 (396)
                      |+.+|.+|||+.
T Consensus       290 l~~dP~~Rps~~  301 (348)
T 1u5q_A          290 LQKIPQDRPTSE  301 (348)
T ss_dssp             TCSSGGGSCCHH
T ss_pred             cccChhhCcCHH
Confidence            999999999964

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.1e-47  Score=381.74  Aligned_cols=240  Identities=28%  Similarity=0.489  Sum_probs=202.1

Q ss_pred             cCCCeEEE-eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHH-HhCCCCCeeeeeEEEEe----
Q 016037          148 GLEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL-TKVDHPFIVQLRYSFQT----  221 (396)
Q Consensus       148 ~~~~~~~~-~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L-~~l~HpnIv~l~~~~~~----  221 (396)
                      ..++|.+. +.||+|+||+||+|+++.+++.||||+++..        ..+.+|+.++ +..+||||++++++|..    
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~  130 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG  130 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence            34678887 6899999999999999999999999998643        2355677776 45689999999999876    


Q ss_pred             cCeEEEEEEecCCCcHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC---CCcEEEEeccc
Q 016037          222 KYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGL  296 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~---~~~ikL~Dfgl  296 (396)
                      ...+|+||||++||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+
T Consensus       131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence            667999999999999999998653  5999999999999999999999999999999999999987   78999999999


Q ss_pred             ccccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCC---
Q 016037          297 AKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ----KIQQKIIKDKIKLP---  369 (396)
Q Consensus       297 a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~----~i~~~i~~~~~~~p---  369 (396)
                      ++...........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..    .+...+..+.+.+|   
T Consensus       211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~  290 (400)
T 1nxk_A          211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE  290 (400)
T ss_dssp             CEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTT
T ss_pred             ccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcc
Confidence            99876655566788999999999999999999999999999999999999999876532    25667777776665   


Q ss_pred             -ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          370 -AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       370 -~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                       ..++.++.+||+.||+.||.+|||+.
T Consensus       291 ~~~~s~~~~~li~~~L~~dP~~Rpt~~  317 (400)
T 1nxk_A          291 WSEVSEEVKMLIRNLLKTEPTQRMTIT  317 (400)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred             cccCCHHHHHHHHHHCCCChhHCcCHH
Confidence             46899999999999999999999864

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.2e-47  Score=366.86  Aligned_cols=250  Identities=21%  Similarity=0.332  Sum_probs=221.4

Q ss_pred             CccccCCCeEEEeEecccCceEEEEEEEc-----CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEE
Q 016037          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYS  218 (396)
Q Consensus       144 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~  218 (396)
                      .+.+..++|++.+.||+|+||.||+|.+.     .++..||+|++....  .....+.+.+|+.+++.++||||++++++
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   94 (314)
T 2ivs_A           17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGA   94 (314)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence            34566789999999999999999999984     455889999997643  34455678899999999999999999999


Q ss_pred             EEecCeEEEEEEecCCCcHHHHHHHhcC------------------------CCHHHHHHHHHHHHHHHHHHHHCCceec
Q 016037          219 FQTKYRLYLVLDFVNGGHLFFQLYRQGL------------------------FREDLARIYTAEIVSAVSHLHANGIMHR  274 (396)
Q Consensus       219 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~------------------------l~e~~~~~~~~qi~~aL~~LH~~~iiHr  274 (396)
                      +.....+|+||||+++++|.+++.....                        +++..++.++.||+.||.|||++||+||
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  174 (314)
T 2ivs_A           95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR  174 (314)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence            9999999999999999999999987543                        8899999999999999999999999999


Q ss_pred             cCCCCCEEEcCCCcEEEEecccccccCCCC---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 016037          275 DLKPENILLDADGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFT  350 (396)
Q Consensus       275 Dlkp~NILl~~~~~ikL~Dfgla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~  350 (396)
                      ||||+|||++.++.+||+|||+++......   ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus       175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999998764432   2234567889999999998889999999999999999999 999999


Q ss_pred             CCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          351 GGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       351 ~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +.+...+...+... ....|..+++++.+||.+||+.||.+||++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  300 (314)
T 2ivs_A          255 GIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFA  300 (314)
T ss_dssp             TCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence            99888888888776 4677889999999999999999999999964

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-47  Score=375.89  Aligned_cols=249  Identities=20%  Similarity=0.369  Sum_probs=222.5

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCCC-------cEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeee
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTS-------EIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLR  216 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~  216 (396)
                      +.+..++|++.+.||+|+||+||+|++..++       ..||+|+++...  .....+.+.+|+.+++.+ +||||++++
T Consensus        64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~  141 (382)
T 3tt0_A           64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL  141 (382)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence            4566789999999999999999999986543       579999997653  334556788999999999 999999999


Q ss_pred             EEEEecCeEEEEEEecCCCcHHHHHHHhc----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 016037          217 YSFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN  280 (396)
Q Consensus       217 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~N  280 (396)
                      +++.....+|+||||+++|+|.+++....                .+++..++.++.||+.||.|||++||+||||||+|
T Consensus       142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  221 (382)
T 3tt0_A          142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  221 (382)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence            99999999999999999999999998764                48999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecccccccCCC---CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 016037          281 ILLDADGHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQK  356 (396)
Q Consensus       281 ILl~~~~~ikL~Dfgla~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~  356 (396)
                      ||++.++.+||+|||+++.....   .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~  301 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  301 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999999876543   22344567889999999999999999999999999999999 999999999999


Q ss_pred             HHHHHHhC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          357 IQQKIIKD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       357 i~~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +.+.+... +...|..++.++.+||++||+.+|.+|||+.
T Consensus       302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~  341 (382)
T 3tt0_A          302 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK  341 (382)
T ss_dssp             HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHH
Confidence            88888876 6677889999999999999999999999974

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.8e-47  Score=360.93  Aligned_cols=248  Identities=19%  Similarity=0.341  Sum_probs=217.7

Q ss_pred             CCccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       143 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      ..+.+..++|++++.||+|+||.||+|.+. ++..||+|++......    .+.+.+|+.++++++||||+++++++.+.
T Consensus        17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   91 (283)
T 3gen_A           17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ   91 (283)
T ss_dssp             CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence            345577889999999999999999999886 5677999999875432    24477899999999999999999999999


Q ss_pred             CeEEEEEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      ..+|+||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||+++...
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  171 (283)
T 3gen_A           92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  171 (283)
T ss_dssp             SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred             CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence            999999999999999999976 5679999999999999999999999999999999999999999999999999998764


Q ss_pred             CCC--CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHH
Q 016037          302 ENT--RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAH  377 (396)
Q Consensus       302 ~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~  377 (396)
                      ...  ......+|+.|+|||++.+..++.++||||||+++|+|+| |+.||...+.......+... ....|..+++++.
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  251 (283)
T 3gen_A          172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY  251 (283)
T ss_dssp             CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHH
Confidence            332  2233456788999999998889999999999999999998 99999999988888888877 4566788999999


Q ss_pred             HHHHHhhccCCCCCCCCC
Q 016037          378 SLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       378 ~li~~~l~~~p~~RPs~s  395 (396)
                      +||..||+.+|.+|||+.
T Consensus       252 ~li~~~l~~~p~~Rps~~  269 (283)
T 3gen_A          252 TIMYSCWHEKADERPTFK  269 (283)
T ss_dssp             HHHHHTTCSSGGGSCCHH
T ss_pred             HHHHHHccCChhHCcCHH
Confidence            999999999999999974

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-47  Score=378.93  Aligned_cols=245  Identities=29%  Similarity=0.433  Sum_probs=200.2

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEEEecC--e
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKY--R  224 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~--~  224 (396)
                      ..++|++++.||+|+||.||+|.++.+++.||||++.+... .....+...+|+.+|+.+. ||||+++++++....  .
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ-NSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--C-CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            35789999999999999999999999999999999875432 3344566778999999997 999999999997544  7


Q ss_pred             EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-  303 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-  303 (396)
                      +|+||||+++ +|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.+... 
T Consensus        86 ~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           86 VYLVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR  163 (388)
T ss_dssp             EEEEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred             EEEEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence            9999999985 78777765 57899999999999999999999999999999999999999999999999999875321 


Q ss_pred             ---------------------CCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 016037          304 ---------------------TRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKI  361 (396)
Q Consensus       304 ---------------------~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i  361 (396)
                                           ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......|
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  243 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI  243 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                                 12244689999999999987 67899999999999999999999999999888877777


Q ss_pred             HhCC-C----------------------------------------------CCCccCCHHHHHHHHHhhccCCCCCCCC
Q 016037          362 IKDK-I----------------------------------------------KLPAFLSSEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       362 ~~~~-~----------------------------------------------~~p~~~s~~~~~li~~~l~~~p~~RPs~  394 (396)
                      ...- .                                              ..+..+++++.+||++||+.||.+|||+
T Consensus       244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~  323 (388)
T 3oz6_A          244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA  323 (388)
T ss_dssp             HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence            5320 0                                              0112679999999999999999999996


Q ss_pred             C
Q 016037          395 S  395 (396)
Q Consensus       395 s  395 (396)
                      .
T Consensus       324 ~  324 (388)
T 3oz6_A          324 N  324 (388)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.7e-47  Score=367.38  Aligned_cols=245  Identities=29%  Similarity=0.458  Sum_probs=204.8

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      -.++|++++.||+|+||+||+|++. +++.||+|+++.... .....+.+.+|+.++++++||||+++++++.+...+|+
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   96 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL   96 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence            3478999999999999999999995 588999999976542 23345667889999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-CC
Q 016037          228 VLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TR  305 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-~~  305 (396)
                      ||||+++ +|...+... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus        97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  175 (311)
T 3niz_A           97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS  175 (311)
T ss_dssp             EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred             EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence            9999986 666666554 56999999999999999999999999999999999999999999999999999876533 23


Q ss_pred             ccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC----------------
Q 016037          306 SNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KI----------------  366 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--~~----------------  366 (396)
                      ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+...++...  ..                
T Consensus       176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  255 (311)
T 3niz_A          176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ  255 (311)
T ss_dssp             --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred             ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence            345678999999999976 56899999999999999999999999987766666665431  00                


Q ss_pred             ------------CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 ------------KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 ------------~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                  .+...+++++.+||++||+.||.+|||+.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  296 (311)
T 3niz_A          256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISAR  296 (311)
T ss_dssp             CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred             cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHH
Confidence                        01235789999999999999999999974

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.3e-47  Score=366.33  Aligned_cols=241  Identities=24%  Similarity=0.404  Sum_probs=215.9

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      .|+..+.||+|+||.||+|+++.+|+.||||++.....   ...+.+.+|+.+++.++||||+++++++......|+|||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  122 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME  122 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            48888999999999999999999999999999976542   334557789999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Ccccc
Q 016037          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSM  309 (396)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~~~~  309 (396)
                      |+++++|.+++.+ ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...... .....
T Consensus       123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  201 (321)
T 2c30_A          123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  201 (321)
T ss_dssp             CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred             cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence            9999999887754 578999999999999999999999999999999999999999999999999998765432 34566


Q ss_pred             ccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCccCCHHHHHHHHHhhcc
Q 016037          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI---KLPAFLSSEAHSLLKGVNSL  386 (396)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~---~~p~~~s~~~~~li~~~l~~  386 (396)
                      +||+.|+|||++.+..++.++||||||+++|||++|+.||.+.+.......+.....   ..+..+++++.+||++||+.
T Consensus       202 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  281 (321)
T 2c30_A          202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVR  281 (321)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCS
T ss_pred             cCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccC
Confidence            899999999999999999999999999999999999999999988888888877633   33457899999999999999


Q ss_pred             CCCCCCCCC
Q 016037          387 LSISVPLLS  395 (396)
Q Consensus       387 ~p~~RPs~s  395 (396)
                      ||.+|||+.
T Consensus       282 dp~~Rps~~  290 (321)
T 2c30_A          282 DPQERATAQ  290 (321)
T ss_dssp             STTTSCCHH
T ss_pred             ChhhCcCHH
Confidence            999999964

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.5e-47  Score=388.01  Aligned_cols=244  Identities=26%  Similarity=0.398  Sum_probs=203.7

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec-----
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----  222 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~-----  222 (396)
                      ..++|++++.||+|+||+||+|++..+++.||||++.+.. ......+.+.+|+.+|+.++||||++++++|...     
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            3578999999999999999999999999999999998653 2344566788999999999999999999999654     


Q ss_pred             -CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          223 -YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       223 -~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                       ..+|+||||++++ |...+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++...
T Consensus       139 ~~~~~lv~E~~~~~-l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  215 (464)
T 3ttj_A          139 FQDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (464)
T ss_dssp             CCEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred             CCeEEEEEeCCCCC-HHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence             4689999999876 444443  358999999999999999999999999999999999999999999999999999877


Q ss_pred             CCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------------
Q 016037          302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK----------------  365 (396)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~----------------  365 (396)
                      ........+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+...+|....                
T Consensus       216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~  295 (464)
T 3ttj_A          216 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  295 (464)
T ss_dssp             -CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred             CCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhh
Confidence            6656667899999999999999999999999999999999999999999998877777765421                


Q ss_pred             -----------CCCCcc---------------CCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 -----------IKLPAF---------------LSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 -----------~~~p~~---------------~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                 ..+|..               .++++.+||++||+.||.+|||+.
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~  351 (464)
T 3ttj_A          296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD  351 (464)
T ss_dssp             HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHH
Confidence                       111111               167899999999999999999964

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=9.2e-47  Score=358.38  Aligned_cols=248  Identities=30%  Similarity=0.480  Sum_probs=223.5

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeecccc------chhhHHHHHHHHHHHHHhCC-CCCeeeeeEEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI------MEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQ  220 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~------~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~  220 (396)
                      ..++|++.+.||+|+||.||+|.++.+++.||+|++.....      ......+.+.+|+.+++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            35789999999999999999999999999999999976431      11234566788999999995 999999999999


Q ss_pred             ecCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccccc
Q 016037          221 TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~  300 (396)
                      .....|+||||+++++|.+++.....+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            99999999999999999999998889999999999999999999999999999999999999999999999999999887


Q ss_pred             CCCCCccccccCCCccchhhhc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----c
Q 016037          301 DENTRSNSMCGTLEYMSPEIVL------GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----A  370 (396)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~------~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~  370 (396)
                      ..........||+.|+|||++.      ...++.++||||||+++|+|++|+.||.+.+.......+......++    .
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (298)
T 1phk_A          175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD  254 (298)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred             CCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccccc
Confidence            7666666778999999999985      45688999999999999999999999999999888888888766554    4


Q ss_pred             cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          371 FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       371 ~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .++.++.+||++||+.||.+|||+.
T Consensus       255 ~~~~~l~~li~~~l~~dp~~Rps~~  279 (298)
T 1phk_A          255 DYSDTVKDLVSRFLVVQPQKRYTAE  279 (298)
T ss_dssp             GSCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHH
Confidence            6899999999999999999999864

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.2e-47  Score=371.82  Aligned_cols=246  Identities=30%  Similarity=0.507  Sum_probs=223.0

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeecccc-----chhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecC
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI-----MEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKY  223 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~-----~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~  223 (396)
                      ++|++.+.||+|+||.||+|+++.+|+.||||+++....     ......+.+.+|+.+++.+ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            579999999999999999999999999999999976431     1123356678899999998 8999999999999999


Q ss_pred             eEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      ..|+||||++|++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+...
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~  253 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG  253 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999999988766


Q ss_pred             CCccccccCCCccchhhhcC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCC
Q 016037          304 TRSNSMCGTLEYMSPEIVLG------KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLS  373 (396)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~------~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~~~s  373 (396)
                      ......+||+.|+|||++.+      ..++.++|||||||++|+|++|+.||.+.+.......+......++    ..++
T Consensus       254 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  333 (365)
T 2y7j_A          254 EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRS  333 (365)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSC
T ss_pred             cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCC
Confidence            66677889999999999863      3578999999999999999999999999998888888888877655    4689


Q ss_pred             HHHHHHHHHhhccCCCCCCCCC
Q 016037          374 SEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       374 ~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .++.+||++||+.||.+|||+.
T Consensus       334 ~~~~~li~~~L~~dP~~Rps~~  355 (365)
T 2y7j_A          334 STVKDLISRLLQVDPEARLTAE  355 (365)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHH
Confidence            9999999999999999999964

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-47  Score=365.62  Aligned_cols=248  Identities=26%  Similarity=0.365  Sum_probs=209.3

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccch--hhHHHHHHHHHHHHHhC---CCCCeeeeeEEEEe
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME--KNHAEYMKSERNILTKV---DHPFIVQLRYSFQT  221 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~E~~~L~~l---~HpnIv~l~~~~~~  221 (396)
                      +..++|++++.||+|+||+||+|++..+++.||+|++.......  ........+|+.+++.+   +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            34578999999999999999999999999999999997543211  11122345566666655   59999999999987


Q ss_pred             cC-----eEEEEEEecCCCcHHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEec
Q 016037          222 KY-----RLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDF  294 (396)
Q Consensus       222 ~~-----~~~lV~E~~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Df  294 (396)
                      ..     .+++||||+.+ +|..++.....  +++..++.++.||+.||.|||++||+||||||+|||++.++++||+||
T Consensus        86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df  164 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF  164 (308)
T ss_dssp             CCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred             cCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence            65     58999999985 89888887654  899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------
Q 016037          295 GLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-------  367 (396)
Q Consensus       295 gla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~-------  367 (396)
                      |+++...........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+......++......       
T Consensus       165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (308)
T 3g33_A          165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  244 (308)
T ss_dssp             SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred             ccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            9998877666667778999999999999999999999999999999999999999999888888777652100       


Q ss_pred             --------------------CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          368 --------------------LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       368 --------------------~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                          +.+.++.++.+||.+||+.||.+|||+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  292 (308)
T 3g33_A          245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF  292 (308)
T ss_dssp             SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHH
Confidence                                1135789999999999999999999964

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.8e-48  Score=377.05  Aligned_cols=241  Identities=27%  Similarity=0.463  Sum_probs=215.2

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchh-----hHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK-----NHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~  223 (396)
                      .++|++.+.||+|+||+||+|+++.+++.||+|++........     ...+.+.+|+.+|++++||||++++++|.+..
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            3679999999999999999999999999999999987543221     13334667999999999999999999999999


Q ss_pred             eEEEEEEecCCC-cHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          224 RLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       224 ~~~lV~E~~~gg-~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      .+++||||+.+| +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  182 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER  182 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence            999999999777 9999999888999999999999999999999999999999999999999999999999999998876


Q ss_pred             CCCccccccCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Q 016037          303 NTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK  381 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~  381 (396)
                      .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....      .........|..++.++.+||+
T Consensus       183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~l~~li~  256 (335)
T 3dls_A          183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPPYLVSKELMSLVS  256 (335)
T ss_dssp             TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCCCCSSCCCHHHHHHHH
T ss_pred             CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhccCCCcccCHHHHHHHH
Confidence            666667789999999999998776 789999999999999999999997632      2334456677889999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      +||+.||.+|||+.
T Consensus       257 ~~L~~dP~~Rps~~  270 (335)
T 3dls_A          257 GLLQPVPERRTTLE  270 (335)
T ss_dssp             HHTCSSGGGSCCHH
T ss_pred             HHccCChhhCcCHH
Confidence            99999999999964

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.3e-47  Score=361.83  Aligned_cols=243  Identities=27%  Similarity=0.428  Sum_probs=205.4

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++++.||+|+||+||+|++ .+++.||+|++...... ....+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence            5799999999999999999999 67889999999765422 223355778999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-CCcc
Q 016037          230 DFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSN  307 (396)
Q Consensus       230 E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-~~~~  307 (396)
                      ||+++ +|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (288)
T ss_dssp             ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence            99986 787777654 67999999999999999999999999999999999999999999999999999876533 2234


Q ss_pred             ccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC------------------
Q 016037          308 SMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KI------------------  366 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--~~------------------  366 (396)
                      ..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+...  ..                  
T Consensus       159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T 1ob3_A          159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF  238 (288)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred             cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccc
Confidence            5578999999999976 45899999999999999999999999998877776666541  00                  


Q ss_pred             ---------CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 ---------KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 ---------~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                               .+...+++++.+||++||+.||.+|||+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  276 (288)
T 1ob3_A          239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK  276 (288)
T ss_dssp             CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHH
Confidence                     11245899999999999999999999964

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.7e-47  Score=355.23  Aligned_cols=245  Identities=20%  Similarity=0.347  Sum_probs=216.9

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~  225 (396)
                      .+..++|++.+.||+|+||.||+|.++ ++..||+|++......    .+.+.+|+.++++++||||+++++++......
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence            355678999999999999999999886 4667999999865432    24477899999999999999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          226 YLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      |+||||+++++|.+++...+ .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++......
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            99999999999999987764 59999999999999999999999999999999999999999999999999998765433


Q ss_pred             C--ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHH
Q 016037          305 R--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLL  380 (396)
Q Consensus       305 ~--~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li  380 (396)
                      .  .....+|+.|+|||++.+..++.++||||||+++|+|+| |+.||...+.......+... ....|..+++++.+||
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  238 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIM  238 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred             hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHH
Confidence            2  233456778999999998889999999999999999999 99999999988888888876 4556778999999999


Q ss_pred             HHhhccCCCCCCCCC
Q 016037          381 KGVNSLLSISVPLLS  395 (396)
Q Consensus       381 ~~~l~~~p~~RPs~s  395 (396)
                      +.||+.+|.+|||+.
T Consensus       239 ~~~l~~~p~~Rps~~  253 (268)
T 3sxs_A          239 YSCWHELPEKRPTFQ  253 (268)
T ss_dssp             HHTTCSSGGGSCCHH
T ss_pred             HHHcCCChhhCcCHH
Confidence            999999999999974

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.3e-47  Score=361.81  Aligned_cols=242  Identities=32%  Similarity=0.570  Sum_probs=217.6

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++.+.||+|+||.||+|++..+|+.||+|+++....   ...+.+.+|+.++++++||||+++++++.....+|+||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            579999999999999999999999999999999986532   23355788999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE---cCCCcEEEEecccccccCCCCCc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRS  306 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl---~~~~~ikL~Dfgla~~~~~~~~~  306 (396)
                      ||+++++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||++   +.++.+||+|||+++..... ..
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~  164 (304)
T 2jam_A           86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IM  164 (304)
T ss_dssp             CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TT
T ss_pred             EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-cc
Confidence            999999999999988999999999999999999999999999999999999999   78899999999999765432 33


Q ss_pred             cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHH
Q 016037          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLKG  382 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~~~s~~~~~li~~  382 (396)
                      ...+||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+...+...+..+...++    ..++.++.+||.+
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  244 (304)
T 2jam_A          165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICH  244 (304)
T ss_dssp             HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHH
T ss_pred             ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHH
Confidence            445799999999999999999999999999999999999999999999999999988865443    5789999999999


Q ss_pred             hhccCCCCCCCCC
Q 016037          383 VNSLLSISVPLLS  395 (396)
Q Consensus       383 ~l~~~p~~RPs~s  395 (396)
                      ||+.||.+|||+.
T Consensus       245 ~l~~dp~~Rps~~  257 (304)
T 2jam_A          245 LLEKDPNERYTCE  257 (304)
T ss_dssp             HHCSSTTTSCCHH
T ss_pred             HcCCChhHCcCHH
Confidence            9999999999964

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.4e-47  Score=363.83  Aligned_cols=249  Identities=25%  Similarity=0.362  Sum_probs=208.7

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~  225 (396)
                      +...++|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++.....+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 2h34_A           30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL  109 (309)
T ss_dssp             ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence            34567899999999999999999999999999999999876555555667789999999999999999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-  304 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-  304 (396)
                      |+||||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  189 (309)
T 2h34_A          110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL  189 (309)
T ss_dssp             EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence            9999999999999999988899999999999999999999999999999999999999999999999999998765432 


Q ss_pred             -CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCccCCHHHHHHH
Q 016037          305 -RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI---KLPAFLSSEAHSLL  380 (396)
Q Consensus       305 -~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~---~~p~~~s~~~~~li  380 (396)
                       ......||+.|+|||++.+..++.++||||||+++|||++|+.||.+.+...+...+.....   .++..++.++.+||
T Consensus       190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  269 (309)
T 2h34_A          190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVI  269 (309)
T ss_dssp             -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHH
T ss_pred             ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHH
Confidence             23456789999999999998899999999999999999999999998777655555544322   34567999999999


Q ss_pred             HHhhccCCCCCC-CC
Q 016037          381 KGVNSLLSISVP-LL  394 (396)
Q Consensus       381 ~~~l~~~p~~RP-s~  394 (396)
                      ++||+.||.+|| ++
T Consensus       270 ~~~l~~dP~~Rp~s~  284 (309)
T 2h34_A          270 ARGMAKNPEDRYVTC  284 (309)
T ss_dssp             HHHTCSSGGGSCSSH
T ss_pred             HHhccCCHHHHHHhH
Confidence            999999999999 53

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.3e-47  Score=360.34  Aligned_cols=247  Identities=21%  Similarity=0.360  Sum_probs=206.5

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCC---CcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      .+..++|++.+.||+|+||.||+|++..+   +..||+|++....  .....+.+.+|+.++++++||||+++++++. .
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   87 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E   87 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence            45667899999999999999999999654   4579999987543  3445667889999999999999999999984 5


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      ...|+||||+++++|.+++...+ .+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++...
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence            67899999999999999987654 68999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCC--ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHH
Q 016037          302 ENTR--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAH  377 (396)
Q Consensus       302 ~~~~--~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~  377 (396)
                      ....  .....+|+.|+|||++.+..++.++||||||+++|||++ |..||.+.+..++...+... ...+|..+++++.
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  247 (281)
T 1mp8_A          168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY  247 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            4332  233456789999999998889999999999999999997 99999998888888888776 5678889999999


Q ss_pred             HHHHHhhccCCCCCCCCC
Q 016037          378 SLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       378 ~li~~~l~~~p~~RPs~s  395 (396)
                      +||+.||+.+|.+|||+.
T Consensus       248 ~li~~~l~~~p~~Rps~~  265 (281)
T 1mp8_A          248 SLMTKCWAYDPSRRPRFT  265 (281)
T ss_dssp             HHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHccCChhhCcCHH
Confidence            999999999999999974

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.5e-47  Score=364.31  Aligned_cols=246  Identities=26%  Similarity=0.342  Sum_probs=202.7

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCe
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~  224 (396)
                      ..+..++|+++++||+|+||+||+|++..+++.||||++...........+.+.++..+.+..+||||++++++|.+...
T Consensus        52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~  131 (311)
T 3p1a_A           52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI  131 (311)
T ss_dssp             SCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence            33455789999999999999999999999999999999876544444444444444445555699999999999999999


Q ss_pred             EEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      +|+||||+ +++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.....
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             EEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             EEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            99999999 55777776654 56999999999999999999999999999999999999999999999999999887666


Q ss_pred             CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCccCCHHHHHHHH
Q 016037          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI--KLPAFLSSEAHSLLK  381 (396)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~--~~p~~~s~~~~~li~  381 (396)
                      .......||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+   ....+.....  .++..++.++.+||+
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~  286 (311)
T 3p1a_A          211 GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPPEFTAGLSSELRSVLV  286 (311)
T ss_dssp             ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCHHHHTTSCHHHHHHHH
T ss_pred             CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCcccccCCCHHHHHHHH
Confidence            66666789999999999987 69999999999999999999977776532   2333333322  245679999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      .||+.||.+|||+.
T Consensus       287 ~~L~~dP~~Rpt~~  300 (311)
T 3p1a_A          287 MMLEPDPKLRATAE  300 (311)
T ss_dssp             HHSCSSTTTSCCHH
T ss_pred             HHcCCChhhCcCHH
Confidence            99999999999974

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.1e-47  Score=370.49  Aligned_cols=247  Identities=30%  Similarity=0.464  Sum_probs=212.9

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc--hhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM--EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      .++|++.+.||+|+||+||+|++..+++.||+|++.+....  .....+.+.+|+.+++.++||||+++++++.+....|
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            36799999999999999999999999999999999865422  2345677889999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHH----------------------------------------hcCCCHHHHHHHHHHHHHHHHHH
Q 016037          227 LVLDFVNGGHLFFQLYR----------------------------------------QGLFREDLARIYTAEIVSAVSHL  266 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~----------------------------------------~~~l~e~~~~~~~~qi~~aL~~L  266 (396)
                      +||||+++|+|.+++..                                        ...+++..++.++.||+.||.||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            99999999999888742                                        11235777888999999999999


Q ss_pred             HHCCceeccCCCCCEEEcCCC--cEEEEecccccccCCCC-----CccccccCCCccchhhhcC--CCCCchhhHHHHHH
Q 016037          267 HANGIMHRDLKPENILLDADG--HVMLTDFGLAKQFDENT-----RSNSMCGTLEYMSPEIVLG--KGHDKAADWWSVGI  337 (396)
Q Consensus       267 H~~~iiHrDlkp~NILl~~~~--~ikL~Dfgla~~~~~~~-----~~~~~~gt~~y~APE~l~~--~~~~~~~DvwSlGv  337 (396)
                      |++||+||||||+|||++.++  .+||+|||+++.+....     ......||+.|+|||++.+  ..++.++|||||||
T Consensus       185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~  264 (345)
T 3hko_A          185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV  264 (345)
T ss_dssp             HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred             HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence            999999999999999998777  89999999998764322     2345679999999999975  67899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          338 LLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       338 il~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~----~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ++|||++|+.||.+.+..+....+......++.    .+++++.+||++||+.+|.+||++.
T Consensus       265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  326 (345)
T 3hko_A          265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAM  326 (345)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred             HHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHH
Confidence            999999999999999999989998888765543    4899999999999999999999864

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4.2e-47  Score=383.26  Aligned_cols=243  Identities=23%  Similarity=0.411  Sum_probs=214.9

Q ss_pred             CccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC
Q 016037          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (396)
Q Consensus       144 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~  223 (396)
                      .+.+..++|++.+.||+|+||+||+|.+.  ++.||||+++...     ..+.+.+|+.+|++++||||+++++++....
T Consensus       187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  259 (450)
T 1k9a_A          187 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK  259 (450)
T ss_dssp             TCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred             ccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence            34567789999999999999999999985  6789999997653     2345788999999999999999999987655


Q ss_pred             -eEEEEEEecCCCcHHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccccc
Q 016037          224 -RLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       224 -~~~lV~E~~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~  300 (396)
                       .+|+||||+++|+|.+++...+.  +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  339 (450)
T 1k9a_A          260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  339 (450)
T ss_dssp             SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence             79999999999999999987654  789999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHH
Q 016037          301 DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHS  378 (396)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~  378 (396)
                      ....  ....+++.|+|||++.+..++.++|||||||+||||+| |+.||.+.+..++...+..+ ++..|..+++++.+
T Consensus       340 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~  417 (450)
T 1k9a_A          340 SSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYD  417 (450)
T ss_dssp             C--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cccc--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence            4332  23467899999999999999999999999999999999 99999998888888888776 67888999999999


Q ss_pred             HHHHhhccCCCCCCCCC
Q 016037          379 LLKGVNSLLSISVPLLS  395 (396)
Q Consensus       379 li~~~l~~~p~~RPs~s  395 (396)
                      ||+.||+.+|.+|||+.
T Consensus       418 li~~cl~~dp~~Rpt~~  434 (450)
T 1k9a_A          418 VMKNCWHLDAATRPTFL  434 (450)
T ss_dssp             HHHHHTCSSGGGSCCHH
T ss_pred             HHHHHcCCChhHCcCHH
Confidence            99999999999999964

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.8e-47  Score=363.22  Aligned_cols=247  Identities=21%  Similarity=0.319  Sum_probs=207.5

Q ss_pred             cccCCCeEEEeEecccCceEEEEEE----EcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~  221 (396)
                      .+..++|++++.||+|+||+||+|+    +..+++.||+|++....   ....+.+.+|+.++++++||||+++++++..
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   82 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS   82 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            3556789999999999999999999    56689999999997643   4455678899999999999999999999854


Q ss_pred             --cCeEEEEEEecCCCcHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccc
Q 016037          222 --KYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK  298 (396)
Q Consensus       222 --~~~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~  298 (396)
                        ...+++||||+++|+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||+++
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence              456899999999999999997754 59999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCC----CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHH
Q 016037          299 QFDENT----RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ----------------KIQ  358 (396)
Q Consensus       299 ~~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~----------------~i~  358 (396)
                      ......    ......++..|+|||++.+..++.++||||||+++|||+||..||......                .+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence            764432    223345778899999999999999999999999999999999998753221                223


Q ss_pred             HHHHhC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          359 QKIIKD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       359 ~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ..+... +.+.|..++.++.+||+.||+.+|.+|||+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  280 (295)
T 3ugc_A          243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFR  280 (295)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHH
Confidence            333333 6677889999999999999999999999974

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.7e-47  Score=366.63  Aligned_cols=249  Identities=21%  Similarity=0.330  Sum_probs=201.4

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCc---EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE---IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      .+..++|++.+.||+|+||.||+|++..++.   .||+|+++..... ....+.+.+|+.+++.++||||+++++++...
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEFDHPHVAKLVGVSLRS   97 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence            3556789999999999999999999987775   7999999765432 33456688999999999999999999999877


Q ss_pred             CeE------EEEEEecCCCcHHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEE
Q 016037          223 YRL------YLVLDFVNGGHLFFQLYRQG------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM  290 (396)
Q Consensus       223 ~~~------~lV~E~~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ik  290 (396)
                      ...      ++||||+.+|+|..++....      .+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence            655      99999999999999887654      589999999999999999999999999999999999999999999


Q ss_pred             EEecccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-C
Q 016037          291 LTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-K  365 (396)
Q Consensus       291 L~Dfgla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~  365 (396)
                      |+|||+++.......   .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.+.+..++...+... .
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~  257 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR  257 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence            999999987644322   223456788999999999999999999999999999999 99999999888888888776 5


Q ss_pred             CCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 IKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 ~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ...+..++.++.+||++||+.||.+|||++
T Consensus       258 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  287 (323)
T 3qup_A          258 LKQPPECMEEVYDLMYQCWSADPKQRPSFT  287 (323)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred             CCCCCccCHHHHHHHHHHccCChhhCcCHH
Confidence            677889999999999999999999999953

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=9.2e-48  Score=375.04  Aligned_cols=249  Identities=22%  Similarity=0.380  Sum_probs=213.1

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEE-----cCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEE
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRR-----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYS  218 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~  218 (396)
                      +.+..++|++.+.||+|+||.||+|++     ..+++.||||+++...  .....+.+.+|+.+++++ +||||++++++
T Consensus        17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~   94 (359)
T 3vhe_A           17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA   94 (359)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence            345668999999999999999999994     4566899999997653  233456688999999999 79999999999


Q ss_pred             EEecC-eEEEEEEecCCCcHHHHHHHhcC---------------------------------------------------
Q 016037          219 FQTKY-RLYLVLDFVNGGHLFFQLYRQGL---------------------------------------------------  246 (396)
Q Consensus       219 ~~~~~-~~~lV~E~~~gg~L~~~l~~~~~---------------------------------------------------  246 (396)
                      +.... .+++||||+++|+|.+++.....                                                   
T Consensus        95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (359)
T 3vhe_A           95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS  174 (359)
T ss_dssp             ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred             eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence            98755 48999999999999999976543                                                   


Q ss_pred             ---------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC---Cccc
Q 016037          247 ---------------FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT---RSNS  308 (396)
Q Consensus       247 ---------------l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~---~~~~  308 (396)
                                     +++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++......   ....
T Consensus       175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (359)
T 3vhe_A          175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD  254 (359)
T ss_dssp             ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred             hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccc
Confidence                           8899999999999999999999999999999999999999999999999998764332   2344


Q ss_pred             cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHhC-CCCCCccCCHHHHHHHHHhhc
Q 016037          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQK-IQQKIIKD-KIKLPAFLSSEAHSLLKGVNS  385 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~-i~~~i~~~-~~~~p~~~s~~~~~li~~~l~  385 (396)
                      ..||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+ +...+... ....|..+++++.+||.+||+
T Consensus       255 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  334 (359)
T 3vhe_A          255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH  334 (359)
T ss_dssp             CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             cCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            568899999999999899999999999999999999 999999876444 44444443 567788999999999999999


Q ss_pred             cCCCCCCCCC
Q 016037          386 LLSISVPLLS  395 (396)
Q Consensus       386 ~~p~~RPs~s  395 (396)
                      .+|.+|||+.
T Consensus       335 ~dP~~Rps~~  344 (359)
T 3vhe_A          335 GEPSQRPTFS  344 (359)
T ss_dssp             SSGGGSCCHH
T ss_pred             CChhhCCCHH
Confidence            9999999974

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.7e-47  Score=368.50  Aligned_cols=240  Identities=25%  Similarity=0.322  Sum_probs=209.0

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCeEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~l  227 (396)
                      .++|++.+.||+|+||+||+|++..+++.||||++.....     .+.+.+|+.+++++ +||||+++++++......|+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   82 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM   82 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence            4689999999999999999999999999999999876432     12467899999999 99999999999999999999


Q ss_pred             EEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc-----EEEEecccccccC
Q 016037          228 VLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH-----VMLTDFGLAKQFD  301 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~-----ikL~Dfgla~~~~  301 (396)
                      ||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.     +||+|||+++.+.
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99999 8999998876 478999999999999999999999999999999999999999887     9999999998764


Q ss_pred             CCCC--------ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCCc
Q 016037          302 ENTR--------SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG---NRQKIQQKIIKDKIKLPA  370 (396)
Q Consensus       302 ~~~~--------~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~---~~~~i~~~i~~~~~~~p~  370 (396)
                      ....        ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.   +..+..+++...+...|.
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  241 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI  241 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence            4322        24678999999999999999999999999999999999999999984   455556666555444332


Q ss_pred             -----cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          371 -----FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       371 -----~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                           .++ ++.+||+.||+.+|.+||+++
T Consensus       242 ~~~~~~~p-~~~~li~~~l~~~p~~RP~~~  270 (330)
T 2izr_A          242 EVLCENFP-EMATYLRYVRRLDFFEKPDYD  270 (330)
T ss_dssp             HHHTTTCH-HHHHHHHHHHHCCTTCCCCHH
T ss_pred             HHHhccCh-HHHHHHHHHHhCCCCCCCCHH
Confidence                 245 999999999999999999964

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.1e-46  Score=368.07  Aligned_cols=245  Identities=27%  Similarity=0.398  Sum_probs=213.6

Q ss_pred             CccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-----CCCeeeeeEE
Q 016037          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-----HPFIVQLRYS  218 (396)
Q Consensus       144 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-----HpnIv~l~~~  218 (396)
                      ...+..++|+++++||+|+||+||+|++..+++.||||+++..    ....+....|+.+++.+.     ||||++++++
T Consensus        29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~  104 (360)
T 3llt_A           29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGK  104 (360)
T ss_dssp             TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred             cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence            3345567899999999999999999999999999999999753    234455677999999986     9999999999


Q ss_pred             EEecCeEEEEEEecCCCcHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC-----------
Q 016037          219 FQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-----------  285 (396)
Q Consensus       219 ~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~-----------  285 (396)
                      +.....+|+||||+ +++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.           
T Consensus       105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~  183 (360)
T 3llt_A          105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVR  183 (360)
T ss_dssp             EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred             eeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchh
Confidence            99999999999999 889999988764  5899999999999999999999999999999999999975           


Q ss_pred             --------------CCcEEEEecccccccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 016037          286 --------------DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG  351 (396)
Q Consensus       286 --------------~~~ikL~Dfgla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~  351 (396)
                                    ++.+||+|||+++....  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus       184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             CTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence                          78999999999987543  23456899999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHHhCCCCCCc----------------------------------------------cCCHHHHHHHHHhhc
Q 016037          352 GNRQKIQQKIIKDKIKLPA----------------------------------------------FLSSEAHSLLKGVNS  385 (396)
Q Consensus       352 ~~~~~i~~~i~~~~~~~p~----------------------------------------------~~s~~~~~li~~~l~  385 (396)
                      .+..+....+......+|.                                              ..++.+.+||++||+
T Consensus       262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  341 (360)
T 3llt_A          262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ  341 (360)
T ss_dssp             SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred             CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence            8888777777654444332                                              124778899999999


Q ss_pred             cCCCCCCCCC
Q 016037          386 LLSISVPLLS  395 (396)
Q Consensus       386 ~~p~~RPs~s  395 (396)
                      .||.+|||++
T Consensus       342 ~dP~~Rpta~  351 (360)
T 3llt_A          342 IDPTLRPSPA  351 (360)
T ss_dssp             SSGGGSCCHH
T ss_pred             CChhhCCCHH
Confidence            9999999974

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.5e-47  Score=358.85  Aligned_cols=246  Identities=29%  Similarity=0.526  Sum_probs=217.2

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEE--ecCeEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ--TKYRLY  226 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~--~~~~~~  226 (396)
                      .++|++++.||+|+||.||+|+++.+++.||+|++...... ....+.+.+|+.++++++||||+++++++.  ....+|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            46899999999999999999999999999999999875533 344567889999999999999999999884  467899


Q ss_pred             EEEEecCCCcHHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCCEEEcCCCcEEEEecccc
Q 016037          227 LVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVSHLHANG-----IMHRDLKPENILLDADGHVMLTDFGLA  297 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~~LH~~~-----iiHrDlkp~NILl~~~~~ikL~Dfgla  297 (396)
                      +||||+++++|.+++....    .+++..++.++.|++.||.|||++|     ++||||||+|||++.++.+||+|||++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            9999999999999887643    4899999999999999999999999     999999999999999999999999999


Q ss_pred             cccCCCCC-ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHH
Q 016037          298 KQFDENTR-SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSE  375 (396)
Q Consensus       298 ~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~-~~p~~~s~~  375 (396)
                      +....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+...+...+..+.. .+|..++.+
T Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (279)
T 2w5a_A          164 RILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE  243 (279)
T ss_dssp             HHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred             eeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCHH
Confidence            87654322 2345789999999999998899999999999999999999999999998888888888755 678899999


Q ss_pred             HHHHHHHhhccCCCCCCCCC
Q 016037          376 AHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       376 ~~~li~~~l~~~p~~RPs~s  395 (396)
                      +.+||++||+.+|.+|||+.
T Consensus       244 l~~li~~~l~~~p~~Rps~~  263 (279)
T 2w5a_A          244 LNEIITRMLNLKDYHRPSVE  263 (279)
T ss_dssp             HHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHcCCCcccCCCHH
Confidence            99999999999999999974

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=5.4e-47  Score=355.14  Aligned_cols=245  Identities=29%  Similarity=0.493  Sum_probs=203.3

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccch-hhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~  225 (396)
                      +..++|++.+.||+|+||.||+|.+.  +..||+|+++...... ....+.+.+|+.+++.++||||+++++++......
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL   81 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred             cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence            45678999999999999999999984  7889999987653222 22346688899999999999999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCCEEEcC--------CCcEEEEec
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG---IMHRDLKPENILLDA--------DGHVMLTDF  294 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~---iiHrDlkp~NILl~~--------~~~ikL~Df  294 (396)
                      |+||||+++++|..++. .+.+++..++.++.|++.||.|||++|   ++||||||+|||++.        ++.+||+||
T Consensus        82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999988774 567899999999999999999999999   999999999999986        778999999


Q ss_pred             ccccccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCccC
Q 016037          295 GLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK--IKLPAFL  372 (396)
Q Consensus       295 gla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~--~~~p~~~  372 (396)
                      |+++....... ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+.......+....  ..+|..+
T Consensus       161 g~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (271)
T 3dtc_A          161 GLAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC  239 (271)
T ss_dssp             CC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTC
T ss_pred             Ccccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCccc
Confidence            99987654433 35579999999999999889999999999999999999999999988888777777664  4667889


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCC
Q 016037          373 SSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       373 s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +.++.+||++||+.+|.+|||+.
T Consensus       240 ~~~~~~li~~~l~~~p~~Rps~~  262 (271)
T 3dtc_A          240 PEPFAKLMEDCWNPDPHSRPSFT  262 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CHHHHHHHHHHhcCCcccCcCHH
Confidence            99999999999999999999974

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4e-47  Score=359.16  Aligned_cols=248  Identities=22%  Similarity=0.345  Sum_probs=222.7

Q ss_pred             CccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC
Q 016037          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (396)
Q Consensus       144 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~  223 (396)
                      .+.+..++|++.+.||+|+||.||+|.++.++..||+|++....    ...+.+.+|+.+++.++||||+++++++....
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   82 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   82 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            34466789999999999999999999999999999999997643    34556788999999999999999999999999


Q ss_pred             eEEEEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      .+|+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            999999999999999999864  458999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCC--ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHH
Q 016037          302 ENTR--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAH  377 (396)
Q Consensus       302 ~~~~--~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~  377 (396)
                      ....  .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+...+...+... ....|..+++++.
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  242 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY  242 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHH
Confidence            4332  233456889999999998889999999999999999999 99999998888888888776 5677889999999


Q ss_pred             HHHHHhhccCCCCCCCCC
Q 016037          378 SLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       378 ~li~~~l~~~p~~RPs~s  395 (396)
                      +||+.||+.||.+|||+.
T Consensus       243 ~li~~~l~~dp~~Rps~~  260 (288)
T 3kfa_A          243 ELMRACWQWNPSDRPSFA  260 (288)
T ss_dssp             HHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHhCCChhhCcCHH
Confidence            999999999999999974

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.4e-47  Score=363.81  Aligned_cols=244  Identities=30%  Similarity=0.505  Sum_probs=209.6

Q ss_pred             CCCeEEE-eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCeEE
Q 016037          149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       149 ~~~~~~~-~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~  226 (396)
                      .+.|++. +.||+|+||+||+|.+..+++.||||++....   ....+.+.+|+.+++++ +||||+++++++.+...+|
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~   87 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY   87 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            3579885 78999999999999999999999999997653   22345577899999885 7999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc---EEEEecccccccCCC
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH---VMLTDFGLAKQFDEN  303 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~---ikL~Dfgla~~~~~~  303 (396)
                      +||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++.....
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            99999999999999999899999999999999999999999999999999999999998876   999999999865422


Q ss_pred             C--------CccccccCCCccchhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------------HH
Q 016037          304 T--------RSNSMCGTLEYMSPEIVLG-----KGHDKAADWWSVGILLFEMLTGQPPFTGGN---------------RQ  355 (396)
Q Consensus       304 ~--------~~~~~~gt~~y~APE~l~~-----~~~~~~~DvwSlGvil~elltg~~Pf~~~~---------------~~  355 (396)
                      .        .....+||+.|+|||++.+     ..++.++|||||||++|||++|+.||.+.+               ..
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  247 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN  247 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence            1        1234569999999999975     457899999999999999999999998754               34


Q ss_pred             HHHHHHHhCCCCCCc----cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          356 KIQQKIIKDKIKLPA----FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       356 ~i~~~i~~~~~~~p~----~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .+...+......+|.    .++.++++||++||+.||.+|||+.
T Consensus       248 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~  291 (316)
T 2ac3_A          248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAA  291 (316)
T ss_dssp             HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             HHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHH
Confidence            577788888888874    6899999999999999999999964

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-47  Score=372.61  Aligned_cols=249  Identities=46%  Similarity=0.833  Sum_probs=216.8

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEc---CCCcEEEEEEeeccccc-hhhHHHHHHHHHHHHHhC-CCCCeeeeeEEE
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIM-EKNHAEYMKSERNILTKV-DHPFIVQLRYSF  219 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~  219 (396)
                      ..+..++|++++.||+|+||.||+|++.   .+++.||||++++.... .....+.+.+|+.+|+.+ +||||+++++++
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  128 (355)
T 1vzo_A           49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF  128 (355)
T ss_dssp             CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred             ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence            3456789999999999999999999994   58999999999764321 112234466799999999 699999999999


Q ss_pred             EecCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          220 QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       220 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                      .....+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.
T Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            99999999999999999999999889999999999999999999999999999999999999999999999999999987


Q ss_pred             cCCC--CCccccccCCCccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCCCCCcc
Q 016037          300 FDEN--TRSNSMCGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKDKIKLPAF  371 (396)
Q Consensus       300 ~~~~--~~~~~~~gt~~y~APE~l~~--~~~~~~~DvwSlGvil~elltg~~Pf~~~----~~~~i~~~i~~~~~~~p~~  371 (396)
                      +...  ......+||+.|+|||++.+  ..++.++|||||||++|||++|+.||...    ....+...+......+|..
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE  288 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcc
Confidence            6432  22345689999999999986  34789999999999999999999999753    4567777788888899999


Q ss_pred             CCHHHHHHHHHhhccCCCCCCC
Q 016037          372 LSSEAHSLLKGVNSLLSISVPL  393 (396)
Q Consensus       372 ~s~~~~~li~~~l~~~p~~RPs  393 (396)
                      ++..+.+||++||+.||.+||+
T Consensus       289 ~~~~~~~li~~~L~~dP~~R~~  310 (355)
T 1vzo_A          289 MSALAKDLIQRLLMKDPKKRLG  310 (355)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTT
T ss_pred             cCHHHHHHHHHHhhhCHHHhcC
Confidence            9999999999999999999993

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.2e-46  Score=364.15  Aligned_cols=249  Identities=29%  Similarity=0.432  Sum_probs=211.7

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      ...++|++++.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++......|
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  100 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY  100 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence            456789999999999999999999999999999999876542 3344566788999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-CC
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TR  305 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-~~  305 (396)
                      +||||+++++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus       101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  180 (331)
T 4aaa_A          101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  180 (331)
T ss_dssp             EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence            99999999999888888888999999999999999999999999999999999999999999999999999876433 23


Q ss_pred             ccccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------C
Q 016037          306 SNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-------------------K  365 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~-------------------~  365 (396)
                      .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...                   .
T Consensus       181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (331)
T 4aaa_A          181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG  260 (331)
T ss_dssp             ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred             cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence            3456799999999999875 6899999999999999999999999998876666555421                   0


Q ss_pred             CCCC------------ccCCHHHHHHHHHhhccCCCCCCCCCC
Q 016037          366 IKLP------------AFLSSEAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       366 ~~~p------------~~~s~~~~~li~~~l~~~p~~RPs~s~  396 (396)
                      ..+|            +.++.++.+||++||+.||.+|||+.+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e  303 (331)
T 4aaa_A          261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAE  303 (331)
T ss_dssp             CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGG
T ss_pred             ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHH
Confidence            1111            257999999999999999999999864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=7e-47  Score=358.79  Aligned_cols=249  Identities=19%  Similarity=0.305  Sum_probs=216.7

Q ss_pred             ccccCCCeEEEe-EecccCceEEEEEEE--cCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe
Q 016037          145 QCVGLEDFEVLK-VVGQGAFAKVYQVRR--IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (396)
Q Consensus       145 ~~~~~~~~~~~~-~IG~G~fG~Vy~~~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~  221 (396)
                      ..+..++|++.+ .||+|+||.||+|.+  ..+++.||+|+++.... .....+.+.+|+.+++.++||||+++++++ .
T Consensus        11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~   88 (291)
T 1xbb_A           11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-E   88 (291)
T ss_dssp             CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred             eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence            345667899998 999999999999955  56678999999976532 334456788999999999999999999999 5


Q ss_pred             cCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          222 KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      ...+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++...
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            67889999999999999999988889999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCC----ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHH
Q 016037          302 ENTR----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSE  375 (396)
Q Consensus       302 ~~~~----~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~  375 (396)
                      ....    .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..++...+... ...+|..++.+
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE  248 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            4322    223346788999999988889999999999999999999 99999999988888888776 56778899999


Q ss_pred             HHHHHHHhhccCCCCCCCCC
Q 016037          376 AHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       376 ~~~li~~~l~~~p~~RPs~s  395 (396)
                      +.+||++||+.||.+||++.
T Consensus       249 l~~li~~~l~~dp~~Rps~~  268 (291)
T 1xbb_A          249 MYDLMNLCWTYDVENRPGFA  268 (291)
T ss_dssp             HHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHHHHcCCChhhCcCHH
Confidence            99999999999999999964

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.1e-47  Score=367.38  Aligned_cols=247  Identities=25%  Similarity=0.397  Sum_probs=204.5

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      ...++|++++.||+|+||+||+|++..+++.||+|+++.... .....+.+.+|+.+++.++||||+++++++.....+|
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            456789999999999999999999999999999999976542 2334455678999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc-----CCCcEEEEecccccccC
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD-----ADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~-----~~~~ikL~Dfgla~~~~  301 (396)
                      +||||+++ +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++     .++.+||+|||+++...
T Consensus       110 lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~  188 (329)
T 3gbz_A          110 LIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG  188 (329)
T ss_dssp             EEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred             EEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence            99999985 8999999888999999999999999999999999999999999999994     45569999999998765


Q ss_pred             CC-CCccccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CC-----------
Q 016037          302 EN-TRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-IK-----------  367 (396)
Q Consensus       302 ~~-~~~~~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~-~~-----------  367 (396)
                      .. ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+...++.... ..           
T Consensus       189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (329)
T 3gbz_A          189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL  268 (329)
T ss_dssp             -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence            33 233456789999999999874 48999999999999999999999999988877777775431 00           


Q ss_pred             ------------------CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          368 ------------------LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       368 ------------------~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                        ++..++.++.+||++||+.||.+|||+.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  314 (329)
T 3gbz_A          269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAK  314 (329)
T ss_dssp             TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHH
Confidence                              0112789999999999999999999964

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.9e-47  Score=366.66  Aligned_cols=247  Identities=22%  Similarity=0.367  Sum_probs=216.8

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEE--EEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecC
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIY--AMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKY  223 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~v--AvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~  223 (396)
                      +..++|++.+.||+|+||.||+|+++.++..+  |+|.+....  .....+.+.+|+.+++++ +||||+++++++.+..
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   99 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   99 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence            55689999999999999999999999998866  999887532  334456688899999999 8999999999999999


Q ss_pred             eEEEEEEecCCCcHHHHHHHhc----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~  287 (396)
                      .+|+||||+++++|.+++...+                .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence            9999999999999999997654                689999999999999999999999999999999999999999


Q ss_pred             cEEEEecccccccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-C
Q 016037          288 HVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-K  365 (396)
Q Consensus       288 ~ikL~Dfgla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~  365 (396)
                      .+||+|||+++............+++.|+|||++.+..++.++||||||+++|||+| |+.||.+.+..++...+..+ .
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~  259 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  259 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC
Confidence            999999999986544444455567899999999998889999999999999999998 99999999998888888776 5


Q ss_pred             CCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 IKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 ~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ...|..++.++.+||++||+.+|.+|||+.
T Consensus       260 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  289 (327)
T 1fvr_A          260 LEKPLNCDDEVYDLMRQCWREKPYERPSFA  289 (327)
T ss_dssp             CCCCTTBCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence            677889999999999999999999999964

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.7e-47  Score=367.44  Aligned_cols=246  Identities=23%  Similarity=0.375  Sum_probs=208.2

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEE----EEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIY----AMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~v----AvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      +..++|++++.||+|+||+||+|++..+++.+    |+|.++...  .....+.+.+|+.++++++||||+++++++...
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            45578999999999999999999998887765    666665432  223446688899999999999999999999875


Q ss_pred             CeEEEEEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      . .++|+||+.+|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++...
T Consensus        90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            4 7899999999999999877 4679999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHH
Q 016037          302 ENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (396)
Q Consensus       302 ~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~  376 (396)
                      ....   .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+...+...+... ....|..++.++
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV  248 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHH
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence            4332   233456889999999999999999999999999999999 99999998888887777765 567788999999


Q ss_pred             HHHHHHhhccCCCCCCCCC
Q 016037          377 HSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~RPs~s  395 (396)
                      .+||..||+.+|.+||++.
T Consensus       249 ~~li~~~l~~~p~~Rps~~  267 (327)
T 3poz_A          249 YMIMVKCWMIDADSRPKFR  267 (327)
T ss_dssp             HHHHHHHTCSCGGGSCCHH
T ss_pred             HHHHHHHcCCChhhCCCHH
Confidence            9999999999999999974

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.3e-47  Score=359.89  Aligned_cols=243  Identities=21%  Similarity=0.280  Sum_probs=210.6

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCC-------cEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTS-------EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSF  219 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~  219 (396)
                      +..++|++.+.||+|+||+||+|++..++       ..||+|++....   ....+.+.+|+.++++++||||+++++++
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (289)
T 4fvq_A            5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVC   81 (289)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred             echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            55678999999999999999999998877       469999987643   33456688899999999999999999999


Q ss_pred             EecCeEEEEEEecCCCcHHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc--------EE
Q 016037          220 QTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH--------VM  290 (396)
Q Consensus       220 ~~~~~~~lV~E~~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~--------ik  290 (396)
                      ......|+||||+++++|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++.        +|
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence            999999999999999999999987654 999999999999999999999999999999999999998887        99


Q ss_pred             EEecccccccCCCCCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Q 016037          291 LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP  369 (396)
Q Consensus       291 L~Dfgla~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p  369 (396)
                      |+|||++......   ....||+.|+|||++.+ ..++.++||||||+++|||++|..|+...........+......+|
T Consensus       162 l~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  238 (289)
T 4fvq_A          162 LSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLP  238 (289)
T ss_dssp             ECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred             eccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCC
Confidence            9999999765332   33468899999999987 6789999999999999999995544444443444455566677888


Q ss_pred             ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          370 AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       370 ~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ...+.++.+||+.||+.||.+|||++
T Consensus       239 ~~~~~~l~~li~~~l~~dp~~Rps~~  264 (289)
T 4fvq_A          239 APKAAELANLINNCMDYEPDHRPSFR  264 (289)
T ss_dssp             CCSSCTTHHHHHHHSCSSGGGSCCHH
T ss_pred             CCCCHHHHHHHHHHcCCChhHCcCHH
Confidence            88999999999999999999999974

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.2e-46  Score=364.58  Aligned_cols=249  Identities=20%  Similarity=0.358  Sum_probs=219.3

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEc-------CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeee
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRI-------GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLR  216 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~  216 (396)
                      +.+..++|++.+.||+|+||.||+|++.       .++..||+|+++...  .....+.+.+|+.+++++ +||||++++
T Consensus        30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~  107 (334)
T 2pvf_A           30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL  107 (334)
T ss_dssp             TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence            3456689999999999999999999986       356789999997653  334556788999999999 899999999


Q ss_pred             EEEEecCeEEEEEEecCCCcHHHHHHHhc----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 016037          217 YSFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN  280 (396)
Q Consensus       217 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~N  280 (396)
                      +++.....+|+||||+++|+|.+++....                .+++..++.++.||+.||.|||++||+||||||+|
T Consensus       108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  187 (334)
T 2pvf_A          108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN  187 (334)
T ss_dssp             EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence            99999999999999999999999998654                38899999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecccccccCCCC---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 016037          281 ILLDADGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQK  356 (396)
Q Consensus       281 ILl~~~~~ikL~Dfgla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~  356 (396)
                      ||++.++++||+|||+++......   ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+.+..+
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence            999999999999999998765432   2334457889999999988889999999999999999999 999999999888


Q ss_pred             HHHHHHhC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          357 IQQKIIKD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       357 i~~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +...+... ....|..++.++.+||++||+.+|.+||++.
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  307 (334)
T 2pvf_A          268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFK  307 (334)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence            88888776 4677889999999999999999999999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=358.70  Aligned_cols=246  Identities=26%  Similarity=0.430  Sum_probs=215.3

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccch-hhHHHHHHHHHHHHHhCCCCCeeeeeEEE--EecCeE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-KNHAEYMKSERNILTKVDHPFIVQLRYSF--QTKYRL  225 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~E~~~L~~l~HpnIv~l~~~~--~~~~~~  225 (396)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....... ....+.+.+|+.+++.++||||+++++++  .+...+
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            367999999999999999999999999999999998754322 23456788999999999999999999998  455689


Q ss_pred             EEEEEecCCCcHHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          226 YLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      |+||||+.++ |...+..  ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  162 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF  162 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence            9999999987 6566654  457899999999999999999999999999999999999999999999999999876432


Q ss_pred             ---CCccccccCCCccchhhhcCCCC--CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHH
Q 016037          304 ---TRSNSMCGTLEYMSPEIVLGKGH--DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHS  378 (396)
Q Consensus       304 ---~~~~~~~gt~~y~APE~l~~~~~--~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~  378 (396)
                         .......||+.|+|||++.+...  +.++||||||+++|||++|+.||.+.+..++...+......+|..++.++.+
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~  242 (305)
T 2wtk_C          163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSD  242 (305)
T ss_dssp             CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHH
T ss_pred             ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHHH
Confidence               22345678999999999987543  7899999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCCCCCCCC
Q 016037          379 LLKGVNSLLSISVPLLS  395 (396)
Q Consensus       379 li~~~l~~~p~~RPs~s  395 (396)
                      ||++||+.||.+|||++
T Consensus       243 li~~~l~~dp~~Rps~~  259 (305)
T 2wtk_C          243 LLKGMLEYEPAKRFSIR  259 (305)
T ss_dssp             HHHHHTCSSTTTSCCHH
T ss_pred             HHHHHccCChhhCCCHH
Confidence            99999999999999864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.6e-46  Score=360.87  Aligned_cols=251  Identities=19%  Similarity=0.284  Sum_probs=220.7

Q ss_pred             CCccccCCCeEEEeEecccCceEEEEEEEc-----CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeE
Q 016037          143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY  217 (396)
Q Consensus       143 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~  217 (396)
                      ..+.+..++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .......+.+|+.+++.++||||+++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            345567789999999999999999999987     357889999997643  2334456788999999999999999999


Q ss_pred             EEEecCeEEEEEEecCCCcHHHHHHHh----------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC
Q 016037          218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ----------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (396)
Q Consensus       218 ~~~~~~~~~lV~E~~~gg~L~~~l~~~----------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~  287 (396)
                      ++.+....|+||||+++|+|.+++...          ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence            999999999999999999999988754          3568899999999999999999999999999999999999999


Q ss_pred             cEEEEecccccccCCCC---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 016037          288 HVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK  363 (396)
Q Consensus       288 ~ikL~Dfgla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~  363 (396)
                      .+||+|||+++......   ......||+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..++...+..
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  255 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  255 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence            99999999998764332   2234467889999999998889999999999999999999 9999999998888888877


Q ss_pred             CC-CCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          364 DK-IKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       364 ~~-~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .. ...+..++.++.+||+.||+.+|.+|||+.
T Consensus       256 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  288 (322)
T 1p4o_A          256 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFL  288 (322)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHH
Confidence            64 467889999999999999999999999974

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.3e-46  Score=355.88  Aligned_cols=244  Identities=26%  Similarity=0.461  Sum_probs=219.8

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .+.|++++.||+|+||.||+|.+..+++.||+|++.....  ....+.+.+|+.+++.++||||+++++++.....+|+|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            3569999999999999999999999999999999976542  23456688999999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Ccc
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSN  307 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~~  307 (396)
                      |||+++++|.+++.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++++||+|||++....... ...
T Consensus        99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  177 (303)
T 3a7i_A           99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN  177 (303)
T ss_dssp             EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBC
T ss_pred             EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccC
Confidence            999999999888754 678999999999999999999999999999999999999999999999999998765433 334


Q ss_pred             ccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHhhcc
Q 016037          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-IKLPAFLSSEAHSLLKGVNSL  386 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~-~~~p~~~s~~~~~li~~~l~~  386 (396)
                      ...||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+.... ..++..++.++.+||+.||+.
T Consensus       178 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  257 (303)
T 3a7i_A          178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK  257 (303)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCS
T ss_pred             ccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCC
Confidence            5679999999999999999999999999999999999999999988888887777664 466788999999999999999


Q ss_pred             CCCCCCCCC
Q 016037          387 LSISVPLLS  395 (396)
Q Consensus       387 ~p~~RPs~s  395 (396)
                      +|.+|||+.
T Consensus       258 dp~~Rps~~  266 (303)
T 3a7i_A          258 EPSFRPTAK  266 (303)
T ss_dssp             SGGGSCCHH
T ss_pred             ChhhCcCHH
Confidence            999999964

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-47  Score=367.67  Aligned_cols=249  Identities=24%  Similarity=0.387  Sum_probs=213.2

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEc-----CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEE
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYS  218 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~  218 (396)
                      +.+..++|++.+.||+|+||.||+|.+.     .++..||+|++....  .....+.+.+|+.+++++ +||||++++++
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  117 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGA  117 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            4456789999999999999999999983     466789999997543  233456688999999999 89999999999


Q ss_pred             EEecCeEEEEEEecCCCcHHHHHHHhc-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 016037          219 FQTKYRLYLVLDFVNGGHLFFQLYRQG-----------------------LFREDLARIYTAEIVSAVSHLHANGIMHRD  275 (396)
Q Consensus       219 ~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrD  275 (396)
                      +.....+|+||||+++|+|.+++....                       .+++..++.++.||+.||.|||++||+|||
T Consensus       118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D  197 (344)
T 1rjb_A          118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD  197 (344)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence            999999999999999999999997653                       378899999999999999999999999999


Q ss_pred             CCCCCEEEcCCCcEEEEecccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 016037          276 LKPENILLDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG  351 (396)
Q Consensus       276 lkp~NILl~~~~~ikL~Dfgla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~  351 (396)
                      |||+|||++.++.+||+|||+++.......   .....||+.|+|||++.+..++.++||||||+++|||+| |..||.+
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            999999999999999999999987644322   234567889999999998889999999999999999998 9999998


Q ss_pred             CCHHHHHHHHHhC--CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          352 GNRQKIQQKIIKD--KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       352 ~~~~~i~~~i~~~--~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .+.......+...  ....|..++.++.+||++||+.||.+|||+.
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  323 (344)
T 1rjb_A          278 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP  323 (344)
T ss_dssp             CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence            7755555555544  4566788999999999999999999999974

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1e-46  Score=352.33  Aligned_cols=243  Identities=18%  Similarity=0.275  Sum_probs=214.8

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec--C
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--Y  223 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~--~  223 (396)
                      .+..++|++.+.||+|+||.||+|++.  ++.||+|++...... ....+.+.+|+.++++++||||+++++++...  .
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   82 (271)
T 3kmu_A            6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP   82 (271)
T ss_dssp             CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred             CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence            466789999999999999999999994  788999999875433 34456688999999999999999999999877  7


Q ss_pred             eEEEEEEecCCCcHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~--iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                      .+++||||+++|+|.+++....  .+++..++.++.|++.||.|||++|  ++||||||+|||++.++.++|+|||++..
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence            8899999999999999998765  4899999999999999999999999  99999999999999999999999998754


Q ss_pred             cCCCCCccccccCCCccchhhhcCCCCCc---hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCH
Q 016037          300 FDENTRSNSMCGTLEYMSPEIVLGKGHDK---AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPAFLSS  374 (396)
Q Consensus       300 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~---~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--~~~~p~~~s~  374 (396)
                      ..    .....||+.|+|||++.+..++.   ++||||||+++|||++|+.||.+.+.......+...  ...+|..++.
T Consensus       163 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (271)
T 3kmu_A          163 FQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP  238 (271)
T ss_dssp             TS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCH
T ss_pred             ec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCH
Confidence            32    23457899999999998765544   899999999999999999999999888887777765  5577889999


Q ss_pred             HHHHHHHHhhccCCCCCCCCC
Q 016037          375 EAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       375 ~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ++.+||+.||+.||.+|||++
T Consensus       239 ~~~~li~~~l~~~p~~Rps~~  259 (271)
T 3kmu_A          239 HVSKLMKICMNEDPAKRPKFD  259 (271)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHHcCCChhhCcCHH
Confidence            999999999999999999974

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=6.2e-47  Score=386.47  Aligned_cols=248  Identities=21%  Similarity=0.348  Sum_probs=221.8

Q ss_pred             CccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC
Q 016037          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (396)
Q Consensus       144 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~  223 (396)
                      .+.+...+|++.+.||+|+||.||+|.++.++..||||+++....    ..+.+.+|+.+|++++||||+++++++....
T Consensus       214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  289 (495)
T 1opk_A          214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP  289 (495)
T ss_dssp             CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            345667889999999999999999999999999999999976542    2455788999999999999999999999999


Q ss_pred             eEEEEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      .+|+||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred             cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence            999999999999999999864  458999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCC--ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHH
Q 016037          302 ENTR--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAH  377 (396)
Q Consensus       302 ~~~~--~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~  377 (396)
                      ....  .....+++.|+|||++.+..++.++|||||||+||||+| |+.||.+.+..++.+.+..+ ++..|..++.++.
T Consensus       370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  449 (495)
T 1opk_A          370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY  449 (495)
T ss_dssp             TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            3322  233456789999999998889999999999999999999 99999999888888877766 6678899999999


Q ss_pred             HHHHHhhccCCCCCCCCC
Q 016037          378 SLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       378 ~li~~~l~~~p~~RPs~s  395 (396)
                      +||.+||+.+|.+|||+.
T Consensus       450 ~li~~cl~~dP~~RPs~~  467 (495)
T 1opk_A          450 ELMRACWQWNPSDRPSFA  467 (495)
T ss_dssp             HHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHcCcChhHCcCHH
Confidence            999999999999999964

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.6e-46  Score=379.38  Aligned_cols=247  Identities=22%  Similarity=0.360  Sum_probs=218.3

Q ss_pred             CCccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       143 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      ..+.+..++|++.+.||+|+||+||+|.++. +..||||+++....    ..+.+.+|+.+|++++||||+++++++. .
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~  254 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-K  254 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence            4456778899999999999999999999964 66799999986542    2456788999999999999999999886 5


Q ss_pred             CeEEEEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccccc
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~  300 (396)
                      ..+|+||||+.+|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI  334 (454)
T ss_dssp             SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred             CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence            6789999999999999999754  37889999999999999999999999999999999999999999999999999876


Q ss_pred             CCCC--CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHH
Q 016037          301 DENT--RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (396)
Q Consensus       301 ~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~  376 (396)
                      ....  ......+|+.|+|||++.+..++.++|||||||+||||+| |+.||.+.+..++...+..+ +++.|..++.++
T Consensus       335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l  414 (454)
T 1qcf_A          335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL  414 (454)
T ss_dssp             CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHH
T ss_pred             CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            4322  1233456789999999998889999999999999999999 99999999998888888776 667788999999


Q ss_pred             HHHHHHhhccCCCCCCCCC
Q 016037          377 HSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~RPs~s  395 (396)
                      .+||++||+.||.+|||+.
T Consensus       415 ~~li~~cl~~dp~~RPt~~  433 (454)
T 1qcf_A          415 YNIMMRCWKNRPEERPTFE  433 (454)
T ss_dssp             HHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHccCChhHCcCHH
Confidence            9999999999999999964

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2e-46  Score=354.87  Aligned_cols=247  Identities=30%  Similarity=0.537  Sum_probs=221.8

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      ...++|++++.||+|+||.||+|++..+++.||+|++...... ....+.+.+|+.++++++||||+++++++.....+|
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            3456899999999999999999999999999999999765432 233456788999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC---CcEEEEecccccccCCC
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD---GHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~---~~ikL~Dfgla~~~~~~  303 (396)
                      +||||+.+++|.+.+...+.+++..++.++.||+.||.|||++|++||||||+||+++.+   +.+||+|||++......
T Consensus        98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~  177 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence            999999999999999888899999999999999999999999999999999999999764   47999999999887665


Q ss_pred             CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHH
Q 016037          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSL  379 (396)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~~~s~~~~~l  379 (396)
                      .......||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+.+...+...+..+...++    ..++.++.+|
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  256 (287)
T 2wei_A          178 TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL  256 (287)
T ss_dssp             SSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHH
T ss_pred             CccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHH
Confidence            555566789999999998765 89999999999999999999999999999999999888866544    4689999999


Q ss_pred             HHHhhccCCCCCCCCC
Q 016037          380 LKGVNSLLSISVPLLS  395 (396)
Q Consensus       380 i~~~l~~~p~~RPs~s  395 (396)
                      |++||+.+|.+|||+.
T Consensus       257 i~~~l~~dp~~Rps~~  272 (287)
T 2wei_A          257 IRKMLTFHPSLRITAT  272 (287)
T ss_dssp             HHHHTCSSGGGSCCHH
T ss_pred             HHHHcccChhhCcCHH
Confidence            9999999999999964

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.8e-47  Score=367.77  Aligned_cols=246  Identities=21%  Similarity=0.341  Sum_probs=211.6

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcE----EEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEI----YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      +..++|++++.||+|+||+||+|++..+++.    ||+|++....  .....+.+.+|+.+++.++||||+++++++. .
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   86 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G   86 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence            4567899999999999999999999988876    6666664332  1122234567999999999999999999886 5


Q ss_pred             CeEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      ...++||||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++...
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            6789999999999999998764 578999999999999999999999999999999999999999999999999998875


Q ss_pred             CCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHH
Q 016037          302 ENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (396)
Q Consensus       302 ~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~  376 (396)
                      ....   .....||..|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++...+... ....|..++.++
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDV  246 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTT
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHH
Confidence            4322   344567889999999998889999999999999999999 99999998888888888776 567788999999


Q ss_pred             HHHHHHhhccCCCCCCCCC
Q 016037          377 HSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~RPs~s  395 (396)
                      .+||..||+.+|.+||++.
T Consensus       247 ~~li~~~l~~dp~~Rps~~  265 (325)
T 3kex_A          247 YMVMVKCWMIDENIRPTFK  265 (325)
T ss_dssp             THHHHHHTCSCTTTSCCHH
T ss_pred             HHHHHHHcCCChhhCcCHH
Confidence            9999999999999999964

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=9.5e-47  Score=360.48  Aligned_cols=249  Identities=22%  Similarity=0.339  Sum_probs=215.8

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEE-----cCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEE
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRR-----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYS  218 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~  218 (396)
                      +.+..++|++.+.||+|+||.||+|.+     ..+++.||+|+++....  ....+.+.+|+.+++++ +||||++++++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   95 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGA   95 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence            345667899999999999999999996     45678999999986542  33456788999999999 99999999999


Q ss_pred             EEecCeEEEEEEecCCCcHHHHHHHhc------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 016037          219 FQTKYRLYLVLDFVNGGHLFFQLYRQG------------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN  280 (396)
Q Consensus       219 ~~~~~~~~lV~E~~~gg~L~~~l~~~~------------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~N  280 (396)
                      +......++||||+++|+|.+++....                  .+++..++.++.||+.||.|||++||+||||||+|
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N  175 (313)
T 1t46_A           96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  175 (313)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence            999999999999999999999998754                  48999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 016037          281 ILLDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQK  356 (396)
Q Consensus       281 ILl~~~~~ikL~Dfgla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~  356 (396)
                      ||++.++.+||+|||+++.......   .....||+.|+|||++.+..++.++||||||+++|||+| |+.||.+.+...
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence            9999999999999999987654432   234557889999999998889999999999999999999 999999876554


Q ss_pred             HHHHHHhC--CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          357 IQQKIIKD--KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       357 i~~~i~~~--~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ....+...  ....+..++.++.+||++||+.||.+|||+.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  296 (313)
T 1t46_A          256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK  296 (313)
T ss_dssp             HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHH
Confidence            44444433  4455778999999999999999999999974

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.9e-46  Score=354.50  Aligned_cols=247  Identities=24%  Similarity=0.403  Sum_probs=195.9

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +..++|++++.||+|+||+||+|++..+++.||+|+++.... .....+.+.++...++.++||||+++++++......|
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence            456789999999999999999999999999999999976542 3334455566667788899999999999999999999


Q ss_pred             EEEEecCCCcHHHHHH----HhcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          227 LVLDFVNGGHLFFQLY----RQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~~LH~~-~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      +||||+++ +|..++.    ....+++..++.++.|++.||.|||++ |++||||||+|||++.++++||+|||+++...
T Consensus        83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99999986 7666554    346899999999999999999999998 99999999999999999999999999998876


Q ss_pred             CCCCccccccCCCccchhhh----cCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHH-HhCCCCCC-ccCCH
Q 016037          302 ENTRSNSMCGTLEYMSPEIV----LGKGHDKAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKI-IKDKIKLP-AFLSS  374 (396)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l----~~~~~~~~~DvwSlGvil~elltg~~Pf~~-~~~~~i~~~i-~~~~~~~p-~~~s~  374 (396)
                      .........||+.|+|||++    .+..++.++||||||+++|+|++|+.||.. .........+ ......++ ..++.
T Consensus       162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (290)
T 3fme_A          162 DDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSA  241 (290)
T ss_dssp             --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCH
T ss_pred             ccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCH
Confidence            66555666899999999996    556789999999999999999999999986 3333333334 44444444 47999


Q ss_pred             HHHHHHHHhhccCCCCCCCCC
Q 016037          375 EAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       375 ~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ++.+||++||+.+|.+|||+.
T Consensus       242 ~~~~li~~~l~~~p~~Rpt~~  262 (290)
T 3fme_A          242 EFVDFTSQCLKKNSKERPTYP  262 (290)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHHhhcChhhCcCHH
Confidence            999999999999999999964

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.9e-46  Score=350.31  Aligned_cols=245  Identities=21%  Similarity=0.367  Sum_probs=218.2

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~  225 (396)
                      .+..++|++.+.||+|+||.||+|.+. ++..||+|++......    .+.+.+|+.+++.++||||+++++++.....+
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   78 (267)
T 3t9t_A            4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   78 (267)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence            356678999999999999999999996 5678999999875432    24578899999999999999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          226 YLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      |+||||+++++|.+++... +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++......
T Consensus        79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence            9999999999999998765 568999999999999999999999999999999999999999999999999998764321


Q ss_pred             --CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHH
Q 016037          305 --RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLL  380 (396)
Q Consensus       305 --~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li  380 (396)
                        ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..++...+..+ ....|..++.++.+||
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  238 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM  238 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred             ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHH
Confidence              2234457789999999998889999999999999999999 99999999988888888876 4566788999999999


Q ss_pred             HHhhccCCCCCCCCC
Q 016037          381 KGVNSLLSISVPLLS  395 (396)
Q Consensus       381 ~~~l~~~p~~RPs~s  395 (396)
                      ++||+.+|.+|||++
T Consensus       239 ~~~l~~~p~~Rps~~  253 (267)
T 3t9t_A          239 NHCWRERPEDRPAFS  253 (267)
T ss_dssp             HHHTCSSGGGSCCHH
T ss_pred             HHHccCChhhCcCHH
Confidence            999999999999974

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.6e-47  Score=374.69  Aligned_cols=248  Identities=22%  Similarity=0.329  Sum_probs=207.9

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEc---CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      .+..++|++.+.||+|+||.||+|+++   .++..||||+++...  .....+.+.+|+.++++++||||+++++++...
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  118 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS  118 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence            355678999999999999999999987   567789999997643  234556788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      ..+|+||||+++|+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            99999999999999999997654 68999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCC----ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHH
Q 016037          302 ENTR----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSE  375 (396)
Q Consensus       302 ~~~~----~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~  375 (396)
                      ....    .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+.+..++...+..+ +...+..++.+
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~  278 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAA  278 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHH
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHH
Confidence            4321    122345778999999999899999999999999999998 99999999988888888776 56667889999


Q ss_pred             HHHHHHHhhccCCCCCCCCC
Q 016037          376 AHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       376 ~~~li~~~l~~~p~~RPs~s  395 (396)
                      +.+||.+||+.+|.+||++.
T Consensus       279 l~~li~~cl~~dp~~RPs~~  298 (373)
T 2qol_A          279 LYQLMLDCWQKDRNNRPKFE  298 (373)
T ss_dssp             HHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHhCcChhhCcCHH
Confidence            99999999999999999864

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.8e-46  Score=353.81  Aligned_cols=243  Identities=21%  Similarity=0.319  Sum_probs=210.3

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCeE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~  225 (396)
                      +..++|++.+.||+|+||.||+|.+..+++.||+|++.....     .+.+.+|+.+++.+ +|+||+++++++......
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   81 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   81 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence            445789999999999999999999999999999999875432     22367799999999 799999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc-----EEEEecccccc
Q 016037          226 YLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH-----VMLTDFGLAKQ  299 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~-----ikL~Dfgla~~  299 (396)
                      |+||||+ +++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.     +||+|||+++.
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            9999999 899999998754 5999999999999999999999999999999999999988776     99999999987


Q ss_pred             cCCCC--------CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCC-
Q 016037          300 FDENT--------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG---NRQKIQQKIIKDKIK-  367 (396)
Q Consensus       300 ~~~~~--------~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~---~~~~i~~~i~~~~~~-  367 (396)
                      .....        ......||+.|+|||++.+..++.++||||||+++|||++|+.||.+.   +.......+...... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            65432        234567999999999999999999999999999999999999999884   445555555443222 


Q ss_pred             ----CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          368 ----LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       368 ----~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                          +...+++++.+||+.||+.+|.+||+++
T Consensus       241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~  272 (298)
T 1csn_A          241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYD  272 (298)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHH
T ss_pred             cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHH
Confidence                2347899999999999999999999974

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.6e-47  Score=363.88  Aligned_cols=243  Identities=28%  Similarity=0.414  Sum_probs=203.1

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC-----
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----  223 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~-----  223 (396)
                      .++|++++.||+|+||.||+|+++.+++.||||+++...  .....+.+.+|+.+|++++||||++++++|.+..     
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            357999999999999999999999999999999998654  2345567889999999999999999999986543     


Q ss_pred             ----------------------------------------------------eEEEEEEecCCCcHHHHHHHhcC---CC
Q 016037          224 ----------------------------------------------------RLYLVLDFVNGGHLFFQLYRQGL---FR  248 (396)
Q Consensus       224 ----------------------------------------------------~~~lV~E~~~gg~L~~~l~~~~~---l~  248 (396)
                                                                          .+|+||||+++++|.+++.+...   ..
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  162 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE  162 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence                                                                38999999999999999987643   45


Q ss_pred             HHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-------------CccccccCCCc
Q 016037          249 EDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-------------RSNSMCGTLEY  315 (396)
Q Consensus       249 e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-------------~~~~~~gt~~y  315 (396)
                      +..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......             .....+||+.|
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            56688899999999999999999999999999999999999999999998875432             23446799999


Q ss_pred             cchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCccCCHHHHHHHHHhhccCCCCCCCC
Q 016037          316 MSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-LPAFLSSEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       316 ~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~-~p~~~s~~~~~li~~~l~~~p~~RPs~  394 (396)
                      +|||++.+..++.++|||||||++|||++|..|+..  .......+.....+ .+...++++.+||++||+.||.+|||+
T Consensus       243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  320 (332)
T 3qd2_B          243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEA  320 (332)
T ss_dssp             SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCH
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCH
Confidence            999999999999999999999999999998877532  23334444443322 224678899999999999999999996


Q ss_pred             C
Q 016037          395 S  395 (396)
Q Consensus       395 s  395 (396)
                      .
T Consensus       321 ~  321 (332)
T 3qd2_B          321 T  321 (332)
T ss_dssp             H
T ss_pred             H
Confidence            4

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.3e-46  Score=353.99  Aligned_cols=245  Identities=23%  Similarity=0.359  Sum_probs=209.5

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhH----HHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNH----AEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~----~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      +..++|++.+.||+|+||+||+|++..+++.||+|++..........    .+.+.+|+.+++.++||||+++++++.+.
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP   95 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence            45678999999999999999999999999999999997654322222    15688999999999999999999999766


Q ss_pred             CeEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEcCCCc-----EEEEec
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLDADGH-----VMLTDF  294 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~--iiHrDlkp~NILl~~~~~-----ikL~Df  294 (396)
                      .  ++||||+++|+|.+.+... ..+++..++.++.|++.||.|||++|  |+||||||+|||++.++.     +||+||
T Consensus        96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            5  6999999999998887654 57999999999999999999999999  999999999999988876     999999


Q ss_pred             ccccccCCCCCccccccCCCccchhhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhC--CCCC
Q 016037          295 GLAKQFDENTRSNSMCGTLEYMSPEIVL--GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKI--QQKIIKD--KIKL  368 (396)
Q Consensus       295 gla~~~~~~~~~~~~~gt~~y~APE~l~--~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i--~~~i~~~--~~~~  368 (396)
                      |+++....  ......||+.|+|||++.  ...++.++|||||||++|||++|+.||...+....  ...+...  ...+
T Consensus       174 g~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  251 (287)
T 4f0f_A          174 GLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI  251 (287)
T ss_dssp             TTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCC
T ss_pred             Cccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCC
Confidence            99976433  344567999999999994  45578999999999999999999999987654333  4444444  4567


Q ss_pred             CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          369 PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       369 p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      |..+++++.+||++||+.||.+|||++
T Consensus       252 ~~~~~~~l~~li~~~l~~dp~~Rps~~  278 (287)
T 4f0f_A          252 PEDCPPRLRNVIELCWSGDPKKRPHFS  278 (287)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CcccCHHHHHHHHHHhcCChhhCcCHH
Confidence            889999999999999999999999974

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-46  Score=368.62  Aligned_cols=242  Identities=27%  Similarity=0.370  Sum_probs=204.7

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec------
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------  222 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~------  222 (396)
                      .++|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+|+.++||||+++++++...      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            468999999999999999999999999999999996643 2344556688999999999999999999999765      


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      ..+|+||||+ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence            3569999999 7789887765 6789999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------------
Q 016037          303 NTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI---------------  366 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~---------------  366 (396)
                      .  ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....|.+...               
T Consensus       181 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~  258 (367)
T 1cm8_A          181 E--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA  258 (367)
T ss_dssp             S--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred             c--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHH
Confidence            3  345689999999999987 6799999999999999999999999999887777666654211               


Q ss_pred             ----------------CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 ----------------KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 ----------------~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                      .+....++++.+||++||+.||.+|||+.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~  303 (367)
T 1cm8_A          259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG  303 (367)
T ss_dssp             HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             HHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHH
Confidence                            12346799999999999999999999864

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.9e-46  Score=363.49  Aligned_cols=245  Identities=27%  Similarity=0.419  Sum_probs=206.5

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC--CCeeeeeEEEEecCe
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH--PFIVQLRYSFQTKYR  224 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~H--pnIv~l~~~~~~~~~  224 (396)
                      +..++|++++.||+|+||.||+|.+ .+++.||+|++..... .....+.+.+|+.+|+.++|  |||+++++++.....
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            4556799999999999999999988 4588899999986543 33455678899999999986  999999999999999


Q ss_pred             EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      +|+||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+....
T Consensus        84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            999999 56789999999999999999999999999999999999999999999999996 7889999999998765433


Q ss_pred             C---ccccccCCCccchhhhcC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhC--CCC
Q 016037          305 R---SNSMCGTLEYMSPEIVLG-----------KGHDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQKIIKD--KIK  367 (396)
Q Consensus       305 ~---~~~~~gt~~y~APE~l~~-----------~~~~~~~DvwSlGvil~elltg~~Pf~~~~-~~~i~~~i~~~--~~~  367 (396)
                      .   ....+||+.|+|||++.+           ..++.++|||||||++|||++|+.||.+.. .......+...  ...
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  241 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE  241 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence            2   345679999999999964           668899999999999999999999998743 33344444432  567


Q ss_pred             CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          368 LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       368 ~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +|...+.++.+||+.||+.||.+|||+.
T Consensus       242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~  269 (343)
T 3dbq_A          242 FPDIPEKDLQDVLKCCLKRDPKQRISIP  269 (343)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             CcccCCHHHHHHHHHHcCCChhHCCCHH
Confidence            7888999999999999999999999964

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.1e-46  Score=366.93  Aligned_cols=246  Identities=27%  Similarity=0.352  Sum_probs=207.9

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe------
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT------  221 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~------  221 (396)
                      ..++|++++.||+|+||+||+|++..+++.||+|++....... .....+.+|+.+++.++||||+++++++..      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence            3478999999999999999999999999999999997654322 223446689999999999999999999977      


Q ss_pred             --cCeEEEEEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccc
Q 016037          222 --KYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK  298 (396)
Q Consensus       222 --~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~  298 (396)
                        ...+|+||||+++ +|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence              4578999999987 55555544 4679999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCC-----CCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc-
Q 016037          299 QFDEN-----TRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAF-  371 (396)
Q Consensus       299 ~~~~~-----~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~-  371 (396)
                      .+...     ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+......++.. 
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  252 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV  252 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence            76422     22345678999999999976 558999999999999999999999999998888877776542222211 


Q ss_pred             -------------------------------CCHHHHHHHHHhhccCCCCCCCCC
Q 016037          372 -------------------------------LSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       372 -------------------------------~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                                     .++++.+||++||+.||.+|||+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  307 (351)
T 3mi9_A          253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD  307 (351)
T ss_dssp             STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHH
Confidence                                           278899999999999999999964

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-46  Score=360.62  Aligned_cols=248  Identities=20%  Similarity=0.303  Sum_probs=212.5

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCC----cEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTS----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~  221 (396)
                      .+..++|++.+.||+|+||.||+|.++.++    ..||+|+++...  .......+.+|+.+++.++||||+++++++..
T Consensus        40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  117 (333)
T 1mqb_A           40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK  117 (333)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            456688999999999999999999987654    459999997643  23445568889999999999999999999999


Q ss_pred             cCeEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccccc
Q 016037          222 KYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~  300 (396)
                      ...+|+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999999998765 67999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCC----ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCH
Q 016037          301 DENTR----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSS  374 (396)
Q Consensus       301 ~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~  374 (396)
                      .....    .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+.+..++...+..+ ++..+..++.
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS  277 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCH
Confidence            53321    223346788999999999999999999999999999999 99999999988888888776 5677889999


Q ss_pred             HHHHHHHHhhccCCCCCCCCC
Q 016037          375 EAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       375 ~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ++.+||++||+.+|.+||++.
T Consensus       278 ~l~~li~~~l~~~p~~Rps~~  298 (333)
T 1mqb_A          278 AIYQLMMQCWQQERARRPKFA  298 (333)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHHHHHcCCChhhCcCHH
Confidence            999999999999999999964

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.5e-46  Score=365.68  Aligned_cols=246  Identities=26%  Similarity=0.438  Sum_probs=213.7

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +..++|++++.||+|+||.||+|.+..+++.||+|++....  .....+.+.+|+.+++.++||||+++++++.....+|
T Consensus        30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  107 (360)
T 3eqc_A           30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS  107 (360)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence            44578999999999999999999999999999999998653  3445567889999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEecccccccCCCCC
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~-~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~  305 (396)
                      +||||+++++|.+++...+.+++..++.++.|++.||.|||++ ||+||||||+|||++.++++||+|||+++..... .
T Consensus       108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~  186 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M  186 (360)
T ss_dssp             EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C
T ss_pred             EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-c
Confidence            9999999999999999988999999999999999999999996 9999999999999999999999999999765332 2


Q ss_pred             ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---------------------------
Q 016037          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ---------------------------  358 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~---------------------------  358 (396)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...+.                           
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (360)
T 3eqc_A          187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK  266 (360)
T ss_dssp             ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred             ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence            34567999999999999999999999999999999999999999887655432                           


Q ss_pred             ---------------HHHHhCC-CCCC-ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          359 ---------------QKIIKDK-IKLP-AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       359 ---------------~~i~~~~-~~~p-~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                     ..+.... ..++ ..++.++.+||++||+.||.+|||+.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  320 (360)
T 3eqc_A          267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK  320 (360)
T ss_dssp             -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHH
T ss_pred             cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHH
Confidence                           2233332 2223 35899999999999999999999974

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.4e-46  Score=369.88  Aligned_cols=245  Identities=27%  Similarity=0.408  Sum_probs=208.9

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC--CCCeeeeeEEEEecCe
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD--HPFIVQLRYSFQTKYR  224 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~--HpnIv~l~~~~~~~~~  224 (396)
                      +...+|++++.||+|+||+||+|.+.. ++.||||++..... .....+.+.+|+.+|++++  ||||+++++++.....
T Consensus        53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~  130 (390)
T 2zmd_A           53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  130 (390)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence            344579999999999999999999865 88999999987543 3445667889999999996  5999999999999999


Q ss_pred             EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      +|+||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+....
T Consensus       131 ~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          131 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             EEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            999999 67789999999988999999999999999999999999999999999999994 6899999999998775432


Q ss_pred             ---CccccccCCCccchhhhcC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhC--CCC
Q 016037          305 ---RSNSMCGTLEYMSPEIVLG-----------KGHDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQKIIKD--KIK  367 (396)
Q Consensus       305 ---~~~~~~gt~~y~APE~l~~-----------~~~~~~~DvwSlGvil~elltg~~Pf~~~~-~~~i~~~i~~~--~~~  367 (396)
                         .....+||+.|+|||++.+           ..++.++|||||||+||||++|+.||.+.. .......+...  .+.
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~  288 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE  288 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC
Confidence               2345689999999999975           368899999999999999999999998753 34455555544  456


Q ss_pred             CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          368 LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       368 ~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +|...+.++.+||+.||+.||.+|||+.
T Consensus       289 ~~~~~~~~~~~li~~~L~~dP~~Rps~~  316 (390)
T 2zmd_A          289 FPDIPEKDLQDVLKCCLKRDPKQRISIP  316 (390)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             CCccchHHHHHHHHHHcccChhhCCCHH
Confidence            7888899999999999999999999964

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.2e-47  Score=378.16  Aligned_cols=246  Identities=31%  Similarity=0.555  Sum_probs=203.8

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccch-----hhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-----KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~-----~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~  223 (396)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++.+.....     ......+.+|+.+|++++||||+++++++. ..
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            478999999999999999999999999999999998754321     122334778999999999999999999985 45


Q ss_pred             eEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC---cEEEEeccccccc
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG---HVMLTDFGLAKQF  300 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~---~ikL~Dfgla~~~  300 (396)
                      .+|+||||+++|+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++   .+||+|||+++..
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence            6899999999999999988888999999999999999999999999999999999999997554   5999999999987


Q ss_pred             CCCCCccccccCCCccchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCCCC----ccC
Q 016037          301 DENTRSNSMCGTLEYMSPEIVLG---KGHDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQKIIKDKIKLP----AFL  372 (396)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~DvwSlGvil~elltg~~Pf~~~~-~~~i~~~i~~~~~~~p----~~~  372 (396)
                      .........+||+.|+|||++.+   ..++.++|||||||++|+|++|+.||.+.. ...+...+......++    ..+
T Consensus       293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  372 (419)
T 3i6u_A          293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV  372 (419)
T ss_dssp             C-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTS
T ss_pred             CCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhccc
Confidence            76666667889999999999864   567889999999999999999999998754 3345566666666554    368


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCC
Q 016037          373 SSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       373 s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +.++.+||++||+.||.+||++.
T Consensus       373 ~~~~~~li~~~L~~dP~~Rps~~  395 (419)
T 3i6u_A          373 SEKALDLVKKLLVVDPKARFTTE  395 (419)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHH
Confidence            99999999999999999999964

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.2e-46  Score=362.01  Aligned_cols=246  Identities=26%  Similarity=0.428  Sum_probs=213.7

Q ss_pred             CCCeEEE-eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCeEE
Q 016037          149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       149 ~~~~~~~-~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~  226 (396)
                      .+.|.+. +.||+|+||.||+|+++.+++.||+|++....... .....+.+|+.+++.+ .||||+++++++.....+|
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~  105 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII  105 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence            4568887 88999999999999999999999999998754322 3345578899999998 4699999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC---CCcEEEEecccccccC
Q 016037          227 LVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFD  301 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~---~~~ikL~Dfgla~~~~  301 (396)
                      +||||+.+|+|..++...  +.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++...
T Consensus       106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~  185 (327)
T 3lm5_A          106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG  185 (327)
T ss_dssp             EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred             EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence            999999999998887543  67999999999999999999999999999999999999988   7899999999999876


Q ss_pred             CCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHH
Q 016037          302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAH  377 (396)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~~~s~~~~  377 (396)
                      ........+||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+......++    ..++.++.
T Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  265 (327)
T 3lm5_A          186 HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLAT  265 (327)
T ss_dssp             --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred             CccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHH
Confidence            66556667899999999999999999999999999999999999999999998888888887755443    46899999


Q ss_pred             HHHHHhhccCCCCCCCCC
Q 016037          378 SLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       378 ~li~~~l~~~p~~RPs~s  395 (396)
                      +||+.||+.||.+|||+.
T Consensus       266 ~li~~~L~~dP~~Rpt~~  283 (327)
T 3lm5_A          266 DFIQSLLVKNPEKRPTAE  283 (327)
T ss_dssp             HHHHHHSCSSGGGSCCHH
T ss_pred             HHHHHHcCCChhhCcCHH
Confidence            999999999999999964

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.5e-46  Score=369.47  Aligned_cols=240  Identities=28%  Similarity=0.417  Sum_probs=205.9

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe------
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT------  221 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~------  221 (396)
                      ..++|++.+.||+|+||+||+|++..+|+.||+|++..+..       ...+|+.+++.++||||++++++|..      
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            34689999999999999999999999999999999876432       12369999999999999999999844      


Q ss_pred             --------------------------------cCeEEEEEEecCCCcHHHHH----HHhcCCCHHHHHHHHHHHHHHHHH
Q 016037          222 --------------------------------KYRLYLVLDFVNGGHLFFQL----YRQGLFREDLARIYTAEIVSAVSH  265 (396)
Q Consensus       222 --------------------------------~~~~~lV~E~~~gg~L~~~l----~~~~~l~e~~~~~~~~qi~~aL~~  265 (396)
                                                      ...+++||||+++ +|...+    ...+.+++..++.++.||+.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            3348999999996 655554    345789999999999999999999


Q ss_pred             HHHCCceeccCCCCCEEEc-CCCcEEEEecccccccCCCCCccccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHH
Q 016037          266 LHANGIMHRDLKPENILLD-ADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEML  343 (396)
Q Consensus       266 LH~~~iiHrDlkp~NILl~-~~~~ikL~Dfgla~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~ell  343 (396)
                      ||++||+||||||+|||++ .++.+||+|||+++............||+.|+|||++.+. .++.++|||||||++|||+
T Consensus       157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  236 (383)
T 3eb0_A          157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI  236 (383)
T ss_dssp             HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred             HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence            9999999999999999997 6899999999999987766666777899999999999875 4899999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHHhC-----------------CC------------CCCccCCHHHHHHHHHhhccCCCCCCCC
Q 016037          344 TGQPPFTGGNRQKIQQKIIKD-----------------KI------------KLPAFLSSEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       344 tg~~Pf~~~~~~~i~~~i~~~-----------------~~------------~~p~~~s~~~~~li~~~l~~~p~~RPs~  394 (396)
                      +|+.||.+.+..+....+.+.                 ..            .+|..++.++.+||++||+.+|.+|||+
T Consensus       237 ~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  316 (383)
T 3eb0_A          237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP  316 (383)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence            999999998887777776541                 11            1456789999999999999999999986


Q ss_pred             C
Q 016037          395 S  395 (396)
Q Consensus       395 s  395 (396)
                      .
T Consensus       317 ~  317 (383)
T 3eb0_A          317 Y  317 (383)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.6e-47  Score=365.67  Aligned_cols=243  Identities=26%  Similarity=0.409  Sum_probs=201.6

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++++.||+|+||+||+|++..+++.||+|+++....  ......+.+|+.+++.++||||+++++++.....+|+||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   79 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence            579999999999999999999999999999999975431  111122446999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Ccc
Q 016037          230 DFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSN  307 (396)
Q Consensus       230 E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~~  307 (396)
                      ||+++ +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~  158 (324)
T 3mtl_A           80 EYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD  158 (324)
T ss_dssp             ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred             ccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccc
Confidence            99985 777777664 468999999999999999999999999999999999999999999999999998654332 234


Q ss_pred             ccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C------------------
Q 016037          308 SMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK--I------------------  366 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~--~------------------  366 (396)
                      ..+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....  .                  
T Consensus       159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
T 3mtl_A          159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN  238 (324)
T ss_dssp             ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC
T ss_pred             cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccc
Confidence            5578999999999977 568999999999999999999999999998888777776521  0                  


Q ss_pred             ----------CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 ----------KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 ----------~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                ..+..+++++.+||++||+.||.+|||+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  277 (324)
T 3mtl_A          239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAE  277 (324)
T ss_dssp             CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHH
Confidence                      01235789999999999999999999964

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.8e-46  Score=372.46  Aligned_cols=245  Identities=24%  Similarity=0.380  Sum_probs=200.8

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec-----C
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----Y  223 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~-----~  223 (396)
                      .++|++.+.||+|+||.||+|+++.+++.||||++.... ......+.+.+|+.+|+.++||||+++++++...     .
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            468999999999999999999999999999999997643 2344556788999999999999999999999776     5


Q ss_pred             eEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      .+|+||||+++ +|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       104 ~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          104 ELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE  182 (432)
T ss_dssp             CEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred             eEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence            79999999875 89999988888999999999999999999999999999999999999999999999999999876533


Q ss_pred             C-----------------------CccccccCCCccchhhh-cCCCCCchhhHHHHHHHHHHHHh-----------CCCC
Q 016037          304 T-----------------------RSNSMCGTLEYMSPEIV-LGKGHDKAADWWSVGILLFEMLT-----------GQPP  348 (396)
Q Consensus       304 ~-----------------------~~~~~~gt~~y~APE~l-~~~~~~~~~DvwSlGvil~ellt-----------g~~P  348 (396)
                      .                       .....+||+.|+|||++ .+..++.++|||||||++|||++           |.++
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~  262 (432)
T 3n9x_A          183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL  262 (432)
T ss_dssp             ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred             ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence            2                       23567899999999986 55679999999999999999998           4444


Q ss_pred             CCCCCH-----------------HH------------------------HHHHHHhCCCCCC-------ccCCHHHHHHH
Q 016037          349 FTGGNR-----------------QK------------------------IQQKIIKDKIKLP-------AFLSSEAHSLL  380 (396)
Q Consensus       349 f~~~~~-----------------~~------------------------i~~~i~~~~~~~p-------~~~s~~~~~li  380 (396)
                      |.+.+.                 ..                        ....+.......+       +.+++++.+||
T Consensus       263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl  342 (432)
T 3n9x_A          263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL  342 (432)
T ss_dssp             CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred             CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence            544320                 11                        1111111111111       45899999999


Q ss_pred             HHhhccCCCCCCCCC
Q 016037          381 KGVNSLLSISVPLLS  395 (396)
Q Consensus       381 ~~~l~~~p~~RPs~s  395 (396)
                      ++||++||.+|||+.
T Consensus       343 ~~mL~~dP~~R~ta~  357 (432)
T 3n9x_A          343 ESMLKFNPNKRITID  357 (432)
T ss_dssp             HHHSCSSTTTSCCHH
T ss_pred             HHHhcCCcccCCCHH
Confidence            999999999999964

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-46  Score=352.57  Aligned_cols=247  Identities=23%  Similarity=0.320  Sum_probs=216.6

Q ss_pred             cccCCCeEEEe-EecccCceEEEEEEEc--CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          146 CVGLEDFEVLK-VVGQGAFAKVYQVRRI--GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       146 ~~~~~~~~~~~-~IG~G~fG~Vy~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      .+..++|.+.+ .||+|+||.||+|.+.  .++..||+|+++...  .....+.+.+|+.+++.++||||+++++++ ..
T Consensus         5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~   81 (287)
T 1u59_A            5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA   81 (287)
T ss_dssp             BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred             cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence            35567898887 9999999999999864  467889999998653  344566788999999999999999999999 55


Q ss_pred             CeEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      ..+|+||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++...
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            6799999999999999988644 569999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCC----ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHH
Q 016037          302 ENTR----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSE  375 (396)
Q Consensus       302 ~~~~----~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~  375 (396)
                      ....    .....||+.|+|||++.+..++.++||||||+++|||+| |+.||.+.+..++...+..+ ...+|..++.+
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  241 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE  241 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHH
Confidence            3322    233456889999999988889999999999999999999 99999998888888888776 46788999999


Q ss_pred             HHHHHHHhhccCCCCCCCCC
Q 016037          376 AHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       376 ~~~li~~~l~~~p~~RPs~s  395 (396)
                      +.+||+.||+.+|.+||++.
T Consensus       242 l~~li~~~l~~~p~~Rps~~  261 (287)
T 1u59_A          242 LYALMSDCWIYKWEDRPDFL  261 (287)
T ss_dssp             HHHHHHHTTCSSGGGSCCHH
T ss_pred             HHHHHHHHcCCChhhCcCHH
Confidence            99999999999999999874

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.1e-46  Score=351.50  Aligned_cols=248  Identities=23%  Similarity=0.367  Sum_probs=213.5

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCC---CcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~  221 (396)
                      ..+..++|++.+.||+|+||+||+|++...   +..||+|++....  .....+.+.+|+.+++.++||||+++++++..
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   84 (281)
T 3cc6_A            7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE   84 (281)
T ss_dssp             CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred             ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence            346678999999999999999999997643   4569999998653  23445678899999999999999999999865


Q ss_pred             cCeEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccccc
Q 016037          222 KYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~  300 (396)
                      . ..|+||||+++++|.+++.+. ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++...
T Consensus        85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence            4 568999999999999999765 45899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCC--CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHH
Q 016037          301 DENT--RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (396)
Q Consensus       301 ~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~  376 (396)
                      ....  ......+|+.|+|||++.+..++.++||||||+++|||+| |+.||...+.......+... ....|..+++.+
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  243 (281)
T 3cc6_A          164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVL  243 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHH
T ss_pred             ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHH
Confidence            5432  2234457889999999998889999999999999999998 99999988877777777765 567788999999


Q ss_pred             HHHHHHhhccCCCCCCCCC
Q 016037          377 HSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~RPs~s  395 (396)
                      .+||++||+.+|.+|||++
T Consensus       244 ~~li~~~l~~~p~~Rps~~  262 (281)
T 3cc6_A          244 YTLMTRCWDYDPSDRPRFT  262 (281)
T ss_dssp             HHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHccCCchhCcCHH
Confidence            9999999999999999974

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.3e-46  Score=366.39  Aligned_cols=243  Identities=26%  Similarity=0.402  Sum_probs=198.7

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC-----
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----  223 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~-----  223 (396)
                      .++|++++.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.+++.++||||+++++++....     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            4789999999999999999999999999999999976432 3345566788999999999999999999997654     


Q ss_pred             -eEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          224 -RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       224 -~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                       .+|+||||+++ +|...+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  179 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred             cceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence             78999999986 6766664  4689999999999999999999999999999999999999999999999999987765


Q ss_pred             CCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------------
Q 016037          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK---------------  367 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~---------------  367 (396)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+......++......               
T Consensus       180 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  259 (371)
T 2xrw_A          180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT  259 (371)
T ss_dssp             ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred             ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence            55556678999999999999999999999999999999999999999998887777776543111               


Q ss_pred             -------C--------------Cc------cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          368 -------L--------------PA------FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       368 -------~--------------p~------~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                             +              |.      ..+.++++||++||+.||.+|||+.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~  314 (371)
T 2xrw_A          260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD  314 (371)
T ss_dssp             HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHH
Confidence                   0              00      1267899999999999999999974

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.4e-45  Score=352.61  Aligned_cols=248  Identities=30%  Similarity=0.475  Sum_probs=204.9

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|+++..........+.+.+|+.+++.++||||+++++++.....+++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            45689999999999999999999999999999999987555555667778899999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          228 VLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      ||||+++++|.+++..    ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~  189 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  189 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence            9999999999988864    456899999999999999999999999999999999999999999999999999876543


Q ss_pred             C-CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCC-C-CccCCHHHHH
Q 016037          304 T-RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG--NRQKIQQKIIKDKIK-L-PAFLSSEAHS  378 (396)
Q Consensus       304 ~-~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~--~~~~i~~~i~~~~~~-~-p~~~s~~~~~  378 (396)
                      . ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.  +...+...+...... + +..++.++.+
T Consensus       190 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  269 (310)
T 2wqm_A          190 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ  269 (310)
T ss_dssp             ---------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHH
T ss_pred             CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHH
Confidence            2 234567899999999999999999999999999999999999999764  445566666655432 2 3578999999


Q ss_pred             HHHHhhccCCCCCCCCC
Q 016037          379 LLKGVNSLLSISVPLLS  395 (396)
Q Consensus       379 li~~~l~~~p~~RPs~s  395 (396)
                      ||+.||+.||.+|||++
T Consensus       270 li~~~l~~dp~~Rps~~  286 (310)
T 2wqm_A          270 LVNMCINPDPEKRPDVT  286 (310)
T ss_dssp             HHHHHTCSSGGGSCCHH
T ss_pred             HHHHHcCCChhhCCCHH
Confidence            99999999999999974

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2e-46  Score=351.94  Aligned_cols=245  Identities=29%  Similarity=0.436  Sum_probs=212.6

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.....  ....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence            3579999999999999999999999999999999976542  23456688999999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC---CC
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---TR  305 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~---~~  305 (396)
                      |||+++++|.+++.....+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......   ..
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  163 (276)
T 2yex_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (276)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence            999999999998887778999999999999999999999999999999999999999999999999999865432   22


Q ss_pred             ccccccCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCC--CCccCCHHHHHHHH
Q 016037          306 SNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQ-KIQQKIIKDKIK--LPAFLSSEAHSLLK  381 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~-~i~~~i~~~~~~--~p~~~s~~~~~li~  381 (396)
                      ....+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.+.+.. .....+......  ....++.++.+||+
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (276)
T 2yex_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  243 (276)
T ss_dssp             BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHH
Confidence            345679999999999988665 78999999999999999999999876543 333344433332  23579999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      +||+.||.+|||+.
T Consensus       244 ~~l~~~p~~Rps~~  257 (276)
T 2yex_A          244 KILVENPSARITIP  257 (276)
T ss_dssp             HHSCSSTTTSCCHH
T ss_pred             HHCCCCchhCCCHH
Confidence            99999999999964

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.2e-45  Score=349.96  Aligned_cols=243  Identities=24%  Similarity=0.379  Sum_probs=211.8

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe----cCeE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT----KYRL  225 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~----~~~~  225 (396)
                      ..|++.+.||+|+||.||+|.+..++..||+|++...... ....+.+.+|+.+++.++||||+++++++..    ...+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            4599999999999999999999999999999999875543 3456678899999999999999999999875    4568


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEc-CCCcEEEEecccccccCC
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLD-ADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~--iiHrDlkp~NILl~-~~~~ikL~Dfgla~~~~~  302 (396)
                      |+||||+++++|.+++...+.+++..++.++.||+.||.|||++|  ++||||||+|||++ .++.+||+|||++.....
T Consensus       105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~  184 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence            999999999999999998899999999999999999999999999  99999999999997 789999999999976543


Q ss_pred             CCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCC--CCCccCCHHHHHH
Q 016037          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG-NRQKIQQKIIKDKI--KLPAFLSSEAHSL  379 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~-~~~~i~~~i~~~~~--~~p~~~s~~~~~l  379 (396)
                      . ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+. +...+...+.....  .++...++++.+|
T Consensus       185 ~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  262 (290)
T 1t4h_A          185 S-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI  262 (290)
T ss_dssp             T-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred             c-ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHH
Confidence            3 3345679999999998875 4899999999999999999999999884 44555555555422  3456788999999


Q ss_pred             HHHhhccCCCCCCCCC
Q 016037          380 LKGVNSLLSISVPLLS  395 (396)
Q Consensus       380 i~~~l~~~p~~RPs~s  395 (396)
                      |+.||+.+|.+|||++
T Consensus       263 i~~~l~~dp~~Rps~~  278 (290)
T 1t4h_A          263 IEGCIRQNKDERYSIK  278 (290)
T ss_dssp             HHHHSCSSGGGSCCHH
T ss_pred             HHHHccCChhhCCCHH
Confidence            9999999999999974

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=7.6e-48  Score=379.54  Aligned_cols=239  Identities=17%  Similarity=0.164  Sum_probs=198.2

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHH---HHHHhCCCCCeeeee-------EE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER---NILTKVDHPFIVQLR-------YS  218 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~---~~L~~l~HpnIv~l~-------~~  218 (396)
                      .++|++.+.||+|+||+||+|++..+|+.||||++...........+.+.+|+   ++|+.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46799999999999999999999999999999999876555556677788999   455556899999998       66


Q ss_pred             EEecC-----------------eEEEEEEecCCCcHHHHHHHhcCCCH-------HHHHHHHHHHHHHHHHHHHCCceec
Q 016037          219 FQTKY-----------------RLYLVLDFVNGGHLFFQLYRQGLFRE-------DLARIYTAEIVSAVSHLHANGIMHR  274 (396)
Q Consensus       219 ~~~~~-----------------~~~lV~E~~~gg~L~~~l~~~~~l~e-------~~~~~~~~qi~~aL~~LH~~~iiHr  274 (396)
                      +...+                 ..|+||||+ +|+|.+++...+.+++       ..++.++.||+.||.|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            66553                 389999999 5799999987766666       7778899999999999999999999


Q ss_pred             cCCCCCEEEcCCCcEEEEecccccccCCCCCccccccCCCccchhhhcCC-----------CCCchhhHHHHHHHHHHHH
Q 016037          275 DLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGK-----------GHDKAADWWSVGILLFEML  343 (396)
Q Consensus       275 Dlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~~gt~~y~APE~l~~~-----------~~~~~~DvwSlGvil~ell  343 (396)
                      ||||+|||++.++.+||+|||+++....  .....+| +.|+|||++.+.           .++.++|||||||+||||+
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell  307 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW  307 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence            9999999999999999999999986433  3445678 999999999887           8999999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          344 TGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       344 tg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +|+.||.+.+.......+.    ..+..+++++.+||.+||+.||.+||++.
T Consensus       308 tg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~  355 (377)
T 3byv_A          308 CADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPL  355 (377)
T ss_dssp             HSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHH
T ss_pred             HCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHH
Confidence            9999998766444333332    23467899999999999999999999864

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=9.9e-46  Score=348.16  Aligned_cols=240  Identities=19%  Similarity=0.278  Sum_probs=207.0

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCeEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~l  227 (396)
                      .++|++++.||+|+||+||+|.+..+++.||+|++....... .....+.+|+..+..+ +||||+++++++.+...+|+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            367999999999999999999999999999999998754333 3345567789899988 99999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC-----------------
Q 016037          228 VLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-----------------  286 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~-----------------  286 (396)
                      ||||+++++|.+++...    +.+++..++.++.||+.||.|||++||+||||||+|||++.+                 
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~  168 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS  168 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence            99999999999998765    678999999999999999999999999999999999999844                 


Q ss_pred             --CcEEEEecccccccCCCCCccccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 016037          287 --GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK  363 (396)
Q Consensus       287 --~~ikL~Dfgla~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~  363 (396)
                        ..+||+|||++......   ....||+.|+|||++.+. .++.++|||||||++|+|++|..++...+   ....+..
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~  242 (289)
T 1x8b_A          169 NKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQ  242 (289)
T ss_dssp             -CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHT
T ss_pred             CceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHc
Confidence              47999999999876543   234689999999999876 56689999999999999999998876543   2344444


Q ss_pred             C-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          364 D-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       364 ~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      . ...+|..++.++.+||++||+.||.+|||+.
T Consensus       243 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  275 (289)
T 1x8b_A          243 GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAM  275 (289)
T ss_dssp             TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHH
Confidence            4 4467889999999999999999999999964

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=5e-46  Score=350.31  Aligned_cols=246  Identities=21%  Similarity=0.344  Sum_probs=216.0

Q ss_pred             CccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC
Q 016037          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (396)
Q Consensus       144 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~  223 (396)
                      .+.+..++|++.+.||+|+||.||+|.+. ++..||+|++.....    ..+.+.+|+.+++.++||||+++++++.. .
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~   80 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E   80 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence            45566789999999999999999999985 466799999976542    23557889999999999999999998864 5


Q ss_pred             eEEEEEEecCCCcHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      ..|+||||+++++|.+++....  .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  160 (279)
T 1qpc_A           81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (279)
T ss_dssp             SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence            6899999999999999886543  78999999999999999999999999999999999999999999999999998775


Q ss_pred             CCCC--ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHH
Q 016037          302 ENTR--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAH  377 (396)
Q Consensus       302 ~~~~--~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~  377 (396)
                      ....  .....+++.|+|||++.+..++.++||||||+++|||++ |+.||.+.+..++.+.+... ....|..++.++.
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  240 (279)
T 1qpc_A          161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY  240 (279)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHH
Confidence            4332  234457889999999988889999999999999999999 99999999988888888776 5567789999999


Q ss_pred             HHHHHhhccCCCCCCCCC
Q 016037          378 SLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       378 ~li~~~l~~~p~~RPs~s  395 (396)
                      +||+.||+.+|.+|||++
T Consensus       241 ~li~~~l~~~p~~Rps~~  258 (279)
T 1qpc_A          241 QLMRLCWKERPEDRPTFD  258 (279)
T ss_dssp             HHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHhccChhhCCCHH
Confidence            999999999999999964

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.4e-46  Score=378.05  Aligned_cols=245  Identities=23%  Similarity=0.334  Sum_probs=189.8

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe-----cC
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-----KY  223 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~-----~~  223 (396)
                      .++|++++.||+|+||+||+|+++.+++.||||++.+.. ......+.+.+|+.+|+.++||||+++++++..     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            368999999999999999999999999999999997643 234455678899999999999999999999943     35


Q ss_pred             eEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      .+|+||||+. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.....
T Consensus       131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            7999999985 689899988888999999999999999999999999999999999999999999999999999876432


Q ss_pred             C----------------------------CccccccCCCccchhhh-cCCCCCchhhHHHHHHHHHHHHh----------
Q 016037          304 T----------------------------RSNSMCGTLEYMSPEIV-LGKGHDKAADWWSVGILLFEMLT----------  344 (396)
Q Consensus       304 ~----------------------------~~~~~~gt~~y~APE~l-~~~~~~~~~DvwSlGvil~ellt----------  344 (396)
                      .                            .....+||+.|+|||++ .+..|+.++|||||||+||||++          
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~  289 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA  289 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence            1                            23446789999999986 45679999999999999999999          


Q ss_pred             -CCCCCCCCCH--------------------HHHHHHHHh-----------------------C-----CC---CCCccC
Q 016037          345 -GQPPFTGGNR--------------------QKIQQKIIK-----------------------D-----KI---KLPAFL  372 (396)
Q Consensus       345 -g~~Pf~~~~~--------------------~~i~~~i~~-----------------------~-----~~---~~p~~~  372 (396)
                       |+++|.+.+.                    ......|..                       .     ..   ...+.+
T Consensus       290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (458)
T 3rp9_A          290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS  369 (458)
T ss_dssp             GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred             cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence             7788876441                    111111111                       0     00   012356


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCC
Q 016037          373 SSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       373 s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ++++.+||++||++||.+|||+.
T Consensus       370 s~~~~dLl~~mL~~dP~~R~t~~  392 (458)
T 3rp9_A          370 SADAIHLLKRMLVFNPNKRITIN  392 (458)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             CHHHHHHHHHHhccCccccCCHH
Confidence            99999999999999999999864

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.8e-46  Score=361.18  Aligned_cols=245  Identities=32%  Similarity=0.572  Sum_probs=208.5

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc-----hhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCe
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~  224 (396)
                      ++|++.+.||+|+||.||+|.+..+++.||||++......     .......+.+|+.+|++++||||+++++++.... 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            5799999999999999999999999999999999765321     1223345778999999999999999999987655 


Q ss_pred             EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc---EEEEecccccccC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH---VMLTDFGLAKQFD  301 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~---ikL~Dfgla~~~~  301 (396)
                      +|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++...
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  168 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG  168 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred             eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence            8999999999999999988889999999999999999999999999999999999999987664   9999999998876


Q ss_pred             CCCCccccccCCCccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCCC----ccCC
Q 016037          302 ENTRSNSMCGTLEYMSPEIVL---GKGHDKAADWWSVGILLFEMLTGQPPFTGGNR-QKIQQKIIKDKIKLP----AFLS  373 (396)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~---~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~-~~i~~~i~~~~~~~p----~~~s  373 (396)
                      ........+||+.|+|||++.   ...++.++|||||||++|+|++|+.||..... ..+...+..+...++    ..++
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (322)
T 2ycf_A          169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS  248 (322)
T ss_dssp             CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSC
T ss_pred             cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcC
Confidence            554445567999999999974   46689999999999999999999999987543 345566666665543    4689


Q ss_pred             HHHHHHHHHhhccCCCCCCCCC
Q 016037          374 SEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       374 ~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .++.+||++||+.||.+||++.
T Consensus       249 ~~~~~li~~~l~~dP~~Rps~~  270 (322)
T 2ycf_A          249 EKALDLVKKLLVVDPKARFTTE  270 (322)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHH
T ss_pred             HHHHHHHHHHcccCHhhCCCHH
Confidence            9999999999999999999864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.9e-46  Score=355.63  Aligned_cols=248  Identities=21%  Similarity=0.321  Sum_probs=209.2

Q ss_pred             cccCCCeEEEeEecccCceEEEEEE----EcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~  221 (396)
                      .+....|++++.||+|+||.||+|+    +..+++.||+|++....  .....+.+.+|+.+++.++||||+++++++..
T Consensus        17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (302)
T 4e5w_A           17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTE   94 (302)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence            3455679999999999999999999    46789999999997653  23345668899999999999999999999987


Q ss_pred             c--CeEEEEEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccc
Q 016037          222 K--YRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK  298 (396)
Q Consensus       222 ~--~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~  298 (396)
                      .  ..+|+||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||+++
T Consensus        95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A           95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence            6  678999999999999999954 4679999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCC----CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---------------CHHHHHH
Q 016037          299 QFDENT----RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG---------------NRQKIQQ  359 (396)
Q Consensus       299 ~~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~---------------~~~~i~~  359 (396)
                      ......    ......||..|+|||++.+..++.++||||||+++|+|+||..|+...               ....+..
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence            775443    234456888999999999888999999999999999999999876432               2223334


Q ss_pred             HHHhC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          360 KIIKD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       360 ~i~~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .+... ....|..+++++.+||++||+.||.+|||+.
T Consensus       255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  291 (302)
T 4e5w_A          255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQ  291 (302)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHH
Confidence            44433 5677889999999999999999999999974

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.2e-46  Score=362.99  Aligned_cols=248  Identities=21%  Similarity=0.293  Sum_probs=203.9

Q ss_pred             CCCCccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEE
Q 016037          141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (396)
Q Consensus       141 ~~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~  220 (396)
                      +..+..+..++|++.++||+|+||+||+|++.  ++.||||++....    ........|+.++++++||||+++++++.
T Consensus        15 ~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~   88 (322)
T 3soc_A           15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEK   88 (322)
T ss_dssp             CCCCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             CccccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceec
Confidence            44456677889999999999999999999885  7889999997543    22334456899999999999999999998


Q ss_pred             ecC----eEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC----------CceeccCCCCCEEEcCC
Q 016037          221 TKY----RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN----------GIMHRDLKPENILLDAD  286 (396)
Q Consensus       221 ~~~----~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~----------~iiHrDlkp~NILl~~~  286 (396)
                      ...    .+|+||||+++|+|.+++.. +.+++..++.++.|++.||.|||+.          ||+||||||+|||++.+
T Consensus        89 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~  167 (322)
T 3soc_A           89 RGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN  167 (322)
T ss_dssp             EECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT
T ss_pred             cCCCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC
Confidence            754    47999999999999998866 4589999999999999999999999          99999999999999999


Q ss_pred             CcEEEEecccccccCCCCC---ccccccCCCccchhhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCC------
Q 016037          287 GHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGK-----GHDKAADWWSVGILLFEMLTGQPPFTGG------  352 (396)
Q Consensus       287 ~~ikL~Dfgla~~~~~~~~---~~~~~gt~~y~APE~l~~~-----~~~~~~DvwSlGvil~elltg~~Pf~~~------  352 (396)
                      +++||+|||+++.+.....   ....+||+.|+|||++.+.     .++.++|||||||++|||+||+.||.+.      
T Consensus       168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~  247 (322)
T 3soc_A          168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML  247 (322)
T ss_dssp             CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred             CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence            9999999999987654332   3446799999999999873     4557889999999999999999999763      


Q ss_pred             ----------CHHHHHHHHHhCC--CCCCcc-----CCHHHHHHHHHhhccCCCCCCCCC
Q 016037          353 ----------NRQKIQQKIIKDK--IKLPAF-----LSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       353 ----------~~~~i~~~i~~~~--~~~p~~-----~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                ....+...+....  ..++..     .+.++.+||++||+.||.+|||+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  307 (322)
T 3soc_A          248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG  307 (322)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHH
Confidence                      2334444443332  222322     245699999999999999999974

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=352.50  Aligned_cols=243  Identities=26%  Similarity=0.436  Sum_probs=211.2

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....     ..+.+.+|+.+++.++||||+++++++.....+|+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            3467999999999999999999999999999999997643     23457789999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHH-HhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-C
Q 016037          228 VLDFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-R  305 (396)
Q Consensus       228 V~E~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~  305 (396)
                      ||||+++++|.+++. ....+++..++.++.|++.||.|||++|++||||||+||+++.++++||+|||++....... .
T Consensus       102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  181 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK  181 (314)
T ss_dssp             EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC
T ss_pred             EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc
Confidence            999999999999886 45679999999999999999999999999999999999999999999999999998765432 3


Q ss_pred             ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---CCCCccCCHHHHHHHHH
Q 016037          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLPAFLSSEAHSLLKG  382 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~---~~~p~~~s~~~~~li~~  382 (396)
                      .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+....   +..+..++.++.+||++
T Consensus       182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  261 (314)
T 3com_A          182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQ  261 (314)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHH
T ss_pred             cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHH
Confidence            345679999999999999889999999999999999999999999988777666666552   34467799999999999


Q ss_pred             hhccCCCCCCCCC
Q 016037          383 VNSLLSISVPLLS  395 (396)
Q Consensus       383 ~l~~~p~~RPs~s  395 (396)
                      ||+.||.+|||+.
T Consensus       262 ~l~~dp~~Rpt~~  274 (314)
T 3com_A          262 CLVKSPEQRATAT  274 (314)
T ss_dssp             HTCSCTTTSCCHH
T ss_pred             HccCChhhCcCHH
Confidence            9999999999964

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.6e-46  Score=361.31  Aligned_cols=249  Identities=23%  Similarity=0.376  Sum_probs=215.9

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCCCc-----EEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEE
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE-----IYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYS  218 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~  218 (396)
                      ..+..++|++.+.||+|+||.||+|.+..++.     .||+|++....  .....+.+.+|+.+++.+ +||||++++++
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            45667899999999999999999999987764     79999997653  234456788999999999 89999999999


Q ss_pred             EEecCeEEEEEEecCCCcHHHHHHHh--------------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc
Q 016037          219 FQTKYRLYLVLDFVNGGHLFFQLYRQ--------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD  284 (396)
Q Consensus       219 ~~~~~~~~lV~E~~~gg~L~~~l~~~--------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~  284 (396)
                      +.....+|+||||+++|+|.+++...              ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus       119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred             EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence            99999999999999999999988754              3578999999999999999999999999999999999999


Q ss_pred             CCCcEEEEecccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 016037          285 ADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQK  360 (396)
Q Consensus       285 ~~~~ikL~Dfgla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~  360 (396)
                      .++.+||+|||+++.......   .....||+.|+|||++.+..++.++||||||+++|||+| |..||.+.........
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  278 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK  278 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence            999999999999987643322   234557889999999998889999999999999999999 9999998765555555


Q ss_pred             HHhC--CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          361 IIKD--KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       361 i~~~--~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +...  ....|..++.++.+||+.||+.+|.+|||+.
T Consensus       279 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  315 (333)
T 2i1m_A          279 LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQ  315 (333)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHH
Confidence            5443  4456788999999999999999999999974

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=354.99  Aligned_cols=245  Identities=29%  Similarity=0.449  Sum_probs=206.9

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEe----
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQT----  221 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~----  221 (396)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++.....    ..+.+.+|+.+++++ +||||+++++++..    
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            445789999999999999999999999999999999976432    234577899999998 89999999999977    


Q ss_pred             --cCeEEEEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccc
Q 016037          222 --KYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA  297 (396)
Q Consensus       222 --~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla  297 (396)
                        ...+|+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  176 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS  176 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence              46899999999999999998764  57899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCC-CccccccCCCccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CC
Q 016037          298 KQFDENT-RSNSMCGTLEYMSPEIVL-----GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK--LP  369 (396)
Q Consensus       298 ~~~~~~~-~~~~~~gt~~y~APE~l~-----~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~--~p  369 (396)
                      ....... ......||+.|+|||++.     +..++.++|||||||++|+|++|+.||.+.+.......+......  .+
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  256 (326)
T 2x7f_A          177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS  256 (326)
T ss_dssp             C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC
T ss_pred             eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCc
Confidence            8765332 234567999999999997     566889999999999999999999999998887777777665332  34


Q ss_pred             ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          370 AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       370 ~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ..++.++.+||++||+.||.+||++.
T Consensus       257 ~~~~~~l~~li~~~l~~dp~~Rps~~  282 (326)
T 2x7f_A          257 KKWSKKFQSFIESCLVKNHSQRPATE  282 (326)
T ss_dssp             SCSCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             cccCHHHHHHHHHHhccChhhCCCHH
Confidence            67899999999999999999999964

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.5e-46  Score=361.94  Aligned_cols=246  Identities=23%  Similarity=0.380  Sum_probs=208.0

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEE----EEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIY----AMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~v----AvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      +..++|++++.||+|+||+||+|++..+++.+    |+|.+....  .....+.+.+|+.+++.++||||+++++++...
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence            45578999999999999999999999888766    555554322  223456678899999999999999999999876


Q ss_pred             CeEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      . .++|+||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++...
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            4 78999999999999998764 679999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHH
Q 016037          302 ENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (396)
Q Consensus       302 ~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~  376 (396)
                      ....   .....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+... ....|..++.++
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  248 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV  248 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHH
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence            3322   233456788999999999999999999999999999999 99999999888888888776 567788999999


Q ss_pred             HHHHHHhhccCCCCCCCCC
Q 016037          377 HSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~RPs~s  395 (396)
                      .+||+.||+.+|.+||++.
T Consensus       249 ~~li~~~l~~dp~~Rps~~  267 (327)
T 3lzb_A          249 YMIMRKCWMIDADSRPKFR  267 (327)
T ss_dssp             HHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHcCCChhHCcCHH
Confidence            9999999999999999974

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.9e-46  Score=377.34  Aligned_cols=248  Identities=23%  Similarity=0.354  Sum_probs=213.4

Q ss_pred             CCCccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe
Q 016037          142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (396)
Q Consensus       142 ~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~  221 (396)
                      ...+.+..++|++.+.||+|+||+||+|.+..+ ..||||+++.....    .+.+.+|+.+|++++||||+++++++..
T Consensus       176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~  250 (452)
T 1fmk_A          176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE  250 (452)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccccccChhHceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            344567778999999999999999999999764 56999999865422    3457889999999999999999999876


Q ss_pred             cCeEEEEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          222 KYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                       ..+|+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       251 -~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  329 (452)
T 1fmk_A          251 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL  329 (452)
T ss_dssp             -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             -CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCcccee
Confidence             6789999999999999999643  5689999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCC--ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHH
Q 016037          300 FDENTR--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSE  375 (396)
Q Consensus       300 ~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~  375 (396)
                      ......  .....+|+.|+|||++.+..++.++||||||++||||+| |+.||.+.+..++...+..+ +++.|..++.+
T Consensus       330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~  409 (452)
T 1fmk_A          330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES  409 (452)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred             cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            653321  233456789999999998889999999999999999999 99999999988888888776 67788999999


Q ss_pred             HHHHHHHhhccCCCCCCCCC
Q 016037          376 AHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       376 ~~~li~~~l~~~p~~RPs~s  395 (396)
                      +.+||.+||+.+|.+|||+.
T Consensus       410 l~~li~~cl~~dP~~Rpt~~  429 (452)
T 1fmk_A          410 LHDLMCQCWRKEPEERPTFE  429 (452)
T ss_dssp             HHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHccCChhhCcCHH
Confidence            99999999999999999974

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4.5e-46  Score=356.59  Aligned_cols=248  Identities=21%  Similarity=0.314  Sum_probs=207.2

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcC---CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~  223 (396)
                      +..++|.+.+.||+|+||.||+|.+..   ++..||+|++..... .....+.+.+|+.++++++||||+++++++....
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            556789999999999999999998876   556899999976543 2344566888999999999999999999997754


Q ss_pred             -----eEEEEEEecCCCcHHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEE
Q 016037          224 -----RLYLVLDFVNGGHLFFQLYR------QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLT  292 (396)
Q Consensus       224 -----~~~lV~E~~~gg~L~~~l~~------~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~  292 (396)
                           ..|+||||+++++|..++..      ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~  189 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVA  189 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEe
Confidence                 45999999999999998853      3568999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCCCC---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCC
Q 016037          293 DFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIK  367 (396)
Q Consensus       293 Dfgla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~  367 (396)
                      |||+++......   ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+...+...+... ...
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  269 (313)
T 3brb_A          190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLK  269 (313)
T ss_dssp             SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC
T ss_pred             ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCC
Confidence            999998764332   2233457889999999999999999999999999999999 99999998888888888776 567


Q ss_pred             CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          368 LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       368 ~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .|..++.++.+||.+||+.+|.+|||++
T Consensus       270 ~~~~~~~~l~~li~~~l~~dp~~Rps~~  297 (313)
T 3brb_A          270 QPEDCLDELYEIMYSCWRTDPLDRPTFS  297 (313)
T ss_dssp             CBTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred             CCccccHHHHHHHHHHcCCChhhCcCHH
Confidence            7889999999999999999999999974

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.3e-45  Score=355.81  Aligned_cols=239  Identities=26%  Similarity=0.410  Sum_probs=204.6

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEEEe--cCe
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQT--KYR  224 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~--~~~  224 (396)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++....      .+.+.+|+.+++.++ ||||+++++++..  ...
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT  107 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence            4578999999999999999999999999999999987532      345788999999997 9999999999987  678


Q ss_pred             EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-cEEEEecccccccCCC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HVMLTDFGLAKQFDEN  303 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~-~ikL~Dfgla~~~~~~  303 (396)
                      .++||||+.+++|..++.   .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus       108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            999999999999987764   489999999999999999999999999999999999999777 8999999999987766


Q ss_pred             CCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHH-------------HHHHhCCCCC
Q 016037          304 TRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGG-NRQKIQ-------------QKIIKDKIKL  368 (396)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~-~~~~i~-------------~~i~~~~~~~  368 (396)
                      ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... +..+..             ..+......+
T Consensus       185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  264 (330)
T 3nsz_A          185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  264 (330)
T ss_dssp             CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence            66667789999999999987 67899999999999999999999999653 222222             2222222222


Q ss_pred             ------------------------CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          369 ------------------------PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       369 ------------------------p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                              +..+++++.+||++||+.||.+|||+.
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~  315 (330)
T 3nsz_A          265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR  315 (330)
T ss_dssp             CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred             ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHH
Confidence                                    223899999999999999999999974

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.2e-46  Score=351.68  Aligned_cols=242  Identities=24%  Similarity=0.407  Sum_probs=207.0

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec-C
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-Y  223 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~-~  223 (396)
                      +.+..++|++.+.||+|+||.||+|.+  +++.||+|+++...     ..+.+.+|+.++++++||||+++++++... .
T Consensus        16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (278)
T 1byg_A           16 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   88 (278)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             ccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence            446678999999999999999999988  47889999997543     345678899999999999999999987544 5


Q ss_pred             eEEEEEEecCCCcHHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      .+|+||||+++++|.+++...+.  +++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence            78999999999999999876643  8999999999999999999999999999999999999999999999999998654


Q ss_pred             CCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHH
Q 016037          302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSL  379 (396)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~l  379 (396)
                      ...  ....+++.|+|||++.+..++.++||||||+++|+|+| |+.||...+..++...+..+ ...++..+++++.+|
T Consensus       169 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  246 (278)
T 1byg_A          169 STQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEV  246 (278)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHH
T ss_pred             ccc--cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHH
Confidence            332  33467899999999998889999999999999999998 99999998888888887766 567788999999999


Q ss_pred             HHHhhccCCCCCCCCC
Q 016037          380 LKGVNSLLSISVPLLS  395 (396)
Q Consensus       380 i~~~l~~~p~~RPs~s  395 (396)
                      |+.||+.+|.+|||+.
T Consensus       247 i~~~l~~~p~~Rps~~  262 (278)
T 1byg_A          247 MKNCWHLDAAMRPSFL  262 (278)
T ss_dssp             HHHHTCSSGGGSCCHH
T ss_pred             HHHHhcCChhhCCCHH
Confidence            9999999999999964

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.9e-46  Score=363.75  Aligned_cols=248  Identities=19%  Similarity=0.210  Sum_probs=201.3

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcC---CCcEEEEEEeeccccchhhH--------HHHHHHHHHHHHhCCCCCeeee
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEKNH--------AEYMKSERNILTKVDHPFIVQL  215 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~--------~~~~~~E~~~L~~l~HpnIv~l  215 (396)
                      +..++|++.+.||+|+||+||+|++..   ++..+|+|++..........        ...+.+|+.+++.++||||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            344689999999999999999999987   78899999998653211111        1234568889999999999999


Q ss_pred             eEEEEe----cCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC--cE
Q 016037          216 RYSFQT----KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG--HV  289 (396)
Q Consensus       216 ~~~~~~----~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~--~i  289 (396)
                      ++++..    ...+|+||||+ +++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~  192 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV  192 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence            999988    77899999999 999999998888999999999999999999999999999999999999999887  99


Q ss_pred             EEEecccccccCCCCC--------ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC--CCHHHHHH
Q 016037          290 MLTDFGLAKQFDENTR--------SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG--GNRQKIQQ  359 (396)
Q Consensus       290 kL~Dfgla~~~~~~~~--------~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~--~~~~~i~~  359 (396)
                      ||+|||+++.+.....        .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+  .+...+..
T Consensus       193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~  272 (345)
T 2v62_A          193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT  272 (345)
T ss_dssp             EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred             EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence            9999999987643221        2455799999999999999999999999999999999999999965  33333333


Q ss_pred             HHHhCCCCCCc---------cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          360 KIIKDKIKLPA---------FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       360 ~i~~~~~~~p~---------~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ........+|.         .++.++.+||+.||+.+|.+||++.
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  317 (345)
T 2v62_A          273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQ  317 (345)
T ss_dssp             HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred             HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHH
Confidence            22222223333         7899999999999999999999974

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.2e-46  Score=353.18  Aligned_cols=249  Identities=23%  Similarity=0.375  Sum_probs=207.1

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcC-CC--cEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIG-TS--EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~-~~--~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      .+..++|++.+.||+|+||.||+|++.. ++  ..||+|+++..........+.+.+|+.+++.++||||+++++++...
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            4556789999999999999999999754 33  36899999876554556677788999999999999999999999876


Q ss_pred             CeEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      . .++||||+.+++|.+++... +.+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++...
T Consensus        94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            5 89999999999999988764 678999999999999999999999999999999999999999999999999998775


Q ss_pred             CCCC----ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC--CCCCCccCCH
Q 016037          302 ENTR----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD--KIKLPAFLSS  374 (396)
Q Consensus       302 ~~~~----~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~--~~~~p~~~s~  374 (396)
                      ....    .....+|..|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..++...+...  ....+..++.
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ  252 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCH
Confidence            4332    234457889999999998889999999999999999999 99999999999988888776  4455678999


Q ss_pred             HHHHHHHHhhccCCCCCCCCC
Q 016037          375 EAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       375 ~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ++.+||++||+.+|.+||+++
T Consensus       253 ~l~~li~~~l~~~p~~Rps~~  273 (291)
T 1u46_A          253 DIYNVMVQCWAHKPEDRPTFV  273 (291)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHHccCCcccCcCHH
Confidence            999999999999999999974

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.8e-46  Score=353.05  Aligned_cols=244  Identities=30%  Similarity=0.460  Sum_probs=210.1

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|++++.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.....+|+|
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   94 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM   94 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence            467999999999999999999999999999999987643   23345678899999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC-CCCc
Q 016037          229 LDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRS  306 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~-~~~~  306 (396)
                      |||+++++|..++.. ...+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++..... ....
T Consensus        95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  174 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR  174 (302)
T ss_dssp             EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-
T ss_pred             EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccccc
Confidence            999999999988865 46799999999999999999999999999999999999999999999999999764321 1223


Q ss_pred             cccccCCCccchhhh-----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCccCCHHHHH
Q 016037          307 NSMCGTLEYMSPEIV-----LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI---KLPAFLSSEAHS  378 (396)
Q Consensus       307 ~~~~gt~~y~APE~l-----~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~---~~p~~~s~~~~~  378 (396)
                      ....||+.|+|||++     .+..++.++||||||+++|+|++|+.||...+.......+.....   ..+..++.++.+
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  254 (302)
T 2j7t_A          175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRD  254 (302)
T ss_dssp             ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred             ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHH
Confidence            445789999999998     366789999999999999999999999999988888888877643   346789999999


Q ss_pred             HHHHhhccCCCCCCCCC
Q 016037          379 LLKGVNSLLSISVPLLS  395 (396)
Q Consensus       379 li~~~l~~~p~~RPs~s  395 (396)
                      ||+.||+.+|.+|||+.
T Consensus       255 li~~~l~~dp~~Rps~~  271 (302)
T 2j7t_A          255 FLKIALDKNPETRPSAA  271 (302)
T ss_dssp             HHHHHSCSCTTTSCCHH
T ss_pred             HHHHHcccChhhCCCHH
Confidence            99999999999999964

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.4e-45  Score=386.88  Aligned_cols=248  Identities=19%  Similarity=0.312  Sum_probs=213.9

Q ss_pred             cccCCCeEEEe-EecccCceEEEEEEE--cCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          146 CVGLEDFEVLK-VVGQGAFAKVYQVRR--IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       146 ~~~~~~~~~~~-~IG~G~fG~Vy~~~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      .+....+.+.. +||+|+||+||+|.+  +.+++.||||+++.... .....+.+.+|+.+|++++||||+++++++.. 
T Consensus       364 ~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  441 (635)
T 4fl3_A          364 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-  441 (635)
T ss_dssp             BCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred             cccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            34445566644 799999999999965  45678899999976543 33445668899999999999999999999864 


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      ..+++||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus       442 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~  521 (635)
T 4fl3_A          442 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  521 (635)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred             CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence            56899999999999999999888999999999999999999999999999999999999999999999999999987654


Q ss_pred             CCC----ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHH
Q 016037          303 NTR----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (396)
Q Consensus       303 ~~~----~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~  376 (396)
                      ...    .....+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+.+..++...+..+ +..+|..++.++
T Consensus       522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l  601 (635)
T 4fl3_A          522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM  601 (635)
T ss_dssp             -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            321    233456789999999999899999999999999999999 99999999999988888876 567889999999


Q ss_pred             HHHHHHhhccCCCCCCCCC
Q 016037          377 HSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~RPs~s  395 (396)
                      .+||+.||+.||.+||++.
T Consensus       602 ~~li~~cl~~dP~~RPs~~  620 (635)
T 4fl3_A          602 YDLMNLCWTYDVENRPGFA  620 (635)
T ss_dssp             HHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHHHcCCCHhHCcCHH
Confidence            9999999999999999964

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.5e-45  Score=368.77  Aligned_cols=238  Identities=32%  Similarity=0.472  Sum_probs=201.8

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec------C
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------Y  223 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~------~  223 (396)
                      .+|++.+.||+|+||.||+|++..+++.||||++.....       ...+|+++|+.++||||++++++|...      .
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            469999999999999999999999999999999876431       134699999999999999999988542      2


Q ss_pred             eEEEEEEecCCCcHHHHHH----HhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC-CcEEEEeccccc
Q 016037          224 RLYLVLDFVNGGHLFFQLY----RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAK  298 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~-~~ikL~Dfgla~  298 (396)
                      .+++||||+++ ++...+.    ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus       127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            47899999987 4544443    34679999999999999999999999999999999999999965 578999999999


Q ss_pred             ccCCCCCccccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Q 016037          299 QFDENTRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-------------  364 (396)
Q Consensus       299 ~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~-------------  364 (396)
                      .+.........+||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.+..+...++.+.             
T Consensus       206 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~  285 (420)
T 1j1b_A          206 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  285 (420)
T ss_dssp             ECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred             hcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            87666556677899999999999764 7999999999999999999999999998876666655431             


Q ss_pred             ----CCC------------CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 ----KIK------------LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 ----~~~------------~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                          .+.            ++..++.++.+||++||++||.+||++.
T Consensus       286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~  332 (420)
T 1j1b_A          286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL  332 (420)
T ss_dssp             SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHH
Confidence                122            2346799999999999999999999864

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-46  Score=363.57  Aligned_cols=246  Identities=27%  Similarity=0.421  Sum_probs=204.3

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchh--hHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK--NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      .++|++.+.||+|+||.||+|++..+|+.||+|++........  ...+.+.+|+.+++.++||||+++++++.....+|
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            4689999999999999999999999999999999976432221  12345678999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-C
Q 016037          227 LVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-T  304 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-~  304 (396)
                      +||||+++ +|..++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+... .
T Consensus        89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  167 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  167 (346)
T ss_dssp             EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence            99999997 777777654 46889999999999999999999999999999999999999999999999999876533 2


Q ss_pred             CccccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC---C-----------
Q 016037          305 RSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KI---K-----------  367 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--~~---~-----------  367 (396)
                      .....+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+...++...  ..   .           
T Consensus       168 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  247 (346)
T 1ua2_A          168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  247 (346)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccc
Confidence            34556899999999999764 5899999999999999999999999999888777777652  10   0           


Q ss_pred             -------C-----CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          368 -------L-----PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       368 -------~-----p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                             .     ...++.++.+||++||+.||.+|||+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  287 (346)
T 1ua2_A          248 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT  287 (346)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHH
T ss_pred             cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHH
Confidence                   0     145679999999999999999999974

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.9e-46  Score=366.37  Aligned_cols=248  Identities=19%  Similarity=0.207  Sum_probs=199.0

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCC-----CcEEEEEEeeccccchhhHH--------HHHHHHHHHHHhCCCCCee
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGT-----SEIYAMKVMRKDKIMEKNHA--------EYMKSERNILTKVDHPFIV  213 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~-----~~~vAvK~i~~~~~~~~~~~--------~~~~~E~~~L~~l~HpnIv  213 (396)
                      +..++|++.+.||+|+||.||+|.+..+     ++.||||++...........        .....|+..++.++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            3456899999999999999999999775     57899999876542111111        1123455667788999999


Q ss_pred             eeeEEEEec----CeEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc--CC
Q 016037          214 QLRYSFQTK----YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD--AD  286 (396)
Q Consensus       214 ~l~~~~~~~----~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~--~~  286 (396)
                      ++++++...    ...|+||||+ |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++  .+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence            999998764    5689999999 99999998776 6799999999999999999999999999999999999999  88


Q ss_pred             CcEEEEecccccccCCCCC--------ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 016037          287 GHVMLTDFGLAKQFDENTR--------SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ  358 (396)
Q Consensus       287 ~~ikL~Dfgla~~~~~~~~--------~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~  358 (396)
                      +.+||+|||+++.+.....        ....+||+.|||||++.+..++.++|||||||++|||+||+.||.+.......
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~  270 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY  270 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence            9999999999987643321        23456999999999999999999999999999999999999999863322211


Q ss_pred             HHHHh----CCC------C-CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          359 QKIIK----DKI------K-LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       359 ~~i~~----~~~------~-~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .....    ..+      . .+..++.++.+||+.||+.+|.+||+++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~  318 (364)
T 3op5_A          271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYE  318 (364)
T ss_dssp             HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred             HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHH
Confidence            11111    010      1 1257899999999999999999999974

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=385.86  Aligned_cols=248  Identities=23%  Similarity=0.319  Sum_probs=213.2

Q ss_pred             ccccCCCeEEEe-EecccCceEEEEEEEc--CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe
Q 016037          145 QCVGLEDFEVLK-VVGQGAFAKVYQVRRI--GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (396)
Q Consensus       145 ~~~~~~~~~~~~-~IG~G~fG~Vy~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~  221 (396)
                      ..+..+++.+.+ .||+|+||+||+|.++  .++..||||+++...  .....+.+.+|+++|++++||||+++++++..
T Consensus       330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  407 (613)
T 2ozo_A          330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA  407 (613)
T ss_dssp             SBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred             eeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence            345567788877 8999999999999886  356679999998653  23345668889999999999999999999976


Q ss_pred             cCeEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccccc
Q 016037          222 KYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~  300 (396)
                       ..+|+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus       408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL  486 (613)
T ss_dssp             -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred             -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence             5699999999999999988654 56899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCC----ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCH
Q 016037          301 DENTR----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSS  374 (396)
Q Consensus       301 ~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~  374 (396)
                      .....    .....+|+.|+|||++.+..++.++|||||||+||||+| |+.||.+.+..++...+..+ ++.+|..++.
T Consensus       487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~  566 (613)
T 2ozo_A          487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP  566 (613)
T ss_dssp             C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCH
T ss_pred             cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCH
Confidence            43321    123345689999999998899999999999999999998 99999999988888888876 5788899999


Q ss_pred             HHHHHHHHhhccCCCCCCCCC
Q 016037          375 EAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       375 ~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ++.+||+.||+.+|.+||++.
T Consensus       567 ~l~~li~~cl~~dP~~RPs~~  587 (613)
T 2ozo_A          567 ELYALMSDCWIYKWEDRPDFL  587 (613)
T ss_dssp             HHHHHHHHTTCSSTTTSCCHH
T ss_pred             HHHHHHHHHcCCChhHCcCHH
Confidence            999999999999999999864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=372.93  Aligned_cols=247  Identities=27%  Similarity=0.411  Sum_probs=211.2

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC--e
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY--R  224 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~--~  224 (396)
                      ...++|++.+.||+|+||+||+|++..+++.||||++......  ...+.+.+|+.++++++||||+++++++....  .
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   83 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH   83 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence            3456899999999999999999999999999999999765422  23455678999999999999999999998755  7


Q ss_pred             EEEEEEecCCCcHHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE----cCCCcEEEEecccc
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGL---FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL----DADGHVMLTDFGLA  297 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl----~~~~~ikL~Dfgla  297 (396)
                      .|+||||+++|+|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            8999999999999999876543   8999999999999999999999999999999999999    77788999999999


Q ss_pred             cccCCCCCccccccCCCccchhhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCC----CCHHHHHHHHHhCC
Q 016037          298 KQFDENTRSNSMCGTLEYMSPEIVLG--------KGHDKAADWWSVGILLFEMLTGQPPFTG----GNRQKIQQKIIKDK  365 (396)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~~DvwSlGvil~elltg~~Pf~~----~~~~~i~~~i~~~~  365 (396)
                      +...........+||+.|+|||++.+        ..++.++|||||||++|||++|+.||..    ....++..++..+.
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  243 (396)
T 4eut_A          164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (396)
T ss_dssp             EECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred             eEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence            98776666667789999999999865        4577899999999999999999999974    33455666666553


Q ss_pred             CC-------------------------CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 IK-------------------------LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 ~~-------------------------~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +.                         ++..++..+.+||+.||+.||.+||++.
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~  298 (396)
T 4eut_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD  298 (396)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHH
T ss_pred             CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHH
Confidence            31                         2245667899999999999999999864

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.9e-46  Score=357.52  Aligned_cols=246  Identities=23%  Similarity=0.358  Sum_probs=212.3

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEE----cCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEE--
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRR----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ--  220 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~----~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~--  220 (396)
                      +..++|++++.||+|+||.||+|++    ..+++.||+|++....   ....+.+.+|++++++++||||+++++++.  
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   96 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGP   96 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence            4567899999999999999999994    6789999999997653   344566889999999999999999999886  


Q ss_pred             ecCeEEEEEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          221 TKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                      ....+|+||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence            45679999999999999999976 45699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCC----CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------------HHHHHH
Q 016037          300 FDENT----RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR---------------QKIQQK  360 (396)
Q Consensus       300 ~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~---------------~~i~~~  360 (396)
                      .....    ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....               ..+...
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            65433    22345688889999999988899999999999999999999999976432               233333


Q ss_pred             HHhC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          361 IIKD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       361 i~~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +..+ ....|..+++++.+||+.||+.||.+|||++
T Consensus       257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~  292 (327)
T 3lxl_A          257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFS  292 (327)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHH
Confidence            3333 5677889999999999999999999999974

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=8.6e-46  Score=357.27  Aligned_cols=248  Identities=19%  Similarity=0.294  Sum_probs=211.9

Q ss_pred             cccCCCeEEEeEecccCceEEEEEE-----EcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVR-----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~  220 (396)
                      .+..++|++.+.||+|+||.||+|+     ...+++.||+|++....  .......+.+|+.++++++||||+++++++.
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (327)
T 2yfx_A           26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL  103 (327)
T ss_dssp             BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence            3556789999999999999999999     55678899999997543  2344556788999999999999999999999


Q ss_pred             ecCeEEEEEEecCCCcHHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC---CCcEE
Q 016037          221 TKYRLYLVLDFVNGGHLFFQLYRQG-------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DGHVM  290 (396)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~~-------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~---~~~ik  290 (396)
                      .....|+||||+++++|.+++....       .+++..++.++.||+.||.|||++||+||||||+|||++.   +..+|
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence            9999999999999999999998763       4889999999999999999999999999999999999984   44699


Q ss_pred             EEecccccccCCCC---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-C
Q 016037          291 LTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-K  365 (396)
Q Consensus       291 L~Dfgla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~  365 (396)
                      |+|||+++......   ......||+.|+|||++.+..++.++||||||+++|+|+| |+.||.+.+..++...+... .
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~  263 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR  263 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence            99999997653322   2334567899999999988889999999999999999998 99999999988888888776 5


Q ss_pred             CCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 IKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 ~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ...+..++.++.+||++||+.+|.+||++.
T Consensus       264 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  293 (327)
T 2yfx_A          264 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFA  293 (327)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHH
Confidence            567889999999999999999999999964

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.7e-46  Score=356.82  Aligned_cols=248  Identities=22%  Similarity=0.381  Sum_probs=213.1

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEc-----CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSF  219 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~  219 (396)
                      .+..++|++.+.||+|+||+||+|.+.     .+++.||+|+++...  .....+.+.+|+.+++++ +||||+++++++
T Consensus        23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  100 (316)
T 2xir_A           23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC  100 (316)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence            355678999999999999999999964     467899999997653  233455688899999999 799999999998


Q ss_pred             EecC-eEEEEEEecCCCcHHHHHHHhcC----------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEE
Q 016037          220 QTKY-RLYLVLDFVNGGHLFFQLYRQGL----------------FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL  282 (396)
Q Consensus       220 ~~~~-~~~lV~E~~~gg~L~~~l~~~~~----------------l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NIL  282 (396)
                      .... .+|+||||+++++|.+++.....                +++..++.++.||+.||.|||++||+||||||+|||
T Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil  180 (316)
T 2xir_A          101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  180 (316)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence            7754 58999999999999999987654                889999999999999999999999999999999999


Q ss_pred             EcCCCcEEEEecccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH-HHH
Q 016037          283 LDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNR-QKI  357 (396)
Q Consensus       283 l~~~~~ikL~Dfgla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~-~~i  357 (396)
                      ++.++++||+|||+++.......   .....||+.|+|||++.+..++.++||||||+++|+|+| |..||.+.+. ..+
T Consensus       181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~  260 (316)
T 2xir_A          181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  260 (316)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence            99999999999999987643322   234567889999999999889999999999999999998 9999988664 344


Q ss_pred             HHHHHhC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          358 QQKIIKD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       358 ~~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ...+... ...+|..+++++.++|.+||+.+|.+|||+.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  299 (316)
T 2xir_A          261 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS  299 (316)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence            4444444 5677888999999999999999999999974

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.6e-45  Score=349.12  Aligned_cols=241  Identities=22%  Similarity=0.307  Sum_probs=204.4

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEE-EEecCeEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYS-FQTKYRLYL  227 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~-~~~~~~~~l  227 (396)
                      .++|++.+.||+|+||.||+|++..+++.||+|++......     +.+.+|+.+++.++|++++..+.. +......++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            46899999999999999999999999999999998765422     236789999999998876655544 467788999


Q ss_pred             EEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE---cCCCcEEEEecccccccCCC
Q 016037          228 VLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl---~~~~~ikL~Dfgla~~~~~~  303 (396)
                      ||||+ +++|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99999 8899998874 4679999999999999999999999999999999999999   48899999999999876543


Q ss_pred             CC--------ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCC---
Q 016037          304 TR--------SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN---RQKIQQKIIKDKIKLP---  369 (396)
Q Consensus       304 ~~--------~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~---~~~i~~~i~~~~~~~p---  369 (396)
                      ..        .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+   ..+....+.......|   
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  241 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence            22        345679999999999999999999999999999999999999998743   3334444444433333   


Q ss_pred             --ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          370 --AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       370 --~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                        ..+++++.+||+.||+.+|.+||+++
T Consensus       242 ~~~~~~~~l~~li~~~l~~dp~~Rps~~  269 (296)
T 3uzp_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYS  269 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHH
T ss_pred             HHhhCCHHHHHHHHHHHhcCcCcCCCHH
Confidence              67999999999999999999999964

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-45  Score=348.41  Aligned_cols=243  Identities=20%  Similarity=0.314  Sum_probs=211.1

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCc---EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE-E
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSE---IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL-Y  226 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~-~  226 (396)
                      .|++.++||+|+||+||+|.+..++.   .||+|++....  .....+.+.+|+.+++.++||||+++++++.+.... +
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   99 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH   99 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence            57788999999999999999866554   79999987533  344567788999999999999999999999876655 9


Q ss_pred             EEEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC--
Q 016037          227 LVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--  303 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~--  303 (396)
                      +||||+.+|+|.+++.. ...+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.....  
T Consensus       100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY  179 (298)
T ss_dssp             EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred             EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence            99999999999999876 467899999999999999999999999999999999999999999999999999865432  


Q ss_pred             ---CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHH
Q 016037          304 ---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHS  378 (396)
Q Consensus       304 ---~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~  378 (396)
                         .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...+...+...+... ....|..++.++.+
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  259 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQ  259 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHH
Confidence               22344567899999999999999999999999999999999 66667777777777777766 46778889999999


Q ss_pred             HHHHhhccCCCCCCCCC
Q 016037          379 LLKGVNSLLSISVPLLS  395 (396)
Q Consensus       379 li~~~l~~~p~~RPs~s  395 (396)
                      ||++||+.+|.+|||+.
T Consensus       260 li~~~l~~~p~~Rps~~  276 (298)
T 3pls_A          260 VMQQCWEADPAVRPTFR  276 (298)
T ss_dssp             HHHHHTCSSGGGSCCHH
T ss_pred             HHHHHccCChhhCcCHH
Confidence            99999999999999964

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.7e-46  Score=364.52  Aligned_cols=246  Identities=24%  Similarity=0.425  Sum_probs=217.8

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhh--------------HHHHHHHHHHHHHhCCCCCe
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN--------------HAEYMKSERNILTKVDHPFI  212 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~--------------~~~~~~~E~~~L~~l~HpnI  212 (396)
                      +..++|++.+.||+|+||.||+|.+  +++.||+|++.........              ..+.+.+|+.+++.++||||
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i  105 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC  105 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence            4567899999999999999999999  8999999999765432211              12668899999999999999


Q ss_pred             eeeeEEEEecCeEEEEEEecCCCcHHHH------HHH--hcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEE
Q 016037          213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQ------LYR--QGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILL  283 (396)
Q Consensus       213 v~l~~~~~~~~~~~lV~E~~~gg~L~~~------l~~--~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDlkp~NILl  283 (396)
                      +++++++.+...+|+||||+++++|.++      +..  ...+++..++.++.|++.||.|||+ +|++||||||+|||+
T Consensus       106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM  185 (348)
T ss_dssp             CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred             ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence            9999999999999999999999999887      655  5779999999999999999999999 999999999999999


Q ss_pred             cCCCcEEEEecccccccCCCCCccccccCCCccchhhhcCC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH
Q 016037          284 DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGK-GHDK-AADWWSVGILLFEMLTGQPPFTGGNR-QKIQQK  360 (396)
Q Consensus       284 ~~~~~ikL~Dfgla~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~-~~DvwSlGvil~elltg~~Pf~~~~~-~~i~~~  360 (396)
                      +.++++||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|||++|+.||...+. .++...
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  264 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN  264 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred             cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence            99999999999999876443 34556799999999999887 5666 99999999999999999999998776 788888


Q ss_pred             HHhCCCCCC-------------------ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          361 IIKDKIKLP-------------------AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       361 i~~~~~~~p-------------------~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +......+|                   ..++.++.+||++||+.||.+|||+.
T Consensus       265 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~  318 (348)
T 2pml_X          265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE  318 (348)
T ss_dssp             HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHH
Confidence            888877777                   67999999999999999999999864

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.5e-45  Score=357.94  Aligned_cols=242  Identities=26%  Similarity=0.367  Sum_probs=207.7

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec-----Ce
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----YR  224 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~-----~~  224 (396)
                      ++|++++.||+|+||.||+|++..+++.||+|++....  .....+.+.+|+.+|++++||||+++++++...     ..
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            58999999999999999999999999999999997543  334456688899999999999999999999665     47


Q ss_pred             EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      +|+||||+.+ +|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       105 ~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          105 VYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            8999999985 88777755 568999999999999999999999999999999999999999999999999998765332


Q ss_pred             C----ccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------------
Q 016037          305 R----SNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-------------  366 (396)
Q Consensus       305 ~----~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~-------------  366 (396)
                      .    ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....             
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence            2    345689999999998765 5589999999999999999999999999887776666653100             


Q ss_pred             -------------C-----CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 -------------K-----LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 -------------~-----~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                   .     +...++.++.+||++||+.||.+|||+.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  309 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE  309 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHH
Confidence                         0     1246799999999999999999999964

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.2e-45  Score=350.06  Aligned_cols=245  Identities=24%  Similarity=0.373  Sum_probs=197.0

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~  225 (396)
                      .+..++|++.++||+|+||+||+|++..   .||+|+++.... .....+.+.+|+.++++++||||+++++++ .....
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~   94 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL   94 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence            4666889999999999999999998754   499999976543 344566788999999999999999999854 56678


Q ss_pred             EEEEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC--
Q 016037          226 YLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE--  302 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~--  302 (396)
                      ++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....  
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence            999999999999988854 45689999999999999999999999999999999999999999999999999986543  


Q ss_pred             -CCCccccccCCCccchhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCC-----CCccC
Q 016037          303 -NTRSNSMCGTLEYMSPEIVL---GKGHDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQKIIKDKIK-----LPAFL  372 (396)
Q Consensus       303 -~~~~~~~~gt~~y~APE~l~---~~~~~~~~DvwSlGvil~elltg~~Pf~~~~-~~~i~~~i~~~~~~-----~p~~~  372 (396)
                       ........||+.|+|||++.   +..++.++||||||+++|+|++|+.||.+.+ ...+...+......     ++..+
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC  254 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTS
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccC
Confidence             22234457999999999996   5668889999999999999999999998854 44555555554332     23478


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCC
Q 016037          373 SSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       373 s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +.++.+||..||+.+|.+|||+.
T Consensus       255 ~~~l~~li~~~l~~~p~~Rps~~  277 (289)
T 3og7_A          255 PKRMKRLMAECLKKKRDERPSFP  277 (289)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CHHHHHHHHHHccCChhhCCCHH
Confidence            99999999999999999999964

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3e-45  Score=367.59  Aligned_cols=242  Identities=25%  Similarity=0.368  Sum_probs=207.6

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC------CCCCeeeeeEEEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV------DHPFIVQLRYSFQ  220 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l------~HpnIv~l~~~~~  220 (396)
                      ....+|++++.||+|+||+||+|.+..+++.||||+++...    ...+.+.+|+.+++.+      +|+||+++++++.
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~  169 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT  169 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence            34567999999999999999999999999999999997643    3344566788887776      5789999999999


Q ss_pred             ecCeEEEEEEecCCCcHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc--EEEEeccc
Q 016037          221 TKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH--VMLTDFGL  296 (396)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~--ikL~Dfgl  296 (396)
                      ....+|+||||+.+ +|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+
T Consensus       170 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          170 FRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             ETTEEEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             cCCeEEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence            99999999999974 7888887654  4899999999999999999999999999999999999999987  99999999


Q ss_pred             ccccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------
Q 016037          297 AKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK---------  367 (396)
Q Consensus       297 a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~---------  367 (396)
                      ++....  .....+||+.|+|||++.+..++.++|||||||+||||+||+.||.+.+..+....+....-.         
T Consensus       249 a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~  326 (429)
T 3kvw_A          249 SCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS  326 (429)
T ss_dssp             CEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTB
T ss_pred             ceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence            976543  344568999999999999999999999999999999999999999998887776666532000         


Q ss_pred             --------------------------------------------------CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          368 --------------------------------------------------LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       368 --------------------------------------------------~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                                                        ++...++++.+||++||+.||.+|||+.
T Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~  404 (429)
T 3kvw_A          327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG  404 (429)
T ss_dssp             TTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence                                                              1123478899999999999999999974

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2e-45  Score=346.26  Aligned_cols=236  Identities=25%  Similarity=0.398  Sum_probs=208.1

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe-------
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-------  221 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~-------  221 (396)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....       +.+.+|+.++++++||||+++++++..       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            357999999999999999999999999999999997643       235679999999999999999998864       


Q ss_pred             ---------cCeEEEEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEE
Q 016037          222 ---------KYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM  290 (396)
Q Consensus       222 ---------~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ik  290 (396)
                               ...+|+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence                     45689999999999999999754  5789999999999999999999999999999999999999999999


Q ss_pred             EEecccccccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc
Q 016037          291 LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA  370 (396)
Q Consensus       291 L~Dfgla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~  370 (396)
                      |+|||++.............||+.|+|||++.+..++.++||||||+++|+|++|..||..  .......+...  .++.
T Consensus       163 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--~~~~~~~~~~~--~~~~  238 (284)
T 2a19_B          163 IGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--TSKFFTDLRDG--IISD  238 (284)
T ss_dssp             ECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH--HHHHHHHHHTT--CCCT
T ss_pred             ECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh--HHHHHHHhhcc--cccc
Confidence            9999999887766556667899999999999999999999999999999999999999854  23334444433  4567


Q ss_pred             cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          371 FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       371 ~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .++.++++||++||+.||.+|||++
T Consensus       239 ~~~~~~~~li~~~l~~dp~~Rps~~  263 (284)
T 2a19_B          239 IFDKKEKTLLQKLLSKKPEDRPNTS  263 (284)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHH
Confidence            8999999999999999999999864

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.2e-45  Score=363.20  Aligned_cols=242  Identities=26%  Similarity=0.353  Sum_probs=191.2

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec------
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------  222 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~------  222 (396)
                      .++|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+|+.++||||+++++++...      
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            368999999999999999999999999999999997643 2334556678899999999999999999999654      


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      ..+|+|+|++ +++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD  184 (367)
T ss_dssp             CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred             CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence            5689999999 6788777765 6799999999999999999999999999999999999999999999999999987543


Q ss_pred             CCCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------------
Q 016037          303 NTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK----------------  365 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~----------------  365 (396)
                      .  ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+.+..                
T Consensus       185 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~  262 (367)
T 2fst_X          185 E--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  262 (367)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHH
T ss_pred             c--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence            3  345689999999999987 678999999999999999999999999988777666665410                


Q ss_pred             -------CCC--------CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 -------IKL--------PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 -------~~~--------p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                             ...        ....++++.+||++||+.||.+|||+.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~  307 (367)
T 2fst_X          263 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA  307 (367)
T ss_dssp             HHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             HHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHH
Confidence                   001        135689999999999999999999964

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.7e-45  Score=351.66  Aligned_cols=242  Identities=26%  Similarity=0.387  Sum_probs=207.2

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEE-cCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCC------CeeeeeEEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRR-IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP------FIVQLRYSF  219 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~-~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~Hp------nIv~l~~~~  219 (396)
                      +..++|++.+.||+|+||+||+|.+ ..+++.||+|+++...    ...+.+.+|+.+++.++|+      +|+++++++
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~   86 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF   86 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence            4457899999999999999999999 5688999999997542    3456678899999888665      599999999


Q ss_pred             EecCeEEEEEEecCCCcHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC------------
Q 016037          220 QTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA------------  285 (396)
Q Consensus       220 ~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~------------  285 (396)
                      .....+|+||||+ +++|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.            
T Consensus        87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence            9999999999999 788988888765  6889999999999999999999999999999999999987            


Q ss_pred             -------CCcEEEEecccccccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 016037          286 -------DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ  358 (396)
Q Consensus       286 -------~~~ikL~Dfgla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~  358 (396)
                             ++.+||+|||+++.....  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+..
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  243 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL  243 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred             cccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                   668999999999875433  34568999999999999999999999999999999999999999998877666


Q ss_pred             HHHHhCCCCCC--------------------------------------------ccCCHHHHHHHHHhhccCCCCCCCC
Q 016037          359 QKIIKDKIKLP--------------------------------------------AFLSSEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       359 ~~i~~~~~~~p--------------------------------------------~~~s~~~~~li~~~l~~~p~~RPs~  394 (396)
                      ..+......+|                                            ...+.++.+||++||+.||.+|||+
T Consensus       244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  323 (339)
T 1z57_A          244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL  323 (339)
T ss_dssp             HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence            55543222222                                            2346789999999999999999996


Q ss_pred             C
Q 016037          395 S  395 (396)
Q Consensus       395 s  395 (396)
                      .
T Consensus       324 ~  324 (339)
T 1z57_A          324 R  324 (339)
T ss_dssp             H
T ss_pred             H
Confidence            4

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.5e-45  Score=365.70  Aligned_cols=239  Identities=28%  Similarity=0.421  Sum_probs=202.2

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCe----
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR----  224 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~----  224 (396)
                      ..+|++.+.||+|+||+||+|++..+++ +|+|++.....       ...+|+.+++.++||||++++++|.....    
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~  110 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE  110 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence            3579999999999999999999988777 78887765431       12369999999999999999999965443    


Q ss_pred             --EEEEEEecCCCcHHHHH---HHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc-CCCcEEEEeccccc
Q 016037          225 --LYLVLDFVNGGHLFFQL---YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD-ADGHVMLTDFGLAK  298 (396)
Q Consensus       225 --~~lV~E~~~gg~L~~~l---~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~-~~~~ikL~Dfgla~  298 (396)
                        +|+||||++++.+....   .....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus       111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence              89999999986543332   2356799999999999999999999999999999999999999 79999999999999


Q ss_pred             ccCCCCCccccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Q 016037          299 QFDENTRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-------------  364 (396)
Q Consensus       299 ~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~-------------  364 (396)
                      ...........+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+.+.             
T Consensus       191 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~  270 (394)
T 4e7w_A          191 ILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN  270 (394)
T ss_dssp             ECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             cccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            87666666678899999999999764 5899999999999999999999999998877766666541             


Q ss_pred             ----CCC------------CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 ----KIK------------LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 ----~~~------------~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                          ...            ++..+++++.+||++||+.||.+|||+.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  317 (394)
T 4e7w_A          271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAI  317 (394)
T ss_dssp             GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHH
Confidence                011            3345899999999999999999999864

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.7e-46  Score=353.71  Aligned_cols=249  Identities=26%  Similarity=0.407  Sum_probs=193.6

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCe
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~  224 (396)
                      +.+..++|++.+.||+|+||.||+|.+..+++.||+|++.....  ....+.+.+|+.+++.++||||+++++++.....
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   87 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE   87 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred             cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence            34667899999999999999999999999999999999876432  2334567789999999999999999999999999


Q ss_pred             EEEEEEecCCCcHHHHHHH--------hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccc
Q 016037          225 LYLVLDFVNGGHLFFQLYR--------QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGL  296 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~--------~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgl  296 (396)
                      .|+||||+++++|.+++..        .+.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            9999999999999998874        45689999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCC------CccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---
Q 016037          297 AKQFDENT------RSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI---  366 (396)
Q Consensus       297 a~~~~~~~------~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~---  366 (396)
                      +.......      ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+.............   
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  247 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL  247 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence            98764321      2234579999999999975 5689999999999999999999999998777666655554422   


Q ss_pred             -------CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 -------KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 -------~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                             ..+..++.++.+||+.||+.||.+||++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  283 (303)
T 2vwi_A          248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAA  283 (303)
T ss_dssp             TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHH
Confidence                   12356889999999999999999999964

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.3e-45  Score=349.07  Aligned_cols=244  Identities=20%  Similarity=0.305  Sum_probs=208.4

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCC---CcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEE-EecCeE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSF-QTKYRL  225 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~-~~~~~~  225 (396)
                      .+|++.+.||+|+||.||+|.+..+   ...+|+|.+....  .....+.+.+|+.++++++||||+++++++ ......
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            4699999999999999999997544   3458999887533  344556788999999999999999999985 456688


Q ss_pred             EEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          226 YLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      |+||||+++|+|.+++... ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++......
T Consensus       103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  182 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  182 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred             EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence            9999999999999999764 568999999999999999999999999999999999999999999999999998764322


Q ss_pred             -----CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHH
Q 016037          305 -----RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDK-IKLPAFLSSEAH  377 (396)
Q Consensus       305 -----~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~~-~~~p~~~s~~~~  377 (396)
                           ......||+.|+|||.+.+..++.++||||||+++|+|++ |.+||.+.+..++...+.... ...|..++.++.
T Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  262 (298)
T 3f66_A          183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY  262 (298)
T ss_dssp             GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHH
Confidence                 2234567889999999999899999999999999999999 778888877777777777764 455788999999


Q ss_pred             HHHHHhhccCCCCCCCCC
Q 016037          378 SLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       378 ~li~~~l~~~p~~RPs~s  395 (396)
                      +||++||+.+|.+|||++
T Consensus       263 ~li~~~l~~~p~~Rps~~  280 (298)
T 3f66_A          263 EVMLKCWHPKAEMRPSFS  280 (298)
T ss_dssp             HHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHcCCChhhCcCHH
Confidence            999999999999999974

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4e-46  Score=366.28  Aligned_cols=244  Identities=15%  Similarity=0.196  Sum_probs=189.2

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC--CCCCeeeee-------EEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV--DHPFIVQLR-------YSF  219 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l--~HpnIv~l~-------~~~  219 (396)
                      ..+|++.+.||+|+||+||+|++..+++.||+|++...........+.+.+|+.+++.+  +||||++++       +.+
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            34699999999999999999999999999999999987655566677788885554444  699988865       444


Q ss_pred             Eec-----------------CeEEEEEEecCCCcHHHHHHHh-cCCCHHHH------HHHHHHHHHHHHHHHHCCceecc
Q 016037          220 QTK-----------------YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLA------RIYTAEIVSAVSHLHANGIMHRD  275 (396)
Q Consensus       220 ~~~-----------------~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~------~~~~~qi~~aL~~LH~~~iiHrD  275 (396)
                      ...                 ..+|+||||++ |+|.+++... ..+.+...      ..++.||+.||+|||++||+|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            433                 34899999999 7999999764 34444444      56779999999999999999999


Q ss_pred             CCCCCEEEcCCCcEEEEecccccccCCCCCccccccCCCccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 016037          276 LKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFTGGN  353 (396)
Q Consensus       276 lkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~DvwSlGvil~elltg~~Pf~~~~  353 (396)
                      |||+|||++.++++||+|||+++......  ....+|+.|+|||++.+  ..++.++|||||||+||||+||+.||.+..
T Consensus       220 ikp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  297 (371)
T 3q60_A          220 FTPDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT  297 (371)
T ss_dssp             CSGGGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred             CCHHHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence            99999999999999999999998764332  24567799999999987  679999999999999999999999998764


Q ss_pred             HHHH--HH-----HHHhCCCCCC--ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          354 RQKI--QQ-----KIIKDKIKLP--AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       354 ~~~i--~~-----~i~~~~~~~p--~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ....  ..     ......+.++  ..++.++.+||++||+.||.+|||+.
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  348 (371)
T 3q60_A          298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPL  348 (371)
T ss_dssp             TTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHH
T ss_pred             cccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHH
Confidence            3211  00     0011123333  58899999999999999999999964

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.5e-45  Score=379.71  Aligned_cols=248  Identities=23%  Similarity=0.356  Sum_probs=218.0

Q ss_pred             CCCccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe
Q 016037          142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (396)
Q Consensus       142 ~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~  221 (396)
                      ...+.+..++|++.++||+|+||+||+|.+..+ ..||||+++.....    .+.+.+|+.+|++++||||+++++++..
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~  333 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE  333 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            344567778999999999999999999999764 56999999865422    3457889999999999999999999866


Q ss_pred             cCeEEEEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          222 KYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                       ..+||||||+.+|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       334 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  412 (535)
T 2h8h_A          334 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL  412 (535)
T ss_dssp             -SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred             -ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence             6789999999999999999643  5689999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCC--CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHH
Q 016037          300 FDENT--RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSE  375 (396)
Q Consensus       300 ~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~  375 (396)
                      .....  ......++..|+|||++.+..++.++|||||||+||||++ |+.||.+.+..++...+..+ ++..|..++.+
T Consensus       413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~  492 (535)
T 2h8h_A          413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES  492 (535)
T ss_dssp             CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            64321  1233456789999999998889999999999999999999 99999999988888888776 66788899999


Q ss_pred             HHHHHHHhhccCCCCCCCCC
Q 016037          376 AHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       376 ~~~li~~~l~~~p~~RPs~s  395 (396)
                      +.+||.+||+.+|.+|||+.
T Consensus       493 l~~li~~cl~~dP~~RPt~~  512 (535)
T 2h8h_A          493 LHDLMCQCWRKEPEERPTFE  512 (535)
T ss_dssp             HHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHcCCChhHCcCHH
Confidence            99999999999999999974

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.5e-45  Score=346.60  Aligned_cols=241  Identities=22%  Similarity=0.303  Sum_probs=200.8

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEE-EEecCeEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYS-FQTKYRLYL  227 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~-~~~~~~~~l  227 (396)
                      .++|++.+.||+|+||+||+|++..+++.||+|++......     +.+.+|+.+++.++|++++..+.. +......++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence            36799999999999999999999999999999987654322     236779999999988776665554 477788999


Q ss_pred             EEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE---cCCCcEEEEecccccccCCC
Q 016037          228 VLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl---~~~~~ikL~Dfgla~~~~~~  303 (396)
                      ||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence            99999 8899988874 4679999999999999999999999999999999999999   78899999999999876543


Q ss_pred             CC--------ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCC---
Q 016037          304 TR--------SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR---QKIQQKIIKDKIKLP---  369 (396)
Q Consensus       304 ~~--------~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~---~~i~~~i~~~~~~~p---  369 (396)
                      ..        .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.   ......+.......|   
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T 4hgt_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  241 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred             ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence            22        2356799999999999999999999999999999999999999987432   233444444333333   


Q ss_pred             --ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          370 --AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       370 --~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                        ..+++++.+||+.||+.+|.+||+++
T Consensus       242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~  269 (296)
T 4hgt_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYS  269 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHH
T ss_pred             hhccCCHHHHHHHHHHHhcCCCCCCCHH
Confidence              67899999999999999999999974

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=8.4e-45  Score=353.28  Aligned_cols=244  Identities=23%  Similarity=0.353  Sum_probs=205.6

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec-----
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----  222 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~-----  222 (396)
                      ..++|++.+.||+|+||.||+|++..+|+.||||++....  .......+.+|+.+++.++||||+++++++...     
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   86 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF   86 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence            3468999999999999999999999999999999996532  334455677899999999999999999988654     


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      ...|+||||+.+ +|..++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        87 ~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           87 NEVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE  164 (353)
T ss_dssp             CCEEEEECCCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             ceEEEEEeccCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence            679999999984 78777765 5789999999999999999999999999999999999999999999999999987653


Q ss_pred             CCC-----------ccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C---
Q 016037          303 NTR-----------SNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--K---  365 (396)
Q Consensus       303 ~~~-----------~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~--~---  365 (396)
                      ...           ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...  .   
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  244 (353)
T 2b9h_A          165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS  244 (353)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred             ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence            221           223578999999998765 67899999999999999999999999998866655544321  0   


Q ss_pred             -------------------CC--------CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 -------------------IK--------LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 -------------------~~--------~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                         ..        .+..++.++.+||++||+.||.+|||+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  301 (353)
T 2b9h_A          245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK  301 (353)
T ss_dssp             TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHH
Confidence                               00        1246899999999999999999999964

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.5e-45  Score=361.70  Aligned_cols=243  Identities=23%  Similarity=0.345  Sum_probs=202.1

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC--------CCCeeeeeE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD--------HPFIVQLRY  217 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~--------HpnIv~l~~  217 (396)
                      .+..++|+++++||+|+||+||+|++..+++.||||+++..    ....+.+.+|+.+++.++        |+||+++++
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~  108 (397)
T 1wak_A           33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD  108 (397)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred             hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence            34457899999999999999999999999999999999754    234566788999999885        788999999


Q ss_pred             EEE----ecCeEEEEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCC---
Q 016037          218 SFQ----TKYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADG---  287 (396)
Q Consensus       218 ~~~----~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~-~iiHrDlkp~NILl~~~~---  287 (396)
                      +|.    ....+|+||||+.+ +|...+...  +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++   
T Consensus       109 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          109 DFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             EEEEEETTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred             ceeecCCCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence            997    56689999999955 555555443  5699999999999999999999998 999999999999999776   


Q ss_pred             ----------------------------------------------cEEEEecccccccCCCCCccccccCCCccchhhh
Q 016037          288 ----------------------------------------------HVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV  321 (396)
Q Consensus       288 ----------------------------------------------~ikL~Dfgla~~~~~~~~~~~~~gt~~y~APE~l  321 (396)
                                                                    .+||+|||+++.....  ....+||+.|+|||++
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHH
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhh
Confidence                                                          7999999999876543  3456799999999999


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHh--------------------------------
Q 016037          322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGN------RQKIQQKIIK--------------------------------  363 (396)
Q Consensus       322 ~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~------~~~i~~~i~~--------------------------------  363 (396)
                      .+..++.++|||||||+||||+||+.||.+.+      .......+..                                
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            99999999999999999999999999998654      2222222221                                


Q ss_pred             ----------CCCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          364 ----------DKIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       364 ----------~~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                ....++...+.++.+||++||+.||.+|||+.
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  387 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAA  387 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHH
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHH
Confidence                      11233455677899999999999999999974

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5.6e-45  Score=350.42  Aligned_cols=245  Identities=26%  Similarity=0.386  Sum_probs=207.8

Q ss_pred             CCCeEEEeEecccCceEEEEEEEc-CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC---CCCCeeeeeEEEE----
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRI-GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIVQLRYSFQ----  220 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l---~HpnIv~l~~~~~----  220 (396)
                      .++|++++.||+|+||.||+|++. .+++.||+|+++....... ....+.+|+.+++.+   +||||+++++++.    
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            468999999999999999999995 6789999999976442211 112244566666655   8999999999987    


Q ss_pred             -ecCeEEEEEEecCCCcHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccc
Q 016037          221 -TKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA  297 (396)
Q Consensus       221 -~~~~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla  297 (396)
                       ....+++||||+. |+|..++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~  167 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  167 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence             5678999999998 48988887653  4899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Q 016037          298 KQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK------------  365 (396)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~------------  365 (396)
                      +............||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+......++....            
T Consensus       168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (326)
T 1blx_A          168 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV  247 (326)
T ss_dssp             CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred             ccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccc
Confidence            87765555566789999999999999899999999999999999999999999988877777776420            


Q ss_pred             ---------------CCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 ---------------IKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 ---------------~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                     ..++..++.++++||++||+.||.+|||+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  292 (326)
T 1blx_A          248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY  292 (326)
T ss_dssp             SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             ccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHH
Confidence                           013356899999999999999999999864

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=346.65  Aligned_cols=248  Identities=29%  Similarity=0.451  Sum_probs=193.8

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~  225 (396)
                      ....++|++++.||+|+||.||+|+++.+|+.||+|++..... .....+.+.++..+++.++||||+++++++.....+
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~   99 (318)
T 2dyl_A           21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV   99 (318)
T ss_dssp             ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence            3556789999999999999999999999999999999987543 233344556666778889999999999999999999


Q ss_pred             EEEEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          226 YLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~-~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      |+||||+ ++.+..+... .+.+++..++.++.|++.||.|||++ |++||||||+|||++.++++||+|||++......
T Consensus       100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            9999999 4455544443 57899999999999999999999996 9999999999999999999999999999877655


Q ss_pred             CCccccccCCCccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC-CCC--ccCCH
Q 016037          304 TRSNSMCGTLEYMSPEIVL-----GKGHDKAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKIIKDKI-KLP--AFLSS  374 (396)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~-----~~~~~~~~DvwSlGvil~elltg~~Pf~~-~~~~~i~~~i~~~~~-~~p--~~~s~  374 (396)
                      .......||+.|+|||++.     +..++.++||||||+++|||++|+.||.. .+..+....+..... .+|  ..++.
T Consensus       179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (318)
T 2dyl_A          179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSG  258 (318)
T ss_dssp             --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCH
T ss_pred             ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCH
Confidence            5555668999999999994     45688999999999999999999999987 455666666666543 333  46899


Q ss_pred             HHHHHHHHhhccCCCCCCCCC
Q 016037          375 EAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       375 ~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ++.+||++||+.||.+||++.
T Consensus       259 ~l~~li~~~l~~dp~~Rps~~  279 (318)
T 2dyl_A          259 DFQSFVKDCLTKDHRKRPKYN  279 (318)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHH
T ss_pred             HHHHHHHHHccCChhHCcCHH
Confidence            999999999999999999964

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.4e-45  Score=351.93  Aligned_cols=246  Identities=25%  Similarity=0.391  Sum_probs=203.5

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEE----ec
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ----TK  222 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~----~~  222 (396)
                      +..++|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.    ..
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK  102 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence            45678999999999999999999999999999999986542   345567889999999999999999999986    34


Q ss_pred             CeEEEEEEecCCCcHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccc
Q 016037          223 YRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK  298 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~  298 (396)
                      ...|+||||+.+|+|.+++..    ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            578999999999999988876    4679999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCC----------ccccccCCCccchhhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHh
Q 016037          299 QFDENTR----------SNSMCGTLEYMSPEIVLGKG---HDKAADWWSVGILLFEMLTGQPPFTGGN--RQKIQQKIIK  363 (396)
Q Consensus       299 ~~~~~~~----------~~~~~gt~~y~APE~l~~~~---~~~~~DvwSlGvil~elltg~~Pf~~~~--~~~i~~~i~~  363 (396)
                      .......          .....||+.|+|||++.+..   ++.++||||||+++|||++|+.||....  ...+...+..
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  262 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN  262 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc
Confidence            6532211          12345799999999997654   6899999999999999999999996421  1112222222


Q ss_pred             C-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          364 D-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       364 ~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      . .++.+..++.++.+||++||+.||.+||++.
T Consensus       263 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  295 (317)
T 2buj_A          263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIP  295 (317)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             cCCCCccccCCHHHHHHHHHHhhcChhhCCCHH
Confidence            1 3344568999999999999999999999864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.6e-45  Score=354.43  Aligned_cols=246  Identities=26%  Similarity=0.350  Sum_probs=207.7

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEc----CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe-
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRI----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-  221 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~-  221 (396)
                      +....|++++.||+|+||+||++.+.    .+++.||+|++....  .....+.+.+|+.+++.++||||+++++++.. 
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA  105 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence            44445699999999999999887653    478899999998653  34456678899999999999999999999987 


Q ss_pred             -cCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccccc
Q 016037          222 -KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       222 -~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~  300 (396)
                       ...+|+||||+++|+|.+++.+. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          106 GAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             TTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             CCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence             46899999999999999888654 5899999999999999999999999999999999999999999999999999887


Q ss_pred             CCCCC----ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHH
Q 016037          301 DENTR----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ---------------KIQQKI  361 (396)
Q Consensus       301 ~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~---------------~i~~~i  361 (396)
                      .....    .....||+.|+|||++.+..++.++||||||+++|+|+||+.||......               .+...+
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence            54432    33456888999999999888999999999999999999999999764221               223333


Q ss_pred             HhC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          362 IKD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       362 ~~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ... ....|..++.++.+||+.||+.+|.+|||++
T Consensus       265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~  299 (318)
T 3lxp_A          265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFE  299 (318)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHH
Confidence            333 5567889999999999999999999999974

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.4e-45  Score=347.08  Aligned_cols=242  Identities=25%  Similarity=0.368  Sum_probs=201.3

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEE--------
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ--------  220 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~--------  220 (396)
                      .++|++++.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence            468999999999999999999999999999999987543   345567889999999999999999998873        


Q ss_pred             ------ecCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc-CCCcEEEEe
Q 016037          221 ------TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD-ADGHVMLTD  293 (396)
Q Consensus       221 ------~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~-~~~~ikL~D  293 (396)
                            ....+|+||||++ |+|.+++. .+.+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             ----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             ccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence                  4468899999998 58888775 46789999999999999999999999999999999999997 567999999


Q ss_pred             cccccccCCC----CCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-
Q 016037          294 FGLAKQFDEN----TRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-  367 (396)
Q Consensus       294 fgla~~~~~~----~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~-  367 (396)
                      ||+++.....    .......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||.+.+..+..+.+...... 
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  244 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV  244 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999876432    22344567999999999875 67899999999999999999999999998887777766543211 


Q ss_pred             -----------------------------CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          368 -----------------------------LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       368 -----------------------------~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                                   ++..++.++.+||++||+.||.+|||+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  301 (320)
T 2i6l_A          245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAE  301 (320)
T ss_dssp             CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred             chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHH
Confidence                                         1246899999999999999999999964

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.4e-45  Score=358.02  Aligned_cols=245  Identities=27%  Similarity=0.376  Sum_probs=196.8

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCe--
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR--  224 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~--  224 (396)
                      ...++|++.+.||+|+||+||+|+++.+++.||||++......    .....+|++.++.++||||++++++|.....  
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            4567899999999999999999999999999999998764322    2234567788889999999999999976443  


Q ss_pred             -----EEEEEEecCCCcHHH---HHHHhcCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCCEEEcC-CCcEEEEe
Q 016037          225 -----LYLVLDFVNGGHLFF---QLYRQGLFREDLARIYTAEIVSAVSHLH--ANGIMHRDLKPENILLDA-DGHVMLTD  293 (396)
Q Consensus       225 -----~~lV~E~~~gg~L~~---~l~~~~~l~e~~~~~~~~qi~~aL~~LH--~~~iiHrDlkp~NILl~~-~~~ikL~D  293 (396)
                           +++||||++++.+..   .......+++..++.++.|++.||.|||  ++||+||||||+|||++. ++++||+|
T Consensus        96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D  175 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD  175 (360)
T ss_dssp             TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred             ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence                 899999999864332   2235567899999999999999999999  999999999999999997 89999999


Q ss_pred             cccccccCCCCCccccccCCCccchhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------
Q 016037          294 FGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG-HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-------  365 (396)
Q Consensus       294 fgla~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~-------  365 (396)
                      ||+++............||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.......+.+..       
T Consensus       176 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (360)
T 3e3p_A          176 FGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV  255 (360)
T ss_dssp             CTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             CCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH
Confidence            99999887666666778999999999997654 8999999999999999999999999988887777776421       


Q ss_pred             -------------------------CCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 -------------------------IKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 -------------------------~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                               ...+...+.++.+||++||+.||.+|||++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  310 (360)
T 3e3p_A          256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY  310 (360)
T ss_dssp             HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHH
Confidence                                     111223678999999999999999999964

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-45  Score=363.07  Aligned_cols=244  Identities=20%  Similarity=0.304  Sum_probs=201.5

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCC---cEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEE-ecCeE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTS---EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ-TKYRL  225 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~-~~~~~  225 (396)
                      ..|++.+.||+|+||+||+|.+..++   ..||+|.++...  .....+.+.+|+.++++++||||+++++++. .....
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            35889999999999999999986443   468999886532  3345667889999999999999999999864 45688


Q ss_pred             EEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          226 YLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      |+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            9999999999999999765 458899999999999999999999999999999999999999999999999998664322


Q ss_pred             -----CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHH
Q 016037          305 -----RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAH  377 (396)
Q Consensus       305 -----~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~  377 (396)
                           ......+|+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..++...+..+ +...|..++.++.
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~  326 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY  326 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence                 1233457789999999999999999999999999999999 88899887777777777766 4566788999999


Q ss_pred             HHHHHhhccCCCCCCCCC
Q 016037          378 SLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       378 ~li~~~l~~~p~~RPs~s  395 (396)
                      +||.+||+.+|.+|||++
T Consensus       327 ~li~~cl~~dp~~RPs~~  344 (373)
T 3c1x_A          327 EVMLKCWHPKAEMRPSFS  344 (373)
T ss_dssp             HHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHcCCChhhCcCHH
Confidence            999999999999999974

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.4e-45  Score=357.77  Aligned_cols=246  Identities=22%  Similarity=0.313  Sum_probs=198.7

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeecccc--------chhhHHHHHHHHHHHHHhCCCCCeeeeeEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI--------MEKNHAEYMKSERNILTKVDHPFIVQLRYSF  219 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~--------~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~  219 (396)
                      ..++|++.+.||+|+||.||+|.+.. ++.||||++.....        ......+.+.+|+.++++++||||+++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF   98 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence            34689999999999999999999865 88999999965332        2233457788999999999999999999998


Q ss_pred             Ee-----cCeEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEe
Q 016037          220 QT-----KYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTD  293 (396)
Q Consensus       220 ~~-----~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~D  293 (396)
                      ..     ...+|+||||+.+ +|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus        99 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D  177 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD  177 (362)
T ss_dssp             EECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             EeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence            44     3478999999985 666666544 4799999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------
Q 016037          294 FGLAKQFDENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-------  365 (396)
Q Consensus       294 fgla~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~-------  365 (396)
                      ||+++...........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....       
T Consensus       178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (362)
T 3pg1_A          178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED  257 (362)
T ss_dssp             TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence            999987665555666789999999999987 678999999999999999999999999988777777665310       


Q ss_pred             -----------------C--------CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 -----------------I--------KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 -----------------~--------~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                       .        .++..+++.+.+||.+||+.||.+|||+.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  312 (362)
T 3pg1_A          258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTE  312 (362)
T ss_dssp             HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHH
Confidence                             0        11245789999999999999999999964

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.6e-46  Score=359.93  Aligned_cols=245  Identities=23%  Similarity=0.311  Sum_probs=205.5

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      ...++|++.+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.....+|
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  111 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI  111 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred             HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            45578999999999999999999974 68899999987653   234566889999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          227 LVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      +||||+++|+|.+++....    .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE  191 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred             EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9999999999988886543    588999999999999999999999999999999999999999999999999987543


Q ss_pred             CC---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCC-------
Q 016037          303 NT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ-------QKIIKDK-------  365 (396)
Q Consensus       303 ~~---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~-------~~i~~~~-------  365 (396)
                      ..   ......||+.|+|||++.+..++.++||||||+++|||+||+.||.+....+..       .......       
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (321)
T 2qkw_B          192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP  271 (321)
T ss_dssp             SSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred             ccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence            22   234456899999999998888999999999999999999999999865332211       1111111       


Q ss_pred             ---CCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 ---IKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 ---~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                         ..++..++.++.+||.+||+.||.+|||++
T Consensus       272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~  304 (321)
T 2qkw_B          272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMG  304 (321)
T ss_dssp             SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hhccccCHHHHHHHHHHHHHHcCCCcccCcCHH
Confidence               123345677899999999999999999974

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.7e-45  Score=347.74  Aligned_cols=238  Identities=27%  Similarity=0.426  Sum_probs=198.5

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +..++|++.+.||+|+||+||+|.+.  ++.||+|++...     ...+.+.+|+.++++++||||+++++++.+  ..|
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~   75 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC   75 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence            45678999999999999999999984  678999998643     344567889999999999999999998864  479


Q ss_pred             EEEEecCCCcHHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCCCCEEEcCCCc-EEEEecccccc
Q 016037          227 LVLDFVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSHLHA---NGIMHRDLKPENILLDADGH-VMLTDFGLAKQ  299 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~---~~iiHrDlkp~NILl~~~~~-ikL~Dfgla~~  299 (396)
                      +||||+++|+|.+++....   .+++..++.++.|++.||.|||+   +||+||||||+|||++.++. +||+|||+++.
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            9999999999999998664   37888999999999999999999   89999999999999998886 79999999976


Q ss_pred             cCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhC-CCCCCccCCHHH
Q 016037          300 FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN--RQKIQQKIIKD-KIKLPAFLSSEA  376 (396)
Q Consensus       300 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~--~~~i~~~i~~~-~~~~p~~~s~~~  376 (396)
                      ....  .....||+.|+|||++.+..++.++||||||+++|||++|+.||....  ...+...+... ...++..++.++
T Consensus       156 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  233 (307)
T 2eva_A          156 IQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI  233 (307)
T ss_dssp             -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHH
T ss_pred             cccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHH
Confidence            5433  234569999999999999999999999999999999999999998643  33344444443 556778899999


Q ss_pred             HHHHHHhhccCCCCCCCCC
Q 016037          377 HSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~RPs~s  395 (396)
                      .+||++||+.+|.+|||++
T Consensus       234 ~~li~~~l~~dp~~Rps~~  252 (307)
T 2eva_A          234 ESLMTRCWSKDPSQRPSME  252 (307)
T ss_dssp             HHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHhcCChhhCcCHH
Confidence            9999999999999999864

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.2e-45  Score=356.39  Aligned_cols=238  Identities=21%  Similarity=0.286  Sum_probs=201.3

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCC--------CcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeee------
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGT--------SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ------  214 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~--------~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~------  214 (396)
                      .++|++.+.||+|+||.||+|++..+        ++.||+|++...        +.+.+|+.++++++||||++      
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            46899999999999999999999884        889999998754        24678999999999999887      


Q ss_pred             ---------eeEEEEe-cCeEEEEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEE
Q 016037          215 ---------LRYSFQT-KYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL  282 (396)
Q Consensus       215 ---------l~~~~~~-~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NIL  282 (396)
                               +++++.. ...+|+||||+ +++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence                     5677765 78899999999 99999999876  78999999999999999999999999999999999999


Q ss_pred             EcCCC--cEEEEecccccccCCCC--------CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 016037          283 LDADG--HVMLTDFGLAKQFDENT--------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG  352 (396)
Q Consensus       283 l~~~~--~ikL~Dfgla~~~~~~~--------~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~  352 (396)
                      ++.++  .+||+|||+++.+....        ......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  99999999998765332        123457999999999999999999999999999999999999999875


Q ss_pred             --CHHHHHHHH---HhCCCCCC------ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          353 --NRQKIQQKI---IKDKIKLP------AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       353 --~~~~i~~~i---~~~~~~~p------~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                        +...+....   ......++      ..++.++.+||+.||+.||.+||+++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  325 (352)
T 2jii_A          272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYA  325 (352)
T ss_dssp             TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred             CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHH
Confidence              333333333   23333332      25799999999999999999999974

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.3e-45  Score=353.75  Aligned_cols=243  Identities=29%  Similarity=0.450  Sum_probs=212.2

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchh---hHHHHHHHHHHHHHhCC--CCCeeeeeEEEE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK---NHAEYMKSERNILTKVD--HPFIVQLRYSFQ  220 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~E~~~L~~l~--HpnIv~l~~~~~  220 (396)
                      ....++|++.+.||+|+||.||+|++..+++.||+|++........   ...+.+.+|+.++++++  ||||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            3456789999999999999999999999999999999987543221   11234567899999986  599999999999


Q ss_pred             ecCeEEEEEEecCC-CcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc-CCCcEEEEeccccc
Q 016037          221 TKYRLYLVLDFVNG-GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD-ADGHVMLTDFGLAK  298 (396)
Q Consensus       221 ~~~~~~lV~E~~~g-g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~-~~~~ikL~Dfgla~  298 (396)
                      .....++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~  198 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA  198 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence            99999999999986 89999999889999999999999999999999999999999999999999 78999999999998


Q ss_pred             ccCCCCCccccccCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHH
Q 016037          299 QFDENTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAH  377 (396)
Q Consensus       299 ~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~  377 (396)
                      ..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||...      ..+......++..+++++.
T Consensus       199 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~------~~~~~~~~~~~~~~~~~~~  271 (320)
T 3a99_A          199 LLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQ  271 (320)
T ss_dssp             ECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSCCCHHHH
T ss_pred             ccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh------hhhhcccccccccCCHHHH
Confidence            77543 3345679999999999987665 68899999999999999999999763      2455667788899999999


Q ss_pred             HHHHHhhccCCCCCCCCC
Q 016037          378 SLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       378 ~li~~~l~~~p~~RPs~s  395 (396)
                      +||++||+.+|.+|||+.
T Consensus       272 ~li~~~l~~dp~~Rps~~  289 (320)
T 3a99_A          272 HLIRWCLALRPSDRPTFE  289 (320)
T ss_dssp             HHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHccCChhhCcCHH
Confidence            999999999999999974

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=9.2e-45  Score=356.88  Aligned_cols=241  Identities=26%  Similarity=0.363  Sum_probs=204.4

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeE---
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL---  225 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~---  225 (396)
                      .++|.+.+.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++......   
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            3689999999999999999999999999999999976542 344556778999999999999999999999877654   


Q ss_pred             ---EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          226 ---YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       226 ---~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                         |+||||+.+ +|...+  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  196 (371)
T 4exu_A          120 YDFYLVMPFMQT-DLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  196 (371)
T ss_dssp             CCCEEEEECCCE-EHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred             eeEEEEEccccc-cHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence               999999984 776665  34589999999999999999999999999999999999999999999999999986643


Q ss_pred             CCCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------------
Q 016037          303 NTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI---------------  366 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~---------------  366 (396)
                      .  ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....-               
T Consensus       197 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  274 (371)
T 4exu_A          197 E--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA  274 (371)
T ss_dssp             -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHH
T ss_pred             C--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhh
Confidence            3  345678999999999987 6789999999999999999999999999887777766654110               


Q ss_pred             ----------------CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 ----------------KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 ----------------~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                      .++..+++++.+||++||+.||.+|||+.
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  319 (371)
T 4exu_A          275 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA  319 (371)
T ss_dssp             HHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred             hhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHH
Confidence                            11245799999999999999999999964

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6.4e-45  Score=344.91  Aligned_cols=244  Identities=28%  Similarity=0.417  Sum_probs=205.2

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|.....||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.....+++|
T Consensus        21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   97 (295)
T 2clq_A           21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF   97 (295)
T ss_dssp             BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence            344555568999999999999999999999999997653   23456688899999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC-CCcEEEEecccccccCCCC
Q 016037          229 LDFVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~-~~~ikL~Dfgla~~~~~~~  304 (396)
                      |||+++++|.+++....   .+++..++.++.|++.||.|||++|++||||||+||+++. ++.+||+|||+++......
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            99999999999987652   4678889999999999999999999999999999999987 8999999999998765432


Q ss_pred             -CccccccCCCccchhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH--HHhCCCCCCccCCHHHHH
Q 016037          305 -RSNSMCGTLEYMSPEIVLGK--GHDKAADWWSVGILLFEMLTGQPPFTGGNR-QKIQQK--IIKDKIKLPAFLSSEAHS  378 (396)
Q Consensus       305 -~~~~~~gt~~y~APE~l~~~--~~~~~~DvwSlGvil~elltg~~Pf~~~~~-~~i~~~--i~~~~~~~p~~~s~~~~~  378 (396)
                       ......||+.|+|||++.+.  .++.++||||||+++|+|++|+.||..... ......  .......+|..++.++.+
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKA  257 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHH
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHH
Confidence             23456799999999999764  388999999999999999999999976432 222222  223456788899999999


Q ss_pred             HHHHhhccCCCCCCCCC
Q 016037          379 LLKGVNSLLSISVPLLS  395 (396)
Q Consensus       379 li~~~l~~~p~~RPs~s  395 (396)
                      ||++||+.||.+||++.
T Consensus       258 li~~~l~~dp~~Rps~~  274 (295)
T 2clq_A          258 FILKCFEPDPDKRACAN  274 (295)
T ss_dssp             HHHHTTCSSTTTSCCHH
T ss_pred             HHHHHccCChhhCCCHH
Confidence            99999999999999964

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.7e-45  Score=347.56  Aligned_cols=240  Identities=25%  Similarity=0.372  Sum_probs=195.0

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHh--CCCCCeeeeeEEEEe---
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK--VDHPFIVQLRYSFQT---  221 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~--l~HpnIv~l~~~~~~---  221 (396)
                      +..++|++.+.||+|+||+||+|++  +++.||||++....      ......|.+++..  ++||||+++++++..   
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~   76 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRH   76 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence            3457899999999999999999998  68899999987542      2234456666665  799999999998654   


Q ss_pred             -cCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCCEEEcCCCcEEEE
Q 016037          222 -KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH--------ANGIMHRDLKPENILLDADGHVMLT  292 (396)
Q Consensus       222 -~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH--------~~~iiHrDlkp~NILl~~~~~ikL~  292 (396)
                       ...+|+||||+++|+|.+++. ...+++..++.++.||+.||.|||        ++||+||||||+|||++.++++||+
T Consensus        77 ~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           77 SSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             TEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             CCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence             356899999999999999884 457899999999999999999999        9999999999999999999999999


Q ss_pred             ecccccccCCCCC-----ccccccCCCccchhhhcCC------CCCchhhHHHHHHHHHHHHhC----------CCCCCC
Q 016037          293 DFGLAKQFDENTR-----SNSMCGTLEYMSPEIVLGK------GHDKAADWWSVGILLFEMLTG----------QPPFTG  351 (396)
Q Consensus       293 Dfgla~~~~~~~~-----~~~~~gt~~y~APE~l~~~------~~~~~~DvwSlGvil~elltg----------~~Pf~~  351 (396)
                      |||+++.......     ....+||+.|+|||++.+.      .++.++|||||||++|||+||          +.||.+
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            9999986643322     2345799999999999876      345799999999999999999          899965


Q ss_pred             C-----CHHHHHHHHHhC--CCCCCc-----cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          352 G-----NRQKIQQKIIKD--KIKLPA-----FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       352 ~-----~~~~i~~~i~~~--~~~~p~-----~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .     ....+...+...  +..+|.     .++.++.+||+.||+.||.+|||+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  291 (301)
T 3q4u_A          236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTAL  291 (301)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             cCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHH
Confidence            3     223333333222  334443     2567899999999999999999974

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.4e-45  Score=351.86  Aligned_cols=244  Identities=26%  Similarity=0.387  Sum_probs=186.8

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEEE----
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQ----  220 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~----  220 (396)
                      .+...+|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.+++++. ||||+++++++.    
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~  100 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE  100 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence            345568999999999999999999999999999999986543   344566788999999995 999999999994    


Q ss_pred             ----ecCeEEEEEEecCCCcHHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEcCCCcEEE
Q 016037          221 ----TKYRLYLVLDFVNGGHLFFQLYR---QGLFREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLDADGHVML  291 (396)
Q Consensus       221 ----~~~~~~lV~E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~~LH~~~--iiHrDlkp~NILl~~~~~ikL  291 (396)
                          ....++++|||+. |+|.+++..   .+.+++..++.++.||+.||.|||++|  |+||||||+|||++.++++||
T Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEE
Confidence                3446899999997 578777754   467999999999999999999999999  999999999999999999999


Q ss_pred             EecccccccCCCCC-------------ccccccCCCccchhhh---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 016037          292 TDFGLAKQFDENTR-------------SNSMCGTLEYMSPEIV---LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ  355 (396)
Q Consensus       292 ~Dfgla~~~~~~~~-------------~~~~~gt~~y~APE~l---~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~  355 (396)
                      +|||+++.......             ....+||+.|+|||++   .+..++.++|||||||++|+|++|+.||.+.+..
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            99999987654322             1245689999999998   5667889999999999999999999999876544


Q ss_pred             HHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          356 KIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       356 ~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .+....  .....+...+..+.+||+.||+.+|.+||++.
T Consensus       260 ~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  297 (337)
T 3ll6_A          260 RIVNGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIA  297 (337)
T ss_dssp             --------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHH
T ss_pred             HhhcCc--ccCCcccccchHHHHHHHHHccCChhhCcCHH
Confidence            333221  13344567889999999999999999999864

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.2e-44  Score=349.47  Aligned_cols=242  Identities=24%  Similarity=0.344  Sum_probs=204.1

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCC-cEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC------eeeeeEEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTS-EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF------IVQLRYSF  219 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~Hpn------Iv~l~~~~  219 (396)
                      +..++|++.+.||+|+||+||+|.+..++ +.||+|+++...    ...+.+.+|+.+++.++|++      ++.+++++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~   91 (355)
T 2eu9_A           16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMSDWF   91 (355)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred             eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence            44578999999999999999999998877 789999997542    34456778999999887655      99999999


Q ss_pred             EecCeEEEEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE--------------
Q 016037          220 QTKYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL--------------  283 (396)
Q Consensus       220 ~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl--------------  283 (396)
                      .....+|+||||+. +++...+...  ..+++..++.++.||+.||.|||++||+||||||+|||+              
T Consensus        92 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           92 NFHGHMCIAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EETTEEEEEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             eeCCeEEEEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence            99999999999995 5566666554  368999999999999999999999999999999999999              


Q ss_pred             -----cCCCcEEEEecccccccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 016037          284 -----DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ  358 (396)
Q Consensus       284 -----~~~~~ikL~Dfgla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~  358 (396)
                           +.++.+||+|||+++.....  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+..
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  248 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL  248 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence                 56789999999999865432  34568999999999999999999999999999999999999999998877665


Q ss_pred             HHHHhCCCCCCc--------------------------------------------cCCHHHHHHHHHhhccCCCCCCCC
Q 016037          359 QKIIKDKIKLPA--------------------------------------------FLSSEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       359 ~~i~~~~~~~p~--------------------------------------------~~s~~~~~li~~~l~~~p~~RPs~  394 (396)
                      ..+.+....+|.                                            ..+.++.+||++||+.||.+|||+
T Consensus       249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  328 (355)
T 2eu9_A          249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL  328 (355)
T ss_dssp             HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence            555443222221                                            225689999999999999999996


Q ss_pred             C
Q 016037          395 S  395 (396)
Q Consensus       395 s  395 (396)
                      .
T Consensus       329 ~  329 (355)
T 2eu9_A          329 A  329 (355)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.9e-45  Score=352.41  Aligned_cols=251  Identities=25%  Similarity=0.402  Sum_probs=185.3

Q ss_pred             CCCccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHH-HHHhCCCCCeeeeeEEEE
Q 016037          142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN-ILTKVDHPFIVQLRYSFQ  220 (396)
Q Consensus       142 ~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~-~L~~l~HpnIv~l~~~~~  220 (396)
                      ...+.+..++|++++.||+|+||.||+|.++.+++.||+|++..... .....+ +..|+. +++.++||||+++++++.
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~-~~~e~~~~~~~~~h~niv~~~~~~~   91 (327)
T 3aln_A           14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQ-LLMDLDVVMRSSDCPYIVQFYGALF   91 (327)
T ss_dssp             CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHH-HHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred             HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHH-HHHHHHHHHHcCCCCcEeeeeeEEE
Confidence            33455677899999999999999999999999999999999986532 222333 444444 778889999999999999


Q ss_pred             ecCeEEEEEEecCCCcHHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEec
Q 016037          221 TKYRLYLVLDFVNGGHLFFQLYR-----QGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDF  294 (396)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~-~iiHrDlkp~NILl~~~~~ikL~Df  294 (396)
                      .....|+||||+.+ +|..++..     ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+||
T Consensus        92 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Df  170 (327)
T 3aln_A           92 REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDF  170 (327)
T ss_dssp             CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCC
T ss_pred             eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccC
Confidence            99999999999986 66666653     56789999999999999999999999 9999999999999999999999999


Q ss_pred             ccccccCCCCCccccccCCCccchhhh----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhC-CCCC
Q 016037          295 GLAKQFDENTRSNSMCGTLEYMSPEIV----LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR-QKIQQKIIKD-KIKL  368 (396)
Q Consensus       295 gla~~~~~~~~~~~~~gt~~y~APE~l----~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~-~~i~~~i~~~-~~~~  368 (396)
                      |+++............||+.|+|||++    .+..++.++||||||+++|+|++|+.||.+.+. .+....+..+ ...+
T Consensus       171 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  250 (327)
T 3aln_A          171 GISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL  250 (327)
T ss_dssp             SSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred             CCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence            999887655555556799999999999    456789999999999999999999999987542 2222222222 2223


Q ss_pred             C----ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          369 P----AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       369 p----~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +    ..++.++.+||+.||+.||.+|||++
T Consensus       251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  281 (327)
T 3aln_A          251 SNSEEREFSPSFINFVNLCLTKDESKRPKYK  281 (327)
T ss_dssp             CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCcccccCCHHHHHHHHHHhhCChhhCcCHH
Confidence            2    36899999999999999999999974

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=352.13  Aligned_cols=241  Identities=26%  Similarity=0.358  Sum_probs=203.6

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCe----
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR----  224 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~----  224 (396)
                      .++|.+.+.||+|+||.||+|+++.+|+.||||++.... ......+.+.+|+.+++.++||||+++++++.....    
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            368999999999999999999999999999999997643 234455667889999999999999999999987653    


Q ss_pred             --EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          225 --LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       225 --~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                        +|+||||+.+ +|...+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          102 YDFYLVMPFMQT-DLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  178 (353)
T ss_dssp             CCCEEEEECCSE-EGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred             eeEEEEeccccC-CHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence              5999999984 7766553  3589999999999999999999999999999999999999999999999999987543


Q ss_pred             CCCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------
Q 016037          303 NTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-----------------  364 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~-----------------  364 (396)
                      .  ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.+.                 
T Consensus       179 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  256 (353)
T 3coi_A          179 E--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA  256 (353)
T ss_dssp             -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHH
T ss_pred             C--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHH
Confidence            3  345678999999999987 67899999999999999999999999998877666655431                 


Q ss_pred             --------------CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 --------------KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 --------------~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                    ...++..++.++.+||++||+.||.+|||+.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~  301 (353)
T 3coi_A          257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA  301 (353)
T ss_dssp             HHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred             HHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHH
Confidence                          0123357899999999999999999999964

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.8e-45  Score=355.79  Aligned_cols=239  Identities=16%  Similarity=0.234  Sum_probs=198.8

Q ss_pred             ccccCCCeEEEeEecccCceEEEEE-----EEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC---CCCeeeee
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQV-----RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD---HPFIVQLR  216 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~-----~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~---HpnIv~l~  216 (396)
                      ..+..++|.+.+.||+|+||+||+|     .+..+++.||+|++....      ...+..|+.+++.++   |+||++++
T Consensus        60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~  133 (365)
T 3e7e_A           60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFY  133 (365)
T ss_dssp             EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred             EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence            3456678999999999999999999     467789999999997643      233566788888876   99999999


Q ss_pred             EEEEecCeEEEEEEecCCCcHHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC------
Q 016037          217 YSFQTKYRLYLVLDFVNGGHLFFQLYR-----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA------  285 (396)
Q Consensus       217 ~~~~~~~~~~lV~E~~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~------  285 (396)
                      +++......|+||||+++|+|.+++..     .+.+++..++.++.||+.||+|||++||+||||||+|||++.      
T Consensus       134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~  213 (365)
T 3e7e_A          134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD  213 (365)
T ss_dssp             EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred             eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence            999999999999999999999999974     457999999999999999999999999999999999999998      


Q ss_pred             -----CCcEEEEecccccccC---CCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 016037          286 -----DGHVMLTDFGLAKQFD---ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKI  357 (396)
Q Consensus       286 -----~~~ikL~Dfgla~~~~---~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i  357 (396)
                           ++.+||+|||+++.+.   ........+||+.|||||++.+..++.++|||||||++|||+||+.||........
T Consensus       214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  293 (365)
T 3e7e_A          214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC  293 (365)
T ss_dssp             -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE
T ss_pred             ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce
Confidence                 8999999999997643   33344567899999999999999999999999999999999999999976432110


Q ss_pred             HHHHHhCCCCCC-ccCCHHHHHHHHHhhccCCCCCCCC
Q 016037          358 QQKIIKDKIKLP-AFLSSEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       358 ~~~i~~~~~~~p-~~~s~~~~~li~~~l~~~p~~RPs~  394 (396)
                           .....++ ...++.+.+++..||+.+|.+|++.
T Consensus       294 -----~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~  326 (365)
T 3e7e_A          294 -----KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPS  326 (365)
T ss_dssp             -----EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCC
T ss_pred             -----eechhccccCcHHHHHHHHHHHcCCCCCCcchH
Confidence                 0011111 1357789999999999999999753

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.7e-44  Score=342.26  Aligned_cols=239  Identities=29%  Similarity=0.467  Sum_probs=199.2

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe--------
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--------  221 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~--------  221 (396)
                      ++|++++.||+|+||.||+|++..+++.||+|++...    ....+.+.+|+.++++++||||+++++++.+        
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM   81 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence            5799999999999999999999999999999999653    3445668889999999999999999998865        


Q ss_pred             -----cCeEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecc
Q 016037          222 -----KYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFG  295 (396)
Q Consensus       222 -----~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfg  295 (396)
                           ...+|+||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg  161 (303)
T 1zy4_A           82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG  161 (303)
T ss_dssp             ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence                 45789999999999999999754 357888999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC---------------CCccccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHH
Q 016037          296 LAKQFDEN---------------TRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTG-GNRQKIQ  358 (396)
Q Consensus       296 la~~~~~~---------------~~~~~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~-~~~~~i~  358 (396)
                      +++.....               .......||+.|+|||++.+. .++.++|||||||++|+|++   ||.. .+...+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~  238 (303)
T 1zy4_A          162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL  238 (303)
T ss_dssp             CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred             chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence            99876422               123455789999999999864 68999999999999999998   6653 3445566


Q ss_pred             HHHHhCCCCCC----ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          359 QKIIKDKIKLP----AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       359 ~~i~~~~~~~p----~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ..+......+|    ...+..+++||++||+.||.+|||+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  279 (303)
T 1zy4_A          239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGAR  279 (303)
T ss_dssp             HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHH
Confidence            66666555555    45677899999999999999999964

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.3e-44  Score=351.22  Aligned_cols=242  Identities=28%  Similarity=0.470  Sum_probs=177.1

Q ss_pred             cccCCCeEEEe-EecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe---
Q 016037          146 CVGLEDFEVLK-VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT---  221 (396)
Q Consensus       146 ~~~~~~~~~~~-~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~---  221 (396)
                      ....++|.+.+ .||+|+||+||+|+++.+++.||+|++....       ....+....++.++||||+++++++..   
T Consensus        24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   96 (336)
T 3fhr_A           24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHH   96 (336)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence            34557899966 5999999999999999999999999997532       112233345677899999999999976   


Q ss_pred             -cCeEEEEEEecCCCcHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC---CCcEEEEecc
Q 016037          222 -KYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFG  295 (396)
Q Consensus       222 -~~~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~---~~~ikL~Dfg  295 (396)
                       ...+|+||||+++|+|.+++.+.+  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence             556899999999999999998764  6999999999999999999999999999999999999976   4559999999


Q ss_pred             cccccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCC--
Q 016037          296 LAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKI----QQKIIKDKIKLP--  369 (396)
Q Consensus       296 la~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i----~~~i~~~~~~~p--  369 (396)
                      +++..... .....+||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+...+    ...+......+|  
T Consensus       177 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (336)
T 3fhr_A          177 FAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP  255 (336)
T ss_dssp             TCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred             cceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence            99876533 33456789999999999888899999999999999999999999987655443    333333333333  


Q ss_pred             --ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          370 --AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       370 --~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                        ..++.++.+||+.||+.||.+|||+.
T Consensus       256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~  283 (336)
T 3fhr_A          256 EWSEVSEDAKQLIRLLLKTDPTERLTIT  283 (336)
T ss_dssp             TSTTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             hhccCCHHHHHHHHHHCCCChhHCcCHH
Confidence              47899999999999999999999974

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.5e-45  Score=347.56  Aligned_cols=242  Identities=29%  Similarity=0.486  Sum_probs=203.6

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchh---hHHHHHHHHHHHHHhC----CCCCeeeeeEEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK---NHAEYMKSERNILTKV----DHPFIVQLRYSF  219 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~E~~~L~~l----~HpnIv~l~~~~  219 (396)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++........   .....+.+|+.+++++    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            345689999999999999999999999999999999976543221   1223355688889888    899999999999


Q ss_pred             EecCeEEEEEEe-cCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc-CCCcEEEEecccc
Q 016037          220 QTKYRLYLVLDF-VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD-ADGHVMLTDFGLA  297 (396)
Q Consensus       220 ~~~~~~~lV~E~-~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~-~~~~ikL~Dfgla  297 (396)
                      ......++|||+ +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~  187 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG  187 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence            999999999999 78999999999988999999999999999999999999999999999999999 8899999999999


Q ss_pred             cccCCCCCccccccCCCccchhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHH
Q 016037          298 KQFDENTRSNSMCGTLEYMSPEIVLGKGHD-KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEA  376 (396)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~  376 (396)
                      +..... ......||+.|+|||++.+..+. .++||||||+++|||++|+.||...      ..+......++..++.++
T Consensus       188 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~~~~~~~~~~  260 (312)
T 2iwi_A          188 ALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPAHVSPDC  260 (312)
T ss_dssp             EECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHTCCCCCTTSCHHH
T ss_pred             hhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHHhhhccCCcccCCHHH
Confidence            877543 33456799999999999776664 5899999999999999999999763      345567788899999999


Q ss_pred             HHHHHHhhccCCCCCCCCC
Q 016037          377 HSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~RPs~s  395 (396)
                      .+||++||+.+|.+|||+.
T Consensus       261 ~~li~~~l~~~p~~Rps~~  279 (312)
T 2iwi_A          261 CALIRRCLAPKPSSRPSLE  279 (312)
T ss_dssp             HHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHHHccCChhhCcCHH
Confidence            9999999999999999964

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.4e-44  Score=342.38  Aligned_cols=248  Identities=27%  Similarity=0.410  Sum_probs=206.3

Q ss_pred             CccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC--CCCeeeeeEEEEe
Q 016037          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD--HPFIVQLRYSFQT  221 (396)
Q Consensus       144 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~--HpnIv~l~~~~~~  221 (396)
                      ...+..++|++++.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+.++++++  ||||+++++++..
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   99 (313)
T 3cek_A           22 SMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   99 (313)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred             eeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence            34455678999999999999999999985 488899999976543 3345667889999999997  5999999999999


Q ss_pred             cCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          222 KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      ...+|+||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...
T Consensus       100 ~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~  177 (313)
T 3cek_A          100 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  177 (313)
T ss_dssp             SSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred             CCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccccc
Confidence            999999999 66789999999988999999999999999999999999999999999999995 5899999999998764


Q ss_pred             CCCC---ccccccCCCccchhhhcC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhC--
Q 016037          302 ENTR---SNSMCGTLEYMSPEIVLG-----------KGHDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQKIIKD--  364 (396)
Q Consensus       302 ~~~~---~~~~~gt~~y~APE~l~~-----------~~~~~~~DvwSlGvil~elltg~~Pf~~~~-~~~i~~~i~~~--  364 (396)
                      ....   ....+||+.|+|||++.+           ..++.++||||||+++|||++|+.||.... .......+...  
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  257 (313)
T 3cek_A          178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH  257 (313)
T ss_dssp             ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred             CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc
Confidence            4322   235579999999999976           468889999999999999999999998753 33334444433  


Q ss_pred             CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 ~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ...+|...+.++.+||++||+.||.+|||+.
T Consensus       258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  288 (313)
T 3cek_A          258 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIP  288 (313)
T ss_dssp             CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             ccCCcccchHHHHHHHHHHccCCcccCcCHH
Confidence            4567888999999999999999999999964

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=348.82  Aligned_cols=246  Identities=21%  Similarity=0.310  Sum_probs=208.6

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEE----cCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRR----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~----~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      +..++|++++.||+|+||.||+|++    ..+++.||+|++....   ....+.+.+|+.++++++||||+++++++...
T Consensus        38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA  114 (326)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred             cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence            4557899999999999999999994    5689999999997643   34556788999999999999999999998654


Q ss_pred             C--eEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          223 Y--RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       223 ~--~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                      .  .+++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            3  789999999999999999875 4589999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCC----ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----------------HHHHH
Q 016037          300 FDENTR----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR----------------QKIQQ  359 (396)
Q Consensus       300 ~~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~----------------~~i~~  359 (396)
                      ......    .....++..|+|||++.+..++.++||||||+++|||+||..||.....                ..+..
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  274 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence            754432    2334577889999999988899999999999999999999999864311                12223


Q ss_pred             HHHhC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          360 KIIKD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       360 ~i~~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .+... +.+.|..++.++.+||++||+.+|.+|||+.
T Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  311 (326)
T 2w1i_A          275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFR  311 (326)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHH
Confidence            33332 5677889999999999999999999999964

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.6e-44  Score=352.53  Aligned_cols=210  Identities=30%  Similarity=0.490  Sum_probs=184.0

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CC-----CeeeeeEEEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HP-----FIVQLRYSFQ  220 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-Hp-----nIv~l~~~~~  220 (396)
                      ...++|++.+.||+|+||+||+|++..+++.||||+++...    ...+.+..|+.+++.++ |+     +|+++++++.
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~  126 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM  126 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence            44678999999999999999999999999999999997542    33455677888888875 44     4999999999


Q ss_pred             ecCeEEEEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCCEEEc--CCCcEEEEec
Q 016037          221 TKYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLH--ANGIMHRDLKPENILLD--ADGHVMLTDF  294 (396)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH--~~~iiHrDlkp~NILl~--~~~~ikL~Df  294 (396)
                      ....+|+||||+.+ +|.+++...  +.+++..++.++.|++.||.|||  ..||+||||||+|||++  .++.+||+||
T Consensus       127 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          127 FRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             ETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             cCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            99999999999975 888888765  46899999999999999999999  46999999999999995  4778999999


Q ss_pred             ccccccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 016037          295 GLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK  363 (396)
Q Consensus       295 gla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~  363 (396)
                      |+++.....  ....+||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+..+...++..
T Consensus       206 G~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~  272 (382)
T 2vx3_A          206 GSSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE  272 (382)
T ss_dssp             TTCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             cCceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999876433  3456899999999999999999999999999999999999999999888887777765

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.6e-44  Score=352.15  Aligned_cols=242  Identities=25%  Similarity=0.379  Sum_probs=202.2

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-----------CCCeeee
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-----------HPFIVQL  215 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-----------HpnIv~l  215 (396)
                      +..++|++.+.||+|+||+||+|.+..+++.||+|++....    ...+.+.+|+.++++++           ||||+++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            44578999999999999999999999999999999997543    33455778999988876           8999999


Q ss_pred             eEEEEecC----eEEEEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEc----
Q 016037          216 RYSFQTKY----RLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLD----  284 (396)
Q Consensus       216 ~~~~~~~~----~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~-~iiHrDlkp~NILl~----  284 (396)
                      ++++....    .+++||||+ +++|..++...  +.+++..++.++.||+.||.|||++ ||+||||||+|||++    
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred             HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence            99997654    789999999 88999888763  4599999999999999999999998 999999999999994    


Q ss_pred             --CCCcEEEEecccccccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHH
Q 016037          285 --ADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN------RQK  356 (396)
Q Consensus       285 --~~~~ikL~Dfgla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~------~~~  356 (396)
                        ..+.+||+|||+++.....  ....+||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+      ...
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             CcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence              4448999999999876543  344579999999999999999999999999999999999999998654      122


Q ss_pred             HHHHH------------------------------------------HhCCCCCCccCCHHHHHHHHHhhccCCCCCCCC
Q 016037          357 IQQKI------------------------------------------IKDKIKLPAFLSSEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       357 i~~~i------------------------------------------~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs~  394 (396)
                      ....+                                          ......++..++.++.+||++||+.||.+|||+
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence            22222                                          223445667788999999999999999999996


Q ss_pred             C
Q 016037          395 S  395 (396)
Q Consensus       395 s  395 (396)
                      .
T Consensus       329 ~  329 (373)
T 1q8y_A          329 G  329 (373)
T ss_dssp             H
T ss_pred             H
Confidence            4

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.1e-44  Score=375.82  Aligned_cols=247  Identities=21%  Similarity=0.361  Sum_probs=214.4

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCC---CcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      .+..++|++.+.||+|+||+||+|.+..+   +..||+|+++...  .....+.+.+|+.++++++||||+++++++. .
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~  462 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E  462 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence            45567899999999999999999998654   4679999987543  3345567889999999999999999999985 4


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      ..+|+||||+++|+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||+++...
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            57899999999999999997654 68999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCC--ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHH
Q 016037          302 ENTR--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAH  377 (396)
Q Consensus       302 ~~~~--~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~  377 (396)
                      ....  .....+|+.|||||++.+..++.++|||||||++|||++ |..||.+.+..++...+..+ ...+|..+++++.
T Consensus       543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  622 (656)
T 2j0j_A          543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY  622 (656)
T ss_dssp             C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHH
T ss_pred             CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHH
Confidence            4332  233456789999999998899999999999999999997 99999999998888888876 5678899999999


Q ss_pred             HHHHHhhccCCCCCCCCC
Q 016037          378 SLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       378 ~li~~~l~~~p~~RPs~s  395 (396)
                      +||.+||+.||.+|||+.
T Consensus       623 ~li~~~l~~dP~~RPs~~  640 (656)
T 2j0j_A          623 SLMTKCWAYDPSRRPRFT  640 (656)
T ss_dssp             HHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHcCCChhHCcCHH
Confidence            999999999999999964

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-44  Score=344.36  Aligned_cols=240  Identities=24%  Similarity=0.349  Sum_probs=194.5

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHh--CCCCCeeeeeEEEEec--
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK--VDHPFIVQLRYSFQTK--  222 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~--l~HpnIv~l~~~~~~~--  222 (396)
                      ...++|++.+.||+|+||.||+|++.  ++.||+|++....    .  .....|..++..  ++||||+++++++...  
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE----E--ASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG----H--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc----c--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            34568999999999999999999985  7899999986542    1  223334555544  5999999999999887  


Q ss_pred             --CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCCEEEcCCCcEEEE
Q 016037          223 --YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--------GIMHRDLKPENILLDADGHVMLT  292 (396)
Q Consensus       223 --~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~--------~iiHrDlkp~NILl~~~~~ikL~  292 (396)
                        ..+|+||||+++|+|.+++.. ..+++..++.++.|++.||.|||++        ||+||||||+|||++.++++||+
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~  184 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA  184 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             CCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence              789999999999999998865 4789999999999999999999999        99999999999999999999999


Q ss_pred             ecccccccCCCCC-----ccccccCCCccchhhhcCCCCCch------hhHHHHHHHHHHHHhC----------CCCCCC
Q 016037          293 DFGLAKQFDENTR-----SNSMCGTLEYMSPEIVLGKGHDKA------ADWWSVGILLFEMLTG----------QPPFTG  351 (396)
Q Consensus       293 Dfgla~~~~~~~~-----~~~~~gt~~y~APE~l~~~~~~~~------~DvwSlGvil~elltg----------~~Pf~~  351 (396)
                      |||+++.+.....     ....+||+.|+|||++.+..++.+      +|||||||++|||+||          +.||..
T Consensus       185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~  264 (337)
T 3mdy_A          185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD  264 (337)
T ss_dssp             CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence            9999987643322     235679999999999988766654      9999999999999999          788865


Q ss_pred             C-----CHHHHHHHHHhC--CCCCCc-----cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          352 G-----NRQKIQQKIIKD--KIKLPA-----FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       352 ~-----~~~~i~~~i~~~--~~~~p~-----~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .     ....+...+...  +..+|.     .++.++.+||++||+.||.+|||+.
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~  320 (337)
T 3mdy_A          265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL  320 (337)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHH
Confidence            3     223333333333  334444     5667899999999999999999964

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.7e-44  Score=345.65  Aligned_cols=243  Identities=20%  Similarity=0.333  Sum_probs=190.6

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe----
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT----  221 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~----  221 (396)
                      .+..++|++.+.||+|+||.||+|++  +++.||||++.....    .......|+..+..++||||+++++.+..    
T Consensus         9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~   82 (336)
T 3g2f_A            9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR----QNFINEKNIYRVPLMEHDNIARFIVGDERVTAD   82 (336)
T ss_dssp             CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred             CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch----hhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence            46678999999999999999999987  678999999975431    11112234444556899999999986543    


Q ss_pred             -cCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCCEEEcCCCcEEE
Q 016037          222 -KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN---------GIMHRDLKPENILLDADGHVML  291 (396)
Q Consensus       222 -~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~---------~iiHrDlkp~NILl~~~~~ikL  291 (396)
                       ...+|+||||+++|+|.+++.... .++..++.++.||+.||.|||++         ||+||||||+|||++.++++||
T Consensus        83 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           83 GRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             SCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             CCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence             336799999999999999886654 48888999999999999999999         9999999999999999999999


Q ss_pred             EecccccccCCCC---------CccccccCCCccchhhhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC--
Q 016037          292 TDFGLAKQFDENT---------RSNSMCGTLEYMSPEIVLG-------KGHDKAADWWSVGILLFEMLTGQPPFTGGN--  353 (396)
Q Consensus       292 ~Dfgla~~~~~~~---------~~~~~~gt~~y~APE~l~~-------~~~~~~~DvwSlGvil~elltg~~Pf~~~~--  353 (396)
                      +|||+++.+....         .....+||+.|+|||++.+       ..++.++|||||||++|||++|..||....  
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            9999998764321         2235579999999999987       345678999999999999999977764321  


Q ss_pred             ----------------HHHHHHHHHhC--CCCCCcc------CCHHHHHHHHHhhccCCCCCCCCC
Q 016037          354 ----------------RQKIQQKIIKD--KIKLPAF------LSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       354 ----------------~~~i~~~i~~~--~~~~p~~------~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                      ...+...+...  +..+|..      +++++.+||.+||+.||.+|||++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  307 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQ  307 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchH
Confidence                            12222222222  3455544      345899999999999999999974

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5.6e-45  Score=349.37  Aligned_cols=248  Identities=22%  Similarity=0.340  Sum_probs=208.6

Q ss_pred             CCccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       143 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      ..+.+..++|++.+.||+|+||.||+|.+.+   .+|+|++...... ....+.+.+|+.++++++||||+++++++...
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSP  101 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            4455778899999999999999999999865   3999999764322 22234466799999999999999999999999


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      ..+++||||+++++|.+++...+ .+++..++.++.||+.||.|||++|++||||||+|||++ ++.+||+|||+++...
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG  180 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred             CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence            99999999999999999987654 689999999999999999999999999999999999997 7899999999987643


Q ss_pred             C------CCCccccccCCCccchhhhcC---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Q 016037          302 E------NTRSNSMCGTLEYMSPEIVLG---------KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI  366 (396)
Q Consensus       302 ~------~~~~~~~~gt~~y~APE~l~~---------~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~  366 (396)
                      .      ........||+.|+|||++.+         ..++.++||||||+++|||++|+.||.+.+...+...+.....
T Consensus       181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  260 (319)
T 2y4i_B          181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK  260 (319)
T ss_dssp             -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC
T ss_pred             cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC
Confidence            1      122334568999999999975         4578999999999999999999999999998888888877643


Q ss_pred             C-C-CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 K-L-PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 ~-~-p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      . + +..++.++.+||..||+.+|.+|||+.
T Consensus       261 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  291 (319)
T 2y4i_B          261 PNLSQIGMGKEISDILLFCWAFEQEERPTFT  291 (319)
T ss_dssp             CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHH
T ss_pred             CCCCcCCCCHHHHHHHHHHhcCChhhCcCHH
Confidence            2 2 246899999999999999999999864

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.1e-43  Score=360.99  Aligned_cols=241  Identities=24%  Similarity=0.343  Sum_probs=205.6

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC-CCeeeeeEEEEecCeEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-PFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~H-pnIv~l~~~~~~~~~~~l  227 (396)
                      .++|++.++||+|+||.||+|++..+++.||||++......     ..+..|+.+++.++| ++|..+..++......||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l   80 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL   80 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence            46899999999999999999999999999999998764422     236779999999987 566667777788889999


Q ss_pred             EEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE---cCCCcEEEEecccccccCCC
Q 016037          228 VLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl---~~~~~ikL~Dfgla~~~~~~  303 (396)
                      ||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||||   +.++.+||+|||+++.+...
T Consensus        81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99999 8899998875 5679999999999999999999999999999999999999   68899999999999876543


Q ss_pred             CC--------ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCC-----C
Q 016037          304 TR--------SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN---RQKIQQKIIKDKI-----K  367 (396)
Q Consensus       304 ~~--------~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~---~~~i~~~i~~~~~-----~  367 (396)
                      ..        ....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+..   ....+.++.....     .
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA  239 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence            22        236789999999999999999999999999999999999999998743   3444444443322     2


Q ss_pred             CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          368 LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       368 ~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ++..++.++.+||+.||+.+|.+||++.
T Consensus       240 l~~~~p~~l~~li~~cl~~dP~~RPs~~  267 (483)
T 3sv0_A          240 LCRGYPTEFASYFHYCRSLRFDDKPDYS  267 (483)
T ss_dssp             HHTTSCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred             HhcCCcHHHHHHHHHHhcCChhhCcCHH
Confidence            3367899999999999999999999864

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.4e-45  Score=353.55  Aligned_cols=249  Identities=22%  Similarity=0.316  Sum_probs=202.9

Q ss_pred             CccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC
Q 016037          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (396)
Q Consensus       144 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~  223 (396)
                      ...+..++|++.+.||+|+||.||+|++ .+++.||+|++.......  ....+.+|+.+++.++||||+++++++....
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  100 (326)
T 3uim_A           24 ELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPT  100 (326)
T ss_dssp             HHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred             HHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence            3445667899999999999999999986 468889999997654221  1224788999999999999999999999999


Q ss_pred             eEEEEEEecCCCcHHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCCEEEcCCCcEEEEeccc
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVSHLHAN---GIMHRDLKPENILLDADGHVMLTDFGL  296 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~~LH~~---~iiHrDlkp~NILl~~~~~ikL~Dfgl  296 (396)
                      ..++||||+.+|+|.+++....    .+++..++.++.|++.||.|||++   ||+||||||+|||++.++++||+|||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  180 (326)
T 3uim_A          101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL  180 (326)
T ss_dssp             CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSS
T ss_pred             ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcc
Confidence            9999999999999999997653    489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCC--CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhC------
Q 016037          297 AKQFDENT--RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKD------  364 (396)
Q Consensus       297 a~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~----~~~~i~~~i~~~------  364 (396)
                      ++......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...    ............      
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  260 (326)
T 3uim_A          181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK  260 (326)
T ss_dssp             CEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC
T ss_pred             ccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchh
Confidence            98765332  234456999999999998888999999999999999999999999521    111111111111      


Q ss_pred             ---------CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 ---------KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 ---------~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                               ...++...+.++.+||..||+.+|.+|||++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  300 (326)
T 3uim_A          261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS  300 (326)
T ss_dssp             STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHH
T ss_pred             hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHH
Confidence                     0122334457899999999999999999975

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=6e-44  Score=354.95  Aligned_cols=239  Identities=26%  Similarity=0.447  Sum_probs=181.6

Q ss_pred             CeEE-EeEecccCceEEEEEEEc--CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe--cCeE
Q 016037          151 DFEV-LKVVGQGAFAKVYQVRRI--GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KYRL  225 (396)
Q Consensus       151 ~~~~-~~~IG~G~fG~Vy~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~--~~~~  225 (396)
                      .|++ .++||+|+||+||+|+++  .+++.||+|++......     ..+.+|+.+|+.++||||++++++|..  ...+
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            4666 357999999999999976  56889999999765422     246789999999999999999999954  6789


Q ss_pred             EEEEEecCCCcHHHHHHHhc---------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE----cCCCcEEEE
Q 016037          226 YLVLDFVNGGHLFFQLYRQG---------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL----DADGHVMLT  292 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl----~~~~~ikL~  292 (396)
                      |+||||+.+ +|..++....         .+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+
T Consensus        96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            999999986 6666665322         48999999999999999999999999999999999999    677899999


Q ss_pred             ecccccccCCC----CCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------HHH
Q 016037          293 DFGLAKQFDEN----TRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ---------KIQ  358 (396)
Q Consensus       293 Dfgla~~~~~~----~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~---------~i~  358 (396)
                      |||+++.+...    ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..         +..
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            99999876533    22345689999999999987 45899999999999999999999999875542         333


Q ss_pred             HHHHhC-CCCC-------------------------------------CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          359 QKIIKD-KIKL-------------------------------------PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       359 ~~i~~~-~~~~-------------------------------------p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ..+... ..+.                                     ....+.++.+||++||+.||.+|||+.
T Consensus       255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~  329 (405)
T 3rgf_A          255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE  329 (405)
T ss_dssp             HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred             HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence            333221 0000                                     011278899999999999999999964

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=9.2e-44  Score=339.36  Aligned_cols=239  Identities=23%  Similarity=0.317  Sum_probs=200.1

Q ss_pred             EEeEecccCceEEEEEEEcCCCcEEEEEEeeccc-cchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEec
Q 016037          154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDK-IMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFV  232 (396)
Q Consensus       154 ~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~  232 (396)
                      ..+.||+|+||.||+|.+  +++.||+|++.... .......+.+.+|+.++++++||||+++++++......|+||||+
T Consensus        35 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  112 (307)
T 2nru_A           35 GGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM  112 (307)
T ss_dssp             TCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             cCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence            447899999999999987  57789999987643 223445677889999999999999999999999999999999999


Q ss_pred             CCCcHHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC---c
Q 016037          233 NGGHLFFQLYRQ---GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR---S  306 (396)
Q Consensus       233 ~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~---~  306 (396)
                      ++++|.+++...   ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||+++.......   .
T Consensus       113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  192 (307)
T 2nru_A          113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT  192 (307)
T ss_dssp             TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEEC
T ss_pred             CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccc
Confidence            999999988743   4689999999999999999999999999999999999999999999999999987654322   3


Q ss_pred             cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCC-----------CCCcc
Q 016037          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ----KIQQKIIKDKI-----------KLPAF  371 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~----~i~~~i~~~~~-----------~~p~~  371 (396)
                      ....||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+.+..    .+...+.....           ..+..
T Consensus       193 ~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (307)
T 2nru_A          193 SRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADST  271 (307)
T ss_dssp             SSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHH
T ss_pred             cccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchH
Confidence            445799999999998764 889999999999999999999999875432    23333322211           23445


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCCC
Q 016037          372 LSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       372 ~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .+..+.+||..||+.+|.+|||+.
T Consensus       272 ~~~~l~~li~~cl~~~p~~Rps~~  295 (307)
T 2nru_A          272 SVEAMYSVASQCLHEKKNKRPDIK  295 (307)
T ss_dssp             HHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHHHHHHHHcCCCcccCcCHH
Confidence            678899999999999999999964

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.5e-43  Score=340.11  Aligned_cols=239  Identities=23%  Similarity=0.331  Sum_probs=200.4

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHh--CCCCCeeeeeEEEEecC--
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK--VDHPFIVQLRYSFQTKY--  223 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~--l~HpnIv~l~~~~~~~~--  223 (396)
                      ..++|++.+.||+|+||.||+|.+  +++.||+|++....      .+.+.+|.++++.  ++||||+++++++....  
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~  111 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT  111 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred             ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence            346899999999999999999998  58899999986532      2345678888887  79999999999998876  


Q ss_pred             --eEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCCEEEcCCCcEEEEe
Q 016037          224 --RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH--------ANGIMHRDLKPENILLDADGHVMLTD  293 (396)
Q Consensus       224 --~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH--------~~~iiHrDlkp~NILl~~~~~ikL~D  293 (396)
                        .+|+||||+++|+|.+++.+ ..+++..++.++.|++.||.|||        ++||+||||||+|||++.++++||+|
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  190 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  190 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred             cceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence              89999999999999998865 46899999999999999999999        89999999999999999999999999


Q ss_pred             cccccccCCCC-----CccccccCCCccchhhhcCCC------CCchhhHHHHHHHHHHHHhC----------CCCCCCC
Q 016037          294 FGLAKQFDENT-----RSNSMCGTLEYMSPEIVLGKG------HDKAADWWSVGILLFEMLTG----------QPPFTGG  352 (396)
Q Consensus       294 fgla~~~~~~~-----~~~~~~gt~~y~APE~l~~~~------~~~~~DvwSlGvil~elltg----------~~Pf~~~  352 (396)
                      ||+++......     ......||+.|+|||++.+..      ++.++|||||||++|||+||          +.||...
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~  270 (342)
T 1b6c_B          191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  270 (342)
T ss_dssp             CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence            99998765443     234567999999999998752      33689999999999999999          8899764


Q ss_pred             -----CHHHHHHHHHhC--CCCCCc-----cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          353 -----NRQKIQQKIIKD--KIKLPA-----FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       353 -----~~~~i~~~i~~~--~~~~p~-----~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                           ....+...+...  +..+|.     ..+..+.+||++||+.+|.+|||+.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~  325 (342)
T 1b6c_B          271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL  325 (342)
T ss_dssp             SCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             CcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHH
Confidence                 345555555444  334443     3346899999999999999999964

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4e-42  Score=345.26  Aligned_cols=236  Identities=27%  Similarity=0.371  Sum_probs=186.1

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCeEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      +.|.+.+.||+|+||+||.+ ...+|+.||||++....      .+.+.+|+.+|+++ +||||+++++++.+...+|+|
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv   87 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA   87 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence            44667788999999999865 44678999999987542      23467899999876 899999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCH-------HHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC-------------Cc
Q 016037          229 LDFVNGGHLFFQLYRQGLFRE-------DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-------------GH  288 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e-------~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~-------------~~  288 (396)
                      |||++ |+|.+++.......+       ..++.++.||+.||.|||++||+||||||+|||++.+             ++
T Consensus        88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence            99996 599999876654332       2346789999999999999999999999999999754             48


Q ss_pred             EEEEecccccccCCCCC-----ccccccCCCccchhhhcC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 016037          289 VMLTDFGLAKQFDENTR-----SNSMCGTLEYMSPEIVLG-------KGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQ  355 (396)
Q Consensus       289 ikL~Dfgla~~~~~~~~-----~~~~~gt~~y~APE~l~~-------~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~  355 (396)
                      +||+|||+++.......     ....+||+.|+|||++.+       ..++.++|||||||++|||+| |+.||.+....
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            99999999988754322     234579999999999976       568999999999999999999 99999875443


Q ss_pred             HHHHHHHhCCCCCC-------ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          356 KIQQKIIKDKIKLP-------AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       356 ~i~~~i~~~~~~~p-------~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .  ..+..+...++       ..++.++.+||++||+.||.+|||+.
T Consensus       247 ~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~  291 (434)
T 2rio_A          247 E--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAM  291 (434)
T ss_dssp             H--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             H--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHH
Confidence            3  34445443332       24568999999999999999999964

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=5.9e-43  Score=365.29  Aligned_cols=247  Identities=28%  Similarity=0.392  Sum_probs=203.5

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe------
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT------  221 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~------  221 (396)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||+++...  .....+.+.+|+.+++.++||||+++++++..      
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~   89 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP   89 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence            3478999999999999999999999999999999987643  34455678889999999999999999998755      


Q ss_pred             cCeEEEEEEecCCCcHHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc---EEEEecc
Q 016037          222 KYRLYLVLDFVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH---VMLTDFG  295 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~---ikL~Dfg  295 (396)
                      ....|+||||++||+|..++....   .+++..++.++.|++.||.|||++||+||||||+|||++.++.   +||+|||
T Consensus        90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            677899999999999999998654   5899999999999999999999999999999999999997775   9999999


Q ss_pred             cccccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---------HH-----H
Q 016037          296 LAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ---------QK-----I  361 (396)
Q Consensus       296 la~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~---------~~-----i  361 (396)
                      ++.............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.......         ..     .
T Consensus       170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  249 (676)
T 3qa8_A          170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD  249 (676)
T ss_dssp             CCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred             cccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence            999887666666778999999999999999999999999999999999999999764322110         00     0


Q ss_pred             HhCCC------C----CCccCCHHHHHHHHHhhccCCCCCCCCCC
Q 016037          362 IKDKI------K----LPAFLSSEAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       362 ~~~~~------~----~p~~~s~~~~~li~~~l~~~p~~RPs~s~  396 (396)
                      ..+..      +    ++..++.++.+||+.||+.||.+|||+.+
T Consensus       250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence            01111      1    22346789999999999999999999864

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.5e-42  Score=345.60  Aligned_cols=242  Identities=21%  Similarity=0.315  Sum_probs=189.6

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCe
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYR  224 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~  224 (396)
                      .++..+|.+.+.||+|+||+||. ....+++.||||++......      ...+|+.+|+.+ +||||+++++++.+...
T Consensus        20 ~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~   92 (432)
T 3p23_A           20 IVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQF   92 (432)
T ss_dssp             EETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTE
T ss_pred             EEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCE
Confidence            34556799999999999999763 44467889999999764422      245799999999 79999999999999999


Q ss_pred             EEEEEEecCCCcHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC-----CcEEEEeccccc
Q 016037          225 LYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-----GHVMLTDFGLAK  298 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~-----~~ikL~Dfgla~  298 (396)
                      +|+||||+.+ +|.+++.... .+.+..++.++.||+.||.|||++||+||||||+|||++.+     ..+||+|||+++
T Consensus        93 ~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~  171 (432)
T 3p23_A           93 QYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK  171 (432)
T ss_dssp             EEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred             EEEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence            9999999975 8888887654 35555677899999999999999999999999999999532     358899999998


Q ss_pred             ccCCC----CCccccccCCCccchhhhc---CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCC---
Q 016037          299 QFDEN----TRSNSMCGTLEYMSPEIVL---GKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIK---  367 (396)
Q Consensus       299 ~~~~~----~~~~~~~gt~~y~APE~l~---~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~~~~---  367 (396)
                      .....    ......+||+.|+|||++.   ...++.++|||||||++|||+| |..||...........+......   
T Consensus       172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~  251 (432)
T 3p23_A          172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLH  251 (432)
T ss_dssp             CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSC
T ss_pred             eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccC
Confidence            76543    2334567999999999997   4567889999999999999999 99999765544433332222222   


Q ss_pred             CCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          368 LPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       368 ~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .+...+..+.+||++||+.||.+|||+.
T Consensus       252 ~~~~~~~~~~~li~~~L~~dP~~Rps~~  279 (432)
T 3p23_A          252 PEKHEDVIARELIEKMIAMDPQKRPSAK  279 (432)
T ss_dssp             TTCHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             ccccccHHHHHHHHHHHhCCHhhCCCHH
Confidence            2234567799999999999999999964

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.9e-41  Score=321.77  Aligned_cols=220  Identities=29%  Similarity=0.507  Sum_probs=183.9

Q ss_pred             ccCCCeEEE-eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHH-HhCCCCCeeeeeEEEEe---
Q 016037          147 VGLEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL-TKVDHPFIVQLRYSFQT---  221 (396)
Q Consensus       147 ~~~~~~~~~-~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L-~~l~HpnIv~l~~~~~~---  221 (396)
                      ...++|.+. +.||+|+||.||+|.+..+++.||+|++...        ....+|+.++ +.++||||+++++++..   
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   85 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA   85 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence            345679888 7799999999999999999999999998653        2355688777 66799999999999987   


Q ss_pred             -cCeEEEEEEecCCCcHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC---CCcEEEEecc
Q 016037          222 -KYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFG  295 (396)
Q Consensus       222 -~~~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~---~~~ikL~Dfg  295 (396)
                       ...+|+||||+++|+|.+++...+  .+++..++.++.|++.||.|||++||+||||||+|||++.   ++.+||+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence             778999999999999999998764  6999999999999999999999999999999999999998   7899999999


Q ss_pred             cccccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCC--
Q 016037          296 LAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ----KIIKDKIKLP--  369 (396)
Q Consensus       296 la~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~----~i~~~~~~~p--  369 (396)
                      ++....                     +..++.++|||||||++|||++|+.||.+.+......    .+......+|  
T Consensus       166 ~a~~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (299)
T 3m2w_A          166 FAKETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP  224 (299)
T ss_dssp             TCEECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHH
T ss_pred             cccccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCch
Confidence            996542                     2347789999999999999999999998765444322    2222334444  


Q ss_pred             --ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          370 --AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       370 --~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                        ..++.++.+||+.||+.||.+|||++
T Consensus       225 ~~~~~~~~~~~li~~~l~~dP~~Rps~~  252 (299)
T 3m2w_A          225 EWSEVSEEVKMLIRNLLKTEPTQRMTIT  252 (299)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hcccCCHHHHHHHHHHcccChhhCCCHH
Confidence              56899999999999999999999964

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=9.8e-42  Score=323.93  Aligned_cols=220  Identities=13%  Similarity=0.106  Sum_probs=186.0

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +..++|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.++++++||||+++++++...+..|
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            34478999999999999999999999999999999998776555566677889999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCc
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS  306 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~  306 (396)
                      +||||++|++|.+++.+ +. ....+..++.|++.||.|||++||+||||||+|||++.+|.+||++++           
T Consensus       108 lv~e~~~g~~L~~~l~~-~~-~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-----------  174 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADT-SP-SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-----------  174 (286)
T ss_dssp             EEEECCCEEEHHHHHTT-CC-CHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred             EEEEecCCCCHHHHHhc-CC-ChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence            99999999999998854 33 555677789999999999999999999999999999999999998443           


Q ss_pred             cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhCCCC----CCccCCHHHHHH
Q 016037          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ---KIIKDKIK----LPAFLSSEAHSL  379 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~---~i~~~~~~----~p~~~s~~~~~l  379 (396)
                              |++       .++.++|||||||++|||+||+.||.+.+......   +.......    ++..++.++.+|
T Consensus       175 --------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  239 (286)
T 3uqc_A          175 --------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAV  239 (286)
T ss_dssp             --------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHH
T ss_pred             --------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHH
Confidence                    333       27899999999999999999999999865433111   11122222    235799999999


Q ss_pred             HHHhhccCCCCCCCCC
Q 016037          380 LKGVNSLLSISVPLLS  395 (396)
Q Consensus       380 i~~~l~~~p~~RPs~s  395 (396)
                      |.+||+.||.+| |+.
T Consensus       240 i~~~l~~dP~~R-s~~  254 (286)
T 3uqc_A          240 AARSVQGDGGIR-SAS  254 (286)
T ss_dssp             HHHHHCTTSSCC-CHH
T ss_pred             HHHHcccCCccC-CHH
Confidence            999999999999 753

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.7e-42  Score=343.38  Aligned_cols=239  Identities=18%  Similarity=0.140  Sum_probs=188.1

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC-CCe----------ee--
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-PFI----------VQ--  214 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~H-pnI----------v~--  214 (396)
                      ...+|+..+.||+|+||+||+|++..+|+.||||+++..........+.+.+|+.+++.++| .|+          +.  
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            34569999999999999999999999999999999985544444445678899999999987 211          11  


Q ss_pred             ---------eeEEEEe-----cCeEEEEEEecCCCcHHHHHHH-------hcCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 016037          215 ---------LRYSFQT-----KYRLYLVLDFVNGGHLFFQLYR-------QGLFREDLARIYTAEIVSAVSHLHANGIMH  273 (396)
Q Consensus       215 ---------l~~~~~~-----~~~~~lV~E~~~gg~L~~~l~~-------~~~l~e~~~~~~~~qi~~aL~~LH~~~iiH  273 (396)
                               +...+..     ...++++|+++ +++|.+++..       .+.+++..++.++.||+.||.|||++||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence                     1111111     23567777766 4688877742       234677788889999999999999999999


Q ss_pred             ccCCCCCEEEcCCCcEEEEecccccccCCCCCccccccCCCccchhhh----------cCCCCCchhhHHHHHHHHHHHH
Q 016037          274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV----------LGKGHDKAADWWSVGILLFEML  343 (396)
Q Consensus       274 rDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~~gt~~y~APE~l----------~~~~~~~~~DvwSlGvil~ell  343 (396)
                      |||||+|||++.++.+||+|||+++.....  ....+| +.|||||++          .+..++.++|||||||++|||+
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            999999999999999999999999876543  455678 999999999          5566889999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCCCCCCCC
Q 016037          344 TGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       344 tg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs~  394 (396)
                      ||+.||.+.+.......+...    ...++.++.+||+.||+.||.+||++
T Consensus       312 tg~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dP~~Rpt~  358 (413)
T 3dzo_A          312 CADLPNTDDAALGGSEWIFRS----CKNIPQPVRALLEGFLRYPKEDRLLP  358 (413)
T ss_dssp             HSSCCCCTTGGGSCSGGGGSS----CCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HCCCCCCCcchhhhHHHHHhh----cccCCHHHHHHHHHHccCChhhCcCH
Confidence            999999987655544444332    23678999999999999999999985

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.7e-41  Score=358.93  Aligned_cols=232  Identities=24%  Similarity=0.283  Sum_probs=193.6

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcC-CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCe--
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIG-TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR--  224 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~--  224 (396)
                      ..++|++.+.||+|+||.||+|.+.. +++.||||++....  .....+.+.+|+.++++++||||+++++++.....  
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence            34789999999999999999999986 78999999987543  23445667889999999999999999999987665  


Q ss_pred             ---EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          225 ---LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       225 ---~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                         .||||||++|++|..++..  .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++...
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             CceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence               7999999999999877654  78999999999999999999999999999999999999875 99999999998765


Q ss_pred             CCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Q 016037          302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK  381 (396)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~  381 (396)
                      ..   ...+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.....+.      ........+..+.+||.
T Consensus       233 ~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~  302 (681)
T 2pzi_A          233 SF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------EDDPVLKTYDSYGRLLR  302 (681)
T ss_dssp             CC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------TTCHHHHHCHHHHHHHH
T ss_pred             cC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc------ccccccccCHHHHHHHh
Confidence            43   456799999999999765 489999999999999999999998763211000      00001235789999999


Q ss_pred             HhhccCCCCCCCC
Q 016037          382 GVNSLLSISVPLL  394 (396)
Q Consensus       382 ~~l~~~p~~RPs~  394 (396)
                      +||+.||.+||+.
T Consensus       303 ~~l~~dP~~R~~~  315 (681)
T 2pzi_A          303 RAIDPDPRQRFTT  315 (681)
T ss_dssp             HHTCSSGGGSCSS
T ss_pred             hhccCChhhCCCH
Confidence            9999999999974

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.5e-42  Score=333.40  Aligned_cols=233  Identities=17%  Similarity=0.211  Sum_probs=187.0

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc-----hhhHHHHHHHHHHHHHhCC---------CCCe
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNILTKVD---------HPFI  212 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~E~~~L~~l~---------HpnI  212 (396)
                      +..++|++.+.||+|+||+||+|++  +|+.||||++......     .....+.+.+|+.+++.++         ||||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            3456899999999999999999998  6799999999875421     2233456788999988875         7777


Q ss_pred             eeeeEEEE-----------------e-------------cCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHH
Q 016037          213 VQLRYSFQ-----------------T-------------KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA  262 (396)
Q Consensus       213 v~l~~~~~-----------------~-------------~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~a  262 (396)
                      +++.+.+.                 +             ...+|+||||+++|++...+.+ +.+++..++.++.||+.|
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence            77766543                 2             6789999999999977666644 678999999999999999


Q ss_pred             HHHHH-HCCceeccCCCCCEEEcCCC--------------------cEEEEecccccccCCCCCccccccCCCccchhhh
Q 016037          263 VSHLH-ANGIMHRDLKPENILLDADG--------------------HVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV  321 (396)
Q Consensus       263 L~~LH-~~~iiHrDlkp~NILl~~~~--------------------~ikL~Dfgla~~~~~~~~~~~~~gt~~y~APE~l  321 (396)
                      |.||| ++||+||||||+|||++.++                    .+||+|||+|+.....    ..+||+.|||||++
T Consensus       174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~  249 (336)
T 2vuw_A          174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLF  249 (336)
T ss_dssp             HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGG
T ss_pred             HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhh
Confidence            99999 99999999999999999887                    8999999999876532    45899999999999


Q ss_pred             cCCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHHhC-CC--C----CCccCCHHHHHHHHHhhccC
Q 016037          322 LGKGHDKAADWWSVGIL-LFEMLTGQPPFTGGNR-QKIQQKIIKD-KI--K----LPAFLSSEAHSLLKGVNSLL  387 (396)
Q Consensus       322 ~~~~~~~~~DvwSlGvi-l~elltg~~Pf~~~~~-~~i~~~i~~~-~~--~----~p~~~s~~~~~li~~~l~~~  387 (396)
                      .+.. +.++||||||++ .+++++|..||.+... ..+...+... ..  .    ++..+|+++++||++||+++
T Consensus       250 ~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d  323 (336)
T 2vuw_A          250 TGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS  323 (336)
T ss_dssp             CCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS
T ss_pred             cCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC
Confidence            8776 899999998777 7888899999965322 2333444422 11  1    12358999999999999976

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=5.3e-35  Score=302.77  Aligned_cols=188  Identities=18%  Similarity=0.164  Sum_probs=139.1

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccc-------hhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEecCeEEE
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-------EKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~-------~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~~~~~l  227 (396)
                      ...+.|++|.+..++....|+.||+|++.+....       .+...+.+.+|+++|+++ .|+||+++++++++...+||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            4467788888888888888999999999864311       233456688999999999 79999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-CCc
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRS  306 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-~~~  306 (396)
                      ||||++|++|.+.+.+.+++++.   .++.||+.||+|+|++|||||||||+|||++.+|++||+|||+|+..... ...
T Consensus       320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~  396 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP  396 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred             EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence            99999999999999999998875   47889999999999999999999999999999999999999999877543 345


Q ss_pred             cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Q 016037          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQP  347 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~  347 (396)
                      .+.+||+.|||||++.+. +..++|+||+|+++++|.++..
T Consensus       397 ~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          397 TNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             HHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred             cCceechhhccHHHhCCC-CCCcccccccccchhhhccccc
Confidence            667899999999999865 6778999999999887765543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=4.9e-30  Score=264.09  Aligned_cols=186  Identities=19%  Similarity=0.170  Sum_probs=147.9

Q ss_pred             EEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc-----hhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       153 ~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      ...+.||+|+||+||+|.+  .++.+++|+.......     .....+.+.+|+++|++++||||+++..++......||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            3456899999999999944  5677899987553321     22234567899999999999999966666667777899


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC--
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR--  305 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~--  305 (396)
                      ||||++|++|.+++..        +..++.|++.||.|||++||+||||||+|||++.  ++||+|||+++.......  
T Consensus       417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~  486 (540)
T 3en9_A          417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA  486 (540)
T ss_dssp             EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred             EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence            9999999999988865        5578999999999999999999999999999988  999999999998755322  


Q ss_pred             ------ccccccCCCccchhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 016037          306 ------SNSMCGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFT  350 (396)
Q Consensus       306 ------~~~~~gt~~y~APE~l~~--~~~~~~~DvwSlGvil~elltg~~Pf~  350 (396)
                            ....+||+.|||||++.+  ..|+..+|+|+..+-..+.+.++.+|.
T Consensus       487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence                  236789999999999987  668889999999999999888877764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=2.8e-26  Score=217.17  Aligned_cols=147  Identities=17%  Similarity=0.184  Sum_probs=118.1

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchh---------------hHHHHHHHHHHHHHhCCCCCeeee
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK---------------NHAEYMKSERNILTKVDHPFIVQL  215 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~---------------~~~~~~~~E~~~L~~l~HpnIv~l  215 (396)
                      .|.+.+.||+|+||.||+|.+ .+|+.||+|+++.......               .....+.+|+.+|++++  | +++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            355669999999999999999 8899999999975432111               23456789999999999  4 666


Q ss_pred             eEEEEecCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecc
Q 016037          216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFG  295 (396)
Q Consensus       216 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfg  295 (396)
                      .+++.. ...|+||||++|++|.. +      .......++.|++.||.|||++||+||||||+|||++ ++++||+|||
T Consensus       167 ~~~~~~-~~~~lvmE~~~g~~L~~-l------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG  237 (282)
T 1zar_A          167 PKVYAW-EGNAVLMELIDAKELYR-V------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP  237 (282)
T ss_dssp             CCEEEE-ETTEEEEECCCCEEGGG-C------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred             CeEEec-cceEEEEEecCCCcHHH-c------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence            665544 45699999999999976 3      1233456899999999999999999999999999999 9999999999


Q ss_pred             cccccCCCCCccccccCCCccchhhhc
Q 016037          296 LAKQFDENTRSNSMCGTLEYMSPEIVL  322 (396)
Q Consensus       296 la~~~~~~~~~~~~~gt~~y~APE~l~  322 (396)
                      +++.            +..++|||.+.
T Consensus       238 ~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          238 QSVE------------VGEEGWREILE  252 (282)
T ss_dssp             TCEE------------TTSTTHHHHHH
T ss_pred             CCeE------------CCCCCHHHHHH
Confidence            9963            35678999875

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=7.3e-22  Score=184.24  Aligned_cols=140  Identities=19%  Similarity=0.186  Sum_probs=108.4

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcE--EEEEEeeccccc---------------------hhhHHHHHHHHHHHHHhCC
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEI--YAMKVMRKDKIM---------------------EKNHAEYMKSERNILTKVD  208 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~--vAvK~i~~~~~~---------------------~~~~~~~~~~E~~~L~~l~  208 (396)
                      |++.+.||+|+||.||+|.+..+|+.  ||||+++.....                     .......+.+|+.+|+.+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            78899999999999999999888989  999998654211                     0112245788999999998


Q ss_pred             CCCe--eeeeEEEEecCeEEEEEEecCC-C----cHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCC
Q 016037          209 HPFI--VQLRYSFQTKYRLYLVLDFVNG-G----HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH-ANGIMHRDLKPEN  280 (396)
Q Consensus       209 HpnI--v~l~~~~~~~~~~~lV~E~~~g-g----~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH-~~~iiHrDlkp~N  280 (396)
                      |+++  +.++..    ...+|||||+.+ |    .|.+....   .++..+..++.|++.||.||| ++||+||||||+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            8754  333332    256899999942 3    56554322   234567788999999999999 9999999999999


Q ss_pred             EEEcCCCcEEEEeccccccc
Q 016037          281 ILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       281 ILl~~~~~ikL~Dfgla~~~  300 (396)
                      ||++.  .++|+|||+|...
T Consensus       202 ILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          202 IMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EEESS--SEEECCCTTCEET
T ss_pred             EEEcC--cEEEEECcccccC
Confidence            99987  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.75  E-value=4.2e-18  Score=166.85  Aligned_cols=141  Identities=14%  Similarity=0.154  Sum_probs=101.5

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc------------h---hh----HHHHHHHHHHHHHhCCCCCe
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM------------E---KN----HAEYMKSERNILTKVDHPFI  212 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~------------~---~~----~~~~~~~E~~~L~~l~HpnI  212 (396)
                      |++.+.||.|+||.||+|.+. +|+.||||+++.....            .   ..    ..-....|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            899999999999999999984 6889999998653211            0   00    01112456777777755544


Q ss_pred             eeeeEEEEecCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-----
Q 016037          213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-----  287 (396)
Q Consensus       213 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~-----  287 (396)
                      .-..- +.... .+|||||++|+.|....      .......++.|++.+|.+||++|||||||||.|||++++|     
T Consensus       176 ~vp~p-~~~~~-~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~  247 (397)
T 4gyi_A          176 PVPEP-IAQSR-HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP  247 (397)
T ss_dssp             SCCCE-EEEET-TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred             CCCee-eeccC-ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence            22111 11122 27999999998874322      2223456789999999999999999999999999998877     


Q ss_pred             -----cEEEEecccccccC
Q 016037          288 -----HVMLTDFGLAKQFD  301 (396)
Q Consensus       288 -----~ikL~Dfgla~~~~  301 (396)
                           .+.|+||+-+....
T Consensus       248 ~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          248 SSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             TSEEEEEEECCCTTCEETT
T ss_pred             cccccceEEEEeCCcccCC
Confidence                 38999999886543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.41  E-value=1.2e-12  Score=121.23  Aligned_cols=140  Identities=14%  Similarity=0.093  Sum_probs=109.5

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEEEecCeEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~lV  228 (396)
                      ..|++...++.|+.+.||++...  +..+++|+.......   ....+.+|+.+++.+. +..+.++++++...+..|+|
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            46899999999999999998753  577999998753211   1224778999999884 66788899999888999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA----------------------------------------  268 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~----------------------------------------  268 (396)
                      |||++|.+|...+.     +......++.+++.+|..||+                                        
T Consensus        89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            99999998865421     122234677899999999998                                        


Q ss_pred             -------------------CCceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          269 -------------------NGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       269 -------------------~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                                         ..++|+|++|.|||+++++.+.|+||+.+..
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                               4489999999999998765667999998754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.29  E-value=9.2e-12  Score=114.39  Aligned_cols=135  Identities=15%  Similarity=0.107  Sum_probs=97.8

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC--eeeeeEEEEecCeEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYL  227 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~Hpn--Iv~l~~~~~~~~~~~l  227 (396)
                      .++.+....+.|..+.||++.. .+|..+++|+.....      ...+..|+.+++.+.+.+  +.++++++..++..|+
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~   92 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL   92 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence            4566655445666799999865 456779999976531      133677888888885444  5558888888888999


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------------
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG-------------------------------------  270 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~-------------------------------------  270 (396)
                      ||||++|.++.  .   ....   ...++.+++..|..||+..                                     
T Consensus        93 v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (264)
T 1nd4_A           93 LLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG  164 (264)
T ss_dssp             EEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred             EEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence            99999998873  1   1111   1245667777777777643                                     


Q ss_pred             ---------------------ceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          271 ---------------------IMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       271 ---------------------iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                                           ++|+|++|.|||++.++.+.|+||+.+..
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                 99999999999998776677999998754

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.16  E-value=7.4e-11  Score=114.45  Aligned_cols=141  Identities=15%  Similarity=0.269  Sum_probs=103.6

Q ss_pred             EEeEecccCceEEEEEEEcCCCcEEEEEEee--ccccchhhHHHHHHHHHHHHHhCC--CCCeeeeeEEEEec---CeEE
Q 016037          154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMR--KDKIMEKNHAEYMKSERNILTKVD--HPFIVQLRYSFQTK---YRLY  226 (396)
Q Consensus       154 ~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~--~~~~~~~~~~~~~~~E~~~L~~l~--HpnIv~l~~~~~~~---~~~~  226 (396)
                      .++.|+.|.++.||++...  +..+++|+..  .....  .....+.+|..+++.+.  +..+++++.++.+.   +..|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence            4677999999999998764  3568888876  33211  12345778999999886  34577888887766   4589


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA--------------------------------------  268 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~--------------------------------------  268 (396)
                      +||||++|..+....  ...++......++.+++.+|..||+                                      
T Consensus       118 ~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999999998763211  1235677778889999999999997                                      


Q ss_pred             --------------------CCceeccCCCCCEEEcCCCc--EEEEeccccccc
Q 016037          269 --------------------NGIMHRDLKPENILLDADGH--VMLTDFGLAKQF  300 (396)
Q Consensus       269 --------------------~~iiHrDlkp~NILl~~~~~--ikL~Dfgla~~~  300 (396)
                                          ..++|+|+++.|||++.++.  +.|+||+.+...
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                35899999999999987763  689999998754

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.10  E-value=8e-11  Score=111.61  Aligned_cols=183  Identities=18%  Similarity=0.252  Sum_probs=119.1

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCC--eeeeeEEEEecC---eEEEEE
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPF--IVQLRYSFQTKY---RLYLVL  229 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~Hpn--Iv~l~~~~~~~~---~~~lV~  229 (396)
                      +.++.|.+..||++.     ..+++|+....     .....+.+|..+|+.+ .+..  +.+++.......   ..|+||
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm   95 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF   95 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence            458999999999863     34889986532     3345678899999887 3332  333444333322   348899


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-----------------------------------------  268 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-----------------------------------------  268 (396)
                      ++++|..+.....  ..++......++.+++..+..||+                                         
T Consensus        96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9999988754332  345666677778888888888885                                         


Q ss_pred             -----------------CCceeccCCCCCEEEcC--CCcEEEEecccccccCCCCCccccccCCCccchhhhcC-----C
Q 016037          269 -----------------NGIMHRDLKPENILLDA--DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG-----K  324 (396)
Q Consensus       269 -----------------~~iiHrDlkp~NILl~~--~~~ikL~Dfgla~~~~~~~~~~~~~gt~~y~APE~l~~-----~  324 (396)
                                       ..++|+|+++.||+++.  .+.+.|+||+.+...+.............-..|+....     .
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                             13699999999999988  45678999999876432211111000000023332211     1


Q ss_pred             CC---------CchhhHHHHHHHHHHHHhCCCCCC
Q 016037          325 GH---------DKAADWWSVGILLFEMLTGQPPFT  350 (396)
Q Consensus       325 ~~---------~~~~DvwSlGvil~elltg~~Pf~  350 (396)
                      ..         ..-.+.|++|.++|.+.+|..+|.
T Consensus       254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            11         122689999999999999988774

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.63  E-value=5.2e-07  Score=83.34  Aligned_cols=132  Identities=15%  Similarity=0.140  Sum_probs=92.3

Q ss_pred             ecccCce-EEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEEEecCeEEEEEEecCCC
Q 016037          158 VGQGAFA-KVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (396)
Q Consensus       158 IG~G~fG-~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~gg  235 (396)
                      +..|..| .||+......+..+.+|+-...      ....+.+|...|+.+. +--+.+++.++...+..|+|||+++|.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            4455555 6999888777778999986543      2345778999888774 223667788888889999999999998


Q ss_pred             cHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 016037          236 HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-----------------------------------------------  268 (396)
Q Consensus       236 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-----------------------------------------------  268 (396)
                      ++........    .....+..++...|..||+                                               
T Consensus       106 ~~~~~~~~~~----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          106 TAFQVLEEYP----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             EHHHHHHHCG----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccccCCH----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            8765443211    1112234444444444441                                               


Q ss_pred             ----C-------CceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          269 ----N-------GIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       269 ----~-------~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                          .       .++|+|+++.|||++.++.+-|+||+.+..
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                1       279999999999998877778999998864

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.62  E-value=6.2e-07  Score=84.98  Aligned_cols=135  Identities=19%  Similarity=0.210  Sum_probs=89.8

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCC---CeeeeeEEEE-ecCeEEEEEE
Q 016037          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP---FIVQLRYSFQ-TKYRLYLVLD  230 (396)
Q Consensus       155 ~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~Hp---nIv~l~~~~~-~~~~~~lV~E  230 (396)
                      ++.++.|....||+.     +..+++|+-..     ......+..|..+|+.+.+.   .+.+.+.+.. ..+..|+|||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            345788999999987     45588898532     23345688899999998642   2445555553 3456789999


Q ss_pred             ecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------
Q 016037          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN-----------------------------------------  269 (396)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~-----------------------------------------  269 (396)
                      |++|..+.....  ..++......++.++...|..||+.                                         
T Consensus        94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            999988765221  1223333333444444444444432                                         


Q ss_pred             -------------------CceeccCCCCCEEEcC---CCc-EEEEecccccccC
Q 016037          270 -------------------GIMHRDLKPENILLDA---DGH-VMLTDFGLAKQFD  301 (396)
Q Consensus       270 -------------------~iiHrDlkp~NILl~~---~~~-ikL~Dfgla~~~~  301 (396)
                                         .++|+|+++.|||++.   ++. +.|+||+.+...+
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                               3699999999999987   455 4899999887644

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.40  E-value=4.7e-07  Score=88.73  Aligned_cols=79  Identities=14%  Similarity=0.179  Sum_probs=48.6

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeecccc-chh---hHHHHHHHHHHHHHhCCC--CCee-eeeEEEEecCeEEE
Q 016037          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI-MEK---NHAEYMKSERNILTKVDH--PFIV-QLRYSFQTKYRLYL  227 (396)
Q Consensus       155 ~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~-~~~---~~~~~~~~E~~~L~~l~H--pnIv-~l~~~~~~~~~~~l  227 (396)
                      .+.||.|.++.||++....+++.+++|....... ...   ...+++..|..+|+.+..  +..+ +++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            5679999999999997766677899998654221 000   112345668888887632  4333 45433  3445689


Q ss_pred             EEEecCCC
Q 016037          228 VLDFVNGG  235 (396)
Q Consensus       228 V~E~~~gg  235 (396)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.19  E-value=2.3e-05  Score=74.42  Aligned_cols=136  Identities=13%  Similarity=0.149  Sum_probs=77.2

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-----CCCCeeeee-E--EEEecCeEE
Q 016037          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-----DHPFIVQLR-Y--SFQTKYRLY  226 (396)
Q Consensus       155 ~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-----~HpnIv~l~-~--~~~~~~~~~  226 (396)
                      ++.|+.|..+.||++... +| .+++|+.....    ..   +..|..+++.|     ..|.++... +  +....+..+
T Consensus        37 ~~~l~gG~~n~~~~v~~~-~~-~~vlk~~~~~~----~~---~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~  107 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD-SG-AVCLKRIHRPE----KK---ALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF  107 (346)
T ss_dssp             EEECC----CEEEEEEET-TE-EEEEEEECSCH----HH---HHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred             eeeccccccCcEEEEEeC-CC-CEEEEecCCCH----HH---HHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence            456777788999998763 33 48999987521    12   22344444433     234444311 0  123467789


Q ss_pred             EEEEecCCCcHH--------------HHHHHh-cCC--C-----------HH--------H-------------------
Q 016037          227 LVLDFVNGGHLF--------------FQLYRQ-GLF--R-----------ED--------L-------------------  251 (396)
Q Consensus       227 lV~E~~~gg~L~--------------~~l~~~-~~l--~-----------e~--------~-------------------  251 (396)
                      ++|+|++|..+.              -.++.. ..+  +           ..        .                   
T Consensus       108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  187 (346)
T 2q83_A          108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL  187 (346)
T ss_dssp             EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred             EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence            999999986431              111111 101  0           00        0                   


Q ss_pred             ----HHHHHHHHHHHHHHHHH-------------CCceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          252 ----ARIYTAEIVSAVSHLHA-------------NGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       252 ----~~~~~~qi~~aL~~LH~-------------~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                          ...+..++..++.+|+.             ..++|+|+++.|||++.++.+.|+||+.+..
T Consensus       188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence                01111223345666652             4799999999999998888999999998854

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.08  E-value=9.1e-06  Score=78.15  Aligned_cols=86  Identities=12%  Similarity=0.088  Sum_probs=54.3

Q ss_pred             eEEEeEe-cccCceEEEEEEEc--C----CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-C--CCeeeeeEEEEe
Q 016037          152 FEVLKVV-GQGAFAKVYQVRRI--G----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-H--PFIVQLRYSFQT  221 (396)
Q Consensus       152 ~~~~~~I-G~G~fG~Vy~~~~~--~----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-H--pnIv~l~~~~~~  221 (396)
                      ....+.| +.|....+|++...  .    ++..+++|+..............+.+|..+++.+. +  -.+.+++.+...
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            4456778 89999999998763  1    15678899865432000000123566777777763 2  245667776655


Q ss_pred             c---CeEEEEEEecCCCcH
Q 016037          222 K---YRLYLVLDFVNGGHL  237 (396)
Q Consensus       222 ~---~~~~lV~E~~~gg~L  237 (396)
                      .   +..|+||||++|..+
T Consensus       102 ~~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          102 GDVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             STTTSSCEEEEECCCCBCC
T ss_pred             CCccCCceEEEEecCCCCh
Confidence            4   356899999998654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.07  E-value=6.6e-06  Score=81.31  Aligned_cols=77  Identities=10%  Similarity=0.117  Sum_probs=48.8

Q ss_pred             HCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCcccccc--CCCccchhhhcCCCC---CchhhHHHHHHHHHHH
Q 016037          268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG--TLEYMSPEIVLGKGH---DKAADWWSVGILLFEM  342 (396)
Q Consensus       268 ~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~~g--t~~y~APE~l~~~~~---~~~~DvwSlGvil~el  342 (396)
                      ...++|+|+++.|||++.++ ++|+||+.+..............  ...|++|+......-   ....++..+...+|+.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            45799999999999998776 99999999876432211111111  134566665532111   1234556788888887


Q ss_pred             HhC
Q 016037          343 LTG  345 (396)
Q Consensus       343 ltg  345 (396)
                      +++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.76  E-value=0.00021  Score=67.74  Aligned_cols=77  Identities=9%  Similarity=0.119  Sum_probs=58.6

Q ss_pred             EEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC---CCCeeeeeEEEEecCeEEEEE
Q 016037          153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD---HPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       153 ~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~---HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      .-.+.|+.|.+..+|+...  ++..+++|+....      ....+..|...|+.|.   ...+.+++......+..|+||
T Consensus        39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm  110 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL  110 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred             eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence            3457799999999999875  4567889987542      2455778888888773   355777888877778899999


Q ss_pred             EecCCCcH
Q 016037          230 DFVNGGHL  237 (396)
Q Consensus       230 E~~~gg~L  237 (396)
                      ||++|..+
T Consensus       111 e~l~G~~~  118 (312)
T 3jr1_A          111 EALNKSKN  118 (312)
T ss_dssp             ECCCCCCC
T ss_pred             EeccCCCC
Confidence            99998754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.66  E-value=7e-05  Score=70.30  Aligned_cols=133  Identities=13%  Similarity=0.057  Sum_probs=73.0

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCe-eeeeEEEEecCeEEEEEEec-
Q 016037          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI-VQLRYSFQTKYRLYLVLDFV-  232 (396)
Q Consensus       155 ~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnI-v~l~~~~~~~~~~~lV~E~~-  232 (396)
                      ++.|+.|....+|++      ..+++|+.......    .....+|..+++.+..-++ .++++..  ...-++++||+ 
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence            577889999999998      34889987653210    1112457766666532222 3454433  33347899999 


Q ss_pred             CCCcHHHHH------------------HHhcC-CC-----HHHHHHHHH--------------HHHHHHHHHH----H--
Q 016037          233 NGGHLFFQL------------------YRQGL-FR-----EDLARIYTA--------------EIVSAVSHLH----A--  268 (396)
Q Consensus       233 ~gg~L~~~l------------------~~~~~-l~-----e~~~~~~~~--------------qi~~aL~~LH----~--  268 (396)
                      +|.++....                  +.... +.     ...+..+..              .+...+..|.    .  
T Consensus        91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~  170 (301)
T 3dxq_A           91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP  170 (301)
T ss_dssp             TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence            665442100                  11000 00     111111111              1111122221    1  


Q ss_pred             --CCceeccCCCCCEEEcCCCcEEEEeccccccc
Q 016037          269 --NGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       269 --~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~  300 (396)
                        ..++|+|+.+.||+ ..++.+.|+||..+...
T Consensus       171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             CCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence              13899999999999 56778999999988754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.56  E-value=0.00015  Score=68.43  Aligned_cols=142  Identities=18%  Similarity=0.190  Sum_probs=79.0

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-----CCCeeeee-E--EEEec
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-----HPFIVQLR-Y--SFQTK  222 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-----HpnIv~l~-~--~~~~~  222 (396)
                      ...-++.|+.|....+|++...+ | .+++|+.....  .   .+.+..|..+++.+.     -|.++... +  +....
T Consensus        23 ~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~--~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~   95 (322)
T 2ppq_A           23 SLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS   95 (322)
T ss_dssp             CEEEEEEECC---EEEEEEEESS-C-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred             cceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCCC--C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEEC
Confidence            44556788889999999987643 3 58899887521  1   122345666665553     23333211 0  11234


Q ss_pred             CeEEEEEEecCCCcHH-----------H---HHHHh-cCC--------CHHHHHH---------------HHHHHHHHHH
Q 016037          223 YRLYLVLDFVNGGHLF-----------F---QLYRQ-GLF--------REDLARI---------------YTAEIVSAVS  264 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~-----------~---~l~~~-~~l--------~e~~~~~---------------~~~qi~~aL~  264 (396)
                      +..+++++|++|..+.           .   .++.. ..+        ....-..               +...+...+.
T Consensus        96 g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~  175 (322)
T 2ppq_A           96 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID  175 (322)
T ss_dssp             TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred             CEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHH
Confidence            6779999999986431           0   11111 000        1000000               0112344555


Q ss_pred             HHHH-------CCceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          265 HLHA-------NGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       265 ~LH~-------~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                      +++.       .+++|+|+++.|||++.++.+.|+||+.+..
T Consensus       176 ~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          176 YLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            6653       3699999999999998776668999998864

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.47  E-value=0.00097  Score=59.45  Aligned_cols=121  Identities=16%  Similarity=0.070  Sum_probs=82.7

Q ss_pred             cHHHHHH-HhcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccccccCC
Q 016037          236 HLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL  313 (396)
Q Consensus       236 ~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~~gt~  313 (396)
                      +|.+.|. ...+++|+++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|.|-+.+ +.+.           ....
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~  101 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEP  101 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cccc
Confidence            6778776 45789999999999999998877632 2222444567999999999998875 2110           1123


Q ss_pred             CccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhcc
Q 016037          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSL  386 (396)
Q Consensus       314 ~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~  386 (396)
                      .+.+||... ...+.+.=|||||+++|..+--..|=                 .-++.+|+++.+||..|.+-
T Consensus       102 ~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e-----------------~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A          102 PPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE-----------------NEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             -----CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------TEEECCCHHHHHHHHHHTTC
T ss_pred             CCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc-----------------ccchhhCHHHHHHHHHHHhc
Confidence            456787664 34567889999999999988633321                 23467999999999999866

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.32  E-value=0.00025  Score=69.10  Aligned_cols=136  Identities=15%  Similarity=0.133  Sum_probs=79.6

Q ss_pred             eEecccCceEEEEEEEcC-------CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEEEecCeEEE
Q 016037          156 KVVGQGAFAKVYQVRRIG-------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~l  227 (396)
                      +.|..|-...+|++....       +++.|.+|+.....    .....+.+|..+++.+. +.-..++++.+..+    +
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~  127 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPEG----R  127 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----E
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----c
Confidence            457778888899988742       35679999864321    12334557888888774 32235566665442    8


Q ss_pred             EEEecCCCcHH----------HHH-------HHhc-----CC--CHHHHHHHHHHHHH-------------------HHH
Q 016037          228 VLDFVNGGHLF----------FQL-------YRQG-----LF--REDLARIYTAEIVS-------------------AVS  264 (396)
Q Consensus       228 V~E~~~gg~L~----------~~l-------~~~~-----~l--~e~~~~~~~~qi~~-------------------aL~  264 (396)
                      ||||++|..|.          ..+       +...     ..  -...+..|..++..                   .+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            99999986542          011       1110     11  12344445544321                   233


Q ss_pred             HHHH----C----CceeccCCCCCEEEcCC----CcEEEEecccccc
Q 016037          265 HLHA----N----GIMHRDLKPENILLDAD----GHVMLTDFGLAKQ  299 (396)
Q Consensus       265 ~LH~----~----~iiHrDlkp~NILl~~~----~~ikL~Dfgla~~  299 (396)
                      +|..    .    .++|+|+.+.||+++.+    +.+.|+||..+..
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            3332    2    58999999999999877    7899999998864

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.32  E-value=0.0011  Score=61.59  Aligned_cols=78  Identities=13%  Similarity=0.102  Sum_probs=53.2

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC--C-CeeeeeEEEEecCeEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH--P-FIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~H--p-nIv~l~~~~~~~~~~~l  227 (396)
                      ...-++.+|.|..+.||+++. .+|+.|.+|+-......   ....+..|...|+.|..  + -+.+++..  .  .-++
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~l   87 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPA---LDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTL   87 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCC---CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEE
T ss_pred             CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcc---hhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceE
Confidence            467788899999999999987 46788999986543211   12346778888887742  2 23344433  2  2378


Q ss_pred             EEEecCCCc
Q 016037          228 VLDFVNGGH  236 (396)
Q Consensus       228 V~E~~~gg~  236 (396)
                      ||||+.++.
T Consensus        88 v~e~l~~~~   96 (288)
T 3f7w_A           88 AMEWVDERP   96 (288)
T ss_dssp             EEECCCCCC
T ss_pred             EEEeecccC
Confidence            999998764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.30  E-value=0.0005  Score=68.12  Aligned_cols=74  Identities=11%  Similarity=0.117  Sum_probs=48.4

Q ss_pred             EEeEecccCceEEEEEEEcC-------CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCe-eeeeEEEEecCeE
Q 016037          154 VLKVVGQGAFAKVYQVRRIG-------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI-VQLRYSFQTKYRL  225 (396)
Q Consensus       154 ~~~~IG~G~fG~Vy~~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnI-v~l~~~~~~~~~~  225 (396)
                      -++.|+.|....||++....       ++..+.+|+.....  .   .+.+..|..+++.+...++ .++++.+..    
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence            35678899999999998753       25679999874321  1   1223468888887743333 556665543    


Q ss_pred             EEEEEecCCCc
Q 016037          226 YLVLDFVNGGH  236 (396)
Q Consensus       226 ~lV~E~~~gg~  236 (396)
                      .+|+||++|..
T Consensus       148 g~v~e~l~G~~  158 (429)
T 1nw1_A          148 GRLEEYIPSRP  158 (429)
T ss_dssp             EEEECCCCEEE
T ss_pred             CEEEEEeCCcc
Confidence            28999998643

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.25  E-value=0.00089  Score=63.17  Aligned_cols=137  Identities=15%  Similarity=0.128  Sum_probs=76.1

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC--eeeeeEE-----EEecCeEEEE
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF--IVQLRYS-----FQTKYRLYLV  228 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~Hpn--Iv~l~~~-----~~~~~~~~lV  228 (396)
                      ..++ |....||++... +|+.+++|+.+.....    .+.+..|..+++.+...+  +++++..     ....+..+++
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            3466 888899987653 4556999998743211    223455777766653211  3333332     2235567899


Q ss_pred             EEecCCCcHH-----------HH---HHHh---c------CCCHHH----HHHH---------------HHHHHHHHHHH
Q 016037          229 LDFVNGGHLF-----------FQ---LYRQ---G------LFREDL----ARIY---------------TAEIVSAVSHL  266 (396)
Q Consensus       229 ~E~~~gg~L~-----------~~---l~~~---~------~l~e~~----~~~~---------------~~qi~~aL~~L  266 (396)
                      |+|++|..+.           ..   ++..   .      ......    ...+               ...+-..+..+
T Consensus       106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l  185 (328)
T 1zyl_A          106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV  185 (328)
T ss_dssp             EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred             EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence            9999985431           01   1110   0      011110    0001               11111223333


Q ss_pred             H-------HCCceeccCCCCCEEEcCCCcEEEEeccccccc
Q 016037          267 H-------ANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       267 H-------~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~  300 (396)
                      .       ...++|+|+++.|||++ + .+.|+||+.+...
T Consensus       186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence            2       23589999999999998 4 8999999988653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.23  E-value=0.00068  Score=64.32  Aligned_cols=33  Identities=30%  Similarity=0.346  Sum_probs=28.3

Q ss_pred             CCceeccCCCCCEEEcCC----CcEEEEecccccccC
Q 016037          269 NGIMHRDLKPENILLDAD----GHVMLTDFGLAKQFD  301 (396)
Q Consensus       269 ~~iiHrDlkp~NILl~~~----~~ikL~Dfgla~~~~  301 (396)
                      ..++|+|+.+.||+++.+    +.+.|+||+.+....
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            369999999999999875    689999999987643

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.03  E-value=0.00075  Score=65.09  Aligned_cols=74  Identities=14%  Similarity=0.090  Sum_probs=42.9

Q ss_pred             EeEecccCceEEEEEEEcC--------CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC-eeeeeEEEEecCeE
Q 016037          155 LKVVGQGAFAKVYQVRRIG--------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF-IVQLRYSFQTKYRL  225 (396)
Q Consensus       155 ~~~IG~G~fG~Vy~~~~~~--------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~Hpn-Iv~l~~~~~~~~~~  225 (396)
                      ++.|+.|....+|++....        .+..+++|+......   . ......|..+++.+...+ +.++++.+  .+  
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---E-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---G-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---c-eecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence            4568889899999988754        135788898765321   1 111356777777764323 34555544  22  


Q ss_pred             EEEEEecCCCc
Q 016037          226 YLVLDFVNGGH  236 (396)
Q Consensus       226 ~lV~E~~~gg~  236 (396)
                      ++||||++|..
T Consensus       110 ~~v~e~i~G~~  120 (369)
T 3c5i_A          110 GRIEEWLYGDP  120 (369)
T ss_dssp             EEEEECCCSEE
T ss_pred             cEEEEEecCCc
Confidence            68999999854

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.80  E-value=0.011  Score=56.25  Aligned_cols=31  Identities=16%  Similarity=0.344  Sum_probs=27.9

Q ss_pred             CceeccCCCCCEEEcCCCcEEEEeccccccc
Q 016037          270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       270 ~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~  300 (396)
                      .++|+|+.+.||+++.++.+.|+||+.+...
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            5999999999999988889999999988754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.80  E-value=0.012  Score=58.71  Aligned_cols=76  Identities=13%  Similarity=0.210  Sum_probs=48.5

Q ss_pred             EEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCe-eeeeEEEEecCeEEEEEEec
Q 016037          154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI-VQLRYSFQTKYRLYLVLDFV  232 (396)
Q Consensus       154 ~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnI-v~l~~~~~~~~~~~lV~E~~  232 (396)
                      -++.|+.|-...+|++.....+..+++|+......   .... ..+|..+++.|...++ .++++.+.  +  .+||||+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~---~~id-R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I  183 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD---EIIN-REREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM  183 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CC---SCSC-HHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChh---hhcC-HHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence            35678899999999998865457789998754321   1111 2568888888864444 45666663  2  2599999


Q ss_pred             CCCcH
Q 016037          233 NGGHL  237 (396)
Q Consensus       233 ~gg~L  237 (396)
                      +|..|
T Consensus       184 ~G~~l  188 (458)
T 2qg7_A          184 DGYAL  188 (458)
T ss_dssp             CSEEC
T ss_pred             CCccC
Confidence            87543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.91  E-value=0.0094  Score=58.79  Aligned_cols=76  Identities=13%  Similarity=0.155  Sum_probs=47.4

Q ss_pred             EEeEecccCceEEEEEEEcCC-------CcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEEEecCeE
Q 016037          154 VLKVVGQGAFAKVYQVRRIGT-------SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRL  225 (396)
Q Consensus       154 ~~~~IG~G~fG~Vy~~~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~  225 (396)
                      -++.|..|-...+|++.....       +..|.+|+.....   .. .-...+|..+++.+. +.-..++++.+.  +  
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--  145 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GK-FYDSKVELDVFRYLSNINIAPNIIADFP--E--  145 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----C-CCCHHHHHHHHHHHHHTTSSCCEEEEET--T--
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---ch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--
Confidence            345677888999999987531       5679999865432   11 111346777777764 222344554332  2  


Q ss_pred             EEEEEecCCCcH
Q 016037          226 YLVLDFVNGGHL  237 (396)
Q Consensus       226 ~lV~E~~~gg~L  237 (396)
                      ++||||++|..|
T Consensus       146 ~~I~efI~G~~l  157 (424)
T 3mes_A          146 GRIEEFIDGEPL  157 (424)
T ss_dssp             EEEEECCCSEEC
T ss_pred             CEEEEEeCCccC
Confidence            689999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.67  E-value=0.077  Score=51.61  Aligned_cols=29  Identities=34%  Similarity=0.531  Sum_probs=25.2

Q ss_pred             ceeccCCCCCEEE------cCCCcEEEEecccccc
Q 016037          271 IMHRDLKPENILL------DADGHVMLTDFGLAKQ  299 (396)
Q Consensus       271 iiHrDlkp~NILl------~~~~~ikL~Dfgla~~  299 (396)
                      ++|+|+.+.|||+      ++++.++++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      4567899999999864

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=85.36  E-value=0.072  Score=53.02  Aligned_cols=61  Identities=7%  Similarity=0.035  Sum_probs=15.7

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEE------EEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEE
Q 016037          156 KVVGQGAFAKVYQVRRIGTSEIYAM------KVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (396)
Q Consensus       156 ~~IG~G~fG~Vy~~~~~~~~~~vAv------K~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~  220 (396)
                      +.||   ||.||+|.+..+...||+      |..+.... ..+....+.+|..+++.++|||+++.+.+..
T Consensus       148 ~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          148 EHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             TTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred             ccCC---chhhhcccccccCCchhhhhccCccccccccc-cccccccccccccccccccccccCCCcceEE
Confidence            4455   999999999876667888      66554332 2334445677889999999999999876653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	396
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-86
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-86
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-78
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-76
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-76
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-76
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-76
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-75
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-75
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	9e-75
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-74
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-74
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-74
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-73
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-73
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-72
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-72
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-69
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-69
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-68
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-67
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-67
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-66
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-64
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-63
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-63
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-63
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-62
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-61
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-61
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-60
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-60
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	7e-60
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-59
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-59
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-59
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-59
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-59
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-59
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-59
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-59
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-58
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-58
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-58
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-58
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-57
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-55
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-55
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-55
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-55
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-55
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-55
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-54
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-53
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	8e-52
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-51
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-50
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-50
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-49
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-48
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-47
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-40
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-20

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  261 bits (668), Expect = 3e-86
 Identities = 97/235 (41%), Positives = 150/235 (63%), Gaps = 3/235 (1%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+NS  GT +Y+SPE++  K  
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
            K++D W++G ++++++ G PPF  GN   I QKIIK +   P     +A  L++
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE 242

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  259 bits (664), Expect = 5e-86
 Identities = 77/233 (33%), Positives = 136/233 (58%), Gaps = 1/233 (0%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + + 
Sbjct: 5   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H+
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ PE++ G+ HD+
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDE 183

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
             D WS+G+L +E L G+PPF     Q+  ++I + +   P F++  A  L+ 
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 236

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  242 bits (619), Expect = 2e-78
 Identities = 61/247 (24%), Positives = 122/247 (49%), Gaps = 4/247 (1%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE +  +G G    V++V    +  + A K++  +  ++      +  E  +L + + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 63

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH-A 268
           P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  +++L   
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           + IMHRD+KP NIL+++ G + L DFG++ Q   ++ +NS  GT  YMSPE + G  +  
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSV 182

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLS 388
            +D WS+G+ L EM  G+ P    + ++++           A       +  + ++S   
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242

Query: 389 ISVPLLS 395
            S P ++
Sbjct: 243 DSRPPMA 249

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  238 bits (609), Expect = 1e-76
 Identities = 99/237 (41%), Positives = 157/237 (66%), Gaps = 1/237 (0%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKG 325
           H+  +++RD+K EN++LD DGH+ +TDFGL K+   +     + CGT EY++PE++    
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG 382
           + +A DWW +G++++EM+ G+ PF   + +++ + I+ ++I+ P  LS EA SLL G
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  238 bits (608), Expect = 2e-76
 Identities = 64/240 (26%), Positives = 115/240 (47%), Gaps = 10/240 (4%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ +++ + +G GAF  V++V    T   +A K +      +K   E ++ E   ++ + 
Sbjct: 25  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLR 81

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLH 267
           HP +V L  +F+    + ++ +F++GG LF ++  +     ED A  Y  ++   + H+H
Sbjct: 82  HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141

Query: 268 ANGIMHRDLKPENILLDAD--GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
            N  +H DLKPENI+        + L DFGL    D         GT E+ +PE+  GK 
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 201

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLK 381
                D WSVG+L + +L+G  PF G N  +  + +      +     + +S +    ++
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 261

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  236 bits (603), Expect = 5e-76
 Identities = 91/234 (38%), Positives = 151/234 (64%), Gaps = 2/234 (0%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+DF++L+ +G G+F +V+ +R       YAMKV++K+ ++     E+   ER +L+ V 
Sbjct: 3   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HPFI+++  +FQ   ++++++D++ GG LF  L +   F   +A+ Y AE+  A+ +LH+
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             I++RDLKPENILLD +GH+ +TDFG AK   + T   ++CGT +Y++PE+V  K ++K
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--TLCGTPDYIAPEVVSTKPYNK 180

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG 382
           + DWWS GIL++EML G  PF   N  K  +KI+  +++ P F + +   LL  
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 234

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  236 bits (603), Expect = 5e-76
 Identities = 89/236 (37%), Positives = 148/236 (62%), Gaps = 2/236 (0%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV- 207
           +EDF + K++G+G+F KV+      T++ +A+K ++KD ++  +  E    E+ +L+   
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           +HPF+  +  +FQTK  L+ V++++NGG L + +     F    A  Y AEI+  +  LH
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGH 326
           + GI++RDLK +NILLD DGH+ + DFG+ K+    + ++N+ CGT +Y++PEI+LG+ +
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG 382
           + + DWWS G+LL+EML GQ PF G + +++   I  D    P +L  EA  LL  
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK 236

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (595), Expect = 3e-75
 Identities = 77/242 (31%), Positives = 125/242 (51%), Gaps = 13/242 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + +E++  +G GAF KVY+ +   TS + A KV+       +   E    E +IL   DH
Sbjct: 12  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDH 68

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA 268
           P IV+L  +F  +  L+++++F  GG +   +   +    E   ++   + + A+++LH 
Sbjct: 69  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNSMCGTLEYMSPEIVLG---- 323
           N I+HRDLK  NIL   DG + L DFG++ +      R +S  GT  +M+PE+V+     
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188

Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLPAFLSSEAHSL 379
            + +D  AD WS+GI L EM   +PP    N  ++  KI K +   +  P+  SS     
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248

Query: 380 LK 381
           LK
Sbjct: 249 LK 250

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  233 bits (595), Expect = 6e-75
 Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 8/237 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + F  L+ +G G+F  VY  R +  SE+ A+K M           + +  E   L K+ H
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P  +Q R  +  ++  +LV+++  G         +   +E      T   +  +++LH++
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG---KGH 326
            ++HRD+K  NILL   G V L DFG A        +NS  GT  +M+PE++L      +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQY 191

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKL--PAFLSSEAHSLLK 381
           D   D WS+GI   E+   +PP    N       I +++         S    + + 
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (590), Expect = 9e-75
 Identities = 73/241 (30%), Positives = 128/241 (53%), Gaps = 9/241 (3%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + ++    E +K E  I   ++
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLN 61

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181

Query: 326 -HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLPAFLSSEAHSLLK 381
            H +  D WS GI+L  ML G+ P+   +    +    K+K   +     + S   +LL 
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241

Query: 382 G 382
            
Sbjct: 242 K 242

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  233 bits (594), Expect = 3e-74
 Identities = 63/240 (26%), Positives = 123/240 (51%), Gaps = 10/240 (4%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
            + +++L+ +G GAF  V++     T  ++  K +     ++K     +K+E +I+ ++ 
Sbjct: 28  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLH 84

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEIVSAVSHLH 267
           HP ++ L  +F+ KY + L+L+F++GG LF ++  +     E     Y  +    + H+H
Sbjct: 85  HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144

Query: 268 ANGIMHRDLKPENILLDA--DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
            + I+H D+KPENI+ +      V + DFGLA + + +        T E+ +PEIV  + 
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP 204

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLK 381
                D W++G+L + +L+G  PF G +  +  Q + +   +      + +S EA   +K
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 264

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (586), Expect = 3e-74
 Identities = 70/245 (28%), Positives = 128/245 (52%), Gaps = 14/245 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED+EVL  +G G++ +  ++RR    +I   K +    + E    + + SE N+L ++ H
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKH 62

Query: 210 PFIVQLRYSF--QTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAV 263
           P IV+       +T   LY+V+++  GG L   + +    +    E+       ++  A+
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 264 SHLH-----ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNSMCGTLEYMS 317
              H      + ++HRDLKP N+ LD   +V L DFGLA+  + + + + +  GT  YMS
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182

Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEA 376
           PE +    +++ +D WS+G LL+E+    PPFT  +++++  KI + K  ++P   S E 
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 242

Query: 377 HSLLK 381
           + ++ 
Sbjct: 243 NEIIT 247

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (588), Expect = 4e-74
 Identities = 69/236 (29%), Positives = 119/236 (50%), Gaps = 8/236 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + +   + +GQGA   VY    + T +  A++ M   +  +K   E + +E  ++ +  +
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKN 76

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV    S+     L++V++++ GG L   +       E        E + A+  LH+N
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSN 135

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDK 328
            ++HRD+K +NILL  DG V LTDFG   Q   E ++ ++M GT  +M+PE+V  K +  
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLK 381
             D WS+GI+  EM+ G+PP+   N  +    I  +   +++ P  LS+     L 
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  228 bits (583), Expect = 2e-73
 Identities = 74/249 (29%), Positives = 121/249 (48%), Gaps = 17/249 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK------SERNI 203
           E++E  +++G+G  + V +     T + YA+K++        +  E  +       E +I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 204 LTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           L KV  HP I+QL+ +++T    +LV D +  G LF  L  +    E   R     ++  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           +  LH   I+HRDLKPENILLD D ++ LTDFG + Q D   +   +CGT  Y++PEI+ 
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 182

Query: 323 G------KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFL 372
                   G+ K  D WS G++++ +L G PPF    +  + + I+    +         
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 242

Query: 373 SSEAHSLLK 381
           S     L+ 
Sbjct: 243 SDTVKDLVS 251

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  230 bits (588), Expect = 2e-73
 Identities = 97/241 (40%), Positives = 157/241 (65%), Gaps = 3/241 (1%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQNT-AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91

Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+ ++CGT E ++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEI 209

Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF      +I +KI+  K++ P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269

Query: 381 K 381
           +
Sbjct: 270 R 270

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  228 bits (582), Expect = 2e-72
 Identities = 93/241 (38%), Positives = 143/241 (59%), Gaps = 8/241 (3%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV- 207
           + DF V +++G+G F +VY  R+  T ++YAMK + K +I  K       +ER +L+ V 
Sbjct: 3   MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62

Query: 208 --DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             D PFIV + Y+F T  +L  +LD +NGG L + L + G+F E   R Y AEI+  + H
Sbjct: 63  TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL-GK 324
           +H   +++RDLKP NILLD  GHV ++D GLA  F    + ++  GT  YM+PE++  G 
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKGV 181

Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGN---RQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
            +D +ADW+S+G +LF++L G  PF       + +I +  +   ++LP   S E  SLL+
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241

Query: 382 G 382
           G
Sbjct: 242 G 242

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  226 bits (577), Expect = 3e-72
 Identities = 79/240 (32%), Positives = 137/240 (57%), Gaps = 9/240 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + ++   V+G GAF++V       T ++ A+K + K  +  K     M++E  +L K+ H
Sbjct: 9   DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--GSMENEIAVLHKIKH 66

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV L   +++   LYL++  V+GG LF ++  +G + E  A     +++ AV +LH  
Sbjct: 67  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126

Query: 270 GIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPEN+L    D D  +M++DFGL+K  D  +  ++ CGT  Y++PE++  K +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 186

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLKG 382
            KA D WS+G++ + +L G PPF   N  K+ ++I+K + +  +     +S  A   ++ 
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (558), Expect = 3e-69
 Identities = 56/239 (23%), Positives = 107/239 (44%), Gaps = 11/239 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E + + + +G+G F  V++     + + Y  K ++     +      +K E +IL    H
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARH 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEIVSAVSHLHA 268
             I+ L  SF++   L ++ +F++G  +F ++        E     Y  ++  A+  LH+
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 269 NGIMHRDLKPENILLDAD--GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           + I H D++PENI+        + + +FG A+Q         +    EY +PE+      
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLK 381
             A D WS+G L++ +L+G  PF     Q+I + I+  +          +S EA   + 
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (555), Expect = 4e-69
 Identities = 69/243 (28%), Positives = 122/243 (50%), Gaps = 11/243 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTK 206
           + ++  + +G G FA V + R   T   YA K ++K +          E ++ E +IL +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           + HP ++ L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +L
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129

Query: 267 HANGIMHRDLKPENILLDADG----HVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           H+  I H DLKPENI+L         + + DFGLA + D      ++ GT E+++PEIV 
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 189

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHS 378
            +     AD WS+G++ + +L+G  PF G  +Q+    +     +      +  S+ A  
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD 249

Query: 379 LLK 381
            ++
Sbjct: 250 FIR 252

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  214 bits (547), Expect = 3e-68
 Identities = 66/244 (27%), Positives = 131/244 (53%), Gaps = 12/244 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + +E+ +++G G  ++V+  R +      A+KV+R D   + +     + E      ++H
Sbjct: 7   DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66

Query: 210 PFIVQLRYSFQTK----YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           P IV +  + + +       Y+V+++V+G  L   ++ +G      A    A+   A++ 
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF----DENTRSNSMCGTLEYMSPEIV 321
            H NGI+HRD+KP NI++ A   V + DFG+A+      +  T++ ++ GT +Y+SPE  
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAF----LSSEAH 377
            G   D  +D +S+G +L+E+LTG+PPFTG +   +  + +++    P+     LS++  
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 246

Query: 378 SLLK 381
           +++ 
Sbjct: 247 AVVL 250

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 1e-67
 Identities = 59/241 (24%), Positives = 113/241 (46%), Gaps = 13/241 (5%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
            +    +G+G+F  VY+     T+   A   ++  K + K+  +  K E  +L  + HP 
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK-LTKSERQRFKEEAEMLKGLQHPN 69

Query: 212 IVQLRYSFQT----KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           IV+   S+++    K  + LV + +  G L   L R  + +  + R +  +I+  +  LH
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 268 ANG--IMHRDLKPENILLDA-DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGK 324
                I+HRDLK +NI +    G V + D GLA      + + ++ GT E+M+PE+   K
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEEK 188

Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK---LPAFLSSEAHSLLK 381
            +D++ D ++ G+ + EM T + P++         + +   +K          E   +++
Sbjct: 189 -YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 247

Query: 382 G 382
           G
Sbjct: 248 G 248

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (542), Expect = 6e-67
 Identities = 119/256 (46%), Positives = 177/256 (69%), Gaps = 13/256 (5%)

Query: 139 NLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHA- 194
           NL    + VG+E+FE+LKV+G GA+ KV+ VR+I    T ++YAMKV++K  I++K    
Sbjct: 13  NLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT 72

Query: 195 EYMKSERNILTKVDH-PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
           E+ ++ER +L  +   PF+V L Y+FQT+ +L+L+LD++NGG LF  L ++  F E   +
Sbjct: 73  EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQ 132

Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD--ENTRSNSMCG 311
           IY  EIV A+ HLH  GI++RD+K ENILLD++GHV+LTDFGL+K+F   E  R+   CG
Sbjct: 133 IYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 192

Query: 312 TLEYMSPEIVLGK--GHDKAADWWSVGILLFEMLTGQPPFTGGNRQ----KIQQKIIKDK 365
           T+EYM+P+IV G   GHDKA DWWS+G+L++E+LTG  PFT    +    +I ++I+K +
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 252

Query: 366 IKLPAFLSSEAHSLLK 381
              P  +S+ A  L++
Sbjct: 253 PPYPQEMSALAKDLIQ 268

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 2e-66
 Identities = 56/245 (22%), Positives = 104/245 (42%), Gaps = 18/245 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
               V + +G G+F  VY+ +  G     A+K++       +    +   E  +L K  H
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRH 63

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHA 268
             I+     + T  +L +V  +  G  L+  L+  +  F          +    + +LHA
Sbjct: 64  VNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE---NTRSNSMCGTLEYMSPEIVLGKG 325
             I+HRDLK  NI L  D  V + DFGLA        + +   + G++ +M+PE++  + 
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182

Query: 326 ---HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAF------LSSEA 376
              +   +D ++ GI+L+E++TGQ P++  N +     ++      P             
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242

Query: 377 HSLLK 381
             L+ 
Sbjct: 243 KRLMA 247

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (521), Expect = 4e-64
 Identities = 70/245 (28%), Positives = 110/245 (44%), Gaps = 4/245 (1%)

Query: 153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA--EYMKSERNILTKVDHP 210
           E L  +G+G FA VY+ R   T++I A+K ++     E           E  +L ++ HP
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I+ L  +F  K  + LV DF+             +      + Y    +  + +LH + 
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KGHDK 328
           I+HRDLKP N+LLD +G + L DFGLAK F    R+ +    T  Y +PE++ G + +  
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLS 388
             D W+VG +L E+L   P   G +      +I +           +  SL   V     
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240

Query: 389 ISVPL 393
             +PL
Sbjct: 241 PGIPL 245

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 2e-63
 Identities = 56/240 (23%), Positives = 116/240 (48%), Gaps = 14/240 (5%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           + +++ ++L+ +G+G F  V      G     A+K ++ D   +        +E +++T+
Sbjct: 4   LNMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQA-----FLAEASVMTQ 56

Query: 207 VDHPFIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAV 263
           + H  +VQL     + K  LY+V +++  G L   L  +G  +   D    ++ ++  A+
Sbjct: 57  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            +L  N  +HRDL   N+L+  D    ++DFGL K+       ++    +++ +PE +  
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE 174

Query: 324 KGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLK 381
           K     +D WS GILL+E+ + G+ P+     + +  ++ K  K+  P       + ++K
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 3e-63
 Identities = 69/239 (28%), Positives = 117/239 (48%), Gaps = 15/239 (6%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN---HAEYMKSERNILTKV 207
            ++V  ++G G F  VY   R+  +   A+K + KD+I +     +   +  E  +L KV
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 208 D--HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVS 264
                 +++L   F+      L+L+        F    + G  +E+LAR +  +++ AV 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124

Query: 265 HLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           H H  G++HRD+K ENIL+D + G + L DFG       +T      GT  Y  PE +  
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRY 183

Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
            + H ++A  WS+GILL++M+ G  PF          +II+ ++     +SSE   L++
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHLIR 236

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 4e-63
 Identities = 60/246 (24%), Positives = 109/246 (44%), Gaps = 12/246 (4%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           +G +D  +L+ +G G+F  V +       G +   A+K ++ D + +    +    E N 
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64

Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSA 262
           +  +DH  +++L Y       + +V +    G L  +L   QG F       Y  ++   
Sbjct: 65  MHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGTLEYMSP 318
           + +L +   +HRDL   N+LL     V + DFGL +   +N               + +P
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKL--PAFLSSE 375
           E +  +    A+D W  G+ L+EM T GQ P+ G N  +I  KI K+  +L  P     +
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243

Query: 376 AHSLLK 381
            ++++ 
Sbjct: 244 IYNVMV 249

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (508), Expect = 6e-62
 Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 15/238 (6%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT 205
           C  +  +E L  +GQG F +V++ R   T +  A+K +  +   E      ++ E  IL 
Sbjct: 6   CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQ 64

Query: 206 KVDHPFIVQLRYSFQT--------KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA 257
            + H  +V L    +T        K  +YLV DF               F     +    
Sbjct: 65  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ 124

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-----NSMCGT 312
            +++ + ++H N I+HRD+K  N+L+  DG + L DFGLA+ F     S      +   T
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184

Query: 313 LEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP 369
           L Y  PE++LG + +    D W  G ++ EM T  P   G   Q     I +    + 
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 4e-61
 Identities = 68/253 (26%), Positives = 129/253 (50%), Gaps = 27/253 (10%)

Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +        E  +  + 
Sbjct: 10  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRA 61

Query: 208 -DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIV 260
              P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I 
Sbjct: 62  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 121

Query: 261 SAVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMS 317
            A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    + C T  Y++
Sbjct: 122 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 181

Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN----RQKIQQKIIKDKIKLP---- 369
           PE++  + +DK+ D WS+G++++ +L G PPF   +       ++ +I   + + P    
Sbjct: 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241

Query: 370 AFLSSEAHSLLKG 382
           + +S E   L++ 
Sbjct: 242 SEVSEEVKMLIRN 254

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 5e-61
 Identities = 51/247 (20%), Positives = 110/247 (44%), Gaps = 14/247 (5%)

Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVYQV--RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           + + + LED    K +G G F  V +   +     +  A+K+++ +   +    + + +E
Sbjct: 4   DRKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAE 58

Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
            N++ ++D+P+IV++           LV++    G L   L +    ++        ++ 
Sbjct: 59  ANVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 117

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGTLEYM 316
             + +L  +  +HRDL   N+LL    +  ++DFGL+K    +             +++ 
Sbjct: 118 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177

Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDK-IKLPAFLSS 374
           +PE +        +D WS G+L++E  + GQ P+ G    ++   + K + +  PA    
Sbjct: 178 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR 237

Query: 375 EAHSLLK 381
           E + L+ 
Sbjct: 238 EMYDLMN 244

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 2e-60
 Identities = 50/237 (21%), Positives = 110/237 (46%), Gaps = 10/237 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D   LK +G G F  V   +  G  +  A+K++++  + E         E  ++  + H
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDE----FIEEAKVMMNLSH 58

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHA 268
             +VQL      +  ++++ +++  G L   L   +  F+         ++  A+ +L +
Sbjct: 59  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGKGH 326
              +HRDL   N L++  G V ++DFGL++    DE T S      + +  PE+++    
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178

Query: 327 DKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLK 381
              +D W+ G+L++E+ + G+ P+      +  + I +  ++  P   S + ++++ 
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 235

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 2e-60
 Identities = 52/260 (20%), Positives = 109/260 (41%), Gaps = 19/260 (7%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P+    +   D +   V+G+G F +V + R           + R  +   K+       E
Sbjct: 1   PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGE 60

Query: 201 RNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ--------------- 244
             +L K+  HP I+ L  + + +  LYL +++   G+L   L +                
Sbjct: 61  LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 120

Query: 245 -GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN 303
                      + A++   + +L     +HRDL   NIL+  +    + DFGL++  +  
Sbjct: 121 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180

Query: 304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKII 362
            +       + +M+ E +    +   +D WS G+LL+E+++ G  P+ G    ++ +K+ 
Sbjct: 181 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240

Query: 363 KD-KIKLPAFLSSEAHSLLK 381
           +  +++ P     E + L++
Sbjct: 241 QGYRLEKPLNCDDEVYDLMR 260

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 7e-60
 Identities = 59/242 (24%), Positives = 108/242 (44%), Gaps = 13/242 (5%)

Query: 150 EDFEVLKVV-GQGAFAKVYQV--RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           ++  +  +  G G F  V Q   R        A+KV+++    EK   E M  E  I+ +
Sbjct: 8   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQ 65

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSH 265
           +D+P+IV+L    Q    L LV++   GG L   L  +              ++   + +
Sbjct: 66  LDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 124

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGTLEYMSPEIV 321
           L     +HRDL   N+LL    +  ++DFGL+K    +    T  ++    L++ +PE +
Sbjct: 125 LEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184

Query: 322 LGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDK-IKLPAFLSSEAHSL 379
             +     +D WS G+ ++E L+ GQ P+      ++   I + K ++ P     E ++L
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL 244

Query: 380 LK 381
           + 
Sbjct: 245 MS 246

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 1e-59
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 12/238 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E   +   +GQG F +V+     GT+   A+K ++   +  +        E  ++ K+ H
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA----FLQEAQVMKKLRH 71

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLH 267
             +VQL Y+  ++  +Y+V ++++ G L   L  +     R        A+I S ++++ 
Sbjct: 72  EKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKG 325
               +HRDL+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L   
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190

Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLK 381
               +D WS GILL E+ T G+ P+ G   +++  ++ +  ++  P       H L+ 
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 248

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 2e-59
 Identities = 53/239 (22%), Positives = 104/239 (43%), Gaps = 7/239 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK--DKIMEKNHAEYMKSERNILTKV 207
            +F+ +KV+G GAF  VY+   I   E   + V  K   +       + +  E  ++  V
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           D+P + +L     T     +      G  L +    +          +  +I   +++L 
Sbjct: 69  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGK 324
              ++HRDL   N+L+    HV +TDFGLAK          +      +++M+ E +L +
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188

Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDK-IKLPAFLSSEAHSLLK 381
            +   +D WS G+ ++E++T G  P+ G    +I   + K + +  P   + + + ++ 
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMV 247

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  193 bits (490), Expect = 2e-59
 Identities = 52/247 (21%), Positives = 109/247 (44%), Gaps = 14/247 (5%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSE---IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           + +   ++ +V+G G F +V         +     A+K ++      +       SE +I
Sbjct: 23  IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASI 80

Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSA 262
           + + DHP ++ L         + ++ +F+  G L  F     G F           I + 
Sbjct: 81  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEYM 316
           + +L     +HRDL   NIL++++    ++DFGL++  +++      T +      + + 
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 200

Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSS 374
           +PE +  +    A+D WS GI+++E+++ G+ P+     Q +   I +D ++  P    S
Sbjct: 201 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPS 260

Query: 375 EAHSLLK 381
             H L+ 
Sbjct: 261 ALHQLML 267

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 3e-59
 Identities = 67/218 (30%), Positives = 120/218 (55%), Gaps = 4/218 (1%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVN-GGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNSMCGTLEYMSPEIVLGKGH 326
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R       TL Y +PEI+LG  +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 327 -DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK 363
              A D WS+G +  EM+T +  F G +      +I +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 3e-59
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 9/227 (3%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTS-EIYAMKVMRKDKIMEKNHAEYMK--SERN 202
           C   + +E +  +G+GA+ KV++ R +       A+K +R     E      ++  +   
Sbjct: 3   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 62

Query: 203 ILTKVDHPFIVQLRYSFQT-----KYRLYLVLDFVNGGHL-FFQLYRQGLFREDLARIYT 256
            L   +HP +V+L           + +L LV + V+     +     +     +  +   
Sbjct: 63  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYM 316
            +++  +  LH++ ++HRDLKP+NIL+ + G + L DFGLA+ +       S+  TL Y 
Sbjct: 123 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYR 182

Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK 363
           +PE++L   +    D WSVG +  EM   +P F G +      KI+ 
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 229

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 4e-59
 Identities = 72/224 (32%), Positives = 115/224 (51%), Gaps = 18/224 (8%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
            +   KV+G G+F  VYQ +   + E+ A+K + +DK  +         E  I+ K+DH 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 73

Query: 211 FIVQLRYSFQT------KYRLYLVLDFVNGGHLFFQLY---RQGLFREDLARIYTAEIVS 261
            IV+LRY F +      +  L LVLD+V         +    +        ++Y  ++  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
           +++++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE+
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193

Query: 321 VLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK 363
           + G   +  + D WS G +L E+L GQP F G +      +IIK
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  191 bits (486), Expect = 4e-59
 Identities = 60/217 (27%), Positives = 114/217 (52%), Gaps = 4/217 (1%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E +  L+ +G+G +  VY+ +     E +A+K +R +K  E   +  ++ E +IL ++ 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR-EISILKELK 58

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV+L     TK RL LV + ++          +G      A+ +  ++++ +++ H 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNSMCGTLEYMSPEIVLGKG-H 326
             ++HRDLKP+N+L++ +G + + DFGLA+ F     +      TL Y +P++++G   +
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK 363
               D WSVG +  EM+ G P F G +      +I +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 7e-59
 Identities = 50/237 (21%), Positives = 113/237 (47%), Gaps = 10/237 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
            +   ++ +G G F  V+    +   +  A+K +R+  + E++       E  ++ K+ H
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEED----FIEEAEVMMKLSH 59

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           P +VQL      +  + LV +F+  G L  +   ++GLF  +       ++   +++L  
Sbjct: 60  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGKGH 326
             ++HRDL   N L+  +  + ++DFG+ +    D+ T S      +++ SPE+     +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179

Query: 327 DKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLK 381
              +D WS G+L++E+ + G+ P+   +  ++ + I    ++  P   S+  + ++ 
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 236

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (482), Expect = 2e-58
 Identities = 55/218 (25%), Positives = 109/218 (50%), Gaps = 4/218 (1%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ +E L+ +G+G +  V++ +   T EI A+K +R D   ++        E  +L ++ 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELK 59

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV+L     +  +L LV +F +     +     G    ++ + +  +++  +   H+
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLGKG-H 326
             ++HRDLKP+N+L++ +G + L +FGLA+ F    R  S    TL Y  P+++ G   +
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179

Query: 327 DKAADWWSVGILLFEMLTG-QPPFTGGNRQKIQQKIIK 363
             + D WS G +  E+    +P F G +     ++I +
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 3e-58
 Identities = 52/238 (21%), Positives = 115/238 (48%), Gaps = 12/238 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++++ +G G F +V+     G ++  A+K +++  +          +E N++ ++ H
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDA----FLAEANLMKQLQH 67

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
             +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++ + 
Sbjct: 68  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--RSNSMCGTLEYMSPEIVLGKG 325
               +HRDL+  NIL+       + DFGLA+  ++N           +++ +PE +    
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLK 381
               +D WS GILL E++T G+ P+ G    ++ Q + +  ++  P     E + L++
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR 244

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 4e-58
 Identities = 59/267 (22%), Positives = 114/267 (42%), Gaps = 37/267 (13%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEI-----YAMKVMRKDKIMEKNHAEYMKSERNIL 204
           E+ E  KV+G GAF KV      G S+       A+K++++    + +  E + SE  ++
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSEREALMSELKMM 94

Query: 205 TKV-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ------------------- 244
           T++  H  IV L  +      +YL+ ++   G L   L  +                   
Sbjct: 95  TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154

Query: 245 ----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
                +   +    +  ++   +  L     +HRDL   N+L+     V + DFGLA+  
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214

Query: 301 DEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQK 356
             +       +    +++M+PE +    +   +D WS GILL+E+ + G  P+ G     
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274

Query: 357 IQQKIIKDKIKL--PAFLSSEAHSLLK 381
              K+I++  K+  P + + E + +++
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQ 301

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  189 bits (480), Expect = 4e-58
 Identities = 53/241 (21%), Positives = 109/241 (45%), Gaps = 10/241 (4%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +   D  +   +G G + +VY+      S   A+K +++D +  +        E  ++ +
Sbjct: 14  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKE 69

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVS 264
           + HP +VQL      +   Y++ +F+  G+L   L           +      +I SA+ 
Sbjct: 70  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVL 322
           +L     +HRDL   N L+  +  V + DFGL++    D  T        +++ +PE + 
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 189

Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLL 380
                  +D W+ G+LL+E+ T G  P+ G +  ++ + + KD +++ P     + + L+
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 249

Query: 381 K 381
           +
Sbjct: 250 R 250

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 3e-57
 Identities = 52/238 (21%), Positives = 113/238 (47%), Gaps = 7/238 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE-IYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           E  E+ + +G+G F  V+Q   +       A+ +         +  E    E   + + D
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+  ++++++    G L  F   R+         +Y  ++ +A+++L 
Sbjct: 67  HPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKG 325
           +   +HRD+   N+L+ ++  V L DFGL++  +++   +++     +++M+PE +  + 
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185

Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK-DKIKLPAFLSSEAHSLLK 381
              A+D W  G+ ++E+L  G  PF G     +  +I   +++ +P       +SL+ 
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 243

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 2e-55
 Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 14/228 (6%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +  L  +G+GA+  V            A+K +   +   + + +    E  IL +  H  
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHEN 67

Query: 212 IVQLRYSFQTKY-----RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           I+ +    +         +YLV   +      ++L +      D    +  +I+  + ++
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLMGADL--YKLLKTQHLSNDHICYFLYQILRGLKYI 125

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGTLEYMSPEIVL 322
           H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +PEI+L
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185

Query: 323 -GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP 369
             KG+ K+ D WSVG +L EML+ +P F G +       I+       
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  182 bits (463), Expect = 2e-55
 Identities = 47/257 (18%), Positives = 99/257 (38%), Gaps = 27/257 (10%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-P 210
           ++V + +G+G+F  +++   +  ++  A+K   +     ++ A  ++ E      +    
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCT 61

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I  + Y  Q      LV+D +              F      +   ++++ V  +H   
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121

Query: 271 IMHRDLKPENILLDA-----DGHVMLTDFGLAKQFDE--------NTRSNSMCGTLEYMS 317
           +++RD+KP+N L+          + + DFG+ K + +             ++ GT  YMS
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK--------LP 369
               LG+   +  D  ++G +    L G  P+ G      +QK  +   K        L 
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241

Query: 370 AFLSSEAHSLLKGVNSL 386
           A    E +  +    +L
Sbjct: 242 AGFPEEFYKYMHYARNL 258

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  182 bits (462), Expect = 3e-55
 Identities = 50/250 (20%), Positives = 93/250 (37%), Gaps = 25/250 (10%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP- 210
           + + + +G G+F  +Y    I   E  A+K+        +     +  E  I   +    
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQGGV 63

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I  +R+         +V++ +         +    F      +   +++S + ++H+  
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123

Query: 271 IMHRDLKPENIL---LDADGHVMLTDFGLAKQFDENT--------RSNSMCGTLEYMSPE 319
            +HRD+KP+N L         V + DFGLAK++ +           + ++ GT  Y S  
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183

Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK--------LPAF 371
             LG    +  D  S+G +L     G  P+ G      +QK  +   K        L   
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243

Query: 372 LSSEAHSLLK 381
             SE  + L 
Sbjct: 244 YPSEFATYLN 253

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 4e-55
 Identities = 58/239 (24%), Positives = 106/239 (44%), Gaps = 10/239 (4%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 74

Query: 209 HPFIVQLRYSFQTK------YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +        +YLV++ ++          Q     +       +++  
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCG 131

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
           G G+ +  D WSVG ++ EM+  +  F G +      K+I+           +    ++
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  182 bits (463), Expect = 4e-55
 Identities = 58/225 (25%), Positives = 111/225 (49%), Gaps = 14/225 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-D 208
           +D+++++ +G+G +++V++   I  +E   +K+++  K       + +K E  IL  +  
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRG 88

Query: 209 HPFIVQLRYSFQ--TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
            P I+ L    +        LV + VN      QLY+     +   R Y  EI+ A+ + 
Sbjct: 89  GPNIITLADIVKDPVSRTPALVFEHVNNTDF-KQLYQT--LTDYDIRFYMYEILKALDYC 145

Query: 267 HANGIMHRDLKPENILLDADG-HVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG-K 324
           H+ GIMHRD+KP N+++D +   + L D+GLA+ +      N    +  +  PE+++  +
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205

Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP 369
            +D + D WS+G +L  M+  + PF  G+    Q   I   +   
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 6e-55
 Identities = 63/236 (26%), Positives = 105/236 (44%), Gaps = 12/236 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
             +  L+ VG GA+  V       T    A+K + +    E       + E  +L  + H
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRH 76

Query: 210 PFIVQLRYSFQTK------YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F            YLV+ F+  G    +L +     ED  +    +++  +
Sbjct: 77  ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++HA GI+HRDLKP N+ ++ D  + + DFGLA+Q D          T  Y +PE++L 
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM--TGYVVTRWYRAPEVILN 192

Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHS 378
              + +  D WSVG ++ EM+TG+  F G +     ++I+K     PA       S
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  180 bits (456), Expect = 2e-54
 Identities = 47/266 (17%), Positives = 106/266 (39%), Gaps = 36/266 (13%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
            + E ++ +G+GAF +V+Q R  G        + A+K+++++     +     + E  ++
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALM 70

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL------------------ 246
            + D+P IV+L         + L+ +++  G L   L                       
Sbjct: 71  AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130

Query: 247 ------FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
                            ++ + +++L     +HRDL   N L+  +  V + DFGL++  
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190

Query: 301 DEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQ-PPFTGGNRQK 356
                     +    + +M PE +    +   +D W+ G++L+E+ +    P+ G   ++
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 357 IQQKIIKDKI-KLPAFLSSEAHSLLK 381
           +   +    I   P     E ++L++
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMR 276

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 7e-53
 Identities = 60/235 (25%), Positives = 103/235 (43%), Gaps = 8/235 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKH 76

Query: 210 PFIVQLRYSFQTKYRL----YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             ++ L   F     L     + L     G     + +     +D  +    +I+  + +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
           +H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L   
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 194

Query: 326 H-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSL 379
           H ++  D WSVG ++ E+LTG+  F G +     + I++      A L  +  S 
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 8e-52
 Identities = 49/243 (20%), Positives = 99/243 (40%), Gaps = 13/243 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILT 205
                 KV+G G F +VY+     +S       A+K ++      +        E  I+ 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMG 64

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVS 264
           +  H  I++L         + ++ +++  G    F   + G F           I + + 
Sbjct: 65  QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGTLEYMSPEI 320
           +L     +HRDL   NIL++++    ++DFGL++  +++      ++     + + +PE 
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184

Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKL--PAFLSSEAHS 378
           +  +    A+D WS GI+++E++T               K I D  +L  P    S  + 
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQ 244

Query: 379 LLK 381
           L+ 
Sbjct: 245 LMM 247

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 1e-51
 Identities = 55/262 (20%), Positives = 106/262 (40%), Gaps = 32/262 (12%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
                 K +G GAF KV +    G      +   A+K+++    +     E + SE  +L
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80

Query: 205 TKV-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL----------------- 246
           + + +H  IV L  +        ++ ++   G L   L R+                   
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 247 -FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-- 303
               +    ++ ++   ++ L +   +HRDL   NILL       + DFGLA+    +  
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 304 -TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKI 361
                +    +++M+PE +    +   +D WS GI L+E+ + G  P+ G        K+
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260

Query: 362 IKDKIKL--PAFLSSEAHSLLK 381
           IK+  ++  P    +E + ++K
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMK 282

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (430), Expect = 2e-50
 Identities = 50/260 (19%), Positives = 116/260 (44%), Gaps = 29/260 (11%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE-------IYAMKVMRKDKIMEKNHAEYMKSERN 202
           +   + K +G+GAF +V     IG  +         A+K+++ D   EK+ ++ +     
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEM 71

Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------L 246
           +     H  I+ L  +      LY+++++ + G+L   L  +                  
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 247 FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--- 303
                      ++   + +L +   +HRDL   N+L+  D  + + DFGLA+        
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKII 362
            ++ +    +++M+PE +  + +   +D WS G+LL+E+ T G  P+ G   +++ + + 
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251

Query: 363 KD-KIKLPAFLSSEAHSLLK 381
           +  ++  P+  ++E + +++
Sbjct: 252 EGHRMDKPSNCTNELYMMMR 271

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 5e-50
 Identities = 52/238 (21%), Positives = 102/238 (42%), Gaps = 14/238 (5%)

Query: 156 KVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           +V+G+G F  VY    +   G     A+K +  ++I +        +E  I+    HP +
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 90

Query: 213 VQL-RYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
           + L     +++    +VL ++  G L  F               +  ++   +  L +  
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150

Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAK-----QFDENTRSNSMCGTLEYMSPEIVLGKG 325
            +HRDL   N +LD    V + DFGLA+     +FD           +++M+ E +  + 
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 210

Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDK-IKLPAFLSSEAHSLLK 381
               +D WS G+LL+E++T G PP+   N   I   +++ + +  P +     + ++ 
Sbjct: 211 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 268

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 2e-49
 Identities = 53/260 (20%), Positives = 110/260 (42%), Gaps = 29/260 (11%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
           +  ++ K +G+GAF +V +    G     T    A+K++++       H   M   + ++
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILI 71

Query: 205 TKVDHPFIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LF 247
               H  +V L     +    L ++++F   G+L   L  +                   
Sbjct: 72  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131

Query: 248 REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---T 304
             +    Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191

Query: 305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTG-QPPFTGGNRQKIQQKIIK 363
           R       L++M+PE +  + +   +D WS G+LL+E+ +    P+ G    +   + +K
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251

Query: 364 D--KIKLPAFLSSEAHSLLK 381
           +  +++ P + + E +  + 
Sbjct: 252 EGTRMRAPDYTTPEMYQTML 271

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 6e-48
 Identities = 48/255 (18%), Positives = 104/255 (40%), Gaps = 22/255 (8%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVR-----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           V  E   + + +GQG+F  VY+       +       A+K + +   M +       +E 
Sbjct: 17  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER--IEFLNEA 74

Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDL---------- 251
           +++ + +   +V+L           ++++ +  G L   L        +           
Sbjct: 75  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134

Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---TRSNS 308
                 EI   +++L+AN  +HRDL   N ++  D  V + DFG+ +   E     +   
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194

Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTG-QPPFTGGNRQKIQQKIIKDKI- 366
               + +MSPE +        +D WS G++L+E+ T  + P+ G + +++ + +++  + 
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254

Query: 367 KLPAFLSSEAHSLLK 381
             P         L++
Sbjct: 255 DKPDNCPDMLFELMR 269

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 8e-47
 Identities = 52/223 (23%), Positives = 95/223 (42%), Gaps = 30/223 (13%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
               + + +G+G F +V++ +     E  A+K+    +        + ++E      + H
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS----WFREAEIYQTVMLRH 56

Query: 210 PFIVQLRYSFQ----TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             I+    +      T  +L+LV D+   G LF  L R  +  E + ++      S ++H
Sbjct: 57  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLA-LSTASGLAH 115

Query: 266 LHA--------NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-----NTRSNSMCGT 312
           LH           I HRDLK +NIL+  +G   + D GLA + D      +   N   GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

Query: 313 LEYMSPEIVLGKGH------DKAADWWSVGILLFEMLTGQPPF 349
             YM+PE++    +       K AD +++G++ +E+       
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  144 bits (362), Expect = 4e-40
 Identities = 46/227 (20%), Positives = 92/227 (40%), Gaps = 17/227 (7%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-------L 204
           + +++ +G G F+ V+  + +  +   AMK++R DK+  +   + +K  + +        
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGH-----LFFQLYRQGLFREDLARIYTAEI 259
             +    I++L   F  K    + +  V            + Y          +  + ++
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 260 VSAVSHLHAN-GIMHRDLKPENILLDADGHVM----LTDFGLAKQFDENTRSNSMCGTLE 314
           +  + ++H   GI+H D+KPEN+L++          +    L      +    +   T E
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKI 361
           Y SPE++LG      AD WS   L+FE++TG   F         +  
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 84.8 bits (209), Expect = 6e-20
 Identities = 26/205 (12%), Positives = 66/205 (32%), Gaps = 32/205 (15%)

Query: 153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN-------HAEYMKSERNILT 205
            + K++G+G  + V+            +K  +      K           +         
Sbjct: 3   AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61

Query: 206 KVDHPFIVQLRYSFQTK----YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           + +   + +L+     K        ++++ ++   L+         R +        I+ 
Sbjct: 62  RNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYR-------VRVENPDEVLDMILE 114

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
            V+  +  GI+H DL   N+L+  +  + + DF  + +  E        G  E +  ++ 
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEE-------GWREILERDVR 166

Query: 322 -----LGKGHDKAADWWSVGILLFE 341
                  + +    D  S    + +
Sbjct: 167 NIITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	396
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.44
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.09
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.99
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.31
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.89
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.74

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-61  Score=453.30  Aligned_cols=247  Identities=32%  Similarity=0.629  Sum_probs=232.1

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      ..++|++++.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+++|+.++||||+++++++.++..+|+
T Consensus         4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i   83 (263)
T d2j4za1           4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   83 (263)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence            45789999999999999999999999999999999987665555566778899999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCcc
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN  307 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~  307 (396)
                      ||||+++|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+..... ...
T Consensus        84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~~~  162 (263)
T d2j4za1          84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRT  162 (263)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-CCE
T ss_pred             EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-ccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999876543 345


Q ss_pred             ccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccC
Q 016037          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLL  387 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~  387 (396)
                      ..+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..++.+++.+..+.+|..+|+++++||++||+.|
T Consensus       163 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d  242 (263)
T d2j4za1         163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN  242 (263)
T ss_dssp             ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred             ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCC
Confidence            67899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCC
Q 016037          388 SISVPLLS  395 (396)
Q Consensus       388 p~~RPs~s  395 (396)
                      |.+|||+.
T Consensus       243 p~~R~t~~  250 (263)
T d2j4za1         243 PSQRPMLR  250 (263)
T ss_dssp             GGGSCCHH
T ss_pred             HhHCcCHH
Confidence            99999874

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-61  Score=456.13  Aligned_cols=249  Identities=39%  Similarity=0.697  Sum_probs=230.2

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|++++||||++++++|.+...+|+
T Consensus         6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i   85 (288)
T d1uu3a_           6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF   85 (288)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred             CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence            34689999999999999999999999999999999987665555666778999999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC---C
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---T  304 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~---~  304 (396)
                      ||||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||+|+.+...   .
T Consensus        86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999987533   2


Q ss_pred             CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhh
Q 016037          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVN  384 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l  384 (396)
                      .....+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+..++.++|.+..+.+|..+|+++++||++||
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L  245 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLL  245 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTS
T ss_pred             ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHc
Confidence            34557899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCC
Q 016037          385 SLLSISVPLLSR  396 (396)
Q Consensus       385 ~~~p~~RPs~s~  396 (396)
                      +.||.+|||+.+
T Consensus       246 ~~dP~~R~t~~e  257 (288)
T d1uu3a_         246 VLDATKRLGCEE  257 (288)
T ss_dssp             CSSGGGSTTSGG
T ss_pred             cCCHhHCcCHHH
Confidence            999999999753

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-60  Score=457.55  Aligned_cols=247  Identities=40%  Similarity=0.746  Sum_probs=234.0

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +.+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|++++||||++++++|++...+|
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence            56789999999999999999999999999999999998876555566777889999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC-CCC
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTR  305 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~-~~~  305 (396)
                      +|||||+||+|..++.+.+.++++.++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.... ...
T Consensus        82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~  161 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999997643 445


Q ss_pred             ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhc
Q 016037          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNS  385 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~  385 (396)
                      ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++.+++..+.+.+|..+|+++++||++||+
T Consensus       162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~  241 (337)
T d1o6la_         162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK  241 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred             cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhcc
Confidence            56789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCC
Q 016037          386 LLSISVPL  393 (396)
Q Consensus       386 ~~p~~RPs  393 (396)
                      +||.+||+
T Consensus       242 ~dP~~R~~  249 (337)
T d1o6la_         242 KDPKQRLG  249 (337)
T ss_dssp             SSTTTSTT
T ss_pred             CCchhhcc
Confidence            99999997

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.1e-58  Score=441.67  Aligned_cols=244  Identities=37%  Similarity=0.715  Sum_probs=229.9

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++|||||++++++.+...+|+
T Consensus         2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   81 (316)
T d1fota_           2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   81 (316)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence            35789999999999999999999999999999999987665555566778899999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCcc
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN  307 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~  307 (396)
                      ||||+.||+|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....  ..
T Consensus        82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~  159 (316)
T d1fota_          82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TY  159 (316)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BC
T ss_pred             EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--cc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999887543  34


Q ss_pred             ccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccC
Q 016037          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLL  387 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~  387 (396)
                      ..+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..++.+++......+|..+|++++++|++||++|
T Consensus       160 ~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d  239 (316)
T d1fota_         160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD  239 (316)
T ss_dssp             CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSC
T ss_pred             cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhC
Confidence            67899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCC
Q 016037          388 SISVPL  393 (396)
Q Consensus       388 p~~RPs  393 (396)
                      |.+||+
T Consensus       240 p~~R~~  245 (316)
T d1fota_         240 LSQRLG  245 (316)
T ss_dssp             TTTCTT
T ss_pred             HHhccc
Confidence            999973

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-58  Score=439.16  Aligned_cols=242  Identities=28%  Similarity=0.450  Sum_probs=218.8

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++++.||+|+||+||+|+++.+|+.||||++......   ..+.+.+|+.+|++++|||||+++++|.+...+|+||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            4699999999999999999999999999999999865432   2456889999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-CCccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNS  308 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-~~~~~  308 (396)
                      ||++||+|..++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+... .....
T Consensus        97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  175 (293)
T d1yhwa1          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (293)
T ss_dssp             ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence            99999999887654 67999999999999999999999999999999999999999999999999999987543 34566


Q ss_pred             cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCCccCCHHHHHHHHHhhc
Q 016037          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGVNS  385 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~---~~~~p~~~s~~~~~li~~~l~  385 (396)
                      .+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..+....+...   .+..|..+|+++++||++||+
T Consensus       176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  255 (293)
T d1yhwa1         176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD  255 (293)
T ss_dssp             CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTC
T ss_pred             cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHcc
Confidence            78999999999999999999999999999999999999999998877777766654   345678899999999999999


Q ss_pred             cCCCCCCCCC
Q 016037          386 LLSISVPLLS  395 (396)
Q Consensus       386 ~~p~~RPs~s  395 (396)
                      .||.+|||+.
T Consensus       256 ~dP~~R~s~~  265 (293)
T d1yhwa1         256 MDVEKRGSAK  265 (293)
T ss_dssp             SSTTTSCCHH
T ss_pred             CChhHCcCHH
Confidence            9999999864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-58  Score=434.66  Aligned_cols=246  Identities=29%  Similarity=0.522  Sum_probs=211.6

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe--cCeEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KYRLY  226 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~--~~~~~  226 (396)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++...... +...+.+.+|+++|++++|||||++++++.+  ...+|
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence            36899999999999999999999999999999999876543 3445678899999999999999999999854  46789


Q ss_pred             EEEEecCCCcHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCCEEEcCCCcEEEEecccc
Q 016037          227 LVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANG-----IMHRDLKPENILLDADGHVMLTDFGLA  297 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~-----iiHrDlkp~NILl~~~~~ikL~Dfgla  297 (396)
                      +||||+++|+|.+++.+    .+.+++..++.++.||+.||.|||++|     |+||||||+|||++.++.+||+|||+|
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence            99999999999998854    357999999999999999999999976     999999999999999999999999999


Q ss_pred             cccCCCC-CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHH
Q 016037          298 KQFDENT-RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSE  375 (396)
Q Consensus       298 ~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~-~~p~~~s~~  375 (396)
                      +.+.... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..++..++..+.+ .+|..+|++
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  241 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE  241 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred             eecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence            9875443 34567899999999999999999999999999999999999999999999999999988865 578899999


Q ss_pred             HHHHHHHhhccCCCCCCCCC
Q 016037          376 AHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       376 ~~~li~~~l~~~p~~RPs~s  395 (396)
                      +++||++||+.||.+|||++
T Consensus       242 l~~li~~~L~~dp~~Rps~~  261 (269)
T d2java1         242 LNEIITRMLNLKDYHRPSVE  261 (269)
T ss_dssp             HHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHcCCChhHCcCHH
Confidence            99999999999999999975

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-59  Score=437.20  Aligned_cols=245  Identities=29%  Similarity=0.436  Sum_probs=211.9

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.....  .+..+.+.+|+.+|++++||||+++++++.++..+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            4689999999999999999999999999999999987542  23345678999999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC---CC
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---TR  305 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~---~~  305 (396)
                      |||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+.+...   ..
T Consensus        82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence            999999999999988889999999999999999999999999999999999999999999999999999876433   23


Q ss_pred             ccccccCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCC--CCccCCHHHHHHHH
Q 016037          306 SNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQ-KIQQKIIKDKIK--LPAFLSSEAHSLLK  381 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~-~i~~~i~~~~~~--~p~~~s~~~~~li~  381 (396)
                      ....+||+.|||||++.+..+ +.++|||||||++|||+||+.||...+.. .....+......  ....+|+++.+||+
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  241 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  241 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHH
Confidence            456789999999999988776 57899999999999999999999876543 333333333322  23578999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      +||+.||.+|||++
T Consensus       242 ~~L~~dP~~R~t~~  255 (271)
T d1nvra_         242 KILVENPSARITIP  255 (271)
T ss_dssp             HHSCSSTTTSCCHH
T ss_pred             HHcCCChhHCcCHH
Confidence            99999999999964

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-58  Score=442.08  Aligned_cols=244  Identities=32%  Similarity=0.550  Sum_probs=206.0

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      +.|++.+.||+|+||+||+|+++.+++.||||++.+....  ...+.+.+|+.+|++++|||||+++++|.++..+||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            5699999999999999999999999999999999876532  23355778999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc---CCCcEEEEecccccccCCCCCc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD---ADGHVMLTDFGLAKQFDENTRS  306 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~---~~~~ikL~Dfgla~~~~~~~~~  306 (396)
                      |||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+.   .++.+||+|||+|+........
T Consensus        87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~  166 (307)
T d1a06a_          87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL  166 (307)
T ss_dssp             CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred             eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence            9999999999999999999999999999999999999999999999999999995   5789999999999988766666


Q ss_pred             cccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHH
Q 016037          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLKG  382 (396)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~~~s~~~~~li~~  382 (396)
                      ...+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++...+.+....++    ..+|+++++||++
T Consensus       167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  246 (307)
T d1a06a_         167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH  246 (307)
T ss_dssp             ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred             eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHH
Confidence            778999999999999999999999999999999999999999999999999999998866544    5799999999999


Q ss_pred             hhccCCCCCCCCC
Q 016037          383 VNSLLSISVPLLS  395 (396)
Q Consensus       383 ~l~~~p~~RPs~s  395 (396)
                      ||+.||.+|||++
T Consensus       247 ~L~~dP~~R~s~~  259 (307)
T d1a06a_         247 LMEKDPEKRFTCE  259 (307)
T ss_dssp             HSCSSGGGSCCHH
T ss_pred             HccCCHhHCcCHH
Confidence            9999999999964

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-57  Score=436.62  Aligned_cols=242  Identities=26%  Similarity=0.384  Sum_probs=221.7

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEE
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (396)
                      .|++++.||+|+||+||+|+++.+++.||||++...........+.+.+|+.+|++++|||||+++++|.++..+|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            49999999999999999999999999999999988766666677788999999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccccc
Q 016037          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMC  310 (396)
Q Consensus       231 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~~~  310 (396)
                      ||.+|+|..++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+....   ....+
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~~~~~  172 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFV  172 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCCCC
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---CCccc
Confidence            999999988888888999999999999999999999999999999999999999999999999999987543   34568


Q ss_pred             cCCCccchhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCccCCHHHHHHHHHhhc
Q 016037          311 GTLEYMSPEIVLG---KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK--LPAFLSSEAHSLLKGVNS  385 (396)
Q Consensus       311 gt~~y~APE~l~~---~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~--~p~~~s~~~~~li~~~l~  385 (396)
                      ||+.|||||++.+   ..|+.++|||||||++|||++|+.||.+.+..+...++......  .+..+|+++++||++||+
T Consensus       173 GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~  252 (309)
T d1u5ra_         173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ  252 (309)
T ss_dssp             SCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTC
T ss_pred             cCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCc
Confidence            9999999999964   45899999999999999999999999999988888888877543  345799999999999999


Q ss_pred             cCCCCCCCCC
Q 016037          386 LLSISVPLLS  395 (396)
Q Consensus       386 ~~p~~RPs~s  395 (396)
                      .||.+|||++
T Consensus       253 ~dP~~Rpt~~  262 (309)
T d1u5ra_         253 KIPQDRPTSE  262 (309)
T ss_dssp             SSGGGSCCHH
T ss_pred             CChhHCcCHH
Confidence            9999999974

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-58  Score=435.83  Aligned_cols=243  Identities=32%  Similarity=0.480  Sum_probs=218.2

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      +.|++++.||+|+||+||+|+++.+++.||+|++....   ....+.+.+|+++|++++|||||+++++|.+...+|+||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence            46999999999999999999999999999999997653   233455788999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-CCcc
Q 016037          230 DFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSN  307 (396)
Q Consensus       230 E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-~~~~  307 (396)
                      ||+++|+|..++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+..... ....
T Consensus        89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~  168 (288)
T d2jfla1          89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD  168 (288)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence            99999999988765 467999999999999999999999999999999999999999999999999999875432 2335


Q ss_pred             ccccCCCccchhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---CCCCccCCHHHHHH
Q 016037          308 SMCGTLEYMSPEIVL-----GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLPAFLSSEAHSL  379 (396)
Q Consensus       308 ~~~gt~~y~APE~l~-----~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~---~~~p~~~s~~~~~l  379 (396)
                      ..+||+.|||||++.     +..|+.++|||||||++|||+||+.||.+.+..++..++....   +..|..+|+++++|
T Consensus       169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~l  248 (288)
T d2jfla1         169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF  248 (288)
T ss_dssp             CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred             ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence            678999999999984     4568899999999999999999999999999999999988874   34567899999999


Q ss_pred             HHHhhccCCCCCCCCC
Q 016037          380 LKGVNSLLSISVPLLS  395 (396)
Q Consensus       380 i~~~l~~~p~~RPs~s  395 (396)
                      |++||+.||.+|||++
T Consensus       249 i~~~L~~dp~~R~t~~  264 (288)
T d2jfla1         249 LKKCLEKNVDARWTTS  264 (288)
T ss_dssp             HHHHSCSSTTTSCCHH
T ss_pred             HHHHccCChhHCcCHH
Confidence            9999999999999975

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-57  Score=436.53  Aligned_cols=246  Identities=36%  Similarity=0.689  Sum_probs=226.8

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHH-hCCCCCeeeeeEEEEecCeEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT-KVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~-~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      ++|++++.||+|+||+||+|+++.+++.||||++++.........+.+..|..++. .++||||+++++++.++..+|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            68999999999999999999999999999999998765444444555566666654 78999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC-CCCcc
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSN  307 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~-~~~~~  307 (396)
                      |||+++|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.... .....
T Consensus        82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~  161 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN  161 (320)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBC
T ss_pred             EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999987643 33345


Q ss_pred             ccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccC
Q 016037          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLL  387 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~  387 (396)
                      ..+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..++..++..+.+.+|..+|+++++||++||+.|
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~d  241 (320)
T d1xjda_         162 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVRE  241 (320)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSS
T ss_pred             ccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhcccC
Confidence            57899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCC
Q 016037          388 SISVPLLS  395 (396)
Q Consensus       388 p~~RPs~s  395 (396)
                      |.+||++.
T Consensus       242 P~~R~s~~  249 (320)
T d1xjda_         242 PEKRLGVR  249 (320)
T ss_dssp             GGGSBTTB
T ss_pred             CCCCcCHH
Confidence            99999973

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-57  Score=432.00  Aligned_cols=246  Identities=28%  Similarity=0.450  Sum_probs=227.7

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchh---hHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK---NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+......   ...+.+.+|+.+|++++|||||+++++|.+...+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            569999999999999999999999999999999987543322   23567889999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC----cEEEEecccccccCC
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG----HVMLTDFGLAKQFDE  302 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~----~ikL~Dfgla~~~~~  302 (396)
                      ||||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++    .+||+|||+++....
T Consensus        90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~  169 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  169 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred             EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence            9999999999999999999999999999999999999999999999999999999998877    599999999998877


Q ss_pred             CCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHH
Q 016037          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHS  378 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~~~s~~~~~  378 (396)
                      .......+||+.|||||++.+..++.++|||||||++|||+||+.||.+.+..+...++......++    ..+|.++++
T Consensus       170 ~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  249 (293)
T d1jksa_         170 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD  249 (293)
T ss_dssp             SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHH
T ss_pred             CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHH
Confidence            7777778899999999999999999999999999999999999999999999999999999877766    478999999


Q ss_pred             HHHHhhccCCCCCCCCC
Q 016037          379 LLKGVNSLLSISVPLLS  395 (396)
Q Consensus       379 li~~~l~~~p~~RPs~s  395 (396)
                      ||++||+.||.+|||+.
T Consensus       250 li~~~L~~dP~~R~s~~  266 (293)
T d1jksa_         250 FIRRLLVKDPKKRMTIQ  266 (293)
T ss_dssp             HHHTTSCSSGGGSCCHH
T ss_pred             HHHHHccCChhHCcCHH
Confidence            99999999999999974

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.2e-57  Score=441.62  Aligned_cols=242  Identities=38%  Similarity=0.741  Sum_probs=228.7

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|+.++||||++++++|.....+|+|
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            47899999999999999999999999999999999876655555667788999999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCCccc
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~~~~  308 (396)
                      |||+.+|+|..++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+...  ...
T Consensus       120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~~  197 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWT  197 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCC
T ss_pred             cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--ccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999987543  345


Q ss_pred             cccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHhhccCC
Q 016037          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGVNSLLS  388 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p  388 (396)
                      .+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+...+..+|....+.+|..+|+++.+||++||+.||
T Consensus       198 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP  277 (350)
T d1rdqe_         198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL  277 (350)
T ss_dssp             CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCT
T ss_pred             ccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhhhCH
Confidence            78999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCC
Q 016037          389 ISVP  392 (396)
Q Consensus       389 ~~RP  392 (396)
                      .+|+
T Consensus       278 ~kR~  281 (350)
T d1rdqe_         278 TKRF  281 (350)
T ss_dssp             TTCT
T ss_pred             Hhcc
Confidence            9995

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.6e-57  Score=440.98  Aligned_cols=244  Identities=26%  Similarity=0.488  Sum_probs=224.8

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      +++|++++.||+|+||+||+|+++.+|+.||||++.+..   ....+.+.+|+.+|++++|||||+++++|.++..+|||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv  101 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  101 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            468999999999999999999999999999999997654   23456688999999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHH-HhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC--CCcEEEEecccccccCCCCC
Q 016037          229 LDFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA--DGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       229 ~E~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~--~~~ikL~Dfgla~~~~~~~~  305 (396)
                      ||||+||+|.+++. ..+.+++..++.++.||+.||.|||++|||||||||+|||++.  ++.+||+|||+|+.+.....
T Consensus       102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  181 (350)
T d1koaa2         102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  181 (350)
T ss_dssp             ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence            99999999999885 4567999999999999999999999999999999999999964  57899999999998877776


Q ss_pred             ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHH
Q 016037          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLK  381 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~~~s~~~~~li~  381 (396)
                      ....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..++...|......++    ..+|+++++||+
T Consensus       182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  261 (350)
T d1koaa2         182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR  261 (350)
T ss_dssp             EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHH
T ss_pred             cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence            7778999999999999999999999999999999999999999999999999999998877665    468999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      +||+.||.+|||+.
T Consensus       262 ~~L~~dP~~R~t~~  275 (350)
T d1koaa2         262 KLLLADPNTRMTIH  275 (350)
T ss_dssp             HHCCSSGGGSCCHH
T ss_pred             HHccCChhHCcCHH
Confidence            99999999999864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.7e-57  Score=439.45  Aligned_cols=244  Identities=25%  Similarity=0.462  Sum_probs=224.5

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|++++.||+|+||+||+|+++.+|+.||||++++...   ...+.+.+|+.+|++++|||||+++++|.++..+|||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv  104 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  104 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4679999999999999999999999999999999987542   2345678899999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEc--CCCcEEEEecccccccCCCCC
Q 016037          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD--ADGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~--~~~~ikL~Dfgla~~~~~~~~  305 (396)
                      ||||+||+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++  .++++||+|||+|+.+.....
T Consensus       105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~  184 (352)
T d1koba_         105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  184 (352)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence            9999999998877655 4699999999999999999999999999999999999997  578999999999999877766


Q ss_pred             ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHH
Q 016037          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLK  381 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~~~s~~~~~li~  381 (396)
                      ....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..++..++......+|    ..+|+++++||+
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  264 (352)
T d1koba_         185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK  264 (352)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHH
T ss_pred             eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence            7778899999999999999999999999999999999999999999999999999999877665    478999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      +||+.||.+|||+.
T Consensus       265 ~~L~~dp~~R~s~~  278 (352)
T d1koba_         265 NLLQKEPRKRLTVH  278 (352)
T ss_dssp             TTSCSSGGGSCCHH
T ss_pred             HHccCChhHCcCHH
Confidence            99999999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-57  Score=437.43  Aligned_cols=246  Identities=26%  Similarity=0.434  Sum_probs=212.5

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +..++|+++++||+|+||+||+|+++.+|+.||+|+++...  .....+.+.+|+.+|++++|||||+++++|.+..++|
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            34578999999999999999999999999999999998653  2344567889999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEcCCCcEEEEecccccccCCCCC
Q 016037          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~-~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~  305 (396)
                      +||||++||+|..++.+.+.+++..++.++.|++.||.|||++ ||+||||||+|||++.+|++||+|||+|+.+... .
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~  159 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M  159 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-T
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-c
Confidence            9999999999999999999999999999999999999999974 9999999999999999999999999999876443 3


Q ss_pred             ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----------------------------
Q 016037          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKI----------------------------  357 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i----------------------------  357 (396)
                      ..+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+....                            
T Consensus       160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (322)
T d1s9ja_         160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS  239 (322)
T ss_dssp             C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred             cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence            4567999999999999999999999999999999999999999987653321                            


Q ss_pred             --------------HHHHHhC-CCCCC-ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          358 --------------QQKIIKD-KIKLP-AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       358 --------------~~~i~~~-~~~~p-~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                    ...+... ...+| ..+|.++.+||++||+.||.+|||++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~  293 (322)
T d1s9ja_         240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK  293 (322)
T ss_dssp             ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence                          1111221 12233 24799999999999999999999975

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.9e-56  Score=419.33  Aligned_cols=247  Identities=30%  Similarity=0.489  Sum_probs=225.3

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccch------hhHHHHHHHHHHHHHhCC-CCCeeeeeEEEEe
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME------KNHAEYMKSERNILTKVD-HPFIVQLRYSFQT  221 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~  221 (396)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+.....      +...+.+.+|+.+|++++ ||||++++++|.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            468999999999999999999999999999999998754322      233456788999999997 9999999999999


Q ss_pred             cCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          222 KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      ...+||||||+++|+|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999887


Q ss_pred             CCCCccccccCCCccchhhhcC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----cc
Q 016037          302 ENTRSNSMCGTLEYMSPEIVLG------KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AF  371 (396)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~------~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~~  371 (396)
                      ........+||+.|+|||.+.+      ..++.++||||+||++|||+||+.||.+.+...+.+.+..+...++    ..
T Consensus       162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (277)
T d1phka_         162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD  241 (277)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred             CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence            7666677889999999999853      4568899999999999999999999999999999999998866544    37


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCCC
Q 016037          372 LSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       372 ~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +|+++++||++||+.+|.+|||+.
T Consensus       242 ~s~~~~~li~~~L~~~p~~R~s~~  265 (277)
T d1phka_         242 YSDTVKDLVSRFLVVQPQKRYTAE  265 (277)
T ss_dssp             SCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHH
Confidence            999999999999999999999864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-56  Score=418.42  Aligned_cols=241  Identities=24%  Similarity=0.388  Sum_probs=212.1

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe----cCeEEE
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT----KYRLYL  227 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~----~~~~~l  227 (396)
                      |++.++||+|+||+||+|+++.+++.||+|++...... ....+.+.+|+++|++++|||||+++++|.+    ...+|+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            47788999999999999999999999999999876543 3445678899999999999999999999865    356899


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEc-CCCcEEEEecccccccCCCC
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLD-ADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~--iiHrDlkp~NILl~-~~~~ikL~Dfgla~~~~~~~  304 (396)
                      ||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||+|+... ..
T Consensus        90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~-~~  168 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-AS  168 (270)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-TT
T ss_pred             EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc-CC
Confidence            9999999999999999999999999999999999999999998  99999999999996 57899999999998643 33


Q ss_pred             CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCC--CCCccCCHHHHHHHH
Q 016037          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG-NRQKIQQKIIKDKI--KLPAFLSSEAHSLLK  381 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~-~~~~i~~~i~~~~~--~~p~~~s~~~~~li~  381 (396)
                      .....+||+.|||||++.+ .++.++|||||||++|||++|+.||.+. +...+.+.+..+..  .++..+++++++||+
T Consensus       169 ~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  247 (270)
T d1t4ha_         169 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE  247 (270)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHH
T ss_pred             ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHH
Confidence            4456789999999999876 4999999999999999999999999875 45666677766532  355678999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      +||+.||.+|||+.
T Consensus       248 ~~l~~dp~~R~s~~  261 (270)
T d1t4ha_         248 GCIRQNKDERYSIK  261 (270)
T ss_dssp             HHSCSSGGGSCCHH
T ss_pred             HHccCCHhHCcCHH
Confidence            99999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.4e-57  Score=426.45  Aligned_cols=247  Identities=21%  Similarity=0.333  Sum_probs=219.4

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCe
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~  224 (396)
                      +.+..++|++.++||+|+||+||+|+++.+++.||||+++.+..    ..+.+.+|+++|++++|||||+++++|.++..
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   87 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence            45677899999999999999999999999999999999976542    23457889999999999999999999999999


Q ss_pred             EEEEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      +|+||||+++|+|..++.+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+....
T Consensus        88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  167 (287)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred             eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence            99999999999999998764  5789999999999999999999999999999999999999999999999999987654


Q ss_pred             CCC--ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCHHHHHHHHHhC-CCCCCccCCHHHHH
Q 016037          303 NTR--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQP-PFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHS  378 (396)
Q Consensus       303 ~~~--~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~-Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~  378 (396)
                      ...  .....||+.|||||++.+..|+.++|||||||++|||++|.. ||.+.+...+.+.+..+ ++.+|..+|+++++
T Consensus       168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  247 (287)
T d1opja_         168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE  247 (287)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHH
Confidence            432  233458899999999999999999999999999999999555 55566777777777665 67888999999999


Q ss_pred             HHHHhhccCCCCCCCCC
Q 016037          379 LLKGVNSLLSISVPLLS  395 (396)
Q Consensus       379 li~~~l~~~p~~RPs~s  395 (396)
                      ||+.||+.||.+|||++
T Consensus       248 li~~cl~~dP~~Rps~~  264 (287)
T d1opja_         248 LMRACWQWNPSDRPSFA  264 (287)
T ss_dssp             HHHHHTCSSGGGSCCHH
T ss_pred             HHHHHcCCCHhHCcCHH
Confidence            99999999999999974

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.3e-56  Score=434.60  Aligned_cols=246  Identities=36%  Similarity=0.655  Sum_probs=217.2

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHH---HHHHHHhCCCCCeeeeeEEEEecCe
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS---ERNILTKVDHPFIVQLRYSFQTKYR  224 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~---E~~~L~~l~HpnIv~l~~~~~~~~~  224 (396)
                      ..++|+++++||+|+||+||+|+++.+|+.||||++.+...........+.+   |+.+++.++|||||+++++|.+...
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            4678999999999999999999999999999999998755433333333333   4677777889999999999999999


Q ss_pred             EEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~  304 (396)
                      +|+||||++||+|..++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+... 
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-  160 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-  160 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred             EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999987544 


Q ss_pred             CccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCccCCHHHHHHH
Q 016037          305 RSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN---RQKIQQKIIKDKIKLPAFLSSEAHSLL  380 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~---~~~i~~~i~~~~~~~p~~~s~~~~~li  380 (396)
                      .....+||+.|||||++.+ ..|+.++|||||||+||||+||+.||.+.+   ...+...+......+|..+|+++++||
T Consensus       161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  240 (364)
T d1omwa3         161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL  240 (364)
T ss_dssp             CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHH
T ss_pred             cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHH
Confidence            3456789999999999974 568999999999999999999999998754   334555555667788899999999999


Q ss_pred             HHhhccCCCCCCCC
Q 016037          381 KGVNSLLSISVPLL  394 (396)
Q Consensus       381 ~~~l~~~p~~RPs~  394 (396)
                      ++||+.||.+|||.
T Consensus       241 ~~~L~~dP~~R~t~  254 (364)
T d1omwa3         241 EGLLQRDVNRRLGC  254 (364)
T ss_dssp             HHHTCSSTTTSTTT
T ss_pred             HHHcccCHHHhCCC
Confidence            99999999999984

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.6e-56  Score=425.13  Aligned_cols=247  Identities=21%  Similarity=0.347  Sum_probs=208.9

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCc---EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSE---IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~  223 (396)
                      +..++|++.+.||+|+||+||+|+++.+++   .||||.+....  .....+.+.+|+.+|++++|||||++++++.+..
T Consensus        23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  100 (299)
T d1jpaa_          23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST  100 (299)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            445789999999999999999999987664   58888876543  2345567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      .+|+|||||++|+|..++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++.+..
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999999999988764 5789999999999999999999999999999999999999999999999999987754


Q ss_pred             CCC------ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCH
Q 016037          303 NTR------SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSS  374 (396)
Q Consensus       303 ~~~------~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~  374 (396)
                      ...      .....||+.|||||.+.+..++.++|||||||+||||+| |+.||.+.+..++...+..+ +++.|..++.
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPS  260 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchH
Confidence            322      122457899999999999999999999999999999998 89999999999999988876 6788889999


Q ss_pred             HHHHHHHHhhccCCCCCCCCC
Q 016037          375 EAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       375 ~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ++++||.+||+.||.+|||++
T Consensus       261 ~l~~li~~cl~~~P~~RPs~~  281 (299)
T d1jpaa_         261 ALHQLMLDCWQKDRNHRPKFG  281 (299)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHH
Confidence            999999999999999999964

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-56  Score=428.06  Aligned_cols=243  Identities=24%  Similarity=0.404  Sum_probs=224.6

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      .++|++++.||+|+||+||+|+++.+++.||||++++..    .....+.+|+++|+.++|||||+++++|.+...+|||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            468999999999999999999999999999999998754    2234577899999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC--CcEEEEecccccccCCCCC
Q 016037          229 LDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD--GHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~--~~ikL~Dfgla~~~~~~~~  305 (396)
                      ||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+  ..+||+|||+++.......
T Consensus        80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~  159 (321)
T d1tkia_          80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence            99999999999997665 79999999999999999999999999999999999999854  4899999999998876666


Q ss_pred             ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHH
Q 016037          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLK  381 (396)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~----~~s~~~~~li~  381 (396)
                      ....+||+.|+|||.+.+..|+.++|||||||++|+|++|+.||.+.+..++..+|.+..+.+|.    .+|+++++||+
T Consensus       160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  239 (321)
T d1tkia_         160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD  239 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred             ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHH
Confidence            67778999999999999999999999999999999999999999999999999999999888875    69999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      +||+.||.+|||+.
T Consensus       240 ~~L~~dp~~R~s~~  253 (321)
T d1tkia_         240 RLLVKERKSRMTAS  253 (321)
T ss_dssp             TTSCSSGGGSCCHH
T ss_pred             HHccCChhHCcCHH
Confidence            99999999999964

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-56  Score=415.78  Aligned_cols=244  Identities=21%  Similarity=0.371  Sum_probs=208.8

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEE
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~  226 (396)
                      +..++|++++.||+|+||+||+|+++ ++..||||+++.....    .+.+.+|++++++++|||||++++++..+..+|
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   76 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence            34578999999999999999999986 4667999999875432    245788999999999999999999999999999


Q ss_pred             EEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC
Q 016037          227 LVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (396)
Q Consensus       227 lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~  305 (396)
                      +||||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++++||+|||+++.......
T Consensus        77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred             EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence            999999999999988655 5688999999999999999999999999999999999999999999999999987654332


Q ss_pred             --ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHH
Q 016037          306 --SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLK  381 (396)
Q Consensus       306 --~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~  381 (396)
                        .....||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..++.+.+..+ +...|..+++++.+||+
T Consensus       157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~  236 (263)
T d1sm2a_         157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN  236 (263)
T ss_dssp             --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred             eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHH
Confidence              334678999999999999999999999999999999999 68888888888899998886 66778899999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      .||+.||.+|||++
T Consensus       237 ~cl~~~p~~Rps~~  250 (263)
T d1sm2a_         237 HCWKERPEDRPAFS  250 (263)
T ss_dssp             HHTCSSGGGSCCHH
T ss_pred             HHccCCHhHCcCHH
Confidence            99999999999975

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.9e-55  Score=413.13  Aligned_cols=244  Identities=27%  Similarity=0.438  Sum_probs=215.5

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC----eE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY----RL  225 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~----~~  225 (396)
                      ++|++++.||+|+||+||+|++..+|+.||||++++....+....+.+.+|+++|+.++||||+++++++....    .+
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            57999999999999999999999999999999998876656666778899999999999999999999997654    48


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC--
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--  303 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~--  303 (396)
                      |+||||++|++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.++.....  
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~  166 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN  166 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred             EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999998765432  


Q ss_pred             --CCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHH
Q 016037          304 --TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAH  377 (396)
Q Consensus       304 --~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p----~~~s~~~~  377 (396)
                        ......+||+.|||||++.+..++.++|||||||++|||+||+.||.+.+..++..++.......|    ..+|+++.
T Consensus       167 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~  246 (277)
T d1o6ya_         167 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD  246 (277)
T ss_dssp             ------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHH
T ss_pred             cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHH
Confidence              234556899999999999999999999999999999999999999999999998888888765443    57899999


Q ss_pred             HHHHHhhccCCCCCCC
Q 016037          378 SLLKGVNSLLSISVPL  393 (396)
Q Consensus       378 ~li~~~l~~~p~~RPs  393 (396)
                      +||++||++||.+||+
T Consensus       247 ~li~~~L~~dp~~R~~  262 (277)
T d1o6ya_         247 AVVLKALAKNPENRYQ  262 (277)
T ss_dssp             HHHHHHTCSSGGGSCS
T ss_pred             HHHHHHccCCHhHCHh
Confidence            9999999999999994

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=417.74  Aligned_cols=246  Identities=23%  Similarity=0.331  Sum_probs=217.2

Q ss_pred             ccCCCeEEEeE-ecccCceEEEEEEEcC--CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC
Q 016037          147 VGLEDFEVLKV-VGQGAFAKVYQVRRIG--TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (396)
Q Consensus       147 ~~~~~~~~~~~-IG~G~fG~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~  223 (396)
                      +..++|.+.+. ||+|+||+||+|.++.  ++..||||+++...  .....+.+.+|+++|++++|||||++++++.. +
T Consensus         5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~   81 (285)
T d1u59a_           5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E   81 (285)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred             ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence            45567999885 9999999999998764  45579999997653  34456678899999999999999999999865 4


Q ss_pred             eEEEEEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          224 RLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      .+|+||||+++|+|.+++.. ++.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence            68999999999999998765 46799999999999999999999999999999999999999999999999999998754


Q ss_pred             CCC----ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHH
Q 016037          303 NTR----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (396)
Q Consensus       303 ~~~----~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~  376 (396)
                      ...    ....+||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..++...+.++ ++.+|..+|+++
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l  241 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL  241 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence            322    334578999999999998899999999999999999998 99999998888888888876 678899999999


Q ss_pred             HHHHHHhhccCCCCCCCCC
Q 016037          377 HSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~RPs~s  395 (396)
                      .+||++||+.+|.+|||+.
T Consensus       242 ~~li~~cl~~~p~~RPs~~  260 (285)
T d1u59a_         242 YALMSDCWIYKWEDRPDFL  260 (285)
T ss_dssp             HHHHHHTTCSSGGGSCCHH
T ss_pred             HHHHHHHcCCCHhHCcCHH
Confidence            9999999999999999964

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-55  Score=415.64  Aligned_cols=243  Identities=20%  Similarity=0.318  Sum_probs=211.9

Q ss_pred             CeEEE-eEecccCceEEEEEEEcC--CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          151 DFEVL-KVVGQGAFAKVYQVRRIG--TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       151 ~~~~~-~~IG~G~fG~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      .+.+. ++||+|+||+||+|.++.  +++.||||+++.... +....+.+.+|+++|++++|||||++++++.. ...||
T Consensus         7 ~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~l   84 (277)
T d1xbba_           7 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML   84 (277)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEE
T ss_pred             hCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEE
Confidence            34444 579999999999998754  567899999976542 34455678899999999999999999999865 46789


Q ss_pred             EEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC--
Q 016037          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR--  305 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~--  305 (396)
                      ||||+++|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.....  
T Consensus        85 vmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          85 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             EEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999987654322  


Q ss_pred             --ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHH
Q 016037          306 --SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLK  381 (396)
Q Consensus       306 --~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~  381 (396)
                        .....||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..++...+.++ ++++|..+|+++++||+
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~  244 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN  244 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHH
Confidence              234578999999999999899999999999999999998 99999999999998888876 67889999999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      +||+.||.+|||++
T Consensus       245 ~cl~~dp~~RPs~~  258 (277)
T d1xbba_         245 LCWTYDVENRPGFA  258 (277)
T ss_dssp             HHTCSSTTTSCCHH
T ss_pred             HHcCCCHhHCcCHH
Confidence            99999999999964

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-56  Score=427.78  Aligned_cols=249  Identities=24%  Similarity=0.393  Sum_probs=214.8

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCCCc-----EEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEE
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE-----IYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYS  218 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~  218 (396)
                      +.+..++|++.++||+|+||+||+|++..+++     .||+|++....  .......+.+|+.+|+++ +|||||+++++
T Consensus        32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~  109 (325)
T d1rjba_          32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGA  109 (325)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence            34666899999999999999999999987654     68999987543  223445678899999987 89999999999


Q ss_pred             EEecCeEEEEEEecCCCcHHHHHHHh-----------------------cCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 016037          219 FQTKYRLYLVLDFVNGGHLFFQLYRQ-----------------------GLFREDLARIYTAEIVSAVSHLHANGIMHRD  275 (396)
Q Consensus       219 ~~~~~~~~lV~E~~~gg~L~~~l~~~-----------------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrD  275 (396)
                      +.+...+|+|||||++|+|.+++..+                       ..+++..++.++.||+.||.|||++||||||
T Consensus       110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD  189 (325)
T d1rjba_         110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD  189 (325)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence            99999999999999999999999754                       2478899999999999999999999999999


Q ss_pred             CCCCCEEEcCCCcEEEEecccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 016037          276 LKPENILLDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG  351 (396)
Q Consensus       276 lkp~NILl~~~~~ikL~Dfgla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~  351 (396)
                      |||+|||++.++++||+|||+|+.......   ....+||+.|||||++.+..++.++|||||||+||||+| |+.||.+
T Consensus       190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987654332   235668999999999999999999999999999999998 9999998


Q ss_pred             CCHHHHHHHHHhC--CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          352 GNRQKIQQKIIKD--KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       352 ~~~~~i~~~i~~~--~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .+......++..+  ++..|..+|+++++||+.||+.+|.+|||++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~  315 (325)
T d1rjba_         270 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP  315 (325)
T ss_dssp             CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHH
Confidence            7766666666655  5677889999999999999999999999975

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=413.69  Aligned_cols=247  Identities=21%  Similarity=0.339  Sum_probs=216.5

Q ss_pred             CCccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       143 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      +.+.+..++|++.+.||+|+||+||+|+++ ++..||||+++.....    .+.+.+|+.+|++++|||||++++++.+ 
T Consensus         6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-   79 (272)
T d1qpca_           6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-   79 (272)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             CCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-
Confidence            345567789999999999999999999986 5678999999765422    3457889999999999999999998754 


Q ss_pred             CeEEEEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccccc
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~  300 (396)
                      +.+|+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+|+..
T Consensus        80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~  159 (272)
T d1qpca_          80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (272)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEc
Confidence            5679999999999998876443  46899999999999999999999999999999999999999999999999999987


Q ss_pred             CCCC--CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHH
Q 016037          301 DENT--RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (396)
Q Consensus       301 ~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~  376 (396)
                      ....  ......||+.|||||++.+..++.++|||||||++|||+| |.+||...+..++.+.+..+ ++..|..+++++
T Consensus       160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l  239 (272)
T d1qpca_         160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL  239 (272)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHH
Confidence            5443  2345678999999999998889999999999999999999 56677778888888888876 677889999999


Q ss_pred             HHHHHHhhccCCCCCCCCC
Q 016037          377 HSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       377 ~~li~~~l~~~p~~RPs~s  395 (396)
                      .+||++||+.+|.+|||++
T Consensus       240 ~~li~~cl~~~P~~Rpt~~  258 (272)
T d1qpca_         240 YQLMRLCWKERPEDRPTFD  258 (272)
T ss_dssp             HHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHcCCCHhHCcCHH
Confidence            9999999999999999975

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-55  Score=410.74  Aligned_cols=243  Identities=19%  Similarity=0.349  Sum_probs=219.6

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEE
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~l  227 (396)
                      ..++|++.++||+|+||+||+|+++ +++.||||++++....    .+.+.+|+.++++++||||+++++++.++..+++
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i   76 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   76 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence            3468999999999999999999985 6778999999876543    2457889999999999999999999999999999


Q ss_pred             EEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC-
Q 016037          228 VLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-  305 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~-  305 (396)
                      ||||+++|+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... 
T Consensus        77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred             EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence            9999999999888654 46789999999999999999999999999999999999999999999999999987654433 


Q ss_pred             -ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHH
Q 016037          306 -SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKG  382 (396)
Q Consensus       306 -~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~~  382 (396)
                       .....||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..++.+++..+ ++..|..+++++++||++
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~  236 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS  236 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHH
Confidence             334678999999999999999999999999999999998 89999999999999999886 678889999999999999


Q ss_pred             hhccCCCCCCCCC
Q 016037          383 VNSLLSISVPLLS  395 (396)
Q Consensus       383 ~l~~~p~~RPs~s  395 (396)
                      ||+.||.+|||++
T Consensus       237 cl~~dP~~RPt~~  249 (258)
T d1k2pa_         237 CWHEKADERPTFK  249 (258)
T ss_dssp             TTCSSGGGSCCHH
T ss_pred             HccCCHhHCcCHH
Confidence            9999999999974

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-56  Score=416.77  Aligned_cols=246  Identities=24%  Similarity=0.330  Sum_probs=205.8

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCe
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~  224 (396)
                      |.+..++|++.+.||+|+||+||+|++++   .||||+++..... ....+.+.+|+.+|++++|||||++++++. .+.
T Consensus         3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~   77 (276)
T d1uwha_           3 WEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ   77 (276)
T ss_dssp             CBCCTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred             cccccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccE
Confidence            34667889999999999999999998643   4999999765433 345677889999999999999999998764 457


Q ss_pred             EEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          225 LYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      +|+||||+++|+|.+++... +.+++..+..++.||+.||+|||++|||||||||+|||++.++++||+|||+|+.....
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            89999999999999999754 56999999999999999999999999999999999999999999999999999876432


Q ss_pred             C---CccccccCCCccchhhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCC-----CCCcc
Q 016037          304 T---RSNSMCGTLEYMSPEIVLGK---GHDKAADWWSVGILLFEMLTGQPPFTGGNRQ-KIQQKIIKDKI-----KLPAF  371 (396)
Q Consensus       304 ~---~~~~~~gt~~y~APE~l~~~---~~~~~~DvwSlGvil~elltg~~Pf~~~~~~-~i~~~i~~~~~-----~~p~~  371 (396)
                      .   .....+||+.|||||++.+.   .|+.++|||||||+||||+||+.||.+.+.. .+...+.++..     .++..
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~  237 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN  237 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence            2   33456899999999999653   4789999999999999999999999986644 44444544422     24567


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCCC
Q 016037          372 LSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       372 ~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +++++++||.+||+.||.+|||++
T Consensus       238 ~~~~l~~li~~cl~~dp~~RPt~~  261 (276)
T d1uwha_         238 CPKAMKRLMAECLKKKRDERPLFP  261 (276)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHH
Confidence            899999999999999999999974

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-54  Score=408.27  Aligned_cols=247  Identities=20%  Similarity=0.308  Sum_probs=209.6

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCCC----cEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTS----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      +..+.|++.++||+|+||+||+|.++.++    ..||||++....  .......+.+|+++|++++|||||++++++.+.
T Consensus         4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            45578999999999999999999988765    479999997643  233445678899999999999999999999999


Q ss_pred             CeEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      ..+++||||+.++++...+... +.+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999999998877655 679999999999999999999999999999999999999999999999999998764


Q ss_pred             CCC----CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHH
Q 016037          302 ENT----RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSE  375 (396)
Q Consensus       302 ~~~----~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~  375 (396)
                      ...    ......||+.|||||++.+..++.++|||||||++|||+| |.+||.+.+..++.+.+..+ +++.|..++.+
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  241 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA  241 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHH
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHH
Confidence            432    2234568999999999999999999999999999999999 56667777888888888776 67888899999


Q ss_pred             HHHHHHHhhccCCCCCCCCC
Q 016037          376 AHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       376 ~~~li~~~l~~~p~~RPs~s  395 (396)
                      +.+||++||+.+|.+|||++
T Consensus       242 l~~li~~cl~~~p~~RPt~~  261 (283)
T d1mqba_         242 IYQLMMQCWQQERARRPKFA  261 (283)
T ss_dssp             HHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHHHHCcCCHhHCcCHH
Confidence            99999999999999999974

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=408.08  Aligned_cols=247  Identities=21%  Similarity=0.361  Sum_probs=207.6

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCC---cEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTS---EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      .+..++|++.+.||+|+||+||+|++..++   ..||||.++...  .....+.+.+|+.+|++++||||+++++++. .
T Consensus         3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~   79 (273)
T d1mp8a_           3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E   79 (273)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred             CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            355678999999999999999999987553   568888886533  3445667889999999999999999999985 4


Q ss_pred             CeEEEEEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      +.+|+||||+++|+|..++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+.+.
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence            678999999999999887655 4578999999999999999999999999999999999999999999999999998765


Q ss_pred             CCC--CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHH
Q 016037          302 ENT--RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAH  377 (396)
Q Consensus       302 ~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~  377 (396)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..++..++..+ ++++|..+|++++
T Consensus       160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  239 (273)
T d1mp8a_         160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY  239 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            332  2345678999999999999999999999999999999998 99999999999999998887 5788999999999


Q ss_pred             HHHHHhhccCCCCCCCCC
Q 016037          378 SLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       378 ~li~~~l~~~p~~RPs~s  395 (396)
                      +||++||+.||.+|||++
T Consensus       240 ~li~~cl~~dp~~Rps~~  257 (273)
T d1mp8a_         240 SLMTKCWAYDPSRRPRFT  257 (273)
T ss_dssp             HHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHcCCCHhHCcCHH
Confidence            999999999999999975

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-54  Score=412.87  Aligned_cols=248  Identities=21%  Similarity=0.350  Sum_probs=217.8

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCCCcE--EEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEEEec
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEI--YAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTK  222 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~--vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~~~~  222 (396)
                      .+..++|++.++||+|+||+||+|+++.++..  ||||.++...  .....+.+.+|+++|+++ +|||||++++++.++
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   83 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   83 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence            46778999999999999999999999998875  5666664332  334556688999999998 799999999999999


Q ss_pred             CeEEEEEEecCCCcHHHHHHHh----------------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD  286 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~  286 (396)
                      +.+|+||||+++|+|.+++.+.                ..+++..++.++.||+.||.|||+++|+||||||+|||++.+
T Consensus        84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  163 (309)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred             CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence            9999999999999999998754                568999999999999999999999999999999999999999


Q ss_pred             CcEEEEecccccccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhC-
Q 016037          287 GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTG-QPPFTGGNRQKIQQKIIKD-  364 (396)
Q Consensus       287 ~~ikL~Dfgla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg-~~Pf~~~~~~~i~~~i~~~-  364 (396)
                      +.+||+|||+++............||..|+|||.+.+..++.++|||||||++|||++| .+||.+.+..++.+.+.++ 
T Consensus       164 ~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~  243 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  243 (309)
T ss_dssp             GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred             CceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence            99999999999877666666667899999999999999999999999999999999995 5689999999999998876 


Q ss_pred             CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 ~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ++++|..+++++++||++||+.||.+|||++
T Consensus       244 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~  274 (309)
T d1fvra_         244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFA  274 (309)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCccCCHHHHHHHHHHcCCChhHCcCHH
Confidence            7888999999999999999999999999975

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-54  Score=411.41  Aligned_cols=242  Identities=27%  Similarity=0.400  Sum_probs=207.0

Q ss_pred             EEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchh--hHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEEEe
Q 016037          154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK--NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (396)
Q Consensus       154 ~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (396)
                      .+++||+|+||+||+|+++.+|+.||||+++.......  ...+.+.+|+.+|++++|||||+++++|..+.++|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            57899999999999999999999999999976543221  2234578899999999999999999999999999999999


Q ss_pred             cCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Cccccc
Q 016037          232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSMC  310 (396)
Q Consensus       232 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~~~~~  310 (396)
                      +.++++..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .....+
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~  161 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV  161 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence            9999887777777889999999999999999999999999999999999999999999999999998775443 345678


Q ss_pred             cCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------------------CC-
Q 016037          311 GTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI--------------------KL-  368 (396)
Q Consensus       311 gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~--------------------~~-  368 (396)
                      ||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+.+..+...+|.+...                    .+ 
T Consensus       162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (299)
T d1ua2a_         162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP  241 (299)
T ss_dssp             CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC
T ss_pred             cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCC
Confidence            9999999999865 4689999999999999999999999999998888877764200                    00 


Q ss_pred             -------CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          369 -------PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       369 -------p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                             ...+++++.+||++||+.||.+|||++
T Consensus       242 ~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~  275 (299)
T d1ua2a_         242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT  275 (299)
T ss_dssp             CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHH
T ss_pred             CCChHHhcccCCHHHHHHHHHHccCChhhCcCHH
Confidence                   125789999999999999999999975

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=419.40  Aligned_cols=239  Identities=28%  Similarity=0.480  Sum_probs=207.5

Q ss_pred             CCCeEEEe-EecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHH-hCCCCCeeeeeEEEEe----c
Q 016037          149 LEDFEVLK-VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT-KVDHPFIVQLRYSFQT----K  222 (396)
Q Consensus       149 ~~~~~~~~-~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~-~l~HpnIv~l~~~~~~----~  222 (396)
                      .++|++++ .||+|+||+||+|+++.+++.||||++++.        ..+.+|+.++. .++|||||+++++|++    .
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~   81 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR   81 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence            57899986 599999999999999999999999999753        23567888865 5589999999999976    4


Q ss_pred             CeEEEEEEecCCCcHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC---CCcEEEEecccc
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLA  297 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~---~~~ikL~Dfgla  297 (396)
                      ..+|+|||||+||+|.+++.++  ..+++..++.++.||+.||+|||++||+||||||+|||++.   ++++||+|||+|
T Consensus        82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence            6799999999999999999875  36999999999999999999999999999999999999985   567999999999


Q ss_pred             cccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCCc---
Q 016037          298 KQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ----QKIIKDKIKLPA---  370 (396)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~----~~i~~~~~~~p~---  370 (396)
                      +...........+||+.|||||++.+..|+.++|||||||+||+|+||+.||.+.+.....    .++......+|.   
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~  241 (335)
T d2ozaa1         162 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW  241 (335)
T ss_dssp             EECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHH
T ss_pred             eeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCccc
Confidence            9887777777889999999999999999999999999999999999999999887654443    344444555653   


Q ss_pred             -cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          371 -FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       371 -~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                       .+|+++++||++||+.||.+|||+.
T Consensus       242 ~~~s~~~~~li~~~L~~dP~~R~s~~  267 (335)
T d2ozaa1         242 SEVSEEVKMLIRNLLKTEPTQRMTIT  267 (335)
T ss_dssp             HHSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHH
Confidence             6899999999999999999999864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-54  Score=405.59  Aligned_cols=249  Identities=23%  Similarity=0.351  Sum_probs=211.5

Q ss_pred             CCCCccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEE
Q 016037          141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (396)
Q Consensus       141 ~~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~  220 (396)
                      ....+.+..++|++.+.||+|+||+||+|+++.+ +.||||+++.....    .+.+.+|+.++++++|||||++++++.
T Consensus         8 ~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~   82 (285)
T d1fmka3           8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS   82 (285)
T ss_dssp             STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEe
Confidence            3445567788999999999999999999999766 46999999765432    345788999999999999999999985


Q ss_pred             ecCeEEEEEEecCCCcHHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccc
Q 016037          221 TKYRLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK  298 (396)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~  298 (396)
                      + ..+|+||||+++|+|..++..  .+.+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++
T Consensus        83 ~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~  161 (285)
T d1fmka3          83 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR  161 (285)
T ss_dssp             S-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred             c-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhh
Confidence            4 568999999999999887754  3579999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCC--CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCH
Q 016037          299 QFDENT--RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSS  374 (396)
Q Consensus       299 ~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~  374 (396)
                      ......  ......||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..++...+..+ ++++|..+++
T Consensus       162 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (285)
T d1fmka3         162 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE  241 (285)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred             hccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCH
Confidence            764333  2344678999999999999999999999999999999999 56666777788888888766 6788999999


Q ss_pred             HHHHHHHHhhccCCCCCCCCC
Q 016037          375 EAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       375 ~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ++++||++||+.||.+|||++
T Consensus       242 ~l~~li~~cl~~dP~~Rps~~  262 (285)
T d1fmka3         242 SLHDLMCQCWRKEPEERPTFE  262 (285)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHHcccCHhHCcCHH
Confidence            999999999999999999975

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-54  Score=406.18  Aligned_cols=239  Identities=29%  Similarity=0.479  Sum_probs=210.9

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhh---HHHHHHHHHHHHHhCC--CCCeeeeeEEEEecCe
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN---HAEYMKSERNILTKVD--HPFIVQLRYSFQTKYR  224 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~---~~~~~~~E~~~L~~l~--HpnIv~l~~~~~~~~~  224 (396)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++++.......   ....+.+|+.+|++++  ||||++++++|.+...
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5799999999999999999999999999999999875433211   1233567999999986  8999999999999999


Q ss_pred             EEEEEEecCC-CcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCC-CcEEEEecccccccCC
Q 016037          225 LYLVLDFVNG-GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDE  302 (396)
Q Consensus       225 ~~lV~E~~~g-g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~-~~ikL~Dfgla~~~~~  302 (396)
                      +|+||||+.+ +++..++.+++.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~  163 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD  163 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence            9999999986 5788888888999999999999999999999999999999999999999854 7999999999987644


Q ss_pred             CCCccccccCCCccchhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Q 016037          303 NTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK  381 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~~~s~~~~~li~  381 (396)
                      . .....+||+.|||||++.+..+ +.++|||||||++|||+||+.||.+.      ..+.+....++..+|+++++||+
T Consensus       164 ~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~~~~s~~~~~li~  236 (273)
T d1xwsa_         164 T-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQHLIR  236 (273)
T ss_dssp             S-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSCCCHHHHHHHH
T ss_pred             c-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCCCCCCHHHHHHHH
Confidence            3 3456789999999999987665 67799999999999999999999863      35677888999999999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      +||+.||.+|||+.
T Consensus       237 ~~L~~dp~~R~s~~  250 (273)
T d1xwsa_         237 WCLALRPSDRPTFE  250 (273)
T ss_dssp             HHTCSSGGGSCCHH
T ss_pred             HHccCCHhHCcCHH
Confidence            99999999999974

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-54  Score=404.93  Aligned_cols=248  Identities=24%  Similarity=0.380  Sum_probs=208.0

Q ss_pred             ccCCCeEEEeEecccCceEEEEEEEcCC---CcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC
Q 016037          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (396)
Q Consensus       147 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~  223 (396)
                      +..++|++++.||+|+||+||+|++..+   ...||||++.+.........+.+.+|+.+|++++||||+++++++.+ .
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~   83 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P   83 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence            5567899999999999999999987543   24689999988766666667788999999999999999999999965 4


Q ss_pred             eEEEEEEecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          224 RLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      .+++||||+++|++.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            67899999999999877654 45799999999999999999999999999999999999999999999999999998754


Q ss_pred             CCC----ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC--CCCCCccCCHH
Q 016037          303 NTR----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD--KIKLPAFLSSE  375 (396)
Q Consensus       303 ~~~----~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~--~~~~p~~~s~~  375 (396)
                      ...    .....||..|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++..++.+.  +++.|..+|++
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  243 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD  243 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHH
Confidence            432    234467889999999999999999999999999999998 89999999999999999877  45667899999


Q ss_pred             HHHHHHHhhccCCCCCCCCC
Q 016037          376 AHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       376 ~~~li~~~l~~~p~~RPs~s  395 (396)
                      +++||+.||+.||.+|||++
T Consensus       244 l~~li~~cl~~dp~~RPt~~  263 (273)
T d1u46a_         244 IYNVMVQCWAHKPEDRPTFV  263 (273)
T ss_dssp             HHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHcCCChhHCcCHH
Confidence            99999999999999999964

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-53  Score=405.51  Aligned_cols=246  Identities=20%  Similarity=0.345  Sum_probs=217.7

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~  222 (396)
                      ..++|++++.||+|+||+||+|++++     +++.||||+++...  .....+.+.+|+.+|++++||||+++++++...
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~   88 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVG   88 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence            45689999999999999999999864     56789999987643  334566789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhc------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQG------------------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKP  278 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~------------------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp  278 (396)
                      ...+++|||+++|+|.+++....                        .+++..+..++.|++.||+|||+++||||||||
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp  168 (301)
T d1lufa_          89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  168 (301)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence            99999999999999999886533                        378889999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEEecccccccCCCC---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCH
Q 016037          279 ENILLDADGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTG-QPPFTGGNR  354 (396)
Q Consensus       279 ~NILl~~~~~ikL~Dfgla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg-~~Pf~~~~~  354 (396)
                      +|||++.++++||+|||+|+......   .....+||+.|||||.+.+..|+.++|||||||+||||++| .+||.+.+.
T Consensus       169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~  248 (301)
T d1lufa_         169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  248 (301)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence            99999999999999999998764332   23456789999999999999999999999999999999997 478999999


Q ss_pred             HHHHHHHHhCC-CCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          355 QKIQQKIIKDK-IKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       355 ~~i~~~i~~~~-~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .++..++..+. +.+|..+++++.+||..||+.+|.+|||+.
T Consensus       249 ~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~  290 (301)
T d1lufa_         249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFC  290 (301)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHH
Confidence            99999998874 567889999999999999999999999974

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=399.17  Aligned_cols=242  Identities=24%  Similarity=0.412  Sum_probs=208.8

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe-cC
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-KY  223 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~-~~  223 (396)
                      |.+..++|++++.||+|+||.||+|+++  |..||||+++++.     ..+.+.+|++++++++||||+++++++.+ ..
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~   74 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   74 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence            4567889999999999999999999994  6789999997643     33557899999999999999999998854 56


Q ss_pred             eEEEEEEecCCCcHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~  301 (396)
                      .+|+||||+++|+|.+++.+++  .+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence            7899999999999999986553  58999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHH
Q 016037          302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSL  379 (396)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~~l  379 (396)
                      ..  .....+|+.|+|||++.+..++.++|||||||++|||+| |++||...+..++...+.++ ++++|..+++++++|
T Consensus       155 ~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l  232 (262)
T d1byga_         155 ST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEV  232 (262)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHH
T ss_pred             CC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence            43  334578999999999998899999999999999999998 89999999999999998875 788999999999999


Q ss_pred             HHHhhccCCCCCCCCC
Q 016037          380 LKGVNSLLSISVPLLS  395 (396)
Q Consensus       380 i~~~l~~~p~~RPs~s  395 (396)
                      |++||+.||.+|||+.
T Consensus       233 i~~cl~~dP~~Rps~~  248 (262)
T d1byga_         233 MKNCWHLDAAMRPSFL  248 (262)
T ss_dssp             HHHHTCSSGGGSCCHH
T ss_pred             HHHHcccCHhHCcCHH
Confidence            9999999999999974

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-53  Score=402.34  Aligned_cols=245  Identities=28%  Similarity=0.436  Sum_probs=207.5

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|++++.||+|+||+||+|++..+|+.||||+++..... ....+.+.+|+++|++++|||||+++++|.++.++|+||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            6899999999999999999999999999999999765422 233456788999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC-CCcc
Q 016037          230 DFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSN  307 (396)
Q Consensus       230 E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~-~~~~  307 (396)
                      ||+.++.+...... ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+..... ....
T Consensus        81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~  160 (298)
T d1gz8a_          81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  160 (298)
T ss_dssp             ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred             eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccce
Confidence            99987655444333 456999999999999999999999999999999999999999999999999999887543 3445


Q ss_pred             ccccCCCccchhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------------CC
Q 016037          308 SMCGTLEYMSPEIVLGKG-HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI------------------KL  368 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~~-~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~------------------~~  368 (396)
                      ..+||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..+...++.+...                  .+
T Consensus       161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T d1gz8a_         161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF  240 (298)
T ss_dssp             CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTS
T ss_pred             eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccccc
Confidence            668999999999987765 57899999999999999999999999887777666643200                  01


Q ss_pred             -----------CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          369 -----------PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       369 -----------p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                 ...+|.++++||++||+.||.+|||++
T Consensus       241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~  278 (298)
T d1gz8a_         241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK  278 (298)
T ss_dssp             CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHH
Confidence                       125689999999999999999999975

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-53  Score=406.51  Aligned_cols=245  Identities=23%  Similarity=0.375  Sum_probs=209.9

Q ss_pred             cCCCeEEEeEecccCceEEEEEEEcCCCc----EEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC
Q 016037          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (396)
Q Consensus       148 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~  223 (396)
                      ...+|+++++||+|+||+||+|.+..+|+    .||+|.++...  .....+.+.+|+.+|++++|||||++++++.++ 
T Consensus         7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-   83 (317)
T d1xkka_           7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   83 (317)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            34679999999999999999999988876    47777776432  233456688999999999999999999999765 


Q ss_pred             eEEEEEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      ..++++||+.+|+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+....
T Consensus        84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            567889999999998877654 6799999999999999999999999999999999999999999999999999998754


Q ss_pred             CCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHH
Q 016037          303 NTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAH  377 (396)
Q Consensus       303 ~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~i~~~i~~~-~~~~p~~~s~~~~  377 (396)
                      ...   .....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..++...+..+ +++.|..+++++.
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~  243 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY  243 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHH
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHH
Confidence            332   234468999999999999999999999999999999999 89999999888888888876 5788999999999


Q ss_pred             HHHHHhhccCCCCCCCCC
Q 016037          378 SLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       378 ~li~~~l~~~p~~RPs~s  395 (396)
                      +||++||+.||.+|||++
T Consensus       244 ~li~~cl~~dP~~RPs~~  261 (317)
T d1xkka_         244 MIMVKCWMIDADSRPKFR  261 (317)
T ss_dssp             HHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHhCCCChhhCcCHH
Confidence            999999999999999974

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-53  Score=401.77  Aligned_cols=249  Identities=20%  Similarity=0.368  Sum_probs=215.9

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEcCCC-------cEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeee
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTS-------EIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLR  216 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~  216 (396)
                      +.+..++|++.+.||+|+||.||+|++..++       ..||||+++++.  .......+.+|...+.++ +|||||+++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~   85 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL   85 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence            4567789999999999999999999987665       479999997654  233445567788888777 899999999


Q ss_pred             EEEEecCeEEEEEEecCCCcHHHHHHHhc----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 016037          217 YSFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN  280 (396)
Q Consensus       217 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~N  280 (396)
                      ++|.+...+|+||||+++|+|.+++....                .+++..++.++.||+.||.|||+++||||||||+|
T Consensus        86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N  165 (299)
T d1fgka_          86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  165 (299)
T ss_dssp             EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence            99999999999999999999999997553                48999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecccccccCCCC---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 016037          281 ILLDADGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQK  356 (396)
Q Consensus       281 ILl~~~~~ikL~Dfgla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~  356 (396)
                      ||++.++.+||+|||+++......   .....+||+.|+|||.+.+..|+.++|||||||++|||+| |..||.+.+...
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~  245 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  245 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence            999999999999999998775433   3345678999999999999999999999999999999998 899999999999


Q ss_pred             HHHHHHhC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          357 IQQKIIKD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       357 i~~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +.+.+..+ ++.+|..+++++++||++||+.||.+|||++
T Consensus       246 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~  285 (299)
T d1fgka_         246 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK  285 (299)
T ss_dssp             HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHH
Confidence            98888776 6788999999999999999999999999975

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=400.04  Aligned_cols=246  Identities=25%  Similarity=0.373  Sum_probs=208.1

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCC-CcEEEEEEeeccccchhhHHHHHHHHHHHHHhC---CCCCeeeeeEEEEe---
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGT-SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIVQLRYSFQT---  221 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l---~HpnIv~l~~~~~~---  221 (396)
                      .++|+++++||+|+||+||+|++..+ ++.||||+++........ ...+.+|+.+|+.+   +||||++++++|..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH-HHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            36899999999999999999999765 677999999765432221 22244566666554   89999999999853   


Q ss_pred             --cCeEEEEEEecCCCcHHHHHH-HhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccc
Q 016037          222 --KYRLYLVLDFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK  298 (396)
Q Consensus       222 --~~~~~lV~E~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~  298 (396)
                        ...+|++|||+.++.+..... ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence              357899999999987754443 34678999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Q 016037          299 QFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-------------  365 (396)
Q Consensus       299 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~-------------  365 (396)
                      ...........+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..+...++....             
T Consensus       165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  244 (305)
T d1blxa_         165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  244 (305)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred             hhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccccc
Confidence            8776666778899999999999999999999999999999999999999999999888877775410             


Q ss_pred             --------------CCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 --------------IKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 --------------~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                    ..++..+|+++++||++||++||.+|||++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~  288 (305)
T d1blxa_         245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY  288 (305)
T ss_dssp             SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             chhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHH
Confidence                          013456899999999999999999999964

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-52  Score=397.25  Aligned_cols=248  Identities=22%  Similarity=0.382  Sum_probs=200.3

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEEcCC-----CcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEEE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGT-----SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSF  219 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~~  219 (396)
                      .+..++|++.++||+|+||+||+|++..+     ++.||||+++....  ....+.+.+|..++.++ +|+||+.+++++
T Consensus         9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~   86 (299)
T d1ywna1           9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGAC   86 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence            35567899999999999999999998654     46899999876442  23344456676666665 789999999988


Q ss_pred             Eec-CeEEEEEEecCCCcHHHHHHHhc----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEE
Q 016037          220 QTK-YRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL  282 (396)
Q Consensus       220 ~~~-~~~~lV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NIL  282 (396)
                      .+. ..+++|||||++|+|.+++...+                .+++..+..++.||+.||.|||++|||||||||+|||
T Consensus        87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL  166 (299)
T d1ywna1          87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  166 (299)
T ss_dssp             CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence            654 56899999999999999997542                4789999999999999999999999999999999999


Q ss_pred             EcCCCcEEEEecccccccCCCC---CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHH-HH
Q 016037          283 LDADGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTG-QPPFTGGNRQ-KI  357 (396)
Q Consensus       283 l~~~~~ikL~Dfgla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg-~~Pf~~~~~~-~i  357 (396)
                      ++.++++||+|||+|+......   .....+||+.|||||++.+..++.++|||||||++|||+|| ..||.+.+.. .+
T Consensus       167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~  246 (299)
T d1ywna1         167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  246 (299)
T ss_dssp             ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999998764332   33456799999999999999999999999999999999995 6688876544 44


Q ss_pred             HHHHHhC-CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          358 QQKIIKD-KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       358 ~~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .+.+..+ ++.+|..+++++++||.+||+.||.+|||++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~  285 (299)
T d1ywna1         247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS  285 (299)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHH
Confidence            4444444 6788899999999999999999999999974

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.8e-52  Score=394.20  Aligned_cols=246  Identities=26%  Similarity=0.417  Sum_probs=211.2

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV  228 (396)
                      +++|+++++||+|+||+||+|+++ +|+.||||+++.... .....+.+.+|+.+|++++||||++++++|...+..|++
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence            368999999999999999999995 788999999977643 233456688899999999999999999999999999999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Ccc
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSN  307 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~~  307 (396)
                      ||++.++.+..+....+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++....... ...
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  158 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence            9999998888877778899999999999999999999999999999999999999999999999999998865433 345


Q ss_pred             ccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------------------
Q 016037          308 SMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---------------------  365 (396)
Q Consensus       308 ~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~---------------------  365 (396)
                      ...|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+...++....                     
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF  238 (286)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred             eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence            56789999999999764 56899999999999999999999999988877777665310                     


Q ss_pred             --------CCCCccCCHHHHHHHHHhhccCCCCCCCCCC
Q 016037          366 --------IKLPAFLSSEAHSLLKGVNSLLSISVPLLSR  396 (396)
Q Consensus       366 --------~~~p~~~s~~~~~li~~~l~~~p~~RPs~s~  396 (396)
                              ..++..+|+++.+||++||++||.+|||+++
T Consensus       239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~e  277 (286)
T d1ob3a_         239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ  277 (286)
T ss_dssp             CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHH
Confidence                    0123568999999999999999999999753

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=394.82  Aligned_cols=250  Identities=20%  Similarity=0.277  Sum_probs=221.3

Q ss_pred             CccccCCCeEEEeEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEE
Q 016037          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYS  218 (396)
Q Consensus       144 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~  218 (396)
                      .+.+..++|++.+.||+|+||+||+|.+++     ++..||||+++...  .......+.+|+.++++++||||++++++
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~   91 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV   91 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            356777899999999999999999999864     35789999997643  23445568899999999999999999999


Q ss_pred             EEecCeEEEEEEecCCCcHHHHHHHh----------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCc
Q 016037          219 FQTKYRLYLVLDFVNGGHLFFQLYRQ----------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (396)
Q Consensus       219 ~~~~~~~~lV~E~~~gg~L~~~l~~~----------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~  288 (396)
                      +.....+++||||+++|+|..++...          ..+++..+..++.|++.||.|||+++|+||||||+|||++.+++
T Consensus        92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred             EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence            99999999999999999999888654          23688889999999999999999999999999999999999999


Q ss_pred             EEEEecccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhC
Q 016037          289 VMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTG-QPPFTGGNRQKIQQKIIKD  364 (396)
Q Consensus       289 ikL~Dfgla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg-~~Pf~~~~~~~i~~~i~~~  364 (396)
                      +||+|||+++.......   ....+||+.|||||.+.+..++.++||||||+++|||+|| +.||.+.+..++...+.++
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~  251 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG  251 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Confidence            99999999987654322   3445789999999999999999999999999999999997 6899999999999988876


Q ss_pred             -CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 -KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 -~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                       ++..|..+++++++||..||+.+|.+|||++
T Consensus       252 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~  283 (308)
T d1p4oa_         252 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFL  283 (308)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCcccchHHHHHHHHHHcCCChhHCcCHH
Confidence             5677899999999999999999999999974

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=395.18  Aligned_cols=249  Identities=22%  Similarity=0.341  Sum_probs=216.6

Q ss_pred             ccccCCCeEEEeEecccCceEEEEEEEc-----CCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhC-CCCCeeeeeEE
Q 016037          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYS  218 (396)
Q Consensus       145 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l-~HpnIv~l~~~  218 (396)
                      +.+..++|++.++||+|+||.||+|++.     .+++.||||+++....  ......+.+|+.+++++ +|||||+++++
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~   95 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGA   95 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            4566789999999999999999999874     4567899999987542  33445678899999998 69999999999


Q ss_pred             EEecCeEEEEEEecCCCcHHHHHHHhc------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 016037          219 FQTKYRLYLVLDFVNGGHLFFQLYRQG------------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN  280 (396)
Q Consensus       219 ~~~~~~~~lV~E~~~gg~L~~~l~~~~------------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~N  280 (396)
                      +.++..+|+|||||++|+|..++.+..                  .+++..+..++.||+.||+|||++|++||||||+|
T Consensus        96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N  175 (311)
T d1t46a_          96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  175 (311)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence            999999999999999999999987653                  58899999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecccccccCCCCC---ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 016037          281 ILLDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQK  356 (396)
Q Consensus       281 ILl~~~~~ikL~Dfgla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~  356 (396)
                      ||++.++.+||+|||+++.......   ....+||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+...
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~  255 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999987754322   345678999999999999999999999999999999999 777787777656


Q ss_pred             HHHHHHhC--CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          357 IQQKIIKD--KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       357 i~~~i~~~--~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ...++.+.  ++..|..++.++.+||.+||+.||.+|||++
T Consensus       256 ~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~  296 (311)
T d1t46a_         256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK  296 (311)
T ss_dssp             HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHH
Confidence            55555443  5667788999999999999999999999975

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-51  Score=395.15  Aligned_cols=249  Identities=46%  Similarity=0.819  Sum_probs=218.0

Q ss_pred             cccCCCeEEEeEecccCceEEEEEEE---cCCCcEEEEEEeeccccch-hhHHHHHHHHHHHHHhCCC-CCeeeeeEEEE
Q 016037          146 CVGLEDFEVLKVVGQGAFAKVYQVRR---IGTSEIYAMKVMRKDKIME-KNHAEYMKSERNILTKVDH-PFIVQLRYSFQ  220 (396)
Q Consensus       146 ~~~~~~~~~~~~IG~G~fG~Vy~~~~---~~~~~~vAvK~i~~~~~~~-~~~~~~~~~E~~~L~~l~H-pnIv~l~~~~~  220 (396)
                      .+++++|++++.||+|+||+||+|++   +.+|+.||||++++..... ....+.+.+|+.+|++++| |||+++++++.
T Consensus        20 ~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~   99 (322)
T d1vzoa_          20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ   99 (322)
T ss_dssp             CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             ccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence            35678999999999999999999997   4478999999997654322 2234557789999999977 89999999999


Q ss_pred             ecCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccccc
Q 016037          221 TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~  300 (396)
                      +...+|++|||+.+|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus       100 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         100 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999876


Q ss_pred             CCC--CCccccccCCCccchhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCCCccC
Q 016037          301 DEN--TRSNSMCGTLEYMSPEIVLGK--GHDKAADWWSVGILLFEMLTGQPPFTGGN----RQKIQQKIIKDKIKLPAFL  372 (396)
Q Consensus       301 ~~~--~~~~~~~gt~~y~APE~l~~~--~~~~~~DvwSlGvil~elltg~~Pf~~~~----~~~i~~~i~~~~~~~p~~~  372 (396)
                      ...  .......|++.|+|||.+.+.  .++.++|||||||+||||+||+.||.+.+    ...+........+++|..+
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM  259 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence            432  334567899999999999764  46889999999999999999999998754    4455566666788899999


Q ss_pred             CHHHHHHHHHhhccCCCCCCCC
Q 016037          373 SSEAHSLLKGVNSLLSISVPLL  394 (396)
Q Consensus       373 s~~~~~li~~~l~~~p~~RPs~  394 (396)
                      |+++.+||++||++||.+|||.
T Consensus       260 s~~~~~li~~~l~~dP~~R~s~  281 (322)
T d1vzoa_         260 SALAKDLIQRLLMKDPKKRLGC  281 (322)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTS
T ss_pred             CHHHHHHHHHHcccCHHHcCCC
Confidence            9999999999999999999974

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-51  Score=391.88  Aligned_cols=246  Identities=26%  Similarity=0.338  Sum_probs=207.5

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe-------
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-------  221 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~-------  221 (396)
                      .++|+++++||+|+||+||+|+++.+|+.||||++...... +...+.+.+|+.+|++++||||+++++++..       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence            47899999999999999999999999999999999775433 3344557789999999999999999998855       


Q ss_pred             -cCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccccccc
Q 016037          222 -KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (396)
Q Consensus       222 -~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~  300 (396)
                       ...+|+||||+.++.+.........+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF  167 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence             3568999999999887766667788999999999999999999999999999999999999999999999999999876


Q ss_pred             CCC-----CCccccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----
Q 016037          301 DEN-----TRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----  370 (396)
Q Consensus       301 ~~~-----~~~~~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~p~----  370 (396)
                      ...     ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+.......+......++.    
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  247 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  247 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence            532     223456899999999999765 6899999999999999999999999998887777776553222111    


Q ss_pred             ----------------------------cCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          371 ----------------------------FLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       371 ----------------------------~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                                  ..++++.+||++||+.||.+|||++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~  300 (318)
T d3blha1         248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD  300 (318)
T ss_dssp             TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHH
Confidence                                        1378899999999999999999975

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-51  Score=395.06  Aligned_cols=238  Identities=32%  Similarity=0.462  Sum_probs=204.9

Q ss_pred             CeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe------cCe
Q 016037          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT------KYR  224 (396)
Q Consensus       151 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~------~~~  224 (396)
                      +|+.+++||+|+||+||+|+++.+|+.||||++.++..       ...+|+++|++++||||++++++|..      ..+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence            69999999999999999999999999999999977542       12469999999999999999999854      335


Q ss_pred             EEEEEEecCCCcHHHHH---HHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-cEEEEeccccccc
Q 016037          225 LYLVLDFVNGGHLFFQL---YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HVMLTDFGLAKQF  300 (396)
Q Consensus       225 ~~lV~E~~~gg~L~~~l---~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~-~ikL~Dfgla~~~  300 (396)
                      +|+||||++++.+....   .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            89999999887543332   3456799999999999999999999999999999999999999876 8999999999988


Q ss_pred             CCCCCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------------
Q 016037          301 DENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---------------  364 (396)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~---------------  364 (396)
                      .........+||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||.+.+..+...++.+.               
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~  253 (350)
T d1q5ka_         174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN  253 (350)
T ss_dssp             CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred             cCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence            77777777899999999999875 56899999999999999999999999998887777766531               


Q ss_pred             --CCCC------------CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 --KIKL------------PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 --~~~~------------p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                        ...+            ...+++++.+||++||++||.+|||+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~  298 (350)
T d1q5ka_         254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL  298 (350)
T ss_dssp             --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHH
Confidence              1111            235799999999999999999999964

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-50  Score=379.87  Aligned_cols=245  Identities=22%  Similarity=0.420  Sum_probs=214.8

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecCeEEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~~~~lV~  229 (396)
                      ++|+++++||+|+||+||+|+++.+++.||||+++.... .....+.+.+|+.+|+.++||||++++++|.....+++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            689999999999999999999999999999999987653 4456677889999999999999999999999999999999


Q ss_pred             EecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-Cccc
Q 016037          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNS  308 (396)
Q Consensus       230 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-~~~~  308 (396)
                      +++.++++..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++...... ....
T Consensus        81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~  160 (292)
T d1unla_          81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred             eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence            999999999988888999999999999999999999999999999999999999999999999999999875443 3344


Q ss_pred             cccCCCccchhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhC----------------------
Q 016037          309 MCGTLEYMSPEIVLGKG-HDKAADWWSVGILLFEMLTGQPPFT-GGNRQKIQQKIIKD----------------------  364 (396)
Q Consensus       309 ~~gt~~y~APE~l~~~~-~~~~~DvwSlGvil~elltg~~Pf~-~~~~~~i~~~i~~~----------------------  364 (396)
                      ..+++.|+|||++.+.. ++.++|||||||++|||++|+.||. +.+..+...++...                      
T Consensus       161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (292)
T d1unla_         161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP  240 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred             eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccc
Confidence            56788999999987654 6899999999999999999998854 55666666665431                      


Q ss_pred             -------CCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          365 -------KIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       365 -------~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                             ....+..+++++.+||++||+.||.+|||++
T Consensus       241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~  278 (292)
T d1unla_         241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE  278 (292)
T ss_dssp             CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             cccccchhhhccccCCHHHHHHHHHHccCChhHCcCHH
Confidence                   1123456799999999999999999999975

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=391.80  Aligned_cols=242  Identities=27%  Similarity=0.371  Sum_probs=202.8

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC-----
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----  223 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~-----  223 (396)
                      .++|+++++||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+++|+.++|||||+++++|....     
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            4689999999999999999999999999999999986543 3455667889999999999999999999997654     


Q ss_pred             -eEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          224 -RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       224 -~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                       .+|+||||+ +.+|... .+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus        96 ~~~~lv~e~~-~~~l~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKL-MKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             CCCEEEEECC-SEEHHHH-HHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ceEEEEEecc-cccHHHH-HHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence             579999999 4566554 4567899999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------------
Q 016037          303 NTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI---------------  366 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~---------------  366 (396)
                      .  ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+.....               
T Consensus       174 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (346)
T d1cm8a_         174 E--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA  251 (346)
T ss_dssp             S--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred             c--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhh
Confidence            3  345689999999999976 4568999999999999999999999999887766655543211               


Q ss_pred             ----------------CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 ----------------KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 ----------------~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                      .+...+++++.+||++||..||.+|||+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~  296 (346)
T d1cm8a_         252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG  296 (346)
T ss_dssp             HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             hhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHH
Confidence                            12346799999999999999999999974

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-49  Score=386.69  Aligned_cols=243  Identities=25%  Similarity=0.353  Sum_probs=201.5

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC----eE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY----RL  225 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~----~~  225 (396)
                      .+|++++.||+|+||+||+|+++.+|+.||||++++..  .....+.+.+|+.+|++++||||+++++++....    ..
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            46999999999999999999999999999999997644  2344566788999999999999999999996643    23


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCC-
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-  304 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~-  304 (396)
                      +++++++.+|+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++...... 
T Consensus        86 ~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  164 (345)
T ss_dssp             EEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             EEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence            444566778999988865 578999999999999999999999999999999999999999999999999998764332 


Q ss_pred             ---CccccccCCCccchhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------------
Q 016037          305 ---RSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---------------  365 (396)
Q Consensus       305 ---~~~~~~gt~~y~APE~l~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~---------------  365 (396)
                         .....+||+.|+|||++.. ..++.++||||+||++|||++|+.||.+.+.......+....               
T Consensus       165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T d1pmea_         165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK  244 (345)
T ss_dssp             BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred             cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence               2455679999999999854 567899999999999999999999999887665555543210               


Q ss_pred             -------------C---CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          366 -------------I---KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       366 -------------~---~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                   .   .+...+|+++.+||.+||+.||.+|||++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~  290 (345)
T d1pmea_         245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE  290 (345)
T ss_dssp             HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHH
Confidence                         0   11246789999999999999999999975

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=380.45  Aligned_cols=240  Identities=20%  Similarity=0.271  Sum_probs=202.2

Q ss_pred             EEeEecccCceEEEEEEEcCCC---cEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe-cCeEEEEE
Q 016037          154 VLKVVGQGAFAKVYQVRRIGTS---EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-KYRLYLVL  229 (396)
Q Consensus       154 ~~~~IG~G~fG~Vy~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~-~~~~~lV~  229 (396)
                      ..++||+|+||+||+|++..++   ..||||++++..  .....+.+.+|+++|++++||||+++++++.. +..+++||
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            3578999999999999986643   468999987532  45556778999999999999999999999765 56899999


Q ss_pred             EecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCCCC---
Q 016037          230 DFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR---  305 (396)
Q Consensus       230 E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~~~---  305 (396)
                      |||++|+|.+++... ..+.+..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++.......   
T Consensus       109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            999999999888754 4577888899999999999999999999999999999999999999999999987654322   


Q ss_pred             --ccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhC-CCCCCccCCHHHHHHHH
Q 016037          306 --SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKIIKD-KIKLPAFLSSEAHSLLK  381 (396)
Q Consensus       306 --~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~-~~~~~i~~~i~~~-~~~~p~~~s~~~~~li~  381 (396)
                        .....||+.|+|||.+.+..++.++||||||++||||+||..||.. .+..++...+..+ ++..|..+++++.+||.
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~  268 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML  268 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHH
Confidence              2335689999999999999999999999999999999997666654 4555666666665 67788999999999999


Q ss_pred             HhhccCCCCCCCCC
Q 016037          382 GVNSLLSISVPLLS  395 (396)
Q Consensus       382 ~~l~~~p~~RPs~s  395 (396)
                      +||+.||.+|||+.
T Consensus       269 ~cl~~dP~~RPs~~  282 (311)
T d1r0pa_         269 KCWHPKAEMRPSFS  282 (311)
T ss_dssp             HHTCSSGGGSCCHH
T ss_pred             HHcCCCHhHCcCHH
Confidence            99999999999974

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-50  Score=389.91  Aligned_cols=243  Identities=26%  Similarity=0.373  Sum_probs=197.5

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEe------c
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT------K  222 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~------~  222 (396)
                      .++|+++++||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|++++||||++++++|..      .
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            3689999999999999999999999999999999987653 34556678899999999999999999999954      4


Q ss_pred             CeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCC
Q 016037          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (396)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~  302 (396)
                      .++|+||||+.++.+. .+  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++....
T Consensus        95 ~~~~iv~Ey~~~~l~~-~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~  171 (355)
T d2b1pa1          95 QDVYLVMELMDANLCQ-VI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_dssp             CEEEEEEECCSEEHHH-HH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             ceeEEEEeccchHHHH-hh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence            6899999999876553 33  45789999999999999999999999999999999999999999999999999998877


Q ss_pred             CCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----------------
Q 016037          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI----------------  366 (396)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~----------------  366 (396)
                      .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+......++.....                
T Consensus       172 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  251 (355)
T d2b1pa1         172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  251 (355)
T ss_dssp             ---------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred             ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence            7777778899999999999999999999999999999999999999999887776666543211                


Q ss_pred             ------CC--------------------CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 ------KL--------------------PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 ------~~--------------------p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                            ..                    +...|+++.+||++||..||++|||++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~  306 (355)
T d2b1pa1         252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD  306 (355)
T ss_dssp             HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHH
Confidence                  00                    012477899999999999999999975

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-49  Score=376.86  Aligned_cols=241  Identities=22%  Similarity=0.312  Sum_probs=197.2

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCC-eeeeeEEEEecCeEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF-IVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~Hpn-Iv~l~~~~~~~~~~~lV  228 (396)
                      ++|++++.||+|+||+||+|++..+|+.||||++......     +.+..|+++++.++|++ |+.+.+++.+....++|
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv   81 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   81 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence            4699999999999999999999999999999998765321     23677999999998765 55566677888899999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC---CCcEEEEecccccccCCCC-
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENT-  304 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~---~~~ikL~Dfgla~~~~~~~-  304 (396)
                      |||+.++.+.......+.+++..+..++.|++.||+|||++|||||||||+|||++.   +..+||+|||+|+.+.... 
T Consensus        82 me~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          82 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             EEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence            999976555544555678999999999999999999999999999999999999864   4579999999999875432 


Q ss_pred             -------CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hCC--C---CCC
Q 016037          305 -------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII---KDK--I---KLP  369 (396)
Q Consensus       305 -------~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~---~~~--~---~~p  369 (396)
                             .....+||+.|||||++.+..++.++|||||||++|||+||+.||.+.+.......+.   ...  .   .++
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC  241 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHT
T ss_pred             ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhc
Confidence                   2345689999999999999999999999999999999999999998865544333332   111  1   234


Q ss_pred             ccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          370 AFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       370 ~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      ..+|+++.+||+.||+.+|.+||+++
T Consensus       242 ~~~p~~~~~li~~cl~~~p~~RP~~~  267 (299)
T d1ckia_         242 KGYPSEFATYLNFCRSLRFDDKPDYS  267 (299)
T ss_dssp             TTSCHHHHHHHHHHHHSCTTCCCCHH
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHH
Confidence            57999999999999999999999864

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.2e-49  Score=379.45  Aligned_cols=238  Identities=26%  Similarity=0.400  Sum_probs=201.8

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEEEe--cCeE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQT--KYRL  225 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~--~~~~  225 (396)
                      .++|+++++||+|+||+||+|+++.+|+.||||++++..      .+.+.+|+++|++++ ||||++++++|..  ...+
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            368999999999999999999999999999999997543      345778999999985 9999999999975  4579


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCC-cEEEEecccccccCCCC
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HVMLTDFGLAKQFDENT  304 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~-~ikL~Dfgla~~~~~~~  304 (396)
                      |+||||+.+++|...   .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus       108 ~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         108 ALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             EEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999999999998654   35699999999999999999999999999999999999998765 69999999999887777


Q ss_pred             CccccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHh-------------CCC---
Q 016037          305 RSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNR-QKIQQKIIK-------------DKI---  366 (396)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~-~~i~~~i~~-------------~~~---  366 (396)
                      .....+||+.|+|||.+.+. .++.++|||||||++|||++|+.||...+. ......+..             ...   
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  264 (328)
T d3bqca1         185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  264 (328)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence            77788899999999998775 479999999999999999999999986542 222222211             000   


Q ss_pred             ---------------------CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 ---------------------KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 ---------------------~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                           .....+|+++.+||++||++||.+|||++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~  314 (328)
T d3bqca1         265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR  314 (328)
T ss_dssp             GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHH
Confidence                                 01135799999999999999999999975

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.6e-48  Score=370.00  Aligned_cols=241  Identities=21%  Similarity=0.312  Sum_probs=204.1

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC-CCeeeeeEEEEecCeEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-PFIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~H-pnIv~l~~~~~~~~~~~l  227 (396)
                      .++|++.++||+|+||+||+|++..+|+.||||++.....     ...+.+|++.++.++| +||+.+++++.+....|+
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~   78 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   78 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence            3689999999999999999999999999999999865432     1235678899999975 899999999999999999


Q ss_pred             EEEecCCCcHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcC-----CCcEEEEecccccccC
Q 016037          228 VLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-----DGHVMLTDFGLAKQFD  301 (396)
Q Consensus       228 V~E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~-----~~~ikL~Dfgla~~~~  301 (396)
                      ||||+ +++|..++... ..+++..+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|+.+.
T Consensus        79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            99999 56888877665 47999999999999999999999999999999999999974     5789999999998764


Q ss_pred             CCC--------CccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCC----
Q 016037          302 ENT--------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN---RQKIQQKIIKDKI----  366 (396)
Q Consensus       302 ~~~--------~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~---~~~i~~~i~~~~~----  366 (396)
                      ...        .....+||+.|||||++.+..++.++|||||||++|||+||+.||.+.+   ......++...+.    
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  237 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence            321        2345689999999999999999999999999999999999999998643   3344444443322    


Q ss_pred             -CCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          367 -KLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       367 -~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                       .++..+++++.+||+.|++.+|++||+++
T Consensus       238 ~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~  267 (293)
T d1csna_         238 RELCAGFPEEFYKYMHYARNLAFDATPDYD  267 (293)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHCCTTCCCCHH
T ss_pred             HHhcCCCCHHHHHHHHHHhcCCcccCcCHH
Confidence             23357899999999999999999999864

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-49  Score=383.54  Aligned_cols=243  Identities=25%  Similarity=0.320  Sum_probs=205.0

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEec-----C
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----Y  223 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~-----~  223 (396)
                      .++|+++++||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+++|++++||||++++++|...     .
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            4689999999999999999999999999999999987543 334455678899999999999999999999643     3


Q ss_pred             eEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEecccccccCCC
Q 016037          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (396)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~~~~~  303 (396)
                      ..+++++++.+|+|.+++. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++..... 
T Consensus        96 ~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-  173 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-  173 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred             ceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-
Confidence            4466778888999988775 45799999999999999999999999999999999999999999999999999976543 


Q ss_pred             CCccccccCCCccchhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------------
Q 016037          304 TRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKL--------------  368 (396)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~i~~~i~~~~~~~--------------  368 (396)
                       ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+.+.....              
T Consensus       174 -~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  252 (348)
T d2gfsa1         174 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR  252 (348)
T ss_dssp             -GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHH
T ss_pred             -ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhh
Confidence             34556799999999998775 46899999999999999999999999988877777775432211              


Q ss_pred             -----------------CccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          369 -----------------PAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       369 -----------------p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                                       ...+|+++.+||++||+.||.+|||+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~  296 (348)
T d2gfsa1         253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA  296 (348)
T ss_dssp             HHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             hhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHH
Confidence                             135799999999999999999999964

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-48  Score=370.64  Aligned_cols=239  Identities=22%  Similarity=0.306  Sum_probs=192.8

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCeeeeeEEEEecC----eE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY----RL  225 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnIv~l~~~~~~~~----~~  225 (396)
                      .+|.+.+.||+|+||.||+|++  +|+.||||+++...    ......+.|+..+.+++||||+++++++.+..    .+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            4699999999999999999997  67899999987543    22222344666667889999999999997654    68


Q ss_pred             EEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH--------CCceeccCCCCCEEEcCCCcEEEEecccc
Q 016037          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA--------NGIMHRDLKPENILLDADGHVMLTDFGLA  297 (396)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~--------~~iiHrDlkp~NILl~~~~~ikL~Dfgla  297 (396)
                      |+|||||++|+|..++.+. .+++...+.++.|++.||.|||+        +||+||||||+|||++.++++||+|||++
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            9999999999999999764 68899999999999999999997        59999999999999999999999999999


Q ss_pred             cccCCCC-----CccccccCCCccchhhhcCCC------CCchhhHHHHHHHHHHHHhCCCCCCC---------------
Q 016037          298 KQFDENT-----RSNSMCGTLEYMSPEIVLGKG------HDKAADWWSVGILLFEMLTGQPPFTG---------------  351 (396)
Q Consensus       298 ~~~~~~~-----~~~~~~gt~~y~APE~l~~~~------~~~~~DvwSlGvil~elltg~~Pf~~---------------  351 (396)
                      +......     .....+||+.|||||++.+..      ++.++|||||||+||||+||..||..               
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            8774432     234568999999999997643      56789999999999999999887743               


Q ss_pred             CCHHHHHHHHHhCC--CCCCcc-----CCHHHHHHHHHhhccCCCCCCCCC
Q 016037          352 GNRQKIQQKIIKDK--IKLPAF-----LSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       352 ~~~~~i~~~i~~~~--~~~p~~-----~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      .....+...+..+.  +.+|..     ....+.+||++||+.||.+|||+.
T Consensus       236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~  286 (303)
T d1vjya_         236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL  286 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHH
T ss_pred             chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHH
Confidence            23344555554443  344443     234699999999999999999964

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.5e-43  Score=338.99  Aligned_cols=240  Identities=25%  Similarity=0.388  Sum_probs=189.9

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-----------CCCeeeeeEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-----------HPFIVQLRYS  218 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-----------HpnIv~l~~~  218 (396)
                      ++|+++++||+|+||+||+|+++.+|+.||||+++++.    ...+...+|+++++.++           |+||++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            46999999999999999999999999999999998754    23345677888888775           5789999988


Q ss_pred             EEe--cCeEEEEEEecCCCcHHHHH---HHhcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEcCCCc----
Q 016037          219 FQT--KYRLYLVLDFVNGGHLFFQL---YRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGH----  288 (396)
Q Consensus       219 ~~~--~~~~~lV~E~~~gg~L~~~l---~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDlkp~NILl~~~~~----  288 (396)
                      +..  ....+++++++..+......   .....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.    
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence            854  35667777776655433222   234578999999999999999999998 89999999999999987653    


Q ss_pred             --EEEEecccccccCCCCCccccccCCCccchhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH
Q 016037          289 --VMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ------KIQQK  360 (396)
Q Consensus       289 --ikL~Dfgla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~------~i~~~  360 (396)
                        ++++|||.+.....  .....+||+.|+|||++.+..++.++||||+||++++|++|+.||...+..      .....
T Consensus       169 ~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~  246 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  246 (362)
T ss_dssp             EEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             ceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence              99999999987543  345678999999999999999999999999999999999999999754321      11111


Q ss_pred             H------------------------------------------HhCCCCCCccCCHHHHHHHHHhhccCCCCCCCCC
Q 016037          361 I------------------------------------------IKDKIKLPAFLSSEAHSLLKGVNSLLSISVPLLS  395 (396)
Q Consensus       361 i------------------------------------------~~~~~~~p~~~s~~~~~li~~~l~~~p~~RPs~s  395 (396)
                      +                                          ......++...++++.+||.+||++||.+|||++
T Consensus       247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            1                                          1112334455688999999999999999999964

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=1.6e-26  Score=204.10  Aligned_cols=169  Identities=15%  Similarity=0.160  Sum_probs=123.5

Q ss_pred             eEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc---------------hhhHHHHHHHHHHHHHhCCCCCeeeee
Q 016037          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---------------EKNHAEYMKSERNILTKVDHPFIVQLR  216 (396)
Q Consensus       152 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~---------------~~~~~~~~~~E~~~L~~l~HpnIv~l~  216 (396)
                      +.+.++||+|+||+||+|++. +|+.||||+++.....               ..........|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            457899999999999999984 6889999998643211               011223345688899999999999887


Q ss_pred             EEEEecCeEEEEEEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEcCCCcEEEEeccc
Q 016037          217 YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGL  296 (396)
Q Consensus       217 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDlkp~NILl~~~~~ikL~Dfgl  296 (396)
                      ++..    .+++|||++++.+.       .+++..+..++.|++.+|.|||++||+||||||+|||++++ .++|+|||+
T Consensus        81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence            6532    27999999987652       24555667889999999999999999999999999999865 589999999


Q ss_pred             ccccCCCCCccccccCCCccch--hh---hcCCCCCchhhHHHHHHHHH
Q 016037          297 AKQFDENTRSNSMCGTLEYMSP--EI---VLGKGHDKAADWWSVGILLF  340 (396)
Q Consensus       297 a~~~~~~~~~~~~~gt~~y~AP--E~---l~~~~~~~~~DvwSlGvil~  340 (396)
                      |+...+....       .|...  +.   ...+.|+.++|+||+.--+.
T Consensus       149 a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         149 SVEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CEETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred             cccCCCCCcH-------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHHh
Confidence            9776433221       11111  10   12356788999999765443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.44  E-value=3.2e-07  Score=82.06  Aligned_cols=140  Identities=14%  Similarity=0.103  Sum_probs=88.6

Q ss_pred             CCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEEEecCeEEEE
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLV  228 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~~~~~~lV  228 (396)
                      +.|+..+..+-++.+.||++..  ++..+.+|+........   ...+.+|..+++.+. +=-+.+++.+...++..|+|
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv   88 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence            4677777665555678998753  55567888876543211   223566777777663 32356677778888899999


Q ss_pred             EEecCCCcHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 016037          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH-----------------------------------------  267 (396)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH-----------------------------------------  267 (396)
                      |++++|..+.......     .....++.++...+..||                                         
T Consensus        89 ~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T d1j7la_          89 MSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred             EEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence            9999998774332110     001111222222222222                                         


Q ss_pred             ------------HC------CceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          268 ------------AN------GIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       268 ------------~~------~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                                  ..      .++|+|+.|.|||+++++.+.|+||+.+..
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                        22      279999999999998776677999998854

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.09  E-value=3.6e-06  Score=80.26  Aligned_cols=81  Identities=14%  Similarity=0.188  Sum_probs=48.4

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeeccccch----hhHHHHHHHHHHHHHhCC-C-C-CeeeeeEEEEecCeEEE
Q 016037          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNILTKVD-H-P-FIVQLRYSFQTKYRLYL  227 (396)
Q Consensus       155 ~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~~E~~~L~~l~-H-p-nIv~l~~~~~~~~~~~l  227 (396)
                      .+.||.|....||++....+++.+++|.-.......    ....++...|...|+.+. + | .+.+++.+  ++...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            456999999999999987778889999764321100    011233456777777652 2 3 34455443  3445578


Q ss_pred             EEEecCCCcH
Q 016037          228 VLDFVNGGHL  237 (396)
Q Consensus       228 V~E~~~gg~L  237 (396)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.99  E-value=9.1e-06  Score=71.87  Aligned_cols=136  Identities=16%  Similarity=0.118  Sum_probs=81.4

Q ss_pred             EecccCc-eEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCC--CCeeeeeEEEEecCeEEEEEEecC
Q 016037          157 VVGQGAF-AKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH--PFIVQLRYSFQTKYRLYLVLDFVN  233 (396)
Q Consensus       157 ~IG~G~f-G~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~  233 (396)
                      .+..|.. +.||+.... ++..+.+|.......      ..+..|...|+.+..  -.+.+++.+..+++..++||++++
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~   89 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   89 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence            4455554 678988763 455688887655432      225667777776632  235667777788889999999998


Q ss_pred             CCcHHH--------------HHHHh-------cCCC--HH-HHH----HHH---------------HHHHHHHHHHHHC-
Q 016037          234 GGHLFF--------------QLYRQ-------GLFR--ED-LAR----IYT---------------AEIVSAVSHLHAN-  269 (396)
Q Consensus       234 gg~L~~--------------~l~~~-------~~l~--e~-~~~----~~~---------------~qi~~aL~~LH~~-  269 (396)
                      |.++..              .+.+-       ..+.  .. ...    .+.               ......+..+... 
T Consensus        90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  169 (255)
T d1nd4a_          90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM  169 (255)
T ss_dssp             SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred             ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence            865421              11110       0000  00 000    000               0112223444433 


Q ss_pred             ------CceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          270 ------GIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       270 ------~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                            .++|+|+.|.|||++.++.+.|+||+.+..
T Consensus       170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                  379999999999998876678999998754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.31  E-value=0.0002  Score=65.89  Aligned_cols=69  Identities=16%  Similarity=0.248  Sum_probs=43.5

Q ss_pred             ceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCCCCCe-----eee--eEEEEecCeEEEEEEecCCC
Q 016037          163 FAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI-----VQL--RYSFQTKYRLYLVLDFVNGG  235 (396)
Q Consensus       163 fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~HpnI-----v~l--~~~~~~~~~~~lV~E~~~gg  235 (396)
                      --.||++.. .+|..|++|+.+.....    .+.+..|...+..|...+|     +..  -..+...+..+.+++++.|.
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            468999877 45777999998875422    2335667777766632111     111  12334567789999999875


Q ss_pred             c
Q 016037          236 H  236 (396)
Q Consensus       236 ~  236 (396)
                      .
T Consensus       110 ~  110 (325)
T d1zyla1         110 Q  110 (325)
T ss_dssp             E
T ss_pred             C
Confidence            3

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.89  E-value=0.0011  Score=62.33  Aligned_cols=78  Identities=13%  Similarity=0.148  Sum_probs=50.9

Q ss_pred             CCeEEEeEecccCceEEEEEEEcC-------CCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-CCCeeeeeEEEEe
Q 016037          150 EDFEVLKVVGQGAFAKVYQVRRIG-------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQT  221 (396)
Q Consensus       150 ~~~~~~~~IG~G~fG~Vy~~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-HpnIv~l~~~~~~  221 (396)
                      +++++ +.|+.|-.-.+|++....       ..+.|.+++.....    .. ....+|..+++.+. +.-..++++++..
T Consensus        43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~  116 (395)
T d1nw1a_          43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TE-SHLVAESVIFTLLSERHLGPKLYGIFSG  116 (395)
T ss_dssp             GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CH-HHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred             cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----hh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence            45555 568899999999998754       24567777765321    11 22456888888774 4334467776643


Q ss_pred             cCeEEEEEEecCCCcH
Q 016037          222 KYRLYLVLDFVNGGHL  237 (396)
Q Consensus       222 ~~~~~lV~E~~~gg~L  237 (396)
                          .+|+||++|..+
T Consensus       117 ----g~I~efi~g~~l  128 (395)
T d1nw1a_         117 ----GRLEEYIPSRPL  128 (395)
T ss_dssp             ----EEEECCCCEEEC
T ss_pred             ----ceEEEEeccccC
Confidence                589999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.74  E-value=0.0067  Score=54.56  Aligned_cols=144  Identities=18%  Similarity=0.227  Sum_probs=75.3

Q ss_pred             CCCeEEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccchhhHHHHHHHHHHHHHhCC-----CCCeeeee---EEEE
Q 016037          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-----HPFIVQLR---YSFQ  220 (396)
Q Consensus       149 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~L~~l~-----HpnIv~l~---~~~~  220 (396)
                      ++...-.+.|..|.--+.|++...+ | .|++|++....  ....   +..|.+++..|.     -|..+...   ....
T Consensus        17 lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~--~~~~---l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~   89 (316)
T d2ppqa1          17 VGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKND---LPFFLGLMQHLAAKGLSCPLPLPRKDGELLGE   89 (316)
T ss_dssp             CCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCH---HHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEE
T ss_pred             CCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCC--CHHH---HHHHHHHHHhhhhccccccccceecCCCccee
Confidence            4456667778888889999988743 4 39999986532  1222   333455554442     23332221   1123


Q ss_pred             ecCeEEEEEEecCCCcHH-----H------H---HHHhc---------CCCHHHHHH---------------HHHHHHHH
Q 016037          221 TKYRLYLVLDFVNGGHLF-----F------Q---LYRQG---------LFREDLARI---------------YTAEIVSA  262 (396)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~-----~------~---l~~~~---------~l~e~~~~~---------------~~~qi~~a  262 (396)
                      .......++.++.+....     .      .   ++...         .........               +...+...
T Consensus        90 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  169 (316)
T d2ppqa1          90 LSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPE  169 (316)
T ss_dssp             ETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHH
T ss_pred             eecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHH
Confidence            345667777777664321     0      0   00000         000000000               11112222


Q ss_pred             HHHHHH-------CCceeccCCCCCEEEcCCCcEEEEecccccc
Q 016037          263 VSHLHA-------NGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (396)
Q Consensus       263 L~~LH~-------~~iiHrDlkp~NILl~~~~~ikL~Dfgla~~  299 (396)
                      ...+..       .|+||+|+.+.||+++.+...-|+||+.+..
T Consensus       170 ~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         170 IDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             HHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            223322       3799999999999999887778999999864